PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Murray, IW; Wolf, BO				Murray, Ian W.; Wolf, Blair O.			Desert Tortoise (Gopherus agassizii) Dietary Specialization Decreases across a Precipitation Gradient	PLOS ONE			English	Article							NUTRITIONAL QUALITY; ECOLOGICAL CAUSES; ATMOSPHERIC CO2; JUVENILE DESERT; NICHE WIDTH; C-4 GRASS; POPULATION; AGE; DIGESTIBILITY; CALIFORNIA	We studied the plant resource use between and within populations of desert tortoise (Gopherus agassizii) across a precipitation gradient in the Sonoran Desert of Arizona. The carbon and nitrogen stable isotope values in animal tissues are a reflection of the carbon and nitrogen isotope values in diet, and consequently represent a powerful tool to study animal feeding ecology. We measured the delta C-13 and delta N-15 values in the growth rings on the shells of tortoises in different populations to characterize dietary specialization and track tortoise use of isotopically distinct C-4/CAM versus C-3 plant resources. Plants using C-3 photosynthesis are generally more nutritious than C-4 plants and these trait differences can have important growth and fitness consequences for consumers. We found that dietary specialization decreases in successively drier and less vegetated sites, and that broader population niche widths are accompanied by an increase in the dietary variability between individuals. Our results highlight how individual consumer plant resource use is bounded under a varying regime of precipitation and plant productivity, lending insight into how intra-individual dietary specialization varies over a spatial scale of environmental variability.	[Murray, Ian W.; Wolf, Blair O.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Murray, Ian W.] Univ Witwatersrand, Brain Funct Res Grp, Sch Physiol, Fac Hlth Sci, Parktown, South Africa	University of New Mexico; University of Witwatersrand	Murray, IW (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	Ian.Murray@wits.ac.za			Arizona Game and Fish Department's Heritage Fund Program [I09003]	Arizona Game and Fish Department's Heritage Fund Program	This work was supported by the Arizona Game and Fish Department's Heritage Fund Program funded this work (I09003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, SW ENV INFORM NETWOR; Araujo MS, 2009, J ANIM ECOL, V78, P848, DOI 10.1111/j.1365-2656.2009.01546.x; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Averill-Murray RC, 2005, J HERPETOL, V39, P65, DOI 10.1670/0022-1511(2005)039[0065:REODAH]2.0.CO;2; Averill-Murray Roy C., 2002, P109; Averill-Murray Roy C., 2002, P135; BAILEY SJ, 1995, J HERPETOL, V29, P361, DOI 10.2307/1564985; Barbehenn RV, 2004, OECOLOGIA, V140, P86, DOI 10.1007/s00442-004-1572-9; Barbehenn RV, 2004, OECOLOGIA, V140, P96, DOI 10.1007/s00442-004-1555-x; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; Bulova Susan J., 1994, Herpetological Monographs, V8, P133, DOI 10.2307/1467077; Crimmins M, 2006, U ARIZONA COLL AGR L; Darimont CT, 2009, J ANIM ECOL, V78, P126, DOI 10.1111/j.1365-2656.2008.01473.x; del Rio CM, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P141; Duda JJ, 1999, J WILDLIFE MANAGE, V63, P1181, DOI 10.2307/3802836; Duffy MA, 2010, FRESHWATER BIOL, V55, P995, DOI 10.1111/j.1365-2427.2009.02336.x; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; EHLERINGER JR, 1988, OECOLOGIA, V76, P562, DOI 10.1007/BF00397870; Franks Bryan R., 2011, Endangered Species Research, V13, P191, DOI 10.3354/esr00313; Germano David J., 2002, P265; GERMANO DJ, 1994, CAN J ZOOL, V72, P918, DOI 10.1139/z94-125; GERMANO DJ, 1992, COPEIA, P367, DOI 10.2307/1446197; HANSEN R M, 1976, Herpetologica, V32, P247; Hartman G, 2011, FUNCT ECOL, V25, P122, DOI 10.1111/j.1365-2435.2010.01782.x; Hazard LC, 2009, J HERPETOL, V43, P38, DOI 10.1670/07-160R1.1; Howland JM, 1994, SONORAN DESERT TORTO; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; JUSTICE KE, 1985, OECOLOGIA, V67, P231, DOI 10.1007/BF00384290; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Martin BE, 1995, THESIS U ARIZONA TUC; Matich P, 2011, J ANIM ECOL, V80, P294, DOI 10.1111/j.1365-2656.2010.01753.x; MEIENBERGER C, 1993, PHYSIOL ZOOL, V66, P847, DOI 10.1086/physzool.66.5.30163827; Muldavin EH, 2008, OECOLOGIA, V155, P123, DOI 10.1007/s00442-007-0880-2; Murray IW, 2012, PHYSIOL BIOCHEM ZOOL, V85, P96, DOI 10.1086/663867; Nagy KA, 1998, J HERPETOL, V32, P260, DOI 10.2307/1565306; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Oftedal Olav T., 2002, Chelonian Conservation and Biology, V4, P341; Oftedal Olav T., 2002, P194; Oftedal OT, 2007, NUTR ECOLOGY SONORAN; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; POLIS GA, 1984, AM NAT, V123, P541, DOI 10.1086/284221; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; Rautenstrauch KR, 1998, J WILDLIFE MANAGE, V62, P98, DOI 10.2307/3802267; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Schoener T.W., 1986, P91; SLATKIN M, 1984, EVOLUTION, V38, P622, DOI 10.1111/j.1558-5646.1984.tb00327.x; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Thiemann GW, 2011, OIKOS, V120, P1469, DOI 10.1111/j.1600-0706.2011.19277.x; Tracy CR, 2006, INTEGR COMP BIOL, V46, P1191, DOI 10.1093/icb/icl054; Ugan A, 2011, J ARCHAEOL SCI, V38, P1417, DOI 10.1016/j.jas.2011.01.015; Van Devender Thomas R., 2002, P159; van Valen L., 1965, AM NAT, V99, P377, DOI DOI 10.1086/282379; Vander Zanden HB, 2010, BIOL LETTERS, V6, P711, DOI 10.1098/rsbl.2010.0124; Vaughn SL, 1984, THESIS ARIZONA STATE; WEBB W, 1978, ECOLOGY, V59, P1239, DOI 10.2307/1938237; Wilson DS, 1999, J HERPETOL, V33, P496, DOI 10.2307/1565652; Woodman P, 2008, DESERT TORTOISE POPU	62	12	12	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66505	10.1371/journal.pone.0066505	http://dx.doi.org/10.1371/journal.pone.0066505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840495	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400015
J	Karayannis, NV; Smeets, RJEM; van den Hoorn, W; Hodges, PW				Karayannis, Nicholas V.; Smeets, Rob J. E. M.; van den Hoorn, Wolbert; Hodges, Paul W.			Fear of Movement Is Related to Trunk Stiffness in Low Back Pain	PLOS ONE			English	Article							AVOIDANCE BELIEFS; MUSCULOSKELETAL PAIN; POSTURAL CONTROL; LUMBAR SPINE; SCALE; DISABILITY; REDUCTION; STATE	Background: Psychological features have been related to trunk muscle activation patterns in low back pain (LBP). We hypothesised higher pain-related fear would relate to changes in trunk mechanical properties, such as higher trunk stiffness. Objectives: To evaluate the relationship between trunk mechanical properties and psychological features in people with recurrent LBP. Methods: The relationship between pain-related fear (Tampa Scale for Kinesiophobia, TSK; Photograph Series of Daily Activities, PHODA-SeV; Fear Avoidance Beliefs Questionnaire, FABQ; Pain Catastrophizing Scale, PCS) and trunk mechanical properties (estimated from the response of the trunk to a sudden sagittal plane forwards or backwards perturbation by unpredictable release of a load) was explored in a case-controlled study of 14 LBP participants. Regression analysis (r(2)) tested the linear relationships between pain-related fear and trunk mechanical properties (trunk stiffness and damping). Mechanical properties were also compared with t-tests between groups based on stratification according to high/low scores based on median values for each psychological measure. Results: Fear of movement (TSK) was positively associated with trunk stiffness (but not damping) in response to a forward perturbation (r(2) = 0.33, P = 0.03), but not backward perturbation (r(2) = 0.22, P = 0.09). Other pain-related fear constructs (PHODA-SeV, FABQ, PCS) were not associated with trunk stiffness or damping. Trunk stiffness was greater for individuals with high kinesiophobia (TSK) for forward (P = 0.03) perturbations, and greater with forward perturbation for those with high fear avoidance scores (FABQ-W, P = 0.01). Conclusions: Fear of movement is positively (but weakly) associated with trunk stiffness. This provides preliminary support an interaction between biological and psychological features of LBP, suggesting this condition may be best understood if these domains are not considered in isolation.	[Karayannis, Nicholas V.; van den Hoorn, Wolbert; Hodges, Paul W.] Univ Queensland, Sch Hlth & Rehabil Sci, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Brisbane, Qld, Australia; [Smeets, Rob J. E. M.] Maastricht Univ, Res Sch CAPHRI, Dept Rehabil Med, Hoensbroek, Netherlands; [Smeets, Rob J. E. M.] Adelante Ctr Expertise Rehabil & Audiol, Hoensbroek, Netherlands	University of Queensland; Maastricht University	Hodges, PW (corresponding author), Univ Queensland, Sch Hlth & Rehabil Sci, NHMRC Ctr Clin Res Excellence Spinal Pain Injury, Brisbane, Qld, Australia.	p.hodges@uq.edu.au	Karayannis, Nicholas Vasilis/AAA-2582-2021; van den Hoorn, Wolbert/F-6894-2010; Karayannis, Nicholas Vasilis/E-3346-2010; Hodges, Paul W/B-6578-2008; Smeets, Rob JEM/D-1522-2011	van den Hoorn, Wolbert/0000-0002-9658-2388; Karayannis, Nicholas Vasilis/0000-0003-1215-750X; Hodges, Paul W/0000-0002-1206-9107; Smeets, Rob JEM/0000-0002-9503-366X	CCRE SPINE; University of Queensland International Research Tuition Award; American Academy of Orthopaedic Manual Physical Therapists - Cardon Grant Award; National Health and Medical Research Council of Australia	CCRE SPINE; University of Queensland International Research Tuition Award; American Academy of Orthopaedic Manual Physical Therapists - Cardon Grant Award; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	NK is supported by a PhD scholarship from The CCRE SPINE, The University of Queensland International Research Tuition Award and the American Academy of Orthopaedic Manual Physical Therapists - Cardon Grant Award. PH is supported by a Senior Principal Research Fellowship from the National Health and Medical Research Council of Australia. The authors have no financial or personal relationships with other people or organisations that could inappropriately bias their work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boersma K, 2006, EUR J PAIN, V10, P551, DOI 10.1016/j.ejpain.2005.08.004; Calley D, 2010, J ORTHOP SPORT PHYS, V40, P774, DOI 10.2519/jospt.2010.3381; Cholewicki J, 2000, J BIOMECH, V33, P1377, DOI 10.1016/S0021-9290(00)00118-4; den Hollander M, 2010, EXPERT REV NEUROTHER, V10, P1733, DOI [10.1586/ERN.10.115, 10.1586/ern.10.115]; Elfving B, 2007, PHYSIOTHER RES INT, V12, P14, DOI 10.1002/pri.355; Fordyce WE, 1976, CONTEMP PSYCHOL, V21, P834; GATCHEL RJ, 1999, PSYCHOSOCIAL FACTORS, P412; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; George SZ, 2010, J ORTHOP SPORT PHYS, V40, P197, DOI 10.2519/jospt.2010.3298; Hall AM, PAIN, V5, P1044; Hodges P, 2009, J BIOMECH, V42, P61, DOI 10.1016/j.jbiomech.2008.10.001; Hodges PW, 2011, PAIN, V152, pS90, DOI 10.1016/j.pain.2010.10.020; Jensen MP KP, 1992, SELF REPORT SCALES P, P193; KOPEC JA, 1995, SPINE, V20, P341, DOI 10.1097/00007632-199502000-00016; Kori SH., 1990, PAIN MANAG, V3, P35, DOI 10.1007/978-3-540-29805-2_4377; Leeuw M, 2008, PAIN, V138, P192, DOI 10.1016/j.pain.2007.12.009; Leeuw M, 2007, J PAIN, V8, P840, DOI 10.1016/j.jpain.2007.05.013; Leeuw M, 2007, J BEHAV MED, V30, P77, DOI 10.1007/s10865-006-9085-0; Linton SJ, 2011, PHYS THER, V5, P1; Moseley GL, 2006, BEHAV NEUROSCI, V120, P474, DOI 10.1037/0735-7044.120.2.474; Nicholas MK, 2008, PAIN, V134, P158, DOI 10.1016/j.pain.2007.04.007; Nicholas MK, 2011, PHYS THER, V91, P1; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Radebold A, 2001, SPINE, V26, P724, DOI 10.1097/00007632-200104010-00004; Reeves NP, 2008, EXP BRAIN RES, V188, P457, DOI 10.1007/s00221-008-1378-9; Reeves NP, 2009, J BIOMECH, V42, P164, DOI 10.1016/j.jbiomech.2008.10.016; Roelofs J, 2011, PAIN, V152, P1090, DOI 10.1016/j.pain.2011.01.028; Smeets RJEM, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-5; Smeets RJEM, 2006, J PAIN, V7, P261, DOI 10.1016/j.jpain.2005.10.011; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; TSUJI T, 1995, BIOL CYBERN, V72, P475, DOI 10.1007/BF00199890; VLAEYEN JWS, 1995, PAIN, V62, P363, DOI 10.1016/0304-3959(94)00279-N; Vlaeyen JWS, 2000, PAIN, V85, P317, DOI 10.1016/S0304-3959(99)00242-0; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Watson PJ, 1997, J MUSCULOSKELET PAIN, V5, P41, DOI 10.1300/J094v05n04_05	36	71	72	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67779	10.1371/journal.pone.0067779	http://dx.doi.org/10.1371/journal.pone.0067779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826339	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000097
J	Schildgen, V; Malecki, M; Tillmann, RL; Brockmann, M; Schildgen, O				Schildgen, Verena; Malecki, Monika; Tillmann, Ramona-Liza; Brockmann, Michael; Schildgen, Oliver			The Human Bocavirus Is Associated with Some Lung and Colorectal Cancers and Persists in Solid Tumors	PLOS ONE			English	Article							HUMAN PARVOVIRUS; HBV CCCDNA; EXPRESSION; INFECTION; VIRUSES; B19	Human bocavirus is the second autonomous human parvovirus with assumed pathogenic potential. Other parvoviruses are known to persist and even integrate into the host genome, eventually contributing to the multi-step development of cancer. Human bocavirus also persists in an unknown percentage of clinically asymptomatic patients in addition to those with primary infection. The aim of the present study was to analyze the role of Human bocavirus in lung and colorectal cancers. Therefore, formalin-fixed, paraffin-embedded, archived tumor samples were screened for Human bocavirus DNA by PCR, Southern blotting, and sequencing. Positive tissues were further subjected to fluorescence in situ hybridization analysis to specifically detect human bocavirus DNA in the infected cells. In total, 11 of the 60 (18.3%) lung and 9 of the 44 (20.5%) colorectal tumors tested positive for human bocavirus DNA by PCR and were confirmed by sequencing and fluorescence in situ hybridization analysis. Thus, human bocavirus DNA is present in the nuclei of infected cells, in either single or multiple copies, and appears to form concatemers. The occurrence of these human bocavirus DNA structures supports the existence of the postulated sigma- or rolling-hairpin replication mechanism. Moreover, the fluorescence in situ hybridization patterns inspired the hypothesis that human bocavirus DNA either persists as cccDNA or is integrated into the host genome. This finding suggests that this virus may indirectly contribute to the development of some colorectal and lung cancers, as do other DNA viruses, such as the human hepatitis B virus, or may play an active role in cancer by interacting with the host genome.	[Schildgen, Verena; Malecki, Monika; Tillmann, Ramona-Liza; Brockmann, Michael; Schildgen, Oliver] Klinikum Privaten Univ Witten Herdecke Sitz Koln, Kliniken Stadt Koln gGmbH, Inst Pathol, Cologne, Germany	University of Cologne	Schildgen, O (corresponding author), Klinikum Privaten Univ Witten Herdecke Sitz Koln, Kliniken Stadt Koln gGmbH, Inst Pathol, Cologne, Germany.	schildgeno@kliniken-koeln.de	Schildgen, Oliver/D-5327-2014	Schildgen, Oliver/0000-0003-4297-9627	Else Kroner-Fresenius Stiftung, Germany	Else Kroner-Fresenius Stiftung, Germany	This work was supported by an unrestricted research grant from the Else Kroner-Fresenius Stiftung, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson LA, 2011, THYROID, V21, P411, DOI 10.1089/thy.2010.0307; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Bourne EJ, 2007, J VIRAL HEPATITIS, V14, P55, DOI 10.1111/j.1365-2893.2006.00775.x; Carmichael L, 1999, RECENT ADV CANINE IN; Chen AY, 2010, VIROLOGY, V403, P145, DOI 10.1016/j.virol.2010.04.014; Chen Y, 2004, WORLD J GASTROENTERO, V10, P82; Hasan N, 2010, INFECT DIS CLIN N AM, V24, P1019, DOI 10.1016/j.idc.2010.07.009; Huang QF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002899; Kantola K, 2011, J INFECT DIS, V204, P1403, DOI 10.1093/infdis/jir525; Kapoor A, 2009, J INFECT DIS, V199, P196, DOI 10.1086/595831; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021362; Khamrin P, 2012, INFECT GENET EVOL, V12, P565, DOI 10.1016/j.meegid.2012.01.025; Korner RW, 2011, EMERG INFECT DIS, V17, P2303, DOI 10.3201/eid1712.110574; Kuethe F, 2009, CLIN INFECT DIS, V49, P1660, DOI 10.1086/648074; Kupfer B, 2006, EMERG INFECT DIS, V12, P1614, DOI 10.3201/eid1210.060520; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li LL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-54; Li YS, 2012, ONCOL LETT, V3, P635, DOI 10.3892/ol.2012.548; Li YF, 2007, AM J GASTROENTEROL, V102, P1489, DOI 10.1111/j.1572-0241.2007.01240.x; Liu HQ, 2011, J VIROL, V85, P9863, DOI 10.1128/JVI.00828-11; Lusebrink J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019457; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nawaz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041346; Oleksiewicz MB, 1997, J VIROL, V71, P1386, DOI 10.1128/JVI.71.2.1386-1396.1997; Op De Beeck A, 1997, Prog Cell Cycle Res, V3, P1; Polcz ME, 2013, J CLIN VIROL; Polcz ME, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.10.014; Scagliotti GV, 2009, CURR OPIN ONCOL, V21, P99, DOI 10.1097/CCO.0b013e328321049e; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Schildgen O, 2010, PEDIATR PULM, V45, P118, DOI 10.1002/ppul.21159; Schildgen V, 2012, PERS MED, V9, P801, DOI [10.2217/PME.12.94, 10.2217/pme.12.94]; Schildgen V, 2010, J VIROL METHODS, V163, P74, DOI 10.1016/j.jviromet.2009.08.024; Subramanian J, 2008, LANCET ONCOL, V9, P676, DOI 10.1016/S1470-2045(08)70174-8; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Tabata Toshiharu, 2005, Kyobu Geka, V58, P1181; Volz T, 2007, GASTROENTEROLOGY, V133, P843, DOI 10.1053/j.gastro.2007.06.057; Wang JH, 2008, BRIT J CANCER, V98, P611, DOI 10.1038/sj.bjc.6604196; Wang JH, 2010, J INFECTION, V60, P360, DOI 10.1016/j.jinf.2010.02.006; Yang Wan-zhu, 2012, Chinese Journal of Virology, V28, P418; Zhao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048980	40	41	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68020	10.1371/journal.pone.0068020	http://dx.doi.org/10.1371/journal.pone.0068020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826357	Green Submitted, gold, Green Published			2022-12-27	WOS:000321150000111
J	Lawrence, TM; Wanjalla, CN; Gomme, EA; Wirblich, C; Gatt, A; Carnero, E; Garcia-Sastre, A; Lyles, DS; McGettigan, JP; Schnell, MJ				Lawrence, Tessa M.; Wanjalla, Celestine N.; Gomme, Emily A.; Wirblich, Christoph; Gatt, Anthony; Carnero, Elena; Garcia-Sastre, Adolfo; Lyles, Douglas S.; McGettigan, James P.; Schnell, Matthias J.			Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses	PLOS ONE			English	Article							VESICULAR-STOMATITIS-VIRUS; NEWCASTLE-DISEASE-VIRUS; SERUM ANTIBODY-RESPONSES; MATRIX PROTEIN MUTANT; VACCINE VECTOR; HIV-1 VACCINE; IMMUNE-RESPONSES; DENDRITIC CELLS; STIMULATES MATURATION; RHESUS MACAQUES	This study analyzed a heterologous prime-boost vaccine approach against HIV-1 using three different antigenically unrelated negative-stranded viruses (NSV) expressing HIV-1 Gag as vaccine vectors: rabies virus (RABV), vesicular stomatitis virus (VSV) and Newcastle disease virus (NDV). We hypothesized that this approach would result in more robust cellular immune responses than those achieved with the use of any of the vaccines alone in a homologous prime-boost regimen. To this end, we primed BALB/c mice with each of the NSV-based vectors. Primed mice were rested for thirty-five days after which we administered a second immunization with the same or heterologous NSV-Gag viruses. The magnitude and quality of the Gag-specific CD8(+) T cells in response to these vectors post boost were measured. In addition, we performed challenge experiments using vaccinia virus expressing HIV-1 Gag (VV-Gag) thirty-three days after the boost inoculation. Our results showed that the choice of the vaccine used for priming was important for the detected Gag-specific CD8(+) T cell recall responses post boost and that NDV-Gag appeared to result in a more robust recall of CD8(+) T cell responses independent of the prime vaccine used. However, the different prime-boost strategies were not distinct for the parameters studied in the challenge experiments using VV-Gag but did indicate some benefits compared to single immunizations. Taken together, our data show that NSV vectors can individually stimulate HIV-Gag specific CD8(+) T cells that are effectively recalled by other NSV vectors in a heterologous prime-boost approach. These results provide evidence that RABV, VSV and NDV can be used in combination to develop vaccines needing prime-boost regimens to stimulate effective immune responses.	[Lawrence, Tessa M.; Wanjalla, Celestine N.; Gomme, Emily A.; Wirblich, Christoph; Gatt, Anthony; McGettigan, James P.; Schnell, Matthias J.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [Carnero, Elena; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY USA; [Carnero, Elena; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, New York, NY USA; [Lyles, Douglas S.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC USA; [Schnell, Matthias J.] Thomas Jefferson Univ, Jefferson Med Coll, Jefferson Vaccine Ctr, Philadelphia, PA 19107 USA	Jefferson University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Wake Forest University; Jefferson University	Schnell, MJ (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	matthias.schnell@jefferson.edu		Lyles, Douglas/0000-0002-8401-3073; Carnero, Elena/0000-0001-9828-2197; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Schnell, Matthias/0000-0001-9040-9405	National Institutes of Health [P01AI082325]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI082325] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant P01AI082325 to MJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2006, J VIROL, V80, P2194, DOI 10.1128/JVI.80.5.2194-2205.2006; Ahmed M, 2003, J VIROL, V77, P4646, DOI 10.1128/JVI.77.8.4646-4657.2003; Ahmed M, 2008, J VIROL, V82, P9273, DOI 10.1128/JVI.00915-08; Ahmed M, 2009, J VIROL, V83, P2962, DOI 10.1128/JVI.02030-08; Baba TW, 1999, NAT MED, V5, P194, DOI 10.1038/5557; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Braxton CL, 2010, J VIROL, V84, P3552, DOI 10.1128/JVI.01572-09; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Carnero E, 2009, J VIROL, V83, P584, DOI 10.1128/JVI.01443-08; CDC, 2012, EST HIV INC US S; Cooper D, 2008, J VIROL, V82, P207, DOI 10.1128/JVI.01515-07; DiNapoli JM, 2010, J VIROL, V84, P1489, DOI 10.1128/JVI.01946-09; Faber M, 2005, J GEN VIROL, V86, P1435, DOI 10.1099/vir.0.80844-0; Fauci AS, 2003, NAT MED, V9, P839, DOI 10.1038/nm0703-839; Faul EJ, 2009, VIRUSES-BASEL, V1, P832, DOI 10.3390/v1030832; Faul EJ, 2009, VACCINE, V28, P299, DOI 10.1016/j.vaccine.2009.10.051; Faul EJ, 2008, VIROLOGY, V382, P226, DOI 10.1016/j.virol.2008.09.019; FENNER F, 1982, REV INFECT DIS, V4, P916; Foley HD, 2000, P NATL ACAD SCI USA, V97, P14680, DOI 10.1073/pnas.011510698; Frahm N, 2012, J CLIN INVEST, V122, P359, DOI 10.1172/JCI60202; Gerlier D, 2011, MICROBIOL MOL BIOL R, V75, P468, DOI 10.1128/MMBR.00007-11; Girard MP, 2011, VACCINE, V29, P6191, DOI [10.1016/j.vaccine.2011.08.031, 10.1016/j.vaccine.2011.06.085]; Gomme EA, 2010, J VIROL, V84, P2820, DOI 10.1128/JVI.01870-09; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Khattar SK, 2011, J VIROL, V85, P10529, DOI 10.1128/JVI.05050-11; Khattar SK, 2010, VACCINE, V28, P3159, DOI 10.1016/j.vaccine.2010.02.051; Khattar SK, 2009, J VIROL, V83, P7779, DOI 10.1128/JVI.00536-09; Kopecky SA, 2001, J VIROL, V75, P12169, DOI 10.1128/JVI.75.24.12169-12181.2001; Kortekaas J, 2012, VACCINE, V30, P3423, DOI 10.1016/j.vaccine.2012.03.027; LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477; Learmont JC, 1999, NEW ENGL J MED, V340, P1715, DOI 10.1056/NEJM199906033402203; Liniger M, 2007, EXPERT REV VACCINES, V6, P255, DOI 10.1586/14760584.6.2.255; MARTHAS ML, 1990, J VIROL, V64, P3694, DOI 10.1128/JVI.64.8.3694-3700.1990; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McGettigan JP, 2006, VIROLOGY, V344, P363, DOI 10.1016/j.virol.2005.09.004; McGettigan JP, 2003, J VIROL, V77, P10889, DOI 10.1128/JVI.77.20.10889-10899.2003; McGettigan JP, 2003, J VIROL, V77, P237, DOI 10.1128/JVI.77.1.237-244.2003; McGettigan JP, 2001, J VIROL, V75, P4430, DOI 10.1128/JVI.75.9.4430-4434.2001; McKenna PM, 2007, J INFECT DIS, V195, P980, DOI 10.1086/512243; McKenna PM, 2003, CURR HIV RES, V1, P229, DOI 10.2174/1570162033485320; Mebatsion T, 1996, P NATL ACAD SCI USA, V93, P7310, DOI 10.1073/pnas.93.14.7310; Moore JP, 2008, SCIENCE, V320, P753, DOI 10.1126/science.1154258; Nakaya T, 2001, J VIROL, V75, P11868, DOI 10.1128/JVI.75.23.11868-11873.2001; Park MS, 2003, J VIROL, V77, P9522, DOI 10.1128/JVI.77.17.9522-9532.2003; Qiu JT, 2000, J VIROL, V74, P5997, DOI 10.1128/JVI.74.13.5997-6005.2000; Samal S, 2011, J GEN VIROL, V92, P2333, DOI 10.1099/vir.0.033399-0; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; Siler CA, 2002, VIROLOGY, V292, P24, DOI 10.1006/viro.2001.1212; Tan GS, 2005, VIROLOGY, V331, P82, DOI 10.1016/j.virol.2004.10.018; Wanjalla CN, 2010, VACCINE, V29, P130, DOI 10.1016/j.vaccine.2010.08.042; zur Megede J, 2000, J VIROL, V74, P2628, DOI 10.1128/JVI.74.6.2628-2635.2000	51	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67123	10.1371/journal.pone.0067123	http://dx.doi.org/10.1371/journal.pone.0067123			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840600	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400073
J	Liu, BR; Lo, SY; Liu, CC; Chyan, CL; Huang, YW; Aronstam, RS; Lee, HJ				Liu, Betty R.; Lo, Shih-Yen; Liu, Chia-Chin; Chyan, Chia-Lin; Huang, Yue-Wern; Aronstam, Robert S.; Lee, Han-Jung			Endocytic Trafficking of Nanoparticles Delivered by Cell-penetrating Peptides Comprised of Nona-arginine and a Penetration Accelerating Sequence	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; QUANTUM DOTS; INTRACELLULAR DELIVERY; PROTEIN TRANSDUCTION; RICH PEPTIDES; PLASMA-MEMBRANE; GENE; INTERNALIZATION; TRANSPORT; SYSTEM	Cell-penetrating peptides (CPPs) can traverse cellular membranes and deliver biologically active molecules into cells. In this study, we demonstrate that CPPs comprised of nona-arginine (R9) and a penetration accelerating peptide sequence (Pas) that facilitates escape from endocytic lysosomes, denoted as PR9, greatly enhance the delivery of noncovalently associated quantum dots (QDs) into human A549 cells. Mechanistic studies, intracellular trafficking analysis and a functional gene assay reveal that endocytosis is the main route for intracellular delivery of PR9/QD complexes. Endocytic trafficking of PR9/QD complexes was monitored using both confocal and transmission electron microscopy (TEM). Zeta-potential and size analyses indicate the importance of electrostatic forces in the interaction of PR9/QD complexes with plasma membranes. Circular dichroism (CD) spectroscopy reveals that the secondary structural elements of PR9 have similar conformations in aqueous buffer at pH 7 and 5. This study of nontoxic PR9 provides a basis for the design of optimized cargo delivery that allows escape from endocytic vesicles.	[Liu, Betty R.; Lee, Han-Jung] Natl Dong Hwa Univ, Dept Nat Resources & Environm Studies, Hualien, Taiwan; [Lo, Shih-Yen] Tzu Chi Univ, Dept Lab Med & Biotechnol, Hualien, Taiwan; [Liu, Chia-Chin] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Chyan, Chia-Lin] Natl Dong Hwa Univ, Dept Chem, Hualien, Taiwan; [Huang, Yue-Wern; Aronstam, Robert S.] Missouri Univ Sci & Technol, Dept Biol Sci, Rolla, MO USA	National Dong Hwa University; Tzu Chi University; Tzu Chi University; National Dong Hwa University; University of Missouri System; Missouri University of Science & Technology	Lee, HJ (corresponding author), Natl Dong Hwa Univ, Dept Nat Resources & Environm Studies, Hualien, Taiwan.	hjlee@mail.ndhu.edu.tw	Liu, Betty Revon/GLU-3300-2022	Liu, Betty Revon/0000-0002-5152-8687	National Science Council of Taiwan [NSC 101-2811-B-259-001, NSC 101-2320-B-259-002-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Postdoctoral Fellowship NSC 101-2811-B-259-001 (to BRL) and the Grant Number NSC 101-2320-B-259-002-MY3 from the National Science Council of Taiwan (HJL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk Z, 2011, ADV COLLOID INTERFAC, V168, P3, DOI 10.1016/j.cis.2011.04.002; [Anonymous], 2013, ADV STUD BIOL; Chan M. H., 2013, PHARM NANOTECHNOL, V1, P151; Chang JC, 2009, BIOMATERIALS, V30, P1937, DOI 10.1016/j.biomaterials.2008.12.039; Chang M, 2007, NEW PHYTOL, V174, P46, DOI 10.1111/j.1469-8137.2007.01977.x; Chen FQ, 2004, NANO LETT, V4, P1827, DOI 10.1021/nl049170q; Chen YJ, 2012, GENE, V493, P201, DOI 10.1016/j.gene.2011.11.060; Choi Y, 2011, BIOCONJUGATE CHEM, V22, P1576, DOI 10.1021/bc200126k; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Dai YH, 2011, GENE, V489, P89, DOI 10.1016/j.gene.2011.08.011; Delehanty JB, 2009, ANAL BIOANAL CHEM, V393, P1091, DOI 10.1007/s00216-008-2410-4; Depalo N, 2008, J COLLOID INTERF SCI, V325, P558, DOI 10.1016/j.jcis.2008.06.018; Doane TL, 2012, ACCOUNTS CHEM RES, V45, P317, DOI 10.1021/ar200113c; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Fonseca SB, 2009, ADV DRUG DELIVER REV, V61, P953, DOI 10.1016/j.addr.2009.06.001; Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808; Gautam A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas015; Gauthier NC, 2005, MOL BIOL CELL, V16, P4852, DOI 10.1091/mbc.E05-05-0398; Gauthier NC, 2007, J CELL BIOL, V177, P343, DOI 10.1083/jcb.200609061; Hirose H, 2012, MOL THER, V20, P984, DOI 10.1038/mt.2011.313; Hu JW, 2009, PEPTIDES, V30, P1669, DOI 10.1016/j.peptides.2009.06.006; Huang Yue-Wern, 2013, Methods Mol Biol, V991, P249, DOI 10.1007/978-1-62703-336-7_23; Irene D, 2013, J BIOMOL STRUCT DYN, V31, P414, DOI 10.1080/07391102.2012.703069; Iversen TG, 2011, NANO TODAY, V6, P176, DOI 10.1016/j.nantod.2011.02.003; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Koren E, 2012, TRENDS MOL MED, V18, P385, DOI 10.1016/j.molmed.2012.04.012; Koshman YE, 2008, J MOL CELL CARDIOL, V45, P853, DOI 10.1016/j.yjmcc.2008.08.006; Kosuge M, 2008, BIOCONJUGATE CHEM, V19, P656, DOI 10.1021/bc700289w; Lee CY, 2011, BIOMATERIALS, V32, P6264, DOI 10.1016/j.biomaterials.2011.05.012; Lei Y, 2008, BIOCONJUGATE CHEM, V19, P421, DOI 10.1021/bc0700685; Liou JS, 2012, PEPTIDES, V37, P273, DOI 10.1016/j.peptides.2012.07.019; Liu BR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064205; Liu BR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-57; Liu BR, 2011, BIOMATERIALS, V32, P3520, DOI 10.1016/j.biomaterials.2011.01.041; Liu BR, 2010, J NANOSCI NANOTECHNO, V10, P7897, DOI 10.1166/jnn.2010.3012; Liu BR, 2010, J NANOSCI NANOTECHNO, V10, P6534, DOI 10.1166/jnn.2010.2637; Liu BR, 2013, MAR BIOTECHNOL, V15, P584, DOI 10.1007/s10126-013-9509-0; Liu BR, 2012, GENE, V505, P37, DOI 10.1016/j.gene.2012.05.053; LIU MJ, 2013, ADV STUD BIOL, V5, P71; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Mattoussi H, 2012, ADV DRUG DELIVER REV, V64, P138, DOI 10.1016/j.addr.2011.09.011; MEGO JL, 1971, BIOCHEM J, V122, P445, DOI 10.1042/bj1220445; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Nakase I, 2010, BIOPOLYMERS, V94, P763, DOI 10.1002/bip.21487; Padari K, 2011, METHODS MOL BIOL, V683, P181, DOI 10.1007/978-1-60761-919-2_13; Perevedentseva E, 2011, LANGMUIR, V27, P1085, DOI 10.1021/la103155c; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; Raagel H, 2010, BBA-BIOMEMBRANES, V1798, P2240, DOI 10.1016/j.bbamem.2010.02.013; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Shu SJ, 2009, CARBOHYD RES, V344, P1197, DOI 10.1016/j.carres.2009.04.018; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Takayama K, 2012, MOL PHARMACEUT, V9, P1222, DOI 10.1021/mp200518n; Takayama K, 2009, J CONTROL RELEASE, V138, P128, DOI 10.1016/j.jconrel.2009.05.019; Takechi Y, 2011, LANGMUIR, V27, P7099, DOI 10.1021/la200917y; Ueda Y, 2012, BIOMATERIALS, V33, P9061, DOI 10.1016/j.biomaterials.2012.09.003; van den Berg A, 2011, CURR OPIN BIOTECH, V22, P888, DOI 10.1016/j.copbio.2011.03.008; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Wagstaff KM, 2006, CURR MED CHEM, V13, P1371, DOI 10.2174/092986706776872871; Walrant A, 2011, BBA-BIOMEMBRANES, V1808, P382, DOI 10.1016/j.bbamem.2010.09.009; Wang YH, 2006, BIOCHEM BIOPH RES CO, V346, P758, DOI 10.1016/j.bbrc.2006.05.205; Webster A, 2005, ANALYST, V130, P163, DOI 10.1039/b413725f; Wei YF, 2009, BIOCONJUGATE CHEM, V20, P1752, DOI 10.1021/bc8003777; Xu Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/948543; Xue FL, 2007, J FLUORESC, V17, P149, DOI 10.1007/s10895-006-0152-2; Yang S, 2009, J CONTROL RELEASE, V135, P159, DOI 10.1016/j.jconrel.2008.12.015; Yasuda Y, 1999, J BIOCHEM-TOKYO, V125, P1137, DOI 10.1093/oxfordjournals.jbchem.a022396; Yukawa H, 2010, BIOMATERIALS, V31, P4094, DOI 10.1016/j.biomaterials.2010.01.134	69	50	56	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67100	10.1371/journal.pone.0067100	http://dx.doi.org/10.1371/journal.pone.0067100			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840594	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400071
J	Watterson, DM; Grum-Tokars, VL; Roy, SM; Schavocky, JP; Bradaric, BD; Bachstetter, AD; Xing, B; Dimayuga, E; Saeed, F; Zhang, H; Staniszewski, A; Pelletier, JC; Minasov, G; Anderson, WF; Arancio, O; Van Eldik, LJ				Watterson, D. Martin; Grum-Tokars, Valerie L.; Roy, Saktimayee M.; Schavocky, James P.; Bradaric, Brinda Desai; Bachstetter, Adam D.; Xing, Bin; Dimayuga, Edgardo; Saeed, Faisal; Zhang, Hong; Staniszewski, Agnieszka; Pelletier, Jeffrey C.; Minasov, George; Anderson, Wayne F.; Arancio, Ottavio; Van Eldik, Linda J.			Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic Dysfunction	PLOS ONE			English	Article							CYTOKINE UP-REGULATION; ALZHEIMERS-DISEASE; BEHAVIORAL DEFICITS; P38-ALPHA MAPK; MOUSE MODEL; INHIBITORS; POTENT; ACTIVATION; DISCOVERY; BINDING	Serine-threonine protein kinases are critical to CNS function, yet there is a dearth of highly selective, CNS-active kinase inhibitors for in vivo investigations. Further, prevailing assumptions raise concerns about whether single kinase inhibitors can show in vivo efficacy for CNS pathologies, and debates over viable approaches to the development of safe and efficacious kinase inhibitors are unsettled. It is critical, therefore, that these scientific challenges be addressed in order to test hypotheses about protein kinases in neuropathology progression and the potential for in vivo modulation of their catalytic activity. Identification of molecular targets whose in vivo modulation can attenuate synaptic dysfunction would provide a foundation for future disease-modifying therapeutic development as well as insight into cellular mechanisms. Clinical and preclinical studies suggest a critical link between synaptic dysfunction in neurodegenerative disorders and the activation of p38 alpha MAPK mediated signaling cascades. Activation in both neurons and glia also offers the unusual potential to generate enhanced responses through targeting a single kinase in two distinct cell types involved in pathology progression. However, target validation has been limited by lack of highly selective inhibitors amenable to in vivo use in the CNS. Therefore, we employed high-resolution co-crystallography and pharmacoinformatics to design and develop a novel synthetic, active site targeted, CNS-active, p38 alpha MAPK inhibitor (MW108). Selectivity was demonstrated by large-scale kinome screens, functional GPCR agonist and antagonist analyses of off-target potential, and evaluation of cellular target engagement. In vitro and in vivo assays demonstrated that MW108 ameliorates beta-amyloid induced synaptic and cognitive dysfunction. A serendipitous discovery during co-crystallographic analyses revised prevailing models about active site targeting of inhibitors, providing insights that will facilitate future kinase inhibitor design. Overall, our studies deliver highly selective in vivo probes appropriate for CNS investigations and demonstrate that modulation of p38 alpha MAPK activity can attenuate synaptic dysfunction.	[Watterson, D. Martin; Grum-Tokars, Valerie L.; Roy, Saktimayee M.; Schavocky, James P.; Bradaric, Brinda Desai; Pelletier, Jeffrey C.; Minasov, George; Anderson, Wayne F.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Bachstetter, Adam D.; Xing, Bin; Dimayuga, Edgardo; Van Eldik, Linda J.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Saeed, Faisal; Zhang, Hong; Staniszewski, Agnieszka; Arancio, Ottavio] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	Northwestern University; University of Kentucky; Columbia University	Watterson, DM (corresponding author), Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA.	d.m.watterson@gmail.com	arancio, ottavio/AAB-7959-2019	Watterson, Daniel/0000-0001-7605-5866; Bradaric, Brinda/0000-0002-3830-7927; arancio, ottavio/0000-0001-6335-164X; Minasov, George/0000-0001-5460-3462; Saeed, Faisal/0000-0003-1194-2792; Bachstetter, Adam/0000-0003-4646-6757	Thome Memorial Foundation; Alzheimer's Association Zenith award; National Institutes of Health [R01 NS064247, R01 NS056051, R01 AG031311, F32 AG037280, U01AG043415]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047586, R01NS064247, R01NS056051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031311, U01AG043415, F32AG037280] Funding Source: NIH RePORTER	Thome Memorial Foundation; Alzheimer's Association Zenith award(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by funds from the Thome Memorial Foundation (LVE), an Alzheimer's Association Zenith award (LVE) and National Institutes of Health grants R01 NS064247 (LVE), R01 NS056051 (DMW), R01 AG031311 (DMW), F32 AG037280 (ADB), U01AG043415 (DMW, JCP, & OA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVDEEF A, 1993, ANAL CHEM, V65, P42, DOI 10.1021/ac00049a010; Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; Bachstetter AD, 2010, AGING DIS, V1, P199; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Chico LK, 2009, NAT REV DRUG DISCOV, V8, P892, DOI 10.1038/nrd2999; Chico LK, 2009, DRUG METAB DISPOS, V37, P2204, DOI 10.1124/dmd.109.028134; Clark Andrew R, 2012, Open Rheumatol J, V6, P209, DOI 10.2174/1874312901206010209; Correa SA, 2012, J SIGNAL TRANSDUCTIO; Craft JM, 2004, NEUROBIOL AGING, V25, P1283, DOI 10.1016/j.neurobiolaging.2004.01.006; Craft JM, 2004, J MOL NEUROSCI, V24, P115, DOI 10.1385/JMN:24:1:115; Devadas B, 2011, BIOORG MED CHEM LETT, V21, P3856, DOI 10.1016/j.bmcl.2011.05.006; Duffy JP, 2011, ACS MED CHEM LETT, V2, P758, DOI 10.1021/ml2001455; Eastwood P, 2011, BIOORG MED CHEM LETT, V21, P4130, DOI 10.1016/j.bmcl.2011.05.114; Fabbro D, 2012, METHODS MOL BIOL, V795, P1, DOI 10.1007/978-1-61779-337-0_1; Fiorito J, 2013, EUR J MED CHEM, V60, P285, DOI 10.1016/j.ejmech.2012.12.009; Fitzgerald CE, 2003, NAT STRUCT BIOL, V10, P764, DOI 10.1038/nsb949; Garuti L, 2010, CURR MED CHEM, V17, P2804, DOI 10.2174/092986710791859333; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gong YS, 2010, AM J ALZHEIMERS DIS, V25, P547, DOI 10.1177/1533317510382893; Hu WH, 2007, BIOORG MED CHEM LETT, V17, P414, DOI 10.1016/j.bmcl.2006.10.028; Jerome KD, 2010, BIOORG MED CHEM LETT, V20, P469, DOI 10.1016/j.bmcl.2009.11.114; Kusakabe K, 2012, ACS MED CHEM LETT, V3, P560, DOI 10.1021/ml3000879; Lamba V, 2012, CURR PHARM DESIGN, V18, P2936, DOI 10.2174/138161212800672813; Lumeras W, 2011, J MED CHEM, V54, P7899, DOI 10.1021/jm200975u; Lumeras W, 2009, J MED CHEM, V52, P5531, DOI 10.1021/jm9008604; Martz KE, 2012, J MED CHEM, V55, P7862, DOI 10.1021/jm300951u; McNamara LK, 2009, ACTA CRYSTALLOGR D, V65, P241, DOI 10.1107/S0907444908043679; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Natarajan SR, 2006, BIOORG MED CHEM LETT, V16, P5809, DOI 10.1016/j.bmcl.2006.08.074; O'Keefe SJ, 2007, J BIOL CHEM, V282, P34663, DOI 10.1074/jbc.M704236200; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Patel SB, 2009, ACTA CRYSTALLOGR D, V65, P777, DOI 10.1107/S090744490901600X; Pettus LH, 2010, J MED CHEM, V53, P2973, DOI 10.1021/jm100095x; Picconi B, 2012, ADV EXP MED BIOL, V970, P553, DOI 10.1007/978-3-7091-0932-8_24; Puzzo D, 2005, J NEUROSCI, V25, P6887, DOI 10.1523/JNEUROSCI.5291-04.2005; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Sabat M, 2006, BIOORG MED CHEM LETT, V16, P4360, DOI 10.1016/j.bmcl.2006.05.050; Scapin G, 2006, CURR DRUG TARGETS, V7, P1443, DOI 10.2174/1389450110607011443; Selness SR, 2009, BIOORG MED CHEM LETT, V19, P5851, DOI 10.1016/j.bmcl.2009.08.082; Shanware NP, 2009, BMB REP, V42, P142, DOI 10.5483/BMBRep.2009.42.3.142; Teich AF, 2012, BIOCHEM J, V446, P165, DOI 10.1042/BJ20120653; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Ul-Haq Z, 2012, J MOL GRAPH MODEL, V36, P48, DOI 10.1016/j.jmgm.2012.02.003; Verkaar F, 2011, CHEM BIOL, V18, P485, DOI 10.1016/j.chembiol.2011.01.015; Vitolo O, 2009, NEUROBIOL AGING, V30, P257, DOI 10.1016/j.neurobiolaging.2007.05.025; Wermuth CG, 2008, PRACTICE OF MEDICINAL CHEMISTRY, 3RD EDITION, P1; Wermuth CG, 2006, DRUG DISCOV TODAY, V11, P348, DOI 10.1016/j.drudis.2006.02.006; Xing L, 2009, BIOCHEMISTRY-US, V48, P6402, DOI 10.1021/bi900655f	50	56	59	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66226	10.1371/journal.pone.0066226	http://dx.doi.org/10.1371/journal.pone.0066226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840427	Green Submitted, gold, Green Published			2022-12-27	WOS:000321424400022
J	Zhang, SH; Wang, CJ; Shi, L; Li, XH; Zhou, J; Song, LB; Liao, WT				Zhang, Shi-Hong; Wang, Chan-Juan; Shi, Ling; Li, Xing-Hua; Zhou, Jing; Song, Li-Bing; Liao, Wen-Ting			High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma	PLOS ONE			English	Article							REGGIE/FLOTILLIN PROTEINS; CANCER PROGRESSION; ALPHA-FETOPROTEIN; BREAST-CANCER; UP-REGULATION; CELLS; REGGIE-1; MICRODOMAINS; DIAGNOSIS; GENES	Background: The flotillin family member flotillin-1 (FLOT1) encodes a caveolae-associated, integral membrane protein that belongs to lipid raft family and involves in vesicular trafficking and signal transduction. However, the role of FLOT1 in development and progression of cancer remains largely unknown. The present study was aimed to investigate the clinical and prognostic significance of FLOT1 in hepatocellular carcinoma (HCC). Methods: Real-time PCR and western blot analyses were applied to examine FLOT1 expression in fourteen HCC cell lines and one normal hepatic cell line, ten pairs of primary HCC and matched adjacent noncancerous liver tissues from the same patient. Immunohistochemistry (IHC) was performed to examine FLOT1 protein expression in paraffin-embedded tissues from 196 HCC patients. Statistical analyses were applied to evaluate the diagnostic value and associations of FLOT1 expression with clinical parameters. Results: FLOT1 expression was evidently up-regulated in HCC tissues compared with that in the matched adjacent noncancerous liver tissues. In the 196 cases of tested HCC samples, FLOT1 protein level was positively correlated with Tumor size (P = 0.025), clinical stage (P<0.002), CLIP stage (P<0.001), vascular invasion (P<0.001), relapse (P<0.001), and serum AFP levels (P = 0.025). Patients with higher FLOT1 expression had shorter overall survival time, whereas those with lower FLOT1 expression had longer survival time. Conclusions: Our study demonstrated FLOT1 is associated with aggressive characteristics of HCC, and suggested the possibility of its use as a prognostic marker in patients with HCC.	[Zhou, Jing; Liao, Wen-Ting] Southern Med Univ, Nanfang Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Wang, Chan-Juan; Shi, Ling; Li, Xing-Hua; Song, Li-Bing] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Shi-Hong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Lab Med, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Jing; Liao, Wen-Ting] Southern Med Univ, Sch Basic Med Sci, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Southern Medical University - China	Song, LB (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China.	lb.song1@gmail.com; liaowt2002@gmail.com	Song, LB/AAL-1968-2020		Natural Science Foundation of China [30901791, 81172055]; National Program on Key Basic Research Project (973 Program) [2012CB519003]; Guangdong Provincial Natural Science Foundation of China [S2012010009643]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province)	This study was supported by: the Natural Science Foundation of China (No. 30901791, 81172055), National Program on Key Basic Research Project (973 Program, No. 2012CB519003), and Guangdong Provincial Natural Science Foundation of China (No. S2012010009643). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; Banning A, 2011, CURR PROTEIN PEPT SC, V12, P725, DOI 10.2174/138920311798841708; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chalasani N, 1999, AM J GASTROENTEROL, V94, P2988, DOI 10.1016/S0002-9270(99)00504-3; Colombo M, 1998, DIGESTION, V59, P70, DOI 10.1159/000051428; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Hazarika P, 2004, CANCER RES, V64, P7361, DOI 10.1158/0008-5472.CAN-04-0823; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Li J, 2008, CLIN CANCER RES, V14, P3319, DOI 10.1158/1078-0432.CCR-07-4054; Liao WT, 2011, CLIN CANCER RES, V17, P3569, DOI 10.1158/1078-0432.CCR-10-2533; Lin CY, 2011, CLIN CANCER RES, V17, P3089, DOI 10.1158/1078-0432.CCR-10-3068; OKA H, 1994, HEPATOLOGY, V19, P61, DOI 10.1016/0270-9139(94)90053-1; Patra SK, 2007, ONCOL REP, V17, P1279; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Pust S., 2012, ONCOGENE; Schulte T, 1997, DEVELOPMENT, V124, P577; Severi T, 2010, ACTA PHARMACOL SIN, V31, P1409, DOI 10.1038/aps.2010.142; Song LB, 2012, GASTROENTEROLOGY, V143, P995, DOI 10.1053/j.gastro.2012.06.033; Soresi M, 2003, ANTICANCER RES, V23, P1747; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Stuermer CAO, 2001, MOL BIOL CELL, V12, P3031, DOI 10.1091/mbc.12.10.3031; Thorn CC, 2009, GUT, V58, P404, DOI 10.1136/gut.2008.157255; Vassilieva EV, 2009, BIOCHEM BIOPH RES CO, V379, P460, DOI 10.1016/j.bbrc.2008.12.118; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	31	33	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e64709	10.1371/journal.pone.0064709	http://dx.doi.org/10.1371/journal.pone.0064709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840303	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400003
J	Teng, IF; Wilson, SA				Teng, I-Fang; Wilson, Stuart A.			Mapping Interactions between mRNA Export Factors in Living Cells	PLOS ONE			English	Article							NUCLEAR SPECKLES; TREX COMPLEX; NXF1; RECRUITMENT; PROTEINS; DYNAMICS; DOMAINS	The TREX complex couples nuclear mRNA processing events with subsequent export to the cytoplasm. TREX also acts as a binding platform for the mRNA export receptor Nxf1. The sites of mRNA transcription and processing within the nucleus have been studied extensively. However, little is known about where TREX assembly takes place and where Nxf1 is recruited to TREX to form the export competent mRNP. Here we have used sensitized emission Forster resonance energy transfer (FRET) and fluorescence lifetime imaging (FLIM)-FRET, to produce a spatial map in living cells of the sites for the interaction of two TREX subunits, Alyref and Chtop, with Nxf1. Prominent assembly sites for export factors are found in the vicinity of nuclear speckles in regions known to be involved in transcription, splicing and exon junction complex formation highlighting the close coupling of mRNA export with mRNP biogenesis.	[Teng, I-Fang; Wilson, Stuart A.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Wilson, SA (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, 5th Court,Western Bank, Sheffield S10 2TN, S Yorkshire, England.	stuart.wilson@sheffield.ac.uk		wilson, stuart/0000-0003-3073-258X	Biotechnology and Biological Sciences Research Council [BB/J015067/1]; BBSRC [BB/J015067/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding provided by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk), grant number: BB/J015067/1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker W, 2012, J MICROSC-OXFORD, V247, P119, DOI 10.1111/j.1365-2818.2012.03618.x; Chang CT, 2013, EMBO J, V32, P473, DOI 10.1038/emboj.2012.342; Cmarko D, 1999, MOL BIOL CELL, V10, P211, DOI 10.1091/mbc.10.1.211; Coyle JH, 2011, RNA, V17, P1344, DOI 10.1261/rna.2616111; Daguenet E, 2012, MOL BIOL CELL, V23, P1765, DOI 10.1091/mbc.E12-01-0040; Dias AP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1103; Dufu K, 2010, GENE DEV, V24, P2043, DOI 10.1101/gad.1898610; Fakan Stanislav, 1994, Trends in Cell Biology, V4, P86, DOI 10.1016/0962-8924(94)90180-5; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Hall LL, 2006, ANAT REC PART A, V288A, P664, DOI 10.1002/ar.a.20336; Hautbergue GM, 2009, CURR BIOL, V19, P1918, DOI 10.1016/j.cub.2009.09.041; Hung ML, 2010, NUCLEIC ACIDS RES, V38, P3351, DOI 10.1093/nar/gkq033; Johnson SA, 2009, MOL CELL, V33, P215, DOI 10.1016/j.molcel.2008.12.007; Katahira J, 2009, EMBO J, V28, P556, DOI 10.1038/emboj.2009.5; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Li YP, 2005, MOL CELL BIOL, V25, P4023, DOI 10.1128/MCB.25.10.4023-4033.2005; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Reed R, 2002, CELL, V108, P523, DOI 10.1016/S0092-8674(02)00627-X; Schmidt U, 2006, J CELL BIOL, V172, P373, DOI 10.1083/jcb.200503061; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; van Dijk TB, 2010, MOL CELL BIOL, V30, P260, DOI 10.1128/MCB.00645-09; Vinciguerra P, 2005, EMBO J, V24, P813, DOI 10.1038/sj.emboj.7600527; Viphakone N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2005; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Zhao R, 2009, CURR OPIN GENET DEV, V19, P172, DOI 10.1016/j.gde.2009.02.007; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	29	14	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67676	10.1371/journal.pone.0067676	http://dx.doi.org/10.1371/journal.pone.0067676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826332	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000321738400165
J	De Brito, SA; Viding, E; Kumari, V; Blackwood, N; Hodgins, S				De Brito, Stephane A.; Viding, Essi; Kumari, Veena; Blackwood, Nigel; Hodgins, Sheilagh			Cool and Hot Executive Function Impairments in Violent Offenders with Antisocial Personality Disorder with and without Psychopathy	PLOS ONE			English	Article							LIFE-COURSE-PERSISTENT; FRONTAL-LOBE; NEUROPSYCHOLOGICAL MEASURES; CRIMINAL PSYCHOPATHS; PREFRONTAL CORTEX; RESPONSE REVERSAL; BEHAVIOR; DEFICITS; INDIVIDUALS; AMYGDALA	Background: Impairments in executive function characterize offenders with antisocial personality disorder (ASPD) and offenders with psychopathy. However, the extent to which those impairments are associated with ASPD, psychopathy, or both is unknown. Methods: The present study examined 17 violent offenders with ASPD and psychopathy (ASPD+P), 28 violent offenders with ASPD without psychopathy (ASPD-P), and 21 healthy non-offenders on tasks assessing cool (verbal working memory and alteration of motor responses to spatial locations) and hot (reversal learning, decision-making under risk, and stimulus-reinforcement-based decision-making) executive function. Results: In comparison to healthy non-offenders, violent offenders with ASPD+P and those with ASPD-P showed similar impairments in verbal working memory and adaptive decision-making. They failed to learn from punishment cues, to change their behaviour in the face of changing contingencies, and made poorer quality decisions despite longer periods of deliberation. Intriguingly, the two groups of offenders did not differ significantly from the non-offenders in terms of their alteration of motor responses to spatial locations and their levels of risk-taking, indicated by betting, and impulsivity, measured as delay aversion. The performance of the two groups of offenders on the measures of cool and hot executive function did not differ, indicating shared deficits. Conclusions: These documented impairments may help to explain the persistence of antisocial behaviours despite the known risks of the negative consequences of such behaviours.	[De Brito, Stephane A.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Viding, Essi] UCL, Div Psychol & Language Sci, London, England; [Kumari, Veena] Kings Coll London, Inst Psychiat, Dept Psychol, London, England; [Blackwood, Nigel; Hodgins, Sheilagh] Kings Coll London, Inst Psychiat, Dept Forens & Neurodev Sci, London, England; [Hodgins, Sheilagh] Univ Montreal, Dept Psychiat, Montreal, PQ H3C 3J7, Canada	University of Birmingham; University of London; University College London; University of London; King's College London; University of London; King's College London; Universite de Montreal	De Brito, SA (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	s.a.debrito@bham.ac.uk	De Brito, Stephane/AAY-1551-2020; Kumari, Veena/C-6842-2009	De Brito, Stephane/0000-0002-9082-6185; Viding, Essi/0000-0001-8468-8874; Blackwood, Nigel/0000-0002-5909-203X; Hodgins, Sheilagh/0000-0002-3436-7121; Kumari, Veena/0000-0002-9635-5505	Department of Health; Ministry of Justice (DSPD); NIHR Biomedical Research Centre, South London; Maudsley NHS Foundation Trust; Institute of Psychiatry (King's College London); MRC; Swiss National Science Foundation [FNS PA00P1_139586]; ESRC [RES-062-23-2202]	Department of Health; Ministry of Justice (DSPD); NIHR Biomedical Research Centre, South London; Maudsley NHS Foundation Trust; Institute of Psychiatry (King's College London)(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This research was funded by research grants from the Department of Health (the National Forensic Mental Health R&D programme), the Ministry of Justice (a DSPD programme grant), the NIHR Biomedical Research Centre, South London, Maudsley NHS Foundation Trust, and Institute of Psychiatry (King's College London). SDB was supported by an MRC Ph.D. studentship and a research fellowship from the Swiss National Science Foundation (FNS PA00P1_139586), EV is supported by ESRC (RES-062-23-2202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Andrews DA, 2010, PSYCHOL PUBLIC POL L, V16, P39, DOI 10.1037/a0018362; [Anonymous], 2007, PSYCHOPATH THEORY RE; [Anonymous], 2009, AM J PSYCHIAT; Barkataki I, 2005, SCHIZOPHR RES, V74, P1, DOI 10.1016/j.schres.2004.08.001; Barker ED, 2007, ARCH GEN PSYCHIAT, V64, P592, DOI 10.1001/archpsyc.64.5.592; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; Blair KS, 2006, NEUROPSYCHOLOGY, V20, P153, DOI 10.1037/0894-4105.20.2.153; Blair R., 2005, PSYCHOPATH EMOTION B; Blair RJR, 2007, TRENDS COGN SCI, V11, P387, DOI 10.1016/j.tics.2007.07.003; Blair RJR, 2004, PERS INDIV DIFFER, V37, P1179, DOI 10.1016/j.paid.2003.12.001; Budhani S, 2006, J ABNORM PSYCHOL, V115, P552, DOI 10.1037/0021-843X.115.3.552; Cardinal R., 2006, ANOVA BEHAV SCI RES, DOI [10.4324/9780203763933, DOI 10.4324/9780203763933]; Cooke DJ, 1999, J ABNORM PSYCHOL, V108, P58, DOI 10.1037/0021-843X.108.1.58; Craig MC, 2009, MOL PSYCHIATR, V14, P946, DOI 10.1038/mp.2009.40; Crowell Timothy A, 2003, Cogn Behav Neurol, V16, P100, DOI 10.1097/00146965-200306000-00003; De Brito S. A., 2009, PERSONALITY PERSONAL, P133; Deckel AW, 1996, J CLIN PSYCHOL, V52, P639; Dolan M, 2012, PSYCHOL MED, V42, P1715, DOI 10.1017/S0033291711002686; Dolan M, 2002, PSYCHOL MED, V32, P417, DOI 10.1017/S0033291702005378; Dolan M, 2006, PSYCHOL MED, V36, P1563, DOI 10.1017/S0033291706008634; Dolan MC, 2009, BIOL PSYCHIAT, V66, P570, DOI 10.1016/j.biopsych.2009.03.019; Duggan C, 2008, PHILOS T R SOC B, V363, P2599, DOI 10.1098/rstb.2008.0025; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; First M.B., 2016, STRUCTURED CLIN INTE; Frick PJ, 2009, DEV PSYCHOPATHOL, V21, P1111, DOI 10.1017/S0954579409990071; Giancola PR, 1998, J ABNORM PSYCHOL, V107, P629, DOI 10.1037/0021-843X.107.4.629; Giancola PR, 1995, AGGRESSIVE BEHAV, V21, P431, DOI 10.1002/1098-2337(1995)21:6<431::AID-AB2480210604>3.0.CO;2-Q; GILLEN R, 1992, ALCOHOL CLIN EXP RES, V16, P206, DOI 10.1111/j.1530-0277.1992.tb01365.x; GORENSTEIN EE, 1982, J ABNORM PSYCHOL, V91, P368, DOI 10.1037/0021-843X.91.5.368; Gregory S, 2012, ARCH GEN PSYCHIAT, V69, P962, DOI 10.1001/archgenpsychiatry.2012.222; Hare R.D, 2003, MANUAL REVISED PSYCH, V2nd; HARE RD, 1984, J ABNORM PSYCHOL, V93, P133, DOI 10.1037/0021-843X.93.2.133; HARE RD, 1984, INT J LAW PSYCHIAT, V7, P35, DOI 10.1016/0160-2527(84)90005-0; HARE RD, 1991, J ABNORM PSYCHOL, V100, P391, DOI 10.1037/0021-843X.100.3.391; Hare Robert D, 2005, Curr Psychiatry Rep, V7, P57, DOI 10.1007/s11920-005-0026-3; Hart S.D., 1995, MANUAL HARE PSYCHOPA; HART SD, 1990, J ABNORM PSYCHOL, V99, P374, DOI 10.1037/0021-843X.99.4.374; Hodgins S., 1999, CRIM BEHAV MENT HEAL, V9, P57, DOI DOI 10.1002/CBM.291; HOFFMAN JJ, 1987, J ABNORM PSYCHOL, V96, P158, DOI 10.1037/0021-843X.96.2.158; Howell D. C., 2007, FUNDAMENTAL STAT BEH; Ishikawa SS, 2001, J ABNORM PSYCHOL, V110, P423, DOI 10.1037/0021-843X.110.3.423; Kelly AMC, 2007, THE HANDBOOK OF ATTE; Kessler RC, 1996, AM J ORTHOPSYCHIAT, V66, P17, DOI 10.1037/h0080151; Koenigs M, 2010, NEUROPSYCHOLOGIA, V48, P2198, DOI 10.1016/j.neuropsychologia.2010.04.012; Kosson DS, 2006, J ABNORM PSYCHOL, V115, P798, DOI 10.1037/0021-843X.115.4.798; LAPIERRE D, 1995, NEUROPSYCHOLOGIA, V33, P139, DOI 10.1016/0028-3932(94)00110-B; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; Marsh AA, 2008, AM J PSYCHIAT, V165, P712, DOI 10.1176/appi.ajp.2007.07071145; Mazas CA, 2000, ALCOHOL CLIN EXP RES, V24, P1036, DOI 10.1111/j.1530-0277.2000.tb04647.x; Miller LA, 2008, J NEUROPSYCH CLIN N, V20, P261, DOI 10.1176/appi.neuropsych.20.3.261; Mitchell DGV, 2006, NEUROPSYCHOLOGY, V20, P280, DOI 10.1037/0894-4105.20.3.280; Mitchell DGV, 2006, NEUROCASE, V12, P164, DOI 10.1080/13554790600611288; Mitchell DGV, 2002, NEUROPSYCHOLOGIA, V40, P2013, DOI 10.1016/S0028-3932(02)00056-8; Moffitt TE, 2002, DEV PSYCHOPATHOL, V14, P179, DOI 10.1017/S0954579402001104; MOFFITT TE, 1993, DEV PSYCHOPATHOL, V5, P135, DOI 10.1017/S0954579400004302; Motzkin JC, 2011, J NEUROSCI, V31, P17348, DOI 10.1523/JNEUROSCI.4215-11.2011; NEWMAN JP, 1986, J ABNORM PSYCHOL, V95, P252, DOI 10.1037/0021-843X.95.3.252; NEWMAN JP, 1992, J ABNORM PSYCHOL, V101, P630, DOI 10.1037/0021-843X.101.4.630; NEWMAN JP, 1987, J ABNORM PSYCHOL, V96, P145, DOI 10.1037/0021-843X.96.2.145; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Ogloff J.R., 1990, BEHAVIORAL SCI LAW, V8, P181, DOI [DOI 10.1002/BSL.2370080210, 10.1002/bsl.2370080210]; Olver ME, 2011, PSYCHOL CRIME LAW, V17, P457, DOI 10.1080/10683160903318876; Rahman S, 1999, BRAIN, V122, P1469, DOI 10.1093/brain/122.8.1469; Raine A, 2005, J ABNORM PSYCHOL, V114, P38, DOI 10.1037/0021-843X.114.1.38; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Roiser JP, 2009, BIPOLAR DISORD, V11, P178, DOI 10.1111/j.1399-5618.2009.00669.x; Ross EH, 2010, CRIM JUSTICE BEHAV, V37, P656, DOI 10.1177/0093854810363104; Rubia K, 2011, BIOL PSYCHIAT, V69, pE69, DOI 10.1016/j.biopsych.2010.09.023; Seguin JR, 2007, CAMB HANDB PSYCHOL, P187; SEGUIN JR, 1995, J ABNORM PSYCHOL, V104, P614, DOI 10.1037/0021-843X.104.4.614; SMITH SS, 1992, PERS INDIV DIFFER, V13, P1233, DOI 10.1016/0191-8869(92)90259-R; Stevens MC, 2003, ADDICT BEHAV, V28, P285, DOI 10.1016/S0306-4603(01)00232-5; Sundram F, 2012, CORTEX, V48, P216, DOI 10.1016/j.cortex.2011.06.005; SUTKER PB, 1987, J ABNORM PSYCHOL, V96, P73, DOI 10.1037/0021-843X.96.1.73; Swann AC, 2009, J PSYCHIATR RES, V43, P1057, DOI 10.1016/j.jpsychires.2009.03.003; Van Hauwaert SM, 2018, EUR J POLIT RES, V57, P68, DOI 10.1111/1475-6765.12216; Verona E, 2012, J ABNORM PSYCHOL, V121, P498, DOI 10.1037/a0025308; Wechsler D., 1997, WECHSLER ADULT INTEL; Wong S., 1985, CRIMINAL I BEHAV PSY; Zelazo P., 2007, HDB EMOTION REGULATI, P135, DOI DOI 10.1177/1545968309354536; Zelazo P. D., 2002, HDB CHILDHOOD COGNIT, P445, DOI [10.1002/9780470996652.ch20, DOI 10.1002/9780470996652.CH20]	83	63	63	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65566	10.1371/journal.pone.0065566	http://dx.doi.org/10.1371/journal.pone.0065566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190LY	23840340	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800013
J	Zaidner, Y				Zaidner, Yossi			Adaptive Flexibility of Oldowan Hominins: Secondary Use of Flakes at Bizat Ruhama, Israel	PLOS ONE			English	Article							WEST TURKANA; OLDUVAI GORGE; SITE; ASSEMBLAGES; INDUSTRY; LOKALALEI; SKILLS; TOOLS	The lithic assemblage of the Early Pleistocene site of Bizat Ruhama, Israel demonstrates the earliest evidence for systematic secondary knapping of flakes. The site, dated to the Matuyama chron, is one of the earliest primary context Oldowan occurrences in Eurasia. According to the experimental replication of the stone-tool production sequence, the secondary knapping of flakes was a part of a multi-stage operational sequence targeted at the production of small (<2 cm) flakes. This sequence included four stages: acquisition of chert pebbles, production of flakes, deliberate selection of flakes of specific morphologies, and their secondary knapping by free-hand or bipolar methods. The results suggest that flakes with retouch-like scars that were produced during this sequence and which commonly are interpreted as shaped tools are unintentional waste products of the small flake production. The intentional manufacture of very small flakes at Bizat Ruhama was probably an economic response to the raw material constrains. Systematic secondary knapping of flakes has not yet been reported from other Early Pleistocene sites. Systematic secondary knapping for small flake production became increasingly important only in the lithic industries of the second half of the Middle Pleistocene, almost a million years later. The results from Bizat Ruhama indicate that Oldowan stone-tool production sequence was conceptually more complex than previously suggested and offer a new perspective on the capabilities for invention and the adaptive flexibility of the Oldowan hominins.	[Zaidner, Yossi] Univ Haifa, Zinman Inst Archaeol, IL-31999 Haifa, Mountt Carmel, Israel; [Zaidner, Yossi] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel	University of Haifa; Hebrew University of Jerusalem	Zaidner, Y (corresponding author), Univ Haifa, Zinman Inst Archaeol, IL-31999 Haifa, Mountt Carmel, Israel.	yzaidner@research.haifa.ac.il		Zaidner, Yossi/0000-0002-4247-4824	Research Authority, University of Haifa, Israel; L.S.B. Leakey Foundation	Research Authority, University of Haifa, Israel; L.S.B. Leakey Foundation	This study is a part of the author PhD dissertation funded by the Research Authority, University of Haifa, Israel. The 2004-05 excavation seasons at Bizat Ruhama were generously funded by the L.S.B. Leakey Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton N., 1992, HIGH LODGE EXCAVATIO, P124; Ashton N., 2007, TOOLS VERSUS CORES A, P1; Bar-Yosef O, 1993, LITHIC ASSEMBLAGES U; Barham L, 1987, S AFRICAN ARCH B, V42, P45, DOI DOI 10.2307/3887773; Barsky D, 2011, J AFR ARCHAEOL, V9, P207, DOI 10.3213/2191-5784-10196; Barsky D, 2010, QUATERN INT, V223, P201, DOI 10.1016/j.quaint.2009.12.004; Barsky D, 2010, QUATERN INT, V223, P71, DOI 10.1016/j.quaint.2009.12.005; Barsky D, 2009, VERTEBR PALEOBIOL PA, P39, DOI 10.1007/978-1-4020-9060-8_4; Bergman CA, 1987, HUMAN USES FLINT CHE, P21; Beyene Y, 2013, P NATL ACAD SCI USA, V110, P1584, DOI 10.1073/pnas.1221285110; Bordes F, 1953, B S P F, VL, P224; Braun DR, 2008, J HUM EVOL, V55, P1053, DOI 10.1016/j.jhevol.2008.05.020; Chavaillon J., 2004, STUDIES EARLY PALEOL, P437; COTTERELL B, 1987, AM ANTIQUITY, V52, P675, DOI 10.2307/281378; Crabtree D. E., 1972, OCCASIONAL PAPERS ID, V28; Crovetto C., 1994, HUMAN EVOLUTION, V9, P175; de la Torre I, 2004, CURR ANTHROPOL, V45, P439, DOI 10.1086/422079; de la Torre I., 2009, PENINJ RES PROJECT H, P145; Delagnes A, 2005, J HUM EVOL, V48, P435, DOI 10.1016/j.jhevol.2004.12.005; Delarue R, 1958, B SOC PREHISTORIQUE, VLI, P29; DELATORRE I, 2005, ETUDES RECHERCHES AR, P112; Dibble H.L., 2007, TOOLS VERSUS CORES N, P75; Dibble HL, 2006, CURR ANTHROPOL, V47, P777, DOI 10.1086/506282; Diez-Martin F, 2010, QUATERNARY RES, V74, P376, DOI 10.1016/j.yqres.2010.07.019; Diez-Martin F, 2011, AM ANTIQUITY, V76, P690, DOI 10.7183/0002-7316.76.4.690; Diez-Martin F, 2009, J ANTHROPOL ARCHAEOL, V28, P274, DOI 10.1016/j.jaa.2009.03.001; Flenniken J. J., 1981, REPLICATIVE SYSTEMS; Gao X., 2000, ARCHAEOL ETHNOL ANTH, V3, P2; Goren-Inbar N, 2002, P NATL ACAD SCI USA, V99, P2455, DOI 10.1073/pnas.032570499; Goren-Inbar N., 1988, LITHIC TECHNOL, V17, P37, DOI [10.1080/01977261.1988.11754524, DOI 10.1080/01977261.1988.11754524]; Goren-Inbar N, 2011, PHILOS T R SOC B, V366, P1038, DOI 10.1098/rstb.2010.0365; Harmand S, 2009, VERTEBR PALEOBIOL PA, P85, DOI 10.1007/978-1-4020-9060-8_8; HARRIS JWK, 1987, J HUM EVOL, V16, P701, DOI 10.1016/0047-2484(87)90020-0; Hovers E., 2009, CUTTING EDGE NEW APP, P137; Hovers E., 2007, CORES TOOLS IDENTIFI, P42, DOI DOI 10.1016/J.JENVRAD.2007.03.002; Hovers E, 2012, DEV QUATER SCI, V16, P51, DOI 10.1016/B978-0-444-53821-5.00005-1; HOWELL FC, 1987, J HUM EVOL, V16, P665; Isaac G. L., 1997, KOOBI FORA RES PROJE, V5, P1; Isaac G.L., 1986, STONE AGE PREHISTORY, P221; Isaac G.Ll., 1997, KOOBI RES PROJECT, P262; Jeske R.J., 1993, MIDCONT J ARCHAEOL, V18, P131; Kobayashi H., 1975, LITHIC TECHNOLOGY MA, P115, DOI DOI 10.1515/9783111390376; Kuijt I., 1995, LITHIC TECHNOL, V20, P116; Kuman K., 2009, CUTTING EDGE NEW APP, P151; Laukhin S., 2001, PALEORIENT, V207, P69, DOI DOI 10.3406/PALE0.2001.4720; Leakey M. D., 1971, OLDUVAI GORGE EXCAVA; Lemorini C., 2010, ANTIQUITY, V84, P325; Longo L, 1997, ANTHROPOLOGIE, V101, P579; Ludwig B.V., 1998, EARLY HUMAN BEHAV GL, P84; MACE A, 1959, P PREHIST SOC, V25, P233, DOI 10.1017/S0079497X00016558; Malinsky-Buller A., 2011, FARMING, P1, DOI [10.3828/bfarm.2011.1.3, DOI 10.3828/BFARM.2011.1.3]; Mallol C, 2011, GEOARCHAEOLOGY, V26, P118, DOI 10.1002/gea.20339; Martinez K, 2010, P NATL ACAD SCI USA, V107, P5762, DOI 10.1073/pnas.0913856107; Martinez-Navarro B, 2012, QUATERN INT, V267, P78, DOI 10.1016/j.quaint.2012.02.041; Merrick H.V., 1976, EARLIEST MAN ENV LAK, P574; Mourre V., 1996, DEBITAGE ENCLUME PAL; Mussi M, 1995, EARLIEST OCCUPATION, P263; Newcomer M, 1972, THESIS U LONDON LOND; Newcomer M.H., 1976, STARINGIA, P62; Ohel MY, 1976, TEL AVIV, V3, P49; Pei WC, 1939, PRELIMINARY STUDY NE; Peretto C., 1994, IND LITTICHE GIACIME; Piperno M, 2009, VERTEBR PALEOBIOL PA, P111, DOI 10.1007/978-1-4020-9060-8_10; Roche H, 1999, NATURE, V399, P57, DOI 10.1038/19959; Roche H, 2005, STONE KNAPPING NECES, P35; Ronen A., 1998, ARCHAEOLOGISCHES KOR, V28, P163; Sahnouni M, 2002, J HUM EVOL, V43, P925, DOI 10.1006/jhev.2002.0608; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; Semaw S., 2006, OLDOWAN CASE STUDIES, P43; Semaw S, 2009, SOURCEBOOK OF PALEOLITHIC TRANSITIONS, P173, DOI 10.1007/978-0-387-76487-0_10; Sharon G., 2007, BAR INT SERIES; Texier P.-J., 1995, EVOLUCION HUMANA EUR, V2, P403; TOTH N, 1985, J ARCHAEOL SCI, V12, P101, DOI 10.1016/0305-4403(85)90056-1; TOTH N, 1987, J HUM EVOL, V16, P763, DOI 10.1016/0047-2484(87)90023-6; Toth N., 1997, KOOBI FORA RES PROJE, V5, P363; Van Riet Lowe P. C, 1946, S AFR J SCI, VXLII, P240; Verges JM, 2011, J ARCHAEOL SCI, V38, P1016, DOI 10.1016/j.jas.2010.11.016; Yeshurun R, 2011, J HUM EVOL, V60, P492, DOI 10.1016/j.jhevol.2010.01.008; Zaidner Y, 2003, ANTHROPOLOGIE, V107, P203, DOI 10.1016/S0003-5521(03)00010-4; Zaidner Y, 2011, LOWER MIDDLE PALAEOL, P13; Zaidner Y, 2010, THESIS U HAIFA ISRAE; Zaidner Y., 2003, OXFORD BAR INT SERIE, V1115, P121; Zaidner Yossi, 2010, Paleoanthropology, V2010, P162	83	51	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e668513	10.1371/journal.pone.0066851	http://dx.doi.org/10.1371/journal.pone.0066851			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	190LY	23840539	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800105
J	Brummelman, E; Thomaes, S; Slagt, M; Overbeek, G; de Castro, BO; Bushman, BJ				Brummelman, Eddie; Thomaes, Sander; Slagt, Meike; Overbeek, Geertjan; de Castro, Bram Orobio; Bushman, Brad J.			My Child Redeems My Broken Dreams: On Parents Transferring Their Unfulfilled Ambitions onto Their Child	PLOS ONE			English	Article							SELF; ENMESHMENT; CLOSENESS	From the early days of psychology, theorists have observed that parents sometimes transfer their own unfulfilled ambitions onto their child. We propose that parents are especially inclined to do so when they see their child as part of themselves, more so than as a separate individual. When parents see their child as part of themselves, their child's achievements may easily come to function as a surrogate for parents' own unfulfilled ambitions. In the present experiment, 73 parents (89% women, M-age = 43 years) were randomly assigned to reflect on either their own or others' unfulfilled ambitions. Results showed that, when faced with their own unfulfilled ambitions, parents who see their child as part of themselves want their child to fulfill their unfulfilled ambitions. This study provides the first experimental evidence to suggest that parents may desire their child to redeem their broken dreams.	[Brummelman, Eddie; Thomaes, Sander; Slagt, Meike; Overbeek, Geertjan; de Castro, Bram Orobio] Univ Utrecht, Dept Psychol, Utrecht, Netherlands; [Thomaes, Sander] Univ Southampton, Sch Psychol, Southampton, Hants, England; [Bushman, Brad J.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Bushman, Brad J.] Vrije Univ Amsterdam, Dept Commun Sci, Amsterdam, Netherlands	Utrecht University; University of Southampton; University System of Ohio; Ohio State University; Vrije Universiteit Amsterdam	Brummelman, E (corresponding author), Univ Utrecht, Dept Psychol, Utrecht, Netherlands.	e.brummelman@uu.nl	Brummelman, Eddie/S-9035-2016; Bushman, Brad/AAN-6427-2021; Bushman, Brad/ABG-3412-2021; De Castro, Bram Orobio/A-8942-2008	Brummelman, Eddie/0000-0001-7695-5135; Bushman, Brad/0000-0002-1266-5101; De Castro, Bram Orobio/0000-0001-5110-6153	Netherlands Organization for Scientific Research [431-09-022]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This study was supported by a grant from The Netherlands Organization for Scientific Research (431-09-022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Allport GW, 1943, PSYCHOL REV, V50, P451, DOI 10.1037/h0055375; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Aron A., 2004, EUR REV SOC PSYCHOL, V15, P101, DOI [10.1080/10463280440000008, DOI 10.1080/10463280440000008]; Aron A., 1986, NEW PSYCHOL LOVE; Association of Universities in the Netherlands, 2012, NETH COD COND SCI PR; Baumeister R. F., 1991, MEANINGS LIFE; Beike DR, 2009, PERS SOC PSYCHOL B, V35, P385, DOI 10.1177/0146167208328329; BELK RW, 1988, J CONSUM RES, V15, P139, DOI 10.1086/209154; Cialdini RB, 1997, J PERS SOC PSYCHOL, V73, P481, DOI 10.1037/0022-3514.73.3.481; CIALDINI RB, 1976, J PERS SOC PSYCHOL, V34, P366, DOI 10.1037//0022-3514.34.3.366; Collins W.A., 2002, HDB PARENTING, P73; Cross SE, 1997, PSYCHOL BULL, V122, P5, DOI 10.1037/0033-2909.122.1.5; Cwir D, 2011, J EXP SOC PSYCHOL, V47, P661, DOI 10.1016/j.jesp.2011.01.009; Freud S, 1914, STANDARD EDITION COM, V7, P69; Gardner WL, 2002, J PERS SOC PSYCHOL, V82, P239, DOI 10.1037//0022-3514.82.2.239; Gollwitzer P., 1986, PUBLIC SELF PRIVATE, P143, DOI DOI 10.1007/978-1-4613-9564-5_7; Gollwitzer P.M., 1998, MOTIVATION SELF REGU, P389, DOI DOI 10.1017/CBO9780511527869.017; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Green RJ, 1996, FAM PROCESS, V35, P115, DOI 10.1111/j.1545-5300.1996.00115.x; Grolnick WS, 2007, DEV PSYCHOL, V43, P991, DOI 10.1037/0012-1649.43.4.991; James W, 1890, PRINCIPLES PSYCHOL, V1; Jung CG, 1925, BASIC WRITINGS CG JU, V17, P187; Manzi C, 2006, J MARRIAGE FAM, V68, P673, DOI 10.1111/j.1741-3737.2006.00282.x; McFarland C, 2001, SOC COGNITION, V19, P547, DOI 10.1521/soco.19.5.547.19911; Miller A., 1981, PRISONERS CHILDHOOD; Miller A., 1997, DRAMA GIFTED CHILD S; Nelson SK, 2013, PSYCHOL SCI, V24, P3, DOI 10.1177/0956797612447798; PRELINGER E, 1959, J PSYCHOL, V47, P13, DOI 10.1080/00223980.1959.9916303; Steinberg L., 2002, HDB PARENTING CHILDR, P103, DOI DOI 10.4324/9781410612137; TESSER A, 1980, J PERS SOC PSYCHOL, V39, P77, DOI 10.1037/0022-3514.39.1.77; Tesser A., 1988, ADV EXP SOC PSYCHOL, V21, P181, DOI 10.1016/S0065-2601(08)60227-0; Weinhold B. K., 2008, BREAKING FREE CODEPE; Wicklund R., 1982, SYMBOLIC SELF COMPLE; Wisman A, 2005, J PERS SOC PSYCHOL, V89, P46, DOI 10.1037/0022-3514.89.1.46; Zeelenberg M, 2007, J CONSUM PSYCHOL, V17, P3, DOI 10.1207/s15327663jcp1701_3	36	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65360	10.1371/journal.pone.0065360	http://dx.doi.org/10.1371/journal.pone.0065360			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190ST	23840325	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200014
J	Farr, C; Nomellini, JF; Ailon, E; Shanina, I; Sangsari, S; Cavacini, LA; Smit, J; Horwitz, MS				Farr, Christina; Nomellini, John F.; Ailon, Evan; Shanina, Iryna; Sangsari, Sassan; Cavacini, Lisa A.; Smit, John; Horwitz, Marc S.			Development of an HIV-1 Microbicide Based on Caulobacter crescentus: Blocking Infection by High-Density Display of Virus Entry Inhibitors	PLOS ONE			English	Article							S-LAYER PROTEIN; C-TERMINAL SECRETION; CYANOVIRIN-N; INACTIVATING PROTEIN; LACTOBACILLUS-JENSENII; SUBTYPE DISTRIBUTION; SURFACE-LAYER; FRESH-WATER; I SECRETION; FUSION	The HIV/AIDS pandemic remains an enormous global health concern. Despite effective prevention options, 2.6 million new infections occur annually, with women in developing countries accounting for more than half of these infections. New prevention strategies that can be used by women are urgently needed. Topical microbicides specific for HIV-1 represent a promising prevention strategy. Conceptually, using harmless bacteria to display peptides or proteins capable of blocking entry provides an inexpensive approach to microbicide development. To avoid the potential pitfalls of engineering commensal bacteria, our strategy is to genetically display infection inhibitors on a non-native bacterium and rely on topical application of stabilized bacteria before potential virus exposure. Due to the high density cell-surface display capabilities and the inherent low toxicity of the bacterium, the S-layer mediated protein display capabilities of the non-pathogenic bacterium Caulobacter crescentus has been exploited for this approach. We have demonstrated that C. crescentus displaying MIP1 alpha or CD4 interfered with the virus entry pathway and provided significant protection from HIV-1 pseudovirus representing clade B in a standard single cycle infection assay. Here we have expanded our C. crescentus based microbicide approach with additional and diverse classes of natural and synthetic inhibitors of the HIV-1 entry pathway. All display constructs provided variable but significant protection from HIV-1 infection; some with protection as high as 70%. Further, we describe protection from infection with additional viral clades. These findings indicate the significant potential for engineering C. crescentus to be an effective and readily adaptable HIV-1 microbicide platform.	[Farr, Christina; Nomellini, John F.; Ailon, Evan; Shanina, Iryna; Sangsari, Sassan; Smit, John; Horwitz, Marc S.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Cavacini, Lisa A.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	University of British Columbia; Harvard University; Beth Israel Deaconess Medical Center	Horwitz, MS (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada.	mhorwitz@mail.ubc.ca	Farr, Christina/ABG-2688-2021		Canadian Institute for Health Research	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Canadian Institute for Health Research. The funders had no role in study design, data collection and analysis. decision to publish, or preparation of the manuscript.	Awram P, 1998, J BACTERIOL, V180, P3062, DOI 10.1128/JB.180.12.3062-3069.1998; Bhatnagar PK, 2006, CANCER BIOL THER, V5, P485, DOI 10.4161/cbt.5.5.2553; Bingle WH, 2000, J BACTERIOL, V182, P3298, DOI 10.1128/JB.182.11.3298-3301.2000; Bingle WH, 1997, MOL MICROBIOL, V26, P277, DOI 10.1046/j.1365-2958.1997.5711932.x; Bingle WH, 1997, J BACTERIOL, V179, P601, DOI 10.1128/jb.179.3.601-611.1997; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Chang TLY, 2003, P NATL ACAD SCI USA, V100, P11672, DOI 10.1073/pnas.1934747100; CHEN CH, 1995, J VIROL, V69, P3771, DOI 10.1128/JVI.69.6.3771-3777.1995; Deng YQ, 2007, BIOCHEMISTRY-US, V46, P4360, DOI 10.1021/bi7001289; Duval M, 2011, ANTIMICROB AGENTS CH, V55, P5547, DOI 10.1128/AAC.00509-11; Emau P, 2007, J MED PRIMATOL, V36, P244, DOI 10.1111/j.1600-0684.2007.00242.x; Esser MT, 1999, J VIROL, V73, P4360, DOI 10.1128/JVI.73.5.4360-4371.1999; GILCHRIST A, 1991, J BACTERIOL, V173, P921, DOI 10.1128/jb.173.2.921-925.1991; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Greenberg ML, 2002, ANTIVIRAL THERAPY S1; Hladik F, 2010, ANTIVIR RES, V88, pS3, DOI 10.1016/j.antiviral.2010.09.011; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; Huskens D, 2012, MAR DRUGS, V10, P1476, DOI 10.3390/md10071476; Huskens D, 2010, J BIOL CHEM, V285, P24845, DOI 10.1074/jbc.M110.128546; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kouokam JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022635; Lau JHY, 2010, CAN J MICROBIOL, V56, P501, DOI [10.1139/W10-036, 10.1139/w10-036]; Liu JJ, 2007, CELL MICROBIOL, V9, P120, DOI 10.1111/j.1462-5822.2006.00772.x; Liu XW, 2006, ANTIMICROB AGENTS CH, V50, P3250, DOI 10.1128/AAC.00493-06; Maniatis G M, 1982, Prog Clin Biol Res, V102 pt A, P13; Mariner JM, 1998, BIOCHEM BIOPH RES CO, V248, P841, DOI 10.1006/bbrc.1998.9060; Marks ME, 2010, J BACTERIOL, V192, P3678, DOI 10.1128/JB.00255-10; Matthews T, 2004, NAT REV DRUG DISCOV, V3, P215, DOI 10.1038/nrd1331; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Ndesendo VMK, 2008, AAPS PHARMSCITECH, V9, P505, DOI 10.1208/s12249-008-9073-5; Network MT, 2011, MTN STAT DEC DISC US; Nomellini JF, 1997, J BACTERIOL, V179, P6349, DOI 10.1128/jb.179.20.6349-6354.1997; Nomellini JF, 2007, APPL ENVIRON MICROB, V73, P3245, DOI 10.1128/AEM.02900-06; Nomellini JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010366; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; RAVENSCROFT N, 1991, J BACTERIOL, V173, P5677, DOI 10.1128/jb.173.18.5677-5684.1991; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shahzad-ul-Hussan S, 2011, J BIOL CHEM, V286, P20788, DOI 10.1074/jbc.M111.232678; SMIT J, 1984, J BACTERIOL, V160, P1137, DOI 10.1128/JB.160.3.1137-1145.1984; Smit J, 2008, INNATE IMMUN-LONDON, V14, P25, DOI 10.1177/1753425907087588; Toporowski MC, 2004, J BACTERIOL, V186, P8000, DOI 10.1128/JB.186.23.8000-8009.2004; Turpin JA, 2011, DRUG DELIV TRANSL RE, V1, P194, DOI 10.1007/s13346-011-0034-2; UNAIDS, 2011, UNAIDS DAT TABL 2011; Vangelista L, 2010, ANTIMICROB AGENTS CH, V54, P2994, DOI 10.1128/AAC.01492-09; Wainberg MA, 2004, AIDS, V18, pS63, DOI 10.1097/00002030-200406003-00012; WALKER SG, 1992, J BACTERIOL, V174, P1783, DOI 10.1128/jb.174.6.1783-1792.1992; WILD C, 1993, AIDS RES HUM RETROV, V9, P1051, DOI 10.1089/aid.1993.9.1051	48	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65965	10.1371/journal.pone.0065965	http://dx.doi.org/10.1371/journal.pone.0065965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840383	gold, Green Submitted, Green Published			2022-12-27	WOS:000322361200044
J	Pappalardo, SE; De Marchi, M; Ferrarese, F				Pappalardo, Salvatore Eugenio; De Marchi, Massimo; Ferrarese, Francesco			Uncontacted Waorani in the Yasuni Biosphere Reserve: Geographical Validation of the Zona Intangible Tagaeri Taromenane (ZITT)	PLOS ONE			English	Article							ECUADOR; DEFORESTATION; CONSERVATION; ALTIMETRY; OIL	The Tagaeri Taromenane People are two indigenous groups belonging to the Waorani first nation living in voluntary isolation within the Napo region of the western Amazon rainforest. To protect their territory the Ecuadorean State has declared and geographically defined, by Decrees, the Zona Intangible Tagaeri Taromenane (ZITT). This zone is located within the UNESCO Yasuni Biosphere Reserve (1989), one of the most biodiverse areas in the world. Due to several hydrocarbon reserve exploitation projects running in the area and the advancing of a large-scale deforestation front, the survival of these groups is presently at risk. The general aim was to validate the ZITT boundary using the geographical references included in the Decree 2187 (2007) by analyzing the geomorphological characteristics of the area. Remote sensing data such as Digital Elevation Models (DEM), Landsat imagery, topographic cartography of IGM-Ecuador, and fieldwork geographical data have been integrated and processed by Geographical Information System (GIS). The ZITT presents two levels of geographic inconsistencies. The first dimension is about the serious cartographical weaknesses in the perimeter delimitation related to the impossibility of linking two rivers belonging to different basins while the second deals with the perimeter line not respecting the hydrographic network. The GIS analysis results clearly show that ZITT boundary is cartographically nonsense due to the impossibility of mapping out the perimeter. Furthermore, GIS analysis of anthropological data shows presence of Tagaeri Taromenane clans outside the ZITT perimeter, within oil production areas and in nearby farmer settlements, reflecting the limits of protection policies for non-contacted indigenous territory. The delimitation of the ZITT followed a traditional pattern of geometric boundary not taking into account the nomadic characteristic of Tagaeri Taromenane: it is necessary to adopt geographical approaches to recognize the indigenous right to their liveable territories in the complex territorialities enacted by different stakeholders.	[Pappalardo, Salvatore Eugenio] Univ Padua, Dept Agron Food Nat Resources Anim & Environm, Padua, Italy; [De Marchi, Massimo] Univ Padua, Dept Civil Environm Architectural Engn, Padua, Italy; [De Marchi, Massimo] Univ Nacl Chimborazo, Prometeo Project, Riobamba, Ecuador; [Ferrarese, Francesco] Univ Padua, GIS Lab, Dept Hist Geog & Antiqu Sci, Padua, Italy	University of Padua; University of Padua; University of Padua	Pappalardo, SE (corresponding author), Univ Padua, Dept Agron Food Nat Resources Anim & Environm, Padua, Italy.	eugenio.pappalardo@geoyasuni.org	De Marchi, Massimo/D-9844-2011	De Marchi, Massimo/0000-0001-8184-013X; ferrarese, francesco/0000-0003-1411-4191	University of Padova, Veneto Region (ESF)	University of Padova, Veneto Region (ESF)	This work was supported by the University of Padova, Veneto Region (ESF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIRRE M, 2013, COMERCIO WEBSITE; AGUIRRE M, 2011, LETRAS VERDES, V8; AGUIRRE M, 2007, QUIEN IMPORTAN ESAS, P232; AGUIRRE M, 2009, OTRA HIST VIOLENCIA; AGUIRRE M, 2010, ITT PUEBLOS OCULTOS; ALBERTO A, 2009, MALDICION ABUNDANCIA, P240; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Beckerman S, 2009, P NATL ACAD SCI USA, V106, P8134, DOI 10.1073/pnas.0901431106; Belaunde LE, 2008, J ROY ANTHROPOL INST, V14, P460, DOI 10.1111/j.1467-9655.2008.00511_27.x; BERTONCIN M, 2004, LOGICHE TERRE ACQUE, P496; Bilsborrow Richard E., 2004, Acta Amaz., V34, P635, DOI 10.1590/S0044-59672004000400015; Birkett CM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000609; BOULDING KE, 1956, IMAGE KNOWLEDGE LIFE, P184; BRANDON R, 2000, MAPPING RURAL LAND U; Brewer C.A., 1997, CARTOGR GEOGR INF SC, V24, DOI [10.1559/152304097782439231, DOI 10.1559/152304097782439231]; Cabodevilla M.A., 2008, ZONA INTANGIBLE PELI, P206; CABODEVILLA MA, 2004, TIEMPOS GUERRA WAORA, P164; CABODEVILLA MA, 1994, HUAORANI HIST PUEBLO, P488; CABODEVILLA MA, 2004, EXTERMINIO PUEBLOS, P211; CABODEVILLA MA, 2003, REFLEXIONES ATAQUE H; CABODEVILLA MA, 1996, COCA REGION SUS HIST, P203; CHAVEZ D, 2010, SITUACION PUEBLOS IN, P37; COLLEONI P, 2010, CAMMINANTES SELVA PU, P48; Vallejo MC, 2010, ECOL ECON, V70, P159, DOI 10.1016/j.ecolecon.2010.03.006; DEMARCHI M, 2010, TERRITORI CITTADINI, P204; DeMarchi M., 2011, POLITICHE AMBIENTE D, P317; DEMARCHI M, 2004, CONFLITTI AJMBIENTEI, P216; DEREK G, 2005, PROGR HUMAN GEOGRAPH, P367; DORLING D, 1997, MAPPING WAYS REPRESE, P184; DUCKHAM M, 2003, FDN GEOGRAPHIC INFOR, P272; DUERTO G, 2011, PROPUESTA CONTROL VI, P94; *EC, 2007, BLOQ PETR ITT 31 RES; *ECORAE, 2008, ROAD NETW AM REG; *EL TEL WEBS, 2012, TRES CAMP MARG ENTR; *EL UN WEBS, 2002, PETR PRWEP NUVE; *EL UN WEBS, 2009, MAT OR SER PETR; ERWIN TL, 2005, P CALIFORNIA ACAD SC, P56; *ET UN WEBS, 2012, QUIER EV EXPL; FAGGI P, 2001, CONFLIOTTI AMBIENTAL, P372; Falorni G, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2003JF000113; Finer M, 2010, BIOTROPICA, V42, P63, DOI 10.1111/j.1744-7429.2009.00587.x; Finer M, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034005; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; FONTAINE G, 2008, IKONOS, V30, P121; FONTAINE G, 2003, LAS REGLAS DE JUEGO, P208; GALO ZR, 2006, LYONIA, V10, P31; GAMBOABALBIN CL, 2007, REGIMEN ESPECIAL TRA, P254; Gesch DB, 2006, PHOTOGRAMM ENG REM S, V72, P233; Greenberg JA, 2005, REMOTE SENS ENVIRON, V96, P202, DOI 10.1016/j.rse.2005.02.010; HARLEY JB, 2002, NEW NATURE MAPS ESSA, P331; Holt FL, 2005, HUM ECOL, V33, P199, DOI 10.1007/s10745-005-2432-X; *HOY COM EC WEBS, 2011, EC EXPL CRUD DUR; *HOY WEBS, 2002, NOV ROND PETR; *IGM, 1997, HOJ RIO YAS EST SER; *IGM, 2010, MOD DIG TERR DEM REG; Imbernon J, 2001, INT J REMOTE SENS, V22, P1753, DOI 10.1080/014311601300176033; INITIATIVE E, 2003, ENERGY BIODIVERSITY, P65; *INST GEOGR MIL, 2010, IGM DIG EL MOD RAST; *INT AM COMM HUM, 2006, PREC MEAS TAG TAR; JEFFREY P, 2001, CONSERVACION DESARRO; Larrea C, 2009, ENERGY SUSTAIN DEV, V13, P219, DOI 10.1016/j.esd.2009.08.003; Larrea Carlos, 2009, YASUNI ITT INITIATIV; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; MACEACHREN A, 2004, MAPS WORK REPRESENTA, P526; MAFFI L, 2010, BIOCULTURAL DIVERSIT, P313; MESSINA JP, 2001, OPEN M HUM DIMENSION, P1; METZGER JP, 2001, REV BIOTA NEOTROPICA, P1; *MIN AMB, 2010, DISTR ESP CLAN AG; *MIN AMB EC, 2010, ZON INT TAG RTAR ZI; *MIN AMB MIN EN MI, 2004, REG OF, V440, P2; MONMONIER M, 1991, LIE MAPS, P207; MORAN EF, 2010, ENV SOCIAL SCI HUMAN, P232; MYERS N, 1993, ENVIRON CONSERV, V20, P9, DOI 10.1017/S0376892900037176; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Napolitano DA, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045005; NARVAEZ I, 2009, PETROLEO PODER COLAP, P584; *NASA EOSDIS, 2012, LBA ECO LC 01 NAT PR, DOI DOI 10.3334/ORNLDAAC/1057; *NASA WEBS, 2012, ADV SPAC THERM EM RE; *NASA WEBS, 2012, LANDS THEM MAPP TM; *NASA WEBS, 2012, SHUTTL RAD TOP MISS; *OILW, 2012, ECUADOR FIRM CONTR P; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; *ONWO, 2013, COM OF ORG NAC WAOR; PAPPALARDO SE, 2013, THESIS; PAPPALARDO SE, 2011, GEOGRAPHY WATER; PAPPALARDO SE, 2009, THESIS; PAPPALARDO SE, 2010, QUADERNI DOTTORATO, V5, P1; PAPPALARDO SE, 2012, ETNOGRAFIE COLLABORA, P113; *PETR, 2010, PETR EC, V1, P1; *PETR WEBS, 2012, MAP BLOQ REG OR; Pimm SL, 2005, SCI AM, V293, P66, DOI 10.1038/scientificamerican0905-66; PLAZA J, 2013, HUARANI MURIERON ATR; PROANO J, 2008, TAROMENANE WAR NANI, P120; QUINTERO ME, 2011, MANEJO SOSTENIBLE PA, P73; RAFFESTIN C, 1980, GEOGRAPHIE POUVOIR, P249; Rieckmann M., 2011, BIODIVERSITY HOTSPOT, P435, DOI [10.1007/978-3-642-20992-5_22, DOI 10.1007/978-3-642-20992-5_22]; Rival L., 2008, J LATIN AM ANTHR, V10, P257, DOI DOI 10.1525/JLCA.2005.10.1.257; Rival L, 2010, ECOL ECON, V70, P358, DOI 10.1016/j.ecolecon.2010.09.007; ROBINSON AH, 1977, CARTOGRAPHY, V10, P73, DOI DOI 10.1080/00690805.1977.10437983.ACCESSED; RODRIGOSIERRA JS, 1998, HUM ECOL, P26; Rodrigues TG, 2011, AN ACAD BRAS CIENC, V83, P953, DOI 10.1590/S0001-37652011000300014; ROMMEL LPA, 2001, CONSERVATION PETROLE, P139; RUDEL TK, 1996, DEFORESTACION TROPIC, P233; *SECR HIDR EC MIN, 2011, FIRM TRES CONTR PETR; *SECR HIDR EC MIN, 2012, MAP BLOQ PETR EC; *SERV WEBS, 2013, EC WAOR EX PROT SUS; SOUTHGATE D, 1991, WORLD DEV, V19, P1145, DOI 10.1016/0305-750X(91)90063-N; STEEGE HT, 2003, BIODIVERS CONSERV, P2255; THOMSEN J, 2001, FOOTPRINTS JUNGLE, V1, P90; TURCO A, 1988, VERSO TEORIA GEOGRAF, P184; *UN EC SOC COUNC, 2009, PERM FOR IND ISS; *UNESCO, 1989, MAB BIOSPH RES; VALLEJOESPINOSA A, 2003, MODERNIZANDO NATURA, P100; VILLAVERDE X, 2005, PARQUE NACL RESERV, P283; WALSH SJ, 2002, LINKING PEOPLE PLACE, P360; Wilson JP, 2012, T GIS, V16, P267, DOI 10.1111/j.1467-9671.2012.01345.x; Wood Dennis, 2002, VISUAL COMMUNICATION, V1, P139, DOI DOI 10.1177/147035720200100201.ACCESSED; WUNDER S, 2003, OIL WEALTH FATE FORE, P456; *XINH, 2013, AM EC	119	26	26	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66293	10.1371/journal.pone.0066293	http://dx.doi.org/10.1371/journal.pone.0066293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840436	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200066
J	van Rijen, MML; Kluytmans-van den Bergh, MFQ; Verkade, EJM; ten Ham, PBG; Feingold, BJ; Kluytmans, JAJW				van Rijen, Miranda M. L.; Kluytmans-van den Bergh, Marjolein F. Q.; Verkade, Erwin J. M.; ten Ham, Peter B. G.; Feingold, Beth J.; Kluytmans, Jan A. J. W.		CAM Study Grp	Lifestyle-Associated Risk Factors for Community-Acquired Methicillin-Resistant Staphylococcus aureus Carriage in the Netherlands: An Exploratory Hospital-Based Case-Control Study	PLOS ONE			English	Article							INFECTIONS; PREVALENCE; EMERGENCE; PRODUCTS; MRSA	Background: Community-acquired MRSA (CA-MRSA) is rapidly increasing. Currently, it is unknown which reservoirs are involved. An exploratory hospital-based case-control study was performed in sixteen Dutch hospitals to identify risk factors for CA-MRSA carriage in patients not belonging to established risk groups. Methods: Cases were in-or outpatients from sixteen Dutch hospitals, colonised or infected with MRSA without healthcare-or livestock-associated risk factors for MRSA carriage. Control subjects were patients not carrying MRSA, and hospitalised on the same ward or visited the same outpatients' clinic as the case. The presence of potential risk factors for CA-MRSA carriage was determined using a standardised questionnaire. Results: Regular consumption of poultry (OR 2.40; 95% CI 1.08-5.33), cattle density per municipality (OR 1.30; 95% CI 1.00-1.70), and sharing of scuba diving equipment (OR 2.93 95% CI 1.19-7.21) were found to be independently associated with CA-MRSA carriage. CA-MRSA carriage was not related to being of foreign origin. Conclusions: The observed association between the consumption of poultry and CA-MRSA carriage suggests that MRSA in the food chain may be a source for MRSA carriage in humans. Although sharing of scuba diving equipment was found to be associated with CA-MRSA carriage, the role played by skin abrasions in divers, the lack of decontamination of diving materials, or the favourable high salt content of sea water is currently unclear. The risk for MRSA MC398 carriage in areas with a high cattle density may be due to environmental contamination with MRSA MC398 or human-to-human transmission. Further studies are warranted to confirm our findings and to determine the absolute risks of MRSA acquisition associated with the factors identified.	[van Rijen, Miranda M. L.; Verkade, Erwin J. M.; Kluytmans, Jan A. J. W.] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Kluytmans-van den Bergh, Marjolein F. Q.] Amphia Hosp, Amphia Acad Infect Dis Fdn, Breda, Netherlands; [Verkade, Erwin J. M.; Kluytmans, Jan A. J. W.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [ten Ham, Peter B. G.] Reg Hlth Author, Sect Infect Dis Control, Leiden, Netherlands; [Feingold, Beth J.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Kluytmans, Jan A. J. W.] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands	Amphia Hospital; Amphia Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Johns Hopkins University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Rijen, MML (corresponding author), Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.	mvrijen@amphia.nl	van den Bergh, Marjolein Kluytmans -/A-7267-2016	van den Bergh, Marjolein Kluytmans -/0000-0002-6576-6408; Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Feingold, Beth/0000-0001-6670-5845	Netherlands Organisation for Health Research and Development (ZonMw) [125020007]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This project was funded by The Netherlands Organisation for Health Research and Development (ZonMw. grant number 125020007). ZonMw is a non-profit organisation working for the Ministry of Health, Welfare and Sport (VWS) and the Dutch Organisation for Scientific Research (NWO). ZonMw had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock PM, 1998, J INFECT DIS, V178, P577, DOI 10.1086/517478; Bocher S, 2008, CLIN MICROBIOL INFEC, V14, P942, DOI 10.1111/j.1469-0691.2008.02055.x; Bochet M, 2008, J TRAVEL MED, V15, P378, DOI 10.1111/j.1708-8305.2008.00243.x; Bode LGM, 2011, J HOSP INFECT, V79, P198, DOI 10.1016/j.jhin.2011.05.009; Bootsma MCJ, 2011, J R SOC INTERFACE, V8, P578, DOI 10.1098/rsif.2010.0349; Carleton HA, 2004, J INFECT DIS, V190, P1730, DOI 10.1086/425019; Coronado F, 2007, EPIDEMIOL INFECT, V135, P492, DOI 10.1017/S0950268806006960; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; de Boer E, 2009, INT J FOOD MICROBIOL, V134, P52, DOI 10.1016/j.ijfoodmicro.2008.12.007; Dutch Workingparty on Infection Prevention, 2007, MRSA HOSP; Feingold BJ, 2012, EMERG INFECT DIS, V18, P1841, DOI 10.3201/eid1811.111850; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Kluytmans JAJW, 2010, CLIN MICROBIOL INFEC, V16, P11, DOI 10.1111/j.1469-0691.2009.03110.x; Kluytmans-VandenBergh MFQ, 2006, CLIN MICROBIOL INFEC, V12, P9, DOI 10.1111/j.1469-0691.2006.01341.x; Larsen AR, 2009, J CLIN MICROBIOL, V47, P73, DOI 10.1128/JCM.01557-08; Lekkerkerk WSN, 2012, CLIN MICROBIOL INFEC, V18, P656, DOI 10.1111/j.1469-0691.2011.03662.x; Longtin Y, 2009, CLIN MICROBIOL INFEC, V15, P552, DOI 10.1111/j.1469-0691.2009.02715.x; Maier J, 2005, EUR J CLIN MICROBIOL, V24, P637, DOI 10.1007/s10096-005-0008-8; Mulders MN, 2010, EPIDEMIOL INFECT, V138, P743, DOI 10.1017/S0950268810000075; Nguyen DM, 2005, EMERG INFECT DIS, V11, P526, DOI 10.3201/eid1104.041094; Noskin GA, 2007, CLIN INFECT DIS, V45, P1132, DOI 10.1086/522186; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Schouls LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005082; Schulz J, 2012, APPL ENVIRON MICROB, V78, P5666, DOI 10.1128/AEM.00550-12; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Van Loo IHM, 2007, EMERG INFECT DIS, V13, P1753, DOI 10.3201/eid1311.070358; Wang J, 2003, UNDERSEA HYPERBAR M, V30, P277; Wendlandt S, 2012, ANN REV FOOD SC 1126; Wulf MW, 2008, EURO SURVEILL, V13	29	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65594	10.1371/journal.pone.0065594	http://dx.doi.org/10.1371/journal.pone.0065594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840344	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200027
J	Gerrard, DT; Fricke, C; Edward, DA; Edwards, DR; Chapman, T				Gerrard, Dave T.; Fricke, Claudia; Edward, Dominic A.; Edwards, Dylan R.; Chapman, Tracey			Genome-Wide Responses of Female Fruit Flies Subjected to Divergent Mating Regimes	PLOS ONE			English	Article							OF-FUNCTION SCREEN; DROSOPHILA-MELANOGASTER; LIFE-SPAN; SEX-PEPTIDE; GENE-EXPRESSION; GERM-LINE; REPRODUCTION; COSTS; PROTEINS; MALES	Elevated rates of mating and reproduction cause decreased female survival and lifetime reproductive success across a wide range of taxa from flies to humans. These costs are fundamentally important to the evolution of life histories. Here we investigate the potential mechanistic basis of this classic life history component. We conducted 4 independent replicated experiments in which female Drosophila melanogaster were subjected to 'high' and 'low' mating regimes, resulting in highly significant differences in lifespan. We sampled females for transcriptomic analysis at day 10 of life, before the visible onset of ageing, and used Tiling expression arrays to detect differential gene expression in two body parts (abdomen versus head+thorax). The divergent mating regimes were associated with significant differential expression in a network of genes showing evidence for interactions with ecdysone receptor. Preliminary experimental manipulation of two genes in that network with roles in post-transcriptional modification (CG11486, eyegone) tended to enhance sensitivity to mating costs. However, the subtle nature of those effects suggests substantial functional redundancy or parallelism in this gene network, which could buffer females against excessive responses. There was also evidence for differential expression in genes involved in germline maintenance, cell proliferation and in gustation / odorant reception. Interestingly, we detected differential expression in three specific genes (EcR, keap1, lbk1) and one class of genes (gustation / odorant receptors) with previously reported roles in determining lifespan. Our results suggest that high and low mating regimes that lead to divergence in lifespan are associated with changes in the expression of genes such as reproductive hormones, that influence resource allocation to the germ line, and that may modify post-translational gene expression. This predicts that the correct signalling of nutrient levels to the reproductive system is important for maintaining organismal integrity.	[Gerrard, Dave T.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Gerrard, Dave T.] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Gerrard, Dave T.; Fricke, Claudia; Edward, Dominic A.; Edwards, Dylan R.; Chapman, Tracey] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Fricke, Claudia] Univ Munster, Inst Evolut & Biodivers, Munster, Germany; [Edward, Dominic A.] Univ Liverpool, Inst Integrat Biol, Neston, Cheshire, England	University of Manchester; University of Manchester; University of East Anglia; University of Munster; University of Liverpool	Chapman, T (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	tracey.chapman@uea.ac.uk	Edwards, Dylan R/B-4734-2009; Chapman, Tracey/E-5100-2011; Fricke, Claudia/M-6536-2014; Edward, Dominic/B-4074-2010	Edwards, Dylan R/0000-0002-3292-2064; Fricke, Claudia/0000-0002-0691-6779; Gerrard, Dave/0000-0001-6890-7213	BigC Local Cancer Care; Biotechnology and Biological Sciences Research Council [BB/H008047/1] Funding Source: researchfish; BBSRC [BB/H008047/1] Funding Source: UKRI	BigC Local Cancer Care; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by research grants from the BigC Local Cancer Care to TC, DTG and DRE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; Barnes AI, 2006, P ROY SOC B-BIOL SCI, V273, P939, DOI 10.1098/rspb.2005.3388; Barnes AI, 2003, ANIM BEHAV, V66, P199, DOI 10.1006/anbe.2003.2122; Barnes AI, 2008, P ROY SOC B-BIOL SCI, V275, P1675, DOI 10.1098/rspb.2008.0139; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2; BELL PD, 1986, COST REPROD, P83; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Carney GE, 2000, GENETICS, V154, P1203; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Chapman T, 2003, P NATL ACAD SCI USA, V100, P9923, DOI 10.1073/pnas.1631635100; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Chapman T, 2006, CURR BIOL, V16, pR744, DOI 10.1016/j.cub.2006.08.020; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crespi B, 2005, TRENDS ECOL EVOL, V20, P545, DOI 10.1016/j.tree.2005.07.007; Crespi BJ, 2006, BIOL REV, V81, P407, DOI 10.1017/S1464793106007056; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Edward DA, 2011, MECHANISMS OF LIFE HISTORY EVOLUTION: THE GENETICS AND PHYSIOLOGY OF LIFE HISTORY TRAITS AND TRADE-OFFS, P137; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Flatt T, 2008, J EXP BIOL, V211, P2712, DOI 10.1242/jeb.014878; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Flatt T, 2011, EXP GERONTOL, V46, P369, DOI 10.1016/j.exger.2010.10.008; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Fricke C, 2009, J EVOLUTION BIOL, V22, P275, DOI 10.1111/j.1420-9101.2008.01638.x; Fricke C, 2008, EVOLUTION, V62, P3170, DOI 10.1111/j.1558-5646.2008.00515.x; Funakoshi M, 2011, BIOCHEM BIOPH RES CO, V405, P667, DOI 10.1016/j.bbrc.2011.01.090; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Girardot F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-74; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; Henrich VC, 2012, INSECT ENDOCRINOLOGY, P177; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Innocenti P, 2009, J EVOLUTION BIOL, V22, P964, DOI 10.1111/j.1420-9101.2009.01708.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivanovska I, 2005, GENE DEV, V19, P2571, DOI 10.1101/gad.1348905; Konig A, 2011, EMBO J, V30, P1549, DOI 10.1038/emboj.2011.73; Kraut R, 2001, CURR BIOL, V11, P417, DOI 10.1016/S0960-9822(01)00124-5; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; LAW R, 1979, AM NAT, V114, P399, DOI 10.1086/283488; Lawniczak MKN, 2007, TRENDS ECOL EVOL, V22, P48, DOI 10.1016/j.tree.2006.09.012; Lawniczak MKN, 2004, GENOME, V47, P900, DOI 10.1139/G04-050; Leroi AM, 2001, TRENDS ECOL EVOL, V16, P24, DOI 10.1016/S0169-5347(00)02032-2; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Mack PD, 2006, P NATL ACAD SCI USA, V103, P10358, DOI 10.1073/pnas.0604046103; McGraw LA, 2004, CURR BIOL, V14, P1509, DOI 10.1016/j.cub.2004.08.028; McGraw LA, 2008, GENETICS, V179, P1395, DOI 10.1534/genetics.108.086934; Montell C, 2009, CURR OPIN NEUROBIOL, V19, P345, DOI 10.1016/j.conb.2009.07.001; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; Moshitzky P, 1996, ARCH INSECT BIOCHEM, V32, P363, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;363::AID-ARCH9&gt;3.0.CO;2-T; NARBONNE P, 2006, CELL DIVISION, P29; Parker G.A., 1979, P123; Partridge L, 1987, FUNCT ECOL, V1, P317, DOI 10.2307/2389786; PARTRIDGE L, 1986, J INSECT PHYSIOL, V32, P925, DOI 10.1016/0022-1910(86)90140-X; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Partridge L, 2002, NAT REV GENET, V3, P165, DOI 10.1038/nrg753; PARTRIDGE L, 1990, J INSECT PHYSIOL, V36, P419, DOI 10.1016/0022-1910(90)90059-O; PARTRIDGE L, 1987, J INSECT PHYSIOL, V33, P745, DOI 10.1016/0022-1910(87)90060-6; Partridge L, 2007, NATURE, V450, P165, DOI 10.1038/450165a; Peng J, 2005, CURR BIOL, V15, P1690, DOI 10.1016/j.cub.2005.08.048; Piper MDW, 2005, J GERONTOL A-BIOL, V60, P549, DOI 10.1093/gerona/60.5.549; Piper MDW, 2005, EXP GERONTOL, V40, P857, DOI 10.1016/j.exger.2005.06.013; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Roman G, 2001, P NATL ACAD SCI USA, V98, P12602, DOI 10.1073/pnas.221303998; Romani P, 2009, GENETICS, V181, P165, DOI 10.1534/genetics.108.096008; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; Schwedes C, 2011, J INSECT PHYSIOL, V57, P899, DOI 10.1016/j.jinsphys.2011.03.027; Schwedes CC, 2012, J INSECT PHYSIOL, V58, P293, DOI 10.1016/j.jinsphys.2012.01.013; Sgro CM, 1999, SCIENCE, V286, P2521, DOI 10.1126/science.286.5449.2521; Simon AF, 2003, SCIENCE, V299, P1407, DOI 10.1126/science.1080539; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; Thorne N, 2008, J COMP NEUROL, V506, P548, DOI 10.1002/cne.21547; Tricoire H, 2009, MECH AGEING DEV, V130, P547, DOI 10.1016/j.mad.2009.05.004; von Trotha JW, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-9; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yao JG, 2008, DEV BIOL, V315, P535, DOI 10.1016/j.ydbio.2007.12.037; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461	90	5	9	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68136	10.1371/journal.pone.0068136	http://dx.doi.org/10.1371/journal.pone.0068136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826372	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000126
J	Peterburs, J; Nitsch, AM; Miltner, WHR; Straube, T				Peterburs, Jutta; Nitsch, Alexander M.; Miltner, Wolfgang H. R.; Straube, Thomas			Impaired Representation of Time in Schizophrenia Is Linked to Positive Symptoms and Cognitive Demand	PLOS ONE			English	Article							INTERNAL CLOCK; NEURAL MECHANISMS; PERCEPTION; INTERVAL; MEMORY; SPEED; DISCRIMINATION; CONSCIOUSNESS; PERFORMANCE; DYSFUNCTION	Time processing critically relies on the mesencephalic dopamine system and striato-prefrontal projections and has thus been suggested to play a key role in schizophrenia. Previous studies have provided evidence for an acceleration of the internal clock in schizophrenia that may be linked to dopaminergic pathology. The present study aimed to assess the relationship between altered time processing in schizophrenia and symptom manifestation in 22 patients and 22 controls. Subjects were required to estimate the time needed for a visual stimulus to complete a horizontal movement towards a target position on trials of varying cognitive demand. It was hypothesized that patients - compared to controls - would be less accurate at estimating the movement time, and that this effect would be modulated by symptom manifestation and task difficulty. In line with the notion of an accelerated internal clock due to dopaminergic dysregulation, particularly patients with severe positive symptoms were expected to underestimate movement time. However, if altered time perception in schizophrenia was better explained in terms of cognitive deficits, patients with severe negative symptoms should be specifically impaired, while generally, task performance should correlate with measures of processing speed and cognitive flexibility. Patients underestimated movement time on more demanding trials, although there was no link to disease-related cognitive dysfunction. Task performance was modulated by symptom manifestation. Impaired estimation of movement time was significantly correlated with PANSS positive symptom scores, with higher positive symptom scores associated with stronger underestimation of movement time. The present data thus support the notion of a deficit in anticipatory and predictive mechanisms in schizophrenia that is modulated both by symptom manifestation and by cognitive demand.	[Peterburs, Jutta; Straube, Thomas] Univ Munster, Inst Med Psychol & Syst Neurosci, Munster, Germany; [Nitsch, Alexander M.; Miltner, Wolfgang H. R.] Univ Jena, Dept Biol & Clin Psychol, Jena, Germany	University of Munster; Friedrich Schiller University of Jena	Peterburs, J (corresponding author), Univ Munster, Inst Med Psychol & Syst Neurosci, Munster, Germany.	jutta.peterburs@uni-muenster.de	Peterburs, Jutta/R-2352-2019	Peterburs, Jutta/0000-0003-3571-126X	German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF) [01GW0740]; Deutsche Forschungsgemeinschaft (DFG); University of Muenster, Germany	German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Muenster, Germany	The present study was supported by a research grant awarded by the German Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, BMBF, grant number 01GW0740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. With regard to publication fees, we acknowledge support by the Deutsche Forschungsgemeinschaft (DFG) and the Open Access Publication Fund of the University of Muenster, Germany.	Allman MJ, 2012, BRAIN, V135, P656, DOI 10.1093/brain/awr210; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andreasen NC, 1999, BIOL PSYCHIAT, V46, P908, DOI 10.1016/S0006-3223(99)00152-3; ANGLE HV, 1973, PSYCHOPHARMACOLOGIA, V28, P185, DOI 10.1007/BF00421403; Arstila V, 2011, LECT NOTES ARTIF INT, V6789, P1, DOI 10.1007/978-3-642-21478-3_1; Bays PM, 2005, CURR BIOL, V15, P1125, DOI 10.1016/j.cub.2005.05.023; Blakemore SJ, 2000, PSYCHOL MED, V30, P1131, DOI 10.1017/S0033291799002676; Bonnot O, 2011, J PHYSIOL-PARIS, V105, P164, DOI 10.1016/j.jphysparis.2011.07.006; Buhusi CV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006268; Buhusi CV, 2009, PHILOS T R SOC B, V364, P1875, DOI 10.1098/rstb.2009.0022; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Carroll CA, 2008, BRAIN COGNITION, V67, P150, DOI 10.1016/j.bandc.2007.12.005; Carroll CA, 2009, BRAIN COGNITION, V71, P345, DOI 10.1016/j.bandc.2009.06.009; Carroll CA, 2009, BRAIN COGNITION, V70, P181, DOI 10.1016/j.bandc.2009.02.001; Coslett HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010324; Coy AL, 2013, COGN NEUROPSYCHIATRY, V18, P463, DOI 10.1080/13546805.2012.730994; Danckert JA, 2005, BRAIN COGNITION, V59, P236, DOI 10.1016/j.bandc.2005.07.002; Davalos DB, 2003, BRAIN COGNITION, V52, P295, DOI 10.1016/S0278-2626(03)00157-X; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; Delevoye-Turrell Y, 2012, SCHIZOPHR RES, V135, P51, DOI 10.1016/j.schres.2011.12.020; Elvevag B, 2003, PSYCHOL MED, V33, P1249, DOI 10.1017/S0033291703008122; First MB, 2002, STRUCTURED CLIN INTE; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; Giersch A, 2009, SCHIZOPHRENIA BULL, V35, P816, DOI 10.1093/schbul/sbn016; Haggard P, 2003, NEUROREPORT, V14, P1081, DOI 10.1097/01.wnr.0000073684.00308.c0; Hagura N, 2012, P ROY SOC B-BIOL SCI, V279, P4399, DOI 10.1098/rspb.2012.1339; Harrington DL, 1998, J NEUROSCI, V18, P1085; Hauser M, 2011, SCHIZOPHR RES, V126, P20, DOI 10.1016/j.schres.2010.10.031; Heaton HK, 1993, WISCONSIN CARD SORTI; Jaspers K, 1973, ALLGEMEINE PSYCHOPAT, P67; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kupke C, 2009, BEGRIFF Z PSYCHOPATH; Lalanne L, 2012, SCHIZOPHRENIA BULL, V38, P506, DOI 10.1093/schbul/sbq107; Lee KH, 2009, PSYCHIAT RES, V166, P174, DOI 10.1016/j.psychres.2008.03.004; Lehrl S., 2005, MANUAL ZUM MWT B MEH; Lewis PA, 2003, NEUROPSYCHOLOGIA, V41, P1583, DOI 10.1016/S0028-3932(03)00118-0; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Meck WH, 2006, BRAIN RES, V1109, P93, DOI 10.1016/j.brainres.2006.06.031; Meck WH, 2006, BRAIN RES, V1108, P157, DOI 10.1016/j.brainres.2006.06.046; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P171, DOI 10.1037/0097-7403.9.2.171; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; MECK WH, 1986, PHARMACOL BIOCHEM BE, V25, P1185, DOI 10.1016/0091-3057(86)90109-7; Miltner WHR, 2008, RASENDER STILLSTAND, P287; Moore JW, 2012, NEUROPSYCHOLOGIA, P1, DOI S0028-3932(12)00293-X; Muller BW, 2004, EUR PSYCHOL, V9, P96, DOI 10.1027/1016-9040.9.2.96; Picton TW, 2006, NEUROPSYCHOLOGIA, V44, P1195, DOI 10.1016/j.neuropsychologia.2005.10.002; RAMMSAYER TH, 1993, BIOL PSYCHOL, V36, P209, DOI 10.1016/0301-0511(93)90018-4; Reitan RM, 1992, TRAIL MAKING TEST MA; Roy M, 2012, PSYCHIAT RES, V200, P159, DOI 10.1016/j.psychres.2012.06.008; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Tanaka T, 2012, PSYCHIAT CLIN NEUROS, V66, P491, DOI 10.1111/j.1440-1819.2012.02390.x; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; TROUTWINE R, 1981, PERCEPT MOTOR SKILL, V52, P865, DOI 10.2466/pms.1981.52.3.865; Turgeon M, 2012, PSYCHIAT RES, V197, P13, DOI 10.1016/j.psychres.2012.03.003; TYSK L, 1983, PERCEPT MOTOR SKILL, V56, P983, DOI 10.2466/pms.1983.56.3.983; Ulferts J, 1999, NEUROPSYCHIATRIE, V13, P133; Vogeley K, 2007, SCHIZOPHRENIA BULL, V33, P157, DOI 10.1093/schbul/sbl056; WAHL OF, 1980, PERCEPT MOTOR SKILL, V50, P535, DOI 10.2466/pms.1980.50.2.535; Ward RD, 2012, NEUROPHARMACOLOGY, V62, P1175, DOI 10.1016/j.neuropharm.2011.04.014	60	13	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67615	10.1371/journal.pone.0067615	http://dx.doi.org/10.1371/journal.pone.0067615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IX	23826328	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000092
J	Cuypers, K; Leenus, DJF; den Berg, FE; Nitsche, MA; Thijs, H; Wenderoth, N; Meesen, RLJ				Cuypers, Koen; Leenus, Daphnie J. F.; van den Berg, Femke E.; Nitsche, Michael A.; Thijs, Herbert; Wenderoth, Nicole; Meesen, Raf L. J.			Is Motor Learning Mediated by tDCS Intensity?	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; NONINVASIVE CORTICAL STIMULATION; PARKINSONS-DISEASE; BRAIN POLARIZATION; CHRONIC STROKE; CORTEX; PLASTICITY; EXCITABILITY; CONSOLIDATION; IMPLICIT	Although tDCS has been shown to improve motor learning, previous studies reported rather small effects. Since physiological effects of tDCS depend on intensity, the present study evaluated this parameter in order to enhance the effect of tDCS on skill acquisition. The effect of different stimulation intensities of anodal tDCS (atDCS) was investigated in a double blind, sham controlled crossover design. In each condition, thirteen healthy subjects were instructed to perform a unimanual motor (sequence) learning task. Our results showed (1) a significant increase in the slope of the learning curve and (2) a significant improvement in motor performance at retention for 1.5 mA atDCS as compared to sham tDCS. No significant differences were reported between 1 mA atDCS and sham tDCS; and between 1.5 mA atDCS and 1 mA atDCS.	[Cuypers, Koen; Leenus, Daphnie J. F.; Meesen, Raf L. J.] Hasselt Univ, BIOMED Biomed Res Inst, Diepenbeek, Belgium; [Cuypers, Koen; Leenus, Daphnie J. F.; Thijs, Herbert; Meesen, Raf L. J.] PHL Univ Coll, REVAL Res Inst, Diepenbeek, Belgium; [Cuypers, Koen; van den Berg, Femke E.; Wenderoth, Nicole; Meesen, Raf L. J.] Katholieke Univ Leuven, Dept Biomed Kinesiol, Motor Control Lab, B-3001 Heverlee, Belgium; [Nitsche, Michael A.] Univ Gottingen, Dept Clin Neurophysiol, D-37073 Gottingen, Germany; [Thijs, Herbert] Hasselt Univ, I BioStat Interuniv Inst Biostat & Stat Bioinfir, Diepenbeek, Belgium; [Thijs, Herbert] Katholieke Univ Leuven, Louvain, Belgium; [Wenderoth, Nicole; Meesen, Raf L. J.] ETH, Neural Control Movement Lab, Dept Hlth Sci & Technol, Zurich, Switzerland	Hasselt University; KU Leuven; University of Gottingen; Hasselt University; KU Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich	Meesen, RLJ (corresponding author), Hasselt Univ, BIOMED Biomed Res Inst, Diepenbeek, Belgium.	raf.meesen@uhasselt.be	Nitsche, Michael A/B-6755-2012; Wenderoth, Nicole/D-7262-2015; Cuypers, Koen/N-9918-2018; Meesen, Raf L/F-2582-2019	Wenderoth, Nicole/0000-0002-3246-9386; Meesen, Raf L/0000-0002-7938-3758	Flanders Fund for Scientific Research [G075810]; Special Research Fund UHasselt	Flanders Fund for Scientific Research(FWO); Special Research Fund UHasselt	This work was supported by the Flanders Fund for Scientific Research [G075810]. Koen Cuypers is supported by the Special Research Fund UHasselt. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal A, 2007, EUR J NEUROSCI, V26, P2687, DOI 10.1111/j.1460-9568.2007.05896.x; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Boggio PS, 2006, NEUROSCI LETT, V404, P232, DOI 10.1016/j.neulet.2006.05.051; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Fregni F, 2006, MOVEMENT DISORD, V21, P1693, DOI 10.1002/mds.21012; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hummel FC, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-73; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Kang Eun Kyoung, 2011, Exp Transl Stroke Med, V3, P4, DOI 10.1186/2040-7378-3-4; Kantak SS, 2012, EUR J NEUROSCI, V36, P2710, DOI 10.1111/j.1460-9568.2012.08175.x; KARNI A, 1995, NATURE, V377, P155; Muellbacher W, 2002, NATURE, V415, P640, DOI 10.1038/nature712; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Reis J, 2009, P NATL ACAD SCI USA, V106, P1590, DOI 10.1073/pnas.0805413106; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Tanaka S, 2011, NEUROREHAB NEURAL RE, V25, P565, DOI 10.1177/1545968311402091; Teo Florence, 2011, Front Psychiatry, V2, P45, DOI 10.3389/fpsyt.2011.00045; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091	24	65	69	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67344	10.1371/journal.pone.0067344	http://dx.doi.org/10.1371/journal.pone.0067344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826272	Green Published, gold			2022-12-27	WOS:000321738400136
J	Gorman, S; Weeden, CE; Tan, DHW; Scott, NM; Hart, J; Foong, RE; Mok, D; Stephens, N; Zosky, G; Hart, PH				Gorman, Shelley; Weeden, Clare E.; Tan, Daryl H. W.; Scott, Naomi M.; Hart, Julie; Foong, Rachel E.; Mok, Danny; Stephens, Nahiid; Zosky, Graeme; Hart, Prue H.			Reversible Control by Vitamin D of Granulocytes and Bacteria in the Lungs of Mice: An Ovalbumin-Induced Model of Allergic Airway Disease	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; 1,25-DIHYDROXYVITAMIN D-3; D DEFICIENCY; ANTIMICROBIAL PEPTIDE; D SUPPLEMENTATION; CHILDHOOD ASTHMA; UV-RADIATION; HOST-DEFENSE; CHILDREN; PREGNANCY	Vitamin D may be essential for restricting the development and severity of allergic diseases and asthma, but a direct causal link between vitamin D deficiency and asthma has yet to be established. We have developed a 'low dose' model of allergic airway disease induced by intraperitoneal injection with ovalbumin (1 mu g) and aluminium hydroxide (0.2 mg) in which characteristics of atopic asthma are recapitulated, including airway hyperresponsiveness, antigen-specific immunoglobulin type-E and lung inflammation. We assessed the effects of vitamin D deficiency throughout life (from conception until adulthood) on the severity of ovalbumin-induced allergic airway disease in vitamin D-replete and -deficient BALB/c mice using this model. Vitamin D had protective effects such that deficiency significantly enhanced eosinophil and neutrophil numbers in the bronchoalveolar lavage fluid of male but not female mice. Vitamin D also suppressed the proliferation and T helper cell type-2 cytokine-secreting capacity of airway-draining lymph node cells from both male and female mice. Supplementation of initially vitamin D-deficient mice with vitamin D for four weeks returned serum 25-hydroxyvitamin D to levels observed in initially vitamin D-replete mice, and also suppressed eosinophil and neutrophil numbers in the bronchoalveolar lavage fluid of male mice. Using generic 16 S rRNA primers, increased bacterial levels were detected in the lungs of initially vitamin D-deficient male mice, which were also reduced by vitamin D supplementation. These results indicate that vitamin D controls granulocyte levels in the bronchoalveolar lavage fluid in an allergen-sensitive manner, and may contribute towards the severity of asthma in a gender-specific fashion through regulation of respiratory bacteria.	[Gorman, Shelley; Weeden, Clare E.; Tan, Daryl H. W.; Scott, Naomi M.; Foong, Rachel E.; Mok, Danny; Zosky, Graeme; Hart, Prue H.] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Gorman, Shelley; Weeden, Clare E.; Tan, Daryl H. W.; Scott, Naomi M.; Foong, Rachel E.; Mok, Danny; Zosky, Graeme; Hart, Prue H.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Hart, Julie] Univ Western Australia, Queen Elizabeth II Med Ctr, Dept Microbiol, PathWest Lab Med WA, Nedlands, WA 6009, Australia; [Stephens, Nahiid] Murdoch Univ, Fac Hlth Sci, Sch Vet & Biol Sci, Perth, WA, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; Murdoch University	Gorman, S (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	shelleyg@ichr.uwa.edu.au	Gorman, Shelley/R-9953-2017; Scott, Naomi/R-9951-2017; Mok, Danny/A-5328-2011; Zosky, Graeme/B-2048-2014; Foong, Rachel/A-4678-2019	Gorman, Shelley/0000-0002-7111-6735; Weeden, Clare/0000-0002-1561-1416; Foong, Rachel/0000-0002-1201-6785; Hart, Prue/0000-0001-7207-6467; Mok, Danny/0000-0001-7425-6891; Zosky, Graeme/0000-0001-9039-0302	National Health and Medical Research Council of Australia [458612]; Cancer Council of Western Australia [1008985]; Asthma Foundation of Western Australia; Raine Medical Research Foundation; BrightSpark Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Western Australia(Cancer Council Western Australia); Asthma Foundation of Western Australia; Raine Medical Research Foundation; BrightSpark Foundation	This work was supported by the National Health and Medical Research Council of Australia (#458612, PHH, SG; http://www.nhmrc.gov.au), the Cancer Council of Western Australia (#1008985, PHH, SG; http://www.cancerwa.asn.au), the Asthma Foundation of Western Australia (SG, PHH; www.asthmawa.org.au), the Raine Medical Research Foundation (SG, PHH; http://www.raine.uwa.edu.au) and the BrightSpark Foundation (SG; http://www.brightsparkfoundation.com.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal T, 2012, EXP MOL PATHOL, V93, P74, DOI 10.1016/j.yexmp.2012.04.004; Akuthota P, 2013, AM J RESP CELL MOL, V48, P758, DOI 10.1165/rcmb.2012-0499OC; Amundsen EK, 2012, AM J CLIN PATHOL, V137, P86, DOI 10.1309/AJCP19BFTHYTMORO; Antunes MA, 2010, J APPL PHYSIOL, V109, P855, DOI 10.1152/japplphysiol.00333.2010; Baker DG, 1998, CLIN MICROBIOL REV, V11, P231, DOI 10.1128/CMR.11.2.231; Beauvillain C, 2011, BLOOD, V117, P1196, DOI 10.1182/blood-2009-11-254490; Becker M, 2011, J IMMUNOL, V186, P7225, DOI 10.4049/jimmunol.1100676; Beisswenger C, 2006, J IMMUNOL, V177, P1833, DOI 10.4049/jimmunol.177.3.1833; Bener A, 2012, INT ARCH ALLERGY IMM, V157, P168, DOI 10.1159/000323941; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Brar T, 2012, CURR OPIN PULM MED, V18, P14, DOI 10.1097/MCP.0b013e32834dccc0; Brehm JM, 2010, J ALLERGY CLIN IMMUN, V126, P52, DOI 10.1016/j.jaci.2010.03.043; Brehm JM, 2009, AM J RESP CRIT CARE, V179, P765, DOI 10.1164/rccm.200808-1361OC; Calvo C, 2007, PEDIATR INFECT DIS J, V26, P904, DOI 10.1097/INF.0b013e31812e52e6; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Carey MA, 2007, AM J PHYSIOL-LUNG C, V293, pL272, DOI 10.1152/ajplung.00174.2007; Chinellato I, 2011, EUR RESPIR J, V37, P1366, DOI 10.1183/09031936.00044710; Chinellato I, 2011, J PEDIATR-US, V158, P437, DOI 10.1016/j.jpeds.2010.08.043; Ciaccio CE, 2010, CURR ALLERGY ASTHM R, V10, P387, DOI 10.1007/s11882-010-0144-9; Correale J, 2010, J IMMUNOL, V185, P4948, DOI 10.4049/jimmunol.1000588; Cremers E, 2011, THORAX, V66, P474, DOI 10.1136/thx.2010.151985; Devereux G, 2010, ALLERGY, V65, P666, DOI 10.1111/j.1398-9995.2009.02220.x; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Erkkola M, 2009, CLIN EXP ALLERGY, V39, P875, DOI 10.1111/j.1365-2222.2009.03234.x; Florian S, 2006, ALLERGY, V61, P1054, DOI 10.1111/j.1398-9995.2006.01171.x; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Goleva E, 2012, J ALLERGY CLIN IMMUN, V129, P1243, DOI 10.1016/j.jaci.2012.01.044; Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273; Gorman Shelley, 2012, Photochem Photobiol Sci, V11, P1788, DOI 10.1039/c2pp25108f; Gorman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046006; Gorman S, 2012, PEDIAT ALLERG IMM-UK, V23, P83, DOI 10.1111/j.1399-3038.2011.01146.x; Gorman S, 2010, J INVEST DERMATOL, V130, P2368, DOI 10.1038/jid.2010.167; Gorman S, 2010, IMMUNOLOGY, V130, P181, DOI 10.1111/j.1365-2567.2009.03222.x; Gupta A, 2011, AM J RESP CRIT CARE, V184, P1342, DOI 10.1164/rccm.201107-1239OC; HANTOS Z, 1992, J APPL PHYSIOL, V72, P168, DOI 10.1152/jappl.1992.72.1.168; Hart PH, 2011, NAT REV IMMUNOL, V11, P584, DOI 10.1038/nri3045; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Hollams EM, 2011, EUR RESPIR J, V38, P1320, DOI 10.1183/09031936.00029011; Hughes AM, 2011, PEDIAT ALLERG IMM-UK, V22, P327, DOI 10.1111/j.1399-3038.2010.01099.x; Hypponen E, 2004, ANN NY ACAD SCI, V1037, P84, DOI 10.1196/annals.1337.013; Keet CA, 2011, J ALLERGY CLIN IMMUN, V128, P414, DOI 10.1016/j.jaci.2011.06.011; Kovach MA, 2012, J IMMUNOL, V189, P304, DOI 10.4049/jimmunol.1103196; Kull I, 2006, J ALLERGY CLIN IMMUN, V118, P1299, DOI 10.1016/j.jaci.2006.08.022; Larsen JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031976; Levy H, 2005, J ALLERGY CLIN IMMUN, V115, P252, DOI 10.1016/j.jaci.2004.11.013; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Ma J, 2010, INFECT IMMUN, V78, P830, DOI 10.1128/IAI.00914-09; Matheu V, 2003, J ALLERGY CLIN IMMUN, V112, P585, DOI [10.1016/S0091-6749(03)01855-4, 10.1037/mai.2003.1703]; McGlade JP, 2007, CLIN EXP ALLERGY, V37, P1267, DOI 10.1111/j.1365-2222.2007.02750.x; Miyake Y, 2010, EUR RESPIR J, V35, P1228, DOI 10.1183/09031936.00100609; Morales E, 2012, EPIDEMIOLOGY, V23, P64, DOI 10.1097/EDE.0b013e31823a44d3; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nashold FE, 2009, J IMMUNOL, V183, P3672, DOI 10.4049/jimmunol.0901351; Scott NM, 2011, PHOTOCH PHOTOBIO SCI, V10, P1894, DOI 10.1039/c1pp05206c; Searing DA, 2010, J ALLERGY CLIN IMMUN, V125, P995, DOI 10.1016/j.jaci.2010.03.008; Sutherland ER, 2010, AM J RESP CRIT CARE, V181, P699, DOI 10.1164/rccm.200911-1710OC; Taher YA, 2008, J IMMUNOL, V180, P5211, DOI 10.4049/jimmunol.180.8.5211; Topilski I, 2004, EUR J IMMUNOL, V34, P1068, DOI 10.1002/eji.200324532; Tse SM, 2012, J ALLERGY CLIN IMMUN, V130, P53, DOI 10.1016/j.jaci.2012.04.005; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Van Overtvelt L, 2008, INT ARCH ALLERGY IMM, V145, P152, DOI 10.1159/000108140; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Wang P, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-7; Weiss ST, 2011, J ALLERGY CLIN IMMUN, V127, P1128, DOI 10.1016/j.jaci.2011.02.025; Wittke A, 2007, ARCH BIOCHEM BIOPHYS, V460, P306, DOI 10.1016/j.abb.2006.12.011; Wjst Matthias, 2009, Allergy Asthma Clin Immunol, V5, P8, DOI 10.1186/1710-1492-5-8; Yoshida R, 1997, J BIOL CHEM, V272, P13803, DOI 10.1074/jbc.272.21.13803; Zosky GR, 2007, CLIN EXP ALLERGY, V37, P973, DOI 10.1111/j.1365-2222.2007.02740.x; Zosky GR, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-15; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	72	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67823	10.1371/journal.pone.0067823	http://dx.doi.org/10.1371/journal.pone.0067823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826346	Green Published, gold			2022-12-27	WOS:000321738400172
J	Riccitelli, E; Giussani, P; Di Vito, C; Condomitti, G; Tringali, C; Caroli, M; Galli, R; Viani, P; Riboni, L				Riccitelli, Elena; Giussani, Paola; Di Vito, Clara; Condomitti, Giuseppe; Tringali, Cristina; Caroli, Manuela; Galli, Rossella; Viani, Paola; Riboni, Laura			Extracellular Sphingosine-1-Phosphate: A Novel Actor in Human Glioblastoma Stem Cell Survival	PLOS ONE			English	Article							SPHINGOSINE KINASE-1 EXPRESSION; GLIOMA-CELLS; MALIGNANT GLIOMAS; GENE-EXPRESSION; 1-PHOSPHATE; TEMOZOLOMIDE; APOPTOSIS; GROWTH; PROLIFERATION; POPULATION	Glioblastomas are the most frequent and aggressive intracranial neoplasms in humans, and despite advances and the introduction of the alkylating agent temozolomide in therapy have improved patient survival, resistance mechanisms limit benefits. Recent studies support that glioblastoma stem-like cells (GSCs), a cell subpopulation within the tumour, are involved in the aberrant expansion and therapy resistance properties of glioblastomas, through still unclear mechanisms. Emerging evidence suggests that sphingosine-1-phosphate (S1P) a potent onco-promoter able to act as extracellular signal, favours malignant and chemoresistance properties in GSCs. Notwithstanding, the origin of S1P in the GSC environment remains unknown. We investigated S1P metabolism, release, and role in cell survival properties of GSCs isolated from either U87-MG cell line or a primary culture of human glioblastoma. We show that both GSC models, grown as neurospheres and expressing GSC markers, are resistant to temozolomide, despite not expressing the DNA repair protein MGMT, a major contributor to temozolomide-resistance. Pulse experiments with labelled sphingosine revealed that both GSC types are able to rapidly phosphorylate the long-chain base, and that the newly produced S1P is efficiently degraded. Of relevance, we found that S1P was present in GSC extracellular medium, its level being significantly higher than in U87-MG cells, and that the extracellular/intracellular ratio of S1P was about ten-fold higher in GSCs. The activity of sphingosine kinases was undetectable in GSC media, suggesting that mechanisms of S1P transport to the extracellular environment are constitutive in GSCs. In addition we found that an inhibitor of S1P biosynthesis made GSCs sensitive to temozolomide (TMZ), and that exogenous S1P reverted this effect, thus involving extracellular S1P as a GSC survival signal in TMZ resistance. Altogether our data implicate for the first time GSCs as a pivotal source of extracellular S1P, which might act as an autocrine/paracrine signal contributing to their malignant properties.	[Riccitelli, Elena; Giussani, Paola; Di Vito, Clara; Condomitti, Giuseppe; Tringali, Cristina; Viani, Paola; Riboni, Laura] Univ Milan, LITA Segrate, Dept Med Biotechnol & Translat Med, Milan, Italy; [Caroli, Manuela] Maggiore Policlin Hosp, IRCCS Ca Granda Fdn, Milan, Italy; [Galli, Rossella] Ist Sci San Raffaele, Div Regenerat Med Stem Cells & Gene Therapy, Neural Stem Cell Biol Unit, I-20132 Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Riboni, L (corresponding author), Univ Milan, LITA Segrate, Dept Med Biotechnol & Translat Med, Milan, Italy.	laura.riboni@unimi.it	Caroli, Manuela/AAB-9019-2019; Galli, Rossella/AAI-8028-2020; VIANI, PAOLA/Q-5955-2017; Di Vito, Clara/ABC-3385-2020; Tringali, Cristina Alessandra/Q-7259-2017; Giussani, Paola/R-4268-2017; Riboni, Laura/R-4281-2017	Galli, Rossella/0000-0001-9023-7033; VIANI, PAOLA/0000-0002-5728-6631; Di Vito, Clara/0000-0001-7248-1710; Tringali, Cristina Alessandra/0000-0002-0632-6197; Giussani, Paola/0000-0002-7793-1757; Riboni, Laura/0000-0002-4149-8226; Condomitti, Giuseppe/0000-0003-1374-1038	University of Milan [PUR2009]; Italian Ministry of University and Scientific and Technological Research PRIN [2008PH4SMA]	University of Milan; Italian Ministry of University and Scientific and Technological Research PRIN(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the University of Milan PUR2009 and from the Italian Ministry of University and Scientific and Technological Research PRIN prot. 2008PH4SMA to L.R. and P.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altaner C, 2008, NEOPLASMA, V55, P369; Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; Anelli V, 2005, J NEUROCHEM, V92, P1204, DOI 10.1111/j.1471-4159.2004.02955.x; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Anelli V, 2010, FASEB J, V24, P2727, DOI 10.1096/fj.09-150540; Annabi B, 2009, MOL CARCINOGEN, V48, P910, DOI 10.1002/mc.20541; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bassi R, 2006, GLIA, V53, P621, DOI 10.1002/glia.20324; Bektas M, 2009, CANCER CHEMOTH PHARM, V64, P1053, DOI 10.1007/s00280-009-1063-0; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Dell'Albani P, 2008, NEUROCHEM RES, V33, P2407, DOI 10.1007/s11064-008-9723-8; Edsall LC, 2001, J NEUROCHEM, V76, P1573, DOI 10.1046/j.1471-4159.2001.00164.x; Estrada-Bernal A, 2012, NEURO-ONCOLOGY, V14, P405, DOI 10.1093/neuonc/nos005; Fu J, 2009, CHINESE MED J-PEKING, V122, P1255, DOI 10.3760/cma.j.issn.0366-6999.2009.11.004; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Giussani P, 2012, CANCER INVEST, V30, P27, DOI 10.3109/07357907.2011.629379; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hegi ME, 2004, CLIN CANCER RES, V10, P1871, DOI 10.1158/1078-0432.CCR-03-0384; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Kim K, 2007, J PHARM PHARMACOL, V59, P1035, DOI 10.1211/jpp.59.7.0017; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Kimura A, 2007, STEM CELLS, V25, P115, DOI 10.1634/stemcells.2006-0223; Le Stunff H, 2004, J CELL BIOCHEM, V92, P882, DOI 10.1002/h=jcb.20097; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li J, 2008, CLIN CANCER RES, V14, P6996, DOI 10.1158/1078-0432.CCR-08-0754; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu H, 2002, PROG NUCLEIC ACID RE, V71, P493, DOI 10.1016/S0079-6603(02)71049-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; Mora R, 2010, GLIA, V58, P1364, DOI 10.1002/glia.21013; Mutter N, 2006, EXPERT REV ANTICANC, V6, P1187, DOI 10.1586/14737140.6.8.1187; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Ostermann S, 2004, CLIN CANCER RES, V10, P3728, DOI 10.1158/1078-0432.CCR-03-0807; Piccirillo SGM, 2009, J MOL MED, V87, P1087, DOI 10.1007/s00109-009-0535-3; Pyne NJ, 2012, BIOCHEM SOC T, V40, P94, DOI 10.1042/BST20110602; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Riboni L, 2000, METHOD ENZYMOL, V311, P656; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Rigogliuso S, 2010, J ONCOL, V2010, DOI 10.1155/2010/509329; Salmaggi A, 2006, GLIA, V54, P850, DOI 10.1002/glia.20414; Serra M, 2010, ADV ENZYME REGUL, V50, P349, DOI 10.1016/j.advenzreg.2009.10.024; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Van Brocklyn JR, 2003, CANCER LETT, V199, P53, DOI 10.1016/S0304-3835(03)00334-3; Van Brocklyn JR, 2002, CANCER LETT, V181, P195, DOI 10.1016/S0304-3835(02)00050-2; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Villano JL, 2009, CANCER CHEMOTH PHARM, V64, P647, DOI 10.1007/s00280-009-1050-5; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yester JW, 2011, CANCER METAST REV, V30, P577, DOI 10.1007/s10555-011-9305-0; Young N, 2007, EXP CELL RES, V313, P1615, DOI 10.1016/j.yexcr.2007.02.009; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Zhang H, 2012, CELL PROLIFERAT, V45, P167, DOI 10.1111/j.1365-2184.2012.00807.x; Zhang MY, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-85	60	35	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e68229	10.1371/journal.pone.0068229	http://dx.doi.org/10.1371/journal.pone.0068229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826381	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400175
J	Bradford, JR; Farren, M; Powell, SJ; Runswick, S; Weston, SL; Brown, H; Delpuech, O; Wappett, M; Smith, NR; Carr, TH; Dry, JR; Gibson, NJ; Barry, ST				Bradford, James R.; Farren, Matthew; Powell, Steve J.; Runswick, Sarah; Weston, Susie L.; Brown, Helen; Delpuech, Oona; Wappett, Mark; Smith, Neil R.; Carr, T. Hedley; Dry, Jonathan R.; Gibson, Neil J.; Barry, Simon T.			RNA-Seq Differentiates Tumour and Host mRNA Expression Changes Induced by Treatment of Human Tumour Xenografts with the VEGFR Tyrosine Kinase Inhibitor Cediranib	PLOS ONE			English	Article							GENE-EXPRESSION; MICROARRAY DATA; LUNG ADENOCARCINOMA; CELL-POPULATIONS; CANCER; MODELS; GROWTH; MOUSE; ANGIOGENESIS; GENOME	Pre-clinical models of tumour biology often rely on propagating human tumour cells in a mouse. In order to gain insight into the alignment of these models to human disease segments or investigate the effects of different therapeutics, approaches such as PCR or array based expression profiling are often employed despite suffering from biased transcript coverage, and a requirement for specialist experimental protocols to separate tumour and host signals. Here, we describe a computational strategy to profile transcript expression in both the tumour and host compartments of pre-clinical xenograft models from the same RNA sample using RNA-Seq. Key to this strategy is a species-specific mapping approach that removes the need for manipulation of the RNA population, customised sequencing protocols, or prior knowledge of the species component ratio. The method demonstrates comparable performance to species-specific RT-qPCR and a standard microarray platform, and allowed us to quantify gene expression changes in both the tumour and host tissue following treatment with cediranib, a potent vascular endothelial growth factor receptor tyrosine kinase inhibitor, including the reduction of multiple murine transcripts associated with endothelium or vessels, and an increase in genes associated with the inflammatory response in response to cediranib. In the human compartment, we observed a robust induction of hypoxia genes and a reduction in cell cycle associated transcripts. In conclusion, the study establishes that RNA-Seq can be applied to pre-clinical models to gain deeper understanding of model characteristics and compound mechanism of action, and to identify both tumour and host biomarkers.				James.Bradford@astrazeneca.com		Bradford, James/0000-0002-7771-914X; Carr, Thomas/0000-0002-8147-9855	AstraZeneca	AstraZeneca(AstraZeneca)	The work was funded by AstraZeneca (www.astrazeneca.com) who are current employers of JRB, SJP, SR, SLW, HB, OD, MW, NRS, THC, JRD and STB, and past employers of MF and NJG. Other than the named authors, the funder had no direct role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bradford JR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-282; Brave SR, 2011, MOL CANCER THER, V10, P861, DOI 10.1158/1535-7163.MCT-10-0976; Cascone T, 2011, J CLIN INVEST, V121, P1313, DOI 10.1172/JCI42405; Clarke J, 2010, BIOINFORMATICS, V26, P1043, DOI 10.1093/bioinformatics/btq097; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Creighton C, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r46; Creighton CJ, 2005, MOL CANCER RES, V3, P119, DOI 10.1158/1541-7786.MCR-04-0189; Farren M, 2012, ANGIOGENESIS, V15, P555, DOI 10.1007/s10456-012-9280-2; Fu GCL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S1-S10; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Ghosh D, 2004, BIOINFORMATICS, V20, P1663, DOI 10.1093/bioinformatics/bth139; Gosink MM, 2007, BIOINFORMATICS, V23, P3328, DOI 10.1093/bioinformatics/btm508; Harrell JC, 2008, CLIN EXP METASTAS, V25, P81, DOI 10.1007/s10585-007-9105-7; Koehler R, 2011, BIOINFORMATICS, V27, P272, DOI 10.1093/bioinformatics/btq640; Lahdesmaki H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-54; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lu P, 2003, P NATL ACAD SCI USA, V100, P10370, DOI 10.1073/pnas.1832361100; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mura M, 2012, ONCOGENE, V31, P293, DOI 10.1038/onc.2011.233; Naef F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni104; Okoniewski MJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r79; Park ES, 2011, P NATL ACAD SCI USA, V108, P17456, DOI 10.1073/pnas.1114210108; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Shojaei F, 2007, NATURE, V450, P825, DOI 10.1038/nature06348; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Shojaei F, 2009, P NATL ACAD SCI USA, V106, P6742, DOI 10.1073/pnas.0902280106; Smith NR, 2007, MOL CANCER THER, V6, P2198, DOI 10.1158/1535-7163.MCT-07-0142; Smith NR, 2010, CLIN CANCER RES, V16, P3548, DOI 10.1158/1078-0432.CCR-09-2797; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Venet D, 2001, Bioinformatics, V17 Suppl 1, pS279; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wedge SR, 2005, CANCER RES, V65, P4389, DOI 10.1158/0008-5472.CAN-04-4409; Wilson CL, 2006, ENDOCR-RELAT CANCER, V13, P617, DOI 10.1677/erc.1.01165	39	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66003	10.1371/journal.pone.0066003	http://dx.doi.org/10.1371/journal.pone.0066003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840389	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000322361200047
J	Jessen, C; Roder, C; Lizcano, JFV; Voolstra, CR; Wild, C				Jessen, Christian; Roder, Cornelia; Lizcano, Javier Felipe Villa; Voolstra, Christian R.; Wild, Christian			In-Situ Effects of Simulated Overfishing and Eutrophication on Benthic Coral Reef Algae Growth, Succession, and Composition in the Central Red Sea	PLOS ONE			English	Article							GREAT-BARRIER-REEF; ORGANIC-MATTER RELEASE; NUTRIENT ENRICHMENT; SCLERACTINIAN CORALS; PRIMARY PRODUCERS; COMMUNITY STRUCTURE; CRUSTOSE CORALLINE; MICROBIAL ACTIVITY; WATER-QUALITY; PHASE-SHIFTS	Overfishing and land-derived eutrophication are major local threats to coral reefs and may affect benthic communities, moving them from coral dominated reefs to algal dominated ones. The Central Red Sea is a highly under-investigated area, where healthy coral reefs are contending against intense coastal development. This in-situ study investigated both the independent and combined effects of manipulated inorganic nutrient enrichment (simulation of eutrophication) and herbivore exclosure (simulation of overfishing) on benthic algae development. Light-exposed and shaded terracotta tiles were positioned at an offshore patch reef close to Thuwal, Saudi Arabia and sampled over a period of 4 months. Findings revealed that nutrient enrichment alone affected neither algal dry mass nor algae-derived C or N production. In contrast, herbivore exclusion significantly increased algal dry mass up to 300-fold, and in conjunction with nutrient enrichment, this total increased to 500-fold. Though the increase in dry mass led to a 7 and 8-fold increase in organic C and N content, respectively, the algal C/N ratio (18 +/- 1) was significantly lowered in the combined treatment relative to controls (26 +/- 2). Furthermore, exclusion of herbivores significantly increased the relative abundance of filamentous algae on the light-exposed tiles and reduced crustose coralline algae and non-coralline red crusts on the shaded tiles. The combination of the herbivore exclusion and nutrient enrichment treatments pronounced these effects. The results of our study suggest that herbivore reduction, particularly when coupled with nutrient enrichment, favors non-calcifying, filamentous algae growth with high biomass production, which thoroughly outcompetes the encrusting (calcifying) algae that dominates in undisturbed conditions. These results suggest that the healthy reefs of the Central Red Sea may experience rapid shifts in benthic community composition with ensuing effects for biogeochemical cycles if anthropogenic impacts, particularly overfishing, are not controlled.	[Jessen, Christian; Wild, Christian] Leibniz Ctr Trop Marine Ecol ZMT, Coral Reef Ecol Grp CORE, Bremen, Germany; [Roder, Cornelia; Lizcano, Javier Felipe Villa; Voolstra, Christian R.] KAUST, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Wild, Christian] Univ Bremen, Fac Biol & Chem, D-28359 Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); King Abdullah University of Science & Technology; University of Bremen	Jessen, C (corresponding author), Leibniz Ctr Trop Marine Ecol ZMT, Coral Reef Ecol Grp CORE, Bremen, Germany.	christian.jessen@zmt-bremen.de	Voolstra, Christian R/H-7158-2014	Voolstra, Christian R/0000-0003-4555-3795; Roder, Cornelia/0000-0003-1074-2473	Leibniz Center for Tropical Marine Ecology (ZMT); King Abdullah University of Science and Technology (KAUST)	Leibniz Center for Tropical Marine Ecology (ZMT); King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology)	This study was jointly funded by the Leibniz Center for Tropical Marine Ecology (ZMT) and the King Abdullah University of Science and Technology (KAUST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2011, GLOBAL CHANGE BIOL, V17, P1798, DOI 10.1111/j.1365-2486.2010.02364.x; Arar EJ., 1997, 4450 US EPA; Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; Ateweberhan M, 2006, CORAL REEFS, V25, P391, DOI 10.1007/s00338-006-0109-6; Baird AH, 2004, MAR FRESHWATER RES, V55, P469, DOI 10.1071/MF03121; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Barott KL, 2012, TRENDS MICROBIOL, V20, P621, DOI 10.1016/j.tim.2012.08.004; Bell PRF, 2007, AMBIO, V36, P416, DOI 10.1579/0044-7447(2007)36[416:ROESFT]2.0.CO;2; BELL PRF, 1992, WATER RES, V26, P553, DOI 10.1016/0043-1354(92)90228-V; Belliveau SA, 2002, MAR ECOL PROG SER, V232, P105, DOI 10.3354/meps232105; Benayahu Y, 1977, Proceedings int Coral Reef Symp, V3, P383; Birrell CL, 2008, OCEANOGR MAR BIOL, V46, P25; Bonaldo RM, 2008, MAR ECOL PROG SER, V360, P237, DOI 10.3354/meps07413; Boyer KE, 2004, CORAL REEFS, V23, P530, DOI 10.1007/s00338-004-0421-y; Brokovich E, 2010, MAR ECOL PROG SER, V399, P69, DOI 10.3354/meps08354; Burke L., 2011, REEFS RISK REVISITED; Burkepile DE, 2007, OECOLOGIA, V154, P167, DOI 10.1007/s00442-007-0801-4; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Burkepile DE, 2009, MAR ECOL PROG SER, V389, P71, DOI 10.3354/meps08142; CARPENTER RC, 1990, J PHYCOL, V26, P6, DOI 10.1111/j.0022-3646.1990.00006.x; Choat JH, 2004, MAR BIOL, V145, P445, DOI 10.1007/s00227-004-1341-7; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; Davey M, 2008, CORAL REEFS, V27, P227, DOI 10.1007/s00338-007-0316-9; Davis KA, 2011, CORAL REEFS, V30, P25, DOI 10.1007/s00338-011-0740-8; Debelius H, 2007, RIFF FUHRER ROTES ME; DEBOER JA, 1978, J PHYCOL, V14, P261, DOI 10.1111/j.1529-8817.1978.tb00296.x; Diaz-Pulido G, 2003, ECOLOGY, V84, P2026, DOI 10.1890/01-3127; Diaz-Pulido G, 2010, CORAL REEFS, V29, P203, DOI 10.1007/s00338-009-0573-x; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; Dinsdale EA, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P231, DOI 10.1007/978-94-007-0114-4_16; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; DOTAN A, 1990, CORAL REEFS, V9, P75, DOI 10.1007/BF00368802; Duhamel S, 2012, AQUAT MICROB ECOL, V67, P225, DOI 10.3354/ame01593; EBERT TA, 1975, AM ZOOL, V15, P755; Fabricius K, 2001, CORAL REEFS, V19, P303, DOI 10.1007/s003380000120; Fabricius KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054399; Ferrari R, 2012, CORAL REEFS, V31, P683, DOI 10.1007/s00338-012-0889-9; Ferreira CEL, 2006, J FISH BIOL, V69, P1533, DOI 10.1111/j.1095-8649.2006.01220.x; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; Figueiredo M.A.O., 2002, P 9 INT COR REEF S, V1, P493; FISHELSON L, 1973, OECOLOGIA, V12, P55, DOI 10.1007/BF00345470; Fong P, 2003, MAR ECOL PROG SER, V262, P111, DOI 10.3354/meps262111; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; FROESE R., 2012, FISHBASE; Furby KA, 2013, CORAL REEFS, V32, P505, DOI 10.1007/s00338-012-0998-5; Furman BT, 2008, MAR ECOL PROG SER, V363, P89, DOI 10.3354/meps07442; GENIN A, 1995, NATURE, V377, P507, DOI 10.1038/377507a0; Goecker ME, 2005, MAR ECOL PROG SER, V286, P239, DOI 10.3354/meps286239; Golbuu Y, 2007, MAR BIOL, V152, P639, DOI 10.1007/s00227-007-0717-x; Green A.L., 2009, MONITORING FUNCTIONA; Haas AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027973; Haas AF, 2010, MAR ECOL PROG SER, V409, P27, DOI 10.3354/meps08631; Harrington L, 2004, ECOLOGY, V85, P3428, DOI 10.1890/04-0298; HATCHER BG, 1983, J EXP MAR BIOL ECOL, V69, P61, DOI 10.1016/0022-0981(83)90172-7; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hixon MA, 1996, ECOL MONOGR, V66, P67, DOI 10.2307/2963481; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jessen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062091; Jessen C, 2013, MAR ECOL PROG SER, V476, P9, DOI 10.3354/meps10157; Jompa J, 2002, LIMNOL OCEANOGR, V47, P527, DOI 10.4319/lo.2002.47.2.0527; Khalaf M. A., 1997, FISHES GULF AQABA; Khalil MT, 2013, ENVIRON BIOL FISH, DOI [10.1007/s10641-012-0103-5, DOI 10.1007/S10641-012-0103-5:]; KINSEY DW, 1979, LIMNOL OCEANOGR, V24, P935, DOI 10.4319/lo.1979.24.5.0935; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Koop K, 2001, MAR POLLUT BULL, V42, P91, DOI 10.1016/S0025-326X(00)00181-8; Korzen L, 2011, J MARINE BIOL; Kuntz NM, 2005, MAR ECOL PROG SER, V294, P173, DOI 10.3354/meps294173; Lapointe BE, 1997, LIMNOL OCEANOGR, V42, P1119, DOI 10.4319/lo.1997.42.5_part_2.1119; LAPOINTE BE, 1981, J EXP MAR BIOL ECOL, V53, P135, DOI 10.1016/0022-0981(81)90015-0; Larkum AWD, 1997, 8 CORAL REEF S, V1, P881; Lieske E, 2009, KORALLENRIFF FUHRER; Littler M., 2011, ENCY MODERN CORAL RE, P20; Littler MM, 2006, J EXP MAR BIOL ECOL, V336, P242, DOI 10.1016/j.jembe.2006.05.014; Littler M.M., 1984, PROGR PHYCOLOGICAL R, V3, P323; Littler M. M, 1972, OCEANOGR MAR BIOL, V10, P103; Littler MM, 2007, AQUAT CONSERV, V17, P195, DOI 10.1002/aqc.790; Littler MM, 2006, HARMFUL ALGAE, V5, P565, DOI 10.1016/j.hal.2005.11.003; Lotze HK, 2000, OIKOS, V89, P46, DOI 10.1034/j.1600-0706.2000.890106.x; Loya Y, 2004, MAR POLLUT BULL, V49, P344, DOI 10.1016/j.marpolbul.2004.06.011; MACISAAC JJ, 1972, DEEP-SEA RES, V19, P209, DOI 10.1016/0011-7471(72)90032-0; McClanahan TR, 2004, MAR POLLUT BULL, V48, P196, DOI 10.1016/j.marpolbul.2003.10.004; McClanahan TR, 2003, MAR ECOL PROG SER, V261, P135, DOI 10.3354/meps261135; McClanahan TR, 2002, MAR POLLUT BULL, V44, P441, DOI 10.1016/S0025-326X(02)00051-6; McClanahan TR, 1997, J EXP MAR BIOL ECOL, V218, P77, DOI 10.1016/S0022-0981(97)00069-5; McClanahan TR, 1999, BIOL CONSERV, V89, P161, DOI 10.1016/S0006-3207(98)00123-2; Miller MW, 1996, ECOL MONOGR, V66, P323, DOI 10.2307/2963521; Miller MW, 1999, LIMNOL OCEANOGR, V44, P1847, DOI 10.4319/lo.1999.44.8.1847; Morse ANC, 1996, BIOL BULL, V191, P149, DOI 10.2307/1542917; Mumby PJ, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P509, DOI 10.1007/978-94-007-0114-4_29; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; MUTHIGA NA, 1987, AFR J ECOL, V25, P1, DOI 10.1111/j.1365-2028.1987.tb01085.x; Nadon MO, 2006, CORAL REEFS, V25, P177, DOI 10.1007/s00338-005-0074-5; O'Leary JK, 2012, CORAL REEFS, V31, P547, DOI 10.1007/s00338-012-0872-5; Paul VJ, 2011, MAR ECOL PROG SER, V426, P161, DOI 10.3354/meps09032; R Development Core Team, 2012, R LANG ENV STAT COMP; RANDALL JE, 1983, RED SEA REEF FISHES; Rasher DB, 2012, OECOLOGIA, V169, P187, DOI 10.1007/s00442-011-2174-y; Rasher DB, 2011, P NATL ACAD SCI USA, V108, P17726, DOI 10.1073/pnas.1108628108; Rasher DB, 2010, P NATL ACAD SCI USA, V107, P9683, DOI 10.1073/pnas.0912095107; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schaffelke B, 2005, MAR POLLUT BULL, V51, P279, DOI 10.1016/j.marpolbul.2004.10.025; Selman M., 2008, EUTROPHICATION HYPOX; Smith JE, 2001, CORAL REEFS, V19, P332, DOI 10.1007/s003380000124; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Smith JE, 2010, OECOLOGIA, V163, P497, DOI 10.1007/s00442-009-1546-z; Sotka EE, 2009, CORAL REEFS, V28, P555, DOI 10.1007/s00338-009-0529-1; Steneck R., 1997, P 8 INT COR REEF S, P695; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Suzuki G, 2011, J MAR BIOL ASSOC UK, V91, P677, DOI 10.1017/S0025315410000573; Sweatman H, 2008, CURR BIOL, V18, pR598, DOI 10.1016/j.cub.2008.05.033; Szmant A.M., 1997, P1527; TANNER JE, 1995, J EXP MAR BIOL ECOL, V190, P151, DOI 10.1016/0022-0981(95)00027-O; Thacker RW, 2001, CORAL REEFS, V19, P318, DOI 10.1007/s003380000122; Vermeij MJA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014312; VINE PJ, 1974, MAR BIOL, V24, P131, DOI 10.1007/BF00389347; Voss JD, 2006, CORAL REEFS, V25, P569, DOI 10.1007/s00338-006-0131-8; Wiedenmann J, 2013, NAT CLIM CHANGE, V3, P160, DOI 10.1038/NCLIMATE1661; WILD C, 2009, P 11 INT COR REEF S, P1319; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Wild C, 2010, MAR ECOL PROG SER, V411, P61, DOI 10.3354/meps08653; Wilkinson C, 2008, STATUS CORAL REEFS W; Williams ID, 2001, CORAL REEFS, V19, P358, DOI 10.1007/s003380000121; Wilson SK, 2003, OCEANOGR MAR BIOL, V41, P279	127	22	22	0	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66992	10.1371/journal.pone.0066992	http://dx.doi.org/10.1371/journal.pone.0066992			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840570	gold, Green Submitted, Green Published			2022-12-27	WOS:000322361200114
J	Stoffregen, TA; Chen, FC; Varlet, M; Alcantara, C; Bardy, BG				Stoffregen, Thomas A.; Chen, Fu-Chen; Varlet, Manuel; Alcantara, Cristina; Bardy, Benoit G.			Getting Your Sea Legs	PLOS ONE			English	Article							MOTION SICKNESS; POSTURAL INSTABILITY; STANCE WIDTH; STANDING POSTURE; VISUAL REFERENCE; BALANCE; DYNAMICS; SWAY; PERFORMANCE; TASKS	Sea travel mandates changes in the control of the body. The process by which we adapt bodily control to life at sea is known as getting one's sea legs. We conducted the first experimental study of bodily control as maritime novices adapted to motion of a ship at sea. We evaluated postural activity (stance width, stance angle, and the kinematics of body sway) before and during a sea voyage. In addition, we evaluated the role of the visible horizon in the control of body sway. Finally, we related data on postural activity to two subjective experiences that are associated with sea travel; seasickness, and mal de debarquement. Our results revealed rapid changes in postural activity among novices at sea. Before the beginning of the voyage, the temporal dynamics of body sway differed among participants as a function of their (subsequent) severity of seasickness. Body sway measured at sea differed among participants as a function of their (subsequent) experience of mal de debarquement. We discuss implications of these results for general theories of the perception and control of bodily orientation, for the etiology of motion sickness, and for general phenomena of perceptual-motor adaptation and learning.	[Stoffregen, Thomas A.] Univ Minnesota, Affordance Percept Act Lab, Minneapolis, MN 55455 USA; [Chen, Fu-Chen] Natl Pingtung Univ Sci & Technol, Dept Recreat Sport & Hlth Promot, Pingung, Taiwan; [Varlet, Manuel] Univ Montpellier I, EuroMov, Movement Hlth Lab, Montpellier, France; [Alcantara, Cristina] Univ Sao Paulo, Escola Educ Fis & Esporte, Sao Paulo, Brazil; [Bardy, Benoit G.] Univ Montpellier I, EuroMov, Movement Hlth Lab, Montpellier, France; [Bardy, Benoit G.] Inst Univ France, Paris, France	University of Minnesota System; University of Minnesota Twin Cities; National Pingtung University Science & Technology; Universite de Montpellier; Universidade de Sao Paulo; Universite de Montpellier; Institut Universitaire de France	Stoffregen, TA (corresponding author), Univ Minnesota, Affordance Percept Act Lab, Minneapolis, MN 55455 USA.	tas@umn.edu	Stoffregen, Thomas/ABC-8710-2021; Bardy, Benoît/AAU-3078-2021	Varlet, Manuel/0000-0001-5772-2061	University of Minnesota; University of Montpellier-1; University of Sao Paulo; National Pingtung University of Science and Technology	University of Minnesota(University of Minnesota System); University of Montpellier-1; University of Sao Paulo; National Pingtung University of Science and Technology	The study was supported by the University of Minnesota, the University of Montpellier-1, the University of Sao Paulo, and National Pingtung University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolph KE, 2012, PSYCHOL SCI, V23, P1387, DOI 10.1177/0956797612446346; Adolph KE, 2008, CHILD DEV, V79, P1648, DOI 10.1111/j.1467-8624.2008.01215.x; ATTIAS J, 1987, AVIAT SPACE ENVIR MD, V58, P60; Beer T., 1997, ENV OCEANOGRAPHY; BITTNER AC, 1985, NAV ENG J, V97, P205, DOI 10.1111/j.1559-3584.1985.tb01355.x; Black FO, 2001, ANN NY ACAD SCI, V942, P446, DOI 10.1111/j.1749-6632.2001.tb03765.x; BLES W, 1980, ACTA OTO-LARYNGOL, V89, P534, DOI 10.3109/00016488009127171; Carter R, 2006, ANTIQUITY, V80, P52, DOI 10.1017/S0003598X0009325X; Chen FC, 2012, J EXP PSYCHOL-APPL, V18, P203, DOI 10.1037/a0026661; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Clement G, 2010, NEUROSCI LETT, V468, P161, DOI 10.1016/j.neulet.2009.10.090; Cruise Lines International Association Inc, 2010, 2010 CLIA CRUIS MARK; Cruisefever.net, 2013, KEEP GETT SEAS CRUIS; Dizziness-and-balance.com, 2013, MOTION SICKNESS; Dobie TG, 2003, AVIAT SPACE ENVIR MD, V74, P838; Draper MH, 2001, HUM FACTORS, V43, P129, DOI 10.1518/001872001775992552; Erlandson JM, 2001, J ARCHAEOL RES, V9, P287, DOI 10.1023/A:1013062712695; Geurts ACH, 2005, GAIT POSTURE, V22, P267, DOI 10.1016/j.gaitpost.2004.10.002; Gibson J.J., 1966, SENSES CONSIDERED PE; GORDON CR, 1992, BRIT MED J, V304, P544, DOI 10.1136/bmj.304.6826.544; GORDON CR, 1995, J VESTIBUL RES-EQUIL, V5, P363, DOI 10.1016/0957-4271(95)00005-Z; Greenwald AG, 2012, PERSPECT PSYCHOL SCI, V7, P99, DOI 10.1177/1745691611434210; Griscom D, 2010, SEISMAC VERSION 3 0; HARM DL, 1994, J CLIN PHARMACOL, V34, P618, DOI 10.1002/j.1552-4604.1994.tb02015.x; Heitz D., 2018, MOTION SICKNESS; Howard I. P., 1982, HUMAN VISUAL ORIENTA; Jang J, 2008, CLIN BIOMECH, V23, P468, DOI 10.1016/j.clinbiomech.2007.11.011; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Koslucher F, 2012, GAIT POSTURE, V36, P605, DOI 10.1016/j.gaitpost.2012.05.027; Lackner JR, 1996, CURR OPIN NEUROBIOL, V6, P744, DOI 10.1016/S0959-4388(96)80023-7; LAWTHER A, 1988, AVIAT SPACE ENVIR MD, V59, P399; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Mayo AM, 2011, PSYCHOL SCI, V22, P118, DOI 10.1177/0956797610392927; McIlroy WE, 1997, CLIN BIOMECH, V12, P66, DOI 10.1016/S0268-0033(96)00040-X; Michalski A, 2012, GAIT POSTURE, V36, P449, DOI 10.1016/j.gaitpost.2012.04.005; Mochizuki L, 2006, J APPL BIOMECH, V22, P51, DOI 10.1123/jab.22.1.51; Nachum Z, 2004, LARYNGOSCOPE, V114, P581, DOI 10.1097/00005537-200403000-00036; Newell KM, 2001, PSYCHOL REV, V108, P57, DOI 10.1037//0033-295X.108.1.57; Oman CM, 1982, ACTA OTO-LARYNGOL, V44, P392, DOI DOI 10.3109/00016488209108197; Owen N, 1998, BRAIN RES BULL, V47, P471, DOI 10.1016/S0361-9230(98)00101-4; PAULUS W, 1989, EXP BRAIN RES, V78, P243; Plowright T, 2013, PREVENTING MOTION SI; Ray CC, 2011, NY TIMES, pD2; REASON JT, 1978, J ROY SOC MED, V71, P819, DOI 10.1177/014107687807101109; Reed-Jones RJ, 2012, GAIT POSTURE, V36, P430, DOI 10.1016/j.gaitpost.2012.03.027; RICCIO G E, 1991, Ecological Psychology, V3, P195, DOI 10.1207/s15326969eco0303_2; Riccio G. E., 1993, VARIABILITY MOTOR CO; Riccio G. E., 1995, LOCAL APPL ECOLOGICA, P122; RICCIO GE, 1992, J EXP PSYCHOL HUMAN, V18, P624, DOI 10.1037/0096-1523.18.3.624; Riley M.A., 2011, SCI MOTRICITE, V74, P5, DOI [DOI 10.1051/SM/2011117, https://doi.org/10.1051/sm/2011117]; Riley MA, 2005, J MOTOR BEHAV, V37, P311, DOI 10.3200/JMBR.37.4.311-324; ROLNICK A, 1989, AVIAT SPACE ENVIR MD, V60, P779; Saint Louis C, 2012, NY TIMES, pTR3; Scheffer AC, 2008, AGE AGEING, V37, P19, DOI 10.1093/ageing/afm169; Smart LJ, 2002, HUM FACTORS, V44, P451, DOI 10.1518/0018720024497745; Stanney K, 1998, INT J HUM-COMPUT INT, V10, P135, DOI 10.1207/s15327590ijhc1002_3; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Stevens SC, 2002, MAR TECHNOL SNAME N, V39, P29; Stoffregen TA, 2001, BEHAV BRAIN SCI, V24, P195, DOI 10.1017/S0140525X01003946; Stoffregen TA, 1998, BRAIN RES BULL, V47, P437, DOI 10.1016/S0361-9230(98)00102-6; Stoffregen TA, 2000, HUM MOVEMENT SCI, V19, P203, DOI 10.1016/S0167-9457(00)00009-9; Stoffregen TA, 1999, J EXP PSYCHOL HUMAN, V25, P1641; STOFFREGEN TA, 1988, PSYCHOL REV, V95, P3, DOI 10.1037/0033-295X.95.1.3; Stoffregen TA, 2011, SCI MOT, V74, P19, DOI DOI 10.1051/SM/2011111; Stoffregen TA, 2011, ECOL PSYCHOL, V23, P19, DOI 10.1080/10407413.2011.539102; Stoffregen TA, 2010, ECOL PSYCHOL, V22, P169, DOI 10.1080/10407413.2010.496645; Stoffregen TA, 2009, AVIAT SPACE ENVIR MD, V80, P1039, DOI 10.3357/ASEM.2538.2009; Stoffregen TA, 2009, AVIAT SPACE ENVIR MD, V80, P845, DOI 10.3357/ASEM.2572.2009; Tal D, 2010, NEUROSCI LETT, V479, P134, DOI 10.1016/j.neulet.2010.05.044; Varoqui D, 2010, GAIT POSTURE, V32, P34, DOI 10.1016/j.gaitpost.2010.03.004; Villard SJ, 2008, HUM FACTORS, V50, P332, DOI 10.1518/001872008X250728; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yokota Y, 2005, ACTA OTO-LARYNGOL, V125, P280, DOI 10.1080/00016480510003192; Yu YW, 2010, AVIAT SPACE ENVIR MD, V81, P375, DOI 10.3357/ASEM.2638.2010	75	72	72	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66949	10.1371/journal.pone.0066949	http://dx.doi.org/10.1371/journal.pone.0066949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190ST	23840560	Green Published, gold			2022-12-27	WOS:000322361200111
J	White, RL; Nash, G; Kavanagh, DPJ; Savage, COS; Kalia, N				White, Rebecca L.; Nash, Gerard; Kavanagh, Dean P. J.; Savage, Caroline O. S.; Kalia, Neena			Modulating the Adhesion of Haematopoietic Stem Cells with Chemokines to Enhance Their Recruitment to the Ischaemically Injured Murine Kidney	PLOS ONE			English	Article							BONE-MARROW; PROGENITOR CELLS; MYOCARDIAL-INFARCTION; STEM/PROGENITOR CELLS; REPERFUSION INJURY; ENDOTHELIAL-CELLS; CD34(+) CELLS; CD44; EXPRESSION; SDF-1	Introduction: Renal disease affects over 500 million people worldwide and is set to increase as treatment options are predominately supportive. Evidence suggests that exogenous haematopoietic stem cells (HSCs) can be of benefit but due to the rarity and poor homing of these cells, benefits are either minor or transitory. Mechanisms governing HSC recruitment to injured renal microcirculation are poorly understood; therefore this study determined (i) the adhesion molecules responsible for HSC recruitment to the injured kidney, (ii) if cytokine HSC pre-treatment can enhance their homing and (iii) the molecular mechanisms accountable for any enhancement. Methods: Adherent and free-flowing HSCs were determined in an intravital murine model of renal ischaemia-reperfusion injury. Some HSCs and animals were pre-treated prior to HSC infusion with function blocking antibodies, hyaluronidase or cytokines. Changes in surface expression and clustering of HSC adhesion molecules were determined using flow cytometry and confocal microscopy. HSC adhesion to endothelial counter-ligands (VCAM-1, hyaluronan) was determined using static adhesion assays in vitro. Results: CD49d, CD44, VCAM-1 and hyaluronan governed HSC adhesion to the IR-injured kidney. Both KC and SDF-1 alpha pretreatment strategies significantly increased HSC adhesion within injured kidney, whilst SDF-1 alpha also increased numbers continuing to circulate. SDF-1 alpha and KC did not increase CD49d or CD44 expression but increased HSC adhesion to VCAM-1 and hyaluronan respectively. SDF-1 alpha increased CD49d surface clustering, as well as HSC deformability. Conclusion: Increasing HSC adhesive capacity for its endothelial counter-ligands, potentially through surface clustering, may explain their enhanced renal retention in vivo. Furthermore, increasing HSC deformability through SDF-1 alpha treatment could explain the prolonged systemic circulation; the HSC can therefore continue to survey the damaged tissue instead of becoming entrapped within non-injured sites. Therefore manipulating these mechanisms of HSC recruitment outlined may improve the clinical outcome of cellular therapies for kidney disease.	[White, Rebecca L.; Nash, Gerard; Kavanagh, Dean P. J.; Kalia, Neena] Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Savage, Caroline O. S.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Kalia, N (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Sch Clin & Expt Med, Birmingham, W Midlands, England.	n.kalia@bham.ac.uk	Nash, Gerard B/E-4182-2010	Nash, Gerard B/0000-0002-5935-2831; KALIA, NEENA/0000-0003-2960-7829	Medical Research Council [G0900175-3/1]; British Heart Foundation [PG/08/043/25067]; British Heart Foundation [PG/11/114/29282] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This study was funded by the Medical Research Council (RLW, NK): G0900175-3/1; British Heart Foundation (DK, NK): PG/08/043/25067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Agrawal M, 2000, AM FAM PHYSICIAN, V61, P2077; Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Akhtar AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012800; Alexandre CS, 2009, STEM CELLS, V27, P682, DOI 10.1634/stemcells.2008-0496; Ando T, 2005, INFLAMM BOWEL DIS, V11, P258, DOI 10.1097/01.MIB.0000160807.53858.1c; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Burne MJ, 2001, J LEUKOCYTE BIOL, V70, P192; Bussolati B, 2009, CURR STEM CELL RES T, V4, P2, DOI 10.2174/157488809787169129; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Dai W, 2011, AM J TRANSPLANT, V11, P2297, DOI 10.1111/j.1600-6143.2011.03750.x; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; do O PP, 2002, BLOOD, V99, P3939, DOI 10.1182/blood.V99.11.3939; do O PP, 2001, EXP HEMATOL, V29, P1019, DOI 10.1016/S0301-472X(01)00666-X; Eltzschig HK, 2004, BRIT MED BULL, V70, P71, DOI 10.1093/bmb/ldh025; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Goransson V, 2004, NEPHROL DIAL TRANSPL, V19, P823, DOI 10.1093/ndt/gfh003; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Herrera MB, 2007, KIDNEY INT, V72, P430, DOI 10.1038/sj.ki.5002334; Holstein-Rathlou NH, 2011, AM J PHYSIOL-RENAL, V300, pF319, DOI 10.1152/ajprenal.00417.2010; Johnsson C, 1996, KIDNEY INT, V50, P1224, DOI 10.1038/ki.1996.431; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kavanagh DPJ, 2010, GUT, V59, P79, DOI 10.1136/gut.2008.168054; Kavanagh DP, 2011, STEM CELL REV; Kavanagh DP, 2012, CELL TRANSPLANT; Khaldoyanidi S, 1996, J LEUKOCYTE BIOL, V60, P579, DOI 10.1002/jlb.60.5.579; Kumar S, 2007, FASEB J, V21, P3917, DOI 10.1096/fj.07-8275com; Lanzoni G, 2008, WORLD J GASTROENTERO, V14, P4616, DOI 10.3748/wjg.14.4616; Lewington AJP, 2000, AM J PHYSIOL-REG I, V278, pR247, DOI 10.1152/ajpregu.2000.278.1.R247; Li B, 2010, CIRCULATION, V121, P2211, DOI 10.1161/CIRCULATIONAHA.109.928796; Li L, 2011, AM J PHYSL RENAL PHY; Li L, 2012, AM J PHYSIOL-RENAL, V302, pF9, DOI 10.1152/ajprenal.00377.2011; Liekens S, 2010, CURR PHARM DESIGN, V16, P3903, DOI 10.2174/138161210794455003; Lin FM, 2003, J AM SOC NEPHROL, V14, P1188, DOI 10.1097/01.ASN.0000061595.28546.A0; Long DA, 2012, NAT REV NEPHROL, V8, P244, DOI 10.1038/nrneph.2011.219; Marelli-Berg FM, 2000, J IMMUNOL METHODS, V244, P205, DOI 10.1016/S0022-1759(00)00258-1; Melo NM, 2010, AM J PHYSIOL-RENAL, V299, pF1299, DOI 10.1152/ajprenal.00217.2010; Molls RR, 2006, AM J PHYSIOL-RENAL, V290, pF1187, DOI 10.1152/ajprenal.00342.2005; Oostendorp RAJ, 2000, BONE MARROW TRANSPL, V26, P559, DOI 10.1038/sj.bmt.1702536; PAPAYANNOPOULOU T, 1995, P NATL ACAD SCI USA, V92, P9647, DOI 10.1073/pnas.92.21.9647; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Peled A, 1999, J CLIN INVEST, V104, P1199, DOI 10.1172/JCI7615; Pinto do O P, 1998, EMBO J, V17, P5744, DOI 10.1093/emboj/17.19.5744; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; Stern JM, 2004, AM J PHYSIOL-RENAL, V286, pF509, DOI 10.1152/ajprenal.00253.2002; Stroo I, 2009, NEPHROL DIAL TRANSPL, V24, P2082, DOI 10.1093/ndt/gfp050; Tang YL, 2005, REGUL PEPTIDES, V125, P1, DOI 10.1016/j.regpep.2004.10.014; Termeer C, 2001, J LEUKOCYTE BIOL, V70, P715; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Togel FE, 2012, AM J KIDNEY DIS, V60, P1012, DOI 10.1053/j.ajkd.2012.08.034; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Tse WY, 2005, KIDNEY INT, V67, P130, DOI 10.1111/j.1523-1755.2005.00063.x; TURNER ML, 1995, STEM CELLS, V13, P311, DOI 10.1002/stem.5530130312; van Kooyk Y, 2000, CURR OPIN CELL BIOL, V12, P542, DOI 10.1016/S0955-0674(00)00129-0; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Vermeulen M, 1998, BLOOD, V92, P894, DOI 10.1182/blood.V92.3.894.415k22_894_900; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Yuen DA, 2012, SEMIN NEPHROL, V32, P215, DOI 10.1016/j.semnephrol.2012.02.008	62	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66489	10.1371/journal.pone.0066489	http://dx.doi.org/10.1371/journal.pone.0066489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840488	gold, Green Submitted, Green Published			2022-12-27	WOS:000322361200086
J	Grayton, HM; Missler, M; Collier, DA; Fernandes, C				Grayton, Hannah Mary; Missler, Markus; Collier, David Andrew; Fernandes, Cathy			Altered Social Behaviours in Neurexin 1 alpha Knockout Mice Resemble Core Symptoms in Neurodevelopmental Disorders	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; ALPHA-NEUREXINS; MENTAL-RETARDATION; MOUSE MODELS; NEUROPSYCHIATRIC DISORDERS; COGNITIVE IMPAIRMENTS; STRUCTURAL VARIANTS; BETA-NEUREXINS; ANIMAL-MODELS; CA2+ CHANNELS	Background: Copy number variants have emerged as an important genomic cause of common, complex neurodevelopmental disorders. These usually change copy number of multiple genes, but deletions at 2p16.3, which have been associated with autism, schizophrenia and mental retardation, affect only the neurexin 1 gene, usually the alpha isoform. Previous analyses of neurexin 1 alpha (Nrxn1 alpha) knockout (KO) mouse as a model of these disorders have revealed impairments in synaptic transmission but failed to reveal defects in social behaviour, one of the core symptoms of autism. Methods: We performed a detailed investigation of the behavioural effects of Nrxn1 alpha deletion in mice bred onto a pure genetic background (C57BL/6J) to gain a better understanding of its role in neurodevelopmental disorders. Wildtype, heterozygote and homozygote Nrxn1 alpha KO male and female mice were tested in a battery of behavioural tests (n = 9-16 per genotype, per sex). Results: In homozygous Nrxn1 alpha KO mice, we observed altered social approach, reduced social investigation, and reduced locomotor activity in novel environments. In addition, male Nrxn1 alpha KO mice demonstrated an increase in aggressive behaviours. Conclusions: These are the first experimental data that associate a deletion of Nrxn1 alpha with alterations of social behaviour in mice. Since this represents one of the core symptom domains affected in autism spectrum disorders and schizophrenia in humans, our findings suggest that deletions within NRXN1 found in patients may be responsible for the impairments seen in social behaviours, and that the Nrxn1 alpha KO mice are a useful model of human neurodevelopmental disorder.	[Grayton, Hannah Mary; Fernandes, Cathy] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London WC2R 2LS, England; [Missler, Markus] Univ Munster, Inst Anat & Mol Neurobiol, D-48149 Munster, Germany; [Collier, David Andrew] Eli Lilly & Co Ltd, Discovery Neurosci Res, Windlesham, Surrey, England	University of London; King's College London; University of Munster; Eli Lilly	Fernandes, C (corresponding author), Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, Crespigny Pk, London WC2R 2LS, England.	catherine.fernandes@kcl.ac.uk	Grayton, Hannah/A-9995-2013; Fernandes, Cathy/F-3422-2011; Collier, David A/D-1649-2011	Collier, David A/0000-0003-4087-1559; Fernandes, Cathy/0000-0001-7318-3352; Missler, Markus/0000-0001-8008-984X	Institute of Psychiatry, King's College London; Deutsche Forschungsgemeinschaft [SFB629TPB11]; Eli Lilly and Company Ltd.; Medical Research Council [G9817803B] Funding Source: researchfish	Institute of Psychiatry, King's College London; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Eli Lilly and Company Ltd.(Eli Lilly); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funds of the Institute of Psychiatry, King's College London, the Deutsche Forschungsgemeinschaft (grant SFB629TPB11, to M.M.) and Eli Lilly and Company Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Brown RZ, 1953, ECOL MONOGR, V23, P23; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Bucan M, 2002, NAT REV GENET, V3, P114, DOI 10.1038/nrg728; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Davisson MT, 1997, TRANSGENIC RES, V6, P309, DOI 10.1023/A:1018466830035; DOTY RL, 1986, EXPERIENTIA, V42, P257, DOI 10.1007/BF01942506; Dudanova I, 2006, J NEUROSCI, V26, P10599, DOI 10.1523/JNEUROSCI.1913-06.2006; Easton AC, 2011, NEUROPHARMACOLOGY, V61, P1424, DOI 10.1016/j.neuropharm.2011.08.036; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Fernandes C, 2006, GENES BRAIN BEHAV, V5, P433, DOI 10.1111/j.1601-183X.2005.00176.x; Fernando ABP, 2011, ANNU REV CLIN PSYCHO, V7, P39, DOI 10.1146/annurev-clinpsy-032210-104454; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Ghebranious N, 2007, AM J MED GENET A, V143A, P1462, DOI 10.1002/ajmg.a.31837; Grayton HM, 2012, PROG NEUROBIOL, V99, P81, DOI 10.1016/j.pneurobio.2012.07.005; Gregor A, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-106; Harrison V, 2011, AM J MED GENET A, V155A, P2826, DOI 10.1002/ajmg.a.34255; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028; Kas MJH, 2007, MOL PSYCHIATR, V12, P324, DOI 10.1038/sj.mp.4001979; Kattenstroth G, 2004, P NATL ACAD SCI USA, V101, P2607, DOI 10.1073/pnas.0308626100; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Laarakker MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031503; Lad HV, 2010, PHYSIOL BEHAV, V99, P301, DOI 10.1016/j.physbeh.2009.11.007; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Nielsen DM, 2002, BRAIN RES, V927, P8, DOI 10.1016/S0006-8993(01)03309-1; Nomura J, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/589524; Parmigiani S, 1998, NEUROSCI BIOBEHAV R, V23, P143, DOI 10.1016/S0149-7634(98)00016-5; Peripato AC, 2002, AM NAT, V160, pS173, DOI 10.1086/342900; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Piskulic D, 2007, PSYCHIAT RES, V150, P111, DOI 10.1016/j.psychres.2006.03.018; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; Reichelt AC, 2012, NEUROPHARMACOLOGY, V62, P1519, DOI 10.1016/j.neuropharm.2011.01.024; Reissner C, 2008, P NATL ACAD SCI USA, V105, P15124, DOI 10.1073/pnas.0801639105; Reissner CRF, GENOME BIOL IN PRESS; Rozic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018579; Rozic-Kotliroff G, 2007, BIOCHEM BIOPH RES CO, V352, P226, DOI 10.1016/j.bbrc.2006.11.008; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Schaaf CP, 2012, EUR J HUM GENET, V20, P1240, DOI 10.1038/ejhg.2012.95; SCHNEIDER CW, 1970, NATURE, V225, P1262, DOI 10.1038/2251262a0; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; STJOHN RD, 1973, BEHAV BIOL, V9, P635, DOI 10.1016/S0091-6773(73)80058-6; Takao K, 2013, DEFICIENCY SCHNURRI; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Voineskos AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020982; VOMSAAL FS, 1976, BEHAV BIOL, V17, P391, DOI 10.1016/S0091-6773(76)90740-9; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; WING L, 1981, J AUTISM DEV DISORD, V11, P31, DOI 10.1007/BF01531339; Winslow JT, 2003, MOUSE SOCIAL RECOGNI; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Yang M, 2011, AUTOMATED 3 CHAMBERE; Yang M, 2009, SIMPLE BEHAV ASSESSM, DOI DOI 10.1002/0471142301.NS0824S48; Zahir FR, 2008, J MED GENET, V45, P239, DOI 10.1136/jmg.2007.054437; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	70	106	108	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67114	10.1371/journal.pone.0067114	http://dx.doi.org/10.1371/journal.pone.0067114			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840597	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400034
J	Zhang, WW; Sun, Q; Gao, XL; Jiang, YM; Li, RT; Ye, J				Zhang, Weiwei; Sun, Qi; Gao, Xiaoli; Jiang, Yimin; Li, Runtao; Ye, Jia			Anti-Inflammation of Spirocyclopiperazinium Salt Compound LXM-10 Targeting alpha 7 nAChR and M4 mAChR and Inhibiting JAK2/STAT3 Pathway in Rats	PLOS ONE			English	Article							CYTOKINE PRODUCTION; VAGUS NERVE; TRANSCRIPTION; SURVIVAL; RELEASE; STIMULATION; ACTIVATION; EXPRESSION; ENDOTOXIN; CNI-1493	The present study aims to investigate the therapeutic effects of LXM-10 by intragastric administration in both acute and chronic inflammatory models, and to explore the underlying molecular mechanisms. The results showed that LXM-10 produced significant anti-inflammatory effects on carrageenan induced paw edema and complete Freund's adjuvant (CFA) induced arthritis, in which LXM-10 inhibited paw swelling in a dose-and time-dependent manner. ELISA analysis showed the production of pro-inflammatory cytokines including TNF-alpha and IL-6 was decreased by LXM-10. Western blot analysis showed that LXM-10 significantly reduced phosphorylation of Janus kinase 2 (JAK2) and further blunted phosphorylation of signal transducer and activator of transcription-3 (STAT3). The effects that LXM-10 had shown were attenuated by methyllycaconitine citrate (an alpha 7 nicotinic acetylcholine receptor antagonist) or tropicamide (an M4 muscarinic acetylcholine receptor antagonist) in vivo. In conclusion, the studies showed that intragastric administration of LXM-10 exerted significant anti-inflammation effects in acute and chronic models, which may be attribute to the activation of alpha 7 nicotinic acetylcholine receptor and M4 muscarinic acetylcholine receptor, thereby inhibiting the JAK2/STAT3 signal pathway, and ultimately reducing the production of pro-inflammatory cytokines of TNF-alpha and IL-6.	[Zhang, Weiwei; Li, Runtao; Ye, Jia] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Zhang, Weiwei; Gao, Xiaoli; Ye, Jia] Peking Univ, Dept Mol & Cellular Pharmacol, Sch Pharmaceut Sci, Beijing 100871, Peoples R China; [Sun, Qi; Li, Runtao] Peking Univ, Dept Biol Chem, Sch Pharmaceut Sci, Beijing 100871, Peoples R China; [Jiang, Yimin] Peking Univ, Med & Hlth Anal Ctr, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University	Ye, J (corresponding author), Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China.	yejia@bjmu.edu.cn			National Science Foundation of China [NSFC 20772009]; Beijing Municipal Natural Science Foundation [7122097]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	The work was supported by the funds of National Science Foundation of China (NSFC 20772009, URL:http://www.nsfc.gov.cn/Portal0/default152.htm), and the Beijing Municipal Natural Science Foundation (7122097, URL:http://www.bjnsf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bowman G, 2006, NEUROCRIT CARE, V5, P222, DOI 10.1385/NCC:5:3:222; Buccafusco JJ, 2005, TRENDS PHARMACOL SCI, V26, P352, DOI 10.1016/j.tips.2005.05.007; Davies NM, 2000, J PHARM PHARM SCI, V3, P137; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Ferrucci L, 2004, AGING CLIN EXP RES, V16, P240, DOI 10.1007/BF03327390; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Gallowitsch-Puerta M, 2007, LIFE SCI, V80, P2325, DOI 10.1016/j.lfs.2007.01.002; Hui L, 2009, J TRAUMA, V66, P859, DOI 10.1097/TA.0b013e318164d05f; James MW, 2003, BRIT J CLIN PHARMACO, V56, P146, DOI 10.1046/j.1365-2125.2003.01934.x; Kawashima K, 2007, LIFE SCI, V80, P2314, DOI 10.1016/j.lfs.2007.02.036; Kim JH, 2009, J IMMUNOL, V182, P2458, DOI 10.4049/jimmunol.0801364; Kumar V. L., 2006, Inflammopharmacology, V14, P17, DOI 10.1007/s10787-006-1512-x; Lee JY, 2001, INFECT IMMUN, V69, P2847, DOI 10.1128/IAI.69.5.2847-2852.2001; Liu H, 2007, SHOCK, V27, P55, DOI 10.1097/01.shk.0000233197.40989.31; Marrero MB, 2009, BRAIN RES, V1256, P1, DOI 10.1016/j.brainres.2008.11.053; Marrero MB LR, 2010, PHARM EXP THER, V332, P73; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Oettinger CW, 2010, J MICROENCAPSUL, V27, P372, DOI 10.3109/02652040903243437; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Pena G, 2010, EUR J IMMUNOL, V40, P2580, DOI 10.1002/eji.201040540; Pena G, 2010, J MOL MED, V88, P851, DOI 10.1007/s00109-010-0628-z; Ruetten H, 1997, BRIT J PHARMACOL, V122, P59, DOI 10.1038/sj.bjp.0701345; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Shined ASP UA, 1999, J ETHNOPHARMACOL, V65, P21; Tsai CC, 1999, J ETHNOPHARMACOL, V64, P85, DOI 10.1016/S0378-8741(98)00108-1; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Xiong YL, 2010, PHARMACOL BIOCHEM BE, V95, P192, DOI 10.1016/j.pbb.2010.01.004; Xiong YL, 2010, EUR J PHARMACOL, V626, P290, DOI 10.1016/j.ejphar.2009.10.003; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Yue CQ, 2007, PHARMACOL BIOCHEM BE, V86, P643, DOI 10.1016/j.pbb.2007.02.009	38	12	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66895	10.1371/journal.pone.0066895	http://dx.doi.org/10.1371/journal.pone.0066895			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840548	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400023
J	Jackson-Sillah, D; Cliff, JM; Mensah, GI; Dickson, E; Sowah, S; Tetteh, JKA; Addo, KK; Ottenhoff, THM; Bothamley, G; Dockrell, HM				Jackson-Sillah, Dolly; Cliff, Jacqueline M.; Mensah, Gloria Ivy; Dickson, Emmanuel; Sowah, Sandra; Tetteh, John K. A.; Addo, Kwasi K.; Ottenhoff, Tom H. M.; Bothamley, Graham; Dockrell, Hazel M.			Recombinant ESAT-6-CFP10 Fusion Protein Induction of Th1/Th2 Cytokines and FoxP3 Expressing Treg Cells in Pulmonary TB	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; MYCOBACTERIUM-TUBERCULOSIS; ACTIVE TUBERCULOSIS; REGULATORY CELLS; INFECTION; DISEASE; INTERLEUKIN-4; DIAGNOSIS; RESPONSES; ESAT-6/CFP-10	Background: Early secretory antigenic target 6 (ESAT-6) and culture filtrate protein 10 (CFP-10) are Mycobacterium tuberculosis (Mtb)-specific antigens that are secreted by actively metabolising bacteria and contribute to the virulence of the bacteria. Their ability to induce Treg and Th2 responses, particularly during the first two weeks of treatment, has not been comprehensively examined to date. The purpose of this work was to characterise Th1, Th2 and Treg responses to rESAT-6-CFP10 fusion protein in TB patients before and during the intensive phase of treatment and in healthy M. bovis BCG vaccinated donors. Methods: Forty-six newly diagnosed, HIV-negative, smear-positive pulmonary TB patients and 20 healthy donors were recruited in the UK and Ghana. Their peripheral blood mononuclear cells (PBMC) were used in ex vivo ELISPOT and in vitro cultures to identify immunological parameters of interest. Results: The study confirmed that protective immune responses to rESAT-6-CFP10 are impaired in active TB but improved during treatment: circulating antigen-specific IL-4-producing T-cells were increased in untreated TB but declined by two weeks of treatment while the circulating antigen-specific IFN-gamma producing T cells which showed a transient rise at one week of treatment, persisted at baseline levels at two months of treatment. In vitro T cell proliferation and IFN-gamma production were reduced, while IL-4 and CD4(+)FoxP3(+)CD25(hi) cell expression were increased in response to rESAT-6-CFP10 fusion protein in untreated TB. These responses were reversed during early treatment of TB. Conclusions: These observations support further investigations into the possible utility of these parameters as markers of active disease and favourable treatment outcomes.	[Jackson-Sillah, Dolly; Cliff, Jacqueline M.; Dockrell, Hazel M.] LSHTM, Fac Infect & Trop Dis, London, England; [Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Jackson-Sillah, Dolly; Mensah, Gloria Ivy; Dickson, Emmanuel; Sowah, Sandra; Tetteh, John K. A.; Addo, Kwasi K.] NMIMR, Accra, Ghana; [Bothamley, Graham] Homerton Univ Hosp, Dept Resp Dis, London, England	University of London; London School of Hygiene & Tropical Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; Queen Mary University London	Jackson-Sillah, D (corresponding author), LSHTM, Fac Infect & Trop Dis, London, England.	dolly.jackson-sillah@lshtm.ac.uk	Sowah, Sandra Akoley/E-4294-2019	Sowah, Sandra Akoley/0000-0003-3339-3763; Mensah, Gloria Ivy/0000-0002-6499-5946; Dockrell, Hazel/0000-0003-1869-9107; Cliff, Jackie/0000-0002-5653-1818	Commonwealth Scholarship Secretariat [GMCS-2004-409]; Afrique-One Consortium for Ecosystem and Population Health; British Federation of Women Graduates (CoA-1.Jackson-Sillah Dolly) [78060]	Commonwealth Scholarship Secretariat; Afrique-One Consortium for Ecosystem and Population Health; British Federation of Women Graduates (CoA-1.Jackson-Sillah Dolly)	This study was funded by the Commonwealth Scholarship Secretariat (GMCS-2004-409; http://www.thecommonwealth.org), Afrique-One Consortium for Ecosystem and Population Health (http://www.afriqueone.net) and the British Federation of Women Graduates (CoA-1.Jackson-Sillah Dolly 78060; http://www.bfwg.org.uk). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Bothamley GH, 2004, CLIN DIAGN LAB IMMUN, V11, P942, DOI 10.1128/CDLI.11.5.942-951.2004; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006; Chee CBE, 2010, EUR RESPIR J, V36, P355, DOI 10.1183/09031936.00151309; Chen XC, 2007, CLIN IMMUNOL, V123, P50, DOI 10.1016/j.clim.2006.11.009; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Dwivedi VP, 2012, J BIOL CHEM; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Ganguly N, 2008, IMMUNOL CELL BIOL, V86, P98, DOI 10.1038/sj.icb.7100117; Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; HORWITZ MA, 1995, P NATL ACAD SCI USA, V92, P1530, DOI 10.1073/pnas.92.5.1530; Hussain R, 2011, J CLIN IMMUNOL, V31, P913, DOI 10.1007/s10875-011-9566-y; Kamath AT, 1999, INFECT IMMUN, V67, P1702; Lalvani A, 2004, CLIN INFECT DIS, V38, P757, DOI 10.1086/381763; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Lee SW, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-300; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Marin ND, 2010, TUBERCULOSIS, V90, P252, DOI 10.1016/j.tube.2010.05.003; Ordway DJ, 2004, J INFECT DIS, V190, P756, DOI 10.1086/422532; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pathan AA, 2001, J IMMUNOL, V167, P5217, DOI 10.4049/jimmunol.167.9.5217; Quinn KM, 2006, IMMUNOL CELL BIOL, V84, P467, DOI 10.1111/j.1440-1711.2006.01460.x; Ribeiro S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-23; Ribeiro-Rodrigues R, 2006, CLIN EXP IMMUNOL, V144, P25, DOI 10.1111/j.1365-2249.2006.03027.x; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Singh B, 2003, CLIN EXP IMMUNOL, V134, P70, DOI 10.1046/j.1365-2249.2003.02258.x; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; van Crevel R, 2000, J INFECT DIS, V181, P1194, DOI 10.1086/315325; Wassie L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001522; Yamaguchi T, 2007, IMMUNITY, V27, P145, DOI 10.1016/j.immuni.2007.04.017; Zelenay S, 2005, P NATL ACAD SCI USA, V102, P4091, DOI 10.1073/pnas.0408679102	39	21	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68121	10.1371/journal.pone.0068121	http://dx.doi.org/10.1371/journal.pone.0068121			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826366	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000321150000120
J	Kumar, RD; Chang, LW; Ellis, MJ; Bose, R				Kumar, Runjun D.; Chang, Li-Wei; Ellis, Matthew J.; Bose, Ron			Prioritizing Potentially Druggable Mutations with dGene: An Annotation Tool for Cancer Genome Sequencing Data	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; INFORMATION-SYSTEM; EXPRESSION; GENES; TPIP	A major goal of cancer genome sequencing is to identify mutations or other somatic alterations that can be targeted by selective and specific drugs. dGene is an annotation tool designed to rapidly identify genes belonging to one of ten druggable classes that are frequently targeted in cancer drug development. These classes were comprehensively populated by combining and manually curating data from multiple specialized and general databases. dGene was used by The Cancer Genome Atlas squamous cell lung cancer project, and here we further demonstrate its utility using recently released breast cancer genome sequencing data. dGene is designed to be usable by any cancer researcher without the need for support from a bioinformatics specialist. A full description of dGene and options for its implementation are provided here.	[Kumar, Runjun D.; Ellis, Matthew J.; Bose, Ron] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Kumar, Runjun D.] Washington Univ, Div Biol & Biomed Sci, Computat & Syst Biol Program, St Louis, MO USA; [Chang, Li-Wei] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Ellis, Matthew J.; Bose, Ron] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Bose, R (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.	rbose@dom.wustl.edu			NIH [R01CA095614, U01HG00651701]; Edward Mallinckrodt, Jr. Foundation; Ohana Breast Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA095614] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt, Jr. Foundation; Ohana Breast Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support for this work was provided by NIH grants R01CA095614 and U01HG00651701 (to MJE), and the Edward Mallinckrodt, Jr. Foundation and the 'Ohana Breast Cancer Research Fund (to RB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Condomines M, 2009, J IMMUNOL, V183, P832, DOI 10.4049/jimmunol.0803298; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; Huang DW, 2008, BIOINFORMATION, V2, P428; Kelemen LE, 2009, CANCER EPIDEM BIOMAR, V18, P1864, DOI 10.1158/1055-9965.EPI-08-0486; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mishra RR, 2012, MOL BIOL REP, V39, P7389, DOI 10.1007/s11033-012-1571-6; Mishra RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028433; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pejovic T, 2009, TRANSL ONCOL, V2, P341, DOI 10.1593/tlo.09199; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Somaiah N, 2011, J THORAC ONCOL, V6, pS1758, DOI 10.1097/01.JTO.0000407557.30793.a6; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Vroling B, 2012, NUCLEIC ACIDS RES, V40, pD377, DOI 10.1093/nar/gkr960; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Weber A, 2003, CLIN CANCER RES, V9, P5683	25	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67980	10.1371/journal.pone.0067980	http://dx.doi.org/10.1371/journal.pone.0067980			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826350	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000104
J	Pike, BL; Guerry, P; Poly, F				Pike, Brian L.; Guerry, Patricia; Poly, Frederic			Global Distribution of Campylobacter jejuni Penner Serotypes: A Systematic Review	PLOS ONE			English	Review							HEAT-STABLE ANTIGENS; FRAGMENT-LENGTH-POLYMORPHISM; GUILLAIN-BARRE-SYNDROME; NEW-ZEALAND; DIARRHEAL DISEASE; PASSIVE HEMAGGLUTINATION; HOSPITALIZED-PATIENTS; DIRECT AGGLUTINATION; CENTRAL AUSTRALIA; COLI STRAINS	Penner serotyping has been the principal method for differentiating Campylobacter isolates since its inception. Campylobacter capsule polysaccharide (CPS), the principal serodeterminant on which Penner serotyping is based, is presently of interest as a vaccine component. To determine the required valency of an effective CPS-based vaccine, a comprehensive understanding of CPS distribution is needed. Because of the association between Penner serotype and CPS, we conducted a systematic review to estimate the frequency and distribution of Penner serotypes associated with cases of Campylobacteriosis. In total, more than 21,000 sporadic cases of C. jejuni cases were identified for inclusion. While regional variation exists, distribution estimates indicate that eight serotypes accounted for more than half of all sporadic diarrheal cases globally and three serotypes (HS4 complex, HS2, and HS1/44) were dominant inter-regionally as well as globally. Furthermore, a total of 17 different serotypes reached a representation of 2% or greater in at least one of the five regions sampled. While this review is an important first step in defining CPS distribution, these results make it clear that significant gaps remain in our knowledge. Eliminating these gaps will be critical to future vaccine development efforts.	[Pike, Brian L.; Guerry, Patricia; Poly, Frederic] Naval Med Res Ctr, Enter Dis Dept, Infect Dis Directorate, Silver Spring, MD 20910 USA	Naval Medical Research Center (NMRC)	Pike, BL (corresponding author), Naval Med Res Ctr, Enter Dis Dept, Infect Dis Directorate, Silver Spring, MD 20910 USA.	brian.pike@med.navy.mil			U.S. Navy Work Unit [6000.RAD1.DA3.A0308]; Military Infectious Disease Research Program	U.S. Navy Work Unit; Military Infectious Disease Research Program	This work supported by U.S. Navy Work Unit [6000.RAD1.DA3.A0308]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The views expressed in this article are those of the author and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government. This is a US Government work. There are no restrictions on its use. There were no financial conflicts of interests among any of the authors. This study was conducted under support of the Military Infectious Disease Research Program.	ALBERT MJ, 1992, J CLIN MICROBIOL, V30, P207, DOI 10.1128/JCM.30.1.207-210.1992; ALBERT MJ, 1992, J MED MICROBIOL, V37, P176, DOI 10.1099/00222615-37-3-176; Asrat DA, 1997, EPIDEMIOL INFECT, V118, P91, DOI 10.1017/S0950268896007315; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Chatzipanagiotou S, 2003, EUR J EPIDEMIOL, V18, P1097, DOI 10.1023/A:1026108702971; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; Cornelius AJ, 2005, INT J FOOD MICROBIOL, V99, P99, DOI 10.1016/j.ijfoodmicro.2004.07.016; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Eyles RF, 2006, J APPL MICROBIOL, V101, P18, DOI 10.1111/j.1365-2672.2006.02945.x; Fang SW, 2006, J FOOD PROTECT, V69, P775, DOI 10.4315/0362-028X-69.4.775; Frost JA, 1998, J CLIN MICROBIOL, V36, P335, DOI 10.1128/JCM.36.2.335-339.1998; Fussing V, 2007, CLIN MICROBIOL INFEC, V13, P635, DOI 10.1111/j.1469-0691.2007.01689.x; GEORGESCOURBOT MC, 1986, J CLIN MICROBIOL, V23, P592, DOI 10.1128/JCM.23.3.592-594.1986; GIBSON JR, 1995, EPIDEMIOL INFECT, V115, P215, DOI 10.1017/S0950268800058349; Gilpin B, 2006, J CLIN MICROBIOL, V44, P406, DOI 10.1128/JCM.44.2.406-412.2006; Gilpin BJ, 2008, J APPL MICROBIOL, V105, P1354, DOI 10.1111/j.1365-2672.2008.03863.x; Grozdanova A, 2011, Prilozi, V32, P113; Guerry P, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00007; Hudson JA, 1999, J APPL MICROBIOL, V87, P115, DOI 10.1046/j.1365-2672.1999.00806.x; Ioannidis A, 2006, EUR J EPIDEMIOL, V21, P823, DOI 10.1007/s10654-006-9073-2; Islam Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007257; JONES DM, 1985, EUR J CLIN MICROBIOL, V4, P562, DOI 10.1007/BF02013395; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; KARMALI MA, 1983, J INFECT DIS, V147, P243, DOI 10.1093/infdis/147.2.243; LASTOVICA AJ, 1986, J MED MICROBIOL, V21, P1, DOI 10.1099/00222615-21-1-1; MARSHALL LE, 1994, EPIDEMIOL INFECT, V112, P347, DOI 10.1017/S0950268800057757; Maue AC, 2013, INFECT IMMUN, V81, P665, DOI 10.1128/IAI.01008-12; McKay D, 2001, J CLIN MICROBIOL, V39, P1917, DOI 10.1128/JCM.39.5.1917-1921.2001; MCMYNE PMS, 1982, J CLIN MICROBIOL, V16, P281, DOI 10.1128/JCM.16.2.281-285.1982; McTavish SM, 2008, EPIDEMIOL INFECT, V136, P1244, DOI 10.1017/S0950268807009892; Miljkovic-Selimovic B, 2010, SRP ARK CELOK LEK, V138, P721, DOI 10.2298/SARH1012721M; Monteiro MA, 2009, INFECT IMMUN, V77, P1128, DOI 10.1128/IAI.01056-08; Moser I, 2002, EPIDEMIOL INFECT, V129, P435, DOI 10.1017/S0950268802007525; Nakari UM, 2010, EPIDEMIOL INFECT, V138, P1712, DOI 10.1017/S0950268810000567; NEOGI PKB, 1987, J MED MICROBIOL, V24, P303, DOI 10.1099/00222615-24-4-303; Nielsen EM, 2006, EPIDEMIOL INFECT, V134, P758, DOI 10.1017/S0950268805005509; Nielsen EM, 2000, J CLIN MICROBIOL, V38, P3800, DOI 10.1128/JCM.38.10.3800-3810.2000; Nielsen EM, 1997, FEMS IMMUNOL MED MIC, V19, P47, DOI 10.1016/S0928-8244(97)00049-7; Nishimura M, 1996, FEMS MICROBIOL LETT, V142, P133, DOI 10.1016/0378-1097(96)00248-0; O'Ryan Miguel, 2005, Semin Pediatr Infect Dis, V16, P125, DOI 10.1053/j.spid.2005.12.008; Owen RJ, 1997, EUR J EPIDEMIOL, V13, P837, DOI 10.1023/A:1007497005152; OWEN RJ, 1994, EPIDEMIOL INFECT, V113, P221, DOI 10.1017/S0950268800051657; Oza AN, 2002, J CLIN MICROBIOL, V40, P996, DOI 10.1128/JCM.40.3.996-1000.2002; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; PATTON CM, 1985, J CLIN MICROBIOL, V22, P558, DOI 10.1128/JCM.22.4.558-565.1985; PENNER JL, 1980, J CLIN MICROBIOL, V12, P732, DOI 10.1128/JCM.12.6.732-737.1980; Petersen L, 2001, APPL ENVIRON MICROB, V67, P3115, DOI 10.1128/AEM.67.7.3115-3121.2001; Poly F, 2011, J CLIN MICROBIOL, V49, P1750, DOI 10.1128/JCM.02348-10; Prasad KN, 2001, INDIAN J MED RES, V114, P12; Saito S, 2005, FEMS IMMUNOL MED MIC, V45, P311, DOI 10.1016/j.femsim.2005.05.006; Schonberg-Norio D, 2006, CLIN MICROBIOL INFEC, V12, P754, DOI 10.1111/j.1469-0691.2006.01501.x; SJOGREN E, 1989, EPIDEMIOL INFECT, V102, P47, DOI 10.1017/S0950268800029678; SJOGREN E, 1989, FEMS MICROBIOL LETT, V57, P237, DOI 10.1016/0378-1097(89)90306-6; SKIRROW MB, 1993, EPIDEMIOL INFECT, V110, P567, DOI 10.1017/S0950268800050986; Smith SI, 1997, Z NATURFORSCH C, V52, P259; Sonnevend A, 2006, J MED MICROBIOL, V55, P1533, DOI 10.1099/jmm.0.46744-0; Sopwith W, 2003, J INFECTION, V46, P35, DOI 10.1053/jinf.2002.1072; Strid MA, 2001, CLIN DIAGN LAB IMMUN, V8, P314, DOI 10.1128/CDLI.8.2.314-319.2001; Takahashi M, 2005, J CLIN MICROBIOL, V43, P335, DOI 10.1128/JCM.43.1.335-339.2005; TAYLOR DN, 1983, ANN INTERN MED, V99, P38, DOI 10.7326/0003-4819-99-1-38; Tribble DR, 2009, CLIN INFECT DIS, V49, P1512, DOI 10.1086/644622; Vierikko A, 2004, EMERG INFECT DIS, V10, P127, DOI 10.3201/eid1001.020636; Wareing DRA, 2002, J APPL MICROBIOL, V92, P502, DOI 10.1046/j.1365-2672.2002.01552.x; Wierzba TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003674; ZAMAN R, 1992, EPIDEMIOL INFECT, V108, P51, DOI 10.1017/S0950268800049499	65	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67375	10.1371/journal.pone.0067375	http://dx.doi.org/10.1371/journal.pone.0067375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826280	Green Submitted, gold, Green Published			2022-12-27	WOS:000321150000069
J	Bosia, C; Pagnani, A; Zecchina, R				Bosia, Carla; Pagnani, Andrea; Zecchina, Riccardo			Modelling Competing Endogenous RNA Networks	PLOS ONE			English	Article							GENE-EXPRESSION; MICRORNA BIOGENESIS; ROBUSTNESS; PATHWAYS; PTEN	MicroRNAs (miRNAs) are small RNA molecules, about 22 nucleotide long, which post-transcriptionally regulate their target messenger RNAs (mRNAs). They accomplish key roles in gene regulatory networks, ranging from signaling pathways to tissue morphogenesis, and their aberrant behavior is often associated with the development of various diseases. Recently it has been experimentally shown that the way miRNAs interact with their targets can be described in terms of a titration mechanism. From a theoretical point of view titration mechanisms are characterized by threshold effect at near-equimolarity of the different chemical species, hypersensitivity of the system around the threshold, and cross-talk among targets. The latter characteristic has been lately identified as competing endogenous RNA (ceRNA) effect to mark those indirect interactions among targets of a common pool of miRNAs they are in competition for. Here we propose a stochastic model to analyze the equilibrium and out-of-equilibrium properties of a network of M miRNAs interacting with N mRNA targets. In particular we are able to describe in detail the peculiar equilibrium and non-equilibrium phenomena that the system displays in proximity to the threshold: (i) maximal cross-talk and correlation between targets, (ii) robustness of ceRNA effect with respect to the model's parameters and in particular to the catalyticity of the miRNA-mRNA interaction, and (iii) anomalous response-time to external perturbations.	[Bosia, Carla; Pagnani, Andrea; Zecchina, Riccardo] Human Genet Fdn HuGeF, Turin, Italy; [Pagnani, Andrea; Zecchina, Riccardo] Politecn Torino, Dept Phys, Turin, Italy; [Pagnani, Andrea; Zecchina, Riccardo] Politecn Torino, Ctr Computat Sci, Turin, Italy	Polytechnic University of Turin; Polytechnic University of Turin	Bosia, C (corresponding author), Human Genet Fdn HuGeF, Turin, Italy.	carla.bosia@hugef-torino.org	Pagnani, Andrea/J-2363-2015	Pagnani, Andrea/0000-0002-6509-0807; ZECCHINA, Riccardo/0000-0002-1221-5207; Bosia, Carla/0000-0002-8960-3443	European Research Council [OPTINF 267915]	European Research Council(European Research Council (ERC)European Commission)	RZ acknowledges support from the European Research Council Grant No. OPTINF 267915. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala U, 2013, P NATL ACAD SCI USA, V110, P7154, DOI 10.1073/pnas.1222509110; Baccarini A, 2011, CURR BIOL, V21, P369, DOI 10.1016/j.cub.2011.01.067; Bosia C, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-131; Buchler NE, 2008, J MOL BIOL, V384, P1106, DOI 10.1016/j.jmb.2008.09.079; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Elf J, 2003, BIOPHYS J, V84, P154, DOI 10.1016/S0006-3495(03)74839-5; Figliuzzi M, 2013, BIOPHYS J, V104, P1203, DOI 10.1016/j.bpj.2013.01.012; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hao Y, 2011, J MOL BIOL, V406, P195, DOI 10.1016/j.jmb.2010.12.008; Hinske LCG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-533; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lafuerza LF, 2009, THESIS U ILLES BALEA; Levine E, 2008, NOISE SILENCE SMALL; Levine E, 2007, PLOS BIOL, V5, P1998, DOI 10.1371/journal.pbio.0050229; Levine E, 2008, CURR OPIN MICROBIOL, V11, P574, DOI 10.1016/j.mib.2008.09.016; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Megraw M, 2010, THEOR CHEM ACC, V125, P593, DOI 10.1007/s00214-009-0647-4; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Mitarai N, 2007, PHYS BIOL, V4, P164, DOI 10.1088/1478-3975/4/3/003; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Muzzey D, 2009, ANNU REV CELL DEV BI, V25, P301, DOI 10.1146/annurev.cellbio.042308.113408; Osella M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001101; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Re A, 2009, MOL BIOSYST, V5, P854, DOI 10.1039/b900177h; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Shimoni Y, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100181; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Wee LM, 2012, CELL, V151, P1055, DOI 10.1016/j.cell.2012.10.036; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yu XP, 2008, NUCLEIC ACIDS RES, V36, P6494, DOI 10.1093/nar/gkn712	46	89	91	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66609	10.1371/journal.pone.0066609	http://dx.doi.org/10.1371/journal.pone.0066609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840508	Green Submitted, gold, Green Published			2022-12-27	WOS:000321424400031
J	Porto, M; de Oliveira, MA; Pissinatti, L; Rodrigues, RL; Rojas-Moscoso, JA; Cogo, JC; Metze, K; Antunes, E; Nahoum, C; Monica, FZ; De Nucci, G				Porto, Marcovan; de Oliveira, Marco Antonio; Pissinatti, Lorenzo; Rodrigues, Renata Lopes; Rojas-Moscoso, Julio Alejandro; Cogo, Jose Carlos; Metze, Konradin; Antunes, Edson; Nahoum, Cesar; Monica, Fabiola Z.; De Nucci, Gilberto			The Evolutionary Implications of Hemipenial Morphology of Rattlesnake Crotalus durissus terrificus (Laurent, 1768) (Serpentes: Viperidae: Crotalinae)	PLOS ONE			English	Article							PENILE ERECTION; REPRODUCTION; COURTSHIP; BEHAVIOR; REPTILIA	Most amniotes vertebrates have an intromittent organ to deliver semen. The reptile Sphenodon and most birds lost the ancestral penis and developed a cloaca-cloaca mating. Known as hemipenises, the copulatory organ of Squamata shows unique features between the amniotes intromittent organ. They are the only paired intromittent organs across amniotes and are fully inverted and encapsulated in the tail when not in use. The histology and ultrastructure of the hemipenes of Crotalus durissus rattlesnake is described as the evolutionary implications of the main features discussed. The organization of hemipenis of Crotalus durissus terrificus in two concentric corpora cavernosa is similar to other Squamata but differ markedly from the organization of the penis found in crocodilians, testudinata, birds and mammals. Based on the available data, the penis of the ancestral amniotes was made of connective tissue and the incorporation of smooth muscle in the framework of the sinusoids occurred independently in mammals and Crotalus durissus. The propulsor action of the muscle retractor penis basalis was confirmed and therefore the named should be changed to musculus hemipenis propulsor. The retractor penis magnus found in Squamata has no homology to the retractor penis of mammals, although both are responsible for the retraction of the copulatory organ.	[Porto, Marcovan; de Oliveira, Marco Antonio; Pissinatti, Lorenzo; Rodrigues, Renata Lopes; Rojas-Moscoso, Julio Alejandro; Antunes, Edson; Nahoum, Cesar; Monica, Fabiola Z.; De Nucci, Gilberto] Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, Sao Paulo, Brazil; [de Oliveira, Marco Antonio; Cogo, Jose Carlos] Univ Vale Paraiba UNIVAP Sao Jose dos Campos, Inst Res & Dev, Sao Paulo, Brazil; [Metze, Konradin] Univ Estadual Campinas, Fac Med Sci, Dept Pathol, Sao Paulo, Brazil; [De Nucci, Gilberto] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade do Vale do Paraiba; Universidade Estadual de Campinas; Universidade de Sao Paulo	de Oliveira, MA (corresponding author), Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, Sao Paulo, Brazil.	oliveirama@univap.br	ANTUNES, EDSON/F-6731-2012; De Nucci, Gilberto/J-5990-2012; Monica, Fabiola Zakia/B-4191-2013; de Oliveira, Marco/B-7543-2013; De Nucci, Gilberto/ABB-7380-2021; Mónica, Fabiola/L-2198-2014	ANTUNES, EDSON/0000-0003-2201-8247; De Nucci, Gilberto/0000-0002-4346-7941; Monica, Fabiola Zakia/0000-0002-8449-6677; de Oliveira, Marco/0000-0001-5971-2553; De Nucci, Gilberto/0000-0002-4346-7941; Mónica, Fabiola/0000-0003-2312-1019; Metze, Konradin/0000-0003-0742-8846	FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/11828-4]; CNPq; FAPESP	FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Financial support FAPESP (Grant #2011/11828-4) Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://www.fapesp.br). JARM, LP, MP and MAdO have fellowships from CNPq. FZM has a fellowship from FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON KE, 1995, PHYSIOL REV, V75, P191, DOI 10.1152/physrev.1995.75.1.191; ANTONIO FB, 1980, HERPETOLOGICA, V36, P231; BASSETT EG, 1961, J ANAT, V95, P61; Beulchelt H, 1936, MORPHOL JB LEIPZIG, V78, P445; Brennan PLR, 2012, J ZOOL, V286, P140, DOI 10.1111/j.1469-7998.2011.00858.x; Capel RO, 2011, J SEX MED, V8, P1616, DOI 10.1111/j.1743-6109.2011.02246.x; Chapman SW, 1935, J MORPHOL, V58, P385; Clayton HM, 2005, CLIN ANATOMY HORSE; Constantinescu G., 2001, GUIDE REGIONAL RUMIN; DOWLING HERNDON G., 1960, ZOOLOGICA [NEW YORK], V45, P17; Dyce K.M., 2009, TXB VET ANATOMY; Evans HE., 2012, MILLERS ANATOMY DOG, V4; GILALVARO MC, 1968, ARCH ANAT MICROSC MO, V57, P329; GILLINGHAM J C, 1977, Southwestern Naturalist, V22, P187, DOI 10.2307/3669809; GILLINGHAM JC, 1983, J HERPETOL, V17, P265, DOI 10.2307/1563829; Goldstein M, 1990, J UROLOGY, V144, P61; HAMMERSON GA, 1978, J HERPETOL, V12, P253, DOI 10.2307/1563418; Jones FW, 1915, J ANAT PHYSIOL, V49, P393; Karim S.A., 1998, JKAU MET ENV ARID LA, V10, P25, DOI [10.4197/Sci.10-1.3, DOI 10.4197/SCI.10-1.3]; Kelly DA, 2002, INTEGR COMP BIOL, V42, P216, DOI 10.1093/icb/42.2.216; Keogh JS, 1999, ZOOL J LINN SOC-LOND, V125, P239, DOI 10.1111/j.1096-3642.1999.tb00592.x; King A.S., 1981, P107; Marjupuria TC, 1968, ZOOL ANZ, V184, P48; Marjupuria TC, 1968, ZOOL ANZ, V181, P386; Olson M, 1998, SPERM COMPETITION SE, P503; Pinheiro ACAD, 2000, J UROLOGY, V164, P1802, DOI 10.1016/S0022-5347(05)67110-8; Pough F.H., 2003, HERPETOLOGY, V3rd; Radwan D, 2011, EGYPTIAN J HISTOLOGY, V34, P93; ROSENBERG HI, 1967, COPEIA, P349; Savage J.M., 2002, AMPHIBIANS REPTILES; Valverde Maria Celeste C., 2006, Sitientibus Serie Ciencias Biologicas, V6, P64; VolsOe H., 1944, SPOLIA ZOOLOGICA MUS, V5, P1; Wopke K, 1930, KLOAKE BEGATTUNGSORG; ZUG GEORGE R., 1966, OCCAS PAP MUS ZOOL UNIV MICH, V647, P1	34	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66903	10.1371/journal.pone.0066903	http://dx.doi.org/10.1371/journal.pone.0066903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840551	gold, Green Submitted, Green Published			2022-12-27	WOS:000321424400051
J	Arguello, A; Yang, XY; Vogt, D; Stanco, A; Rubenstein, JLR; Cheyette, BNR				Arguello, Annie; Yang, XiaoYong; Vogt, Daniel; Stanco, Amelia; Rubenstein, John L. R.; Cheyette, Benjamin N. R.			Dapper Antagonist of Catenin-1 Cooperates with Dishevelled-1 during Postsynaptic Development in Mouse Forebrain GABAergic Interneurons	PLOS ONE			English	Article							EXCITATORY SYNAPSE DEVELOPMENT; DIFFERENTIAL GENE-EXPRESSION; GREEN FLUORESCENT PROTEIN; CORTICAL INTERNEURONS; HIPPOCAMPAL-NEURONS; DENDRITIC SPINE; INHIBITORY SYNAPSES; SIGNALING PROMOTES; HOMEOBOX GENES; WNT SIGNALS	Synaptogenesis has been extensively studied along with dendritic spine development in glutamatergic pyramidal neurons, however synapse development in cortical interneurons, which are largely aspiny, is comparatively less well understood. Dact1, one of 3 paralogous Dact (Dapper/Frodo) family members in mammals, is a scaffold protein implicated in both the Wnt/beta-catenin and the Wnt/Planar Cell Polarity pathways. We show here that Dact1 is expressed in immature cortical interneurons. Although Dact1 is first expressed in interneuron precursors during proliferative and migratory stages, constitutive Dact1 mutant mice have no major defects in numbers or migration of these neurons. However, cultured cortical interneurons derived from these mice have reduced numbers of excitatory synapses on their dendrites. We selectively eliminated Dact1 from mouse cortical interneurons using a conditional knock-out strategy with a Dlx-I12b enhancer-Cre allele, and thereby demonstrate a cell-autonomous role for Dact1 during postsynaptic development. Confirming this cell-autonomous role, we show that synapse numbers in Dact1 deficient cortical interneurons are rescued by virally-mediated re-expression of Dact1 specifically targeted to these cells. Synapse numbers in these neurons are also rescued by similarly targeted expression of the Dact1 binding partner Dishevelled-1, and partially rescued by expression of Disrupted in Schizophrenia-1, a synaptic protein genetically implicated in susceptibility to several major mental illnesses. In sum, our results support a novel cell-autonomous postsynaptic role for Dact1, in cooperation with Dishevelled-1 and possibly Disrupted in Schizophrenia-1, in the formation of synapses on cortical interneuron dendrites.	[Arguello, Annie; Rubenstein, John L. R.; Cheyette, Benjamin N. R.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Arguello, Annie; Yang, XiaoYong; Vogt, Daniel; Stanco, Amelia; Rubenstein, John L. R.; Cheyette, Benjamin N. R.] Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cheyette, BNR (corresponding author), Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA.	bc@lppi.ucsf.edu	Cheyette, Benjamin/K-5535-2014	Cheyette, Benjamin/0000-0001-9934-7941; Vogt, Daniel/0000-0003-1876-5936	US National Institutes of Health: Initiative to Maximize Student Diversity (IMSD) [R25GM56847, T32MH089920, R01MH081880, R37MH049428, R21MH085995]; Simons Foundation Autism Research Initiative; UCSF Department of Psychiatry; UCSF Center for Neurobiology and Psychiatry; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH089920, R01MH081880, R21MH085995, R37MH049428] Funding Source: NIH RePORTER	US National Institutes of Health: Initiative to Maximize Student Diversity (IMSD); Simons Foundation Autism Research Initiative; UCSF Department of Psychiatry; UCSF Center for Neurobiology and Psychiatry; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors acknowledge funding from the US National Institutes of Health: Initiative to Maximize Student Diversity (IMSD) Grant R25GM56847 (A.A.), T32MH089920 (XY.Y. & A.S.), R01MH081880 (D.V./J.L.R.), R37MH049428 (J.L.R.) and R21MH085995 (B.N.R.C.). In addition, the authors received funding from the Simons Foundation Autism Research Initiative (B.N.R.C.), and from the UCSF Department of Psychiatry and the UCSF Center for Neurobiology and Psychiatry (B.N.R.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Alifragis P, 2004, J NEUROSCI, V24, P5643, DOI 10.1523/JNEUROSCI.1245-04.2004; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Antypa M, 2011, EUR J NEUROSCI, V34, P1584, DOI 10.1111/j.1460-9568.2011.07896.x; Arikkath J, 2008, TRENDS NEUROSCI, V31, P487, DOI 10.1016/j.tins.2008.07.001; Badawy RAB, 2009, J CLIN NEUROSCI, V16, P485, DOI 10.1016/j.jocn.2008.10.001; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bradshaw NJ, 2012, NEUROPHARMACOLOGY, V62, P1230, DOI 10.1016/j.neuropharm.2010.12.027; Brigidi GS, 2011, CURR OPIN NEUROBIOL, V21, P208, DOI 10.1016/j.conb.2010.12.004; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Ciani L, 2011, P NATL ACAD SCI USA, V108, P10732, DOI 10.1073/pnas.1018132108; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dean CaS P, 2009, IMAGING SYNAPTOGENES, P1; DENO RL, 1949, CEREBRAL CORTEX ARCH; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Farias GG, 2009, J BIOL CHEM, V284, P15857, DOI 10.1074/jbc.M808986200; Faux C, 2010, J COMP NEUROL, V518, P1232, DOI 10.1002/cne.22271; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Ghanem N, 2007, J NEUROSCI, V27, P5012, DOI 10.1523/JNEUROSCI.4725-06.2007; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kirkpatrick B, 2006, J COMP NEUROL, V497, P436, DOI 10.1002/cne.21007; Kivimae S, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-33; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Long JE, 2007, J NEUROSCI, V27, P3230, DOI 10.1523/JNEUROSCI.5265-06.2007; Long JE, 2009, CEREB CORTEX S1, V19, P196; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Okerlund ND, 2010, J NEUROSCI, V30, P4362, DOI 10.1523/JNEUROSCI.0354-10.2010; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; PARNAVELAS JG, 1984, CEREB CORTEX, P205; Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rubenstein JLR, 2011, J CHILD PSYCHOL PSYC, V52, P339, DOI 10.1111/j.1469-7610.2010.02307.x; Sala C, 2008, ACTA NEUROBIOL EXP, V68, P289; Singh KK, 2010, NEURON, V67, P33, DOI 10.1016/j.neuron.2010.06.002; Suriben R, 2009, NAT GENET, V41, P977, DOI 10.1038/ng.435; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Ting AK, 2011, J NEUROSCI, V31, P15, DOI 10.1523/JNEUROSCI.2538-10.2011; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Varela-Nallar L, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-41; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wiens KM, 2005, J NEUROSCI, V25, P10627, DOI 10.1523/JNEUROSCI.1947-05.2005; Yun K, 2002, DEVELOPMENT, V129, P5029; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhao Y, 2008, J COMP NEUROL, V510, P79, DOI 10.1002/cne.21772	71	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67679	10.1371/journal.pone.0067679	http://dx.doi.org/10.1371/journal.pone.0067679			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826333	gold, Green Published			2022-12-27	WOS:000321738400166
J	Ayieko, P; Griffiths, UK; Ndiritu, M; Moisi, J; Mugoya, IK; Kamau, T; English, M; Scott, JAG				Ayieko, Philip; Griffiths, Ulla K.; Ndiritu, Moses; Moisi, Jennifer; Mugoya, Isaac K.; Kamau, Tatu; English, Mike; Scott, J. Anthony G.			Assessment of Health Benefits and Cost-Effectiveness of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Kenyan Children	PLOS ONE			English	Article							MILLENNIUM DEVELOPMENT GOALS; DEVELOPING-COUNTRIES; DISEASE; PNEUMONIA; CARE; SURVEILLANCE; IMMUNIZATION; STRATEGIES; MORTALITY; EFFICACY	Background: The GAVI Alliance supported10-valent pneumococcal conjugate vaccine (PCV10) introduction in Kenya. We estimated the cost-effectiveness of introducing either PCV10 or the 13-valent vaccine (PCV13) from a societal perspective and explored the incremental impact of including indirect vaccine effects. Methods: The costs and effects of pneumococcal vaccination among infants born in Kenya in 2010 were assessed using a decision analytic model comparing PCV10 or PCV13, in turn, with no vaccination. Direct vaccine effects were estimated as a reduction in the incidence of pneumococcal meningitis, sepsis, bacteraemic pneumonia and non-bacteraemic pneumonia. Pneumococcal disease incidence was extrapolated from a population-based hospital surveillance system in Kilifi and adjustments were made for variable access to care across Kenya. We used vaccine efficacy estimates from a trial in The Gambia and accounted for serotype distribution in Kilifi. We estimated indirect vaccine protection and serotype replacement by extrapolating from the USA. Multivariable sensitivity analysis was conducted using Monte Carlo simulation. We assumed a vaccine price of US$ 3.50 per dose. Findings: The annual cost of delivering PCV10 was approximately US$ 14 million. We projected a 42.7% reduction in pneumococcal disease episodes leading to a US$ 1.97 million reduction in treatment costs and a 6.1% reduction in childhood mortality annually. In the base case analysis, costs per discounted DALY and per death averted by PCV10, amounted to US$ 59 (95% CI 26-103) and US$ 1,958 (95% CI 866-3,425), respectively. PCV13 introduction improved the cost-effectiveness ratios by approximately 20% and inclusion of indirect effects improved cost-effectiveness ratios by 43-56%. The break-even prices for introduction of PCV10 and PCV13 are US$ 0.41 and 0.51, respectively. Conclusions: Introducing either PCV10 or PCV13 in Kenya is highly cost-effective from a societal perspective. Indirect effects, if they occur, would significantly improve the cost-effectiveness.	[Ayieko, Philip; Ndiritu, Moses; Moisi, Jennifer; English, Mike; Scott, J. Anthony G.] Wellcome Trust Programme, Kenya Med Res Inst, Nairobi, Kenya; [Griffiths, Ulla K.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Mugoya, Isaac K.; Kamau, Tatu] Minist Publ Hlth & Sanitat, Div Vaccine & immunizat, Nairobi, Kenya; [English, Mike] Univ Oxford, Nuffield Dept Paediat, Oxford, England; [Moisi, Jennifer; Scott, J. Anthony G.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Scott, J. Anthony G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Ayieko, P (corresponding author), Wellcome Trust Programme, Kenya Med Res Inst, Nairobi, Kenya.	payieko@nairobi.kemri-wellcome.org		English, Michael/0000-0002-7427-0826	GAVI Alliance through the PneumoADIP; Wellcome Trust [081835, 076827, 092654/Z/10/A]; GlaxoSmithKline Biologicals	GAVI Alliance through the PneumoADIP; Wellcome Trust(Wellcome TrustEuropean Commission); GlaxoSmithKline Biologicals(GlaxoSmithKline)	This work was supported by the GAVI Alliance through the PneumoADIP and by the Wellcome Trust through research fellowships to JAGS (081835) and ME (076827). The KEMRI-Wellcome Trust Research Programme is supported by core funding from the Wellcome Trust (#092654/Z/10/A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JAGS has received research funding from GlaxoSmithKline Biologicals and travel/hotel support from Merck to attend a Merck sponsored scientific meeting. The remaining authors have declared that no competing interests exist. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P434; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1148; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; [Anonymous], 2011, GAVI ALL PLEDG C IMM; [Anonymous], 2005, WHO POCK BOOK HOSP C; [Anonymous], 1996, GLOBAL BURDEN DIS CO; [Anonymous], COST EFF RESOUR ALLO, DOI DOI 10.1186/1478-7547-7-3; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Beutels P, 2007, VACCINE, V25, P1355, DOI 10.1016/j.vaccine.2006.10.034; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P893; Cernuschi T, 2009, LANCET, V374, P684, DOI 10.1016/S0140-6736(09)61556-7; Chuma J, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-15; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Edejer TTT, 2005, BMJ-BRIT MED J, V331, P1177, DOI 10.1136/bmj.38652.550278.7C; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; Gentry B, 2008, GETTING STARTED GUID, pC; Hogan DR, 2005, BRIT MED J, V331, P1431, DOI 10.1136/bmj.38643.368692.68; Jodar L, 2003, VACCINE, V21, P3265, DOI 10.1016/S0264-410X(03)00230-5; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Kim SY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-260; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Kumaranayake L, 2000, HEALTH POLICY PLANN, V15, P230, DOI 10.1093/heapol/15.2.230; Larson BA, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-314; Moisi JC, 2011, B WORLD HEALTH ORGAN, V89, P102, DOI 10.2471/BLT.10.080796; Moisi JC, 2010, VACCINE, V28, P5725, DOI 10.1016/j.vaccine.2010.06.011; Moszynski P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1075; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Obaro SK, 2006, LANCET INFECT DIS, V6, P150, DOI 10.1016/S1473-3099(06)70411-X; Scott JAG, 2007, VACCINE, V25, P2398, DOI 10.1016/j.vaccine.2006.09.008; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Sinha A, 2007, LANCET, V369, P389, DOI 10.1016/S0140-6736(07)60195-0; Tate JE, 2011, VACCINE, V29, P3329, DOI 10.1016/j.vaccine.2010.12.122; Touray MML, 2011, J PHARM HEALTH SERV, V2, P175, DOI 10.1111/j.1759-8893.2011.00057.x; World Health Organisation, 2008, PROGR PROJ IMM SURV	37	34	34	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67324	10.1371/journal.pone.0067324	http://dx.doi.org/10.1371/journal.pone.0067324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826268	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000321738400133
J	Choo, YM; Pelletier, J; Atungulu, E; Leal, WS				Choo, Young-Moo; Pelletier, Julien; Atungulu, Elizabeth; Leal, Walter S.			Identification and Characterization of an Antennae-Specific Aldehyde Oxidase from the Navel Orangeworm	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER ADULTS; SEX-PHEROMONE; ALCOHOL-DEHYDROGENASE; ANTHERAEA-POLYPHEMUS; DIFFERENTIAL INHIBITION; AMYELOIS-TRANSITELLA; VOLATILE ALDEHYDES; MOTH; ACETALDEHYDE; LEPIDOPTERA	Antennae-specific odorant-degrading enzymes (ODEs) are postulated to inactivate odorant molecules after they convey their signal. Different classes of insect ODEs are specific to esters, alcohols, and aldehydes - the major functional groups of female-produced, hydrophobic sex pheromones from moth species. Esterases that rapidly inactive acetate and other esters have been well-studied, but less is known about aldehyde oxidases (AOXs). Here we report cloning of an aldehyde oxidase, AtraAOX2, from the antennae of the navel orangeworm (NOW), Amyelois transitella, and the first activity characterization of a recombinant insect AOX. AtraAOX2 gene spans 3,813 bp and encodes a protein with 1,270 amino acid residues. AtraAOX2 cDNA was expressed in baculovirus-infected insect Sf21 cells as a approximate to 280 kDa homodimer with 140 kDa subunits. Recombinant AtraAOX2 degraded Z11Z13-16Ald and plant volatile aldehydes as substrates. However, as expected for aldehyde oxidases, recombinant AtraAOX2 did not show specificity for Z11Z13-16Ald, the main constituent of the sex pheromone, but showed high activity for plant volatile aldehydes. Our data suggest AtraAOX2 might be involved in degradation of a diversity of aldehydes including sex pheromones, plant-derived semiochemicals, and chemical cues for oviposition sites. Additionally, AtraAOX2 could protect the insect's olfactory system from xenobiotics, including pesticides that might reach the sensillar lymph surrounding the olfactory receptor neurons.	[Choo, Young-Moo; Pelletier, Julien; Atungulu, Elizabeth; Leal, Walter S.] Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA	University of California System; University of California Davis	Leal, WS (corresponding author), Univ Calif Davis, Honorary Maeda Duffey Lab, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021	Leal, Walter/0000-0002-6800-1240; Leal Filho, Walter/0000-0002-1241-5225	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2010-65105-20582]	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This project was supported in part by Agriculture and Food Research Initiative Competitive Grant 2010-65105-20582 from the USDA National Institute of Food and Agriculture. No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaba S, 1999, J BIOCHEM-TOKYO, V126, P395, DOI 10.1093/oxfordjournals.jbchem.a022463; Alfaro JF, 2009, DRUG METAB DISPOS, V37, P2393, DOI 10.1124/dmd.109.029520; ANDERSON SM, 1991, GENETICA, V83, P99, DOI 10.1007/BF00058526; Burks CS, 2008, ENTOMOL EXP APPL, V129, P66, DOI 10.1111/j.1570-7458.2008.00754.x; Gonzalez-Mas MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022016; Chertemps T, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-56; COFFELT JA, 1979, J CHEM ECOL, V5, P955, DOI 10.1007/BF00990218; Coleman M, 2002, EUR J BIOCHEM, V269, P768, DOI 10.1046/j.0014-2956.2001.02682.x; DAVID JR, 1984, BIOCHEM GENET, V22, P1015, DOI 10.1007/BF00499628; de Groot P, 1999, NATURWISSENSCHAFTEN, V86, P81, DOI 10.1007/s001140050576; Deisig N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033159; DICKINSON WJ, 1975, DEV BIOL, V42, P131, DOI 10.1016/0012-1606(75)90319-X; Durand N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029147; Durand N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015026; Garattini E, 2008, CELL MOL LIFE SCI, V65, P1019, DOI 10.1007/s00018-007-7398-y; Garattini E, 2003, BIOCHEM J, V372, P15, DOI 10.1042/BJ20030121; Hammond DG, 2000, J AGR FOOD CHEM, V48, P4410, DOI 10.1021/jf000233+; Hartmann T, 2012, DRUG METAB DISPOS, V40, P856, DOI 10.1124/dmd.111.043828; HEINSTRA PWH, 1989, BIOCHEM J, V259, P791, DOI 10.1042/bj2590791; Hemingway J, 2000, INSECT MOL BIOL, V9, P93, DOI 10.1046/j.1365-2583.2000.00160.x; Huber DPW, 2001, J CHEM ECOL, V27, P217, DOI 10.1023/A:1005668019434; Hubert J, 2008, PEST MANAG SCI, V64, P57, DOI 10.1002/ps.1471; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Itoh K, 2007, XENOBIOTICA, V37, P709, DOI 10.1080/00498250701397713; JOHNS DG, 1967, J CLIN INVEST, V46, P1492, DOI 10.1172/JCI105641; KASANG G, 1978, ANGEW CHEM INT EDIT, V17, P60, DOI 10.1002/anie.197800601; KIMMERER TW, 1987, PLANT PHYSIOL, V84, P1204, DOI 10.1104/pp.84.4.1204; Kishimoto K, 2008, PHYTOCHEMISTRY, V69, P2127, DOI 10.1016/j.phytochem.2008.04.023; KLEIN U, 1987, INSECT BIOCHEM, V17, P1193, DOI 10.1016/0020-1790(87)90093-X; KOCHANSKY J, 1975, J INSECT PHYSIOL, V21, P1977, DOI 10.1016/0022-1910(75)90230-9; Koshiba T, 1996, PLANT PHYSIOL, V110, P781, DOI 10.1104/pp.110.3.781; Kuenen LPS, 2010, J ECON ENTOMOL, V103, P314, DOI 10.1603/EC09177; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEAL JFM, 1993, INSECT BIOCHEM MOLEC, V23, P543, DOI 10.1016/0965-1748(93)90027-P; LEAL JFM, 1992, INSECT BIOCHEM MOLEC, V22, P885, DOI 10.1016/0965-1748(92)90115-U; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Leal WS, 2005, NATURWISSENSCHAFTEN, V92, P139, DOI 10.1007/s00114-004-0598-5; Matsui K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036433; Moriwaki Y, 1997, HISTOL HISTOPATHOL, V12, P513; Nakamura S, 2002, J AGR FOOD CHEM, V50, P7639, DOI 10.1021/jf025808c; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Party V, 2009, CHEM SENSES, V34, P763, DOI 10.1093/chemse/bjp060; Pelletier J, 2007, GENE, V404, P31, DOI 10.1016/j.gene.2007.08.022; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pregitzer P, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00042; RAJAGOPALAN KV, 1962, J BIOL CHEM, V237, P922; RAJAGOPALAN KV, 1964, J BIOL CHEM, V239, P2022; RAJAGOPALAN KV, 1964, J BIOL CHEM, V239, P2027; Reddy GVP, 2004, TRENDS PLANT SCI, V9, P253, DOI 10.1016/j.tplants.2004.03.009; Rogers ME, 1999, J EXP BIOL, V202, P1625; RYBCZYNSKI R, 1990, J BIOL CHEM, V265, P19712; RYBCZYNSKI R, 1989, J NEUROSCI, V9, P1341; TEBBETS JS, 1978, J ECON ENTOMOL, V71, P875, DOI 10.1093/jee/71.6.875; Vancanneyt G, 2001, P NATL ACAD SCI USA, V98, P8139, DOI 10.1073/pnas.141079498; Vickers NJ, 2006, CHEM SENSES, V31, P155, DOI 10.1093/chemse/bjj011; Vogt R.G., 2005, P753; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; WILLIAMSON JH, 1978, CAN J GENET CYTOL, V20, P545, DOI 10.1139/g78-064; Yoshihara S, 1997, ARCH BIOCHEM BIOPHYS, V338, P29, DOI 10.1006/abbi.1996.9774; Zhang QH, 1999, J CHEM ECOL, V25, P2847, DOI 10.1023/A:1020816011131	61	36	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67794	10.1371/journal.pone.0067794	http://dx.doi.org/10.1371/journal.pone.0067794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826341	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400171
J	Kitaoka, S; Morielli, AD; Zhao, FQ				Kitaoka, Shun; Morielli, Anthony D.; Zhao, Feng-Qi			FGT-1 Is a Mammalian GLUT2-Like Facilitative Glucose Transporter in Caenorhabditis elegans Whose Malfunction Induces Fat Accumulation in Intestinal Cells	PLOS ONE			English	Article							SUBSTRATE SPECIFICITIES; TISSUE DISTRIBUTION; XENOPUS OOCYTES; EXPRESSION; GENE; SEQUENCE; ENCODES; FAMILY; RNA	Caenorhabditis elegans (C. elegans) is an attractive animal model for biological and biomedical research because it permits relatively easy genetic dissection of cellular pathways, including insulin/IGF-like signaling (IIS), that are conserved in mammalian cells. To explore C. elegans as a model system to study the regulation of the facilitative glucose transporter (GLUT), we have characterized the GLUT gene homologues in C. elegans: fgt-1, R09B5.11, C35A11.4, F53H8.3, F48E3.2, F13B12.2, Y61A9LA. 1, K08F9.1 and Y37A1A. 3. The exogenous expression of these gene products in Xenopus oocytes showed transport activity to unmetabolized glucose analogue 2-deoxy-D-glucose only in FGT-1. The FGT-1-mediated transport activity was inhibited by the specific GLUT inhibitor phloretin and exhibited a Michaelis constant (K-m) of 2.8 mM. Mannose, galactose, and fructose were able to inhibit FGT-1-mediated 2-deoxy-D-glucose uptake (P < 0.01), indicating that FGT-1 is also able to transport these hexose sugars. A GFP fusion protein of FGT-1 was observed only on the basolateral membrane of digestive tract epithelia in C. elegans, but not in other tissues. FGT-1:: eGFP expression was observed from early embryonic stages. The knockdown or mutation of fgt-1 resulted in increased fat staining in both wild-type and daf-2 (mammalian insulin receptor homologue) mutant animals. Other common phenotypes of IIS mutant animals, including dauer formation and brood size reduction, were not affected by fgt-1 knockdown in wild-type or daf-2 mutants. Our results indicated that in C. elegans, FGT-1 is mainly a mammalian GLUT2-like intestinal glucose transporter and is involved in lipid metabolism.	[Kitaoka, Shun; Zhao, Feng-Qi] Univ Vermont, Dept Anim Sci, Lab Lactat & Metab Physiol, Burlington, VT 05405 USA; [Morielli, Anthony D.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Zhao, FQ (corresponding author), Univ Vermont, Dept Anim Sci, Lab Lactat & Metab Physiol, Burlington, VT 05405 USA.	Feng-Qi.Zhao@uvm.edu			University of Vermont; Developmental Studies Hybridoma Bank; NICHD	University of Vermont; Developmental Studies Hybridoma Bank; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This project was supported by the University of Vermont. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Michael Koelle (Yale University) for providing us with the pRF4 marker plasmid. We thank Gwyn Gould (University of Glasgow) for providing us with the hGLUT1 construct and pSP64T vector. The MH33 antibody that was developed by Robert H. Waterston was obtained from the Developmental Studies Hybridoma Bank, which was developed under the auspices of the NICHD and maintained by the Department of Biology, University of Iowa. We also thank Ruth Blauwiekel and Yong Shao (both at the University of Vermont) for technical assistance with Xenopus laevis surgery.	Bentley PA, 2012, J DAIRY SCI, V95, P1188, DOI 10.3168/jds.2011-4430; Bossinger O, 2004, DEV BIOL, V268, P448, DOI 10.1016/j.ydbio.2004.01.003; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CHEESEMAN CI, 1993, GASTROENTEROLOGY, V105, P1050, DOI 10.1016/0016-5085(93)90948-C; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FUKUMOTO H, 1988, P NATL ACAD SCI USA, V85, P5434, DOI 10.1073/pnas.85.15.5434; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; GOULD GW, 1991, BIOCHEMISTRY-US, V30, P5139, DOI 10.1021/bi00235a004; GOULD GW, 1993, BIOCHEM J, V295, P329, DOI 10.1042/bj2950329; HABER RS, 1993, ENDOCRINOLOGY, V132, P2538, DOI 10.1210/en.132.6.2538; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Karabinos A, 2001, P NATL ACAD SCI USA, V98, P7863, DOI 10.1073/pnas.121169998; KELLER K, 1990, BIOMED BIOCHIM ACTA, V49, P1201; KELLER K, 1989, J BIOL CHEM, V264, P18884; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; MAENZ DD, 1987, J MEMBRANE BIOL, V97, P259, DOI 10.1007/BF01869228; Mello C, 1995, METHOD CELL BIOL, V48, P451; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schurmann A, 1997, BIOCHEMISTRY-US, V36, P12897, DOI 10.1021/bi971173c; SHEPHERD PR, 1992, BIOCHEM BIOPH RES CO, V188, P149, DOI 10.1016/0006-291X(92)92362-2; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Takashima Y, 2012, GENES GENET SYST, V87, P243, DOI 10.1266/ggs.87.243; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Togo SH, 2000, EUR J BIOCHEM, V267, P1307, DOI 10.1046/j.1432-1327.2000.01091.x; WRIGHT EM, 1992, ACTA PHYSIOL SCAND, V146, P201; Yokota S, 2002, HISTOCHEM CELL BIOL, V118, P329, DOI 10.1007/s00418-002-0450-y; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187	32	22	27	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e68475	10.1371/journal.pone.0068475	http://dx.doi.org/10.1371/journal.pone.0068475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826391	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400176
J	Murakoshi, T; Hisa, M; Wada, Y; Osada, Y				Murakoshi, Takuma; Hisa, Masako; Wada, Yuji; Osada, Yoshihisa			Differential Functioning of Retrieval/Comparison Processing in Detection of the Presence and Absence of Change	PLOS ONE			English	Article							VISUAL WORKING-MEMORY; CHANGE BLINDNESS; NATURAL SCENES	Background: The phenomenon of change blindness may reflect the failure to detect the presence of change or the absence of change. Although performing the latter is considered more difficult than the former, the differential functioning of retrieval/comparison processing that leads to differences between the detection of the presence and the absence of change has not been clarified. This study aimed to fill this research gap by comparing performance in the detection of the presence and the absence of a change in one item among a set of items. Methodology/Principal Findings: Twenty subjects performed two types of change detection tasks, the first task was detection of one changed item among a set of unchanged items (detection of the presence of a change) and the other was the detection of one unchanged item among a set of changed items (detection of the absence of a change). The ANOVA results for the percentage of correct responses and signal detection measurement of A' values regarding change detection and the pattern of the results indicate that the subjects found (1) detection of the presence of change less difficult than detection of the absence of change (2), rejection of the presence of change less difficult than acceptance of the presence of change, and (3) rejection of the absence of change as difficult as acceptance of the absence of change. Conclusions/Significance: Retrieval/comparison processing for the detection of the presence of change differs from that for the absence of change, likely because the retrieval/comparison process appears aimed at determining whether an item has changed but not whether an item appears the same as it had previously. This conclusion suggests the existence of an identification process that recognizes each item as the same as that observed previously that exists apart from the mechanism underlying retrieval/comparison processing.	[Murakoshi, Takuma; Wada, Yuji] Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan; [Hisa, Masako; Osada, Yoshihisa] Rikkyo Univ, Dept Psychol, Niiza, Saitama, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; Rikkyo University	Murakoshi, T (corresponding author), Natl Agr & Food Res Org, Natl Food Res Inst, Tsukuba, Ibaraki, Japan.	murakoshi@affrc.go.jp			KAKENHI [22906011, 23330218]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI - Grants-in-Aid for Scientific Research (22906011, 23330218). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austen E. L, 2000, PSYCHE, V6; Becker MW, 2000, PERCEPTION, V29, P273; Busch NA, 2010, J COGNITIVE NEUROSCI, V22, P1852, DOI 10.1162/jocn.2009.21294; Busch NA, 2010, NEUROREPORT, V21, P371, DOI 10.1097/WNR.0b013e3283378379; Corbett JE, 2011, ACTA PSYCHOL, V138, P289, DOI 10.1016/j.actpsy.2011.08.002; Hollingworth A, 2003, J EXP PSYCHOL HUMAN, V29, P388, DOI 10.1037/0096-1523.29.2.388; Hollingworth A, 2002, J EXP PSYCHOL HUMAN, V28, P113, DOI 10.1037//0096-1523.28.1.113; Hyun JS, 2009, J EXP PSYCHOL HUMAN, V35, P1140, DOI 10.1037/a0015019; Jiang YH, 2004, PERCEPT PSYCHOPHYS, V66, P446, DOI 10.3758/BF03194892; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Mitroff SR, 2004, PERCEPT PSYCHOPHYS, V66, P1268, DOI 10.3758/BF03194997; Rensink R, 1999, INVSTIGATIVE OPHTHAL, V40, P52; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Rensink RA, 2000, VISION RES, V40, P1469, DOI 10.1016/S0042-6989(00)00003-1; Rensink Ronald A., 2001, P169; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Theeuwes J, 2004, PSYCHOL SCI, V15, P65, DOI 10.1111/j.0963-7214.2004.01501011.x; Werner S, 2000, VIS COGN, V7, P163, DOI 10.1080/135062800394748	20	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e68789	10.1371/journal.pone.0068789	http://dx.doi.org/10.1371/journal.pone.0068789			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JP	23826395	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400180
J	Neuhaus, J; Schiffer, E; von Wilcke, P; Bauer, HW; Leung, H; Siwy, J; Ulrici, W; Paasch, U; Horn, LC; Stolzenburg, JU				Neuhaus, Jochen; Schiffer, Eric; von Wilcke, Philine; Bauer, Hartwig W.; Leung, Hing; Siwy, Justyna; Ulrici, Wolfram; Paasch, Uwe; Horn, Lars-Christian; Stolzenburg, Jens-Uwe			Seminal Plasma as a Source of Prostate Cancer Peptide Biomarker Candidates for Detection of Indolent and Advanced Disease	PLOS ONE			English	Article							ENHANCED LASER-DESORPTION/IONIZATION; ELECTRON-TRANSFER DISSOCIATION; URINARY PROTEOME ANALYSIS; MASS-SPECTROMETRY; CAPILLARY-ELECTROPHORESIS; RADIATION-THERAPY; SEQUENCE-ANALYSIS; DISCOVERY; DIAGNOSIS; SCORE	Background: Extensive prostate specific antigen screening for prostate cancer generates a high number of unnecessary biopsies and over-treatment due to insufficient differentiation between indolent and aggressive tumours. We hypothesized that seminal plasma is a robust source of novel prostate cancer (PCa) biomarkers with the potential to improve primary diagnosis of and to distinguish advanced from indolent disease. Methodology/Principal Findings: In an open-label case/control study 125 patients (70 PCa, 21 benign prostate hyperplasia, 25 chronic prostatitis, 9 healthy controls) were enrolled in 3 centres. Biomarker panels a) for PCa diagnosis (comparison of PCa patients versus benign controls) and b) for advanced disease (comparison of patients with post surgery Gleason score <7 versus Gleason score >7) were sought. Independent cohorts were used for proteomic biomarker discovery and testing the performance of the identified biomarker profiles. Seminal plasma was profiled using capillary electrophoresis mass spectrometry. Pre-analytical stability and analytical precision of the proteome analysis were determined. Support vector machine learning was used for classification. Stepwise application of two biomarker signatures with 21 and 5 biomarkers provided 83% sensitivity and 67% specificity for PCa detection in a test set of samples. A panel of 11 biomarkers for advanced disease discriminated between patients with Gleason score 7 and organ-confined (<pT3a) or advanced (>= pT3a) disease with 80% sensitivity and 82% specificity in a preliminary validation setting. Seminal profiles showed excellent pre-analytical stability. Eight biomarkers were identified as fragments of N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase, prostatic acid phosphatase, stabilin-2, GTPase IMAP family member 6, semenogelin-1 and -2. Restricted sample size was the major limitation of the study. Conclusions/Significance: Seminal plasma represents a robust source of potential peptide makers for primary PCa diagnosis. Our findings warrant further prospective validation to confirm the diagnostic potential of identified seminal biomarker candidates.	[Neuhaus, Jochen; von Wilcke, Philine; Stolzenburg, Jens-Uwe] Univ Leipzig, Dept Urol, D-04109 Leipzig, Germany; [Schiffer, Eric; Siwy, Justyna] Mosa Diagnost GmbH, Hannover, Germany; [Bauer, Hartwig W.] Univ Munich, Munich, Germany; [Leung, Hing] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Ulrici, Wolfram] Med Practice, Leipzig, Germany; [Paasch, Uwe] Univ Leipzig, Dept Dermatol, D-04109 Leipzig, Germany; [Horn, Lars-Christian] Univ Leipzig, Dept Pathol, D-04109 Leipzig, Germany	Leipzig University; Modular Open Systems Approach (MOSA) Solutions; University of Munich; Beatson Institute; Leipzig University; Leipzig University	Neuhaus, J (corresponding author), Univ Leipzig, Dept Urol, D-04109 Leipzig, Germany.	jochen.neuhaus@medizin.uni-leipzig.de		Siwy, Justyna/0000-0003-1407-2534	German Ministry of Economy and Technolgy BMWi [KF0362802MD8, EP110141]	German Ministry of Economy and Technolgy BMWi	This study was funded in part by the German Ministry of Economy and Technolgy BMWi with grant No. KF0362802MD8 to JUS, JN, PW, ES, JS and grant No. EP110141 to ES and JS. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batruch I, 2011, J PROTEOME RES, V10, P941, DOI 10.1021/pr100745u; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bright E, 2010, UROL INT, V84, P180, DOI 10.1159/000277595; Chuang TD, 2010, J BIOL CHEM, V285, P23598, DOI 10.1074/jbc.M109.098301; Coon JJ, 2005, J AM SOC MASS SPECTR, V16, P880, DOI 10.1016/j.jasms.2005.01.015; Cooperberg MR, 2011, CANCER-AM CANCER SOC, V117, P5039, DOI 10.1002/cncr.26169; Cooperberg MR, 2005, J UROLOGY, V173, P1938, DOI 10.1097/01.ju.0000158155.33890.e7; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Dakna M, 2009, J CHROMATOGR B, V877, P1250, DOI 10.1016/j.jchromb.2008.10.048; DeLeo J. M., 1993, [1993] Proceedings Second International Symposium on Uncertainty Modeling and Analysis, P318, DOI 10.1109/ISUMA.1993.366750; Dudoit S, 2008, SPRINGER SER STAT, P1; Emami N, 2008, J BIOL CHEM, V283, P19561, DOI 10.1074/jbc.M801194200; Fiedler GM, 2007, CLIN CHEM, V53, P421, DOI 10.1373/clinchem.2006.077834; Girolami M, 2007, DRUG DISCOV TODAY TE, V3, P12; Goo YA, 2010, J PROTEOMICS, V73, P1839, DOI 10.1016/j.jprot.2010.04.002; Good DM, 2006, BIOTECHNIQUES, V40, P783, DOI 10.2144/000112194; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Hanno PM, 2011, J UROLOGY, V185, P2162, DOI 10.1016/j.juro.2011.03.064; Heidenreich A, 2011, EUR UROL, V59, P61, DOI 10.1016/j.eururo.2010.10.039; Ilic D, 2011, BJU INT, V107, P882, DOI 10.1111/j.1464-410X.2010.10032.x; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kim Y, 2012, MOL CELL PROTEOMICS; Kolch W, 2005, MASS SPECTROM REV, V24, P959, DOI 10.1002/mas.20051; Marshall S, 2009, WORLD J UROL, V27, P577, DOI 10.1007/s00345-009-0435-8; Metzger J, 2013, GUT, V62, P122, DOI 10.1136/gutjnl-2012-302047; Mischak H, 2007, PROTEOM CLIN APPL, V1, P792, DOI 10.1002/prca.200700043; Mischak H, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001249; Mohler JL, 2010, J NATL COMPR CANC NE, V8, P145, DOI 10.6004/jnccn.2010.0010; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; Roach M, 2000, INT J RADIAT ONCOL, V47, P609, DOI 10.1016/S0360-3016(00)00578-2; Schaub S, 2004, KIDNEY INT, V65, P323, DOI 10.1111/j.1523-1755.2004.00352.x; Schiffer E, 2012, INT J UROL, V19, P118, DOI 10.1111/j.1442-2042.2011.02901.x; Siddiqui E, 2004, J R SOC PROMO HEALTH, V124, P219, DOI 10.1177/146642400412400518; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Theodorescu D, 2008, PROTEOM CLIN APPL, V2, P556, DOI 10.1002/prca.200780082; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; Villanueva J, 2008, MOL CELL PROTEOMICS, V7, P509, DOI 10.1074/mcp.M700397-MCP200; von zur Muhlen C, 2009, J PROTEOME RES, V8, P335, DOI 10.1021/pr800615t; Weissinger EM, 2004, KIDNEY INT, V65, P2426, DOI 10.1111/j.1523-1755.2004.00659.x; Yang ZR, 2004, BRIEF BIOINFORM, V5, P328, DOI 10.1093/bib/5.4.328; Yang ZR, 2004, BIOINFORMATICS, V20, P735, DOI 10.1093/bioinformatics/btg477; You JJ, 2010, CRIT REV ONCOL HEMAT, V73, P10, DOI 10.1016/j.critrevonc.2009.02.007; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	46	36	37	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67514	10.1371/journal.pone.0067514	http://dx.doi.org/10.1371/journal.pone.0067514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826311	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000321738400153
J	Sasaki, MM; Nichols, JT; Kimmel, CB				Sasaki, Mark M.; Nichols, James T.; Kimmel, Charles B.			edn1 and hand2 Interact in Early Regulation of Pharyngeal Arch Outgrowth during Zebrafish Development	PLOS ONE			English	Article							BHLH TRANSCRIPTION FACTOR; NEURAL CREST CELLS; A RECEPTOR; CRANIOFACIAL DEVELOPMENT; SIGNALING PATHWAYS; ENDOTHELIN-1; DEFICIENT; CARTILAGE; MUTANTS; ROLES	Endothelin-1 (Edn1) signaling provides a critical input to development of the embryonic pharygneal arches and their skeletal derivatives, particularly the articulating joints and the ventral skeleton including the lower jaw. Previous work in zebrafish has mostly focused on the role of Edn1 in dorsal-ventral (DV) patterning, but Edn1 signaling must also regulate tissue size, for with severe loss of the pathway the ventral skeleton is not only mispatterned, but is also prominently hypoplastic - reduced in size. Here we use mutational analyses to show that in the early pharyngeal arches, ventral-specific edn1-mediated proliferation of neural crest derived cells is required for DV expansion and outgrowth, and that this positive regulation is counterbalanced by a negative one exerted through a pivotal, ventrally expressed Edn1-target gene, hand2. We also describe a new morphogenetic cell movement in the ventral first arch, sweeping cells anterior in the arch to the region where the lower jaw forms. This movement is negatively regulated by hand2 in an apparently edn1-independent fashion. These findings point to complexity of regulation by edn1 and hand2 at the earliest stages of pharyngeal arch development, in which control of growth and morphogenesis can be genetically separated.	[Sasaki, Mark M.; Nichols, James T.; Kimmel, Charles B.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Nichols, JT (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	jnichols@uoneuro.uoregon.edu		Nichols, James/0000-0002-7263-1704	National Institutes of Health (NIH) [RO1 DE13834, PO1HD22486, F32-086027, F32-DE019056]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F32DE019056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM086027] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (NIH) RO1 DE13834 and PO1HD22486, and a NIH postdoctoral fellowships F32-086027 (to JTN) and F32-DE019056 (to MMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2007, INT J DEV BIOL, V51, P97, DOI 10.1387/ijdb.062237ma; Aiyer AR, 2005, DEV BIOL, V278, P155, DOI 10.1016/j.ydbio.2004.11.001; Alexander C, 2011, DEVELOPMENT, V138, P5135, DOI 10.1242/dev.067801; AVERY L, 1992, TRENDS GENET, V8, P312, DOI 10.1016/0168-9525(92)90263-4; Bagnato A, 1997, CANCER RES, V57, P1306; Barron F, 2011, DEVELOPMENT, V138, P2249, DOI 10.1242/dev.056929; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Bonano M, 2008, DEV BIOL, V323, P114, DOI 10.1016/j.ydbio.2008.08.007; Clouthier David E, 2004, Birth Defects Res C Embryo Today, V72, P190, DOI 10.1002/bdrc.20007; Clouthier DE, 1998, DEVELOPMENT, V125, P813; Clouthier DE, 2000, DEV BIOL, V217, P10, DOI 10.1006/dbio.1999.9527; Crump JG, 2004, PLOS BIOL, V2, P1432, DOI 10.1371/journal.pbio.0020244; Del Bufalo D, 2002, CLIN SCI, V103, p302S, DOI 10.1042/CS103S302S; Del Bufalo D, 2002, MOL PHARMACOL, V61, P524, DOI 10.1124/mol.61.3.524; Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Huycke TR, 2012, DEVELOPMENT, V139, P2371, DOI 10.1242/dev.079806; Kempf H, 1998, DEVELOPMENT, V125, P4931; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimmel CB, 2007, J EXP ZOOL PART B, V308B, P609, DOI 10.1002/jez.b.21155; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Miller CT, 2000, DEVELOPMENT, V127, P3815; Miller CT, 2003, DEVELOPMENT, V130, P1353, DOI 10.1242/dev.00339; Nair S, 2007, DEVELOPMENT, V134, P335, DOI 10.1242/dev.02704; Nichols JT, 2013, DEVELOPMENT IN PRESS; Piotrowski T, 1996, DEVELOPMENT, V123, P345; ROHLF FJ, 2005, TPS DIG VERSION 2 04; Ruest LB, 2004, DEVELOPMENT, V131, P4413, DOI 10.1242/dev.01291; Ruest LB, 2009, DEV BIOL, V328, P94, DOI 10.1016/j.ydbio.2009.01.005; Schilling TF, 1996, DEVELOPMENT, V123, P329; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Talbot JC, 2010, DEVELOPMENT, V137, P2506, DOI 10.1242/dev.049700; Tavares ALP, 2012, DEV BIOL, V371, P47, DOI 10.1016/j.ydbio.2012.08.003; Thomas T, 1998, DEVELOPMENT, V125, P3005; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Walker MB, 2006, DEV BIOL, V295, P194, DOI 10.1016/j.ydbio.2006.03.028; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yanagisawa H, 1998, DEVELOPMENT, V125, P825; Yelon D, 2000, DEVELOPMENT, V127, P2573; Zuniga E, 2011, DEVELOPMENT, V138, P5147, DOI 10.1242/dev.067785; Zuniga E, 2010, DEVELOPMENT, V137, P1843, DOI 10.1242/dev.049056	43	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67522	10.1371/journal.pone.0067522	http://dx.doi.org/10.1371/journal.pone.0067522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826316	Green Submitted, gold, Green Published			2022-12-27	WOS:000321738400156
J	Tewari-Singh, N; Jain, AK; Inturi, S; White, CW; Agarwal, R				Tewari-Singh, Neera; Jain, Anil K.; Inturi, Swetha; White, Carl W.; Agarwal, Rajesh			Clinically-Relevant Cutaneous Lesions by Nitrogen Mustard: Useful Biomarkers of Vesicants Skin Injury in SKH-1 Hairless and C57BL/6 Mice	PLOS ONE			English	Article							SULFIDE-INDUCED SKIN; SULFUR MUSTARD; NONINVASIVE METHODS; IRANIAN VETERANS; DNA-DAMAGE; GUINEA-PIG; MOUSE SKIN; EXPOSURE; MODEL; COMPLICATIONS	A paucity of clinically applicable biomarkers to screen therapies in laboratory is a limitation in the development of countermeasures against cutaneous injuries by chemical weapon, sulfur mustard (SM), and its analog nitrogen mustard (NM). Consequently, we assessed NM-caused progression of clinical cutaneous lesions; notably, skin injury with NM is comparable to SM. Exposure of SKH-1 hairless and C57BL/6 (haired) mice to NM (3.2 mg) for 12-120 h caused clinical sequelae of toxicity, including microblister formation, edema, erythema, altered pigmentation, wounding, xerosis and scaly dry skin. These toxic effects of NM were similar in both mouse strains, except that wounding and altered pigmentation at 12-24 h and appearance of dry skin at 24 and 72 h post-NM exposure were more pronounced in C57BL/6 compared to SKH-1 mice. Conversely, edema, erythema and microblister formation were more prominent in SKH-1 than C57BL/6 mice at 24-72 h after NM exposure. In addition, 40-60% mortality was observed following 120 h of NM exposure in the both mouse strains. Overall, these toxic effects of NM are comparable to those reported in humans and other animal species with SM, and thus represent clinically-relevant cutaneous injury endpoints in screening and optimization of therapies for skin injuries by vesicating agents.	[Tewari-Singh, Neera; Jain, Anil K.; Inturi, Swetha; Agarwal, Rajesh] Univ Colorado Denver, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO USA; [White, Carl W.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Agarwal, R (corresponding author), Univ Colorado Denver, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO USA.	Rajesh.Agarwal@ucdenver.edu			Countermeasures Against Chemical Threats (CounterACT) Program; Office of the Director National Institutes of Health (OD); National Institute of Environmental Health Sciences (NIEHS) [U54 ES015678]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES015678] Funding Source: NIH RePORTER	Countermeasures Against Chemical Threats (CounterACT) Program; Office of the Director National Institutes of Health (OD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Countermeasures Against Chemical Threats (CounterACT) Program, Office of the Director National Institutes of Health (OD) and the National Institute of Environmental Health Sciences (NIEHS), [Grant Number U54 ES015678]. The study sponsors have no involvement in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Anumolu SS, 2011, BIOMATERIALS, V32, P1204, DOI 10.1016/j.biomaterials.2010.08.117; Balali-Mood M, 2005, FUND CLIN PHARMACOL, V19, P713, DOI 10.1111/j.1472-8206.2005.00364.x; Balali-Mood M, 2005, FUND CLIN PHARMACOL, V19, P297, DOI 10.1111/j.1472-8206.2005.00325.x; Balali-Mood M, 2006, BASIC CLIN PHARMACOL, V99, P273, DOI 10.1111/j.1742-7843.2006.pto_429.x; Benson JM, 2011, WOUND REPAIR REGEN, V19, P348, DOI 10.1111/j.1524-475X.2011.00675.x; Casillas RP, 2000, J APPL TOXICOL, V21, pS145; Clery-Barraud C, 2013, SKIN RES TECHNOL, V19, pE146, DOI 10.1111/j.1600-0846.2012.00621.x; Dachir S, 2010, SKIN RES TECHNOL, V16, P114, DOI 10.1111/j.1600-0846.2009.00409.x; Dorandeu F, 2011, HUM EXP TOXICOL, V30, P470, DOI 10.1177/0960327110373615; DORR RT, 1988, CANCER CHEMOTH PHARM, V22, P299; Emadi SN, 2012, CUTAN OCUL TOXICOL, V31, P214, DOI 10.3109/15569527.2011.641196; Emadi SN, 2011, CUTAN OCUL TOXICOL, V30, P170, DOI 10.3109/15569527.2010.539585; Evison D, 2002, BRIT MED J, V324, P332, DOI 10.1136/bmj.324.7333.332; Firooz A, 2011, CUTAN OCUL TOXICOL, V30, P64, DOI 10.3109/15569527.2010.529547; Ghabili K, 2011, CRIT REV TOXICOL, V41, P384, DOI 10.3109/10408444.2010.541224; Ghabili K, 2010, J APPL TOXICOL, V30, P627, DOI 10.1002/jat.1581; Ghanei M, 2010, CUTAN OCUL TOXICOL, V29, P269, DOI 10.3109/15569527.2010.511367; Graham John S, 2005, J Burns Wounds, V4, pe1; Henemyre-Harris Claudia L, 2008, Eplasty, V8, pe16; Jain AK, 2011, TOXICOL LETT, V205, P293, DOI 10.1016/j.toxlet.2011.06.019; Jain AK, 2011, TOXICOLOGY, V282, P129, DOI 10.1016/j.tox.2011.01.021; Joseph LB, 2011, EXP MOL PATHOL, V91, P515, DOI 10.1016/j.yexmp.2011.05.010; Kehe K, 2005, TOXICOLOGY, V214, P198, DOI 10.1016/j.tox.2005.06.014; Kehe K, 2009, TOXICOLOGY, V263, P3, DOI 10.1016/j.tox.2009.04.060; Kehe Kai, 2008, Eplasty, V8, pe32; Milatovic S, 2003, WOUND REPAIR REGEN, V11, P213, DOI 10.1046/j.1524-475X.2003.11310.x; Naraghi ZS, 2005, EUR J DERMATOL, V15, P140; Pal A, 2009, FREE RADICAL BIO MED, V47, P1640, DOI 10.1016/j.freeradbiomed.2009.09.011; Panahi Y., 2007, SMJ Singapore Medical Journal, V48, P392; Reid FM, 2007, SKIN RES TECHNOL, V13, P217, DOI 10.1111/j.1600-0846.2007.00204.x; Rowell M, 2009, TOXICOLOGY, V263, P9, DOI 10.1016/j.tox.2009.05.015; Shakarjian MP, 2010, TOXICOL SCI, V114, P5, DOI 10.1093/toxsci/kfp253; Sharma M, 2010, INT J TOXICOL, V29, P391, DOI 10.1177/1091581810365730; Sharma M, 2009, TOXICOL LETT, V188, P243, DOI 10.1016/j.toxlet.2009.04.015; Shohrati M, 2007, CUTAN OCUL TOXICOL, V26, P249, DOI 10.1080/15569520701212340; Smith KJ, 1997, J DERMATOL SCI, V14, P126, DOI 10.1016/S0923-1811(96)00560-9; Smith KJ, 1998, AM J DERMATOPATH, V20, P22, DOI 10.1097/00000372-199802000-00005; Tewari-Singh N, 2009, TOXICOL SCI, V108, P194, DOI 10.1093/toxsci/kfn261; Vallet V, 2012, CUTAN OCUL TOXICOL, V31, P38, DOI 10.3109/15569527.2011.609206; WAHLBERG JE, 1993, CONTACT DERMATITIS, V28, P141, DOI 10.1111/j.1600-0536.1993.tb03374.x; Wang GQ, 2007, BURNS, V33, P923, DOI 10.1016/j.burns.2006.11.004; Wormser U, 2002, ARCH TOXICOL, V76, P119, DOI 10.1007/s00204-001-0307-5	42	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67557	10.1371/journal.pone.0067557	http://dx.doi.org/10.1371/journal.pone.0067557			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826320	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400158
J	Gefenaite, G; Tacken, M; Bos, J; Stirbu-Wagner, I; Korevaar, JC; Stolk, RP; Wolters, B; Bijl, M; Postma, MJ; Wilschut, J; Nichol, KL; Hak, E				Gefenaite, Giedre; Tacken, Margot; Bos, Jens; Stirbu-Wagner, Irina; Korevaar, Joke C.; Stolk, Ronald P.; Wolters, Bert; Bijl, Marc; Postma, Maarten J.; Wilschut, Jan; Nichol, Kristin L.; Hak, Eelko			Effectiveness of A(H1N1)pdm09 Influenza Vaccine in Adults Recommended for Annual Influenza Vaccination	PLOS ONE			English	Article							PANDEMIC INFLUENZA; PRIMARY-CARE; SAFETY; IMMUNOGENICITY; COHORT; RISK; AGE	Introduction: Because of variability in published A(H1N1)pdm09 influenza vaccine effectiveness estimates, we conducted a study in the adults belonging to the risk groups to assess the A(H1N1)pdm09 MF59-adjuvanted influenza vaccine effectiveness. Methods: VE against influenza and/or pneumonia was assessed in the cohort study (n>25000), and vaccine effectiveness against laboratory-confirmed A(H1N1)pdm09 influenza was assessed in a matched case-control study (16 pairs). Odds ratios (OR) and their 95% confidence intervals (95% CI) were calculated by using multivariate logistic regression; vaccine effectiveness was estimated as (1-odds ratio)*100%. Results: Vaccine effectiveness against laboratory-confirmed A(H1N1)pdm09 influenza and influenza and/or pneumonia was 98% (84-100%) and 33% (2-54%) respectively. The vaccine did not prevent influenza and/or pneumonia in 18-59 years old subjects, and was 49% (16-69%) effective in 60 years and older subjects. Conclusions: Even though we cannot entirely rule out that selection bias, residual confounding and/or cross-protection has played a role, the present results indicate that the MF59-adjuvanted A(H1N1)pdm09 influenza vaccine has been effective in preventing laboratory-confirmed A(H1N1)pdm09 influenza and influenza and/or pneumonia, the latter notably in 60 years and older subjects.	[Gefenaite, Giedre; Bos, Jens; Postma, Maarten J.; Hak, Eelko] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands; [Gefenaite, Giedre; Stolk, Ronald P.; Postma, Maarten J.; Hak, Eelko] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9700 AB Groningen, Netherlands; [Tacken, Margot] Radboud Univ Nijmegen, Sci Inst Qual Healthcare IQ Healthcare, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Stirbu-Wagner, Irina; Korevaar, Joke C.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; [Wolters, Bert] Community Hlth Serv, Groningen, Netherlands; [Bijl, Marc] Martini Hosp, Dept Internal Med & Rheumatol, Groningen, Netherlands; [Wilschut, Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Mol Virol Sect, Groningen, Netherlands; [Nichol, Kristin L.] Vet Affairs Med Ctr, Res Serv, Minneapolis, MN 55417 USA; [Nichol, Kristin L.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	University of Groningen; University of Groningen; Radboud University Nijmegen; Netherlands Institute for Health Services Research; Martini Hospital; University of Groningen; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Gefenaite, G (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands.	g.gefenaite@umcg.nl	Tacken, M.A.J.B./L-4679-2015	Postma, Maarten/0000-0002-6306-3653; Stolk, Ronald/0000-0002-0518-1205; Gefenaite, Giedre/0000-0001-9952-9446	University of Groningen, University Medical Center Groningen, the Netherlands	University of Groningen, University Medical Center Groningen, the Netherlands(Netherlands Government)	The work was supported by the University of Groningen, University Medical Center Groningen, the Netherlands. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews N, 2011, J INFECT DIS, V203, P32, DOI 10.1093/infdis/jiq014; Castilla J, 2011, VACCINE, V29, P5919, DOI 10.1016/j.vaccine.2011.06.063; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Cheong HJ, 2011, CLIN VACCINE IMMUNOL, V18, P1358, DOI 10.1128/CVI.05111-11; Donker G, 2011, CONTINUOUS MORBIDITY; EMEA, 2010, ANN 1 SUMM PROD CHAR; FluNet Global Influenza Surveillance and Response System (GISRS), 2013, GLOB INFL SURV RESP; Fukase H, 2012, VACCINE, V30, P5030, DOI 10.1016/j.vaccine.2012.03.053; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Groenwold RHH, 2009, EUR RESPIR J, V34, P56, DOI 10.1183/09031936.00190008; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Health Council of the Netherlands, 2009, VACC TEG PAND INFL A; Health Council of the Netherlands, 2007, GRIEPV HERZ IND; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Lamberts H, 1996, INT J BIOMED COMPUT, V42, P35, DOI 10.1016/0020-7101(96)01179-8; McElhaney JE, 2011, AGEING RES REV, V10, P379, DOI 10.1016/j.arr.2010.10.008; Ortqvist A, 2011, CLIN INFECT DIS, V52, P1203, DOI 10.1093/cid/cir182; Rahamat-Langendoen JC, 2012, J CLIN VIROL, V54, P135, DOI 10.1016/j.jcv.2012.02.010; Rodriguez-Rieiro C, 2010, VACCINE, V28, P6203, DOI 10.1016/j.vaccine.2010.07.013; Soler JK, 2008, FAM PRACT, V25, P312, DOI 10.1093/fampra/cmn028; Steens A, 2011, EUROSURVEILLANCE, V16, P23; Steens A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-196; Tacken M, 2010, MONITORING VACCINATI; Tacken MAJB, 2013, VACCINE, V31, P900, DOI 10.1016/j.vaccine.2012.12.002; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; Weiner MG, 2008, PHARMACOEPIDEM DR S, V17, P661, DOI 10.1002/pds.1585; Wong K, 2012, ARCH INTERN MED, V172, P484, DOI 10.1001/archinternmed.2011.2038; Wu JA, 2010, NEW ENGL J MED, V363, P2416, DOI 10.1056/NEJMoa1006736	28	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66125	10.1371/journal.pone.0066125	http://dx.doi.org/10.1371/journal.pone.0066125			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840413	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800035
J	Ohnishi, S; Maehara, O; Nakagawa, K; Kameya, A; Otaki, K; Fujita, H; Higashi, R; Takagi, K; Asaka, M; Sakamoto, N; Kobayashi, M; Takeda, H				Ohnishi, Shunsuke; Maehara, Osamu; Nakagawa, Koji; Kameya, Ayano; Otaki, Kanako; Fujita, Hirotoshi; Higashi, Ryosuke; Takagi, Kikuko; Asaka, Masahiro; Sakamoto, Naoya; Kobayashi, Masanobu; Takeda, Hiroshi			Hypoxia-Inducible Factors Activate CD133 Promoter through ETS Family Transcription Factors	PLOS ONE			English	Article							CANCER STEM-CELLS; TUMOR-GROWTH; HEMATOPOIETIC STEM; PANCREATIC-CANCER; IDENTIFICATION; FACTOR-1-ALPHA; HIF-2-ALPHA; EXPRESSION; PROGNOSIS; EXPANSION	CD133 is a cellular surface protein that has been reported to be a cancer stem cell marker, and thus it is considered to be a potential target for cancer treatment. However, the mechanism regulating CD133 expression is not yet understood. In this study, we analyzed the activity of five putative promoters (P1-P5) of CD133 in human embryonic kidney (HEK) 293 cells and colon cancer cell line WiDr, and found that the activity of promoters, particularly of P5, is elevated by overexpression of hypoxia-inducible factors (HIF-1 alpha and HIF-2 alpha). Deletion and mutation analysis identified one of the two E-twenty six (ETS) binding sites (EBSs) in the P5 region as being essential for its promoter activity induced by HIF-1 alpha and HIF-2 alpha. In addition, a chromatin imunoprecipitation assay demonstrated that HIF-1 alpha and HIF-2 alpha bind to the proximal P5 promoter at the EBSs. The immunoprecipitation assay showed that HIF-1 alpha physically interacts with Elk1; however, HIF-2 alpha did not bind to Elk1 or ETS1. Furthermore, knockdown of both HIF-1 alpha and HIF-2 alpha resulted in a reduction of CD133 expression in WiDr. Taken together, our results revealed that HIF-1 alpha and HIF-2 alpha activate CD133 promoter through ETS proteins.	[Ohnishi, Shunsuke; Takagi, Kikuko; Sakamoto, Naoya] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Maehara, Osamu; Nakagawa, Koji; Kameya, Ayano; Otaki, Kanako; Fujita, Hirotoshi; Higashi, Ryosuke; Takeda, Hiroshi] Hokkaido Univ, Fac Pharmaceut Sci, Dept Pathophysiol & Therapeut, Sapporo, Hokkaido 060, Japan; [Asaka, Masahiro] Hokkaido Univ, Grad Sch Med, Dept Canc Prevent Med, Sapporo, Hokkaido, Japan; [Kobayashi, Masanobu] Hlth Sci Univ Hokkaido, Dept Nursing, Ishikari, Hokkaido 06102, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Health Sciences University of Hokkaido	Ohnishi, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan.	sonishi@pop.med.hokudai.ac.jp	Nakagawa, Koji/B-2889-2015; Takeda, Hiroshi/C-6551-2015; Ohnishi, Shunsuke/A-5982-2012	Ohnishi, Shunsuke/0000-0003-1194-4149	Japan Society for the Promotion of Science (JSPS); Yasuda Memorial Foundation; Grants-in-Aid for Scientific Research [24390185] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yasuda Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science (JSPS), and by the Yasuda Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Baba Y, 2010, AM J PATHOL, V176, P2292, DOI 10.2353/ajpath.2010.090972; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; FISHER RJ, 1991, ONCOGENE, V6, P2249; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hashimoto O, 2011, PATHOBIOLOGY, V78, P181, DOI 10.1159/000325538; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Iida H, 2012, INT J ONCOL, V40, P71, DOI 10.3892/ijo.2011.1207; Karapetsas A, 2011, INT J BIOCHEM CELL B, V43, P1582, DOI 10.1016/j.biocel.2011.07.007; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Matsumoto K, 2009, CANCER RES, V69, P7160, DOI 10.1158/0008-5472.CAN-09-1289; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mylonis I, 2006, J BIOL CHEM, V281, P33095, DOI 10.1074/jbc.M605058200; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Rasheed S, 2009, BRIT J CANCER, V100, P1666, DOI 10.1038/sj.bjc.6605026; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schwab LP, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3087; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shmelkov SV, 2004, BLOOD, V103, P2055, DOI 10.1182/blood-2003-06-1881; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Sun C, 2012, J CANC RES CLIN ONCO; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Tabu K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-39; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wollenick K, 2012, NUCLEIC ACIDS RES, V40, P1928, DOI 10.1093/nar/gkr978; Yi JM, 2008, CANCER RES, V68, P8094, DOI 10.1158/0008-5472.CAN-07-6208; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476	34	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66255	10.1371/journal.pone.0066255	http://dx.doi.org/10.1371/journal.pone.0066255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840432	Green Published, gold			2022-12-27	WOS:000322342800044
J	Gazdhar, A; Susuri, N; Hostettler, K; Gugger, M; Knudsen, L; Roth, M; Ochs, M; Geiser, T				Gazdhar, Amiq; Susuri, Njomeza; Hostettler, Katrin; Gugger, Mathias; Knudsen, Lars; Roth, Michael; Ochs, Matthias; Geiser, Thomas			HGF Expressing Stem Cells in Usual Interstitial Pneumonia Originate from the Bone Marrow and Are Antifibrotic	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; IDIOPATHIC PULMONARY-FIBROSIS; PERIPHERAL-BLOOD; FACTOR ACTIVATION; STROMAL CELLS; GENE-TRANSFER; LUNG; PATHOGENESIS; TISSUE; FIBROBLASTS	Background: Pulmonary fibrosis may result from abnormal alveolar wound repair after injury. Hepatocyte growth factor (HGF) improves alveolar epithelial wound repair in the lung. Stem cells were shown to play a major role in lung injury, repair and fibrosis. We studied the presence, origin and antifibrotic properties of HGF-expressing stem cells in usual interstitial pneumonia. Methods: Immunohistochemistry was performed in lung tissue sections and primary alveolar epithelial cells obtained from patients with usual interstitial pneumonia (UIP, n = 7). Bone marrow derived stromal cells (BMSC) from adult male rats were transfected with HGF, instilled intratracheally into bleomycin injured rat lungs and analyzed 7 and 14 days later. Results: In UIP, HGF was expressed in specific cells mainly located in fibrotic areas close to the hyperplastic alveolar epithelium. HGF-positive cells showed strong co-staining for the mesenchymal stem cell markers CD44, CD29, CD105 and CD90, indicating stem cell origin. HGF-positive cells also co-stained for CXCR4 (HGF+/CXCR4+) indicating that they originate from the bone marrow. The stem cell characteristics were confirmed in HGF secreting cells isolated from UIP lung biopsies. In vivo experiments showed that HGF-expressing BMSC attenuated bleomycin induced pulmonary fibrosis in the rat, indicating a beneficial role of bone marrow derived, HGF secreting stem cells in lung fibrosis. Conclusions: HGF-positive stem cells are present in human fibrotic lung tissue (UIP) and originate from the bone marrow. Since HGF-transfected BMSC reduce bleomycin induced lung fibrosis in the bleomycin lung injury and fibrosis model, we assume that HGF-expressing, bone-marrow derived stem cells in UIP have antifibrotic properties.	[Gazdhar, Amiq; Susuri, Njomeza; Geiser, Thomas] Univ Hosp Bern, Dept Pulm Med, CH-3010 Bern, Switzerland; [Gazdhar, Amiq; Susuri, Njomeza; Geiser, Thomas] Univ Bern, Dept Clin Res, Bern, Switzerland; [Gugger, Mathias] Univ Bern, Dept Pathol, CH-3000 Bern, Switzerland; [Hostettler, Katrin; Roth, Michael] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Knudsen, Lars; Ochs, Matthias] Hannover Med Sch, Inst Funct & Appl Anat, Hannover, Germany	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Basel; Hannover Medical School	Geiser, T (corresponding author), Univ Hosp Bern, Dept Pulm Med, CH-3010 Bern, Switzerland.	thomas.geiser@insel.ch	Gazdhar, Amiq/AAJ-6835-2020; Knudsen, Lars/G-3146-2013; Roth, Michael/H-8657-2019; Gazdhar, Amiq/AAN-6024-2020	Gazdhar, Amiq/0000-0002-4807-8785; Knudsen, Lars/0000-0002-7926-3879; Roth, Michael/0000-0002-8139-2821; Hostettler, Katrin/0000-0001-8118-7441	Swiss national science foundation [SNF120-408]	Swiss national science foundation(Swiss National Science Foundation (SNSF)European Commission)	This work supported by a Swiss national science foundation grant to Thomas Geiser (SNF120-408; www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; BURKHARDT A, 1989, AM REV RESPIR DIS, V140, P513, DOI 10.1164/ajrccm/140.2.513; Crestani B, 2002, LAB INVEST, V82, P1015, DOI 10.1097/01.LAB.0000024361.92500.19; De Wever O, 2004, FASEB J, V18, P1016, DOI 10.1096/fj.03-1110fje; Galvin JR, 2010, RADIOLOGY, V255, P692, DOI 10.1148/radiol.10090717; Gazdhar A, 2007, AM J PHYSIOL-LUNG C, V292, pL529, DOI 10.1152/ajplung.00082.2006; Geiser T, 2003, SWISS MED WKLY, V133, P586; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Grenier A, 2002, BLOOD, V99, P2997, DOI 10.1182/blood.V99.8.2997; Gundersen HJG, 2002, J MICROSC-OXFORD, V207, P191, DOI 10.1046/j.1365-2818.2002.01054.x; Gunther A, 1999, EUR RESPIR J, V14, P565, DOI 10.1034/j.1399-3003.1999.14c14.x; Hsia CCW, 2010, RESP PHYSIOL NEUROBI, V171, P72, DOI 10.1016/j.resp.2010.02.016; Hyde DM, 2004, ANAT REC PART A, V277A, P216, DOI 10.1002/ar.a.20012; Jaffre S, 2002, AM J PHYSIOL-LUNG C, V282, pL310, DOI 10.1152/ajplung.00121.2001; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Karoubi G, 2009, LAB INVEST, V89, P1100, DOI 10.1038/labinvest.2009.73; KATZENSTEIN ALA, 1985, HUM PATHOL, V16, P1015, DOI 10.1016/S0046-8177(85)80279-3; Kim HJ, 1999, CHEST, V116, p94S, DOI 10.1378/chest.116.suppl_1.94S; Knudsen L, 2012, AM J RESP CRIT CARE, pA1987; Knudsen Lars, 2011, Expert Opin Med Diagn, V5, P319, DOI 10.1517/17530059.2011.577414; Kucia M, 2004, CIRC RES, V95, P1191, DOI 10.1161/01.RES.0000150856.47324.5b; Kucia M, 2006, ARCH IMMUNOL THER EX, V54, P121, DOI 10.1007/s00005-006-0015-1; Kucia M, 2005, BIOL CELL, V97, P133, DOI 10.1042/BC20040069; Lama VN, 2007, J CLIN INVEST, V117, P989, DOI 10.1172/JCI29713; Leslie KO, 2011, ARCH PATHOL LAB MED; Leuenberger A, 2012, J APPL PHYSL; Marchand-Adam S, 2003, AM J RESP CRIT CARE, V168, P1156, DOI 10.1164/rccm.200212-1514OC; Marchand-Adam S, 2006, AM J RESP CRIT CARE, V174, P58, DOI 10.1164/rccm.200507-1074OC; Mehrad B, 2007, BIOCHEM BIOPH RES CO, V353, P104, DOI 10.1016/j.bbrc.2006.11.149; MYERS JL, 1988, CHEST, V94, P1309, DOI 10.1378/chest.94.6.1309; Nakamura T, 2011, J GASTROEN HEPATOL, V26, P188, DOI 10.1111/j.1440-1746.2010.06549.x; Nathan SD, 2011, CHEST, V140, P221, DOI 10.1378/chest.10-2572; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Ochs M, 2006, J MICROSC-OXFORD, V222, P188, DOI 10.1111/j.1365-2818.2006.01587.x; Ohki Y, 2009, NEONATOLOGY, V95, P332, DOI 10.1159/000187651; Phin S, 2010, AM J RESP CELL MOL, V42, P286, DOI 10.1165/rcmb.2008-0305OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Sakai T, 1997, AM J RESP CELL MOL, V16, P388, DOI 10.1165/ajrcmb.16.4.9115749; SCHERLE W, 1970, Mikroskopie, V26, P57; Schittny JC, 2008, AM J PHYSIOL-LUNG C, V294, pL246, DOI 10.1152/ajplung.00296.2007; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Seyfried DM, 2010, J NEUROSURG, V112, P329, DOI 10.3171/2009.2.JNS08907; SINGHKAW P, 1995, AM J PHYSIOL-LUNG C, V268, pL1012, DOI 10.1152/ajplung.1995.268.6.L1012; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Sueblinvong V, 2010, TRANSL RES, V156, P188, DOI 10.1016/j.trsl.2010.06.007; Tjin EPM, 2005, J IMMUNOL, V175, P2807, DOI 10.4049/jimmunol.175.5.2807; Ueda H, 1997, VIRCHOWS ARCH, V430, P407, DOI 10.1007/s004280050050; Umeda Y, 2004, LAB INVEST, V84, P836, DOI 10.1038/labinvest.3700098; Watanabe M, 2005, MOL THER, V12, P58, DOI 10.1016/j.ymthe.2005.02.019; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02; Wuyts WA, 2012, EUROPEAN RESP J; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551	56	48	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65453	10.1371/journal.pone.0065453	http://dx.doi.org/10.1371/journal.pone.0065453			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840329	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200018
J	Wang, XT; Li, L; Zhu, YB; Du, YS; Song, XR; Chen, YX; Huang, RL; Que, HY; Fang, XD; Zhang, GF				Wang, Xiaotong; Li, Li; Zhu, Yabing; Du, Yishuai; Song, Xiaorui; Chen, Yuanxin; Huang, Ronglian; Que, Huayong; Fang, Xiaodong; Zhang, Guofan			Oyster Shell Proteins Originate from Multiple Organs and Their Probable Transport Pathway to the Shell Formation Front	PLOS ONE			English	Article							EASTERN OYSTER; MINERALIZATION; INTERFACE; MOLLUSK; MATRIX; NACRE	Mollusk shell is one kind of potential biomaterial, but its vague mineralization mechanism hinders its further application. Mollusk shell matrix proteins are important functional components that are embedded in the shell, which play important roles in shell formation. The proteome of the oyster shell had been determined based on the oyster genome sequence by our group and gives the chance for further deep study in this area. The classical model of shell formation posits that the shell proteins are mantle-secreted. But, in this study, we further analyzed the shell proteome data in combination with organ transcriptome data and we found that the shell proteins may be produced by multiple organs though the mantle is still the most important organ for shell formation. To identify the transport pathways of these shell proteins not in classical model of shell formation, we conducted a shell damage experiment and we determined the shell-related gene set to identify the possible transport pathways from multiple organs to the shell formation front. We also found that there may exist a remodeling mechanism in the process of shell formation. Based on these results along with some published results, we proposed a new immature model, which will help us think about the mechanism of shell formation in a different way.	[Wang, Xiaotong; Li, Li; Du, Yishuai; Song, Xiaorui; Huang, Ronglian; Que, Huayong; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Zhu, Yabing; Chen, Yuanxin; Fang, Xiaodong] BGI Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Beijing Genomics Institute (BGI)	Zhang, GF (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	gfzhang@qdio.ac.cn	Fang, Xiaodong/K-6743-2018; Li, Li/AEM-3636-2022; li, li/GPX-3938-2022; LI, LI/GVS-5344-2022; li, li/HII-4157-2022	Fang, Xiaodong/0000-0001-7061-3337; 	National Basic Research Program of China (973 Program) [2010CB126401]; National Natural Science Foundation of China [40730845]; National High Technology Research and Development Program (863 program) [2012AA10A405]; Mollusc Research and Development Center; CARS [CARS-48]; Taishan Scholars Climbing Program of Shandong; Oversea Taishan Scholar Program of Shandong	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 program)(National High Technology Research and Development Program of China); Mollusc Research and Development Center; CARS; Taishan Scholars Climbing Program of Shandong; Oversea Taishan Scholar Program of Shandong	This research was supported by National Basic Research Program of China (973 Program, No. 2010CB126401), the National Natural Science Foundation of China (no. 40730845), National High Technology Research and Development Program (863 program, 2012AA10A405), Mollusc Research and Development Center, CARS (CARS-48), Taishan Scholars Climbing Program of Shandong and Oversea Taishan Scholar Program of Shandong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berland S, 2005, BIOMATERIALS, V26, P2767, DOI 10.1016/j.biomaterials.2004.07.019; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; CRENSHAW MA, 1969, AM ZOOL, V9, P881; Duplat D, 2007, BIOMATERIALS, V28, P4769, DOI 10.1016/j.biomaterials.2007.07.036; Ficai M, 2010, REV ROM MATER, V40, P359; Furuhashi T, 2009, COMP BIOCHEM PHYS B, V154, P351, DOI 10.1016/j.cbpb.2009.07.011; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Geist J, 2008, J MOLLUS STUD, V74, P337, DOI 10.1093/mollus/eyn025; GORDON J, 1978, SCIENCE, V202, P519, DOI 10.1126/science.202.4367.519; Johnstone MB, 2008, J EXP ZOOL PART B, V310B, P227, DOI 10.1002/jez.b.21206; Lao YX, 2007, COMP BIOCHEM PHYS B, V148, P201, DOI 10.1016/j.cbpb.2007.05.010; Liu HL, 2007, BIOCHEMISTRY-US, V46, P844, DOI 10.1021/bi061881a; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6; Mount A, 2009, J ENVIRON MANAGE, V91, P168, DOI 10.1016/j.jenvman.2009.08.002; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Wang X SX, 2012, ISRAELI J AQUACULTUR; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	20	32	36	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66522	10.1371/journal.pone.0066522	http://dx.doi.org/10.1371/journal.pone.0066522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840499	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200091
J	d'Avo, AF; Cunha, S; Mingote, A; Lamosa, P; da Costa, MS; Costa, J				d'Avo, Ana Filipa; Cunha, Sofia; Mingote, Ana; Lamosa, Pedro; da Costa, Milton S.; Costa, Joana			A Unique Pool of Compatible Solutes on Rhodopirellula baltica, Member of the Deep-Branching Phylum Planctomycetes	PLOS ONE			English	Article							CYANOBACTERIA; EVOLUTION; GLUCOSYLGLYCERATE; OSMOADAPTATION; MICROORGANISMS; HETEROGENEITY; ACCUMULATION; ENVIRONMENTS; DIVERSITY; PIRELLULA	The intracellular accumulation of small organic solutes was described in the marine bacterium Rhodopirellula baltica, which belongs to the globally distributed phylum Planctomycetes whose members exhibit an intriguing lifestyle and cell morphology. Sucrose, alpha-glutamate, trehalose and mannosylglucosylglycerate (MGG) are the main solutes involved in the osmoadaptation of R. baltica. The ratio and total intracellular organic solutes varied significantly in response to an increase in salinity, temperature and nitrogen content. R. baltica displayed an initial response to both osmotic and thermal stresses that includes alpha-glutamate accumulation. This trend was followed by a rather unique and complex osmoadaptation mechanism characterized by a dual response to sub-optimal and supra-optimal salinities. A reduction in the salinity to suboptimal conditions led primarily to the accumulation of trehalose. In contrast, R. baltica responded to salt stress mostly by increasing the intracellular levels of sucrose. The switch between the accumulation of trehalose and sucrose was by far the most significant effect caused by increasing the salt levels of the medium. Additionally, MGG accumulation was found to be salt- as well as nitrogen-dependent. MGG accumulation was regulated by nitrogen levels replacing alpha-glutamate as a K+ counterion in nitrogen-poor environments. This is the first report of the accumulation of compatible solutes in the phylum Planctomycetes and of the MGG accumulation in a mesophilic organism.	[d'Avo, Ana Filipa; Cunha, Sofia; da Costa, Milton S.; Costa, Joana] Univ Coimbra, Ctr Neurosci & Cellular Biol, Coimbra, Portugal; [Mingote, Ana] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal; [Lamosa, Pedro] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Ctr Ressonancia Magnet Antonio Xavier, P-2780156 Oeiras, Portugal; [da Costa, Milton S.; Costa, Joana] Univ Coimbra, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Universidade de Coimbra	Costa, J (corresponding author), Univ Coimbra, Ctr Neurosci & Cellular Biol, Coimbra, Portugal.	jcosta@cnc.uc.pt	Costa, Joana/B-9176-2009	Costa, Joana/0000-0001-7028-2873; Cunha, Sofia/0000-0001-7113-3108; Lamosa, Pedro/0000-0002-3003-1516; da Costa, Milton/0000-0003-4027-4412	Fundacao para a Ciencia e a Tecnologia [PEst-C/SAU/LA0001/2011, PTDC/BIA-MIC/105247/2008]; FCT [SFRH/BD/46212/2008, SFRH/BPD/34007/2006]; POCI [REDE/1517/RMN/2005]; Fundacao para a Ciencia e a Tecnologia	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); POCI(European Commission); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	The research was funded by Fundacao para a Ciencia e a Tecnologia under the projects PEst-C/SAU/LA0001/2011 and PTDC/BIA-MIC/105247/2008. SC and JC acknowledge scholarships from FCT (SFRH/BD/46212/2008 and SFRH/BPD/34007/2006). The National NMR Network (REDE/1517/RMN/2005) was supported by POCI 2010 and Fundacao para a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buckley DH, 2006, APPL ENVIRON MICROB, V72, P4522, DOI 10.1128/AEM.00149-06; COHENBAZIRE G, 1957, J CELL COMPAR PHYSL, V49, P25, DOI 10.1002/jcp.1030490104; Costa J, 2013, WOODH PUB SER BIOMED, P465, DOI 10.1533/9781908818355.3.465; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Empadinhas N, 2008, INT MICROBIOL, V11, P151, DOI 10.2436/20.1501.01.55; Fernandes C, 2010, J BACTERIOL, V192, P1624, DOI 10.1128/JB.01424-09; FUERST JA, 1995, MICROBIOL-UK, V141, P1493, DOI 10.1099/13500872-141-7-1493; Fuerst JA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00167; Fuerst JA, 2011, NAT REV MICROBIOL, V9, P403, DOI 10.1038/nrmicro2578; Goude R, 2004, APPL ENVIRON MICROB, V70, P6535, DOI 10.1128/AEM.70.11.6535-6541.2004; Jorge CD, 2007, FEBS J, V274, P3120, DOI 10.1111/j.1742-4658.2007.05844.x; Khmelenina VN, 1999, ARCH MICROBIOL, V172, P321, DOI 10.1007/s002030050786; Klahn S, 2011, ENVIRON MICROBIOL, V13, P551, DOI 10.1111/j.1462-2920.2010.02366.x; Klahn S, 2010, ENVIRON MICROBIOL, V12, P83, DOI 10.1111/j.1462-2920.2009.02045.x; Lunn JE, 2002, PLANT PHYSIOL, V128, P1490, DOI 10.1104/pp.010898; Lyman J, 1940, J MAR RES, V3, P134; REED RH, 1986, FEMS MICROBIOL LETT, V39, P51; Roberts Mary F, 2005, Saline Syst, V1, P5, DOI 10.1186/1746-1448-1-5; Santos H, 2002, ENVIRON MICROBIOL, V4, P501, DOI 10.1046/j.1462-2920.2002.00335.x; Santos H, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P86; Schlesner H, 2004, INT J SYST EVOL MICR, V54, P1567, DOI 10.1099/ijs.0.63113-0; SCHLESNER H, 1994, SYST APPL MICROBIOL, V17, P135, DOI 10.1016/S0723-2020(11)80042-1; Silva Z, 1999, EXTREMOPHILES, V3, P163, DOI 10.1007/s007920050112; STALEY JT, 1968, J BACTERIOL, V95, P1921, DOI 10.1128/JB.95.5.1921-1942.1968; Wecker P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-410	27	5	5	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68289	10.1371/journal.pone.0068289	http://dx.doi.org/10.1371/journal.pone.0068289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826385	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000138
J	Mogren, CL; Walton, WE; Parker, DR; Trumble, JT				Mogren, Christina L.; Walton, William E.; Parker, David R.; Trumble, John T.			Trophic Transfer of Arsenic from an Aquatic Insect to Terrestrial Insect Predators	PLOS ONE			English	Article							CONTAMINANTS; BIOACCUMULATION; WATER; PREY; METHYLMERCURY; ACCUMULATION; ARTHROPODS; TRANSPORT; ABUNDANCE; TOXICITY	The movement of energy and nutrients from aquatic to terrestrial ecosystems can be substantial, and emergent aquatic insects can serve as biovectors not only for nutrients, but also for contaminants present in the aquatic environment. The terrestrial predators Tenodera aridifolia sinensis (Mantodea: Mantidae) and Tidarren haemorrhoidale (Araneae: Theridiidae) and the aquatic predator Buenoa scimitra (Hemiptera: Notonectidae) were chosen to evaluate the efficacy of arsenic transfer between aquatic and terrestrial environments. Culex tarsalis larvae were reared in either control water or water containing 1000 mu g l(-1) arsenic. Adults that emerged from the control and arsenic treatments were fed to the terrestrial predators, and fourth instar larvae were fed to the aquatic predator reared in control or arsenic contaminated water. Tenodera a. sinensis fed arsenic-treated Cx. tarsalis accumulated 658 +/- 130 ng g(-1) of arsenic. There was no significant difference between control and arsenic-fed T. haemorrhoidale (range 142-290 ng g(-1)). Buenoa scimitra accumulated 5120 +/- 406 ng g(-1) of arsenic when exposed to arsenic-fed Cx. tarsalis and reared in water containing 1000 mu g l(-1) arsenic. There was no significant difference between controls or arsenic-fed B. scimitra that were not exposed to water-borne arsenic, indicating that for this species environmental exposure was more important in accumulation than strictly dietary arsenic. These results indicate that transfer to terrestrial predators may play an important role in arsenic cycling, which would be particularly true during periods of mass emergence of potential insect biovectors. Trophic transfer within the aquatic environment may still occur with secondary predation, or in predators with different feeding strategies.	[Mogren, Christina L.; Walton, William E.; Trumble, John T.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Parker, David R.] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Mogren, CL (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	christina.mogren@email.ucr.edu	Mogren, Christina/W-4699-2019	Mogren, Christina/0000-0002-9164-7197	UCR Entomology Department	UCR Entomology Department	The research in this manuscript was supported in part by the UCR Entomology Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Akamatsu F, 2011, ENVIRON POLLUT, V159, P1390, DOI 10.1016/j.envpol.2011.01.005; Albert CA, 2008, ENVIRON TOXICOL CHEM, V27, P605, DOI 10.1897/07-147.1; Andrahennadi R, 2008, ENVIRON CHEM, V5, P413, DOI 10.1071/EN08065; Baxter CV, 2005, FRESHWATER BIOL, V50, P201, DOI 10.1111/j.1365-2427.2004.01328.x; Blais JM, 2007, ENVIRON SCI TECHNOL, V41, P1075, DOI 10.1021/es061314a; Burghelea CI, 2011, J ENVIRON MONITOR, V13, P1308, DOI 10.1039/c1em10016e; Chen X., 2003, REGRESSION SAS; Croisetiere L, 2006, ENVIRON SCI TECHNOL, V40, P873, DOI 10.1021/es0516209; Culioli JL, 2009, AQUAT TOXICOL, V94, P286, DOI 10.1016/j.aquatox.2009.07.016; DeLorenzo ME, 2001, ENVIRON TOXICOL CHEM, V20, P84, DOI [10.1897/1551-5028(2001)020&lt;0084:TOPTAM&gt;2.0.CO;2, 10.1002/etc.5620200108]; Dreyer J, 2012, OIKOS, V121, P252, DOI 10.1111/j.1600-0706.2011.19588.x; Dutton J, 2011, SCI TOTAL ENVIRON, V409, P3438, DOI 10.1016/j.scitotenv.2011.05.022; Farag AM, 1998, ARCH ENVIRON CON TOX, V34, P119, DOI 10.1007/s002449900295; Gade G, 2004, PHYSIOL ENTOMOL, V29, P84, DOI 10.1111/j.0307-6962.2004.0375.x; Gratton C, 2008, ECOSYSTEMS, V11, P764, DOI 10.1007/s10021-008-9158-8; Green K, 2008, ARCT ANTARCT ALP RES, V40, P74, DOI 10.1657/1523-0430(06-100)[GREEN]2.0.CO;2; Green Ken, 2001, Victorian Naturalist (Blackburn), V118, P112; Hazelrigg JE, 1973, THESIS U CALIFORNIA; Hoekman D, 2012, OECOLOGIA, V170, P735, DOI 10.1007/s00442-012-2329-5; Hopkins WA, 2002, ENVIRON TOXICOL CHEM, V21, P906, DOI 10.1897/1551-5028(2002)021<0906:EOCDET>2.0.CO;2; Hughes MF, 2002, ECOPHYSIOLOGY METALS; Jensen PD, 2007, ENVIRON TOXICOL, V22, P287, DOI 10.1002/tox.20254; Kaltenpoth M, 2005, ENTOMOL GEN, V28, P1; Kral K, 2012, EUR J ENTOMOL, V109, P295, DOI 10.14411/eje.2012.039; Lavilla I, 2010, J ENVIRON MONITOR, V12, P724, DOI 10.1039/b920379f; Levi H. W., 1957, Journal of the New York Entomological Society, V63, P59; Mandal BK, 2002, TALANTA, V58, P201, DOI 10.1016/S0039-9140(02)00268-0; Martin S, 2008, LIMNOL OCEANOGR, V53, P411, DOI 10.4319/lo.2008.53.2.0411; Mason RP, 2000, ARCH ENVIRON CON TOX, V38, P283, DOI 10.1007/s002449910038; MENZIE CA, 1980, WATER AIR SOIL POLL, V13, P473, DOI 10.1007/BF02191848; Mogren CL, 2013, ENVIRON POLLUT, V180, P78, DOI 10.1016/j.envpol.2013.05.021; Mogren CL, 2012, SCI TOTAL ENVIRON, V425, P60, DOI 10.1016/j.scitotenv.2012.03.009; Morrissey CA, 2008, ECOL APPL, V18, P172, DOI 10.1890/07-0015.1; Morrissey CA, 2007, ENVIRON SCI TECHNOL, V41, P1494, DOI 10.1021/es061967r; Muller G, 2006, INT J PARASITOL, V36, P1077, DOI 10.1016/j.ijpara.2006.06.008; Nriagu JO, 1994, ARSENIC ENV; NYFFELER M, 1988, SOUTHWEST NAT, V33, P215, DOI 10.2307/3671897; Ortiz JGM, 2009, TOXICOL SCI, V107, P416, DOI 10.1093/toxsci/kfn192; Ravenscroft P., 2009, ARSENIC POLLUTION GL; Ringmann S, 2002, ANAL CHIM ACTA, V452, P207, DOI 10.1016/S0003-2670(01)01477-5; Rodriguez-Castro VA, 2006, J AM MOSQUITO CONTR, V22, P123, DOI 10.2987/8756-971X(2006)22[123:MRAERO]2.0.CO;2; Runck C, 2007, ECOL APPL, V17, P740, DOI 10.1890/05-1026; Schmidt-Rhaesa A, 2001, ZOOL ANZ, V240, P167, DOI 10.1078/0044-5231-00014; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; STEWART KW, 1970, ANN ENTOMOL SOC AM, V63, P139, DOI 10.1093/aesa/63.1.139; Sullivan SMP, 2012, ENVIRON TOXICOL CHEM, V31, P1175, DOI 10.1002/etc.1842; Torres KC, 2001, ENVIRON TOXICOL CHEM, V20, P2617, DOI [10.1002/etc.5620201130, 10.1897/1551-5028(2001)020&lt;2617:BOMIPA&gt;2.0.CO;2]; U.S. EPA, 2006, NAT REC WAT QUAL CRI; Walters DM, 2008, ECOL APPL, V18, P1835, DOI 10.1890/08-0354.1; ZAMAN K, 1995, ARCH INSECT BIOCHEM, V29, P199, DOI 10.1002/arch.940290209; ZHANG ML, 1993, J CHEM ECOL, V19, P1109, DOI 10.1007/BF00987372; Zhang ZM, 2012, FRONT EARTH SCI-PRC, V6, P433, DOI 10.1007/s11707-012-0301-7	53	24	24	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67817	10.1371/journal.pone.0067817	http://dx.doi.org/10.1371/journal.pone.0067817			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826344	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000101
J	Muller, BM; Keil, E; Lehmann, A; Winzer, KJ; Richter-Ehrenstein, C; Prinzler, J; Bangemann, N; Reles, A; Stadie, S; Schoenegg, W; Eucker, J; Schmidt, M; Lippek, F; Johrens, K; Pahl, S; Sinn, BV; Budczies, J; Dietel, M; Denkert, C				Mueller, Berit Maria; Keil, Elke; Lehmann, Annika; Winzer, Klaus-Juergen; Richter-Ehrenstein, Christiane; Prinzler, Judith; Bangemann, Nikola; Reles, Angela; Stadie, Sylvia; Schoenegg, Winfried; Eucker, Jan; Schmidt, Marcus; Lippek, Frank; Joehrens, Korinna; Pahl, Stefan; Sinn, Bruno Valentin; Budczies, Jan; Dietel, Manfred; Denkert, Carsten			The EndoPredict Gene-Expression Assay in Clinical Practice - Performance and Impact on Clinical Decisions	PLOS ONE			English	Article							PARAFFIN-EMBEDDED TISSUE; EARLY BREAST-CANCER; INTERNATIONAL EXPERT CONSENSUS; RECURRENCE SCORE ASSAY; ESTROGEN-RECEPTOR; PRIMARY THERAPY; MESSENGER-RNA; HIGHLIGHTS; EXTRACTION; SURVIVAL	The validated EndoPredict assay is a novel tool to predict the risk of metastases of patients with estrogen receptor positive, HER2 negative breast cancer treated with endocrine therapy alone. It has been designed to integrate genomic and clinical information and includes clinico-pathological factors such as tumor size and nodal status. The test is feasible in a decentral setting in molecular pathology laboratories. In this project, we investigated the performance of this test in clinical practice, and performed a retrospective evaluation of its impact on treatment decisions in breast cancer. During one year, EndoPredict assays from 167 patients could be successfully performed. For retrospective evaluation of treatment decisions, a questionnaire was sent to the clinical partner. Regarding the molecular EP class, samples from 56 patients (33.5%) had a low-risk, whereas 111 patients (66.5%) showed a high-risk gene profile. After integration of the clinicopathological factors the combined clinical and molecular score (EPclin) resulted in a low-risk group of 77 patients (46.4%), while 89 (53.6%) had a high risk EPclin score. The EPclin-based estimated median 10-year-risk for metastases with endocrine therapy alone was 11% for the whole cohort. The median handling time averaged three days (range: 0 to 11 days), 59.3% of the tests could be performed in three or less than three days. Comparison of pre- and post-test therapy decisions showed a change of therapy in 37.7% of patients. 16 patients (12.3%) had a change to an additional chemotherapy while 25.4% of patients (n = 33) changed to an endocrine therapy alone. In 73 patients (56.2%) no change of therapy resulted. In 6.1% of patients (n = 8), the patients did not agree to the recommendation of the tumor board. Our results show that the EndoPredict assay could be routinely performed in decentral molecular pathology laboratories and the results markedly change treatment decisions.	[Mueller, Berit Maria; Lehmann, Annika; Prinzler, Judith; Joehrens, Korinna; Pahl, Stefan; Sinn, Bruno Valentin; Budczies, Jan; Dietel, Manfred; Denkert, Carsten] Charite, Inst Pathol, Berlin, Germany; [Keil, Elke; Stadie, Sylvia] Breast Ctr, Berlin, Germany; [Winzer, Klaus-Juergen; Richter-Ehrenstein, Christiane; Bangemann, Nikola] Charite, Breast Ctr, Berlin, Germany; [Reles, Angela; Schoenegg, Winfried] Gynecol Clin, Berlin, Germany; [Eucker, Jan] Charite, Dept Internal Med, Berlin, Germany; [Schmidt, Marcus] Johannes Gutenberg Univ Mainz, Breast Ctr, D-55122 Mainz, Germany; [Lippek, Frank] Inst Pathol, Neuruppin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johannes Gutenberg University of Mainz	Muller, BM (corresponding author), Charite, Inst Pathol, Campus Mitte, Berlin, Germany.	berit.mueller@charite.de	Schmidt, Marcus/H-3383-2013; Denkert, Carsten/AHE-2675-2022; Budczies, Jan/AAG-8122-2020	Schmidt, Marcus/0000-0003-1365-2414; Lindner, Judith Lea/0000-0003-2223-4468; Denkert, Carsten/0000-0002-2249-0982; Lehmann, Annika/0000-0001-9424-5882; Eucker, Jan/0000-0002-6714-8056	university research advancement	university research advancement	The project was funded by the university research advancement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi S, 2011, ANN ONCOL, V21, pv9; Albanell J, 2012, ANN ONCOL, V23, P625, DOI 10.1093/annonc/mdr278; Benson JR, 2009, LANCET, V373, P1463, DOI 10.1016/S0140-6736(09)60316-0; Blohmer JU, 2013, J MED EC; Bohmann K, 2009, CLIN CHEM, V55, P1719, DOI 10.1373/clinchem.2008.122572; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Curigliano G, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.299; Denkert C, 2012, VIRCHOWS ARCH, V460, P251, DOI 10.1007/s00428-012-1204-4; Dietel M, 2013, CANCER GENE THER, V20, P211, DOI 10.1038/cgt.2013.13; Dubsky P, 2013, ANN ONCOL; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Hennig G, 2010, CLIN CHEM, V56, P1845, DOI 10.1373/clinchem.2010.151233; Kronenwett R, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-456; Lo SS, 2010, J CLIN ONCOL, V28, P1671, DOI 10.1200/JCO.2008.20.2119; Muller BM, 2011, DIAGN MOL PATHOL, V20, P1, DOI 10.1097/PDM.0b013e3181e3630c; Oakman C, 2010, NAT REV CLIN ONCOL, V7, P725, DOI 10.1038/nrclinonc.2010.170; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Weigelt B, 2012, ANN ONCOL, V23, P211, DOI 10.1093/annonc/mds323	24	53	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68252	10.1371/journal.pone.0068252	http://dx.doi.org/10.1371/journal.pone.0068252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826382	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000135
J	van de Ven, V; Wingen, M; Kuypers, KPC; Ramaekers, JG; Formisano, E				van de Ven, Vincent; Wingen, Marleen; Kuypers, Kim P. C.; Ramaekers, Johannes G.; Formisano, Elia			Escitalopram Decreases Cross-Regional Functional Connectivity within the Default-Mode Network	PLOS ONE			English	Article							RESTING-STATE NETWORKS; INDEPENDENT COMPONENT ANALYSIS; BOLD SIGNAL FLUCTUATIONS; MEDIAL PREFRONTAL CORTEX; CEREBRAL-BLOOD-FLOW; ALZHEIMERS-DISEASE; BRAIN-FUNCTION; IN-VIVO; TRYPTOPHAN DEPLETION; MEMORY IMPAIRMENT	The default-mode network (DMN), which comprises medial frontal, temporal and parietal regions, is part of the brain's intrinsic organization. The serotonergic (5-HT) neurotransmitter system projects to DMN regions from midbrain efferents, and manipulation of this system could thus reveal insights into the neurobiological mechanisms of DMN functioning. Here, we investigate intrinsic functional connectivity of the DMN as a function of activity of the serotonergic system, through the administration of the selective serotonin reuptake inhibitor (SSRI) escitalopram. We quantified DMN functional connectivity using an approach based on dual-regression. Specifically, we decomposed group data of a subset of the functional time series using spatial independent component analysis, and projected the group spatial modes to the same and an independent resting state time series of individual participants. We found no effects of escitalopram on global functional connectivity of the DMN at the map-level; that is, escitalopram did not alter the global functional architecture of the DMN. However, we found that escitalopram decreased DMN regional pairwise connectivity, which included anterior and posterior cingulate cortex, hippocampal complex and lateral parietal regions. Further, regional DMN connectivity covaried with alertness ratings across participants. Our findings show that escitalopram altered intrinsic regional DMN connectivity, which suggests that the serotonergic system plays an important role in DMN connectivity and its contribution to cognition. Pharmacological challenge designs may be a useful addition to resting-state functional MRI to investigate intrinsic brain functional organization.	[van de Ven, Vincent; Formisano, Elia] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands; [Wingen, Marleen; Kuypers, Kim P. C.; Ramaekers, Johannes G.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands	Maastricht University; Maastricht University	van de Ven, V (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	v.vandeven@maastrichtuniversity.nl	van de Ven, Vincent/D-3003-2009; Kuypers, Kim/L-1206-2019	van de Ven, Vincent/0000-0001-8735-3711; Kuypers, Kim/0000-0001-7634-3809; Formisano, Elia/0000-0001-5008-2460	Organon; Pierre Fabre; FAES pharma; GSK; European Committee; Netherlands Organisation for Scientific Research (NWO)	Organon; Pierre Fabre; FAES pharma; GSK(GlaxoSmithKline); European Committee; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was in part financially supported by grants from pharmaceutical industries (Organon, Pierre Fabre, FAES pharma, GSK) and the European Committee to JR, and by grants from the Netherlands Organisation for Scientific Research (NWO) to VV, JR and EF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Elseoud A, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00037; Aghajanian GK, 1999, NEUROPSYCHOPHARMACOL, V21, pS16; Anderson IM, 2008, NEUROPHARMACOLOGY, V55, P1029, DOI 10.1016/j.neuropharm.2008.06.029; Aronson S, 2004, DRUG TODAY, V40, P121, DOI 10.1358/dot.2004.40.2.799424; Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Birn RM, 2009, NEUROIMAGE, V47, P1092, DOI 10.1016/j.neuroimage.2009.05.030; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BOND A, 1974, BRIT J MED PSYCHOL, V47, P211, DOI 10.1111/j.2044-8341.1974.tb02285.x; Bozkurt A, 2005, NEUROIMAGE, V25, P219, DOI 10.1016/j.neuroimage.2004.10.040; Brady CA, 2007, NEUROPHARMACOLOGY, V52, P1284, DOI 10.1016/j.neuropharm.2007.01.009; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carhart-Harris RL, 2012, P NATL ACAD SCI USA, V109, P2138, DOI 10.1073/pnas.1119598109; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Weerd P, 2012, J NEUROSCI, V32, P1981, DOI 10.1523/JNEUROSCI.3712-11.2011; Del-Ben CM, 2005, NEUROPSYCHOPHARMACOL, V30, P1724, DOI 10.1038/sj.npp.1300728; Drummond SPA, 2005, SLEEP, V28, P1059; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Esposito F, 2008, MAGN RESON IMAGING, V26, P905, DOI 10.1016/j.mri.2008.01.045; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Esposito F, 2010, NEUROIMAGE, V53, P534, DOI 10.1016/j.neuroimage.2010.06.061; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Formisano E, 2004, MAGN RESON IMAGING, V22, P1493, DOI 10.1016/j.mri.2004.10.020; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Geday J, 2005, SYNAPSE, V55, P224, DOI 10.1002/syn.20112; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Harmer CJ, 2002, PSYCHOPHARMACOLOGY, V163, P106, DOI 10.1007/s00213-002-1151-x; Harmer CJ, 2006, BIOL PSYCHIAT, V59, P816, DOI 10.1016/j.biopsych.2005.10.015; Hasson U, 2009, P NATL ACAD SCI USA, V106, P10841, DOI 10.1073/pnas.0903253106; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Jardri R, 2007, NEUROIMAGE, V35, P1645, DOI 10.1016/j.neuroimage.2007.02.002; Kelly C, 2009, J NEUROSCI, V29, P7364, DOI 10.1523/JNEUROSCI.0810-09.2009; Khalili-Mahani N, 2011, HUMAN BRAIN MAPPING; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Liao R, 2006, MAGN RESON MED, V55, P1396, DOI 10.1002/mrm.20893; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Loubinoux I, 2005, NEUROIMAGE, V27, P299, DOI 10.1016/j.neuroimage.2004.12.023; Loubinoux I, 2002, NEUROIMAGE, V15, P26, DOI 10.1006/nimg.2001.0957; Mann JJ, 1996, J CEREBR BLOOD F MET, V16, P418, DOI 10.1097/00004647-199605000-00008; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McBean DE, 1999, BRAIN RES, V847, P80, DOI 10.1016/S0006-8993(99)02033-8; McKeown MJ, 1998, HUM BRAIN MAPP, V6, P160, DOI 10.1002/(SICI)1097-0193(1998)6:3<160::AID-HBM5>3.0.CO;2-1; McKie S, 2005, PSYCHOPHARMACOLOGY, V180, P680, DOI 10.1007/s00213-005-2270-y; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Meeter M, 2006, NEUROPSYCHOPHARMACOL, V31, P712, DOI 10.1038/sj.npp.1300869; Meltzer CC, 1998, NEUROPSYCHOPHARMACOL, V18, P407; Meneses A, 1999, NEUROSCI BIOBEHAV R, V23, P1111, DOI 10.1016/S0149-7634(99)00067-6; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; Pariente J, 2001, ANN NEUROL, V50, P718, DOI 10.1002/ana.1257; Penttila J, 2001, PSYCHOPHARMACOLOGY, V154, P343, DOI 10.1007/s002130000664; Puig MV, 2004, CEREB CORTEX, V14, P1365, DOI 10.1093/cercor/bhh097; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RAMAEKERS JG, 1995, BRIT J CLIN PHARMACO, V39, P397, DOI 10.1111/j.1365-2125.1995.tb04468.x; Ramaekers JG, 2009, NEUROPSYCHOPHARMACOL, V34, P1641, DOI 10.1038/npp.2008.219; Rasmussen SL, 1999, J CLIN PSYCHOPHARM, V19, P407, DOI 10.1097/00004714-199910000-00004; Rauch A, 2008, P NATL ACAD SCI USA, V105, P6759, DOI 10.1073/pnas.0800312105; Riedel WJ, 2005, J PSYCHOPHARMACOL, V19, P12, DOI 10.1177/0269881105048887; Riedel WJ, 1999, PSYCHOPHARMACOLOGY, V141, P362, DOI 10.1007/s002130050845; Roerig B, 1997, J NEUROSCI, V17, P8324; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rombouts SARB, 2003, NEUROIMAGE, V20, P1236, DOI 10.1016/S1053-8119(03)00386-0; Rose EJ, 2006, PSYCHOPHARMACOLOGY, V185, P339, DOI 10.1007/s00213-006-0334-2; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Schmitt JAJ, 2006, CURR PHARM DESIGN, V12, P2473, DOI 10.2174/138161206777698909; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Schwarz AJ, 2007, NEUROIMAGE, V34, P1627, DOI 10.1016/j.neuroimage.2006.11.010; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seifritz E, 1996, NEUROPSYCHOPHARMACOL, V14, P253, DOI 10.1016/0893-133X(95)00117-V; Sestieri C, 2011, J NEUROSCI, V31, P4407, DOI 10.1523/JNEUROSCI.3335-10.2011; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Sidtis JJ, 2004, NEUROIMAGE, V22, P1407, DOI 10.1016/j.neuroimage.2004.03.019; Smith SM, 2012, NEUROIMAGE, V62, P1257, DOI 10.1016/j.neuroimage.2012.01.022; Sobczak S, 2002, PSYCHOL MED, V32, P503, DOI 10.1017/S0033291702005342; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Svensen M, 2002, NEUROIMAGE, V16, P551, DOI 10.1006/nimg.2002.1122; Talairach J., 1988, COPLANAR STEREOTAXIC; Tambini A, 2010, NEURON, V65, P280, DOI 10.1016/j.neuron.2010.01.001; Tamminga CA, 2006, J CLIN PSYCHIAT, V67, P9; Thomas CG, 2002, NEUROIMAGE, V17, P1521, DOI 10.1006/nimg.2002.1200; Trujillo-Ortiz A, 2010, RMAOV33 3 WAY ANAL V; van de Ven V., 2012, NEUROSCIENCE HALLUCI, P393; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van de Ven V, 2008, HUM BRAIN MAPP, V29, P1450, DOI 10.1002/hbm.20479; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Wible CG, 2009, BRAIN IMAGING BEHAV, V3, P85, DOI 10.1007/s11682-008-9052-1; WILSON MA, 1991, NEUROSCIENCE, V44, P537, DOI 10.1016/0306-4522(91)90076-Z; Wingen M, 2007, J PSYCHOPHARMACOL, V21, P477, DOI 10.1177/0269881106072506; Wingen M, 2008, HUM PSYCHOPHARM CLIN, V23, P221, DOI 10.1002/hup.923; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	108	44	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68355	10.1371/journal.pone.0068355	http://dx.doi.org/10.1371/journal.pone.0068355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826388	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000141
J	Zheng, JS; Arnett, DK; Parnell, LD; Lee, YC; Ma, YY; Smith, CE; Richardson, K; Li, D; Borecki, IB; Tucker, KL; Ordovas, JM; Lai, CQ				Zheng, Ju-Sheng; Arnett, Donna K.; Parnell, Laurence D.; Lee, Yu-Chi; Ma, Yiyi; Smith, Caren E.; Richardson, Kris; Li, Duo; Borecki, Ingrid B.; Tucker, Katherine L.; Ordovas, Jose M.; Lai, Chao-Qiang			Polyunsaturated Fatty Acids Modulate the Association between PIK3CA-KCNMB3 Genetic Variants and Insulin Resistance	PLOS ONE			English	Article							FOOD FREQUENCY QUESTIONNAIRE; BK CHANNELS; FISH CONSUMPTION; GLUCOSE-HOMEOSTASIS; PUERTO-RICAN; PPAR-GAMMA; SENSITIVITY; RISK; POLYMORPHISM; METAANALYSIS	Background: Neighboring genes PIK3CA and KCNMB3 are both important for insulin signaling and beta-cell function, but their associations with glucose-related traits are unclear. Objective: The objective was to examine associations of PIK3CA-KCNMB3 variants with glucose-related traits and potential interaction with dietary fat. Design: We first investigated genetic associations and their modulation by dietary fat in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN) study (n = 820). Nine single-nucleotide polymorphisms (SNPs) were selected for analysis, covering more than 80% of the SNPs in the region. We then sought to replicate the findings in the Boston Puerto Rican Health Study (BPRHS) (n = 844). Results: For KCNMB3 missense mutation rs7645550, meta-analysis indicated that homeostasis model assessment of insulin resistance (HOMA-IR) was significantly lower in minor allele T homozygotes compared with major allele C carriers (pooled P-value = 0.004); for another SNP rs1183319, which is in moderate LD with rs7645550, minor allele G carriers had higher HOMA-IR compared with non-carriers in both populations (pooled P-value = 0.028). In GOLDN, rs7645550 T allele homozygotes had lower HOMA-IR only when dietary n-3: n-6 PUFA ratio was low (<= 0.11, P = 0.001), but not when it was high (. 0.11, P-interaction = 0.033). Similar interaction was observed between rs1183319 and n-3: n-6 PUFA ratio on HOMAIR (P-interaction = 0.001) in GOLDN. Variance contribution analyses in GOLDN confirmed the genetic association and gene-diet interaction. In BPRHS, dietary n-3: n-6 PUFA ratio significantly modulated the association between rs1183319 and HbA1c (P-interaction = 0.034). Conclusion: PIK3CA-KCNMB3 variants are associated with insulin resistance in populations of different ancestries, and are modified by dietary PUFA.	[Zheng, Ju-Sheng; Li, Duo] Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310003, Zhejiang, Peoples R China; [Zheng, Ju-Sheng; Parnell, Laurence D.; Lee, Yu-Chi; Ma, Yiyi; Smith, Caren E.; Richardson, Kris; Ordovas, Jose M.; Lai, Chao-Qiang] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Arnett, Donna K.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Borecki, Ingrid B.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Tucker, Katherine L.] Northeastern Univ, Dept Hlth Sci, Boston, MA 02115 USA	Zhejiang University; Tufts University; United States Department of Agriculture (USDA); University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Northeastern University	Li, D (corresponding author), Zhejiang Univ, Dept Food Sci & Nutr, Hangzhou 310003, Zhejiang, Peoples R China.	duoli@zju.edu.cn; chaoqiang.lai@ars.usda.gov	Ma, Yiyi/J-5237-2017; Ordovas, Jose/B-8727-2013; Zheng, Ju-Sheng/J-3970-2015; Li, Duo/N-3682-2013	Ma, Yiyi/0000-0002-3609-8877; Lai, Chao-Qiang/0000-0003-1107-8375; Ordovas, Jose/0000-0002-7581-5680; Zheng, Ju-Sheng/0000-0001-6560-4890; Tucker, Katherine/0000-0001-7640-662X; Li, Duo/0000-0001-5227-5565	China Scholarship Council; National Basic Research Program of China (973 Program) [2011CB504002]; National Heart, Lung, and Blood Institute [HL54776, HL078885]; US Department of Agriculture Research Service [53-K06-5-10, 58-1950-9-001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL105185, U01HL072524, R01HL091357] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Agriculture Research Service(United States Department of Agriculture (USDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by the China Scholarship Council; by the National Basic Research Program of China (973 Program: 2011CB504002); by National Heart, Lung, and Blood Institute grant number HL54776 and HL078885; by the contracts 53-K06-5-10 and 58-1950-9-001 from the US Department of Agriculture Research Service. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. The USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete I, 2008, J HUM NUTR DIET, V21, P591, DOI 10.1111/j.1365-277X.2008.00902.x; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akinkuolie AO, 2011, CLIN NUTR, V30, P702, DOI 10.1016/j.clnu.2011.08.013; Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, pE581, DOI 10.1152/ajpendo.90437.2008; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Corella D, 2007, CLIN CHEM, V53, P1144, DOI 10.1373/clinchem.2006.084863; Corella D, 2006, DIABETES CARE, V29, P1313, DOI 10.2337/dc06-0045; Corella D, 2012, BRIT J NUTR, V107, pS271, DOI 10.1017/S0007114512001651; Cornelis MC, 2012, ANNU REV NUTR, V32, P245, DOI 10.1146/annurev-nutr-071811-150648; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dedoussis George V Z, 2007, Rev Diabet Stud, V4, P13, DOI 10.1900/RDS.2007.4.13; Djousse L, 2011, AM J CLIN NUTR, V93, P143, DOI 10.3945/ajcn.110.005603; Dufer M, 2011, DIABETOLOGIA, V54, P423, DOI 10.1007/s00125-010-1936-0; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Foukas LC, 2006, NATURE, V441, P366, DOI 10.1038/nature04694; Hartweg J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003205.pub2; Higgins M, 1996, AM J EPIDEMIOL, V143, P1219, DOI 10.1093/oxfordjournals.aje.a008709; Houamed KM, 2010, J PHYSIOL-LONDON, V588, P3511, DOI 10.1113/jphysiol.2009.184341; Hu S, 2003, PHYSIOL GENOMICS, V15, P191, DOI 10.1152/physiolgenomics.00110.2003; Kelly G S, 2000, Altern Med Rev, V5, P109; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Lai CQ, 2009, HUM GENET, V125, P199, DOI 10.1007/s00439-008-0612-7; Lee Yu-Chi, 2011, J Data Mining Genomics Proteomics, V2; Liao W, 2007, AM J PHYSIOL-ENDOC M, V293, pE219, DOI 10.1152/ajpendo.00695.2006; Marin C, 2005, AM J CLIN NUTR, V82, P196, DOI 10.1093/ajcn/82.1.196; Marin C, 2011, MOL NUTR FOOD RES, V55, P328, DOI 10.1002/mnfr.201000235; Mostad IL, 2006, AM J CLIN NUTR, V84, P540, DOI 10.1093/ajcn/84.3.540; Nanri A, 2011, AM J CLIN NUTR, V94, P884, DOI 10.3945/ajcn.111.012252; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Richardson K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-504; Riserus U, 2008, CURR OPIN CLIN NUTR, V11, P100, DOI 10.1097/MCO.0b013e3282f52708; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Smith CE, 2012, NUTR METAB CARDIOVAS, V22, P449, DOI 10.1016/j.numecd.2010.09.003; Sopasakis VR, 2010, CELL METAB, V11, P220, DOI 10.1016/j.cmet.2010.02.002; Subar AF, 2001, AM J EPIDEMIOL, V154, P1089, DOI 10.1093/aje/154.12.1089; Thompson FE, 2002, J AM DIET ASSOC, V102, P212, DOI 10.1016/S0002-8223(02)90050-7; Tucker KL, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-107; Tucker KL, 1998, AM J EPIDEMIOL, V148, P507, DOI 10.1093/oxfordjournals.aje.a009676; Villegas R, 2011, AM J CLIN NUTR, V94, P543, DOI 10.3945/ajcn.111.013193; Wallin A, 2012, DIABETES CARE, V35, P918, DOI 10.2337/dc11-1631; Wang RX, 2011, CARDIOVASC RES, V90, P344, DOI 10.1093/cvr/cvq411; Watanabe RM, 2010, CURR DIABETES REP, V10, P476, DOI 10.1007/s11892-010-0143-1; Woodman RJ, 2002, AM J CLIN NUTR, V76, P1007, DOI 10.1093/ajcn/76.5.1007; Xun PC, 2012, DIABETES CARE, V35, P930, DOI 10.2337/dc11-1869; Zheng JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044525	48	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67394	10.1371/journal.pone.0067394	http://dx.doi.org/10.1371/journal.pone.0067394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826284	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000072
J	Fanelli, D; Glanzel, W				Fanelli, Daniele; Glaenzel, Wolfgang			Bibliometric Evidence for a Hierarchy of the Sciences	PLOS ONE			English	Article							SELF-ORGANIZATION; SOFT SCIENCE; JOURNALS; CLASSIFICATION; DISCIPLINES; MISCONDUCT; CITATION; IMPACT	The hypothesis of a Hierarchy of the Sciences, first formulated in the 19th century, predicts that, moving from simple and general phenomena (e. g. particle dynamics) to complex and particular (e. g. human behaviour), researchers lose ability to reach theoretical and methodological consensus. This hypothesis places each field of research along a continuum of complexity and "softness", with profound implications for our understanding of scientific knowledge. Today, however, the idea is still unproven and philosophically overlooked, too often confused with simplistic dichotomies that contrast natural and social sciences, or science and the humanities. Empirical tests of the hypothesis have usually compared few fields and this, combined with other limitations, makes their results contradictory and inconclusive. We verified whether discipline characteristics reflect a hierarchy, a dichotomy or neither, by sampling nearly 29,000 papers published contemporaneously in 12 disciplines and measuring a set of parameters hypothesised to reflect theoretical and methodological consensus. The biological sciences had in most cases intermediate values between the physical and the social, with bio-molecular disciplines appearing harder than zoology, botany or ecology. In multivariable analyses, most of these parameters were independent predictors of the hierarchy, even when mathematics and the humanities were included. These results support a "gradualist" view of scientific knowledge, suggesting that the Hierarchy of the Sciences provides the best rational framework to understand disciplines' diversity. A deeper grasp of the relationship between subject matter's complexity and consensus could have profound implications for how we interpret, publish, popularize and administer scientific research.	[Fanelli, Daniele] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Glaenzel, Wolfgang] Katholieke Univ Leuven, Ctr R&D Monitoring ECOOM, Louvain, Belgium; [Glaenzel, Wolfgang] Lib Hungarian Acad Sci, Dept Sci Policy & Scientometr, Budapest, Hungary	University of Edinburgh; KU Leuven; Hungarian Academy of Sciences	Fanelli, D (corresponding author), Univ Edinburgh, Edinburgh, Midlothian, Scotland.	dfanelli@exseed.ed.ac.uk	Glänzel, Wolfgang/A-6280-2008; Glanzel, Wolfgang/AAE-4395-2021	Glänzel, Wolfgang/0000-0001-7529-5198; Fanelli, Daniele/0000-0003-1780-1958	Leverhulme Early-Career fellowship	Leverhulme Early-Career fellowship(Leverhulme Trust)	DF was funded by a Leverhulme Early-Career fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, NATURE, V435, P1003, DOI 10.1038/4351003a; Bastian M., 2009, GEPHI OPEN SOURCE SO, DOI DOI 10.13140/2.1.1341.1520; Bishop R., 2007, PHILOS SOCIAL SCI IN; Boyack KW, 2010, J AM SOC INF SCI TEC, V61, P2389, DOI 10.1002/asi.21419; Braxton JM, 1996, VARIATION ACAD DISCI; Bu┬rner K., 2010, ATLAS SCI VISUALIZIN; Clarke S, 1998, METAPHYSICS DISUNITY; Clinton Sprott J, 2006, CHAOS TIME SEIRES AN; Cole, 2001, WHATS WRONG SOCIOLOG; COLE S, 1994, SOCIOL FORUM, V9, P133, DOI 10.1007/BF01476359; COLE S, 1983, AM J SOCIOL, V89, P111, DOI 10.1086/227835; Comte A, 1835, COURS PHILOS POSITIV; Cooper R, 2008, PSYCHIAT PHILOS SCI; COZZENS SE, 1985, SCIENTOMETRICS, V7, P431, DOI 10.1007/BF02017159; Cranmer SJ, 2011, POLIT ANAL, V19, P66, DOI 10.1093/pan/mpq037; DUPRE J, 1983, MIND, V92, P321; Dupre J., 1995, DISORDER THINGS META; Fanelli D, 2012, SCIENTOMETR IN PRESS; Fanelli D, 2012, P 17 INT C SCI TECHN, P452; Fanelli D., 2010, PLOS ONE, P5, DOI 10.1371/journal.pone.0010271; Fanelli D, 2013, EUR J PERSONALITY, V27, P124; Fanelli D, 2013, NATURE, V494, P149, DOI 10.1038/494149a; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Feyerabend P., 2002, METHOD; Forbes Andrew E., 2004, Ecological Society of America Annual Meeting Abstracts, V89, P160; Glanzel W, 1996, SCIENTOMETRICS, V37, P195, DOI 10.1007/BF02093621; Glanzel W, 1999, INFORM PROCESS MANAG, V35, P31, DOI 10.1016/S0306-4573(98)00028-4; GRAYDONALD K, 1988, AM J EPIDEMIOL, V127, P885, DOI 10.1093/oxfordjournals.aje.a114891; Halley JD, 2008, BIOSYSTEMS, V92, P148, DOI 10.1016/j.biosystems.2008.01.005; Halley JD, 2006, AUST J CHEM, V59, P849, DOI 10.1071/CH06191; Handcock Mark S., 2003, STATNET SOFTWARE TOO; Handcock MS, 2012, ERGM PACKAGE FIT SIM; Hardy PMA, 2009, HDB DATA ANAL; HUMPHREYS P, 1990, TOPOI-INT REV PHILOS, V9, P157, DOI 10.1007/BF00135895; Humphreys P., 1989, CHANCES EXPLANATION; Hyland K, 2001, ENGL SPECIF PURP, V20, P207, DOI 10.1016/S0889-4906(00)00012-0; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2008, SEMIN HEMATOL, V45, P160, DOI 10.1053/j.seminhematol.2008.04.010; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kagan J., 2009, 3 CULTURES NATURAL S; Krausz E, 2000, LIMITS SCI; Kuhn T., 1970, STRUCTURE SCI REVOLU; Lariviere V, 2006, J AM SOC INF SCI TEC, V57, P997, DOI 10.1002/asi.20349; Lewes G. H., 1853, COMTES PHILOS SCI; Leydesdorff L, 2011, J INFORMETR, V5, P87, DOI 10.1016/j.joi.2010.09.002; LINDSAY RM, 1993, AM STAT, V47, P217, DOI 10.2307/2684982; Lipton P, 2005, SCIENCE, V307, P219, DOI 10.1126/science.1103024; Lovy A, 2010, TEACH LEARN MED, V22, P319, DOI 10.1080/10401334.2010.513196; Mazlish B, 2007, UNCERTAIN SCI; Merton R.K., 1973, SOCIOLOGY SCI THEORE, P497; Moed HF, 1998, J DOC, V54, P387, DOI 10.1108/EUM0000000007175; Moses JW., 2007, WAYS KNOWING COMPETI; Nicolaisen J, 2012, J INFORMETR, V6, P276, DOI 10.1016/j.joi.2011.08.001; Price D.J., 1970, COMMUNICATION SCI EN, P3; Reich E. S., 2009, PLASTIC FANTASTIC BI; Robins G, 2007, SOC NETWORKS, V29, P173, DOI 10.1016/j.socnet.2006.08.002; Rosenbaum PR, 2001, AM STAT, V55, P223, DOI 10.1198/000313001317098220; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Shwed U, 2010, AM SOCIOL REV, V75, P817, DOI 10.1177/0003122410388488; Simonton DK, 2009, PERSPECT PSYCHOL SCI, V4, P441, DOI 10.1111/j.1745-6924.2009.01152.x; Simonton DK, 2006, REV GEN PSYCHOL, V10, P98, DOI 10.1037/1089-2680.10.2.98; Simonton DK, 2004, REV GEN PSYCHOL, V8, P59, DOI 10.1037/1089-2680.8.1.59; Skilton PF, 2006, SCIENTOMETRICS, V68, P73, DOI 10.1007/s11192-006-0084-2; Slingerland Edward, 2008, WHAT SCI OFFERS HUMA; Snow CP, 2012, 2 CULTURES; Song F, 2010, HLTH TECHNOLOGY ASSE, P14; Stroebe W, 2012, PERSPECT PSYCHOL SCI, V7, P670, DOI 10.1177/1745691612460687; Tanner RES, 2011, CHANCE PROBABILITY L; Tapp A, 2008, EUR J MARKETING, V42, P265, DOI 10.1108/03090560810852913; Team RC, 2012, R LANG ENV STAT COMP; Thomas H, 2011, BRIT J MANAGE, V22, P443, DOI 10.1111/j.1467-8551.2011.00766.x; Vaio, 2005, NONLINEARITY CHAOS C; Varga AV, 2011, SCIENTOMETRICS, V88, P163, DOI 10.1007/s11192-011-0342-9; Windelband W, 1998, THEOR PSYCHOL, V8, P5, DOI 10.1177/0959354398081001; Yitzhaki M, 2002, SCIENTOMETRICS, V54, P435, DOI 10.1023/A:1016038617639; Yitzhaki M, 1997, SCIENTOMETRICS, V38, P219, DOI 10.1007/BF02457410; Zuchowski LC, 2012, ENTROPY-SWITZ, V14, P177, DOI 10.3390/e14020177	78	81	81	5	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66938	10.1371/journal.pone.0066938	http://dx.doi.org/10.1371/journal.pone.0066938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DN	23840557	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400055
J	Saugy, J; Place, N; Millet, GY; Degache, F; Schena, F; Millet, GP				Saugy, Jonas; Place, Nicolas; Millet, Guillaume Y.; Degache, Francis; Schena, Federico; Millet, Gregoire P.			Alterations of Neuromuscular Function after the World's Most Challenging Mountain Ultra-Marathon	PLOS ONE			English	Article							SLEEP-DEPRIVATION; MUSCLE DAMAGE; ECCENTRIC EXERCISE; FATIGUE; PERFORMANCE; DOWNHILL; CONTRACTIONS; RESPONSES; UPHILL; MODEL	We investigated the physiological consequences of the most challenging mountain ultra-marathon (MUM) in the world: a 330-km trail run with 24000 m of positive and negative elevation change. Neuromuscular fatigue (NMF) was assessed before (Pre-), during (Mid-) and after (Post-) the MUM in experienced ultra-marathon runners (n = 15; finish time = 122.43 hours +/- 17.21 hours) and in Pre- and Post-in a control group with a similar level of sleep deprivation (n = 8). Blood markers of muscle inflammation and damage were analyzed at Pre- and Post-. Mean +/- SD maximal voluntary contraction force declined significantly at Mid- (-13 +/- 17% and -10 +/- 16%, P<0.05 for knee extensor, KE, and plantar flexor muscles, PF, respectively), and further decreased at Post- (-24 +/- 13% and -26 +/- 19%, P<0.01) with alteration of the central activation ratio (-24 +/- 24% and -28 +/- 34% between Pre- and Post-, P<0.05) in runners whereas these parameters did not change in the control group. Peripheral NMF markers such as 100 Hz doublet (KE: -18 +/- 18% and PF: -20 +/- 15%, P<0.01) and peak twitch (KE: -33 +/- 12%, P<0.001 and PF: -19 +/- 14%, P<0.01) were also altered in runners but not in controls. Post-MUM blood concentrations of creatine kinase (3719 +/- 3045 Ul.(1)), lactate dehydrogenase (1145 +/- 511 UI.L-1), C-Reactive Protein (13.1 +/- 7.5 mg.L-1) and myoglobin (449.3 +/- 338.2 mu g.L-1) were higher (P<0.001) than at Pre- in runners but not in controls. Our findings revealed less neuromuscular fatigue, muscle damage and inflammation than in shorter MUMs. In conclusion, paradoxically, such extreme exercise seems to induce a relative muscle preservation process due likely to a protective anticipatory pacing strategy during the first half of MUM and sleep deprivation in the second half.	[Saugy, Jonas; Degache, Francis; Millet, Gregoire P.] Univ Lausanne, Fac Biol & Med, Inst Sport Sci, Lausanne, Switzerland; [Place, Nicolas] Univ Geneva, Inst Movement Sci & Sports Med, Geneva, Switzerland; [Millet, Guillaume Y.] Univ Lyon, St Etienne, France; [Millet, Guillaume Y.] Univ St Etienne, Exercise Physiol Lab, St Etienne, France; [Schena, Federico] Univ Verona, Fac Motor Sci, I-37100 Verona, Italy	University of Lausanne; University of Geneva; Universite Jean Monnet; University of Verona	Saugy, J (corresponding author), Univ Lausanne, Fac Biol & Med, Inst Sport Sci, Lausanne, Switzerland.	jonas.saugy@unil.ch	Millet, Guillaume/AAO-6520-2020; Millet, Gregoire P/F-4104-2012; Millet, Grégoire/M-3220-2019; Degache, Francis/Y-8618-2019; Place, Nicolas/B-3416-2018	Millet, Guillaume/0000-0002-6395-0762; Millet, Gregoire P/0000-0001-8081-4423; Millet, Grégoire/0000-0001-8081-4423; Degache, Francis/0000-0002-1620-9330; Place, Nicolas/0000-0001-9044-0621				Bellinger AM, 2008, P NATL ACAD SCI USA, V105, P2198, DOI 10.1073/pnas.0711074105; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; Blazevich AJ, 2007, J APPL PHYSIOL, V103, P1565, DOI 10.1152/japplphysiol.00578.2007; Blumert PA, 2007, J STRENGTH COND RES, V21, P1146; Braun WA, 2012, RES SPORTS MED, V20, P274, DOI 10.1080/15438627.2012.697084; Bulbulian R, 1996, EUR J APPL PHYSIOL O, V73, P273, DOI 10.1007/BF02425487; Burnley M, 2012, J APPL PHYSIOL, V113, P215, DOI 10.1152/japplphysiol.00022.2012; Chapman D, 2006, INT J SPORTS MED, V27, P591, DOI 10.1055/s-2005-865920; ESTON RG, 1995, BRIT J SPORT MED, V29, P89, DOI 10.1136/bjsm.29.2.89; Fallon KE, 1999, BRIT J SPORT MED, V33, P264, DOI 10.1136/bjsm.33.4.264; Guilhem G, 2011, EUR J APPL PHYSIOL, V111, P2723, DOI 10.1007/s00421-011-1894-3; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hoffman MD, 2012, WILD ENVIRON MED, V23, P56, DOI 10.1016/j.wem.2011.11.001; KentBraun JA, 1996, MUSCLE NERVE, V19, P861, DOI 10.1002/(SICI)1097-4598(199607)19:7<861::AID-MUS8>3.0.CO;2-7; Lippi G, 2008, SCAND J CLIN LAB INV, V68, P667, DOI 10.1080/00365510802126844; Lippi G, 2012, BLOOD TRANSFUS-ITALY, V10, P377, DOI 10.2450/2012.0167-11; LOSCHER WN, 1994, ACTA PHYSIOL SCAND, V152, P73, DOI 10.1111/j.1748-1716.1994.tb09786.x; Lucas SJE, 2008, J SPORT SCI, V26, P477, DOI 10.1080/02640410701552872; Malm C, 2004, J PHYSIOL-LONDON, V556, P983, DOI 10.1113/jphysiol.2003.056598; MARTIN BJ, 1981, EUR J APPL PHYSIOL O, V47, P345, DOI 10.1007/BF02332962; Martin V, 2010, J APPL PHYSIOL, V108, P1224, DOI 10.1152/japplphysiol.01202.2009; Millet GY, 2012, J APPL PHYSIOL, V113, P507, DOI 10.1152/japplphysiol.00016.2012; Millet GY, 2011, SCAND J MED SCI SPOR, V21, P54, DOI 10.1111/j.1600-0838.2009.01001.x; Millet GP, 2012, J APPL PHYSIOL, V113, P686, DOI 10.1152/japplphysiol.00642.2012; Millet GP, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-77; Millet GY, 2011, SPORTS MED, V41, P489, DOI 10.2165/11588760-000000000-00000; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; Millet GY, 2004, SPORTS MED, V34, P105, DOI 10.2165/00007256-200434020-00004; Millet GY, 2002, J APPL PHYSIOL, V92, P486, DOI 10.1152/japplphysiol.00122.2001; Minetti AE, 2002, J APPL PHYSIOL, V93, P1039, DOI 10.1152/japplphysiol.01177.2001; Mischler I, 2003, MED SCI SPORT EXER, V35, P75, DOI 10.1097/00005768-200301000-00013; MYLES WS, 1985, MED SCI SPORT EXER, V17, P580; Noakes TD, 2007, SPORTS MED, V37, P374, DOI 10.2165/00007256-200737040-00026; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; Nosaka K, 2001, EUR J APPL PHYSIOL, V85, P34, DOI 10.1007/s004210100430; Oliver SJ, 2009, EUR J APPL PHYSIOL, V107, P155, DOI 10.1007/s00421-009-1103-9; Place N, 2007, J ELECTROMYOGR KINES, V17, P253, DOI 10.1016/j.jelekin.2006.04.001; Place N, 2007, MUSCLE NERVE, V35, P486, DOI 10.1002/mus.20714; Place N, 2010, EUR J APPL PHYSIOL, V110, P1, DOI 10.1007/s00421-010-1480-0; Place N, 2009, CLIN EXP PHARMACOL P, V36, P334, DOI 10.1111/j.1440-1681.2008.05021.x; Robach P, 2012, SCANDINAVIAN J MED S; Sasaki K, 2006, J BIOMECH, V39, P2005, DOI 10.1016/j.jbiomech.2005.06.019; Schutz UHW, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-78; Skenderi KP, 2006, MED SCI SPORT EXER, V38, P1054, DOI 10.1249/01.mss.0000222831.35897.5f; Snyder KL, 2012, J EXP BIOL, V215, P2283, DOI 10.1242/jeb.066332; SYMONS JD, 1988, CAN J SPORT SCI, V13, P225; SYMONS JD, 1988, MED SCI SPORT EXER, V20, P374, DOI 10.1249/00005768-198808000-00008; Tsatalas T, 2013, J SPORT SCI, V31, P288, DOI 10.1080/02640414.2012.729135; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; Verges S, 2009, J APPL PHYSIOL, V106, P701, DOI 10.1152/japplphysiol.01051.2007; WARREN GL, 1993, J PHYSIOL-LONDON, V464, P457, DOI 10.1113/jphysiol.1993.sp019645	51	99	99	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65596	10.1371/journal.pone.0065596	http://dx.doi.org/10.1371/journal.pone.0065596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840345	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400008
J	Shah, S; Kim, Y; Ostrovnaya, I; Murali, R; Schrader, KA; Lach, FP; Sarrel, K; Rau-Murthy, R; Hansen, N; Zhang, L; Kirchhoff, T; Stadler, Z; Robson, M; Vijai, J; Offit, K; Smogorzewska, A				Shah, Sohela; Kim, Yonghwan; Ostrovnaya, Irina; Murali, Rajmohan; Schrader, Kasmintan A.; Lach, Francis P.; Sarrel, Kara; Rau-Murthy, Rohini; Hansen, Nichole; Zhang, Liyng; Kirchhoff, Tomas; Stadler, Zsofia; Robson, Mark; Vijai, Joseph; Offit, Kenneth; Smogorzewska, Agata			Assessment of SLX4 Mutations in Hereditary Breast Cancers	PLOS ONE			English	Article							HOLLIDAY JUNCTION RESOLVASE; FANCONI-ANEMIA PATHWAY; CROSS-LINK REPAIR; DNA-REPAIR; GERMLINE MUTATIONS; OVARIAN-CANCER; SUSCEPTIBILITY; ENDONUCLEASES; PROTEIN; GENE	Background: SLX4 encodes a DNA repair protein that regulates three structure-specific endonucleases and is necessary for resistance to DNA crosslinking agents, topoisomerase I and poly (ADP-ribose) polymerase (PARP) inhibitors. Recent studies have reported mutations in SLX4 in a new subtype of Fanconi anemia (FA), FA-P. Monoallelic defects in several FA genes are known to confer susceptibility to breast and ovarian cancers. Methods and Results: To determine if SLX4 is involved in breast cancer susceptibility, we sequenced the entire SLX4 coding region in 738 (270 Jewish and 468 non-Jewish) breast cancer patients with 2 or more family members affected by breast cancer and no known BRCA1 or BRCA2 mutations. We found a novel nonsense (c.2469G>A, p.W823*) mutation in one patient. In addition, we also found 51 missense variants [13 novel, 23 rare (MAF<0.1%), and 15 common (MAF>1%)], of which 22 (5 novel and 17 rare) were predicted to be damaging by Polyphen2 (score = 0.65-1). We performed functional complementation studies using p.W823* and 5 SLX4 variants (4 novel and 1 rare) cDNAs in a human SLX4-null fibroblast cell line, RA3331. While wild type SLX4 and all the other variants fully rescued the sensitivity to mitomycin C (MMC), campthothecin (CPT), and PARP inhibitor (Olaparib) the p.W823* SLX4 mutant failed to do so. Conclusion: Loss-of-function mutations in SLX4 may contribute to the development of breast cancer in very rare cases.	[Shah, Sohela; Schrader, Kasmintan A.; Sarrel, Kara; Rau-Murthy, Rohini; Hansen, Nichole; Kirchhoff, Tomas; Stadler, Zsofia; Robson, Mark; Vijai, Joseph; Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; [Kim, Yonghwan; Lach, Francis P.; Smogorzewska, Agata] Rockefeller Univ, Lab Genome Maintenance, New York, NY 10021 USA; [Ostrovnaya, Irina] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Murali, Rajmohan; Zhang, Liyng] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Murali, Rajmohan] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Stadler, Zsofia; Robson, Mark; Offit, Kenneth] Weill Cornell Coll Med, New York, NY USA	Memorial Sloan Kettering Cancer Center; Rockefeller University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Offit, K (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, 1275 York Ave, New York, NY 10021 USA.	offitk@mskcc.org; asmogorzewska@rockefeller.edu	Joseph, Vijai/J-9158-2013; Murali, Rajmohan/A-7960-2008	Joseph, Vijai/0000-0002-7933-151X; Lach, Francis/0000-0003-3708-7122; Robson, Mark/0000-0002-3109-1692; Murali, Rajmohan/0000-0001-6988-4295; Schrader, Kasmintan/0000-0002-7413-4314; Smogorzewska, Agata/0000-0001-6285-1562; Kirchhoff, Tomas/0000-0002-9055-2364	Starr Cancer Consortium; Rita Allen Foundation Scholars Program Grant; Burroughs Wellcome Fund Career Award for Medical Scientists; Breast Cancer Research Foundation; Sabin Family Research Fund; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Starr Cancer Consortium; Rita Allen Foundation Scholars Program Grant; Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Breast Cancer Research Foundation; Sabin Family Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Starr Cancer Consortium. The Rita Allen Foundation Scholars Program Grant. Burroughs Wellcome Fund Career Award for Medical Scientists. Breast Cancer Research Foundation. Sabin Family Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bakker JL, 2012, HUM MUTAT; Catucci I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031038; Chen K, 2007, GENOME RES, V17, P659, DOI 10.1101/gr.6151507; de Garibay GR, 2012, EUR J HUM GENET; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Fernandez-Rodriguez J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-84; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Garner E, 2011, FEBS LETT, V585, P2853, DOI 10.1016/j.febslet.2011.04.078; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Kim Y, 2013, BLOOD, V121, P54, DOI 10.1182/blood-2012-07-441212; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; King TA, 2007, ANN SURG ONCOL, V14, P2510, DOI 10.1245/s10434-007-9372-1; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Landwehr R, 2011, BREAST CANCER RES TR, V130, P1021, DOI 10.1007/s10549-011-1681-1; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Rozen S, 2000, Methods Mol Biol, V132, P365; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339	29	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66961	10.1371/journal.pone.0066961	http://dx.doi.org/10.1371/journal.pone.0066961			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840564	gold, Green Submitted, Green Published			2022-12-27	WOS:000321424400059
J	Bolstad, I; Andreassen, OA; Reckless, GE; Sigvartsen, NP; Server, A; Jensen, J				Bolstad, Ingeborg; Andreassen, Ole A.; Reckless, Greg E.; Sigvartsen, Niels P.; Server, Andres; Jensen, Jimmy			Aversive Event Anticipation Affects Connectivity between the Ventral Striatum and the Orbitofrontal Cortex in an fMRI Avoidance Task	PLOS ONE			English	Article							FUNCTIONAL NEUROANATOMY; NUCLEUS-ACCUMBENS; COGNITIVE CONTROL; HUMAN AMYGDALA; REWARD; ACTIVATION; SALIENCE; DOPAMINE; VALENCE; SYSTEM	Ability to anticipate aversive events is important for avoiding dangerous or unpleasant situations. The motivation to avoid an event is influenced by the incentive salience of an event-predicting cue. In an avoidance fMRI task we used tone intensities to manipulate salience in order to study the involvement of the orbitofrontal cortex in processing of incentive salience. In the task, cues predicting either aversive or neutral avoidable tones were presented. Ventral striatum, amygdala and anterior insula activations were significantly stronger during presentation of cues for aversive than neutral tones. A psychophysiological interaction analysis showed stronger connectivity between the ventral striatum and the orbitofrontal cortex during aversive than neutral conditions. The present study shows an interaction between the ventral striatum, a structure previously linked to negative incentive salience, and the orbitofrontal cortex supporting a role for this region in processing salience. In addition, this study replicates previous findings suggesting that the task is robust.	[Bolstad, Ingeborg; Andreassen, Ole A.; Reckless, Greg E.; Sigvartsen, Niels P.; Jensen, Jimmy] Oslo Univ Hosp, Div Mental Hlth & Addict, KG Jebsen Ctr Psychosis Res, Oslo, Norway; [Bolstad, Ingeborg; Andreassen, Ole A.; Reckless, Greg E.; Jensen, Jimmy] Univ Oslo, Inst Clin Med, Oslo, Norway; [Server, Andres] Oslo Univ Hosp, Dept Neuroradiol, Oslo, Norway; [Jensen, Jimmy] Kristianstad Univ, Ctr Psychol, Kristianstad, Sweden	University of Oslo; University of Oslo; University of Oslo; Kristianstad University	Bolstad, I (corresponding author), Oslo Univ Hosp, Div Mental Hlth & Addict, KG Jebsen Ctr Psychosis Res, Oslo, Norway.	Ingeborg.bolstad@medisin.uio.no	Andreassen, Ole A./AAY-7531-2020; Jensen, Jimmy/H-7517-2014	Jensen, Jimmy/0000-0001-6841-1808; Andreassen, Ole A./0000-0002-4461-3568; Bolstad, Ingeborg/0000-0001-7316-6309; Reckless, Greg/0000-0001-6899-9015	South-East Norway Health Authority; Research Council of Norway [199472]	South-East Norway Health Authority; Research Council of Norway(Research Council of Norway)	This project was funded by South-East Norway Health Authority (http://www.helse-sorost.no/Sider/side.aspx) and The Research Council of Norway (http://www.forskningsradet.no/en/Home_page/1177315753906). The study was supported by a grant (#199472) from the Research Council of Norway (http://www.forskningsradet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; Cunningham WA, 2004, J COGNITIVE NEUROSCI, V16, P1717, DOI 10.1162/0898929042947919; Cunningham WA, 2012, CURR DIR PSYCHOL SCI, V21, P54, DOI 10.1177/0963721411430832; Delgado MR, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.033.2009; Esslinger C, 2012, SCHIZOPHR RES, V140, P114, DOI 10.1016/j.schres.2012.06.025; FitzGerald THB, 2009, J NEUROSCI, V29, P8388, DOI 10.1523/JNEUROSCI.0717-09.2009; FOX PT, 1994, SCIENCE, V266, P994, DOI 10.1126/science.7973682; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Horvitz JC, 2002, BEHAV BRAIN RES, V137, P65, DOI 10.1016/S0166-4328(02)00285-1; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Jensen J, 2007, HUM BRAIN MAPP, V28, P294, DOI 10.1002/hbm.20274; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Kirsch P, 2003, NEUROIMAGE, V20, P1086, DOI 10.1016/S1053-8119(03)00381-1; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Mohr PNC, 2010, J NEUROSCI, V30, P6613, DOI 10.1523/JNEUROSCI.0003-10.2010; Morrison SE, 2011, ANN NY ACAD SCI, V1239, P59, DOI 10.1111/j.1749-6632.2011.06255.x; Nielsen FA, 2004, ARTIF INTELL MED, V30, P141, DOI 10.1016/S0933-3657(03)00041-1; Nitschke JB, 2006, NEUROIMAGE, V29, P106, DOI 10.1016/j.neuroimage.2005.06.068; Ousdal OT, 2012, NEUROIMAGE, V62, P95, DOI 10.1016/j.neuroimage.2012.04.035; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Pohlack ST, 2012, BIOL PSYCHOL, V91, P74, DOI 10.1016/j.biopsycho.2012.04.004; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shi CJ, 1998, J COMP NEUROL, V399, P469, DOI 10.1002/(SICI)1096-9861(19981005)399:4<469::AID-CNE3>3.0.CO;2-#; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065	47	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e68494	10.1371/journal.pone.0068494	http://dx.doi.org/10.1371/journal.pone.0068494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826392	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400177
J	Haney, S; Zhao, J; Tiwari, S; Eng, K; Guey, LT; Tien, E				Haney, Steven; Zhao, Juan; Tiwari, Shiwani; Eng, Kurt; Guey, Lin T.; Tien, Eric			RNAi Screening in Primary Human Hepatocytes of Genes Implicated in Genome-Wide Association Studies for Roles in Type 2 Diabetes Identifies Roles for CAMK1D and CDKAL1, among Others, in Hepatic Glucose Regulation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEPENDENT PROTEIN-KINASE; CREB COACTIVATOR TORC2; PANCREATIC BETA-CELLS; CDK5; INSULIN; PHOSPHORYLATION; INHIBITION; NUCLEAR; METABOLISM	Genome-wide association (GWA) studies have described a large number of new candidate genes that contribute to of Type 2 Diabetes (T2D). In some cases, small clusters of genes are implicated, rather than a single gene, and in all cases, the genetic contribution is not defined through the effects on a specific organ, such as the pancreas or liver. There is a significant need to develop and use human cell-based models to examine the effects these genes may have on glucose regulation. We describe the development of a primary human hepatocyte model that adjusts glucose disposition according to hormonal signals. This model was used to determine whether candidate genes identified in GWA studies regulate hepatic glucose disposition through siRNAs corresponding to the list of identified genes. We find that several genes affect the storage of glucose as glycogen (glycolytic response) and/or affect the utilization of pyruvate, the critical step in gluconeogenesis. Of the genes that affect both of these processes, CAMK1D, TSPAN8 and KIF11 affect the localization of a mediator of both gluconeogenesis and glycolysis regulation, CRTC2, to the nucleus in response to glucagon. In addition, the gene CDKAL1 was observed to affect glycogen storage, and molecular experiments using mutant forms of CDK5, a putative target of CDKAL1, in HepG2 cells show that this is mediated by coordinate regulation of CDK5 and PKA on MEK, which ultimately regulates the phosphorylation of ribosomal protein S6, a critical step in the insulin signaling pathway.	[Haney, Steven; Zhao, Juan; Tiwari, Shiwani; Guey, Lin T.; Tien, Eric] Pfizer Res Technol Ctr, Target Generat Unit, Cambridge, MA USA; [Eng, Kurt] Pfizer Res Technol Ctr, Oligonucleotide Therapeut Unit, Cambridge, MA USA	Pfizer; Pfizer	Haney, S (corresponding author), Eli Lilly Pharmaceut, Dept Quantitat Biol, Indianapolis, IN USA.	haney_steven_a@lilly.com						Arif A, 2012, MOL CELL BIOL, V32, P5046, DOI 10.1128/MCB.01168-12; Arif A, 2012, BIOCHEM PHARMACOL, V84, P985, DOI 10.1016/j.bcp.2012.06.027; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Basu R, 2005, DIABETES, V54, P1942, DOI 10.2337/diabetes.54.7.1942; Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; Bhaskar V, 2012, DIABETES, V61, P1263, DOI 10.2337/db11-1578; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao RS, 2010, J LIPID RES, V51, P2234, DOI 10.1194/jlr.M004929; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cavelti-Weder C, 2012, DIABETES CARE, V35, P1654, DOI 10.2337/dc11-2219; Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200; Cui J, 2011, DIABETES, V60, P320, DOI 10.2337/db09-1078; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Dhariwala FA, 2008, CELL MOL NEUROBIOL, V28, P351, DOI 10.1007/s10571-007-9242-1; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Falnikar A, 2011, MOL BIOL CELL, V22, P1561, DOI 10.1091/mbc.E10-11-0905; FANCONI G., 1949, HELVETICA PAEDIATR ACTA, V4, P359; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Gu W, 2009, J PHARMACOL EXP THER, V331, P871, DOI 10.1124/jpet.109.157685; Guguen-Guillouzo C, 2010, METHODS MOL BIOL, P640; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hassuna N, 2009, BIODRUGS, V23, P341, DOI 10.2165/11315650-000000000-00000; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; MacDonnell SM, 2009, CIRC RES, V105, P316, DOI 10.1161/CIRCRESAHA.109.194035; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; MANZ F, 1987, PEDIATR NEPHROL, V1, P509, DOI 10.1007/BF00849262; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Negash S, 2002, J CELL SCI, V115, P2109; Okamura T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049055; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pan F, 2005, EMBO J, V24, P2104, DOI 10.1038/sj.emboj.7600685; Qiao F, 2008, EXPT CELL RES, V314; Reiter V, 2012, NUCLEIC ACIDS RES, V40, P6235, DOI 10.1093/nar/gks240; Roden M, 2003, BEST PRACT RES CL EN, V17, P365, DOI 10.1016/S1521-690X(03)00031-9; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Santer R, 1997, NATURE GENETICS, V17; Sato K, 2006, NAT MED, V12, P1410, DOI 10.1038/nm1515; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Sharma M, 2007, BIOCHEM BIOPH RES CO, V358, P379, DOI 10.1016/j.bbrc.2007.04.149; Sharma P, 2002, J BIOL CHEM, V277, P528, DOI 10.1074/jbc.M109324200; Skroblin P, 2010, INT REV CEL MOL BIO, V283, P235, DOI 10.1016/S1937-6448(10)83005-9; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smith FD, 2010, NAT CELL BIOL, V12, P1242, DOI 10.1038/ncb2130; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Varadi A, 2002, J CELL SCI, V115, P4177, DOI 10.1242/jcs.00083; Wang XJ, 2000, J BIOL CHEM, V275, P31763, DOI 10.1074/jbc.M004358200; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wayman GA, 2011, CELL CALCIUM, V50, P1, DOI 10.1016/j.ceca.2011.02.007; Wei FY, 2011, J CLIN INVEST, V121, P3598, DOI 10.1172/JCI58056; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Xu JHJ, 2008, TOXICOL SCI, V105, P97, DOI 10.1093/toxsci/kfn109; Xu JHJ, 2012, METHODS MOL BIOL, V795, P83, DOI 10.1007/978-1-61779-337-0_6; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zheng YL, 2007, MOL BIOL CELL, V18, P404, DOI 10.1091/mbc.E06-09-0851; Zheng YL, 2007, MOL CELLULAR BIOL, V18	71	54	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e64946	10.1371/journal.pone.0064946	http://dx.doi.org/10.1371/journal.pone.0064946			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840313	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800007
J	Samelko, L; Caicedo, MS; Lim, SJ; Della-Valle, C; Jacobs, J; Hallab, NJ				Samelko, Lauryn; Caicedo, Marco S.; Lim, Seung-Jae; Della-Valle, Craig; Jacobs, Joshua; Hallab, Nadim J.			Cobalt-Alloy Implant Debris Induce HIF-1 alpha Hypoxia Associated Responses: A Mechanism for Metal-Specific Orthopedic Implant Failure	PLOS ONE			English	Article							EXPRESSION; OSTEOLYSIS; PARTICLES; CYTOKINES; BEARINGS; VEGF	The historical success of orthopedic implants has been recently tempered by unexpected pathologies and early failures of some types of Cobalt-Chromium-Molybdenum alloy containing artificial hip implants. Hypoxia-associated responses to Cobalt-alloy metal debris were suspected as mediating this untoward reactivity at least in part. Hypoxia Inducible Factor-1 alpha is a major transcription factor involved in hypoxia, and is a potent coping mechanism for cells to rapidly respond to changing metabolic demands. We measured signature hypoxia associated responses (i.e. HIF-1 alpha, VEGF and TNF-alpha) to Cobalt-alloy implant debris both in vitro (using a human THP-1 macrophage cell line and primary human monocytes/macrophages) and in vivo. HIF-1 alpha in peri-implant tissues of failed metal-on-metal implants were compared to similar tissues from people with metal-on-polymer hip arthroplasties, immunohistochemically. Increasing concentrations of cobalt ions significantly up-regulated HIF-1 alpha with a maximal response at 0.3 mM. Cobalt-alloy particles (1 um-diameter, 10 particles/cell) induced significantly elevated HIF-1 alpha, VEGF, TNF-alpha and ROS expression in human primary macrophages whereas Titanium-alloy particles did not. Elevated expression of HIF-1 alpha was found in peri-implant tissues and synovial fluid of people with failing Metal-on-Metal hips (n = 5) compared to failed Metal-on-Polymer articulating hip arthroplasties (n = 10). This evidence suggests that Cobalt-alloy, more than other metal implant debris (e. g. Titanium alloy), can elicit hypoxia-like responses that if unchecked can lead to unusual peri-implant pathologies, such as lymphocyte infiltration, necrosis and excessive fibrous tissue growths.	[Samelko, Lauryn; Caicedo, Marco S.; Della-Valle, Craig; Jacobs, Joshua; Hallab, Nadim J.] Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA; [Samelko, Lauryn] Rush Univ, Med Ctr, Dept Immunol, Chicago, IL 60612 USA; [Lim, Seung-Jae] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Orthoped Surg, Seoul, South Korea	Rush University; Rush University; Sungkyunkwan University (SKKU); Samsung Medical Center	Hallab, NJ (corresponding author), Rush Univ, Med Ctr, Dept Orthoped Surg, Chicago, IL 60612 USA.	nhallab@rush.edu	Caicedo, Marco/M-1350-2019; Jacobs, Joshua/AGG-8284-2022	Lim, Seung-Jae/0000-0002-7209-9690; Jacobs, Joshua/0000-0003-3902-7334	Crown Family Chair of Orthopedics; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health [R01AR060782]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060782] Funding Source: NIH RePORTER	Crown Family Chair of Orthopedics; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported in part by Crown Family Chair of Orthopedics and the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number R01AR060782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroukatos P, 2010, CLIN ORTHOP RELAT R, V468, P2135, DOI 10.1007/s11999-009-1187-x; Caicedo MS, 2010, J BIOMED MATER RES A, V93A, P1312, DOI 10.1002/jbm.a.32627; Caicedo MS, 2009, J ORTHOP RES, V27, P847, DOI 10.1002/jor.20826; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dalal A, 2012, J BIOMED MATER RES A, V100A, P2147, DOI 10.1002/jbm.a.34122; Davies AP, 2005, J BONE JOINT SURG AM, V87A, P18, DOI 10.2106/JBJS.C.00949; Goodman SB, 2007, BIOMATERIALS, V28, P5044, DOI 10.1016/j.biomaterials.2007.06.035; Guyer RD, 2011, SPINE, V36, pE492, DOI 10.1097/BRS.0b013e31820ea9a2; Hallab NJ, 2005, J BIOMED MATER RES A, V74A, P124, DOI 10.1002/jbm.a.30345; Hallab NJ, 2011, J BIOMED MAT RES B; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Jacobs JJ, 2006, J BONE JOINT SURG AM, V88A, P1171, DOI 10.2106/JBJS.F.00453; Kim SY, 2010, IMMUNOLOGY, V129, P516, DOI 10.1111/j.1365-2567.2009.03203.x; Korovessis P, 2006, J BONE JOINT SURG AM, V88A, P1183, DOI 10.2106/JBJS.D.02916; Kwon YM, 2011, J ARTHROPLASTY, V26, P511, DOI 10.1016/j.arth.2010.05.030; Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2; Milosev I, 2006, J BONE JOINT SURG AM, V88A, P1173, DOI 10.2106/JBJS.E.00604; Murdoch C, 2005, J IMMUNOL, V175, P6257, DOI 10.4049/jimmunol.175.10.6257; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Schwarz EM, 2000, J ORTHOPAED RES, V18, P472, DOI 10.1002/jor.1100180321; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Spanogle JP, 2006, BIOMATERIALS, V27, P3882, DOI 10.1016/j.biomaterials.2006.02.035; Waris V, 2012, J ORTHOP RES, V30, P1830, DOI 10.1002/jor.22138	25	41	41	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67127	10.1371/journal.pone.0067127	http://dx.doi.org/10.1371/journal.pone.0067127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840602	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800121
J	Santra, M; Bagchi, B				Santra, Mantu; Bagchi, Biman			Kinetic Proofreading at Single Molecular Level: Aminoacylation of tRNA(Ile) and the Role of Water as an Editor	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; MISACTIVATED AMINO-ACIDS; EDITING MECHANISMS; DISCRIMINATION; EVOLUTION; INSIGHTS; COMPLEX; ERRORS; VALINE	Proofreading/editing in protein synthesis is essential for accurate translation of information from the genetic code. In this article we present a theoretical investigation of efficiency of a kinetic proofreading mechanism that employs hydrolysis of the wrong substrate as the discriminatory step in enzyme catalytic reactions. We consider aminoacylation of tRNA(Ile) which is a crucial step in protein synthesis and for which experimental results are now available. We present an augmented kinetic scheme and then employ methods of stochastic simulation algorithm to obtain time dependent concentrations of different substances involved in the reaction and their rates of formation. We obtain the rates of product formation and ATP hydrolysis for both correct and wrong substrates (isoleucine and valine in our case, respectively), in single molecular enzyme as well as ensemble enzyme kinetics. The present theoretical scheme correctly reproduces (i) the amplitude of the discrimination factor in the overall rates between isoleucine and valine which is obtained as (1.8x10(2)).(4.33x10(2)) = 7.8x10(4), (ii) the rates of ATP hydrolysis for both Ile and Val at different substrate concentrations in the aminoacylation of tRNA(Ile). The present study shows a non-michaelis type dependence of rate of reaction on tRNA(Ile) concentration in case of valine. The overall editing in steady state is found to be independent of amino acid concentration. Interestingly, the computed ATP hydrolysis rate for valine at high substrate concentration is same as the rate of formation of Ile-tRNA(Ile) whereas at intermediate substrate concentration the ATP hydrolysis rate is relatively low. We find that the presence of additional editing domain in class I editing enzyme makes the kinetic proofreading more efficient through enhanced hydrolysis of wrong product at the editing CP1 domain.	[Santra, Mantu; Bagchi, Biman] Indian Inst Sci, Solid State & Struct Chem Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Bagchi, B (corresponding author), Indian Inst Sci, Solid State & Struct Chem Unit, Bangalore 560012, Karnataka, India.	bbagchi@sscu.iisc.ernet.in		BAGCHI, BIMAN/0000-0002-7146-5994	DST; CSIR (India)	DST(Department of Science & Technology (India)); CSIR (India)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in parts by grants from DST and CSIR (India). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostol I, 1997, J BIOL CHEM, V272, P28980, DOI 10.1074/jbc.272.46.28980; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fersht A., 1985, ENZYME STRUCTURE MEC; FERSHT AR, 1981, PROC R SOC SER B-BIO, V212, P351, DOI 10.1098/rspb.1981.0044; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; HOPFIELD JJ, 1976, P NATL ACAD SCI USA, V73, P1164, DOI 10.1073/pnas.73.4.1164; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Hussain T, 2010, P NATL ACAD SCI USA, V107, P22117, DOI 10.1073/pnas.1014299107; KIMURA M, 1973, GENETICS, V73, P19; Lehninger A.L., 1970, BIOCH MOL BASIS CELL; LOFTFIELD RB, 1966, BIOCHIM BIOPHYS ACTA, V130, P426, DOI 10.1016/0304-4165(66)90239-X; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Mascarenhas AP, 2008, BIOCHEMISTRY-US, V47, P4808, DOI 10.1021/bi702494q; Nomanbhoy TK, 1999, MOL CELL, V4, P519, DOI 10.1016/S1097-2765(00)80203-8; Nomanbhoy TK, 2000, P NATL ACAD SCI USA, V97, P5119, DOI 10.1073/pnas.090102197; Qian H, 2003, BIOPHYS CHEM, V105, P585, DOI 10.1016/S0301-4622(03)00068-1; Santra M, 2012, J PHYS CHEM B, V116, P11809, DOI 10.1021/jp305045w; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Splan KE, 2008, J BIOL CHEM, V283, P7128, DOI 10.1074/jbc.M709902200; Stoll A., 1958, FESTSCHRIFT A STOLL, P597; Watson J.D., 1970, MOL BIOL GENE; Zhao MW, 2005, EMBO J, V24, P1430, DOI 10.1038/sj.emboj.7600618; Zhu B, 2009, J BIOL CHEM, V284, P3418, DOI 10.1074/jbc.M806717200	30	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66112	10.1371/journal.pone.0066112	http://dx.doi.org/10.1371/journal.pone.0066112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840412	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000322342800034
J	Ackema, KB; Sauder, U; Solinger, JA; Spang, A				Ackema, Karin B.; Sauder, Ursula; Solinger, Jachen A.; Spang, Anne			The ArfGEF GBF-1 Is Required for ER Structure, Secretion and Endocytic Transport in C. elegans	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTORS; CAENORHABDITIS-ELEGANS; RETROGRADE TRANSPORT; DISTINCT FUNCTIONS; PICHIA-PASTORIS; GOLGI STRUCTURE; FACTORS GEA1P; CIS-GOLGI; GERM-LINE; PROTEIN	Small GTPases of the Sar/Arf family are essential to generate transport containers that mediate communication between organelles of the secretory pathway. Guanine nucleotide exchange factor (GEFs) activate the small GTPases and help their anchorage in the membrane. Thus, GEFs in a way temporally and spatially control Sar1/Arf1 GTPase activation. We investigated the role of the ArfGEF GBF-1 in C. elegans oocytes and intestinal epithelial cells. GBF-1 localizes to the cis-Golgi and is part of the t-ER-Golgi elements. GBF-1 is required for secretion and Golgi integrity. In addition, gbf-1(RNAi) causes the ER reticular structure to become dispersed, without destroying ER exit sites (ERES) because the ERES protein SEC-16 was still localized in distinct punctae at t-ER-Golgi units. Moreover, GBF-1 plays a role in receptor-mediated endocytosis in oocytes, without affecting recycling pathways. We find that both the yolk receptor RME-2 and the recycling endosome-associated RAB-11 localize similarly in control and gbf-1(RNAi) oocytes. While RAB5-positive early endosomes appear to be less prominent and the RAB-5 levels are reduced by gbf-1(RNAi) in the intestine, RAB-7-positive late endosomes were more abundant and formed aggregates and tubular structures. Our data suggest a role for GBF-1 in ER structure and endosomal traffic.	[Ackema, Karin B.; Solinger, Jachen A.; Spang, Anne] Univ Basel, Biozentrum, Basel, Switzerland; [Sauder, Ursula] Univ Basel, Biozentrum, Microscopy Ctr, Basel, Switzerland	University of Basel; University of Basel	Spang, A (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	anne.spang@unibas.ch	Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019	Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203	Swiss National Science Foundation; University of Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel	Funding provided by the Swiss National Science Foundation and the University of Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHSTETTER T, 1988, J BIOL CHEM, V263, P11711; Andrews R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000493; Armbruster K, 2012, J CELL SCI, V125, P1318, DOI 10.1242/jcs.096263; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Bembenek JN, 2007, DEVELOPMENT, V134, P3837, DOI 10.1242/dev.011361; Ben-Tekaya H, 2010, MOL BIOL CELL, V21, P4130, DOI 10.1091/mbc.E10-01-0022; Bianchi L, 2006, C ELEGANS RES COMMUN; BRENNER S, 1974, GENETICS, V77, P71; Esaki M, 2006, FEBS LETT, V580, P5215, DOI 10.1016/j.febslet.2006.08.058; Faure J, 2004, CURR BIOL, V14, P1056, DOI 10.1016/j.cub.2004.06.021; FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27; Frederick RL, 2004, J CELL BIOL, V167, P87, DOI 10.1083/jcb.200405100; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Grant Barth D, 2006, WormBook, P1; Gu F, 2000, J BIOL CHEM, V275, P8154, DOI 10.1074/jbc.275.11.8154; Gupta GD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006768; Hadwiger G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010161; Herpers B, 2004, MOL BIOL CELL, V15, P5306, DOI 10.1091/mbc.E04-05-0398; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Johnson D, 2010, MOL BIOL CELL, V21, P2191, DOI 10.1091/mbc.E09-10-0874; Johnston WL, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-35; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kondylis V, 2009, FEBS LETT, V583, P3827, DOI 10.1016/j.febslet.2009.09.048; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Manolea F, 2008, MOL BIOL CELL, V19, P523, DOI 10.1091/mbc.E07-04-0394; Morinaga N, 1996, P NATL ACAD SCI USA, V93, P12856, DOI 10.1073/pnas.93.23.12856; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; Page AP, 2007, WORMBOOK, P1, DOI DOI 10.1895/WORMBOOK.1.138.1; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Peyroche A, 2001, J CELL SCI, V114, P2241; Poteryaev D, 2005, MOL BIOL CELL, V16, P2139, DOI 10.1091/mbc.E04-08-0726; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Roberts B, 2003, MOL BIOL CELL, V14, P4414, DOI 10.1091/mbc.E03-03-0162; Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Sato K, 2006, MOL BIOL CELL, V17, P3085, DOI 10.1091/mbc.E06-03-0211; Sato M, 2008, J CELL SCI, V121, P3177, DOI 10.1242/jcs.034678; SCHIERENBERG E, 1992, ROUX ARCH DEV BIOL, V202, P10, DOI 10.1007/BF00364592; Schmutz C, 2007, DEVELOPMENT, V134, P3495, DOI 10.1242/dev.000802; Shaham S., 2006, WORMBOOK; Shi AB, 2009, EMBO J, V28, P3290, DOI 10.1038/emboj.2009.272; Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035; Szul Tomasz, 2011, Cell Logist, V1, P69; Tang LC, 2012, BBA-GEN SUBJECTS, V1820, P829, DOI 10.1016/j.bbagen.2012.03.004; Trzebiatowska A, 2008, MOL BIOL CELL, V19, P3898, DOI 10.1091/mbc.E08-01-0028; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang SS, 2012, J CELL SCI, V125, P461, DOI 10.1242/jcs.092551; Witte K, 2011, NAT CELL BIOL, V13, P550, DOI 10.1038/ncb2225; Wolff NA, 2011, TOXICOL LETT, V203, P210, DOI 10.1016/j.toxlet.2011.03.014; WormBook, 2006, C ELEGANS RES COMMUN, DOI 10.1895/wormbook.1.47.1; Zhao XH, 2002, MOL BIOL CELL, V13, P119, DOI 10.1091/mbc.01-08-0420; Zhao XH, 2006, J CELL SCI, V119, P3743, DOI 10.1242/jcs.03173	53	17	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67076	10.1371/journal.pone.0067076	http://dx.doi.org/10.1371/journal.pone.0067076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840591	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200119
J	Aslan, CE; Zavaleta, ES; Tershy, B; Croll, D				Aslan, Clare E.; Zavaleta, Erika S.; Tershy, Bernie; Croll, Donald			Mutualism Disruption Threatens Global Plant Biodiversity: A Systematic Review	PLOS ONE			English	Review							SEED-DISPERSAL; EXTINCTION; POLLINATION; RECRUITMENT; ECOLOGY; FRUIT; DIVERSIFICATION; FRUGIVORY; MAMMALS; CLIMATE	Background: As global environmental change accelerates, biodiversity losses can disrupt interspecific interactions. Extinctions of mutualist partners can create "widow" species, which may face reduced ecological fitness. Hypothetically, such mutualism disruptions could have cascading effects on biodiversity by causing additional species coextinctions. However, the scope of this problem - the magnitude of biodiversity that may lose mutualist partners and the consequences of these losses - remains unknown. Methodology/Principal Findings: We conducted a systematic review and synthesis of data from a broad range of sources to estimate the threat posed by vertebrate extinctions to the global biodiversity of vertebrate-dispersed and -pollinated plants. Though enormous research gaps persist, our analysis identified Africa, Asia, the Caribbean, and global oceanic islands as geographic regions at particular risk of disruption of these mutualisms; within these regions, percentages of plant species likely affected range from 2.1-4.5%. Widowed plants are likely to experience reproductive declines of 40-58%, potentially threatening their persistence in the context of other global change stresses. Conclusions: Our systematic approach demonstrates that thousands of species may be impacted by disruption in one class of mutualisms, but extinctions will likely disrupt other mutualisms, as well. Although uncertainty is high, there is evidence that mutualism disruption directly threatens significant biodiversity in some geographic regions. Conservation measures with explicit focus on mutualistic functions could be necessary to bolster populations of widowed species and maintain ecosystem functions.	[Aslan, Clare E.; Zavaleta, Erika S.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Tershy, Bernie; Croll, Donald] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Aslan, CE (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA.	caslan@desertmuseum.org			Smith Conservation Postdoctoral Fellowship	Smith Conservation Postdoctoral Fellowship	CEA was supported by a Smith Conservation Postdoctoral Fellowship (www.smithfellows.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Anderson SH, 2011, SCIENCE, V331, P1068, DOI 10.1126/science.1199092; [Anonymous], 1999, WALKERS MAMMALS WORL; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; BAWA KS, 1990, ANNU REV ECOL SYST, V21, P399, DOI 10.1146/annurev.es.21.110190.002151; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; BOUCHER DH, 1982, ANNU REV ECOL SYST, V13, P315, DOI 10.1146/annurev.es.13.110182.001531; Brodie JF, 2012, RESTOR ECOL, V20, P153, DOI 10.1111/j.1526-100X.2011.00833.x; Brodie JF, 2009, ECOL APPL, V19, P854, DOI 10.1890/08-0955.1; Bronstein J.L., 2004, EVOLUTIONARY CONSERV, P305, DOI DOI 10.1017/CB09780511542022; Bronstein JL, 2009, J ECOL, V97, P1160, DOI 10.1111/j.1365-2745.2009.01566.x; Calix M., 2018, EUROPEAN RED LIST SA; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Corlett RT, 1998, BIOL REV, V73, P413, DOI 10.1017/S0006323198005234; Cox PA, 2000, CONSERV BIOL, V14, P1237, DOI 10.1046/j.1523-1739.2000.00017.x; del Hoyo J., 2011, HDB BIRDS WORLD; Douglas Pratt H., 2005, HAWAIIAN HONEYCREEPE; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; Dunn RR, 2005, CONSERV BIOL, V19, P1030, DOI 10.1111/j.1523-1739.2005.00078.x; ESTES JA, 1989, CONSERV BIOL, V3, P252, DOI 10.1111/j.1523-1739.1989.tb00085.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Govaerts R, 2001, TAXON, V50, P1085, DOI 10.2307/1224723; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Guimaraes Paulo R. Jr, 2008, PLoS ONE, V3, pUnpaginated, DOI 10.1371/journal.pone.0001745; Harder LD, 1996, FLORAL BIOL STUDIES, P140, DOI DOI 10.1007/978-1-4613-1165-2_6; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; HERRERA CM, 1989, OIKOS, V55, P250, DOI 10.2307/3565429; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Horn MH, 2011, ACTA OECOL, V37, P561, DOI 10.1016/j.actao.2011.06.004; Hyatt LA, 2003, OIKOS, V103, P590, DOI 10.1034/j.1600-0706.2003.12235.x; JANZEN DH, 1982, SCIENCE, V215, P19, DOI 10.1126/science.215.4528.19; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Johnson NC, 2010, P NATL ACAD SCI USA, V107, P2093, DOI 10.1073/pnas.0906710107; Kaiser-Bunbury CN, 2010, PERSPECT PLANT ECOL, V12, P131, DOI 10.1016/j.ppees.2009.10.002; Kevan Peter G., 2003, Biodiversity (Ottawa), V4, P3; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Lengyel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005480; Levey DJ, 2001, AUK, V118, P819, DOI 10.1642/0004-8038(2001)118[0819:ITGAMT]2.0.CO;2; LORD JM, 1991, NEW ZEAL J BOT, V29, P83, DOI 10.1080/0028825X.1991.10415545; McConkey KR, 2006, ECOLOGY, V87, P271, DOI 10.1890/05-0386; McFall-Ngai M, 2008, NAT REV MICROBIOL, V6, P789, DOI 10.1038/nrmicro1982; McKinney ML, 1999, CONSERV BIOL, V13, P1273, DOI 10.1046/j.1523-1739.1999.97393.x; McKinney ML, 1997, ANNU REV ECOL SYST, V28, P495, DOI 10.1146/annurev.ecolsys.28.1.495; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Meehan HJ, 2002, J BIOGEOGR, V29, P695, DOI 10.1046/j.1365-2699.2002.00718.x; Moran C, 2009, BIOL CONSERV, V142, P541, DOI 10.1016/j.biocon.2008.11.006; Mortensen HS, 2008, BIOL CONSERV, V141, P2146, DOI 10.1016/j.biocon.2008.06.014; Olesen J., 2004, ECOLOGIA INSULAR ISL, P229; Olesen JM, 2003, TRENDS ECOL EVOL, V18, P177, DOI 10.1016/S0169-5347(03)00004-1; Olesen JM, 2000, SCANDINAVIAN ASS POL, P161; Palmer TM, 2008, SCIENCE, V319, P192, DOI 10.1126/science.1151579; Parker KA, 2010, RESTOR ECOL, V18, P269, DOI 10.1111/j.1526-100X.2010.00676.x; Petanidou T, 2008, ECOL LETT, V11, P564, DOI 10.1111/j.1461-0248.2008.01170.x; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Reynolds HL, 2003, ECOLOGY, V84, P2281, DOI 10.1890/02-0298; ROSENZWEIG ML, 1994, CONSERV BIOL, V8, P491, DOI 10.1046/j.1523-1739.1994.08020491.x; Sakai AK, 2002, SYST BIOL, V51, P276, DOI 10.1080/10635150252899770; Shiels AB, 2011, BIOL INVASIONS, V13, P781, DOI 10.1007/s10530-010-9868-7; Silva W. R., 2007, Seed dispersal: theory and its application in a changing world, P561, DOI 10.1079/9781845931650.0561; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; Silvertown J, 1996, CONSERV BIOL, V10, P591, DOI 10.1046/j.1523-1739.1996.10020591.x; Soto-Gamboa M, 2002, PLANT ECOL, V159, P171, DOI 10.1023/A:1015514707286; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; TIFFNEY BH, 1995, EVOL ECOL, V9, P93, DOI 10.1007/BF01237700; Traveset A, 2005, CONSERV BIOL, V19, P421, DOI 10.1111/j.1523-1739.2005.00019.x; Traveset Anna, 2002, P339, DOI 10.1079/9780851995250.0339; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Valido A., 2007, Seed dispersal: theory and its application in a changing world, P124, DOI 10.1079/9781845931650.0124; Valiente-Banuet A, 2004, AM J BOT, V91, P850, DOI 10.3732/ajb.91.6.850; ValienteBanuet A, 1996, J TROP ECOL, V12, P103, DOI 10.1017/S0266467400009330; Vanthomme H, 2010, BIOTROPICA, V42, P672, DOI 10.1111/j.1744-7429.2010.00630.x; Venable DL, 2008, ECOLOGY, V89, P2218, DOI 10.1890/07-0386.1; Westcott DA, 2008, DIVERS DISTRIB, V14, P432, DOI 10.1111/j.1472-4642.2007.00416.x; WILLSON MF, 1993, OIKOS, V67, P159, DOI 10.2307/3545106; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x	80	90	92	6	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66993	10.1371/journal.pone.0066993	http://dx.doi.org/10.1371/journal.pone.0066993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840571	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200115
J	Hempenius, L; Slaets, JPJ; van Asselt, D; de Bock, GH; Wiggers, T; van Leeuwen, BL				Hempenius, Liesbeth; Slaets, Joris P. J.; van Asselt, Dieneke; de Bock, Geertruida H.; Wiggers, Theo; van Leeuwen, Barbara L.			Outcomes of a Geriatric Liaison Intervention to Prevent the Development of Postoperative Delirium in Frail Elderly Cancer Patients: Report on a Multicentre, Randomized, Controlled Trial	PLOS ONE			English	Article							RISK-FACTORS; OLDER-ADULTS; SURGERY; COMPLICATIONS; SCALE	Background: Delirium is a serious and common postoperative complication, especially in frail elderly patients. The aim of this study was to evaluate the effect of a geriatric liaison intervention in comparison with standard care on the incidence of postoperative delirium in frail elderly cancer patients treated with an elective surgical procedure for a solid tumour. Methods: Patients over 65 years of age who were undergoing elective surgery for a solid tumour were recruited to a multicentre, prospective, randomized, controlled trial. The patients were randomized to standard treatment versus a geriatric liaison intervention. The intervention consisted of a preoperative geriatric consultation, an individual treatment plan targeted at risk factors for delirium, daily visits by a geriatric nurse during the hospital stay and advice on managing any problems encountered. The primary outcome was the incidence of postoperative delirium. The secondary outcome measures were the severity of delirium, length of hospital stay, complications, mortality, care dependency, quality of life, return to an independent preoperative living situation and additional care at home. Results: In total, the data of 260 patients were analysed. Delirium occurred in 31 patients (11.9%), and there was no significant difference between the incidence of delirium in the intervention group and the usual-care group (9.4% vs. 14.3%, OR: 0.63, 95% CI: 0.29-1.35). Conclusions: Within this study, a geriatric liaison intervention based on frailty for the prevention of postoperative delirium in frail elderly cancer patients undergoing elective surgery for a solid tumour has not proven to be effective.	[Hempenius, Liesbeth; Slaets, Joris P. J.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands; [Hempenius, Liesbeth; van Asselt, Dieneke] Med Ctr Leeuwarden, Geriatr Ctr, Leeuwarden, Netherlands; [de Bock, Geertruida H.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Wiggers, Theo; van Leeuwen, Barbara L.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands	University of Groningen; Medical Center Leeuwarden; University of Groningen; University of Groningen	Hempenius, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, Groningen, Netherlands.	l.hempenius@umcg.nl	de Bock, Geertruida Hendrika/F-6529-2014; van Asselt, Dieneke/ABF-4742-2020	de Bock, Geertruida Hendrika/0000-0003-3104-4471; van Leeuwen, Barbara/0000-0002-6745-4424	Netherlands Organisation for Health Research and Development (ZonMw) [945-07-516]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	The study was funded by the Netherlands Organisation for Health Research and Development (ZonMw), trial number 945-07-516. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Al-Aama T, 2011, INT J GERIATR PSYCH, V26, P687, DOI 10.1002/gps.2582; Ansaloni L, 2010, BRIT J SURG, V97, P273, DOI 10.1002/bjs.6843; Audisio RA, 2008, CRIT REV ONCOL HEMAT, V65, P156, DOI 10.1016/j.critrevonc.2007.11.001; Brouquet A, 2010, ANN SURG, V251, P759, DOI 10.1097/SLA.0b013e3181c1cfc9; Caplan GA, 2007, INTERN MED J, V37, P95, DOI 10.1111/j.1445-5994.2007.01265.x; Dasgupta M, 2006, J AM GERIATR SOC, V54, P1578, DOI 10.1111/j.1532-5415.2006.00893.x; Dasgupta M, 2009, ARCH GERONTOL GERIAT, V48, P78, DOI 10.1016/j.archger.2007.10.007; Dijkstra A, 1996, SCAND J CARING SCI, V10, P137, DOI 10.1111/j.1471-6712.1996.tb00326.x; Elie M, 1998, J GEN INTERN MED, V13, P204, DOI 10.1046/j.1525-1497.1998.00047.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Hempenius L, 2013, J GERIATR ONCOL, V4, P26, DOI 10.1016/j.jgo.2012.08.004; Hempenius L, 2011, INT J GERIATR PSYCH, V26, P441, DOI 10.1002/gps.2560; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Inouye SK, 1996, JAMA-J AM MED ASSOC, V275, P852, DOI 10.1001/jama.275.11.852; Inouye SK, 1998, J GEN INTERN MED, V13, P234, DOI 10.1046/j.1525-1497.1998.00073.x; International Institute for Applied Systems Analysis, 2002, EUR POP AG GROUPS 19, P1950; Kalisvaart KJ, 2005, THESIS U AMSTERDAM A; Kammerlander C, 2010, OSTEOPOROSIS INT, V21, pS637, DOI 10.1007/s00198-010-1396-x; Koebrugge B, 2009, DIGEST SURG, V26, P63, DOI 10.1159/000194947; Leslie DL, 2008, ARCH INTERN MED, V168, P27, DOI 10.1001/archinternmed.2007.4; Leung JM, 2011, ANESTH ANALG, V112, P1199, DOI 10.1213/ANE.0b013e31820c7c06; MacLullich AMJ, 2008, J PSYCHOSOM RES, V65, P229, DOI 10.1016/j.jpsychores.2008.05.019; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; McCusker J, 2001, CAN MED ASSOC J, V165, P575; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Milisen K, 2001, J AM GERIATR SOC, V49, P523, DOI 10.1046/j.1532-5415.2001.49109.x; Monson K, 2003, ARCH SURG-CHICAGO, V138, P1061, DOI 10.1001/archsurg.138.10.1061; Morley JE, 2002, J GERONTOL A-BIOL, V57, pM698, DOI 10.1093/gerona/57.11.M698; Niam DMWT, 2005, AUSTRALAS J AGEING, V24, P174, DOI 10.1111/j.1741-6612.2005.00108.x; OKeeffe S, 1997, J AM GERIATR SOC, V45, P174, DOI 10.1111/j.1532-5415.1997.tb04503.x; Paradela S, 2010, J EUR ACAD DERMATOL, V24, P1207, DOI 10.1111/j.1468-3083.2010.03628.x; Quinlan N, 2011, J AM GERIATR SOC, V59, pS262, DOI 10.1111/j.1532-5415.2011.03674.x; Rao VSR, 2007, BREAST J, V13, P368, DOI 10.1111/j.1524-4741.2007.00444.x; Robinson TN, 2009, ANN SURG, V249, P173, DOI 10.1097/SLA.0b013e31818e4776; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Schuurmans H, 2004, J GERONTOL A-BIOL, V59, P962; Schuurmans Marieke J, 2003, Res Theory Nurs Pract, V17, P31, DOI 10.1891/088971803780956425; Steverink N, 2001, GERONTOLOGIST, V41, P236; Tei M, 2010, SURG ENDOSC, V24, P2135, DOI 10.1007/s00464-010-0911-7; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; van Munster BC, 2010, BRAIN COGNITION, V74, P18, DOI 10.1016/j.bandc.2010.05.010; vanderMast RC, 1996, J PSYCHOSOM RES, V41, P13, DOI 10.1016/0022-3999(96)00005-0; Witlox J, 2010, JAMA-J AM MED ASSOC, V304, P443, DOI 10.1001/jama.2010.1013	45	72	74	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e64834	10.1371/journal.pone.0064834	http://dx.doi.org/10.1371/journal.pone.0064834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190ST	23840308	Green Submitted, gold, Green Published			2022-12-27	WOS:000322361200006
J	Szymanski, CR; Chiha, W; Morellini, N; Cummins, N; Bartlett, CA; Doig, RLO; Savigni, DL; Payne, SC; Harvey, AR; Dunlop, SA; Fitzgerald, M				Szymanski, Charis R.; Chiha, Wissam; Morellini, Natalie; Cummins, Nadia; Bartlett, Carole A.; Doig, Ryan L. O'Hare; Savigni, Donna L.; Payne, Sophie C.; Harvey, Alan R.; Dunlop, Sarah A.; Fitzgerald, Melinda			Paranode Abnormalities and Oxidative Stress in Optic Nerve Vulnerable to Secondary Degeneration: Modulation by 670 nm Light Treatment	PLOS ONE			English	Article							SPINAL-CORD-INJURY; RETINAL GANGLION-CELLS; TRAUMATIC BRAIN-INJURY; CYTOCHROME-C-OXIDASE; NEAR-INFRARED LIGHT; REACTIVE OXYGEN; ABSORPTION-MEASUREMENTS; OLIGODENDROCYTES; CALCIUM; DEATH	Secondary degeneration of nerve tissue adjacent to a traumatic injury results in further loss of neurons, glia and function, via mechanisms that may involve oxidative stress. However, changes in indicators of oxidative stress have not yet been demonstrated in oligodendrocytes vulnerable to secondary degeneration in vivo. We show increases in the oxidative stress indicator carboxymethyl lysine at days 1 and 3 after injury in oligodendrocytes vulnerable to secondary degeneration. Dihydroethidium staining for superoxide is reduced, indicating endogenous control of this particular reactive species after injury. Concurrently, node of Ranvier/paranode complexes are altered, with significant lengthening of the paranodal gap and paranode as well as paranode disorganisation. Therapeutic administration of 670 nm light is thought to improve oxidative metabolism via mechanisms that may include increased activity of cytochrome c oxidase. Here, we show that light at 670 nm, delivered for 30 minutes per day, results in in vivo increases in cytochrome c oxidase activity co-localised with oligodendrocytes. Short term (1 day) 670 nm light treatment is associated with reductions in reactive species at the injury site. In optic nerve vulnerable to secondary degeneration superoxide in oligodendrocytes is reduced relative to handling controls, and is associated with reduced paranode abnormalities. Long term (3 month) administration of 670 nm light preserves retinal ganglion cells vulnerable to secondary degeneration and maintains visual function, as assessed by the optokinetic nystagmus visual reflex. Light at a wavelength of 670 nm may serve as a therapeutic intervention for treatment of secondary degeneration following neurotrauma.	[Szymanski, Charis R.; Chiha, Wissam; Morellini, Natalie; Cummins, Nadia; Bartlett, Carole A.; Doig, Ryan L. O'Hare; Savigni, Donna L.; Payne, Sophie C.; Dunlop, Sarah A.; Fitzgerald, Melinda] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia; [Harvey, Alan R.] Univ Western Australia, Sch Anat Physiol & Human Biol, Crawley, WA, Australia	University of Western Australia; University of Western Australia	Fitzgerald, M (corresponding author), Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia.	lindy.fitzgerald@uwa.edu.au	Fitzgerald, Melinda/C-4235-2011; Dunlop, Sarah A/G-9357-2013; Doig, Ryan O'Hare/AAG-7585-2019	Fitzgerald, Melinda/0000-0002-4823-8179; Dunlop, Sarah/0000-0002-1306-3962; Cummins, Nadia/0000-0002-4494-2345; , Alan/0000-0002-2590-831X	Neurotrauma Research Program (Western Australia); National Health and Medical Research Council (NHMRC), Australia [572550]; NHMRC, Australia [APP1002347]	Neurotrauma Research Program (Western Australia); National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Neurotrauma Research Program (Western Australia) and National Health and Medical Research Council (NH&MRC), Australia (Grant ID: 572550). Prof. Dunlop is a Principal Research Fellow of the NH&MRC, Australia (Grant ID: APP1002347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvanian VL, 2009, EXP NEUROL, V216, P471, DOI 10.1016/j.expneurol.2009.01.004; Back SA, 1998, J NEUROSCI, V18, P6241; Balabanov R, 2005, NAT NEUROSCI, V8, P262, DOI 10.1038/nn0305-262; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Buttermore ED, 2011, J NEUROSCI, V31, P8013, DOI 10.1523/JNEUROSCI.1015-11.2011; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Chan YC, 2009, J PHARMACOL EXP THER, V329, P450, DOI 10.1124/jpet.108.148353; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; DANNENBERG AM, 1994, J LEUKOCYTE BIOL, V56, P436, DOI 10.1002/jlb.56.4.436; Eells JT, 2004, MITOCHONDRION, V4, P559, DOI 10.1016/j.mito.2004.07.033; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fitzgerald M, 2010, J NEUROTRAUM, V27, P2107, DOI 10.1089/neu.2010.1426; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Fu MX, 1996, J BIOL CHEM, V271, P9982, DOI 10.1074/jbc.271.17.9982; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006705; Funfschilling U, 2012, NATURE, V485, P517, DOI 10.1038/nature11007; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Giaume C, 2007, CELL DEATH DIFFER, V14, P1324, DOI 10.1038/sj.cdd.4402144; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Griselda CM, 2011, NEUROSCI BIOBEHAV R, V35, P1353, DOI 10.1016/j.neubiorev.2011.02.009; Haynes RL, 2003, J NEUROPATH EXP NEUR, V62, P441, DOI 10.1093/jnen/62.5.441; Howell OW, 2006, BRAIN, V129, P3173, DOI 10.1093/brain/awl290; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Karu TI, 2005, J PHOTOCH PHOTOBIO B, V81, P98, DOI 10.1016/j.jphotobiol.2005.07.002; Karu TI, 2008, PHOTOMED LASER SURG, V26, P593, DOI 10.1089/pho.2008.2246; Kitada M, 2006, GLIA, V54, P35, DOI 10.1002/glia.20354; Kokkinopoulos I, 2013, NEUROBIOL AGING, V34, P602, DOI 10.1016/j.neurobiolaging.2012.04.014; Komel'kova L V, 2004, Patol Fiziol Eksp Ter, P15; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lasiene J, 2008, J NEUROSCI, V28, P3887, DOI 10.1523/JNEUROSCI.4756-07.2008; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Li ZS, 2010, FEBS LETT, V584, P2291, DOI 10.1016/j.febslet.2010.03.040; McLellan ME, 2003, J NEUROSCI, V23, P2212; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Nickells RW, 2004, BRAIN RES BULL, V62, P439, DOI 10.1016/j.brainresbull.2003.07.007; Othman A, 2011, GLIA, V59, P914, DOI 10.1002/glia.21163; Owusu-Ansah E, 2008, PROTOCOL IN VIVO DET; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Payne SC, 2012, INVEST OPHTHALMOL VI; Payne SC, 2011, J NEUROTRAUM, V28, P1077, DOI 10.1089/neu.2010.1665; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Reyes RC, 2012, J NEUROSCI, V32, P12973, DOI 10.1523/JNEUROSCI.1597-12.2012; Rinholm JE, 2012, NATURE, V487, P435, DOI 10.1038/487435a; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Rojas JC, 2008, J NEUROSCI, V28, P13511, DOI 10.1523/JNEUROSCI.3457-08.2008; Rosenbluth J, 2009, J NEUROSCI RES, V87, P3250, DOI 10.1002/jnr.22013; Rutar M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-257; Saggu SK, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-97; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Schlieve CR, 2006, INVEST OPHTH VIS SCI, V47, P3878, DOI 10.1167/iovs.05-1010; Sharikabad MN, 2001, AM J PHYSIOL-HEART C, V280, pH344, DOI 10.1152/ajpheart.2001.280.1.H344; Shen SL, 1999, NEURON, V23, P285, DOI 10.1016/S0896-6273(00)80780-1; Stemer Andrew B, 2010, Curr Cardiol Rep, V12, P29, DOI 10.1007/s11886-009-0071-3; Totoiu MO, 2005, J COMP NEUROL, V486, P373, DOI 10.1002/cne.20517; Tretter L, 2007, J NEUROSCI RES, V85, P3471, DOI 10.1002/jnr.21405; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Wong-Riley MTT, 2001, NEUROREPORT, V12, P3033, DOI 10.1097/00001756-200110080-00011; Ziabreva I, 2010, GLIA, V58, P1827, DOI 10.1002/glia.21052	65	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66448	10.1371/journal.pone.0066448	http://dx.doi.org/10.1371/journal.pone.0066448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840470	Green Published, gold			2022-12-27	WOS:000322361200080
J	Huang, CJ; Luo, YA; Zhao, JW; Yang, FW; Zhao, HW; Fan, WH; Ge, PF				Huang, Chuanjiang; Luo, Yinan; Zhao, Jingwei; Yang, Fuwei; Zhao, Hongwei; Fan, Wenhai; Ge, Pengfei			Shikonin Kills Glioma Cells through Necroptosis Mediated by RIP-1	PLOS ONE			English	Article							APOPTOSIS; DEATH; NECROSIS; KINASE; CONTRIBUTES; RESISTANCE; INDUCTION; MECHANISM	Background and Purpose: Shikonin was reported to induce necroptosis in leukemia cells, but apoptosis in glioma cell lines. Thus, it is needed to clarify whether shikonin could cause necroptosis in glioma cells and investigate its underlying mechanisms. Methods: Shikonin and rat C6 glioma cell line and Human U87 glioma cell line were used in this study. The cellular viability was assayed by MTT. Flow cytometry with annexin V-FITC and PI double staining was used to analyze cellular death modes. Morphological alterations in C6 glioma cells treated with shikoinin were evaluated by electronic transmission microscopy and fluorescence microscopy with Hoechst 33342 and PI double staining. The level of reactive oxygen species was assessed by using redox-sensitive dye DCFH-DA. The expressional level of necroptosis associated protein RIP-1 was analyzed by western blotting. Results: Shikonin induced cell death in C6 and U87 glioma cells in a dose and time dependent manner. The cell death in C6 and U87 glioma cells could be inhibited by necroptosis inhibitor necrotatin-1, not by pan-caspase inhibitor z-VAD-fmk. Shikonin treated C6 glioma cells presented electron-lucent cytoplasm, loss of plasma membrane integrity and intact nuclear membrane in morphology. The increased ROS level caused by shikonin was attenuated by necrostatin-1 and blocking ROS by anti-oxidant NAC rescued shikonin-induced cell death in both C6 and U87 glioma cells. Moreover, the expressional level of RIP-1 was up-regulated by shikonin in a dose and time dependent manner as well, but NAC suppressed RIP-1 expression. Conclusions: We demonstrated that the cell death caused by shikonin in C6 and U87 glioma cells was mainly via necroptosis. Moreover, not only RIP-1 pathway, but also oxidative stress participated in the activation of shikonin induced necroptosis.	[Huang, Chuanjiang; Luo, Yinan; Yang, Fuwei; Zhao, Hongwei; Ge, Pengfei] Jilin Univ, Dept Neurosurg, Bethune Hosp 1, Changchun 130023, Peoples R China; [Zhao, Jingwei] Jilin Univ, China Japan Union Hosp, Dept Neurosurg, Changchun 130023, Peoples R China; [Fan, Wenhai] Dlian Univ, Zhongshan Hosp, Dept Neurosurg, Dalian, Peoples R China	Jilin University; Jilin University; Dalian University of Technology	Ge, PF (corresponding author), Jilin Univ, Dept Neurosurg, Bethune Hosp 1, Changchun 130023, Peoples R China.	pengfeige@gmail.com			National Nature and Science Foundation of China [81072071, 81171234]; Nature and Science Foundation of Jilin province [201115068, 20121809]; Bethune project of Jilin University [2012203]	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature and Science Foundation of Jilin province; Bethune project of Jilin University	This work was supported by National Nature and Science Foundation of China (81072071) and (81171234), Nature and Science Foundation of Jilin province (201115068, 20121809), and Bethune project of Jilin University (No. 2012203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; Chandrasekher G, 2004, INVEST OPHTH VIS SCI, V45, P3577, DOI 10.1167/iovs.04-0279; Chang IC, 2010, BIOL PHARM BULL, V33, P816, DOI 10.1248/bpb.33.816; Chen CH, 2012, ANN SURG ONCOL, V19, P3097, DOI 10.1245/s10434-012-2324-4; Cho KS, 1999, INVEST OPHTH VIS SCI, V40, P911; Cho Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023209; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Dunai ZA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041945; Ge PF, 2010, NEUROL RES, V32, P94, DOI 10.1179/016164109X12518779082273; Gong K, 2011, FREE RADICAL BIO MED, V51, P2259, DOI 10.1016/j.freeradbiomed.2011.09.018; Han WD, 2007, MOL CANCER THER, V6, P1641, DOI 10.1158/1535-7163.MCT-06-0511; He SP, 2011, KAOHSIUNG J MED SCI, V27, P477, DOI 10.1016/j.kjms.2011.06.010; Horita H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003909; Hsu TS, 2009, TOXICOL APPL PHARM, V235, P153, DOI 10.1016/j.taap.2008.12.012; Jouan-Lanhouet S, 2012, CELL DEATH DIFFER, V19, P2003, DOI 10.1038/cdd.2012.90; Kelly KJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1309, DOI 10.1152/ajpcell.00353.2002; Khan MJ, 2012, J BIOL CHEM, V287, P21110, DOI 10.1074/jbc.M111.319129; Kim SK, 2012, ATHEROSCLEROSIS, V225, P315, DOI 10.1016/j.atherosclerosis.2012.09.021; Kim Sunja, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P137; Krakstad C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-135; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Li N, 2011, J CELL BIOCHEM, V112, P3834, DOI 10.1002/jcb.23314; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Mao X, 2008, CELL RES, V18, P879, DOI 10.1038/cr.2008.86; Nehs MA, 2011, SURGERY, V150, P1032, DOI 10.1016/j.surg.2011.09.012; Ouyang ZZ, 2012, PHARMAZIE, V67, P725, DOI 10.1691/ph.2012.1837; Saddoughi SA, 2013, EMBO MOL MED, V5, P105, DOI 10.1002/emmm.201201283; Smith CCT, 2007, CARDIOVASC DRUG THER, V21, P227, DOI 10.1007/s10557-007-6035-1; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu W, 2012, CRIT REV ONCOL HEMAT, V82, P249, DOI 10.1016/j.critrevonc.2011.08.004; Ye YC, 2012, INT IMMUNOPHARMACOL, V14, P674, DOI 10.1016/j.intimp.2012.08.003	37	100	106	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66326	10.1371/journal.pone.0066326	http://dx.doi.org/10.1371/journal.pone.0066326			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840441	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400012
J	Akhtar, S; Yousif, MHM; Dhaunsi, GS; Sarkhouh, F; Chandrasekhar, B; Attur, S; Benter, IF				Akhtar, Saghir; Yousif, Mariam H. M.; Dhaunsi, Gursev S.; Sarkhouh, Fatma; Chandrasekhar, Bindu; Attur, Sreeja; Benter, Ibrahim F.			Activation of ErbB2 and Downstream Signalling via Rho Kinases and ERK1/2 Contributes to Diabetes-Induced Vascular Dysfunction	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ENDOPLASMIC-RETICULUM STRESS; ANGIOTENSIN-II; OXIDATIVE STRESS; TYROSINE KINASE; TRANSACTIVATION; EGFR; INHIBITION; MECHANISMS; CARDIOTOXICITY	Diabetes mellitus leads to vascular complications but the underlying signalling mechanisms are not fully understood. Here, we examined the role of ErbB2 (HER2/Neu), a transmembrane receptor tyrosine kinase of the ErbB/EGFR (epidermal growth factor receptor) family, in mediating diabetes-induced vascular dysfunction in an experimental model of type 1 diabetes. Chronic treatment of streptozotocin-induced diabetic rats (1 mg/kg/alt diem) or acute, ex-vivo (10(-6), 10(-5) M) administration of AG825, a specific inhibitor of ErbB2, significantly corrected the diabetes-induced hyper-reactivity of the perfused mesenteric vascular bed (MVB) to the vasoconstrictor, norephinephrine (NE) and the attenuated responsiveness to the vasodilator, carbachol. Diabetes led to enhanced phosphorylation of ErbB2 at multiple tyrosine (Y) residues (Y1221/1222, Y1248 and Y877) in the MVB that could be attenuated by chronic AG825 treatment. Diabetes-or high glucose-mediated upregulation of ErbB2 phosphorylation was coupled with activation of Rho kinases (ROCKs) and ERK1/2 in MVB and in cultured vascular smooth muscle cells (VSMC) that were attenuated upon treatment with either chronic or acute AG825 or with anti-ErbB2 siRNA. ErbB2 likley heterodimerizes with EGFR, as evidenced by increased co-association in diabetic MVB, and further supported by our finding that ERK1/2 and ROCKs are common downstream effectors since their activation could also be blocked by AG1478. Our results show for the first time that ErbB2 is an upstream effector of ROCKs and ERK1/2 in mediating diabetes-induced vascular dysfunction. Thus, potential strategies aimed at modifying actions of signal transduction pathways involving ErbB2 pathway may prove to be beneficial in treatment of diabetes-induced vascular complications.	[Akhtar, Saghir; Yousif, Mariam H. M.; Sarkhouh, Fatma; Chandrasekhar, Bindu; Attur, Sreeja; Benter, Ibrahim F.] Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Safat, Kuwait; [Dhaunsi, Gursev S.] Kuwait Univ, Fac Med, Dept Pediat, Safat, Kuwait	Kuwait University; Kuwait University	Akhtar, S (corresponding author), Kuwait Univ, Fac Med, Dept Pharmacol & Toxicol, Safat, Kuwait.	Saghir@hsc.edu.kw	Benter, Ibrahim Fadil/AAY-2527-2020	Yousif, Mariam/0000-0002-6464-031X; Akhtar, Saghir/0000-0003-3177-946X	Kuwait University Research Sector [MR 05/09]	Kuwait University Research Sector	This study was supported by a grant from Kuwait University Research Sector (Project number MR 05/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar S, 2013, BIOIMPACTS, V3, P5, DOI 10.5681/bi.2013.008; Akhtar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039066; Akhtar S, 2012, BRIT J PHARMACOL, V165, P1390, DOI 10.1111/j.1476-5381.2011.01613.x; Almendro V, 2010, CURR DRUG TARGETS, V11, P1169, DOI 10.2174/138945010792006807; Anand-Apte B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013444; Arita R, 2009, DIABETES, V58, P215, DOI 10.2337/db08-0762; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Belmadani S, 2008, DIABETES, V57, P1629, DOI 10.2337/db07-0739; Benter IF, 2009, VASC PHARMACOL, V51, P236, DOI 10.1016/j.vph.2009.06.008; Benter IF, 2005, J VASC RES, V42, P284, DOI 10.1159/000085904; Benter IF, 2005, BRIT J PHARMACOL, V145, P829, DOI 10.1038/sj.bjp.0706238; Cai Z, 2010, SEMIN CELL DEV BIOL, V21, P961, DOI 10.1016/j.semcdb.2010.09.005; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; De Giusti VC, 2011, HYPERTENSION, V58, P912, DOI 10.1161/HYPERTENSIONAHA.111.176024; De Keulenaer GW, 2010, CIRC RES, V106, P35, DOI 10.1161/CIRCRESAHA.109.205906; Desai MD, 2013, EXPERT OPIN INV DRUG, V22, P341, DOI 10.1517/13543784.2013.761972; Dhomen Nathalie S., 2012, Critical Reviews in Oncogenesis, V17, P31; Dong M, 2010, DRUG DISCOV TODAY, V15, P622, DOI 10.1016/j.drudis.2010.06.011; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Galan M, 2012, HYPERTENSION, V60, P71, DOI 10.1161/HYPERTENSIONAHA.112.192500; Gao P, 2013, CARDIOVASC RES, V97, P533, DOI 10.1093/cvr/cvs369; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Hervent AS, 2012, INT J MOL SCI, V13, P12268, DOI 10.3390/ijms131012268; Higuchi S, 2007, CLIN SCI, V112, P417, DOI 10.1042/CS20060342; Izzo JL, 2011, J CLIN HYPERTENS, V13, P290, DOI 10.1111/j.1751-7176.2011.00447.x; Kobayashi T, 2012, HYPERTENSION, V60, P20, DOI 10.1161/HYPERTENSIONAHA.112.197038; Li JM, 2010, DIABETES, V59, P2033, DOI 10.2337/db09-1800; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Liu B, 2012, INTERNAL MED, V51, P1177, DOI 10.2169/internalmedicine.51.6771; Maisch B, 2011, HERZ, V36, P102, DOI 10.1007/s00059-011-3429-4; Mandavia CH, 2012, LIFE SCI; Matsumoto T, 2008, PEPTIDES, V29, P1338, DOI 10.1016/j.peptides.2008.04.001; Montezano AC, 2012, ANN MED, V44, pS2, DOI 10.3109/07853890.2011.653393; Moon JY, 2011, AM J PHYSL RENAL PHY; Rodrigues-Diez R, 2008, PHARM RES-DORDR, V25, P2447, DOI 10.1007/s11095-008-9636-x; Schinzari F, 2012, AM J PHYSIOL-ENDOC M, V303, pE806, DOI 10.1152/ajpendo.00206.2012; Schneider JW, 2001, SEMIN ONCOL, V28, P18, DOI 10.1053/sonc.2001.28546; Scully Tony, 2012, Nature, V485, pS2; Shatanawi A, 2011, AM J PHYSIOL-CELL PH, V300, pC1181, DOI 10.1152/ajpcell.00328.2010; Surma M, 2011, FUTUR CARDIOL, V7, P657, DOI [10.2217/fca.11.51, 10.2217/FCA.11.51]; Suzuki K, 2012, J SURG RES, V178, P352, DOI 10.1016/j.jss.2012.01.043; Von Lueder TG, 2012, CARDIOVASC DRUGS THE; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wilkinson-Berka JL, 2013, CLIN SCI, V124, P597, DOI 10.1042/CS20120212; Xu JC, 2009, J CELL MOL MED, V13, P1499, DOI 10.1111/j.1582-4934.2009.00833.x; Yousif M. H. M., 2005, Autonomic & Autacoid Pharmacology, V25, P69, DOI 10.1111/j.1474-8673.2004.00333.x; Zhao TT, 2010, ONCOGENE, V29, P4682, DOI 10.1038/onc.2010.219; Zhou QA, 2011, TRENDS PHARMACOL SCI, V32, P167, DOI 10.1016/j.tips.2010.12.006	50	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67813	10.1371/journal.pone.0067813	http://dx.doi.org/10.1371/journal.pone.0067813			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826343	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000100
J	Hill, BM; Shaw, A				Hill, Benjamin Mako; Shaw, Aaron			The Wikipedia Gender Gap Revisited: Characterizing Survey Response Bias with Propensity Score Estimation	PLOS ONE			English	Article							WEB SURVEYS; ATTITUDES; INTERNET	Opt-in surveys are the most widespread method used to study participation in online communities, but produce biased results in the absence of adjustments for non-response. A 2008 survey conducted by the Wikimedia Foundation and United Nations University at Maastricht is the source of a frequently cited statistic that less than 13% of Wikipedia contributors are female. However, the same study suggested that only 39.9% of Wikipedia readers in the US were female - a finding contradicted by a representative survey of American adults by the Pew Research Center conducted less than two months later. Combining these two datasets through an application and extension of a propensity score estimation technique used to model survey non-response bias, we construct revised estimates, contingent on explicit assumptions, for several of the Wikimedia Foundation and United Nations University at Maastricht claims about Wikipedia editors. We estimate that the proportion of female US adult editors was 27.5% higher than the original study reported (22.7%, versus 17.8%), and that the total proportion of female editors was 26.8% higher (16.1%, versus 12.7%).	[Hill, Benjamin Mako] MIT, Cambridge, MA 02139 USA; [Shaw, Aaron] Northwestern Univ, Dept Commun Studies, Evanston, IL USA; [Hill, Benjamin Mako; Shaw, Aaron] Harvard Univ, Berkman Ctr Internet & Soc, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Northwestern University; Harvard University	Hill, BM (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mako@mit.edu	Hill, Benjamin Mako/AAE-8825-2019	Hill, Benjamin Mako/0000-0001-8588-7429	MIT Sloan School of Management, Northwestern University; Berkman Center for Internet and Society; Ford Visionary Leadership Fund	MIT Sloan School of Management, Northwestern University; Berkman Center for Internet and Society; Ford Visionary Leadership Fund	This work has funded by the MIT Sloan School of Management, Northwestern University, the Berkman Center for Internet and Society and the Ford Visionary Leadership Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENKLER Y, 2006, WEALTH NETWORKS; BUSCH T, 1995, J EDUC COMPUT RES, V12, P147, DOI 10.2190/H7E1-XMM7-GU9B-3HWR; Chang L, 2009, PUBLIC OPIN QUART, V73, P641, DOI 10.1093/poq/nfp075; Cohen N, 2011, NY TIMES; Collier Benjamin, 2012, P ACM 2012 C COMP SU, P383, DOI [10.1145/2145204.2145265, DOI 10.1145/2145204.2145265]; ComScore, 2008, MY MATR WIK FDN SIT; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Fox S., 2008, TECHNICAL REPORT; Glott Ruedige, 2010, TECHNICAL REPORT; Hargittai Eszter, 2008, Information Communication & Society, V11, P239, DOI 10.1080/13691180801946150; Lee S, 2009, SOCIOL METHOD RES, V37, P319, DOI 10.1177/0049124108329643; LUNDEBERG MA, 1994, J EDUC PSYCHOL, V86, P114, DOI 10.1037/0022-0663.86.1.114; Morgan J.T., 2013, P 2013 C COMP SUPP C, P839, DOI DOI 10.1145/2441776.2441871; Pew Research Center, 2008, DEC 2008 HLTH; Princeton Survey Research Associates International, 2008, FALL TRACK 2008 QUES; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schonlau M, 2004, SOC SCI COMPUT REV, V22, P128, DOI 10.1177/0894439303256551; Schonlau M, 2009, SOCIOL METHOD RES, V37, P291, DOI 10.1177/0049124108327128; Schumacher P, 2001, COMPUT HUM BEHAV, V17, P95, DOI 10.1016/S0747-5632(00)00032-7; US Census Bureau, 2010, TECHNICAL REPORT; Valliant R, 2011, SOCIOL METHOD RES, V40, P105, DOI 10.1177/0049124110392533; Wikimedia Foundation, 2011, TECHNICAL REPORT	22	81	81	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65782	10.1371/journal.pone.0065782	http://dx.doi.org/10.1371/journal.pone.0065782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DN	23840366	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400013
J	Karagianni, F; Prakoura, N; Kaltsa, G; Politis, P; Arvaniti, E; Kaltezioti, V; Psarras, S; Pagakis, S; Katsimboulas, M; Abed, A; Chatziantoniou, C; Charonis, A				Karagianni, Fani; Prakoura, Niki; Kaltsa, Garyfallia; Politis, Panagiotis; Arvaniti, Elena; Kaltezioti, Valeria; Psarras, Stelios; Pagakis, Stamatis; Katsimboulas, Michalis; Abed, Ahmed; Chatziantoniou, Christos; Charonis, Aristidis			Transgelin Up-Regulation in Obstructive Nephropathy	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; EXPRESSION; CELLS; SM22-ALPHA; MICROARRAY; RECEPTORS; INDUCTION; FIBROSIS; DISEASE; MARKER	Fibrosis is a complex and multifactorial process, affecting the structure and compromising the function of several organs. Among those, renal fibrosis is an important pathological change, eventually leading to renal failure. Proteomic analysis of the renal parenchyma in the well-established rat model of unilateral ureteral obstruction (UUO model) suggested that transgelin was up-regulated during the development of fibrosis. Transgelin up-regulation was confirmed both at the protein and at the mRNA level. It was observed that at early stages of fibrosis transgelin was mainly expressed in the interstitial compartment and, more specifically, in cells surrounding the glomeruli. Subsequently, it was confirmed that transgelin expressing cells were activated fibroblasts, based on their extensive co-expression of alpha-SMA and their complete lack of co-distribution with markers of other cell types (endothelial, epithelial and cells of the immune system). These periglomerular fibroblasts exhibited staining for transgelin mainly cytoplasmic but occasionally nuclear as well. In addition, transgelin expression in periglomerular fibroblasts was absent in renal fibrosis developed in a hypertensive model, compared to the UUO model. Promoter analysis indicated that there are several conserved motifs for transcription factor binding. Among those, Kruppel-like factor 6 was found to be up-regulated in transgelin positive periglomerular activated fibroblasts, suggesting a possible involvement in the mechanism of transgelin up-regulation. These data strongly suggest that transgelin is up-regulated in the obstructive nephropathy and could be used as a novel marker for renal fibrosis in the future.	[Karagianni, Fani; Prakoura, Niki; Kaltsa, Garyfallia; Politis, Panagiotis; Arvaniti, Elena; Kaltezioti, Valeria; Psarras, Stelios; Charonis, Aristidis] Acad Athens, Biomed Res Fdn, Sect Histol, Ctr Basic Res 1, Athens, Greece; [Pagakis, Stamatis] Acad Athens, Biomed Res Fdn, Biol Imaging Unit, Athens, Greece; [Katsimboulas, Michalis] Acad Athens, Biomed Res Fdn, Ctr Expt Surg, Athens, Greece; [Abed, Ahmed; Chatziantoniou, Christos] INSERM, Paris, France; [Abed, Ahmed; Chatziantoniou, Christos] Univ Paris 06, Paris, France	Academy of Athens; Academy of Athens; Academy of Athens; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Charonis, A (corresponding author), Acad Athens, Biomed Res Fdn, Sect Histol, Ctr Basic Res 1, Athens, Greece.	acharonis@bioacademy.gr	Politis, Panagiotis/AAO-2423-2020; Chatziantoniou, Christos/L-2501-2016	Charonis, Aristidis/0000-0001-9956-732X; Katsimpoulas, Michalis/0000-0001-8083-3878; Politis, Panagiotis/0000-0002-2556-2857	BRFAA; General Secretariat for Research and Technology of the Ministry of Education [09FR07, 2681]	BRFAA; General Secretariat for Research and Technology of the Ministry of Education	This work was supported from a fellowship from BRFAA (to FK), from a Greek-French Cooperation grant (#09FR07) from the General Secretariat for Research and Technology of the Ministry of Education (to AC) and from an ARISTEIA grant (#2681) from the General Secretariat for Research and Technology of the Ministry of Education (to AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benfield MR, 2003, PEDIATR TRANSPLANT, V7, P321, DOI 10.1034/j.1399-3046.2003.00029.x; Bregant E, 2009, MOL CELL BIOCHEM, V327, P145, DOI 10.1007/s11010-009-0052-2; Caron KMI, 2002, P NATL ACAD SCI USA, V99, P8248, DOI 10.1073/pnas.112222199; Daniel C, 2012, LAB INVEST, V92, P812, DOI 10.1038/labinvest.2012.63; de Jong PE, 2008, CLIN J AM SOC NEPHRO, V3, P616, DOI 10.2215/CJN.04381007; Gerolymos M, 2011, NEPHRON CLIN PRACT, V119, pC74, DOI 10.1159/000324655; Goncalves RG, 2006, KIDNEY INT, V70, P1599, DOI 10.1038/sj.ki.5001804; Hauser PV, 2009, NEPHRON EXP NEPHROL, V112, pE43, DOI 10.1159/000213505; Higgins DF, 2003, KIDNEY INT, V64, P2079, DOI 10.1046/j.1523-1755.2003.00306.x; Huby AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052362; Huby AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006721; Inomata S, 2011, NEPHRON EXP NEPHROL, V117, pE104, DOI 10.1159/000320175; Jennings J, 2008, BIOELECTROMAGNETICS, V29, P394, DOI 10.1002/bem.20408; Kaneko Y, 2003, J IMMUNOL, V170, P3377, DOI 10.4049/jimmunol.170.6.3377; Kim Y, 1998, J BIOL CHEM, V273, P33750, DOI 10.1074/jbc.273.50.33750; Klein J, 2011, INT J EXP PATHOL, V92, P168, DOI 10.1111/j.1365-2613.2010.00727.x; Kypreou KP, 2008, PROTEOMICS, V8, P2407, DOI 10.1002/pmic.200700831; Marshall CB, 2001, AM J PHYSIOL-RENAL, V300, P1026; Ogawa A, 2007, NEPHRON EXP NEPHROL, V106, P77, DOI 10.1159/000103020; Ratziu V, 1998, P NATL ACAD SCI USA, V95, P9500, DOI 10.1073/pnas.95.16.9500; Sakamaki Y, 2011, NEPHROLOGY, V16, P211, DOI 10.1111/j.1440-1797.2010.01322.x; Starkel P, 2003, J HEPATOL, V39, P538, DOI 10.1016/S0168-8278(03)00360-X; Tarabishi R, 2005, KIDNEY INT, V68, P1511, DOI 10.1111/j.1523-1755.2005.00563.x; Wang X, 2012, NEPRHON EXP NEPHROL, V120, P1; Yamamura H, 1997, J BIOCHEM, V122, P157	25	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66887	10.1371/journal.pone.0066887	http://dx.doi.org/10.1371/journal.pone.0066887			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840546	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400048
J	Oluwafemi, S; Dewhirst, SY; Veyrat, N; Powers, S; Bruce, TJA; Caulfield, JC; Pickett, JA; Birkett, MA				Oluwafemi, Sunday; Dewhirst, Sarah Y.; Veyrat, Nathalie; Powers, Stephen; Bruce, Toby J. A.; Caulfield, John C.; Pickett, John A.; Birkett, Michael A.			Priming of Production in Maize of Volatile Organic Defence Compounds by the Natural Plant Activator cis-Jasmone	PLOS ONE			English	Article							ZEA-MAYS; APHID; PARASITOIDS; EMISSION; GENES; IDENTIFICATION; TRANSMISSION; HOMOPTERA; PHEROMONE; SIGNALS	cis-Jasmone (CJ) is a natural plant product that activates defence against herbivores in model and crop plants. In this study, we investigated whether CJ could prime defence in maize, Zea mays, against the leafhopper, Cicadulina storeyi, responsible for the transmission of maize streak virus (MSV). Priming occurs when a pre-treatment, in this case CJ, increases the potency and speed of a defence response upon subsequent attack on the plant. Here, we tested insect responses to plant volatile organic compounds (VOCs) using a Y-tube olfactometer bioassay. Our initial experiments showed that, in this system, there was no significant response of the herbivore to CJ itself and no difference in response to VOCs collected from unexposed plants compared to CJ exposed plants, both without insects. VOCs were then collected from C. storeyi-infested maize seedlings with and without CJ pre-treatment. The bioassay revealed a significant preference by this pest for VOCs from infested seedlings without the CJ pre-treatment. A timed series of VOC collections and bioassays showed that the effect was strongest in the first 22 h of insect infestation, i.e. before the insects had themselves induced a change in VOC emission. Chemical analysis showed that treatment of maize seedlings with CJ, followed by exposure to C. storeyi, led to a significant increase in emission of the defensive sesquiterpenes (E)-(1R,9S)-caryophyllene, (E)-alpha-bergamotene, (E)-beta-farnesene and (E)-4,8-dimethyl-1,3,7-nonatriene, known to act as herbivore repellents. The chemical analysis explains the behavioural effects observed in the olfactometer, as the CJ treatment caused plants to emit a blend of VOCs comprising more of the repellent components in the first 22 h of insect infestation than control plants. The speed and potency of VOC emission was increased by the CJ pre-treatment. This is the first indication that CJ can prime plants for enhanced production of defensive VOCs antagonist towards herbivores.	[Oluwafemi, Sunday] Bowen Univ, Dept Crop Prod Soil & Environm Management, Iwo, Osun State, Nigeria; [Oluwafemi, Sunday; Dewhirst, Sarah Y.; Bruce, Toby J. A.; Caulfield, John C.; Pickett, John A.; Birkett, Michael A.] Rothamsted Res, Biol Chem & Crop Protect Dept, Harpenden, Herts, England; [Veyrat, Nathalie] Univ Neuchatel, Inst Biol, CH-2000 Neuchatel, Switzerland; [Powers, Stephen] Rothamsted Res, Biomath & Bioinformat Dept, Harpenden, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Neuchatel; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Birkett, MA (corresponding author), Rothamsted Res, Biol Chem & Crop Protect Dept, Harpenden, Herts, England.	mike.birkett@rothamsted.ac.uk	Bruce, Toby JA/H-3131-2011	Bruce, Toby JA/0000-0002-9912-0605; Birkett, Michael/0000-0002-3302-2025	Rothamsted International African Fellows Programme; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom; BBSRC [BBS/E/C/00004945, BB/L001683/1, BBS/E/C/00005194] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L001683/1, BBS/E/C/00005194, BBS/E/C/00004945] Funding Source: researchfish	Rothamsted International African Fellows Programme; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Rothamsted International African Fellows Programme (Fellowship to SO). Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom. SO gratefully acknowledges the permission of Bowen University, Nigeria, to undertake this Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelopoulos NG, 1999, J CHEM ECOL, V25, P1411, DOI 10.1023/A:1020939112234; [Anonymous], 2005, NIST MASS SPECTR SEA; Asanzi MC, 1995, AFR ENTOMOL, V3, P173; Beale MH, 2006, P NATL ACAD SCI USA, V103, P10509, DOI 10.1073/pnas.0603998103; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Bruce TJA, 2003, PEST MANAG SCI, V59, P1031, DOI 10.1002/ps.730; Bruce TJA, 2008, P NATL ACAD SCI USA, V105, P4553, DOI 10.1073/pnas.0710305105; Bruce TJ, 2007, CURR OPIN PLANT BIOL, V10, P387, DOI 10.1016/j.pbi.2007.05.002; Chamberlain K, 2000, MOL PLANT PATHOL, V1, P67, DOI 10.1046/j.1364-3703.2000.00009.x; D'Alessandro M, 2005, CHEM SENSES, V30, P739, DOI 10.1093/chemse/bji066; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Frost CJ, 2008, NEW PHYTOL, V180, P722, DOI 10.1111/j.1469-8137.2008.02599.x; Hegde M, 2012, PHYTOCHEMISTRY, V78, P81, DOI 10.1016/j.phytochem.2012.03.004; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Herde M, 2008, PLANT CELL, V20, P1152, DOI 10.1105/tpc.106.049478; HOPKE J, 1994, FEBS LETT, V352, P146, DOI 10.1016/0014-5793(94)00948-1; Kessler A, 2006, OECOLOGIA, V148, P280, DOI 10.1007/s00442-006-0365-8; KIM SK, 1981, 3 OAU STRC WORKSH MA; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; Lee S, 2010, P NATL ACAD SCI USA, V107, P21205, DOI 10.1073/pnas.1009975107; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; Moraes MCB, 2009, ENTOMOL EXP APPL, V131, P178, DOI 10.1111/j.1570-7458.2009.00836.x; Moraes MCB, 2008, PHYTOCHEMISTRY, V69, P9, DOI 10.1016/j.phytochem.2007.06.020; Oikawa A, 2001, PHYTOCHEMISTRY, V56, P669, DOI 10.1016/S0031-9422(00)00494-5; Oluwafemi S, 2007, ENTOMOL EXP APPL, V124, P235, DOI 10.1111/j.1570-7458.2007.00577.x; Oluwafemi S, 2011, J CHEM ECOL, V37, P40, DOI 10.1007/s10886-010-9891-2; Ozawa R, 2004, J CHEM ECOL, V30, P1797, DOI 10.1023/B:JOEC.0000042402.04012.c7; Pickett JA, 2001, TRENDS PLANT SCI, V6, P137, DOI 10.1016/S1360-1385(01)01899-4; Pickett JA, 2007, PHYTOCHEMISTRY, V68, P2937, DOI 10.1016/j.phytochem.2007.09.025; Powell W, 2003, PEST MANAG SCI, V59, P149, DOI 10.1002/ps.550; Schmelz EA, 2003, PLANTA, V216, P665, DOI 10.1007/s00425-002-0898-y; Skelton AC, 2010, J MED ENTOMOL, V47, P798, DOI 10.1603/ME09295; Tamiru A, 2011, ECOL LETT, V14, P1075, DOI 10.1111/j.1461-0248.2011.01674.x; THOTTAPPILLY G, 1993, PLANT PATHOL, V42, P494, DOI 10.1111/j.1365-3059.1993.tb01529.x; Ton J, 2007, PLANT J, V49, P16, DOI 10.1111/j.1365-313X.2006.02935.x; Turlings TCJ, 2006, CURR OPIN PLANT BIOL, V9, P421, DOI 10.1016/j.pbi.2006.05.010	37	27	27	4	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e62299	10.1371/journal.pone.0062299	http://dx.doi.org/10.1371/journal.pone.0062299			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840295	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400002
J	Pradels, A; Pradon, D; Hlavackova, P; Diot, B; Vuillerme, N				Pradels, Antoine; Pradon, Didier; Hlavackova, Petra; Diot, Bruno; Vuillerme, Nicolas			Sensory Re-Weighting in Human Bipedal Postural Control: The Effects of Experimentally-Induced Plantar Pain	PLOS ONE			English	Article							MUSCLE FATIGUE; HEAD EXTENSION; SENSORIMOTOR INTEGRATION; UPRIGHT STANCE; ORIENTATION; VIBRATION; POSITION; VISION; TOUCH; SWAY	The present study was designed to assess the effects of experimentally-induced plantar pain on the displacement of centre of foot pressure during unperturbed upright stance in different sensory conditions of availability and/or reliability of visual input and somatosensory input from the vestibular system and neck. To achieve this goal, fourteen young healthy adults were asked to stand as still as possible in three sensory conditions: (1) No-vision, (2) Vision, and (3) No-vision - Head tilted backward, during two experimental conditions: (1) a No-pain condition, and (2) a condition when a painful stimulation was applied to the plantar surfaces of both feet (Plantar-pain condition). Centre of foot pressure (CoP) displacements were recorded using a force platform. Results showed that (1) experimentally-induced plantar pain increased CoP displacements in the absence of vision (No-vision condition), (2) this deleterious effect was more accentuated when somatosensory information from the vestibular and neck was altered (No-vision - Head tilted backward condition) and (3) this deleterious effect was suppressed when visual information was available (Vision condition). From a fundamental point of view, these results lend support to the sensory re-weighting hypothesis whereby the central nervous system dynamically and selectively adjusts the relative contributions of sensory inputs (i.e. the sensory weightings) in order to maintain balance when one or more sensory channels are altered by the task (novel or challenging), environmental or individual conditions. From a clinical point of view, the present findings further suggest that prevention and treatment of plantar pain may be relevant for the preservation or improvement of balance control, particularly in situations (or individuals) in which information provided by the visual, neck proprioceptive and vestibular systems is unavailable or disrupted.	[Pradels, Antoine; Hlavackova, Petra; Diot, Bruno; Vuillerme, Nicolas] Univ Grenoble Alpes, FRE AGIM Lab 3405, CNRS UJF UPMF EPHE, La Tronche, France; [Pradels, Antoine; Pradon, Didier; Vuillerme, Nicolas] Univ Versailles St Quentin Yvelines, Hop Raymond Poincare, APHP Serv Physiol & Explorat Fonct, EA 4497,CIC IT 805, Garches, France; [Pradels, Antoine] Ctr Podol Estacade, Grenoble, France; [Hlavackova, Petra] CHU Grenoble, Hop Couple Enfant, Grenoble, France; [Diot, Bruno] IDS, Montceau Les Mines, France; [Vuillerme, Nicolas] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut Universitaire de France	Vuillerme, N (corresponding author), Univ Grenoble Alpes, FRE AGIM Lab 3405, CNRS UJF UPMF EPHE, La Tronche, France.	nicolas.vuillerme@agim.eu	VUILLERME, Nicolas/U-5767-2019	VUILLERME, Nicolas/0000-0003-3773-393X				Anand V, 2003, INVEST OPHTH VIS SCI, V44, P2885, DOI 10.1167/iovs.02-1031; Anand V, 2002, OPHTHAL PHYSL OPT, V22, P528, DOI 10.1046/j.1475-1313.2002.00067.x; Andersson G, 2002, ACTA OTO-LARYNGOL, V122, P284, DOI 10.1080/000164802753648169; BRANDT T, 1981, ANN NY ACAD SCI, V374, P636, DOI 10.1111/j.1749-6632.1981.tb30907.x; BRANDT T, 1986, DISORDERS POSTURE GA, P353; Buckley JG, 2005, GAIT POSTURE, V21, P59, DOI 10.1016/j.gaitpost.2003.11.005; Fransson PA, 2007, EUR J APPL PHYSIOL, V101, P81, DOI 10.1007/s00421-007-0476-x; Hansson EE, 2010, ACTA OTO-LARYNGOL, V130, P1358, DOI 10.3109/00016489.2010.498024; Hlavackova P, 2012, GAIT POSTURE, V112, P789; Horak F, 1996, HDB PHYSIOL 12, V12, P255; JACKSON RT, 1991, ANN OTO RHINOL LARYN, V100, P63, DOI 10.1177/000348949110000110; Johnson MB, 2012, MOTOR CONTROL, V16, P81, DOI 10.1123/mcj.16.1.81; KARLBERG M, 1995, THESIS U HOSP LUND; Kavounoudias A, 1998, NEUROREPORT, V9, P3247, DOI 10.1097/00001756-199810050-00021; Ledin T, 2004, GAIT POSTURE, V19, P184, DOI 10.1016/S0966-6362(03)00061-4; Massion Jean, 1994, Current Opinion in Neurobiology, V4, P877, DOI 10.1016/0959-4388(94)90137-6; Maurer C, 2000, NEUROSCI LETT, V281, P99, DOI 10.1016/S0304-3940(00)00814-4; Mergner T, 1998, BRAIN RES REV, V28, P118, DOI 10.1016/S0165-0173(98)00032-0; Meyer PF, 2004, EXP BRAIN RES, V156, P505, DOI 10.1007/s00221-003-1804-y; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; PAULUS WM, 1984, BRAIN, V107, P1143, DOI 10.1093/brain/107.4.1143; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pinsault N, 2008, EXP BRAIN RES, V191, P99, DOI 10.1007/s00221-008-1500-z; Pinsault N, 2010, EXP BRAIN RES, V202, P253, DOI 10.1007/s00221-009-2122-9; Pinsault N, 2009, MED ENG PHYS, V31, P276, DOI 10.1016/j.medengphy.2008.08.003; Pradels A, 2011, CLIN BIOMECH, V26, P424, DOI 10.1016/j.clinbiomech.2010.11.016; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; RYAN GMS, 1955, LANCET, V2, P1355; SIMONEAU GG, 1992, J GERONTOL, V47, pM151, DOI 10.1093/geronj/47.5.M151; STRAUBE A, 1992, HEAD NECK SENSORY MO, P548; Thedon T, 2011, GAIT POSTURE, V33, P686, DOI 10.1016/j.gaitpost.2011.02.027; Vuillerme N, 2008, NEUROSCIENCE, V155, P291, DOI 10.1016/j.neuroscience.2008.05.018; Vuillerme N, 2007, INT J SPORTS MED, V28, P243, DOI 10.1055/s-2006-924292; Vuillerme N, 2005, GAIT POSTURE, V21, P318, DOI 10.1016/j.gaitpost.2004.04.007; Vuillerme N, 2003, ARCH PHYS MED REHAB, V84, P1560, DOI 10.1016/S0003-9993(03)00235-1; Vuillerme N, 2002, NEUROSCI LETT, V333, P131, DOI 10.1016/S0304-3940(02)00999-0; Vuillerme N, 2001, ADAPT PHYS ACT Q, V18, P417, DOI 10.1123/apaq.18.4.417; Vuillerme N, 2008, GAIT POSTURE, V28, P521, DOI 10.1016/j.gaitpost.2008.03.005; Vuillerme N, 2007, EXP BRAIN RES, V183, P235, DOI 10.1007/s00221-007-1039-4; Vuillerme N, 2006, GAIT POSTURE, V24, P169, DOI 10.1016/j.gaitpost.2005.07.011; Zok M, 2008, MED ENG PHYS, V30, P913, DOI 10.1016/j.medengphy.2007.12.002	43	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65510	10.1371/journal.pone.0065510	http://dx.doi.org/10.1371/journal.pone.0065510			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840337	gold, Green Published			2022-12-27	WOS:000321424400006
J	Santofimia, E; Gonzalez-Toril, E; Lopez-Pamo, E; Gomariz, M; Amils, R; Aguilera, A				Santofimia, Esther; Gonzalez-Toril, Elena; Lopez-Pamo, Enrique; Gomariz, Maria; Amils, Ricardo; Aguilera, Angeles			Microbial Diversity and Its Relationship to Physicochemical Characteristics of the Water in Two Extreme Acidic Pit Lakes from the Iberian Pyrite Belt (SW Spain)	PLOS ONE			English	Article							RIO TINTO SW; EUKARYOTIC COMMUNITY; MINE DRAINAGE; MINING LAKES; GOLD-MINE; ENVIRONMENT; IRON; BACTERIAL; ECOLOGY; STRATIFICATION	The Iberian Pyrite Belt (IPB) hosts one of the world's largest accumulations of acidic mine wastes and pit lakes. The mineralogical and textural characteristics of the IPB ores have favored the oxidation and dissolution of metallic sulfides, mainly pyrite, and the subsequent formation of acidic mining drainages. This work reports the physical properties, hydrogeochemical characteristics, and microbial diversity of two pit lakes located in the IPB. Both pit lakes are acidic and showed high concentrations of sulfate and dissolved metals. Concentrations of sulfate and heavy metals were higher in the Nuestra Senora del Carmen lake (NSC) by one order of magnitude than in the Concepcion (CN) lake. The hydrochemical characteristics of NSC were typical of acid mine waters and can be compared with other acidic environments. When compared to other IPB acidic pit lakes, the superficial water of CN is more diluted than that of any of the others due, probably, to the strong influence of runoff water. Both pit lakes showed chemical and thermal stratification with well defined chemoclines. One particular characteristic of NSC is that it has developed a chemocline very close to the surface (2 m depth). Microbial community composition of the water column was analyzed by 16S and 18S rRNA gene cloning and sequencing. The microorganisms detected in NSC were characteristic of acid mine drainage (AMD), including iron oxidizing bacteria (Leptospirillum, Acidithiobacillus ferrooxidans) and facultative iron reducing bacteria and archaea (Acidithiobacillus ferrooxidans, Acidiphilium, Actinobacteria, Acidimicrobiales, Ferroplasma) detected in the bottom layer. Diversity in CN was higher than in NSC. Microorganisms known from AMD systems (Acidiphilium, Acidobacteria and Ferrovum) and microorganisms never reported from AMD systems were identified. Taking into consideration the hydrochemical characteristics of these pit lakes and the spatial distribution of the identified microorganisms, a model explaining their geomicrobiology is advanced.	[Santofimia, Esther; Lopez-Pamo, Enrique] Inst Geol & Minero Espan, Madrid, Spain; [Gonzalez-Toril, Elena; Amils, Ricardo; Aguilera, Angeles] Ctr Astrobiol, Madrid, Spain; [Gomariz, Maria] Univ Alicante, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain; [Amils, Ricardo] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Universitat d'Alacant; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Aguilera, A (corresponding author), Ctr Astrobiol, Madrid, Spain.	aguileraba@cab.inta-csic.es	Gomariz Clemente, María/ABF-5222-2021; Amils, Ricardo/X-2706-2019; Pamo, Enrique Lopez/ABG-9618-2020; santofimia, esther/ABG-5263-2020	santofimia, esther/0000-0003-4236-6812; Gonzalez-Toril, Elena/0000-0002-5750-0765	MINECO-Spain [CGL2011-22540, CGL2009-11059]; IGME 478 Grant; ERC [250-350-IPBSL]	MINECO-Spain(Spanish Government); IGME 478 Grant; ERC(European Research Council (ERC)European Commission)	This work has been supported by grants from the MINECO-Spain (www.mineco.gob.es) (CGL2011-22540 and CGL2009-11059), IGME 478 Grant (www.igme.es) and an ERC project (http://erc.europa.eu) (250-350-IPBSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach L., 1995, P521; Aguilera A, 2007, SYST APPL MICROBIOL, V30, P531, DOI 10.1016/j.syapm.2007.05.003; Aguilera A, 2007, MICROB ECOL, V53, P294, DOI 10.1007/s00248-006-9092-2; Aguilera A, 2006, APPL ENVIRON MICROB, V72, P5325, DOI 10.1128/AEM.00513-06; Bartie C, 2003, WATER RES, V37, P1362, DOI 10.1016/S0043-1354(02)00220-8; Beulker C, 2003, ACTA OECOL, V24, pS25, DOI 10.1016/S1146-609X(03)00002-X; Blodau C, 2006, SCI TOTAL ENVIRON, V369, P307, DOI 10.1016/j.scitotenv.2006.05.004; Boehrer B, 2008, REV GEOPHYS, V46, DOI 10.1029/2006RG000210; Brown JF, 2011, APPL ENVIRON MICROB, V77, P545, DOI 10.1128/AEM.01550-10; CHAO A, 1984, SCAND J STAT, V11, P265; Cid C, 2010, PROTEOMICS, V10, P2026, DOI 10.1002/pmic.200900592; COLLIENNE RH, 1983, LIMNOL OCEANOGR, V28, P83, DOI 10.4319/lo.1983.28.1.0083; Costello EK, 2006, ENVIRON MICROBIOL, V8, P1471, DOI 10.1111/j.1462-2920.2006.01041.x; Coupland K, 2008, FEMS MICROBIOL LETT, V279, P30, DOI 10.1111/j.1574-6968.2007.00998.x; de Andalucia Junta, 1986, MIN AND LIBR BLANC C; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Ercilla MD, 2009, AQUAT GEOCHEM, V15, P391, DOI 10.1007/s10498-008-9044-1; Drewniak L, 2008, ENVIRON POLLUT, V156, P1069, DOI 10.1016/j.envpol.2008.04.019; Ehrlich HL., 2015, GEOMICROBIOL J; Eskandarpour A, 2006, MATER TRANS, V47, P1832, DOI 10.2320/matertrans.47.1832; Espana JS, 2005, APPL GEOCHEM, V20, P1320, DOI 10.1016/j.apgeochem.2005.01.011; Garcia-Moyano A, 2007, SYST APPL MICROBIOL, V30, P601, DOI 10.1016/j.syapm.2007.08.002; Garcia-Moyano A, 2008, HYDROMETALLURGY, V94, P155, DOI 10.1016/j.hydromet.2008.05.046; Garcia-Moyano A, 2012, FEMS MICROBIOL ECOL, V81, P303, DOI 10.1111/j.1574-6941.2012.01346.x; Gonzalez-Toril E, 2003, APPL ENVIRON MICROB, V69, P4853, DOI 10.1128/AEM.69.8.4853-4865.2003; Hao CB, 2010, EXTREMOPHILES, V14, P465, DOI 10.1007/s00792-010-0324-5; Hedrich S, 2011, MICROBIOL-SGM, V157, P1551, DOI 10.1099/mic.0.045344-0; Herzsprung P, 1998, ACTA HYDROCH HYDROB, V26, P253; Hiraishi A, 2001, J GEN APPL MICROBIOL, V47, P161, DOI 10.2323/jgam.47.161; Jameson E, 2010, HYDROMETALLURGY, V104, P488, DOI 10.1016/j.hydromet.2010.03.029; Johnson DB, 2009, ADV MICROB PHYSIOL, V54, P201, DOI 10.1016/S0065-2911(08)00003-9; Johnson DB, 2003, RES MICROBIOL, V154, P466, DOI 10.1016/S0923-2508(03)00114-1; KISHIMOTO N, 1995, FEMS MICROBIOL ECOL, V16, P291, DOI 10.1111/j.1574-6941.1995.tb00293.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lin YB, 2012, J BACTERIOL, V194, P199, DOI 10.1128/JB.06359-11; Lopez-Pamo E, 2009, SERIE MEDIO AMBIENTE, V13, P279; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Malki A, 2006, HYDROMETALLURGY, V83, P223, DOI 10.1016/j.hydromet.2006.03.053; Margesin R, 2001, EXTREMOPHILES, V5, P73, DOI 10.1007/s007920100184; Niehaus F, 1999, APPL MICROBIOL BIOT, V51, P711, DOI 10.1007/s002530051456; Nixdorf B, 2003, ACTA OECOL, V24, pS281, DOI 10.1016/S1146-609X(03)00031-6; Nordstrom DK, 1999, GEOCHEMISTRY OF THE EARTH'S SURFACE, P139; Pellicori DA, 2005, APPL GEOCHEM, V20, P2116, DOI 10.1016/j.apgeochem.2005.07.010; Ramstedt M, 2003, APPL GEOCHEM, V18, P97, DOI 10.1016/S0883-2927(02)00068-9; Rawlings DE, 2007, MICROBIOL-SGM, V153, P315, DOI 10.1099/mic.0.2006/001206-0; Russell NJ, 2000, EXTREMOPHILES, V4, P83, DOI 10.1007/s007920050141; Saez R, 1999, MINER DEPOSITA, V34, P549, DOI 10.1007/s001260050220; Espana JS, 2008, APPL GEOCHEM, V23, P1260, DOI 10.1016/j.apgeochem.2007.12.036; Santofimia E, 2013, J HYDROL, V490, P21, DOI 10.1016/j.jhydrol.2013.03.018; Santofimia E, 2012, J GEOCHEM EXPLOR, V116, P40, DOI 10.1016/j.gexplo.2012.03.004; Santofimia E, 2011, MINERAL MAGAZINE 5, V75, P1796; Schimmele M, 2000, INT VER THEOR ANGEW, V27, P251; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Senko JM, 2008, ISME J, V2, P1134, DOI 10.1038/ismej.2008.60; Sheehan KB, 2005, APPL ENVIRON MICROB, V71, P507, DOI 10.1128/AEM.71.1.507-511.2005; Souza-Egipsy V, 2009, INT MICROBIOL, V11, P251, DOI 10.2436/20.1501.01.69; Sun LN, 2010, BIORESOURCE TECHNOL, V101, P501, DOI 10.1016/j.biortech.2009.08.011; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Tornos F, 2006, ORE GEOL REV, V28, P259, DOI 10.1016/j.oregeorev.2004.12.005; Tuovinen Olli H., 1993, Current Opinion in Biotechnology, V4, P344, DOI 10.1016/0958-1669(93)90106-7; Wendt-Potthoff K, 2012, LIMNOLOGICA, V42, P175, DOI 10.1016/j.limno.2011.10.004; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Zhang HB, 2007, J MICROBIOL, V45, P479	64	60	61	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66746	10.1371/journal.pone.0066746	http://dx.doi.org/10.1371/journal.pone.0066746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840525	Green Published, gold			2022-12-27	WOS:000321424400037
J	Schoppmann, SF; Alidzanovic, L; Schultheis, A; Perkmann, T; Brostjan, C; Birner, P				Schoppmann, Sebastian F.; Alidzanovic, Lejla; Schultheis, Andrea; Perkmann, Thomas; Brostjan, Christine; Birner, Peter			Thrombocytes Correlate with Lymphangiogenesis in Human Esophageal Cancer and Mediate Growth of Lymphatic Endothelial Cells In Vitro	PLOS ONE			English	Article							ACTIVATION RECEPTOR CLEC-2; LYMPHOVASCULAR INVASION; VESSEL INVASION; TUBE FORMATION; HER-2 STATUS; PODOPLANIN; PROGNOSIS; PLATELETS; METASTASIS; EXPRESSION	Recent data provide evidence for an important role of thrombocytes in lymphangiogenesis within human malignant disease. The aim of this study was to investigate the role of thrombocytes in lymphangiogenesis in human esophageal cancer. Perioperative peripheral blood platelet counts (PBPC) were evaluated retrospectively in 320 patients with esophageal cancer, comprising 184 adenocarcinomas (AC), and 136 squamous cell carcinomas (SCC). Data on lymphangiogenesis evaluated by anti-podoplanin immunostaining were available from previous studies, platelets within the tumor tissue were assessed by CD61 immunostaining. For in vitro studies, human lymphatic endothelial cells (LECs) were isolated and co-cultured with peripheral blood platelets. Stromal thrombocytic clusters (STC) were evident in 82 samples (25.6%), and vascular thrombocytic clusters (VTC) in 56 (17.5%). STC and VTC were associated with a significantly higher PBPC at investigation of all cases. The presence of STC was associated with higher lymphatic microvessel density (p<0.001), PBPC and STC were associated with lymphovascular invasion of tumor cells in a regression model. The presence of STCs was associated with shorter DFS of all patients (p = 0.036, Breslow test), and VTC with shorter DFS in in SCC (p = 0.025, Breslow test). In cell culture, LEC proliferation was enhanced by co-culture with human platelets in a dose- and time-dependent manner mediated by the release of PDGF-BB and VEGF-C. Platelets play an important role in lymphangiogenesis and lymphovascular invasion in esophageal cancer, influencing prognosis. So the disruption of signaling pathways between platelets, tumor cells and lymphatic endothelium might be of benefit for patients.	[Schoppmann, Sebastian F.; Alidzanovic, Lejla; Brostjan, Christine] Med Univ Vienna, Dept Surg, Vienna, Austria; [Schultheis, Andrea] Hosp Rudolfsstiftung, Dept Pathol, Vienna, Austria; [Perkmann, Thomas] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Birner, Peter] Med Univ Vienna, Dept Pathol, Vienna, Austria; [Schoppmann, Sebastian F.; Birner, Peter] Med Univ Vienna, Gastroesophageal Unit, Ctr Comprehens Canc, Vienna, Austria	Medical University of Vienna; Rudolfstiftung Hospital; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Birner, P (corresponding author), Med Univ Vienna, Dept Pathol, Vienna, Austria.	peter.birner@meduniwien.ac.at	Schoppmann, Sebastian F./M-5831-2019; Perkmann, Thomas/F-3074-2012; Schoppmann, Sebastian F. F./K-1530-2017	Schoppmann, Sebastian F./0000-0002-1725-7086; Schoppmann, Sebastian F. F./0000-0002-1725-7086; Brostjan, Christine/0000-0003-1462-5397; Perkmann, Thomas/0000-0002-7976-0285				Abe H, 2011, P NATL ACAD SCI USA, V108, P12497, DOI 10.1073/pnas.1109940108; Birner P, 2001, CLIN CANCER RES, V7, P93; Birner P, 2012, CLIN EXP METASTAS, V29, P551, DOI 10.1007/s10585-012-9470-8; Birner P, 2011, ANN SURG ONCOL, V18, P3330, DOI 10.1245/s10434-011-1730-3; Buergy D, 2012, INT J CANCER, V130, P2747, DOI 10.1002/ijc.27441; Carramolino L, 2010, CIRC RES, V106, P1197, DOI 10.1161/CIRCRESAHA.110.218073; Chuang WY, 2009, HISTOL HISTOPATHOL, V24, P1021, DOI 10.14670/HH-24.1021; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Ikeda M, 2002, ANN SURG ONCOL, V9, P287, DOI 10.1245/aso.2002.9.3.287; Kaser A, 2001, BLOOD, V98, P2720, DOI 10.1182/blood.V98.9.2720; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kerjaschki D, 2011, J CLIN INVEST, V121, P2000, DOI 10.1172/JCI44751; Kozlowski M, 2011, FOLIA HISTOCHEM CYTO, V49, P90, DOI 10.5603/FHC.2011.0013; Ling FC, 2010, WORLD J SURG, V34, P2628, DOI 10.1007/s00268-010-0707-x; Lowe KL, 2012, THROMB RES, V129, pS30, DOI 10.1016/S0049-3848(12)70013-0; McQuaid KR, 2011, ALIMENT PHARM THER, V34, P146, DOI 10.1111/j.1365-2036.2011.04709.x; Morita M, 2010, INT J CLIN ONCOL, V15, P126, DOI 10.1007/s10147-010-0056-7; Osada M, 2012, J BIOL CHEM, V287, P22241, DOI 10.1074/jbc.M111.329987; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Pipili-Synetos E, 1998, BRIT J PHARMACOL, V125, P1252, DOI 10.1038/sj.bjp.0702191; Saad RS, 2009, AM J CLIN PATHOL, V131, P92, DOI 10.1309/AJCPKWUQSIPVG90H; Schoppmann SF, 2011, BRIT J SURG, V98, P1408, DOI 10.1002/bjs.7562; Schoppmann SF, 2013, CLIN EXP METASTAS, V30, P441, DOI 10.1007/s10585-012-9549-2; Schoppmann SF, 2013, SURGERY, V153, P526, DOI 10.1016/j.surg.2012.10.007; Schoppmann SF, 2012, CLIN EXP METASTAS, V29, P615, DOI 10.1007/s10585-012-9475-3; Schoppmann SF, 2010, AM J SURG PATHOL, V34, P1868, DOI 10.1097/PAS.0b013e3181f8be17; Schoppmann SF, 2002, ONCOL REP, V9, P455; Schoppmann SF, 2004, ANN SURG, V240, P306, DOI 10.1097/01.sla.0000133355.48672.22; Schoppmann SF, 2013, SURGERY; Suzuki-Inoue K, 2011, J BIOCHEM, V150, P127, DOI 10.1093/jb/mvr079; Tong L, 2012, DIS ESOPHAGUS, V25, P72, DOI 10.1111/j.1442-2050.2011.01211.x; TZANAKAKIS GN, 1993, CANCER, V71, P2466, DOI 10.1002/1097-0142(19930415)71:8<2466::AID-CNCR2820710807>3.0.CO;2-Q; Vial M, 2010, RECENT RESULTS CANC, V182, P1, DOI 10.1007/978-3-540-70579-6_1; Wartiovaara U, 1998, THROMB HAEMOSTASIS, V80, P171, DOI 10.1055/s-0037-1615158	34	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66941	10.1371/journal.pone.0066941	http://dx.doi.org/10.1371/journal.pone.0066941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840559	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400056
J	Speth, C; Brodde, MF; Hagleitner, M; Rambach, G; Van Aken, H; Dierich, M; Kehrel, BE				Speth, Cornelia; Brodde, Martin F.; Hagleitner, Magdalena; Rambach, Guenter; Van Aken, Hugo; Dierich, Manfred; Kehrel, Beate E.			Neutrophils Turn Plasma Proteins into Weapons against HIV-1	PLOS ONE			English	Article							HYPOCHLOROUS ACID; DISULFIDE-ISOMERASE; THIOL/DISULFIDE EXCHANGE; PLASMINOGEN-ACTIVATOR; EXTRACELLULAR TRAPS; ALPHA-DEFENSINS; CORECEPTOR USE; MYELOPEROXIDASE; INFECTION; BINDING	As a consequence of innate immune activation granulocytes and macrophages produce hypochlorite/hypochlorous acid (HOCl) via secretion of myeloperoxidase (MPO) to the outside of the cells, where HOCl immediately reacts with proteins. Most proteins that become altered by this system do not belong to the invading microorganism but to the host. While there is no doubt that the myeloperoxidase system is capable of directly inactivating HIV-1, we hypothesized that it may have an additional indirect mode of action. We show in this article that HOCl is able to chemically alter proteins and thus turn them into Idea-Ps (Idea-P = immune defence-altered protein), potent amyloid-like and SH-groups capturing antiviral weapons against HIV-1. HOCl-altered plasma proteins (Idea-PP) have the capacity to bind efficiently and with high affinity to the HIV-1 envelope protein gp120, and to its receptor CD4 as well as to the protein disulfide isomerase (PDI). Idea-PP was able to inhibit viral infection and replication in a cell culture system as shown by reduced number of infected cells and of syncytia, resulting in reduction of viral capsid protein p24 in the culture supernatant. The unmodified plasma protein fraction had no effect. HOCl-altered isolated proteins antithrombin III and human serum albumin, taken as representative examples of the whole pool of plasma proteins, were both able to exert the same activity of binding to gp120 and inhibition of viral proliferation. These data offer an opportunity to improve the understanding of the intricacies of host-pathogen interactions and allow the generation of the following hypothetical scheme: natural immune defense mechanisms generate by posttranslational modification of plasma proteins a potent virucidal weapon that immobilizes the virus as well as inhibits viral fusion and thus entry into the host cells. Furthermore simulation of this mechanism in vitro might provide an interesting new therapeutic approach against microorganisms.	[Speth, Cornelia; Hagleitner, Magdalena; Rambach, Guenter; Dierich, Manfred] Med Univ Innsbruck, Div Hyg & Med Microbiol, A-6020 Innsbruck, Austria; [Brodde, Martin F.; Van Aken, Hugo; Kehrel, Beate E.] Univ Munster, Univ Klinikum Munster, Klin Anasthesiol Operat Intens Med & Schmerzthera, D-48149 Munster, Germany	Medical University of Innsbruck; University of Munster	Kehrel, BE (corresponding author), Univ Munster, Univ Klinikum Munster, Klin Anasthesiol Operat Intens Med & Schmerzthera, D-48149 Munster, Germany.	kehrel@uni-muenster.de		rambach, gunter/0000-0002-7574-7868; speth, cornelia/0000-0001-5637-5993	Deutsche Forschungsgemein-schaft [SFB 293]	Deutsche Forschungsgemein-schaft(German Research Foundation (DFG))	The work was supported in parts by grants to B. E. K. from the Deutsche Forschungsgemein-schaft by SFB 293. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akong-Moore K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042984; AKRIGG A, 1991, AIDS, V5, P153, DOI 10.1097/00002030-199102000-00004; Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Barbouche R, 2005, MOL PHARMACOL, V67, P1111, DOI 10.1124/mol.104.008276; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Chapman ALP, 2003, BIOCHEM J, V375, P33, DOI 10.1042/BJ20030685; CHASE MJ, 1992, P NATL ACAD SCI USA, V89, P5582, DOI 10.1073/pnas.89.12.5582; CHENGMAYER C, 1988, ANN NEUROL, V23, pS58, DOI 10.1002/ana.410230716; CHOCHOLA J, 1994, ANTIMICROB AGENTS CH, V38, P969, DOI 10.1128/AAC.38.5.969; Conant CG, 2007, CELL MICROBIOL, V9, P222, DOI 10.1111/j.1462-5822.2006.00783.x; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Crombie R, 1998, J EXP MED, V187, P25, DOI 10.1084/jem.187.1.25; Crombie R, 2000, AIDS PATIENT CARE ST, V14, P211, DOI 10.1089/108729100317821; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; ELLIS M, 1988, J INFECT DIS, V158, P1268, DOI 10.1093/infdis/158.6.1268; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Furuhata A, 2002, J BIOL CHEM, V277, P27919, DOI 10.1074/jbc.M202794200; GABRILOVICH D, 1994, SCAND J INFECT DIS, V26, P41, DOI 10.3109/00365549409008589; Gao F, 1998, J VIROL, V72, P5680, DOI 10.1128/JVI.72.7.5680-5698.1998; Gebbink MFBG, 2005, NAT REV MICROBIOL, V3, P333, DOI 10.1038/nrmicro1127; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Hawkins CL, 2005, CHEM RES TOXICOL, V18, P1600, DOI 10.1021/tx050207b; Higazi AAR, 1996, J BIOL CHEM, V271, P17650, DOI 10.1074/jbc.271.30.17650; Honda T, 2009, J VIROL, V83, P12622, DOI 10.1128/JVI.01201-09; Horn M, 2012, J THROMB HAEMOST, V10, P647, DOI 10.1111/j.1538-7836.2012.04640.x; Jain S, 2007, J VIROL, V81, P2328, DOI 10.1128/JVI.01940-06; Jenne CN, 2013, CELL HOST MICROBE, V13, P169, DOI 10.1016/j.chom.2013.01.005; JINDADAMRONGWEC.S, 2010, ARCH VIROL, V149, P915; Karala AR, 2010, FEBS J, V277, P2454, DOI 10.1111/j.1742-4658.2010.07660.x; KEHREL BE, 2002, Patent No. 2002022150; KEHREL BE, 2004, Patent No. 20040047861; KLEBANOFF SJ, 1992, J CLIN INVEST, V89, P2014, DOI 10.1172/JCI115810; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kornbluth RS, 2004, BLOOD, V103, P1567, DOI 10.1182/blood-2003-12-4284; Lacy P, 2008, FRONT BIOSCI-LANDMRK, V13, P5559; Maas C, 2008, AMYLOID, V15, P166, DOI 10.1080/13506120802193498; Mackewicz CE, 2003, AIDS, V17, pF23, DOI 10.1097/00002030-200309260-00001; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; McDonald JF, 2003, BIOCHEMISTRY-US, V42, P10001, DOI 10.1021/bi0341408; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Naguleswaran A, 2005, INT J PARASITOL, V35, P1459, DOI 10.1016/j.ijpara.2005.06.006; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Nieba L, 1996, ANAL BIOCHEM, V234, P155, DOI 10.1006/abio.1996.0067; Parker H, 2012, J LEUKOCYTE BIOL, V91, P369, DOI 10.1189/jlb.0711387; Pattison DI, 2007, BIOCHEMISTRY-US, V46, P9853, DOI 10.1021/bi7008294; Pattison DI, 2009, CHEM RES TOXICOL, V22, P807, DOI 10.1021/tx800372d; PITRAK DL, 1993, J INFECT DIS, V167, P1406, DOI 10.1093/infdis/167.6.1406; POPOVIC M, 1984, SCIENCE, V226, P459, DOI 10.1126/science.6093248; Pullar JM, 2000, IUBMB LIFE, V50, P259, DOI 10.1080/15216540051080958; REEVES EP, 2002, NATURE; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Saitoh T, 2012, CELL HOST MICROBE, V12, P109, DOI 10.1016/j.chom.2012.05.015; SCHULTZ J, 1962, ARCH BIOCHEM BIOPHYS, V96, P465, DOI 10.1016/0003-9861(62)90321-1; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; SEGAL AW, 1983, BIOCHEM J, V210, P215, DOI 10.1042/bj2100215; Simmons G, 2000, IMMUNOL REV, V177, P112, DOI 10.1034/j.1600-065X.2000.17719.x; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Upanan S, 2008, J VIROL METHODS, V151, P325, DOI 10.1016/j.jviromet.2008.05.001; Vasilyev N, 2005, CIRCULATION, V112, P2812, DOI 10.1161/CIRCULATIONAHA.105.542340; WATARAI M, 1995, P NATL ACAD SCI USA, V92, P4927, DOI 10.1073/pnas.92.11.4927; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024	66	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66073	10.1371/journal.pone.0066073	http://dx.doi.org/10.1371/journal.pone.0066073			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840401	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400020
J	Zhang, Y; Chen, MB; Zhou, XY; Hong, XN				Zhang, Yan; Chen, Min-Bin; Zhou, Xiao-Yan; Hong, Xiao-Nan			Lymphotoxin Alpha (LTA) Polymorphism Is Associated with Prognosis of Non-Hodgkin's Lymphoma in a Chinese Population	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; B-CELL LYMPHOMA; RANDOMIZED CONTROLLED-TRIAL; GENETIC POLYMORPHISMS; CHOP CHEMOTHERAPY; ELDERLY-PATIENTS; DES-LYMPHOMES; RITUXIMAB; PATHWAY; RISK	Background: Non-Hodgkin's lymphoma (NHL) has been widely reported to be associated with autoimmune and pro-inflammatory response, and genetic polymorphisms of candidate genes involved in autoimmune and pro-inflammatory response may influence the survival and prognosis of NHL patients. To evaluate the role of such genetic variations in prognosis of NHL, we conducted this study in a Chinese population. Methods: We used the TaqMan assay to genotype six single nucleotide polymorphisms (SNPs) (TNF rs1799964T>C, LTA rs1800683G>A, IL-10 rs1800872T>G, LEP rs2167270G>A, LEPR rs1327118C>G, TNFAIP8 rs1045241C>T) for 215 NHL cases. Kaplan-Meier analysis was performed to compare progression free survival among two common genotypes. Cox proportional hazard models were used to identify independent risk factors. Results: We observed that LTA rs1800683G>A was significantly associated with risk of progression or relapse in NHL patients (HR = 1.63, 95% CI = 1.06-2.51; P = 0.028), particularly in Diffuse large B cell lymphoma (DLBCL) cases (HR = 1.50, 95% CI = 1.10-2.04, P = 0.01). Both univariate and multivariate Cox regression analysis showed that in DLBCL patients, Ann Arbor stage III/IV, elevated LDH level before treatment and LTA rs1800683 AA genotype carrier were independent risk factors for progression or relapse. While in NK/T cell lymphoma, Ann Arbor stage III/IV and elevated beta(2)-MG level before treatment indicated poorer prognosis. Conclusions: The polymorphism of LTA rs1800683G>A contributes to NHL prognosis in a Chinese population. Further large-scale and well-designed studies are needed to confirm these results.	[Zhang, Yan; Chen, Min-Bin] Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Med Oncol, Zhenjiang, Jiangsu, Peoples R China; [Zhou, Xiao-Yan] Fudan Univ, Shanghai Canc Ctr, Canc Res Lab, Shanghai 200433, Peoples R China; [Hong, Xiao-Nan] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China	Jiangsu University; Fudan University; Fudan University	Zhang, Y (corresponding author), Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Med Oncol, Zhenjiang, Jiangsu, Peoples R China.	zy-zl-126@126.com			National Natural Science Foundation of China [30870985]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by a grant from National Natural Science Foundation of China (30870985). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamid T, 2011, J EGYPT NATL CANCER, V23, P17, DOI 10.1016/j.jnci.2011.07.003; Aschebrook-Kilfoy B, 2011, J CANCER SURVIV, V6, P102; AVILES A, 1993, LEUKEMIA LYMPHOMA, V9, P377, DOI 10.3109/10428199309148537; Cabanillas Fernando, 2011, Clin Lymphoma Myeloma Leuk, V11 Suppl 1, pS87, DOI 10.1016/j.clml.2011.03.029; Chae YS, 2010, CANCER CHEMOTH PHARM, V65, P571, DOI 10.1007/s00280-009-1066-x; Chen WL, 2010, ANN HEMATOL, V89, P553, DOI 10.1007/s00277-009-0870-z; Coiffier B, 2010, BLOOD, V116, P2040, DOI 10.1182/blood-2010-03-276246; Fernberg P, 2010, CANCER CAUSE CONTROL, V21, P759, DOI 10.1007/s10552-010-9504-y; Feugier P, 2005, J CLIN ONCOL, V23, P4117, DOI 10.1200/JCO.2005.09.131; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Jost PJ, 2007, BLOOD, V109, P2700, DOI 10.1182/blood-2006-07-025809; Kuppers R, 2004, NEW ENGL J MED, V351, P2152, DOI 10.1056/NEJMp048257; Lan Q, 2006, BLOOD, V107, P4101, DOI 10.1182/blood-2005-10-4160; Lan Q, 2011, BRIT J HAEMATOL, V153, P341, DOI 10.1111/j.1365-2141.2010.08424.x; Lech-Maranda E, 2004, BLOOD, V103, P3529, DOI 10.1182/blood-2003-06-1850; Luminari S, 2007, HEMATOL ONCOL, V25, P189, DOI 10.1002/hon.826; Nogai H, 2011, J CLIN ONCOL, V29, P1803, DOI 10.1200/JCO.2010.33.3252; Pfreundschuh M, 2008, LANCET ONCOL, V9, P105, DOI 10.1016/S1470-2045(08)70002-0; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Purdue MP, 2007, CARCINOGENESIS, V28, P704, DOI 10.1093/carcin/bgl200; Seidemann K, 2005, J CLIN ONCOL, V23, P8414, DOI 10.1200/JCO.2005.01.2179; Seki R, 2010, INT J HEMATOL, V91, P258, DOI 10.1007/s12185-009-0475-2; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Skibola CF, 2010, AM J EPIDEMIOL, V171, P267, DOI 10.1093/aje/kwp383; Swerdlow SH, 2008, WHO CLASSIFICATION T; Warzocha K, 1998, BLOOD, V91, P3574; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037846	27	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66411	10.1371/journal.pone.0066411	http://dx.doi.org/10.1371/journal.pone.0066411			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840460	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800058
J	Zhang, ZH; Sun, J; Hao, LH; Liu, CQ; Ma, HY; Jia, L				Zhang, Zhaohai; Sun, Jie; Hao, Lihong; Liu, Chunqing; Ma, Hongye; Jia, Li			Modification of Glycosylation Mediates the Invasive Properties of Murine Hepatocarcinoma Cell Lines to Lymph Nodes	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSIONS; N-GLYCAN STRUCTURE; ADHESIVE CAPABILITY; MASS-SPECTROMETRY; GASTRIC-CANCER; SIALYLTRANSFERASES; METASTASIS; CD147; IDENTIFICATION; GLYCOBIOLOGY	Among the various posttranslational modification reactions, glycosylation is the most common, and nearly 50% of all known proteins are thought to be glycosylated. In fact, changes in glycosylation readily occur in carcinogenesis, invasion and metastasis. This report investigated the modification of glycosylation mediated the invasive properties of Hca-F and Hca-P murine hepatocarcinoma cell lines, which have high, low metastatic potential in the lymph nodes, respectively. Analysis revealed that the N-glycan composition profiling, expression of glycogenes and lectin binding profiling were different in Hca-F cells, as compared to those in Hca-P cells. Further analysis of the N-glycan regulation by tunicamycin (TM) application or PNGase F treatment in Hca-F cells showed partial inhibition of N-glycan glycosylation and decreased invasion both in vitro and in vivo. We targeted glycogene ST6GAL1, which was expressed differently in Hca-F and Hca-P cells, and regulated the expression of ST6GAL1. The altered levels of ST6GAL1 were also responsible for changed invasive properties of Hca-F and Hca-P cells both in vitro and in vivo. These findings indicate a role for glycosylation modification as a mediator of tumor lymphatic metastasis, with its altered expression causing an invasive ability differentially.	[Zhang, Zhaohai; Sun, Jie; Liu, Chunqing; Ma, Hongye; Jia, Li] Dalian Med Univ, Coll Lab Med, Dept Basic Lab Med, Dalian, Liaoning Provin, Peoples R China; [Sun, Jie] Liaoning Int Travel Hlth Care Ctr, Dalian, Liaoning Provin, Peoples R China; [Hao, Lihong] Dalian Med Univ, Dept Histol & Embryol, Dalian, Liaoning Provin, Peoples R China	Dalian Medical University; Dalian Medical University	Jia, L (corresponding author), Dalian Med Univ, Coll Lab Med, Dept Basic Lab Med, Dalian, Liaoning Provin, Peoples R China.	jiali@dlmedu.edu.cn	Jia, li/GPW-8015-2022; li, jia/GVT-7587-2022		National Natural Science Foundation of China [81071415, 81271910]; Program for Liaoning Excellent Talents in University [LR2011025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Liaoning Excellent Talents in University	This work was supported by grants from National Natural Science Foundation of China (81071415, 81271910), and supported by Program for Liaoning Excellent Talents in University (LR2011025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balog CIA, 2012, MOL CELL PROTEOMICS, V11, P571, DOI 10.1074/mcp.M111.011601; Calle Y, 2000, CHEMOTHERAPY, V46, P408, DOI 10.1159/000007322; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Costello CE, 2007, J AM SOC MASS SPECTR, V18, P1799, DOI 10.1016/j.jasms.2007.07.016; de Leoz MLA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002717; Dell A, 2001, SCIENCE, V291, P2351, DOI 10.1126/science.1058890; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; DWEK RA, 1995, BIOCHEM SOC T, V23, P1; GESSNER P, 1993, CANCER LETT, V75, P143, DOI 10.1016/0304-3835(93)90056-F; Goldman R, 2009, CLIN CANCER RES, V15, P1808, DOI 10.1158/1078-0432.CCR-07-5261; Granovsky M, 2000, NAT MED, V6, P306; Guo HB, 2001, J CANCER RES CLIN, V127, P231, DOI 10.1007/s004320000186; Guo R, 2013, INT J BIOCHEM CELL B, V45, P347, DOI 10.1016/j.biocel.2012.10.006; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Harvey DJ, 2005, EXPERT REV PROTEOMIC, V2, P87, DOI 10.1586/14789450.2.1.87; Hirabayashi J, 2004, GLYCOCONJUGATE J, V21, P35, DOI 10.1023/B:GLYC.0000043745.18988.a1; Hou L, 2001, WORLD J GASTROENTERO, V7, P532; Jia L, 2006, INT J BIOCHEM CELL B, V38, P1584, DOI 10.1016/j.biocel.2006.03.019; Jia L, 2006, IUBMB LIFE, V58, P209, DOI 10.1080/15216540600719580; Kaneko Y, 1996, ACTA NEUROPATHOL, V91, P284, DOI 10.1007/s004010050427; Kim E. H., 2011, INT J PROTEOMICS, V2011, DOI DOI 10.1155/2011/601937; Li HF, 1998, ONCOL RES, V10, P569; Li J, 2012, MED ONCOL, V29, P84, DOI 10.1007/s12032-010-9771-1; Lin SQ, 2002, EXP CELL RES, V276, P101, DOI 10.1006/excr.2002.5521; Mehta A, 2012, CANCER EPIDEM BIOMAR, V21, P925, DOI 10.1158/1055-9965.EPI-11-1183; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Recchi MA, 1998, GLYCOCONJUGATE J, V15, P19, DOI 10.1023/A:1006983214918; Ruhaak LR, 2013, MOL CELL PROTEOMICS, V12, P846, DOI 10.1074/mcp.R112.026799; Sakuma K, 2006, BIOCHEM BIOPH RES CO, V340, P829, DOI 10.1016/j.bbrc.2005.12.072; Saxon E, 2001, ANNU REV CELL DEV BI, V17, P1, DOI 10.1146/annurev.cellbio.17.1.1; SKACEL PO, 1991, BLOOD, V78, P1452; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Taniguchi N, 2001, PROTEOMICS, V1, P239; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Venable A, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-15; Viseux N, 1999, J MASS SPECTROM, V34, P364, DOI 10.1002/(SICI)1096-9888(199904)34:4<364::AID-JMS787>3.0.CO;2-P; Wang PH, 2005, GYNECOL ONCOL, V99, P631, DOI 10.1016/j.ygyno.2005.07.016; Yu SJ, 2012, BIOCHEM BIOPH RES CO, V427, P506, DOI 10.1016/j.bbrc.2012.09.086; Zaia J, 2004, MASS SPECTROM REV, V23, P161, DOI 10.1002/mas.10073; Zhang MH, 2013, ANAT REC, V296, P590, DOI 10.1002/ar.22642; Zhu YT, 2001, BBA-MOL BASIS DIS, V1536, P148, DOI 10.1016/S0925-4439(01)00044-8	44	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65218	10.1371/journal.pone.0065218	http://dx.doi.org/10.1371/journal.pone.0065218			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840320	gold, Green Published			2022-12-27	WOS:000322342800009
J	Kassam, KS; Markey, AR; Cherkassky, VL; Loewenstein, G; Just, MA				Kassam, Karim S.; Markey, Amanda R.; Cherkassky, Vladimir L.; Loewenstein, George; Just, Marcel Adam			Identifying Emotions on the Basis of Neural Activation	PLOS ONE			English	Article							FUNCTIONAL NEUROANATOMY; BRAIN; METAANALYSIS; AMYGDALA; ANGER; REPRESENTATION; RECOGNITION; SPECIFICITY; VALENCE; CORTEX	We attempt to determine the discriminability and organization of neural activation corresponding to the experience of specific emotions. Method actors were asked to self-induce nine emotional states (anger, disgust, envy, fear, happiness, lust, pride, sadness, and shame) while in an fMRI scanner. Using a Gaussian Naive Bayes pooled variance classifier, we demonstrate the ability to identify specific emotions experienced by an individual at well over chance accuracy on the basis of: 1) neural activation of the same individual in other trials, 2) neural activation of other individuals who experienced similar trials, and 3) neural activation of the same individual to a qualitatively different type of emotion induction. Factor analysis identified valence, arousal, sociality, and lust as dimensions underlying the activation patterns. These results suggest a structure for neural representations of emotion and inform theories of emotional processing.	[Kassam, Karim S.; Markey, Amanda R.; Loewenstein, George] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Cherkassky, Vladimir L.; Just, Marcel Adam] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University	Kassam, KS (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA.	kskassam@cmu.edu	Loewenstein, George/G-7616-2014	Loewenstein, George/0000-0003-2790-0474; Just, Marcel/0000-0003-1245-3050	National Institute of Mental Health [MH029617]; Carnegie Mellon University; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH029617] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Carnegie Mellon University; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded through a National Institute of Mental Health grant to M. A. J. (MH029617), and a faculty research grant from Carnegie Mellon University to G. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Anders S, 2004, HUM BRAIN MAPP, V23, P200, DOI 10.1002/hbm.20048; Barrett LF, 1999, CURR DIR PSYCHOL SCI, V8, P10, DOI 10.1111/1467-8721.00003; Barrett LF, 2006, PERSPECT PSYCHOL SCI, V1, P28, DOI 10.1111/j.1745-6916.2006.00003.x; Baucom LB, 2012, NEUROIMAGE, V59, P718, DOI 10.1016/j.neuroimage.2011.07.037; Beauregard M, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-18-j0001.2001; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; Britton JC, 2006, NEUROIMAGE, V31, P397, DOI 10.1016/j.neuroimage.2005.11.027; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Clore GL, 2007, TRENDS COGN SCI, V11, P393, DOI 10.1016/j.tics.2007.08.005; Cosmides L, 2004, HDB EMOTIONS; Damarla SR, 2013, HUM BRAIN M IN PRESS; Damasio A.R., 2005, DESCARTES ERROR EMOT; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; Frijda N.H., 1994, EMOTION CULTURE EMPI, P51, DOI [10.1037/10152-002, DOI 10.1037/10152-002]; Hand DJ, 2001, INT STAT REV, V69, P385, DOI 10.1111/j.1751-5823.2001.tb00465.x; Harmon-Jones E, 2003, PSYCHOPHYSIOLOGY, V40, P838, DOI 10.1111/1469-8986.00121; Harmon-Jones E, 2009, EMOTION, V9, P183, DOI 10.1037/a0014959; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Izard CE, 2007, PERSPECT PSYCHOL SCI, V2, P260, DOI [10.1111/j.1745-6916.2007.00044.x, 10.1111/j.1745-6916.2007.00053.x]; Jimura K, 2012, NEUROPSYCHOLOGIA, V50, P544, DOI 10.1016/j.neuropsychologia.2011.11.007; Just MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008622; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Keltner D, 1998, REV GEN PSYCHOL, V2, P320, DOI [10.1037/1089-2680.2.3.320, DOI 10.1037/1089-2680.2.3.320]; Kober H, 2008, NEUROIMAGE, V42, P998, DOI 10.1016/j.neuroimage.2008.03.059; Kolodyazhniy V, 2011, PSYCHOPHYSIOLOGY, V48, P908, DOI 10.1111/j.1469-8986.2010.01170.x; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lang PJ, 1995, INT AFFECTIVE PICTUR; Larsen J.T., 2008, HDB EMOTIONS, P180, DOI DOI 10.1249/00005768-200405001-00432; Leary M.R., 2000, FEELING THINKING ROL; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lerner JS, 2006, J BEHAV DECIS MAKING, V19, P115, DOI 10.1002/bdm.515; Lerner JS, 2001, J PERS SOC PSYCHOL, V81, P146, DOI 10.1037//0022-3514.81.1.146; Levenson RW, 2003, SER AFFECTIVE SCI, P212; Lindquist KA, 2012, TRENDS COGN SCI, V16, P533, DOI 10.1016/j.tics.2012.09.005; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Loewenstein G, 2007, SOC SCI INFORM, V46, P405, DOI 10.1177/05390184070460030106; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; Mitchell JP, 2008, CURR DIR PSYCHOL SCI, V17, P142, DOI 10.1111/j.1467-8721.2008.00564.x; Mitchell T.M, 1997, MACH LEARN; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Mouras H, 2003, NEUROIMAGE, V20, P855, DOI 10.1016/S1053-8119(03)00408-7; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Nielen MMA, 2009, BRAIN COGNITION, V71, P387, DOI 10.1016/j.bandc.2009.05.007; Overskeid G., 2000, REV GEN PSYCHOL, V4, P284; Panksepp J., 1998, AFFECTIVE NEUROSCIEN; Panksepp J, 2007, PERSPECT PSYCHOL SCI, V2, P281, DOI 10.1111/j.1745-6916.2007.00045.x; Peelen MV, 2010, J NEUROSCI, V30, P10127, DOI 10.1523/JNEUROSCI.2161-10.2010; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phelps EA, 2006, PSYCHOL SCI, V17, P292, DOI 10.1111/j.1467-9280.2006.01701.x; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Robinson MD, 2002, PSYCHOL BULL, V128, P934, DOI 10.1037//0033-2909.128.6.934; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; RUSSELL JA, 1995, PSYCHOL BULL, V118, P379, DOI 10.1037/0033-2909.118.3.379; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Said CP, 2010, J VISION, V10, DOI 10.1167/10.5.11; Scarantino A, 2011, EMOT REV, V3, P444, DOI 10.1177/1754073911410745; Scott SK, 1997, NATURE, V385, P254, DOI 10.1038/385254a0; Stemmler G, 2003, SER AFFECTIVE SCI, P131; Vytal K, 2010, J COGNITIVE NEUROSCI, V22, P2864, DOI 10.1162/jocn.2009.21366; Wager TD, 2003, NEUROIMAGE, V19, P513, DOI 10.1016/S1053-8119(03)00078-8; WATSON D, 1985, PSYCHOL BULL, V98, P219, DOI 10.1037/0033-2909.98.2.219; Winkielman P, 2004, CURR DIR PSYCHOL SCI, V13, P120, DOI 10.1111/j.0963-7214.2004.00288.x	71	134	135	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66032	10.1371/journal.pone.0066032	http://dx.doi.org/10.1371/journal.pone.0066032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190ST	23840392	gold, Green Published			2022-12-27	WOS:000322361200050
J	Musa, N; Andersson, K; Burman, J; Andersson, F; Hedenstrom, E; Jansson, N; Paltto, H; Westerberg, L; Winde, I; Larsson, MC; Bergman, KO; Milberg, P				Musa, Najihah; Andersson, Klas; Burman, Joseph; Andersson, Fredrik; Hedenstrom, Erik; Jansson, Nicklas; Paltto, Heidi; Westerberg, Lars; Winde, Inis; Larsson, Mattias C.; Bergman, Karl-Olof; Milberg, Per			Using Sex Pheromone and a Multi-Scale Approach to Predict the Distribution of a Rare Saproxylic Beetle	PLOS ONE			English	Article							OSMODERMA-EREMITA SCOP.; ELATER-FERRUGINEUS; KAIROMONE SYSTEM; TREE HOLLOWS; CONSERVATION; COLEOPTERA; SIZE; SCARABAEIDAE; HABITAT; SCALES	The European red click beetle, Elater ferrugineus L., is associated with wood mould in old hollow deciduous trees. As a result of severe habitat fragmentation caused by human disturbance, it is threatened throughout its distribution range. A new pheromone-based survey method, which is very efficient in detecting the species, was used in the present study to relate the occurrence of E. ferrugineus to the density of deciduous trees. The latter data were from a recently completed regional survey in SE Sweden recording >120,000 deciduous trees. The occurrence of E. ferrugineus increased with increasing amount of large hollow and large non-hollow trees in the surrounding landscape. Quercus robur (oak) was found to be the most important substrate for E. ferrugineus, whereas two groups of tree species (Carpinus betulus, Fagus sylvatica, Ulmus glabra, vs. Acer platanoides, Aesculus hippocastanum, Fraxinus excelsior, Tilia cordata) were less important but may be a complement to oak in sustaining populations of the beetle. The occurrence of E. ferrugineus was explained by the density of oaks at two different spatial scales, within the circle radii 327 m and 4658 m. In conclusion, priority should be given to oaks in conservation management of E. ferrugineus, and then to the deciduous trees in the genera listed above. Conservation planning at large spatial and temporal scales appears to be essential for long-term persistence of E. ferrugineus. We also show that occurrence models based on strategic sampling might result in pessimistic predictions. This study demonstrates how pheromone-based monitoring make insects excellent tools for sustained feedback to models for landscape conservation management.	[Musa, Najihah; Jansson, Nicklas; Paltto, Heidi; Westerberg, Lars; Bergman, Karl-Olof; Milberg, Per] Linkoping Univ, IFM Biol, Conservat Ecol Grp, Linkoping, Sweden; [Andersson, Klas; Burman, Joseph; Winde, Inis; Larsson, Mattias C.] Swedish Univ Agr Sci, Dept Plant Protect Biol, Alnarp, Sweden; [Andersson, Fredrik; Hedenstrom, Erik] Mid Sweden Univ, Dept Appl Sci & Design, Sundsvall, Sweden	Linkoping University; Swedish University of Agricultural Sciences; Mid-Sweden University	Bergman, KO (corresponding author), Linkoping Univ, IFM Biol, Conservat Ecol Grp, Linkoping, Sweden.	karbe@ifm.liu.se	Westerberg, Lars/AAE-5366-2019; Larsson, Mattias C/E-4791-2014; Milberg, Per/G-6153-2012	Westerberg, Lars/0000-0001-9820-3460; Milberg, Per/0000-0001-6128-1051	Marie-Claire Cronstedts Stiftelse; Wala & Folke Danielssons fond; Stiftelsen Eklandskapet i Linkopings Kommun; Skogssallskapet; European Regional Development Fund; County Administrative Board of Vasternorrland; Linnaeus initiative grant from FORMAS (The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning) [217-2006-1750]	Marie-Claire Cronstedts Stiftelse; Wala & Folke Danielssons fond; Stiftelsen Eklandskapet i Linkopings Kommun; Skogssallskapet; European Regional Development Fund(European Commission); County Administrative Board of Vasternorrland; Linnaeus initiative grant from FORMAS (The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)	Sources of funding: Marie-Claire Cronstedts Stiftelse (PM), Wala & Folke Danielssons fond (NM, Stiftelsen Oscar & Lili Lamms minne (NM)(http://www.stiftelsenlamm.a.se/), Stiftelsen Eklandskapet i Linkopings Kommun (ML) (http://www.eklandskapet.nu/index2.html), Skogssallskapet (ML) (http://www.skogssallskapet.se/) the European Regional Development Fund and the County Administrative Board of Vasternorrland (EH) http://www.lansstyrelsen.se/vasternorrland/En/Pages/default.aspx. Linnaeus initiative grant (# 217-2006-1750) to IC-E3 (Insect Chemical Ecology, Ethology and Evolution) from FORMAS (The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning) (ML). http://www.formas.se/en/. The funds without URLs have no websites or specific websites for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A. A., 1966, ENTOMOLOGISTS RECORD, V78, P14; Artdatabanken, 2013, SPEC FACT SHEET EL F; Bergman KO, 2012, FOREST ECOL MANAG, V265, P133, DOI 10.1016/j.foreco.2011.10.030; Branton M, 2011, CONSERV BIOL, V25, P9, DOI 10.1111/j.1523-1739.2010.01606.x; Claesson K., 2009, SKYDDSVARDA TRAD OST; Dennis RLH, 2000, J INSECT CONSERV, V4, P73, DOI 10.1023/A:1009690919835; Driscoll DA, 2010, AUSTRAL ECOL, V35, P13, DOI 10.1111/j.1442-9993.2009.02007.x; Dubois GF, 2009, LANDSCAPE URBAN PLAN, V91, P152, DOI 10.1016/j.landurbplan.2008.12.009; ESRI, 2011, ARCGIS DESKT REL 10; Flate P. O., 2009, Forest & Landscape Working Papers, P65; Gardenfors U., 2010, RED LIST SWEDISH SPE; GBIF, 2012, EL FERR; HANNAH L, 1995, BIODIVERS CONSERV, V4, P128, DOI 10.1007/BF00137781; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; Holland JD, 2004, BIOSCIENCE, V54, P227, DOI 10.1641/0006-3568(2004)054[0227:DTSSOS]2.0.CO;2; Horion A., 1953, FAUNISTIK MITTELEURO; Jackson HB, 2012, LANDSCAPE ECOL, V27, P929, DOI 10.1007/s10980-012-9757-9; Jansson N, 2009, THESIS LINKOPING U; Jansson N, 2009, BIODIVERS CONSERV, V18, P3891, DOI 10.1007/s10531-009-9687-2; Jansson N, 2009, J INSECT CONSERV, V13, P399, DOI 10.1007/s10841-008-9187-9; Jonsell M, 1998, BIODIVERS CONSERV, V7, P749, DOI 10.1023/A:1008888319031; Larsson MC, 2011, J INSECT CONSERV, V15, P891, DOI 10.1007/s10841-011-9388-5; Larsson MC, 2009, CONSERV BIOL, V23, P1516, DOI 10.1111/j.1523-1739.2009.01263.x; Larsson MC, 2003, J CHEM ECOL, V29, P575, DOI 10.1023/A:1022850704500; Lindenmayer DB, 2000, BIODIVERS CONSERV, V9, P15, DOI 10.1023/A:1008943713765; Lobo Jorge M., 2008, Biodiversity Informatics, V5, P14; Merzijevskis Aleksandras, 2010, Acta Zoologica Lituanica, V20, P242, DOI 10.2478/v10043-010-0036-1; Nilsson Sven G., 1994, Entomologisk Tidskrift, V115, P81; Oleksa A, 2007, POL J ECOL, V55, P315; Palm T, 1959, OPUSCULA ENTOMOLOG S, V16; Paltto H, 2006, BIOL CONSERV, V133, P442, DOI 10.1016/j.biocon.2006.07.006; Paltto H, 2010, CONSERV BIOL, V24, P758, DOI 10.1111/j.1523-1739.2009.01423.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Ranius T, 2002, BIODIVERS CONSERV, V11, P1759, DOI 10.1023/A:1020343030085; Ranius T, 2002, BIOL CONSERV, V103, P85, DOI 10.1016/S0006-3207(01)00124-0; Ranius T, 2000, BIOL CONSERV, V95, P85, DOI 10.1016/S0006-3207(00)00007-0; Ranius T, 2009, FOREST ECOL MANAG, V257, P303, DOI 10.1016/j.foreco.2008.09.007; Ranius T, 1997, J INSECT CONSERV, V1, P193, DOI 10.1023/A:1018416000766; Ranius T, 2011, BIODIVERS CONSERV, V20, P2027, DOI 10.1007/s10531-011-0072-6; StatSoft Inc, 2012, STATISTICA; Svensson GP, 2008, J CHEM ECOL, V34, P189, DOI 10.1007/s10886-007-9423-x; Svensson GP, 2012, J INSECT CONSERV, V16, P549, DOI 10.1007/s10841-011-9440-5; Svensson GP, 2004, J CHEM ECOL, V30, P353, DOI 10.1023/B:JOEC.0000017982.51642.8c; Tolasch T, 2007, J CHEM ECOL, V33, P2156, DOI 10.1007/s10886-007-9365-3; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x	45	28	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66149	10.1371/journal.pone.0066149	http://dx.doi.org/10.1371/journal.pone.0066149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840415	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200057
J	Okuyama, J; Nakajima, K; Noda, T; Kimura, S; Kamihata, H; Kobayashi, M; Arai, N; Kagawa, S; Kawabata, Y; Yamada, H				Okuyama, Junichi; Nakajima, Kana; Noda, Takuji; Kimura, Satoko; Kamihata, Hiroko; Kobayashi, Masato; Arai, Nobuaki; Kagawa, Shiro; Kawabata, Yuuki; Yamada, Hideaki			Ethogram of Immature Green Turtles: Behavioral Strategies for Somatic Growth in Large Marine Herbivores	PLOS ONE			English	Article							CHELONIA-MYDAS; HOME-RANGE; SEA-TURTLES; ACCELERATION DATA; DIVING BEHAVIOR; HABITAT USE; MOVEMENT; PATTERNS; DEPTH; INSIGHTS	Animals are assumed to obtain/conserve energy effectively to maximise their fitness, which manifests itself in a variety of behavioral strategies. For marine animals, however, these behavioral strategies are generally unknown due to the lack of high-resolution monitoring techniques in marine habitats. As large marine herbivores, immature green turtles do not need to allocate energy to reproduction but are at risk of shark predation, although it is a rare occurrence. They are therefore assumed to select/use feeding and resting sites that maximise their fitness in terms of somatic growth, while avoiding predation. We investigated fine-scale behavioral patterns (feeding, resting and other behaviors), microhabitat use and time spent on each behavior for eight immature green turtles using data loggers including: depth, global positioning system, head acceleration, speed and video sensors. Immature green turtles at Iriomote Island, Japan, spent an average of 4.8 h feeding on seagrass each day, with two peaks, between 5: 00 and 9: 00, and between 17: 00 and 20: 00. This feeding pattern appeared to be restricted by gut capacity, and thus maximised energy acquisition. Meanwhile, most of the remaining time was spent resting at locations close to feeding grounds, which allowed turtles to conserve energy spent travelling and reduced the duration of periods exposed to predation. These behavioral patterns and time allocations allow immature green turtles to effectively obtain/conserve energy for growth, thus maximising their fitness.	[Okuyama, Junichi; Nakajima, Kana; Noda, Takuji; Kimura, Satoko; Kamihata, Hiroko; Arai, Nobuaki; Kawabata, Yuuki] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan; [Okuyama, Junichi] NOAA, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA USA; [Kimura, Satoko] Nagoya Univ, Grad Sch Environm Studies, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kobayashi, Masato; Yamada, Hideaki] Fisheries Res Agcy, Res Ctr Subtrop Fisheries, Seikai Natl Fisheries Res Inst, Ishigaki, Okinawa, Japan; [Arai, Nobuaki] Kyoto Univ, Grad Sch Agr, Sakyo Ku, Kyoto, Japan; [Kagawa, Shiro] NHK Enterprises Inc, Nat Program, Shibuya Ku, Tokyo, Japan; [Kagawa, Shiro] NHK Enterprises Inc, Sci Program, Shibuya Ku, Tokyo, Japan; [Kawabata, Yuuki] Nagasaki Univ, Inst East China Sea Res, Nagasaki 852, Japan	Kyoto University; National Oceanic Atmospheric Admin (NOAA) - USA; Nagoya University; Japan Fisheries Research & Education Agency (FRA); Kyoto University; NHK Japan Broadcasting Corp; NHK Japan Broadcasting Corp; Nagasaki University	Okuyama, J (corresponding author), Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan.	okuyamajunichi@gmail.com	Kawabata, Yuuki/H-4109-2019; Noda, Takuji/W-1420-2019	Okuyama, Junichi/0000-0002-9993-6030	Espec; Sumitomo Foundation; Kyoto University Global COE Program: Informatics Education and Research Center for Knowledge-Circulation Society;  [22710236]	Espec; Sumitomo Foundation; Kyoto University Global COE Program: Informatics Education and Research Center for Knowledge-Circulation Society(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This study was partly supported by the Espec and Sumitomo Foundation, a Grant-in-Aid for JSPS Young Scientists B (JO No. 22710236) and the Kyoto University Global COE Program: Informatics Education and Research Center for Knowledge-Circulation Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Balazs GH, 1987, NMFSSWFC71 NOAA US D; Batschelet E, 1981, CIRCULAR STAT BIOL; Biodiversity center of Japan, 2008, REP EC SURV NER WAT; Bjorndal KA, 2000, ECOL APPL, V10, P269, DOI 10.2307/2641001; Bjorndal KA, 2003, MAR ECOL PROG SER, V252, P273, DOI 10.3354/meps252273; BJORNDAL KA, 1985, COPEIA, P736, DOI 10.2307/1444767; BJORNDAL KA, 1980, MAR BIOL, V56, P147, DOI 10.1007/BF00397131; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Burkholder DA, 2011, MAR ECOL PROG SER, V439, P277, DOI 10.3354/meps09313; CACERES CW, 1994, OECOLOGIA, V99, P118, DOI 10.1007/BF00317091; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chilvers BL, 2004, J EXP MAR BIOL ECOL, V304, P203, DOI 10.1016/j.jembe.2003.12.010; Davies NB, 2012, INTRO BEHAV ECOLOGY; FORD RG, 1983, AM ZOOL, V23, P315; Fossette S, 2012, FUNCT ECOL, V26, P324, DOI 10.1111/j.1365-2435.2011.01960.x; Godley BJ, 2003, MAR ECOL PROG SER, V253, P279, DOI 10.3354/meps253279; Hamabata Tomoko, 2009, Bulletin of the Graduate School of Social and Cultural Studies Kyushu University, V15, P35; Hays GC, 2004, ECOLOGY, V85, P1137, DOI 10.1890/03-0251; Hays GC, 2002, MAR BIOL, V141, P985, DOI 10.1007/s00227-002-0885-7; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Heithaus MR, 2002, J MAR BIOL ASSOC UK, V82, P1049, DOI 10.1017/S0025315402006689; Hochscheid S, 2007, COMP BIOCHEM PHYS A, V148, P360, DOI 10.1016/j.cbpa.2007.05.010; Houghton JDR, 2002, MAR ECOL PROG SER, V227, P63, DOI 10.3354/meps227063; Houghton JDR, 2008, J EXP MAR BIOL ECOL, V356, P115, DOI 10.1016/j.jembe.2007.12.008; Jones D.R, 2011, NOAANMFSSWFSC480; Lemons G, 2011, J EXP MAR BIOL ECOL, V405, P25, DOI 10.1016/j.jembe.2011.05.012; LOBEL PS, 1981, MAR BIOL, V64, P173, DOI 10.1007/BF00397106; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MacDonald BD, 2013, J EXP MAR BIOL ECOL, V443, P56, DOI 10.1016/j.jembe.2013.02.033; MacDonald BD, 2012, MAR ECOL PROG SER, V461, P211, DOI 10.3354/meps09820; Makowski C, 2006, MAR BIOL, V148, P1167, DOI 10.1007/s00227-005-0150-y; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; MENDONCA MT, 1983, COPEIA, P1013, DOI 10.2307/1445104; Ministry of the environment government of Japan, 2006, SURV REP COR POP DYN; Ministry of the environment government of Japan, 2004, COR REEFS JAP; Mortimer Jeanne A., 1995, P103; NAGY KA, 1984, PHYSIOL ZOOL, V57, P281, DOI 10.1086/physzool.57.3.30163716; Newman Jonathan, 2007, P175; Nishizawa Hideaki, 2011, Endangered Species Research, V14, P141, DOI 10.3354/esr00355; OGDEN JC, 1983, J EXP MAR BIOL ECOL, V66, P199, DOI 10.1016/0022-0981(83)90160-0; Okuyama Junichi, 2010, Endangered Species Research, V10, P39, DOI 10.3354/esr00215; R Development Core Team, 2012, R LANG ENV STAT COMP; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Schofield G, 2010, BIOL CONSERV, V143, P722, DOI 10.1016/j.biocon.2009.12.011; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Seminoff JA, 2002, MAR ECOL PROG SER, V242, P253, DOI 10.3354/meps242253; Seminoff JA, 2006, MAR ECOL PROG SER, V322, P269, DOI 10.3354/meps322269; Sheppard JK, 2010, MAR MAMMAL SCI, V26, P855, DOI 10.1111/j.1748-7692.2010.00374.x; Siegel JM, 2005, NATURE, V437, P1264, DOI 10.1038/nature04285; Stearns S.C., 1992, pi; Swimmer Y, 2005, MAR ECOL PROG SER, V295, P273, DOI 10.3354/meps295273; Tanaka H, 2001, J EXP BIOL, V204, P3895; Taquet C, 2006, MAR ECOL PROG SER, V306, P295, DOI 10.3354/meps306295; Valentine JF, 1999, MAR ECOL PROG SER, V176, P291, DOI 10.3354/meps176291; van Gils JA, 2003, AM NAT, V161, P777, DOI 10.1086/374205; Watson KP, 1998, J EXP BIOL, V201, P2497; WESTOBY M, 1974, AM NAT, V108, P290, DOI 10.1086/282908; WILLIAMS SL, 1988, MAR BIOL, V98, P447, DOI 10.1007/BF00391121; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Yamamoto T, 1995, ANN REP OKINAWA PREF, V57, P227	63	18	19	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65783	10.1371/journal.pone.0065783	http://dx.doi.org/10.1371/journal.pone.0065783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840367	gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200034
J	Teh, LSL; Teh, LCL; Sumaila, UR				Teh, Louise S. L.; Teh, Lydia C. L.; Sumaila, U. Rashid			A Global Estimate of the Number of Coral Reef Fishers	PLOS ONE			English	Article							CLIMATE-CHANGE; CONSERVATION; MANAGEMENT; IMPACTS; BIOMASS; SABAH	Overfishing threatens coral reefs worldwide, yet there is no reliable estimate on the number of reef fishers globally. We address this data gap by quantifying the number of reef fishers on a global scale, using two approaches - the first estimates reef fishers as a proportion of the total number of marine fishers in a country, based on the ratio of reef-related to total marine fish landed values. The second estimates reef fishers as a function of coral reef area, rural coastal population, and fishing pressure. In total, we find that there are 6 million reef fishers in 99 reef countries and territories worldwide, of which at least 25% are reef gleaners. Our estimates are an improvement over most existing fisher population statistics, which tend to omit accounting for gleaners and reef fishers. Our results suggest that slightly over a quarter of the world's small-scale fishers fish on coral reefs, and half of all coral reef fishers are in Southeast Asia. Coral reefs evidently support the socioeconomic well-being of numerous coastal communities. By quantifying the number of people who are employed as reef fishers, we provide decision-makers with an important input into planning for sustainable coral reef fisheries at the appropriate scale.	[Teh, Louise S. L.; Teh, Lydia C. L.; Sumaila, U. Rashid] Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Teh, LSL (corresponding author), Univ British Columbia, Fisheries Ctr, Vancouver, BC V5Z 1M9, Canada.	l.teh@fisheries.ubc.ca	Sumaila, U. Rashid/ABE-6475-2020		Sea Around Us Project; Pew Charitable Trusts of Philadelphia, United States of America	Sea Around Us Project; Pew Charitable Trusts of Philadelphia, United States of America	R. Sumaila acknowledges support from the Sea Around Us Project, funded by the Pew Charitable Trusts of Philadelphia, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrivilaga Alejandro, 2004, P473; Bell JD, 2006, OCEAN COAST MANAGE, V49, P976, DOI 10.1016/j.ocecoaman.2005.12.001; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bene C, 2003, WORLD DEV, V31, P949, DOI 10.1016/S0305-750X(03)00045-7; Boblin P., 2009, MARSHALL ISLANDS COU; Brewer TD, 2012, GLOBAL ENVIRON CHANG, V22, P399, DOI 10.1016/j.gloenvcha.2012.01.006; Burke L., 2004, REEFS RISK CARIBBEAN; Burke L., 2011, REEFS RISK REVISITED; Center for International Earth Science Information Network (CIESIN) Columbia University International Food Policy Research Institute (IFPRI) The World Bank (CIAT) CIdAT, 2004, GLOB RUR URB MAPP PR; Cesar H., 2003, EC WORLDWIDE CORAL R; CHAPMAN MD, 1987, HUM ECOL, V15, P267, DOI 10.1007/BF00888026; Cinner J, 2006, ENVIRON CONSERV, V22, P1; Cinner J, 2006, ECOL SOC, V11; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Cushion N, 2007, P 60 GULF CAR FISH I, V60, P162; Dalzell P., 1996, REEF FISHERIES, V20, P161, DOI [DOI 10.1007/978-94-015-8779-2, 10.1007/978-94-015-8779-2\_7.500]; Donner SD, 2007, BIOSCIENCE, V57, P214, DOI 10.1641/B570302; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Gillett R, 2011, FISHERIES PACIFIC IS; Gonzalez JA, 2008, ECOL SOC, V13; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes S, 2012, ENVIRON SCI POLICY, V23, P95, DOI 10.1016/j.envsci.2012.07.012; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jennings S, 1996, J APPL ECOL, V33, P400, DOI 10.2307/2404761; Kronen M, 2010, FISH RES, V101, P1, DOI 10.1016/j.fishres.2009.08.011; Kronen M, 2009, NEW CALEDONIA COUNTR; Kronen M., 2008, FRENCH POLYNESIA COU, P282; Kronen M, 2009, WALLIS FUTUNA RAPPOR; Kronen M, 2010, MAR POLICY, V34, P1135, DOI 10.1016/j.marpol.2010.03.013; Loper C, 2008, CONDITIONS WORLDS TR; McClanahan TR, 2009, CONSERV BIOL, V23, P662, DOI 10.1111/j.1523-1739.2008.01154.x; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; McClanahan TR, 2008, ECOL APPL, V18, P1516, DOI 10.1890/07-0876.1; McClanahan TR, 2001, ECOL APPL, V11, P559, DOI 10.2307/3060909; Muallil R, 2012, 12 INT COR REEF S 9; Munday P.L., 2000, STATUS CORAL REEFS P; National CTI Coordinating Committee of Timor-Leste, 2012, STAT COR REEF TIM LE; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; PAULY D, 1988, AMBIO, V17, P200; Pauly D, 1997, AM FISH S S, V20, P40; Pinca S., 2009, COOK ISLANDS COUNTRY; Purcell SW, 2013, FISH FISH, V14, P34, DOI 10.1111/j.1467-2979.2011.00443.x; Ruddle K., 1996, REEF FISHERIES, P137, DOI [10.1007/978-94-015-8779-2_6, DOI 10.1007/978-94-015-8779-2_6]; Sadovy Y, 2005, FISH FISH, V6, P167, DOI 10.1111/j.1467-2979.2005.00186.x; Sadovy YJ, 2003, WHILE STOCKS LAST LI; Sale PF, 2008, MAR POLLUT BULL, V56, P805, DOI 10.1016/j.marpolbul.2008.04.009; Sauni S, 2008, TUVALU COUNTRY REPOR; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Starkhouse B, 2009, WHATS CATCH UNCOVERI; Sumaila U. Rashid, 2007, Journal of Bioeconomics, V9, P39, DOI 10.1007/s10818-007-9015-4; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Teh LSL, 2007, CORAL REEFS, V26, P251, DOI 10.1007/s00338-006-0182-x; Teh L, 2007, MAR POLICY, V31, P451, DOI 10.1016/j.marpol.2007.01.001; Teh LSL, 2011, FISH RES, V110, P450, DOI 10.1016/j.fishres.2011.06.001; Teh LCL, 2013, FISH FISH, V14, P77, DOI 10.1111/j.1467-2979.2011.00450.x; Tun K, 2004, STATUS CORAL REEFS W, V1, P235; United Nations, 2011, WORLD POP PROSP 2010; United Nations, 2012, RUR POP DEV ENV 2011; Unsworth R, 2010, CONSERV LETT, V00, P1; Wabnitz C., 2003, OCEAN AQUARIUM GLOBA; Whittingham E., 2003, POVERTY REEFS; Wilkinson C, 2008, STATUS CORAL REEFS W; WWF, 2012, PROBL COR TRIANGL; Zeller D, 2006, CORAL REEFS, V25, P144, DOI 10.1007/s00338-005-0067-4	65	128	128	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65397	10.1371/journal.pone.0065397	http://dx.doi.org/10.1371/journal.pone.0065397			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840327	Green Published, gold			2022-12-27	WOS:000322361200016
J	Fiorito, V; Crich, SG; Silengo, L; Aime, S; Altruda, F; Tolosano, E				Fiorito, Veronica; Crich, Simonetta Geninatti; Silengo, Lorenzo; Aime, Silvio; Altruda, Fiorella; Tolosano, Emanuela			Lack of Plasma Protein Hemopexin Results in Increased Duodenal Iron Uptake	PLOS ONE			English	Article							HEME; EXPRESSION; MICE; IDENTIFICATION; TRANSPORTER; METABOLISM; HEPCIDIN; ANEMIA; DAMAGE; DMT1	Purpose: The body concentration of iron is regulated by a fine equilibrium between absorption and losses of iron. Iron can be absorbed from diet as inorganic iron or as heme. Hemopexin is an acute phase protein that limits iron access to microorganisms. Moreover, it is the plasma protein with the highest binding affinity for heme and thus it mediates heme-iron recycling. Considering its involvement in iron homeostasis, it was postulated that hemopexin may play a role in the physiological absorption of inorganic iron. Methods and Results: Hemopexin-null mice showed elevated iron deposits in enterocytes, associated with higher duodenal H-Ferritin levels and a significant increase in duodenal expression and activity of heme oxygenase. The expression of heme-iron and inorganic iron transporters was normal. The rate of iron absorption was assessed by measuring the amount of Fe-57 retained in tissues from hemopexin-null and wild-type animals after administration of an oral dose of (FeSO4)-Fe-57 or of Fe-57-labelled heme. Higher iron retention in the duodenum of hemopexin-null mice was observed as compared with normal mice. Conversely, iron transfer from enterocytes to liver and bone marrow was unaffected in hemopexin-null mice. Conclusions: The increased iron level in hemopexin-null duodenum can be accounted for by an increased iron uptake by enterocytes and storage in ferritins. These data indicate that the lack of hemopexin under physiological conditions leads to an enhanced duodenal iron uptake thus providing new insights to our understanding of body iron homeostasis.	[Fiorito, Veronica; Crich, Simonetta Geninatti; Silengo, Lorenzo; Aime, Silvio; Altruda, Fiorella; Tolosano, Emanuela] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Fiorito, Veronica; Crich, Simonetta Geninatti; Silengo, Lorenzo; Aime, Silvio; Altruda, Fiorella; Tolosano, Emanuela] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy	University of Turin; University of Turin	Tolosano, E (corresponding author), Univ Turin, Ctr Mol Biotechnol, Turin, Italy.	emanuela.tolosano@unito.it	Tolosano, Emanuela/L-8080-2019; Aime, Silvio/J-8009-2018; Crich, Simonetta Geninatti/AAC-7506-2022; Fiorito, Veronica/AAC-3331-2022; Tolosano, Emanuela/A-4684-2015	Tolosano, Emanuela/0000-0002-1622-2340; Aime, Silvio/0000-0002-5373-4708; Crich, Simonetta Geninatti/0000-0003-2998-5424; Fiorito, Veronica/0000-0001-9063-7918; Tolosano, Emanuela/0000-0002-1622-2340	Italian Ministry of University and Research; Regione Piemonte	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Regione Piemonte(Regione Piemonte)	This work was supported by the Italian Ministry of University and Research to ET and FA, and by the Regione Piemonte to FA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Canonne-Hergaux F, 2001, BLOOD, V97, P1138, DOI 10.1182/blood.V97.4.1138; Chepelev NL, 2011, FREE RADICAL BIO MED, V50, P645, DOI 10.1016/j.freeradbiomed.2010.12.023; Chiabrando D, 2011, ACUTE PHASE PROTEINS - REGULATION AND FUNCTIONS OF ACUTE PHASE PROTEINS, P261; Chiabrando D, 2012, J CLIN INVEST, V122, P4569, DOI 10.1172/JCI62422; Chiabrando D, 2013, BLOOD CELL MOL DIS, V50, P25, DOI 10.1016/j.bcmd.2012.08.002; Dunn LL, 2007, TRENDS CELL BIOL, V17, P93, DOI 10.1016/j.tcb.2006.12.003; Fiorito V, 2012, EUR J NUTR, V51, P783, DOI 10.1007/s00394-011-0256-6; Frazer DM, 2003, GUT, V52, P340, DOI 10.1136/gut.52.3.340; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Knutson MD, 2010, ANNU REV NUTR, V30, P149, DOI 10.1146/annurev.nutr.012809.104801; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; LANE RS, 1973, BRIT J HAEMATOL, V25, P533, DOI 10.1111/j.1365-2141.1973.tb01764.x; Marro S, 2007, GASTROENTEROLOGY, V133, P1261, DOI 10.1053/j.gastro.2007.07.004; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; Morello N, 2009, J CELL MOL MED, V13, P4192, DOI 10.1111/j.1582-4934.2008.00611.x; Peyssonnaux C, 2008, CELL CYCLE, V7, P28, DOI 10.4161/cc.7.1.5145; Rish KR, 2007, BBA-BIOENERGETICS, V1767, P1107, DOI 10.1016/j.bbabio.2007.06.003; Santambrogio P, 2000, PROTEIN EXPRES PURIF, V19, P212, DOI 10.1006/prep.2000.1212; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Tchernitchko D, 2002, BIOCHEM J, V363, P449, DOI 10.1042/0264-6021:3630449; Tolosano E, 1999, BLOOD, V94, P3906, DOI 10.1182/blood.V94.11.3906; Tolosano E, 2010, ANTIOXID REDOX SIGN, V12, P305, DOI 10.1089/ars.2009.2787; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Vinchi F, 2008, AM J PATHOL, V173, P289, DOI 10.2353/ajpath.2008.071130; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Yang ZT, 2010, J BIOL CHEM, V285, P28874, DOI 10.1074/jbc.M110.119131; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006	32	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68146	10.1371/journal.pone.0068146	http://dx.doi.org/10.1371/journal.pone.0068146			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826373	Green Published, gold			2022-12-27	WOS:000321150000127
J	Ljubicic, S; Bezzi, P; Brajkovic, S; Nesca, V; Guay, C; Ohbayashi, N; Fukuda, M; Abderrhamani, A; Regazzi, R				Ljubicic, Sanda; Bezzi, Paola; Brajkovic, Saska; Nesca, Valeria; Guay, Claudiane; Ohbayashi, Norihiko; Fukuda, Mitsunori; Abderrhamani, Amar; Regazzi, Romano			The GTPase Rab37 Participates in the Control of Insulin Exocytosis	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; SECRETORY GRANULES; VESICLE DOCKING; PLASMA-MEMBRANE; PC12 CELLS; GLUCOSE; EXPRESSION; RAB27A; INHIBITION; MECHANISMS	Rab37 belongs to a subclass of Rab GTPases regulating exocytosis, including also Rab3a and Rab27a. Proteomic studies indicate that Rab37 is associated with insulin-containing large dense core granules of pancreatic beta-cells. In agreement with these observations, we detected Rab37 in extracts of beta-cell lines and human pancreatic islets and confirmed by confocal microscopy the localization of the GTPase on insulin-containing secretory granules. We found that, as is the case for Rab3a and Rab27a, reduction of Rab37 levels by RNA interference leads to impairment in glucose-induced insulin secretion and to a decrease in the number of granules in close apposition to the plasma membrane. Pull-down experiments revealed that, despite similar functional effects, Rab37 does not interact with known Rab3a or Rab27a effectors and is likely to operate through a different mechanism. Exposure of insulin-secreting cells to proinflammatory cytokines, fatty acids or oxidized low-density lipoproteins, mimicking physiopathological conditions that favor the development of diabetes, resulted in a decrease in Rab37 expression. Our data identify Rab37 as an additional component of the machinery governing exocytosis of b-cells and suggest that impaired expression of this GTPase may contribute to defective insulin release in pre-diabetic and diabetic conditions.	[Ljubicic, Sanda; Bezzi, Paola; Nesca, Valeria; Guay, Claudiane; Regazzi, Romano] Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland; [Brajkovic, Saska; Abderrhamani, Amar] Univ Lille 2, EGID FR 3508, INSERM U859, Lille, France; [Ohbayashi, Norihiko; Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Sendai, Miyagi 980, Japan	University of Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Tohoku University	Regazzi, R (corresponding author), Univ Lausanne, Dept Fundamental Neurosci, Lausanne, Switzerland.	Romano.Regazzi@unil.ch	Guay, Claudiane/AAF-5381-2019; Fukuda, MItsunori/I-1511-2015; Bezzi, Paola/AAP-2440-2020	Fukuda, MItsunori/0000-0002-8620-5853; Guay, Claudiane/0000-0002-6478-8744; Regazzi, Romano/0000-0002-9773-2915	Swiss National Science Foundation [31003A-127254]; Grants-in-Aid for Scientific Research [24570206] Funding Source: KAKEN	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Swiss National Science Foundation (http://www.snf.ch) grant number 31003A-127254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2006, EMBO J, V25, P977, DOI 10.1038/sj.emboj.7601008; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Brunner Y, 2007, MOL CELL PROTEOMICS, V6, P1007, DOI 10.1074/mcp.M600443-MCP200; Casey TM, 2007, MOL CELL PROTEOMICS, V6, P767, DOI 10.1074/mcp.M600365-MCP200; Coppola T, 1999, EMBO J, V18, P5885, DOI 10.1093/emboj/18.21.5885; Favre D, 2011, DIABETOLOGIA, V54, P2337, DOI 10.1007/s00125-011-2165-x; Favre D, 2011, DIABETES, V60, P3169, DOI 10.2337/db10-1743; Fukuda M, 2004, J BIOL CHEM, V279, P13065, DOI 10.1074/jbc.M306812200; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Izumi T, 2007, DIABETES OBES METAB, V9, P109, DOI 10.1111/j.1463-1326.2007.00789.x; Izumi T, 2003, CELL STRUCT FUNCT, V28, P465, DOI 10.1247/csf.28.465; Kasai K, 2005, J CLIN INVEST, V115, P388, DOI 10.1172/JCI200522955; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Lin Y, 2010, J ENDOCRINOL, V204, P1, DOI 10.1677/JOE-09-0260; Masuda ES, 2000, FEBS LETT, V470, P61, DOI 10.1016/S0014-5793(00)01288-6; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Merrins MJ, 2008, J PHYSIOL-LONDON, V586, P5367, DOI 10.1113/jphysiol.2008.158477; Petyuk VA, 2008, J PROTEOME RES, V7, P3114, DOI 10.1021/pr800205b; Plaisance V, 2005, J BIOL CHEM, V280, P401, DOI 10.1074/jbc.M411825200; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Prada I, 2011, J CELL BIOL, V193, P537, DOI 10.1083/jcb.201010126; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rorsman P, 2003, DIABETOLOGIA, V46, P1029, DOI 10.1007/s00125-003-1153-1; Schuit FC, 2001, DIABETES, V50, P1, DOI 10.2337/diabetes.50.1.1; Tsuboi T, 2003, BIOCHEM SOC T, V31, P833, DOI 10.1042/BST0310833; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Waselle L, 2003, MOL BIOL CELL, V14, P4103, DOI 10.1091/mbc.E03-01-0022; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Yaekura K, 2003, J BIOL CHEM, V278, P9715, DOI 10.1074/jbc.M211352200; Zhou YP, 2003, J BIOL CHEM, V278, P51316, DOI 10.1074/jbc.M307972200	34	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68255	10.1371/journal.pone.0068255	http://dx.doi.org/10.1371/journal.pone.0068255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826383	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000136
J	Ohno, M; Togashi, Y; Tsuda, K; Okawa, K; Kamaya, M; Sakaguchi, M; Sugahara, Y; Oyama, F				Ohno, Misa; Togashi, Yuto; Tsuda, Kyoko; Okawa, Kazuaki; Kamaya, Minori; Sakaguchi, Masayoshi; Sugahara, Yasusato; Oyama, Fumitaka			Quantification of Chitinase mRNA Levels in Human and Mouse Tissues by Real-Time PCR: Species-Specific Expression of Acidic Mammalian Chitinase in Stomach Tissues	PLOS ONE			English	Article							HUMAN CHITOTRIOSIDASE; HUMAN LUNG; INFLAMMATION; PROTEINS; DISEASE; GENE; ACTIVATION; EVOLUTION; CLONING; FAMILY	Chitinase hydrolyzes chitin, which is an N-acetyl-D-glucosamine polymer that is present in a wide range of organisms, including insects, parasites and fungi. Although mammals do not contain any endogenous chitin, humans and mice express two active chitinases, chitotriosidase (Chit1) and acidic mammalian chitinase (AMCase). Because the level of expression of these chitinases is increased in many inflammatory conditions, including Gaucher disease and mouse models of asthma, both chitinases may play important roles in the pathophysiologies of these and other diseases. We recently established a quantitative PCR system using a single standard DNA and showed that AMCase mRNA is synthesized at extraordinarily high levels in mouse stomach tissues. In this study, we applied this methodology to the quantification of chitinase mRNAs in human tissues and found that both chitinase mRNAs were widely expressed in normal human tissues. Chit1 mRNA was highly expressed in the human lung, whereas AMCase mRNA was not overexpressed in normal human stomach tissues. The levels of these mRNAs in human tissues were significantly lower than the levels of housekeeping genes. Because the AMCase expression levels were quite different between the human and mouse stomach tissues, we developed a quantitative PCR system to compare the mRNA levels between human and mouse tissues using a human-mouse hybrid standard DNA. Our analysis showed that Chit1 mRNA is expressed at similar levels in normal human and mouse lung. In contrast, the AMCase expression level in human stomach was significantly lower than that expression level observed in mouse stomach. These mRNA differences between human and mouse stomach tissues were reflecting differences in the chitinolytic activities and levels of protein expression. Thus, the expression level of the AMCase in the stomach is species-specific.	[Ohno, Misa; Togashi, Yuto; Tsuda, Kyoko; Okawa, Kazuaki; Sakaguchi, Masayoshi; Sugahara, Yasusato; Oyama, Fumitaka] Kogakuin Univ, Dept Appl Chem, Hachioji, Tokyo, Japan; [Kamaya, Minori] Kogakuin Univ, Dept Environm & Energy Chem, Hachioji, Tokyo, Japan	Kogakuin University; Kogakuin University	Oyama, F (corresponding author), Kogakuin Univ, Dept Appl Chem, Hachioji, Tokyo, Japan.	f-oyama@cc.kogakuin.ac.jp	Oyama, Fumitaka/Q-4268-2019	Oyama, Fumitaka/0000-0002-1095-8306	Research Institute of Science and Technology, Kogakuin University	Research Institute of Science and Technology, Kogakuin University	This work was supported by the Project Research Grant from the Research Institute of Science and Technology, Kogakuin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierbaum S, 2005, AM J RESP CRIT CARE, V172, P1505, DOI 10.1164/rccm.200506-890OC; Boot RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1283, DOI 10.1369/jhc.4A6547.2005; BOOT RG, 1995, J BIOL CHEM, V270, P26252, DOI 10.1074/jbc.270.44.26252; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Boot RG, 1998, J BIOL CHEM, V273, P25680, DOI 10.1074/jbc.273.40.25680; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Chou YT, 2006, BIOCHEMISTRY-US, V45, P4444, DOI 10.1021/bi0525977; Cozzarini E, 2009, EUR J GASTROEN HEPAT, V21, P1119, DOI 10.1097/MEG.0b013e328329742a; HOLLAK CEM, 1994, J CLIN INVEST, V93, P1288, DOI 10.1172/JCI117084; Kageyama T, 2002, CELL MOL LIFE SCI, V59, P288, DOI 10.1007/s00018-002-8423-9; Khoushab F, 2010, MAR DRUGS, V8, P1988, DOI 10.3390/md8071988; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Letuve S, 2010, AM J PATHOL, V176, P638, DOI 10.2353/ajpath.2010.090455; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Ohno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050381; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; RENKEMA GH, 1995, J BIOL CHEM, V270, P2198, DOI 10.1074/jbc.270.5.2198; Richter C, 1998, BIOCHEM J, V335, P481, DOI 10.1042/bj3350481; Saito A, 1999, GENE, V239, P325, DOI 10.1016/S0378-1119(99)00394-7; Seibold MA, 2008, J ALLERGY CLIN IMMUN, V122, P944, DOI 10.1016/j.jaci.2008.08.023; Seibold MA, 2009, J BIOL CHEM, V284, P19650, DOI 10.1074/jbc.M109.012443; Suzuki M, 2002, J HISTOCHEM CYTOCHEM, V50, P1081, DOI 10.1177/002215540205000810; van Eijk M, 2005, INT IMMUNOL, V17, P1505, DOI 10.1093/intimm/dxh328; Watabe-Rudolph M, 2012, NEUROLOGY, V78, P569, DOI 10.1212/WNL.0b013e318247caa1; Zheng T, 2005, GENE, V357, P37, DOI 10.1016/j.gene.2005.05.006; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	27	39	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67399	10.1371/journal.pone.0067399	http://dx.doi.org/10.1371/journal.pone.0067399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826286	Green Submitted, gold, Green Published			2022-12-27	WOS:000321150000074
J	Peltzer, N; Vanli, G; Yang, JY; Widmann, C				Peltzer, Nieves; Vanli, Gueliz; Yang, Jiang-Yan; Widmann, Christian			Role of mTOR, Bad, and Survivin in RasGAP Fragment N-Mediated Cell Protection	PLOS ONE			English	Article							BREAST-CANCER CELLS; CYTOPLASMIC SURVIVIN; SIGNALING PATHWAY; INDUCED APOPTOSIS; DEATH; CASPASE-3; AKT; EXPRESSION; DIFFERENTIATION; ACTIVATION	Partial cleavage of p120 RasGAP by caspase-3 in stressed cells generates an N-terminal fragment, called fragment N, which activates an anti-apoptotic Akt-dependent survival response. Akt regulates several effectors but which of these mediate fragment N-dependent cell protection has not been defined yet. Here we have investigated the role of mTORC1, Bad, and survivin in the capacity of fragment N to protect cells from apoptosis. Neither rapamycin, an inhibitor of mTORC1, nor silencing of raptor, a subunit of the mTORC1 complex, altered the ability of fragment N from inhibiting cisplatin-and Fas ligand-induced death. Cells lacking Bad, despite displaying a stronger resistance to apoptosis, were still protected by fragment N against cisplatin-induced death. Fragment N was also able to protect cells from Fas ligand-induced death in conditions where Bad plays no role in apoptosis regulation. Fragment N expression in cells did neither modulate survivin mRNA nor its protein expression. Moreover, the expression of cytoplasmic survivin, known to exert anti-apoptotic actions in cells, still occurred in UV-B-irradiated epidermis of mouse expressing a caspase-3-resistant RasGAP mutant that cannot produce fragment N. Additionally, survivin function in cell cycle progression was not affected by fragment N. These results indicate that, taken individually, mTOR, Bad, or Survivin are not required for fragment N to protect cells from cell death. We conclude that downstream targets of Akt other than mTORC1, Bad, or survivin mediate fragment N-induced protection or that several Akt effectors can compensate for each other to induce the pro-survival fragment N-dependent response.	[Peltzer, Nieves; Vanli, Gueliz; Yang, Jiang-Yan; Widmann, Christian] Univ Lausanne, Dept Physiol, Lausanne, Switzerland	University of Lausanne	Widmann, C (corresponding author), Univ Lausanne, Dept Physiol, Lausanne, Switzerland.	Christian.Widmann@unil.ch	Widmann, Christian/N-9851-2013; Peltzer, Nieves/AAI-2831-2020	Widmann, Christian/0000-0002-6881-0363; Peltzer, Nieves/0000-0002-4134-5852	Swiss National Science Foundation [31003A_141242/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation grant 31003A_141242/1 (to CW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibaldi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029024; Annibaldi A, 2009, EXP CELL RES, V315, P2081, DOI 10.1016/j.yexcr.2009.03.015; Arora V, 2007, J BIOL CHEM, V282, P26202, DOI 10.1074/jbc.M700776200; Belyanskaya LL, 2005, INT J CANCER, V117, P755, DOI 10.1002/ijc.21242; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Bulat N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022609; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Castedo M, 2002, CELL DEATH DIFFER, V9, P99, DOI 10.1038/sj/cdd/4400978; Chen YH, 2005, ONCOGENE, V24, P672, DOI 10.1038/sj.onc.1208099; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Connell CM, 2008, J BIOL CHEM, V283, P3289, DOI 10.1074/jbc.M704461200; Dan HC, 2004, ONCOGENE, V23, P706, DOI 10.1038/sj.onc.1207171; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Downward J, 1999, NAT CELL BIOL, V1, pE33, DOI 10.1038/10026; Droin N, 2008, BIOCHIMIE, V90, P416, DOI 10.1016/j.biochi.2007.08.007; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Gadir N, 2008, ONCOGENE, V27, P1055, DOI 10.1038/sj.onc.1210721; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hayakawa J, 2000, CANCER RES, V60, P5988; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Hu H, 2010, GUT; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Jiang YY, 2004, J BIOL CHEM, V279, P40511, DOI 10.1074/jbc.M404496200; Johnson NC, 2004, EXP CELL RES, V298, P9, DOI 10.1016/j.yexcr.2004.04.003; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Juntilla MA, 2008, IMMUNOL LETT, V116, P104, DOI 10.1016/j.imlet.2007.12.008; Khalil H, 2012, MOL CELL BIOL, V32, P4523, DOI 10.1128/MCB.00774-12; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Li FZ, 1999, CANCER RES, V59, P3143; Li Y, 2006, ONCOGENE, V25, P3296, DOI 10.1038/sj.onc.1209363; Mandal M, 1996, J BIOL CHEM, V271, P30354, DOI 10.1074/jbc.271.48.30354; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; Newton K, 2003, GENE DEV, V17, P819, DOI 10.1101/gad.1077403; Peltzer N, 2012, J DERMATOL SCI, V67, P196, DOI 10.1016/j.jdermsci.2012.05.007; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Stauber RH, 2007, CANCER RES, V67, P5999, DOI 10.1158/0008-5472.CAN-07-0494; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Tomasoni R, 2011, BIOCHEM SOC T, V39, P466, DOI 10.1042/BST0390466; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; Yang JY, 2009, DIABETES, V58, P2596, DOI 10.2337/db09-0104; Yang JY, 2005, J BIOL CHEM, V280, P32835, DOI 10.1074/jbc.M504058200; Yang JY, 2005, MOL BIOL CELL, V16, P3511, DOI 10.1091/mbc.E05-01-0080; Yang JY, 2004, BIOCHEM PHARMACOL, V68, P1027, DOI 10.1016/j.bcp.2004.03.043; Yang JY, 2004, MOL CELL BIOL, V24, P10425, DOI 10.1128/MCB.24.23.10425-10436.2004; Yang JY, 2002, J BIOL CHEM, V277, P14641, DOI 10.1074/jbc.M111540200; Yang JY, 2001, MOL CELL BIOL, V21, P5346, DOI 10.1128/MCB.21.16.5346-5358.2001; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yue ZJ, 2008, J CELL BIOL, V183, P279, DOI 10.1083/jcb.200806118; Zhao P, 2010, BIOCHEM BIOPH RES CO, V395, P219, DOI 10.1016/j.bbrc.2010.03.165	63	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68123	10.1371/journal.pone.0068123	http://dx.doi.org/10.1371/journal.pone.0068123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826368	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000122
J	Alobeidy, BF; Li, C; Alzobair, AA; Liu, T; Zhao, JZ; Fang, Y; Zheng, F				Alobeidy, Barrak F.; Li, Cong; Alzobair, Alya A.; Liu, Tao; Zhao, Junzhang; Fang, Yuan; Zheng, Fang			The Association Study between Twenty One Polymorphisms in Seven Candidate Genes and Coronary Heart Diseases in Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MYOCARDIAL-INFARCTION; COMMON DISEASES; RISK; EXPRESSION; GLUCOSE; MLX	Previous genome-wide association studies (GWAS) in multiple populations identified several genetic loci for coronary heart diseases (CHD). Here we utilized a 2-stage candidate gene association strategy in Chinese Han population to shed light on the putative association between several metabolic-related candidate genes and CHD. At the 1st stage, 190 patients with CHD and 190 controls were genotyped through the MassARRAY platform. At the 2nd stage, a larger sample including 400 patients and 392 controls was genotyped by the High Resolution Melt (HRM) method to confirm or rule out the associations with CHD. MLXIP expression level was quantified by the real time PCR in 65 peripheral blood samples. From the 21 studied single nucleotide polymorphisms (SNPs) of seven candidate genes: MLXIPL, MLXIP, MLX, ADIPOR1, VDR, SREBF1 and NR1H3, only one tag SNP rs4758685 (T -> C) was found to be statistically associated with CHD (P-value = 0.02, Odds ratio (OR) of 0.83). After adjustment for the age, sex, lipid levels and diabetes, the association remained significant (P-value = 0.03). After adjustment for the hypertension, P-value became 0.20 although there was a significant difference in the allele distribution between the CHD patients with hypertension and the controls (P-value = 0.04, 406 vs 582). In conclusion, among the 21 tested SNPs, we identified a novel association between rs4758685 of MLXIP gene and CHD. The C allele of common variant rs4758685 interacted with hypertension, and was found to be protective against CHD in both allelic and genotypic models in Chinese Han population.	[Alobeidy, Barrak F.; Li, Cong; Alzobair, Alya A.; Liu, Tao; Zhao, Junzhang; Fang, Yuan; Zheng, Fang] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Hubei, Peoples R China; [Alzobair, Alya A.] Univ Mosul, Coll Med, Dept Internal Med, Mosul, Iraq	Wuhan University; University of Mosul	Zheng, F (corresponding author), Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Hubei, Peoples R China.	zhengfang@whu.edu.cn	ZOBAIR, ALYA AL/AAM-5578-2020	ZOBAIR, ALYA AL/0000-0003-0676-3300	National Natural Science Foundation of China [81071420]; Key Natural Science Foundation of Hubei Province [2010CDA032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Natural Science Foundation of Hubei Province	The study was supported by National Natural Science Foundation of China with grant 81071420, and the Key Natural Science Foundation of Hubei Province (2010CDA032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo J, 2012, ANIMAL INT J ANIMAL, P1; BARRETT J, 2009, COLD SPRING HARBOR P; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Ferreira NE, 2011, ATHEROSCLEROSIS; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Guo S, 2011, CLIN CHIMICA ACTA; Ha M, 2008, BBA-GENE REGUL MECH, V1779, P735, DOI 10.1016/j.bbagrm.2008.03.004; Halvatsiotis I, 2010, CARDIOVASC DIABETOL, P9; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Krycer JR, 2011, J BIOL CHEM, V286, P20637, DOI 10.1074/jbc.M111.227082; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Pan LA, 2009, CARDIOLOGY, V114, P174, DOI 10.1159/000226610; Peterson CW, 2010, MOL CELL BIOL, V30, P2887, DOI 10.1128/MCB.01613-09; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Sans CL, 2006, MOL CELL BIOL, V26, P4863, DOI 10.1128/MCB.00657-05; Sloan Elizabeth J, 2010, Genes Cancer, V1, P587, DOI 10.1177/1947601910377489; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; Vedie B, 2001, ATHEROSCLEROSIS, V154, P589, DOI 10.1016/S0021-9150(00)00569-4; Wilker EH, 2009, ATHEROSCLEROSIS, V206, P480, DOI 10.1016/j.atherosclerosis.2009.03.004; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yu FX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008397	27	14	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66976	10.1371/journal.pone.0066976	http://dx.doi.org/10.1371/journal.pone.0066976			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840567	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400061
J	Garcia, PJ; Carcamo, CP; Chiappe, M; Valderrama, M; La Rosa, S; Holmes, KK; Mabey, DCW; Peeling, RW				Garcia, Patricia J.; Carcamo, Cesar P.; Chiappe, Marina; Valderrama, Maria; La Rosa, Sayda; Holmes, King K.; Mabey, David C. W.; Peeling, Rosanna W.			Rapid Syphilis Tests as Catalysts for Health Systems Strengthening: A Case Study from Peru	PLOS ONE			English	Article							CONGENITAL-SYPHILIS; PREVENTION; PREGNANCY	Objectives: Untreated maternal syphilis leads to adverse pregnancy outcomes. The use of point of care tests (POCT) offers an opportunity to improve screening coverage for syphilis and other aspects of health systems. Our objective is to present the experience of the introduction of POCT for syphilis in Peru and describe how new technology can catalyze health system strengthening. Methods: The study was implemented from September 2009-November 2010 to assess the feasibility of the use of a POCT for syphilis for screening pregnant women in Lima, Peru. Outcomes measured included access to syphilis screening, treatment coverage, partner treatment, effect on patient flow and service efficiency, acceptability among providers and patients, and sustainability. Results: Before the introduction of POCT, a pregnant woman needed 6 visits to the health center in 27 days before she received her syphilis result. We trained 604 health providers and implemented the POCT for syphilis as the "two for one strategy", offering with one finger stick both syphilis and HIV testing. Implementation of the POCT resulted in testing and treatment on the first visit. Screening and treatment coverages for syphilis improved significantly compared with the previous year. Implementation of POCT has been scaled up nationally since the study ended, and coverages for screening, treatment and partner treatment have remained over 92%. Conclusions: Implementation of POCT for syphilis proved feasible and acceptable, and led to improvement in several aspects of health services. For the process to be effective we highlight the importance of: (1) engaging the authorities; (2) dissipating tensions between providers and identifying champions; (3) training according to the needs; (4) providing monitoring, supervision, support and recognition; (5) sharing results and discussing actions together; (6) consulting and obtaining feedback from users; and (7) integrating with other services such as with rapid HIV testing.	[Garcia, Patricia J.; Carcamo, Cesar P.; Chiappe, Marina; Valderrama, Maria; La Rosa, Sayda] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol STD & HIV Unit, Lima, Peru; [Garcia, Patricia J.; Holmes, King K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Mabey, David C. W.; Peeling, Rosanna W.] London Sch Hyg & Trop Med, London WC1, England	Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine	Garcia, PJ (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Epidemiol STD & HIV Unit, Lima, Peru.	patricia.garcia@upch.pe	, Holmes/K-6215-2019	Mabey, David/0000-0002-0031-8276	Bill & Melinda Gates Foundation [47697]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Financial support for this study was provided by the Bill & Melinda Gates Foundation through a grant (#47697) to Rosanna Peeling at the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training for Tropical Diseases (now at the London School of Hygiene and Tropical Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, GUIAS NAC AT INT SAL; Benzaken AS, 2011, INT J STD AIDS, V22, P15, DOI 10.1258/ijsa.2010.010145; Bronzan RN, 2007, SEX TRANSM DIS, V34, pS55, DOI 10.1097/01.olq.0000245987.78067.0c; Garcia SG, 2007, SEX TRANSM DIS, V34, pS37, DOI 10.1097/olq.0000251236.48770.35; Hawkes S, 2011, LANCET INFECT DIS, V11, P684, DOI 10.1016/S1473-3099(11)70104-9; Herring A, 2006, NAT REV MICROBIOL, pS33, DOI 10.1038/nrmicro1563; Kamb ML, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/312798; London School of Hygiene & Tropical Medicine, 2011, RAP SYPH TEST TOOLK; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; MCDERMOTT J, 1993, B WORLD HEALTH ORGAN, V71, P773; Saloojee H, 2004, B WORLD HEALTH ORGAN, V82, P424; Watson-Jones D, 2002, J INFECT DIS, V186, P948, DOI 10.1086/342951; World Health Organization, 2007, EV BOD BUS STRENGTH; World Health Organization, 2000, WORLD HLTH REP 2000	14	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66905	10.1371/journal.pone.0066905	http://dx.doi.org/10.1371/journal.pone.0066905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840552	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000321424400052
J	Turac, G; Hindley, CJ; Thomas, R; Davis, JA; Deleidi, M; Gasser, T; Karaoz, E; Pruszak, J				Turac, Gizem; Hindley, Christopher J.; Thomas, Ria; Davis, Jason A.; Deleidi, Michela; Gasser, Thomas; Karaoz, Erdal; Pruszak, Jan			Combined Flow Cytometric Analysis of Surface and Intracellular Antigens Reveals Surface Molecule Markers of Human Neuropoiesis	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; NEURONS; DIFFERENTIATION; EXPRESSION; FIXATION; PERMEABILIZATION; TRANSPLANTATION; INFLAMMATION	Surface molecule profiles undergo dynamic changes in physiology and pathology, serve as markers of cellular state and phenotype and can be exploited for cell selection strategies and diagnostics. The isolation of well-defined cell subsets is needed for in vivo and in vitro applications in stem cell biology. In this technical report, we present an approach for defining a subset of interest in a mixed cell population by flow cytometric detection of intracellular antigens. We have developed a fully validated protocol that enables the co-detection of cluster of differentiation (CD) surface antigens on fixed, permeabilized neural cell populations defined by intracellular staining. Determining the degree of co-expression of surface marker candidates with intracellular target population markers (nestin, MAP2, doublecortin, TUJ1) on neuroblastoma cell lines (SH-SY5Y, BE(2)-M17) yielded a combinatorial CD49f-/CD200(high) surface marker panel. Its application in fluorescence-activated cell sorting (FACS) generated enriched neuronal cultures from differentiated cell suspensions derived from human induced pluripotent stem cells. Our data underlines the feasibility of using the described co-labeling protocol and co-expression analysis for quantitative assays in mammalian neurobiology and for screening approaches to identify much needed surface markers in stem cell biology.	[Turac, Gizem; Hindley, Christopher J.; Thomas, Ria; Davis, Jason A.; Pruszak, Jan] Univ Freiburg, Inst Anat & Cell Biol, Dept Mol Embryol, Emmy Noether Grp Stem Cell Biol, D-79106 Freiburg, Germany; [Turac, Gizem; Karaoz, Erdal] Kocaeli Univ, Ctr Stem Cell & Gene Therapies Res & Practice, Kocaeli, Turkey; [Thomas, Ria] Univ Freiburg, Fac Biol, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Deleidi, Michela; Gasser, Thomas] Univ Tubingen, German Ctr Neurodegenerat Dis DZNE, Dept Neurodegenerat Dis, Inst Clin Brain Res, Tubingen, Germany; [Pruszak, Jan] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79106 Freiburg, Germany	University of Freiburg; Kocaeli University; University of Freiburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Freiburg	Pruszak, J (corresponding author), Univ Freiburg, Inst Anat & Cell Biol, Dept Mol Embryol, Emmy Noether Grp Stem Cell Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.	jan.pruszak@anat.uni-freiburg.de	Turaç, Gizem/B-1549-2018; Pruszak, Jan/G-6972-2015; Gasser, Thomas/GNH-5293-2022; Thomas, Ria/AAX-8063-2020; Karaoz, Erdal/AAO-1470-2020	Turaç, Gizem/0000-0001-8219-2015; Pruszak, Jan/0000-0003-4297-4009; Gasser, Thomas/0000-0002-1069-1146; Thomas, Ria/0000-0003-2037-7473; Deleidi, Michela/0000-0003-0357-0124	German Research Council (DFG) [PR1132/3-1, KR2119/8-1]; Alexander von Humboldt-Foundation Postdoctoral Fellowship; Excellence Initiative of the German Research Foundation [GSC-4]; Marie Curie Career Integration [MC CIG304108]; NEUREX network (JP)	German Research Council (DFG)(German Research Foundation (DFG)); Alexander von Humboldt-Foundation Postdoctoral Fellowship; Excellence Initiative of the German Research Foundation(German Research Foundation (DFG)); Marie Curie Career Integration; NEUREX network (JP)	The authors' research program is funded by the German Research Council (DFG) grant PR1132/3-1 (JP). CH and MD were each supported by an Alexander von Humboldt-Foundation Postdoctoral Fellowship. Further support by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School) (RT), Marie Curie Career Integration Grant MC CIG304108 (MD), DFG grant KR2119/8-1 (TG) and from the NEUREX network (JP) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Brunlid G, 2007, STEM CELLS, V25, P2551, DOI 10.1634/stemcells.2006-0745; Chitnis T, 2007, AM J PATHOL, V170, P1695, DOI 10.2353/ajpath.2007.060677; Constantinescu R, 2007, J NEURAL TRANSM-SUPP, P17; Deleidi M, 2011, STEM CELLS, V29, P1052, DOI 10.1002/stem.662; Delorme B, 2008, BLOOD, V111, P2631, DOI 10.1182/blood-2007-07-099622; Diogo MM, 2012, BIOTECHNOL BIOENG, V109, P2699, DOI 10.1002/bit.24706; Dubois NC, 2011, NAT BIOTECHNOL, V29, P1011, DOI 10.1038/nbt.2005; Elghetany MT, 2005, CYTOM PART B-CLIN CY, V65B, P1, DOI 10.1002/cyto.b.20051; Gerner W, 2008, VET IMMUNOL IMMUNOP, V121, P251, DOI 10.1016/j.vetimm.2007.09.019; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; Hedlund E, 2008, STEM CELLS, V26, P1526, DOI 10.1634/stemcells.2007-0996; Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251; Hulspas R, 2009, CYTOM PART B-CLIN CY, V76B, P355, DOI 10.1002/cyto.b.20485; Humphrey RK, 2003, DIABETES, V52, P2519, DOI 10.2337/diabetes.52.10.2519; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Israel MA, 2011, GENOME MED, V3, DOI 10.1186/gm265; Jaye DL, 2012, J IMMUNOL, V188, P4715, DOI 10.4049/jimmunol.1290017; Jouhilahti EM, 2008, J HISTOCHEM CYTOCHEM, V56, P1113, DOI 10.1369/jhc.2008.952002; Kappelmayer J, 2000, J IMMUNOL METHODS, V242, P53, DOI 10.1016/S0022-1759(00)00220-9; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Meng FX, 2012, CELL RES, V22, P436, DOI 10.1038/cr.2011.185; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; POLLICE AA, 1992, CYTOMETRY, V13, P432, DOI 10.1002/cyto.990130414; Preffer F, 2009, CYTOM PART B-CLIN CY, V76B, P295, DOI 10.1002/cyto.b.20480; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Rieseberg M, 2001, APPL MICROBIOL BIOT, V56, P350, DOI 10.1007/s002530100673; Sanchez-Pernaute R, 2005, STEM CELLS, V23, P914, DOI 10.1634/stemcells.2004-0172; Schriebl K, 2012, TISSUE ENG PT A, V18, P899, DOI [10.1089/ten.tea.2011.0311, 10.1089/ten.TEA.2011.0311]; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Sergent-Tanguy S, 2003, J NEUROSCI METH, V129, P73, DOI 10.1016/S0165-0270(03)00210-3; Sonntag KC, 2007, STEM CELLS, V25, P411, DOI 10.1634/stemcells.2006-0380; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Walker DG, 2009, EXP NEUROL, V215, P5, DOI 10.1016/j.expneurol.2008.09.003; WEBB M, 1984, J NEUROCHEM, V43, P1061, DOI 10.1111/j.1471-4159.1984.tb12844.x; Yu KR, 2012, STEM CELLS, V30, P876, DOI 10.1002/stem.1052; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zelnickova P, 2007, J IMMUNOL METHODS, V327, P18, DOI 10.1016/j.jim.2007.07.006; Zhao F, 2009, FREE RADICAL BIO MED, V47, P867, DOI 10.1016/j.freeradbiomed.2009.06.029	43	23	23	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e68519	10.1371/journal.pone.0068519	http://dx.doi.org/10.1371/journal.pone.0068519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826393	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400178
J	Beitzinger, C; Bronnhuber, A; Duscha, K; Riedl, Z; Huber-Lang, M; Benz, R; Hajos, G; Barth, H				Beitzinger, Christoph; Bronnhuber, Anika; Duscha, Kerstin; Riedl, Zsuzsanna; Huber-Lang, Markus; Benz, Roland; Hajos, Gyoergy; Barth, Holger			Designed Azolopyridinium Salts Block Protective Antigen Pores In Vitro and Protect Cells from Anthrax Toxin	PLOS ONE			English	Article							CLOSTRIDIUM-BOTULINUM C2-TOXIN; CURRENT NOISE-ANALYSIS; LETHAL FACTOR CLEAVES; FUSED AZOLIUM SALTS; COLI OUTER-MEMBRANE; ESCHERICHIA-COLI; BINDING-KINETICS; EDEMA FACTOR; MALTOPORIN CHANNEL; BILAYER-MEMBRANES	Background: Several intracellular acting bacterial protein toxins of the AB-type, which are known to enter cells by endocytosis, are shown to produce channels. This holds true for protective antigen (PA), the binding component of the tripartite anthrax-toxin of Bacillus anthracis. Evidence has been presented that translocation of the enzymatic components of anthrax-toxin across the endosomal membrane of target cells and channel formation by the heptameric/octameric PA(63) binding/translocation component are related phenomena. Chloroquine and some 4-aminoquinolones, known as potent drugs against Plasmodium falciparium infection of humans, block efficiently the PA(63)-channel in a dose dependent way. Methodology/Principal Findings: Here we demonstrate that related positively charged heterocyclic azolopyridinium salts block the PA(63)-channel in the mu M range, when both, inhibitor and PA(63) are added to the same side of the membrane, the cis-side, which corresponds to the lumen of acidified endosomal vesicles of target cells. Noise-analysis allowed the study of the kinetics of the plug formation by the heterocycles. In vivo experiments using J774A.1 macrophages demonstrated that the inhibitors of PA(63)-channel function also efficiently block intoxication of the cells by the combination lethal factor and PA(63) in the same concentration range as they block the channels in vitro. Conclusions/Significance: These results strongly argue in favor of a transport of lethal factor through the PA(63)-channel and suggest that the heterocycles used in this study could represent attractive candidates for development of novel therapeutic strategies against anthrax.	[Beitzinger, Christoph; Duscha, Kerstin; Benz, Roland] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97070 Wurzburg, Germany; [Bronnhuber, Anika; Barth, Holger] Univ Ulm, Inst Pharmacol & Toxicol, Med Ctr, D-89069 Ulm, Germany; [Riedl, Zsuzsanna; Hajos, Gyoergy] Hungarian Acad Sci, Inst Organ Chem, Res Ctr Nat Sci, Budapest, Hungary; [Huber-Lang, Markus] Univ Ulm, Inst Traumatol Hand & Reconstruct Surg, Med Ctr, D-89069 Ulm, Germany; [Benz, Roland] Jacobs Univ Bremen, Sch Sci & Engn, Bremen, Germany	German Research Foundation (DFG); University of Wurzburg; Ulm University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Ulm University; Jacobs University	Benz, R (corresponding author), Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97070 Wurzburg, Germany.	r.benz@jacobs-university.de; holger.barth@uni-ulm.de	Huber-Lang, Markus/AAJ-2209-2020	Benz, Roland/0000-0002-9510-9265	Deutsche Forschungsgemeinschaft (DFG) [BA 2087/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was financially supported by the Deutsche Forschungsgemeinschaft (DFG grant BA 2087/2-1 to HB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Abrami L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000792; ANDERSEN C, 1995, J GEN PHYSIOL, V105, P385, DOI 10.1085/jgp.105.3.385; Artenstein AW, 2004, J INFECT DIS, V190, P1655, DOI 10.1086/424853; Bachmeyer C, 2003, J MOL BIOL, V333, P527, DOI 10.1016/j.jmb.2003.08.044; Bachmeyer C, 2001, FASEB J, V15, P1658, DOI 10.1096/fj.00-0671fje; BAHNER CT, 1951, J AM CHEM SOC, V73, P3499, DOI 10.1021/ja01151a501; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1987, J MEMBRANE BIOL, V100, P21, DOI 10.1007/BF02209137; Bezrukov SM, 2012, BIOPHYS J, V103, P1208, DOI 10.1016/j.bpj.2012.07.050; Bezrukov SM, 2000, PHYS REV LETT, V85, P202, DOI 10.1103/PhysRevLett.85.202; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; BLAUSTEIN RO, 1990, J GEN PHYSIOL, V96, P921, DOI 10.1085/jgp.96.5.921; Blocker D, 2003, BIOCHEMISTRY-US, V42, P5368, DOI 10.1021/bi034199e; Blocker D, 2001, INFECT IMMUN, V69, P2980, DOI 10.1128/IAI.69.5.2980-2987.2001; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brown MJ, 2011, J BIOL CHEM, V286, P23189, DOI 10.1074/jbc.M111.231167; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; CONTI F, 1975, J PHYSIOL-LONDON, V248, P45, DOI 10.1113/jphysiol.1975.sp010962; Cunningham K, 2002, P NATL ACAD SCI USA, V99, P7049, DOI 10.1073/pnas.062160399; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; EIGEN M, 1964, PROG REACT KINET, V2, P287; Elliott JL, 2000, BIOCHEMISTRY-US, V39, P6706, DOI 10.1021/bi000310u; ESCUYER V, 1991, INFECT IMMUN, V59, P3381, DOI 10.1128/IAI.59.10.3381-3386.1991; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; HAJOS G, 1984, J HETEROCYCLIC CHEM, V21, P809, DOI 10.1002/jhet.5570210334; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Karginov VA, 2005, P NATL ACAD SCI USA, V102, P15075, DOI 10.1073/pnas.0507488102; Karginov VA, 2007, BIOORGAN MED CHEM, V15, P5424, DOI 10.1016/j.bmc.2007.05.058; Karginov VA, 2006, ANTIMICROB AGENTS CH, V50, P3740, DOI 10.1128/AAC.00693-06; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Kronhardt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023133; Lacy DB, 2002, CURR TOP MICROBIOL, V271, P61; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Leppla SH, 1989, ANTHRACIS ANDENYL CY, P153; Menard A, 1996, BIOCHEM J, V320, P687, DOI 10.1042/bj3200687; Menard A, 1996, FEBS LETT, V386, P161, DOI 10.1016/0014-5793(96)00422-X; MESSMER A, 1986, TETRAHEDRON, V42, P4827, DOI 10.1016/S0040-4020(01)82063-9; MILNE JC, 1993, MOL MICROBIOL, V10, P647, DOI 10.1111/j.1365-2958.1993.tb00936.x; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; NEKOLLA S, 1994, BIOPHYS J, V66, P1388, DOI 10.1016/S0006-3495(94)80929-4; Nestorovich EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023927; Nestorovich EM, 2010, BIOPHYS J, V99, P134, DOI 10.1016/j.bpj.2010.03.070; Neumeyer T, 2006, BIOCHEMISTRY-US, V45, P3060, DOI 10.1021/bi0524316; Neumeyer T, 2008, J BIOL CHEM, V283, P3904, DOI 10.1074/jbc.M709807200; Neumeyer T, 2006, J BIOL CHEM, V281, P32335, DOI 10.1074/jbc.M606552200; Orlik F, 2005, BIOPHYS J, V88, P1715, DOI 10.1529/biophysj.104.050336; Orlik F, 2002, BIOPHYS J, V83, P309, DOI 10.1016/S0006-3495(02)75171-0; Palko R, 2006, J ORG CHEM, V71, P7805, DOI 10.1021/jo061361l; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; SINGH Y, 1989, J BIOL CHEM, V264, P11099; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Sun J, 2008, P NATL ACAD SCI USA, V105, P4346, DOI 10.1073/pnas.0800701105; TIMARI G, 1990, J HETEROCYCLIC CHEM, V27, P2005, DOI 10.1002/jhet.5570270730; Tonello F, 2002, NATURE, V418, P386, DOI 10.1038/418386a; Tonello F, 2009, MOL ASPECTS MED, V30, P431, DOI 10.1016/j.mam.2009.07.006; Verveen A A, 1974, Prog Biophys Mol Biol, V28, P189, DOI 10.1016/0079-6107(74)90019-4; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Wohnsland F, 1997, J MEMBRANE BIOL, V158, P77, DOI 10.1007/s002329900245; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zornetta I, 2010, CELL MICROBIOL, V12, P1435, DOI 10.1111/j.1462-5822.2010.01480.x	69	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66099	10.1371/journal.pone.0066099	http://dx.doi.org/10.1371/journal.pone.0066099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840407	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800030
J	Mushtaq, F; Stoet, G; Bland, AR; Schaefer, A				Mushtaq, Faisal; Stoet, Gijsbert; Bland, Amy Rachel; Schaefer, Alexandre			Relative Changes from Prior Reward Contingencies Can Constrain Brain Correlates of Outcome Monitoring	PLOS ONE			English	Article							MEDIAL FRONTAL-CORTEX; FEEDBACK-RELATED NEGATIVITY; STRESSFUL LIFE EVENTS; ANTERIOR CINGULATE; MEDIOFRONTAL NEGATIVITIES; PROACTIVE BRAIN; DECISION-MAKING; TIME-COURSE; ERROR; POTENTIALS	It is well-known that the affective value of an environment can be relative to whether it reflects an improvement or a worsening from a previous state. A potential explanation for this phenomenon suggests that relative changes from previous reward contingencies can constrain how brain monitoring systems form predictions about future events. In support of this idea, we found that changes per se relative to previous states of learned reward contingencies modulated the Feedback-Related Negativity (FRN), a human brain potential known to index discrepancies between predictions and affective outcomes. Specifically, we observed that environments with a 50% reward probability yielded different FRN patterns according to whether they reflected an improvement or a worsening from a previous environment. Further, we also found that this pattern of results was driven mainly by variations in the amplitude of ERPs to positive outcomes. Overall, these results suggest that relative changes in reward probability from previous learned environments can constrain how neural systems of outcome monitoring formulate predictions about the likelihood of future rewards and nonrewards.	[Mushtaq, Faisal] Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England; [Stoet, Gijsbert] Univ Glasgow, Sch Educ, Glasgow, Lanark, Scotland; [Bland, Amy Rachel] Univ Manchester, Neurosci & Psychiat Unit, Manchester, Lancs, England; [Schaefer, Alexandre] Univ Durham, Wolfson Res Inst, Thornaby, England	University of Leeds; University of Glasgow; University of Manchester; Durham University	Mushtaq, F (corresponding author), Univ Leeds, Inst Psychol Sci, Leeds, W Yorkshire, England.	f.mushtaq@leeds.ac.uk; alexandre.schaefer@durham.ac.uk	Stoet, Gijsbert/D-6710-2016; Mushtaq, Faisal/H-4800-2019; Mushtaq, Faisal/H-8770-2013	Stoet, Gijsbert/0000-0002-7557-483X; Mushtaq, Faisal/0000-0001-7881-1127; Mushtaq, Faisal/0000-0001-7881-1127; Bland, Amy/0000-0002-7170-1491; Schaefer, Alexandre/0000-0003-0864-9384	University of Leeds (UK); Biotechnology and Biological Sciences Research Council [BB/H001476/2, BB/H001476/1] Funding Source: researchfish; BBSRC [BB/H001476/2, BB/H001476/1] Funding Source: UKRI	University of Leeds (UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for this study was provided by the University of Leeds (UK), and no additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitsuki Y, 2003, NEUROIMAGE, V19, P1674, DOI 10.1016/S1053-8119(03)00250-7; Alexander WH, 2011, NAT NEUROSCI, V14, P1338, DOI 10.1038/nn.2921; Alexander WH, 2010, NEUROIMAGE, V49, P3210, DOI 10.1016/j.neuroimage.2009.11.065; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Bellebaum C, 2008, EUR J NEUROSCI, V27, P1823, DOI 10.1111/j.1460-9568.2008.06138.x; Bellebaum C, 2010, NEUROPSYCHOLOGIA, V48, P3343, DOI 10.1016/j.neuropsychologia.2010.07.023; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Bland AR, 2011, BRAIN RES, V1417, P55, DOI 10.1016/j.brainres.2011.08.031; Boksem MAS, 2011, PSYCHOPHYSIOLOGY, V48, P973, DOI 10.1111/j.1469-8986.2010.01163.x; Carlson JM, 2011, NEUROIMAGE, V57, P1608, DOI 10.1016/j.neuroimage.2011.05.037; Chase HW, 2011, J COGNITIVE NEUROSCI, V23, P936, DOI 10.1162/jocn.2010.21456; Deng Z, 2012, NEUROSCIENCE LETT; Donkers FCL, 2005, COGNITIVE BRAIN RES, V25, P777, DOI 10.1016/j.cogbrainres.2005.09.007; Donkers FCL, 2005, J PSYCHOPHYSIOL, V19, P256, DOI 10.1027/0269-8803.19.4.256; Elliott R, 2008, EUR J NEUROSCI, V27, P2213, DOI 10.1111/j.1460-9568.2008.06202.x; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Ferdinand NK, 2012, J NEUROSCI, V32, P12087, DOI 10.1523/JNEUROSCI.1410-12.2012; Foti D, 2011, HUM BRAIN MAPP, V32, P2207, DOI 10.1002/hbm.21182; Frank MJ, 2005, NEURON, V47, P495, DOI 10.1016/j.neuron.2005.06.020; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Hajcak G, 2006, BIOL PSYCHOL, V71, P148, DOI 10.1016/j.biopsycho.2005.04.001; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P161, DOI 10.1111/j.1469-8986.2005.00278.x; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P905, DOI 10.1111/j.1469-8986.2007.00567.x; Hermans D, 2001, COGNITION EMOTION, V15, P143, DOI 10.1080/0269993004200033; Holroyd CB, 2004, PSYCHOPHYSIOLOGY, V41, P245, DOI 10.1111/j.1469-8986.2004.00152.x; Holroyd CB, 2003, NEUROREPORT, V14, P2481, DOI 10.1097/00001756-200312190-00037; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2008, PSYCHOPHYSIOLOGY, V45, P688, DOI 10.1111/j.1469-8986.2008.00668.x; Holroyd CB, 2009, COGN AFFECT BEHAV NE, V9, P59, DOI 10.3758/CABN.9.1.59; Ibanez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037306; Ibanez A, 2012, NEUROLOGY, V78, P1354, DOI 10.1212/WNL.0b013e3182518375; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; Joshua M, 2008, J NEUROSCI, V28, P11673, DOI 10.1523/JNEUROSCI.3839-08.2008; Kamarajan C, 2009, BEHAV BRAIN RES, V197, P62, DOI 10.1016/j.bbr.2008.08.011; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Koban L, 2012, COGN AFFECT BEHAV NE, V12, P460, DOI 10.3758/s13415-012-0091-0; Kreussel L, 2012, PSYCHOPHYSIOLOGY, V49, P207, DOI 10.1111/j.1469-8986.2011.01291.x; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Liu YN, 2009, NEUROREPORT, V20, P632, DOI 10.1097/WNR.0b013e32832a3250; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Mai XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018774; Marco-Pallares J, 2011, PSYCHOPHYSIOLOGY, V48, P852, DOI 10.1111/j.1469-8986.2010.01152.x; Mars RB, 2005, NEUROIMAGE, V28, P1007, DOI 10.1016/j.neuroimage.2005.06.041; Moser JS, 2009, PSYCHOPHYSIOLOGY, V46, P313, DOI 10.1111/j.1469-8986.2008.00760.x; Mushtaq F, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00249; Nieuwenhuis S, 2004, NEUROSCI BIOBEHAV R, V28, P441, DOI 10.1016/j.neubiorev.2004.05.003; Nieuwenhuis S, 2004, CEREB CORTEX, V14, P741, DOI 10.1093/cercor/bhh034; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; OKEN BS, 1986, ANN NEUROL, V19, P493, DOI 10.1002/ana.410190511; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Pfabigan DM, 2011, PSYCHOPHYSIOLOGY, V48, P656, DOI 10.1111/j.1469-8986.2010.01136.x; Pfabigan DM, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00100; PLOMIN R, 1992, PERS INDIV DIFFER, V13, P921, DOI 10.1016/0191-8869(92)90009-E; Polezzi D, 2010, NEUROIMAGE, V49, P1886, DOI 10.1016/j.neuroimage.2009.08.068; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Potts GF, 2006, J COGNITIVE NEUROSCI, V18, P1112, DOI 10.1162/jocn.2006.18.7.1112; Price Richard H, 2002, J Occup Health Psychol, V7, P302, DOI 10.1037/1076-8998.7.4.302; Sailer U, 2010, BRAIN RES, V1342, P85, DOI 10.1016/j.brainres.2010.04.051; Sambrook TD, 2012, PSYCHOPHYSIOLOGY, V49, P1533, DOI 10.1111/j.1469-8986.2012.01482.x; San Martin R., 2012, FRONTIERS HUMAN NEUR, V6; San Martin R, 2010, NEUROIMAGE, V51, P1194, DOI 10.1016/j.neuroimage.2010.03.031; Sato A, 2005, NEUROREPORT, V16, P407, DOI 10.1097/00001756-200503150-00020; Schuermann B, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00204; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tukey JW, 1977, EXPLORATORY DATA ANA; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Walsh MM, 2012, NEUROSCI BIOBEHAV R, V36, P1870, DOI 10.1016/j.neubiorev.2012.05.008; Wu Y, 2009, BRAIN RES, V1286, P114, DOI 10.1016/j.brainres.2009.06.032; Yeung N, 2005, CEREB CORTEX, V15, P535, DOI 10.1093/cercor/bhh153; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; Yu F, 2010, INT CONF BIOMED, P1209, DOI 10.1109/BMEI.2010.5639294; Yu R., 2011, PLOS ONE, V6; Zhou ZH, 2010, NEUROPSYCHOLOGIA, V48, P3606, DOI 10.1016/j.neuropsychologia.2010.08.010	76	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66350	10.1371/journal.pone.0066350	http://dx.doi.org/10.1371/journal.pone.0066350			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190LY	23840446	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800049
J	Rangel-Gomez, M; Hickey, C; van Amelsvoort, T; Bet, P; Meeter, M				Rangel-Gomez, Mauricio; Hickey, Clayton; van Amelsvoort, Therese; Bet, Pierre; Meeter, Martijn			The Detection of Novelty Relies on Dopaminergic Signaling: Evidence from Apomorphine's Impact on the Novelty N2	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; MISMATCH NEGATIVITY; STIMULUS NOVELTY; AUDITORY-STIMULI; ERP; BRAIN; COMPONENT; MEMORY; OVEREXPRESSION; PERFORMANCE	Despite much research, it remains unclear if dopamine is directly involved in novelty detection or plays a role in orchestrating the subsequent cognitive response. This ambiguity stems in part from a reliance on experimental designs where novelty is manipulated and dopaminergic activity is subsequently observed. Here we adopt the alternative approach: we manipulate dopamine activity using apomorphine (D1/D2 agonist) and measure the change in neurological indices of novelty processing. In separate drug and placebo sessions, participants completed a von Restorff task. Apomorphine speeded and potentiated the novelty-elicited N2, an Event-Related Potential (ERP) component thought to index early aspects of novelty detection, and caused novel-font words to be better recalled. Apomorphine also decreased the amplitude of the novelty-P3a. An increase in D1/D2 receptor activation thus appears to potentiate neural sensitivity to novel stimuli, causing this content to be better encoded.	[Rangel-Gomez, Mauricio; Hickey, Clayton; Meeter, Martijn] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [van Amelsvoort, Therese] Maastricht Univ, Dept Psychiat & Psychol, Maastricht, Netherlands; [Bet, Pierre] Vrije Univ Amsterdam Med Ctr, Dept Clin Pharmacol & Pharm, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Maastricht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Rangel-Gomez, M (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	m.rangelgomez@vu.nl	Meeter, Martijn/A-2926-2009	Meeter, Martijn/0000-0002-5112-6717; Rangel-Gomez, Mauricio/0000-0002-9079-0346; Hickey, Clayton/0000-0002-4162-5643	VIDI grant from NWO [452-09-007]; VENI grant from NWO [016-125-283]	VIDI grant from NWO; VENI grant from NWO	MM is financially supported by the VIDI grant 452-09-007 from NWO. CH is financially supported by the VENI grant 016-125-283 from NWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht MA, 2010, J PSYCHOPHARMACOLOGY; ALHO K, 1994, PSYCHOPHYSIOLOGY, V31, P469, DOI 10.1111/j.1469-8986.1994.tb01050.x; Barcelo F, 2007, CEREB CORTEX, V17, pI51, DOI 10.1093/cercor/bhm111; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Costa A, 2003, DEMENT GERIATR COGN, V15, P55, DOI 10.1159/000067968; COURCHESNE E, 1975, ELECTROEN CLIN NEURO, V39, P131, DOI 10.1016/0013-4694(75)90003-6; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; Daffner KR, 2000, PSYCHOPHYSIOLOGY, V37, P737, DOI 10.1017/S0048577200990814; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Djamshidian A, 2011, NEUROPSYCHOLOGIA, V49, P2483, DOI 10.1016/j.neuropsychologia.2011.04.026; Ferrari V, 2010, J COGNITIVE NEUROSCI, V22, P404, DOI 10.1162/jocn.2009.21244; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Gabbay FH, 2010, EXP CLIN PSYCHOPHARM, V18, P470, DOI 10.1037/a0021653; Garcia-Garcia M, 2011, NEUROIMAGE, V56, P1641, DOI 10.1016/j.neuroimage.2011.02.053; Garcia-Garcia M, 2010, NEUROPSYCHOLOGIA, V48, P4136, DOI 10.1016/j.neuropsychologia.2010.10.005; Garcia-Garcia M, 2010, NEUROPSYCHOLOGIA, V48, P1483, DOI 10.1016/j.neuropsychologia.2010.01.018; Grzella I, 2001, J PSYCHIATR NEUROSCI, V26, P235; Hansenne M, 2003, HUM PSYCHOPHARM CLIN, V18, P201, DOI 10.1002/hup.468; Hasselmo ME, 1996, HIPPOCAMPUS, V6, P693, DOI 10.1002/(SICI)1098-1063(1996)6:6<693::AID-HIPO12>3.0.CO;2-W; Hazy TE, 2010, NEUROSCI BIOBEHAV R, V34, P701, DOI 10.1016/j.neubiorev.2009.11.019; Hoormann J, 1998, BEHAV RES METH INS C, V30, P103, DOI 10.3758/BF03209420; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kenemans JL, 2011, NEUROPSYCHOPHARMACOL, V36, P26, DOI 10.1038/npp.2010.157; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; Kimura M, 2011, NEUROREPORT, V22, P669, DOI 10.1097/WNR.0b013e32834973ba; Kishiyama MM, 2004, J COGNITIVE NEUROSCI, V16, P15, DOI 10.1162/089892904322755511; Kopp B, 2010, COGN AFFECT BEHAV NE, V10, P316, DOI 10.3758/CABN.10.2.316; Kujala T, 2001, CLIN NEUROPHYSIOL, V112, P1712, DOI 10.1016/S1388-2457(01)00625-3; Li YC, 2011, P NATL ACAD SCI USA, V108, P12107, DOI 10.1073/pnas.1109718108; Meeter M, 2004, HIPPOCAMPUS, V14, P722, DOI 10.1002/hipo.10214; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 1980, Prog Brain Res, V54, P343, DOI 10.1016/S0079-6123(08)61645-3; Nakamura K, 1998, EUR J PHARMACOL, V342, P127, DOI 10.1016/S0014-2999(97)01457-X; Pirtosek Z, 2009, PSYCHIAT DANUB, V21, P114; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Potts GF, 1996, BRAIN TOPOGR, V9, P3, DOI 10.1007/BF01191637; PRASHER D, 1991, J NEUROL NEUROSUR PS, V54, P603, DOI 10.1136/jnnp.54.7.603; Pritchard W., 1991, ADV PSYCHOPHYSIOLOGY, P43; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Rangel-Gomez M, 2013, BRAIN BEHAV; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; RUZICKA E, 1994, J NEUROL NEUROSUR PS, V57, P998, DOI 10.1136/jnnp.57.8.998; SanMiguel I, 2010, BIOL PSYCHOL, V83, P143, DOI 10.1016/j.biopsycho.2009.11.012; Schellekens AFA, 2010, PSYCHOPHARMACOLOGY, V207, P559, DOI 10.1007/s00213-009-1686-1; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; Spencer KM, 1999, PSYCHOPHYSIOLOGY, V36, P409, DOI 10.1017/S0048577299981180; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Szucs D, 2007, NEUROSCI LETT, V412, P18, DOI 10.1016/j.neulet.2006.08.090; TAKESHITA S, 1994, INT J PSYCHOPHYSIOL, V16, P99, DOI 10.1016/0167-8760(94)90046-9; Tarbi EC, 2011, PSYCHOPHYSIOLOGY, V48, P624, DOI 10.1111/j.1469-8986.2010.01129.x; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Van Overschelde JP, 2004, J MEM LANG, V50, P289, DOI 10.1016/j.jml.2003.10.003; von Restorff H, 1933, PSYCHOL FORSCH, V18, P299, DOI 10.1007/BF02409636; Wittmann BC, 2007, NEUROIMAGE, V38, P194, DOI 10.1016/j.neuroimage.2007.06.038	59	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66469	10.1371/journal.pone.0066469	http://dx.doi.org/10.1371/journal.pone.0066469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840482	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800065
J	Klein, G; Schanstra, JP; Hoffmann, J; Mischak, H; Siwy, J; Zimmermann, K				Klein, Guenter; Schanstra, Joost P.; Hoffmann, Janosch; Mischak, Harald; Siwy, Justyna; Zimmermann, Kurt			Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products	PLOS ONE			English	Article							MASS-SPECTROMETRY; BIOMARKER DISCOVERY; ATOPIC-DERMATITIS; DIAGNOSIS; PEPTIDES; PROTEINS; IMPURITY; STRAINS; RISK; GG	Probiotic bacteria have a wide range of applications in veterinary and human therapeutics. Inactivated probiotics are complex samples and quality control (QC) should measure as many molecular features as possible. Capillary electrophoresis coupled to mass spectrometry (CE/MS) has been used as a multidimensional and high throughput method for the identification and validation of biomarkers of disease in complex biological samples such as biofluids. In this study we evaluate the suitability of CE/MS to measure the consistency of different lots of the probiotic formulation Pro-Symbioflor which is a bacterial lysate of heat-inactivated Escherichia coli and Enterococcus faecalis. Over 5000 peptides were detected by CE/MS in 5 different lots of the bacterial lysate and in a sample of culture medium. 71 to 75% of the total peptide content was identical in all lots. This percentage increased to 87-89% when allowing the absence of a peptide in one of the 5 samples. These results, based on over 2000 peptides, suggest high similarity of the 5 different lots. Sequence analysis identified peptides of both E. coli and E. faecalis and peptides originating from the culture medium, thus confirming the presence of the strains in the formulation. Ontology analysis suggested that the majority of the peptides identified for E. coli originated from the cell membrane or the fimbrium, while peptides identified for E. faecalis were enriched for peptides originating from the cytoplasm. The bacterial lysate peptides as a whole are recognised as highly conserved molecular patterns by the innate immune system as microbe associated molecular pattern (MAMP). Sequence analysis also identified the presence of soybean, yeast and casein protein fragments that are part of the formulation of the culture medium. In conclusion CE/MS seems an appropriate QC tool to analyze complex biological products such as inactivated probiotic formulations and allows determining the similarity between lots.	[Klein, Guenter] Univ Vet Med, Inst Food Qual & Food Safety, Hannover, Germany; [Schanstra, Joost P.] Inst Cardiovasc & Metab Dis, INSERM, U1048, Toulouse, France; [Schanstra, Joost P.] Univ Toulouse 3, F-31062 Toulouse, France; [Hoffmann, Janosch; Mischak, Harald; Siwy, Justyna] Mosa Diagnost, Hannover, Germany; [Mischak, Harald] Univ Glasgow, Fac Med Vet & Life Sci, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Siwy, Justyna] Charite, D-13353 Berlin, Germany; [Zimmermann, Kurt] SymbioPharm GmbH, Herborn, Germany	University of Veterinary Medicine Hannover, Foundation; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Glasgow; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Klein, G (corresponding author), Univ Vet Med, Inst Food Qual & Food Safety, Hannover, Germany.	guenter.klein@tiho-hannover.de	Klein, Günter/G-5321-2013; Schanstra, Joost P/X-7724-2018	Klein, Günter/0000-0003-1931-2701; Schanstra, Joost P/0000-0002-7471-372X; Siwy, Justyna/0000-0003-1407-2534; Mischak, Harald/0000-0003-0323-0306	Mosaiques Diagnostics; SymbioPharm GmbH	Mosaiques Diagnostics; SymbioPharm GmbH	H. Mischak is the co-founder and co-owner of Mosaiques Diagnostics. J. Hoffmann and J. Siwy are employed by Mosaiques Diagnostics. Kurt Zimmermann is employed by SymbioPharm GmbH. The authors received no external funding for this study. Only the institutions of the authors funded the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-29; Albalat A, 2011, EXPERT REV PROTEOMIC, V8, P615, DOI [10.1586/EPR.11.46, 10.1586/epr.11.46]; AMG, 2013, ARZN FASS BEK 12 DEZ; Arbeitsgruppe BGVV Probiotische Mikroorganismenkulturen in Lebensmitteln am Bundesinstitut fur gesundheitlichen Verbraucherschutz und Veterinarmedizin BgVV (now BfR), 2000, ERNAHRUNGS UMSCHAU, V47, P191; Bioray, 2013, CYTOFLORA; Carty DM, 2011, HYPERTENSION, V57, P561, DOI 10.1161/HYPERTENSIONAHA.110.164285; Cazzola M, 2012, CURR OPIN PHARMACOL, V12, P300, DOI 10.1016/j.coph.2012.01.019; Collado MC, 2009, CURR DRUG METAB, V10, P68, DOI 10.2174/138920009787048437; Simionato AVC, 2011, J SEP SCI, V34, P947, DOI 10.1002/jssc.201000677; Dehlink E, 2007, J FOOD PROTECT, V70, P2417, DOI 10.4315/0362-028X-70.10.2417; Enck P, 2008, NEUROGASTROENT MOTIL, V20, P1103, DOI 10.1111/j.1365-2982.2008.01156.x; Gaggia F, 2010, INT J FOOD MICROBIOL, V141, pS15, DOI 10.1016/j.ijfoodmicro.2010.02.031; Giese T, 2003, ARZNEIMITTELFORSCH, V53, P385; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Hamilton-Miller JMT, 1999, PUBLIC HEALTH NUTR, V2, P223, DOI 10.1017/S1368980099000282; Haselberg R, 2011, ANAL BIOANAL CHEM, V400, P295, DOI 10.1007/s00216-011-4738-4; Hoffmann J, 2013, CURR OPIN IMMUNOL, V25, P1, DOI 10.1016/j.coi.2013.01.008; Hommerson P, 2009, RAPID COMMUN MASS SP, V23, P2878, DOI 10.1002/rcm.4206; Indrio F, 2011, CURR OPIN PEDIATR, V23, P145, DOI 10.1097/MOP.0b013e3283444ccb; Jahne J, 2013, BERL MUNCH TIERARZTL, V126, P10, DOI 10.2376/0005-9366-126-10; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Lau S, 2012, J ALLERGY CLIN IMMUN, V129, P1040, DOI 10.1016/j.jaci.2012.02.005; Leuschner RGK, 2010, TRENDS FOOD SCI TECH, V21, P425, DOI 10.1016/j.tifs.2010.07.003; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Mischak H, 2011, PROTEOM CLIN APPL, V5, P9, DOI 10.1002/prca.201000058; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; Ohashi Y, 2009, ANIM SCI J, V80, P361, DOI 10.1111/j.1740-0929.2009.00645.x; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; Sanchez-Hernandez L, 2010, J PHARMACEUT BIOMED, V53, P1217, DOI 10.1016/j.jpba.2010.03.031; Sanders ME, 2008, CLIN INFECT DIS, V46, pS58, DOI 10.1086/523341; Santini C, 2010, INT J FOOD MICROBIOL, V141, pS98, DOI 10.1016/j.ijfoodmicro.2010.03.039; Savijoki K, 2011, J PROTEOME RES, V10, P3460, DOI 10.1021/pr2000896; Schiffer E, 2007, WORLD J UROL, V25, P557, DOI 10.1007/s00345-007-0203-6; Sherman PM, 2009, NUTR CLIN PRACT, V24, P10, DOI 10.1177/0884533608329231; Siwy J, 2011, PROTEOM CLIN APPL, V5, P367, DOI 10.1002/prca.201000155; Sun YQ, 2008, CHIN J CHROMATOGR, V26, P160; Theodorescu D, 2005, ELECTROPHORESIS, V26, P2797, DOI 10.1002/elps.200400208; THOMSEN A, 1995, ARZNEIMITTEL-FORSCH, V45-1, P657; Volz T, 2012, ALLERGO J, V21, P470, DOI 10.1007/s15007-012-0443-7; Volz T, 2010, FASEB J, V24, P4089, DOI 10.1096/fj.09-151001; Wittke S, 2003, J CHROMATOGR A, V1013, P173, DOI 10.1016/S0021-9673(03)00713-1; Zhang LY, 2005, J NUTR, V135, P1752, DOI 10.1093/jn/135.7.1752; Zurbig P, 2008, CONTRIB NEPHROL, V160, P107, DOI 10.1159/000125938; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827; Zurbig P, 2008, PEPTIDOMICS: METHODS AND APPLICATIONS, P319	45	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66682	10.1371/journal.pone.0066682	http://dx.doi.org/10.1371/journal.pone.0066682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840518	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000322361200100
J	Walker, AK; Gong, Z; Park, WM; Zigman, JM; Sakata, I				Walker, Angela K.; Gong, Zhi; Park, Won-Mee; Zigman, Jeffrey M.; Sakata, Ichiro			Expression of Serum Retinol Binding Protein and Transthyretin within Mouse Gastric Ghrelin Cells	PLOS ONE			English	Article							DES-ACYL GHRELIN; STIMULATES FOOD-INTAKE; INSULIN-RESISTANCE; O-ACYLTRANSFERASE; PANCREATIC-ISLETS; PLASMA GHRELIN; ENERGY-BALANCE; MESSENGER-RNA; SECRETION; PEPTIDE	Ghrelin is an orexigenic peptide hormone produced mainly by a distinct group of dispersed endocrine cells located within the gastric oxyntic mucosa. Besides secreted gene products derived from the preproghrelin gene, which include acyl-ghrelin, desacyl-ghrelin and obestatin, ghrelin cells also synthesize the secreted protein nesfatin-1. The main goal of the current study was to identify other proteins secreted from ghrelin cells. An initial gene chip screen using mRNAs derived from highly enriched pools of mouse gastric ghrelin cells demonstrated high levels of serum retinol-binding protein (RBP4) and transthyretin (TTR), both of which are known to circulate in the bloodstream bound to each other. This high expression was confirmed by quantitative RT-PCR using as template mRNA derived from the enriched gastric ghrelin cell pools and from two ghrelin-producing cell lines (SG-1 and PG-1). RBP4 protein also was shown to be secreted into the culture medium of ghrelin cell lines. Neither acute nor chronic caloric restriction had a significant effect on RBP4 mRNA levels within stomachs of C57BL/6J mice, although both manipulations significantly decreased stomach TTR mRNA levels. In vitro studies using PG-1 cells showed no effect on RBP4 release of octanoic acid, epinephrine or norepinephrine, all of which are known to act directly on ghrelin cells to stimulate ghrelin secretion. These data provide new insights into ghrelin cell physiology, and given the known functions of RBP4 and TTR, support an emerging role for the ghrelin cell in blood glucose handling and metabolism.	[Walker, Angela K.; Park, Won-Mee; Zigman, Jeffrey M.; Sakata, Ichiro] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA; [Walker, Angela K.; Park, Won-Mee; Zigman, Jeffrey M.; Sakata, Ichiro] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Endocrinol & Metab, Dallas, TX 75390 USA; [Walker, Angela K.; Park, Won-Mee; Zigman, Jeffrey M.; Sakata, Ichiro] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Gong, Zhi] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Area Regulatory Biol, Saitama 3388570, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Saitama University	Zigman, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Hypothalam Res, Dallas, TX 75390 USA.	jeffrey.zigman@utsouthwestern.edu	Sakata, Ichiro/F-9194-2012	Sakata, Ichiro/0000-0002-6067-0407; Zigman, Jeffrey/0000-0003-3477-1295	International Research Alliance; Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen	International Research Alliance; Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen	This work was funded by an International Research Alliance with The Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Asakawa A, 2005, GUT, V54, P18, DOI 10.1136/gut.2004.038737; BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; CAVALLARO T, 1990, INVEST OPHTH VIS SCI, V31, P497; Chuang JC, 2011, MOL ENDOCRINOL, V25, P1600, DOI 10.1210/me.2011-1001; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; de la Cour CD, 2001, REGUL PEPTIDES, V99, P141, DOI 10.1016/S0167-0115(01)00243-9; Dezaki K, 2004, DIABETES, V53, P3142, DOI 10.2337/diabetes.53.12.3142; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; Erlandsen SE, 2012, REGUL PEPT; Field BCT, 2010, NAT REV ENDOCRINOL, V6, P444, DOI 10.1038/nrendo.2010.93; Gagnon J, 2013, DIABETES OBES METAB, V15, P276, DOI 10.1111/dom.12021; Gagnon J, 2013, ENDOCRINOLOGY, V154, P666, DOI 10.1210/en.2012-1994; Gagnon J, 2012, ENDOCRINOLOGY, V153, P3646, DOI 10.1210/en.2012-1040; Gourcerol G, 2007, OBESITY, V15, P2643, DOI 10.1038/oby.2007.316; Graham TE, 2007, HORM METAB RES, V39, P717, DOI 10.1055/s-2007-985879; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Gutierrez JA, 2008, P NATL ACAD SCI USA, V105, P6320, DOI 10.1073/pnas.0800708105; Haider DG, 2007, J CLIN ENDOCR METAB, V92, P1168, DOI 10.1210/jc.2006-1839; Hosoda H, 2000, BIOCHEM BIOPH RES CO, V279, P909, DOI 10.1006/bbrc.2000.4039; Ikezaki A, 2002, DIABETES, V51, P3408, DOI 10.2337/diabetes.51.12.3408; Iwakura H, 2011, ENDOCRINOLOGY, V152, P2619, DOI 10.1210/en.2010-1455; Iwakura H, 2010, ENDOCRINOLOGY, V151, P2940, DOI 10.1210/en.2010-0090; JACOBSSON B, 1989, HISTOCHEMISTRY, V91, P299, DOI 10.1007/BF00493004; KATO M, 1985, P NATL ACAD SCI USA, V82, P2488, DOI 10.1073/pnas.82.8.2488; Kobelt P, 2008, PEPTIDES, V29, P1018, DOI 10.1016/j.peptides.2008.01.020; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kwon GS, 2009, GENESIS, V47, P447, DOI 10.1002/dvg.20522; Lu X, 2012, AM J PHYSL GASTROINT; Lutter M, 2008, NAT NEUROSCI, V11, P752, DOI 10.1038/nn.2139; MAKOVER A, 1989, J LIPID RES, V30, P171; MARTONE RL, 1988, BIOCHEM BIOPH RES CO, V157, P1078, DOI 10.1016/S0006-291X(88)80984-7; Mizutani M, 2009, AM J PHYSIOL-GASTR L, V297, pG974, DOI 10.1152/ajpgi.00147.2009; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Neary NM, 2006, GUT, V55, P135; Nogueiras R, 2007, ENDOCRINOLOGY, V148, P21, DOI 10.1210/en.2006-0915; Ozawa A, 2007, ANAL BIOCHEM, V366, P182, DOI 10.1016/j.ab.2007.04.020; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Poykko SM, 2003, DIABETES, V52, P2546, DOI 10.2337/diabetes.52.10.2546; Quadro L, 2004, J LIPID RES, V45, P1975, DOI 10.1194/jlr.M400137-JLR200; Richardson SJ, 2009, FEBS J, V276, P5342, DOI 10.1111/j.1742-4658.2009.07244.x; Rindi G, 2002, HISTOCHEM CELL BIOL, V117, P511, DOI 10.1007/s00418-002-0415-1; Riva M, 2011, CELL TISSUE RES, V346, P393, DOI 10.1007/s00441-011-1268-5; Robbins J., 2000, THYROID A FUNDAMENTA, V8th ed., P105; ROUILLE Y, 1995, J BIOL CHEM, V270, P26488, DOI 10.1074/jbc.270.44.26488; Sakata I, 2002, PEPTIDES, V23, P531, DOI 10.1016/S0196-9781(01)00633-7; Sakata I, 2012, AM J PHYSIOL-ENDOC M, V302, pE1300, DOI 10.1152/ajpendo.00041.2012; Sakata I, 2009, AM J PHYSIOL-ENDOC M, V297, pE134, DOI 10.1152/ajpendo.90859.2008; Sakata I, 2009, REGUL PEPTIDES, V155, P91, DOI 10.1016/j.regpep.2009.04.001; Sanger GJ, 2008, NAT REV DRUG DISCOV, V7, P241, DOI 10.1038/nrd2444; Santos SD, 2010, J NEUROCHEM, V115, P1434, DOI 10.1111/j.1471-4159.2010.07047.x; Seoane LM, 2006, J ENDOCRINOL INVEST, V29, pRC13, DOI 10.1007/BF03344174; SOPRANO DR, 1988, J BIOL CHEM, V263, P2934; Stengel A, 2009, ENDOCRINOLOGY, V150, P232, DOI 10.1210/en.2008-0747; Stengel A, 2012, J NEUROGASTROENTEROL, V18, P138, DOI 10.5056/jnm.2012.18.2.138; Stengel A, 2010, PEPTIDES, V31, P357, DOI 10.1016/j.peptides.2009.11.019; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Toshinai K, 2006, ENDOCRINOLOGY, V147, P2306, DOI 10.1210/en.2005-1357; Toshinai K, 2001, BIOCHEM BIOPH RES CO, V281, P1220, DOI 10.1006/bbrc.2001.4518; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; van Bennekum AM, 2001, J BIOL CHEM, V276, P1107, DOI 10.1074/jbc.M008091200; Walker AK, 2012, PHYSIOL BEHAV, V108, P34, DOI 10.1016/j.physbeh.2012.10.003; Westermark GT, 2008, EXP DIABETES RES, DOI 10.1155/2008/429274; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Yabuki A, 2004, J ANAT, V205, P239, DOI 10.1111/j.0021-8782.2004.00331.x; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zhang JV, 2005, SCIENCE, V310, P996, DOI 10.1126/science.1117255; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P15868, DOI 10.1073/pnas.1011116107; Zhao TJ, 2010, P NATL ACAD SCI USA, V107, P7467, DOI 10.1073/pnas.1002271107; Zhu XR, 2006, J BIOL CHEM, V281, P38867, DOI 10.1074/jbc.M607955200; Zigman JM, 2005, J CLIN INVEST, V115, P3564, DOI 10.1172/JCI26002	74	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e64882	10.1371/journal.pone.0064882	http://dx.doi.org/10.1371/journal.pone.0064882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840311	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200008
J	Wan, GH; Yan, DC; Tung, TH; Tang, CS; Liu, CH				Wan, Gwo-Hwa; Yan, Dah-Chin; Tung, Tao-Hsin; Tang, Chin-Sheng; Liu, Chiu-Hsin			Seasonal Changes in Endotoxin Exposure and Its Relationship to Exhaled Nitric Oxide and Exhaled Breath Condensate pH Levels in Atopic and Healthy Children	PLOS ONE			English	Article							HOUSE-DUST ENDOTOXIN; ACID-BASE-EQUILIBRIUM; CHILDHOOD ASTHMA; BIRTH COHORT; LUNG INFLAMMATION; ALLERGIC RHINITIS; UNSTABLE ASTHMA; EARLY-LIFE; DETERMINANTS; HOMES	Endotoxin, a component of the cell walls of gram-negative bacteria, is a contaminant in organic dusts (house dust) and aerosols. In humans, small amounts of endotoxin may cause a local inflammatory response. Exhaled nitric oxide (eNO) levels, an inflammation indicator, are associated with the pH values of exhaled breath condensate (EBC). This study evaluated seasonal changes on indoor endotoxin concentrations in homes and the relationships between endotoxin exposure and eNO/EBC pH levels for healthy children and children with allergy-related respiratory diseases. In total, 34 children with allergy-related respiratory diseases and 24 healthy children were enrolled. Indoor air quality measurements and dust sample analysis for endotoxin were conducted once each season inside 58 surveyed homes. The eNO, EBC pH levels, and pulmonary function of the children were also determined. The highest endotoxin concentrations were on kitchen floors of homes of children with allergy-related respiratory diseases and healthy children, and on bedroom floors of homes of asthmatic children and healthy children. Seasonal changes existed in endotoxin concentrations in dust samples from homes of children with allergic rhinitis, with or without asthma, and in EBC pH values among healthy children and those with allergy-related respiratory diseases. Strong relationships existed between endotoxin exposure and EBC pH values in children with allergic rhinitis.	[Wan, Gwo-Hwa; Liu, Chiu-Hsin] Chang Gung Univ, Dept Resp Therapy, Coll Med, Tao Yuan, Taiwan; [Yan, Dah-Chin] Chang Gung Mem Hosp, Div Taipei Pediat, Dept Pediat, Chang Gung Childrens Hosp, Taipei 10591, Taiwan; [Yan, Dah-Chin] Chang Gung Univ, Dept Med, Coll Med, Tao Yuan, Taiwan; [Tung, Tao-Hsin] Cheng Hsin Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Tang, Chin-Sheng] Fu Jen Catholic Univ, Coll Med, Dept Publ Hlth, New Taipei City, Taiwan; [Yan, Dah-Chin] Chang Gung Mem Hosp, Dept Resp Therapy, Taipei 10591, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Cheng Hsin General Hospital; Fu Jen Catholic University; Chang Gung Memorial Hospital	Wan, GH (corresponding author), Chang Gung Univ, Dept Resp Therapy, Coll Med, Tao Yuan, Taiwan.	ghwan@mail.cgu.edu.tw			National Science Council of Taiwan [NSC95-2314-B-182-056, NSC96-2314-B-182-017]; Chang Gung Memorial Hospital, Taiwan [CMRPD150091]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This study was supported by grants NSC95-2314-B-182-056 and NSC96-2314-B-182-017 from the National Science Council of Taiwan. Also, the authors would like to thank the Chang Gung Memorial Hospital, Taiwan, for financially supporting this research under grants CMRPD150091. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JH, 2005, ENVIRON HEALTH PERSP, V113, P1516, DOI 10.1289/ehp.7632; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bolte G, 2003, CLIN EXP ALLERGY, V33, P770, DOI 10.1046/j.1365-2222.2003.01665.x; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Brozek JL, 2010, J ALLERGY CLIN IMMUN, V126, P466, DOI 10.1016/j.jaci.2010.06.047; Brunetti L, 2006, PEDIAT ALLERG IMM-UK, V17, P422, DOI 10.1111/j.1399-3038.2006.00426.x; Carraro S, 2005, ALLERGY, V60, P476, DOI 10.1111/j.1398-9995.2005.00718.x; Celedon JC, 2007, J ALLERGY CLIN IMMUN, V120, P144, DOI 10.1016/j.jaci.2007.03.037; Cieslewicz G, 1999, J CLIN INVEST, V104, P301, DOI 10.1172/JCI7010; de Kluijver J, 2002, AM J RESP CRIT CARE, V166, P294, DOI 10.1164/rccm.2112097; Douwes J, 2003, ANN OCCUP HYG, V47, P187, DOI 10.1093/annhyg/meg032; Gehring U, 2001, J ALLERGY CLIN IMMUN, V108, P847, DOI 10.1067/mai.2001.119026; Giovannangelo M, 2007, INDOOR AIR, V17, P70, DOI 10.1111/j.1600-0668.2006.00461.x; Glorieux G, 2009, NEPHROL DIAL TRANSPL, V24, P548, DOI 10.1093/ndt/gfn485; Holguin F, 2007, AM J RESP CRIT CARE, V176, P1236, DOI 10.1164/rccm.200611-1616OC; Kay AB, 2001, NEW ENGL J MED, V344, P109, DOI 10.1056/NEJM200101113440206; Kline JN, 1999, AM J RESP CRIT CARE, V160, P297, DOI 10.1164/ajrccm.160.1.9808144; Kwok MY, 2006, PEDIATRICS, V117, pS71, DOI 10.1542/peds.2005-2000D; Leung TF, 2010, INT ARCH ALLERGY IMM, V152, P279, DOI 10.1159/000283039; Liao MF, 2009, J ASTHMA, V46, P541, DOI 10.1080/02770900902795546; Liao VHC, 2010, SCI TOTAL ENVIRON, V408, P1530, DOI 10.1016/j.scitotenv.2010.01.007; Litonjua AA, 2002, J ALLERGY CLIN IMMUN, V110, P736, DOI 10.1067/mai.2002.128948; Malmberg LP, 2003, THORAX, V58, P494, DOI 10.1136/thorax.58.6.494; Monn C, 2003, ENVIRON RES, V91, P35, DOI 10.1016/S0013-9351(02)00021-X; Navratil M, 2009, J ASTHMA, V46, P822, DOI 10.3109/02770900903159718; Nicolaou NC, 2006, AM J RESP CRIT CARE, V174, P254, DOI 10.1164/rccm.200601-140OC; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Paramesh H., 2008, International Journal of Environment and Health, V2, P410, DOI 10.1504/IJENVH.2008.020932; Park JH, 2001, AM J RESP CRIT CARE, V163, P322, DOI 10.1164/ajrccm.163.2.2002088; Pirie RS, 2003, CLIN EXP ALLERGY, V33, P1289, DOI 10.1046/j.1365-2745.2003.01651.x; Ratnawati, 2006, PEDIATR PULM, V41, P929, DOI 10.1002/ppul.20469; Roberts G, 2004, THORAX, V59, P752, DOI 10.1136/thx.2003.008722; Shahid SK, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-79; Singh J, 2005, J ALLERGY CLIN IMMUN, V115, P330, DOI 10.1016/j.jaci.2004.11.021; Sordillo JE, 2011, J ALLERGY CLIN IMMUN, V127, P1165, DOI 10.1016/j.jaci.2011.01.066; Tamagawa E, 2008, AM J PHYSIOL-LUNG C, V295, pL79, DOI 10.1152/ajplung.00048.2007; Thorne PS, 2009, ENVIRON HEALTH PERSP, V117, P763, DOI 10.1289/ehp.11759; Thorne PS, 2004, AM J IND MED, V46, P419, DOI 10.1002/ajim.20066; Thorne PS, 2005, AM J RESP CRIT CARE, V172, P1371, DOI 10.1164/rccm.200505-758OC; Thorne PS, 1999, AM J RESP CELL MOL, V20, P1155, DOI 10.1165/ajrcmb.20.6.3632; Tomasiak-Lozowska MM, 2012, INT ARCH ALLERGY IMM, V159, P121, DOI 10.1159/000335674; Wickens K, 2003, INDOOR AIR, V13, P128, DOI 10.1034/j.1600-0668.2003.00187.x; Zanconato S, 2004, J ALLERGY CLIN IMMUN, V113, P257, DOI 10.1016/j.jaci.2003.10.046	43	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66785	10.1371/journal.pone.0066785	http://dx.doi.org/10.1371/journal.pone.0066785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840530	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200105
J	Au, SLK; Wong, CCL; Lee, JMF; Wong, CM; Ng, IOL				Au, Sandy Leung-Kuen; Wong, Carmen Chak-Lui; Lee, Joyce Man-Fong; Wong, Chun-Ming; Ng, Irene Oi-Lin			EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HEPATOCELLULAR-CARCINOMA CELLS; HISTONE METHYLTRANSFERASE EZH2; TUMOR-SUPPRESSOR GENES; GROUP PROTEIN EZH2; PROSTATE-CANCER; LYSINE-27 METHYLATION; DEVELOPMENTAL GENES; BREAST-CANCER; DLC-1 GENE	Enhancer of zeste homolog 2 (EZH2), the histone methyltransferase of the Polycomb Repressive complex 2 catalyzing histone H3 lysine 27 tri-methylation (H3K27me3), is frequently up-regulated in human cancers. In this study, we identified the tumor suppressor Deleted in liver cancer 1 (DLC1) as a target of repression by EZH2-mediated H3K27me3. DLC1 is a GTPase-activating protein for Rho family proteins. Inactivation of DLC1 results in hyper-activated Rho/ROCK signaling and is implicated in actin cytoskeleton reorganization to promote cancer metastasis. By chromatin immunoprecipitation assay, we demonstrated that H3K27me3 was significantly enriched at the DLC1 promoter region of a DLC1-nonexpressing HCC cell line, MHCC97L. Depletion of EZH2 in MHCC97L by shRNA reduced H3K27me3 level at DLC1 promoter and induced DLC1 gene re-expression. Conversely, transient overexpression of GFP-EZH2 in DLC1-expressing Huh7 cells reduced DLC1 mRNA level with a concomitant enrichment of EZH2 on DLC1 promoter. An inverse relation between EZH2 and DLC1 expression was observed in the liver, lung, breast, prostate, and ovarian cancer tissues. Treating cancer cells with the EZH2 small molecular inhibitor, 3-Deazaneplanocin A (DZNep), restored DLC1 expression in different cancer cell lines, indicating that EZH2-mediated H3K27me3 epigenetic regulation of DLC1 was a common mechanism in human cancers. Importantly, we found that DZNep treatment inhibited HCC cell migration through disrupting actin cytoskeleton network, suggesting the therapeutic potential of DZNep in targeting cancer metastasis. Taken together, our study has shed mechanistic insight into EZH2-H3K27me3 epigenetic repression of DLC1 and advocated the significant pro-metastatic role of EZH2 via repressing tumor and metastasis suppressors.	[Ng, Irene Oi-Lin] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Ng, IOL (corresponding author), Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China.	iolng@hkucc.hku.hk	WONG, Chun-Ming/A-6739-2009; Wong, Carmen Chak Lui/C-4660-2009	WONG, Chun-Ming/0000-0002-2497-7858; Ng, Irene Oi-lin/0000-0001-7532-2029; Wong, Carmen Chak Lui/0000-0001-5866-4705	University of Hong Kong Seed Funding Program for Basic Research [200811159061, 201011159045]; Hong Kong Research Grants Council General Research Fund [HKU 782411M]; Hong Kong Research Grants Council Collaborative Research Fund [HKU 1/06C, HKU 7/CRG/09]	University of Hong Kong Seed Funding Program for Basic Research; Hong Kong Research Grants Council General Research Fund(Hong Kong Research Grants Council); Hong Kong Research Grants Council Collaborative Research Fund(Hong Kong Research Grants Council)	The study was supported by The University of Hong Kong Seed Funding Program for Basic Research (200811159061 and 201011159045 to CMW), Hong Kong Research Grants Council General Research Fund (HKU 782411M to CMW) and Hong Kong Research Grants Council Collaborative Research Fund (HKU 1/06C and HKU 7/CRG/09 to IN). IN is Loke Yew Professor in Pathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib TR, 2004, BRIT J CANCER, V90, P686, DOI 10.1038/sj.bjc.6601603; Au SLK, 2012, HEPATOLOGY, V56, P622, DOI 10.1002/hep.25679; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chiba T, 2012, INT J CANCER, V130, P2557, DOI 10.1002/ijc.26264; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Fujii S, 2008, J BIOL CHEM, V283, P17324, DOI 10.1074/jbc.M800224200; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li Y, 2001, WORLD J GASTROENTERO, V7, P630; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Plimack ER, 2007, LEUKEMIA LYMPHOMA, V48, P1472, DOI 10.1080/10428190701471981; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Seng TJ, 2007, ONCOGENE, V26, P934, DOI 10.1038/sj.onc.1209839; Shih YP, 2010, CANCER RES, V70, P8270, DOI 10.1158/0008-5472.CAN-10-1174; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Taniguchi H, 2012, ONCOGENE, V31, P1988, DOI 10.1038/onc.2011.387; Ullmannova V, 2006, INT J ONCOL, V29, P1127; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wong CCL, 2009, HEPATOLOGY, V49, P1583, DOI 10.1002/hep.22836; Wong CC, 2008, PLOS ONE, V3, pe2779, DOI [10.1371/journal.pone.0002779, DOI 10.1371/J0URNAL.P0NE.0002779.PUBMED:18648664]; Wong CM, 2003, CANCER RES, V63, P7646; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Yu J, 2010, ONCOGENE, V29, P5370, DOI 10.1038/onc.2010.269; Yuan BZ, 1998, CANCER RES, V58, P2196; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhou XL, 2004, ONCOGENE, V23, P1308, DOI 10.1038/sj.onc.1207246	49	41	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68226	10.1371/journal.pone.0068226	http://dx.doi.org/10.1371/journal.pone.0068226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826380	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000134
J	Bednarczyk, P; Wieckowski, MR; Broszkiewicz, M; Skowronek, K; Siemen, D; Szewczyk, A				Bednarczyk, Piotr; Wieckowski, Mariusz R.; Broszkiewicz, Malgorzata; Skowronek, Krzysztof; Siemen, Detlef; Szewczyk, Adam			Putative Structural and Functional Coupling of the Mitochondrial BKCa Channel to the Respiratory Chain	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; POTASSIUM CHANNEL; MEMBRANE; MODULATION; ACTIVATION; COMPLEX	Potassium channels have been found in the inner mitochondrial membranes of various cells. These channels regulate the mitochondrial membrane potential, the matrix volume and respiration. The activation of these channels is cytoprotective. In our study, the single-channel activity of a large-conductance Ca2+-regulated potassium channel (mitoBK(Ca) channel) was measured by patch-clamping mitoplasts isolated from the human astrocytoma (glioblastoma) U-87 MG cell line. A potassium-selective current was recorded with a mean conductance of 290 pS in symmetrical 150 mM KCl solution. The channel was activated by Ca2+ at micromolar concentrations and by the potassium channel opener NS1619. The channel was inhibited by paxilline and iberiotoxin, known inhibitors of BKCa channels. Western blot analysis, immuno-gold electron microscopy, high-resolution immunofluorescence assays and polymerase chain reaction demonstrated the presence of the BKCa channel beta 4 subunit in the inner mitochondrial membrane of the human astrocytoma cells. We showed that substrates of the respiratory chain, such as NADH, succinate, and glutamate/malate, decrease the activity of the channel at positive voltages. This effect was abolished by rotenone, antimycin and cyanide, inhibitors of the respiratory chain. The putative interaction of the beta 4 subunit of mitoBK(Ca) with cytochrome c oxidase was demonstrated using blue native electrophoresis. Our findings indicate possible structural and functional coupling of the mitoBK(Ca) channel with the mitochondrial respiratory chain in human astrocytoma U-87 MG cells.	[Bednarczyk, Piotr; Skowronek, Krzysztof; Szewczyk, Adam] Nencki Inst Expt Biol, Lab Intracellular Ion Channels, Warsaw, Poland; [Bednarczyk, Piotr] Warsaw Univ Life Sci SGGW, Dept Biophys, Warsaw, Poland; [Wieckowski, Mariusz R.] Nencki Inst Expt Biol, Lab Bioenerget & Biomembranes, Warsaw, Poland; [Skowronek, Krzysztof] Int Inst Mol & Cell Biol, Lab Bioinformat & Prot Engn, Warsaw, Poland; [Siemen, Detlef] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Broszkiewicz, Malgorzata] Nencki Inst Expt Biol, Lab Mol & System Neuromorphol, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Warsaw University of Life Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Otto von Guericke University; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Szewczyk, A (corresponding author), Nencki Inst Expt Biol, Lab Intracellular Ion Channels, Warsaw, Poland.	adam@nencki.gov.pl	Bednarczyk, Piotr/B-4973-2018; Broszkiewicz, Marzenna/S-9893-2016; Skowronek, Krzysztof/G-2855-2010	Bednarczyk, Piotr/0000-0002-7125-0715; Broszkiewicz, Marzenna/0000-0002-4868-6350; Skowronek, Krzysztof/0000-0001-9973-7085; Szewczyk, Adam/0000-0001-5519-260X; Wieckowski, Mariusz/0000-0003-0789-4521	Ministry of Science and Higher Education [793/N-DAAD/2010/0]; DAAD Short-Term Fellowship [A/08/06055]; Polish Mitochondrial Network, MitoNet.pl; DZNE (Deutches Zentrum fur Neurodegenerative Erkrankungen)	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); DAAD Short-Term Fellowship; Polish Mitochondrial Network, MitoNet.pl; DZNE (Deutches Zentrum fur Neurodegenerative Erkrankungen)	This study was supported by a grant from the Ministry of Science and Higher Education to AS (No 793/N-DAAD/2010/0) and a DAAD Short-Term Fellowship to PB (A/08/06055). The Polish Mitochondrial Network, MitoNet.pl, supported part of this study. Support to DS by the DZNE (Deutches Zentrum fur Neurodegenerative Erkrankungen) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ASN00022011 ANSIATCC; Ardehali H, 2004, P NATL ACAD SCI USA, V101, P11880, DOI 10.1073/pnas.0401703101; Bednarczyk P, 2010, BIOCHEM BIOPH RES CO, V397, P614, DOI 10.1016/j.bbrc.2010.06.011; Cheng Y, 2008, CELL PHYSIOL BIOCHEM, V22, P127, DOI 10.1159/000149790; Cheng Y, 2011, CELL PHYSIOL BIOCHEM, V27, P191, DOI 10.1159/000327944; DiChiara TJ, 1997, J NEUROSCI, V17, P4942; Douglas RM, 2006, NEUROSCIENCE, V139, P1249, DOI 10.1016/j.neuroscience.2006.01.061; Foster DB, 2012, CIRC RES, V111, P446, DOI 10.1161/CIRCRESAHA.112.266445; Hanley PJ, 2005, J MOL CELL CARDIOL, V39, P17, DOI 10.1016/j.yjmcc.2005.04.002; Heinen A, 2007, AM J PHYSIOL-CELL PH, V292, pC148, DOI 10.1152/ajpcell.00215.2006; Kajma A, 2012, BBA-BIOENERGETICS, V1817, P1867, DOI 10.1016/j.bbabio.2012.02.029; Kathiresan T, 2009, MOL CELL PROTEOMICS, V8, P1972, DOI 10.1074/mcp.M800495-MCP200; Koszela-Piotrowska I, 2009, BIOCHEM J, V424, P307, DOI 10.1042/BJ20090991; Liu YP, 2002, CLIN EXP PHARMACOL P, V29, P305, DOI 10.1046/j.1440-1681.2002.03649.x; Masters JR, 2001, P NATL ACAD SCI USA, V98, P8012, DOI 10.1073/pnas.121616198; Mathiisen TM, 2006, NEUROANATOMICAL TRACT-TRACING 3: MOLECULES, NEURONS, AND SYSTEMS, P72; O'Rourke B, 2004, CIRC RES, V94, P420, DOI 10.1161/01.RES.0000117583.66950.43; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Ohya S, 2005, AM J PHYSIOL-HEART C, V289, pH1635, DOI 10.1152/ajpheart.00016.2005; Piwonska M, 2008, NEUROSCIENCE, V153, P446, DOI 10.1016/j.neuroscience.2008.01.050; Queliconi BB, 2011, BBA-MOL CELL RES, V1813, P1309, DOI 10.1016/j.bbamcr.2010.11.005; Raffaello A, 2012, CELL CALCIUM, V52, P16, DOI 10.1016/j.ceca.2012.04.006; Sato T, 2005, CIRCULATION, V111, P198, DOI 10.1161/01.CIR.0000151099.15706.B1; Siemen D, 1999, BIOCHEM BIOPH RES CO, V257, P549, DOI 10.1006/bbrc.1999.0496; Skalska J, 2008, BBA-BIOENERGETICS, V1777, P651, DOI 10.1016/j.bbabio.2008.05.007; Sokolowski B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028532; Stowe DF, 2013, BBA-BIOMEMBRANES, V1828, P427, DOI 10.1016/j.bbamem.2012.08.031; Stowe DF, 2006, AM J PHYSIOL-HEART C, V290, pH434, DOI 10.1152/ajpheart.00763.2005; Szabo I, 2005, J BIOL CHEM, V280, P12790, DOI 10.1074/jbc.M413548200; Szabo I, 2012, PFLUG ARCH EUR J PHY, V463, P231, DOI 10.1007/s00424-011-1058-7; Thiede A, 2012, BBA-BIOENERGETICS, V1817, P1747, DOI 10.1016/j.bbabio.2012.02.034; Wang ZW, 1997, J GEN PHYSIOL, V110, P35, DOI 10.1085/jgp.110.1.35; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Zhang DX, 2001, CIRC RES, V89, P1177, DOI 10.1161/hh2401.101752	34	78	79	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68125	10.1371/journal.pone.0068125	http://dx.doi.org/10.1371/journal.pone.0068125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826369	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000123
J	Chen, JW; Feng, G; Song, Y; Wardenburg, JB; Lin, S; Inoshima, I; Otto, M; Wunderink, RG				Chen, Jiwang; Feng, Gang; Song, Yang; Wardenburg, Juliane B.; Lin, Simon; Inoshima, Ichiro; Otto, Michael; Wunderink, Richard G.			Linezolid Exerts Greater Bacterial Clearance but No Modification of Host Lung Gene Expression Profiling: A Mouse MRSA Pneumonia Model	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; ILLUMINA MICROARRAY; DISEASE-ONTOLOGY; ANTIBIOTICS; INFECTION; SEPSIS; PATHOGENESIS; MANAGEMENT; CELLS	Background: Linezolid (LZD) is beneficial to patients with MRSA pneumonia, but whether and how LZD influences global host lung immune responses at the mRNA level during MRSA-mediated pneumonia is still unknown. Methods: A lethal mouse model of MRSA pneumonia mediated by USA300 was employed to study the influence of LZD on survival, while the sublethal mouse model was used to examine the effect of LZD on bacterial clearance and lung gene expression during MRSA pneumonia. LZD (100mg/kg/day, IP) was given to C57Bl6 mice for three days. On Day 1 and Day 3 post infection, bronchoalveolar lavage fluid (BALF) protein concentration and levels of cytokines including IL6, TNF alpha, IL1 beta, Interferon-gamma and IL17 were measured. In the sublethal model, left lungs were used to determine bacterial clearance and right lungs for whole-genome transcriptional profiling of lung immune responses. Results: LZD therapy significantly improved survival and bacterial clearance. It also significantly decreased BALF protein concentration and levels of cytokines including IL6, IL1 beta, Interferon-gamma and IL17. No significant gene expression changes in the mouse lungs were associated with LZD therapy. Conclusion: LZD is beneficial to MRSA pneumonia, but it does not modulate host lung immune responses at the transcriptional level.	[Chen, Jiwang; Wunderink, Richard G.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Chen, Jiwang] Univ Illinois, Sect Pulm Crit Care Med Allergy & Sleep, Chicago, IL USA; [Feng, Gang; Lin, Simon] Northwestern Univ, Biomed Informat Ctr, Chicago, IL 60611 USA; [Song, Yang] Illinois State Univ, Microbiol Grp, Sch Biol Sci, Normal, IL 61761 USA; [Wardenburg, Juliane B.; Inoshima, Ichiro] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Lin, Simon] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Otto, Michael] NIAID, Bethesda, MD 20892 USA	Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; Illinois State University; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chen, JW (corresponding author), Northwestern Univ, Dept Med, Chicago, IL 60611 USA.	chenjw@uic.edu	song, yang/P-1033-2015	Otto, Michael/0000-0002-2222-4115; Wunderink, Richard/0000-0002-8527-4195	Pfizer [WS1826185]; National Center for Advancing Translational Sciences Grant [8UL1TR000150]; NCI Cancer Center Support Grant [NCI CA060553]; Intramural Research Program of the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000904] Funding Source: NIH RePORTER	Pfizer(Pfizer); National Center for Advancing Translational Sciences Grant; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Pfizer ASPIRE Award, Pfizer Investigator-Initiated Grant (WS1826185, to JC), the National Center for Advancing Translational Sciences Grant (8UL1TR000150) and the NCI Cancer Center Support Grant (NCI CA060553 to GF and SL) and the Intramural Research Program of the NIAID (to MO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adem PV, 2005, NEW ENGL J MED, V353, P1245, DOI 10.1056/NEJMoa044194; Akinnusi ME, 2011, CRIT CARE MED, V39, P1944, DOI 10.1097/CCM.0b013e31821bd79e; Andes D, 2002, ANTIMICROB AGENTS CH, V46, P3484, DOI 10.1128/AAC.46.11.3484-3489.2002; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; Cangara HM, 2010, MICROVASC RES, V80, P133, DOI 10.1016/j.mvr.2010.02.006; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Deng YM, 2011, FASEB J, V25, P703, DOI 10.1096/fj.10-171488; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Draganov D, 2010, ADV EXP MED BIOL, V660, P89, DOI 10.1007/978-1-60761-350-3_9; Du P, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-16; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Du P, 2009, BIOINFORMATICS, V25, pI63, DOI 10.1093/bioinformatics/btp193; Dumitrescu O, 2008, CLIN MICROBIOL INFEC, V14, P384, DOI 10.1111/j.1469-0691.2007.01947.x; Dumitrescu O, 2007, ANTIMICROB AGENTS CH, V51, P1515, DOI 10.1128/AAC.01201-06; Feng Gang, 2010, BMC Res Notes, V3, P10, DOI 10.1186/1756-0500-3-10; Garcia-Roca P, 2006, ARCH MED RES, V37, P31, DOI 10.1016/j.arcmed.2005.05.022; Gill CJ, 2007, ANTIMICROB AGENTS CH, V51, P3434, DOI 10.1128/AAC.01567-06; LaPlante KL, 2008, ANTIMICROB AGENTS CH, V52, P2156, DOI 10.1128/AAC.01046-07; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Moitra J, 2008, TRANSL RES, V151, P141, DOI 10.1016/j.trsl.2007.12.008; Montgomery CP, 2009, INFECT IMMUN, V77, P2159, DOI 10.1128/IAI.00021-09; MOSER B, 1990, J EXP MED, V171, P1797, DOI 10.1084/jem.171.5.1797; Osborne JD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S6; Paulus P, 2011, BIOMARKERS, V16, pS11, DOI 10.3109/1354750X.2011.587893; Peng KT, 2010, INFECT IMMUN, V78, P2723, DOI 10.1128/IAI.00008-10; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Swaney SM, 1998, ANTIMICROB AGENTS CH, V42, P3251, DOI 10.1128/AAC.42.12.3251; Tacconelli E, 2009, CURR OPIN PULM MED, V15, P218, DOI 10.1097/MCP.0b013e3283292666; Ventura CL, 2008, INFECT IMMUN, V76, P5862, DOI 10.1128/IAI.00865-08; Wardenburg JB, 2008, J INFECT DIS, V198, P1166, DOI 10.1086/592053; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wu H, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-96; Zhu DM, 2008, CHINESE MED J-PEKING, V121, P2258, DOI 10.1097/00029330-200811020-00010	36	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67994	10.1371/journal.pone.0067994	http://dx.doi.org/10.1371/journal.pone.0067994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826353	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000107
J	Guo, R; Abdelmohsen, K; Morin, PJ; Gorospe, M				Guo, Rong; Abdelmohsen, Kotb; Morin, Patrice J.; Gorospe, Myriam			Novel MicroRNA Reporter Uncovers Repression of Let-7 by GSK-3 beta	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; POSTTRANSCRIPTIONAL REGULATION; COLORECTAL-CANCER; INDUCE APOPTOSIS; CELL-SURVIVAL; EXPRESSION; P53; TARGET; GROWTH; GLYCOGEN-SYNTHASE-KINASE-3-BETA	Several members of the let-7 microRNA family are downregulated in ovarian and other cancers. They are thought to act as tumor suppressors by lowering growth-promoting and anti-apoptotic proteins. In order to measure cellular let-7 levels systematically, we have developed a highly sensitive let-7 reporter assay system based on the expression of a chimeric mRNA that contains the luciferase coding region and a 3'-untranslated region (UTR) bearing two let-7-binding sites. In cells expressing the reporter construct, termed pmirGLO-let7, luciferase activity was high when let-7 was absent, while luciferase activity was low when let-7 levels were elevated. The ovarian cancer cell lines BG-1 and UCI-101 were transfected with the let-7 reporter and surveyed with a library of kinase inhibitors in order to identify pathways affecting let-7 activity. Among the inhibitors causing changes in endogenous let-7 abundance, the lowering of glycogen synthase kinase 3 (GSK-3)beta function specifically increased let-7 levels and lowered luciferase activity. Similarly, silencing GSK-3 beta increased both mature and primary-let-7 levels in BG-1 cells, and decreased BG-1 cell survival. Further studies identified p53 as a downstream effector of the GSK-3 beta-mediated repression of let-7 biosynthesis. Our studies highlight GSK-3 beta as a novel therapeutic target in ovarian tumorigenesis.	[Guo, Rong; Abdelmohsen, Kotb; Gorospe, Myriam] NIA, Genet Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Morin, Patrice J.] NIA, Lab Mol Biol & Immunol, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Morin, Patrice J.] Amer Assoc Canc Res, Philadelphia, PA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Morin, PJ (corresponding author), NIA, Lab Mol Biol & Immunol, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	pat.morin@aacr.org; myriam-gorospe@nih.gov	Abdelmohsen, Kotb/AAX-4191-2020	Abdelmohsen, Kotb/0000-0001-6240-5810	National Institute on Aging-Intramural Research Program of the National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000511, ZIAAG000393] Funding Source: NIH RePORTER	National Institute on Aging-Intramural Research Program of the National Institutes of Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was funded entirely by the National Institute on Aging-Intramural Research Program of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2012, MOL CELL BIOL, V32, P2530, DOI 10.1128/MCB.00510-12; Baldwin WS, 1998, IN VITRO CELL DEV-AN, V34, P649; Boominathan L, 2010, NATURE PRECEDINGS, V4252, P1; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen X, 2011, ONCOGENE, V30, P2874, DOI 10.1038/onc.2011.11; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farago M, 2005, CANCER RES, V65, P5792, DOI 10.1158/0008-5472.CAN-05-1021; Furlong MT, 2000, GYNECOL ONCOL, V77, P97, DOI 10.1006/gyno.1999.5718; GEISINGER KR, 1989, CANCER-AM CANCER SOC, V63, P280, DOI 10.1002/1097-0142(19890115)63:2<280::AID-CNCR2820630213>3.0.CO;2-N; Ghosh JC, 2005, CLIN CANCER RES, V11, P4580, DOI 10.1158/1078-0432.CCR-04-2624; Grammatikakis I, 2013, INT J MOL SCI, V14, P1822, DOI 10.3390/ijms14011822; Hebert C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-5; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hilliard TS, 2011, ANTI-CANCER DRUG, V22, P978, DOI 10.1097/CAD.0b013e32834ac8fc; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jacobs KM, 2012, INT J CELL BIOL, V35, P1052; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Ketting RF, 2010, ADV EXP MED BIOL, V700, P1, DOI 10.1007/978-1-4419-7823-3_1; Kitano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055289; Kulikov R, 2005, MOL CELL BIOL, V25, P7170, DOI 10.1128/MCB.25.16.7170-7180.2005; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Leost M, 2000, EUR J BIOCHEM, V267, P5983, DOI 10.1046/j.1432-1327.2000.01673.x; Liu SQ, 2004, J MED CHEM, V47, P999, DOI 10.1021/jm030346v; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; Marasa BS, 2009, SCI SIGNAL RA, Vra69, P1126; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Melo SA, 2011, FEBS LETT, V585, P2087, DOI 10.1016/j.febslet.2010.08.009; Miyashita K, 2009, ANTI-CANCER AGENT ME, V9, P1114, DOI 10.2174/187152009789734982; Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832; Nana-Sinkam SP, 2013, CLIN PHARMACOL THER, V93, P98, DOI 10.1038/clpt.2012.192; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Saleh AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024429; Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x; Shakoori A, 2005, BIOCHEM BIOPH RES CO, V334, P1365, DOI 10.1016/j.bbrc.2005.07.041; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Stavridi ES, 2004, GENE DEV, V18, P241, DOI 10.1101/gad.1181704; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Wang DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031240; Wang TS, 2007, GENE CHROMOSOME CANC, V46, P336, DOI 10.1002/gcc.20415; Wang ZF, 2011, J BIOL CHEM, V286, P39703, DOI 10.1074/jbc.M111.293126; Winter J, 2011, METHODS MOL BIOL, V676, P3, DOI 10.1007/978-1-60761-863-8_1; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com	61	21	21	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66330	10.1371/journal.pone.0066330	http://dx.doi.org/10.1371/journal.pone.0066330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840442	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400023
J	Onteru, SK; Gorbach, DM; Young, JM; Garrick, DJ; Dekkers, JCM; Rothschild, MF				Onteru, Suneel K.; Gorbach, Danielle M.; Young, Jennifer M.; Garrick, Dorian J.; Dekkers, Jack C. M.; Rothschild, Max F.			Whole Genome Association Studies of Residual Feed Intake and Related Traits in the Pig	PLOS ONE			English	Article							MELANOCORTIN-4 RECEPTOR MC4R; GENETIC-PARAMETERS; LARGE WHITE; GROWTH-RATE; INSULIN; DUROC; CARCASS; EFFICIENCY; POLYMORPHISMS; SELECTION	Background: Residual feed intake (RFI), a measure of feed efficiency, is the difference between observed feed intake and the expected feed requirement predicted from growth and maintenance. Pigs with low RFI have reduced feed costs without compromising their growth. Identification of genes or genetic markers associated with RFI will be useful for marker-assisted selection at an early age of animals with improved feed efficiency. Methodology/Principal findings: Whole genome association studies (WGAS) for RFI, average daily feed intake (ADFI), average daily gain (ADG), back fat (BF) and loin muscle area (LMA) were performed on 1,400 pigs from the divergently selected ISU-RFI lines, using the Illumina PorcineSNP60 BeadChip. Various statistical methods were applied to find SNPs and genomic regions associated with the traits, including a Bayesian approach using GenSel software, and frequentist approaches such as allele frequency differences between lines, single SNP and haplotype analyses using PLINK software. Single SNP and haplotype analyses showed no significant associations (except for LMA) after genomic control and FDR. Bayesian analyses found at least 2 associations for each trait at a false positive probability of 0.5. At generation 8, the RFI selection lines mainly differed in allele frequencies for SNPs near (<0.05 Mb) genes that regulate insulin release and leptin functions. The Bayesian approach identified associations of genomic regions containing insulin release genes (e. g., GLP1R, CDKAL, SGMS1) with RFI and ADFI, of regions with energy homeostasis (e. g., MC4R, PGM1, GPR81) and muscle growth related genes (e. g., TGFB1) with ADG, and of fat metabolism genes (e. g., ACOXL, AEBP1) with BF. Specifically, a very highly significantly associated QTL for LMA on SSC7 with skeletal myogenesis genes (e. g., KLHL31) was identified for subsequent fine mapping. Conclusions/significance: Important genomic regions associated with RFI related traits were identified for future validation studies prior to their incorporation in marker-assisted selection programs.	[Rothschild, Max F.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; Iowa State Univ, Ctr Integrated Anim Genom, Ames, IA USA	Iowa State University; Iowa State University	Rothschild, MF (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	mfrothsc@iastate.edu	Garrick, Dorian/Q-3239-2019; Garrick, Dorian/P-9628-2019	Garrick, Dorian/0000-0001-8640-5372	Pfizer Animal Health; National Pork Board; Iowa Pork Producers Association; ISU Center for Integrated Animal Genomics; National Needs Fellowship [2007-38420-17767]; PIC/Genus and Newsham Choice Genetics; College of Agriculture and Life Sciences	Pfizer Animal Health; National Pork Board; Iowa Pork Producers Association; ISU Center for Integrated Animal Genomics; National Needs Fellowship; PIC/Genus and Newsham Choice Genetics; College of Agriculture and Life Sciences	The authors greatly appreciate the financial support provided by Pfizer Animal Health, National Pork Board, Iowa Pork Producers Association, ISU Center for Integrated Animal Genomics, National Needs Fellowship grant no. 2007-38420-17767, PIC/Genus and Newsham Choice Genetics, and the College of Agriculture and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elhamd A, 2009, MECH DEVELOP, V126, P852, DOI 10.1016/j.mod.2009.07.006; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Begriche K, 2012, GENES BRAIN BEHAV, V11, P291, DOI 10.1111/j.1601-183X.2012.00766.x; Bejamini Y, 1995, J R STAT SOC B, V57, P287; Boggess M, 2009, PIG GEN 3 C HINXT UK; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; Cai W, 2008, J ANIM SCI, V86, P287, DOI 10.2527/jas.2007-0396; Casey DS, 2005, J ANIM SCI, V83, P969; Clemente-Postigo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024783; Damon M, 2006, J ANIM SCI, V84, P1083, DOI 10.2527/2006.8451083x; Davoli R, 2012, MEAT SCI, V90, P887, DOI 10.1016/j.meatsci.2011.11.025; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Fernando R. L., 2008, ANIMAL BREEDING GENE; Flock GB, 2012, DIABETES; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gilbert H, 2007, J ANIM SCI, V85, P3182, DOI 10.2527/jas.2006-590; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hoff PD, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-92407-6_1; Hoque MA, 2007, J ANIM SCI, V85, P1873, DOI 10.2527/jas.2006-730; Hoque MA, 2009, ASIAN AUSTRAL J ANIM, V22, P747, DOI 10.5713/ajas.2009.80467; Johnson ZB, 1999, J ANIM SCI, V77, P1679; JUNG YC, 1989, ANIM GENET, V20, P79; Kim HR, 2009, DEV DYNAM, V238, P56, DOI 10.1002/dvdy.21812; Kim KS, 2006, ANIM GENET, V37, P419, DOI 10.1111/j.1365-2052.2006.01482.x; Kim KS, 2000, MAMM GENOME, V11, P131, DOI 10.1007/s003350010025; Kobayashi T, 2007, FEBS LETT, V581, P3157, DOI 10.1016/j.febslet.2007.05.081; Le NT, 2012, J ANIM SCI; Lee KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016356; Li QJ, 2011, HEPATOL RES, V41, P776, DOI 10.1111/j.1872-034X.2011.00827.x; Lin CS, 2005, J ANIM SCI, V83, P2075; Liu WL, 2010, P NATL ACAD SCI USA, V107, P11056, DOI 10.1073/pnas.1001269107; Meuwissen THE, 2001, GENETICS, V157, P1819; MRODE RA, 1993, ANIM PROD, V56, P225, DOI 10.1017/S0003356100021309; Mujibi FDN, 2011, J ANIM SCI, V89, P3353, DOI 10.2527/jas.2010-3361; Nguyen NH, 2005, J ANIM BREED GENET, V122, P264, DOI 10.1111/j.1439-0388.2005.00531.x; Nkrumah JD, 2007, J ANIM SCI, V85, P3170, DOI 10.2527/jas.2007-0234; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Ohara-Imaizumi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015553; Okamoto K, 2012, DIABETES, V61, P1734, DOI 10.2337/db11-1201; Onteru SK, 2012, ANIM GENET, V43, P18, DOI 10.1111/j.1365-2052.2011.02213.x; Onteru SK, 2011, J ANIM SCI, V89, P988, DOI 10.2527/jas.2010-3236; Pal A, 2012, NEW ENGL J MED, V367, P1002, DOI 10.1056/NEJMoa1113966; Piorkowska K, 2010, MEAT SCI, V85, P297, DOI 10.1016/j.meatsci.2010.01.017; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2011, R LANG ENV STAT COMP; Rolf MM, 2012, ANIM GENET, V43, P367, DOI 10.1111/j.1365-2052.2011.02273.x; Saatchi M, 2012, PLANT AN GEN C 20 JA, pP0552; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Sherman EL, 2010, J ANIM SCI, V88, P16, DOI 10.2527/jas.2008-1759; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strowski MZ, 2009, REGUL PEPTIDES, V157, P19, DOI 10.1016/j.regpep.2009.05.010; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Townsend KL, 2012, FASEB J, V26, P2187, DOI 10.1096/fj.11-199067; Van den Maagdenberg K, 2007, ANIMAL, V1, P1089, DOI 10.1017/S1751731107000456; VonFelde A, 1996, LIVEST PROD SCI, V47, P11, DOI 10.1016/S0301-6226(96)01006-8; Woods SC, 2006, PHILOS T R SOC B, V361, P1219, DOI 10.1098/rstb.2006.1858; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Young JM, 2011, J ANIM SCI, V89, P639, DOI 10.2527/jas.2010-2892; Yuzaki M, 2008, CELL MOL LIFE SCI, V65, P1698, DOI 10.1007/s00018-008-7550-3; Zeng J, 2011, THESIS IOWA STATE U	67	89	95	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e61756	10.1371/journal.pone.0061756	http://dx.doi.org/10.1371/journal.pone.0061756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840294	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400001
J	Beuzelin, C; Evnouchidou, I; Rigolet, P; Cauvet-Burgevin, A; Girard, PM; Dardalhon, D; Culina, S; Gdoura, A; van Endert, P; Francesconi, S				Beuzelin, Clementine; Evnouchidou, Irini; Rigolet, Pascal; Cauvet-Burgevin, Anne; Girard, Pierre-Marie; Dardalhon, Delphine; Culina, Slobodan; Gdoura, Abdelaziz; van Endert, Peter; Francesconi, Stefania			Deletion of the Fission Yeast Homologue of Human Insulinase Reveals a TORC1-Dependent Pathway Mediating Resistance to Proteotoxic Stress	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DEGRADING ENZYME; SIGNAL INTEGRATION; TOR1 FUNCTIONS; ER STRESS; GROWTH; GENE; DEGRADATION; PEPTIDASE; APOPTOSIS	Insulin Degrading Enzyme (IDE) is a protease conserved through evolution with a role in diabetes and Alzheimer's disease. The reason underlying its ubiquitous expression including cells lacking identified IDE substrates remains unknown. Here we show that the fission yeast IDE homologue (Iph1) modulates cellular sensitivity to endoplasmic reticulum (ER) stress in a manner dependent on TORC1 (Target of Rapamycin Complex 1). Reduced sensitivity to tunicamycin was associated with a smaller number of cells undergoing apoptosis. Wild type levels of tunicamycin sensitivity were restored in iph1 null cells when the TORC1 complex was inhibited by rapamycin or by heat inactivation of the Tor2 kinase. Although Iph1 cleaved hallmark IDE substrates including insulin efficiently, its role in the ER stress response was independent of its catalytic activity since expression of inactive Iph1 restored normal sensitivity. Importantly, wild type as well as inactive human IDE complemented gene-invalidated yeast cells when expressed at the genomic locus under the control of iph1(+) promoter. These results suggest that IDE has a previously unknown function unrelated to substrate cleavage, which links sensitivity to ER stress to a pro-survival role of the TORC1 pathway.	[Beuzelin, Clementine; Rigolet, Pascal; Girard, Pierre-Marie; Dardalhon, Delphine; Francesconi, Stefania] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Beuzelin, Clementine; Girard, Pierre-Marie; Dardalhon, Delphine; Francesconi, Stefania] Ctr Univ, CNRS, Unite Mixte Rech 3348, Orsay, France; [Beuzelin, Clementine; Rigolet, Pascal] Univ Paris 11, Orsay, France; [Beuzelin, Clementine; Evnouchidou, Irini; Cauvet-Burgevin, Anne; Culina, Slobodan; Gdoura, Abdelaziz; van Endert, Peter] Univ Paris 05, Fac Med, Sorbonne Paris Cite, Paris, France; [Beuzelin, Clementine; Evnouchidou, Irini; Cauvet-Burgevin, Anne; Culina, Slobodan; Gdoura, Abdelaziz; van Endert, Peter] INSERM, U1013, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Francesconi, S (corresponding author), Inst Curie, Ctr Rech, F-91405 Orsay, France.	stefania.francesconi@curie.fr	van Endert, Peter/R-4606-2017; Evnouchidou, Irini/Z-3072-2019; Rigolet, Pascal/S-8602-2018; Francesconi, Stefania/J-7910-2016	van Endert, Peter/0000-0003-3782-0750; Rigolet, Pascal/0000-0001-6868-4953; girard, pierre-marie/0000-0001-9703-4407; francesconi, stefania/0000-0002-9665-349X	Agence Nationale de la Recherche [05-BLAN-0162]; Juvenile Diabetes Research Foundation [RRG1-2008-555]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was supported by Agence Nationale de la Recherche [05-BLAN-0162] and Juvenile Diabetes Research Foundation [RRG1-2008-555]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper BJ, 2009, YEAST, V26, P595, DOI 10.1002/yea.1709; Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Appenzeller-Herzog C, 2012, TRENDS CELL BIOL, V22, P274, DOI 10.1016/j.tcb.2012.02.006; Aspuria PJ, 2007, CELL CYCLE, V6, P1692, DOI 10.4161/cc.6.14.4478; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Cheng Yan, 2011, World J Biol Chem, V2, P226, DOI 10.4331/wjbc.v2.i10.226; Chou SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039679; de Tullio MB, 2008, PRION, V2, P51, DOI 10.4161/pri.2.2.6710; DEBERNARDO AP, 1995, DEV BIOL, V169, P65, DOI 10.1006/dbio.1995.1127; Eizirik DL, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3110pe7; Eswar N, 2006, CURR PROTOC BIOINFOR, V5; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; Fonseca SG, 2010, ISLETS, V2, P1, DOI 10.4161/isl.2.1.10456; GEHM BD, 1991, ENDOCRINOLOGY, V128, P1603, DOI 10.1210/endo-128-3-1603; Guerin R, 2008, MOL BIOL CELL, V19, P4404, DOI 10.1091/mbc.E08-02-0188; Hartmuth S, 2009, J CELL SCI, V122, P1737, DOI 10.1242/jcs.049387; Ikeda K, 2008, CELL CYCLE, V7, P358, DOI 10.4161/cc.7.3.5245; Karamohamed S, 2003, DIABETES, V52, P1562, DOI 10.2337/diabetes.52.6.1562; Kato H, 2012, CELL DEATH DIFFER, V19, P310, DOI 10.1038/cdd.2011.98; Kawai M, 2001, CURR GENET, V39, P166; Kim S, 2005, J BIOL CHEM, V280, P27481, DOI 10.1074/jbc.M414192200; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046; Llovera RE, 2008, J BIOL CHEM, V283, P17039, DOI 10.1074/jbc.M706316200; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Mukaiyama H, 2009, MICROBIOL-SGM, V155, P3816, DOI 10.1099/mic.0.034389-0; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; PERLMAN RK, 1993, J BIOL CHEM, V268, P21538; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Ralat LA, 2011, J MOL BIOL, V406, P454, DOI 10.1016/j.jmb.2010.12.026; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Schonbrun M, 2009, MOL CELL BIOL, V29, P4584, DOI 10.1128/MCB.01879-08; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; SHII K, 1986, P NATL ACAD SCI USA, V83, P4147, DOI 10.1073/pnas.83.12.4147; Smeets MFMA, 2003, GENES CELLS, V8, P573, DOI 10.1046/j.1365-2443.2003.00657.x; Song ES, 2011, J BIOL CHEM, V286, P13852, DOI 10.1074/jbc.M110.191668; Takahara T, 2012, GENES CELLS, V17, P698, DOI 10.1111/j.1365-2443.2012.01618.x; Tundo GR, 2013, J BIOL CHEM, V288, P2281, DOI 10.1074/jbc.M112.393108; Udrisar DP, 2005, EXP BIOL MED, V230, P479; Uritani M, 2006, GENES CELLS, V11, P1367, DOI 10.1111/j.1365-2443.2006.01025.x; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	48	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67705	10.1371/journal.pone.0067705	http://dx.doi.org/10.1371/journal.pone.0067705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826334	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400167
J	Nogueira-Silva, C; Piairo, P; Carvalho-Dias, E; Veiga, C; Moura, RS; Correia-Pinto, J				Nogueira-Silva, Cristina; Piairo, Paulina; Carvalho-Dias, Emanuel; Veiga, Carla; Moura, Rute S.; Correia-Pinto, Jorge			The Role of Glycoprotein 130 Family of Cytokines in Fetal Rat Lung Development	PLOS ONE			English	Article							RECOMBINANT HUMAN INTERLEUKIN-11; CILIARY NEUROTROPHIC FACTOR; PROGRAMMED CELL-DEATH; ONCOSTATIN-M; BRANCHING MORPHOGENESIS; FACTOR CNTF; EXPRESSION; GP130; CARDIOTROPHIN-1; MECHANISMS	The glycoprotein 130 (gp130) dependent family of cytokines comprises interleukin-6 (IL-6), IL-11, leukemia inhibitory factor (LIF), cardiotrophin-like cytokine (CLC), ciliary neurotrophic factor (CNTF), cardiotrophin-1 (CT-1) and oncostatin M (OSM). These cytokines share the membrane gp130 as a common signal transducer. Recently, it was demonstrated that IL-6 promotes, whereas LIF inhibits fetal lung branching. Thus, in this study, the effects on fetal lung morphogenesis of the other classical members of the gp130-type cytokines (IL-11, CLC, CNTF, CT-1 and OSM) were investigated. We also provide the first description of these cytokines and their common gp130 receptor protein expression patterns during rat lung development. Fetal rat lung explants were cultured in vitro with increasing concentrations of IL-11, CLC, CNTF, CT-1 and OSM. Treated lung explants were morphometrically analyzed and assessed for MAPK, PI3K/AKT and STAT3 signaling modifications. IL-11, which similarly to IL-6 acts through a gp130 homodimer receptor, significantly stimulated lung growth via p38 phosphorylation. On the other hand, CLC, CNTF, CT-1 and OSM, whose receptors are gp130 heterodimers, inhibited lung growth acting in different signal-transducing pathways. Thus, the present study demonstrated that although cytokines of the gp130 family share a common signal transducer, there are specific biological activities for each cytokine on lung development. Indeed, cytokine signaling through gp130 homodimers stimulate, whereas cytokine signaling through gp130 heterodimers inhibit lung branching.	[Nogueira-Silva, Cristina; Piairo, Paulina; Carvalho-Dias, Emanuel; Veiga, Carla; Moura, Rute S.; Correia-Pinto, Jorge] Univ Minho, Life & Hlth Sci Res Inst, Sch Hlth Sci, Braga, Portugal; [Nogueira-Silva, Cristina; Piairo, Paulina; Carvalho-Dias, Emanuel; Veiga, Carla; Moura, Rute S.; Correia-Pinto, Jorge] 3Bs PT Govt Associate Lab, Life & Hlth Sci Res Inst, Braga, Portugal; [Nogueira-Silva, Cristina] Hosp Braga, Dept Obstet & Gynecol, Braga, Portugal; [Carvalho-Dias, Emanuel] Hosp Braga, Dept Urol, Braga, Portugal; [Correia-Pinto, Jorge] Hosp Braga, Dept Pediat Surg, Braga, Portugal	Universidade do Minho; Hospital de Braga; Hospital de Braga; Hospital de Braga	Correia-Pinto, J (corresponding author), Univ Minho, Life & Hlth Sci Res Inst, Sch Hlth Sci, Braga, Portugal.	jcp@ecsaude.uminho.pt	Moura, Rute/GYV-3259-2022; Moura, Rute S/B-4208-2011; Nogueira-Silva, Cristina/T-6998-2018; Correia-Pinto, Jorge/B-3344-2012	Moura, Rute S/0000-0003-1763-9014; Nogueira-Silva, Cristina/0000-0001-7273-2911; Correia-Pinto, Jorge/0000-0002-9265-6896; Piairo, Paulina/0000-0003-1905-671X	Fundacao para a Ciencia e a Tecnologia [PTDC/SAU-OBD/108051/2008, SFRH/BD/33410/2008, SFRH/BPD/15408/2005]; Seccao de Neonatologia da Sociedade Portuguesa de Pediatria; Fundação para a Ciência e a Tecnologia [PTDC/SAU-OBD/108051/2008] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Seccao de Neonatologia da Sociedade Portuguesa de Pediatria; Fundação para a Ciência e a Tecnologia	This project was funded by Fundacao para a Ciencia e a Tecnologia (PTDC/SAU-OBD/108051/2008) and by Seccao de Neonatologia da Sociedade Portuguesa de Pediatria (Grant ZERU 2008). PP was supported by Fundacao para a Ciencia e a Tecnologia (reference SFRH/BD/33410/2008). RSM was supported by Fundacao para a Ciencia e a Tecnologia (reference SFRH/BPD/15408/2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betz UAK, 1998, J EXP MED, V188, P1955, DOI 10.1084/jem.188.10.1955; Carbia-Nagashima A, 2004, IUBMB LIFE, V56, P83, DOI 10.1080/15216540410001668064; Castro CP, 2001, J ENDOCRINOL, V169, P539, DOI 10.1677/joe.0.1690539; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; de Bovis Beatrice, 2005, Cell Commun Signal, V3, P1, DOI 10.1186/1478-811X-3-1; Deister C, 2006, J NEURAL ENG, V3, P172, DOI 10.1088/1741-2560/3/2/011; Dickinson EC, 2000, J PEDIATR SURG, V35, P1079, DOI 10.1053/jpsu.2000.7826; Du XX, 1996, J CELL PHYSIOL, V168, P362; Fasnacht N, 2008, SEMIN CELL DEV BIOL, V19, P379, DOI 10.1016/j.semcdb.2008.07.001; Fujio Y, 2011, J PHARMACOL SCI, V117, P213, DOI 10.1254/jphs.11R05CR; Hata K, 2002, NEUROREPORT, V13, P735, DOI 10.1097/00001756-200204160-00039; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Igaz P, 2006, ENDOCRINOLOGY, V147, P1037, DOI 10.1210/en.2005-0729; Imamura M, 2007, EXP CELL RES, V313, P1951, DOI 10.1016/j.yexcr.2007.03.010; Jougasaki M, 2010, ADV CLIN CHEM, V52, P41, DOI 10.1016/S0065-2423(10)52002-X; Kling DE, 2002, AM J PHYSIOL-LUNG C, V282, pL370, DOI 10.1152/ajplung.00200.2001; Knight DA, 2003, PHARMACOL THERAPEUT, V99, P327, DOI 10.1016/S0163-7258(03)00095-0; Kovanen PE, 1999, CURR BIOL, V9, pR899, DOI 10.1016/S0960-9822(00)80079-2; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Kresch MJ, 1998, PEDIATR RES, V43, P426, DOI 10.1203/00006450-199803000-00020; Levesque BM, 2000, PEDIATR RES, V47, P481, DOI 10.1203/00006450-200004000-00012; Lopez N, 2006, J MOL CELL CARDIOL, V41, P902, DOI 10.1016/j.yjmcc.2006.03.433; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Minshall E, 2000, J ALLERGY CLIN IMMUN, V105, P232, DOI 10.1016/S0091-6749(00)90070-8; Morikawa Yoshihiro, 2005, Anatomical Science International, V80, P53, DOI 10.1111/j.1447-073x.2005.00100.x; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Mozaffarian A, 2008, J IMMUNOL, V181, P7243, DOI 10.4049/jimmunol.181.10.7243; Murakami M, 2004, GROWTH FACTORS, V22, P75, DOI 10.1080/08977190410001715181; Nogueira-Silva C, 2008, PEDIATR PULM, V43, P680, DOI 10.1002/ppul.20840; Nogueira-Silva C, 2006, PEDIATR RES, V60, P530, DOI 10.1203/01.pdr.0000242300.09427.3b; Nogueira-Silva C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030517; Ohta M, 1996, BIOCHEM MOL BIOL INT, V40, P671; Opal SM, 2003, J INFECT DIS, V187, P70, DOI 10.1086/345864; Ozog MA, 2002, CANCER RES, V62, P3544; Sango K, 2008, HISTOCHEM CELL BIOL, V130, P669, DOI 10.1007/s00418-008-0484-x; Schmidt-Ott KM, 2005, J AM SOC NEPHROL, V16, P1993, DOI 10.1681/ASN.2004121127; Stejskal D, 2008, BIOMED PAP, V152, P9, DOI 10.5507/bp.2008.002; Stiles AD, 2001, EXP LUNG RES, V27, P569; Tamura S, 2002, MECH DEVELOP, V115, P127, DOI 10.1016/S0925-4773(02)00081-3; Tamura S, 2002, DEV DYNAM, V225, P327, DOI 10.1002/dvdy.10156; Tanaka M, 2004, REV PHYSIOL BIOCH P, V149, P39, DOI 10.1007/s10254-003-0013-1; Taylor BK, 2000, AM J PHYSIOL-LUNG C, V278, pL1062, DOI 10.1152/ajplung.2000.278.5.L1062; Uemura A, 2002, CYTOKINE, V18, P1, DOI 10.1006/cyto.2002.1006; Vlotides G, 2004, CYTOKINE GROWTH F R, V15, P325, DOI 10.1016/j.cytogfr.2004.04.002; Wang JM, 2003, J BIOL CHEM, V278, P31226, DOI 10.1074/jbc.M301820200; Wang RJ, 2006, WORLD J GASTROENTERO, V12, P3055, DOI 10.3748/wjg.v12.i19.3055; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; Waxman AB, 1998, J CLIN INVEST, V101, P1970, DOI 10.1172/JCI1337; Waxman AB, 2003, AM J RESP CELL MOL, V29, P513, DOI 10.1165/rcmb.2002-0044OC; White UA, 2011, CURR PHARM DESIGN, V17, P340; White UA, 2010, BIOCHEM BIOPH RES CO, V395, P48, DOI 10.1016/j.bbrc.2010.03.132; Wongtrakool C, 2008, EXP LUNG RES, V34, P481, DOI 10.1080/01902140802271842; Wormald S, 2004, J BIOL CHEM, V279, P821, DOI 10.1074/jbc.R300030200; Zheng T, 2001, J ALLERGY CLIN IMMUN, V108, P489; Zhou DY, 2003, BRIT J PHARMACOL, V140, P1237, DOI 10.1038/sj.bjp.0705562	55	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67607	10.1371/journal.pone.0067607	http://dx.doi.org/10.1371/journal.pone.0067607			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826327	gold, Green Submitted, Green Published			2022-12-27	WOS:000321738400163
J	Renicke, C; Spadaccini, R; Taxis, C				Renicke, Christian; Spadaccini, Roberta; Taxis, Christof			A Tobacco Etch Virus Protease with Increased Substrate Tolerance at the P1' position	PLOS ONE			English	Article							SITE-SPECIFIC PROTEASES; END RULE PATHWAY; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; YEAST; UBIQUITIN; SPECIFICITY; SYSTEM; DEGRADATION; PROTEOLYSIS	Site-specific proteases are important tools for in vitro and in vivo cleavage of proteins. They are widely used for diverse applications, like protein purification, assessment of protein-protein interactions or regulation of protein localization, abundance or activity. Here, we report the development of a procedure to select protease variants with altered specificity based on the well-established Saccharomyces cerevisiae adenine auxotrophy-dependent red/white colony assay. We applied this method on the tobacco etch virus (TEV) protease to obtain a protease variant with altered substrate specificity at the P1' Position. In vivo experiments with tester substrates showed that the mutated TEV protease still efficiently recognizes the sequence ENLYFQ, but has almost lost all bias for the amino acid at the P1' Position. Thus, we generated a site-specific protease for synthetic approaches requiring in vivo generation of proteins or peptides with a specific N-terminal amino acid.	[Renicke, Christian; Taxis, Christof] Univ Marburg, Dept Biol Genet, Marburg, Germany; [Spadaccini, Roberta] Univ Sannio, Dipartimento Sci & Tecnol, Benevento, Italy	Philipps University Marburg; University of Sannio	Taxis, C (corresponding author), Univ Marburg, Dept Biol Genet, Marburg, Germany.	taxis@biologie.uni-marburg.de	Renicke, Christian/AAG-8487-2019; Taxis, Christof/P-6188-2019; Taxis, Christof/AAP-7408-2021	Renicke, Christian/0000-0003-3226-9840; Taxis, Christof/0000-0001-5952-7091; SPADACCINI, Roberta/0000-0002-2262-1065	DFG [GK1216];  [TA320/3-1]	DFG(German Research Foundation (DFG)); 	This work was supported by the DFG grants GK1216 "Intra- and Intercellular Transport and Communication" and TA320/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2005, MOL PLANT PATHOL, V6, P471, DOI 10.1111/J.1364-3703.2005.00296.X; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Barbour Leslie, 2006, Methods Mol Biol, V313, P161; Choi WS, 2010, NAT STRUCT MOL BIOL, V17, P1175, DOI 10.1038/nsmb.1907; Cottier V, 2006, ANTIMICROB AGENTS CH, V50, P565, DOI 10.1128/AAC.50.2.565-571.2006; Dunkler A, 2012, METHODS MOL BIOL, V786, P115, DOI 10.1007/978-1-61779-292-2_7; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GORBALENYA AE, 1989, FEBS LETT, V243, P103, DOI 10.1016/0014-5793(89)80109-7; Henrichs T, 2005, P NATL ACAD SCI USA, V102, P4246, DOI 10.1073/pnas.0408520102; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jansen G, 2005, GENE, V344, P43, DOI 10.1016/j.gene.2004.10.016; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Jungbluth M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-176; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kim SY, 2000, ANAL BIOCHEM, V284, P42, DOI 10.1006/abio.2000.4662; MCGREW JT, 1989, YEAST, V5, P271, DOI 10.1002/yea.320050407; Moore DD, 1995, GLOB MOB SURV; Nunn CM, 2005, J MOL BIOL, V350, P145, DOI 10.1016/j.jmb.2005.04.013; O'Loughlin TL, 2006, MOL BIOL EVOL, V23, P764, DOI 10.1093/molbev/msj098; PARKS TD, 1995, VIROLOGY, V210, P194, DOI 10.1006/viro.1995.1331; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pereira G, 2001, EMBO J, V20, P6359, DOI 10.1093/emboj/20.22.6359; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; Renicke C, 2013, CHEM BIOL, V20, P619, DOI 10.1016/j.chembiol.2013.03.005; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Sices HJ, 1998, P NATL ACAD SCI USA, V95, P2828, DOI 10.1073/pnas.95.6.2828; SIKORSKI RS, 1989, GENETICS, V122, P19; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sun P, 2010, PROTEIN SCI, V19, P2240, DOI 10.1002/pro.506; Taxis C, 2006, BIOTECHNIQUES, V40, P73, DOI 10.2144/000112040; Taxis C, 2006, TRAFFIC, V7, P1628, DOI 10.1111/j.1600-0854.2006.00496.x; Taxis C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.25; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Verhoeven KD, 2012, APPL BIOCHEM BIOTECH, V166, P1340, DOI 10.1007/s12010-011-9522-6; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200	43	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67915	10.1371/journal.pone.0067915	http://dx.doi.org/10.1371/journal.pone.0067915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826349	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400174
J	Yip, C; Ignjatovic, V; Attard, C; Monagle, P; Linden, MD				Yip, Christina; Ignjatovic, Vera; Attard, Chantal; Monagle, Paul; Linden, Matthew D.			First Report of Elevated Monocyte-Platelet Aggregates in Healthy Children	PLOS ONE			English	Article							SELECTIN GLYCOPROTEIN LIGAND-1; SURFACE P-SELECTIN; TISSUE FACTOR; TYROSINE PHOSPHORYLATION; REFERENCE VALUES; FLOW-CYTOMETRY; WHOLE-BLOOD; NEUTROPHILS; ACTIVATION; ADHESION	Platelets are subcellular fragments which circulate in blood and have well established roles in thrombosis and haemostasis in adults. Upon activation, platelets undergo granule exocytosis and express P-Selectin on the cell membrane which binds a ligand on monocytes, leading to monocyte-platelet aggregation. Elevated circulating monocyte-platelet aggregates in adults are linked to atherothrombosis, but have not been investigated in children where thrombosis is less common. This study aimed to measure monocyte-platelet aggregate formation in children using whole blood flow cytometry. Monocyte-platelet aggregates as well as activation and granule exocytosis of platelets were measured in healthy adults (n = 15, median age 28 years) and healthy children (n = 28, median age 7 years). Monocyte-platelet aggregates in healthy children were elevated compared to healthy adults (37.8 +/- 4.4% vs 15.5 +/- 1.9% respectively, p<0.01). However, this was not accompanied by any difference in platelet activation (PAC-1 binding 6.8 +/- 1.5% vs 6.3 +/- 2.0% respectively, p = ns) or granule exocytosis (P-selectin expression 4.4 +/- 0.5% vs 3.1 +/- 0.5% respectively, p = ns). Despite comparable numbers of platelets bound per monocyte (GPIb MFI 117.3 +/- 13.7 vs 130.9 +/- 28.6 respectively, p = ns), surface P-selectin expression per platelet-bound monocyte was lower in children compared to adults. We therefore provide the first data of elevated monocyte-platelet aggregates in healthy children.	[Yip, Christina] RMIT Univ, Sch Med Sci, Melbourne, Vic 3001, Australia; [Yip, Christina; Ignjatovic, Vera; Attard, Chantal; Monagle, Paul] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Ignjatovic, Vera; Monagle, Paul] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Monagle, Paul] Royal Childrens Hosp, Dept Clin Haematol, Melbourne, Vic, Australia; [Linden, Matthew D.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia	Royal Melbourne Institute of Technology (RMIT); Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne; University of Western Australia	Linden, MD (corresponding author), Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia.	matthew.linden@uwa.edu.au	Ignjatovic, Vera/F-8598-2011; Linden, Matthew D/G-9644-2012; Attard, Chantal/AAB-8406-2019	Linden, Matthew D/0000-0002-9126-2166; Attard, Chantal/0000-0002-4428-1663; Monagle, Paul/0000-0002-3970-8984; Ignjatovic, Vera/0000-0002-5548-5813	Royal Melbourne Institute of Technology University; Murdoch Childrens Research Institute	Royal Melbourne Institute of Technology University; Murdoch Childrens Research Institute	This work was supported by internal project funding provided by Royal Melbourne Institute of Technology University and the Murdoch Childrens Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard MR, 2005, J THROMB HAEMOST, V3, P2563, DOI 10.1111/j.1538-7836.2005.01603.x; Biino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054289; Blanks JE, 1998, EUR J IMMUNOL, V28, P433, DOI 10.1002/(SICI)1521-4141(199802)28:02<433::AID-IMMU433>3.0.CO;2-U; CELI A, 1994, P NATL ACAD SCI USA, V91, P8767, DOI 10.1073/pnas.91.19.8767; Chapman LM, 2012, J IMMUNOL, V189, P916, DOI 10.4049/jimmunol.1200580; Christersson C, 2008, J THROMB HAEMOST, V6, P986, DOI 10.1111/j.1538-7836.2008.02956.x; Evangelista V, 1999, BLOOD, V93, P876, DOI 10.1182/blood.V93.3.876.403k25_876_885; FURIE B, 1995, THROMB HAEMOSTASIS, V74, P224; Gawaz M, 2006, BLOOD CELL MOL DIS, V36, P206, DOI 10.1016/j.bcmd.2005.12.022; HAMBURGER SA, 1990, BLOOD, V75, P550; Haselboeck J, 2012, ANN HEMATOL, V91, P109, DOI 10.1007/s00277-011-1249-5; Hezard N, 2003, THROMB HAEMOSTASIS, V90, P116, DOI 10.1055/s-0037-1613607; Hidari KIPJ, 1997, J BIOL CHEM, V272, P28750, DOI 10.1074/jbc.272.45.28750; Hoffman R.A., 2005, CURRENT PROTOCOLS CY; Ignjatovic V, 2012, PEDIATR CARDIOL, V33, P55, DOI 10.1007/s00246-011-0079-5; Ignjatovic V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017213; Lanza GA, 2011, EUR HEART J, V32, P2042, DOI 10.1093/eurheartj/ehr109; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; Linden MD, 2007, J THROMB HAEMOST, V5, P761, DOI 10.1111/j.1538-7836.2007.02462.x; Linden MD, 2010, INT J BIOCHEM CELL B, V42, P1762, DOI 10.1016/j.biocel.2010.07.012; Linden MD, 2006, CONTEMP CARDIOL, P487, DOI 10.1007/978-1-59745-051-5_28; Linden MD, 2004, SEMIN THROMB HEMOST, V30, P501, DOI 10.1055/s-2004-835671; Linden MD, 2005, CONT CARDIOLOGY CARD, P487; Lindmark E, 2000, ARTERIOSCL THROM VAS, V20, P2322, DOI 10.1161/01.ATV.20.10.2322; Lugada ES, 2004, CLIN DIAGN LAB IMMUN, V11, P29, DOI 10.1128/CDLI.11.1.29-34.2004; Michelson AD, 1996, P NATL ACAD SCI USA, V93, P11877, DOI 10.1073/pnas.93.21.11877; Michelson AD, 2001, CIRCULATION, V104, P1533, DOI 10.1161/hc3801.095588; Monagle P, 2006, THROMB HAEMOSTASIS, V95, P362, DOI 10.1160/TH05-01-0047; Newall F, 2003, J PAEDIATR CHILD H, V39, P289, DOI 10.1046/j.1440-1754.2003.00139.x; O'Sullivan BP, 2005, BLOOD, V105, P4635, DOI 10.1182/blood-2004-06-2098; Ponthieux A, 2003, CLIN CHEM, V49, P1544, DOI 10.1373/49.9.1544; Segal JB, 2006, ANN EPIDEMIOL, V16, P123, DOI 10.1016/j.annepidem.2005.06.052; Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193; Smith TL, 2011, THROMB RES, V127, P391, DOI 10.1016/j.thromres.2010.10.013; Totani L, 2010, ARTERIOSCL THROM VAS, V30, P2357, DOI 10.1161/ATVBAHA.110.207480; Weber C, 1997, J CLIN INVEST, V100, P2085, DOI 10.1172/JCI119742	36	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67416	10.1371/journal.pone.0067416	http://dx.doi.org/10.1371/journal.pone.0067416			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826296	Green Published, gold			2022-12-27	WOS:000321738400144
J	Liu, ZQ; Wen, XY; Wang, HB; Zhou, J; Zhao, MG; Lin, QX; Wang, Y; Li, JJ; Li, DX; Du, ZY; Yao, AN; Cao, F; Wang, CY				Liu, Zhiqiang; Wen, Xinyu; Wang, Haibin; Zhou, Jin; Zhao, Mengge; Lin, Qiuxia; Wang, Yan; Li, Junjie; Li, Dexue; Du, Zhiyan; Yao, Anning; Cao, Feng; Wang, Changyong			Molecular Imaging of Induced Pluripotent Stem Cell Immunogenicity with In Vivo Development in Ischemic Myocardium	PLOS ONE			English	Article							INFARCTED MYOCARDIUM; CARDIAC DIFFERENTIATION; IPS CELLS; CARDIOMYOCYTES; TRANSPLANTATION; ENGRAFTMENT; SURVIVAL; PROLIFERATION; OPTIMIZATION; FIBROBLASTS	Whether differentiation of induced pluripotent stem cells (iPSCs) in ischemic myocardium enhances their immunogenicity, thereby increasing their chance for rejection, is unclear. Here, we dynamically demonstrated the immunogenicity and rejection of iPSCs in ischemic myocardium using bioluminescent imaging (BLI). Murine iPSCs were transduced with a tri-fusion (TF) reporter gene consisting of firefly luciferase-red fluorescent protein-truncated thymidine kinase (fluc-mrfp-tTK). Ascorbic acid (Vc) were used to induce iPSCs to differentiate into cardiomyocytes (CM). iPSCs and iPS-CMs were intramyocardially injected into immunocompetent or immunosuppressed allogenic murine with myocardial infarction. BLI was performed to track transplanted cells. Immune cell infiltration was evaluated by immunohistochemistry. Syngeneic iPSCs were also injected and evaluated. The results demonstrated that undifferentiated iPSCs survived and proliferated in allogenic immunocompetent recipients early post-transplantation, accompanying with mild immune cell infiltration. With in vivo differentiation, a progressive immune cell infiltration could be detected. While transplantation of allogenic iPSC-CMs were observed an acute rejection from receipts. In immune-suppressed recipients, the proliferation of iPSCs could be maintained and intramyocardial teratomas were formed. Transplantation of syngeneic iPSCs and iPSC-CMs were also observed progressive immune cell infiltration. This study demonstrated that iPSC immunogenicity increases with in vivo differentiation, which will increase their chance for rejection in iPSC-based therapy.	[Liu, Zhiqiang; Wang, Haibin; Zhou, Jin; Zhao, Mengge; Lin, Qiuxia; Wang, Yan; Li, Junjie; Li, Dexue; Du, Zhiyan; Yao, Anning; Wang, Changyong] Acad Mil Med Sci, Inst Basic Med Sci, Dept Adv Interdisciplinary Studies, Beijing, Peoples R China; [Liu, Zhiqiang; Wang, Haibin; Zhou, Jin; Zhao, Mengge; Lin, Qiuxia; Wang, Yan; Li, Junjie; Li, Dexue; Du, Zhiyan; Yao, Anning; Wang, Changyong] Acad Mil Med Sci, Tissue Engn Res Ctr, Beijing, Peoples R China; [Wen, Xinyu] Chinese Peoples Liberat Army Gen Hosp, Dept Clin Biochem, Beijing, Peoples R China; [Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shanxi, Peoples R China; [Zhao, Mengge] Michigan State Univ, Dept Chem Engn & Mat Sci, E Lansing, MI 48824 USA	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Chinese People's Liberation Army General Hospital; Air Force Military Medical University; Michigan State University	Wang, CY (corresponding author), Acad Mil Med Sci, Inst Basic Med Sci, Dept Adv Interdisciplinary Studies, Beijing, Peoples R China.	wcy2000_te@yahoo.com	Li, Junjie/B-7068-2012	Li, Junjie/0000-0003-2152-6952	National Natural Science Foundation of China [31030032, 81101160]; National Key Basic Research and Development Program of China [2011CB606206]; National Natural Science Funds for Distinguished Young Scholar [31125013]; National High Technology Research and Development Program of China [2012AA020506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China (No. 31030032), National Key Basic Research and Development Program of China (No. 2011CB606206), National Natural Science Funds for Distinguished Young Scholar (No. 31125013), National High Technology Research and Development Program of China (No. 2012AA020506), and National Natural Science Foundation of China (No. 81101160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2003, TRANSPLANTATION, V76, P1061, DOI 10.1097/01.TP.0000090342.85649.81; Asgari S, 2010, J HEPATOL, V53, P738, DOI 10.1016/j.jhep.2010.05.009; Bulte JWM, 2004, NMR BIOMED, V17, P484, DOI 10.1002/nbm.924; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Cao N, 2012, CELL RES, V22, P219, DOI 10.1038/cr.2011.195; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chan SSK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014414; Crescini E, 2013, BBA-MOL CELL RES, V1833, P140, DOI 10.1016/j.bbamcr.2012.06.024; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Huang JY, 2009, CELL RES, V19, P1127, DOI 10.1038/cr.2009.106; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; Li ZJ, 2009, J AM COLL CARDIOL, V53, P1229, DOI 10.1016/j.jacc.2008.12.036; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Liu ZQ, 2012, BIOMATERIALS, V33, P3093, DOI 10.1016/j.biomaterials.2011.12.044; Love Z, 2007, J NUCL MED, V48, P2011, DOI 10.2967/jnumed.107.043166; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; Ou DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055233; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Qiao H, 2009, RADIOLOGY, V250, P821, DOI 10.1148/radiol.2503080205; Smith AJ, 2012, STEM CELL TRANSL MED, V1, P709, DOI 10.5966/sctm.2012-0066; Swijnenburg RJ, 2005, CIRCULATION, V112, pI166, DOI 10.1161/CIRCULATIONAHA.104.525824; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Terrovitis J, 2009, J AM COLL CARDIOL, V54, P1619, DOI 10.1016/j.jacc.2009.04.097; Uosaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023657; Vazquez-Martin A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00964; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Willmann JK, 2009, RADIOLOGY, V252, P117, DOI 10.1148/radiol.2513081616; Xu CH, 2002, CIRC RES, V91, P501, DOI 10.1161/01.RES.0000035254.80718.91; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhou R, 2006, J AM COLL CARDIOL, V48, P2094, DOI 10.1016/j.jacc.2006.08.026	37	12	14	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66369	10.1371/journal.pone.0066369	http://dx.doi.org/10.1371/journal.pone.0066369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840453	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800053
J	Shi, H; Qi, XB; Zhong, H; Peng, Y; Zhang, XM; Ma, RZL; Su, B				Shi, Hong; Qi, Xuebin; Zhong, Hua; Peng, Yi; Zhang, Xiaoming; Ma, Runlin Z.; Su, Bing			Genetic Evidence of an East Asian Origin and Paleolithic Northward Migration of Y-chromosome Haplogroup N	PLOS ONE			English	Article							DIVERGENCE TIME; NORTHERN ROUTE; MODERN HUMANS; POPULATIONS; RESOLUTION; HERITAGE; JAPANESE; POLYMORPHISMS; PERSPECTIVE; SETTLEMENT	The Y-chromosome haplogroup N-M231 (Hg N) is distributed widely in eastern and central Asia, Siberia, as well as in eastern and northern Europe. Previous studies suggested a counterclockwise prehistoric migration of Hg N from eastern Asia to eastern and northern Europe. However, the root of this Y chromosome lineage and its detailed dispersal pattern across eastern Asia are still unclear. We analyzed haplogroup profiles and phylogeographic patterns of 1,570 Hg N individuals from 20,826 males in 359 populations across Eurasia. We first genotyped 6,371 males from 169 populations in China and Cambodia, and generated data of 360 Hg N individuals, and then combined published data on 1,210 Hg N individuals from Japanese, Southeast Asian, Siberian, European and Central Asian populations. The results showed that the sub-haplogroups of Hg N have a distinct geographical distribution. The highest Y-STR diversity of the ancestral Hg N sub-haplogroups was observed in the southern part of mainland East Asia, and further phylogeographic analyses supports an origin of Hg N in southern China. Combined with previous data, we propose that the early northward dispersal of Hg N started from southern China about 21 thousand years ago (kya), expanding into northern China 12-18 kya, and reaching further north to Siberia about 12-14 kya before a population expansion and westward migration into Central Asia and eastern/northern Europe around 8.0-10.0 kya. This northward migration of Hg N likewise coincides with retreating ice sheets after the Last Glacial Maximum (22-18 kya) in mainland East Asia.	[Shi, Hong; Qi, Xuebin; Zhong, Hua; Peng, Yi; Zhang, Xiaoming; Su, Bing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Zhong, Hua; Ma, Runlin Z.] Chinese Acad Sci, Ctr Dev Biol, Inst Genet & Dev Biol, Beijing, Peoples R China; [Zhang, Xiaoming] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Shi, H (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	shihong@mail.kiz.ac.cn; sub@mail.kiz.ac.cn	Zhang, Xiaoming/AFS-9807-2022; peng, yi/J-5500-2019; Zhong, Hua/C-1262-2017; Xuebin, Qi/L-7139-2019; peng, yi/AAR-8853-2020	Zhang, Xiaoming/0000-0003-3139-2361; 	National 973 Program of China [2012CBA01303, 2012CB518202]; National Natural Science Foundation of China [91131001, 31071101, 91231203]; Natural Science Foundation of Yunnan Province [2009CD107, 2010CI044]	National 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This study was supported by the National 973 Program of China (2012CBA01303 to HS; 2012CB518202 to XQ), the National Natural Science Foundation of China (91131001 and 31071101 to HS; 91231203 to BS) and the Natural Science Foundation of Yunnan Province (2009CD107 and 2010CI044 to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Butler JM, 2002, FORENSIC SCI INT, V129, P10, DOI 10.1016/S0379-0738(02)00195-0; Cai XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024282; Capelli C, 2007, MOL PHYLOGENET EVOL, V44, P228, DOI 10.1016/j.ympev.2006.11.030; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Derenko M, 2007, J HUM GENET, V52, P763, DOI 10.1007/s10038-007-0179-5; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Gusmao A, 2008, ANN HUM GENET, V72, P215, DOI 10.1111/j.1469-1809.2007.00421.x; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; He JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036437; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; King RJ, 2008, ANN HUM GENET, V72, P205, DOI 10.1111/j.1469-1809.2007.00414.x; Kumar V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-47; Lappalainen T, 2008, ANN HUM GENET, V72, P337, DOI 10.1111/j.1469-1809.2007.00429.x; Lappalainen T, 2006, GENE, V376, P207, DOI 10.1016/j.gene.2006.03.004; Lell JT, 2002, AM J HUM GENET, V70, P192, DOI 10.1086/338457; Li H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-146; Lopez-Parra AM, 2009, ANN HUM GENET, V73, P42, DOI 10.1111/j.1469-1809.2008.00478.x; Malyarchuk B, 2010, ANN HUM GENET, V74, P539, DOI 10.1111/j.1469-1809.2010.00601.x; Martinez L, 2007, EUR J HUM GENET, V15, P485, DOI 10.1038/sj.ejhg.5201769; Mirabal S, 2009, EUR J HUM GENET, V17, P1260, DOI 10.1038/ejhg.2009.6; Nonaka I, 2007, ANN HUM GENET, V71, P480, DOI 10.1111/j.1469-1809.2006.00343.x; Peakall R., 2012, BIOINFORMATICS; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; Shi H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-45; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247; Zhong H, 2010, J HUM GENET, V55, P428, DOI 10.1038/jhg.2010.40	35	29	33	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66102	10.1371/journal.pone.0066102	http://dx.doi.org/10.1371/journal.pone.0066102			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840409	gold, Green Submitted, Green Published			2022-12-27	WOS:000322342800032
J	Valdez-Velazquez, LL; Quintero-Hernandez, V; Romero-Gutierrez, MT; Coronas, FIV; Possani, LD				Valdez-Velazquez, Laura L.; Quintero-Hernandez, Veronica; Teresa Romero-Gutierrez, Maria; Coronas, Fredy I. V.; Possani, Lourival D.			Mass Fingerprinting of the Venom and Transcriptome of Venom Gland of Scorpion Centruroides tecomanus	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; TITYUS-SERRULATUS SCORPIONES; RICH ANTIMICROBIAL PEPTIDES; MEXICAN SCORPION; SPECTROMETRY ANALYSIS; MOLECULAR DIVERSITY; PROTEOMIC ANALYSIS; BETA-TOXINS; CHANNELS; PURIFICATION	Centruroides tecomanus is a Mexican scorpion endemic of the State of Colima, that causes human fatalities. This communication describes a proteome analysis obtained from milked venom and a transcriptome analysis from a cDNA library constructed from two pairs of venom glands of this scorpion. High perfomance liquid chromatography separation of soluble venom produced 80 fractions, from which at least 104 individual components were identified by mass spectrometry analysis, showing to contain molecular masses from 259 to 44,392 Da. Most of these components are within the expected molecular masses for Na+- and K+-channel specific toxic peptides, supporting the clinical findings of intoxication, when humans are stung by this scorpion. From the cDNA library 162 clones were randomly chosen, from which 130 sequences of good quality were identified and were clustered in 28 contigs containing, each, two or more expressed sequence tags (EST) and 49 singlets with only one EST. Deduced amino acid sequence analysis from 53% of the total ESTs showed that 81% (24 sequences) are similar to known toxic peptides that affect Na+-channel activity, and 19% (7 unique sequences) are similar to K+-channel especific toxins. Out of the 31 sequences, at least 8 peptides were confirmed by direct Edman degradation, using components isolated directly from the venom. The remaining 19%, 4%, 4%, 15% and 5% of the ESTs correspond respectively to proteins involved in cellular processes, antimicrobial peptides, venom components, proteins without defined function and sequences without similarity in databases. Among the cloned genes are those similar to metalloproteinases.	[Valdez-Velazquez, Laura L.; Teresa Romero-Gutierrez, Maria] Univ Colima, Fac Ciencias Quim, Colima, Mexico; [Valdez-Velazquez, Laura L.; Teresa Romero-Gutierrez, Maria] Univ Colima, Fac Med, Colima, Mexico; [Quintero-Hernandez, Veronica; Coronas, Fredy I. V.; Possani, Lourival D.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico	Universidad de Colima; Universidad de Colima; Universidad Nacional Autonoma de Mexico	Possani, LD (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico.	possani@ibt.unam.mx	Valdez-Velazquez, Laura L/AAM-1280-2021	Valdez-Velazquez, Laura L/0000-0001-8474-1495; Romero-Gutierrez, Teresa/0000-0002-4882-7491; Quintero-Hernandez, Veronica/0000-0002-1856-8134	Direccion General de Asuntos del Personal Academico (DGAPA-UNAM) [IN2000113]; SEP-CONACyT [153496]	Direccion General de Asuntos del Personal Academico (DGAPA-UNAM)(Universidad Nacional Autonoma de Mexico); SEP-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially financed by grants from Direccion General de Asuntos del Personal Academico (DGAPA-UNAM) number IN2000113 and SEP-CONACyT number 153496 to LDP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida DD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-362; Almeida FM, 2002, TOXICON, V40, P1041, DOI 10.1016/S0041-0101(02)00084-3; Batista CVF, 2007, COMP BIOCHEM PHYS C, V146, P147, DOI 10.1016/j.cbpc.2006.12.004; Batista CVF, 2004, J CHROMATOGR B, V803, P55, DOI 10.1016/j.jchromb.2003.09.002; BECERRIL B, 1993, GENE, V128, P165, DOI 10.1016/0378-1119(93)90559-L; Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; CESTELE S, 1995, J BIOL CHEM, V270, P15153, DOI 10.1074/jbc.270.25.15153; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Chowell G, 2006, TOXICON, V47, P753, DOI 10.1016/j.toxicon.2006.02.004; Chuang RSI, 1998, NAT NEUROSCI, V1, P668, DOI 10.1038/3669; D'Suze G, 2009, BIOCHIMIE, V91, P1010, DOI 10.1016/j.biochi.2009.05.005; de la Vega R.C.R., 2013, HDB BIOL ACT PEPT, P423, DOI [10.1016/B978-0-12-385095-9.00059-2, DOI 10.1016/B978-0-12-385095-9.00059-2]; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; DEBIN JA, 1993, AM J PHYSIOL, V264, pC361, DOI 10.1152/ajpcell.1993.264.2.C361; DehesaDavila M, 1996, COMP BIOCHEM PHYS B, V113, P331, DOI 10.1016/0305-0491(95)02031-4; del Rio-Portilla F, 2004, EUR J BIOCHEM, V271, P2504, DOI 10.1111/j.1432-1033.2004.04181.x; Diego-Garcia E, 2005, TOXICON, V45, P273, DOI 10.1016/j.toxicon.2004.10.014; Diego-Garcia E, 2012, PROTEOMICS, V12, P313, DOI 10.1002/pmic.201100409; EhretSabatier L, 1996, J BIOL CHEM, V271, P29537, DOI 10.1074/jbc.271.47.29537; Fet V, 2000, CATALOG SCORPIONS WO; Fletcher PL, 2010, J BIOL CHEM, V285, P7405, DOI 10.1074/jbc.M109.028365; FREIREMAIA L, 1994, TOXICON, V32, P1009, DOI 10.1016/0041-0101(94)90382-4; Gao R, 2008, TOXICON, V52, P348, DOI 10.1016/j.toxicon.2008.06.003; Gennaro R, 2002, CURR PHARM DESIGN, V8, P763, DOI 10.2174/1381612023395394; Gonzalez-Santillan E, 2004, DIVERSIDAD TAXONOMIA; Gurevitz M, 2012, TOXICON, V60, P502, DOI 10.1016/j.toxicon.2012.03.022; Hoffmann C. C., 1931, Anales del Instituto de Biologia Mexico T, V2, P291; HONG SJ, 1995, BRIT J PHARMACOL, V116, P1577, DOI 10.1111/j.1476-5381.1995.tb16375.x; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; JOVER E, 1984, BIOCHEMISTRY-US, V23, P1147, DOI 10.1021/bi00301a018; KIRSCH GE, 1989, J GEN PHYSIOL, V93, P67, DOI 10.1085/jgp.93.1.67; Kozminsky-Atias A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-333; Lazo GR, 2001, BIOTECHNIQUES, V30, P1300, DOI 10.2144/01306bc03; Leipold E, 2012, J GEN PHYSIOL, V139, P305, DOI 10.1085/jgp.201110720; Lopez-Gonzalez I, 2003, BIOCHEM BIOPH RES CO, V300, P408, DOI 10.1016/S0006-291X(02)02859-0; Luna-Ramirez K, 2013, TOXICON, V63, P44, DOI 10.1016/j.toxicon.2012.11.017; Ma YB, 2012, J PROTEOMICS, V75, P1563, DOI 10.1016/j.jprot.2011.11.029; Ma YB, 2010, PROTEOMICS, V10, P2471, DOI 10.1002/pmic.200900763; Ma YB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-290; MARTIN BM, 1988, TOXICON, V26, P785, DOI 10.1016/0041-0101(88)90319-4; MARTIN MF, 1987, J BIOL CHEM, V262, P4452; Monroy Velasco J, 1960, REV MEXICANA CIENCIA, V1, P1; Morgenstern D, 2011, TOXICON, V57, P695, DOI 10.1016/j.toxicon.2011.02.001; Olamendi-Portugal T, 2002, BIOCHEM BIOPH RES CO, V299, P562, DOI 10.1016/S0006-291X(02)02706-7; Olamendi-Portugal T, 2008, PROTEOMICS, V8, P1919, DOI 10.1002/pmic.200700668; Escalona MP, 2013, FRONT BIOSCI-LANDMRK, V18, P572, DOI 10.2741/4121; Pimenta AMC, 2003, RAPID COMMUN MASS SP, V17, P413, DOI 10.1002/rcm.934; Pimenta AMC, 2001, RAPID COMMUN MASS SP, V15, P1562, DOI 10.1002/rcm.415; Ponce J, 2004, NUEVA ESPECIE ALACRA; Ponce-Saavedra J, 2009, REV MEX BIODIVERS, V80, P71; POSSANI LD, 1980, TOXICON, V18, P175, DOI 10.1016/0041-0101(80)90071-9; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Quintero-Hernandez V, 2011, TOXICON, V58, P644, DOI 10.1016/j.toxicon.2011.09.015; RAMIREZ AN, 1988, TOXICON, V26, P773, DOI 10.1016/0041-0101(88)90318-2; Rendon-Anaya M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043331; de la Vega RCR, 2010, TOXICON, V56, P1155, DOI 10.1016/j.toxicon.2009.11.010; Roeding F, 2009, MOL PHYLOGENET EVOL, V53, P826, DOI 10.1016/j.ympev.2009.08.014; Schiavon E, 2012, TOXICON, V59, P283, DOI 10.1016/j.toxicon.2011.12.003; Schwartz EF, 2008, TOXICON, V51, P1499, DOI 10.1016/j.toxicon.2008.03.029; Schwartz EF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-119; Silva ECN, 2009, TOXICON, V54, P252, DOI 10.1016/j.toxicon.2009.04.010; Soudani N, 2005, Arch Inst Pasteur Tunis, V82, P39; SSA, 2013, AN MORB; TAN NH, 1992, COMP BIOCHEM PHYS C, V103, P299, DOI 10.1016/0742-8413(92)90011-U; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Valdivia HH, 1998, TRENDS CARDIOVAS MED, V8, P111, DOI 10.1016/S1050-1738(97)00138-2; VAZQUEZ A, 1995, TOXICON, V33, P1161, DOI 10.1016/0041-0101(95)00058-T; ZAMUDIO F, 1992, EUR J BIOCHEM, V204, P281, DOI 10.1111/j.1432-1033.1992.tb16635.x; Zhang JZ, 2012, J BIOL CHEM, V287, P30719, DOI 10.1074/jbc.M112.370742; Zhao RM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-452	72	48	56	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66486	10.1371/journal.pone.0066486	http://dx.doi.org/10.1371/journal.pone.0066486			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840487	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800069
J	Gueguen, E; Durand, E; Zhang, XY; d'Amalric, Q; Journet, L; Cascales, E				Gueguen, Erwan; Durand, Eric; Zhang, Xiang Y.; d'Amalric, Quentin; Journet, Laure; Cascales, Eric			Expression of a Yersinia pseudotuberculosis Type VI Secretion System Is Responsive to Envelope Stresses through the OmpR Transcriptional Activator	PLOS ONE			English	Article							BACTERIAL TYPE-VI; ENTEROAGGREGATIVE ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PROTEIN SECRETION; OUTER-MEMBRANE; GENE-EXPRESSION; CELL-ENVELOPE; TARGET-CELLS; PHOSPHORYLATION; IDENTIFICATION	The Type VI secretion system (T6SS) is a macromolecular complex widespread in Gram-negative bacteria. Although several T6SS are required for virulence towards host models, most are necessary to eliminate competitor bacteria. Other functions, such as resistance to amoeba predation, biofilm formation or adaptation to environmental conditions have also been reported. This multitude of functions is reflected by the large repertoire of regulatory mechanisms shown to control T6SS expression, production or activation. Here, we demonstrate that one T6SS gene cluster encoded within the Yersinia pseudotuberculosis genome, T6SS-4, is regulated by OmpR, the response regulator of the two-component system EnvZ-OmpR. We first identified OmpR in a transposon mutagenesis screen. OmpR does not control the expression of the four other Y. pseudotuberculosis T6SS gene clusters and of an isolated vgrG gene, and responds to osmotic stresses to bind to and activate the T6SS-4 promoter. Finally, we show that T6SS-4 promotes Y. pseudotuberculosis survival in high osmolarity conditions and resistance to deoxycholate.	[Gueguen, Erwan; Durand, Eric; Zhang, Xiang Y.; d'Amalric, Quentin; Journet, Laure; Cascales, Eric] Aix Marseille Univ, CNRS, LISM, IMM,UMR 7255, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Gueguen, E (corresponding author), Univ Lyon 1, INSA, Lab Microbiol Adaptat & Pathogenie, F-69622 Villeurbanne, France.	erwan.gueguen@univ-lyon1.fr; cascales@imm.cnrs.fr	Durand, Eric/E-6739-2017; GUEGUEN, Erwan/AAC-1241-2019; CASCALES, ERIC/G-7420-2011	Durand, Eric/0000-0002-0577-8220; GUEGUEN, Erwan/0000-0001-8784-1491; CASCALES, ERIC/0000-0003-0611-9179; Journet, Laure/0000-0002-5847-2962	Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-10-JCJC-1303-03]; Fondation pour la Recherche Medicale [SPF-2009-12-17571, SPF-2010-12-21116]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Centre National de la Recherche Scientifique and a grant from the Agence Nationale de la Recherche (ANR-10-JCJC-1303-03) to E. C. E. G. and E. D. were recipients of post-doctoral fellowships from the Fondation pour la Recherche Medicale (SPF-2009-12-17571 and SPF-2010-12-21116 respectively). X.-Y.Z. was supported by the ANR-10-JCJC-1303-03 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA H, 1989, J BIOCHEM-TOKYO, V106, P5, DOI 10.1093/oxfordjournals.jbchem.a122817; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Aschtgen MS, 2012, MICROBIOLOGYOPEN, V1, P71, DOI 10.1002/mbo3.9; Aschtgen MS, 2010, VIRULENCE, V1, P535, DOI 10.4161/viru.1.6.13732; Aschtgen MS, 2010, MOL MICROBIOL, V75, P886, DOI 10.1111/j.1365-2958.2009.07028.x; Bang IS, 2002, MOL MICROBIOL, V44, P1235, DOI 10.1046/j.1365-2958.2002.02937.x; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Baumler AJ, 1996, GENE, V183, P207, DOI 10.1016/S0378-1119(96)00560-4; Bernard CS, 2010, J BACTERIOL, V192, P3850, DOI 10.1128/JB.00370-10; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Brunet YR, 2013, CELL REP, V3, P36, DOI 10.1016/j.celrep.2012.11.027; Brunet YR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002205; Brzostek K, 2007, MICROBIOL-SGM, V153, P2416, DOI 10.1099/mic.0.2006/003202-0; Cai SJ, 2002, J BIOL CHEM, V277, P24155, DOI 10.1074/jbc.M110715200; Casabona MG, 2013, ENVIRON MICROBIOL, V15, P471, DOI 10.1111/j.1462-2920.2012.02816.x; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Cascales E, 2012, PHILOS T R SOC B, V367, P1102, DOI 10.1098/rstb.2011.0209; Cathelyn JS, 2006, P NATL ACAD SCI USA, V103, P13514, DOI 10.1073/pnas.0603456103; Darwin AJ, 1999, MOL MICROBIOL, V32, P51, DOI 10.1046/j.1365-2958.1999.01324.x; Durand E, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.390153; Durand E, 2012, J BIOL CHEM, V287, P14157, DOI 10.1074/jbc.M111.338731; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; English G, 2012, MOL MICROBIOL, V86, P921, DOI 10.1111/mmi.12028; Eppinger M, 2007, PLOS GENET, V3, P1508, DOI 10.1371/journal.pgen.0030142; Felisberto-Rodrigues C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002386; Ferrieres L, 2010, J BACTERIOL, V192, P6418, DOI 10.1128/JB.00621-10; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Gao H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-39; Gueguen E, 2013, APPL ENVIRON MICROB, V79, P32, DOI 10.1128/AEM.02504-12; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Hsu FS, 2009, MOL MICROBIOL, V72, P1111, DOI 10.1111/j.1365-2958.2009.06701.x; Huang KJ, 1997, P NATL ACAD SCI USA, V94, P2828, DOI 10.1073/pnas.94.7.2828; Ishikawa T, 2012, INFECT IMMUN, V80, P575, DOI 10.1128/IAI.05510-11; Jubelin G, 2005, J BACTERIOL, V187, P2038, DOI 10.1128/JB.187.6.2038-2049.2005; Kenney LJ, 2002, CURR OPIN MICROBIOL, V5, P135, DOI 10.1016/S1369-5274(02)00310-7; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lertpiriyapong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042842; Leung KY, 2011, CURR OPIN MICROBIOL, V14, P9, DOI 10.1016/j.mib.2010.09.017; Lossi NS, 2011, MICROBIOL-SGM, V157, P3292, DOI 10.1099/mic.0.051987-0; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Maxson ME, 2005, APPL ENVIRON MICROB, V71, P5614, DOI 10.1128/AEM.71.9.5614-5618.2005; Maxson ME, 2004, J BACTERIOL, V186, P4199, DOI 10.1128/JB.186.13.4199-4208.2004; Merriam JJ, 1997, INFECT IMMUN, V65, P2497, DOI 10.1128/IAI.65.6.2497-2501.1997; MIZUNO T, 1990, MOL MICROBIOL, V4, P1077, DOI 10.1111/j.1365-2958.1990.tb00681.x; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Pieper R, 2009, MICROBIOL-SGM, V155, P498, DOI 10.1099/mic.0.022160-0; Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Records AR, 2011, MOL PLANT MICROBE IN, V24, P751, DOI 10.1094/MPMI-11-10-0262; Robinson JB, 2009, MICROB PATHOGENESIS, V47, P243, DOI 10.1016/j.micpath.2009.08.005; Ruiz N, 2009, NAT REV MICROBIOL, V7, P677, DOI 10.1038/nrmicro2184; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Schwarz S, 2010, TRENDS MICROBIOL, V18, P531, DOI 10.1016/j.tim.2010.09.001; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Silverman JM, 2011, MOL MICROBIOL, V82, P1277, DOI 10.1111/j.1365-2958.2011.07889.x; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Weber B, 2009, ENVIRON MICROBIOL, V11, P3018, DOI 10.1111/j.1462-2920.2009.02005.x; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103; Yoshida T, 2006, J BIOL CHEM, V281, P17114, DOI 10.1074/jbc.M602112200; Zaslaver A, 2006, NAT METHODS, V3, P623, DOI 10.1038/NMETH895; Zhang WP, 2013, ENVIRON MICROBIOL, V15, P557, DOI 10.1111/1462-2920.12005; Zhang WP, 2011, ARCH MICROBIOL, V193, P351, DOI 10.1007/s00203-011-0680-2; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zheng J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023876	78	34	36	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66615	10.1371/journal.pone.0066615	http://dx.doi.org/10.1371/journal.pone.0066615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840509	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200095
J	Ogura, T; Date, Y; Kikuchi, J				Ogura, Tatsuki; Date, Yasuhiro; Kikuchi, Jun			Differences in Cellulosic Supramolecular Structure of Compositionally Similar Rice Straw Affect Biomass Metabolism by Paddy Soil Microbiota	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; BACTERIAL CELLULOSE; PLANT RESIDUE; NMR ANALYSIS; CORN STOVER; WOOD; DEGRADATION; LIGNIN; HYDROLYSIS; STATE	Because they are strong and stable, lignocellulosic supramolecular structures in plant cell walls are resistant to decomposition. However, they can be degraded and recycled by soil microbiota. Little is known about the biomass degradation profiles of complex microbiota based on differences in cellulosic supramolecular structures without compositional variations. Here, we characterized and evaluated the cellulosic supramolecular structures and composition of rice straw biomass processed under different milling conditions. We used a range of techniques including solid-and solution-state nuclear magnetic resonance (NMR) and Fourier transform infrared spectroscopy followed by thermodynamic and microbial degradability characterization using thermogravimetric analysis, solution-state NMR, and denaturing gradient gel electrophoresis. These measured data were further analyzed using an "ECOMICS" web-based toolkit. From the results, we found that physical pretreatment of rice straw alters the lignocellulosic supramolecular structure by cleaving significant molecular lignocellulose bonds. The transformation from crystalline to amorphous cellulose shifted the thermal degradation profiles to lower temperatures. In addition, pretreated rice straw samples developed different microbiota profiles with different metabolic dynamics during the biomass degradation process. This is the first report to comprehensively characterize the structure, composition, and thermal degradation and microbiota profiles using the ECOMICS toolkit. By revealing differences between lignocellulosic supramolecular structures of biomass processed under different milling conditions, our analysis revealed how the characteristic compositions of microbiota profiles develop in addition to their metabolic profiles and dynamics during biomass degradation.	[Ogura, Tatsuki; Date, Yasuhiro; Kikuchi, Jun] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa 232, Japan; [Date, Yasuhiro; Kikuchi, Jun] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Kikuchi, Jun] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Kikuchi, Jun] RIKEN Res Cluster Innovat, Biomass Engn Program, Wako, Saitama, Japan	Yokohama City University; RIKEN; Nagoya University; RIKEN	Kikuchi, J (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa 232, Japan.	jun.kikuchi@riken.jp	DATE, Yasuhiro/V-3630-2018; Kikuchi, Jun/O-4725-2019; Kikuchi, Jun/M-5512-2015; Ogura, Tatsuki/AAB-9044-2022	DATE, Yasuhiro/0000-0001-9645-4370; Kikuchi, Jun/0000-0002-6809-394X; Kikuchi, Jun/0000-0002-6809-394X; Ogura, Tatsuki/0000-0003-1165-1207	Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology, Japan	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in part by Grants-in-Aid for Scientific Research for Advanced Low Carbon Technology Research (JK), Science and Technology Research Partnership for Sustainable Development (to JK) from Japan Science and Technology Agency, as well as Scientific Research (A) (JK) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adani F, 2011, ENVIRON SCI TECHNOL, V45, P1107, DOI 10.1021/es1020263; Akasaka H, 2003, FEMS MICROBIOL ECOL, V43, P149, DOI 10.1111/j.1574-6941.2003.tb01054.x; Akiyama Kenji, 2008, In Silico Biology, V8, P339; Avolio R, 2012, CARBOHYD POLYM, V87, P265, DOI 10.1016/j.carbpol.2011.07.047; Ben HX, 2011, ENERG FUEL, V25, P2322, DOI 10.1021/ef2001162; Binder JB, 2010, P NATL ACAD SCI USA, V107, P4516, DOI 10.1073/pnas.0912073107; Cao XY, 2012, ENERG FUEL, V26, P5983, DOI 10.1021/ef300947s; Chikayama E, 2010, ANAL CHEM, V82, P1653, DOI 10.1021/ac9022023; Chikayama E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003805; Date Y, 2012, J PROTEOME RES, V11, P5602, DOI 10.1021/pr3008682; Date Y, 2012, POLYM J, V44, P888, DOI 10.1038/pj.2012.105; Date Y, 2010, J BIOSCI BIOENG, V110, P87, DOI 10.1016/j.jbiosc.2010.01.004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Everroad RC, 2012, JOVE-J VIS EXP, DOI 10.3791/3163; Gierlinger N, 2008, BIOMACROMOLECULES, V9, P2194, DOI 10.1021/bm800300b; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grinhut T, 2011, ENVIRON SCI TECHNOL, V45, P2748, DOI 10.1021/es1036139; Hallac BB, 2009, J AGR FOOD CHEM, V57, P1275, DOI 10.1021/jf8030277; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Holtman KM, 2010, J AGR FOOD CHEM, V58, P9882, DOI 10.1021/jf101258x; Horikawa Y, 2009, BIOMACROMOLECULES, V10, P2235, DOI 10.1021/bm900413k; Iino T, 2010, INT J SYST EVOL MICR, V60, P1376, DOI 10.1099/ijs.0.012484-0; Ikeda T, 2002, J AGR FOOD CHEM, V50, P129, DOI 10.1021/jf010870f; KAMIDE K, 1985, POLYM J, V17, P701, DOI 10.1295/polymj.17.701; Ke J, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-17; Ke J, 2011, BIOMACROMOLECULES, V12, P1610, DOI 10.1021/bm2000132; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; KIKUCHI J., 2011, J ECOSYSTEM ECOGRA S, VS2, P1, DOI DOI 10.4172/2157-7625.S2-001; Kikuchi Jun, 2007, V358, P273, DOI 10.1007/978-1-59745-244-1_15; Kim H, 2010, ORG BIOMOL CHEM, V8, P576, DOI 10.1039/b916070a; Kono H, 2003, MACROMOLECULES, V36, P5131, DOI 10.1021/ma021769u; Kudo T, 2009, BIOSCI BIOTECH BIOCH, V73, P2561, DOI 10.1271/bbb.90304; Lan W, 2011, J AGR FOOD CHEM, V59, P8691, DOI 10.1021/jf201508g; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mao JD, 2010, J AGR FOOD CHEM, V58, P11680, DOI 10.1021/jf102514r; Martinez AT, 2011, ENVIRON MICROBIOL, V13, P96, DOI 10.1111/j.1462-2920.2010.02312.x; Matulova M, 2008, FEBS J, V275, P3503, DOI 10.1111/j.1742-4658.2008.06497.x; Maunu SL, 2002, PROG NUCL MAG RES SP, V40, P151, DOI 10.1016/S0079-6565(01)00041-3; McGrath CE, 2006, BIOCHEMISTRY-US, V45, P14094, DOI 10.1021/bi061757r; Mochida K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-568; Mori T, 2012, CARBOHYD POLYM, V90, P1197, DOI 10.1016/j.carbpol.2012.06.027; Ogata Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030263; Okamoto M, 2009, PLANT BIOTECHNOL-NAR, V26, P551, DOI 10.5511/plantbiotechnology.26.551; Okushita K, 2012, POLYM J, V44, P895, DOI 10.1038/pj.2012.82; Okushita K, 2012, BIOMACROMOLECULES, V13, P1323, DOI 10.1021/bm300537k; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Popescu CM, 2010, APPL SPECTROSC, V64, P1054, DOI 10.1366/000370210792434413; Pu YQ, 2006, CARBOHYD RES, V341, P591, DOI 10.1016/j.carres.2005.12.012; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; Sathitsuksanoh N, 2011, BIOTECHNOL BIOENG, V108, P521, DOI 10.1002/bit.22964; Schwanninger M, 2004, VIB SPECTROSC, V36, P23, DOI 10.1016/j.vibspec.2004.02.003; Sekiyama Y, 2007, PHYTOCHEMISTRY, V68, P2320, DOI 10.1016/j.phytochem.2007.04.011; Sekiyama Y, 2011, ANAL CHEM, V83, P719, DOI 10.1021/ac102097u; Sekiyama Y, 2010, ANAL CHEM, V82, P1643, DOI 10.1021/ac9019076; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Suzuki S, 2012, CELLULOSE, V19, P713, DOI 10.1007/s10570-012-9678-4; Tian C, 2007, J BIOL CHEM, V282, P18532, DOI 10.1074/jbc.M700549200; Tonbul Y, 2001, TURK J CHEM, V25, P333; Ueki A, 2006, INT J SYST EVOL MICR, V56, P39, DOI 10.1099/ijs.0.63896-0; Valaskova V, 2006, MICROBIOL-SGM, V152, P3613, DOI 10.1099/mic.0.29149-0; Vinogradov E, 2004, CARBOHYD RES, V339, P1483, DOI 10.1016/j.carres.2004.04.001; WAINHOUSE D, 1990, OECOLOGIA, V85, P257, DOI 10.1007/BF00319411; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe T, 2012, PLANT BIOTECHNOL-NAR, V29, P163, DOI 10.5511/plantbiotechnology.12.0222a; Witter R, 2006, MACROMOLECULES, V39, P6125, DOI 10.1021/ma052439n; Wojdyr M, 2010, J APPL CRYSTALLOGR, V43, P1126, DOI 10.1107/S0021889810030499; Yamamura M, PLANT BIOTECHNOL, V30, P25; Yao F, 2008, POLYM DEGRAD STABIL, V93, P90, DOI 10.1016/j.polymdegradstab.2007.10.012; Zeng MJ, 2007, BIOTECHNOL BIOENG, V97, P265, DOI 10.1002/bit.21298; Zhang YHP, 2006, BIOTECHNOL ADV, V24, P452, DOI 10.1016/j.biotechadv.2006.03.003; Zhao HB, 2006, ENERG FUEL, V20, P807, DOI 10.1021/ef050319a	72	26	27	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66919	10.1371/journal.pone.0066919	http://dx.doi.org/10.1371/journal.pone.0066919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840554	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200110
J	Takenaka, Y; Inoue, I; Nakano, T; Shinoda, Y; Ikeda, M; Awata, T; Katayama, S				Takenaka, Yasuhiro; Inoue, Ikuo; Nakano, Takanari; Shinoda, Yuichi; Ikeda, Masaaki; Awata, Takuya; Katayama, Shigehiro			A Novel Splicing Variant of Peroxisome Proliferator-Activated Receptor-gamma (Ppar gamma 1sv) Cooperatively Regulates Adipocyte Differentiation with Ppar gamma 2	PLOS ONE			English	Article							PPAR-GAMMA; MESSENGER-RNA; C/EBP-BETA; EXPRESSION; IDENTIFICATION; ADIPOGENESIS; PROMOTER; ISOFORMS; ALPHA	Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that regulate expression of a number of genes associated with the cellular differentiation and development. Here, we show the abundant and ubiquitous expression of a newly identified splicing variant of mouse Ppar gamma (Ppar gamma 1sv) that encodes Ppar gamma 1 protein, and its importance in adipogenesis. The novel splicing variant has a unique 5'-UTR sequence, relative to those of Ppar gamma 1 and Ppar gamma 2 mRNAs, indicating the presence of a novel transcriptional initiation site and promoter for Ppar gamma expression. Ppar gamma 1sv was highly expressed in the white and brown adipose tissues at levels comparable to Ppar gamma 2. Ppar gamma 1sv was synergistically up-regulated with Ppar gamma 2 during adipocyte differentiation of 3T3-L1 cells and mouse primary cultured preadipocytes. Inhibition of Ppar gamma 1sv by specific siRNAs completely abolished the induced adipogenesis in 3T3-L1 cells. C/EBP beta and C/EBP delta activated both the Ppar gamma 1sv and Ppar gamma 2 promoters in 3T3-L1 preadipocytes. These findings suggest that Ppar gamma 1sv and Ppar gamma 2 synergistically regulate the early stage of the adipocyte differentiation.	[Takenaka, Yasuhiro; Inoue, Ikuo; Awata, Takuya; Katayama, Shigehiro] Saitama Med Univ, Dept Endocrinol & Diabet, Saitama, Japan; [Nakano, Takanari] Saitama Med Univ, Dept Biochem, Saitama, Japan; [Shinoda, Yuichi] Misato Cent Gen Hosp, Saitama, Japan; [Ikeda, Masaaki] Saitama Med Univ, Dept Physiol, Saitama, Japan	Saitama Medical University; Saitama Medical University; Saitama Medical University	Takenaka, Y (corresponding author), Saitama Med Univ, Dept Endocrinol & Diabet, Saitama, Japan.	t_yasu@saitama-med.ac.jp; i1901018@saitama-med.ac.jp	Takenaka, Yasuhiro/HDO-7290-2022	Awata, Takuya/0000-0003-2622-8129	Grants-in-Aid for Scientific Research [25460299] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Calkhoven CF, 2000, GENE DEV, V14, P1920; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chen Y, 2006, BBA-GENE STRUCT EXPR, V1759, P32, DOI 10.1016/j.bbaexp.2006.01.005; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Fajas L, 1998, FEBS LETT, V438, P55, DOI 10.1016/S0014-5793(98)01273-3; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Hamm JK, 2001, J BIOL CHEM, V276, P18464, DOI 10.1074/jbc.M100797200; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Omi T, 2005, J ANIM BREED GENET, V122, P45, DOI 10.1111/j.1439-0388.2005.00508.x; Ricote M, 1998, P NATL ACAD SCI USA, V95, P7614, DOI 10.1073/pnas.95.13.7614; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Saladin R, 1999, CELL GROWTH DIFFER, V10, P43; Strand DW, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.99; Sundvold H, 2001, BIOCHEM BIOPH RES CO, V287, P383, DOI 10.1006/bbrc.2001.5602; Takahashi S, 2010, J ATHEROSCLER THROMB, V17, P73, DOI 10.5551/jat.2410; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Zhou JM, 2002, BIOCHEM BIOPH RES CO, V293, P274, DOI 10.1016/S0006-291X(02)00138-9	21	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65583	10.1371/journal.pone.0065583	http://dx.doi.org/10.1371/journal.pone.0065583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840343	gold, Green Submitted, Green Published			2022-12-27	WOS:000322361200026
J	Berliere, M; Duhoux, FP; Dalenc, F; Baurain, JF; Dellevigne, L; Galant, C; Van Maanen, A; Piette, P; Machiels, JP				Berliere, Martine; Duhoux, Francois P.; Dalenc, Florence; Baurain, Jean-Francois; Dellevigne, Laurence; Galant, Christine; Van Maanen, Aline; Piette, Philippe; Machiels, Jean-Pascal			Tamoxifen and Ovarian Function	PLOS ONE			English	Article							BREAST-CANCER; PREMENOPAUSAL WOMEN; ADJUVANT CHEMOTHERAPY; ENDOCRINE THERAPY; INHIBIN-B; HORMONE	Background: Some studies suggest that the clinical parameter "amenorrhea'' is insufficient to define the menopausal status of women treated with chemotherapy or tamoxifen. In this study, we investigated and compared the ovarian function defined either by clinical or biological parameters in pre-menopausal breast cancer patients treated with tamoxifen administered as adjuvant therapy. Materials and Methods: Between 1999 and 2003, 138 premenopausal patients consecutively treated for early breast cancer were included. Sixty-eight received tamoxifen in monotherapy as the only adjuvant systemic treatment (Group I) and 70 were treated with tamoxifen after adjuvant chemotherapy (Group II). All patients had a confirmed premenopausal status based on clinical parameters and hormonal values at study entry. They were followed prospectively every 3 months for 3 years: menses data, physical examination and blood tests (LH, FSH, 17-beta-estradiol). Vaginal ultrasonography was carried out every 6 months. After 3 years, prospective evaluation was completed and monitoring of ovarian function was performed as usual in our institution (1x/year). All data were retrospectively evaluated in 2011. Results: Three patients were excluded from the study in group I and 2 were excluded in group II. Patients were divided into 4 subgroups according to clinical data, i.e. menses patterns. These patterns were assessed by questionnaires. a: Regular menses (>10 cycles/year) b: Oligomenorrhea (5 to 9 cycles/year) c: Severe oligomenorrhea (1 to 4 cycles/year) d: Complete amenorrhea Estrogen levels did not appear to have any impact on disease-free survival rates after 3 or 8 years. FSH values were also documented and analyzed. They exhibited the same profile as estradiol values. Conclusions: Amenorrhea is an insufficient parameter to define menopausal status in patients receiving tamoxifen. Low estradiol levels must be coupled with other biological parameters to characterize endocrine status. These data are very important for the choice of endocrine therapy.	[Berliere, Martine; Duhoux, Francois P.; Dellevigne, Laurence; Galant, Christine; Piette, Philippe; Machiels, Jean-Pascal] Catholic Univ Louvain, Clin Univ St Luc, Ctr Canc, Clin Sein, B-1200 Brussels, Belgium; [Dalenc, Florence] Ctr Claudius Regaud, Med Oncol Serv, Toulouse, France; [Berliere, Martine; Duhoux, Francois P.; Baurain, Jean-Francois; Machiels, Jean-Pascal] Clin Univ St Luc, Med Oncol Serv, B-1200 Brussels, Belgium; [Berliere, Martine; Duhoux, Francois P.; Baurain, Jean-Francois; Machiels, Jean-Pascal] Catholic Univ Louvain, Inst Rech Clin & Expt Pole MIRO, B-1200 Brussels, Belgium; [Van Maanen, Aline] Catholic Univ Louvain, Clin Univ St Luc, Ctr Canc, Stat Unit, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; UNICANCER; Institut Claudius Regaud; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Berliere, M (corresponding author), Catholic Univ Louvain, Clin Univ St Luc, Ctr Canc, Clin Sein, B-1200 Brussels, Belgium.	martine.berliere@uclouvain.be		Duhoux, Francois/0000-0002-5429-7888				ABE O, 1992, LANCET, V339, P71; Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ahmad A, 2010, CLIN PHARMACOL THER, V88, P814, DOI 10.1038/clpt.2010.196; Bath LE, 2003, HUM REPROD, V18, P2368, DOI 10.1093/humrep/deg473; Burger HG, 2007, HUM REPROD UPDATE, V13, P559, DOI 10.1093/humupd/dmm020; Colleoni M, 2006, J CLIN ONCOL, V24, P1332, DOI 10.1200/JCO.2005.03.0783; Cuzick J, 2007, LANCET, V369, P1711; Dellapasqua S, 2005, J CLIN ONCOL, V23, P1736, DOI 10.1200/JCO.2005.11.050; Ganz PA, 2011, J CLIN ONCOL, V29, P1110, DOI 10.1200/JCO.2010.29.7689; Goetz MP, 2005, J CLIN ONCOL, V23, P9312, DOI 10.1200/JCO.2005.03.3266; Gonzalez Martin A, 2010, BREAST CANC RES TREA, V10, P1045; Guidelines of the NCCN, 2011, DEFINITION MENOPAUSE; JORDAN VC, 1987, CANCER RES, V47, P624; JORDAN VC, 1991, J NATL CANCER I, V83, P1488, DOI 10.1093/jnci/83.20.1488; MANNI A, 1980, CANCER TREAT REP, V64, P779; Mourits MJE, 2007, J CLIN ONCOL, V25, P3787, DOI 10.1200/JCO.2007.11.1633; Ortmann O, 2011, CANCER TREAT REV, V37, P97, DOI 10.1016/j.ctrv.2010.05.005; Petrek JA, 2006, J CLIN ONCOL, V24, P1045, DOI 10.1200/JCO.2005.03.3969; Rafdim PM, 1988, CANCER RES, V48, P1026; Sakurai K, 2011, J CANCER RES CLIN, V137, P615, DOI 10.1007/s00432-010-0894-8; Shapiro CL, 2001, NEW ENGL J MED, V344, P1997, DOI 10.1056/NEJM200106283442607; Singh MS, 2011, BREAST, V20, P111, DOI 10.1016/j.breast.2010.11.003; Speroff L, 1999, CLIN GYNAECOLOGIC EN; Stebbing J, 2007, PHARMACOGENOMICS, V8, P1, DOI 10.2217/14622416.8.1.1; Su HI, 2010, CANCER-AM CANCER SOC, V116, P592, DOI 10.1002/cncr.24746; Walshe JM, 2006, J CLIN ONCOL, V24, P5769, DOI 10.1200/JCO.2006.07.2793	26	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66616	10.1371/journal.pone.0066616	http://dx.doi.org/10.1371/journal.pone.0066616			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840510	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400017
J	Mizutani, Y; Sun, H; Ohno, Y; Sassa, T; Wakashima, T; Obara, M; Yuyama, K; Kihara, A; Igarashi, Y				Mizutani, Yukiko; Sun, Hui; Ohno, Yusuke; Sassa, Takayuki; Wakashima, Takeshi; Obara, Mari; Yuyama, Kohei; Kihara, Akio; Igarashi, Yasuyuki			Cooperative Synthesis of Ultra Long-Chain Fatty Acid and Ceramide during Keratinocyte Differentiation	PLOS ONE			English	Article							PERMEABILITY BARRIER HOMEOSTASIS; SPHINGOSINE 1-PHOSPHATE; SUBSTRATE-SPECIFICITY; STRATUM-CORNEUM; SKIN; ELOVL4; SYNTHASE; PPAR; EXPRESSION; BIOSYNTHESIS	The lipid lamellae in the stratum corneum is important for the epidermal permeability barrier. The lipid lamellae component ceramide (CER), comprising an ultra long-chain (ULC) fatty acid (FA) of >= 26 carbons (ULC CER), plays an essential role in barrier formation. ULC acyl-CoAs, produced by the FA elongase ELOVL4, are converted to ULC CERs by the CER synthase CERS3. In the presented study, we observed that ELOVL4 and CERS3 mRNAs increased during keratinocyte differentiation in vivo and in vitro. We also determined that peroxisome proliferator-activated receptor beta/delta is involved in the up-regulation of the mRNAs. Knockdown of CERS3 caused a reduction in the elongase activities toward ULC acyl-CoAs, suggesting that CERS3 positively regulates ULCFA. Thus, we reveal that the two key players in ULC CER production in epidermis, CERS3 and ELOVL4, are coordinately regulated at both the transcriptional and enzymatic levels.	[Mizutani, Yukiko; Sun, Hui; Obara, Mari; Yuyama, Kohei; Igarashi, Yasuyuki] Hokkaido Univ, Fac Adv Life Sci, Lab Biomembrane & Biofunct Chem, Sapporo, Hokkaido, Japan; [Ohno, Yusuke; Sassa, Takayuki; Wakashima, Takeshi; Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University	Kihara, A (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Biochem Lab, Kita 12, Sapporo, Hokkaido 060, Japan.	kihara@pharm.hokudai.ac.jp; yigarash@pharm.hokudai.ac.jp	KIHARA, AKIO/A-3802-2012; Ohno, Yusuke/Q-3285-2019; SASSA, Takayuki/B-2519-2012; Ohno, Yusuke/B-5621-2014	KIHARA, AKIO/0000-0001-5889-0788; Ohno, Yusuke/0000-0003-3702-1043; SASSA, Takayuki/0000-0003-3145-9829; Ohno, Yusuke/0000-0003-3702-1043; MIZUTANI, YUKIKO/0000-0002-1018-9156	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan [22770095]; Sapporo Biocluster 'Bio-S'; Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (MEXT)	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sapporo Biocluster 'Bio-S'; Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Young Scientists (B) (22770095) from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan, and in part by grants from the Sapporo Biocluster 'Bio-S', the Knowledge Cluster Initiative of the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbaga MP, 2008, P NATL ACAD SCI USA, V105, P12843, DOI 10.1073/pnas.0802607105; Aldahmesh MA, 2011, AM J HUM GENET, V89, P745, DOI 10.1016/j.ajhg.2011.10.011; Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748; Cameron DJ, 2007, INT J BIOL SCI, V3, P111; Eckl KM, 2013, J INVEST DE IN PRESS; ELIAS PM, 1991, ADV LIPID RES, V24, P1; Escher P, 2000, MUTAT RES-FUND MOL M, V448, P121, DOI 10.1016/S0027-5107(99)00231-6; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Hong I, 2010, ARCH PHARM RES, V33, P1443, DOI 10.1007/s12272-010-0919-5; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Jiang YJ, 2010, J INVEST DERMATOL, V130, P511, DOI 10.1038/jid.2009.245; Kihara A, 2007, PROG LIPID RES, V46, P126, DOI 10.1016/j.plipres.2007.03.001; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Li WM, 2007, INT J BIOL SCI, V3, P120; Man MQ, 2008, J INVEST DERMATOL, V128, P370, DOI 10.1038/sj.jid.5701026; Man MQ, 2006, J INVEST DERMATOL, V126, P386, DOI 10.1038/sj.jid.5700046; Marekov LN, 1998, J BIOL CHEM, V273, P17763, DOI 10.1074/jbc.273.28.17763; Masukawa Y, 2008, J LIPID RES, V49, P1466, DOI 10.1194/jlr.M800014-JLR200; McMahon A, 2007, MOL VIS, V13, P258; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2008, J LIPID RES, V49, P2356, DOI 10.1194/jlr.M800158-JLR200; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mizutani Y, 2009, BIOCHIMIE, V91, P784, DOI 10.1016/j.biochi.2009.04.001; Ohno Y, 2010, P NATL ACAD SCI USA, V107, P18439, DOI 10.1073/pnas.1005572107; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Stewart ME, 2001, J LIPID RES, V42, P1105; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480; Westergaard M, 2001, J INVEST DERMATOL, V116, P702, DOI 10.1046/j.1523-1747.2001.01329.x	35	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67317	10.1371/journal.pone.0067317	http://dx.doi.org/10.1371/journal.pone.0067317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826266	Green Published, gold			2022-12-27	WOS:000321150000061
J	Pierce, EJ; Rey, MEC				Pierce, Erica J.; Rey, M. E. Chrissie			Assessing Global Transcriptome Changes in Response to South African Cassava Mosaic Virus [ZA-99] Infection in Susceptible Arabidopsis thaliana	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GENE-EXPRESSION; CELL-CYCLE; REPLICASE PROTEIN; DNA-REPLICATION; ABIOTIC STRESS; COMPLEX ARRAY; HOST-DEFENSE; PLANT; TOBACCO	In susceptible plant hosts, co-evolution has favoured viral strategies to evade host defenses and utilize resources to their own benefit. The degree of manipulation of host gene expression is dependent on host-virus specificity and certain abiotic factors. In order to gain insight into global transcriptome changes for a geminivirus pathosystem, South African cassava mosaic virus [ZA:99] and Arabidopsis thaliana, 4x44K Agilent microarrays were adopted. After normalization, a log2 fold change filtering of data (p<0.05) identified 1,743 differentially expressed genes in apical leaf tissue. A significant increase in differential gene expression over time correlated with an increase in SACMV accumulation, as virus copies were 5-fold higher at 24 dpi and 6-fold higher at 36 dpi than at 14 dpi. Many altered transcripts were primarily involved in stress and defense responses, phytohormone signalling pathways, cellular transport, cell-cycle regulation, transcription, oxidation-reduction, and other metabolic processes. Only forty-one genes (2.3%) were shown to be continuously expressed across the infection period, indicating that the majority of genes were transient and unique to a particular time point during infection. A significant number of pathogen-responsive genes were suppressed during the late stages of pathogenesis, while during active systemic infection (14 to 24 dpi), there was an increase in up-regulated genes in several GO functional categories. An adaptive response was initiated to divert energy from growth-related processes to defense, leading to disruption of normal biological host processes. Similarities in cell-cycle regulation correlated between SACMV and Cabbage leaf curl virus (CaLCuV), but differences were also evident. Differences in gene expression between the two geminiviruses clearly demonstrated that, while some global transcriptome responses are generally common in plant virus infections, temporal host-specific interactions are required for successful geminivirus infection. To our knowledge this is the first geminivirus microarray study identifying global differentially expressed transcripts at 3 time points.	[Pierce, Erica J.; Rey, M. E. Chrissie] Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa	University of Witwatersrand	Rey, MEC (corresponding author), Univ Witwatersrand, Sch Mol & Cell Biol, Johannesburg, South Africa.	Chrissie.rey@wits.ac.za			National Bioinformatics Network through the Department of Science and Technology; National Research Foundation	National Bioinformatics Network through the Department of Science and Technology; National Research Foundation	Funding was from the National Bioinformatics Network through the Department of Science and Technology (www.dst.gov.za) and the National Research Foundation (www.nrf.ac.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Romero P, 2008, BMC GENOMICS, V3, pe2397; Agudelo-Romero P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-92; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Andrietta MH, 2001, GENET MOL BIOL, V24, P61, DOI 10.1590/S1415-47572001000100010; Aranda MA, 1996, P NATL ACAD SCI USA, V93, P15289, DOI 10.1073/pnas.93.26.15289; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Babu M, 2008, J GEN VIROL, V89, P1069, DOI 10.1099/vir.0.83531-0; Baena-Gonzalez E, 2010, MOL PLANT, V3, P300, DOI 10.1093/mp/ssp113; Ballare CL, 2011, TRENDS PLANT SCI, V16, P249, DOI 10.1016/j.tplants.2010.12.001; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Berrie LC, 2001, J GEN VIROL, V82, P53, DOI 10.1099/0022-1317-82-1-53; Boevink P, 2005, PLANT PHYSIOL, V138, P1815, DOI 10.1104/pp.105.066761; Brini F, 2011, PLANT CELL PHYSIOL, V52, P676, DOI 10.1093/pcp/pcr030; BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1016/j.chiabu.2021.105188; Busch W, 2007, CURR OPIN PLANT BIOL, V10, P136, DOI 10.1016/j.pbi.2007.01.002; Camborde L, 2010, PLANT CELL, V22, P3142, DOI 10.1105/tpc.109.072090; Carrington JC, 1998, CURR OPIN PLANT BIOL, V1, P336, DOI 10.1016/1369-5266(88)80056-6; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; De Schutter K, 2007, PLANT CELL, V19, P211, DOI 10.1105/tpc.106.045047; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Doyle JJ, 1987, PHYTOCHEMISTRY B, V19, P11; Dudits D, 2007, ANN BOT, V107, P1193; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elena SF, 2011, CURR OPIN PLANT BIOL, V14, P372, DOI 10.1016/j.pbi.2011.03.013; Epel BL, 2009, SEMIN CELL DEV BIOL, V20, P1074, DOI 10.1016/j.semcdb.2009.05.010; Escaler M, 2000, VIROLOGY, V267, P318, DOI 10.1006/viro.1999.0119; Fisher R, 1970, STATISTICAL METHODS, P96; Fontes EPB, 2004, GENE DEV, V18, P2545, DOI 10.1101/gad.1245904; Fregene M, 2004, PLANT MOL BIOL, V56, P563, DOI 10.1007/s11103-004-3477-8; Gafni Y, 2002, PHYSIOL MOL PLANT P, V60, P231, DOI 10.1006/pmpp.2002.0402; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Golem S, 2003, MOL PLANT MICROBE IN, V16, P681, DOI 10.1094/MPMI.2003.16.8.681; Gorovits R, 2007, MOL PLANT MICROBE IN, V20, P1376, DOI 10.1094/MPMI-20-11-1376; Guerra-Peraza O, 2005, J GEN VIROL, V86, P1815, DOI 10.1099/vir.0.80920-0; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Gutierrez C, 2002, PHYSIOL MOL PLANT P, V60, P219, DOI 10.1006/pmpp.2002.0401; Gutierrez C, 2000, EMBO J, V19, P792, DOI 10.1093/emboj/19.5.792; Hanley-Bowdoin L, 2004, MOL PLANT PATHOL, V5, P149, DOI [10.1111/j.1364-3703.2004.00214.x, 10.1111/J.1364-3703.2004.00214.X]; Harrison BD, 2002, PHYSIOL MOL PLANT P, V60, P215, DOI 10.1006/pmpp.2002.0400; Havelda Z, 2003, J VIROL, V77, P6082, DOI 10.1128/JVI.77.10.6082-6086.2003; Jeske H, 2009, CURR TOP MICROBIOL, V331, P185; Jin HL, 2006, PLANT PHYSIOL, V142, P651, DOI 10.1104/pp.106.083519; Kanzaki H, 2003, MOL PLANT PATHOL, V4, P383, DOI [10.1046/j.1364-3703.2003.00186.x, 10.1046/J.1364-3703.2003.00186.X]; Kim DH, 2011, PLANT PHYSIOL, V157, P132, DOI 10.1104/pp.111.178681; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Koornneef M, 2010, PLANT J, V61, P909, DOI 10.1111/j.1365-313X.2009.04086.x; Levy A, 2007, PLANT SIGNAL BEHAV, V2, P404, DOI 10.4161/psb.2.5.4334; Li G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016546; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Llorente F, 2008, MOL PLANT, V1, P496, DOI 10.1093/mp/ssn025; Love AJ, 2005, PLANT PHYSIOL, V139, P935, DOI 10.1104/pp.105.066803; Lozano-Duran R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022383; Ma SS, 2007, GENOME RES, V17, P1614, DOI 10.1101/gr.6911207; Marathe R, 2004, PLANT MOL BIOL, V55, P501, DOI 10.1007/s11103-004-0439-0; Mariano AC, 2004, VIROLOGY, V318, P24, DOI 10.1016/j.virol.2003.09.038; Maule A, 2002, CURR OPIN PLANT BIOL, V5, P279, DOI 10.1016/S1369-5266(02)00272-8; Mills-Lujan K, 2010, PROTOPLASMA, V239, P95, DOI 10.1007/s00709-009-0086-z; Mishra A, 2009, J BIOL CHEM, V284, P10537, DOI 10.1074/jbc.M806804200; NAGAR S, 1995, PLANT CELL, V7, P705, DOI 10.1105/tpc.7.6.705; Nakashita H, 2003, PLANT J, V33, P887, DOI 10.1046/j.1365-313X.2003.01675.x; O'Donnell PJ, 2003, PLANT J, V33, P245, DOI 10.1046/j.1365-313X.2003.01619.x; Owens RA, 2012, MOL PLANT MICROBE IN, V25, P582, DOI 10.1094/MPMI-09-11-0258; Padmanabhan MS, 2006, MOL PLANT MICROBE IN, V19, P864, DOI 10.1094/MPMI-19-0864; Pallas V, 2011, J GEN VIROL, V92, P2691, DOI 10.1099/vir.0.034603-0; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Petti C, 2009, J BIOSCI BIOENG, V107, P301, DOI 10.1016/j.jbiosc.2008.11.012; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Piroux N, 2007, VIROLOGY, V362, P428, DOI 10.1016/j.virol.2006.12.034; Postnikova OA, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-101; Ricaud L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000430; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Scarpeci TE, 2008, PLANT SIGNAL BEHAV, V3, P856, DOI 10.4161/psb.3.10.6021; Selth LA, 2005, PLANT CELL, V17, P311, DOI 10.1105/tpc.104.027235; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Sorrell DA, 2001, PLANT PHYSIOL, V126, P1214, DOI 10.1104/pp.126.3.1214; Spaepen S, 2010, COLD SPRING HARB PER, V3; Sun WN, 2001, PLANT J, V27, P407, DOI 10.1046/j.1365-313X.2001.01107.x; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Trinks D, 2005, J VIROL, V79, P2517, DOI 10.1128/JVI.79.4.2517-2527.2005; Vandepoele K, 2002, PLANT CELL, V14, P903, DOI 10.1105/tpc.010445; Veena, 2003, PLANT J, V35, P219, DOI 10.1046/j.1365-313X.2003.01796.x; Vilaine F, 2003, PLANT J, V36, P67, DOI 10.1046/j.1365-313X.2003.01855.x; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang X, 2009, J VIROL, V83, P9720, DOI 10.1128/JVI.00941-09; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Xie Q, 1999, PLANT MOL BIOL, V39, P647, DOI 10.1023/A:1006138221874; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875	92	39	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67534	10.1371/journal.pone.0067534	http://dx.doi.org/10.1371/journal.pone.0067534			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826319	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000089
J	Rebello, MR; Maliphol, AB; Medler, KF				Rebello, Michelle R.; Maliphol, Amanda B.; Medler, Kathryn F.			Ryanodine Receptors Selectively Interact with L Type Calcium Channels in Mouse Taste Cells	PLOS ONE			English	Article							CA2+-INDUCED CA2+ RELEASE; DIHYDROPYRIDINE RECEPTORS; MAMMALIAN TASTE; SPONTANEOUS EXOCYTOSIS; SYNAPTIC-TRANSMISSION; CHROMAFFIN CELLS; NERVE-TERMINALS; SKELETAL-MUSCLE; LOCAL-CONTROL; BUDS	Introduction: We reported that ryanodine receptors are expressed in two different types of mammalian peripheral taste receptor cells: Type II and Type III cells. Type II cells lack voltage-gated calcium channels (VGCCs) and chemical synapses. In these cells, ryanodine receptors contribute to the taste-evoked calcium signals that are initiated by opening inositol trisphosphate receptors located on internal calcium stores. In Type III cells that do have VGCCs and chemical synapses, ryanodine receptors contribute to the depolarization-dependent calcium influx. Methodology/Principal Findings: The goal of this study was to establish if there was selectivity in the type of VGCC that is associated with the ryanodine receptor in the Type III taste cells or if the ryanodine receptor opens irrespective of the calcium channels involved. We also wished to determine if the ryanodine receptors and VGCCs require a physical linkage to interact or are simply functionally associated with each other. Using calcium imaging and pharmacological inhibitors, we found that ryanodine receptors are selectively associated with L type VGCCs but likely not through a physical linkage. Conclusions/Significance: Taste cells are able to undergo calcium induced calcium release through ryanodine receptors to increase the initial calcium influx signal and provide a larger calcium response than would otherwise occur when L type channels are activated in Type III taste cells.	[Rebello, Michelle R.; Maliphol, Amanda B.; Medler, Kathryn F.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Medler, KF (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	kmedler@buffalo.edu		Medler, Kathryn/0000-0001-9664-3606	NSF [0917893]	NSF(National Science Foundation (NSF))	This work was supported by NSF Grant 0917893 to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babai N, 2010, NEUROSCIENCE, V165, P1447, DOI 10.1016/j.neuroscience.2009.11.032; BEHE P, 1990, J GEN PHYSIOL, V96, P1061, DOI 10.1085/jgp.96.5.1061; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Berrout J, 2009, CELL CALCIUM, V46, P30, DOI 10.1016/j.ceca.2009.03.018; Cadetti L, 2006, EUR J NEUROSCI, V23, P2983, DOI 10.1111/j.1460-9568.2006.04845.x; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; De Crescenzo V, 2004, J NEUROSCI, V24, P1226, DOI 10.1523/JNEUROSCI.4286-03.2004; De Crescenzo V, 2006, J NEUROSCI, V26, P7565, DOI 10.1523/JNEUROSCI.1512-06.2006; De Crescenzo V, 2012, P NATL ACAD SCI USA, V109, P610, DOI 10.1073/pnas.1115111108; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; GILKEY JC, 1978, J CELL BIOL, V76, P448, DOI 10.1083/jcb.76.2.448; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2008, J NEUROSCI, V28, P13088, DOI 10.1523/JNEUROSCI.4187-08.2008; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; Kennedy HJ, 2002, J PHYSIOL-LONDON, V539, P15, DOI 10.1113/jphysiol.2001.013171; Kim S, 2007, J BIOL CHEM, V282, P32877, DOI 10.1074/jbc.M701418200; Krizaj D, 1999, J NEUROSCI, V19, P7249, DOI 10.1523/JNEUROSCI.19-17-07249.1999; Lanner JT, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003996; Lefkowitz JJ, 2009, J GEN PHYSIOL, V134, P267, DOI 10.1085/jgp.200910285; McNally JM, 2009, J NEUROSCI, V29, P14120, DOI 10.1523/JNEUROSCI.1726-09.2009; Medler KF, 2003, J NEUROSCI, V23, P2608; Mouton J, 2001, BIOCHEM J, V354, P597, DOI 10.1042/0264-6021:3540597; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ouardouz M, 2003, NEURON, V40, P53, DOI 10.1016/j.neuron.2003.08.016; Ouyang K, 2005, J BIOL CHEM, V280, P15898, DOI 10.1074/jbc.C500026200; Ouyang KF, 2005, P NATL ACAD SCI USA, V102, P12259, DOI 10.1073/pnas.0408494102; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Rebello MR, 2010, EUR J NEUROSCI, V32, P1825, DOI 10.1111/j.1460-9568.2010.07463.x; Richter TA, 2003, J PHYSIOL-LONDON, V547, P475, DOI 10.1113/jphysiol.2002.033811; RIOS E, 1987, NATURE, V325, P717, DOI 10.1038/325717a0; Roberts CD, 2009, J PHYSIOL-LONDON, V587, P1657, DOI 10.1113/jphysiol.2009.170555; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; SUN XH, 1995, J CELL BIOL, V129, P659, DOI 10.1083/jcb.129.3.659; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Vandenbeuch A, 2010, J NEUROSCI, V30, P14695, DOI 10.1523/JNEUROSCI.1570-10.2010; WIER WG, 1994, J PHYSIOL-LONDON, V474, P463, DOI 10.1113/jphysiol.1994.sp020037; Wier WG, 1999, CIRC RES, V85, P770, DOI 10.1161/01.RES.85.9.770; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; ZhuGe R, 2006, BIOPHYS J, V90, P2027, DOI 10.1529/biophysj.105.071654; Zucchi R, 1997, PHARMACOL REV, V49, P1	45	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68174	10.1371/journal.pone.0068174	http://dx.doi.org/10.1371/journal.pone.0068174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826376	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000130
J	Roslin, T; Wirta, H; Hopkins, T; Hardwick, B; Varkonyi, G				Roslin, Tomas; Wirta, Helena; Hopkins, Tapani; Hardwick, Bess; Varkonyi, Gergely			Indirect Interactions in the High Arctic	PLOS ONE			English	Article							QUANTITATIVE FOOD WEBS; APPARENT COMPETITION; HERBIVOROUS INSECTS; BOTTOM-UP; INTERSPECIFIC INTERACTIONS; PHYTOPHAGOUS INSECTS; COMMUNITY STRUCTURE; HOST-SPECIFICITY; PARASITOIDS; PLANTS	Indirect interactions as mediated by higher and lower trophic levels have been advanced as key forces structuring herbivorous arthropod communities around the globe. Here, we present a first quantification of the interaction structure of a herbivore-centered food web from the High Arctic. Targeting the Lepidoptera of Northeast Greenland, we introduce generalized overlap indices as a novel tool for comparing different types of indirect interactions. First, we quantify the scope for top-down-up interactions as the probability that a herbivore attacking plant species i itself fed as a larva on species j. Second, we gauge this herbivore overlap against the potential for bottom-up-down interactions, quantified as the probability that a parasitoid attacking herbivore species i itself developed as a larva on species j. Third, we assess the impact of interactions with other food web modules, by extending the core web around the key herbivore Sympistis nigrita to other predator guilds (birds and spiders). We find the host specificity of both herbivores and parasitoids to be variable, with broad generalists occurring in both trophic layers. Indirect links through shared resources and through shared natural enemies both emerge as forces with a potential for shaping the herbivore community. The structure of the host-parasitoid submodule of the food web suggests scope for classic apparent competition. Yet, based on predation experiments, we estimate that birds kill as many (8%) larvae of S. nigrita as do parasitoids (8%), and that spiders kill many more (38%). Interactions between these predator guilds may result in further complexities. Our results caution against broad generalizations from studies of limited food web modules, and show the potential for interactions within and between guilds of extended webs. They also add a data point from the northernmost insect communities on Earth, and describe the baseline structure of a food web facing imminent climate change.	[Roslin, Tomas; Wirta, Helena; Hopkins, Tapani; Hardwick, Bess] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Varkonyi, Gergely] Friendship Pk Res Ctr, Nat Environm Ctr, Finnish Environm Inst, Kuhmo, Finland	University of Helsinki; Finnish Environment Institute	Roslin, T (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.	tomas.roslin@helsinki.fi	Wirta, Helena/U-1892-2019; Várkonyi, Gergely/I-2310-2012; Hopkins, Tapani/U-6088-2019; Roslin, Tomas/E-8648-2016	Wirta, Helena/0000-0002-4667-2166; Várkonyi, Gergely/0000-0002-7977-2753; Roslin, Tomas/0000-0002-2957-4791; Hopkins, Tapani/0000-0002-2256-0098; Hardwick, Bess/0000-0001-5195-6115	INTERACT under the European Community's Seventh Framework Programme; University of Helsinki [788/51/2010]; Kone foundation	INTERACT under the European Community's Seventh Framework Programme; University of Helsinki; Kone foundation	Funding by INTERACT (http://www.eu-interact.org/; project QUANTIC) under the European Community's Seventh Framework Programme, by the University of Helsinki (http://www.helsinki.fi/university/index.html; grant number 788/51/2010 to TR), and by the Kone foundation (http://www.koneensaatio.fi/en/, through a grant to HW) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1998, SCIENCE, V279, P1201, DOI 10.1126/science.279.5354.1201; Ahola M., 2005, LARVAE NO EUROPEAN N; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Allesina S, 2008, SCIENCE, V320, P658, DOI 10.1126/science.1156269; Baiser B, 2012, GLOBAL ECOL BIOGEOGR, V21, P579, DOI 10.1111/j.1466-8238.2011.00705.x; Bay C., 1998, VEGETATION MAPPING Z; Bluthgen N, 2004, OIKOS, V106, P344, DOI 10.1111/j.0030-1299.2004.12687.x; Bonsall MB, 1997, NATURE, V388, P371, DOI 10.1038/41084; Bukovinszky T, 2008, SCIENCE, V319, P804, DOI 10.1126/science.1148310; Chaneton EJ, 2000, OIKOS, V88, P380, DOI 10.1034/j.1600-0706.2000.880217.x; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; COLINVAUX P, 1993, ECOLOGY, V2; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; Dobzhansky T., 1950, American Scientist, V38, P209; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Elton C., 1927, ANIMAL ECOLOGY; Ertl S, 2008, ZACKENBERG ECOLOGICA, P85; Fernandez-Triana J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023719; Floren A, 2002, OECOLOGIA, V131, P137, DOI 10.1007/s00442-002-0874-z; Fontaine C, 2011, ECOL LETT, V14, P1170, DOI 10.1111/j.1461-0248.2011.01688.x; FRETWELL SD, 1987, OIKOS, V50, P291, DOI 10.2307/3565489; FRETWELL SD, 1977, PERSPECT BIOL MED, V20, P169; Gauthier G, 2011, ECOSCIENCE, V18, P223, DOI 10.2980/18-3-3453; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Gripenberg S, 2007, OIKOS, V116, P181, DOI [10.1111/j.2006.0030-1299.15266.x, 10.1111/j.0030-1299.2007.15266.x]; Grosman AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002276; Hansen BU, 2008, ADV ECOL RES, V40, P111, DOI 10.1016/S0065-2504(07)00006-2; Hansen Jannik, 2012, Bird Populations, V11, P30; Harvey JA, 2010, BIOL CONSERV, V143, P2251, DOI 10.1016/j.biocon.2010.03.004; HAVENS K, 1992, SCIENCE, V257, P1107, DOI 10.1126/science.257.5073.1107; Hawkins B. A., 1994, PATTERN PROCESS HOST; Hawkins BA, 1997, ECOLOGY, V78, P2145, DOI 10.1890/0012-9658(1997)078[2145:PPAPAM]2.0.CO;2; Henson KSE, 2009, ECOLOGY, V90, P1840, DOI 10.1890/07-2108.1; Hirao T, 2008, ECOL RES, V23, P159, DOI 10.1007/s11284-007-0351-6; Hodkinson ID, 2004, OIKOS, V106, P427; Hodkinson ID, 2001, OIKOS, V95, P349, DOI 10.1034/j.1600-0706.2001.950217.x; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Howe A, 2009, ENTOMOL EXP APPL, V131, P325, DOI 10.1111/j.1570-7458.2009.00860.x; HUNTER MD, 1992, ECOLOGY, V73, P724; Janzen D.H., 1979, HERBIVORES THEIR INT, P331; JEANNE RL, 1979, ECOLOGY, V60, P1211, DOI 10.2307/1936968; Johnson PTJ, 2010, TRENDS ECOL EVOL, V25, P362, DOI 10.1016/j.tree.2010.01.005; Kaartinen R, 2012, OIKOS, V121, P1771, DOI 10.1111/j.1600-0706.2012.20108.x; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Krebs CJ, 2003, CAN J ZOOL, V81, P827, DOI [10.1139/z03-061, 10.1139/Z03-061]; KUKAL O, 1988, J EXP BIOL, V138, P181; Larsen S, 2000, ZACKENBERG ECOLOGICA, P54; Legagneux P, 2012, ECOLOGY, V93, P1707, DOI 10.1890/11-1973.1; Lewinsohn TM, 2008, ECOL LETT, V11, P398, DOI 10.1111/j.1461-0248.2008.01155.x; Lewis OT, 2002, J ANIM ECOL, V71, P855, DOI 10.1046/j.1365-2656.2002.00651.x; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Lundgren R, 2005, ARCT ANTARCT ALP RES, V37, P514, DOI 10.1657/1523-0430(2005)037[0514:TDAHCW]2.0.CO;2; MacArthur R.H., 1972, pvii; MARTINEZ ND, 1993, OIKOS, V66, P403, DOI 10.2307/3544934; Martinson HM, 2012, ECOLOGY, V93, P1779, DOI 10.1890/11-1497.1; Meltofte H, 2008, ADV ECOL RES, V40, P101, DOI 10.1016/S0065-2504(07)00005-0; Memmott J, 1999, ECOL LETT, V2, P276, DOI 10.1046/j.1461-0248.1999.00087.x; MEMMOTT J, 1994, J ANIM ECOL, V63, P521, DOI 10.2307/5219; Memmott J, 2009, PHILOS T R SOC B, V364, P1693, DOI 10.1098/rstb.2008.0255; Moles AT, 2011, FUNCT ECOL, V25, P380, DOI 10.1111/j.1365-2435.2010.01814.x; Morin P., 1999, COMMUNITY ECOL; Morris RJ, 2005, ANN ZOOL FENN, V42, P449; Morris RJ, 2004, NATURE, V428, P310, DOI 10.1038/nature02394; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; MURDOCH WW, 1966, AM NAT, V100, P219, DOI 10.1086/282415; Novotny V, 1999, AUST J ECOL, V24, P477, DOI 10.1046/j.1440-169x.1999.00987.x; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; Oksanen L, 2000, AM NAT, V155, P703, DOI 10.1086/303354; OKSANEN L, 1981, AM NAT, V118, P240, DOI 10.1086/283817; Olesen JM, 2011, P ROY SOC B-BIOL SCI, V278, P725, DOI 10.1098/rspb.2010.1371; Pennings SC, 2005, ECOLOGY, V86, P2310, DOI 10.1890/04-1022; PIMENTEL D, 1984, INSECT SCI APPL, V5, P141, DOI 10.1017/S1742758400008201; PIMM SL, 1980, J ANIM ECOL, V49, P879, DOI 10.2307/4233; PIMM SL, 1982, FOOD WEBS; Pocock MJO, 2012, SCIENCE, V335, P973, DOI 10.1126/science.1214915; Poisot T, 2011, BIOL LETTERS, V7, P201, DOI 10.1098/rsbl.2010.0774; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; R Core Team, 2012, R LANG ENV STAT COMP; Richards LA, 2007, OIKOS, V116, P31, DOI 10.1111/j.2006.0030-1299.15043.x; Roslin T, 2005, ECOSCIENCE, V12, P172, DOI 10.2980/i1195-6860-12-2-172.1; Rott AS, 2000, J ANIM ECOL, V69, P274, DOI 10.1046/j.1365-2656.2000.00390.x; Schleuning M, 2012, CURR BIOL, V22, P1925, DOI 10.1016/j.cub.2012.08.015; Slade E, 2007, EFFECTS TROPICAL FOR; Strong D., 1984, INSECTS PLANTS COMMU; Tack AJM, 2011, J ANIM ECOL, V80, P108, DOI 10.1111/j.1365-2656.2010.01744.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x; van Veen FJF, 2006, ANNU REV ENTOMOL, V51, P187, DOI 10.1146/annurev.ento.51.110104.151120; Varkonyi G, 2013, CAN ENTOMOL, V145, P193, DOI 10.4039/tce.2013.9; WILLIAMSON MH, 1957, NATURE, V180, P422, DOI 10.1038/180422a0; WILSON E O, 1992	101	27	28	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67367	10.1371/journal.pone.0067367	http://dx.doi.org/10.1371/journal.pone.0067367			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826279	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400138
J	Chen, BM; Peng, SL; D'Antonio, CM; Li, DJ; Ren, WT				Chen, Bao-Ming; Peng, Shao-Lin; D'Antonio, Carla M.; Li, Dai-Jiang; Ren, Wen-Tao			Non-Additive Effects on Decomposition from Mixing Litter of the Invasive Mikania micrantha HBK with Native Plants	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; LEAF-LITTER; ACCELERATE DECOMPOSITION; NITROGEN DYNAMICS; AQUEOUS EXTRACTS; DECAY-RATES; IMPACTS; RELEASE; LIGNIN; BIODIVERSITY	A common hypothesis to explain the effect of litter mixing is based on the difference in litter N content between mixed species. Although many studies have shown that litter of invasive non-native plants typically has higher N content than that of native plants in the communities they invade, there has been surprisingly little study of mixing effects during plant invasions. We address this question in south China where Mikania micrantha H. B. K., a non-native vine, with high litter N content, has invaded many forested ecosystems. We were specifically interested in whether this invader accelerated decomposition and how the strength of the litter mixing effect changes with the degree of invasion and over time during litter decomposition. Using litterbags, we evaluated the effect of mixing litter of M. micrantha with the litter of 7 native resident plants, at 3 ratios: M-1 (1:4, = exotic:native litter), M-2 (1:1) and M-3 (4:1, = exotic:native litter) over three incubation periods. We compared mixed litter with unmixed litter of the native species to identify if a non-additive effect of mixing litter existed. We found that there were positive significant non-additive effects of litter mixing on both mass loss and nutrient release. These effects changed with native species identity, mixture ratio and decay times. Overall the greatest accelerations of mixture decay and N release tended to be in the highest degree of invasion (mix ratio M-3) and during the middle and final measured stages of decomposition. Contrary to expectations, the initial difference in litter N did not explain species differences in the effect of mixing but overall it appears that invasion by M. micrantha is accelerating the decomposition of native species litter. This effect on a fundamental ecosystem process could contribute to higher rates of nutrient turnover in invaded ecosystems.	[Chen, Bao-Ming; Peng, Shao-Lin; Li, Dai-Jiang; Ren, Wen-Tao] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [D'Antonio, Carla M.] Univ Calif Santa Barbara, Santa Barbara, CA 93106 USA	Sun Yat Sen University; University of California System; University of California Santa Barbara	Peng, SL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lsspsl@mail.sysu.edu.cn	Chen, Bao-Ming/H-9024-2016	Chen, Bao-Ming/0000-0003-1891-8752; Li, Daijiang/0000-0002-0925-3421	National Natural Science Foundation of China [31070481, 31030015]; Doctoral Foundation of Ministry of Education of China [20100171120030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China (31070481, 31030015) and Doctoral Foundation of Ministry of Education of China (20100171120030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; [Anonymous], [No title captured]; APLET GH, 1990, OECOLOGIA, V82, P414, DOI 10.1007/BF00317491; Ashton IW, 2005, ECOL APPL, V15, P1263, DOI 10.1890/04-0741; Austin AT, 2009, ECOLOGY, V90, P2642, DOI 10.1890/08-1804.1; Ball BA, 2009, ECOSYSTEMS, V12, P87, DOI 10.1007/s10021-008-9208-2; Berg B, 2000, FOREST ECOL MANAG, V133, P13, DOI 10.1016/S0378-1127(99)00294-7; Berg B., 1980, Ecological Bulletins, V32, P373; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; BLAIR JM, 1990, ECOLOGY, V71, P1976, DOI 10.2307/1937606; Bragazza L, 2010, BIOL FERT SOILS, V46, P877, DOI 10.1007/s00374-010-0483-7; Chen BM, 2007, ALLELOPATHY J, V20, P307; Chen BM, 2009, ALLELOPATHY J, V23, P453; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Elgersma KJ, 2011, BIOL INVASIONS, V13, P757, DOI 10.1007/s10530-010-9866-9; Eppinga MB, 2011, J ECOL, V99, P503, DOI 10.1111/j.1365-2745.2010.01781.x; Evans RD, 2001, ECOL APPL, V11, P1301, DOI 10.1890/1051-0761(2001)011[1301:EPIAND]2.0.CO;2; Gartner TB, 2004, OIKOS, V104, P230, DOI 10.1111/j.0030-1299.2004.12738.x; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Hattenschwiler S, 2010, J ECOL, V98, P754, DOI 10.1111/j.1365-2745.2010.01671.x; Hattenschwiler S, 2000, TRENDS ECOL EVOL, V15, P238, DOI 10.1016/S0169-5347(00)01861-9; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Heneghan L, 2007, PEDOBIOLOGIA, V50, P543, DOI 10.1016/j.pedobi.2006.10.002; Hoorens B, 2003, OECOLOGIA, V137, P578, DOI 10.1007/s00442-003-1365-6; Huang Zhong-liang, 2000, Journal of Tropical and Subtropical Botany, V8, P131; Klotzbucher T, 2011, ECOLOGY, V92, P1052, DOI 10.1890/i0012-9658-92-5-1052; Kourtev P.S., 1999, Biological Invasions, V1, P237, DOI 10.1023/A:1010048909563; Kourtev PS, 2002, ECOLOGY, V83, P3152, DOI 10.1890/0012-9658(2002)083[3152:EPSATM]2.0.CO;2; Lecerf A, 2011, ECOLOGY, V92, P160, DOI 10.1890/10-0315.1; Li DJ, 2013, PLANT SOIL, V365, P255, DOI 10.1007/s11104-012-1337-x; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Liu ZG, 2002, ECOL APPL, V12, P1406, DOI 10.1890/1051-0761(2002)012[1406:EEAPLD]2.0.CO;2; Mack MC, 2003, ECOSYSTEMS, V6, P723, DOI 10.1007/s10021-003-0119-y; Maisto G, 2011, SOIL BIOL BIOCHEM, V43, P520, DOI 10.1016/j.soilbio.2010.11.017; Makkonen M, 2013, OIKOS, V122, P987, DOI 10.1111/j.1600-0706.2012.20750.x; MCCLAUGHERTY CA, 1985, ECOLOGY, V66, P266, DOI 10.2307/1941327; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; PALM CA, 1990, BIOTROPICA, V22, P330, DOI 10.2307/2388550; Prescott CE, 2000, CAN J FOREST RES, V30, P1742, DOI 10.1139/cjfr-30-11-1742; Quested HM, 2002, OECOLOGIA, V130, P88, DOI 10.1007/s004420100780; Rosemond AD, 2010, OIKOS, V119, P326, DOI 10.1111/j.1600-0706.2009.17904.x; Salamanca EF, 1998, ECOL ENG, V10, P53, DOI 10.1016/S0925-8574(97)10020-9; Schimel JP, 2007, SOIL BIOL BIOCHEM, V39, P1428, DOI 10.1016/j.soilbio.2006.12.037; Scowcroft PG, 1997, J TROP ECOL, V13, P407, DOI 10.1017/S0266467400010592; Sheng ZB, 1987, BIOMASS CHEM ENG, V6, P2; Smith VC, 2003, OIKOS, V102, P235, DOI 10.1034/j.1600-0706.2003.12503.x; Srivastava DS, 2009, ECOLOGY, V90, P1073, DOI 10.1890/08-0439.1; STOCK WD, 1995, OECOLOGIA, V101, P375, DOI 10.1007/BF00328825; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; TAYLOR BR, 1989, ECOLOGY, V70, P97, DOI 10.2307/1938416; Wang SJ, 2010, ECOL RES, V25, P1113, DOI 10.1007/s11284-010-0736-9; Ward SE, 2010, OECOLOGIA, V164, P511, DOI 10.1007/s00442-010-1636-y; Wardle DA, 2003, SOIL BIOL BIOCHEM, V35, P827, DOI 10.1016/S0038-0717(03)00118-4; Wardle DA, 1997, OIKOS, V79, P247, DOI 10.2307/3546010; Waterhouse D.F., 1994, BIOL CONTROL WEEDS S, V125; Yelenik SG, 2004, RESTOR ECOL, V12, P44, DOI 10.1111/j.1061-2971.2004.00289.x; Zhang LY, 2004, WEED RES, V44, P42, DOI 10.1111/j.1365-3180.2003.00371.x; Zhang Weiyin, 2002, Yingyong Shengtai Xuebao, V13, P1684; [周先叶 Zhou Xianye], 2003, [生态科学, Ecologic Science], V22, P332	60	30	32	5	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66289	10.1371/journal.pone.0066289	http://dx.doi.org/10.1371/journal.pone.0066289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840435	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800045
J	Getty, A; Kovacs, AD; Lengyel-Nelson, T; Cardillo, A; Hof, C; Chan, CH; Pearce, DA				Getty, Amanda; Kovacs, Attila D.; Lengyel-Nelson, Timea; Cardillo, Andrew; Hof, Caitlin; Chan, Chun-Hung; Pearce, David A.			Osmotic Stress Changes the Expression and Subcellular Localization of the Batten Disease Protein CLN3	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; GREEN FLUORESCENT PROTEIN; HEAT-SHOCK FACTOR; MEMBRANE GLYCOPROTEIN; MAMMALIAN-CELLS; DILEUCINE MOTIF; BINDING PROTEIN; IN-VITRO; GENE; TRANSCRIPTION	Juvenile CLN3 disease (formerly known as juvenile neuronal ceroid lipofuscinosis) is a fatal childhood neurodegenerative disorder caused by mutations in the CLN3 gene. CLN3 encodes a putative lysosomal transmembrane protein with unknown function. Previous cell culture studies using CLN3-overexpressing vectors and/or anti-CLN3 antibodies with questionable specificity have also localized CLN3 in cellular structures other than lysosomes. Osmoregulation of the mouse Cln3 mRNA level in kidney cells was recently reported. To clarify the subcellular localization of the CLN3 protein and to investigate if human CLN3 expression and localization is affected by osmotic changes we generated a stably transfected BHK (baby hamster kidney) cell line that expresses a moderate level of myc-tagged human CLN3 under the control of the human ubiquitin C promoter. Hyperosmolarity (800 mOsm), achieved by either NaCl/urea or sucrose, dramatically increased the mRNA and protein levels of CLN3 as determined by quantitative real-time PCR and Western blotting. Under isotonic conditions (300 mOsm), human CLN3 was found in a punctate vesicular pattern surrounding the nucleus with prominent Golgi and lysosomal localizations. CLN3-positive early endosomes, late endosomes and cholesterol/sphingolipid-enriched plasma membrane microdomain caveolae were also observed. Increasing the osmolarity of the culture medium to 800 mOsm extended CLN3 distribution away from the perinuclear region and enhanced the lysosomal localization of CLN3. Our results reveal that CLN3 has multiple subcellular localizations within the cell, which, together with its expression, prominently change following osmotic stress. These data suggest that CLN3 is involved in the response and adaptation to cellular stress.	[Getty, Amanda; Kovacs, Attila D.; Lengyel-Nelson, Timea; Cardillo, Andrew; Hof, Caitlin; Chan, Chun-Hung; Pearce, David A.] Sanford Res USD, Sanford Childrens Hlth Res Ctr, Sioux Falls, SD USA; [Pearce, David A.] Univ S Dakota, Sanford Sch Med, Dept Pediat, Sioux Falls, SD USA	Sanford Health; University of South Dakota	Pearce, DA (corresponding author), Sanford Res USD, Sanford Childrens Hlth Res Ctr, Sioux Falls, SD USA.	David.Pearce@sanfordhealth.org	Chan, Chun-Hung/F-5358-2015	Chan, Chun-Hung/0000-0001-9646-2944	Luke and Rachel Batten Foundation; National Institutes of Health (NIH) [R01 NS044310, R21 NS067147]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044310, R21NS067147] Funding Source: NIH RePORTER	Luke and Rachel Batten Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Luke and Rachel Batten Foundation and the National Institutes of Health (NIH) grants R01 NS044310 and R21 NS067147. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca C, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-28; [Anonymous], 1995, Cell, V82, P949; Arakawa Y, 2004, BIOCHEM BIOPH RES CO, V322, P297, DOI 10.1016/j.bbrc.2004.04.208; Brenner BM, 2008, BRENNER RECTORS KIDN; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Caruccio L, 1997, BIOCHEM J, V327, P341, DOI 10.1042/bj3270341; Codlin S, 2009, J CELL SCI, V122, P1163, DOI 10.1242/jcs.038323; Cooper JD, 2008, EXP NEUROL, V211, P329, DOI 10.1016/j.expneurol.2008.02.016; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Ezaki J, 2003, J NEUROCHEM, V87, P1296, DOI 10.1046/j.1471-4159.2003.02132.x; Getty AL, 2010, CELL MOL LIFE SCI; Getty AL, 2011, EXP CELL RES, V317, P51, DOI 10.1016/j.yexcr.2010.09.007; Golabek AA, 1999, MOL GENET METAB, V66, P277, DOI 10.1006/mgme.1999.2836; Haskell RE, 2000, HUM MOL GENET, V9, P735, DOI 10.1093/hmg/9.5.735; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Jarvela I, 1999, HUM MOL GENET, V8, P1091, DOI 10.1093/hmg/8.6.1091; Jarvela I, 1998, HUM MOL GENET, V7, P85, DOI 10.1093/hmg/7.1.85; Kaczmarski W, 1999, MOL GENET METAB, V66, P261, DOI 10.1006/mgme.1999.2833; Kama R, 2011, J CELL BIOL, V195, P203, DOI 10.1083/jcb.201102115; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kast C, 2003, J BIOL CHEM, V278, P6787, DOI 10.1074/jbc.M210935200; Khan AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046098; Kida E, 1999, MOL GENET METAB, V66, P265, DOI 10.1006/mgme.1999.2837; Ko BCB, 1997, J BIOL CHEM, V272, P16431, DOI 10.1074/jbc.272.26.16431; Kremmidiotis G, 1999, HUM MOL GENET, V8, P523, DOI 10.1093/hmg/8.3.523; Kuper C, 2007, CURR GENOMICS, V8, P209; Kwon JM, 2011, NEUROLOGY, V77, P1801, DOI 10.1212/WNL.0b013e318237f649; Kyttala A, 2005, J BIOL CHEM, V280, P10277, DOI 10.1074/jbc.M411862200; Kyttala A, 2004, MOL BIOL CELL, V15, P1313, DOI 10.1091/mbc.E03-02-0120; Lin GGH, 2011, INSECT MOL BIOL, V20, P87, DOI 10.1111/j.1365-2583.2010.01047.x; LoCoco F, 1997, HAEMATOLOGICA, V82, P364; Luiro K, 2001, HUM MOL GENET, V10, P2123, DOI 10.1093/hmg/10.19.2123; Mao L, 2008, J PROTEOME RES, V7, P3968, DOI 10.1021/pr800245x; Mao QW, 2003, FEBS LETT, V555, P351, DOI 10.1016/S0014-5793(03)01274-2; Margraf LR, 1999, MOL GENET METAB, V66, P283, DOI 10.1006/mgme.1999.2830; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Michalewski MP, 1998, BIOCHEM BIOPH RES CO, V253, P458, DOI 10.1006/bbrc.1998.9210; Michalewski MP, 1999, MOL GENET METAB, V66, P272, DOI 10.1006/mgme.1999.2818; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; Pedersen SF, 2002, EXP CELL RES, V277, P57, DOI 10.1006/excr.2002.5529; Persaud-Sawin DA, 2004, PEDIATR RES, V56, P449, DOI 10.1203/01.PDR.0000136152.54638.95; Phillips SN, 2005, J NEUROSCI RES, V79, P573, DOI 10.1002/jnr.20367; Pullarkat RK, 1997, NEUROPEDIATRICS, V28, P42, DOI 10.1055/s-2007-973665; Qin JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010611; RABINDRAN SK, 1991, P NATL ACAD SCI USA, V88, P6906, DOI 10.1073/pnas.88.16.6906; SCHUETZ TJ, 1991, P NATL ACAD SCI USA, V88, P6911, DOI 10.1073/pnas.88.16.6911; SHIEH BH, 1993, GENOMICS, V16, P266, DOI 10.1006/geno.1993.1174; Stein CS, 2010, AM J PHYSL CELL PHYS; Storch S, 2004, J BIOL CHEM, V279, P53625, DOI 10.1074/jbc.M410930200; Storch S, 2007, TRAFFIC, V8, P431, DOI 10.1111/j.1600-0854.2007.00537.x; Uchiumi F, 2008, GENES CELLS, V13, P1229, DOI 10.1111/j.1365-2443.2008.01240.x; Uusi-Rauva K, 2008, EXP CELL RES, V314, P2895, DOI 10.1016/j.yexcr.2008.06.016; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Williams RE, 2012, NEUROLOGY, V79, P183, DOI 10.1212/WNL.0b013e31825f0547; Wolfe DM, 2011, DIS MODEL MECH, V4, P120, DOI 10.1242/dmm.006114; Wu YL, 2012, BIOCHIMIE, V94, P384, DOI 10.1016/j.biochi.2011.08.006; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	57	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66203	10.1371/journal.pone.0066203	http://dx.doi.org/10.1371/journal.pone.0066203			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840424	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800041
J	Kamata, T; Handa, M; Takakuwa, S; Sato, Y; Kawai, Y; Ikeda, Y; Aiso, S				Kamata, Tetsuji; Handa, Makoto; Takakuwa, Sonomi; Sato, Yukiko; Kawai, Yohko; Ikeda, Yasuo; Aiso, Sadakazu			Epitope Mapping for Monoclonal Antibody Reveals the Activation Mechanism for alpha V beta 3 Integrin	PLOS ONE			English	Article							GLYCOPROTEIN-IIB-IIIA; CRYSTAL-STRUCTURE; EXTRACELLULAR SEGMENT; STRUCTURAL BASIS; LIGAND-BINDING; HUMAN-MELANOMA; COMPLEX; FIBRINOGEN; ADHESION; CELLS	Epitopes for a panel of anti-alpha V beta 3 monoclonal antibodies (mAbs) were investigated to explore the activation mechanism of alpha V beta 3 integrin. Experiments utilizing alpha V/alpha IIb domain-swapping chimeras revealed that among the nine mAbs tested, five recognized the ligand-binding beta-propeller domain and four recognized the thigh domain, which is the upper leg of the alpha V chain. Interestingly, the four mAbs included function-blocking as well as non-functional mAbs, although they bound at a distance from the ligand-binding site. The epitopes for these four mAbs were further determined using human-to-mouse alpha V chimeras. Among the four, P3G8 recognized an amino acid residue, Ser-528, located on the side of the thigh domain, while AMF-7, M9, and P2W7 all recognized a common epitope, Ser-462, that was located close to the a-genu, where integrin makes a sharp bend in the crystal structure. Fibrinogen binding studies for cells expressing wild-type alpha V beta 3 confirmed that AMF-7, M9, and P2W7 were inhibitory, while P3G8 was non-functional. However, these mAbs were all unable to block binding when alpha V beta 3 was constrained in its extended conformation. These results suggest that AMF-7, M9, and P2W7 block ligand binding allosterically by stabilizing the angle of the bend in the bent conformation. Thus, a switchblade-like movement of the integrin leg is indispensable for the affinity regulation of alpha V beta 3 integrin.	[Kamata, Tetsuji; Takakuwa, Sonomi; Sato, Yukiko; Aiso, Sadakazu] Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Tokyo, Japan; [Handa, Makoto] Keio Univ, Sch Med, Ctr Transfus Med & Cell Therapy, Shinjuku Ku, Tokyo, Japan; [Kawai, Yohko] Int Univ Hlth & Welf, Prevent Hlth Examinat Ctr, Minato Ku, Tokyo, Japan; [Ikeda, Yasuo] Waseda Univ, Grad Sch Adv Sci & Engn, Fac Sci & Engn, Shinjuku Ku, Tokyo, Japan	Keio University; Keio University; International University of Health & Welfare; Waseda University	Kamata, T (corresponding author), Keio Univ, Sch Med, Dept Anat, Shinjuku Ku, Tokyo, Japan.	kamata@z7.keio.jp	Handa, Makoto/B-1121-2014		Health and Labor Sciences Research Grants (Research on Public Essential Drugs and Medical Devices) from the Ministry of Health, Labour and Welfare, Japan; Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research, Japan	Health and Labor Sciences Research Grants (Research on Public Essential Drugs and Medical Devices) from the Ministry of Health, Labour and Welfare, Japan; Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research, Japan	This work was supported by Health and Labor Sciences Research Grants (Research on Public Essential Drugs and Medical Devices) from the Ministry of Health, Labour and Welfare, Japan (to TK and MH), and by a grant from Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research, Japan (to TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Blue R, 2010, J BIOL CHEM, V285, P17604, DOI 10.1074/jbc.M110.107763; Chen W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001086; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; CHUNTHARAPAI A, 1993, EXP CELL RES, V205, P345, DOI 10.1006/excr.1993.1096; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; DEVRIES JE, 1986, INT J CANCER, V38, P465, DOI 10.1002/ijc.2910380403; Friedlander DR, 1996, CANCER RES, V56, P1939; HORTON MA, 1985, CANCER RES, V45, P5663; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kamata T, 2005, J BIOL CHEM, V280, P24775, DOI 10.1074/jbc.M409548200; Kamata T, 1996, J BIOL CHEM, V271, P18610, DOI 10.1074/jbc.271.31.18610; Kamata T, 2010, J BIOL CHEM, V285, P38428, DOI 10.1074/jbc.M110.139667; LEHMANN M, 1994, CANCER RES, V54, P2102; Litvinov RI, 2012, J BIOL CHEM; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; MITJANS F, 1995, J CELL SCI, V108, P2825; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; Springer TA, 2008, J CELL BIOL, V182, P791, DOI 10.1083/jcb.200801146; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Tang XY, 2008, J IMMUNOL, V180, P4793, DOI 10.4049/jimmunol.180.7.4793; Tokuhira M, 1996, THROMB HAEMOSTASIS, V76, P1038; von Schlippe M, 2000, J CELL SCI, V113, P425; WAYNER EA, 1991, J CELL BIOL, V113, P919, DOI 10.1083/jcb.113.4.919; WEISEL JW, 1992, J BIOL CHEM, V267, P16637; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xie C, 2004, P NATL ACAD SCI USA, V101, P15422, DOI 10.1073/pnas.0406680101; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Ye F, 2008, J MOL BIOL, V378, P976, DOI 10.1016/j.jmb.2008.03.014; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66096	10.1371/journal.pone.0066096	http://dx.doi.org/10.1371/journal.pone.0066096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840404	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800029
J	Lau, EY; Wong, SE; Baker, SE; Bearinger, JP; Koziol, L; Valdez, CA; Satcher, JH; Aines, RD; Lightstone, FC				Lau, Edmond Y.; Wong, Sergio E.; Baker, Sarah E.; Bearinger, Jane P.; Koziol, Lucas; Valdez, Carlos A.; Satcher, Joseph H., Jr.; Aines, Roger D.; Lightstone, Felice C.			Comparison and Analysis of Zinc and Cobalt-Based Systems as Catalytic Entities for the Hydration of Carbon Dioxide	PLOS ONE			English	Article							HYDROGEN-BOND NETWORK; ANHYDRASE-II; ACTIVE-SITE; PROTON-TRANSFER; X-RAY; SPECTROSCOPIC MODEL; SYNTHETIC ANALOGS; ATMOSPHERIC CO2; MECHANISM; COMPLEXES	In nature, the zinc metalloenzyme carbonic anhydrase II (CAII) efficiently catalyzes the conversion of carbon dioxide (CO2) to bicarbonate under physiological conditions. Many research efforts have been directed towards the development of small molecule mimetics that can facilitate this process and thus have a beneficial environmental impact, but these efforts have met very limited success. Herein, we undertook quantum mechanical calculations of four mimetics, 1,5,9-triazacyclododedacane, 1,4,7,10-tetraazacyclododedacane, tris(4,5-dimethyl-2-imidazolyl)phosphine, and tris(2-benzimidazolylmethyl)amine, in their complexed form either with the Zn2+ or the Co2+ ion and studied their reaction coordinate for CO2 hydration. These calculations demonstrated that the ability of the complex to maintain a tetrahedral geometry and bind bicarbonate in a unidentate manner were vital for the hydration reaction to proceed favorably. Furthermore, these calculations show that the catalytic activity of the examined zinc complexes was insensitive to coordination states for zinc, while coordination states above four were found to have an unfavorable effect on product release for the cobalt counterparts.	[Lau, Edmond Y.; Wong, Sergio E.; Baker, Sarah E.; Bearinger, Jane P.; Koziol, Lucas; Valdez, Carlos A.; Satcher, Joseph H., Jr.; Aines, Roger D.; Lightstone, Felice C.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Aines, RD (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA.	aines1@llnl.gov; felice@llnl.gov	Wilson, Adam Benjamin/H-9918-2019	Wilson, Adam Benjamin/0000-0002-1221-5602; Valdez, Carlos A./0000-0002-8641-9077; Lau, Edmond/0000-0003-0619-7249; Baker, Sarah/0000-0003-4695-3918	Laboratory Directed Research and Development Program at Lawrence Livermore National Laboratory [10-ERD-035]	Laboratory Directed Research and Development Program at Lawrence Livermore National Laboratory	The authors thank the Laboratory Directed Research and Development Program at Lawrence Livermore National Laboratory for funding 10-ERD-035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber BE, 1999, BIOCHEMISTRY-US, V38, P13119, DOI 10.1021/bi9828876; Amata O, 2011, PHYS CHEM CHEM PHYS, V13, P3468, DOI 10.1039/c0cp01053g; AQVIST J, 1993, J AM CHEM SOC, V115, P631; Azari F, 1999, BIOTECHNOL BIOENG, V62, P193, DOI 10.1002/(SICI)1097-0290(19990120)62:2<193::AID-BIT9>3.0.CO;2-H; Bao LH, 2006, J MEMBRANE SCI, V280, P330, DOI 10.1016/j.memsci.2006.01.036; Barone V, 1998, J PHYS CHEM A, V102, P1995, DOI 10.1021/jp9716997; Barone V, 1998, J COMPUT CHEM, V19, P404, DOI 10.1002/(SICI)1096-987X(199803)19:4<404::AID-JCC3>3.0.CO;2-W; Barone V, 1997, J CHEM PHYS, V107, P3210, DOI 10.1063/1.474671; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BEHRAVAN G, 1990, EUR J BIOCHEM, V190, P351, DOI 10.1111/j.1432-1033.1990.tb15582.x; BENELLI C, 1984, INORG CHEM, V23, P1422, DOI 10.1021/ic00178a024; Bergquist C, 2003, J AM CHEM SOC, V125, P6189, DOI 10.1021/ja034711j; BERTINI I, 1981, INORG CHEM, V20, P1670, DOI 10.1021/ic50220a010; BERTINI I, 1983, J AM CHEM SOC, V105, P5116, DOI 10.1021/ja00353a043; BERTINI I, 1983, ACCOUNTS CHEM RES, V16, P272, DOI 10.1021/ar00092a002; Bhattacharya S, 2004, BIOTECHNOL BIOENG, V86, P37, DOI 10.1002/bit.20042; Bottoni A, 2004, J AM CHEM SOC, V126, P1542, DOI 10.1021/ja030336j; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Brauer M, 2002, INORG CHEM, V41, P1454, DOI 10.1021/ic0010510; BROWN RS, 1981, J AM CHEM SOC, V103, P6953, DOI 10.1021/ja00413a031; Cowan RM, 2003, ANN NY ACAD SCI, V984, P453, DOI 10.1111/j.1749-6632.2003.tb06019.x; Cullinane JT, 2006, IND ENG CHEM RES, V45, P2531, DOI 10.1021/ie050230s; Davy R, 2009, ENRGY PROCED, V1, P885, DOI 10.1016/j.egypro.2009.01.118; Domsic JF, 2008, J BIOL CHEM, V283, P30766, DOI 10.1074/jbc.M805353200; Elliott S, 2001, GEOPHYS RES LETT, V28, P1235, DOI 10.1029/2000GL011572; Fan YB, 2007, J AM CHEM SOC, V129, P905, DOI 10.1021/ja0660251; Figueroa JD, 2008, INT J GREENH GAS CON, V2, P9, DOI 10.1016/S1750-5836(07)00094-1; Fisher SZ, 2007, BIOCHEMISTRY-US, V46, P2930, DOI 10.1021/bi062066y; Frisch G. W., 2013, GAUSSIAN 09; Frisch M.J., 2016, GAUSSIAN16 REV B01; GARMER DR, 1992, J AM CHEM SOC, V114, P6487, DOI 10.1021/ja00042a031; HAFFNER PH, 1973, J BIOL CHEM, V248, P6630; HAKANSSON K, 1992, J MOL BIOL, V227, P1192, DOI 10.1016/0022-2836(92)90531-N; HAKANSSON K, 1994, ACTA CRYSTALLOGR D, V50, P101, DOI 10.1107/S0907444993009667; HAKANSSON K, 1994, ACTA CRYSTALLOGR D, V50, P93, DOI 10.1107/S0907444993008790; HAKANSSON K, 1992, J MOL BIOL, V228, P1212, DOI 10.1016/0022-2836(92)90327-G; HAN R, 1993, J INORG BIOCHEM, V49, P105, DOI 10.1016/0162-0134(93)85020-9; Innocenti A, 2004, BIOORG MED CHEM LETT, V14, P3327, DOI 10.1016/j.bmcl.2004.03.101; Iverson TM, 2000, BIOCHEMISTRY-US, V39, P9222, DOI 10.1021/bi000204s; Keith DW, 2006, CLIMATIC CHANGE, V74, P17, DOI 10.1007/s10584-005-9026-x; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; KIMURA E, 1988, INORG CHEM, V27, P3687, DOI 10.1021/ic00293a056; KITAJIMA N, 1993, J AM CHEM SOC, V115, P5496, DOI 10.1021/ja00066a018; KOGUT KA, 1987, J BIOL CHEM, V262, P16417; Koziol L, 2012, INORG CHEM, V51, P6803, DOI 10.1021/ic300526b; KREBS JF, 1993, J BIOL CHEM, V268, P27458; Krishnamurthy VM, 2008, CHEM REV, V108, P946, DOI 10.1021/cr050262p; Kunz PC, 2007, Z ANORG ALLG CHEM, V633, P955, DOI 10.1002/zaac.200700031; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; LIANG JY, 1987, BIOCHEMISTRY-US, V26, P5293, DOI 10.1021/bi00391a012; LIANG ZW, 1993, EUR J BIOCHEM, V211, P821, DOI 10.1111/j.1432-1033.1993.tb17614.x; LILJAS A, 1972, NATURE-NEW BIOL, V235, P131, DOI 10.1038/newbio235131a0; LINDSKOG S, 1964, BIOCHIM BIOPHYS ACTA, V85, P462, DOI 10.1016/0926-6569(64)90310-4; Lindskog S, 1997, PHARMACOL THERAPEUT, V74, P1, DOI 10.1016/S0163-7258(96)00198-2; Loferer MJ, 2003, J AM CHEM SOC, V125, P8921, DOI 10.1021/ja035072f; Lu DS, 1998, J AM CHEM SOC, V120, P4006, DOI 10.1021/ja973397o; MacAuley SR, 2009, BIOCHEMISTRY-US, V48, P817, DOI 10.1021/bi802246s; Marino T, 2005, J AM CHEM SOC, V127, P4242, DOI 10.1021/ja045546q; Mauksch M, 2001, CHEMBIOCHEM, V2, P190, DOI 10.1002/1439-7633(20010302)2:3<190::AID-CBIC190>3.0.CO;2-7; Mazumdar PA, 2008, ACTA CRYSTALLOGR F, V64, P163, DOI 10.1107/S1744309108002078; MERZ KM, 1989, J AM CHEM SOC, V111, P5636, DOI 10.1021/ja00197a021; Merz KM, 1997, J AM CHEM SOC, V119, P863, DOI 10.1021/ja963296a; Mineva T, 1998, J COMPUT CHEM, V19, P290, DOI 10.1002/(SICI)1096-987X(199802)19:3<290::AID-JCC3>3.0.CO;2-O; Miranda FDS, 2008, TETRAHEDRON, V64, P5410, DOI 10.1016/j.tet.2008.02.097; Miscione GP, 2007, THEOR CHEM ACC, V118, P193, DOI 10.1007/s00214-007-0274-x; Nakata K, 2002, J INORG BIOCHEM, V89, P255, DOI 10.1016/S0162-0134(01)00419-6; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Parkin G, 2004, CHEM REV, V104, P699, DOI 10.1021/cr0206263; RAPPE AK, 1992, J AM CHEM SOC, V114, P10024, DOI 10.1021/ja00051a040; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; Rodionov VO, 2007, J AM CHEM SOC, V129, P12696, DOI 10.1021/ja072678l; Schultz NE, 2005, J PHYS CHEM A, V109, P11127, DOI 10.1021/jp0539223; SILVERMAN DN, 1988, ACCOUNTS CHEM RES, V21, P30, DOI 10.1021/ar00145a005; SIMONSSON I, 1979, EUR J BIOCHEM, V93, P409, DOI 10.1111/j.1432-1033.1979.tb12837.x; Sjoblom B, 2009, P NATL ACAD SCI USA, V106, P10609, DOI 10.1073/pnas.0904184106; SOLA M, 1992, J AM CHEM SOC, V114, P869, DOI 10.1021/ja00029a010; STEINER H, 1975, EUR J BIOCHEM, V59, P253, DOI 10.1111/j.1432-1033.1975.tb02449.x; Stolaroff J.K., 2006, THESIS CARNEGIE MELL; Stolaroff JK, 2008, ENVIRON SCI TECHNOL, V42, P2728, DOI 10.1021/es702607w; Stumm W, 1996, AQUATIC CHEM; Tautermann CS, 2003, J PHYS CHEM B, V107, P12013, DOI 10.1021/jp0353789; XUE YF, 1993, PROTEINS, V17, P93, DOI 10.1002/prot.340170112; YACHANDRA V, 1983, J AM CHEM SOC, V105, P6596, DOI 10.1021/ja00360a009; Yan M, 2007, BIOMACROMOLECULES, V8, P560, DOI 10.1021/bm060746a; Yin XC, 1999, TRANSIT METAL CHEM, V24, P537, DOI 10.1023/A:1006967503458; Zastrow ML, 2012, NAT CHEM, V4, P118, DOI [10.1038/NCHEM.1201, 10.1038/nchem.1201]; ZHANG XP, 1993, INORG CHEM, V32, P5749, DOI 10.1021/ic00077a017; ZHANG XP, 1995, INORG CHEM, V34, P5606, DOI 10.1021/ic00126a034; ZHENG YJ, 1992, J AM CHEM SOC, V114, P10498, DOI 10.1021/ja00052a054	89	10	10	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66187	10.1371/journal.pone.0066187	http://dx.doi.org/10.1371/journal.pone.0066187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840420	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800040
J	Yang, JP; Wang, WB; Yang, XX; Yang, L; Ren, L; Zhou, FX; Hu, L; He, W; Li, BY; Zhu, Y; Jiang, HG; Zhou, YF				Yang, Jun-Ping; Wang, Wen-Bo; Yang, Xiao-Xi; Yang, Lei; Ren, Li; Zhou, Fu-Xiang; Hu, Liu; He, Wei; Li, Bai-Yu; Zhu, Yan; Jiang, Huan-Gang; Zhou, Yun-Feng			The MPO-463G > A Polymorphism and Lung Cancer Risk: A Meta-Analysis Based on 22 Case-Control Studies	PLOS ONE			English	Article							MYELOPEROXIDASE GENE; REDUCED RISK; CLINICAL-TRIALS; MPO; SMOKERS; DNA; SUSCEPTIBILITY; BIAS; HETEROGENEITY; PUBLICATION	Background: Myeloperoxidase (MPO) is an endogenous oxidant enzyme that produces reactive oxygen species (ROS) and may be involved in lung carcinogenesis. The MPO-463G>A polymorphism influences MPO transcription and has been associated with lung cancer susceptibility. However, the association between the MPO-463G>A polymorphism and lung cancer risk remains controversial. Method: To investigate the effect of this polymorphism on lung cancer susceptibility, we performed a meta-analysis based on 22 published case-control studies including 7,520 patients with lung cancer and 8,600 controls. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of the association. Results: Overall, there was no evidence for significant association between MPO-463G>A polymorphism and lung cancer susceptibility (for AA versus GG: OR = 0.91, 95% CI = 0.67-1.24; for GA versus GG: OR = 0.87, 95% CI = 0.78-0.98; for AA/GA versus GG: OR = 0.90, 95% CI = 0.80-1.01; for AA versus GA/GG: OR = 0.96, 95% CI = 0.72-1.28). In the stratified analyses by ethnicity, source of controls and smoking status, we also did not find any significant association between them. Conclusions: In summary, this meta-analysis suggests MPO-463G>A polymorphism may not be a risk factor for developing lung cancer. However, further prospective well-designed population-based studies with larger sample size are expected to validate the results.	[Yang, Jun-Ping] Wuhan Univ, Affiliated Hosp 3, Dept Radiotherapy Oncol, Wuhan, Hubei, Peoples R China; [Wang, Wen-Bo; Yang, Xiao-Xi; Yang, Lei; Ren, Li; Zhou, Fu-Xiang; Hu, Liu; He, Wei; Li, Bai-Yu; Zhu, Yan; Jiang, Huan-Gang; Zhou, Yun-Feng] Wuhan Univ, Zhongnan Hosp, Dept Chemoradiotherapy Oncol, Wuhan, Hubei, Peoples R China	Wuhan University; Wuhan University	Zhou, YF (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Chemoradiotherapy Oncol, Wuhan, Hubei, Peoples R China.	yfzhouwhu@163.com			National Natural Science foundation of China [81071825/H1610]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science foundation of China (81071825/H1610). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, HLTH CONS INV EXP TO; [Anonymous], 2004, HLTH CONS SMOK REP S; Arslan S, 2011, MOL MED REP, V4, P87, DOI 10.3892/mmr.2010.378; AUSTIN GE, 1993, LEUKEMIA, V7, P1445; Bax L, 2009, AM J EPIDEMIOL, V169, P249, DOI 10.1093/aje/kwn340; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cascorbi I, 2000, CANCER RES, V60, P644; Chan EC, 2005, CANCER GENET CYTOGEN, V162, P10, DOI 10.1016/j.cancergencyto.2005.03.008; Chevrier I, 2003, PHARMACOGENETICS, V13, P729, DOI 10.1097/00008571-200312000-00004; Chu HY, 2010, MUTAGENESIS, V25, P389, DOI 10.1093/mutage/geq018; Dally H, 2002, INT J CANCER, V102, P530, DOI 10.1002/ijc.10756; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FEIG DI, 1994, CANCER RES, V54, pS1890; Feyler A, 2002, CANCER EPIDEM BIOMAR, V11, P1550; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Harms C, 2004, ENVIRON MOL MUTAGEN, V44, P74, DOI 10.1002/em.20031; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hua Feng, 2010, Zhongguo Fei Ai Za Zhi, V13, P122, DOI 10.3779/j.issn.1009-3419.2010.02.08; Kantarci OH, 2002, MAYO CLIN PROC, V77, P17, DOI 10.4065/77.1.17; Klebanoff SJ, 1999, P ASSOC AM PHYSICIAN, V111, P383, DOI 10.1111/paa.1999.111.5.383; Klinchid J, 2009, CANCER GENET CYTOGEN, V195, P143, DOI 10.1016/j.cancergencyto.2009.08.011; Larsen JE, 2006, CARCINOGENESIS, V27, P525, DOI 10.1093/carcin/bgi227; Le Marchand L, 2000, CANCER EPIDEM BIOMAR, V9, P181; Liu G, 2004, CANCER LETT, V214, P69, DOI 10.1016/j.canlet.2004.06.027; London SJ, 1997, CANCER RES, V57, P5001; Lu Wenfu, 2002, Zhonghua Zhongliu Zazhi, V24, P250; Misra RR, 2001, CANCER LETT, V164, P161, DOI 10.1016/S0304-3835(01)00384-6; Park JH, 2006, CANCER DETECT PREV, V30, P257, DOI 10.1016/j.cdp.2006.04.002; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Pharoah PDP, 2004, NAT REV CANCER, V4, P850, DOI 10.1038/nrc1476; Piedrafita FJ, 1996, J BIOL CHEM, V271, P14412, DOI 10.1074/jbc.271.24.14412; Schabath MB, 2002, LUNG CANCER-J IASLC, V37, P35, DOI 10.1016/S0169-5002(02)00034-X; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Skuladottir H, 2005, LUNG CANCER, V48, P187, DOI 10.1016/j.lungcan.2004.10.013; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; van Helden YGJ, 2009, FREE RADICAL BIO MED, V46, P299, DOI 10.1016/j.freeradbiomed.2008.10.038; Van Schooten FJ, 2004, CANCER EPIDEM BIOMAR, V13, P828; Xu LL, 2002, CANCER EPIDEM BIOMAR, V11, P1555; Yang M, 2007, LUNG CANCER, V57, P135, DOI 10.1016/j.lungcan.2007.03.005; Yoon KA, 2008, LUNG CANCER, V60, P40, DOI 10.1016/j.lungcan.2007.09.009; Zienolddiny S, 2008, CARCINOGENESIS, V29, P1164, DOI 10.1093/carcin/bgn020	42	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65778	10.1371/journal.pone.0065778	http://dx.doi.org/10.1371/journal.pone.0065778			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840365	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800021
J	Campos, PRA; Rosas, A; de Oliveira, VM; Gomes, MAF				Campos, Paulo R. A.; Rosas, Alexandre; de Oliveira, Viviane M.; Gomes, Marcelo A. F.			Effect of Landscape Structure on Species Diversity	PLOS ONE			English	Article							HABITAT FRAGMENTATION; AREA RELATIONSHIPS; NEUTRAL MODELS; PERCOLATION; DYNAMICS; CURVES	The effects of habitat fragmentation and their implications for biodiversity is a central issue in conservation biology which still lacks an overall comprehension. There is not yet a clear consensus on how to quantify fragmentation even though it is quite common to couple the effects of habitat loss with habitat fragmentation on biodiversity. Here we address the spatial patterns of species distribution in fragmented landscapes, assuming a neutral community model. To build up the fragmented landscapes, we employ the fractional Brownian motion approach, which in turn permits us to tune the amount of habitat loss and degree of clumping of the landscape independently. The coupling between the neutral community model, here simulated by means of the coalescent method, and fractal neutral landscape models enables us to address how the species-area relationship changes as the spatial patterns of a landscape is varied. The species-area relationship is one of the most fundamental laws in ecology, considered as a central tool in conservation biology, and is used to predict species loss following habitat disturbances. Our simulation results indicate that the level of clumping has a major role in shaping the species-area relationship. For instance, more compact landscapes are more sensitive to the effects of habitat loss and speciation rate. Besides, the level of clumping determines the existence and extension of the power-law regime which is expected to hold at intermediate scales. The distributions of species abundance are strongly influenced by the degree of fragmentation. We also show that the first and second commonest species have approximately self-similar spatial distributions across scales, with the fractal dimensions of the support of the first and second commonest species being very robust to changes in the spatial patterns of the landscape.	[Campos, Paulo R. A.; Gomes, Marcelo A. F.] Univ Fed Pernambuco, Dept Fis, BR-50739 Recife, PE, Brazil; [Rosas, Alexandre] Univ Fed Paraiba, Dept Fis, BR-58059900 Joao Pessoa, Paraiba, Brazil; [de Oliveira, Viviane M.] Univ Fed Rural Pernambuco, Dept Fis, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal da Paraiba; Universidade Federal Rural de Pernambuco (UFRPE)	Campos, PRA (corresponding author), Univ Fed Pernambuco, Dept Fis, BR-50739 Recife, PE, Brazil.	prac@df.ufpe.br	Rosas, Alexandre/F-7412-2010; Campos, Paulo/AAC-7734-2019; Campos, Paulo/G-2459-2012; de Oliveira, Viviane Moraes/AAZ-1514-2020	Rosas, Alexandre/0000-0001-7983-358X; Campos, Paulo/0000-0002-7823-1998; Campos, Paulo/0000-0002-7823-1998; 	Conselho Nacional de Desenvolvimento Cientfico e Tecnologico (CNPq); program PRONEX/MCT-CNPq-FACEPE; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE); program CAPES/Nanobiotec	Conselho Nacional de Desenvolvimento Cientfico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); program PRONEX/MCT-CNPq-FACEPE; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); program CAPES/Nanobiotec	The authors are partially supported by Conselho Nacional de Desenvolvimento Cientfico e Tecnologico (CNPq). PRAC, VMO and MAFG also acknowledge financial support from the program PRONEX/MCT-CNPq-FACEPE and Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE). AR acknowledges financial support from the program CAPES/Nanobiotec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmford A, 2005, ECOL LETT, V8, P1218, DOI 10.1111/j.1461-0248.2005.00814.x; Campos PRA, 2012, OIKOS, V121, P1737, DOI 10.1111/j.1600-0706.2011.20336.x; Campos PRA, 1997, PHYS REV B, V56, P40, DOI 10.1103/PhysRevB.56.40; Cencini M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038232; Chave J, 2004, ECOL LETT, V7, P241, DOI 10.1111/j.1461-0248.2003.00566.x; Condit R, 2000, SCIENCE, V288, P1414, DOI 10.1126/science.288.5470.1414; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Durrett R, 1996, J THEOR BIOL, V179, P119, DOI 10.1006/jtbi.1996.0053; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; GARDNER RH, 1993, HUMANS AS COMPONENTS OF ECOSYSTEMS, P208; Gardner RH, 1987, LANDSCAPE ECOL, V1, P19, DOI 10.1007/BF02275262; Gascon C, 1999, BIOL CONSERV, V91, P223, DOI 10.1016/S0006-3207(99)00080-4; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; Halley JM, 2004, ECOL LETT, V7, P254, DOI 10.1111/j.1461-0248.2004.00568.x; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; HOLLEY RA, 1975, ANN PROBAB, V3, P643, DOI 10.1214/aop/1176996306; HOLT RD, 1995, ECOLOGY, V76, P1610, DOI 10.2307/1938162; Hoshen J, 1997, PHYS REV E, V56, P1455, DOI 10.1103/PhysRevE.56.1455; HOSHEN J, 1976, PHYS REV B, V14, P3438, DOI 10.1103/PhysRevB.14.3438; Hubbell Stephen P., 2001, V32, pi; Keitt TH, 2000, LANDSCAPE ECOL, V15, P479, DOI 10.1023/A:1008193015770; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Leidner AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009534; Lomolino MV, 2000, J BIOGEOGR, V27, P17, DOI 10.1046/j.1365-2699.2000.00377.x; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; PEITGEN H, 1998, SCI FRACTAL IMAGES; Pereira HM, 2006, ECOLOGY, V87, P1877, DOI 10.1890/0012-9658(2006)87[1877:MBDICL]2.0.CO;2; Pigolotti S, 2009, J THEOR BIOL, V260, P83, DOI 10.1016/j.jtbi.2009.05.023; Plotkin JB, 2000, J THEOR BIOL, V207, P81, DOI 10.1006/jtbi.2000.2158; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Rahbek C, 2011, NATURE, V473, P288, DOI 10.1038/473288a; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosindell J, 2008, ECOL INFORM, V3, P259, DOI 10.1016/j.ecoinf.2008.05.001; Rosindell J, 2007, ECOL LETT, V10, P586, DOI 10.1111/j.1461-0248.2007.01050.x; Rosindell J, 2009, ECOLOGY, V90, P1743, DOI 10.1890/08-0661.1; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Sole RV, 2004, ECOL COMPLEX, V1, P65, DOI 10.1016/j.ecocom.2003.12.003; Stauffer D, 1984, INTRO PERCOLATION TH; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Williamson M, 2005, J ANIM ECOL, V74, P409, DOI 10.1111/j.1365-2656.2005.00936.x; With KA, 1999, LANDSCAPE ECOL, V14, P73, DOI 10.1023/A:1008030215600; With KA, 1997, CONSERV BIOL, V11, P1069, DOI 10.1046/j.1523-1739.1997.96210.x; Yaacobi G, 2007, P ROY SOC B-BIOL SCI, V274, P2409, DOI 10.1098/rspb.2007.0674	45	23	26	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66495	10.1371/journal.pone.0066495	http://dx.doi.org/10.1371/journal.pone.0066495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840490	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200087
J	Huang, L; Wang, GS; Wang, Y; Blanzieri, E; Su, C				Huang, Lan; Wang, Guishen; Wang, Yan; Blanzieri, Enrico; Su, Chao			Link Clustering with Extended Link Similarity and EQ Evaluation Division	PLOS ONE			English	Article							COMMUNITY STRUCTURE; COMPLEX NETWORKS; MODULARITY; FEATURES	Link Clustering (LC) is a relatively new method for detecting overlapping communities in networks. The basic principle of LC is to derive a transform matrix whose elements are composed of the link similarity of neighbor links based on the Jaccard distance calculation; then it applies hierarchical clustering to the transform matrix and uses a measure of partition density on the resulting dendrogram to determine the cut level for best community detection. However, the original link clustering method does not consider the link similarity of non-neighbor links, and the partition density tends to divide the communities into many small communities. In this paper, an Extended Link Clustering method (ELC) for overlapping community detection is proposed. The improved method employs a new link similarity, Extended Link Similarity (ELS), to produce a denser transform matrix, and uses the maximum value of EQ (an extended measure of quality of modularity) as a means to optimally cut the dendrogram for better partitioning of the original network space. Since ELS uses more link information, the resulting transform matrix provides a superior basis for clustering and analysis. Further, using the EQ value to find the best level for the hierarchical clustering dendrogram division, we obtain communities that are more sensible and reasonable than the ones obtained by the partition density evaluation. Experimentation on five real-world networks and artificially-generated networks shows that the ELC method achieves higher EQ and In-group Proportion (IGP) values. Additionally, communities are more realistic than those generated by either of the original LC method or the classical CPM method.	[Huang, Lan; Wang, Guishen; Wang, Yan; Su, Chao] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China; [Wang, Yan; Blanzieri, Enrico] Univ Trento, Dept Informat & Commun Technol, Povo, Italy	Jilin University; University of Trento	Wang, Y (corresponding author), Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Peoples R China.	wy6868@hotmail.com; blanzier@disi.unitn.it	王, 参 贵/E-6669-2011	王, 参 贵/0000-0001-6039-9285; Blanzieri, Enrico/0000-0001-6524-0601	Natural Science Foundation of China [60903097]; Jilin Innovation Team Project [20122805]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Innovation Team Project	This work is supported by the Natural Science Foundation of China (60903097) and Jilin Innovation Team Project (20122805) and assisted by Key Laboratory of Symbolic Computation and Knowledge Engineering of Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; [Anonymous], [No title captured]; [Anonymous], UNPUB; Breve F, 2009, LECT NOTES ARTIF INT, V5855, P619, DOI 10.1007/978-3-642-05253-8_68; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; Kalinka Alex T, 2011, Bioinformatics, V27, P2011, DOI 10.1093/bioinformatics/btr311; Kapp AV, 2007, BIOSTATISTICS, V8, P9, DOI 10.1093/biostatistics/kxj029; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Shen HW, 2009, PHYSICA A, V388, P1706, DOI 10.1016/j.physa.2008.12.021; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zhang SH, 2007, PHYSICA A, V374, P483, DOI 10.1016/j.physa.2006.07.023; Zhang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043092	26	24	29	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66005	10.1371/journal.pone.0066005	http://dx.doi.org/10.1371/journal.pone.0066005			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840390	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200048
J	Mandai, Y; Takahashi, D; Hase, K; Obata, Y; Furusawa, Y; Ebisawa, M; Nakagawa, T; Sato, T; Katsuno, T; Saito, Y; Shimaoka, T; Yokosuka, O; Yokote, K; Ohno, H				Mandai, Yasushi; Takahashi, Daisuke; Hase, Koji; Obata, Yuuki; Furusawa, Yukihiro; Ebisawa, Masashi; Nakagawa, Tomoo; Sato, Toru; Katsuno, Tatsuro; Saito, Yasushi; Shimaoka, Takeshi; Yokosuka, Osamu; Yokote, Kotaro; Ohno, Hiroshi			Distinct Roles for CXCR6(+) and CXCR6(-) CD4(+) T Cells in the Pathogenesis of Chronic Colitis	PLOS ONE			English	Article							FOLLICLE-ASSOCIATED EPITHELIUM; TRANSMEMBRANE CXC-CHEMOKINE; CROHNS-DISEASE; MEMORY; EXPRESSION; DIFFERENTIATION; LYMPHOCYTES; RECRUITMENT; SUBSETS; LIGAND	CD4(+) T cells play a central role in the development of inflammatory bowel disease (IBD) via high-level production of effector cytokines such as IFN-gamma and TNF-alpha. To better characterize the colitogenic CD4(+) T cells, we examined their expression of CXCR6, a chemokine receptor that is expressed by T cells upon activation and is upregulated in several inflammatory diseases. We found that 80% of colonic lamina propria CD4(+) T cells expressed CXCR6 in the CD45RB(high) T cell-transferred colitis model. CXCR6 expression was similarly upregulated in inflamed mucosa of patients with Crohn's disease. Although surface marker analysis demonstrated that both CXCR6(+) and CXCR6(-) CD4(+) T-cell subsets consist of the cells with effector and effector-memory cells, the more cells in the CXCR6(+) subset produced IFN-gamma and TNF-alpha compared to CXCR6(-) subset, and only the CXCR6(+) subset produced IL-17A. Nevertheless, adoptive retransfer of lamina propria CXCR6(+) T cells into Rag1(-/-) recipients failed to induce the disease due to limited expansion of the transferred cells. By contrast, retransfer of CXCR6(-) cells evoked colitis similar to that observed in CD4(+)CD45RB(high) T cell-transferred mice, and resulted in their conversion into CXCR6(+) cells. Collectively, these observations suggest that the CXCR6(+) CD4(+) T-cell subset consists of terminally differentiated effector cells that serve as the major source of effector cytokines in the inflamed tissue, whereas CXCR6(-)CD4(+) T-cell subset serves as a colitogenic memory compartment that retains the ability to proliferate and differentiate into CXCR6(+)CD4(+) T cells.	[Mandai, Yasushi; Nakagawa, Tomoo; Sato, Toru; Katsuno, Tatsuro; Saito, Yasushi; Yokote, Kotaro] Chiba Univ, Grad Sch Med, Dept Clin Cell Biol, Chiba, Japan; [Obata, Yuuki; Ohno, Hiroshi] Chiba Univ, Grad Sch Med, Dept Immune Regulat, Chiba, Japan; [Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Med & Clin Oncol, Chiba, Japan; [Mandai, Yasushi; Takahashi, Daisuke; Ebisawa, Masashi; Ohno, Hiroshi] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Epithelial Immunobiol, Yokohama, Kanagawa, Japan; [Hase, Koji; Obata, Yuuki; Furusawa, Yukihiro] RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Bioenvironm Epigenet, Yokohama, Kanagawa, Japan; [Takahashi, Daisuke; Ebisawa, Masashi; Ohno, Hiroshi] Yokohama City Univ, Grad Sch Nanobiosci, Dept Supramol Biol, Div Immunobiol, Yokohama, Kanagawa 232, Japan; [Hase, Koji; Furusawa, Yukihiro] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Div Mucosal Barriol,Minato Ku, Tokyo, Japan; [Shimaoka, Takeshi] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo, Japan	Chiba University; Chiba University; Chiba University; RIKEN; RIKEN; Yokohama City University; University of Tokyo; University of Tokyo	Hase, K (corresponding author), RIKEN Yokohama Inst, Res Ctr Allergy & Immunol, Lab Bioenvironm Epigenet, Yokohama, Kanagawa, Japan.	hase@ims.u-tokyo.ac.jp; ohno@rcai.riken.jp	Takahashi, Daisuke/C-3799-2019; Ohno, Hiroshi/L-7899-2014	Takahashi, Daisuke/0000-0001-8624-1160; Ohno, Hiroshi/0000-0001-8776-9661; Hase, Koji/0000-0001-9550-2334; Obata, Yuuki/0000-0001-5461-3521	Ministry of Education, Culture, Sports, Science and Technology of Japan [20790383, 22689017, 24249029, 15079203, 22021046, 20113003]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in-Aid for Young Scientists (B: #20790383) and (A: #22689017) (KH), Scientific research (A: 24249029) (HO), Scientific Research in Priority Areas (#15079203) (HO) and (#22021046) (KH), and Scientific Research on Innovative Areas (#20113003) (HO) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2004, J IMMUNOL, V172, P6362, DOI 10.4049/jimmunol.172.10.6362; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Atreya R, 2010, DIGEST DIS, V28, P386, DOI 10.1159/000320392; Diegelmann J, 2010, INFLAMM BOWEL DIS, V16, P1871, DOI 10.1002/ibd.21306; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fritsch RD, 2005, J IMMUNOL, V175, P6489, DOI 10.4049/jimmunol.175.10.6489; Hase K, 2006, J IMMUNOL, V176, P43, DOI 10.4049/jimmunol.176.1.43; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; Kanai T, 2009, INFLAMM BOWEL DIS, V15, P926, DOI 10.1002/ibd.20738; Kim CH, 2001, J CLIN INVEST, V107, P595, DOI 10.1172/JCI11902; Matloubian M, 2000, NAT IMMUNOL, V1, P298, DOI 10.1038/79738; Nemoto Y, 2007, GASTROENTEROLOGY, V132, P176, DOI 10.1053/j.gastro.2006.10.035; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Ruth JH, 2006, ARTHRITIS RHEUM-US, V54, P765, DOI 10.1002/art.21662; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sato T, 2005, J IMMUNOL, V174, P277, DOI 10.4049/jimmunol.174.1.277; Shimaoka T, 2003, J IMMUNOL, V171, P1647, DOI 10.4049/jimmunol.171.4.1647; Shimaoka T, 2004, J LEUKOCYTE BIOL, V75, P267, DOI 10.1189/jlb.1003465; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Swain SL, 2006, IMMUNOL REV, V211, P8, DOI 10.1111/j.0105-2896.2006.00388.x; Tomita T, 2008, INFLAMM BOWEL DIS, V14, P1630, DOI 10.1002/ibd.20636; Totsuka T, 2007, J IMMUNOL, V178, P4737, DOI 10.4049/jimmunol.178.8.4737; Unutmaz D, 2000, J IMMUNOL, V165, P3284, DOI 10.4049/jimmunol.165.6.3284; Uza N, 2011, GUT, V60, P1494, DOI 10.1136/gut.2010.221879; van der Voort R, 2005, ARTHRITIS RHEUM-US, V52, P1381, DOI 10.1002/art.21004; WENG NP, 1995, P NATL ACAD SCI USA, V92, P11091, DOI 10.1073/pnas.92.24.11091	28	13	14	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65488	10.1371/journal.pone.0065488	http://dx.doi.org/10.1371/journal.pone.0065488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840334	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200020
J	Nicolaou, M; Kunst, AE; Busschers, WB; van Valkengoed, IG; Dijkshoorn, H; Boateng, L; Brewster, LM; Snijder, MB; Stronks, K; Agyemang, C				Nicolaou, Mary; Kunst, Anton E.; Busschers, Wim B.; van Valkengoed, Irene G.; Dijkshoorn, Henriette; Boateng, Linda; Brewster, Lizzy M.; Snijder, Marieke B.; Stronks, Karien; Agyemang, Charles			Differences in Body Fat Distribution Play a Role in the Lower Levels of Elevated Fasting Glucose amongst Ghanaian Migrant Women Compared to Men	PLOS ONE			English	Article							SEX-DIFFERENCES; WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; HIP CIRCUMFERENCE; RISK-FACTORS; CARDIOVASCULAR-DISEASES; GENDER-DIFFERENCES; DIABETES-MELLITUS; POPULATION; PREVALENCE	Background: Despite higher levels of obesity, West African migrant women appear to have lower rates of type 2 diabetes than their male counterparts. We investigated the role of body fat distribution in these differences. Methods: Cross-sectional study of Ghanaian migrants (97 men, 115 women) aged 18-60 years in Amsterdam, the Netherlands. Weight, height, waist and hip circumferences were measured. Logistic regression was used to explore the association of BMI, waist and hip measurements with elevated fasting glucose (glucose >= 5.6 mmol/L). Linear regression was used to study the association of the same parameters with fasting glucose. Results: Mean BMI, waist and hip circumferences were higher in women than men while the prevalence of elevated fasting glucose was higher in men than in women, 33% versus 19%. With adjustment for age only, men were non-significantly more likely than women to have an elevated fasting glucose, odds ratio (OR) 1.81, 95% CI: 0.95, 3.46. With correction for BMI, the higher odds among men increased and were statistically significant (OR 2.84, 95% CI: 1.32, 6.10), but with consideration of body fat distribution (by adding both hip and waist in the analysis) differences were no longer significant (OR 1.56 95% CI: 0.66, 3.68). Analysis with fasting glucose as continuous outcome measure showed somewhat similar results. Conclusion: Compared to men, the lower rates of elevated fasting glucose observed among Ghanaian women may be partly due to a more favorable body fat distribution, characterized by both hip and waist measurements.	[Nicolaou, Mary; Kunst, Anton E.; Busschers, Wim B.; van Valkengoed, Irene G.; Boateng, Linda; Snijder, Marieke B.; Stronks, Karien; Agyemang, Charles] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Dijkshoorn, Henriette] Municipal Hlth Serv Amsterdam, Dept Epidemiol Documentat & Hlth Promot, Amsterdam, Netherlands; [Brewster, Lizzy M.] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Brewster, Lizzy M.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Nicolaou, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.nicolaou@amc.uva.nl	van Valkengoed, Irene/ABA-1551-2021; van Valkengoed, Irene G.M./B-2974-2013; Brewster, Lizzy M/K-7675-2019	van Valkengoed, Irene/0000-0002-9306-7831; van Valkengoed, Irene G.M./0000-0002-9306-7831; Kunst, Anton/0000-0002-3313-5273; Stronks, Karien/0000-0002-0921-2232; Brewster, Lizzy M/0000-0002-7434-0038	Municipal Health Service of Amsterdam	Municipal Health Service of Amsterdam	This study was financed by the Municipal Health Service of Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish.	Abell JE, 2008, AM J PUBLIC HEALTH, V98, P63, DOI 10.2105/AJPH.2006.093781; Abubakari AR, 2008, OBES REV, V9, P297, DOI 10.1111/j.1467-789X.2007.00462.x; Abubakari AR, 2009, PUBLIC HEALTH, V123, P602, DOI 10.1016/j.puhe.2009.07.009; Agyemang C, 2013, EUR J PREV CARDIOL, V20, P938, DOI 10.1177/2047487312451540; Agyemang C, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-7; Agyemang C, 2009, PUBLIC HEALTH NUTR, V12, P909, DOI 10.1017/S1368980008003510; Alberts M, 2005, EUR J CARDIOV PREV R, V12, P347, DOI 10.1097/01.hjr.0000174792.24188.8e; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Amoah AGB, 2002, ACTA DIABETOL, V39, P7, DOI 10.1007/s005920200006; [Anonymous], STAT YB 2009; BJORNTORP P, 1991, DIABETES CARE, V14, P1132, DOI 10.2337/diacare.14.12.1132; Cameron AJ, 2013, OBES REV, V14, P86, DOI 10.1111/j.1467-789X.2012.01051.x; Camhi SM, 2011, OBESITY, V19, P402, DOI 10.1038/oby.2010.248; Chen BH, 2009, DIABETES CARE, V32, P329, DOI 10.2337/dc08-1625; Creatore MI, 2010, CAN MED ASSOC J, V182, P781, DOI 10.1503/cmaj.091551; Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288; Donahue RP, 1997, DIABETES CARE, V20, P1670, DOI 10.2337/diacare.20.11.1670; Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3; Eriksen M, 2012, TOBACCO ATLAS; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Hanley AJG, 2009, DIABETOLOGIA, V52, P2079, DOI 10.1007/s00125-009-1464-y; International Organization for Migration, 2008, IBA RUL TAK EV INT C, P13; Janghorbani M, 2012, OBES REV, V13, P1172, DOI 10.1111/j.1467-789X.2012.01030.x; Johnson RL, 2005, PUBLIC HEALTH NURS, V22, P130, DOI 10.1111/j.0737-1209.2005.220206.x; Katzmarzyk PT, 2011, OBESITY, V19, P1272, DOI 10.1038/oby.2010.319; Kautzky-Willer A, 2009, EUR J CLIN INVEST, V39, P631, DOI 10.1111/j.1365-2362.2009.02161.x; LEY CJ, 1992, AM J CLIN NUTR, V55, P950, DOI 10.1093/ajcn/55.5.950; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Logue J, 2011, DIABETOLOGIA, V54, P3003, DOI 10.1007/s00125-011-2313-3; McCabe K., 2011, AFRICAN IMMIGRANTS U; Meisinger C, 2002, ARCH INTERN MED, V162, P82, DOI 10.1001/archinte.162.1.82; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Nimako K, 2000, AFRIKANEN NEDERLAND, P165; Njolstad I, 1998, AM J EPIDEMIOL, V147, P49; Power ML, 2008, BRIT J NUTR, V99, P931, DOI 10.1017/S0007114507853347; Ravussin E, 2002, ANN NY ACAD SCI, V967, P363; Research and Statistics, 2005, NONW FOR AMST; Seidell JC, 1997, J INTERN MED, V242, P401, DOI 10.1046/j.1365-2796.1997.00235.x; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Snijder MB, 2004, OBES RES, V12, P1370, DOI 10.1038/oby.2004.173; Snijder MB, 2004, DIABETES CARE, V27, P372, DOI 10.2337/diacare.27.2.372; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Tulloch-Reid MK, 2004, OBES RES, V12, P1352, DOI 10.1038/oby.2004.170; Van Pelt RE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1023, DOI 10.1152/ajpendo.00467.2001; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; WHO / IDF, 2006, DEF DIAGN DIAB MELL; Williams JW, 2003, DIABETIC MED, V20, P915, DOI 10.1046/j.1464-5491.2003.01059.x; World Health Organization/International Diabetes Federation, 2006, DEF DIAGN DIAB MELL; YKIJARVINEN H, 1985, CLIN PHYSIOL, V5, P45, DOI 10.1111/j.1475-097X.1985.tb00745.x; 2006, HLTH SURVEY ENGLAND	51	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66516	10.1371/journal.pone.0066516	http://dx.doi.org/10.1371/journal.pone.0066516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840498	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200090
J	Roy, S; Banerjee, J; Gnyawali, SC; Khanna, S; He, GL; Pfeiffer, D; Zweier, JL; Sen, CK				Roy, Sashwati; Banerjee, Jaideep; Gnyawali, Surya C.; Khanna, Savita; He, Guanglong; Pfeiffer, Douglas; Zweier, Jay L.; Sen, Chandan K.			Suppression of Induced microRNA-15b Prevents Rapid Loss of Cardiac Function in a Dicer Depleted Model of Cardiac Dysfunction	PLOS ONE			English	Article							CULTURED HL-1 CARDIOMYOCYTES; PROCESSING ENZYME DICER; MUSCLE CELL-LINE; VITAMIN-E ACTION; OXIDATIVE STRESS; HEART-FAILURE; MYOCARDIAL-INFARCTION; PIM-1 KINASE; DILATED CARDIOMYOPATHY; LASER MICRODISSECTION	Background: Dicer endonuclease, critical for maturation of miRNAs, is depleted in certain forms of cardiomyopathy which results in differential expression of certain microRNAs. We sought to elucidate the mechanisms underlying the rapid loss of cardiac function following cardiac-specific Dicer depletion in adult mice. Results: Conditional Dicer deletion in the adult murine myocardium demonstrated compromised heart function, mitochondrial dysfunction and oxidant stress. Elevated miR-15b was observed as an early response to Dicer depletion and was found to silence Pim-1 kinase, a protein responsible for maintaining mitochondrial integrity and function. Anti-miRNA based suppression of induced miRNA-15b rescued the function of Dicer-depleted adult heart and attenuated hypertrophy. Conclusions: Anti-miRNA based suppression of inducible miRNA-15b can prevent rapid loss of cardiac function in a Dicer-depleted adult heart and can be a key approach worthy of therapeutic consideration.	[Sen, Chandan K.] Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; Ohio State Univ, Med Ctr, Dept Surg, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Sen, CK (corresponding author), Ohio State Univ, Med Ctr, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	chandan.sen@osumc.edu	Gnyawali, Surya/HGB-8982-2022; Gnyawali, Surya/AAC-3082-2020; Khanna, Savita/E-3378-2011; Pfeiffer, Douglas/AFR-2249-2022; Roy, sashwati/E-3990-2011; Gnyawali, Surya/AAC-3082-2020	Gnyawali, Surya/0000-0001-8980-4889; Gnyawali, Surya/0000-0002-4214-8068; Banerjee, Jaideep/0000-0002-8688-7137	R01 awards [HL073087, GM069589]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069589] Funding Source: NIH RePORTER	R01 awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by R01 awards HL073087 and GM069589 to CKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan A, 2003, J BIOL CHEM, V278, P40105, DOI 10.1074/jbc.M307837200; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Borillo GA, 2010, CIRC RES; Carlson DL, 2002, AM J PHYSIOL-HEART C, V282, pH1907, DOI 10.1152/ajpheart.00393.2001; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cottage CT, 2010, CIRC RES, V106, P891, DOI 10.1161/CIRCRESAHA.109.208629; Crouser ED, 2002, CRIT CARE MED, V30, P276, DOI 10.1097/00003246-200202000-00002; Dai BS, 2002, BIOCHEM BIOPH RES CO, V296, P429, DOI 10.1016/S0006-291X(02)00894-X; Dhalla AK, 1996, J AM COLL CARDIOL, V28, P506, DOI 10.1016/0735-1097(96)00140-4; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Fischer KM, 2009, CIRCULATION, V120, P2077, DOI 10.1161/CIRCULATIONAHA.109.884403; Fryer RM, 2000, J PHARMACOL EXP THER, V294, P451; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; George CH, 2003, CIRC RES, V93, P531, DOI 10.1161/01.RES.0000091335.07574.86; Gnyawali S.C., 2010, J VISUALIZED EXPT JO; Gnyawali SC, 2009, ANTIOXID REDOX SIGN, V11, P1829, DOI [10.1089/ars.2009.2635, 10.1089/ARS.2009.2635]; Gonzalez-Juanatey JR, 2003, CIRCULATION, V107, P127, DOI 10.1161/01.CIR.0000043803.20822.D1; Hullinger TG, 2011, CIRC RES; Humphreys DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030933; Hussain SRA, 2008, BLOOD, V111, P3190, DOI 10.1182/blood-2007-10-115733; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Katakowski M, 2010, CANCER RES, V70, P8259, DOI 10.1158/0008-5472.CAN-10-0604; Khanna S, 2005, STROKE, V36, pE144, DOI 10.1161/01.STR.0000181082.70763.22; Khanna S, 2003, J BIOL CHEM, V278, P43508, DOI 10.1074/jbc.M307075200; Khanna S, 2006, J NEUROCHEM, V98, P1474, DOI 10.1111/j.1471-4159.2006.04000.x; Kitta K, 2001, BIOCHEM J, V359, P375, DOI 10.1042/0264-6021:3590375; Kitta K, 2001, FREE RADICAL BIO MED, V31, P902, DOI 10.1016/S0891-5849(01)00663-3; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kuhn DE, 2007, AM J PHYSIOL-HEART C, V292, pH1245, DOI 10.1152/ajpheart.01069.2006; Kuhn DE, 2006, AM J PHYSIOL-HEART C, V290, pH2625, DOI 10.1152/ajpheart.01346.2005; LANSON NA, 1992, CIRCULATION, V85, P1835, DOI 10.1161/01.CIR.85.5.1835; Li S, 2010, ONCOL REP, V24, P997, DOI 10.3892/or_00000947; Lilly M, 1999, ONCOGENE, V18, P4022, DOI 10.1038/sj.onc.1202741; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Montecalvo A, 2011, BLOOD; Muraski JA, 2008, P NATL ACAD SCI USA, V105, P13889, DOI 10.1073/pnas.0709135105; Muraski JA, 2007, NAT MED, V13, P1467, DOI 10.1038/nm1671; Narula N, 2011, JACC-CARDIOVASC IMAG, V4, P1, DOI 10.1016/j.jcmg.2010.06.018; Nguyen SV, 1999, BIOCHEM BIOPH RES CO, V265, P382, DOI 10.1006/bbrc.1999.1674; Nishi H, 2010, J BIOL CHEM, V285, P4920, DOI 10.1074/jbc.M109.082610; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Rainer J, 2009, LEUKEMIA, V23, P746, DOI 10.1038/leu.2008.370; Reid AB, 2005, J PHARMACOL EXP THER, V312, P509, DOI 10.1124/jpet.104.075945; Rissland OS, 2011, MOL CELL, V43, P993, DOI 10.1016/j.molcel.2011.08.021; Roy S, 2007, MOL BIOL CELL, V18, P4837, DOI 10.1091/mbc.E07-03-0270; Roy S, 2010, CARDIOVASC RES, V87, P647, DOI 10.1093/cvr/cvq123; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Sanders DB, 2001, PERFUSION-UK, V16, P67, DOI 10.1177/026765910101600110; Sartiani L, 2002, J PHYSIOL-LONDON, V545, P81, DOI 10.1113/jphysiol.2002.021535; Saxena A, 2010, P NATL ACAD SCI USA, V107, P87, DOI 10.1073/pnas.0912870107; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Sen CK, 2000, J BIOL CHEM, V275, P13049, DOI 10.1074/jbc.275.17.13049; Sen CK, 2002, J BIOL CHEM, V277, P33284, DOI 10.1074/jbc.M203391200; Seymour EM, 2003, J SURG RES, V114, P187, DOI 10.1016/S0022-4804(03)00248-8; Shilo S, 2008, ARTERIOSCL THROM VAS, V28, P471, DOI 10.1161/ATVBAHA.107.160655; Singh MK, 2011, J BIOL CHEM, V286, P41036, DOI 10.1074/jbc.M111.268573; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Sussman Mark A, 2009, Expert Rev Cardiovasc Ther, V7, P929, DOI 10.1586/erc.09.48; Thum T, 2008, CIRCULATION, V118, P1524, DOI 10.1161/CIRCULATIONAHA.108.807230; Tsutsui H, 2006, ANTIOXID REDOX SIGN, V8, P1737, DOI 10.1089/ars.2006.8.1737; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Watanabe E, 1998, CELL TRANSPLANT, V7, P239, DOI 10.1016/S0963-6897(98)00011-6; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhu XH, 2007, ANTIOXID REDOX SIGN, V9, P447, DOI 10.1089/ars.2006.1389	72	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66789	10.1371/journal.pone.0066789	http://dx.doi.org/10.1371/journal.pone.0066789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840532	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200106
J	Wilson, S; Anderson, EM; Wilson, ASG; Bertram, DF; Arcese, P				Wilson, Scott; Anderson, Eric M.; Wilson, Amy S. G.; Bertram, Douglas F.; Arcese, Peter			Citizen Science Reveals an Extensive Shift in the Winter Distribution of Migratory Western Grebes	PLOS ONE			English	Article							BIRD ABUNDANCE; CLIMATE; FOOD; POPULATIONS; ECOSYSTEM; DECLINES; RECOVERY; SEABIRDS; TRENDS; STOCKS	Marine waterbirds have shown variable trends in abundance over the past four decades with some species displaying steep declines along the Pacific coast from British Columbia through California. One of the most dramatic changes has been that of western grebes (Aechmophorus occidentalis) in the Salish Sea. This region was a former core of the species wintering distribution but they have become increasingly rare prompting calls for conservation action. A more thorough understanding of this situation requires the analysis of trends at broader geographic scales as well as a consideration of mechanisms that might have led to a change in abundance. We used hierarchical modeling with a Bayesian framework applied to 36 years of Audubon Christmas Bird Count data to assess continent-wide and regional population trends in western and Clark's grebes (A. clarkii) from 1975 to 2010. Our results show that the North American wintering population of Aechmophorus grebes decreased by similar to 52% after 1975, but also that western grebes displayed strongly opposing regional patterns. Abundance decreased by about 95% over 36 years in the Salish Sea but increased by over 300% along coastal California. As a result, the mean centre of the species distribution shifted south by an estimated 895 km between 1980 and 2010. Mechanisms underlying this shift require further study but we hypothesize that it may be related to a change in the abundance and availability of their forage fish prey base. Since the mid-1980s, the Pacific sardine stock off the California coast increased from a few thousand metric tonnes to over two million. At the same time both the abundance and availability of Pacific herring declined in the Salish Sea. Studies are needed to examine this hypothesis further and additional consideration should be directed at other changes in the marine environment that may have contributed to a range shift.	[Wilson, Scott] Environm Canada, Canadian Wildlife Serv, Saskatoon, SK, Canada; [Anderson, Eric M.] Simon Fraser Univ, Ctr Wildlife Ecol, Burnaby, BC V5A 1S6, Canada; [Wilson, Amy S. G.; Arcese, Peter] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [Bertram, Douglas F.] Environm Canada, Sci & Technol Branch, Inst Ocean Sci, Sidney, BC, Canada	Environment & Climate Change Canada; Canadian Wildlife Service; Simon Fraser University; University of British Columbia; Environment & Climate Change Canada	Wilson, S (corresponding author), Environm Canada, Canadian Wildlife Serv, Saskatoon, SK, Canada.	ScottD.Wilson@ec.gc.ca	Wilson, Scott/AAC-7144-2021		Environment Canada	Environment Canada(CGIAR)	A portion of this work was funded by a grant and contribution by Environment Canada to PA. The funder had no role in study design, analysis, decision to publish, or preparation of the manuscript. Data collection was organized by the Audubon Society and performed by volunteers as part of the annual Audubon Christmas Bird Count.	Agler BA, 1999, WATERBIRDS, V22, P98, DOI 10.2307/1521998; Ainley DG, 2010, PROG OCEANOGR, V84, P242, DOI 10.1016/j.pocean.2009.10.001; AINLEY DG, 1995, MAR ECOL PROG SER, V118, P69, DOI 10.3354/meps118069; Alheit J, 2004, PROG OCEANOGR, V60, P201, DOI 10.1016/j.pocean.2004.02.006; Anderson Eric M., 2009, Marine Ornithology, V37, P19; Barrett RT, 1996, ICES J MAR SCI, V53, P713, DOI 10.1006/jmsc.1996.0090; Bent AC, 1919, LIFE HIST N AM DIVIN, P1; Bower John L., 2009, Marine Ornithology, V37, P9; Burger A. E., 1997, WR87 BRIT COL MIN EN; BUTCHER G S, 1990, U S Fish and Wildlife Service Biological Report, V90, P120; Carter Harry R., 2003, Marine Ornithology, V31, P1; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Clowater JS, 1998, THESIS S FRASER U BU; Cogswell H. L, 1977, WATER BIRDS CALIFORN; Crawford RJM, 2007, J ORNITHOL, V148, pS253, DOI 10.1007/s10336-007-0228-z; Crawford RJM, 2007, ICES J MAR SCI, V64, P169, DOI 10.1093/icesjms/fsl011; DFO, 2004, 2004037 DFO CAN SCI; Dickinson JL, 2010, ANNU REV ECOL EVOL S, V41, P149, DOI 10.1146/annurev-ecolsys-102209-144636; Eichhorst BA, 1994, N AM BIRD BANDER, V17, P108; Erickson MA, 2010, THESIS U ALBERTA EDM; Gaston AJ, 2009, ENVIRON REV, V17, P267, DOI 10.1139/A09-013; Gelman A., 2004, BAYESIAN DATA ANAL; Gjerdrum C, 2003, P NATL ACAD SCI USA, V100, P9377, DOI 10.1073/pnas.1133383100; Grosbois V, 2005, OIKOS, V109, P273, DOI 10.1111/j.0030-1299.2005.13774.x; Hayward TL, 1997, TRENDS ECOL EVOL, V12, P150, DOI 10.1016/S0169-5347(97)01002-1; HILL KT, 2009, NOAATMNMFSSWFSC452 U; Hipfner J. Mark, 2012, Marine Ornithology, V40, P39; Humple D. L., 2009, THESIS SONOMA STATE; Johnsgard PA, 1987, DIVING BIRDS N AM; Julian F, 1997, FISHERY B, V96, P271; Kery M., 2010, INTRO WINBUGS ECOLOG; Kushlan J.A., 2002, WATERBIRD CONSERVATI; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Landis WG, 2010, RISK ANAL, V30, P183, DOI 10.1111/j.1539-6924.2009.01288.x; Link WA, 2007, ECOLOGY, V88, P49, DOI 10.1890/0012-9658(2007)88[49:SCOAPC]2.0.CO;2; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Morris W. F., 2002, QUANTITATIVE CONSERV; Neuchterlein GL, 1975, THESIS COLORADO STAT; Newton I., 1998, POPULATION LIMITATIO; Poole A., 1992, BIRDS N AM ONLINE; Robison KM, 2008, W CLARKS GREBE CONSE; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; SAUER JR, 2011, N AM BREEDING BIRD S; Schweigert JF, 2010, ICES J MAR SCI, V67, P1903, DOI 10.1093/icesjms/fsq134; Stick K.C., 2009, 0905 FPA; Therriault Thomas W., 2009, Marine Ornithology, V37, P3; Veit RR, 1996, MAR ECOL PROG SER, V139, P11, DOI 10.3354/meps139011; Wilson S, 2011, ECOLOGY, V92, P1789, DOI 10.1890/10-1757.1; Wollis S, 2010, 138 ALB SUST RES DEV; Wynn RB, 2011, BIOL LETT, V3, P529; Yanch J, 2006, 60 ALB SUST RES DEV; Zwolinski JP, 2012, FISH B-NOAA, V110, P110	53	41	42	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65408	10.1371/journal.pone.0065408	http://dx.doi.org/10.1371/journal.pone.0065408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840328	gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200017
J	Ilango, A; Shumake, J; Wetzel, W; Scheich, H; Ohl, FW				Ilango, Anton; Shumake, Jason; Wetzel, Wolfram; Scheich, Henning; Ohl, Frank W.			Electrical Stimulation of Lateral Habenula during Learning: Frequency-Dependent Effects on Acquisition but Not Retrieval of a Two-Way Active Avoidance Response	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS DOPAMINE; NEGATIVE REWARD SIGNALS; CENTRAL-NERVOUS-SYSTEM; MODULATED TONES; MOTIVATIONAL CONTROL; PREFRONTAL CORTEX; SUBSTANTIA-NIGRA; AUDITORY-CORTEX; NEURAL SYSTEMS	The lateral habenula (LHb) is an epithalamic structure involved in signaling reward omission and aversive stimuli, and it inhibits dopaminergic neurons during motivated behavior. Less is known about LHb involvement in the acquisition and retrieval of avoidance learning. Our previous studies indicated that brief electrical stimulation of the LHb, time-locked to the avoidance of aversive footshock (presumably during the positive affective "relief'' state that occurs when an aversive outcome is averted), inhibited the acquisition of avoidance learning. In the present study, we used the same paradigm to investigate different frequencies of LHb stimulation. The effect of 20 Hz vs. 50 Hz vs. 100 Hz stimulation was investigated during two phases, either during acquisition or retrieval in Mongolian gerbils. The results indicated that 50 Hz, but not 20 Hz, was sufficient to produce a long-term impairment in avoidance learning, and was somewhat more effective than 100 Hz in this regard. None of the stimulation parameters led to any effects on retrieval of avoidance learning, nor did they affect general motor activity. This suggests that, at frequencies in excess of the observed tonic firing rates of LHb neurons (>1-20 Hz), LHb stimulation may serve to interrupt the consolidation of new avoidance memories. However, these stimulation parameters are not capable of modifying avoidance memories that have already undergone extensive consolidation.	[Ilango, Anton; Shumake, Jason; Wetzel, Wolfram; Scheich, Henning; Ohl, Frank W.] Leibniz Inst Neurobiol, Dept Syst Physiol Learning, Magdeburg, Germany; [Ohl, Frank W.] Otto Von Guericke Univ, Inst Biol, Magdeburg, Germany; [Shumake, Jason] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Scheich, Henning; Ohl, Frank W.] Otto Von Guericke Univ, Ctr Behav Brain Sci, Magdeburg, Germany	Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; University of Texas System; University of Texas Austin; Otto von Guericke University	Ohl, FW (corresponding author), Leibniz Inst Neurobiol, Dept Syst Physiol Learning, Magdeburg, Germany.	frank.ohl@lin-magdeburg.de	Shumake, Jason/AAP-3506-2020	Shumake, Jason/0000-0003-4655-436X	Deutsche Forschungsgemeinschaft DFG [SFB 779, SFB-TRR-62]; Center for Behavioral Brain Research (CBBS)	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Center for Behavioral Brain Research (CBBS)	The study was supported by grants from the Deutsche Forschungsgemeinschaft DFG (SFB 779, SFB-TRR-62) and from the Center for Behavioral Brain Research (CBBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Benabid AL, 2005, ACTA NEUROL BELG, V105, P149; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; Chang SY, 2004, J NEUROSCI, V24, P2172, DOI 10.1523/JNEUROSCI.4891-03.2004; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Darvas M, 2011, LEARN MEMORY, V18, P136, DOI 10.1101/lm.2041211; Dinsmoor JA, 2001, J EXP ANAL BEHAV, V75, P311, DOI 10.1901/jeab.2001.75-311; Dombrowski P. A., 2012, BEHAV BRAIN IN PRESS; Domjan M., 1998, PRINCIPLES LEARNING; Filali M, 2004, EXP BRAIN RES, V156, P274, DOI 10.1007/s00221-003-1784-y; Gao DM, 1996, EUR J NEUROSCI, V8, P1474, DOI 10.1111/j.1460-9568.1996.tb01609.x; Pobbe RLH, 2010, NEUROSCI LETT, V479, P87, DOI 10.1016/j.neulet.2010.05.021; Hikosaka O, 2008, J NEUROSCI, V28, P11825, DOI 10.1523/JNEUROSCI.3463-08.2008; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Hoebel BG, 2007, CURR OPIN PHARMACOL, V7, P617, DOI 10.1016/j.coph.2007.10.014; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Hu WH, 2011, MED SCI MONITOR, V17, pBR153, DOI 10.12659/MSM.881802; Ide JS, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00025; IIango A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00132; Ilango A, 2010, NEUROSCIENCE, V166, P752, DOI 10.1016/j.neuroscience.2010.01.010; Ilango A, 2011, BEHAV BRAIN RES, V225, P515, DOI 10.1016/j.bbr.2011.08.014; Jensen AL, 2009, EXP NEUROL, V220, P57, DOI 10.1016/j.expneurol.2009.07.023; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Kim H, 2006, PLOS BIOL, V4, P1453, DOI 10.1371/journal.pbio.0040233; Konorski J., 1967, INTEGRATIVE ACTIVITY; Kowski AB, 2009, NEUROSCIENCE, V161, P1154, DOI 10.1016/j.neuroscience.2009.04.026; Lecourtier L, 2008, EUR J NEUROSCI, V27, P1755, DOI 10.1111/j.1460-9568.2008.06130.x; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; LISOPRAWSKI A, 1980, BRAIN RES, V183, P229, DOI 10.1016/0006-8993(80)90135-3; Loskota W.J., 1974, STEREOTAXIC ATLAS MO; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026701; Matsumoto M, 2008, PROG BRAIN RES, V171, P399, DOI 10.1016/S0079-6123(08)00658-4; McCracken CB, 2007, J NEUROSCI, V27, P12601, DOI 10.1523/JNEUROSCI.3750-07.2007; MCCULLOUGH LD, 1993, NEUROSCIENCE, V52, P919, DOI 10.1016/0306-4522(93)90538-Q; Ohl FW, 2001, NATURE, V412, P733, DOI 10.1038/35089076; Ohl FW, 1999, LEARN MEMORY, V6, P347; OLDS ME, 1963, J COMP NEUROL, V120, P259, DOI 10.1002/cne.901200206; Oleson EB, 2012, J NEUROSCI, V32, P14804, DOI 10.1523/JNEUROSCI.3087-12.2012; OVERMIER JB, 1967, J COMP PHYSIOL PSYCH, V63, P28, DOI 10.1037/h0024166; Pobbe RLH, 2008, LIFE SCI, V82, P1256, DOI 10.1016/j.lfs.2008.04.012; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; SALAMONE JD, 1994, BEHAV BRAIN RES, V61, P117, DOI 10.1016/0166-4328(94)90153-8; Schlund MW, 2011, BEHAV BRAIN RES, V225, P437, DOI 10.1016/j.bbr.2011.07.054; SELIGMAN ME, 1967, J EXP PSYCHOL, V74, P1, DOI 10.1037/h0024514; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; Seymour B, 2007, NAT REV NEUROSCI, V8, P300, DOI 10.1038/nrn2119; Shabel SJ, 2012, NEURON, V74, P475, DOI 10.1016/j.neuron.2012.02.037; Sharp PE, 2006, BEHAV BRAIN RES, V166, P55, DOI 10.1016/j.bbr.2005.07.004; Shelton L, 2012, PROG NEUROBIOL, V96, P208, DOI 10.1016/j.pneurobio.2012.01.004; Shumake J, 2003, BRAIN RES, V963, P274, DOI 10.1016/S0006-8993(02)04048-9; Shumake J, 2003, BEHAV COGN NEUROSCI, V2, P3198; Shumake J, 2010, BRAIN RES, V1343, P218, DOI 10.1016/j.brainres.2010.05.015; Shumake J, 2010, J NEUROSCI, V30, P5876, DOI 10.1523/JNEUROSCI.3604-09.2010; Stark H, 2000, EUR J PHARMACOL, V405, P263, DOI 10.1016/S0014-2999(00)00558-6; Stark H, 1999, NEUROSCI LETT, V264, P77, DOI 10.1016/S0304-3940(99)00174-3; THORNTON EW, 1984, BEHAV BRAIN RES, V12, P327, DOI 10.1016/0166-4328(84)90158-X; THORNTON EW, 1989, PHYSIOL BEHAV, V45, P929, DOI 10.1016/0031-9384(89)90217-5; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; ValeMartinez A, 1997, NEUROBIOL LEARN MEM, V68, P68, DOI 10.1006/nlme.1997.3777; VALENSTEIN ES, 1964, SCIENCE, V145, P1456, DOI 10.1126/science.145.3639.1456; VANHOESEN GW, 1969, J COMP PHYSIOL PSYCH, V68, P80, DOI 10.1037/h0027643; Wang DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017047; WANG RY, 1977, SCIENCE, V197, P89, DOI 10.1126/science.194312; Wetzel W, 1998, BEHAV BRAIN RES, V91, P29, DOI 10.1016/S0166-4328(97)00099-5; Wetzel W, 2008, P NATL ACAD SCI USA, V105, P6753, DOI 10.1073/pnas.0707844105; Wickens J, 2008, NEURON, V60, P530, DOI 10.1016/j.neuron.2008.11.002; WILCOX KS, 1986, PHYSIOL BEHAV, V36, P413, DOI 10.1016/0031-9384(86)90307-0; Williams ZM, 2006, NAT NEUROSCI, V9, P562, DOI 10.1038/nn1662; Yeomans J. S., 1990, PRINCIPLES BRAIN STI	74	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e65684	10.1371/journal.pone.0065684	http://dx.doi.org/10.1371/journal.pone.0065684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840355	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400007
J	Wang, YL; Wang, ZM; Yang, Q; Zou, YB; Zhang, HJ; Yan, CW; Feng, XX; Chen, Y; Zhang, Y; Wang, JZ; Zhou, XL; Ahmad, F; Hui, RT; Song, L				Wang, Yilu; Wang, Zhimin; Yang, Qi; Zou, Yubao; Zhang, Hongju; Yan, Chaowu; Feng, Xinxing; Chen, Yi; Zhang, Yin; Wang, Jizheng; Zhou, Xianliang; Ahmad, Ferhaan; Hui, Rutai; Song, Lei			Autosomal Recessive Transmission of MYBPC3 Mutation Results in Malignant Phenotype of Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							BINDING PROTEIN-C; HOMOZYGOUS MUTATION; MISSENSE MUTATIONS; GENE-MUTATIONS; SUDDEN-DEATH; COMPOUND; CHAIN; RISK	Background: Hypertrophic cardiomyopathy (HCM) due to mutations in genes encoding sarcomere proteins is most commonly inherited as an autosomal dominant trait. Since nearly 50% of HCM cases occur in the absence of a family history, a recessive inheritance pattern may be involved. Methods: A pedigree was identified with suspected autosomal recessive transmission of HCM. Twenty-six HCM-related genes were comprehensively screened for mutations in the proband with targeted second generation sequencing, and the identified mutation was confirmed with bi-directional Sanger sequencing in all family members and 376 healthy controls. Results: A novel missense mutation (c. 1469G>T, p. Gly490Val) in exon 17 of MYBPC3 was identified. Two siblings with HCM were homozygous for this mutation, whereas other family members were either heterozygous or wild type. Clinical evaluation showed that both homozygotes manifested a typical HCM presentation, but none of others, including 5 adult heterozygous mutation carriers up to 71 years of age, had any clinical evidence of HCM. Conclusions: Our data identified a MYBPC3 mutation in HCM, which appeared autosomal recessively inherited in this family. The absence of a family history of clinical HCM may be due to not only a de novo mutation, but also recessive mutations that failed to produce a clinical phenotype in heterozygous family members. Therefore, consideration of recessive mutations leading to HCM is essential for risk stratification and genetic counseling.	[Wang, Yilu; Zou, Yubao; Zhang, Yin; Hui, Rutai; Song, Lei] Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis, Dept Cardiol,Fuwai Hosp, Beijing 100730, Peoples R China; [Wang, Yilu; Wang, Zhimin; Zou, Yubao; Zhang, Hongju; Yan, Chaowu; Feng, Xinxing; Chen, Yi; Zhang, Yin; Wang, Jizheng; Zhou, Xianliang; Hui, Rutai; Song, Lei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Zhimin; Zhang, Hongju] Chinese Acad Med Sci, Dept Ultrasound, Fuwai Hosp, Beijing 100730, Peoples R China; [Yang, Qi] Capital Med Univ, Dept Radiol, Xuanwu Hosp, Beijing, Peoples R China; [Yan, Chaowu] Chinese Acad Med Sci, Dept Radiol, Fuwai Hosp, Beijing 100730, Peoples R China; [Feng, Xinxing] Chinese Acad Med Sci, Endocrinol & Cardiovasc Ctr, Fuwai Hosp, Beijing 100730, Peoples R China; [Chen, Yi] Chinese Acad Med Sci, Surg ICU, Fuwai Hosp, Beijing 100730, Peoples R China; [Wang, Jizheng; Hui, Rutai] Chinese Acad Med Sci, Sinogerman Lab Mol Med, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Zhou, Xianliang; Hui, Rutai; Song, Lei] Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Hypertens Ctr, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Ahmad, Ferhaan] Univ Pittsburgh, Cardiovasc Genet Ctr, UPMC Heart & Vasc Inst, Pittsburgh, PA USA; [Ahmad, Ferhaan] Univ Pittsburgh, Hypertroph Cardiomyopathy Ctr, UPMC Heart & Vasc Inst, Pittsburgh, PA USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hui, RT (corresponding author), Chinese Acad Med Sci, State Key Lab Cardiovasc Dis, Natl Ctr Cardiovasc Dis, Dept Cardiol,Fuwai Hosp, Beijing 100730, Peoples R China.	huirutai@gmail.com; lsongqd@yahoo.com		Ahmad, Ferhaan/0000-0003-2877-4641	Ministry of Science and Technology of China [2010CB732601, 2009DFB30050]; National Natural Science Foundation of China [30971233, 81070100]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China (2010CB732601 to Lei Song and 2009DFB30050 to Rutai Hui) and the National Natural Science Foundation of China (30971233 to Lei Song and 81070100 to Yubao Zou). The URL of the Ministry of Science and Technology of China is http://www.most.gov.cn/eng/, and the URL of the National Natural Science Foundation of China is http://www.nsfc.gov.cn/Portal0/default166.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bonne G, 1998, CIRC RES, V83, P580, DOI 10.1161/01.RES.83.6.580; BONNE G, 1995, NAT GENET, V11, P438, DOI 10.1038/ng1295-438; Brito Dulce, 2008, Rev Port Cardiol, V27, P147; Brito Dulce, 2005, Rev Port Cardiol, V24, P1137; FURST DO, 1992, J CELL SCI, V102, P769; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Gersh BJ, 2011, CIRCULATION, V124, P2761, DOI 10.1161/CIR.0b013e318223e230; Girolami F, 2010, J AM COLL CARDIOL, V55, P1444, DOI 10.1016/j.jacc.2009.11.062; Gray B, 2012, INT J CARDIOL; Ho CY, 2000, CIRCULATION, V102, P1950, DOI 10.1161/01.CIR.102.16.1950; Ingles J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033886; Ingles J, 2012, HEART, V98, P625, DOI 10.1136/heartjnl-2011-300368; Kimura Akinori, 2008, Circ J, V72 Suppl A, pA38, DOI 10.1253/circj.CJ-08-0050; Kubo T, 2011, CIRC J, V75, P2654, DOI 10.1253/circj.CJ-10-1314; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maron BJ, 2012, HEART RHYTHM, V9, P57, DOI 10.1016/j.hrthm.2011.08.009; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Moolman-Smook J, 2002, CIRC RES, V91, P704, DOI 10.1161/01.RES.0000036750.81083.83; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; Olivotto I, 2008, MAYO CLIN PROC, V83, P630, DOI 10.4065/83.6.630; Olson TM, 2002, CIRCULATION, V105, P2337, DOI 10.1161/01.CIR.0000018444.47798.94; Ortiz MF, 2009, REV ESP CARDIOL, V62, P572, DOI 10.1016/S0300-8932(09)71039-5; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; Wang SX, 2008, CLIN CARDIOL, V31, P114, DOI 10.1002/clc.20151; Zahka K, 2008, HEART, V94, P1326, DOI 10.1136/hrt.2007.127241; Zou YB, 2004, AM J MED, V116, P14, DOI 10.1016/j.amjmed.2003.05.009	28	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67087	10.1371/journal.pone.0067087	http://dx.doi.org/10.1371/journal.pone.0067087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840593	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000321148400032
J	Yang, IP; Tsai, HL; Huang, CW; Huang, MY; Hou, MF; Juo, SHH; Wang, JY				Yang, I-Ping; Tsai, Hsiang-Lin; Huang, Ching-Wen; Huang, Ming-Yii; Hou, Ming-Feng; Juo, Suh-Hang Hank; Wang, Jaw-Yuan			The Functional Significance of MicroRNA-29c in Patients with Colorectal Cancer: A Potential Circulating Biomarker for Predicting Early Relapse	PLOS ONE			English	Article							LUNG-CANCER; TUMOR-GROWTH; EXPRESSION; COLON; SURVEILLANCE; PROFILES; MIR-29C; CELLS; SERUM; GENE	Background: The recurrence of colorectal cancer (CRC) is frequent within the first year of curative resection surgery and may be unavoidable. microRNAs have been suggested to play roles in carcinogenesis and cancer recurrence. We recently identified microRNA-29c (miRNA-29c) as a predictor of early recurrence in CRC. In the present study, we further investigated the functions and serum level of miRNA-29c in relation to early recurrence of CRC. Methods: First we further confirmed overexpression of miRNA-29c in non-early relapse subjects. Gain-of-function in vitro studies were used to evaluate the effect of miRNA-29c on cell proliferation, migration, invasion, and cell cycle progression. The colon cancer cell line Caco2 and a stable clone overexpressing miRNA-29c were xenografted to evaluate the in vivo effect of miRNA-29c in null mice. Finally, circulating miRNA-29c was investigated as a potential biomarker for identifying early relapse. Results: miRNA-29c expression significantly decreased during early relapse compared to non-early relapse in UICC stage II and III CRC patients (P = 0.021). In vitro studies showed that overexpression of miRNA-29c inhibited cell proliferation and migration. The cell cycle studies also revealed that miRNA-29c caused an accumulation of the G1 and G2 population. In vivo, miRNA-29c suppressed tumor growth in null mice. The serum miRNA-29c increased significantly in early relapsed patients compared to non-early elapsed patients (P = 0.012). Conclusions: miRNA-29c shows anti-tumorigenesis activity, and preoperative circulating miRNA-29c levels can be used to predict postoperative early relapse of CRC.	[Yang, I-Ping; Juo, Suh-Hang Hank; Wang, Jaw-Yuan] Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan; [Yang, I-Ping] Shu Zen Jr Coll Med & Management, Dept Nursing, Kaohsiung, Taiwan; [Tsai, Hsiang-Lin] Kaohsiung Med Univ Hosp, Dept Surg, Div Gen Surg Med, Kaohsiung, Taiwan; [Tsai, Hsiang-Lin; Huang, Ming-Yii; Hou, Ming-Feng; Juo, Suh-Hang Hank; Wang, Jaw-Yuan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Tsai, Hsiang-Lin; Huang, Ching-Wen; Wang, Jaw-Yuan] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Huang, Ching-Wen; Hou, Ming-Feng; Wang, Jaw-Yuan] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Surg, Div Gastrointestinal & Gen Surg, Kaohsiung, Taiwan; [Huang, Ching-Wen] Kaohsiung Med Univ, Municipal Hsiao Kang Hosp, Dept Surg, Kaohsiung, Taiwan; [Huang, Ming-Yii] Kaohsiung Med Univ, Fac Med, Coll Med, Dept Radiat Oncol, Kaohsiung, Taiwan; [Huang, Ming-Yii] Kaohsiung Med Univ, Dept Radiat Oncol, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Wang, Jaw-Yuan] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Surg, Kaohsiung, Taiwan; [Hou, Ming-Feng; Wang, Jaw-Yuan] Kaohsiung Med Univ, Coll Med, Inst Clin Med, Kaohsiung, Taiwan; [Juo, Suh-Hang Hank] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Wang, JY (corresponding author), Kaohsiung Med Univ, Coll Med, Dept Med Genet, Kaohsiung, Taiwan.	cy614112@ms14.hinet.net	Huang, Ming-Yii/AAS-8132-2021; Jaw-Yuan, Wang/AFS-8845-2022	Jaw-Yuan, Wang/0000-0002-7705-2621; Hou, Ming-Feng/0000-0001-6030-9702; Yang, I-Ping/0000-0001-7051-3328	National Science Council of the Republic of China [NSC 99-2320 B-037-014-MY3]; Kaohsiung Medical University Hospital [KMUH98-8I04, KMUH100-OR16]; Biosignature in Colorectal Cancers, Academia Sinica, Taiwan; Excellence for Cancer Research Center; Department of Health, Executive Yuan, Taiwan, Republic of China [DOH102 TD-C-111-002]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital; Biosignature in Colorectal Cancers, Academia Sinica, Taiwan; Excellence for Cancer Research Center; Department of Health, Executive Yuan, Taiwan, Republic of China	This work was supported by grants from the National Science Council of the Republic of China (NSC 99-2320 B-037-014-MY3); Kaohsiung Medical University Hospital (KMUH98-8I04, KMUH100-OR16); Biosignature in Colorectal Cancers, Academia Sinica, Taiwan; and an Excellence for Cancer Research Center Grant funded by the Department of Health, Executive Yuan, Taiwan, Republic of China (DOH102 TD-C-111-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, BIOCHEM BIOPH RES CO, V364, P937; Becker H, 1995, Praxis (Bern 1994), V84, P1371; Boyle P, 2002, BRIT MED BULL, V64, P1, DOI 10.1093/bmb/64.1.1; Burfeind P, 1996, P NATL ACAD SCI USA, V93, P7263, DOI 10.1073/pnas.93.14.7263; Cao D, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-432; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cho WCS, 2010, BBA-REV CANCER, V1805, P209, DOI 10.1016/j.bbcan.2009.11.003; Davous D, 2009, B ACAD NAT MED PARIS, V193, P1529, DOI 10.1016/S0001-4079(19)32443-4; Ding DP, 2011, CARCINOGENESIS, V32, P1025, DOI 10.1093/carcin/bgr078; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kobayashi H, 2007, SURGERY, V141, P67, DOI 10.1016/j.surg.2006.07.020; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Kuo TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031587; Longo WE, 2002, SURG CLIN N AM, V82, P1091, DOI 10.1016/S0039-6109(02)00050-6; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mraz M, 2009, LEUKEMIA, V23, P1159, DOI 10.1038/leu.2008.377; Nasser MW, 2008, J BIOL CHEM, V283, P33394, DOI 10.1074/jbc.M804788200; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Nugent M, 2012, J SURG ONCOL; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Tsai HL, 2009, J SURG ONCOL, V100, P736, DOI 10.1002/jso.21404; Tsai HL, 2009, INT J COLORECTAL DIS, V24, P177, DOI 10.1007/s00384-008-0594-x; Wang LG, 2012, CANCER EPIDEMIOL, V36, pE61, DOI 10.1016/j.canep.2011.05.002; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang IP, 2012, CARCINOGENESIS, V33, P1522, DOI 10.1093/carcin/bgs166; Yang IP, 2012, CARCINOGENESIS	34	37	44	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66842	10.1371/journal.pone.0066842	http://dx.doi.org/10.1371/journal.pone.0066842			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840538	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400021
J	MacLean, EL; Sandel, AA; Bray, J; Oldenkamp, RE; Reddy, RB; Hare, BA				MacLean, Evan L.; Sandel, Aaron A.; Bray, Joel; Oldenkamp, Ricki E.; Reddy, Rachna B.; Hare, Brian A.			Group Size Predicts Social but Not Nonsocial Cognition in Lemurs	PLOS ONE			English	Article							FISSION-FUSION DYNAMICS; RELATIVE BRAIN SIZE; EULEMUR-FULVUS; NEOCORTEX SIZE; NETWORK SIZE; EVOLUTION; INTELLIGENCE; BEHAVIOR; SOCIOECOLOGY; COMPLEXITY	The social intelligence hypothesis suggests that living in large social networks was the primary selective pressure for the evolution of complex cognition in primates. This hypothesis is supported by comparative studies demonstrating a positive relationship between social group size and relative brain size across primates. However, the relationship between brain size and cognition remains equivocal. Moreover, there have been no experimental studies directly testing the association between group size and cognition across primates. We tested the social intelligence hypothesis by comparing 6 primate species (total N = 96) characterized by different group sizes on two cognitive tasks. Here, we show that a species' typical social group size predicts performance on cognitive measures of social cognition, but not a nonsocial measure of inhibitory control. We also show that a species' mean brain size (in absolute or relative terms) does not predict performance on either task in these species. These data provide evidence for a relationship between group size and social cognition in primates, and reveal the potential for cognitive evolution without concomitant changes in brain size. Furthermore our results underscore the need for more empirical studies of animal cognition, which have the power to reveal species differences in cognition not detectable by proxy variables, such as brain size.	[MacLean, Evan L.; Bray, Joel; Reddy, Rachna B.; Hare, Brian A.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA; [Sandel, Aaron A.] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA; [Oldenkamp, Ricki E.] No Michigan Univ, Dept Biol, Marquette, MI 49855 USA; [Hare, Brian A.] Duke Univ, Ctr Cognit Neurosci, Durham, NC USA	Duke University; University of Michigan System; University of Michigan; Northern Michigan University; Duke University	MacLean, EL (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA.	maclean@duke.edu		MacLean, Evan/0000-0001-7595-662X; Sandel, Aaron/0000-0003-3060-5310	NSF [BCS-0923791]; National Evolutionary Synthesis Center (NSF) [EF-0905606]; National Science Foundation [NSF-BCS-08-27552, NSF-BCS-10-25172]; Duke University URS grants; Duke University Mechanisms of Behavior award	NSF(National Science Foundation (NSF)); National Evolutionary Synthesis Center (NSF); National Science Foundation(National Science Foundation (NSF)); Duke University URS grants; Duke University Mechanisms of Behavior award	We thank Isabel Bernstein, Camila Caceres, and Jesse St. Clair for help with data collection. We thank Sarah Zehr, David Brewer and the Duke Lemur Center staff for making this research possible. We thank the editor and two anonymous reviewers for their helpful comments on an earlier draft of this manuscript. We thank Christine Wall and Kari Allen for statistical advice, and the Anthrotree workshop which is supported by the NSF (BCS-0923791) and the National Evolutionary Synthesis Center (NSF grant EF-0905606) for training in phylogenetic comparative methods.; This work was supported in part by the National Science Foundation grants NSF-BCS-08-27552 and NSF-BCS-10-25172 to BH, Duke University URS grants to JB, RR, and AS, and a Duke University Mechanisms of Behavior award to RO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG., 1999, PRACTICAL STAT MED R; Amici F, 2008, CURR BIOL, V18, P1415, DOI 10.1016/j.cub.2008.08.020; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Balda Russell P., 1996, Current Ornithology, V13, P33; Banerjee K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005883; Barton R. A., 1999, COMP PRIMATE SOCIOEC, P167, DOI DOI 10.1017/CBO9780511542466.010; Barton RA, 1996, P ROY SOC B-BIOL SCI, V263, P173, DOI 10.1098/rspb.1996.0028; Barton RA, 2006, EVOL ANTHROPOL, V15, P224, DOI 10.1002/evan.20105; Bayart F, 2005, AM J PRIMATOL, V67, P299, DOI 10.1002/ajp.20186; Bond AB, 2003, ANIM BEHAV, V65, P479, DOI 10.1006/anbe.2003.2101; Boogert NJ, 2011, ANIM BEHAV, V81, P1209, DOI 10.1016/j.anbehav.2011.03.004; Botting JL, 2011, FOLIA PRIMATOL, V82, P165, DOI 10.1159/000333142; Byrne RW, 2007, CURR BIOL, V17, pR714, DOI 10.1016/j.cub.2007.05.069; Byrne RW, 1988, MACHIAVELLIAN INTELL, Vxiv; Cheney DL, 1990, MONKEYS SEE WORLD IN, Vx; Cheney DL, 2007, BABOON METAPHYSICS E, Vx; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; Curtis DJ, 1999, FOLIA PRIMATOL, V70, P79, DOI 10.1159/000021679; de Waal FBM, 2003, ANIMAL SOCIAL COMPLE, Vxiv; Deaner R. O., 2006, EVOL PSYCHOL, V4, DOI [10.1177/147470490600400114, DOI 10.1177/147470490600400114]; Deaner RO, 2007, BRAIN BEHAV EVOLUT, V70, P115, DOI 10.1159/000102973; DIAMOND A, 1990, ANN NY ACAD SCI, V608, P637, DOI 10.1111/j.1749-6632.1990.tb48913.x; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Dunbar RIM, 2007, PHILOS T R SOC B, V362, P649, DOI 10.1098/rstb.2006.2001; Dunbar RIM, 1998, EVOL ANTHROPOL, V6, P178, DOI 10.1002/(SICI)1520-6505(1998)6:5<178::AID-EVAN5>3.0.CO;2-8; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; Emery NJ, 2007, PHILOS T R SOC B, V362, P485, DOI 10.1098/rstb.2006.2022; Erhart EM, 2008, AM J PHYS ANTHROPOL, V136, P183, DOI 10.1002/ajpa.20793; Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076; Genty E, 2006, J EXP PSYCHOL-ANIM B, V32, P196, DOI 10.1037/0097-7403.32.2.196; Gigerenzer G., 1997, MACHIAVELLIAN INTELL, V2, P264; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hare B, 2006, COGNITION, V101, P495, DOI 10.1016/j.cognition.2005.01.011; Healy SD, 2007, P ROY SOC B-BIOL SCI, V274, P453, DOI 10.1098/rspb.2006.3748; Herrmann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012438; HOLLOWAY RL, 1966, AM J PHYS ANTHROPOL, V25, P305, DOI 10.1002/ajpa.1330250310; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; Humphrey NK., 1976, GROWING POINTS ETHOL, P303; Isler K, 2008, J HUM EVOL, V55, P967, DOI 10.1016/j.jhevol.2008.08.004; Jerison HJ, 1973, EVOLUTION BRAIN INTE, Vxiv; JOLLY A, 1966, SCIENCE, V153, P501, DOI 10.1126/science.153.3735.501; KAPPELER PM, 1993, ETHOLOGY, V93, P125; Kappelman J, 1996, J HUM EVOL, V30, P243, DOI 10.1006/jhev.1996.0021; KREBS J. R., 1984, BEHAV ECOLOGY, V2nd, P380; Kudo H, 2001, ANIM BEHAV, V62, P711, DOI 10.1006/anbe.2001.1808; Lakshminarayanan V. R., 2009, J NEUROSCI PSYCHOL E, V2, P12, DOI [DOI 10.1037/A0015457, 10.1037/a0015457]; Liedtke J, 2011, ANIM COGN, V14, P143, DOI 10.1007/s10071-010-0347-4; Maclean EL, 2008, ANIM BEHAV, V76, P479, DOI 10.1016/j.anbehav.2008.01.025; MacLean EL, 2012, ANIM COGN, V15, P223, DOI 10.1007/s10071-011-0448-8; MacLean EL, 2009, J HUM EVOL, V56, P471, DOI 10.1016/j.jhevol.2008.12.005; MISCHEL W, 1989, SCIENCE, V244, P933, DOI 10.1126/science.2658056; MITTERMEIER RA, 2006, LEMURS MADAGASCAR; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Nunn CL, 2001, ADV PRIMATO, P159; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Preuss TM, 2001, EVOLUTIONARY ANATOMY OF THE PRIMATE CEREBRAL CORTEX, P138; Reader SM, 2011, PHILOS T R SOC B, V366, P1017, DOI 10.1098/rstb.2010.0342; RICE WR, 1994, TRENDS ECOL EVOL, V9, P235, DOI 10.1016/0169-5347(94)90258-5; RICHARD AF, 1991, ANNU REV ECOL SYST, V22, P145, DOI 10.1146/annurev.es.22.110191.001045; Richard AF, 1978, BEHAV VARIATION CASE; Ruiz A, 2009, ANIM COGN, V12, P427, DOI 10.1007/s10071-008-0202-z; Sallet J, 2011, SCIENCE, V334, P697, DOI 10.1126/science.1210027; Sandel AA, 2011, ANIM BEHAV, V81, P925, DOI 10.1016/j.anbehav.2011.01.020; Santos LR, 1999, J COMP PSYCHOL, V113, P186; Sauther ML, 1999, EVOL ANTHROPOL, V8, P120, DOI 10.1002/(SICI)1520-6505(1999)8:4<120::AID-EVAN3>3.0.CO;2-O; Schmitt V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032024; Shepherd SV, 2008, ANIM COGN, V11, P13, DOI 10.1007/s10071-007-0083-6; SHERRY DF, 1987, PSYCHOL REV, V94, P439, DOI 10.1037/0033-295X.94.4.439; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Shultz S, 2010, J COMP PSYCHOL, V124, P252, DOI 10.1037/a0018894; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; Smaers JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009123; Tomasello M, 2004, ANIM COGN, V7, P213, DOI 10.1007/s10071-004-0227-x; Tomasello M, 2007, J HUM EVOL, V52, P314, DOI 10.1016/j.jhevol.2006.10.001; Vasey N, 2007, PRIMATES, V48, P41, DOI 10.1007/s10329-006-0010-5; Vlamings PHJM, 2010, ANIM COGN, V13, P273, DOI 10.1007/s10071-009-0265-5; Wobber V, 2009, BEHAV PROCESS, V81, P423, DOI 10.1016/j.beproc.2009.04.003	79	50	51	2	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66359	10.1371/journal.pone.0066359	http://dx.doi.org/10.1371/journal.pone.0066359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840450	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400027
J	McArt, DG; Dunne, PD; Blayney, JK; Salto-Tellez, M; Van Schaeybroeck, S; Hamilton, PW; Zhang, SD				McArt, Darragh G.; Dunne, Philip D.; Blayney, Jaine K.; Salto-Tellez, Manuel; Van Schaeybroeck, Sandra; Hamilton, Peter W.; Zhang, Shu-Dong			Connectivity Mapping for Candidate Therapeutics Identification Using Next Generation Sequencing RNA-Seq Data	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; ENRICHMENT ANALYSIS; CANCER; ALIGNMENT; BIOCONDUCTOR; COTININE; PIPELINE; NICOTINE	The advent of next generation sequencing technologies (NGS) has expanded the area of genomic research, offering high coverage and increased sensitivity over older microarray platforms. Although the current cost of next generation sequencing is still exceeding that of microarray approaches, the rapid advances in NGS will likely make it the platform of choice for future research in differential gene expression. Connectivity mapping is a procedure for examining the connections among diseases, genes and drugs by differential gene expression initially based on microarray technology, with which a large collection of compound-induced reference gene expression profiles have been accumulated. In this work, we aim to test the feasibility of incorporating NGS RNA-Seq data into the current connectivity mapping framework by utilizing the microarray based reference profiles and the construction of a differentially expressed gene signature from a NGS dataset. This would allow for the establishment of connections between the NGS gene signature and those microarray reference profiles, alleviating the associated incurring cost of re-creating drug profiles with NGS technology. We examined the connectivity mapping approach on a publicly available NGS dataset with androgen stimulation of LNCaP cells in order to extract candidate compounds that could inhibit the proliferative phenotype of LNCaP cells and to elucidate their potential in a laboratory setting. In addition, we also analyzed an independent microarray dataset of similar experimental settings. We found a high level of concordance between the top compounds identified using the gene signatures from the two datasets. The nicotine derivative cotinine was returned as the top candidate among the overlapping compounds with potential to suppress this proliferative phenotype. Subsequent lab experiments validated this connectivity mapping hit, showing that cotinine inhibits cell proliferation in an androgen dependent manner. Thus the results in this study suggest a promising prospect of integrating NGS data with connectivity mapping.	[McArt, Darragh G.; Dunne, Philip D.; Blayney, Jaine K.; Salto-Tellez, Manuel; Van Schaeybroeck, Sandra; Hamilton, Peter W.; Zhang, Shu-Dong] Queens Univ Belfast, CCRCB, Belfast, Antrim, North Ireland	Queens University Belfast	Zhang, SD (corresponding author), Queens Univ Belfast, CCRCB, Belfast, Antrim, North Ireland.	s.zhang@qub.ac.uk	Zhang, Shu-Dong/G-1269-2010	Zhang, Shu-Dong/0000-0002-7721-0167; McArt, Darragh/0000-0001-6426-8776; Salto-Tellez, Manuel/0000-0001-8586-282X; Dunne, Philip/0000-0001-9160-283X	Biotechnology and Biological Sciences Research Council (BBSRC, UK) [BB/I009051/1]; Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative; Biotechnology and Biological Sciences Research Council [BB/I009051/1] Funding Source: researchfish; BBSRC [BB/I009051/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC, UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was partly supported by the Biotechnology and Biological Sciences Research Council (BBSRC, UK) grant BB/I009051/1 and by the Department for Employment and Learning through its "Strengthening the all-Island Research Base" initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BARBIERI RL, 1986, J CLIN INVEST, V77, P1727, DOI 10.1172/JCI112494; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Brunelli C, 2012, BIOCHEM J, V443, P379, DOI 10.1042/BJ20111236; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Ding L, 2010, HUM MOL GENET, V19, pR188, DOI 10.1093/hmg/ddq391; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman R., GENEFILTER METHODS F; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Goncalves A, 2011, BIOINFORMATICS, V27, P867, DOI 10.1093/bioinformatics/btr012; Iorio F, 2013, DRUG DISCOV TODAY, V18, P350, DOI 10.1016/j.drudis.2012.07.014; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Iskar M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000925; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kvam VM, 2012, AM J BOT, V99, P248, DOI 10.3732/ajb.1100340; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Langley RE, 2011, BRIT J CANCER, V105, P1107, DOI 10.1038/bjc.2011.289; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2008, P NATL ACAD SCI USA, V105, P20179, DOI 10.1073/pnas.0807121105; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lin DL, 2001, CLIN CANCER RES, V7, P1773; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McArt DG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016382; Mehta PB, 2001, ONCOGENE, V20, P5359, DOI 10.1038/sj.onc.1204688; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pacini C, 2013, BIOINFORMATICS, V29, P132, DOI 10.1093/bioinformatics/bts656; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Berriguete G., 2012, J SIGNAL TRANSDUCT, V2012; Rumble SM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000386; Soldin OP, 2011, STEROIDS, V76, P653, DOI 10.1016/j.steroids.2011.02.042; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Tabas-Madrid D, 2012, NUCLEIC ACIDS RES, V40, pW478, DOI 10.1093/nar/gks402; Tavolari S, 2012, CANCER LETT, V321, P187, DOI 10.1016/j.canlet.2012.02.003; Tibshirani R, SAM SIGNIFICANCE ANA; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; YEH J, 1989, J STEROID BIOCHEM, V33, P627, DOI 10.1016/0022-4731(89)90051-4; Zhang SD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-236; Zhang SD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-258	49	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66902	10.1371/journal.pone.0066902	http://dx.doi.org/10.1371/journal.pone.0066902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840550	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400050
J	Picq, CA; Clarencon, D; Sinniger, VE; Bonaz, BL; Mayol, JFS				Picq, Chloe A.; Clarencon, Didier; Sinniger, Valerie E.; Bonaz, Bruno L.; Mayol, Jean-Francois S.			Impact of Anesthetics on Immune Functions in a Rat Model of Vagus Nerve Stimulation	PLOS ONE			English	Article							CHOLINERGIC ANTIINFLAMMATORY PATHWAY; ISCHEMIA-REPERFUSION INJURY; VOLATILE ANESTHETICS; ENDOTOXEMIC RATS; ISOFLURANE; INFLAMMATION; CELLS; LUNG; ACTIVATION; EXPRESSION	Vagus nerve stimulation (VNS) has been successfully performed in animals for the treatment of different experimental models of inflammation. The anti-inflammatory effect of VNS involves the release of acetylcholine by vagus nerve efferent fibers inhibiting pro-inflammatory cytokines (e.g. TNF-alpha) produced by macrophages. Moreover, it has recently been demonstrated that splenic lymphocytic populations may also be involved. As anesthetics can modulate the inflammatory response, the current study evaluated the effect of two different anesthetics, isoflurane and pentobarbital, on splenic cellular and molecular parameters in a VNS rat model. Spleens were collected for the characterization of lymphocytes sub-populations by flow cytometry and quantification of cytokines secretion after in vitro activation. Different results were observed depending on the anesthetic used. The use of isoflurane displayed a non-specific effect of VNS characterized by a decrease of most splenic lymphocytes sub-populations studied, and also led to a significantly lower TNF-a secretion by splenocytes. However, the use of pentobarbital brought to light immune modifications in non-stimulated animals that were not observed with isoflurane, and also revealed a specific effect of VNS, notably at the level of T lymphocytes' activation. These differences between the two anesthetics could be related to the anti-inflammatory properties of isoflurane. In conclusion, pentobarbital is more adapted than isoflurane in the study of the anti-inflammatory effect of VNS on an anesthetized rat model in that it allows more accurate monitoring of subtle immunomodulatory processes.	[Picq, Chloe A.; Clarencon, Didier; Mayol, Jean-Francois S.] Ctr Rech Serv Sante Armees, Antenne La Tronche, Inst Rech Biomed Armees, La Tronche, France; [Picq, Chloe A.; Clarencon, Didier; Sinniger, Valerie E.; Bonaz, Bruno L.] Ctr Rech INSERM 836 UJF CEA CHU, Stress & Interact Neurodigest Grenoble Inst Neuro, La Tronche, France; [Bonaz, Bruno L.] CHU Grenoble, Clin Univ Hepatogastroenterol, F-38043 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Picq, CA (corresponding author), Ctr Rech Serv Sante Armees, Antenne La Tronche, Inst Rech Biomed Armees, La Tronche, France.	picq.chloe@gmail.com			Direction Generale de l'Armement, France [10co601]	Direction Generale de l'Armement, France	Funding was provided by Direction Generale de l'Armement, France. Number of contract: 10co601. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BRAIN BEHAV IMMUN, V24, P316; Barbulescu K, 1998, J IMMUNOL; Bedirli N, 2012, J SURG RES, V178, pE17, DOI 10.1016/j.jss.2011.12.037; Bonaz B, 2007, GASTROENTEROLOGY, V133, P1370, DOI 10.1053/j.gastro.2007.08.061; Boost KA, 2009, INT J MOL MED, V23, P665, DOI 10.3892/ijmm_00000178; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Chiang N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001879; Chung IS, 2013, ANESTH ANALG, V116, P327, DOI 10.1213/ANE.0b013e31827aec06; de Rossi LW, 2004, ANESTH ANALG, V98, P1007, DOI 10.1213/01.ANE.0000106860.27791.44; Flondor M, 2008, EUR SURG RES, V40, P1, DOI 10.1159/000107614; Hofstetter C, 2005, INT IMMUNOPHARMACOL, V5, P1519, DOI 10.1016/j.intimp.2005.04.008; Hofstetter C, 2007, INT J MOL MED, V20, P597; Hotta H, 2009, AUTON NEUROSCI-BASIC, V151, P98, DOI 10.1016/j.autneu.2009.07.008; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Karimi K, 2010, BRAIN BEHAV IMMUN, V24, P316, DOI 10.1016/j.bbi.2009.10.016; Kawaguchi M, 1996, ANESTHESIOLOGY, V85, P1176, DOI 10.1097/00000542-199611000-00027; Kim M, 2012, ANN SURG, V255, P492, DOI 10.1097/SLA.0b013e3182441767; Lee HT, 2004, ANESTHESIOLOGY, V101, P1313; Meregnani J, 2011, AUTON NEUROSCI-BASIC, V160, P82, DOI 10.1016/j.autneu.2010.10.007; Mu JL, 2010, SHOCK, V34, P183, DOI 10.1097/SHK.0b013e3181cffc3f; Olofsson PS, 2012, IMMUNOL REV, V248, P188, DOI 10.1111/j.1600-065X.2012.01138.x; Park WR, 2004, INT IMMUNOL, V16, P295, DOI 10.1093/intimm/dxh034; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Plachinta RV, 2003, ANESTHESIOLOGY, V98, P89, DOI 10.1097/00000542-200301000-00017; Reyt S, 2010, NEUROIMAGE, V52, P1456, DOI 10.1016/j.neuroimage.2010.05.021; Roederer M, 2001, CYTOMETRY, V45, P194, DOI 10.1002/1097-0320(20011101)45:3<194::AID-CYTO1163>3.0.CO;2-C; Saad MM, 2010, CAN J ANAESTH, V57, P50, DOI 10.1007/s12630-009-9205-8; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tschaikowsky K, 2000, ANESTHESIOLOGY, V92, P1093, DOI 10.1097/00000542-200004000-00028; Yamamoto M, 1998, ANESTH ANALG, V86, P552, DOI 10.1097/00000539-199803000-00021; Zaaimi B, 2008, AUTON NEUROSCI-BASIC, V143, P20, DOI 10.1016/j.autneu.2008.07.002	33	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67086	10.1371/journal.pone.0067086	http://dx.doi.org/10.1371/journal.pone.0067086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840592	Green Published, gold			2022-12-27	WOS:000321424400070
J	Tso, FY; Abrahamyan, L; Hu, SL; Ruprecht, RM; Wood, C				Tso, For Yue; Abrahamyan, Levon; Hu, Shiu-Lok; Ruprecht, Ruth M.; Wood, Charles			Variations in the Biological Functions of HIV-1 Clade C Envelope in a SHIV-Infected Rhesus Macaque during Disease Progression	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; NEUTRALIZATION SENSITIVITY; MULLER RATCHET; FITNESS; GP120; ENV; R5; CCR5; CD4	A better understanding of how the biological functions of the HIV-1 envelope (Env) changes during disease progression may aid the design of an efficacious anti-HIV-1 vaccine. Although studies from patient had provided some insights on this issue, the differences in the study cohorts and methodology had make it difficult to reach a consensus of the variations in the HIV-1 Env functions during disease progression. To this end, an animal model that can be infected under controlled environment and reflect the disease course of HIV-1 infection in human will be beneficial. Such an animal model was previously demonstrated by the infection of macaque with SHIV, expressing HIV-1 clade C Env V1-V5 region. By using this model, we examined the changes in biological functions of Env in the infected animal over the entire disease course. Our data showed an increase in the neutralization resistance phenotype over time and coincided with the decrease in the net charges of the V1-V5 region. Infection of PBMC with provirus expressing various Env clones, isolated from the infected animal over time, showed a surprisingly better replicative fitness for viruses expressing the Env from early time point. Biotinylation and ELISA data also indicated a decrease of cell-surface-associated Env and virion-associated gp120 content with disease progression. This decrease did not affect the CD4-binding capability of Env, but were positively correlated with the decrease of Env fusion ability. Interestingly, some of these changes in biological functions reverted to the pre-AIDS level during advance AIDS. These data suggested a dynamic relationship between the Env V1-V5 region with the host immune pressure. The observed changes of biological functions in this setting might reflect and predict those occurring during natural disease progression in human.	[Tso, For Yue; Abrahamyan, Levon; Wood, Charles] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68588 USA; [Tso, For Yue; Abrahamyan, Levon; Wood, Charles] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Hu, Shiu-Lok] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Hu, Shiu-Lok] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Ruprecht, Ruth M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Ruprecht, Ruth M.] Harvard Univ, Sch Med, Boston, MA USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Wood, C (corresponding author), Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68588 USA.	cwood1@unl.edu	Wood, Charles/AAH-4536-2021; Hu, Shiu-Lok/A-3196-2008; Abrahamyan, Levon/E-1982-2013; Tso, For Yue/AAF-1131-2019	Hu, Shiu-Lok/0000-0003-4336-7964; Abrahamyan, Levon/0000-0002-0849-0134; Wood, Charles/0000-0002-4256-1530	Public Health Service [CA75903, TW001429]; National Institute of Medical Sciences, Center for Biomedical Research Excellence [P30 GM103509, R01 AI076170, P01 AI48240]; American Recovery and Reinvestment Act [3P01 AI048240-08S1]; NATIONAL CANCER INSTITUTE [R01CA075903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI048240, R01AI076170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institute of Medical Sciences, Center for Biomedical Research Excellence; American Recovery and Reinvestment Act; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service grants, CA75903, TW001429 and the National Institute of Medical Sciences, Center for Biomedical Research Excellence grant P30 GM103509 to C. W; R01 AI076170 to S. L. H; P01 AI48240 to R. M. R., S. L. H and C. W.; American Recovery and Reinvestment Act funding 3P01 AI048240-08S1 to R. M. R., C. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamyan LG, 2003, J VIROL, V77, P5829, DOI 10.1128/JVI.77.10.5829-5836.2003; Arnott A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012631; Asmal M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023673; Binley JM, 1997, J VIROL, V71, P2799, DOI 10.1128/JVI.71.4.2799-2809.1997; Blay WM, 2007, J VIROL, V81, P13037, DOI 10.1128/JVI.01215-07; Borggren M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020135; Bunnik EM, 2009, VIROLOGY, V390, P348, DOI 10.1016/j.virol.2009.05.028; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Cavrois Marielle, 2004, Methods Mol Biol, V263, P333; CHAO L, 1990, NATURE, V348, P454, DOI 10.1038/348454a0; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; CLARKE DK, 1994, P NATL ACAD SCI USA, V91, P4821, DOI 10.1073/pnas.91.11.4821; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; DUARTE E, 1992, P NATL ACAD SCI USA, V89, P6015, DOI 10.1073/pnas.89.13.6015; Etemad B, 2009, J VIROL, V83, P9694, DOI 10.1128/JVI.00925-09; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; HOFFMAN AD, 1985, VIROLOGY, V147, P326, DOI 10.1016/0042-6822(85)90135-7; Humbert M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-94; Kozak SL, 1997, J VIROL, V71, P873, DOI 10.1128/JVI.71.2.873-882.1997; Kwa D, 2003, J INFECT DIS, V187, P1397, DOI 10.1086/374650; LANDAU NR, 1991, J VIROL, V65, P162, DOI 10.1128/JVI.65.1.162-169.1991; Loomis-Price LD, 1998, J INFECT DIS, V178, P1306, DOI 10.1086/314436; Mahalanabis M, 2006, AMINO TRACK AUTOMATI, P549; Means RE, 2001, J VIROL, V75, P3903, DOI 10.1128/JVI.75.8.3903-3915.2001; Morikis D, 2007, INT J MOL MED, V19, P343; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Repits J, 2005, J GEN VIROL, V86, P2859, DOI 10.1099/vir.0.81111-0; Repits J, 2008, VIROLOGY, V379, P125, DOI 10.1016/j.virol.2008.06.014; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Seclen E, 2011, AIDS RES HUM RETROV, V27, P965, DOI 10.1089/aid.2010.0359; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Tso FY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032827; Tso FY, 2009, AIDS, V23, P1817, DOI 10.1097/QAD.0b013e32832f3da6; VANVALEN L, 1974, J MOL EVOL, V3, P89, DOI 10.1007/BF01796554; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wodarz D, 2007, P ROY SOC B-BIOL SCI, V274, P2481, DOI 10.1098/rspb.2007.0413; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Yuste E, 1999, J VIROL, V73, P2745, DOI 10.1128/JVI.73.4.2745-2751.1999; Zhang HL, 2004, J VIROL, V78, P1718, DOI 10.1128/JVI.78.4.1718-1729.2004; Zhang H, 2010, VIROLOGY, V407, P68, DOI 10.1016/j.virol.2010.07.047; Zhang H, 2010, VIROLOGY, V400, P164, DOI 10.1016/j.virol.2009.12.019	52	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66973	10.1371/journal.pone.0066973	http://dx.doi.org/10.1371/journal.pone.0066973			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840566	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400060
J	van Laarhoven, T; Marchiori, E				van Laarhoven, Twan; Marchiori, Elena			Predicting Drug-Target Interactions for New Drug Compounds Using a Weighted Nearest Neighbor Profile	PLOS ONE			English	Article							INFORMATION; NETWORKS; KERNELS	In silico discovery of interactions between drug compounds and target proteins is of core importance for improving the efficiency of the laborious and costly experimental determination of drug-target interaction. Drug-target interaction data are available for many classes of pharmaceutically useful target proteins including enzymes, ion channels, GPCRs and nuclear receptors. However, current drug-target interaction databases contain a small number of drug-target pairs which are experimentally validated interactions. In particular, for some drug compounds (or targets) there is no available interaction. This motivates the need for developing methods that predict interacting pairs with high accuracy also for these 'new' drug compounds (or targets). We show that a simple weighted nearest neighbor procedure is highly effective for this task. We integrate this procedure into a recent machine learning method for drug-target interaction we developed in previous work. Results of experiments indicate that the resulting method predicts true interactions with high accuracy also for new drug compounds and achieves results comparable or better than those of recent state-of-the-art algorithms. Software is publicly available at http://cs.ru.nl/tvanlaarhoven/drugtarget2013/.	[van Laarhoven, Twan; Marchiori, Elena] Radboud Univ Nijmegen, Inst Comp & Informat Sci, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	van Laarhoven, T (corresponding author), Radboud Univ Nijmegen, Inst Comp & Informat Sci, NL-6525 ED Nijmegen, Netherlands.	tvanlaarhoven@cs.ru.nl; elenam@cs.ru.nl			Netherlands Organization for Scientic Research (NWO) within the NWO project [612.066.927]	Netherlands Organization for Scientic Research (NWO) within the NWO project	This work has been partially funded by the Netherlands Organization for Scientic Research (NWO) within the NWO project 612.066.927. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleakley K, 2009, BIOINFORMATICS, V25, P2397, DOI 10.1093/bioinformatics/btp433; Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; Csermely P., 2013, PHARM THERAPEUTICS; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gonen M, 2012, BIOINFORMATICS, V28, P2304, DOI 10.1093/bioinformatics/bts360; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Hattori M, 2003, J AM CHEM SOC, V125, P11853, DOI 10.1021/ja036030u; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kashima H, 2009, IEICE T INF SYST, VE92D, P1338, DOI 10.1587/transinf.E92.D.1338; Mei JP, 2013, BIOINFORMATICS, V29, P238, DOI 10.1093/bioinformatics/bts670; Okuno Y, 2007, NUCLEIC ACIDS RES, V36, pD907; Overington J, 2009, COMMUNICATION; Prado-Prado F, 2011, EUR J MED CHEM, V46, P1074, DOI 10.1016/j.ejmech.2011.01.023; Riera-Fernandez P, 2012, CURR TOP MED CHEM, V12, P927, DOI 10.2174/156802612800166819; Riera-Fernandez P, 2011, CURR COMPUT-AID DRUG, V7, P315; Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; van Laarhoven T, 2011, BIOINFORMATICS, V27, P3036, DOI 10.1093/bioinformatics/btr500; Wassermann AM, 2009, J CHEM INF MODEL, V49, P2155, DOI 10.1021/ci9002624; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Yamanishi Y, 2010, BIOINFORMATICS, V26, pi246, DOI 10.1093/bioinformatics/btq176	25	161	161	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66952	10.1371/journal.pone.0066952	http://dx.doi.org/10.1371/journal.pone.0066952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840562	Green Published, gold			2022-12-27	WOS:000321424400058
J	Watanabe, Y; Singamsetty, S; Zou, BB; Guo, LP; Stefanovski, D; Alonso, LC; Garcia-Ocana, A; O'Donnell, CP; McVerry, BJ				Watanabe, Yoshio; Singamsetty, Srikanth; Zou, Baobo; Guo, Lanping; Stefanovski, Darko; Alonso, Laura C.; Garcia-Ocana, Adolfo; O'Donnell, Christopher P.; McVerry, Bryan J.			Exogenous Glucose Administration Impairs Glucose Tolerance and Pancreatic Insulin Secretion during Acute Sepsis in Non-Diabetic Mice	PLOS ONE			English	Article							HYPERGLYCEMIA; THERAPY; MODEL; HYPERINSULINEMIA; INTERLEUKIN-1; HYPOGLYCEMIA; CONTRIBUTES; SENSITIVITY; RESISTANCE	Objectives: The development of hyperglycemia and the use of early parenteral feeding are associated with poor outcomes in critically ill patients. We therefore examined the impact of exogenous glucose administration on the integrated metabolic function of endotoxemic mice using our recently developed frequently sampled intravenous glucose tolerance test (FSIVGTT). We next extended our findings using a cecal ligation and puncture (CLP) sepsis model administered early parenteral glucose support. Methods: Male C57BL/6J mice, 8-12 weeks, were instrumented with chronic indwelling arterial and venous catheters. Endotoxemia was initiated with intra-arterial lipopolysaccharide (LPS; 1 mg/kg) in the presence of saline or glucose infusion (100 mu L/hr), and an FSIVGTT was performed after five hours. In a second experiment, catheterized mice underwent CLP and the impact of early parenteral glucose administration on glucose homeostasis and mortality was assessed over 24 hrs. Measurements: And MAIN RESULTS: Administration of LPS alone did not impair metabolic function, whereas glucose administration alone induced an insulin sensitive state. In contrast, LPS and glucose combined caused marked glucose intolerance and insulin resistance and significantly impaired pancreatic insulin secretion. Similarly, CLP mice receiving parenteral glucose developed fulminant hyperglycemia within 18 hrs (all > 600 mg/dl) associated with increased systemic cytokine release and 40% mortality, whereas CLP alone (85 +/- 2 mg/dL) or sham mice receiving parenteral glucose (113 +/- 3 mg/dL) all survived and were not hyperglycemic. Despite profound hyperglycemia, plasma insulin in the CLP glucose- infused mice (3.7 +/- 1.2 ng/ml) was not higher than sham glucose infused mice (2.1 +/- 0.3 ng/ml). Conclusions: The combination of parenteral glucose support and the systemic inflammatory response in the acute phase of sepsis induces profound insulin resistance and impairs compensatory pancreatic insulin secretion, leading to the development of fulminant hyperglycemia.	[Watanabe, Yoshio; Singamsetty, Srikanth; Zou, Baobo; Guo, Lanping; O'Donnell, Christopher P.; McVerry, Bryan J.] Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Stefanovski, Darko] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Alonso, Laura C.; Garcia-Ocana, Adolfo] Univ Pittsburgh, Sch Med, Div Endocrinol & Metab, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McVerry, BJ (corresponding author), Univ Pittsburgh, Sch Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	mcverrybj@upmc.edu	McVerry, Bryan/AAS-7790-2021	McVerry, Bryan/0000-0002-1175-4874; O'Donnell, Christopher/0000-0002-9120-6850	University of Pittsburgh Medical Center Competitive Medical Research Fund; University of Pittsburgh Vascular Medicine Institute in affiliation with the Institute for Transfusion Medicine; University of Pittsburgh Metabolic Center	University of Pittsburgh Medical Center Competitive Medical Research Fund; University of Pittsburgh Vascular Medicine Institute in affiliation with the Institute for Transfusion Medicine; University of Pittsburgh Metabolic Center	Funding for this work was provided by the University of Pittsburgh Medical Center Competitive Medical Research Fund (BJM), the University of Pittsburgh Vascular Medicine Institute in affiliation with the Institute for Transfusion Medicine (CPO), and the University of Pittsburgh Metabolic Center (BJM, CPO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agwunobi AO, 2000, J CLIN ENDOCR METAB, V85, P3770, DOI 10.1210/jc.85.10.3770; Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; Alonso LC, 2012, OBESITY, V20, P1403, DOI 10.1038/oby.2012.36; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; BERK JL, 1970, ANN SURG, V171, P400, DOI 10.1097/00000658-197003000-00013; Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finney SJ, 2003, JAMA-J AM MED ASSOC, V290, P2041, DOI 10.1001/jama.290.15.2041; FRANKENFIELD DC, 1994, JPEN-PARENTER ENTER, V18, P398, DOI 10.1177/0148607194018005398; Hagiwara S, 2009, CRIT CARE MED, V37, P2223, DOI 10.1097/CCM.0b013e3181a007c6; Heuer JG, 2006, J TRAUMA, V60, P865, DOI 10.1097/01.ta.0000215565.29846.ab; Krogh-Madsen R, 2004, AM J PHYSIOL-ENDOC M, V286, pE766, DOI 10.1152/ajpendo.00468.2003; Losser MR, 2010, CRIT CARE, V14, DOI 10.1186/cc9100; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y; MEHTA VK, 1994, EUR J ENDOCRINOL, V130, P208, DOI 10.1530/eje.0.1300208; NAYLOR JM, 1985, AM J PHYSIOL, V248, pE309, DOI 10.1152/ajpendo.1985.248.3.E309; Patino JF, 1999, WORLD J SURG, V23, P553, DOI 10.1007/PL00012346; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vila G, 2007, J CLIN ENDOCR METAB, V92, P3930, DOI 10.1210/jc.2007-1194; Wei YZ, 2008, AM J PHYSIOL-REG I, V294, pR673, DOI 10.1152/ajpregu.00561.2007; Woodske ME, 2009, CRIT CARE MED, V37, P2596, DOI 10.1097/CCM.0b013e3181a9338a	27	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67716	10.1371/journal.pone.0067716	http://dx.doi.org/10.1371/journal.pone.0067716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826335	gold, Green Accepted, Green Published			2022-12-27	WOS:000321738400168
J	Craine, JM				Craine, Joseph M.			Long-Term Climate Sensitivity of Grazer Performance: A Cross-Site Study	PLOS ONE			English	Article							TALLGRASS PRAIRIE; BODY-SIZE; ECOSYSTEM; VARIABILITY; BISON; PLANT; GRASSLANDS; COMMUNITY; DYNAMICS; FIRE	Climate change will affect grasslands in a number of ways, but the consequences of a warmer, drier world for grazers is uncertain. Predicting future grazer performance is complex since climate change affects both the quantity and quality of forage through a combination of processes that occur over a range of time scales. To better predict the consequences of climate change for grazer performance, a dataset was compiled of over a quarter million bison weights distributed across 22 US herds that span a large range of climates. Patterns of bison body mass among sites, age classes, and sexes were analyzed with respect to differences in geographic patterns of climate and interannual variation in climate. While short-term effects of climate variability are likely to depend on the magnitude and timing of precipitation during the year, grazers will be negatively affected by sustained hotter, drier conditions most likely associated with reductions in forage quality. Short-term, little effect of high temperatures on bison performance is observed, which suggests that the long-term effects of higher temperatures are likely to accrue over time as nitrogen availability in grasslands is reduced and forage quality declines. If relationships observed for bison are general for cattle, the economic consequences of higher temperatures due to decreased weight gain in US cattle could be on the order of US$1B per 1 degrees C increase in temperature. Long-term monitoring of forage quality as well as native and domesticated grazer performance is recommended to better understand climate change effects on grazers.	Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	Kansas State University	Craine, JM (corresponding author), Kansas State Univ, Div Biol, Manhattan, KS 66506 USA.	jcraine@ksu.edu	Craine, Joseph/D-4569-2009	Craine, Joseph/0000-0001-6561-3244	Kansas State University	Kansas State University	Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An YA, 2005, GLOBAL CHANGE BIOL, V11, P1733, DOI 10.1111/j.1365-2486.2005.01030.x; Anderson TM, 2007, AM NAT, V170, P343, DOI 10.1086/520120; Augustine DJ, 2003, ECOL APPL, V13, P1325, DOI 10.1890/02-5283; Biondini ME, 1998, ECOL APPL, V8, P469, DOI 10.1890/1051-0761(1998)008[0469:GIAEPI]2.0.CO;2; Cheng X, 2011, BIOGEOSCIENCES, V8, P1487, DOI 10.5194/bg-8-1487-2011; Craine JM., 2009, RESOURCE STRATEGIES; Craine JM, 2013, OIKOS, V122, P191, DOI 10.1111/j.1600-0706.2012.20400.x; Craine JM, 2012, P NATL ACAD SCI USA, V109, P3401, DOI 10.1073/pnas.1118438109; Craine JM, 2010, GLOBAL CHANGE BIOL, V16, P2901, DOI 10.1111/j.1365-2486.2009.02060.x; Craine JM, 2009, GLOBAL CHANGE BIOL, V15, P772, DOI 10.1111/j.1365-2486.2008.01769.x; EAST R, 1984, AFR J ECOL, V22, P245, DOI 10.1111/j.1365-2028.1984.tb00700.x; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; Frank DA, 1998, ECOLOGY, V79, P2229, DOI 10.1890/0012-9658(1998)079[2229:UVLCOS]2.0.CO;2; FRITZ H, 1994, P ROY SOC B-BIOL SCI, V256, P77, DOI 10.1098/rspb.1994.0052; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Gates C.C., 2010, IUCN RED LIST THREAT; Hamel S, 2010, ECOLOGY, V91, P2034, DOI 10.1890/09-1311.1; Hobbs NT, 1996, J WILDLIFE MANAGE, V60, P695, DOI 10.2307/3802368; Karl T. R., 2009, Global climate change impacts in the United States; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; MAGNUSON JJ, 1990, BIOSCIENCE, V40, P495, DOI 10.2307/1311317; Martinez-Jauregui M, 2009, GLOBAL CHANGE BIOL, V15, P1727, DOI 10.1111/j.1365-2486.2008.01778.x; McLauchlan KK, 2010, NEW PHYTOL, V187, P1135, DOI 10.1111/j.1469-8137.2010.03322.x; MCNAUGHTON SJ, 1989, NATURE, V341, P142, DOI 10.1038/341142a0; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Oltjen JW, 1996, J ANIM SCI, V74, P1406; Pachauri R.K, 2007, CLIMATE CHANGE 2007, P104; Peters DPC, 2010, TRENDS ECOL EVOL, V25, P592, DOI 10.1016/j.tree.2010.07.005; Rastetter EB, 1996, BIOSCIENCE, V46, P190, DOI 10.2307/1312740; SALA OE, 1988, ECOLOGY, V69, P40, DOI 10.2307/1943158; Seydack AH, 2012, KOEDOE AFRICAN PROTE, V54; Solomon S., 2007, CONTRIBUTION WORKING, P996; Toigo C, 2006, ECOGRAPHY, V29, P301, DOI 10.1111/j.2006.0906-7590.04394.x; USDA National Agricultural Statistics Service, 2012, LIV SLAUGHT 2011 SUM; Veen GF, 2008, OIKOS, V117, P859, DOI [10.1111/j.2008.0030-1299.16515.x, 10.1111/j.0030-1299.2008.16515.x]; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Wheeler R.O., 1981, WORLD LIVESTOCK PROD; Wilson GA, 1999, GENOME, V42, P483, DOI 10.1139/gen-42-3-483; Wu Z, 2012, NATURE CLIMATE CHANG; ZIMOV SA, 1995, AM NAT, V146, P765, DOI 10.1086/285824	41	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67065	10.1371/journal.pone.0067065	http://dx.doi.org/10.1371/journal.pone.0067065			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840584	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800116
J	Drame, PM; Diallo, A; Poinsignon, A; Boussari, O; Dos Santos, S; Machault, V; Lalou, R; Cornelie, S; LeHesran, JY; Remoue, F				Drame, Papa Makhtar; Diallo, Abdoulaye; Poinsignon, Anne; Boussari, Olayide; Dos Santos, Stephanie; Machault, Vanessa; Lalou, Richard; Cornelie, Sylvie; LeHesran, Jean-Yves; Remoue, Franck			Evaluation of the Effectiveness of Malaria Vector Control Measures in Urban Settings of Dakar by a Specific Anopheles Salivary Biomarker	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; SUB-SAHARAN AFRICA; ANTIBODY-RESPONSE; EXPOSURE; URBANIZATION; TRANSMISSION; TANZANIA; PEPTIDE; GAMBIAE; BURDEN	Standard entomological methods for evaluating the impact of vector control lack sensitivity in low-malaria-risk areas. The detection of human IgG specific to Anopheles gSG6-P1 salivary antigen reflects a direct measure of human-vector contact. This study aimed to assess the effectiveness of a range of vector control measures (VCMs) in urban settings by using this biomarker approach. The study was conducted from October to December 2008 on 2,774 residents of 45 districts of urban Dakar. IgG responses to gSG6-P1 and the use of malaria VCMs highly varied between districts. At the district level, specific IgG levels significantly increased with age and decreased with season and with VCM use. The use of insecticide-treated nets, by drastically reducing specific IgG levels, was by far the most efficient VCM regardless of age, season or exposure level to mosquito bites. The use of spray bombs was also associated with a significant reduction of specific IgG levels, whereas the use of mosquito coils or electric fans/air conditioning did not show a significant effect. Human IgG response to gSG6-P1 as biomarker of vector exposure represents a reliable alternative for accurately assessing the effectiveness of malaria VCM in low-malaria-risk areas. This biomarker tool could be especially relevant for malaria control monitoring and surveillance programmes in low-exposure/low-transmission settings.	[Drame, Papa Makhtar; Poinsignon, Anne; Cornelie, Sylvie; Remoue, Franck] Univ Montpellier I, Inst Rech Dev, UMR MIVEGEC IRD224 CNRS5290, Montpellier, France; [Drame, Papa Makhtar; Poinsignon, Anne; Cornelie, Sylvie; Remoue, Franck] Univ Montpellier 2, Montpellier, France; [Diallo, Abdoulaye; LeHesran, Jean-Yves] Fac Pharmaceut Sci, UMR 216 Mere & Enfant Face Infect Tropicales, Inst Rech Dev, Paris, France; [Boussari, Olayide] Univ Abomey Calavi, Int Chair Math Phys & Applicat ICMPA UNESCO Chair, Lab Etud & Rech Stat Appl & Modelisat, Cotonou, Benin; [Dos Santos, Stephanie] Campus Int Rech UCAD IRD, Inst Rech Dev, UMR 151, Dakar, Senegal; [Machault, Vanessa] Observ Midi Pyrenees, Lab Aerol, F-31400 Toulouse, France; [Lalou, Richard] Univ Aix Marseille 1, IRD, UMR 151, Marseille, France; [Remoue, Franck] Univ Montpellier I, Inst Rech Dev, Ctr Rech Entomol Cotonou, UMR MIVEGEC IRD224 CNRS5290, Cotonou, Benin; [Remoue, Franck] Univ Montpellier 2, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi; Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Entomological Research Center of Cotonou (CREC); Institut de Recherche pour le Developpement (IRD)	Drame, PM (corresponding author), Univ Montpellier I, Inst Rech Dev, UMR MIVEGEC IRD224 CNRS5290, Montpellier, France.	papa-makhtar.drame@ird.fr	LALOU, Richard/A-7322-2017	LALOU, Richard/0000-0001-9489-7661; Poinsignon, Anne/0000-0003-2921-4486; cornelie, sylvie/0000-0003-3662-1450	ANR (Agence Nationale pour la Recherche) [2007 SEST 001 02]; IRD (Departement de la Valorisation au Sud: DVS); IRD (DSF Department); InfectioPole Sud Fundation; IRD-DSF Department	ANR (Agence Nationale pour la Recherche)(French National Research Agency (ANR)); IRD (Departement de la Valorisation au Sud: DVS); IRD (DSF Department); InfectioPole Sud Fundation; IRD-DSF Department	The work was supported by ANR (Agence Nationale pour la Recherche) grant no2007 SEST 001 02 and by IRD (Departement de la Valorisation au Sud: DVS). PMD was supported by a PhD scholarship provided by IRD (DSF Department) then a fellowship from InfectioPole Sud Fundation. AD is a PhD student supported by IRD-DSF Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, COCHRANE DB SYST REV; ANSD-Senegal, 2008, KEY IND SEN; BrummerKorvenkontio H, 1997, ALLERGY, V52, P342, DOI 10.1111/j.1398-9995.1997.tb01002.x; Byrne Neville, 2007, Travel Med Infect Dis, V5, P135, DOI 10.1016/j.tmaid.2006.04.003; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; CARNEVALE P, 1978, B WORLD HEALTH ORGAN, V56, P147; Doannio J M C, 2006, Med Trop (Mars), V66, P45; Donnelly MJ, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-12; Drame PM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-72; Drame PM, 2010, AM J TROP MED HYG, V83, P115, DOI 10.4269/ajtmh.2010.09-0684; Drame PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015596; Fillinger Ulrike, 2006, Trop Med Int Health, V11, P1629, DOI 10.1111/j.1365-3156.2006.01733.x; Gadiaga L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-312; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Hoffman SJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-363; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Le Menach A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00093; Machault V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-252; Machault V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-138; Maxwell CA, 2002, TROP MED INT HEALTH, V7, P1003, DOI 10.1046/j.1365-3156.2002.00966.x; Mboera L E G, 2005, Tanzan Health Res Bull, V7, P117; National Malaria Control Program (NMCP)_Senegal, 2011, NAT STRAT PLAN 20011; National Malaria Control Program (NMCP)_Senegal, 2006, NAT STRAT PLAN 2006; National Meteorological Services_Senegal, 2009, ANN RAINF SEN 2008; Ndiaye S., 2009, ENQUETE NATL PALUDIS; Pages F, 2007, MED MALADIES INFECT, V37, P153, DOI 10.1016/j.medmal.2006.10.009; PALMER SM, 1993, LUPUS, V2, P251, DOI 10.1177/096120339300200408; Poinsignon A, 2010, TROP MED INT HEALTH, V15, P1198, DOI 10.1111/j.1365-3156.2010.02611.x; Poinsignon A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-198; Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472; Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Rogier C, 2003, Med Trop (Mars), V63, P449; UN, 2008, WORLD URB PROSP 2007; Vanek MJ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-154; Waitayakul A, 2006, ACTA TROP, V98, P66, DOI 10.1016/j.actatropica.2006.02.004	37	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66354	10.1371/journal.pone.0066354	http://dx.doi.org/10.1371/journal.pone.0066354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840448	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800050
J	Goni-Moreno, A; Amos, M; de la Cruz, F				Goni-Moreno, Angel; Amos, Martyn; de la Cruz, Fernando			Multicellular Computing Using Conjugation for Wiring	PLOS ONE			English	Article							SYNTHETIC BIOLOGY; PLASMID INVASION; PHASE VARIATION; SWITCH; RECOMBINATION; CONSTRUCTION; COMPUTATION; DYNAMICS; NETWORK; SYSTEM	Recent efforts in synthetic biology have focussed on the implementation of logical functions within living cells. One aim is to facilitate both internal "re-programming" and external control of cells, with potential applications in a wide range of domains. However, fundamental limitations on the degree to which single cells may be re-engineered have led to a growth of interest in multicellular systems, in which a "computation" is distributed over a number of different cell types, in a manner analogous to modern computer networks. Within this model, individual cell type perform specific sub-tasks, the results of which are then communicated to other cell types for further processing. The manner in which outputs are communicated is therefore of great significance to the overall success of such a scheme. Previous experiments in distributed cellular computation have used global communication schemes, such as quorum sensing (QS), to implement the "wiring" between cell types. While useful, this method lacks specificity, and limits the amount of information that may be transferred at any one time. We propose an alternative scheme, based on specific cell-cell conjugation. This mechanism allows for the direct transfer of genetic information between bacteria, via circular DNA strands known as plasmids. We design a multicellular population that is able to compute, in a distributed fashion, a Boolean XOR function. Through this, we describe a general scheme for distributed logic that works by mixing different strains in a single population; this constitutes an important advantage of our novel approach. Importantly, the amount of genetic information exchanged through conjugation is significantly higher than the amount possible through QS-based communication. We provide full computational modelling and simulation results, using deterministic, stochastic and spatially-explicit methods. These simulations explore the behaviour of one possible conjugation-wired cellular computing system under different conditions, and provide baseline information for future laboratory implementations.	[Goni-Moreno, Angel] CSIC, Ctr Nacl Biotecnol, Syst Biol Program, Canto Blanco, Spain; [Amos, Martyn] Manchester Metropolitan Univ, Sch Comp Math & Digital Technol, Manchester M15 6BH, Lancs, England; [de la Cruz, Fernando] Univ Cantabria, CSIC, SODERCAN, Dept Biol Mol, E-39005 Santander, Spain; [de la Cruz, Fernando] Univ Cantabria, CSIC, SODERCAN, Inst Biomed & Biotecnol Cantabria IBBTEC, E-39005 Santander, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Manchester Metropolitan University; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Goni-Moreno, A (corresponding author), CSIC, Ctr Nacl Biotecnol, Syst Biol Program, Canto Blanco, Spain.	agoni@cnb.csic.es	Goni-Moreno, Angel/N-8674-2016; de la Cruz, Fernando/L-2812-2014	de la Cruz, Fernando/0000-0003-4758-6857; Goni-Moreno, Angel/0000-0002-2097-2507; Amos, Martyn/0000-0003-1680-5535	European Commission FP7 Future and Emerging Technologies Proactive initiative: Bio-chemistry-based Information Technology (CHEM-IT) [248919, ICT-2009.8.3]; Spanish Ministry of Education [BFU2011-26608]; European VII Framework Program [248919/FP7-ICT-2009-4, 282004/FP7-HEALTH.2001.2.3.1-2]	European Commission FP7 Future and Emerging Technologies Proactive initiative: Bio-chemistry-based Information Technology (CHEM-IT); Spanish Ministry of Education(Spanish Government); European VII Framework Program	This work was supported by the European Commission FP7 Future and Emerging Technologies Proactive initiative: Bio-chemistry-based Information Technology (CHEM-IT, ICT-2009.8.3), project reference 248919 (BACTOCOM). Work in FdlC lab was supported by Spanish Ministry of Education (BFU2011-26608), and European VII Framework Program grants num 248919/FP7-ICT-2009-4 and 282004/FP7-HEALTH.2001.2.3.1-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Atkinson S, 2009, J R SOC INTERFACE, V6, P959, DOI 10.1098/rsif.2009.0203; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Baumgardner Jordan, 2009, J Biol Eng, V3, P11, DOI 10.1186/1754-1611-3-11; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; Cho HJ, 2007, PLOS BIOL, V5, P2614, DOI 10.1371/journal.pbio.0050302; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; de la Cruz F, 2010, FEMS MICROBIOL REV, V34, P18, DOI 10.1111/j.1574-6976.2009.00195.x; de Lorenzo V, 2008, EMBO REP, V9, P822, DOI 10.1038/embor.2008.159; de-Leon SBT, 2009, DEV BIOL, V325, P317, DOI 10.1016/j.ydbio.2008.10.043; del Campo I, 2012, PLASMID, V67, P174, DOI 10.1016/j.plasmid.2012.01.008; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; GALLY DL, 1993, J BACTERIOL, V175, P6186, DOI 10.1128/JB.175.19.6186-6193.1993; Garcillan-Barcia MP, 2008, PLASMID, V60, P1, DOI 10.1016/j.plasmid.2008.03.002; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goni-Moreno A, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-126; Goni-Moreno A, 2012, BIOSYSTEMS, V109, P52, DOI 10.1016/j.biosystems.2012.02.001; Goni-Moreno A, 2011, NAT COMPUT, V10, P119, DOI 10.1007/s11047-010-9184-2; Gorochowski TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042790; Grad YH, 2013, MBIO, V4; Gregory R, 2008, BIOSYSTEMS, V91, P201, DOI 10.1016/j.biosystems.2007.09.003; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Ham TS, 2006, BIOTECHNOL BIOENG, V94, P1, DOI 10.1002/bit.20916; Haynes Karmella A, 2008, J Biol Eng, V2, P8, DOI 10.1186/1754-1611-2-8; Heinemann M, 2006, BIOINFORMATICS, V22, P2790, DOI 10.1093/bioinformatics/btl469; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kreft JU, 1998, MICROBIOL-UK, V144, P3275, DOI 10.1099/00221287-144-12-3275; Krone SM, 2007, MICROBIOL-SGM, V153, P2803, DOI 10.1099/mic.0.2006/004531-0; Lardon LA, 2011, ENVIRON MICROBIOL, V13, P2416, DOI 10.1111/j.1462-2920.2011.02414.x; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x; Lou CB, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.2; Macia J, 2012, TRENDS BIOTECHNOL, V30, P342, DOI 10.1016/j.tibtech.2012.03.006; MCCLAIN MS, 1991, J BACTERIOL, V173, P5308, DOI 10.1128/jb.173.17.5308-5314.1991; Melke P, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000819; Merkey BV, 2011, ENVIRON MICROBIOL, V13, P2435, DOI 10.1111/j.1462-2920.2011.02535.x; Meyer B, 1988, OBJECT ORIENTED SOFT, V2; Moon TS, 2011, J MOL BIOL, V406, P215, DOI 10.1016/j.jmb.2010.12.019; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; Oldham P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034368; Ortiz ME, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-16; Purcell O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016140; Purcell O, 2010, J R SOC INTERFACE, V7, P1503, DOI 10.1098/rsif.2010.0183; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Rudge TJ, 2012, ACS SYNTH BIOL, V1, P345, DOI 10.1021/sb300031n; Seoane J, 2011, FEMS MICROBIOL ECOL, V75, P17, DOI 10.1111/j.1574-6941.2010.00994.x; Siuti P, 2013, NATURE BIOTECHNOLOGY; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Tamsir A, 2011, NATURE, V469, P212, DOI 10.1038/nature09565; TATUM EL, 1947, J BACTERIOL, V53, P673, DOI 10.1128/JB.53.6.673-684.1947; Volfson D, 2008, P NATL ACAD SCI USA, V105, P15346, DOI 10.1073/pnas.0706805105; Xavier JB, 2005, ENVIRON MICROBIOL, V7, P1085, DOI 10.1111/j.1462-2920.2005.00787.x; Yamanishi M, 2012, ACS SYNTH BIOL, V1, P172, DOI 10.1021/sb200017p	60	32	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65986	10.1371/journal.pone.0065986	http://dx.doi.org/10.1371/journal.pone.0065986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840385	Green Published, Green Accepted, gold			2022-12-27	WOS:000322342800025
J	Gouveia, K; Hurst, JL				Gouveia, Kelly; Hurst, Jane L.			Reducing Mouse Anxiety during Handling: Effect of Experience with Handling Tunnels	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; ENVIRONMENTAL ENRICHMENT; BEHAVIOR; MICE; REACTIVITY; RESPONSES; STRESS; RATS	Handling stress is a well-recognised source of variation in animal studies that can also compromise the welfare of research animals. To reduce background variation and maximise welfare, methods that minimise handling stress should be developed and used wherever possible. Recent evidence has shown that handling mice by a familiar tunnel that is present in their home cage can minimise anxiety compared with standard tail handling. As yet, it is unclear whether a tunnel is required in each home cage to improve response to handling. We investigated the influence of prior experience with home tunnels among two common strains of laboratory mice: ICR(CD-1) and C57BL/6. We compared willingness to approach the handler and anxiety in an elevated plus maze test among mice picked up by the tail, by a home cage tunnel or by an external tunnel shared between cages. Willingness to interact with the handler was much greater for mice handled by a tunnel, even when this was unfamiliar, compared to mice picked up by the tail. Once habituated to handling, C57BL/6 mice were most interactive towards a familiar home tunnel, whereas the ICR strain showed strong interaction with all tunnel handling regardless of any experience of a home cage tunnel. Mice handled by a home cage or external tunnel showed less anxiety in an elevated plus maze than those picked up by the tail. This study shows that using a tunnel for routine handling reduces anxiety among mice compared to tail handling regardless of prior familiarity with tunnels. However, as home cage tunnels can further improve response to handling in some mice, we recommend that mice are handled with a tunnel provided in their home cage where possible as a simple practical method to minimise handling stress.	[Gouveia, Kelly; Hurst, Jane L.] Univ Liverpool, Inst Integrat Biol, Neston, Cheshire, England	University of Liverpool	Hurst, JL (corresponding author), Univ Liverpool, Inst Integrat Biol, Neston, Cheshire, England.	jhurst@liverpool.ac.uk	Hurst, Jane L/G-8793-2015	Hurst, Jane L/0000-0002-3728-9624	National Centre for the Replacement, Refinement and Reduction of Animals in Research [Hurst.J.14-07-2009]; National Centre for the Replacement [NC/K500446/1] Funding Source: researchfish	National Centre for the Replacement, Refinement and Reduction of Animals in Research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); National Centre for the Replacement	This study was supported by a studentship from the National Centre for the Replacement, Refinement and Reduction of Animals in Research (Hurst.J.14-07-2009) awarded to JLH and held by KG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anna I, 2002, LAB ANIM-UK, V36, P243, DOI 10.1258/002367702320162379; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; BRUCE HM, 1959, NATURE, V184, P105, DOI 10.1038/184105a0; Festing MFW, 1998, ATLA-ALTERN LAB ANIM, V26, P283; Howard B R, 2002, ILAR J, V43, P194; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; Kim S, 2002, BEHAV PROCESS, V60, P181, DOI 10.1016/S0376-6357(02)00085-2; Koyama S, 2004, HORM BEHAV, V46, P303, DOI 10.1016/j.yhbeh.2004.03.002; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Maurer BM, 2008, APPL ANIM BEHAV SCI, V114, P554, DOI 10.1016/j.applanim.2008.04.013; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Meijer MK, 2007, LAB ANIM-UK, V41, P161, DOI 10.1258/002367707780378168; Michalikova S, 2010, BEHAV BRAIN RES, V207, P402, DOI 10.1016/j.bbr.2009.10.028; Moncho-Bogani J, 2002, PHYSIOL BEHAV, V77, P167, DOI 10.1016/S0031-9384(02)00842-9; Nicol CJ, 2008, APPL ANIM BEHAV SCI, V110, P341, DOI 10.1016/j.applanim.2007.05.006; Nunez JF, 1996, PHYSIOL BEHAV, V60, P1355, DOI 10.1016/S0031-9384(96)00225-9; Pankevich DE, 2006, BEHAV NEUROSCI, V120, P925, DOI 10.1037/0735-7044.120.4.925; Parmigiani S, 1999, NEUROSCI BIOBEHAV R, V23, P957, DOI 10.1016/S0149-7634(99)00029-9; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Roy V, 2004, BEHAV BRAIN RES, V154, P439, DOI 10.1016/j.bbr.2004.03.010; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; WIEPKEMA PR, 1993, ANIM WELFARE, V2, P195	23	102	103	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66401	10.1371/journal.pone.0066401	http://dx.doi.org/10.1371/journal.pone.0066401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840458	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800057
J	Perot, S; Regad, L; Reynes, C; Sperandio, O; Miteva, MA; Villoutreix, BO; Camproux, AC				Perot, Stephanie; Regad, Leslie; Reynes, Christelle; Sperandio, Olivier; Miteva, Maria A.; Villoutreix, Bruno O.; Camproux, Anne-Claude			Insights into an Original Pocket-Ligand Pair Classification: A Promising Tool for Ligand Profile Prediction	PLOS ONE			English	Article							PROTEIN-BINDING POCKET; DRUG DISCOVERY; MOLECULAR DOCKING; PDBBIND DATABASE; ANALYTICAL SHAPE; CHEMICAL SPACE; PROTEOCHEMOMETRICS; SIMILARITY; SURFACES; CAVITIES	Pockets are today at the cornerstones of modern drug discovery projects and at the crossroad of several research fields, from structural biology to mathematical modeling. Being able to predict if a small molecule could bind to one or more protein targets or if a protein could bind to some given ligands is very useful for drug discovery endeavors, anticipation of binding to off-and anti-targets. To date, several studies explore such questions from chemogenomic approach to reverse docking methods. Most of these studies have been performed either from the viewpoint of ligands or targets. However it seems valuable to use information from both ligands and target binding pockets. Hence, we present a multivariate approach relating ligand properties with protein pocket properties from the analysis of known ligand-protein interactions. We explored and optimized the pocket-ligand pair space by combining pocket and ligand descriptors using Principal Component Analysis and developed a classification engine on this paired space, revealing five main clusters of pocket-ligand pairs sharing specific and similar structural or physico-chemical properties. These pocket-ligand pair clusters highlight correspondences between pocket and ligand topological and physico-chemical properties and capture relevant information with respect to protein-ligand interactions. Based on these pocket-ligand correspondences, a protocol of prediction of clusters sharing similarity in terms of recognition characteristics is developed for a given pocket-ligand complex and gives high performances. It is then extended to cluster prediction for a given pocket in order to acquire knowledge about its expected ligand profile or to cluster prediction for a given ligand in order to acquire knowledge about its expected pocket profile. This prediction approach shows promising results and could contribute to predict some ligand properties critical for binding to a given pocket, and conversely, some key pocket properties for ligand binding.	[Perot, Stephanie; Regad, Leslie; Reynes, Christelle; Sperandio, Olivier; Miteva, Maria A.; Villoutreix, Bruno O.; Camproux, Anne-Claude] INSERM, UMRS 973, MTi, Paris, France; [Perot, Stephanie; Regad, Leslie; Reynes, Christelle; Sperandio, Olivier; Miteva, Maria A.; Villoutreix, Bruno O.; Camproux, Anne-Claude] Univ Paris Diderot, Sorbonne Paris Cite, UMRS 973, MTi, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Camproux, AC (corresponding author), INSERM, UMRS 973, MTi, Paris, France.	anne.camproux@univ-paris-diderot.fr	Sperandio, Olivier/AAM-4134-2021; Villoutreix, Bruno/I-4565-2015; Miteva, Maria M/N-2419-2018	Sperandio, Olivier/0000-0001-6610-2729; Villoutreix, Bruno/0000-0002-6456-7730; Miteva, Maria M/0000-0001-6895-1214; Regad, Leslie/0000-0002-9292-5283; Camproux, Anne-Claude/0000-0001-8821-9952	Ministere de la Recherche; French Institute of Health and Medical Research (Inserm); University Paris Diderot	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); French Institute of Health and Medical Research (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Paris Diderot	This work has been partially promoted by the French IA BipBip project. SP had a grant from the Ministere de la Recherche. The authors thank the French Institute of Health and Medical Research (Inserm) and the University Paris Diderot for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson CD, 2010, PROTEINS, V78, P1408, DOI 10.1002/prot.22655; Chen YZ, 2001, J MOL GRAPH MODEL, V20, P199, DOI 10.1016/S1093-3263(01)00109-7; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Eyrisch S, 2007, J MED CHEM, V50, P3457, DOI 10.1021/jm070095g; Filmoser P, 2009, J CHEMOMETR, V23, P160; Gordon AD, 1999, CLASSIFICATION; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; Hoffmann B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-99; Hubbard S. J., 1993, NACCESS; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Junaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014353; Kahraman A, 2007, J MOL BIOL, V368, P283, DOI 10.1016/j.jmb.2007.01.086; Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284; Kinnings SL, 2011, J CHEM INF MODEL, V51, P624, DOI 10.1021/ci1003174; Klabunde T, 2007, BRIT J PHARMACOL, V152, P5, DOI 10.1038/sj.bjp.0707308; Koutsoukas A, 2011, J PROTEOMICS, V74, P2554, DOI 10.1016/j.jprot.2011.05.011; Kufareva I, 2011, STRUCTURE, V19, P1108, DOI 10.1016/j.str.2011.05.012; Lagorce D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-396; Lapinsh M, 2005, BIOINFORMATICS, V21, P4289, DOI 10.1093/bioinformatics/bti703; Larsson J, 2007, J NAT PROD, V70, P789, DOI 10.1021/np070002y; Lee S, 2008, FACTOMINER R PACKAGE; Liang J, 1998, PROTEINS, V33, P18, DOI 10.1002/(SICI)1097-0134(19981001)33:1<18::AID-PROT2>3.3.CO;2-X; Liang J, 1998, PROTEINS, V33, P1; Martin YC, 2002, J MED CHEM, V45, P4350, DOI 10.1021/jm020155c; Meslamani J, 2011, J CHEM INF MODEL, V51, P1593, DOI 10.1021/ci200166t; Mestres J, 2004, CURR OPIN DRUG DISC, V7, P304; Morris RJ, 2005, BIOINFORMATICS, V21, P2347, DOI 10.1093/bioinformatics/bti337; Najmanovich R, 2008, BIOINFORMATICS, V24, pI105, DOI 10.1093/bioinformatics/btn263; Nayal M, 2006, PROTEINS, V63, P892, DOI 10.1002/prot.20897; Oprea TI, 2001, J COMB CHEM, V3, P157, DOI 10.1021/cc0000388; Perot S, 2010, DRUG DISCOV TODAY, V15, P656, DOI 10.1016/j.drudis.2010.05.015; Pettit FK, 1999, J MOL BIOL, V285, P1377, DOI 10.1006/jmbi.1998.2411; Ruppert J, 1997, PROTEIN SCI, V6, P524; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; Sonavane S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000188; Strombergsson H, 2006, PROTEINS, V63, P24, DOI 10.1002/prot.20777; Strombergsson H, 2006, PROTEINS, V65, P568, DOI 10.1002/prot.21163; Sugaya N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-263; Taboureau O, 2011, NUCLEIC ACIDS RES, V39, pD367, DOI 10.1093/nar/gkq906; van Westen GJP, 2011, MEDCHEMCOMM, V2, P16, DOI 10.1039/c0md00165a; van Westen GJP, 2013, NAT METHODS, V10, P116, DOI 10.1038/nmeth.2339; Wang RX, 2005, J MED CHEM, V48, P4111, DOI 10.1021/jm048957q; Wang RX, 2004, J MED CHEM, V47, P2977, DOI 10.1021/jm030580l; Weill N, 2009, J CHEM INF MODEL, V49, P1049, DOI 10.1021/ci800447g; Wolber G, 2008, DRUG DISCOV TODAY, V13, P23, DOI 10.1016/j.drudis.2007.09.007; Xie L, 2011, CURR OPIN STRUC BIOL, V21, P189, DOI 10.1016/j.sbi.2011.01.004; Yamanishi Y, 2011, J CHEM INF MODEL, V51, P1183, DOI 10.1021/ci100476q	49	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e63730	10.1371/journal.pone.0063730	http://dx.doi.org/10.1371/journal.pone.0063730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840299	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800002
J	Seni, J; Bwanga, F; Najjuka, CF; Makobore, P; Okee, M; Mshana, SE; Kidenya, BR; Joloba, ML; Kateete, DP				Seni, Jeremiah; Bwanga, Freddie; Najjuka, Christine F.; Makobore, Patson; Okee, Moses; Mshana, Stephen E.; Kidenya, Benson R.; Joloba, Moses L.; Kateete, David P.			Molecular Characterization of Staphylococcus aureus from Patients with Surgical Site Infections at Mulago Hospital in Kampala, Uganda	PLOS ONE			English	Article							METHICILLIN-RESISTANT; ANTIMICROBIAL SUSCEPTIBILITY; NASAL CARRIAGE; MULTIPLEX PCR; EPIDEMIOLOGY; IDENTIFICATION; SURVEILLANCE; EVOLUTION; MARKER; MRSA	Background: The prevalence of Methicillin resistant Staphylococcus aureus (MRSA) is progressively increasing globally with significant regional variation. Understanding the Staphylococcus aureus lineages is crucial in controlling nosocomial infections. Recent studies on S. aureus in Uganda have revealed an escalating burden of MRSA. However, the S. aureus genotypes circulating among patients are not known. Here, we report S. aureus lineages circulating in patients with surgical site infections (SSI) at Mulago National hospital, Kampala, Uganda. Methods: A cross-sectional study involving 314 patients with SSI at Mulago National Hospital was conducted from September 2011 to April 2012. Pus swabs from the patients' SSI were processed using standard microbiological procedures. Methicillin sensitive Staphylococcus aureus (MSSA) and MRSA were identified using phenotypic tests and confirmed by PCR-detection of the nuc and mecA genes, respectively. SCCmec genotypes were determined among MRSA isolates using multiplex PCR. Furthermore, to determine lineages, spa sequence based-genotyping was performed on all S. aureus isolates. Results: Of the 314 patients with SSI, S. aureus accounted for 20.4% (64/314), of which 37.5% (24/64) were MRSA. The predominant SCCmec types were type V (33.3%, 8/24) and type I (16.7%, 4/24). The predominant spa lineages were t645 (17.2%, 11/64) and t4353 (15.6%, 10/64), and these were found to be clonally circulating in all the surgical wards. On the other hand, lineages t064, t355, and t4609 were confined to the obstetrics and gynecology wards. A new spa type (t10277) was identified from MSSA isolate. On multivariate logistic regression analysis, cancer and inducible clindamycin resistance remained as independent predictors of MRSA-SSI. Conclusion: SCCmec types I and V are the most prevalent MRSA mecA types from the patients' SSI. The predominant spa lineages (t645 and t4353) are clonally circulating in all the surgical wards, calling for strengthening of infection control practices at Mulago National Hospital.	[Seni, Jeremiah; Bwanga, Freddie; Najjuka, Christine F.; Okee, Moses; Joloba, Moses L.; Kateete, David P.] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Makobore, Patson] Makerere Univ, Coll Hlth Sci, Dept Surg, Kampala, Uganda; [Seni, Jeremiah; Mshana, Stephen E.] Catholic Univ Hlth & Allied Sci Bugando, Dept Microbiol & Immunol, Mwanza, Tanzania; [Kidenya, Benson R.] Catholic Univ Hlth & Allied Sci Bugando, Dept Biochem & Mol Biol, Mwanza, Tanzania	Makerere University; Makerere University	Seni, J (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda.	senijj80@gmail.com	Mshana, Stephen/AAE-1900-2022; Kateete, David Patrick/HCH-5603-2022	Joloba, Moses/0000-0002-0334-9983; Seni, Jeremiah/0000-0003-2420-5329; Kateete, David Patrick/0000-0001-8075-3069	Catholic University of Health and Allied Sciences Bugando, Mwanza, Tanzania	Catholic University of Health and Allied Sciences Bugando, Mwanza, Tanzania	This work was funded by Catholic University of Health and Allied Sciences Bugando, Mwanza, Tanzania to JS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi IK, 2010, INT J INFECT CONTROL, V6; Anguzu J R, 2007, Afr Health Sci, V7, P148; [Anonymous], 2011, 21 INFORMATIONAL SUP, V31; Boye K, 2007, CLIN MICROBIOL INFEC, V13, P725, DOI 10.1111/j.1469-0691.2007.01720.x; BRAKSTAD OG, 1992, J CLIN MICROBIOL, V30, P1654, DOI 10.1128/JCM.30.7.1654-1660.1992; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kateete David P, 2011, BMC Res Notes, V4, P326, DOI 10.1186/1756-0500-4-326; Kateete DP, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-23; Kesah C, 2003, CLIN MICROBIOL INFEC, V9, P153, DOI 10.1046/j.1469-0691.2003.00531.x; Khandavilli S, 2009, J HOSP INFECT, V71, P29, DOI 10.1016/j.jhin.2008.09.011; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Koneman EW, 1997, COLOR ATLAS TXB DIAG, V5th; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Mawalla B, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-21; McClure JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006; Moremi N, 2012, J INFECT DEV COUNTR, V6, P620, DOI 10.3855/jidc.2093; Mshana S. S., 2009, Tanzania Journal of Health Research, V11, P59; Ojulong J, 2009, Tanzan J Health Res, V11, P149; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; Onyango MD, 2009, J INFECT DEV COUNTR, V3, P685; Peng Q, 2010, AFRICAN J MICROBIOLO, V4; Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102; Shittu AO, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-125; Shittu AO, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-92; Shopsin B, 2001, EMERG INFECT DIS, V7, P323, DOI 10.3201/eid0702.010236; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Struelens MJ, 2009, CLIN MICROBIOL INFEC, V15, P112, DOI 10.1111/j.1469-0691.2009.02698.x; Truong H, 2011, SAMJ S AFR MED J, V101, P413; Wang JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009489; WENZEL RP, 1995, J HOSP INFECT, V31, P13, DOI 10.1016/0195-6701(95)90079-9	38	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66153	10.1371/journal.pone.0066153	http://dx.doi.org/10.1371/journal.pone.0066153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840416	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800037
J	Gao, BX; Zhang, LX; Wang, HY				Gao, Bixia; Zhang, Luxia; Wang, Haiyan		China Natl Survey Chronic Kidney D	Clustering of Major Cardiovascular Risk Factors and the Association with Unhealthy Lifestyles in the Chinese Adult Population	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; DISEASE; PREVALENCE; HYPERTENSION; STROKE; COUNTRIES; OBESITY; IMPACT; URBAN; DIET	Background: Previous studies indicated that lifestyle-related cardiovascular risk factors tend to be clustered in certain individuals. However, population-based studies, especially from developing countries with substantial economic heterogeneity, are extremely limited. Our study provides updated data on the clustering of cardiovascular risk factors, as well as the impact of lifestyle on those factors in China. Methods: A representative sample of adult population in China was obtained using a multistage, stratified sampling method. We investigated the clustering of four cardiovascular disease (CVD) risk factors (defined as two or more of the following: hypertension, diabetes, dyslipidemia and overweight) and their association with unhealthy lifestyles (habitual drinking, physical inactivity, chronic use of non-steroidal anti-inflammatory drugs (NSAIDs) and a low modified Dietary Approaches to Stop Hypertension (DASH) score). Results: Among the 46,683 participants enrolled in this study, only 31.1% were free of any pre-defined CVD risk factor. A total of 20,292 subjects had clustering of CVD risk factors, and 83.5% of them were younger than 65 years old. The adjusted prevalence of CVD risk factor clustering was 36.2%, and the prevalence was higher among males than among females (37.9% vs. 34.5%). Habitual drinking, physical inactivity, and chronic use of NSAIDs were positively associated with the clustering of CVD risk factors, with ORs of 1.60 (95% confidence interval [CI] 1.40 to1.85), 1.20 (95% CI 1.11 to 1.30) and 2.17 (95% CI 1.84 to 2.55), respectively. The modified DASH score was inversely associated with the clustering of CVD risk factors, with an OR of 0.73 (95% CI 0.67 to 0.78) for those with modified DASH scores in the top tertile. The lifestyle risk factors were more prominent among participants with low socioeconomic status. Conclusion: Clustering of CVD risk factors was common in China. Lifestyle modification might be an effective strategy to control CVD risk factors.	[Gao, Bixia; Zhang, Luxia; Wang, Haiyan; China Natl Survey Chronic Kidney D] Peking Univ, Div Renal,Hosp 1, Key Lab Chron Kidney Dis Prevent & Treatment, Inst Nephrol,Minist Hlth China,Minist Educ,Dept M, Beijing 100871, Peoples R China	Peking University	Zhang, LX (corresponding author), Peking Univ, Div Renal,Hosp 1, Key Lab Chron Kidney Dis Prevent & Treatment, Inst Nephrol,Minist Hlth China,Minist Educ,Dept M, Beijing 100871, Peoples R China.	zhanglx@bjmu.edu.cn		Luxia, Zhang/0000-0003-2349-2936				Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Boden-Albala B, 2008, DIABETES CARE, V31, P1132, DOI 10.2337/dc07-0797; CARMELLI D, 1994, AM J HUM GENET, V55, P566; Chiu M, 2010, CAN MED ASSOC J, V182, P1334, DOI 10.1503/cmaj.110-2098; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Gu DF, 2005, CIRCULATION, V112, P658, DOI 10.1161/CIRCULATIONAHA.104.515072; Guenther ALB, 2009, HYPERTENSION, V53, P6, DOI 10.1161/HYPERTENSIONAHA.108.116665; Kapral MK, 2002, STROKE, V33, P268, DOI 10.1161/hs0102.101169; Kim S, 2004, AM J EPIDEMIOL, V159, P184, DOI 10.1093/aje/kwh006; Liu K, 2012, CIRCULATION, V125, P996, DOI 10.1161/CIRCULATIONAHA.111.060681; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Lv J, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-40; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; MYERS GL, 1989, CLIN LAB MED, V9, P105, DOI 10.1016/S0272-2712(18)30645-0; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; O'Meara JG, 2004, ARCH INTERN MED, V164, P1313, DOI 10.1001/archinte.164.12.1313; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Smith SC, 2010, ARCH INTERN MED, V170, P40, DOI 10.1001/archinternmed.2009.457; Sobngwi E, 2002, INT J OBESITY, V26, P1009, DOI 10.1038/sj.ijo.0802008; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	28	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66780	10.1371/journal.pone.0066780	http://dx.doi.org/10.1371/journal.pone.0066780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840529	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200104
J	Kostova, D; Reed, C; Finelli, L; Cheng, PY; Gargiullo, PM; Shay, DK; Singleton, JA; Meltzer, MI; Lu, PJ; Bresee, JS				Kostova, Deliana; Reed, Carrie; Finelli, Lyn; Cheng, Po-Yung; Gargiullo, Paul M.; Shay, David K.; Singleton, James A.; Meltzer, Martin I.; Lu, Peng-Jun; Bresee, Joseph S.			Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005-2011	PLOS ONE			English	Article							COST-EFFECTIVENESS; SEASONAL INFLUENZA; EFFICACY; VACCINES; PNEUMONIA; FAILURE; NETWORK; ADULTS; IMPACT	Context: The goal of influenza vaccination programs is to reduce influenza-associated disease outcomes. Therefore, estimating the reduced burden of influenza as a result of vaccination over time and by age group would allow for a clear understanding of the value of influenza vaccines in the US, and of areas where improvements could lead to greatest benefits. Objective: To estimate the direct effect of influenza vaccination in the US in terms of averted number of cases, medically-attended cases, and hospitalizations over six recent influenza seasons. Design: Using existing surveillance data, we present a method for assessing the impact of influenza vaccination where impact is defined as either the number of averted outcomes or as the prevented disease fraction (the number of cases estimated to have been averted relative to the number of cases that would have occurred in the absence of vaccination). Results: We estimated that during our 6-year study period, the number of influenza illnesses averted by vaccination ranged from a low of approximately 1.1 million (95% confidence interval (CI) 0.6-1.7 million) during the 2006-2007 season to a high of 5 million (CI 2.9-8.6 million) during the 2010-2011 season while the number of averted hospitalizations ranged from a low of 7,700 (CI 3,700-14,100) in 2009-2010 to a high of 40,400 (CI 20,800-73,000) in 2010-2011. Prevented fractions varied across age groups and over time. The highest prevented fraction in the study period was observed in 2010-2011, reflecting the post-pandemic expansion of vaccination coverage. Conclusions: Influenza vaccination programs in the US produce a substantial health benefit in terms of averted cases, clinic visits and hospitalizations. Our results underscore the potential for additional disease prevention through increased vaccination coverage, particularly among nonelderly adults, and increased vaccine effectiveness, particularly among the elderly.	[Kostova, Deliana; Reed, Carrie; Finelli, Lyn; Cheng, Po-Yung; Gargiullo, Paul M.; Shay, David K.; Bresee, Joseph S.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Singleton, James A.; Lu, Peng-Jun] Ctr Dis Control & Prevent, Immunizat Serv Div, Atlanta, GA USA; [Meltzer, Martin I.] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Natl Ctr Enter & Zoonot Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Kostova, D (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	kiv0@cdc.gov	Finelli, Lyn/AAK-2360-2020; Meltzer, Martin/AAT-3235-2021	Meltzer, Martin/0000-0002-7250-0472; Shay, David/0000-0001-9619-4820				BARKER WH, 1982, ARCH INTERN MED, V142, P85, DOI 10.1001/archinte.142.1.85; BARKER WH, 1980, JAMA-J AM MED ASSOC, V244, P2547, DOI 10.1001/jama.244.22.2547; BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; Belongia EA, 2011, VACCINE, V29, P6558, DOI 10.1016/j.vaccine.2011.07.002; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Biggerstaff M, 2012, AM J PUBLIC HEALTH, V102, pE21, DOI 10.2105/AJPH.2012.300651; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; DALESSIO DJ, 1969, J AMER MED ASSOC, V210, P485, DOI 10.1001/jama.210.3.485; Frey S, 2010, CLIN INFECT DIS, V51, P997, DOI 10.1086/656578; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Kamimoto L, 2010, 27 ANN BEH RISK FACT; KEREN G, 1988, J MED VIROL, V25, P85, DOI 10.1002/jmv.1890250112; Maciosek MV, 2006, AM J PREV MED, V31, P72, DOI 10.1016/j.amepre.2006.03.008; Meltzer MI, 2005, VACCINE, V23, P1004, DOI 10.1016/j.vaccine.2004.07.040; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; National Center for Immunization and Respiratory Diseases CDC, 2009, MMWR Recomm Rep, V58, P1; Nichol KL, 2003, VACCINE, V21, P1769, DOI 10.1016/S0264-410X(03)00070-7; Ohmit SE, 2008, J INFECT DIS, V198, P312, DOI 10.1086/589885; Prosser LA, 2006, EMERG INFECT DIS, V12, P1548, DOI 10.3201/eid1210.051015; Reed C, 2011, P 49 ANN M IDSA OCT; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Roberts S, 2006, OBSTET GYNECOL, V107, P1323, DOI 10.1097/01.AOG.0000210225.45986.99; Salo H, 2006, VACCINE, V24, P4934, DOI 10.1016/j.vaccine.2006.03.057; Shay D, 2011, WORKING PAPER UNPUB; Singleton JA, 2011, M ADV COMM IMM PRACT; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Staples J. Erin, 2010, Morbidity and Mortality Weekly Report, V59, P1; STRASSBURG MA, 1986, VACCINE, V4, P38, DOI 10.1016/S0264-410X(86)80002-0; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Treanor JJ, 2012, CLIN INFECT DIS, V55, P951, DOI 10.1093/cid/cis574	32	147	151	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66312	10.1371/journal.pone.0066312	http://dx.doi.org/10.1371/journal.pone.0066312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840439	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200067
J	Moreau, C; Liu, Q; Graeff, R; Wagner, GK; Thomas, MP; Swarbrick, JM; Shuto, S; Lee, HC; Hao, Q; Potter, BVL				Moreau, Christelle; Liu, Qun; Graeff, Richard; Wagner, Gerd K.; Thomas, Mark P.; Swarbrick, Joanna M.; Shuto, Satoshi; Lee, Hon Cheung; Hao, Quan; Potter, Barry V. L.			CD38 Structure-Based Inhibitor Design Using the N1-Cyclic Inosine 5 '-Diphosphate Ribose Template	PLOS ONE			English	Article							CYCLIC-ADP-RIBOSE; MEDICINAL CHEMISTRY; GENETIC ALGORITHM; CALCIUM-RELEASE; DIPHOSPHORIBOSE; HYDROLYSIS; PHARMACOLOGY; DEGRADATION; DERIVATIVES; CYCLIZATION	Few inhibitors exist for CD38, a multifunctional enzyme catalyzing the formation and metabolism of the Ca2+-mobilizing second messenger cyclic adenosine 5'-diphosphoribose (cADPR). Synthetic, non-hydrolyzable ligands can facilitate structure-based inhibitor design. Molecular docking was used to reproduce the crystallographic binding mode of cyclic inosine 5'-diphosphoribose (N1-cIDPR) with CD38, revealing an exploitable pocket and predicting the potential to introduce an extra hydrogen bond interaction with Asp-155. The purine C-8 position of N1-cIDPR (IC50 276 mu M) was extended with an amino or diaminobutane group and the 8-modified compounds were evaluated against CD38-catalyzed cADPR hydrolysis. Crystallography of an 8-amino N1-cIDPR: CD38 complex confirmed the predicted interaction with Asp-155, together with a second H-bond from a realigned Glu-146, rationalizing the improved inhibition (IC50 56 mu M). Crystallography of a complex of cyclic ADP-carbocyclic ribose (cADPcR, IC50 129 mu M) with CD38 illustrated that Glu-146 hydrogen bonds with the ligand N6-amino group. Both 8-amino N1-cIDPR and cADPcR bind deep in the active site reaching the catalytic residue Glu-226, and mimicking the likely location of cADPR during catalysis. Substantial overlap of the N1-cIDPR "northern'' ribose monophosphate and the cADPcR carbocyclic ribose monophosphate regions suggests that this area is crucial for inhibitor design, leading to a new compound series of N1-inosine 5'-monophosphates (N1-IMPs). These small fragments inhibit hydrolysis of cADPR more efficiently than the parent cyclic compounds, with the best in the series demonstrating potent inhibition (IC50 = 7.6 mu M). The lower molecular weight and relative simplicity of these compounds compared to cADPR make them attractive as a starting point for further inhibitor design.	[Moreau, Christelle; Wagner, Gerd K.; Thomas, Mark P.; Swarbrick, Joanna M.; Potter, Barry V. L.] Univ Bath, Wolfson Lab Med Chem, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Liu, Qun; Hao, Quan] Cornell Univ, Cornell High Energy Synchrotron Source, Macromolar Diffract Facil, Ithaca, NY 14853 USA; [Graeff, Richard] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; [Shuto, Satoshi] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido 060, Japan; [Lee, Hon Cheung] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	University of Bath; Cornell University; University of Minnesota System; University of Minnesota Twin Cities; Hokkaido University; University of Hong Kong	Potter, BVL (corresponding author), Univ Bath, Wolfson Lab Med Chem, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.	V.L.Potter@bath.ac.uk	Watt, Joanna M/F-2603-2010; Shuto, Satoshi/AAH-4998-2020; Liu, Qun/A-8757-2011; Lee, Hon Cheung/C-4329-2009; Hao, Quan/C-4304-2009; Potter, Barry/AAX-4781-2020; Wagner, Gerd/D-4759-2013	Watt, Joanna M/0000-0003-2854-6622; Shuto, Satoshi/0000-0001-7850-8064; Liu, Qun/0000-0002-1179-290X; Wagner, Gerd/0000-0003-1086-2301; Hao, Quan/0000-0002-9642-0514	Wellcome Trust [084068, 082837]; Hong Kong General Research Fund [769107, 768408, 769309, 770610]; National Institutes of Health [RR01646]	Wellcome Trust(Wellcome TrustEuropean Commission); Hong Kong General Research Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the Wellcome Trust through Project Grant No 084068 and Programme Grant 082837 (to BVLP) and by Hong Kong General Research Fund Grants 769107, 768408, 769309, and 770610 (to HCL) and by National Institutes of Health Grant RR01646 (to QH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashamu GA, 1997, BIOCHEMISTRY-US, V36, P9509, DOI 10.1021/bi9705671; Bailey VC, 1996, FEBS LETT, V379, P227, DOI 10.1016/0014-5793(95)01515-9; Briggs AP, 1922, J BIOL CHEM, V53, P13; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Dong M, 2011, ORG BIOMOL CHEM, V9, P3246, DOI 10.1039/c0ob00768d; Elliott TS, 2012, MEDCHEMCOMM, V3, P735, DOI 10.1039/c2md20079a; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Graeff R, 2006, J BIOL CHEM, V281, P28951, DOI 10.1074/jbc.M604370200; Graeff R, 2009, J BIOL CHEM, V284, P27629, DOI 10.1074/jbc.M109.030965; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Guse AH, 2004, CURR MED CHEM, V11, P847, DOI 10.2174/0929867043455602; Guse AH, 2004, CURR MOL MED, V4, P239, DOI 10.2174/1566524043360771; Guse AH, 2002, BIOCHEMISTRY-US, V41, P6744, DOI 10.1021/bi020171b; HOWARD M, 1993, SCIENCE, V262, P1056, DOI 10.1126/science.8235624; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kellenberger E, 2011, BIOORG MED CHEM LETT, V21, P3939, DOI 10.1016/j.bmcl.2011.05.022; KIM H, 1993, SCIENCE, V261, P1330, DOI 10.1126/science.8395705; Kirchberger T, 2006, BRIT J PHARMACOL, V149, P337, DOI 10.1038/sj.bjp.0706869; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; Liu Q, 2005, STRUCTURE, V13, P1331, DOI 10.1016/j.str.2005.05.012; Liu Q, 2007, J BIOL CHEM, V282, P24825, DOI 10.1074/jbc.M701653200; Liu Q, 2007, J BIOL CHEM, V282, P5853, DOI 10.1074/jbc.M609093200; Liu Q, 2009, J BIOL CHEM, V284, P27637, DOI 10.1074/jbc.M109.031005; Moreau C, 2006, CHEM COMMUN, P1127, DOI 10.1039/b517916e; Moreau C, 2006, J MED CHEM, V49, P5162, DOI 10.1021/jm060275a; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Munshi C, 2000, J BIOL CHEM, V275, P21566, DOI 10.1074/jbc.M909365199; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nissink JWM, 2002, PROTEINS, V49, P457, DOI 10.1002/prot.10232; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potter BVL, 2004, CURR MOL MED, V4, P303, DOI 10.2174/1566524043360744; Sauve AA, 2002, BIOCHEMISTRY-US, V41, P8455, DOI 10.1021/bi0258795; Sauve AA, 2000, J AM CHEM SOC, V122, P7855, DOI 10.1021/ja001139c; Shuto S, 2004, CURR MED CHEM, V11, P827, DOI 10.2174/0929867043455639; Shuto S, 2001, J AM CHEM SOC, V123, P8750, DOI 10.1021/ja010756d; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wagner GK, 2005, J ORG CHEM, V70, P4810, DOI 10.1021/jo050085s; Wagner GK, 2003, CHEM COMMUN, P1944, DOI 10.1039/b305660k; Wall KA, 1998, BIOCHEM J, V335, P631, DOI 10.1042/bj3350631; Zhang FJ, 1999, BIOORGAN MED CHEM, V7, P653, DOI 10.1016/S0968-0896(98)00256-9; Zhou Y, 2012, CHEMMEDCHEM, V7, P223, DOI 10.1002/cmdc.201100487	45	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66247	10.1371/journal.pone.0066247	http://dx.doi.org/10.1371/journal.pone.0066247			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840430	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200064
J	Ott, LE; Sung, EJ; Melvin, AT; Sheats, MK; Haugh, JM; Adler, KB; Jones, SL				Ott, Laura E.; Sung, Eui Jae; Melvin, Adam T.; Sheats, Mary K.; Haugh, Jason M.; Adler, Kenneth B.; Jones, Samuel L.			Fibroblast Migration Is Regulated by Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Protein	PLOS ONE			English	Article							FILAMENT CROSS-LINKING; GROWTH-FACTOR; IN-VITRO; MYOBLAST MIGRATION; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; SUBCELLULAR-DISTRIBUTION; NEUTROPHIL CHEMOTAXIS; INTEGRIN ACTIVATION; CELL-PROLIFERATION; SIGNALING PATHWAY	Myristoylated alanine-rich C-kinase substrate (MARCKS) is a ubiquitously expressed substrate of protein kinase C (PKC) that is involved in reorganization of the actin cytoskeleton. We hypothesized that MARCKS is involved in regulation of fibroblast migration and addressed this hypothesis by utilizing a unique reagent developed in this laboratory, the MANS peptide. The MANS peptide is a myristoylated cell permeable peptide corresponding to the first 24-amino acids of MARCKS that inhibits MARCKS function. Treatment of NIH-3T3 fibroblasts with the MANS peptide attenuated cell migration in scratch wounding assays, while a myristoylated, missense control peptide (RNS) had no effect. Neither MANS nor RNS peptide treatment altered NIH-3T3 cell proliferation within the parameters of the scratch assay. MANS peptide treatment also resulted in inhibited NIH-3T3 chemotaxis towards the chemoattractant platelet-derived growth factor-BB (PDGF-BB), with no effect observed with RNS treatment. Live cell imaging of PDGF-BB induced chemotaxis demonstrated that MANS peptide treatment resulted in weak chemotactic fidelity compared to RNS treated cells. MANS and RNS peptides did not affect PDGF-BB induced phosphorylation of MARCKS or phosphoinositide 3-kinase (PI3K) signaling, as measured by Akt phosphorylation. Further, no difference in cell migration was observed in NIH-3T3 fibroblasts that were transfected with MARCKS siRNAs with or without MANS peptide treatment. Genetic structure-function analysis revealed that MANS peptide-mediated attenuation of NIH-3T3 cell migration does not require the presence of the myristic acid moiety on the amino-terminus. Expression of either MANS or unmyristoylated MANS (UMANS) C-terminal EGFP fusion proteins resulted in similar levels of attenuated cell migration as observed with MANS peptide treatment. These data demonstrate that MARCKS regulates cell migration and suggests that MARCKS-mediated regulation of fibroblast migration involves the MARCKS amino-terminus. Further, this data demonstrates that MANS peptide treatment inhibits MARCKS function during fibroblast migration and that MANS mediated inhibition occurs independent of myristoylation.	[Ott, Laura E.; Sung, Eui Jae; Sheats, Mary K.; Jones, Samuel L.] N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27695 USA; [Ott, Laura E.; Sung, Eui Jae; Sheats, Mary K.; Haugh, Jason M.; Adler, Kenneth B.; Jones, Samuel L.] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [Melvin, Adam T.; Haugh, Jason M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA; [Adler, Kenneth B.] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Jones, SL (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC 27695 USA.	sam_jones@ncsu.edu	Sung, Eui Jae/AAX-6647-2020	Sung, Eui Jae/0000-0002-7255-3734; Sheats, Mary Katherine/0000-0002-5270-4566; jones, samuel/0000-0003-3040-8157; Ott, Laura/0000-0002-9645-7608; Haugh, Jason/0000-0002-2476-4027	National Science Foundation [0828936]; National Institute of Health (NIH) [R37 HL 36982]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011130, K01OD015136] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	ATM and JMH were supported by National Science Foundation grant # 0828936 and KBA was supported by National Institute of Health (NIH) grant # R37 HL 36982. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEREM A, 1992, CELL, V71, P713, DOI 10.1016/0092-8674(92)90546-O; ALLEN LAH, 1995, J EXP MED, V182, P829, DOI 10.1084/jem.182.3.829; Alon R, 2011, EXP CELL RES, V317, P632, DOI 10.1016/j.yexcr.2010.12.007; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; BELL PB, 1977, J CELL BIOL, V74, P963, DOI 10.1083/jcb.74.3.963; Beurden HE, 2006, WOUND REPAIR REGEN, V14, P66, DOI 10.1111/j.1743-6109.2005.00090.x; BLACKSHEAR PJ, 1992, J BIOL CHEM, V267, P13540; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Bornfeldt KE, 1995, ANN NY ACAD SCI, V766, P416, DOI 10.1111/j.1749-6632.1995.tb26691.x; Braun T, 2000, BIOCHIMIE, V82, P705, DOI 10.1016/S0300-9084(00)01154-8; Brown MV, 2009, EXP CELL RES, V315, P39, DOI 10.1016/j.yexcr.2008.09.025; Carballo E, 1999, AM J PHYSIOL-CELL PH, V277, pC163, DOI 10.1152/ajpcell.1999.277.1.C163; Chappell DS, 2009, DIABETOLOGIA, V52, P901, DOI 10.1007/s00125-009-1298-7; Chun KR, 2009, CELL IMMUNOL, V256, P92, DOI 10.1016/j.cellimm.2009.01.011; DALTON SL, 1992, J BIOL CHEM, V267, P8186; Dedieu S, 2003, BIOL CELL, V95, P615, DOI 10.1016/j.biolcel.2003.09.005; Dedieu S, 2004, EXP CELL RES, V292, P187, DOI 10.1016/j.yexcr.2003.08.014; Denisov G, 1998, BIOPHYS J, V74, P731, DOI 10.1016/S0006-3495(98)73998-0; Disatnik MH, 2004, J CELL SCI, V117, P4469, DOI 10.1242/jcs.01309; Disatnik MH, 2002, J CELL SCI, V115, P2151; Dulong S, 2004, BIOCHEM J, V382, P1015, DOI 10.1042/BJ20040347; Eckert RE, 2010, AM J RESP CELL MOL, V42, P586, DOI 10.1165/rcmb.2008-0394OC; Glaser M, 1996, J BIOL CHEM, V271, P26187, DOI 10.1074/jbc.271.42.26187; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Green TD, 2012, J LEUKOCYTE BIOL, V92, P633, DOI 10.1189/jlb.1211604; HARTWIG JH, 1992, NATURE, V356, P618, DOI 10.1038/356618a0; Hellberg C, 2009, MOL BIOL CELL, V20, P2856, DOI 10.1091/mbc.E08-12-1228; HERGET T, 1993, P NATL ACAD SCI USA, V90, P2945, DOI 10.1073/pnas.90.7.2945; HERGET T, 1994, EUR J BIOCHEM, V225, P539, DOI 10.1111/j.1432-1033.1994.00539.x; ISACKE CM, 1986, EMBO J, V5, P2889, DOI 10.1002/j.1460-2075.1986.tb04584.x; JAMES G, 1989, J BIOL CHEM, V264, P20928; JOSEPH CK, 1992, J BIOL CHEM, V267, P1327; KATO S, 1988, EXP CELL RES, V179, P31, DOI 10.1016/0014-4827(88)90345-X; Kramer C, 2008, EXP PARASITOL, V119, P391, DOI 10.1016/j.exppara.2008.04.005; Kulkarni S, 1999, J BIOL CHEM, V274, P21265, DOI 10.1074/jbc.274.30.21265; Lampe WR, 2012, PULM PHARMACOL THER, V25, P427, DOI 10.1016/j.pupt.2012.06.003; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; LI JX, 1992, CELL, V70, P791, DOI 10.1016/0092-8674(92)90312-Z; Li YH, 2001, J BIOL CHEM, V276, P40982, DOI 10.1074/jbc.M105614200; Lokuta MA, 2003, P NATL ACAD SCI USA, V100, P4006, DOI 10.1073/pnas.0636533100; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; Manenti S, 1998, CANCER RES, V58, P1429; McBrien NA, 2006, INVEST OPHTH VIS SCI, V47, P4674, DOI 10.1167/iovs.05-1150; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Melvin AT, 2011, BIOPHYS J, V100, P1893, DOI 10.1016/j.bpj.2011.02.047; Micallef J, 2009, CANCER RES, V69, P7548, DOI 10.1158/0008-5472.CAN-08-4783; Miller JD, 2010, AM J RESP CELL MOL, V43, P253, DOI 10.1165/rcmb.2010-0015RC; Monahan TS, 2009, FASEB J, V23, P557, DOI 10.1096/fj.08-114173; Myat MM, 1997, CURR BIOL, V7, P611, DOI 10.1016/S0960-9822(06)00262-4; Nakai M, 1999, J NEUROCHEM, V72, P1179, DOI 10.1046/j.1471-4159.1999.0721179.x; Nakai M, 2001, NEUROCHEM INT, V38, P593, DOI 10.1016/S0197-0186(00)00126-1; Nakai M, 1998, NEUROREPORT, V9, P3467, DOI 10.1097/00001756-199810260-00024; Nuzzi PA, 2007, MOL BIOL CELL, V18, P795, DOI 10.1091/mbc.E06-09-0876; Ohmori S, 2000, J BIOL CHEM, V275, P26449, DOI 10.1074/jbc.M003588200; OTSUKA M, 1991, BIOCHEM BIOPH RES CO, V178, P494, DOI 10.1016/0006-291X(91)90134-S; REED JC, 1991, CELL SIGNAL, V3, P569, DOI 10.1016/0898-6568(91)90033-Q; Rombouts K, 2008, EXP CELL RES, V314, P1444, DOI 10.1016/j.yexcr.2008.01.029; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P7244, DOI 10.1073/pnas.80.23.7244; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Satoh K, 2009, AM J PHYSIOL-GASTR L, V296, pG1382, DOI 10.1152/ajpgi.90536.2008; Schneider IC, 2006, CELL CYCLE, V5, P1130, DOI 10.4161/cc.5.11.2770; Schneider IC, 2005, J CELL BIOL, V171, P883, DOI 10.1083/jcb.200509028; Sechi AS, 2000, J CELL SCI, V113, P3685; Seykora JT, 1996, J BIOL CHEM, V271, P18797, DOI 10.1074/jbc.271.31.18797; Shiraishi M, 2006, J CELL PHYSIOL, V209, P1029, DOI 10.1002/jcp.20814; Singer M, 2004, NAT MED, V10, P193, DOI 10.1038/nm983; Song JC, 1999, AM J PHYSIOL-CELL PH, V277, pC1239, DOI 10.1152/ajpcell.1999.277.6.C1239; Spizz G, 2001, J BIOL CHEM, V276, P32264, DOI 10.1074/jbc.M103960200; Stensman H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-365; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Sundaram M, 2004, BIOCHEM CELL BIOL, V82, P191, DOI 10.1139/o03-087; SWIERCZYNSKI SL, 1995, J BIOL CHEM, V270, P13436, DOI 10.1074/jbc.270.22.13436; Tapp H, 2005, J BIOL CHEM, V280, P9946, DOI 10.1074/jbc.M414614200; Techasen A, 2010, CANCER SCI, V101, P658, DOI 10.1111/j.1349-7006.2009.01427.x; Uberall F, 1997, J BIOL CHEM, V272, P4072, DOI 10.1074/jbc.272.7.4072; UMEKAGE T, 1991, FEBS LETT, V286, P147, DOI 10.1016/0014-5793(91)80961-2; Weiger MC, 2009, J CELL SCI, V122, P313, DOI 10.1242/jcs.037564; Yarmola EG, 2001, J BIOL CHEM, V276, P22351, DOI 10.1074/jbc.M101457200; Zhao Y, 2000, AM J PHYSIOL-CELL PH, V279, pC1611, DOI 10.1152/ajpcell.2000.279.5.C1611	81	23	24	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66512	10.1371/journal.pone.0066512	http://dx.doi.org/10.1371/journal.pone.0066512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840497	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200089
J	Takagi, S; Iguchi, Y; Katsuno, M; Ishigaki, S; Ikenaka, K; Fujioka, Y; Honda, D; Niwa, J; Tanaka, F; Watanabe, H; Adachi, H; Sobue, G				Takagi, Shinnosuke; Iguchi, Yohei; Katsuno, Masahisa; Ishigaki, Shinsuke; Ikenaka, Kensuke; Fujioka, Yusuke; Honda, Daiyu; Niwa, Jun-ichi; Tanaka, Fumiaki; Watanabe, Hirohisa; Adachi, Hiroaki; Sobue, Gen			RNP2 of RNA Recognition Motif 1 Plays a Central Role in the Aberrant Modification of TDP-43	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; DNA-BINDING PROTEIN; HEXANUCLEOTIDE REPEAT; TERMINAL FRAGMENTS; MUTATIONS; ALS; DEPLETION; PROTEINOPATHIES	Phosphorylated and truncated TAR DNA-binding protein-43 (TDP-43) is a major component of ubiquitinated cytoplasmic inclusions in neuronal and glial cells of two TDP-43 proteinopathies, amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Modifications of TDP-43 are thus considered to play an important role in the pathogenesis of TDP-43 proteinopathies. However, both the initial cause of these abnormal modifications and the TDP-43 region responsible for its aggregation remain uncertain. Here we report that the 32 kDa C-terminal fragment of TDP-43, which lacks the RNP2 motif of RNA binding motif 1 (RRM1), formed aggregates in cultured cells, and that similar phenotypes were obtained when the RNP2 motif was either deleted from or mutated in full-length TDP-43. These aggregations were ubiquitinated, phosphorylated and truncated, and sequestered the 25 kDa C-terminal TDP-43 fragment seen in the neurons of TDP-43 proteinopathy patients. In addition, incubation with RNase decreased the solubility of TDP-43 in cell lysates. These findings suggest that the RNP2 motif of RRM1 plays a substantial role in pathological TDP-43 modifications and that it is possible that disruption of RNA binding may underlie the process of TDP-43 aggregation.	[Takagi, Shinnosuke; Iguchi, Yohei; Katsuno, Masahisa; Ishigaki, Shinsuke; Ikenaka, Kensuke; Fujioka, Yusuke; Honda, Daiyu; Watanabe, Hirohisa; Adachi, Hiroaki; Sobue, Gen] Nagoya Univ, Dept Neurol, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Niwa, Jun-ichi] Aichi Med Univ, Stroke Ctr, Nagakute, Aichi, Japan; [Tanaka, Fumiaki] Yokohama City Univ, Dept Neurol & Stroke Med, Grad Sch Med, Yokohama, Kanagawa 232, Japan	Nagoya University; Aichi Medical University; Yokohama City University	Katsuno, M (corresponding author), Nagoya Univ, Dept Neurol, Grad Sch Med, Nagoya, Aichi 4648601, Japan.	ka2no@med.nagoya-u.ac.jp; sobueg@med.nagoya-u.ac.jp	KATSUNO, MASAHISA/I-7502-2014; Adachi, Hiroaki/AAM-7812-2020; ISHIGAKI, Shinsuke/I-7305-2014	KATSUNO, MASAHISA/0000-0001-9453-9311; Adachi, Hiroaki/0000-0002-9302-4663; Watanabe, Hirohisa/0000-0001-8553-8536; Ishigaki, Shinsuke/0000-0002-9555-0659	Center-of-Excellence (COE); Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science KAKENHI Grant [21229011, 21689024, 22110005, 23390230]; Strategic Research Program for Brain Sciences, MEXT, Japan; Health Labour Sciences Research Grants, MHLW, Japan; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research [25293207] Funding Source: KAKEN	Center-of-Excellence (COE); Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Strategic Research Program for Brain Sciences, MEXT, Japan; Health Labour Sciences Research Grants, MHLW, Japan; Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Center-of-Excellence (COE) grant; Ministry of Education, Culture, Sports, Science and Technology/Japan Society for the Promotion of Science KAKENHI Grant Numbers 21229011, 21689024, 22110005, and 23390230; Strategic Research Program for Brain Sciences, MEXT, Japan; Health Labour Sciences Research Grants, MHLW, Japan; and Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala V, 2011, ACTA NEUROPATHOL, V122, P259, DOI 10.1007/s00401-011-0850-y; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Caragounis A, 2010, FREE RADICAL BIO MED, V48, P1152, DOI 10.1016/j.freeradbiomed.2010.01.035; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Choi SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002677; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Iguchi Y, 2012, NEUROBIOL DIS, V45, P862, DOI 10.1016/j.nbd.2011.12.002; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; MANN DMA, 1974, J NEUROL NEUROSUR PS, V37, P1036, DOI 10.1136/jnnp.37.9.1036; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sato T, 2009, NEUROSCIENCE, V164, P1565, DOI 10.1016/j.neuroscience.2009.09.050; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Tashiro Y, 2012, J BIOL CHEM, V287, P42984, DOI 10.1074/jbc.M112.417600; van Eersel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022850; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Volkening K, 2009, BRAIN RES, V1305, P168, DOI 10.1016/j.brainres.2009.09.105; Wang IF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1766; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	40	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66966	10.1371/journal.pone.0066966	http://dx.doi.org/10.1371/journal.pone.0066966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840565	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400026
J	Burd, NA; Hamer, HM; Pennings, B; Pellikaan, WF; Senden, JMG; Gijsen, AP; van Loon, LJC				Burd, Nicholas A.; Hamer, Henrike M.; Pennings, Bart; Pellikaan, Wilbert F.; Senden, Joan M. G.; Gijsen, Annemie P.; van Loon, Luc J. C.			Substantial Differences between Organ and Muscle Specific Tracer Incorporation Rates in a Lactating Dairy Cow	PLOS ONE			English	Article							TISSUE PROTEIN-SYNTHESIS; INTRINSICALLY LABELED MILK; HUMAN-NUTRITION RESEARCH; AMINO-ACIDS; RESISTANCE EXERCISE; SKELETAL-MUSCLE; NEONATAL PIGS; WHEY-PROTEIN; ELDERLY-MEN; WHOLE-BODY	We aimed to produce intrinsically L-[1-C-13]phenylalanine labeled milk and beef for subsequent use in human nutrition research. The collection of the various organ tissues after slaughter allowed for us to gain insight into the dynamics of tissue protein turnover in vivo in a lactating dairy cow. One lactating dairy cow received a constant infusion of L-[1-C-13]phenylalanine (450 mu mol/min) for 96 h. Plasma and milk were collected prior to, during, and after the stable isotope infusion. Twenty-four hours after cessation of the infusion the cow was slaughtered. The meat and samples of the various organ tissues (liver, heart, lung, udder, kidney, rumen, small intestine, and colon) were collected and stored. Approximately 210 kg of intrinsically labeled beef (bone and fat free) with an average L-[1-C-13]phenylalanine enrichment of 1.8 +/- 0.1 mole percent excess (MPE) was obtained. The various organ tissues differed substantially in L-[1-C-13]phenylalanine enrichments in the tissue protein bound pool, the highest enrichment levels were achieved in the kidney (11.7 MPE) and the lowest enrichment levels in the skeletal muscle tissue protein of the cow (between 1.5-2.4 MPE). The estimated protein synthesis rates of the various organ tissues should be regarded as underestimates, particularly for the organs with the higher turnover rates and high secretory activity, due to the lengthened (96 h) measurement period necessary for the production of the intrinsically labeled beef. Our data demonstrates that there are relatively small differences in L-[1-C-13]phenylalanine enrichments between the various meat cuts, but substantial higher enrichment values are observed in the various organ tissues. We conclude that protein turnover rates of various organs are much higher when compared to skeletal muscle protein turnover rates in large lactating ruminants.	[Burd, Nicholas A.; Hamer, Henrike M.; Pennings, Bart; Senden, Joan M. G.; van Loon, Luc J. C.] TIFN, Wageningen, Netherlands; [Burd, Nicholas A.; Hamer, Henrike M.; Pennings, Bart; Senden, Joan M. G.; Gijsen, Annemie P.; van Loon, Luc J. C.] MUMC, Dept Human Movement Sci, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Pellikaan, Wilbert F.] Wageningen Univ, Anim Nutr Grp, NL-6700 AP Wageningen, Netherlands	Top Institute Food & Nutrition; Maastricht University; Maastricht University Medical Centre (MUMC); Wageningen University & Research	van Loon, LJC (corresponding author), TIFN, Wageningen, Netherlands.	L.vanLoon@maastrichtuniversity.nl	van Loon, Luc J C/G-5920-2010; van Loon, Luc J.C./ABG-9158-2020	van Loon, Luc J C/0000-0002-6768-9231; van Loon, Luc J.C./0000-0002-6768-9231; Burd, Nicholas/0000-0001-5581-3154	Top Institute Food and Nutrition (TIFN)	Top Institute Food and Nutrition (TIFN)	Top Institute Food and Nutrition (TIFN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARACOS VE, 1991, BRIT J NUTR, V66, P451, DOI 10.1079/BJN19910047; BAUMANN PQ, 1994, AM J PHYSIOL, V267, pE203, DOI 10.1152/ajpendo.1994.267.2.E203; Bequette BJ, 1997, P NUTR SOC, V56, P593, DOI 10.1079/PNS19970060; BOIRIE Y, 1995, J NUTR, V125, P92; BUCHANAN DL, 1961, ARCH BIOCHEM BIOPHYS, V94, P500, DOI 10.1016/0003-9861(61)90078-9; Burd NA, 2012, BRIT J NUTR, V108, P958, DOI 10.1017/S0007114511006271; Burd NA, 2009, J APPL PHYSIOL, V106, P1692, DOI 10.1152/japplphysiol.91351.2008; CARRARO F, 1991, METABOLISM, V40, P553, DOI 10.1016/0026-0495(91)90043-V; CHAMPREDON C, 1990, J NUTR, V120, P1006, DOI 10.1093/jn/120.9.1006; Dangin M, 2002, J NUTR, V132, p3228S, DOI 10.1093/jn/131.10.3228S; Davis TA, 2002, AM J PHYSIOL-ENDOC M, V282, pE880, DOI 10.1152/ajpendo.00517.2001; Davis TA, 1999, AM J PHYSIOL-ENDOC M, V277, pE103, DOI 10.1152/ajpendo.1999.277.1.E103; EISEMANN JH, 1989, BRIT J NUTR, V62, P657, DOI 10.1079/BJN19890066; GARLICK PJ, 1991, P NUTR SOC, V50, P217, DOI 10.1079/PNS19910031; GARLICK PJ, 1975, BIOCHIM BIOPHYS ACTA, V414, P71, DOI 10.1016/0005-2787(75)90126-4; GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719; GOLDSPINK DF, 1984, BIOCHEM J, V217, P507, DOI 10.1042/bj2170507; Hanigan MD, 2009, J NUTR, V139, P1118, DOI 10.3945/jn.108.103002; Koopman R, 2009, AM J CLIN NUTR, V90, P106, DOI 10.3945/ajcn.2009.27474; Lescoat P, 1997, REPROD NUTR DEV, V37, P493, DOI 10.1051/rnd:19970502; LOBLEY GE, 1992, BRIT J NUTR, V68, P373, DOI 10.1079/BJN19920096; LOBLEY GE, 1980, BRIT J NUTR, V43, P491, DOI 10.1079/BJN19800116; LOBLEY GE, 1993, J NUTR, V123, P337, DOI 10.1093/jn/123.suppl_2.337; LOBLEY GE, 1994, BRIT J NUTR, V71, P3, DOI 10.1079/BJN19940106; Millward DJ, 2008, AM J CLIN NUTR, V87, p1576S, DOI 10.1093/ajcn/87.5.1576S; Pennings B, 2011, J DAIRY SCI, V94, P4366, DOI 10.3168/jds.2011-4451; Pennings B, 2012, AM J PHYSIOL-ENDOC M, V302, pE992, DOI 10.1152/ajpendo.00517.2011; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; Pennings B, 2011, AM J CLIN NUTR, V93, P322, DOI 10.3945/ajcn.2010.29649; PREEDY VR, 1988, BIOCHEM J, V250, P179, DOI 10.1042/bj2500179; Reeds PJ, 2003, J NUTR, V133, p2953S, DOI 10.1093/jn/133.9.2953S; RENNIE MJ, 1994, AM J PHYSIOL, V266, pE298, DOI 10.1152/ajpendo.1994.266.3.E298; SCHAEFER AL, 1986, BRIT J NUTR, V56, P281, DOI 10.1079/BJN19860107; Schei I, 2007, ANIMAL, V1, P501, DOI 10.1017/S175173110768505X; SCHWENK WF, 1985, AM J PHYSIOL, V248, pE482, DOI 10.1152/ajpendo.1985.248.4.E482; Spears RA, 2003, J DAIRY SCI, V86, P4178, DOI 10.3168/jds.S0022-0302(03)74033-8; Suryawan A, 2009, AMINO ACIDS, V37, P97, DOI 10.1007/s00726-008-0149-z; Symons TB, 2007, AM J CLIN NUTR, V86, P451, DOI 10.1093/ajcn/86.2.451; TAMMINGA S, 1994, LIVEST PROD SCI, V40, P139, DOI 10.1016/0301-6226(94)90043-4; Tang JE, 2009, J APPL PHYSIOL, V107, P987, DOI 10.1152/japplphysiol.00076.2009; Ternman E, 2012, APPL ANIM BEHAV SCI, V140, P25, DOI 10.1016/j.applanim.2012.05.005; Tessari P, 1996, J CLIN INVEST, V98, P1481, DOI 10.1172/JCI118937; van Loon LJC, 2009, J DAIRY SCI, V92, P4812, DOI 10.3168/jds.2009-2317; vanEijk HMH, 1997, J CHROMATOGR B, V691, P287, DOI 10.1016/S0378-4347(96)00475-6; VANES AJH, 1978, LIVEST PROD SCI, V5, P331, DOI 10.1016/0301-6226(78)90029-5; Vanhatalo A, 2003, J DAIRY SCI, V86, P3260, DOI 10.3168/jds.S0022-0302(03)73929-0; Yuan CL, 2008, AM J PHYSIOL-ENDOC M, V295, pE216, DOI 10.1152/ajpendo.00545.2007	47	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68109	10.1371/journal.pone.0068109	http://dx.doi.org/10.1371/journal.pone.0068109			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826365	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000119
J	Chen, HF; Liu, MD; Chen, P; Chen, LH; Chang, YH; Wen, PC; Li, CY				Chen, Hua-Fen; Liu, Ming-Der; Chen, Peter; Chen, Li-Huan; Chang, Ya-Hui; Wen, Pei-Chun; Li, Chung-Yi			Risks of Breast and Endometrial Cancer in Women with Diabetes: A Population-Based Cohort Study	PLOS ONE			English	Article							SEX STRATIFICATIONS; MELLITUS; TAIWAN; HEALTH; EPIDEMIOLOGY; METAANALYSIS; ASSOCIATION; INSURANCE; ONSET; JAPAN	Objective: We investigated the overall and age-specific risks of developing breast and endometrial cancer among women with diabetes in a population-based cohort study. Methods: Women with diabetes (n = 319310) and age-matched controls (n = 319308), selected from ambulatory care claims and beneficiary registry in 2000, respectively were linked to the in-patient claims (2000-2008) to identify admissions due to breast (ICD-9-CM: 174) and endometrial (ICD-9-CM: 182) cancer. The person-year approach with Poisson assumption was used to estimate the incidence density rate. The age-specific hazard ratios (HRs) of above malignancies in relation to diabetes with multivariate Cox proportional hazard regression. Results: The overall incidence density rate of breast and endometrial cancer was estimated at 1.21 and 0.21 per 10,000 patient-years, respectively, for diabetes. The corresponding figures for controls were lower at 1.00 and 0.14 per 10,000 patient-years. Compared with the controls, the covariate adjusted HR for breast and endometrial cancer was 1.42 (95% confidence interval (CI) 1.34-1.50) and 1.71 (95% CI 1.48-1.97), respectively in women with diabetes. Elderly (>=65 years) diabetes had the highest HR (1.61) of breast cancer, while the highest HR (1.85) of endometrial cancer was observed in diabetes aged <=50 years. Conclusions: Diabetes may significantly increase the risks of breast and endometrial cancer in all age stratifications. Health education for strict adherence of cancer screening program in women with diabetes is essential.	[Chen, Hua-Fen] Far Eastern Mem Hosp, Dept Endocrinol, New Taipei City, Taiwan; [Chen, Hua-Fen] Fujen Catholic Univ, Sch Med, New Taipei City, Taiwan; [Liu, Ming-Der] Hungkuang Univ, Coll Gen Educ, Taichung, Taiwan; [Liu, Ming-Der] Natl United Univ, Ctr Gen Educ, Miaoli, Taiwan; [Chen, Peter] Cent Med Hosp Grp, Dept Gastroenterol, New Taipei City, Taiwan; [Chen, Li-Huan] Yuanpei Univ, Dept Nursing, Hsinchu, Taiwan; [Chen, Li-Huan] Chang Gung Univ, Grad Inst Nursing, Tao Yuan, Taiwan; [Chang, Ya-Hui; Wen, Pei-Chun; Li, Chung-Yi] Natl Cheng Kung Univ, Coll Med, Dept & Grad Inst Publ Hlth, Tainan 70101, Taiwan; [Wen, Pei-Chun] Buddhist Tzu Chi Gen Hosp, Dept Dent, Dalin Branch, Chiayi, Taiwan; [Li, Chung-Yi] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan	Far Eastern Memorial Hospital; Fu Jen Catholic University; Hungkuang University; National United University; Chang Gung University; National Cheng Kung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; China Medical University Taiwan	Wen, PC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept & Grad Inst Publ Hlth, Tainan 70101, Taiwan.	t86004047@mail.ncku.edu.tw	LI, CHUNG-YI/ABI-1419-2020	LI, CHUNG-YI/0000-0002-0321-8908	National Scientific Council [NSC-100-2314-B-006-052]	National Scientific Council	This study was supported by a grant from the National Scientific Council (grant number: NSC-100-2314-B-006-052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1991, CANCER CAUSE CONTROL, V2, P307, DOI 10.1007/BF00051670; Anderson KE, 2001, CANCER EPIDEM BIOMAR, V10, P611; Arcidiacono B, 2012, EXP DIABETES RES, DOI 10.1155/2012/789174; Bowker SL, 2011, DIABETES CARE, V34, P2542, DOI 10.2337/dc11-1199; Bureau of health promotion, 2009, CANC STAT; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CJ, 2002, JPN J CLIN ONCOL, V32, pS66, DOI 10.1093/jjco/hye138; Chen HF, 2011, DIABETES CARE, V34, P1177, DOI 10.2337/dc10-2006; Chen HF, 2010, HEPATOLOGY, V52, P155, DOI 10.1002/hep.23641; Chuang LM, 2001, DIABETES RES CLIN PR, V54, pS55; Cleveland RJ, 2012, CANCER CAUSE CONTROL, V23, P1193, DOI 10.1007/s10552-012-9989-7; Cramer DW, 2012, HEMATOL ONCOL CLIN N, V26, P1, DOI 10.1016/j.hoc.2011.10.009; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Friberg E, 2007, CANCER EPIDEM BIOMAR, V16, P276, DOI 10.1158/1055-9965.EPI-06-0751; Gordis L, 2000, EPIDEMIOLOGY, V8; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Kuriki K, 2007, EUR J CANCER PREV, V16, P83, DOI 10.1097/01.cej.0000228404.37858.40; La Vecchia C, 2011, ONCOLOGIST, V16, P726, DOI 10.1634/theoncologist.2011-0050; Lambe M, 2011, CANCER CAUSE CONTROL, V22, P1163, DOI 10.1007/s10552-011-9794-8; Largent JA, 2010, CANCER CAUSE CONTROL, V21, P1615, DOI 10.1007/s10552-010-9590-x; LAVECCHIA C, 1994, BRIT J CANCER, V70, P950, DOI 10.1038/bjc.1994.427; Liao SC, 2011, ASIAN PAC J CANCER P, V12, P1061; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lindemann K, 2008, BRIT J CANCER, V98, P1582, DOI 10.1038/sj.bjc.6604313; Lipscombe LL, 2006, BREAST CANCER RES TR, V98, P349, DOI 10.1007/s10549-006-9172-5; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Mataltiotakis IM, 2008, SURG ONCOL, V17, P289, DOI 10.1016/j.suronc.2008.01.002; Michels KB, 2003, DIABETES CARE, V26, P1752, DOI 10.2337/diacare.26.6.1752; Noto H, 2010, J DIABETES COMPLICAT, V24, P345, DOI 10.1016/j.jdiacomp.2010.06.004; Parazzini F, 1999, INT J CANCER, V81, P539, DOI 10.1002/(SICI)1097-0215(19990517)81:4<539::AID-IJC6>3.0.CO;2-Q; Pinho Valéria Fernandes de Souza, 2005, Cad. Saúde Pública, V21, P351, DOI 10.1590/S0102-311X2005000200002; Rose DP, 2012, ENDOCR-RELAT CANCER, V19, pR225, DOI 10.1530/ERC-12-0203; Saltzman BS, 2008, AM J EPIDEMIOL, V167, P607, DOI 10.1093/aje/kwm333; Sun Y, 2012, DIABETES CARE, V35, P1047, DOI 10.2337/dc11-1511; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Weiderpass E, 1997, INT J CANCER, V71, P360, DOI 10.1002/(SICI)1097-0215(19970502)71:3<360::AID-IJC9>3.0.CO;2-W; Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360	38	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67420	10.1371/journal.pone.0067420	http://dx.doi.org/10.1371/journal.pone.0067420			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826297	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000080
J	Mestrovic, N; Pavlek, M; Car, A; Castagnone-Sereno, P; Abad, P; Plohl, M				Mestrovic, Nevenka; Pavlek, Martina; Car, Ana; Castagnone-Sereno, Philippe; Abad, Pierre; Plohl, Miroslav			Conserved DNA Motifs, Including the CENP-B Box-like, Are Possible Promoters of Satellite DNA Array Rearrangements in Nematodes	PLOS ONE			English	Article							ROOT-KNOT NEMATODES; ALPHA-SATELLITE; MELOIDOGYNE-CHITWOODI; EVOLUTIONARY DYNAMICS; CENTROMERE SATELLITES; SEQUENCE ALIGNMENT; M-FALLAX; M-HAPLA; GENOME; RECOMBINATION	Tandemly arrayed non-coding sequences or satellite DNAs (satDNAs) are rapidly evolving segments of eukaryotic genomes, including the centromere, and may raise a genetic barrier that leads to speciation. However, determinants and mechanisms of satDNA sequence dynamics are only partially understood. Sequence analyses of a library of five satDNAs common to the root-knot nematodes Meloidogyne chitwoodi and M. fallax together with a satDNA, which is specific for M. chitwoodi only revealed low sequence identity (32-64%) among them. However, despite sequence differences, two conserved motifs were recovered. One of them turned out to be highly similar to the CENP-B box of human alpha satDNA, identical in 10-12 out of 17 nucleotides. In addition, organization of nematode satDNAs was comparable to that found in alpha satDNA of human and primates, characterized by monomers concurrently arranged in simple and higher-order repeat (HOR) arrays. In contrast to alpha satDNA, phylogenetic clustering of nematode satDNA monomers extracted either from simple or from HOR array indicated frequent shuffling between these two organizational forms. Comparison of homogeneous simple arrays and complex HORs composed of different satDNAs, enabled, for the first time, the identification of conserved motifs as obligatory components of monomer junctions. This observation highlights the role of short motifs in rearrangements, even among highly divergent sequences. Two mechanisms are proposed to be involved in this process, i.e., putative transposition-related cut-and-paste insertions and/or illegitimate recombination. Possibility for involvement of the nematode CENP-B box-like sequence in the transposition-related mechanism and together with previously established similarity of the human CENP-B protein and pogo-like transposases implicate a novel role of the CENP-B box and related sequence motifs in addition to the known function in centromere protein binding.	[Mestrovic, Nevenka; Pavlek, Martina; Car, Ana; Plohl, Miroslav] Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia; [Castagnone-Sereno, Philippe; Abad, Pierre] Inst Sophia Agrobiotech, French Natl Inst Agr Res INRA, Sophia Antipolis, France; [Castagnone-Sereno, Philippe; Abad, Pierre] UNSA, UMR Inst Sophia Agrobiotech, Sophia Antipolis, France; [Castagnone-Sereno, Philippe; Abad, Pierre] Inst Sophia Agrobiotech, CNRS, Sophia Antipolis, France	Rudjer Boskovic Institute; INRAE; UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Mestrovic, N (corresponding author), Rudjer Boskovic Inst, Dept Mol Biol, Zagreb, Croatia.	nevenka@irb.hr	Pavlek, Martina/AAD-9359-2019; Plohl, Miroslav/AAQ-6428-2021; Car, Ana/AAT-5455-2020	Pavlek, Martina/0000-0001-6710-0581	Ministry of Science, Education and Sports of the Republic Croatia [098-0982913-2756]; INRA (Institut National de la Recherche Agronomique)	Ministry of Science, Education and Sports of the Republic Croatia(Ministry of Science, Education and Sports, Republic of Croatia); INRA (Institut National de la Recherche Agronomique)	This research was financially supported by grants from the Ministry of Science, Education and Sports of the Republic Croatia (http://public.mzos.hr) (no. 098-0982913-2756) and INRA (Institut National de la Recherche Agronomique) (http://www.international.inra.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Alkan C, 2007, PLOS COMPUT BIOL, V3, P1807, DOI 10.1371/journal.pcbi.0030181; Alkan C, 2011, GENOME RES, V21, P137, DOI 10.1101/gr.111278.110; Bird DM, 2009, ANNU REV PHYTOPATHOL, V47, P333, DOI 10.1146/annurev-phyto-080508-081839; Carneiro RMDG, 2000, NEMATOLOGY, V2, P645, DOI 10.1163/156854100509510; Casola C, 2008, MOL BIOL EVOL, V25, P29, DOI 10.1093/molbev/msm221; Castagnone-Sereno P, 1998, J MOL EVOL, V46, P225, DOI 10.1007/PL00006297; Castagnone-Sereno P, 1998, MOL BIOL EVOL, V15, P1115, DOI 10.1093/oxfordjournals.molbev.a026019; Castagnone-Sereno P, 2000, GENOME, V43, P346, DOI 10.1139/gen-43-2-346; Cellamare A, 2009, MOL BIOL EVOL, V26, P1889, DOI 10.1093/molbev/msp101; Csink AK, 1998, TRENDS GENET, V14, P200, DOI 10.1016/S0168-9525(98)01444-9; DOVER GA, 1986, TRENDS GENET, V2, P159, DOI 10.1016/0168-9525(86)90211-8; EARNSHAW WC, 1991, COLD SH Q B, V56, P675; Fantaccione S, 2005, FEBS LETT, V579, P2519, DOI 10.1016/j.febslet.2005.03.064; Fowler KJ, 2000, GENOME RES, V10, P30; Hall SE, 2005, GENETICS, V170, P1913, DOI 10.1534/genetics.104.038208; Hall SE, 2003, GENOME RES, V13, P195, DOI 10.1101/gr.593403; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Jaco I, 2008, J CELL BIOL, V181, P885, DOI 10.1083/jcb.200803042; Kipling D, 1997, TRENDS GENET, V13, P141, DOI 10.1016/S0168-9525(97)01098-6; KIPLING D, 1995, MOL CELL BIOL, V15, P4009; Kuhn GCS, 2009, HEREDITY, V102, P453, DOI 10.1038/hdy.2009.9; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee HR, 2006, MOL BIOL EVOL, V23, P2505, DOI 10.1093/molbev/msl127; Lopez CC, 1998, NUCLEIC ACIDS RES, V26, P4168, DOI 10.1093/nar/26.18.4168; Masumoto H, 2004, CHROMOSOME RES, V12, P543, DOI 10.1023/B:CHRO.0000036593.72788.99; Masumoto H, 1993, CHROMOSOME SEGREGATI, P31, DOI DOI 10.1007/9783-64284938-1_3; Mestrovic N, 1998, MOL BIOL EVOL, V15, P1062, DOI 10.1093/oxfordjournals.molbev.a026005; Mestrovic N, 2009, MOL PHYLOGENET EVOL, V50, P204, DOI 10.1016/j.ympev.2008.10.013; Mestrovic N, 2006, MOL BIOL EVOL, V23, P2316, DOI 10.1093/molbev/msl119; Mravinac B, 2010, MOL BIOL EVOL, V27, P1857, DOI 10.1093/molbev/msq068; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Plohl M, 2008, GENE, V409, P72, DOI 10.1016/j.gene.2007.11.013; Rosandic M, 2003, J THEOR BIOL, V221, P29, DOI 10.1006/jtbi.2003.3165; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Rudd MK, 2006, GENOME RES, V16, P88, DOI 10.1101/gr.3810906; Rudd MK, 2004, TRENDS GENET, V20, P529, DOI 10.1016/j.tig.2004.08.008; Sambrook J., 2001, MOL CLONING LAB MANU; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Shi JH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000327; Swofford D. L., 2002, MESQUITE MODULAR SYS, V4, P1; Talbert PB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000326; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Megen H, 2009, NEMATOLOGY, V11, P927, DOI 10.1163/156854109X456862; vanderBeek JG, 1997, PHYTOPATHOLOGY, V87, P1061, DOI 10.1094/PHYTO.1997.87.10.1061; WARBURTON PE, 1993, MOL CELL BIOL, V13, P6520, DOI 10.1128/MCB.13.10.6520; Zijlstra C, 2000, EUR J PLANT PATHOL, V106, P283, DOI 10.1023/A:1008765303364	48	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67328	10.1371/journal.pone.0067328	http://dx.doi.org/10.1371/journal.pone.0067328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826269	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000063
J	Lazova, R; LaBerge, GS; Duvall, E; Spoelstra, N; Klump, V; Sznol, M; Cooper, D; Spritz, RA; Chang, JT; Pawelek, JM				Lazova, Rossitza; LaBerge, Greggory S.; Duvall, Eric; Spoelstra, Nicole; Klump, Vincent; Sznol, Mario; Cooper, Dennis; Spritz, Richard A.; Chang, Joseph T.; Pawelek, John M.			A Melanoma Brain Metastasis with a Donor-Patient Hybrid Genome following Bone Marrow Transplantation: First Evidence for Fusion in Human Cancer	PLOS ONE			English	Article							CELL-FUSION; CARCINOMA CELLS; STR LOCI; TUMOR; TRANSFORMATION; MALIGNANCY	Background: Tumor cell fusion with motile bone marrow-derived cells (BMDCs) has long been posited as a mechanism for cancer metastasis. While there is much support for this from cell culture and animal studies, it has yet to be confirmed in human cancer, as tumor and marrow-derived cells from the same patient cannot be easily distinguished genetically. Methods: We carried out genotyping of a metastatic melanoma to the brain that arose following allogeneic bone-marrow transplantation (BMT), using forensic short tandem repeat (STR) length-polymorphisms to distinguish donor and patient genomes. Tumor cells were isolated free of leucocytes by laser microdissection, and tumor and pre-transplant blood lymphocyte DNAs were analyzed for donor and patient alleles at 14 autosomal STR loci and the sex chromosomes. Results: All alleles in the donor and patient pre-BMT lymphocytes were found in tumor cells. The alleles showed disproportionate relative abundances in similar patterns throughout the tumor, indicating the tumor was initiated by a clonal fusion event. Conclusions: Our results strongly support fusion between a BMDC and a tumor cell playing a role in the origin of this metastasis. Depending on the frequency of such events, the findings could have important implications for understanding the generation of metastases, including the origins of tumor initiating cells and the cancer epigenome.	[Lazova, Rossitza; Klump, Vincent; Pawelek, John M.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Lazova, Rossitza; Sznol, Mario; Cooper, Dennis; Pawelek, John M.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT USA; [LaBerge, Greggory S.; Spritz, Richard A.] Univ Colorado, Sch Med, Human Med Genet & Genom Program, Aurora, CO USA; [LaBerge, Greggory S.] Denver Police Dept, Crime Lab, Denver, CO USA; [Spoelstra, Nicole] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA; [Sznol, Mario; Cooper, Dennis] Yale Univ, Sch Med, New Haven, CT USA; [Chang, Joseph T.] Yale Univ, Dept Stat, New Haven, CT USA	Yale University; Yale University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Yale University; Yale University	Pawelek, JM (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.	john.pawelek@yale.edu		Sznol, Mario/0000-0002-4359-8749	Amway Corporation; University of Colorado Cancer Center NCI Support Grant [P30CA046934]; Yale University; University of Colorado; Denver Police Crime Lab; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER	Amway Corporation; University of Colorado Cancer Center NCI Support Grant; Yale University; University of Colorado; Denver Police Crime Lab; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided in part by an unrestricted gift from the Amway Corporation and from the University of Colorado Cancer Center NCI Support Grant (P30CA046934). Additional costs were covered internally by the involved institutions: Yale University, the University of Colorado, and the Denver Police Crime Lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichel O., 1911, CELL FUSION QUALITAT, P92; Berndt Benjamin, 2013, Critical Reviews in Oncogenesis, V18, P97; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Boon LK, 2006, INT C SERIES, V1288, P379; Chakraborty A, 2004, BONE MARROW TRANSPL, V34, P183, DOI 10.1038/sj.bmt.1704547; Chakraborty AK, 2001, GENE, V275, P103, DOI 10.1016/S0378-1119(01)00647-3; Chakraborty AK, 2000, CANCER RES, V60, P2512; Clawson GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041052; Collins PJ, 2004, J FORENSIC SCI, V49, P1265; DAVIDSON RL, 1971, FED PROC, V30, P926; Ding JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041942; Dittmar T, 2006, CONTRIB MICROBIOL, V13, P156, DOI 10.1159/000092971; Duelli D, 2007, NAT REV CANCER, V7, P968, DOI 10.1038/nrc2272; Gamerman D., 2006, MARKOV CHAIN MONTE C, V68; Goldenberg DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055324; Goldenberg DM, 2012, INT J CANCER, V131, P49, DOI 10.1002/ijc.26327; GOLDENBERG DM, 1974, NATURE, V250, P649, DOI 10.1038/250649a0; HARRIS H, 1988, CANCER RES, V48, P3302; Itakura E, 2011, AM J SURG PATHOL, V35, P1657, DOI 10.1097/PAS.0b013e3182322cf7; Krnjajic M., 2011, APPL METHODS STAT AN; Leclair B, 2004, J FORENSIC SCI, V49, P968; Lluis F, 2010, J CELL PHYSIOL, V223, P6, DOI 10.1002/jcp.22003; Mercapide J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053364; Mercapide J, 2012, INT J CANCER, V131, P334, DOI 10.1002/ijc.26361; Nagler C, 2011, CANCER CELL INT, V11, DOI 10.1186/1475-2867-11-21; Ohsie SJ, 2008, J CUTAN PATHOL, V35, P433, DOI 10.1111/j.1600-0560.2007.00891.x; Pawelek JM, 2005, LANCET ONCOL, V6, P988, DOI 10.1016/S1470-2045(05)70466-6; Pawelek JM, 2000, MELANOMA RES, V10, P507, DOI 10.1097/00008390-200012000-00001; Pawelek JM, 1999, CELL MOL BIOL, V45, P1011; Pawelek JM, 2008, NAT REV CANCER, V8, P377, DOI 10.1038/nrc2371; Pawelek JM, 2008, ADV CANCER RES, V101, P397, DOI 10.1016/S0065-230X(08)00410-7; Plummer M., 2003, P 3 INT WORKSH DISTR; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; R: A Language and Environment for Statistical Computing, 2010, R LANG ENV STAT COMP; Rachkovsky M, 1998, CLIN EXP METASTAS, V16, P299; Rachkovsky M, 1999, CELL GROWTH DIFFER, V10, P517; Rappa G, 2012, AM J PATHOL, V180, P2504, DOI 10.1016/j.ajpath.2012.02.020; Vlachos PK, 2003, J STAT PLAN INFER, V111, P223, DOI 10.1016/S0378-3758(02)00304-X; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Yilmaz Y, 2005, BONE MARROW TRANSPL, V35, P1021, DOI 10.1038/sj.bmt.1704939; Zhang S, 2004, CIRCULATION, V110, P3803, DOI 10.1161/01.CIR.0000150796.18473.8E	41	78	81	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66731	10.1371/journal.pone.0066731	http://dx.doi.org/10.1371/journal.pone.0066731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840523	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400036
J	Mann, JFS; Mckay, PF; Arokiasamy, S; Patel, RK; Tregoning, JS; Shattock, RJ				Mann, Jamie F. S.; Mckay, Paul F.; Arokiasamy, Samantha; Patel, Reeyeshkumar K.; Tregoning, John S.; Shattock, Robin J.			Mucosal Application of gp140 Encoding DNA Polyplexes to Different Tissues Results in Altered Immunological Outcomes in Mice	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING ANTIBODIES; IMMUNE-RESPONSES; VACCINE ANTIGEN; INFLUENZA-VIRUS; HIV VACCINES; IMMUNIZATION; PROTEIN; PRIME; EXPRESSION	Increasing evidence suggests that mucosally targeted vaccines will enhance local humoral and cellular responses whilst still eliciting systemic immunity. We therefore investigated the capacity of nasal, sublingual or vaginal delivery of DNA-PEI polyplexes to prime immune responses prior to mucosal protein boost vaccination. Using a plasmid expressing the model antigen HIV CN54gp140 we show that each of these mucosal surfaces were permissive for DNA priming and production of antigen-specific antibody responses. The elicitation of systemic immune responses using nasally delivered polyplexed DNA followed by recombinant protein boost vaccination was equivalent to a systemic prime-boost regimen, but the mucosally applied modality had the advantage in that significant levels of antigen-specific IgA were detected in vaginal mucosal secretions. Moreover, mucosal vaccination elicited both local and systemic antigen-specific IgG(+) and IgA(+) antibody secreting cells. Finally, using an Influenza challenge model we found that a nasal or sublingual, but not vaginal, DNA prime/protein boost regimen protected against infectious challenge. These data demonstrate that mucosally applied plasmid DNA complexed to PEI followed by a mucosal protein boost generates sufficient antigen-specific humoral antibody production to protect from mucosal viral challenge.	[Mann, Jamie F. S.; Mckay, Paul F.; Arokiasamy, Samantha; Tregoning, John S.; Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, Dept Med, London, England; [Patel, Reeyeshkumar K.] St Georges Univ London, Ctr Infect, Div Clin Sci, London, England	Imperial College London; St Georges University London	Mann, JFS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, Dept Med, London, England.	j.mann@imperial.ac.uk		Mann, Jamie/0000-0001-7037-1286; Tregoning, John/0000-0001-8093-8741; McKay, Paul/0000-0001-5195-6254	Bill & Melinda Gates Foundation; Wellcome Trust, under the Grand Challenges in Global Health Initiative [37872]; CUT'HIVAC under a European Commission FP7 award [241904]; Wellcome Trust; Fondation Dormeur; Imperial College Central Biological Research Facility [70/7457]	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Wellcome Trust, under the Grand Challenges in Global Health Initiative(Wellcome Trust); CUT'HIVAC under a European Commission FP7 award; Wellcome Trust(Wellcome TrustEuropean Commission); Fondation Dormeur; Imperial College Central Biological Research Facility	This work was funded in part by a grant to SGUL by the Bill & Melinda Gates Foundation and the Wellcome Trust, under the Grand Challenges in Global Health Initiative (grant number 37872) and by CUT'HIVAC under a European Commission FP7 award (grant number 241904). The CN54 env plasmid was developed as part of the UK HIV Vaccine Consortium (www.ukhvc.org). The UK HVC is funded by an award from the Wellcome Trust for the provision of GMP vaccines, clinical trial support, and laboratory assays. The authors are also are grateful to the Fondation Dormeur for the provision of an equipment grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Simon Jeffs (Imperial College London, UK), Roger Tatoud (UK HVC, Imperial College London) and Dietmar Katinger (Polymun Scientific, AUT) for the provision of plasmids and antigen. GENEART AG (Regensburg, Germany) owns a European Patent EP1240333B1 covering the complete clade C/B' HIV-1 97CN54 coding sequence and codon optimized genes. The VRC 8400 CMV/R backbone vector used to construct the plasmid DNA has been developed by the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) (Bethesda, USA). Support for the animal work in these studies was provided by the Imperial College Central Biological Research Facility (project license no. 70/7457). The authors wish to thank Mr Ivan Vallado for his contribution to the work. The authors declared no conflicts of interest.	Arias MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041144; Azizi A, 2010, VACCINE, V28, P4015, DOI 10.1016/j.vaccine.2010.04.018; Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Bivas-Benita M, 2013, MUCOSAL IMMUNOL; Bivas-Benita M, 2010, J VIROL, V84, P5764, DOI 10.1128/JVI.02202-09; Buonaguro L, 2007, VACCINE, V25, P5968, DOI 10.1016/j.vaccine.2007.05.052; De Calisto J, 2011, METHODS MOL BIOL, V757, P411, DOI 10.1007/978-1-61779-166-6_24; Geiben-Lynn R, 2008, BLOOD, V112, P4585, DOI 10.1182/blood-2008-06-165803; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Jiang HX, 2011, IMMUNOL RES, V49, P147, DOI 10.1007/s12026-010-8178-6; Kantele A, 1999, J IMMUNOL, V162, P5173; Klavinskis LS, 1997, VACCINE, V15, P818, DOI 10.1016/S0264-410X(96)00278-2; Koblin BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024517; Lindholm C, 2004, INFECT IMMUN, V72, P1004, DOI 10.1128/IAI.72.2.1004-1009.2004; Lu S, 2006, SPRINGER SEMIN IMMUN, V28, P255, DOI 10.1007/s00281-006-0028-1; Mann JFS, 2012, J CONTROL RELEASE, V158, P240, DOI 10.1016/j.jconrel.2011.11.009; Marks E, 2011, EUR J IMMUNOL, V41, P2642, DOI 10.1002/eji.201041297; Mazumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014644; Minne A, 2007, IMMUNOLOGY, V122, P316, DOI 10.1111/j.1365-2567.2007.02641.x; Mora JR, 2008, MUCOSAL IMMUNOL, V1, P96, DOI 10.1038/mi.2007.14; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Richmond JFL, 1998, J VIROL, V72, P9092, DOI 10.1128/JVI.72.11.9092-9100.1998; Rush CM, 2010, VACCINE, V28, P1620, DOI 10.1016/j.vaccine.2009.11.014; Song JH, 2008, P NATL ACAD SCI USA, V105, P1644, DOI 10.1073/pnas.0708684105; Torrieri-Dramard L, 2011, MOL THER, V19, P602, DOI 10.1038/mt.2010.222; Wang SX, 2005, J VIROL, V79, P7933, DOI 10.1128/JVI.79.12.7933-7937.2005; Wang Z, 2009, CHINESE MED J-PEKING, V122, P2339, DOI 10.3760/cma.j.issn.0366-6999.2009.19.028; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009; Wu L, 2005, J VIROL, V79, P8024, DOI 10.1128/JVI.79.13.8024-8031.2005; Yao XD, 2007, J REPROD IMMUNOL, V75, P106, DOI 10.1016/j.jri.2007.04.008	31	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67412	10.1371/journal.pone.0067412	http://dx.doi.org/10.1371/journal.pone.0067412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826293	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400142
J	Tiklova, K; Tsarouhas, V; Samakovlis, C				Tiklova, Katarina; Tsarouhas, Vasilios; Samakovlis, Christos			Control of Airway Tube Diameter and Integrity by Secreted Chitin-Binding Proteins in Drosophila	PLOS ONE			English	Article							SEPTATE JUNCTIONS; EPITHELIAL TUBES; MORPHOGENESIS; REQUIREMENT; ELONGATION; MATRIX; ENDOCYTOSIS; EXPANSION; ENCODES; CUTICLE	The transporting function of many branched tubular networks like our lungs and circulatory system depend on the sizes and shapes of their branches. Understanding the mechanisms of tube size control during organ development may offer new insights into a variety of human pathologies associated with stenoses or cystic dilations in tubular organs. Here, we present the first secreted luminal proteins involved in tube diametric expansion in the Drosophila airways. obst-A and gasp are conserved among insect species and encode secreted proteins with chitin binding domains. We show that the widely used tracheal marker 2A12, recognizes the Gasp protein. Analysis of obst-A and gasp single mutants and obst-A; gasp double mutant shows that both genes are primarily required for airway tube dilation. Similarly, Obst-A and Gasp control epidermal cuticle integrity and larval growth. The assembly of the apical chitinous matrix of the airway tubes is defective in gasp and obst-A mutants. The defects become exaggerated in double mutants indicating that the genes have partially redundant functions in chitin structure modification. The phenotypes in luminal chitin assembly in the airway tubes are accompanied by a corresponding reduction in tube diameter in the mutants. Conversely, overexpression of Obst-A and Gasp causes irregular tube expansion and interferes with tube maturation. Our results suggest that the luminal levels of matrix binding proteins determine the extent of diametric growth. We propose that Obst-A and Gasp organize luminal matrix assembly, which in turn controls the apical shapes of adjacent cells during tube diameter expansion.	[Tiklova, Katarina; Tsarouhas, Vasilios; Samakovlis, Christos] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden	Stockholm University	Samakovlis, C (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	christos@devbio.su.se	Tsarouhas, Vasilios/AAG-8226-2020	Tsarouhas, Vasilios/0000-0002-2933-1351	Cancerfonden; Vetenskapsradet	Cancerfonden(Swedish Cancer Society); Vetenskapsradet(Swedish Research Council)	The work was supported by grants from Cancerfonden and Vetenskapsradet to CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew DJ, 2010, DEV BIOL, V341, P34, DOI 10.1016/j.ydbio.2009.09.024; Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031; Behr M, 2005, FEBS LETT, V579, P6827, DOI 10.1016/j.febslet.2005.11.021; Casanova J, 2007, EMBO REP, V8, P335, DOI 10.1038/sj.embor.7400942; Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102; Dong B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2347; Forster D, 2012, NAT CELL BIOL, V14, P526, DOI 10.1038/ncb2456; Forster D, 2010, CURR BIOL, V20, P62, DOI 10.1016/j.cub.2009.11.062; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Grieder NC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003241; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Laprise P, 2010, CURR BIOL, V20, P55, DOI 10.1016/j.cub.2009.11.017; Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072; Massarwa R, 2009, DEV CELL, V16, P877, DOI 10.1016/j.devcel.2009.04.010; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Nelson KS, 2012, NAT CELL BIOL, V14, P518, DOI 10.1038/ncb2467; Norum M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010802; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Petkau G, 2012, J BIOL CHEM, V287, P21396, DOI 10.1074/jbc.M112.359984; Schottenfeld J, 2010, CURR OPIN CELL BIOL, V22, P633, DOI 10.1016/j.ceb.2010.07.016; Swanson LE, 2006, CURR BIOL, V16, pR51, DOI 10.1016/j.cub.2006.01.008; Syed ZA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002850; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tiklova K, 2010, NAT CELL BIOL, V12, P1071, DOI 10.1038/ncb2111; Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7; Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074; Wu VM, 2004, CURR OPIN CELL BIOL, V16, P493, DOI 10.1016/j.ceb.2004.07.008; Zhang L, 2009, DEV BIOL, V336, P201, DOI 10.1016/j.ydbio.2009.09.040	35	36	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67415	10.1371/journal.pone.0067415	http://dx.doi.org/10.1371/journal.pone.0067415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826295	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400143
J	Jrad-Lamine, A; Henry-Berger, J; Damon-Soubeyrand, C; Saez, F; Kocer, A; Janny, L; Pons-Rejraji, H; Munn, DH; Mellor, AL; Gharbi, N; Cadet, R; Guiton, R; Aitken, RJ; Drevet, JR				Jrad-Lamine, Aicha; Henry-Berger, Joelle; Damon-Soubeyrand, Christelle; Saez, Fabrice; Kocer, Ayhan; Janny, Laurent; Pons-Rejraji, Hanae; Munn, David H.; Mellor, Andrew L.; Gharbi, Najoua; Cadet, Remi; Guiton, Rachel; Aitken, Robert J.; Drevet, Joel R.			Indoleamine 2,3-Dioxygenase 1 (Ido1) Is Involved in the Control of Mouse Caput Epididymis Immune Environment	PLOS ONE			English	Article							REGULATORY T-CELLS; POLYUNSATURATED FATTY-ACIDS; TRYPTOPHAN CATABOLISM; DENDRITIC CELLS; TGF-BETA; EXPRESSION; TOLERANCE; INFLAMMATION; CYCLOOXYGENASE-1; LEPTIN	The epididymis maintains a state of immune tolerance towards spermatozoa while also protecting them and itself against infection and acute inflammation. The immunosuppressive enzyme indoleamine 2,3-dioxygenase 1 (Ido1) participates in this delicate local equilibrium. Using the mouse Ido1(-/-) model, we show here that the absence of IDO1 expression leads in the epididymis but not in serum to (1) an increase in the inflammatory state as evidenced by changes in the content of cytokines and chemokines, (2) the engagement of a Th1-driven inflammatory response as evidenced by changes in the Th17/Treg as well as Th1/Th2 equilibria, as well as (3) differences in the content of lipid intermediates classically involved in inflammation. Despite this more pronounced inflammatory state, Ido1(-/-) animals succeed in preserving the local epididymal immune situation due to the activation of compensatory mechanisms that are discussed.	[Jrad-Lamine, Aicha; Henry-Berger, Joelle; Damon-Soubeyrand, Christelle; Saez, Fabrice; Kocer, Ayhan; Janny, Laurent; Pons-Rejraji, Hanae; Cadet, Remi; Guiton, Rachel; Drevet, Joel R.] Clermont Univ, INSERM, CNRS, GReD Lab,U1103,UMR 6293, Aubiere, France; [Janny, Laurent; Pons-Rejraji, Hanae] CECOS, CHU Estaing, Clermont Ferrand, France; [Munn, David H.; Mellor, Andrew L.] Med Coll Georgia, Immunotherapy Ctr, Augusta, GA 30912 USA; [Munn, David H.] Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; [Mellor, Andrew L.] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Jrad-Lamine, Aicha; Gharbi, Najoua] Fac Sci Tunis, Dept Biol, Tunis 1060, Tunisia; [Aitken, Robert J.] Univ Newcastle, Prior Res Ctr Reprod Sci, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); University of Newcastle	Drevet, JR (corresponding author), Clermont Univ, INSERM, CNRS, GReD Lab,U1103,UMR 6293, Aubiere, France.	joel.drevet@univ-bpclermont.fr	Kocer, Ayhan/N-7927-2014; PONS, HANAE/X-8673-2019; Aitken, Robert John/AAY-8238-2020; Drevet, Joël/W-2692-2019	PONS, HANAE/0000-0002-9779-9693; Aitken, Robert John/0000-0002-9152-156X; Drevet, Joël/0000-0003-3077-6558; Munn, David/0000-0002-7711-2858; Guiton, Rachel/0000-0002-7155-8736	French Ministry of Higher Education; CNRS (Centre National de la Recherche Scientifique); INSERM (Institut National de la Sante et de la Recherche Medicale)	French Ministry of Higher Education; CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm))	Institutional fundings from the French Ministry of Higher Education, the CNRS (Centre National de la Recherche Scientifique) and the INSERM (Institut National de la Sante et de la Recherche Medicale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 1999, INT ARCH ALLERGY IMM, V118, P391, DOI 10.1159/000024145; Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; Balaji Thotakura, 2009, Journal of Basic and Clinical Physiology and Pharmacology, V20, P357; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Beissert S, 2006, J INVEST DERMATOL, V126, P15, DOI 10.1038/sj.jid.5700004; Belladonna ML, 2007, TRANSPLANTATION, V84, pS17, DOI 10.1097/01.tp.0000269199.16209.22; Blaho VA, 2009, J IMMUNOL, V183, P5644, DOI 10.4049/jimmunol.0901499; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borish Larry C., 2003, Journal of Allergy and Clinical Immunology, V111, pS460; Britan A, 2006, CELL TISSUE RES, V324, P301, DOI 10.1007/s00441-005-0151-7; Calder PC, 2006, PROSTAG LEUKOTR ESS, V75, P197, DOI 10.1016/j.plefa.2006.05.012; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Caspar-Bauguil S, 2009, J PHYSIOL BIOCHEM, V65, P423, DOI 10.1007/BF03185938; Chen M, 2008, ARTHRITIS RHEUM, V58, P1354, DOI 10.1002/art.23453; Chen WH, 2004, CELL MOL IMMUNOL, V1, P328; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen YG, 2009, INT J COMPUT INT SYS, V2, P1, DOI 10.2991/jnmp.2009.2.1.1; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; D'Acquisto F, 2011, BIOCHEM PHARMACOL, V82, P333, DOI 10.1016/j.bcp.2011.05.019; Da Silva N, 2011, REPRODUCTION, V141, P653, DOI 10.1530/REP-10-0493; Fallarino F, 2011, CURR MED CHEM, V18, P2215, DOI 0929-8673/11 $58.00+.00; FOLCH J, 1957, J BIOL CHEM, V226, P497; Johnston DS, 2005, BIOL REPROD, V73, P404, DOI 10.1095/biolreprod.105.039719; Jrad-Lamine A, 2011, J BIOL CHEM, V286, P8030, DOI 10.1074/jbc.M110.172114; Juvet SC, 2012, J MOL CELL BIOL, V4, P48, DOI 10.1093/jmcb/mjr043; Karpus WJ, 1998, J EXP MED, V187, P733, DOI 10.1084/jem.187.5.733; Khanapure SP, 2007, CURR TOP MED CHEM, V7, P311, DOI 10.2174/156802607779941314; Kwidzinski E, 2005, FASEB J, V19, P1347, DOI 10.1096/fj.04-3228fje; La Cava A, 2004, J MOL MED, V82, P4, DOI 10.1007/s00109-003-0492-1; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Matarese G, 2000, EUR CYTOKINE NETW, V11, P7; McIntyre MSF, 2008, J IMMUNOL, V181, P2271, DOI 10.4049/jimmunol.181.4.2271; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mellor AL, 2003, ADV EXP MED BIOL, V527, P27; Munn DH, 2010, EUR J IMMUNOL, V40, P315, DOI 10.1002/eji.200940238; NASHAN D, 1989, INT J ANDROL, V12, P85, DOI 10.1111/j.1365-2605.1989.tb01289.x; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; Orabona C, 2006, BLOOD, V107, P2846, DOI 10.1182/blood-2005-10-4077; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Petitjean G, 2012, AIDS, V26, P139, DOI 10.1097/QAD.0b013e32834e1484; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Qureshi N, 2005, IMMUNOL RES, V31, P243, DOI 10.1385/IR:31:3:243; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Schmidt N, 2010, GUT, V59, P896, DOI 10.1136/gut.2009.203554; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Stone TW, 2002, NAT REV DRUG DISCOV, V1, P609, DOI 10.1038/nrd870; Takikawa O, 1999, ADV EXP MED BIOL, V467, P553; Tardy AL, 2008, J LIPID RES, V49, P1445, DOI 10.1194/jlr.M700561-JLR200; Tone S, 2007, INT C SER, V1304, P233; Vieu C, 2002, J LIPID RES, V43, P510; Wheeler K, 2011, P NATL ACAD SCI USA, V108, P7511, DOI 10.1073/pnas.1017615108; Widner B, 1997, CLIN CHEM, V43, P2424; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Xu H, 2008, IMMUNOL LETT, V121, P1, DOI 10.1016/j.imlet.2008.08.008; Zhao GQ, 1998, DEVELOPMENT, V125, P1103; Zhao GQ, 2001, DEV BIOL, V240, P212, DOI 10.1006/dbio.2001.0448	57	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66494	10.1371/journal.pone.0066494	http://dx.doi.org/10.1371/journal.pone.0066494			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840489	Green Published, gold			2022-12-27	WOS:000322342800070
J	Kumarathasan, P; Vincent, R; Blais, E; Saravanamuthu, A; Gupta, P; Wyatt, H; Mitchel, R; Hannan, M; Trivedi, A; Whitman, S				Kumarathasan, Prem; Vincent, Renaud; Blais, Erica; Saravanamuthu, Anu; Gupta, Pallavi; Wyatt, Heather; Mitchel, Ronald; Hannan, Mohammed; Trivedi, Akilesh; Whitman, Stewart			Cardiovascular Changes in Atherosclerotic ApoE-Deficient Mice Exposed to Co60 (gamma) Radiation	PLOS ONE			English	Article							ATOMIC-BOMB SURVIVORS; ISLAND ACCIDENT AREA; OXIDATIVE STRESS; IONIZING-RADIATION; TYROSINE NITRATION; NITRIC-OXIDE; IN-VIVO; DISEASE; MORTALITY; CANCER	Background: There is evidence for a role of ionizing radiation in cardiovascular diseases. The goal of this work was to identify changes in oxidative and nitrative stress pathways and the status of the endothelinergic system during progression of atherosclerosis in ApoE-deficient mice after single and repeated exposure to ionizing radiation. Methods and Results: B6.129P2-ApoE tmlUnc mice on a low-fat diet were acutely exposed (whole body) to Co60 (gamma) (single dose 0, 0.5, and 2 Gy) at a dose rate of 36.32 cGy/min, or repeatedly (cumulative dose 0 and 2 Gy) at a dose-rate of 0.1 cGy/min for 5 d/wk, over a period of 4 weeks. Biological endpoints were investigated after 3-6 months of recovery post-radiation. The nitrative stress marker 3-nitrotyrosine and the vasoregulator peptides endothelin-1 and endothelin-3 in plasma were increased (p<0.05) in a dose-dependent manner 3-6 months after acute or chronic exposure to radiation. The oxidative stress marker 8-isoprostane was not affected by radiation, while plasma 8-hydroxydeoxyguanosine and L-3,4-dihydroxyphenylalanine decreased (p<0.05) after treatment. At 2Gy radiation dose, serum cholesterol was increased (p = 0.008) relative to controls. Percent lesion area increased (p = 0.005) with age of animal, but not with radiation treatment. Conclusions: Our observations are consistent with persistent nitrative stress and activation of the endothelinergic system in ApoE-/- mice after low-level ionizing radiation exposures. These mechanisms are known factors in the progression of atherosclerosis and other cardiovascular diseases.	[Kumarathasan, Prem; Blais, Erica; Saravanamuthu, Anu; Gupta, Pallavi] Hlth Canada, Analyt Biochem & Prote Lab, Environm Hlth Sci & Res Bur, Hlth Environm & Consumer Safety Branch, Ottawa, ON K1A 0L2, Canada; [Vincent, Renaud; Hannan, Mohammed] Hlth Canada, Inhalat Toxicol Lab, Environm Hlth Sci & Res Bur, Hlth Environm & Consumer Safety Branch, Ottawa, ON K1A 0L2, Canada; [Wyatt, Heather; Mitchel, Ronald] Atom Energy Canada Ltd, Chalk River Labs, Radiol Protect Res & Instrumentat Branch, Chalk River, ON K0J 1J0, Canada; [Trivedi, Akilesh] Hlth Canada, Radiat Protect Bur, Hlth Environm & Consumer Safety Branch, Ottawa, ON K1A 0L2, Canada; [Whitman, Stewart] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada	Health Canada; Health Canada; Atomic Energy of Canada Limited; Health Canada; University of Ottawa	Kumarathasan, P (corresponding author), Hlth Canada, Analyt Biochem & Prote Lab, Environm Hlth Sci & Res Bur, Hlth Environm & Consumer Safety Branch, Ottawa, ON K1A 0L2, Canada.	premkumari.kumarathasan@hc-sc.gc.ca			Health Canada; AECL (Atomic Energy of Canada Limited)	Health Canada; AECL (Atomic Energy of Canada Limited)	The work was supported by operational funds at Health Canada and AECL (Atomic Energy of Canada Limited). Outside of the investigators directly involved in the study, the institutional funders had no direct role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; ALEXANDER RW, 1995, HYPERTENSION, V25, P155, DOI 10.1161/01.HYP.25.2.155; Ashmore JP, 1998, AM J EPIDEMIOL, V148, P564, DOI 10.1093/oxfordjournals.aje.a009682; Azzam EI, 2004, HUM EXP TOXICOL, V23, P61, DOI 10.1191/0960327104ht418oa; Azzam EI, 2002, CANCER RES, V62, P5436; Basavaraju SR, 2002, MED PHYS, V29, P2391, DOI 10.1118/1.1509442; Bielecki A, 2012, J ANAL TOXICOL, V36, P595, DOI 10.1093/jat/bks070; Boerma M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/858262; Bohm F, 2002, ATHEROSCLEROSIS, V160, P215, DOI 10.1016/S0021-9150(01)00564-0; Broome EJ, 2002, RADIAT RES, V158, P181, DOI 10.1667/0033-7587(2002)158[0181:DRFATL]2.0.CO;2; CRAWLEY DE, 1992, J APPL PHYSIOL, V72, P1425, DOI 10.1152/jappl.1992.72.4.1425; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; Elahi MM, 2009, OXID MED CELL LONGEV, V2, P259, DOI 10.4161/oxim.2.5.9441; Friedlander AH, 2003, J AM DENT ASSOC, V134, P1615, DOI 10.14219/jada.archive.2003.0108; Higashi Y, 2009, CIRC J, V73, P411, DOI 10.1253/circj.CJ-08-1102; Ilnytskyy Y, 2009, ENVIRON MOL MUTAGEN, V50, P105, DOI 10.1002/em.20440; Ivanov VK, 2006, HEALTH PHYS, V90, P199, DOI 10.1097/01.HP.0000175835.31663.ea; Kooy NW, 1997, CRIT CARE MED, V25, P812, DOI 10.1097/00003246-199705000-00017; Koturbash I, 2008, INT J RADIAT ONCOL, V70, P554, DOI 10.1016/j.ijrobp.2007.09.039; Koturbash I, 2007, CARCINOGENESIS, V28, P1831, DOI 10.1093/carcin/bgm053; Kumarathasan P, 2003, J CHROMATOGR A, V987, P349, DOI 10.1016/S0021-9673(02)01598-4; Kumarathasan P, 2001, ANAL BIOCHEM, V299, P37, DOI 10.1006/abio.2001.5362; LERMAN A, 1995, CIRCULATION, V92, P2426, DOI 10.1161/01.CIR.92.9.2426; Little MP, 2010, RADIAT ENVIRON BIOPH, V49, P139, DOI 10.1007/s00411-009-0250-z; Little MP, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000539; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Martinez F, 1996, NEPHROL DIAL TRANSPL, V11, P270, DOI 10.1093/oxfordjournals.ndt.a027252; Michaud DS, 2005, INT J RADIAT BIOL, V81, P299, DOI 10.1080/09553000500084795; Minamino T, 1997, CIRCULATION, V95, P221, DOI 10.1161/01.CIR.95.1.221; Mitchel REJ, 2011, RADIAT RES, V175, P665, DOI 10.1667/RR2176.1; Mitchel REJ, 1999, RADIAT RES, V152, P273, DOI 10.2307/3580327; Mitchel REJ, 2002, RADIAT RES, V158, P458, DOI 10.1667/0033-7587(2002)158[0458:IOPETL]2.0.CO;2; Monseau V, 2013, PLOS ONE, V8, P1; Montani D, 2007, CHEST, V131, P101, DOI 10.1378/chest.06-0682; Morgan WF, 2007, MUTAT RES-FUND MOL M, V616, P159, DOI 10.1016/j.mrfmmm.2006.11.009; Mothersill C, 2004, NAT REV CANCER, V4, P158, DOI 10.1038/nrc1277; O'Sullivan B, 2003, SEMIN RADIAT ONCOL, V13, P274, DOI 10.1016/S1053-4296(03)00037-7; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pawlak K, 2004, AM J NEPHROL, V24, P154, DOI 10.1159/000076244; Peluffo G, 2007, CARDIOVASC RES, V75, P291, DOI 10.1016/j.cardiores.2007.04.024; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Reiter CD, 2000, J BIOL CHEM, V275, P32460, DOI 10.1074/jbc.M910433199; Richardson DB, 1999, ENVIRON HEALTH PERSP, V107, P649, DOI 10.2307/3434457; Rogers L, 2008, CARDIOVASC RES, V78, P167, DOI 10.1093/cvr/cvn005; Sauvageau S, 2008, PEPTIDES, V29, P2039, DOI 10.1016/j.peptides.2008.08.003; Shimizu Y, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5349; Sowa M, 2006, EXP SUPPL, V96, P293; Talbott EO, 2003, ENVIRON HEALTH PERSP, V111, P341, DOI 10.1289/ehp.5662; Talbott EO, 2000, ENVIRON HEALTH PERSP, V108, P545, DOI 10.2307/3454617; Trivedi A, 2004, J ENVIRON PATHOL TOX, V23, P99, DOI 10.1615/JEnvPathToxOncol.v23.i2.20; Wakeford R, 2004, ONCOGENE, V23, P6404, DOI 10.1038/sj.onc.1207896; Wong FL, 1999, RADIAT RES, V151, P736, DOI 10.2307/3580213; Wright EG, 2006, MUTAT RES-FUND MOL M, V597, P119, DOI 10.1016/j.mrfmmm.2005.03.035; Yamada M, 2004, RADIAT RES, V161, P622, DOI 10.1667/RR3183; Yi A, 2009, KOREAN J RADIOL, V10, P496, DOI 10.3348/kjr.2009.10.5.496	55	8	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65486	10.1371/journal.pone.0065486	http://dx.doi.org/10.1371/journal.pone.0065486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840332	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800011
J	Li, LP; Wang, ZH; Zerbe, S; Abdusalih, N; Tang, ZY; Ma, M; Yin, LK; Mohammat, A; Han, WX; Fang, JY				Li, Liping; Wang, Zhiheng; Zerbe, Stefan; Abdusalih, Nurbay; Tang, Zhiyao; Ma, Ming; Yin, Linke; Mohammat, Anwar; Han, Wenxuan; Fang, Jingyun			Species Richness Patterns and Water-Energy Dynamics in the Drylands of Northwest China	PLOS ONE			English	Article							CROSS-TAXON CONGRUENCE; WOODY PLANT; BROAD-SCALE; VASCULAR PLANTS; SPATIAL SCALE; DIVERSITY; CLIMATE; BIODIVERSITY; CONCORDANCE; DETERMINANTS	Dryland ecosystems are highly vulnerable to climatic and land-use changes, while the mechanisms underlying patterns of dryland species richness are still elusive. With distributions of 3637 native vascular plants, 154 mammals, and 425 birds in Xinjiang, China, we tested the water-energy dynamics hypothesis for species richness patterns in Central Asian drylands. Our results supported the water-energy dynamics hypothesis. We found that species richness of all three groups was a humpshaped function of energy availability, but a linear function of water availability. We further found that water availability had stronger effects on plant richness, but weaker effects on vertebrate richness than energy availability. We conducted piecewise linear regressions to detect the breakpoints in the relationship between species richness and potential evapotranspiration which divided Xinjiang into low and high energy regions. The concordance between mammal and plant richness was stronger in high than in low energy regions, which was opposite to that between birds and plants. Plant richness had stronger effects than climate on mammal richness regardless of energy levels, but on bird richness only in high energy regions. The changes in the concordance between vertebrate and plant richness along the climatic gradient suggest that cautions are needed when using concordance between taxa in conservation planning.	[Li, Liping; Tang, Zhiyao; Fang, Jingyun] Peking Univ, Minist Educ, Coll Urban & Environm Sci, Dept Ecol,Key Lab Earth Surface Proc, Beijing 100871, Peoples R China; [Wang, Zhiheng] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Li, Liping; Zerbe, Stefan] Free Univ Bozen Bolzano, Fac Sci & Technol, Bolzano, Italy; [Abdusalih, Nurbay] Xinjiang Univ, Minist Educ, Coll Resources & Environm Sci, Key Lab Oasis Ecol, Urumqi, Peoples R China; [Ma, Ming; Yin, Linke; Mohammat, Anwar] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China; [Han, Wenxuan] China Agr Univ, Coll Resources & Environm Sci, Minist Educ, Key Lab Plant Soil Interact, Beijing 100094, Peoples R China	Peking University; University of Copenhagen; Free University of Bozen-Bolzano; Xinjiang University; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; China Agricultural University	Li, LP (corresponding author), Peking Univ, Minist Educ, Coll Urban & Environm Sci, Dept Ecol,Key Lab Earth Surface Proc, Beijing 100871, Peoples R China.	liliping@pku.edu.cn	Han, Wenxuan/B-8791-2016; Li, Liping/C-2574-2011; MaMing, Roller/AAJ-1085-2020; Tang, Zhiyao/B-8795-2008; Wang, Zhiheng/G-1750-2010	Han, Wenxuan/0000-0001-8678-7147; Li, Liping/0000-0002-5550-1932; Wang, Zhiheng/0000-0003-0808-7780; Tang, Zhiyao/0000-0003-0154-6403	Funds for Creative Research Groups of China [31021001]; Sino-Japan Project [2010DFA31290]	Funds for Creative Research Groups of China(Science Fund for Creative Research Groups); Sino-Japan Project	This study was supported by the Funds for Creative Research Groups of China (Grant No. 31021001) and Sino-Japan Project (Grant No. 2010DFA31290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P, 2000, J ZOOL, V251, P205, DOI 10.1111/j.1469-7998.2000.tb00605.x; Apdukader A, 2002, CHECKLIST MAMMALS XI; Brown JH, 1998, BIOGEOGRAPHY SUNDERL; Chen C. D, 1998, BIODIVERSITY CHINA C; Commissione Redactorum Florae Xinjiangensis, 1992, FLOR XINJ; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Dale MRT, 2002, ECOSCIENCE, V9, P162, DOI 10.1080/11956860.2002.11682702; Dang RL, 2001, B BOT RES, V21, P519; Editorial Committee of Chinese Physical Geography of the Chinese Academy of Sciences, 1984, CHIN PHYS GEOGR CLIM; Field R, 2005, ECOLOGY, V86, P2263, DOI 10.1890/04-1910; Francis AP, 2003, AM NAT, V161, P523, DOI 10.1086/368223; Grace J.B., 2006, STRUCT EQ MOD NAT; Groombridge B., 2002, World atlas of biodiversity: earth's living resources in the 21st century; Hawkins BA, 2003, ECOLOGY, V84, P1608, DOI 10.1890/0012-9658(2003)084[1608:PAHAPO]2.0.CO;2; Hawkins BA, 2004, DIVERS DISTRIB, V10, P247, DOI 10.1111/j.1366-9516.2004.00085.x; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kerr JT, 1997, NATURE, V385, P252, DOI 10.1038/385252a0; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Kissling WD, 2012, GLOBAL ECOL BIOGEOGR, V21, P328, DOI 10.1111/j.1466-8238.2011.00679.x; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P327, DOI 10.1111/j.1466-8238.2007.00379.x; Kissling WD, 2007, P ROY SOC B-BIOL SCI, V274, P799, DOI 10.1098/rspb.2006.0311; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Legendre P., 2012, NUMERICAL ECOLOGY; Lei FM, 2006, INTEGR ZOOL, V1, P162, DOI 10.1111/j.1749-4877.2006.00037.x; Lennon JJ, 2000, ECOGRAPHY, V23, P101, DOI 10.1034/j.1600-0587.2000.230111.x; [李利平 Li Liping], 2011, [干旱区研究, Arid Zone Research], V28, P25; Li LiPing, 2011, Ganhanqu Yanjiu (Arid Zone Research), V28, P1, DOI 10.3724/SP.J.1148.2011.00001; [李利平 Li Liping], 2011, [干旱区研究, Arid Zone Research], V28, P60; Lin Xin, 2009, Shengwu Duoyangxing, V17, P652, DOI 10.3724/SP.J.1003.2009.09065; Ma M, 2001, CHECKLIST BIRDS XINJ; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Moreno-Rueda G, 2010, REV ECOL-TERRE VIE, V65, P265; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; O'Brien EM, 1998, J BIOGEOGR, V25, P379, DOI 10.1046/j.1365-2699.1998.252166.x; OBRIEN EM, 1993, J BIOGEOGR, V20, P181, DOI 10.2307/2845670; Qian H, 2008, ECOL LETT, V11, P547, DOI 10.1111/j.1461-0248.2008.01168.x; Qian H, 2010, ECOLOGY, V91, P1172, DOI 10.1890/09-0620.1; Qian H, 2009, J BIOGEOGR, V36, P1685, DOI 10.1111/j.1365-2699.2009.02128.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Santi E, 2010, J NAT CONSERV, V18, P2, DOI 10.1016/j.jnc.2009.02.003; Schuldt A, 2009, ECOGRAPHY, V32, P1019, DOI 10.1111/j.1600-0587.2009.05973.x; Tang ZY, 2006, FRONT ECOL ENVIRON, V4, P347, DOI 10.1890/1540-9295(2006)004[0347:BICM]2.0.CO;2; THORNTHWAITE C. W., 1955, Unasylva, V9, P51; Virtanen R, 2009, FRESHWATER BIOL, V54, P1651, DOI 10.1111/j.1365-2427.2009.02212.x; Wang SP, 2010, CHINESE SCI BULL, V55, P1968, DOI 10.1007/s11434-010-3236-y; Wang ZH, 2012, ECOGRAPHY, V35, P1124, DOI 10.1111/j.1600-0587.2011.06781.x; Wang ZH, 2011, P ROY SOC B-BIOL SCI, V278, P2122, DOI 10.1098/rspb.2010.1897; Wang ZH, 2009, P NATL ACAD SCI USA, V106, P13388, DOI 10.1073/pnas.0905030106; Wei WS, 2008, CHINESE SCI BULL, V53, P22, DOI 10.1007/s11434-008-6002-7; Williams PH, 1997, P ROY SOC B-BIOL SCI, V264, P141, DOI 10.1098/rspb.1997.0021; Xinjiang Integrated Survey Team & Institute of Botany Chinese Academy of Sciences, 1978, VEG ITS UT XINJ; [徐卫华 XU WeiHua], 2006, [生态学报, Acta Ecologica Sinica], V26, P271; Zhang J, 2013, J BIOGEOGR, V40, P1131, DOI 10.1111/jbi.12063; Zhao SQ, 2006, DIVERS DISTRIB, V12, P189, DOI 10.1111/j.1366-9516.2005.00215.x	58	43	58	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66450	10.1371/journal.pone.0066450	http://dx.doi.org/10.1371/journal.pone.0066450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840472	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800060
J	Ghezzo, A; Visconti, P; Abruzzo, PM; Bolotta, A; Ferreri, C; Gobbi, G; Malisardi, G; Manfredini, S; Marini, M; Nanetti, L; Pipitone, E; Raffaelli, F; Resca, F; Vignini, A; Mazzanti, L				Ghezzo, Alessandro; Visconti, Paola; Abruzzo, Provvidenza M.; Bolotta, Alessandra; Ferreri, Carla; Gobbi, Giuseppe; Malisardi, Gemma; Manfredini, Stefano; Marini, Marina; Nanetti, Laura; Pipitone, Emanuela; Raffaelli, Francesca; Resca, Federica; Vignini, Arianna; Mazzanti, Laura			Oxidative Stress and Erythrocyte Membrane Alterations in Children with Autism: Correlation with Clinical Features	PLOS ONE			English	Article							FATTY-ACID COMPOSITIONS; FALSE DISCOVERY RATE; DOCOSAHEXAENOIC ACID; LIPID-PEROXIDATION; SPECTRUM DISORDERS; BRAIN; INFLAMMATION; BIOMARKERS; ASSAY; OMEGA-3-FATTY-ACIDS	It has been suggested that oxidative stress may play a role in the pathogenesis of Autism Spectrum Disorders (ASD), but the literature reports somewhat contradictory results. To further investigate the issue, we evaluated a high number of peripheral oxidative stress parameters, and some related issues such as erythrocyte membrane functional features and lipid composition. Twenty-one autistic children (Au) aged 5 to 12 years, were gender and age-matched with 20 typically developing children (TD). Erythrocyte thiobarbituric acid reactive substances, urinary isoprostane and hexanoyl-lysine adduct levels were elevated in Au, thus confirming the occurrence of an imbalance of the redox status of Au, whilst other oxidative stress markers or associated parameters (urinary 8-oxo-dG, plasma radical absorbance capacity and carbonyl groups, erythrocyte superoxide dismutase and catalase activities) were unchanged. A very significant reduction of Na+/K+-ATPase activity (-66%, p<0.0001), a reduction of erythrocyte membrane fluidity and alteration in erythrocyte fatty acid membrane profile (increase in monounsaturated fatty acids, decrease in EPA and DHA-omega 3 with a consequent increase in omega 6/omega 3 ratio) were found in Au compared to TD, without change in membrane sialic acid content. Some Au clinical features appear to be correlated with these findings; in particular, hyperactivity score appears to be related with some parameters of the lipidomic profile and membrane fluidity. Oxidative stress and erythrocyte membrane alterations may play a role in the pathogenesis of ASD and prompt the development of palliative therapeutic protocols. Moreover, the marked decrease in NKA could be potentially utilized as a peripheral biomarker of ASD.	[Ghezzo, Alessandro; Abruzzo, Provvidenza M.; Bolotta, Alessandra; Marini, Marina] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Visconti, Paola; Gobbi, Giuseppe; Resca, Federica] Osped Maggiore Bologna, Neuropsichiat Unit, Bologna, Italy; [Abruzzo, Provvidenza M.; Bolotta, Alessandra; Marini, Marina] Don Carlo Gnocchi Fdn ONLUS, Milan, Italy; [Ferreri, Carla] CNR, ISOF, I-40126 Bologna, Italy; [Malisardi, Gemma; Manfredini, Stefano] Univ Ferrara, Dept Pharmaceut Sci, I-44100 Ferrara, Italy; [Malisardi, Gemma; Manfredini, Stefano] Univ Ferrara, AmbrosiaLab, I-44100 Ferrara, Italy; [Nanetti, Laura; Raffaelli, Francesca; Vignini, Arianna; Mazzanti, Laura] Polytech Univ Marche, Dept Clin Sci Biochem, Ancona, Italy; [Pipitone, Emanuela] Azienda USL, Bologna, Italy	University of Bologna; AUSL di Bologna; IRCCS Fondazione Don Carlo Gnocchi Onlus; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR); University of Ferrara; University of Ferrara; Marche Polytechnic University; AUSL di Bologna	Marini, M (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.	marina.marini@unibo.it	FERRERI, CARLA/G-6821-2013; Marini, Marina/B-1490-2012; Marini, Marina/Y-6191-2019; Abruzzo, Provvidenza Maria/G-7009-2015; Manfredini, Stefano/B-7052-2015	FERRERI, CARLA/0000-0002-1359-0869; Marini, Marina/0000-0003-1932-7380; Marini, Marina/0000-0003-1932-7380; Abruzzo, Provvidenza Maria/0000-0001-5242-9448; Manfredini, Stefano/0000-0003-1348-4422; VIGNINI, ARIANNA/0000-0002-2496-7932	ANGSA (Associazione Nazionale Genitori Soggetti Autistici)	ANGSA (Associazione Nazionale Genitori Soggetti Autistici)	The present work was exclusively supported by a legacy of late Ms. Maria Luisa Cimadori, a member of ANGSA (Associazione Nazionale Genitori Soggetti Autistici). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abruzzo PM, 2010, FREE RADICAL RES, V44, P563, DOI 10.3109/10715761003692487; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amminger GP, 2007, BIOL PSYCHIAT, V61, P551, DOI 10.1016/j.biopsych.2006.05.007; Andreazza AC, 2008, J AFFECT DISORDERS, V111, P135, DOI 10.1016/j.jad.2008.04.013; Anselmi CV, 2010, J INTERV CARD ELECTR, V27, P95, DOI 10.1007/s10840-009-9466-8; Bazan NG, 2005, MOL NEUROBIOL, V32, P89, DOI 10.1385/MN:32:1:089; Bell JG, 2000, PROSTAG LEUKOTR ESS, V63, P21, DOI 10.1054/plef.2000.0186; Bell JG, 2004, PROSTAG LEUKOTR ESS, V71, P201, DOI 10.1016/j.plefa.2004.03.008; Bell JG, 2010, BRIT J NUTR, V103, P1160, DOI 10.1017/S0007114509992881; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bent S, 2011, J AUTISM DEV DISORD, V41, P545, DOI 10.1007/s10803-010-1078-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bradstreet JJ, 2010, ALTERN MED REV, V15, P15; Brookes KJ, 2006, BIOL PSYCHIAT, V60, P1053, DOI 10.1016/j.biopsych.2006.04.025; Bu B, 2006, PROSTAG LEUKOTR ESS, V74, P215, DOI 10.1016/j.plefa.2006.02.001; Calder PC, 2011, EUR J PHARMACOL, V668, pS50, DOI 10.1016/j.ejphar.2011.05.085; Chalon S, 2006, PROSTAG LEUKOTR ESS, V75, P259, DOI 10.1016/j.plefa.2006.07.005; Chauhan A, 2004, LIFE SCI, V75, P2539, DOI 10.1016/j.lfs.2004.04.038; Chauhan Abha, 2006, Pathophysiology, V13, P171, DOI 10.1016/j.pathophys.2006.05.007; CORASH LM, 1974, J LAB CLIN MED, V84, P147; DENNY PC, 1983, CLIN CHIM ACTA, V131, P333, DOI 10.1016/0009-8981(83)90103-1; Farook MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043030; Ferreri C, 2005, FREE RADICAL BIO MED, V38, P1180, DOI 10.1016/j.freeradbiomed.2004.12.026; Ferreri C, 2012, EXPERT REV MOL DIAGN, V12, P767, DOI [10.1586/erm.12.73, 10.1586/ERM.12.73]; Fiorini R, 1991, APPL FLUORESC TECH, V3, P33; Fiske CH, 1925, J BIOL CHEM, V66, P375; Frossi B, 2003, EUR J IMMUNOL, V33, P2168, DOI 10.1002/eji.200323995; Frustaci A, 2012, FREE RADICAL BIO MED, V52, P2128, DOI 10.1016/j.freeradbiomed.2012.03.011; Geier DA, 2008, EXPERT REV MOL DIAGN, V8, P671, DOI 10.1586/14737159.8.6.671; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; James S, 2011, COCHRANE DB SYST REV; James SJ, 2006, AM J MED GENET B, V141B, P947, DOI 10.1002/ajmg.b.30366; James SJ, 2004, AM J CLIN NUTR, V80, P1611, DOI 10.1093/ajcn/80.6.1611; Ji LN, 2009, LIFE SCI, V85, P788, DOI 10.1016/j.lfs.2009.10.008; Kamboj SS, 2009, NEUROSCIENCE, V162, P349, DOI 10.1016/j.neuroscience.2009.05.002; Kaphzan H, 2011, J NEUROSCI, V31, P17637, DOI 10.1523/JNEUROSCI.4162-11.2011; Kim HY, 2007, J BIOL CHEM, V282, P18661, DOI 10.1074/jbc.R700015200; Kim M, 2010, NUTR RES, V30, P756, DOI 10.1016/j.nutres.2010.10.005; KITAO T, 1983, EXPERIENTIA, V39, P1362, DOI 10.1007/BF01990105; Kramer JKC, 1997, LIPIDS, V32, P1219, DOI 10.1007/s11745-997-0156-3; Krey JF, 2007, CURR OPIN NEUROBIOL, V17, P112, DOI 10.1016/j.conb.2007.01.010; Kurup RK, 2003, INT J NEUROSCI, V113, P1537, DOI 10.1080/00207450390231482; Lord C., 1999, AUTISM DIAGNOSTIC OB; MAKRIDES M, 1994, AM J CLIN NUTR, V60, P189, DOI 10.1093/ajcn/60.2.189; Meguid NA, 2011, BIOL TRACE ELEM RES, V143, P58, DOI 10.1007/s12011-010-8840-9; Momeni N, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.19; Mosig MO, 2001, GENETICS, V157, P1683; MURPHY MG, 1990, J NUTR BIOCHEM, V1, P68, DOI 10.1016/0955-2863(90)90052-M; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Orr SK, 2008, CURR OPIN INVEST DR, V9, P735; Ou PM, 1996, J BIOCHEM BIOPH METH, V31, P59, DOI 10.1016/0165-022X(95)00039-T; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; Pecorelli A, 2012, BRAIN DEV APR, P23; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Pessina F, 2004, N-S ARCH PHARMACOL, V370, P521, DOI 10.1007/s00210-004-0998-2; Pietilainen KH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000623; RENNIE CM, 1979, CLIN CHIM ACTA, V98, P119, DOI 10.1016/0009-8981(79)90172-4; Richardson AJ, 2000, PROSTAG LEUKOTR ESS, V63, P1, DOI 10.1054/plef.2000.0184; Rodrigo R, 2007, MOL CELL BIOCHEM, V303, P73, DOI 10.1007/s11010-007-9457-y; Roid G.H., 1997, LEITER INT PERFORMAN; Rose S, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.61; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Schengrund CL, 2012, NEUROCHEM RES, V37, P1201, DOI 10.1007/s11064-011-0697-6; Schopler E., 1988, CHILDHOOD AUTISM RAT; Schopler E., 2005, PSYCHOEDUCATIONAL PR, V3rd edition, DOI [10.1037/t52601-000, DOI 10.1037/T52601-000]; SHERIDAN NP, 1988, J CELL PHYSIOL, V134, P117, DOI 10.1002/jcp.1041340114; Sies H., 1985, OXIDATIVE STRESS, V501, P1, DOI DOI 10.1016/B978-0-12-642760-8.50005-3; Skoumalova A, 2012, CELL BIOCHEM FUNCT, V30, P205, DOI 10.1002/cbf.1836; Sobenin IA, 1998, J LIPID RES, V39, P2293; Sultana R, 2006, ANTIOXID REDOX SIGN, V8, P2021, DOI 10.1089/ars.2006.8.2021; Tan ZS, 2012, NEUROLOGY, V78, P658, DOI 10.1212/WNL.0b013e318249f6a9; Theoharides TC, 2009, EXPERT OPIN PHARMACO, V10, P2127, DOI 10.1517/14656560903107789; Tsaluchidu S, 2008, BMC PSYCHIAT S1, V8, pS1; Turner N, 2003, NATURWISSENSCHAFTEN, V90, P521, DOI 10.1007/s00114-003-0470-z; VANDERVEGT SGL, 1985, BRIT J HAEMATOL, V61, P393, DOI 10.1111/j.1365-2141.1985.tb02843.x; Vargas DL, 2005, ANN NEUROL, V57, P67, DOI 10.1002/ana.20315; Vignini A, 2009, REPROD BIOMED ONLINE, V18, P132, DOI 10.1016/S1472-6483(10)60435-X; WARREN L, 1959, J BIOL CHEM, V234, P1971	80	101	106	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66418	10.1371/journal.pone.0066418	http://dx.doi.org/10.1371/journal.pone.0066418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840462	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200073
J	Miller, DAW; Nichols, JD; Gude, JA; Rich, LN; Podruzny, KM; Hines, JE; Mitchell, MS				Miller, David A. W.; Nichols, James D.; Gude, Justin A.; Rich, Lindsey N.; Podruzny, Kevin M.; Hines, James E.; Mitchell, Michael S.			Determining Occurrence Dynamics when False Positives Occur: Estimating the Range Dynamics of Wolves from Public Survey Data	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; SPECIES OCCURRENCE; CAPTURE-RECAPTURE; CITIZEN SCIENCE; OBSERVER BIAS; MODELS; ERRORS; CALL; STATES; MISIDENTIFICATION	Large-scale presence-absence monitoring programs have great promise for many conservation applications. Their value can be limited by potential incorrect inferences owing to observational errors, especially when data are collected by the public. To combat this, previous analytical methods have focused on addressing non-detection from public survey data. Misclassification errors have received less attention but are also likely to be a common component of public surveys, as well as many other data types. We derive estimators for dynamic occupancy parameters (extinction and colonization), focusing on the case where certainty can be assumed for a subset of detections. We demonstrate how to simultaneously account for non-detection (false negatives) and misclassification (false positives) when estimating occurrence parameters for gray wolves in northern Montana from 2007-2010. Our primary data source for the analysis was observations by deer and elk hunters, reported as part of the state's annual hunter survey. This data was supplemented with data from known locations of radio-collared wolves. We found that occupancy was relatively stable during the years of the study and wolves were largely restricted to the highest quality habitats in the study area. Transitions in the occupancy status of sites were rare, as occupied sites almost always remained occupied and unoccupied sites remained unoccupied. Failing to account for false positives led to over estimation of both the area inhabited by wolves and the frequency of turnover. The ability to properly account for both false negatives and false positives is an important step to improve inferences for conservation from large-scale public surveys. The approach we propose will improve our understanding of the status of wolf populations and is relevant to many other data types where false positives are a component of observations.	[Miller, David A. W.; Nichols, James D.; Hines, James E.] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA; [Miller, David A. W.] Penn State Univ, Dept Ecosyst Sci & Management, University Pk, PA 16802 USA; [Gude, Justin A.; Podruzny, Kevin M.] Montana Fish Wildlife & Pk, Helena, MT USA; [Rich, Lindsey N.; Mitchell, Michael S.] Univ Montana, Montana Cooperat Wildlife Res Unit, US Geol Survey, Missoula, MT 59812 USA	United States Department of the Interior; United States Geological Survey; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey; University of Montana System; University of Montana	Miller, DAW (corresponding author), US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA.	dxm84@psu.edu	Nichols, James/AAF-7336-2020; Miller, David AW/E-4492-2012	Miller, David AW/0000-0002-3011-3677	sale of hunting and fishing licenses in Montana; Pittman-Robertson program	sale of hunting and fishing licenses in Montana; Pittman-Robertson program	Funding for data collection was provided by the sale of hunting and fishing licenses in Montana, the Pittman-Robertson program administered by the United States Fish and Wildlife Service, and the United States Fish and Wildlife Service wolf recovery program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo MA, 2009, ECOL INFORM, V4, P206, DOI 10.1016/j.ecoinf.2009.06.005; BART J, 1985, WILSON BULL, V97, P161; Campbell M, 2011, AUK, V128, P303, DOI 10.1525/auk.2011.10005; Cohn JP, 2008, BIOSCIENCE, V58, P192, DOI 10.1641/B580303; Farmer RG, 2012, AUK, V129, P76, DOI 10.1525/auk.2012.11129; Fitzpatrick MC, 2009, ECOL APPL, V19, P1673, DOI 10.1890/09-0265.1; Genet KS, 2003, WILDLIFE SOC B, V31, P703; Gude JA, 2012, J WILDLIFE MANAGE, V76, P108, DOI 10.1002/jwmg.201; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hanauska-Brown L., 2012, MONTANA GRAY WOLF CO; Hanks EM, 2011, ECOL APPL, V21, P1173, DOI 10.1890/09-1549.1; Hines J. E., 2010, PRESENCE3 SOFTWARE E; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Kery M, 2010, J BIOGEOGR, V37, P1851, DOI 10.1111/j.1365-2699.2010.02345.x; Lotz A, 2007, J WILDLIFE MANAGE, V71, P675, DOI 10.2193/2005-759; Lukacs PM, 2011, WILDLIFE SOC B, V35, P430, DOI 10.1002/wsb.61; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Martin J, 2010, ECOL APPL, V20, P1173, DOI 10.1890/09-0276.1; McClintock BT, 2010, ECOLOGY, V91, P2446, DOI 10.1890/09-1287.1; McClintock BT, 2010, ECOL LETT, V13, P659, DOI 10.1111/j.1461-0248.2010.01472.x; McKelvey KS, 2008, BIOSCIENCE, V58, P549, DOI 10.1641/B580611; Miller DA, 2011, ECOLOGY, V92, P1422, DOI 10.1890/10-1396.1; Miller DAW, 2012, J ANIM ECOL, V81, P1288, DOI 10.1111/j.1365-2656.2012.02001.x; Miller DAW, 2012, ECOL APPL, V22, P1665; Molinari-Jobin A, 2012, ANIM CONSERV, V15, P266, DOI 10.1111/j.1469-1795.2011.00511.x; Oakleaf JK, 2006, J WILDLIFE MANAGE, V70, P554, DOI 10.2193/0022-541X(2006)70[554:HSBRWI]2.0.CO;2; Pradel R, 2005, BIOMETRICS, V61, P442, DOI 10.1111/j.1541-0420.2005.00318.x; Rich LN, 2012, J MAMMAL, V93, P722, DOI 10.1644/11-MAMM-A-079.2; Rich LN, 2013, J WILDLIFE IN PRESS; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Royle JA, 2006, ECOLOGY, V87, P835, DOI 10.1890/0012-9658(2006)87[835:GSOMAF]2.0.CO;2; Sauer JR, 2003, J WILDLIFE MANAGE, V67, P372, DOI 10.2307/3802778; Sewell D, 2010, BIOL CONSERV, V143, P2102, DOI 10.1016/j.biocon.2010.05.019; Shea CP, 2011, J N AM BENTHOL SOC, V30, P446, DOI 10.1899/10-073.1; Waddle JH, 2009, HERPETOL CONSERV BIO, V4, P384; Weir LA, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P307; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Wright JA, 2009, BIOMETRICS, V65, P833, DOI 10.1111/j.1541-0420.2008.01165.x; Yoshizaki J, 2009, ECOLOGY, V90, P3, DOI 10.1890/08-0304.1	42	67	67	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65808	10.1371/journal.pone.0065808	http://dx.doi.org/10.1371/journal.pone.0065808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840372	gold, Green Published			2022-12-27	WOS:000322361200038
J	Moles, L; Gomez, M; Heilig, H; Bustos, G; Fuentes, S; de Vos, W; Fernandez, L; Rodriguez, JM; Jimenez, E				Moles, Laura; Gomez, Marta; Heilig, Hans; Bustos, Gerardo; Fuentes, Susana; de Vos, Willem; Fernandez, Leonides; Rodriguez, Juan M.; Jimenez, Esther			Bacterial Diversity in Meconium of Preterm Neonates and Evolution of Their Fecal Microbiota during the First Month of Life	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; BIRTH-WEIGHT INFANTS; INTESTINAL MICROBIOTA; NECROTIZING ENTEROCOLITIS; AMNIOTIC-FLUID; COLONIZATION; GUT; PCR; COMMUNITIES; COMPLEX	The establishment and succession of bacterial communities in infants may have a profound impact in their health, but information about the composition of meconium microbiota and its evolution in hospitalized preterm infants is scarce. In this context, the objective of this work was to characterize the microbiota of meconium and fecal samples obtained during the first 3 weeks of life from 14 donors using culture and molecular techniques, including DGGE and the Human Intestinal Tract Chip (HITChip) analysis of 16S rRNA amplicons. Culture techniques offer a quantification of cultivable bacteria and allow further study of the isolate, while molecular techniques provide deeper information on bacterial diversity. Culture and HITChip results were very similar but the former showed lower sensitivity. Inter-individual differences were detected in the microbiota profiles although the meconium microbiota was peculiar and distinct from that of fecal samples. Bacilli and other Firmicutes were the main bacteria groups detected in meconium while Proteobacteria dominated in the fecal samples. Culture technique showed that Staphylococcus predominated in meconium and that Enterococcus, together with Gram-negative bacteria such as Escherichia coli, Escherichia fergusonii, Klebsiella pneumoniae and Serratia marcescens, was more abundant in fecal samples. In addition, HITChip results showed the prevalence of bacteria related to Lactobacillus plantarum and Streptococcus mitis in meconium samples whereas those related to Enterococcus, Escherichia coli, Klebsiella pneumoniae and Yersinia predominated in the 3rd week feces. This study highlights that spontaneously-released meconium of preterm neonates contains a specific microbiota that differs from that of feces obtained after the first week of life. Our findings indicate that the presence of Serratia was strongly associated with a higher degree of immaturity and other hospital-related parameters, including antibiotherapy and mechanical ventilation.	[Moles, Laura; Gomez, Marta; Fernandez, Leonides; Rodriguez, Juan M.; Jimenez, Esther] Univ Complutense Madrid, Dept Nutr Bromatol & Tecnol Alimentos, Madrid, Spain; [Heilig, Hans; Fuentes, Susana; de Vos, Willem] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Bustos, Gerardo] Hosp Univ 12 Octubre, Serv Neonatol, Madrid, Spain; [de Vos, Willem] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland	Complutense University of Madrid; Wageningen University & Research; Hospital Universitario 12 de Octubre; University of Helsinki	Jimenez, E (corresponding author), Univ Complutense Madrid, Dept Nutr Bromatol & Tecnol Alimentos, Madrid, Spain.	esjimene@vet.ucm.es	Fernández, Leonides/N-7521-2019; Álvarez, Leónides Fernández/I-6616-2015; Alegre, Laura Moles/AAX-5445-2020; Rodriguez, Juan Miguel/ABB-6650-2020	Fernández, Leonides/0000-0003-2380-0767; Álvarez, Leónides Fernández/0000-0003-2380-0767; Alegre, Laura Moles/0000-0001-6902-2097; Rodriguez, Juan Miguel/0000-0002-1285-9686; Jimenez, Esther/0000-0002-7141-3588; Gomez, Marta/0000-0003-0475-075X	Ministerio de Ciencia e Innovacion (Spain) [AGL2010-15420]; Ministerio de Sanidad y Consumo, Spain [FIS PS09/00040]; unrestricted Spinoza Award; FEMS Research Fellowship; FUN-C-FOOD, Consolider-Ingenio [CSD2007-00063]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Sanidad y Consumo, Spain(Spanish Government); unrestricted Spinoza Award; FEMS Research Fellowship; FUN-C-FOOD, Consolider-Ingenio	This work was supported by the projects CSD2007-00063 (FUN-C-FOOD, Consolider-Ingenio 2010) and AGL2010-15420 from the Ministerio de Ciencia e Innovacion (Spain), by the project FIS PS09/00040 (Ministerio de Sanidad y Consumo, Spain) and the unrestricted Spinoza Award to WMdV of the Netherlands Foundation for Scientific Research. EJ was granted with a FEMS Research Fellowship to perform HITChip analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearfield C, 2002, BJOG-INT J OBSTET GY, V109, P527, DOI 10.1016/S1470-0328(02)01349-6; BLAKEY JL, 1982, J MED MICROBIOL, V15, P519, DOI 10.1099/00222615-15-4-519; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; Butel MJ, 2007, J PEDIATR GASTR NUTR, V44, P577, DOI 10.1097/MPG.0b013e3180406b20; Campeotto F, 2011, BRIT J NUTR, V105, P1843, DOI 10.1017/S0007114510005702; Claud EC, 2001, FASEB J, V15, P1398, DOI 10.1096/fj.00-0833hyp; Dasanayake AP, 2005, J PERIODONTOL, V76, P171, DOI 10.1902/jop.2005.76.2.171; De la Cochetiere MF, 2004, PEDIATR RES, V56, P366, DOI 10.1203/01.PDR.0000134251.45878.D5; de Man P, 2000, LANCET, V355, P973, DOI 10.1016/S0140-6736(00)90015-1; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; DUTKAMALEN S, 1995, J CLIN MICROBIOL, V33, P24, DOI 10.1128/JCM.33.1.24-27.1995; Fanaro S, 2003, ACTA PAEDIATR, V92, P48; Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001; Favier CF, 2002, APPL ENVIRON MICROB, V68, P219, DOI 10.1128/AEM.68.1.219-226.2002; Felske A, 1998, APPL ENVIRON MICROB, V64, P4581; Ferraris L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030594; Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167; Gosalbes MJ, 2013, CLIN EXP ALLERGY, V43, P198, DOI 10.1111/cea.12063; Hong PY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009964; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hufnagel M, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-107; Jacquot A, 2011, J PEDIATR-US, V158, P390, DOI 10.1016/j.jpeds.2010.09.007; Jimenez E, 2005, CURR MICROBIOL, V51, P270, DOI 10.1007/s00284-005-0020-3; Jimenez E, 2008, RES MICROBIOL, V159, P187, DOI 10.1016/j.resmic.2007.12.007; Jimenez E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-143; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; KORNMAN KS, 1980, J PERIODONTAL RES, V15, P111, DOI 10.1111/j.1600-0765.1980.tb00265.x; Kullen MJ, 2000, J APPL MICROBIOL, V89, P511, DOI 10.1046/j.1365-2672.2000.01146.x; LaTuga MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027858; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Madan JC, 2012, ARCH DIS CHILD-FETAL, V97, pF456, DOI 10.1136/fetalneonatal-2011-301373; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Rouge C, 2010, ANAEROBE, V16, P362, DOI 10.1016/j.anaerobe.2010.06.002; Rouge C, 2009, AM J CLIN NUTR, V89, P1828, DOI 10.3945/ajcn.2008.26919; Ruiz-Barba JL, 2005, ANAL BIOCHEM, V347, P333, DOI 10.1016/j.ab.2005.09.028; SAKATA H, 1985, EUR J PEDIATR, V144, P186, DOI 10.1007/BF00451911; Satokari R, 2009, LETT APPL MICROBIOL, V48, P8, DOI 10.1111/j.1472-765X.2008.02475.x; Schwiertz A, 2003, PEDIATR RES, V54, P393, DOI 10.1203/01.PDR.0000078274.74607.7A; Siggers RH, 2011, J NUTR BIOCHEM, V22, P511, DOI 10.1016/j.jnutbio.2010.08.002; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37	47	237	253	7	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66986	10.1371/journal.pone.0066986	http://dx.doi.org/10.1371/journal.pone.0066986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840569	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400027
J	Johansson, A; Enroth, S; Gyllensten, U				Johansson, Asa; Enroth, Stefan; Gyllensten, Ulf			Continuous Aging of the Human DNA Methylome Throughout the Human Lifespan	PLOS ONE			English	Article							MONOZYGOTIC TWINS; METHYLATION; GENE; IDENTIFICATION; DISCORDANCE; DISORDERS; DISEASE; AGE	DNA methylation plays an important role in development of disease and the process of aging. In this study we examine DNA methylation at 476,366 sites throughout the genome of white blood cells from a population cohort (N = 421) ranging in age from 14 to 94 years old. Age affects DNA methylation at almost one third (29%) of the sites (Bonferroni adjusted P-value <0.05), of which 60.5% becomes hypomethylated and 39.5% hypermethylated with increasing age. DNA methylation sites that are located within CpG islands (CGIs) more often become hypermethylated compared to sites outside an island. CpG sites in promoters are more unaffected by age, whereas sites in enhancers more often becomes hypo-or hypermethylated. Hypermethylated sites are overrepresented among genes that are involved in DNA binding, transcription regulation, processes of anatomical structure and developmental process and cortex neuron differentiation (P-value down to P = 9.14* 10(-67)). By contrast, hypomethylated sites are not strongly overrepresented among any biological function or process. Our results indicate that the 23% of the variation in DNA methylation is attributed chronological age, and that hypermethylation is more site-specific than hypomethylation. It appears that the change in DNA methylation partly overlap with regions that change histone modifications with age, indicating an interaction between the two major epigenetic mechanisms. Epigenetic modifications and change in gene expression over time most likely reflects the natural process of aging and variation between individuals might contribute to the development of age-related phenotypes and diseases such as type II diabetes, autoimmune and cardiovascular disease.	[Johansson, Asa; Enroth, Stefan; Gyllensten, Ulf] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, SciLifeLab Uppsala, Uppsala, Sweden; [Johansson, Asa] Uppsala Univ, Univ Uppsala Hosp, Uppsala Clin Res Ctr, Uppsala, Sweden	SciLifeLab; Uppsala University; Uppsala University; Uppsala University Hospital	Johansson, A (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, SciLifeLab Uppsala, Uppsala, Sweden.	asa.johansson@igp.uu.se	Johansson, Åsa/G-5270-2011; Enroth, Stefan/C-7396-2009; Johansson, Åsa/AAG-6799-2021	Johansson, Åsa/0000-0002-2915-4498; Enroth, Stefan/0000-0002-5056-9137; Johansson, Åsa/0000-0002-2915-4498	Swedish Medical Research Council [K2007-66X-20270-01-3, 2011-2354]; Foundation for Strategic Research (SSF); Swedish Society for Medical Research (SSMF)	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Swedish Society for Medical Research (SSMF)	This work was supported by the Swedish Medical Research Council (K2007-66X-20270-01-3 to UG, 2011-2354 to AJ); the Foundation for Strategic Research (SSF); and the Swedish Society for Medical Research (SSMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bell JT, 2012, PLOS GENET, V8, P189, DOI 10.1371/journal.pgen.1002629; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elashoff MR, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-26; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Han S, 2012, TRENDS CELL BIOL, V22, P42, DOI 10.1016/j.tcb.2011.11.001; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Johansson A, 2009, HUM MOL GENET, V18, P373, DOI 10.1093/hmg/ddn350; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kuratomi G, 2008, MOL PSYCHIATR, V13, P429, DOI 10.1038/sj.mp.4002001; Li BZ, 2011, CELL RES, V21, P1172, DOI 10.1038/cr.2011.92; Li J, 2007, J MACH LEARN RES, V8, P1687; Liu Y, 2013, NAT BIOTECHNOL, V31, P142, DOI 10.1038/nbt.2487; Mascalzoni D, 2010, EUR J HUM GENET, V18, P296, DOI 10.1038/ejhg.2009.155; Oates NA, 2006, AM J HUM GENET, V79, P155, DOI 10.1086/505031; Petronis A, 2003, SCHIZOPHRENIA BULL, V29, P169, DOI 10.1093/oxfordjournals.schbul.a006988; R Core Team, 2012, R LANG ENV STAT COMP; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Skinner MK, 2010, NATURE, V467, P922, DOI 10.1038/467922a; Tang B, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.61; Winnefeld M, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-7-165, 10.1186/gb4033]	31	213	216	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67378	10.1371/journal.pone.0067378	http://dx.doi.org/10.1371/journal.pone.0067378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826282	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000071
J	Corchado, S; Marquez, M; de Oca, MM; Romero-Cores, P; Fernandez-Gutierrez, C; Giron-Gonzalez, JA				Corchado, Sara; Marquez, Mercedes; Montes de Oca, Montserrat; Romero-Cores, Paula; Fernandez-Gutierrez, Clotilde; Giron-Gonzalez, Jose-Antonio			Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSFORMING GROWTH-FACTOR-BETA-1; FIBROSIS PROGRESSION; PROMOTER POLYMORPHISMS; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; IN-VIVO; INFECTION; METAANALYSIS	Objective: Analysis of the contribution of genetic (single nucleotide polymorphisms (SNP) at position -238 and -308 of the tumor necrosis factor alpha (TNF-alpha) and -592 of the interleukin-10 (IL-10) promotor genes) and of classical factors (age, alcohol, immunodepression, antirretroviral therapy) on the risk of liver cirrhosis in human immunodeficiency (HIV)-hepatitis C (HCV) virus coinfected patients. Patients and Methods: Ninety one HIV-HCV coinfected patients (50 of them with chronic hepatitis and 41 with liver cirrhosis) and 55 healthy controls were studied. Demographic, risk factors for the HIV-HCV infection, HIV-related (CD4+ T cell count, antiretroviral therapy, HIV viral load) and HCV-related (serum ALT concentration, HCV viral load, HCV genotype) characteristics and polymorphisms at position -238 and -308 of the tumor necrosis factor alfa (TNF-alpha) and -592 of the interleukin-10 (IL-10) promotor genes were studied. Results: Evolution time of the infection was 21 years in both patients' groups (chronic hepatitis and liver cirrhosis). The group of patients with liver cirrhosis shows a lower CD4+ T cell count at the inclusion in the study (but not at diagnosis of HIV infection), a higher percentage of individuals with previous alcohol abuse, and a higher proportion of patients with the genotype GG at position -238 of the TNF-alpha promotor gene; polymorphism at -592 of the IL-10 promotor gene approaches to statistical significance. Serum concentrations of profibrogenic transforming growth factor beta1 were significantly higher in healthy controls with genotype GG at -238 TNF-alpha promotor gene. The linear regression analysis demonstrates that the genotype GG at -238 TNF-alpha promotor gene was the independent factor associated to liver cirrhosis. Conclusion: It is stressed the importance of immunogenetic factors (TNF-alpha polymorphism at -238 position), above other factors previously accepted (age, gender, alcohol, immunodepression), on the evolution to liver cirrhosis among HIV-infected patients with established chronic HCV infections.	[Corchado, Sara; Marquez, Mercedes; Montes de Oca, Montserrat; Romero-Cores, Paula; Giron-Gonzalez, Jose-Antonio] Hosp Univ Puerta del Mar, Unidad Enfermedades Infecciosas, Cadiz, Spain; [Fernandez-Gutierrez, Clotilde] Hosp Univ Puerta del Mar, Microbiol Serv, Cadiz, Spain	Universidad de Cadiz; Hospital Universitario Puerta del Mar; Universidad de Cadiz; Hospital Universitario Puerta del Mar	Giron-Gonzalez, JA (corresponding author), Hosp Univ Puerta del Mar, Unidad Enfermedades Infecciosas, Cadiz, Spain.	joseantonio.giron@uca.es	Girón-González, José-Antonio/H-3990-2014; Girón-González, José-Antonio/AAG-4199-2020	Girón-González, José-Antonio/0000-0002-7482-5828; Girón-González, José-Antonio/0000-0002-7482-5828; Marquez-Coello, Mercedes/0000-0003-3948-6258; Fernandez Gutierrez del Alamo, Clotilde/0000-0003-2664-3103	"Consejeria de Salud, Junta de Andalucia'' Spain [PI-0076/2008]; "Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III'' Spain [PI 08/0869]; "Intensificacion de la Actividad Investigadora'' in the S.N.S, Instituto de Salud Carlos III, Spain	"Consejeria de Salud, Junta de Andalucia'' Spain(Junta de Andalucia); "Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III'' Spain(Instituto de Salud Carlos III); "Intensificacion de la Actividad Investigadora'' in the S.N.S, Instituto de Salud Carlos III, Spain	This research has been conducted with grants from the "Consejeria de Salud, Junta de Andalucia'' Spain (PI-0076/2008), and the "Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III'' Spain (PI 08/0869). JAGG has a grant for "Intensificacion de la Actividad Investigadora'' in the S.N.S, Instituto de Salud Carlos III, Spain, 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Z, 2005, WORLD J GASTROENTERO, V11, P6656, DOI 10.3748/wjg.v11.i42.6656; Barreiro P, 2011, J INFECT DIS, V203, P1629, DOI 10.1093/infdis/jir113; Bataller R, 2004, GASTROENTEROLOGY, V126, P529, DOI 10.1053/j.gastro.2003.11.018; Bataller R, 2003, HEPATOLOGY, V37, P493, DOI 10.1053/jhep.2003.50127; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Chen D, 2011, GENET MOL RES, V10, P2765, DOI 10.4238/2011.November.8.2; Dai CY, 2006, J VIRAL HEPATITIS, V13, P770, DOI 10.1111/j.1365-2893.2006.00767.x; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Eskdale J, 1998, P NATL ACAD SCI USA, V95, P9465, DOI 10.1073/pnas.95.16.9465; Fabris C, 1998, J INTERF CYTOK RES, V18, P705, DOI 10.1089/jir.1998.18.705; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Friedman SL, 1997, J GASTROENTEROL, V32, P424, DOI 10.1007/BF02934504; FUJII D, 1986, SOMAT CELL MOLEC GEN, V12, P281, DOI 10.1007/BF01570787; Giron-Gonzalez JA, 2005, SCAND J GASTROENTERO, V40, P217, DOI 10.1080/00365520510011470; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Hohler T, 1998, J MED VIROL, V54, P173, DOI 10.1002/(SICI)1096-9071(199803)54:3<173::AID-JMV5>3.0.CO;2-2; Jonsson JR, 2008, HEPATOLOGY, V48, P80, DOI 10.1002/hep.22311; Kawelke N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028181; Knapp S, 2003, IMMUNOGENETICS, V55, P362, DOI 10.1007/s00251-003-0594-5; Macias J, 2006, GUT, V55, P409, DOI 10.1136/gut.2005.065904; Mangia A, 2004, CYTOKINE, V25, P103, DOI 10.1016/j.cyto.2003.10.005; Martinez E, 2007, HIV MED, V8, P251, DOI 10.1111/j.1468-1293.2007.00468.x; Martinez-Sierra C, 2003, CLIN INFECT DIS, V36, P491, DOI 10.1086/367643; MONTSERRAT MD, 2011, J ACQ IMMUN DEF SYND, V56, P420; Nelson DR, 2000, GASTROENTEROLOGY, V118, P655, DOI 10.1016/S0016-5085(00)70134-X; Perrey C, 1998, TRANSPL IMMUNOL, V6, P193, DOI 10.1016/S0966-3274(98)80045-2; Pineda JA, 2005, HEPATOLOGY, V41, P779, DOI 10.1002/hep.20626; POCIOT F, 1995, SCAND J IMMUNOL, V42, P501, DOI 10.1111/j.1365-3083.1995.tb03686.x; Powell EE, 2000, HEPATOLOGY, V31, P828, DOI 10.1053/he.2000.6253; Radwan MI, 2012, CYTOKINE, V60, P271, DOI 10.1016/j.cyto.2012.05.010; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Romero-Gomez M, 2004, GUT, V53, P446, DOI 10.1136/gut.2003.028274; Sandler NG, 2012, NAT REV MICROBIOL, V10, P655, DOI 10.1038/nrmicro2848; Schippers EF, 2004, CYTOKINE, V26, P16, DOI 10.1016/j.cyto.2003.12.003; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; sterreicher CH, NAT MED, V13, P1324; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Tsushima H, 1999, J HEPATOL, V30, P1, DOI 10.1016/S0168-8278(99)80001-4; Veloso S, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-63; Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195; WILSON AG, 1993, J EXP MED, V177, P557, DOI 10.1084/jem.177.2.557; Wright M, 2003, GUT, V52, P574, DOI 10.1136/gut.52.4.574; Yee LJ, 2000, GENES IMMUN, V1, P386, DOI 10.1038/sj.gene.6363696	44	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66619	10.1371/journal.pone.0066619	http://dx.doi.org/10.1371/journal.pone.0066619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840511	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400032
J	Ender, SA; Wetterau, E; Ender, M; Kuhn, JP; Merk, HR; Kayser, R				Ender, Stephan Albrecht; Wetterau, Elmar; Ender, Michaela; Kuehn, Jens-Peter; Merk, Harry Rudolf; Kayser, Ralph			Percutaneous Stabilization System Osseofix (R) for Treatment of Osteoporotic Vertebral Compression Fractures - Clinical and Radiological Results after 12 Months	PLOS ONE			English	Article							BALLOON KYPHOPLASTY; RISK-FACTORS; VERTEBROPLASTY; BODY; CEMENT; EXPERIENCE; EFFICACY	Study Design: A prospective consecutive cohort study (follow-up study). Objective: Our study investigated whether implantation of an expandable titanium mesh cage (Osseofix (R)) is a successful and safe minimally invasive therapy for osteoporotic vertebral compression fractures (VCF). Our experiences, clinical and radiological findings after 12 months follow-up are presented. Kypho- and vertebroplasty are well-established minimally invasive procedures for the treatment of osteoporotic VCF. The main complications associated with both procedures are uncontrolled bone cement leakage. Therefore a suitable alternative has been investigated. Methods: During June 2010 to May 2011 24 patients were included with 32 osteoporotic VCF (T6 to L4). All of them were stabilized with the Osseofix (R) system. Preinterventionally we performed X-ray, MRI, and bone density measurements (DXA). Clinical and radiological results were evaluated preop., postop. and after 12 months postop. based on the Oswestry Disability Index (ODI) and the Visual Analogue Scale (VAS), X-ray (Beck Index, Cobb-angle) and CT. Results: There was a significant improvement in the mean ODI (70,6% to 30,1%) as well as a significant reduction in pain intensity (VAS) (7,7 to 1,4) after 12 month. The mean kyphotic angle according to Cobb showed significant improvements (11,7 degrees to 10,4 degrees) after 12 months. Postinterventional imaging showed only one case of loss of height in a stabilized vertebral body (3.1%). We saw no changes in posterior vertebral wall or adjacent fractures. Except for one pronounced postoperative hematoma we saw no surgical complications including no cement leakage. Conclusions: Stabilization of symptomatic osteoporotic VCF with Osseofix (R) system is a safe and effective procedure, even in fractures with posterior wall involvement. The clinical mid-term results are good at a very low complication rate. The Osseofix (R) system is an interesting alternative to the established procedures of cement augmentation.	[Ender, Stephan Albrecht; Wetterau, Elmar; Merk, Harry Rudolf; Kayser, Ralph] Univ Med Greifswald, Dept Orthopaed & Orthopaed Surg, Greifswald, Germany; [Ender, Michaela; Kuehn, Jens-Peter] Univ Med Greifswald, Dept Diagnost Radiol & Neuroradiol, Greifswald, Germany	Greifswald Medical School; Greifswald Medical School	Ender, SA (corresponding author), Univ Med Greifswald, Dept Orthopaed & Orthopaed Surg, Greifswald, Germany.	stephan.ender@uni-greifswald.de						[Anonymous], 2009, OSTEOLOGIE, V4, P304; Atalay B, 2005, SURG NEUROL, V64, P72, DOI 10.1016/j.surmeu.2005.07.039; Beck E, 1971, Hefte Unfallheilkd, V108, P36; Blattert T, 2009, OSTEOPOROSIS INT, V20, P53; Boonen S, 2011, OSTEOPOROSIS INT, V22, P2915, DOI 10.1007/s00198-011-1639-5; Bouza C, 2006, EUR SPINE J, V15, P1050, DOI 10.1007/s00586-005-0048-x; Bula P, 2010, Z ORTHOP UNFALLCHIR, V148, P646, DOI 10.1055/s-0030-1250379; Bullmann V, 2010, ORTHOPADIE UNFALLCHI, V5, P279; Campbell PG, 2008, CURR REV MUSCULOSKE, V1, P61, DOI 10.1007/s12178-007-9007-y; Chen LH, 2011, ARCH ORTHOP TRAUM SU, V131, P927, DOI 10.1007/s00402-010-1236-7; Cobb J., 1948, AM ACADEMY ORTHOPAED, V5, P261; Dansie DM, 2005, AM J NEURORADIOL, V26, P1595; Felder-Puig R, 2009, ORTHOPADE, V38, P606, DOI 10.1007/s00132-009-1446-2; Felsenberg D, 2002, J BONE MINER RES, V17, P716; Frankel BM, 2007, SPINE J, V7, P575, DOI 10.1016/j.spinee.2006.10.020; Garfin SR, 2001, SPINE, V26, P1511, DOI 10.1097/00007632-200107150-00002; Gaul C, 2008, SCHMERZ, V22, P51, DOI 10.1007/s00482-007-0566-z; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Ghofrani H, 2010, IS BONE CEMENT NECES, V16, P768; Heyde CE, 2006, MAN MED, V44, P504, DOI 10.1007/s00337-006-0486-5; Hierl F, 2007, THESIS LUDWIG MAXIMI; Kasperk C, 2010, J VASC INTERV RADIOL, V21, P701, DOI 10.1016/j.jvir.2010.01.003; Kim SH, 2004, ACTA RADIOL, V45, P440, DOI 10.1080/02841850410005615; Kim YY, 2010, EUR SPINE J, V19, P1907, DOI 10.1007/s00586-010-1479-6; Li XG, 2012, J SPINAL DISORD TECH, V25, P142, DOI 10.1097/BSD.0b013e318213c113; Lieberman IH, 2001, SPINE, V26, P1631, DOI 10.1097/00007632-200107150-00026; Lin EP, 2004, AM J NEURORADIOL, V25, P175; Lin J T, 2004, Eura Medicophys, V40, P233; Lin WC, 2008, EUR SPINE J, V17, P592, DOI 10.1007/s00586-007-0564-y; McGirt MJ, 2009, SPINE J, V9, P501, DOI 10.1016/j.spinee.2009.01.003; Pflugmacher R, 2006, ACTA RADIOL, V47, P830, DOI 10.1080/02841850600854928; Pflugmacher R, 2005, ROFO-FORTSCHR RONTG, V177, P1670, DOI 10.1055/s-2005-858631; Pflugmacher R, 2012, Z ORTHOP UNFALLCHIR, V150, P56, DOI 10.1055/s-0031-1280122; Phillips FM, 2003, SPINE, V28, P2260, DOI 10.1097/01.BRS.0000085092.84097.7B; Phillips FM, 2002, SPINE, V27, P2173, DOI 10.1097/00007632-200210010-00018; Rho YJ, 2012, EUR SPINE J, V21, P905, DOI 10.1007/s00586-011-2099-5; Robinson Y, 2008, PATIENT SAF SURG, V2, P1, DOI 10.1186/1754-9493-2-2; Rollinghoff M, 2010, MINERVA CHIR, V65, P429; Seibel MJ, 2001, DTSCH ARZTEBL, V98, P1681; Stein KV, 2009, WIEN MED WOCHENSCHR, V159, P253, DOI 10.1007/s10354-009-0674-8; Taylor RS, 2007, EUR SPINE J, V16, P1085, DOI 10.1007/s00586-007-0308-z; Theodorou DJ, 2002, CLIN IMAG, V26, P1, DOI 10.1016/S0899-7071(01)00350-3; United Nations (Publisher), 2005, WORLD POP PROSP 2004, P43; Upasani VV, 2010, SPINE, V35, P1783, DOI 10.1097/BRS.0b013e3181b7cc5d; Vallejo R., 2010, TECH REG ANESTH PAIN, V14, P133; WEBSTER FS, 1957, J BONE JOINT SURG AM, V39, P688; Wiener JM, 2002, INT J EPIDEMIOL, V31, P776, DOI 10.1093/ije/31.4.776; Wilhelm K, 2003, ROFO-FORTSCHR RONTG, V175, P1690; Zhao YL, 2010, ORTHOPEDICS, V33, P8	49	15	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65119	10.1371/journal.pone.0065119	http://dx.doi.org/10.1371/journal.pone.0065119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840316	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400005
J	Lin, CS; Liu, Y; Huang, WY; Lu, CF; Teng, S; Ju, TC; He, Y; Wu, YT; Jiang, T; Hsieh, JC				Lin, Chia-Shu; Liu, Yong; Huang, Wei-Yuan; Lu, Chia-Feng; Teng, Shin; Ju, Tzong-Ching; He, Yong; Wu, Yu-Te; Jiang, Tianzi; Hsieh, Jen-Chuen			Sculpting the Intrinsic Modular Organization of Spontaneous Brain Activity by Art	PLOS ONE			English	Article							FUNCTIONAL NETWORKS; DEFAULT MODE; SMALL-WORLD; PREFRONTAL CORTEX; CONNECTIVITY; MUSIC; CEREBELLUM; MOTION	Artistic training is a complex learning that requires the meticulous orchestration of sophisticated polysensory, motor, cognitive, and emotional elements of mental capacity to harvest an aesthetic creation. In this study, we investigated the architecture of the resting-state functional connectivity networks from professional painters, dancers and pianists. Using a graph-based network analysis, we focused on the art-related changes of modular organization and functional hubs in the resting-state functional connectivity network. We report that the brain architecture of artists consists of a hierarchical modular organization where art-unique and artistic form-specific brain states collectively mirror the mind states of virtuosos. We show that even in the resting state, this type of extraordinary and long-lasting training can macroscopically imprint a neural network system of spontaneous activity in which the related brain regions become functionally and topologically modularized in both domain-general and domain-specific manners. The attuned modularity reflects a resilient plasticity nurtured by long-term experience.	[Lin, Chia-Shu] Natl Yang Ming Univ, Sch Dent, Dept Dent, Taipei 112, Taiwan; [Liu, Yong; Jiang, Tianzi] Chinese Acad Sci, LIAMA Ctr Computat Med, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China; [Huang, Wei-Yuan; Hsieh, Jen-Chuen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Integrated Brain Res Unit, Taipei, Taiwan; [Lu, Chia-Feng; Teng, Shin; Wu, Yu-Te] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Ju, Tzong-Ching] Taipei Natl Univ Arts, Sch Mus, Dept Mus, Taipei, Taiwan; [He, Yong] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Wu, Yu-Te; Hsieh, Jen-Chuen] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Jiang, Tianzi] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab NeuroInformat, Minist Educ, Chengdu 610054, Peoples R China; [Hsieh, Jen-Chuen] Ctr Neuropsychiat Res, Natl Hlth Res Inst, Taipei, Taiwan	National Yang Ming Chiao Tung University; Chinese Academy of Sciences; Institute of Automation, CAS; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Beijing Normal University; National Yang Ming Chiao Tung University; University of Electronic Science & Technology of China; National Health Research Institutes - Taiwan	Jiang, T (corresponding author), Chinese Acad Sci, LIAMA Ctr Computat Med, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China.	jiangtz@nlpr.ia.ac.cn; jchsieh@ym.edu.tw	Jiang, Tianzi/I-4256-2012; Lin, Chia-shu/AAA-5143-2019; Lin, Chia-Shu/HGD-7267-2022; Liu, Yong/F-2682-2011; He, Yong/C-2161-2009; He, Yong/Q-5756-2018	Jiang, Tianzi/0000-0001-9531-291X; Lin, Chia-Shu/0000-0002-6575-0887; Liu, Yong/0000-0002-1862-3121; He, Yong/0000-0002-7039-2850	Taipei Veterans General Hospital [V98C1-117, V99C1-155, V101E3-002]; National Science Council of Taiwan [NSC 102-2420-H-075-001-MY3, NSC 102-2420-H-010-004-MY3, NSC 102-2420-H-010-005-MY3]; Aim for the Top University Plan from the Ministry of Education; National Key Basic Research and Development Program of China (973) [2011CB707800]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Aim for the Top University Plan from the Ministry of Education; National Key Basic Research and Development Program of China (973)(National Basic Research Program of China)	This work was supported by the Taipei Veterans General Hospital (V98C1-117, V99C1-155, V101E3-002), the National Science Council of Taiwan (NSC 102-2420-H-075-001-MY3, NSC 102-2420-H-010-004-MY3, NSC 102-2420-H-010-005-MY3), the Aim for the Top University Plan from the Ministry of Education for National Yang-Ming University, and the National Key Basic Research and Development Program of China (973) (Grant No. 2011CB707800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Alexander-Bloch A, 2012, NEUROIMAGE, V59, P3889, DOI 10.1016/j.neuroimage.2011.11.035; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Bassett DS, 2011, P NATL ACAD SCI USA, V108, P7641, DOI 10.1073/pnas.1018985108; Bhattacharya J, 2002, COGNITIVE BRAIN RES, V13, P179, DOI 10.1016/S0926-6410(01)00110-0; Brown S, 2006, CEREB CORTEX, V16, P1157, DOI 10.1093/cercor/bhj057; Brown S, 2011, NEUROIMAGE, V58, P250, DOI 10.1016/j.neuroimage.2011.06.012; Cinzia D, 2009, CURR OPIN NEUROBIOL, V19, P682, DOI 10.1016/j.conb.2009.09.001; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Davison AP, 2006, J NEUROSCI, V26, P5604, DOI 10.1523/JNEUROSCI.5263-05.2006; Dobromyslin VI, 2012, NEUROIMAGE, V60, P2073, DOI 10.1016/j.neuroimage.2012.01.139; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Freedberg D, 2007, TRENDS COGN SCI, V11, P197, DOI 10.1016/j.tics.2007.02.003; Gong GL, 2011, NEUROSCIENTIST, V17, P575, DOI 10.1177/1073858410386492; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Joassin F, 2011, CORTEX, V47, P367, DOI 10.1016/j.cortex.2010.03.003; Kelly C, 2012, TRENDS COGN SCI, V16, P181, DOI 10.1016/j.tics.2012.02.001; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Molnar-Szakacs I, 2006, SOC COGN AFFECT NEUR, V1, P235, DOI 10.1093/scan/nsl029; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Platel H, 2003, NEUROIMAGE, V20, P244, DOI 10.1016/S1053-8119(03)00287-8; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Sang L, 2012, NEUROIMAGE, V61, P1213, DOI 10.1016/j.neuroimage.2012.04.011; Simonton DK, 2009, PERSPECT PSYCHOL SCI, V4, P441, DOI 10.1111/j.1745-6924.2009.01152.x; Tagliazucchi E, 2013, NEUROIMAGE, V70, P327, DOI 10.1016/j.neuroimage.2012.12.073; Taubert M, 2011, NEUROIMAGE, V57, P1492, DOI 10.1016/j.neuroimage.2011.05.078; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66761	10.1371/journal.pone.0066761	http://dx.doi.org/10.1371/journal.pone.0066761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840527	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400039
J	Liu, XJ; Kong, FZ; Wang, YH; Zheng, JH; Wan, WD; Deng, CL; Mao, GY; Li, J; Yang, XM; Zhang, YL; Zhang, XL; Yang, SL; Zhang, ZG				Liu, Xiao-Jin; Kong, Fan-Zhi; Wang, Ya-Hui; Zheng, Jiang-Hong; Wan, Wei-Dong; Deng, Chen-Liang; Mao, Guang-Yu; Li, Jun; Yang, Xiao-Mei; Zhang, Yan-Li; Zhang, Xue-li; Yang, Song-lin; Zhang, Zhi-Gang			Lumican Accelerates Wound Healing by Enhancing alpha 2 beta 1 Integrin-Mediated Fibroblast Contractility	PLOS ONE			English	Article							KERATINOCYTE ACTIVATION; REPAIR; MATRIX; MYOFIBROBLASTS; ANGIOGENESIS; INFLAMMATION; MECHANISMS; MIGRATION; MODEL	Lumican is a dermatan sulfate proteoglycan highly expressed in connective tissue and has the ability to regulate collagen fibril assembly. Previous studies have shown that lumican is involved in wound healing, but the precise effects of lumican on reepithelialization and wound contraction, the two pivotal aspects of skin wound healing, have not been investigated. Here we explored the roles of lumican in fibroblast contractility, a main aspect of skin wound healing, by adopting mice skin wound healing model and the corresponding in vitro cellular experiments. Our results showed that lumican can promote skin wound healing by facilitating wound fibroblast activation and contraction but not by promoting keratinocyte proliferation and migration. Silencing of integrin alpha 2 completely abolished the pro-contractility of lumican, indicating lumican enhances fibroblast contractility via integrin alpha 2. Our study for the first time demonstrated that lumican can affect fibroblast's mechanical property, which is pivotal for many important pathological processes, such as wound healing, fibrosis, and tumor development, suggesting that lumican might have a potential to be used to modulate these processes.	[Liu, Xiao-Jin; Zheng, Jiang-Hong; Wan, Wei-Dong; Deng, Chen-Liang; Mao, Guang-Yu; Yang, Song-lin] Shanghai Jiao Tong Univ, Dept Plast Surg, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Liu, Xiao-Jin; Kong, Fan-Zhi; Wang, Ya-Hui; Li, Jun; Yang, Xiao-Mei; Zhang, Yan-Li; Zhang, Zhi-Gang] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Ren Ji Hosp, Shanghai 200030, Peoples R China; [Kong, Fan-Zhi; Zhang, Xue-li] Cent Hosp Fengxian Dist, Dept Gen Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, SL (corresponding author), Shanghai Jiao Tong Univ, Dept Plast Surg, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	slyang@sjtu.edu.cn; zzhang@shsci.org		Deng, Chen-Liang/0000-0001-6924-9195	National Key Sci-Tech Special Projects of Infectious Diseases [2013ZX10002-007-006]; National Science Foundation of China [81000837, 81071738, 81101600, 81201624]; Innovation Program of Shanghai Municipal Education Commission [12YZ043]	National Key Sci-Tech Special Projects of Infectious Diseases; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	The work was supported by the National Key Sci-Tech Special Projects of Infectious Diseases (2013ZX10002-007-006), the National Science Foundation of China (81000837, 81071738, 81101600 and 81201624) and the Innovation Program of Shanghai Municipal Education Commission (12YZ043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha R, 2011, J SURG RES, V171, P700, DOI 10.1016/j.jss.2011.07.007; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brezillon S, 2009, CANCER LETT, V283, P92, DOI 10.1016/j.canlet.2009.03.032; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Carlson MA, 2004, WOUND REPAIR REGEN, V12, P134, DOI 10.1111/j.1067-1927.2004.012208.x; D'Onofrio MF, 2008, BIOCHEM BIOPH RES CO, V365, P266, DOI 10.1016/j.bbrc.2007.10.155; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Geiger B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005033; GRINNELL F, 1992, J CELL SCI, V101, P1; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Gunter CI, 2012, EUR SURG RES, V49, P16, DOI 10.1159/000339860; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Huang CY, 2012, CONNECT TISSUE RES, V53, P187, DOI 10.3109/03008207.2011.642035; Ingber DE, 2008, PROG BIOPHYS MOL BIO, V97, P163, DOI 10.1016/j.pbiomolbio.2008.02.005; Junker JPE, 2013, J CRANIOFAC SURG, V24, P12, DOI 10.1097/SCS.0b013e31827104fb; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Langevin HM, 2011, J CELL PHYSIOL, V226, P1166, DOI 10.1002/jcp.22442; Lee S, 2009, J BIOL CHEM, V284, P23662, DOI 10.1074/jbc.M109.026229; Li J, 2007, CLIN DERMATOL, V25, P9, DOI 10.1016/j.clindermatol.2006.09.007; Liu X, 2013, J INVESTIGATIVE DERM; Lohr K, 2012, INFLAMM BOWEL DIS, V18, P143, DOI 10.1002/ibd.21713; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Niewiarowska J, 2011, THROMB RES, V128, P452, DOI 10.1016/j.thromres.2011.06.011; Nikitovic D, 2008, IUBMB LIFE, V60, P818, DOI 10.1002/iub.131; Okamoto O, 2006, CONNECT TISSUE RES, V47, P177, DOI 10.1080/03008200600846564; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Schedin P, 2011, COLD SPRING HARBOR P, P3; Schultz GS, 2011, WOUND REPAIR REGEN, V19, P134, DOI 10.1111/j.1524-475X.2011.00673.x; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vuillermoz B, 2004, EXP CELL RES, V296, P294, DOI 10.1016/j.yexcr.2004.02.005; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P116, DOI 10.1016/j.ceb.2011.11.001; Wong VW, 2012, SEMIN CELL DEV BIOL, V23, P981, DOI 10.1016/j.semcdb.2012.09.010; Yeh JT, 2010, BRIT J DERMATOL, V163, P1174, DOI 10.1111/j.1365-2133.2010.10008.x; Yeh LK, 2005, INVEST OPHTH VIS SCI, V46, P479, DOI 10.1167/iovs.04-1014; Zeltz C, 2010, EXP CELL RES, V316, P2922, DOI 10.1016/j.yexcr.2010.08.002	42	33	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67124	10.1371/journal.pone.0067124	http://dx.doi.org/10.1371/journal.pone.0067124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840601	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400074
J	Champion, K; Chiu, L; Ferbas, J; Pepe, M				Champion, Keith; Chiu, Laura; Ferbas, John; Pepe, Michael			Endotoxin Neutralization as a Biomonitor for Inflammatory Bowel Disease	PLOS ONE			English	Article							SEVERE SEPSIS; LIPID-A; ANTIENDOTOXIN ANTIBODIES; INTESTINAL PERMEABILITY; SYSTEMIC ENDOTOXEMIA; HUMORAL COMPONENT; CROHNS-DISEASE; PROTEIN; INACTIVATION; GENDER	Gram-negative bacterial endotoxin is a potent immunostimulant implicated in the development and/or progression of a variety of diseases. The mammalian immune system has both innate and adaptive immune responses to neutralize endotoxin. In this study, a system was developed to monitor bacterial exposure by measuring the extent and nature of endotoxin neutralization in plasma. In control patients, females had higher levels of endotoxin neutralization than males, mirroring clinical outcomes from bacterial infection and sepsis. In addition to the total amount of neutralization, we used inactivation techniques to elucidate the nature of this activity and develop a system to compare early and late immune responses. Using this method to monitor patients with inflammatory bowel disease, we found a more robust total response that relies more on long-term, adaptive components of the immune system and less on early, innate components. Our results indicate that endotoxin neutralization is a valuable method to discern inflammatory bowel disease patients from a control population. Additionally, the nature of neutralization may be valuable in monitoring disease severity and/or the role of medication.	[Champion, Keith; Pepe, Michael] BioDtech Inc, Birmingham, AL USA; [Chiu, Laura; Ferbas, John] Amgen Inc, Dept Clin Immunol, Thousand Oaks, CA 91320 USA	Amgen	Champion, K (corresponding author), BioDtech Inc, Birmingham, AL USA.	kchampion@biodtechinc.com			BioDtech, Inc.; Amgen, Inc.	BioDtech, Inc.; Amgen, Inc.(Amgen)	KC and MP are both employed and own stock options in BioDtech, Inc., whose company partly funded this study. LC and JF are employees of Amgen, Inc., whose company partly funded this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adrie C, 2007, CHEST, V132, P1786, DOI 10.1378/chest.07-0420; Al-Muzairai IA, 2008, TRANSPL P, V40, P2198, DOI 10.1016/j.transproceed.2008.07.045; Barclay G R, 1995, Prog Clin Biol Res, V392, P263; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; BERGER D, 1990, FEBS LETT, V277, P33, DOI 10.1016/0014-5793(90)80803-Q; Birrenbach T, 2004, INFLAMM BOWEL DIS, V10, P848, DOI 10.1097/00054725-200411000-00019; BJORNSON BH, 1988, INFECT IMMUN, V56, P1602, DOI 10.1128/IAI.56.6.1602-1607.1988; Caradonna L, 2000, J ENDOTOXIN RES, V6, P205, DOI 10.1177/09680519000060030101; EMANCIPATOR K, 1992, INFECT IMMUN, V60, P596, DOI 10.1128/IAI.60.2.596-601.1992; Foxman B, 2002, AM J MED, V113, p5S; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; GARDINER KR, 1995, GUT, V36, P897, DOI 10.1136/gut.36.6.897; Halme L, 2006, WORLD J GASTROENTERO, V12, P3668, DOI 10.3748/wjg.v12.i23.3668; Hardy Karolyn W., 2001, Journal of Neurochemistry, V78, P1183, DOI 10.1046/j.1471-4159.2001.00486.x; JACKSON SK, 1993, EUR J CLIN INVEST, V23, P540, DOI 10.1111/j.1365-2362.1993.tb00963.x; Jirillo E, 1991, Acta Neurol (Napoli), V13, P188; JOHNS MA, 1988, INFECT IMMUN, V56, P1593, DOI 10.1128/IAI.56.6.1593-1601.1988; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; KATSCHINSKI B, 1993, DIGEST DIS SCI, V38, P1596, DOI 10.1007/BF01303165; KEENE WR, 1961, J CLIN INVEST, V40, P302, DOI 10.1172/JCI104257; KRUIS W, 1984, DIGEST DIS SCI, V29, P502, DOI 10.1007/BF01296269; LANDY M, 1960, ANN NY ACAD SCI, V88, P1273, DOI 10.1111/j.1749-6632.1960.tb20118.x; Liao W, 1996, J LAB CLIN MED, V128, P452, DOI 10.1016/S0022-2143(96)90042-6; Macfarlane S, 2009, CRIT REV CL LAB SCI, V46, P25, DOI [10.1080/10408360802485792, 10.1080/10408360802485792 ]; Macpherson A, 1996, GUT, V38, P365, DOI 10.1136/gut.38.3.365; MARGET W, 1987, INFECTION, V15, P142, DOI 10.1007/BF01650220; MARTSEV SP, 1995, FEBS LETT, V361, P173, DOI 10.1016/0014-5793(95)00145-Y; MATTSBYBALTZER I, 1984, REV INFECT DIS, V6, P553; Maury E, 2003, J CRIT CARE, V18, P115, DOI 10.1053/jcrc.2003.50004; MCGUE M, 1990, HUM HERED, V40, P231, DOI 10.1159/000153935; Mehrzad J, 2007, VET RES, V38, P655, DOI 10.1051/vetres:2007024; MODICA MA, 1989, EXP CLIN IMMUNOGENET, V6, P251; Neylan TC, 2011, BRAIN BEHAV IMMUN, V25, P524, DOI 10.1016/j.bbi.2010.12.001; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; ODEH M, 1994, J CLIN GASTROENTEROL, V19, P146, DOI 10.1097/00004836-199409000-00016; Oertelt-Prigione S, 2012, AUTOIMMUN REV, V11, pA479, DOI 10.1016/j.autrev.2011.11.022; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Orholm M, 2000, SCAND J GASTROENTERO, V35, P1075; ORIISHI T, 1995, GUT, V36, P891, DOI 10.1136/gut.36.6.891; Parracho HMRT, 2005, J MED MICROBIOL, V54, P987, DOI 10.1099/jmm.0.46101-0; Rojo OP, 2007, INFLAMM BOWEL DIS, V13, P269, DOI 10.1002/ibd.20019; Petsch D, 1998, ANAL BIOCHEM, V259, P42, DOI 10.1006/abio.1998.2655; Poelstra K, 1997, LAB INVEST, V76, P319; PORAT R, 1992, INFECT IMMUN, V60, P1756, DOI 10.1128/IAI.60.5.1756-1760.1992; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rampton DS, 2011, J RHEUMATOL, V38, P43, DOI 10.3899/jrheum.110904; RAYNAUD M, 1973, J INFECT DIS, V128, pS35, DOI 10.1093/infdis/128.Supplement_1.S35; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; SCHETTERS T, 1988, J IMMUNOL METHODS, V109, P193, DOI 10.1016/0022-1759(88)90242-6; Schroder J, 1998, ARCH SURG-CHICAGO, V133, P1200, DOI 10.1001/archsurg.133.11.1200; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Shoda R, 1996, AM J CLIN NUTR, V63, P741, DOI 10.1093/ajcn/63.5.741; SKARNES RC, 1958, J EXP MED, V108, P685, DOI 10.1084/jem.108.5.685; Vermeer AWP, 2000, BIOPHYS J, V78, P394, DOI 10.1016/S0006-3495(00)76602-1; Vermeire S, 2005, NAT CLIN PRACT GASTR, V2, P580, DOI 10.1038/ncpgasthep0359; Vilela EG, 2012, WORLD J GASTROENTERO, V18, P872, DOI 10.3748/wjg.v18.i9.872; Welcker K, 2004, EUR J MED RES, V9, P456; Wichmann MW, 2000, INTENS CARE MED, V26, P167, DOI 10.1007/s001340050041; WILMOTT RW, 1994, PEDIATR PULM, V18, P21, DOI 10.1002/ppul.1950180107; YAMAGUCHI Y, 1986, P SOC EXP BIOL MED, V181, P163	60	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67736	10.1371/journal.pone.0067736	http://dx.doi.org/10.1371/journal.pone.0067736			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826338	gold, Green Submitted, Green Published			2022-12-27	WOS:000321738400170
J	Isik, G; Chung, NPY; van Montfort, T; Menis, S; Matthews, K; Schief, WR; Moore, JP; Sanders, RW				Isik, Gozde; Chung, Nancy P. Y.; van Montfort, Thijs; Menis, Sergey; Matthews, Katie; Schief, William R.; Moore, John P.; Sanders, Rogier W.			An HIV-1 Envelope Glycoprotein Trimer with an Embedded IL-21 Domain Activates Human B Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; COLONY-STIMULATING FACTOR; 2ND HYPERVARIABLE REGION; NEUTRALIZING ANTIBODY; RECOMBINANT GLYCOPROTEIN-120; METASTATIC MELANOMA; VACCINE EFFICACY; PARTIAL DELETION; MACAQUE MONKEYS; IMMUNE-RESPONSE	Broadly neutralizing antibodies (bNAbs) that target the HIV-1 envelope glycoproteins (Env) can prevent virus acquisition, but several Env properties limit its ability to induce an antibody response that is of sufficient quantity and quality. The immunogenicity of Env can be increased by fusion to co-stimulatory molecules and here we describe novel soluble Env trimers with embedded interleukin-4 (IL-4) or interleukin-21 (IL-21) domains, designed to activate B cells that recognize Env. In particular, the chimeric Env(IL-21) molecule activated B cells efficiently and induced the differentiation of antibody secreting plasmablast-like cells. We studied whether we could increase the activity of the embedded IL-21 by designing a chimeric IL-21/IL-4 (ChimIL-21/4) molecule and by introducing amino acid substitutions in the receptor binding domain of IL-21 that were predicted to enhance its binding. In addition, we incorporated IL-21 into a cleavable Env trimer and found that insertion of IL-21 did not impair Env cleavage, while Env cleavage did not impair IL-21 activity. These studies should guide the further design of chimeric proteins and Env(IL-21) may prove useful in improving antibody responses against HIV-1.	[Isik, Gozde; van Montfort, Thijs; Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Chung, Nancy P. Y.; Matthews, Katie; Moore, John P.; Sanders, Rogier W.] Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; [Menis, Sergey] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Menis, Sergey; Schief, William R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, San Diego, CA USA; [Menis, Sergey; Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, San Diego, CA USA; [Schief, William R.] Scripps Res Inst, Scripps Ctr HIV AIDS Vaccine Immunol & Immunogen, San Diego, CA USA	University of Amsterdam; Academic Medical Center Amsterdam; Cornell University; University of Washington; University of Washington Seattle; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Sanders, RW (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, Lab Expt Virol,Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands.	r.w.sanders@amc.uva.nl	Schief, William/ABF-3645-2020	Schief, William/0000-0002-1120-0150; Isik, Gozde/0000-0002-1329-6782	Aids Fonds (the Netherlands) [2008013, 2009012]; National Institutes of Health [POI AI82362, R37 AI36082]; Netherlands Organization for Scientific Research; European Research Council [ERC-StG-2011-280829-SHEV]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036082, P01AI082362] Funding Source: NIH RePORTER	Aids Fonds (the Netherlands)(Netherlands Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Aids Fonds (the Netherlands) grants #2008013 and #2009012 and by National Institutes of Health Grants POI AI82362 and R37 AI36082. RWS is a recipient of a Vidi fellowship from the Netherlands Organization for Scientific Research, and a Starting Investigator grant from the European Research Council (ERC-StG-2011-280829-SHEV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON KP, 1989, J INFECT DIS, V160, P960, DOI 10.1093/infdis/160.6.960; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Banerjee K, 2012, AIDS RES HUM RETROV, V28, P206, DOI 10.1089/aid.2011.0101; Banerjee K, 2009, VIROLOGY, V389, P108, DOI 10.1016/j.virol.2009.04.001; Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Bondensgaard K, 2007, J BIOL CHEM, V282, P23326, DOI 10.1074/jbc.M701313200; Bontjer I, 2010, J BIOL CHEM, V285, P36456, DOI 10.1074/jbc.M110.156588; Bontjer I, 2009, J VIROL, V83, P368, DOI 10.1128/JVI.01404-08; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cao J, 1997, J VIROL, V71, P9808, DOI 10.1128/JVI.71.12.9808-9812.1997; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Chung NPY, 2012, J IMMUNOL, V189, P5257, DOI 10.4049/jimmunol.1201905; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; Crooks ET, 2011, J VIROL, V85, P5825, DOI 10.1128/JVI.00154-11; Cutalo JM, 2004, J AM SOC MASS SPECTR, V15, P1545, DOI 10.1016/j.jasms.2004.07.008; Davis ID, 2007, CLIN CANCER RES, V13, P3630, DOI 10.1158/1078-0432.CCR-07-0410; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Denecker G, 1997, CYTOKINE, V9, P631, DOI 10.1006/cyto.1997.0218; Dey AK, 2009, VIROLOGY, V385, P275, DOI 10.1016/j.virol.2008.12.009; Eggink D, 2010, VIROLOGY, V401, P236, DOI 10.1016/j.virol.2010.02.019; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Ettinger R, 2005, J IMMUNOL, V175, P7867, DOI 10.4049/jimmunol.175.12.7867; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Hill EE, 2002, J MOL BIOL, V322, P205, DOI 10.1016/S0022-2836(02)00653-8; Isik G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060126; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; JUST U, 1993, GROWTH FACTORS, V9, P291, DOI 10.3109/08977199308991589; Kang LS, 2010, J BIOL CHEM, V285, P12223, DOI 10.1074/jbc.M110.101444; KLEIN B, 1982, EXP HEMATOL, V10, P373; Kuhlman B, 2001, P NATL ACAD SCI USA, V98, P10687, DOI 10.1073/pnas.181354398; Kutzler MA, 2004, J CLIN INVEST, V114, P1241, DOI 10.1172/JCI200423467; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Li YX, 2012, J VIROL, V86, P11231, DOI 10.1128/JVI.01543-12; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu Y, 2006, NUCLEIC ACIDS RES, V34, pW235, DOI 10.1093/nar/gkl163; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McHeyzer-Williams LJ, 2009, CURR OPIN IMMUNOL, V21, P266, DOI 10.1016/j.coi.2009.05.010; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Melchers M, 2012, J VIROL, V86, P2488, DOI 10.1128/JVI.06259-11; Melchers M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-48; Moore PL, 2006, J VIROL, V80, P2515, DOI 10.1128/JVI.80.5.2515-2528.2006; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Ozaki K, 2004, J IMMUNOL, V173, P5361, DOI 10.4049/jimmunol.173.9.5361; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Parren PWHI, 1997, NAT MED, V3, P366, DOI 10.1038/nm0497-366d; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Parren PWHI, 1997, CHEM IMMUNOL, V65, P18; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Reitter JN, 1998, J VIROL, V72, P5399, DOI 10.1128/JVI.72.7.5399-5407.1998; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Shan MM, 2007, PLOS PATHOG, V3, P1637, DOI 10.1371/journal.ppat.0030169; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Si ZH, 2003, AIDS RES HUM RETROV, V19, P217, DOI 10.1089/088922203763315722; Srivastava IK, 2003, J VIROL, V77, P2310, DOI 10.1128/JVI.77.4.2310-2320.2003; Thompson JA, 2008, J CLIN ONCOL, V26, P2034, DOI 10.1200/JCO.2007.14.5193; THORBECKE GJ, 1994, FASEB J, V8, P832, DOI 10.1096/fasebj.8.11.8070632; Van Montfort T, 2011, J BIOL CHEM, V286, P22250, DOI 10.1074/jbc.M111.229625; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yu HF, 2011, J LEUKOCYTE BIOL, V90, P205, DOI 10.1189/jlb.1010579; Zeng R, 2005, J EXP MED, V201, P139, DOI 10.1084/jem.20041057; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhu XG, 2000, BIOCHEMISTRY-US, V39, P11194, DOI 10.1021/bi000432m; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	88	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67309	10.1371/journal.pone.0067309	http://dx.doi.org/10.1371/journal.pone.0067309			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826263	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400132
J	Malqvist, M; Yuan, BB; Trygg, N; Selling, K; Thomsen, S				Malqvist, Mats; Yuan, Beibei; Trygg, Nadja; Selling, Katarina; Thomsen, Sarah			Targeted Interventions for Improved Equity in Maternal and Child Health in Low- and Middle-Income Settings: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							CASH TRANSFER PROGRAM; VOUCHER SCHEME; INSTITUTIONAL DELIVERY; COVERAGE; POOR; CARE; IMMUNIZATION; MORTALITY; SERVICES; IMPACT	Background: Targeted interventions to improve maternal and child health is suggested as a feasible and sometimes even necessary strategy to reduce inequity. The objective of this systematic review was to gather the evidence of the effectiveness of targeted interventions to improve equity in MDG 4 and 5 outcomes. Methods and Findings: We identified primary studies in all languages by searching nine health and social databases, including grey literature and dissertations. Studies evaluating the effect of an intervention tailored to address a structural determinant of inequity in maternal and child health were included. Thus general interventions targeting disadvantaged populations were excluded. Outcome measures were limited to indicators proposed for Millennium Development Goals 4 and 5. We identified 18 articles, whereof 15 evaluated various incentive programs, two evaluated a targeted policy intervention, and only one study evaluated an intervention addressing a cultural custom. Meta-analyses of the effectiveness of incentives programs showed a pooled effect size of RR 1.66 (95% CI 1.43-1.93) for antenatal care attendance (four studies with 2,476 participants) and RR 2.37 (95% CI 1.38-4.07) for health facility delivery (five studies with 25,625 participants). Meta-analyses were not performed for any of the other outcomes due to scarcity of studies. Conclusions: The targeted interventions aiming to improve maternal and child health are mainly limited to addressing economic disparities through various incentive schemes like conditional cash transfers and voucher schemes. This is a feasible strategy to reduce inequity based on income. More innovative action-oriented research is needed to speed up progress in maternal and child survival among the most disadvantaged populations through interventions targeting the underlying structural determinants of inequity.	[Malqvist, Mats; Selling, Katarina] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Yuan, Beibei] Peking Univ, China Ctr Hlth Dev Studies, Beijing 100871, Peoples R China; [Trygg, Nadja; Thomsen, Sarah] Karolinska Inst, Global Hlth IHCAR, Dept Publ Hlth Sci, Solna, Sweden	Uppsala University; Peking University; Karolinska Institutet	Malqvist, M (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	mats.malqvist@kbh.uu.se	Målqvist, Mats/G-6748-2017; Målqvist, Mats/Q-1274-2019	Målqvist, Mats/0000-0002-8184-3530; Målqvist, Mats/0000-0002-8184-3530; Selling, Katarina/0000-0001-8036-168X	Swedish International Development Cooperation Agency (Sida)	Swedish International Development Cooperation Agency (Sida)	This review has been funded through a grant from Swedish International Development Cooperation Agency (Sida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha S, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-57; Agha S, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-10; Ahmed S, 2011, SOC SCI MED, V72, P1704, DOI 10.1016/j.socscimed.2011.03.031; Ahmed S, 2011, HEALTH POLICY PLANN, V26, P25, DOI 10.1093/heapol/czq015; Bailey EJ, 2009, COCHRANE DATABASE SY; Banerjee Abhijit Vinayak, 2010, BMJ, V340, pc2220, DOI 10.1136/bmj.c2220; Barham T, 2005, IMPACT MEXICAN CONDI; Barham T, 2009, J HEALTH ECON, V28, P611, DOI 10.1016/j.jhealeco.2008.12.010; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Feldman BS, 2009, STUD FAMILY PLANN, V40, P51, DOI 10.1111/j.1728-4465.2009.00186.x; Gwatkin DR, 2004, LANCET, V364, P1273, DOI 10.1016/S0140-6736(04)17145-6; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Hawthorne K, 2010, DIABETIC MED, V27, P613, DOI 10.1111/j.1464-5491.2010.02954.x; Hill K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001303; Ir P, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-1; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lagarde M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008137; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Mavalankar D, 2009, INT J GYNECOL OBSTET, V107, P271, DOI 10.1016/j.ijgo.2009.09.008; McQuestion MJ, 2006, HEALTH POLICY, V77, P221, DOI 10.1016/j.healthpol.2005.07.007; Meegan ME, 2001, LANCET, V358, P640, DOI 10.1016/S0140-6736(01)05787-7; Meuwissen Liesbeth E, 2006, J Adolesc Health, V38, P56; Morris SS, 2004, LANCET, V364, P2030, DOI 10.1016/S0140-6736(04)17515-6; Nguyen HTH, 2012, SOC SCI MED, V74, P989, DOI 10.1016/j.socscimed.2011.11.030; R Core Team, 2018, R LANG ENV STAT COMP; Rob U, 2010, INT Q COMMUNITY HEAL, V30, P293, DOI 10.2190/IQ.30.4.b; Sosa-Rubi SG, 2011, HEALTH POLICY PLANN, V26, P496, DOI 10.1093/heapol/czq085; Thomas B H, 2004, Worldviews Evid Based Nurs, V1, P176, DOI 10.1111/j.1524-475X.2004.04006.x; Thomsen S, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.19650; Thomsen S, 2011, REPROD HEALTH MATTER, V19, P176, DOI 10.1016/S0968-8080(11)38586-2; Uddin MJ, 2012, VACCINE, V30, P168, DOI 10.1016/j.vaccine.2011.11.030; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Witter S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007899.pub2	34	38	39	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66453	10.1371/journal.pone.0066453	http://dx.doi.org/10.1371/journal.pone.0066453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190LY	23840474	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800061
J	Peiffer, JA; Flint-Garcia, SA; De Leon, N; McMullen, MD; Kaeppler, SM; Buckler, ES				Peiffer, Jason A.; Flint-Garcia, Sherry A.; De Leon, Natalia; McMullen, Michael D.; Kaeppler, Shawn M.; Buckler, Edward S.			The Genetic Architecture of Maize Stalk Strength	PLOS ONE			English	Article							RIND PENETROMETER RESISTANCE; GENOME-WIDE ASSOCIATION; QUANTITATIVE RESISTANCE; LEAF-BLIGHT; SELECTION; TRAITS; POPULATION; MODEL; PREDICTION; PARAMETER	Stalk strength is an important trait in maize (Zea mays L.). Strong stalks reduce lodging and maximize harvestable yield. Studies show rind penetrometer resistance (RPR), or the force required to pierce a stalk rind with a spike, is a valid approximation of strength. We measured RPR across 4,692 recombinant inbreds (RILs) comprising the maize nested association mapping (NAM) panel derived from crosses of diverse inbreds to the inbred, B73. An intermated B73xMo17 family (IBM) of 196 RILs and a panel of 2,453 diverse inbreds from the North Central Regional Plant Introduction Station (NCRPIS) were also evaluated. We measured RPR in three environments. Family-nested QTL were identified by joint-linkage mapping in the NAM panel. We also performed a genome-wide association study (GWAS) and genomic best linear unbiased prediction (GBLUP) in each panel. Broad sense heritability computed on a line means basis was low for RPR. Only 8 of 26 families had a heritability above 0.20. The NCRPIS diversity panel had a heritability of 0.54. Across NAM and IBM families, 18 family-nested QTL and 141 significant GWAS associations were identified for RPR. Numerous weak associations were also found in the NCRPIS diversity panel. However, few were linked to loci involved in phenylpropanoid and cellulose synthesis or vegetative phase transition. Using an identity-by-state (IBS) relationship matrix estimated from 1.6 million single nucleotide polymorphisms (SNPs) and RPR measures from 20% of the NAM panel, genomic prediction by GBLUP explained 64 +/- 2% of variation in the remaining RILs. In the NCRPIS diversity panel, an IBS matrix estimated from 681,257 SNPs and RPR measures from 20% of the panel explained 33 +/- 3% of variation in the remaining inbreds. These results indicate the high genetic complexity of stalk strength and the potential for genomic prediction to hasten its improvement.	[Peiffer, Jason A.; Buckler, Edward S.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY USA; [Flint-Garcia, Sherry A.; McMullen, Michael D.] Univ Missouri, USDA ARS, Plant Genet Res Unit, Columbia, MO USA; [Flint-Garcia, Sherry A.; McMullen, Michael D.] Univ Missouri, Div Plant Sci, Columbia, MO USA; [De Leon, Natalia; Kaeppler, Shawn M.] Univ Wisconsin, Dept Agron, Madison, WI USA; [Buckler, Edward S.] USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA	Cornell University; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA)	Peiffer, JA (corresponding author), N Carolina State Univ, Bioinformat Res Ctr, Dept Genet, Raleigh, NC 27695 USA.	japeiffe@ncsu.edu	Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022	Buckler, Edward/0000-0002-3100-371X; Flint-Garcia, Sherry/0000-0003-4156-5318; Kaeppler, Shawn/0000-0002-5964-1668	National Science Foundation [0820619]; United States Department of Agriculture - Agricultural Research Service; Direct For Biological Sciences [1238014] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0820619] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture - Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation award 0820619 and the United States Department of Agriculture - Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon BG, 1999, CROP SCI, V39, P108, DOI 10.2135/cropsci1999.0011183X003900010017x; ARNOLD JM, 1974, AGRON J, V66, P605, DOI 10.2134/agronj1974.00021962006600050003x; Asoro FG, 2011, PLANT GENOME-US, V4, P132, DOI 10.3835/plantgenome2011.02.0007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERZONSKY WA, 1986, CROP SCI, V26, P482, DOI 10.2135/cropsci1986.0011183X002600030009x; Bosch M, 2011, J EXP BOT, V62, P3545, DOI 10.1093/jxb/err045; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brown PJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002383; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; CHAMBERS KR, 1987, J PHYTOPATHOL, V118, P103, DOI 10.1111/j.1439-0434.1987.tb00438.x; Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Flint-Garcia SA, 2003, CROP SCI, V43, P23, DOI 10.2135/cropsci2003.0023; Gibson B.K., 2010, Midsouth Entomologist, V3, P7; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; HerediaDiaz O, 1996, MAYDICA, V41, P65; Hu HX, 2012, THEOR APPL GENET, V124, P1439, DOI 10.1007/s00122-012-1799-5; Hung HY, 2012, HEREDITY, V108, P490, DOI 10.1038/hdy.2011.103; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Lee EA, 1996, GENOME, V39, P898, DOI 10.1139/g96-113; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Lipka A, 2011, USER MANUAL GAPIT GE; LOESCH P. J., 1962, CROP SCI, V2, P469, DOI 10.2135/cropsci1962.0011183X000200060007x; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Meuwissen THE, 2001, GENETICS, V157, P1819; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Papst C, 2004, THEOR APPL GENET, V108, P1545, DOI 10.1007/s00122-003-1579-3; PE ME, 1993, MOL GEN GENET, V241, P11; Podlich DW, 2004, CROP SCI, V44, P1560, DOI 10.2135/cropsci2004.1560; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Rincent R, 2012, GENETICS, V192, P715, DOI 10.1534/genetics.112.141473; SAS, 2004, SAS 2004 2008 SAS 9; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SIBALE EM, 1992, MAYDICA, V37, P111; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Valdar W, 2009, GENETICS, V182, P1263, DOI 10.1534/genetics.109.100727; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhao YS, 2013, PLANT BREEDING, V132, P99, DOI 10.1111/pbr.12008; Zhao YS, 2012, THEOR APPL GENET, V125, P707, DOI 10.1007/s00122-012-1862-2; ZUBER M. S., 1961, CROP SCI, V1, P378, DOI 10.2135/cropsci1961.0011183X000100050028x; ZUBER MS, 1980, CROP SCI, V20, P711, DOI 10.2135/cropsci1980.0011183X002000060009x	50	80	87	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67066	10.1371/journal.pone.0067066	http://dx.doi.org/10.1371/journal.pone.0067066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840585	Green Published, gold			2022-12-27	WOS:000322342800117
J	Shmueli, MD; Schnaider, L; Rosenblum, D; Herzog, G; Gazit, E; Segal, D				Shmueli, Merav D.; Schnaider, Lee; Rosenblum, Daniel; Herzog, Gal; Gazit, Ehud; Segal, Daniel			Structural Insights into the Folding Defects of Oncogenic pVHL Lead to Correction of Its Function In Vitro	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; HIPPEL-LINDAU GENE; BIOLOGICALLY-ACTIVE PRODUCT; RENAL-CELL CARCINOMA; TUMORIGENIC MUTATIONS; PROLYL HYDROXYLATION; ORGANIC OSMOLYTES; ELONGIN-C; HIF-ALPHA; VHL GENE	Loss of function mutations in the von Hippel-Lindau (pVHL) tumor suppressor protein are tumorigenic. In silico analysis of the structure and folding of WT pVHL identified in its core an aromatic tetrahedron, essential for stabilizing the protein. The mutations disrupt the aromatic tetrahedron, leading to misfolding of pVHL. Using biophysical methods we confirmed the in silico predictions, demonstrating that mutant pVHL proteins have lower stability than the WT, distort the core domain and as a result reduce the ability of the protein to bind its target HIF-1 alpha. Using bacterial pVHL-EGFP based assay we screened for osmolytes capable of restoring folding of mutant pVHL. Among them, Arginine was the most effective and was verified by in vitro assays as a potent re-folder of pVHL. This resulted in functional restoration of the mutant proteins to the level of the WT.	[Shmueli, Merav D.; Schnaider, Lee; Rosenblum, Daniel; Herzog, Gal; Gazit, Ehud; Segal, Daniel] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Segal, D (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	dsegal@post.tau.ac.il	Gazit, Ehud/C-3715-2011; Gazit, Ehud/AHE-9332-2022; Gazit, Ehud/M-8026-2019; Shmueli, Merav/HDM-9859-2022	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Shmueli, Merav/0000-0002-9196-7633; Rosenblum, Daniel/0000-0001-9602-6026; Segal, Daniel/0000-0002-6777-505X	Israel Cancer Association; Cancer Biology Research Center, Tel Aviv University	Israel Cancer Association; Cancer Biology Research Center, Tel Aviv University	This work was supported in part by grants from the Israel Cancer Association (http://en.cancer.org.il/) and the Cancer Biology Research Center, Tel Aviv University,(http://www.tau.ac.il/institutes/cbrc/) to DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Arjumand W, 2012, TUMOR BIOL, V33, P9, DOI 10.1007/s13277-011-0257-3; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Beroud C, 1998, NUCLEIC ACIDS RES, V26, P256, DOI 10.1093/nar/26.1.256; Blankenship C, 1999, ONCOGENE, V18, P1529, DOI 10.1038/sj.onc.1202473; Bourne PE, 2004, BRIEF BIOINFORM, V5, P23, DOI 10.1093/bib/5.1.23; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Chang YC, 2010, BIOCHEMISTRY-US, V49, P5086, DOI 10.1021/bi100222h; Chen CH, 2009, LANGMUIR, V25, P6717, DOI 10.1021/la9002065; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; DUAN DR, 1995, P NATL ACAD SCI USA, V92, P6459, DOI 10.1073/pnas.92.14.6459; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gryczynski I, 2004, PHOTOCHEM PHOTOBIOL, V80, P482, DOI 10.1562/2004-08-13-RA-273.1; Iliopoulos O, 1998, P NATL ACAD SCI USA, V95, P11661, DOI 10.1073/pnas.95.20.11661; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Khan SH, 2010, IUBMB LIFE, V62, P891, DOI 10.1002/iub.406; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Knauth K, 2006, ONCOGENE, V25, P370, DOI 10.1038/sj.onc.1209062; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; LAKOWICZ JR, 1983, BIOCHEMISTRY-US, V22, P1741, DOI 10.1021/bi00277a001; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Li JG, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3469790; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; MARTENSON RE, 1978, J BIOL CHEM, V253, P8887; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Miller F, 2005, J BIOL CHEM, V280, P7985, DOI 10.1074/jbc.M413160200; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Nagaraj NS, 2010, EXPERT REV PROTEOMIC, V7, P613, DOI 10.1586/EPR.10.70; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Ohh M, 2006, NEOPLASIA, V8, P623, DOI 10.1593/neo.06442; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Roe JS, 2006, CELL CYCLE, V5, P2054, DOI 10.4161/cc.5.18.3247; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schoenfeld A, 1998, P NATL ACAD SCI USA, V95, P8817, DOI 10.1073/pnas.95.15.8817; SHUIN T, 1994, CANCER RES, V54, P2852; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Sutovsky H, 2004, J BIOL CHEM, V279, P17190, DOI 10.1074/jbc.M311225200; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Tsvetkov P, 2009, NAT CHEM BIOL, V5, P778, DOI 10.1038/nchembio.233; Waldo GS, 1999, NAT BIOTECHNOL, V17, P691, DOI 10.1038/10904; WHALEY JM, 1994, AM J HUM GENET, V55, P1092; Xu D, 2011, PROTEINS, V79, P147, DOI 10.1002/prot.23111; Yang H, 2007, MOL CELL, V28, P15, DOI 10.1016/j.molcel.2007.09.010; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	63	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66333	10.1371/journal.pone.0066333	http://dx.doi.org/10.1371/journal.pone.0066333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840444	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800048
J	Zhang, ZQ; Li, D; Xu, HR; Xin, Y; Zhang, TT; Ma, LX; Wang, X; Chen, ZL; Zhang, ZY				Zhang, Zhiqiang; Li, Duo; Xu, Huarong; Xin, Ying; Zhang, Tingting; Ma, Lixia; Wang, Xin; Chen, Zhilong; Zhang, Zhiying			A Simple and Efficient Method for Assembling TALE Protein Based on Plasmid Library	PLOS ONE			English	Article							TARGETED GENE DISRUPTION; DNA; NUCLEASES; EFFECTORS; TRANSCRIPTION; CONSTRUCTION; RECOGNITION; ACTIVATION; KNOCKOUT; CLONING	DNA binding domain of the transcription activator-like effectors (TALEs) from Xanthomonas sp. consists of tandem repeats that can be rearranged according to a simple cipher to target new DNA sequences with high DNA-binding specificity. This technology has been successfully applied in varieties of species for genome engineering. However, assembling long TALE tandem repeats remains a big challenge precluding wide use of this technology. Although several new methodologies for efficiently assembling TALE repeats have been recently reported, all of them require either sophisticated facilities or skilled technicians to carry them out. Here, we described a simple and efficient method for generating customized TALE nucleases (TALENs) and TALE transcription factors (TALE-TFs) based on TALE repeat tetramer library. A tetramer library consisting of 256 tetramers covers all possible combinations of 4 base pairs. A set of unique primers was designed for amplification of these tetramers. PCR products were assembled by one step of digestion/ligation reaction. 12 TALE constructs including 4 TALEN pairs targeted to mouse Gt(ROSA)26Sor gene and mouse Mstn gene sequences as well as 4 TALE-TF constructs targeted to mouse Oct4, c-Myc, Klf4 and Sox2 gene promoter sequences were generated by using our method. The construction routines took 3 days and parallel constructions were available. The rate of positive clones during colony PCR verification was 64% on average. Sequencing results suggested that all TALE constructs were performed with high successful rate. This is a rapid and cost-efficient method using the most common enzymes and facilities with a high success rate.	[Zhang, Zhiqiang; Li, Duo; Xu, Huarong; Xin, Ying; Zhang, Tingting; Ma, Lixia; Wang, Xin; Chen, Zhilong; Zhang, Zhiying] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China	Zhang, ZY (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	zhangzhy@nwsuaf.edu.cn		Zhang, Zhiqiang/0000-0002-3855-8101; Zhang, Zhiying/0000-0001-6012-0889	National Natural Science Foundation of China (NSFC) [31172186]; 973 program [2011CBA01002]; Genetically Modified Organisms Breeding Major Projects of China [2013XZ08008-003]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China); Genetically Modified Organisms Breeding Major Projects of China	This study was supported by the National Natural Science Foundation of China (NSFC) (31172186) (http://www.nsfc.gov.cn) and 973 program (2011CBA01002) (http://www.973.gov.cn/AreaAppl.aspx) and grant 'Genetically Modified Organisms Breeding Major Projects of China (2013XZ08008-003) (http://www.nmp.gov.cn/).' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Bultmann S, 2012, NUCLEIC ACIDS RES, V40, P5368, DOI 10.1093/nar/gks199; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Hockemeyer D, 2011, NAT BIOTECHNOL, V29, P731, DOI 10.1038/nbt.1927; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Li LX, 2012, PLANT MOL BIOL, V78, P407, DOI 10.1007/s11103-012-9875-4; Li T, 2011, NUCLEIC ACIDS RES, V39, P6315, DOI 10.1093/nar/gkr188; Ma SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045035; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Morbitzer R, 2011, NUCLEIC ACIDS RES, V39, P5790, DOI 10.1093/nar/gkr151; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; Pennisi E, 2012, SCIENCE, V338, P1408, DOI 10.1126/science.338.6113.1408; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Tesson L, 2011, NAT BIOTECHNOL, V29, P695, DOI 10.1038/nbt.1940; Weber E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019722; Young JJ, 2011, P NATL ACAD SCI USA, V108, P7052, DOI 10.1073/pnas.1102030108; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	27	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66459	10.1371/journal.pone.0066459	http://dx.doi.org/10.1371/journal.pone.0066459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840477	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800063
J	Klohs, J; Politano, IW; Deistung, A; Grandjean, J; Drewek, A; Dominietto, M; Keist, R; Schweser, F; Reichenbach, JR; Nitsch, RM; Knuesel, I; Rudin, M				Klohs, Jan; Politano, Igna Wojtyna; Deistung, Andreas; Grandjean, Joanes; Drewek, Anna; Dominietto, Marco; Keist, Ruth; Schweser, Ferdinand; Reichenbach, Juergen R.; Nitsch, Roger M.; Knuesel, Irene; Rudin, Markus			Longitudinal Assessment of Amyloid Pathology in Transgenic ArcA beta Mice Using Multi-Parametric Magnetic Resonance Imaging	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; MOUSE MODEL; CEREBRAL AMYLOIDOSIS; IN-VIVO; QUANTITATIVE MRI; CONTRAST AGENT; DIFFUSION; ANGIOPATHY; MICROVASCULATURE	Magnetic resonance imaging (MRI) can be used to monitor pathological changes in Alzheimer's disease (AD). The objective of this longitudinal study was to assess the effects of progressive amyloid-related pathology on multiple MRI parameters in transgenic arcA beta mice, a mouse model of cerebral amyloidosis. Diffusion-weighted imaging (DWI), T-1-mapping and quantitative susceptibility mapping (QSM), a novel MRI based technique, were applied to monitor structural alterations and changes in tissue composition imposed by the pathology over time. Vascular function and integrity was studied by assessing blood-brain barrier integrity with dynamic contrast-enhanced MRI and cerebral microbleed (CMB) load with susceptibility weighted imaging and QSM. A linear mixed effects model was built for each MRI parameter to incorporate effects within and between groups (i.e. genotype) and to account for changes unrelated to the disease pathology. Linear mixed effects modelling revealed a strong association of all investigated MRI parameters with age. DWI and QSM in addition revealed differences between arcA beta and wt mice over time. CMBs became apparent in arcA beta mice with 9 month of age; and the CMB load reflected disease stage. This study demonstrates the benefits of linear mixed effects modelling of longitudinal imaging data. Moreover, the diagnostic utility of QSM and assessment of CMB load should be exploited further in studies of AD.	[Klohs, Jan; Politano, Igna Wojtyna; Grandjean, Joanes; Dominietto, Marco; Keist, Ruth; Rudin, Markus] ETH, Inst Biomed Engn, Zurich, Switzerland; [Klohs, Jan; Politano, Igna Wojtyna; Grandjean, Joanes; Dominietto, Marco; Keist, Ruth; Rudin, Markus] Univ Zurich, Zurich, Switzerland; [Klohs, Jan; Grandjean, Joanes; Nitsch, Roger M.; Knuesel, Irene; Rudin, Markus] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland; [Klohs, Jan; Grandjean, Joanes; Nitsch, Roger M.; Knuesel, Irene; Rudin, Markus] ETH, Zurich, Switzerland; [Deistung, Andreas; Schweser, Ferdinand; Reichenbach, Juergen R.] Univ Jena, Med Phys Grp, Inst Diagnost & Intervent Radiol 1, Jena Univ Hosp, Jena, Germany; [Drewek, Anna] ETH, Seminar Stat, Zurich, Switzerland; [Nitsch, Roger M.] Univ Zurich, Div Psychiat Res, Zurich, Switzerland; [Knuesel, Irene; Rudin, Markus] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Friedrich Schiller University of Jena; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Zurich	Klohs, J (corresponding author), ETH, Inst Biomed Engn, Zurich, Switzerland.	klohs@biomed.ee.ethz.ch	Schweser, Ferdinand/Q-6932-2019; Grandjean, Joanes/T-7614-2019; Grandjean, Joanes/AAV-2468-2020; Klohs, Jan/K-2142-2016; Reichenbach, Jürgen R./B-4333-2011; Deistung, Andreas/AAN-9412-2021	Schweser, Ferdinand/0000-0003-0399-9211; Grandjean, Joanes/0000-0001-8413-0491; Klohs, Jan/0000-0003-4065-2807; Reichenbach, Jürgen R./0000-0002-2640-0630; Knuesel, Irene/0000-0003-0396-9952; Deistung, Andreas/0000-0002-2427-1302	Swiss National Science Foundation [3100A0-112835, 310030-126029, 310030-132629]; German Research Foundation [RE 1123/9-2]; Carl Zeiss Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation(German Research Foundation (DFG)); Carl Zeiss Foundation	The work was supported by the Swiss National Science Foundation (grants 3100A0-112835 and 310030-126029 to MR; 310030-132629 to IK), by the German Research Foundation Grant RE 1123/9-2) and by the Carl Zeiss Foundation (dissertation fellowship to FS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman HS, 2007, APPL OPTICS, V46, P6623, DOI 10.1364/AO.46.006623; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Badea A, 2010, NEUROIMAGE, V50, P416, DOI 10.1016/j.neuroimage.2009.12.070; Bernal-Rusiel JL, 2013, NEUROIMAGE, V66, P249, DOI 10.1016/j.neuroimage.2012.10.065; BRUNBERG JA, 1995, AM J NEURORADIOL, V16, P361; Chamberlain R, 2009, MAGN RESON MED, V61, P1158, DOI 10.1002/mrm.21951; Cheng YCN, 2009, PHYS MED BIOL, V54, P1169, DOI 10.1088/0031-9155/54/5/005; de Rochefort L, 2010, MAGN RESON MED, V63, P194, DOI 10.1002/mrm.22187; Delatour B, 2006, NEUROBIOL AGING, V27, P835, DOI 10.1016/j.neurobiolaging.2005.04.011; El Tayara NE, 2006, NEUROBIOL DIS, V22, P199, DOI 10.1016/j.nbd.2005.10.013; Falangola MF, 2007, NMR BIOMED, V20, P343, DOI 10.1002/nbm.1163; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Giesel FL, 2010, EUR RADIOL, V20, P2461, DOI 10.1007/s00330-010-1805-8; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Gouw AA, 2008, BRAIN, V131, P3286, DOI 10.1093/brain/awn265; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Helpern JA, 2004, MAGNET RESON MED, V51, P794, DOI 10.1002/mrm.20038; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Kahle P J, 2001, Expert Opin Ther Targets, V5, P125, DOI 10.1517/14728222.5.1.125; Klohs J, 2012, J NEUROSCI, V32, P1705, DOI 10.1523/JNEUROSCI.5626-11.2012; Klohs J, 2011, J CEREBR BLOOD F MET, V31, P2282, DOI 10.1038/jcbfm.2011.118; Klohs J, 2011, NEUROSCIENTIST, V17, P539, DOI 10.1177/1073858410383433; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; LeBihan D, 1995, NMR BIOMED, V8, P375, DOI 10.1002/nbm.1940080711; Liu CL, 2011, NEUROIMAGE, V56, P930, DOI 10.1016/j.neuroimage.2011.02.024; Liu T, 2011, NMR BIOMED, V24, P1129, DOI 10.1002/nbm.1670; Lo RY, 2012, NEUROLOGY, V78, P1376, DOI 10.1212/WNL.0b013e318253d5b3; MASSIE HR, 1979, MECH AGEING DEV, V10, P93, DOI 10.1016/0047-6374(79)90073-3; Merlini M, 2011, ACTA NEUROPATHOL, V122, P293, DOI 10.1007/s00401-011-0834-y; Mueggler T, 2004, EUR J NEUROSCI, V20, P811, DOI 10.1111/j.1460-9568.2004.03534.x; OCALLAGHAN JP, 1991, NEUROBIOL AGING, V12, P171, DOI 10.1016/0197-4580(91)90057-Q; Princz-Kranz FL, 2010, NEUROBIOL DIS, V40, P284, DOI 10.1016/j.nbd.2010.06.002; R Development Core Team, 2012, R LANG ENV STAT COMP; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; RUDICK RA, 1983, NEUROBIOL AGING, V4, P283, DOI 10.1016/0197-4580(83)90004-0; Rudin M, 2005, NMR BIOMED, V18, P308, DOI 10.1002/nbm.961; Schweser F, 2012, NEUROIMAGE, V62, P2083, DOI 10.1016/j.neuroimage.2012.05.067; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Song SK, 2004, NEUROBIOL DIS, V15, P640, DOI 10.1016/j.nbd.2003.12.003; Spring S, 2007, NEUROIMAGE, V35, P1424, DOI 10.1016/j.neuroimage.2007.02.023; Sykova E, 2005, P NATL ACAD SCI USA, V102, P479, DOI 10.1073/pnas.0408235102; Teipel SJ, 2011, WORLD J BIOL PSYCHIA, V12, P109, DOI 10.3109/15622975.2011.603222; Thakker DR, 2009, P NATL ACAD SCI USA, V106, P4501, DOI 10.1073/pnas.0813404106; Thiessen JD, 2010, BRAIN STRUCT FUNCT, V215, P29, DOI 10.1007/s00429-010-0271-z; Van Dijck A, 2011, NEUROMETHODS, V48, P53, DOI 10.1007/978-1-60761-898-0_4; Vanhoutte G, 2011, NEUROMETHODS, V48, P187, DOI 10.1007/978-1-60761-898-0_11; Venables WN., 2002, MODERN APPL STAT S 4; VORBRODT AW, 1994, FOLIA HISTOCHEM CYTO, V32, P63; Weidensteiner C, 2009, MAGN RESON MED, V62, P35, DOI 10.1002/mrm.21985; Weller RO, 2009, ACTA NEUROPATHOL, V118, P87, DOI 10.1007/s00401-009-0498-z; Winkler DT, 2001, J NEUROSCI, V21, P1619, DOI 10.1523/JNEUROSCI.21-05-01619.2001	52	24	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66097	10.1371/journal.pone.0066097	http://dx.doi.org/10.1371/journal.pone.0066097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840405	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000322361200054
J	Liu, R; Guo, XG; Park, Y; Wang, J; Huang, XM; Hollenbeck, A; Blair, A; Chen, HL				Liu, Rui; Guo, Xuguang; Park, Yikyung; Wang, Jian; Huang, Xuemei; Hollenbeck, Albert; Blair, Aaron; Chen, Honglei			Alcohol Consumption, Types of Alcohol, and Parkinson's Disease	PLOS ONE			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; HEALTH-AMERICAN-ASSOCIATION; RETIRED-PERSONS DIET; NATIONAL-INSTITUTES; PLASMA URATE; RISK; RESVERATROL; PREDICTOR; DEMENTIA; DECLINE	Background: The epidemiologic evidence on alcohol consumption and Parkinson's disease (PD) is equivocal. We prospectively examined total alcohol consumption and consumption of specific types of alcoholic beverage in relation to future risk of PD. Methods: The study comprised 306,895 participants (180,235 male and 126,660 female) ages 50-71 years in 1995-1996 from the NIH-AARP Diet and Health Study. Consumption of alcoholic beverages in the past 12 months was assessed in 1995-1996. Multivariate odds ratios (OR) and 95% confidence intervals (CI) were obtained from logistic regression models. Results: A total of 1,113 PD cases diagnosed between 2000 and 2006 were included in the analysis. Total alcohol consumption was not associated with PD. However, the association differed by types of alcoholic beverages. Compared with non-beer drinkers, the multivariate ORs for beer drinkers were 0.79 (95% CI: 0.68, 0.92) for <1 drink/day, 0.73 (95% CI: 0.50, 1.07) for 1-1.99 drinks/day, and 0.86 (95% CI: 0.60, 1.21) for >= 2 drinks/day. For liquor consumption, a monotonic increase in PD risk was suggested: ORs (95% CI) were 1.06 (0.91, 1.23), 1.22 (0.94, 1.58), and 1.35 (1.02, 1.80) for<1, 1-1.99, and >= 2 drinks/day, respectively (P for trend <0.03). Additional analyses among exclusive drinkers of one specific type of alcoholic beverage supported the robustness of these findings. The results for wine consumption were less clear, although a borderline lower PD risk was observed when comparing wine drinkers of 1-1.99 drinks/day with none drinkers (OR = 0.74, 95% CI: 0.53, 1.02). Conclusions: Our results suggest that beer and liquor consumption may have opposite associations with PD: low to moderate beer consumption with lower PD risk and greater liquor consumption with higher risk. These findings and potential underlying mechanisms warrant further investigations.	[Liu, Rui; Chen, Honglei] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Guo, Xuguang] Westat Corp, Res Triangle Pk, NC USA; [Park, Yikyung; Blair, Aaron] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Wang, Jian] Fudan Univ, Dept Neurol, Huashan Hosp, Shanghai 200433, Peoples R China; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA; [Hollenbeck, Albert] AARP, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Westat; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fudan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; American Association of Retired Persons (AARP)	Liu, R (corresponding author), NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA.	liur2@niehs.nih.gov	Hollenbeck, Albert/AAG-9461-2020	Park, Yikyung/0000-0002-6281-489X; Chen, Honglei/0000-0003-3446-7779	National Institute of Health; National Institute of Environmental Health Sciences [Z01-ES-101986]; National Cancer Institute [Z01 CP010196-02]; NATIONAL CANCER INSTITUTE [Z01CP010196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986, Z01ES101986] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by the intramural research program of the National Institute of Health, the National Institute of Environmental Health Sciences (Z01-ES-101986) and the National Cancer Institute (Z01 CP010196-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Ascherio A, 2009, ARCH NEUROL-CHICAGO, V66, P1460, DOI 10.1001/archneurol.2009.247; BAUMBAICKER C, 1985, DRUG ALCOHOL DEPEN, V15, P207, DOI 10.1016/0376-8716(85)90001-8; Cao G, 2000, NUTR CLIN CARE, V3, P76, DOI DOI 10.1046/J.1523-5408.2000.00024.X; Chen H, 2010, NEUROLOGY, V74, P878, DOI 10.1212/WNL.0b013e3181d55f38; Chen HL, 2009, AM J EPIDEMIOL, V169, P1064, DOI 10.1093/aje/kwp033; Choi HK, 2004, ARTHRIT RHEUM-ARTHR, V51, P1023, DOI 10.1002/art.20821; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; Friday JE, 2006, MYPYRAMID EQUIVALENT; Gao X, 2008, AM J EPIDEMIOL, V167, P831, DOI 10.1093/aje/kwm385; Hellenbrand W, 1996, NEUROLOGY, V47, P644, DOI 10.1212/WNL.47.3.644; Hernan MA, 2003, ANN NEUROL, V54, P170, DOI 10.1002/ana.10611; Jin F, 2008, EUR J PHARMACOL, V600, P78, DOI 10.1016/j.ejphar.2008.10.005; Khan MM, 2010, BRAIN RES, V1328, P139, DOI 10.1016/j.brainres.2010.02.031; Mann Laura B, 2004, Pathophysiology, V10, P105, DOI 10.1016/j.pathophys.2003.10.011; Menza M, 2000, Curr Psychiatry Rep, V2, P421, DOI 10.1007/s11920-000-0027-1; Palacios N, 2012, MOVEMENT DISORD, V27, P980, DOI 10.1002/mds.25050; Panza F, 2009, J ALZHEIMERS DIS, V17, P7, DOI 10.3233/JAD-2009-1009; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Thompson FE, 2008, PUBLIC HEALTH NUTR, V11, P183, DOI 10.1017/S1368980007000419; Weisskopf MG, 2007, AM J EPIDEMIOL, V166, P561, DOI 10.1093/aje/kwm127; Wirdefeldt K, 2005, ANN NEUROL, V57, P27, DOI 10.1002/ana.20307	24	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66452	10.1371/journal.pone.0066452	http://dx.doi.org/10.1371/journal.pone.0066452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840473	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200081
J	Nery, MF; Gonzalez, DJ; Opazo, JC				Nery, Mariana F.; Gonzalez, Dimar J.; Opazo, Juan C.			How to Make a Dolphin: Molecular Signature of Positive Selection in Cetacean Genome	PLOS ONE			English	Article							ADAPTIVE EVOLUTION; GENES; ACCURACY; RESOLUTION; KIDNEYS; WHALES; CHANCE; ORIGIN; MOUSE; POWER	Cetaceans are unique in being the only mammals completely adapted to an aquatic environment. This adaptation has required complex changes and sometimes a complete restructuring of physiology, behavior and morphology. Identifying genes that have been subjected to selection pressure during cetacean evolution would greatly enhance our knowledge of the ways in which genetic variation in this mammalian order has been shaped by natural selection. Here, we performed a genome-wide scan for positive selection in the dolphin lineage. We employed models of codon substitution that account for variation of selective pressure over branches on the tree and across sites in a sequence. We analyzed 7,859 nuclear-coding ortholog genes and using a series of likelihood ratio tests (LRTs), we identified 376 genes (4.8%) with molecular signatures of positive selection in the dolphin lineage. We used the cow as the sister group and compared estimates of selection in the cetacean genome to this using the same methods. This allowed us to define which genes have been exclusively under positive selection in the dolphin lineage. The enrichment analysis found that the identified positively selected genes are significantly over-represented for three exclusive functional categories only in the dolphin lineage: segment specification, mesoderm development and system development. Of particular interest for cetacean adaptation to an aquatic life are the following GeneOntology targets under positive selection: genes related to kidney, heart, lung, eye, ear and nervous system development.	[Nery, Mariana F.; Gonzalez, Dimar J.; Opazo, Juan C.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Nery, Mariana F.] Univ Austral Chile, Fac Ciencias, Programa Doctorado Ciencias Menc Ecol & Evoluc, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile	Nery, MF (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile.	mariananery@gmail.com; jopazo@gmail.com		Nery, Mariana/0000-0001-6501-0486; Opazo, Juan C./0000-0001-7938-4083	Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 11080181]; CONICYT Chile	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was funded by a grant to JCO from the Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 11080181). MFN was supported by a doctoral fellowship from CONICYT Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam PJ, 2008, ENCY MARINE MAMMALS, P562; Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Arbiza L, 2006, PLOS COMPUT BIOL, V2, P288, DOI 10.1371/journal.pcbi.0020038; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bakewell MA, 2007, P NATL ACAD SCI USA, V104, P7489, DOI 10.1073/pnas.0701705104; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Cho RJ, 2000, TRENDS GENET, V16, P409, DOI 10.1016/S0168-9525(00)02065-5; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Delgado S, 2005, J MOL EVOL, V60, P12, DOI 10.1007/s00239-003-0070-8; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fordyce Ewan, 2001, P169; GINGERICH PD, 1983, SCIENCE, V222, P159, DOI 10.1126/science.222.4620.159; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Hallstrom BM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-162; HILL DA, 1989, ACTA ANAT, V135, P53; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Jorgensen FG, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-2; Kishida T, 2012, GENE, V492, P349, DOI 10.1016/j.gene.2011.11.013; Kooyman G, 2008, ENCY MARINE MAMMALS, P327; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Liu Y, 2010, CURR BIOL, V20, pR53, DOI 10.1016/j.cub.2009.11.058; Maluf NSR, 1998, ANAT RECORD, V250, P34; Mass AM, 2007, ANAT REC, V290, P701, DOI 10.1002/ar.20529; McGowen MR, 2008, SYST BIOL, V57, P574, DOI 10.1080/10635150802304787; McGowen MR, 2012, P ROY SOC B-BIOL SCI, V279, P3643, DOI 10.1098/rspb.2012.0869; Meredith RW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000634; Montoya-Burgos JI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024800; Nery MF, 2012, MOL PHYLOGENET EVOL, V64, P685, DOI 10.1016/j.ympev.2012.04.012; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Oelschlager HHA, 2008, BRAIN RES BULL, V75, P450, DOI 10.1016/j.brainresbull.2007.10.051; Ortiz RM, 2001, J EXP BIOL, V204, P1831; Roth ACJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-518; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Shapiro JA, 2005, GENE, V345, P91, DOI 10.1016/j.gene.2004.11.020; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; Sun YB, 2013, GENOME BIOL EVOL, V5, P130, DOI 10.1093/gbe/evs123; Suyama M, 2011, NUCLEIC ACIDS RES, V34, pW609; Tarpley RJ, 1997, ANAT RECORD, V247, P556; Thewissen J.G.M., 2009, Evolution Education and Outreach, V2, P272; Thewissen JGM, 2001, NATURE, V413, P277, DOI 10.1038/35095005; Thewissen JGM, 2001, BIOSCIENCE, V51, P1037, DOI 10.1641/0006-3568(2001)051[1037:WOAAPC]2.0.CO;2; Thewissen JGM, 1996, SENCKENBERG, V191, P1; Uhen MD., 2004, U MICHIGAN PAP PALEO, V34, P1; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; VARDY PH, 1981, J MORPHOL, V167, P13, DOI 10.1002/jmor.1051670103; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang Z, 2009, MOL BIOL EVOL, V26, P613, DOI 10.1093/molbev/msn282; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yang ZH, 2011, MOL BIOL EVOL, V28, P1217, DOI 10.1093/molbev/msq303; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhao HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008326	59	27	27	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65491	10.1371/journal.pone.0065491	http://dx.doi.org/10.1371/journal.pone.0065491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840335	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200021
J	Vijayaraghavan, S; Karami, A; Aeinehband, S; Behbahani, H; Grandien, A; Nilsson, B; Ekdahl, KN; Lindblom, RPF; Piehl, F; Darreh-Shori, T				Vijayaraghavan, Swetha; Karami, Azadeh; Aeinehband, Shahin; Behbahani, Homira; Grandien, Alf; Nilsson, Bo; Ekdahl, Kristina N.; Lindblom, Rickard P. F.; Piehl, Fredrik; Darreh-Shori, Taher			Regulated Extracellular Choline Acetyltransferase Activity- The Plausible Missing Link of the Distant Action of Acetylcholine in the Cholinergic Anti-Inflammatory Pathway	PLOS ONE			English	Article							BUTYRYLCHOLINESTERASE K-VARIANT; HUMAN CEREBROSPINAL-FLUID; APOLIPOPROTEIN-E EPSILON-4; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; MESSENGER-RNA; DIURNAL OSCILLATION; NONNEURONAL ACETYLCHOLINE; MONONUCLEAR LEUKOCYTES; MULTIPLE-SCLEROSIS	Acetylcholine (ACh), the classical neurotransmitter, also affects a variety of nonexcitable cells, such as endothelia, microglia, astrocytes and lymphocytes in both the nervous system and secondary lymphoid organs. Most of these cells are very distant from cholinergic synapses. The action of ACh on these distant cells is unlikely to occur through diffusion, given that ACh is very short-lived in the presence of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), two extremely efficient ACh-degrading enzymes abundantly present in extracellular fluids. In this study, we show compelling evidence for presence of a high concentration and activity of the ACh-synthesizing enzyme, choline-acetyltransferase (ChAT) in human cerebrospinal fluid (CSF) and plasma. We show that ChAT levels are physiologically balanced to the levels of its counteracting enzymes, AChE and BuChE in the human plasma and CSF. Equilibrium analyses show that soluble ChAT maintains a steady-state ACh level in the presence of physiological levels of fully active ACh-degrading enzymes. We show that ChAT is secreted by cultured human-brain astrocytes, and that activated spleen lymphocytes release ChAT itself rather than ACh. We further report differential CSF levels of ChAT in relation to Alzheimer's disease risk genotypes, as well as in patients with multiple sclerosis, a chronic neuroinflammatory disease, compared to controls. Interestingly, soluble CSF ChAT levels show strong correlation with soluble complement factor levels, supporting a role in inflammatory regulation. This study provides a plausible explanation for the long-distance action of ACh through continuous renewal of ACh in extracellular fluids by the soluble ChAT and thereby maintenance of steady-state equilibrium between hydrolysis and synthesis of this ubiquitous cholinergic signal substance in the brain and peripheral compartments. These findings may have important implications for the role of cholinergic signaling in states of inflammation in general and in neurodegenerative disease, such as Alzheimer's disease and multiple sclerosis in particular.	[Vijayaraghavan, Swetha; Karami, Azadeh; Darreh-Shori, Taher] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Alzheimer Neurobiol Ctr, Stockholm, Sweden; [Behbahani, Homira] Karolinska Inst, Div Alzheimer Dis Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Grandien, Alf] Ctr Hematol & Regenerat Med, Dept Med, Stockholm, Sweden; [Aeinehband, Shahin; Lindblom, Rickard P. F.; Piehl, Fredrik] Dept Clin Neurosci, Unit Neuroimmunol, Stockholm, Sweden; [Nilsson, Bo; Ekdahl, Kristina N.] Uppsala Univ, Dept Immunol Genet & Pathol, Div Clin Immunol, Uppsala, Sweden; [Ekdahl, Kristina N.] Linnaeus Univ, Linnaeus Ctr Biomat Chem, Kalmar, Sweden	Karolinska Institutet; Karolinska Institutet; Uppsala University; Linnaeus University	Darreh-Shori, T (corresponding author), Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Alzheimer Neurobiol Ctr, Stockholm, Sweden.	Taher.Darreh-Shori@ki.se	DARREH-SHORI, TAHER/G-3931-2013; Ekdahl, Kristina Nilsson/B-5301-2012; Nilsson, Bo/B-3102-2012	Nilsson, Bo/0000-0003-0057-2730; Darreh-Shori, Taher/0000-0003-1176-6258; Lindblom, Rickard/0000-0001-7913-4981	Foundation Olle Engkvist Byggmastare; Karolinska Institute Foundations; Loo & Hans Osterman Foundation; Magnus Bergvalls Foundation; Dementia Foundation (Demensfonden); foundation for Old Servants (Gamla Tjanarinnor); Gun and Bertil Stohnes Foundation; Ahlen Foundation; Foundation for Ragnhild and Einar Lundstroms Memory; Alzheimer Foundation in Sweden; Ake Wiberg Foundation	Foundation Olle Engkvist Byggmastare; Karolinska Institute Foundations(Karolinska Institutet); Loo & Hans Osterman Foundation; Magnus Bergvalls Foundation; Dementia Foundation (Demensfonden); foundation for Old Servants (Gamla Tjanarinnor); Gun and Bertil Stohnes Foundation; Ahlen Foundation; Foundation for Ragnhild and Einar Lundstroms Memory; Alzheimer Foundation in Sweden; Ake Wiberg Foundation	This research was supported by the Foundation Olle Engkvist Byggmastare; Karolinska Institute Foundations; Loo & Hans Osterman Foundation; Magnus Bergvalls Foundation; Dementia Foundation (Demensfonden); the foundation for Old Servants (Gamla Tjanarinnor); Gun and Bertil Stohnes Foundation; Ahlen Foundation; Foundation for Ragnhild and Einar Lundstroms Memory; the Alzheimer Foundation in Sweden and Ake Wiberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRIAMAMPANDRY C, 1993, NEUROBIOL AGING, V14, P367, DOI 10.1016/0197-4580(93)90123-S; Anglade P, 2010, BIOMED RES-TOKYO, V31, P1, DOI 10.2220/biomedres.31.1; AQUILONIUS SM, 1976, J NEUROCHEM, V27, P317, DOI 10.1111/j.1471-4159.1976.tb01588.x; Behbahani H, 2010, NEUROCHEM INT, V57, P668, DOI 10.1016/j.neuint.2010.08.004; CHAO LP, 1974, J NEUROCHEM, V23, P697, DOI 10.1111/j.1471-4159.1974.tb04393.x; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Darreh-Shori T, 2006, NEUROBIOL DIS, V24, P326, DOI 10.1016/j.nbd.2006.07.013; Darreh-Shori T, 2004, J NEUROCHEM, V88, P1102, DOI 10.1046/j.1471-4159.2003.02230.x; Darreh-Shori T, 2013, NEUROBIOL A IN PRESS; Darreh-Shori T, 2009, ALZHEIMERS DEMENTIA, V5, pP225; Darreh-Shori T, 2012, J ALZHEIMERS DIS, V28, P443, DOI 10.3233/JAD-2011-111088; Darreh-Shori T, 2011, NEUROBIOL AGING, V32, P1236, DOI 10.1016/j.neurobiolaging.2009.07.015; DEKOSKY ST, 1989, NEUROCHEM RES, V14, P191, DOI 10.1007/BF00969638; Dobransky T, 2005, J NEUROCHEM, V95, P305, DOI 10.1111/j.1471-4159.2005.03367.x; Dobransky T, 2003, J BIOL CHEM, V278, P5883, DOI 10.1074/jbc.M212080200; ECKERNAS SA, 1979, MED BIOL, V57, P36; Ferris S, 2009, PHARMACOGENET GENOM, V19, P635, DOI 10.1097/FPC.0b013e32832f8c17; Foldes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010501; FROISSART C, 1979, CELL MOL BIOL, V24, P199; Fujii T, 1998, J NEUROIMMUNOL, V82, P101, DOI 10.1016/S0165-5728(97)00195-1; Fujii T, 1995, NEUROSCI LETT, V201, P207, DOI 10.1016/0304-3940(95)12180-3; Fujii T, 2008, J PHARMACOL SCI, V106, P186, DOI 10.1254/jphs.FM0070109; Fujimoto K, 2001, LIFE SCI, V69, P1629, DOI 10.1016/S0024-3205(01)01237-1; GOODMAN DR, 1984, CHEM-BIOL INTERACT, V49, P39, DOI 10.1016/0009-2797(84)90051-6; Grando SA, 2006, EXP DERMATOL, V15, P265, DOI 10.1111/j.0906-6705.2006.00410.x; Grando SA, 2003, LIFE SCI, V72, P2009, DOI 10.1016/S0024-3205(03)00063-8; GROSMAN DD, 1995, J NEUROCHEM, V65, P484; Henningsson AJ, 2007, J NEUROIMMUNOL, V183, P200, DOI 10.1016/j.jneuroim.2006.10.022; IBANEZ CF, 1991, P NATL ACAD SCI USA, V88, P3676, DOI 10.1073/pnas.88.9.3676; JOHNSON S, 1971, CLIN CHIM ACTA, V35, P421, DOI 10.1016/0009-8981(71)90216-6; Kawashima K, 2008, J PHARMACOL SCI, V106, P167, DOI 10.1254/jphs.FM0070073; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kurzen H, 2007, HORM METAB RES, V39, P125, DOI 10.1055/s-2007-961816; Lane R, 2008, PHARMACOGENET GENOM, V18, P289, DOI 10.1097/FPC.0b013e3282f63f29; Lehman DJ, 2000, HUM GENET, V106, P447, DOI 10.1007/s004390000277; Lehmann DJ, 1997, HUM MOL GENET, V6, P1933, DOI 10.1093/hmg/6.11.1933; MADER M, 1988, J CLIN CHEM CLIN BIO, V26, P857; MASSARELLI R, 1977, NEUROSCI LETT, V5, P95, DOI 10.1016/0304-3940(77)90171-9; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MENZEL EJ, 1988, ANAL CHIM ACTA, V205, P183, DOI 10.1016/S0003-2670(00)82327-2; MESULAM MM, 1994, ANN NEUROL, V36, P722, DOI 10.1002/ana.410360506; NACHMANSOHN D, 1955, METHOD ENZYMOL, V1, P619, DOI 10.1016/0076-6879(55)01109-9; Ni L, 2007, PEDIATR RES, V61, P15, DOI 10.1203/01.pdr.0000249981.70618.18; Nunes-Tavares N, 2012, J BIOL CHEM, V287, P19377, DOI 10.1074/jbc.M111.321448; Oda Y, 1999, PATHOL INT, V49, P921, DOI 10.1046/j.1440-1827.1999.00977.x; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Pavlov VA, 2004, CELL MOL LIFE SCI, V61, P2322, DOI 10.1007/s00018-004-4102-3; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; PENG JH, 1980, NEUROCHEM RES, V5, P943, DOI 10.1007/BF00966135; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; SASTRY BVR, 1981, J PHARMACOL EXP THER, V216, P378; Serobyan N, 2007, LIFE SCI, V80, P2352, DOI 10.1016/j.lfs.2007.04.017; SINGH I, 1994, NEUROBIOL AGING, V15, P643, DOI 10.1016/0197-4580(94)00059-X; SINGH VK, 1975, BRAIN RES, V96, P187, DOI 10.1016/0006-8993(75)90595-8; Tooyama I, 2000, J CHEM NEUROANAT, V17, P217, DOI 10.1016/S0891-0618(99)00043-5; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; Veerhuis R, 2011, CURR ALZHEIMER RES, V8, P34, DOI 10.2174/156720511794604589; Wang Y, 2011, AM J PATHOL, V178, P1509, DOI 10.1016/j.ajpath.2011.01.006; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Wiebusch H, 1999, HUM GENET, V104, P158, DOI 10.1007/s004390050929; Yu WF, 2005, EXP NEUROL, V192, P215, DOI 10.1016/j.expneurol.2004.12.015	63	66	69	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65936	10.1371/journal.pone.0065936	http://dx.doi.org/10.1371/journal.pone.0065936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840379	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200042
J	Clausen, TD; Mortensen, EL; Schmidt, L; Mathiesen, ER; Hansen, T; Jensen, DM; Damm, P				Clausen, Tine D.; Mortensen, Erik L.; Schmidt, Lone; Mathiesen, Elisabeth R.; Hansen, Torben; Jensen, Dorte M.; Damm, Peter			Cognitive Function in Adult Offspring of Women with Gestational Diabetes-The Role of Glucose and Other Factors	PLOS ONE			English	Article							ANTEPARTUM MATERNAL METABOLISM; PSYCHOMOTOR DEVELOPMENT; CHILDREN; MOTHERS; MELLITUS; PREGNANCY; HEALTH; PERFORMANCE; EXPOSURE; OBESITY	Objective: We aimed to evaluate cognitive function in adult offspring of women with diet-treated gestational diabetes and to study potential associations with maternal glucose values. Materials and Methods: In 2003-2005 cognitive function was assessed in a cohort of 18-27 year old offspring of women with diet-treated gestational diabetes mellitus (n = 153) and offspring from the background population (n = 118). The main outcome measure was global cognitive score derived from Raven's Progressive Matrices and three verbal subtests from the Weschler Adult Intelligence Scale. Maternal fasting-and 2-hour blood glucose values from the diagnostic oral glucose tolerance test were used as exposure variables. Results: Offspring of women with gestational diabetes mellitus had a lower global cognitive score, than offspring from the background population (93.1 vs. 100.0, P < 0.001). However, when adjusted for maternal age at delivery, parity, smoking during pregnancy, pre-pregnancy overweight, family social class, parental educational level, gender, birth weight, gestational age, perinatal complications and offspring age at follow-up, the difference was no longer statistically significant. Offspring global cognitive score decreased significantly with increasing maternal fasting glucose (beta = -4.5, 95% CI -8.0 to -0.9, P = 0.01) and 2-hour glucose (beta = -1.5, -2.9 to -0.2, P = 0.03) in univariate general linear models, but not when adjusted for family social class and parental educational level. Conclusions: Lower cognitive test scores in adult offspring of women with diet-treated gestational diabetes were explained by well known predictors of cognitive function, but not by maternal hyperglycaemia during pregnancy. We find it reassuring that mild intrauterine hyperglycaemia does not seem to have adverse effect on offspring cognitive function.	[Clausen, Tine D.] Univ Copenhagen, Dept Gynecol & Obstet, Hilleroed Hosp, Copenhagen, Denmark; [Clausen, Tine D.; Damm, Peter] Univ Copenhagen, Rigshosp, Ctr Pregnant Women Diabet, Dept Obstet,Fac Hlth Sci, DK-2100 Copenhagen, Denmark; [Mathiesen, Elisabeth R.] Univ Copenhagen, Rigshosp, Ctr Pregnant Women Diabet, Dept Endocrinol,Fac Hlth Sci, DK-2100 Copenhagen, Denmark; [Mortensen, Erik L.] Univ Copenhagen, Environm Hlth Sect, Dept Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik L.] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark; [Schmidt, Lone] Univ Copenhagen, Dept Publ Hlth, Sect Social Med, Copenhagen, Denmark; [Hansen, Torben] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth Sci, Copenhagen, Denmark; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Odense C, Denmark; [Jensen, Dorte M.] Univ Southern Denmark, Fac Hlth Sci, Dept Endocrinol, Odense C, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen; University of Southern Denmark; University of Southern Denmark	Clausen, TD (corresponding author), Univ Copenhagen, Dept Gynecol & Obstet, Hilleroed Hosp, Copenhagen, Denmark.	tine.dalsgaard.clausen@dadlnet.dk	Jensen, Dorte Møller/T-6656-2019; Clausen, Tine Dalsgaard/X-3720-2019	Jensen, Dorte Møller/0000-0002-3298-9824; Damm, Peter/0000-0002-2067-5246; Clausen, Tine Dalsgaard/0000-0001-5585-2153; Hansen, Torben/0000-0001-8748-3831; Mathiesen, elisabeth/0000-0003-3279-0863; Schmidt, Lone/0000-0002-9518-1734; Mortensen, Erik Lykke/0000-0002-6985-451X	Copenhagen University; Danish Medical Research Council; Lundbeck Foundation; Aase and Ejnar Danielsens Foundation; Gangsted Foundation; Civilingenior H.C. Bechgaards Foundation; A. P. Moller Foundation for the Advancement of Medical Science; Danish Diabetes Association	Copenhagen University; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Aase and Ejnar Danielsens Foundation; Gangsted Foundation; Civilingenior H.C. Bechgaards Foundation; A. P. Moller Foundation for the Advancement of Medical Science; Danish Diabetes Association	The study was funded by The Copenhagen University, The Danish Medical Research Council, The Lundbeck Foundation, The Aase and Ejnar Danielsens Foundation, The Gangsted Foundation, The Civilingenior H. C. Bechgaards Foundation, The A. P. Moller Foundation for the Advancement of Medical Science and The Danish Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg A, 2001, ACTA PAEDIATR, V90, P746, DOI 10.1080/080352501750315645; Aerts L, 2006, INT J BIOCHEM CELL B, V38, P894, DOI 10.1016/j.biocel.2005.07.006; Biessels GJ, 2005, NEUROBIOL AGING, V26, pS36, DOI 10.1016/j.neurobiolaging.2005.08.015; Bonilla C, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-90; Brinciotti M, 2009, CLIN NEUROPHYSIOL, V120, P563, DOI 10.1016/j.clinph.2008.12.028; Christensen U, 2004, PSYCHOSOM MED, V66, P572, DOI 10.1097/01.psy.0000126206.35683.d1; Clausen TD, 2011, DIABETIC MED, V28, P838, DOI 10.1111/j.1464-5491.2011.03300.x; Clausen TD, 2008, DIABETES CARE, V31, P340, DOI 10.2337/dc07-1596; Clausen TD, 2009, J CLIN ENDOCR METAB, V94, P2464, DOI 10.1210/jc.2009-0305; Dahlquist G, 2007, DIABETOLOGIA, V50, P1826, DOI 10.1007/s00125-007-0744-7; Dionne G, 2008, PEDIATRICS, V122, pE1073, DOI 10.1542/peds.2007-3028; Fraser A, 2012, EXP DIABETES RES, DOI 10.1155/2012/963735; GUTTORM E, 1974, ACTA ENDOCRINOL-COP, V75, P11; HADDEN DR, 1984, DIABETOLOGIA, V26, P250; Hansen EJ, 2002, SOCIALGRUPPER DANMAR; Jensen DM, 2003, AM J OBSTET GYNECOL, V189, P1383, DOI 10.1067/S0002-9378(03)00601-X; Kowalczyk M, 2002, J PEDIATR ENDOCR MET, V15, P277; Krishnaveni GV, 2010, DIABETES CARE, V33, P402, DOI 10.2337/dc09-1393; KUHL C, 1975, ACTA ENDOCRINOL-COP, V79, P709, DOI 10.1530/acta.0.0790709; MORTENSEN EL, 1990, SCAND J PSYCHOL, V31, P149, DOI 10.1111/j.1467-9450.1990.tb00826.x; MORTENSEN EL, 1993, SCAND J PSYCHOL, V34, P305, DOI 10.1111/j.1467-9450.1993.tb01127.x; Nielsen GL, 2010, DIABETIC MED, V27, P786, DOI 10.1111/j.1464-5491.2010.03024.x; Nomura Y, 2012, ARCH PEDIAT ADOL MED, V166, P337, DOI 10.1001/archpediatrics.2011.784; Ornoy A, 2001, J PEDIATR ENDOCR MET, V14, P681; PERSSON B, 1984, ACTA PAEDIATR SCAND, V73, P349, DOI 10.1111/j.1651-2227.1994.tb17747.x; PETTITT DJ, 1983, NEW ENGL J MED, V308, P242, DOI 10.1056/NEJM198302033080502; Plagemann A, 2005, PHYSIOL BEHAV, V86, P661, DOI 10.1016/j.physbeh.2005.08.065; Plagemann A, 2005, DIABETES CARE, V28, P573, DOI 10.2337/diacare.28.3.573; Plagemann A, 2010, J PERINAT MED; Plagemann A, 2007, DIABETES CARE, V30, P451, DOI 10.2337/dc06-2180; Raven JC., 1992, MANUAL RAVENS PROGR; REINISCH JM, 1993, ACTA PSYCHIAT SCAND, V87, P54, DOI 10.1111/j.1600-0447.1993.tb05361.x; RIZZO T, 1990, AM J OBSTET GYNECOL, V163, P1458, DOI 10.1016/0002-9378(90)90606-8; RIZZO T, 1991, NEW ENGL J MED, V325, P911, DOI 10.1056/NEJM199109263251303; Rizzo TA, 1997, ACTA PAEDIATR, V86, P969, DOI 10.1111/j.1651-2227.1997.tb15181.x; Rizzo TA, 1995, AM J OBSTET GYNECOL, V173, P1753, DOI 10.1016/0002-9378(95)90422-0; Silverman BL, 1998, DIABETES CARE, V21, pB142; Temple RC, 2011, DIABETIC MED, V28, P845, DOI 10.1111/j.1464-5491.2011.03285.x; Veena SR, 2010, DIABETOLOGIA, V53, P2134, DOI 10.1007/s00125-010-1847-0; Wechsler D, 1958, MEASUREMENT APPRAISA	40	28	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67107	10.1371/journal.pone.0067107	http://dx.doi.org/10.1371/journal.pone.0067107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840595	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400033
J	Jiang, Y; Wang, H; Liu, ZY; Dong, YR; Dong, Y; Xiang, XH; Bai, LJ; Tian, J; Wu, LZ; Han, JS; Cui, CL				Jiang, Yin; Wang, Hong; Liu, Zhenyu; Dong, Yuru; Dong, Yue; Xiang, Xiaohui; Bai, Lijun; Tian, Jie; Wu, Liuzhen; Han, Jisheng; Cui, Cailian			Manipulation of and Sustained Effects on the Human Brain Induced by Different Modalities of Acupuncture: An fMRI Study	PLOS ONE			English	Article							ELECTRICAL ACUPOINT STIMULATION; DEFAULT-MODE; MANUAL ACUPUNCTURE; NETWORK; ELECTROACUPUNCTURE; CONNECTIVITY; PERCEPTION; ACTIVATION; CHINESE; GRAY	The javascript: void(0) manipulation and sustained effects of acupuncture have been investigated in multiple studies, but several findings are inconsistent with one another. One possible explanation for these discrepancies is that different modalities of acupuncture were utilized in these studies. In the present study, we investigated both the manipulation and sustained effects of acupuncture in different modalities, including manual acupuncture (MA), electroacupuncture (EA) and transcutaneous electrical acupoint stimulation (TEAS). MA, EA, TEAS and sensory control stimulation were applied to 18 healthy subjects, and combined block-designed and resting-state fMRI scans were performed. In analyzing these data, the block-designed datasets were used to assess the manipulation effect by employing a modified general linear model. The data from the resting states, before and after stimulation, were used to explore the brain networks involved in the sustained effect. The results showed that the two 1-min stimulation periods produced similar activation patterns in the sensory control with positive activation in the sensorimotor areas and negative activation in the default mode areas. Although similar patterns could be detected in the first stimulation period in MA, EA and TEAS, no positive activation result was observed in the second stimulation period, and EA showed a more extensive deactivation compared to MA and TEAS. Additionally, all three of the modalities of acupuncture stimulation could increase the instinct brain network in rest. A more secure and spatially extended connectivity of the default mode network was observed following MA and EA, and TEAS specifically increased the functional connectivity in the sensorimotor network. The present study suggested that different brain mechanisms might be recruited in different acupuncture modalities. In addition, the findings from our work could provide methodological information for further research into the mechanism of acupuncture.	[Jiang, Yin; Xiang, Xiaohui; Wu, Liuzhen; Han, Jisheng; Cui, Cailian] Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China; [Jiang, Yin; Dong, Yue; Xiang, Xiaohui; Wu, Liuzhen; Han, Jisheng; Cui, Cailian] Peking Univ, Sch Basic Med Sci, Dept Neurobiol, Beijing 100871, Peoples R China; [Jiang, Yin; Xiang, Xiaohui; Wu, Liuzhen; Han, Jisheng; Cui, Cailian] Minist Educ Res, Key Lab Neurosci, Beijing, Peoples R China; [Jiang, Yin; Xiang, Xiaohui; Wu, Liuzhen; Han, Jisheng; Cui, Cailian] Minist Publ Hlth, Beijing, Peoples R China; [Wang, Hong; Dong, Yuru] Gen Hosp Armed Police Forces, Dept Magnet Resonance, Beijing, Peoples R China; [Liu, Zhenyu; Bai, Lijun; Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Peking University; Peking University; Chinese Academy of Sciences; Institute of Automation, CAS	Cui, CL (corresponding author), Peking Univ, Neurosci Res Inst, Beijing 100871, Peoples R China.	clcui@bjmu.edu.cn	Tian, Jie/H-1190-2011; tian, jie/M-6336-2013; Bai, Lijun/C-5119-2015; Liu, Zhenyu/G-8444-2018; Xiang, Xiaohui/D-8093-2015	Tian, Jie/0000-0003-0498-0432; Bai, Lijun/0000-0001-8790-5424; Liu, Zhenyu/0000-0001-7559-8519; Cui, Cailian/0000-0002-8638-8258; Xiang, Xiaohui/0000-0002-5762-5007	National Basic Research Program of China [2007CB512501, 2013CB531905, 2009CB522003]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (2007CB512501, 2013CB531905, 2009CB522003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bai LJ, 2009, HUM BRAIN MAPP, V30, P3445, DOI 10.1002/hbm.20769; Bai LJ, 2009, BRAIN RES, V1279, P37, DOI 10.1016/j.brainres.2009.04.056; Baliki MN, 2008, J NEUROSCI, V28, P1398, DOI 10.1523/JNEUROSCI.4123-07.2008; Beissner F., 2011, NEUROIMAGE; Cheng X, 1997, CHINESE ACUPUNCTURE; Cui CL, 2008, NEUROCHEM RES, V33, P2013, DOI 10.1007/s11064-008-9784-8; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Fang JL, 2009, HUM BRAIN MAPP, V30, P1196, DOI 10.1002/hbm.20583; Franco AR, 2009, HUM BRAIN MAPP, V30, P2293, DOI 10.1002/hbm.20668; Han JS, 2011, PAIN, V152, pS41, DOI 10.1016/j.pain.2010.10.012; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; Huang WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032960; Hui KKKS, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-2; Hui KKS, 2009, BRAIN RES, V1287, P84, DOI 10.1016/j.brainres.2009.06.061; Hui KK, 2010, AUTON NEUROSCI; Hui KKS, 2005, NEUROIMAGE, V27, P479, DOI 10.1016/j.neuroimage.2005.04.037; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Jiang Y, 2012, BRAIN RES; Kong JA, 2002, J ALTERN COMPLEM MED, V8, P411, DOI 10.1089/107555302760253603; Kong J, 2007, J ALTERN COMPLEM MED, V13, P1059, DOI 10.1089/acm.2007.0524; Li G, 2003, NEUROREPORT, V14, P669, DOI 10.1097/00001756-200304150-00002; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039342; Liu JX, 2010, NEUROSCI LETT, V468, P353, DOI 10.1016/j.neulet.2009.11.031; Liu P, 2009, NEUROSCI LETT, V462, P183, DOI 10.1016/j.neulet.2009.07.015; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Meesen RLJ, 2011, HUM BRAIN MAPP, V32, P872, DOI 10.1002/hbm.21075; Napadow V, 2005, HUM BRAIN MAPP, V24, P193, DOI 10.1002/hbm.20081; Napadow V, 2012, HUM BRAIN MAPP, DOI 10.1002/hbm.22091; Napadow V, 2009, NEUROIMAGE, V47, P1055, DOI 10.1016/j.neuroimage.2009.05.079; Napadow V, 2009, NEUROIMAGE, V47, P289, DOI 10.1016/j.neuroimage.2009.03.060; PRICE DD, 1984, PAIN, V19, P27, DOI 10.1016/0304-3959(84)90062-9; Qin W, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-55; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Research Group Of Acupuncture Anesthesia PMC, 1973, CHIN MED J, P151; Schliessbach J, 2011, PAIN MED, V12, P268, DOI 10.1111/j.1526-4637.2010.01051.x; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6; Unterrainer AF, 2010, J NEUROSURG ANESTH, V22, P1, DOI 10.1097/ANA.0b013e3181b7fef5; WANG JQ, 1992, INT J NEUROSCI, V65, P117, DOI 10.3109/00207459209003283; Wang ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042730; Wu MT, 2002, NEUROIMAGE, V16, P1028, DOI 10.1006/nimg.2002.1145; Xiang XH, 2012, PHYSIOL GENOMICS, V44, P318, DOI 10.1152/physiolgenomics.00162.2011; Zhang R, 2012, RES DEV DISABIL, V33, P1136, DOI 10.1016/j.ridd.2012.02.001; Zhang R, 2011, FERTIL STERIL, V96, P912, DOI 10.1016/j.fertnstert.2011.07.1093; Zhang WT, 2003, BRAIN RES, V982, P168, DOI 10.1016/S0006-8993(03)02983-4; Zhang Y, 2011, BRAIN RES, V1402, P46, DOI 10.1016/j.brainres.2011.05.054; Zhong C, 2011, J MAGN RESON IMAGING; Zyloney CE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-80	48	18	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66815	10.1371/journal.pone.0066815	http://dx.doi.org/10.1371/journal.pone.0066815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840533	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400019
J	Chung, SD; Lin, CC; Wang, LH; Lin, HC; Kang, JH				Chung, Shiu-Dong; Lin, Ching-Chun; Wang, Li-Hsuan; Lin, Herng-Ching; Kang, Jiunn-Horng			Zolpidem Use and the Risk of Injury: A Population-Based Follow-Up Study	PLOS ONE			English	Article							TRAFFIC ACCIDENTS; HIP-FRACTURES; BENZODIAZEPINE; INSOMNIA; FALLS; HOSPITALIZATION; ANXIOLYTICS; SEDATIVES; PEOPLE; TAIWAN	Background: While an association between zolpidem use and fracture and road accident was previously proposed, this study aimed to further explore the frequency and risk of a wide spectrum of injuries in subjects prescribed with zolpidem in Taiwan. Methods: We identified 77,036 subjects who received Zolpidem treatment between 2005 and 2007. We randomly selected 77,036 comparison subjects who were frequency-matched based-on their demographic profiles. We individually tracked each subject for a 90-day period to identify those who subsequently suffered an injury. Cox proportional hazards regressions were performed to calculate the hazard ratio of injury between the two groups. Results: The incidence rate of injury during the 90-day follow-up period for the total subjects was 18.11 (95% CI = 17.69-18.54) per 100 person-years; this was 24.35 (95% CI = 23.66-25.05) and 11.86 (95% CI = 11.39-12.36) for the study and comparison cohort, respectively. After adjusting for demographic variables, the hazard ratio (HR) of injury during the 90-day follow-up period for study subjects was 1.83 (95% CI = 1.73-1.94) that of comparison subjects. Additionally, compared to comparison subjects, the adjusted HR of injury during the 90-day follow-up period for study subjects who were prescribed Zolpidem for >30 days was as high as 2.17 (95% CI = 2.05-2.32). The adjusted HR of injury to blood vessels for study subjects was particularly high when compared to comparison subjects (HR = 6.34; 95% CI = 1.37-29.38). Conclusions: We found that patients prescribed with Zolpidem were at a higher risk for a wide range of injuries.	[Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, New Taipei City, Taiwan; [Chung, Shiu-Dong; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Lin, Ching-Chun] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan; [Wang, Li-Hsuan] Taipei Med Univ, Sch Pharm, Taipei, Taiwan; [Wang, Li-Hsuan] Taipei Med Univ Hosp, Dept Pharm, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ, Coll Med, Sch Med, Dept Phys Med & Rehabil, Taipei, Taiwan	Far Eastern Memorial Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Kang, JH (corresponding author), Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	jhk@tmu.edu.tw	Wang, Li-Hsuan/AAU-3257-2021					Avidan AY, 2005, J AM GERIATR SOC, V53, P955, DOI 10.1111/j.1532-5415.2005.53304.x; Chang CM, 2008, AM J GERIAT PSYCHIAT, V16, P686, DOI 10.1097/JGP.0b013e31817c6a99; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cooper James W, 2007, Consult Pharm, V22, P483, DOI 10.4140/TCP.n.2007.483; Czerwinski Edward, 2008, Ortop Traumatol Rehabil, V10, P419; Finkle WD, 2011, J AM GERIATR SOC, V59, P1883, DOI 10.1111/j.1532-5415.2011.03591.x; Gjerde H, 2011, ACCIDENT ANAL PREV, V43, P1197, DOI 10.1016/j.aap.2010.12.034; Greenblatt DJ, 2012, EXPERT OPIN PHARMACO, V13, P879, DOI 10.1517/14656566.2012.667074; Hoque R, 2009, J CLIN SLEEP MED, V5, P471; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Koski K, 1998, GERONTOLOGY, V44, P232, DOI 10.1159/000022017; Lin HC, 2008, STROKE, V39, P2744, DOI 10.1161/STROKEAHA.108.519090; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; Nurmi-Luthje I, 2006, DRUG AGING, V23, P27, DOI 10.2165/00002512-200623010-00003; Orriols L, 2011, CLIN PHARMACOL THER, V89, P595, DOI 10.1038/clpt.2011.3; Seymour A, 1999, FORENSIC SCI INT, V103, P89, DOI 10.1016/S0379-0738(99)00061-4; Smink BE, 2010, CNS DRUGS, V24, P639, DOI 10.2165/11533170-000000000-00000; Stone KL, 2008, SLEEP MED, V9, pS18, DOI 10.1016/S1389-9457(08)70012-1; Takkouche B, 2007, DRUG SAFETY, V30, P171, DOI 10.2165/00002018-200730020-00006; Vestergaard P, 2006, OSTEOPOROSIS INT, V17, P807, DOI 10.1007/s00198-005-0065-y; Vestergaard P, 2008, CALCIFIED TISSUE INT, V82, P34, DOI 10.1007/s00223-007-9095-0; Vitry AI, 2010, ARCH GERONTOL GERIAT, V50, pE1, DOI 10.1016/j.archger.2009.04.004; Yang YH, 2011, J EPIDEMIOL, V21, P37, DOI 10.2188/jea.JE20090195	24	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67459	10.1371/journal.pone.0067459	http://dx.doi.org/10.1371/journal.pone.0067459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826304	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000082
J	Kim, H; Kim, K; Kim, DW; Jung, HD; Cheong, HM; Kim, KH; Kim, DS; Kim, YJ				Kim, Hak; Kim, Kisoon; Kim, Dae-Won; Jung, Hee-Dong; Cheong, Hyang Min; Kim, Ki Hwan; Kim, Dong Soo; Kim, You-Jin			Identification of Recombinant Human Rhinovirus A and C in Circulating Strains from Upper and Lower Respiratory Infections	PLOS ONE			English	Article							CLINICAL-FEATURES; GENETIC DIVERSITY; SPECIES C; HRV-C; CHILDREN; ILLNESS; EPIDEMIOLOGY; GENOTYPE; SEQUENCE	Human rhinoviruses (HRVs), in the Enterovirus genus within the family Picornaviridae, are a highly prevalent cause of acute respiratory infection (ARI). Enteroviruses are genetically highly variable, and recombination between serotypes is known to be a major contribution to their diversity. Recently it was reported that recombination events in HRVs cause the diversity of HRV-C. This study analyzed parts of the viral genes spanning the 5' non-coding region (NCR) through to the viral protein (VP) encoding sequences of 105 HRV field isolates from 51 outpatient cases of Acute Respiratory Infectious Network (ARINET) and 54 inpatient cases of severe lower respiratory infection (SLRI) surveillance, in order to identify recombination in field samples. When analyzing parts of the 5' NCR and VP4/VP2 encoding sequences, we found intra-and interspecies recombinants in field strains of HRV-A and -C. Nineteen cases of recombination events (18.1%) were found among 105 field strains. For HRV-A, there were five cases (4.8%) of intraspecies recombination events and three cases (2.8%) of interspecies recombination events. For HRV-C, there were four cases (3.8%) of intraspecies recombination events and seven cases (6.7%) of interspecies recombination events. Recombination events were significantly more frequently observed in the ARINET samples (18 cases) than in the SLRI samples (1 case; P< 0.0001). The recombination breakpoints were located in nucleotides (nt) 472-554, which comprise stem-loop 5 in the internal ribosomal entry site (IRES), based on the HRV-B 35 sequence (accession no. FJ445187). Our findings regarding genomic recombination in circulating HRV-A and -C strains suggest that recombination might play a role in HRV fitness and could be a possible determinant of disease severity caused by various HRV infections in patients with ARI.	[Kim, Hak; Kim, Kisoon; Jung, Hee-Dong; Cheong, Hyang Min; Kim, You-Jin] Korea Ctr Dis Control & Prevent, Korea Natl Inst Hlth, Ctr Infect Dis, Div Resp Viruses, Chungbuk, South Korea; [Kim, Dae-Won] Korea Ctr Dis Control & Prevent, Korea Natl Inst Hlth, Ctr Immun & Pathol, Syst Biol Team, Chungbuk, South Korea; [Kim, Ki Hwan; Kim, Dong Soo] Yonsei Univ, Coll Med, Dept Pediat, Severance Childrens Hosp, Seoul, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Infectious Disease; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Yonsei University; Yonsei University Health System	Kim, YJ (corresponding author), Korea Ctr Dis Control & Prevent, Korea Natl Inst Hlth, Ctr Infect Dis, Div Resp Viruses, Chungbuk, South Korea.	youjin3693@gmail.com		Kim, Hak/0000-0003-2439-9354	Korea NIH [2011-N47001-00]	Korea NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported with funds from the intramural research fund of Korea NIH (2011-N47001-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Bochkov YA, 2012, MICROBES INFECT, V14, P485, DOI 10.1016/j.micinf.2011.12.011; BORMAN A, 1992, VIROLOGY, V188, P685, DOI 10.1016/0042-6822(92)90523-R; Chun JK, 2009, EUR J CLIN MICROBIOL, V28, P841, DOI 10.1007/s10096-009-0701-0; Dougherty RH, 2009, CLIN EXP ALLERGY, V39, P193, DOI 10.1111/j.1365-2222.2008.03157.x; Gern JE, 1999, CLIN MICROBIOL REV, V12, P9, DOI 10.1128/CMR.12.1.9; Hayden FG, 2004, REV MED VIROL, V14, P17, DOI 10.1002/rmv.406; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355; HUGHES PJ, 1988, J GEN VIROL, V69, P49, DOI 10.1099/0022-1317-69-1-49; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Kafasla P, 2010, EMBO J, V29, P3710, DOI 10.1038/emboj.2010.231; Lamson D, 2006, J INFECT DIS, V194, P1398, DOI 10.1086/508551; Landa-Cardena A, 2012, VIRUSES-BASEL, V4, P200, DOI 10.3390/v4020200; Lau SKP, 2007, J CLIN MICROBIOL, V45, P3655, DOI 10.1128/JCM.01254-07; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Liu GHF, 2012, PHARM STAT, V11, P163, DOI 10.1002/pst.540; Lukashev AN, 2005, REV MED VIROL, V15, P157, DOI 10.1002/rmv.457; Mackay IM, 2008, J CLIN VIROL, V42, P297, DOI 10.1016/j.jcv.2008.04.002; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; MCINTYRE CL, 2013, ARCH VIROL, P43931; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mulders MN, 2000, J GEN VIROL, V81, P803, DOI 10.1099/0022-1317-81-3-803; Palmenberg AC, 2010, J ALLERGY CLIN IMMUN, V125, P1190, DOI 10.1016/j.jaci.2010.04.010; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Papadopoulos NG, 1999, J MED VIROL, V58, P100, DOI 10.1002/(SICI)1096-9071(199905)58:1&lt;100::AID-JMV16&gt;3.0.CO;2-D; PELON W, 1957, P SOC EXP BIOL MED, V94, P262; Piralla A, 2009, J CLIN VIROL, V45, P311, DOI 10.1016/j.jcv.2009.04.016; PRICE WH, 1956, P NATL ACAD SCI USA, V42, P892, DOI 10.1073/pnas.42.12.892; Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; Schibler M, 2012, J GEN VIROL, V93, P93, DOI 10.1099/vir.0.035808-0; Simmonds P, 2010, J GEN VIROL, V91, P2409, DOI 10.1099/vir.0.023994-0; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Smuts HE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-65; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wisdom A, 2009, J CLIN MICROBIOL, V47, P3958, DOI 10.1128/JCM.00993-09; Wisdom A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008518; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10	42	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68081	10.1371/journal.pone.0068081	http://dx.doi.org/10.1371/journal.pone.0068081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826363	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000117
J	Soininen, EM; Ravolainen, VT; Brathen, KA; Yoccoz, NG; Gielly, L; Ims, RA				Soininen, Eeva M.; Ravolainen, Virve T.; Brathen, Kari Anne; Yoccoz, Nigel G.; Gielly, Ludovic; Ims, Rolf A.			Arctic Small Rodents Have Diverse Diets and Flexible Food Selection	PLOS ONE			English	Article							DIFFERING GROWTH FORM; MAMMALIAN HERBIVORES; FUNCTIONAL-RESPONSE; HABITAT USE; VACCINIUM-MYRTILLUS; MICROTINE RODENTS; TUNDRA PLANTS; VOLE; COMPETITION; VEGETATION	The ecology of small rodent food selection is poorly understood, as mammalian herbivore food selection theory has mainly been developed by studying ungulates. Especially, the effect of food availability on food selection in natural habitats where a range of food items are available is unknown. We studied diets and selectivity of grey-sided voles (Myodes rufocanus) and tundra voles (Microtus oeconomus), key herbivores in European tundra ecosystems, using DNA metabarcoding, a novel method enabling taxonomically detailed diet studies. In order to cover the range of food availabilities present in the wild, we employed a large-scale study design for sampling data on food availability and vole diets. Both vole species had ingested a range of plant species and selected particularly forbs and grasses. Grey-sided voles also selected ericoid shrubs and tundra voles willows. Availability of a food item rarely affected its utilization directly, although seasonal changes of diets and selection suggest that these are positively correlated with availability. Moreover, diets and selectivity were affected by availability of alternative food items. These results show that the focal sub-arctic voles have diverse diets and flexible food preferences and rarely compensate low availability of a food item with increased searching effort. Diet diversity itself is likely to be an important trait and has previously been underrated owing to methodological constraints. We suggest that the roles of alternative food item availability and search time limitations for small rodent feeding ecology should be investigated.	[Soininen, Eeva M.; Ravolainen, Virve T.; Brathen, Kari Anne; Yoccoz, Nigel G.; Ims, Rolf A.] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Gielly, Ludovic] Univ Grenoble 1, Lab ECol Alpine, Grenoble, France	UiT The Arctic University of Tromso; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie	Soininen, EM (corresponding author), Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway.	eeva.soininen@uit.no	Soininen, Eeva/AAJ-5909-2021; Gielly, Ludovic/ADQ-6036-2022; Bråthen, Kari Anne/AAN-4666-2020; Yoccoz, Nigel/C-8561-2014	Soininen, Eeva/0000-0003-4280-8350; Bråthen, Kari Anne/0000-0003-0942-1074; Yoccoz, Nigel/0000-0003-2192-1039	Norwegian Research Council; Oskar Huttunen Foundation; Norwegian Directorate for Nature Management	Norwegian Research Council(Research Council of NorwayEuropean Commission); Oskar Huttunen Foundation; Norwegian Directorate for Nature Management	This study was funded by Norwegian Research Council (http://www.forskningsradet.no/, project Ecosystem Finnmark), Oskar Huttunen Foundation http://www.oskhuttusensaatio.net/, PhD-scholarship for EMS) and Norwegian Directorate for Nature Management (http://http://www.dirnat.no/, support for EMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, ECOLOGY, V74, P1313, DOI 10.2307/1940062; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; ALIPAYO D, 1992, J RANGE MANAGE, V45, P148, DOI 10.2307/4002773; ANDERSSON M, 1986, OIKOS, V46, P93, DOI 10.2307/3565385; Bates D., 2008, LME4 LINEAR MIXED EF; BATZLI GO, 1980, ARCTIC ALPINE RES, V12, P483, DOI 10.2307/1550496; BATZLI GO, 1990, ARCTIC ALPINE RES, V22, P51, DOI 10.2307/1551720; Berg T.B., 2003, THESIS U COPENHAGEN; Bergvall UA, 2005, ECOLOGY, V86, P2450, DOI 10.1890/04-0978; Bolnick DI, 2005, ECOLOGY, V86, P2771, DOI 10.1890/04-1249; Brathen KA, 2004, J VEG SCI, V15, P653, DOI 10.1111/j.1654-1103.2004.tb02307.x; Brathen KA, 2007, ECOSYSTEMS, V10, P773, DOI 10.1007/s10021-007-9058-3; Bren M, 2011, COMPOSITIONS COMPOSI; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; CHAPIN FS, 1986, J ECOL, V74, P707; CHAPIN FS, 1989, FUNCT ECOL, V3, P73, DOI 10.2307/2389677; CHAPIN FS, 1980, J ECOL, V68, P189; Cornelissen JHC, 2004, FUNCT ECOL, V18, P779, DOI 10.1111/j.0269-8463.2004.00900.x; Dahlgren J, 2007, OECOLOGIA, V152, P525, DOI 10.1007/s00442-007-0664-8; Deagle Bruce E, 2006, Front Zool, V3, P11, DOI 10.1186/1742-9994-3-11; Fortin D, 2004, ECOLOGY, V85, P2312, DOI 10.1890/03-0485; Ggbczynska Z., 1970, Acta theriol., V15, P33; Gilbert S, 2013, BASIC APPL ECOL, V14, P12, DOI 10.1016/j.baae.2012.11.005; Gilg O, 2006, OIKOS, V113, P193, DOI 10.1111/j.2006.0030-1299.14125.x; GROSS JE, 1993, ECOLOGY, V74, P778, DOI 10.2307/1940805; Hamback PA, 2004, OIKOS, V106, P85, DOI 10.1111/j.0030-1299.2004.13029.x; Hamback PA, 1997, OIKOS, V80, P276, DOI 10.2307/3546596; Hansen TF, 1999, P NATL ACAD SCI USA, V96, P986, DOI 10.1073/pnas.96.3.986; Hansson L., 1978, Holarctic Ecology, V1, P16; Harju A, 1996, THESIS U JOENSUU; Henden JA, 2011, BASIC APPL ECOL, V12, P413, DOI 10.1016/j.baae.2011.05.006; Henden JA, 2011, POLAR BIOL, V34, P533, DOI 10.1007/s00300-010-0908-7; Hjalten J, 1996, OIKOS, V76, P181, DOI 10.2307/3545760; Hobbs NT, 2003, ECOLOGY, V84, P666; Hornfeldt B, 2004, OIKOS, V107, P376, DOI 10.1111/j.0030-1299.2004.13348.x; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; IMS RA, 1987, OIKOS, V50, P103, DOI 10.2307/3565406; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Ims RA, 2011, P NATL ACAD SCI USA, V108, P1970, DOI 10.1073/pnas.1012714108; Iversen M, 2009, J VEG SCI, V20, P903, DOI 10.1111/j.1654-1103.2009.01088.x; Jensen PM, 1993, BIOL LEMMINGS, P547; Jensen SP, 1999, J THEOR BIOL, V199, P63, DOI 10.1006/jtbi.1999.0941; JONASSON S, 1988, OIKOS, V52, P101, DOI 10.2307/3565988; JUNG HJG, 1981, J MAMMAL, V62, P286, DOI 10.2307/1380705; Kowalczyk R, 2011, FOREST ECOL MANAG, V261, P821, DOI 10.1016/j.foreco.2010.11.026; LAINE KM, 1987, OIKOS, V50, P389, DOI 10.2307/3565500; LEE WB, 1993, J COMP PHYSIOL B, V163, P337, DOI 10.1007/BF00347785; LEE WB, 1993, FUNCT ECOL, V7, P427, DOI 10.2307/2390030; LUNDBERG P, 1988, J ANIM ECOL, V57, P999, DOI 10.2307/5107; Marell A, 2006, BASIC APPL ECOL, V7, P13, DOI 10.1016/j.baae.2005.04.005; Marsh KJ, 2006, J CHEM ECOL, V32, P1247, DOI 10.1007/s10886-006-9082-3; MYLLYMAKI A, 1971, Annales Zoologici Fennici, V8, P177; Mysterud A, 2011, BASIC APPL ECOL, V12, P195, DOI 10.1016/j.baae.2011.03.002; Nersesian CL, 2012, BEHAV ECOL, V23, P879, DOI 10.1093/beheco/ars049; Oksanen T, 2008, EVOL ECOL RES, V10, P415; Olofsson J, 2004, OIKOS, V106, P324, DOI 10.1111/j.0030-1299.2004.13224.x; Olofsson J, 2012, NAT CLIM CHANGE, V2, P880, DOI 10.1038/NCLIMATE1537; OSTFELD RS, 1985, AM NAT, V126, P1, DOI 10.1086/284391; Owl MY, 1998, FUNCT ECOL, V12, P4, DOI 10.1046/j.1365-2435.1998.00151.x; PALO RT, 1984, J CHEM ECOL, V10, P499, DOI 10.1007/BF00988096; Pegard A, 2009, J AGR FOOD CHEM, V57, P5700, DOI 10.1021/jf803680c; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; Predavec M, 2000, CAN J ZOOL, V78, P1885, DOI 10.1139/cjz-78-11-1885; Provenza FD, 2007, CROP SCI, V47, P382, DOI 10.2135/cropsci2006.02.0083; Pusenius J, 2003, ECOSCIENCE, V10, P155, DOI 10.1080/11956860.2003.11682762; Quested HM, 2003, ECOLOGY, V84, P3209, DOI 10.1890/02-0426; R Development Core Team, 2011, R LANG ENV STAT COMP; Ravolainen VT, 2010, ECOSYSTEMS, V13, P157, DOI 10.1007/s10021-009-9308-7; Ravolainen VT, 2011, BASIC APPL ECOL, V12, P643, DOI 10.1016/j.baae.2011.09.009; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; Saetnan ER, 2009, J MAMMAL, V90, P183, DOI 10.1644/07-MAMM-A-259.1; Searle KR, 2008, BEHAV ECOL, V19, P475, DOI 10.1093/beheco/arn004; Soininen EM, 2013, OIKOS, V122, P30, DOI 10.1111/j.1600-0706.2012.20689.x; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; Sonstebo JH, 2010, MOL ECOL RESOUR, V10, P1009, DOI 10.1111/j.1755-0998.2010.02855.x; SPALINGER DE, 1992, AM NAT, V140, P325, DOI 10.1086/285415; Speed JDM, 2010, J ECOL, V98, P1002, DOI 10.1111/j.1365-2745.2010.01685.x; Swihart Robert K., 2009, BMC Ecology, V9, P5, DOI 10.1186/1472-6785-9-5; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; TAST J, 1974, Aquilo Ser Zoologica, V15, P25; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; van Langevelde F, 2008, ECOL MODEL, V213, P273, DOI 10.1016/j.ecolmodel.2007.12.009; Vare H, 2005, SUURI POHJOLAN KASVI; Vehvilainen H, 2006, ECOGRAPHY, V29, P497, DOI 10.1111/j.0906-7590.2006.04457.x; WILLIAMS LR, 1990, ECOLOGY, V71, P797, DOI 10.2307/1940331; Ylonen H, 2008, RODENT SOC ECOLOGICA, P345; Yoccoz N. G., 2004, Animal Biodiversity and Conservation, V27, P427; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x; Zuur Alain F., 2009, P1; [No title captured]	92	39	43	5	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68128	10.1371/journal.pone.0068128	http://dx.doi.org/10.1371/journal.pone.0068128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826371	gold, Green Published			2022-12-27	WOS:000321150000125
J	Capewell, P; Monk, S; Ivens, A; MacGregor, P; Fenn, K; Walrad, P; Bringaud, F; Smith, TK; Matthews, KR				Capewell, Paul; Monk, Stephanie; Ivens, Alasdair; MacGregor, Paula; Fenn, Katelyn; Walrad, Pegine; Bringaud, Frederic; Smith, Terry K.; Matthews, Keith R.			Regulation of Trypanosoma brucei Total and Polysomal mRNA during Development within Its Mammalian Host	PLOS ONE			English	Article							BLOOD-STREAM FORMS; LIFE-CYCLE STAGES; AFRICAN TRYPANOSOMES; GENE-EXPRESSION; SYNCHRONOUS DIFFERENTIATION; TRANSMISSION; LEISHMANIA; ABUNDANCE; PROTEOME; PATHWAY	The gene expression of Trypanosoma brucei has been examined extensively in the blood of mammalian hosts and in forms found in the midgut of its arthropod vector, the tsetse fly. However, trypanosomes also undergo development within the mammalian bloodstream as they progress from morphologically 'slender forms' to transmissible 'stumpy forms' through morphological intermediates. This transition is temporally progressive within the first wave of parasitaemia such that gene expression can be monitored in relatively pure slender and stumpy populations as well as during the progression between these extremes. The development also represents the progression of cells from translationally active forms adapted for proliferation in the host to translationally quiescent forms, adapted for transmission. We have used metabolic labelling to quantitate translational activity in slender forms, stumpy forms and in forms undergoing early differentiation to procyclic forms in vitro. Thereafter we have examined the cohort of total mRNAs that are enriched throughout development in the mammalian bloodstream (slender, intermediate and stumpy forms), irrespective of strain, revealing those that exhibit consistent developmental regulation rather than sample specific changes. Transcripts that cosediment with polysomes in stumpy forms and slender forms have also been enriched to identify transcripts that escape translational repression prior to transmission. Combined, the expression and polysomal association of transcripts as trypanosomes undergo development in the mammalian bloodstream have been defined, providing a resource for trypanosome researchers. This facilitates the identification of those that undergo developmental regulation in the bloodstream and therefore those likely to have a role in the survival and capacity for transmission of stumpy forms.	[Capewell, Paul; Monk, Stephanie; Ivens, Alasdair; MacGregor, Paula; Fenn, Katelyn; Walrad, Pegine; Matthews, Keith R.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Smith, Terry K.] Univ St Andrews, St Andrews, Fife, Scotland; [Bringaud, Frederic] Univ Bordeaux Segalen, Ctr Resonance Magnet Syst Biol RMSB, Bordeaux, France	University of Edinburgh; University of St Andrews; UDICE-French Research Universities; Universite de Bordeaux	Matthews, KR (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland.	keith.matthews@ed.ac.uk	Capewell, Paul/R-1935-2017; GenePool, The/D-8812-2012	Capewell, Paul/0000-0002-8803-5034; Walrad, Pegine B./0000-0002-2302-0720; Ivens, Al/0000-0002-0112-3876; MacGregor, Paula/0000-0003-0919-3745; Matthews FRS FMedSci FRSE, Professor Keith/0000-0003-0309-9184	Wellcome Trust; Medical Research Council, UK; MRC [MR/K001744/1] Funding Source: UKRI; Medical Research Council [MR/K001744/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust Programme grant to KM and by a Wellcome Trust Strategic award to the Centre for Immunity, Infection and Evolution at the University of Edinburgh. SM was supported by a studentship from the Medical Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSFORD S, 2011, GENOME RES; Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333; Aslett M, NUCL ACIDS RES, V38, pD457; Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Barnwell EM, 2010, J CELL SCI, V123, P3401, DOI 10.1242/jcs.068684; Brecht M, 1998, MOL BIOCHEM PARASIT, V97, P189, DOI 10.1016/S0166-6851(98)00151-0; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-34; Clayton C, 2007, MOL BIOCHEM PARASIT, V156, P93, DOI 10.1016/j.molbiopara.2007.07.007; Dean S, 2009, NATURE, V459, P213, DOI 10.1038/nature07997; Droll D, 2010, FEBS LETT, V584, P1156, DOI 10.1016/j.febslet.2010.02.018; Durrani Z, 2012, CELL MICROBIOL, V14, P1434, DOI 10.1111/j.1462-5822.2012.01809.x; Engstler M, 2004, GENE DEV, V18, P2798, DOI 10.1101/gad.323404; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gunasekera K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-556; HAMM B, 1990, MOL BIOCHEM PARASIT, V40, P13, DOI 10.1016/0166-6851(90)90075-W; HERBERT WJ, 1976, EXP PARASITOL, V40, P427, DOI 10.1016/0014-4894(76)90110-7; Jackson AP, 2012, P NATL ACAD SCI USA, V109, P3416, DOI 10.1073/pnas.1117313109; Jensen BC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-482; Kabani S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-427; Kieft R, 2010, P NATL ACAD SCI USA, V107, P16137, DOI 10.1073/pnas.1007074107; L angmead B., 2010, CURR PROTOC BIOINFOR; Lahav T, 2011, FASEB J, V25, P515, DOI 10.1096/fj.10-157529; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Macgregor P, 2012, NUCL ACIDS RES; MacGregor P, 2012, NUCLEIC ACIDS RES, V40, P7705, DOI 10.1093/nar/gks533; MacGregor P, 2012, NAT REV MICROBIOL, V10, P431, DOI 10.1038/nrmicro2779; MacGregor P, 2011, CELL HOST MICROBE, V9, P310, DOI 10.1016/j.chom.2011.03.013; Matthews KR, 2011, SCIENCE, V331, P1149, DOI 10.1126/science.1198077; MATTHEWS KR, 1994, J CELL BIOL, V125, P1147, DOI 10.1083/jcb.125.5.1147; Mayho M, 2006, NUCLEIC ACIDS RES, V34, P5312, DOI 10.1093/nar/gkl598; Minning TA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-370; Muller IB, 2002, MOL BIOL CELL, V13, P3787, DOI 10.1091/mbc.E02-02-0093; Nagamune K, 2004, J EXP MED, V199, P1445, DOI 10.1084/jem.20030635; Nilsson D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001037; Nolan DP, 2000, EUR J BIOCHEM, V267, P18, DOI 10.1046/j.1432-1327.2000.00935.x; Paape D, 2008, MOL CELL PROTEOMICS, V7, P1688, DOI 10.1074/mcp.M700343-MCP200; PAYS E, 1993, MOL BIOCHEM PARASIT, V61, P107, DOI 10.1016/0166-6851(93)90163-R; PRIEST JW, 1994, J BIOENERG BIOMEMBR, V26, P179, DOI 10.1007/BF00763067; Queiroz R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-495; Reuner B, 1997, MOL BIOCHEM PARASIT, V90, P269, DOI 10.1016/S0166-6851(97)00160-6; Robertson M, 1912, P R SOC LOND B-CONTA, V85, P241, DOI 10.1098/rspb.1912.0048; Roditi I, 2008, CURR OPIN MICROBIOL, V11, P345, DOI 10.1016/j.mib.2008.06.006; Sanchez MA, 2004, MOL BIOCHEM PARASIT, V136, P265, DOI 10.1016/j.molbiopara.2004.04.009; SHAPIRO SZ, 1984, ACTA TROP, V41, P313; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Szoor B, 2010, GENE DEV, V24, P1306, DOI 10.1101/gad.570310; Tsigankov P, 2012, PARASITOLOGY, V139, P1146, DOI 10.1017/S0031182012000157; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Vanhollebeke B, 2010, EUKARYOT CELL, V9, P1272, DOI 10.1128/EC.00076-10; Vassella E, 1997, J CELL SCI, V110, P2661; VICKERMAN K, 1965, NATURE, V208, P762, DOI 10.1038/208762a0; Walrad PB, 2012, NUCLEIC ACIDS RES, V40, P2869, DOI 10.1093/nar/gkr1106; Wijers D. J. B., 1960, Annals of Tropical Medicine and Parasitology, V54, P341; Zhang XB, 2010, NUCLEIC ACIDS RES, V38, P7378, DOI 10.1093/nar/gkq618; Zhu Y, 2009, INT J PARASITOL, V39, P713, DOI 10.1016/j.ijpara.2008.11.010; ZIEGELBAUER K, 1990, EUR J BIOCHEM, V192, P373, DOI 10.1111/j.1432-1033.1990.tb19237.x	57	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67069	10.1371/journal.pone.0067069	http://dx.doi.org/10.1371/journal.pone.0067069			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840587	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000321424400067
J	Cross, TJ; Kavanagh, JJ; Breskovic, T; Maslov, PZ; Lojpur, M; Johnson, BD; Dujic, Z				Cross, Troy J.; Kavanagh, Justin J.; Breskovic, Toni; Maslov, Petra Zubin; Lojpur, Mihajlo; Johnson, Bruce D.; Dujic, Zeljko			The Effects of Involuntary Respiratory Contractions on Cerebral Blood Flow during Maximal Apnoea in Trained Divers	PLOS ONE			English	Article							DIFFERENT LUNG-VOLUMES; BREATHING MOVEMENTS; ARTERIAL-PRESSURE; STROKE VOLUME; DOPPLER ULTRASOUND; STRUGGLE PHASE; ELITE DIVERS; AIR HUNGER; HUMANS; VELOCITY	The effects of involuntary respiratory contractions on the cerebral blood flow response to maximal apnoea is presently unclear. We hypothesised that while respiratory contractions may augment left ventricular stroke volume, cardiac output and ultimately cerebral blood flow during the struggle phase, these contractions would simultaneously cause marked 'respiratory' variability in blood flow to the brain. Respiratory, cardiovascular and cerebrovascular parameters were measured in ten trained, male apnoea divers during maximal 'dry' breath holding. Intrathoracic pressure was estimated via oesophageal pressure. Left ventricular stroke volume, cardiac output and mean arterial pressure were monitored using finger photoplethysmography, and cerebral blood flow velocity was obtained using transcranial ultrasound. The increasingly negative inspiratory intrathoracic pressure swings of the struggle phase significantly influenced the rise in left ventricular stroke volume (R-2 = 0.63, P<0.05), thereby contributing to the increase in cerebral blood flow velocity throughout this phase of apnoea. However, these contractions also caused marked respiratory variability in left ventricular stroke volume, cardiac output, mean arterial pressure and cerebral blood flow velocity during the struggle phase (R-2 = 0.99, P<0.05). Interestingly, the magnitude of respiratory variability in cerebral blood flow velocity was inversely correlated with struggle phase duration (R-2 = 0.71, P<0.05). This study confirms the hypothesis that, on the one hand, involuntary respiratory contractions facilitate cerebral haemodynamics during the struggle phase while, on the other, these contractions produce marked respiratory variability in blood flow to the brain. In addition, our findings indicate that such variability in cerebral blood flow negatively impacts on struggle phase duration, and thus impairs breath holding performance.	[Cross, Troy J.; Kavanagh, Justin J.] Griffith Univ, Griffith Hlth Inst, Nathan, Qld 4111, Australia; [Cross, Troy J.; Kavanagh, Justin J.] Griffith Univ, Heart Fdn Res Ctr, Nathan, Qld 4111, Australia; [Breskovic, Toni; Maslov, Petra Zubin; Dujic, Zeljko] Univ Split, Sch Med, Dept Physiol, Split, Croatia; [Cross, Troy J.; Johnson, Bruce D.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Lojpur, Mihajlo] Clin Hosp Ctr Split, Dept Anaesthesiol, Split, Croatia	Griffith University; Menzies Health Institute Queensland; Griffith University; University of Split; Mayo Clinic; University of Split	Cross, TJ (corresponding author), Griffith Univ, Griffith Hlth Inst, Gold Coast Campus, Nathan, Qld 4111, Australia.	t.cross@griffith.edu.au	dujic, zeljko/D-5549-2017; Lojpur, Mihajlo/D-8005-2017; Cross, Troy J/D-4435-2012	Cross, Troy J/0000-0003-2902-7787; Dujic, Zeljko/0000-0002-6450-0130; Kavanagh, Justin/0000-0002-1046-260X; Breskovic, Toni/0000-0001-7266-2087	Croatian Ministry of Science, Education and Sports [216-2160133-0130]; Australian Postgraduate Award; Griffith University International Exchange Incentive Scheme Grant; Mayo Clinic; Mayo Clinic from the Gonda Family	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); Australian Postgraduate Award(Australian Government); Griffith University International Exchange Incentive Scheme Grant; Mayo Clinic; Mayo Clinic from the Gonda Family	This study was supported by the Croatian Ministry of Science, Education and Sports Grant No. 216-2160133-0130 (procured by ZD). TJC was supported by an Australian Postgraduate Award, a Griffith University International Exchange Incentive Scheme Grant, and a grant from the Mayo Clinic. BDJ was supported by a grant to the Mayo Clinic from the Gonda Family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie PN, 2005, J PHYSIOL-LONDON, V566, P613, DOI 10.1113/jphysiol.2005.087320; Albert B, 1961, J APPL PHYSIOL, V16, P583; Andersson JPA, 2002, J APPL PHYSIOL, V93, P882, DOI 10.1152/japplphysiol.00863.2001; Bakovic D, 2003, J APPL PHYSIOL, V95, P1460, DOI 10.1152/japplphysiol.00221.2003; BANZETT RB, 1990, RESP PHYSIOL, V81, P1, DOI 10.1016/0034-5687(90)90065-7; BAYDUR A, 1987, J APPL PHYSIOL, V62, P315, DOI 10.1152/jappl.1987.62.1.315; Blunch N. J., 2008, INTRO STRUCTURAL EQU; Boker SM, 2005, PATH ANAL PATH DIAGR; BRECHER GA, 1955, CIRC RES, V3, P210, DOI 10.1161/01.RES.3.2.210; Breskovic T, 2012, RESP PHYSIOL NEUROBI, V181, P228, DOI 10.1016/j.resp.2012.03.007; Breskovic T, 2011, AUTON NEUROSCI-BASIC, V164, P74, DOI 10.1016/j.autneu.2011.05.003; COUGHTREY H, 1993, ARCH DIS CHILD-FETAL, V68, P312, DOI 10.1136/adc.68.3_Spec_No.312; CRAIG AB, 1976, MED SCI SPORT EXER, V8, P171, DOI 10.1249/00005768-197600830-00007; Cross TJ, 2012, RESP MUSCLE PRESSURE; DAHL A, 1992, STROKE, V23, P15, DOI 10.1161/01.STR.23.1.15; Dujic Z, 2009, J APPL PHYSIOL, V107, P1840, DOI 10.1152/japplphysiol.00334.2009; Elstad M, 2001, J PHYSIOL-LONDON, V536, P251, DOI 10.1111/j.1469-7793.2001.t01-1-00251.x; FERRIGNO M, 1986, J APPL PHYSIOL, V60, P1871, DOI 10.1152/jappl.1986.60.6.1871; GODFREY S, 1968, RESP PHYSIOL, V5, P385, DOI 10.1016/0034-5687(68)90030-3; GUZ A, 1987, J PHYSIOL-LONDON, V393, P499, DOI 10.1113/jphysiol.1987.sp016836; GUZMAN PA, 1981, BRIT HEART J, V46, P657; Harms MPM, 1999, CLIN SCI, V97, P291, DOI 10.1042/CS19990061; Heusser K, 2009, HYPERTENSION, V53, P719, DOI 10.1161/HYPERTENSIONAHA.108.127530; INNES JA, 1993, J PHYSIOL-LONDON, V460, P487, DOI 10.1113/jphysiol.1993.sp019483; Jellema WT, 1999, ANESTHESIOLOGY, V90, P1317, DOI 10.1097/00000542-199905000-00016; KETY SS, 1948, J CLIN INVEST, V27, P484, DOI 10.1172/JCI101995; KILBURN KH, 1960, CIRC RES, V8, P660, DOI 10.1161/01.RES.8.3.660; Kjeld T, 2009, J APPL PHYSIOL, V106, P1243, DOI 10.1152/japplphysiol.90370.2008; KONTOS HA, 1989, STROKE, V20, P1; LIN YC, 1974, J APPL PHYSIOL, V37, P291, DOI 10.1152/jappl.1974.37.3.291; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; MILICEMILI J, 1964, J APPL PHYSIOL, V19, P207, DOI 10.1152/jappl.1964.19.2.207; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moosavi SH, 2003, J APPL PHYSIOL, V94, P141, DOI 10.1152/japplphysiol.00594.2002; O'Leary DD, 2004, AM J PHYSIOL-REG I, V287, pR670, DOI 10.1152/ajpregu.00408.2003; Palada I, 2008, RESP PHYSIOL NEUROBI, V161, P174, DOI 10.1016/j.resp.2008.01.008; Palada I, 2007, RESP PHYSIOL NEUROBI, V157, P374, DOI 10.1016/j.resp.2007.02.002; Pan AW, 1997, EUR J APPL PHYSIOL O, V75, P388, DOI 10.1007/s004210050177; Parkes MJ, 2006, EXP PHYSIOL, V91, P1, DOI 10.1113/expphysiol.2005.031625; PINSKY MR, 1984, J APPL PHYSIOL, V56, P1237, DOI 10.1152/jappl.1984.56.5.1237; Poulin MJ, 1996, STROKE, V27, P2244, DOI 10.1161/01.STR.27.12.2244; Przyby owski T, 2003, J PHYSL, V548, P323; RAHN H, 1946, AM J PHYSIOL, V146, P161, DOI 10.1152/ajplegacy.1946.146.2.161; RUDIKOFF MT, 1980, CIRCULATION, V61, P345, DOI 10.1161/01.CIR.61.2.345; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Shipley B., 2000, CAUSE CORRELATIONS B; Tacq J, 2004, PART CORRELATION SAG; TOSKA K, 1993, J PHYSIOL-LONDON, V472, P501, DOI 10.1113/jphysiol.1993.sp019958; VIROLAINEN J, 1995, EUR HEART J, V16, P1293, DOI 10.1093/oxfordjournals.eurheartj.a061088; von Leupoldt A, 2005, CHEST, V128, P345, DOI 10.1378/chest.128.1.345; WHITELAW WA, 1981, J APPL PHYSIOL, V50, P435, DOI 10.1152/jappl.1981.50.2.435; WISE RA, 1981, LUNG, V159, P175, DOI 10.1007/BF02713914; Wong K, 2006, MED BIOL ENG COMPUT, V44, P971, DOI 10.1007/s11517-006-0113-6; Wong KKL, 2013, METHODS IN RESEARCH AND DEVELOPMENT OF BIOMEDICAL DEVICES, P1, DOI 10.1142/8621; Wong KKL, 2010, ANZIAM J, P51; Zhang R, 1998, AM J PHYSIOL-HEART C, V274, pH233, DOI 10.1152/ajpheart.1998.274.1.H233	56	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66950	10.1371/journal.pone.0066950	http://dx.doi.org/10.1371/journal.pone.0066950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840561	Green Submitted, gold, Green Published			2022-12-27	WOS:000321424400057
J	Palavicini, JP; Lloyd, BN; Hayes, CD; Bianchi, E; Kang, DE; Dawson-Scully, K; Lakshmana, MK				Palavicini, Juan Pablo; Lloyd, Brandon Noel; Hayes, Crystal D.; Bianchi, Elisabetta; Kang, David E.; Dawson-Scully, Ken; Lakshmana, Madepalli K.			RanBP9 Plays a Critical Role in Neonatal Brain Development in Mice	PLOS ONE			English	Article							MURINE CEREBRAL WALL; ADHESION MOLECULE L1; PROTEIN RANBPM; CELL-CYCLE; SCAFFOLDING PROTEIN; NUCLEAR-PROTEIN; BINDING-PROTEIN; ACTIVATION; INTERACTS; COMPLEX	RanBP9 is known to act as a scaffolding protein bringing together a variety of cell surface receptors and intracellular targets thereby regulating functions as diverse as neurite and axonal outgrowth, cell morphology, cell proliferation, myelination, gonad development, myofibrillogenesis and migration of neuronal precursors. Though RanBP9 is ubiquitously expressed in all tissues, brain is one of the organs with the highest expression levels of RanBP9. In the neurons, RanBP9 is localized mostly in the cytoplasm but also in the neurites and dendritic processes. We recently demonstrated that RanBP9 plays pathogenic role in Alzheimer's disease. To understand the role of RanBP9 in the brain, here we generated RanBP9 null mice by gene-trap based strategy. Most of Ran-/- mice die neonatally due to defects in the brain growth and development. The major defects include smaller cortical plate (CP), robustly enlarged lateral ventricles (LV) and reduced volume of hippocampus (HI). The lethal phenotype is due to a suckling defect as evidenced by lack of milk in the stomachs even several hours after parturition. The complex somatosensory system which is required for a behavior such as suckling appears to be compromised in Ran-/- mice due to under developed CP. Most importantly, RanBP9 phenotype is similar to ERK1/2 double knockout and the neural cell adhesion receptor, L1CAM knockout mice. Both ERK1 and L1CAM interact with RanBP9. Thus, RanBP9 appears to control brain growth and development through signaling mechanisms involving ERK1 and L1CAM receptor.	[Palavicini, Juan Pablo; Hayes, Crystal D.; Lakshmana, Madepalli K.] Torrey Pines Inst Mol Studies, Neurobiol Sect, Port St Lucie, FL USA; [Lloyd, Brandon Noel; Dawson-Scully, Ken] Florida Atlantic Univ, Dept Biol Sci, Charles E Schmidt Coll Sci, Boca Raton, FL 33431 USA; [Bianchi, Elisabetta] Inst Pasteur, Dept Immunol, Lab Immuneregulat, F-75724 Paris, France; [Kang, David E.] USF Hlth Byrd Alzheimers Inst, Dept Mol Med, Tampa, FL USA	Torrey Pines Institute for Molecular Studies, Florida; State University System of Florida; Florida Atlantic University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; State University System of Florida; University of South Florida	Lakshmana, MK (corresponding author), Torrey Pines Inst Mol Studies, Neurobiol Sect, Port St Lucie, FL USA.	mlakshmana@tpims.org	Kang, David E./E-5234-2012	Lloyd, Brandon/0000-0003-3623-1145; Kang, David E./0000-0002-7132-821X	U.S. National Institute of Aging (NIA)/National Institutes of Health (NIH) [1R03AG032064-01, R01AG036859-01, 1R01AG033055-01A1, 1Ko2AG031920-10A1]; NATIONAL INSTITUTE ON AGING [R01AG036859, R01AG033055, R03AG032064] Funding Source: NIH RePORTER	U.S. National Institute of Aging (NIA)/National Institutes of Health (NIH); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Institute of Aging (NIA)/National Institutes of Health (NIH) grants (1R03AG032064-01, R01AG036859-01) to M. K. L. and (1R01AG033055-01A1, 1Ko2AG031920-10A1) to D. E. K. The authors thank all members of the vivarium for their cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Basson MA, 2008, DEVELOPMENT, V135, P889, DOI 10.1242/dev.011569; Bayer SA, 1981, NEOCORTICAL DEV; Bowman AL, 2008, MOL BIOL CELL, V19, P3782, DOI 10.1091/mbc.E08-03-0237; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Chang Y, 2010, DEV NEUROBIOL, V70, P1, DOI 10.1002/dneu.20750; Cheng L, 2005, J NEUROCHEM, V94, P1102, DOI 10.1111/j.1471-4159.2005.03254.x; Cohen NR, 1998, CURR BIOL, V8, P26, DOI 10.1016/S0960-9822(98)70017-X; Denti S, 2004, J BIOL CHEM, V279, P13027, DOI 10.1074/jbc.M313515200; Gerlitz G, 2005, CELL CYCLE, V4, P1632, DOI 10.4161/cc.4.11.2151; Kim T, 2009, BIOCHEM BIOPH RES CO, V378, P15, DOI 10.1016/j.bbrc.2008.09.034; Kobayashi N, 2007, GENE, V396, P236, DOI 10.1016/j.gene.2007.02.032; Lakshmana MK, 2009, J BIOL CHEM, V284, P11863, DOI 10.1074/jbc.M807345200; Mateja A, 2006, J MOL BIOL, V357, P621, DOI 10.1016/j.jmb.2006.01.002; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Monuki ES, 2007, J NEUROPATH EXP NEUR, V66, P566, DOI 10.1097/nen.0b013e3180986e1b; Murrin LC, 2007, J NEUROIMMUNE PHARM, V2, P290, DOI 10.1007/s11481-007-9079-x; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Pitre S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-365; Puverel S, 2011, DEVELOPMENT, V138, P2511, DOI 10.1242/dev.062505; Rao MA, 2002, J BIOL CHEM, V277, P48020, DOI 10.1074/jbc.M209741200; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Satoh Y, 2011, J NEUROSCI, V31, P1149, DOI 10.1523/JNEUROSCI.2243-10.2011; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Seebahn A, 2008, FEBS LETT, V582, P2453, DOI 10.1016/j.febslet.2008.06.010; Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428; Suresh B, 2012, DRUG DISCOV TODAY, V17, P379, DOI 10.1016/j.drudis.2011.10.030; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Takahashi T, 1999, J NEUROSCI, V19, P10357; Togashi H, 2006, J NEUROSCI, V26, P4961, DOI 10.1523/JNEUROSCI.0704-06.2006; Turgeon B, 2009, PHYSIOL REV, V89, P1, DOI 10.1152/physrev.00040.2007; Umeda M, 2003, GENE, V303, P47, DOI 10.1016/S0378-1119(02)01153-8; Valiyaveettil M, 2008, J CELL BIOL, V182, P727, DOI 10.1083/jcb.200801133; Wang DK, 2002, J BIOL CHEM, V277, P36216, DOI 10.1074/jbc.M205111200; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Woo JA, 2012, FASEB J, V26, P1672, DOI 10.1096/fj.11-194423; Wu Y, 2006, BIOCHEM J, V396, P23, DOI 10.1042/BJ20051568; Yin YX, 2010, J NEUROCHEM, V114, P110, DOI 10.1111/j.1471-4159.2010.06745.x	39	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66908	10.1371/journal.pone.0066908	http://dx.doi.org/10.1371/journal.pone.0066908			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840553	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400053
J	Zhang, LH; Smith, DW; Gardiner, BS; Grodzinsky, AJ				Zhang, Lihai; Smith, David W.; Gardiner, Bruce S.; Grodzinsky, Alan J.			Modeling the Insulin-Like Growth Factor System in Articular Cartilage	PLOS ONE			English	Article							IGF-BINDING-PROTEINS; FACTOR-I-RECEPTOR; SOLUTE TRANSPORT; FACTOR BINDING-PROTEIN-3; SYNOVIAL-FLUID; FACTOR (IGF)-I; CANCER; ACTIVATION; SERUM; CHONDROCYTES	IGF signaling is involved in cell proliferation, differentiation and apoptosis in a wide range of tissues, both normal and diseased, and so IGF-IR has been the focus of intense interest as a promising drug target. In this computational study on cartilage, we focus on two questions: (i) what are the key factors influencing IGF-IR complex formation, and (ii) how might cells regulate IGF-IR complex formation? We develop a reaction-diffusion computational model of the IGF system involving twenty three parameters. A series of parametric and sensitivity studies are used to identify the key factors influencing IGF signaling. From the model we predict the free IGF and IGF-IR complex concentrations throughout the tissue. We estimate the degradation half-lives of free IGF-I and IGFBPs in normal cartilage to be 20 and 100 mins respectively, and conclude that regulation of the IGF half-life, either directly or indirectly via extracellular matrix IGF-BP protease concentrations, are two critical factors governing the IGF-IR complex formation in the cartilage. Further we find that cellular regulation of IGF-II production, the IGF-IIR concentration and its clearance rate, all significantly influence IGF signaling. It is likely that negative feedback processes via regulation of these factors tune IGF signaling within a tissue, which may help explain the recent failures of single target drug therapies aimed at modifying IGF signaling.	[Zhang, Lihai] Univ Melbourne, Dept Infrastruct Engn, Melbourne, Vic 3010, Australia; [Smith, David W.; Gardiner, Bruce S.] Univ Western Australia, Fac Engn Comp & Math, Nedlands, WA 6009, Australia; [Grodzinsky, Alan J.] MIT, Dept Elect Engn & Comp Sci, Ctr Biomed Engn, Dept Mech Engn, Cambridge, MA 02139 USA	University of Melbourne; University of Western Australia; Massachusetts Institute of Technology (MIT)	Zhang, LH (corresponding author), Univ Melbourne, Dept Infrastruct Engn, Melbourne, Vic 3010, Australia.	lihzhang@unimelb.edu.au	Zhang, Lihai/F-6823-2014; Smith, David W/H-5856-2014; Gardiner, Bruce/C-8593-2012	Zhang, Lihai/0000-0002-1282-992X; Smith, David W/0000-0003-4864-0288; Gardiner, Bruce/0000-0001-8770-5908	National Health and Medical Research Council, Australian Government [APP1051455]	National Health and Medical Research Council, Australian Government	The authors wish to thank the National Health and Medical Research Council, Australian Government (APP1051455) for its support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison M, 2012, NAT BIOTECHNOL, V30, P906, DOI 10.1038/nbt1012-906c; Bach LA, 1999, HORM METAB RES, V31, P226, DOI 10.1055/s-2007-978723; Bach LA, 2005, TRENDS ENDOCRIN MET, V16, P228, DOI 10.1016/j.tem.2005.05.005; Barta E, 2006, J THEOR BIOL, V241, P628, DOI 10.1016/j.jtbi.2006.01.004; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Benini S, 2006, INT J CANCER, V119, P1039, DOI 10.1002/ijc.21929; Bhakta NR, 2000, J BIOL CHEM, V275, P5860, DOI 10.1074/jbc.275.8.5860; Blakesley Vicky A., 1996, Cytokine and Growth Factor Reviews, V7, P153, DOI 10.1016/1359-6101(96)00015-9; Boden G, 1997, J CLIN INVEST, V100, P1107, DOI 10.1172/JCI119621; BROCKLEHURST R, 1984, J BONE JOINT SURG AM, V66A, P95, DOI 10.2106/00004623-198466010-00013; Bunn RC, 2003, TRENDS ENDOCRIN MET, V14, P176, DOI 10.1016/S1043-2760(03)00049-3; Busby WH, 2000, J BIOL CHEM, V275, P37638, DOI 10.1074/jbc.M006107200; Cai L, 2002, OSTEOARTHR CARTILAGE, V10, P692, DOI 10.1053/joca.2002.0813; Chernausek SD, 2007, J CLIN ENDOCR METAB, V92, P902, DOI 10.1210/jc.2006-1610; Chu CH, 2009, ENDOCRINOLOGY, V150, P2723, DOI 10.1210/en.2008-0975; COMSOL, 2007, COMSOL MULT; D'Ercole AJ, 2008, ENDOCRINOLOGY, V149, P5958, DOI 10.1210/en.2008-0920; DORE S, 1994, ARTHRITIS RHEUM-US, V37, P253, DOI 10.1002/art.1780370215; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Durai R, 2005, INT J COLORECTAL DIS, V20, P203, DOI 10.1007/s00384-004-0675-4; Eviatar T, 2003, ARTHRITIS RHEUM, V48, P410, DOI 10.1002/art.10761; Flessner MF, 1996, J AM SOC NEPHROL, V7, P225; Fong CC, 2002, ANAL CHIM ACTA, V456, P201, DOI 10.1016/S0003-2670(02)00033-8; Foulstone E, 2005, J PATHOL, V205, P145, DOI 10.1002/path.1712; Garcia AM, 2003, ARCH BIOCHEM BIOPHYS, V415, P69, DOI 10.1016/S0003-9861(03)00215-7; Gardiner Bruce, 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P265, DOI 10.1080/10255840701309163; Gardiner BS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-46; Grimberg A, 2000, J CELL PHYSIOL, V183, P1, DOI 10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J; GULER HP, 1989, ACTA ENDOCRINOL-COP, V121, P753, DOI 10.1530/acta.0.1210753; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hayes AJ, 2001, ANAT EMBRYOL, V203, P469, DOI 10.1007/s004290100178; Headey SJ, 2004, J MOL ENDOCRINOL, V33, P377, DOI 10.1677/jme.1.01547; Heding A, 1996, J BIOL CHEM, V271, P13948, DOI 10.1074/jbc.271.24.13948; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Juul A, 2003, GROWTH HORM IGF RES, V13, P113, DOI 10.1016/S1096-6374(03)00038-8; Lambert S, 2006, INT J CANCER, V48, P826; Lee AS, 1984, MODELING DYNAMIC PHE; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Loechel F, 2000, BIOCHEM BIOPH RES CO, V278, P511, DOI 10.1006/bbrc.2000.3835; Manara MC, 2007, CLIN CANCER RES, V13, P1322, DOI 10.1158/1078-0432.CCR-06-1518; Marinaro JA, 2000, EUR J ENDOCRINOL, V142, P512, DOI 10.1530/eje.0.1420512; Martel-Pelletier J, 1998, INFLAMM RES, V47, P90, DOI 10.1007/s000110050288; Mauck R. L., 2000, J BIOMECHANICAL ENG, V125, P602; Mohan S, 2002, J ENDOCRINOL, V175, P19, DOI 10.1677/joe.0.1750019; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Oh YM, 1996, J BIOL CHEM, V271, P30322, DOI 10.1074/jbc.271.48.30322; Olmos D, 2010, LANCET ONCOL, V11, P129, DOI 10.1016/S1470-2045(09)70354-7; Osipo C, 2001, EXP CELL RES, V264, P388, DOI 10.1006/excr.2000.5121; Paye JMD, 2006, ANN BIOMED ENG, V34, P618, DOI 10.1007/s10439-005-9064-6; Pollak M, 2000, EUR J CANCER, V36, P1224, DOI 10.1016/S0959-8049(00)00102-7; Qiu YC, 2000, ANN BIOMED ENG, V28, P26, DOI 10.1114/1.251; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Sadick MD, 1999, J PHARMACEUT BIOMED, V19, P883, DOI 10.1016/S0731-7085(98)00144-7; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Schneiderman R, 1995, ARCH BIOCHEM BIOPHYS, V324, P173, DOI 10.1006/abbi.1995.9913; Scotlandi K, 2006, ADV EXP MED BIOL, V587, P13; SESSIONS CM, 1987, ENDOCRINOLOGY, V120, P2108, DOI 10.1210/endo-120-5-2108; Slaaby R, 2006, J BIOL CHEM, V281, P25869, DOI 10.1074/jbc.M605189200; Stoltz J. F., 2006, MECHANOBIOLOGY CARTI; Stumm S, 1996, AQUATIC CHEM; Tavera C, 1996, OSTEOARTHR CARTILAGE, V4, P263, DOI 10.1016/S1063-4584(05)80104-9; Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153; VERSCHURE PJ, 1995, ANN RHEUM DIS, V54, P645, DOI 10.1136/ard.54.8.645; Vorwerk P, 2002, ENDOCRINOLOGY, V143, P1677, DOI 10.1210/en.143.5.1677; Wang HS, 1999, J ENDOCRINOL, V161, P1, DOI 10.1677/joe.0.1610001; Wilson EM, 2006, J BIOL CHEM, V281, P29962, DOI 10.1074/jbc.M605445200; Yamanaka Y, 1997, J BIOL CHEM, V272, P30729, DOI 10.1074/jbc.272.49.30729; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Zhang L., 2010, POROUS MEDIA APPL BI; Zhang L., 2011, INT J APPL MECH, V3, P1; Zhang LH, 2008, J BIOL SYST, V16, P175, DOI 10.1142/S0218339008002575; Zhang L, 2007, ARCH BIOCHEM BIOPHYS, V457, P47, DOI 10.1016/j.abb.2006.10.007; Zhang LH, 2010, J THEOR BIOL, V263, P20, DOI 10.1016/j.jtbi.2009.11.023; Zhang LH, 2009, J ENG MECH, V135, P439, DOI 10.1061/(ASCE)0733-9399(2009)135:5(439); Zhang Lihai, 2008, Molecular & Cellular Biomechanics, V5, P133	76	26	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66870	10.1371/journal.pone.0066870	http://dx.doi.org/10.1371/journal.pone.0066870			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840540	Green Published, gold			2022-12-27	WOS:000321424400044
J	Leuenberger, N; Schumacher, YO; Pradervand, S; Sander, T; Saugy, M; Pottgiesser, T				Leuenberger, Nicolas; Schumacher, Yorck Olaf; Pradervand, Sylvain; Sander, Thomas; Saugy, Martial; Pottgiesser, Torben			Circulating microRNAs as Biomarkers for Detection of Autologous Blood Transfusion	PLOS ONE			English	Article							IRON STATUS; MARKERS; CELLS; ERYTHROPOIESIS	MicroRNAs (miRNAs) are small non-coding RNAs that regulate various biological processes. Cell-free miRNAs measured in blood plasma have emerged as specific and sensitive markers of physiological processes and disease. In this study, we investigated whether circulating miRNAs can serve as biomarkers for the detection of autologous blood transfusion, a major doping technique that is still undetectable. Plasma miRNA levels were analyzed using high-throughput quantitative real-time PCR. Plasma samples were obtained before and at several time points after autologous blood transfusion (blood bag storage time 42 days) in 10 healthy subjects and 10 controls without transfusion. Other serum markers of erythropoiesis were determined in the same samples. Our results revealed a distinct change in the pattern of circulating miRNAs. Ten miRNAs were upregulated in transfusion samples compared with control samples. Among these, miR-30b, miR-30c, and miR-26b increased significantly and showed a 3.9-, 4.0-, and 3.0-fold change, respectively. The origin of these miRNAs was related to pulmonary and liver tissues. Erythropoietin (EPO) concentration decreased after blood reinfusion. A combination of miRNAs and EPO measurement in a mathematical model enhanced the efficiency of autologous transfusion detection through miRNA analysis. Therefore, our results lay the foundation for the development of miRNAs as novel blood-based biomarkers to detect autologous transfusion.	[Leuenberger, Nicolas; Saugy, Martial] Univ Ctr Legal Med, Swiss Lab Doping Anal, Geneva, Switzerland; [Leuenberger, Nicolas; Saugy, Martial] Univ Ctr Legal Med, Swiss Lab Doping Anal, Lausanne, Switzerland; [Leuenberger, Nicolas; Saugy, Martial] CHU Vaudois, CH-1011 Lausanne, Switzerland; [Leuenberger, Nicolas; Saugy, Martial] Univ Lausanne, Lausanne, Switzerland; [Schumacher, Yorck Olaf; Sander, Thomas; Pottgiesser, Torben] Univ Hosp Freiburg, Dept Sports Med, Freiburg, Germany; [Schumacher, Yorck Olaf] Aspetar Orthoped & Sports Med Hosp, Doha, Qatar; [Pradervand, Sylvain] Univ Lausanne, Genom Technol Facil, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Freiburg; Aspetar Orthopaedic & Sports Medicine Hospital; University of Lausanne	Leuenberger, N (corresponding author), Univ Ctr Legal Med, Swiss Lab Doping Anal, Geneva, Switzerland.	Nicolas.leuenberger@chuv.ch		Pottgiesser, Torben/0000-0003-4925-8478	Exiqon grant program; "Bundesinstitut fur Sportwissenschaft" based on a decision of "Deutscher Bundestag" [IIA1-070303/10-11]	Exiqon grant program; "Bundesinstitut fur Sportwissenschaft" based on a decision of "Deutscher Bundestag"	The authors are grateful to the Partnership for Clean Competition and Exiqon grant program for providing funds. In addition, the hematology and clinical chemistry analyses were in part funded by a grant of the "Bundesinstitut fur Sportwissenschaft" based on a decision of "Deutscher Bundestag" (IIA1-070303/10-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen D, 2010, METHODS, V50, pS6, DOI 10.1016/j.ymeth.2010.01.006; Ashenden M, 2011, VOX SANG, V101, P320, DOI 10.1111/j.1423-0410.2011.01493.x; Audran M, 1999, MED SCI SPORT EXER, V31, P639, DOI 10.1097/00005768-199905000-00003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BETTS JC, 1991, SCAND J IMMUNOL, V34, P471, DOI 10.1111/j.1365-3083.1991.tb01570.x; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; DellaValle DM, 2012, MED SCI SPORT EXER, V44, P1552, DOI 10.1249/MSS.0b013e3182517ceb; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Hod EA, 2011, BLOOD, V118, P6675, DOI 10.1182/blood-2011-08-371849; Hod EA, 2010, BLOOD, V115, P4284, DOI 10.1182/blood-2009-10-245001; Holley CL, 2011, CARDIOVASC DRUG THER, V25, P151, DOI 10.1007/s10557-011-6290-z; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kwiatkowski JL, 2011, J BLOOD MED, V2, P135, DOI 10.2147/JBM.S13065; Leuenberger N, 2011, DRUG TEST ANAL, V3, P771, DOI 10.1002/dta.370; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Mangalmurti NS, 2009, BLOOD, V113, P1158, DOI 10.1182/blood-2008-07-166264; McClung JP, 2012, J TRACE ELEM MED BIO, V26, P124, DOI 10.1016/j.jtemb.2012.03.006; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Monfort N, 2012, TRANSFUSION, V52, P647, DOI 10.1111/j.1537-2995.2011.03331.x; Mossuz P, 2005, CLIN CHEM, V51, P1018, DOI 10.1373/clinchem.2004.047365; Parisotto R, 2000, HAEMATOLOGICA, V85, P564; Pottgiesser T, 2011, TRANSFUSION, V51, P1707, DOI 10.1111/j.1537-2995.2011.03076.x; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Schumacher YO, 2012, DRUG TEST ANAL, V4, P846, DOI 10.1002/dta.406; Sottas PE, 2012, BIOANALYSIS, V4, P1645, DOI [10.4155/BIO.12.130, 10.4155/bio.12.130]; Thevis M, 2012, DRUG TEST ANAL, V4, P2, DOI 10.1002/dta.415; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Tzouvelekis A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-78; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vlaar APJ, 2012, TRANSFUS CLIN BIOL, V19, P117, DOI 10.1016/j.tracli.2012.03.001; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850	35	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66309	10.1371/journal.pone.0066309	http://dx.doi.org/10.1371/journal.pone.0066309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840438	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800047
J	Li, QT; Lu, QJ; Lu, HY; Tian, SF; Lu, QX				Li, Qiutang; Lu, Qingjun; Lu, Huayi; Tian, Shifu; Lu, Qingxian			Systemic Autoimmunity in TAM Triple Knockout Mice Causes Inflammatory Brain Damage and Cell Death	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INTERCELLULAR-ADHESION MOLECULE-1; RECEPTOR TYROSINE KINASES; TYRO-3 FAMILY RECEPTORS; HUMAN ENDOTHELIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; LUPUS-PRONE MICE; MRL-LPR MICE; BLOOD-BRAIN; MULTIPLE-SCLEROSIS	The Tyro3, Axl and Mertk (TAM) triply knockout (TKO) mice exhibit systemic autoimmune diseases, with characteristics of increased proinflammatory cytokine production, autoantibody deposition and autoreactive lymphocyte infiltration into a variety of tissues. Here we show that TKO mice produce high level of serum TNF-alpha and specific autoantibodies deposited onto brain blood vessels. The brain-blood barrier (BBB) in mutant brains exhibited increased permeability for Evans blue and fluorescent-dextran, suggesting a breakdown of the BBB in the mutant brains. Impaired BBB integrity facilitated autoreactive T cells infiltrating into all regions of the mutant brains. Brain autoimmune disorder caused accumulation of the ubiquitin-reactive aggregates in the mutant hippocampus, and early formation of autofluorescent lipofuscins in the neurons throughout the entire brains. Chronic neuroinflammation caused damage of the hippocampal mossy fibers and neuronal apoptotic death. This study shows that chronic systemic inflammation and autoimmune disorders in the TKO mice cause neuronal damage and death.	[Li, Qiutang; Lu, Huayi; Tian, Shifu; Lu, Qingxian] Univ Louisville, Dept Ophthalmol & Visual Sci, Louisville, KY 40292 USA; [Lu, Qingxian] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Li, Qiutang; Lu, Qingxian] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Lu, Qingjun] Capital Med Univ, Sch Basic Med, Beijing, Peoples R China; [Lu, Qingjun] Capital Med Univ, Beijing Tong Ren Hosp, Beijing Ophthalmol & Visual Sci Key Lab, Beijing, Peoples R China	University of Louisville; University of Louisville; University of Louisville; Capital Medical University; Capital Medical University	Lu, QX (corresponding author), Univ Louisville, Dept Ophthalmol & Visual Sci, Louisville, KY 40292 USA.	q.lu@louisville.edu			National Institutes of Health (NIH) [R01-EY018830];  [NIH R01-EY01989]; NATIONAL EYE INSTITUTE [R01EY018830] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (NIH) grant R01-EY018830 and general support by The Research-to-Prevent-Blindness Foundation and core facility at the Department of Ophthalmology, University of Louisville. QLI was supported by grant NIH R01-EY01989. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbott NJ, 2003, LUPUS, V12, P908, DOI 10.1191/0961203303lu501oa; Ballok DA, 2004, HIPPOCAMPUS, V14, P649, DOI 10.1002/hipo.10205; Ballok DA, 2003, BRAIN RES, V964, P200, DOI 10.1016/S0006-8993(02)03980-X; Bullard DC, 2007, J IMMUNOL, V178, P851, DOI 10.4049/jimmunol.178.2.851; Burstyn-Cohen T, 2009, J CLIN INVEST, V119, P2942, DOI 10.1172/JCI39325; Camenisch TD, 1999, J IMMUNOL, V162, P3498; Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dickstein JB, 2000, AM J PHYSIOL-REG I, V279, pR148, DOI 10.1152/ajpregu.2000.279.1.R148; Dobbie MS, 1999, BRAIN RES, V830, P330, DOI 10.1016/S0006-8993(99)01436-5; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Gray Douglas A, 2003, Sci Aging Knowledge Environ, V2003, pRE6, DOI 10.1126/sageke.2003.34.re6; Hanly JG, 2006, J RHEUMATOL, V33, P1553; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; Jacob A, 2010, FASEB J, V24, P1682, DOI 10.1096/fj.09-138834; James WG, 2006, CLIN EXP IMMUNOL, V144, P299, DOI 10.1111/j.1365-2249.2006.03056.x; Jiao YQ, 2007, EXP NEUROL, V205, P569, DOI 10.1016/j.expneurol.2007.03.025; Korshunov VA, 2006, CIRC RES, V98, P1446, DOI 10.1161/01.RES.0000223322.16149.9a; Layfield R, 2001, NEUROPATH APPL NEURO, V27, P171, DOI 10.1046/j.1365-2990.2001.00335.x; Lemke G, 2003, CURR OPIN IMMUNOL, V15, P31, DOI 10.1016/S0952-7915(02)00016-X; Li ZM, 2003, INT J BIOCHEM CELL B, V35, P547, DOI 10.1016/S1357-2725(02)00384-9; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Ma XX, 2006, J NEUROIMMUNOL, V179, P26, DOI 10.1016/j.jneuroim.2006.06.023; MacKenzie-Graham A, 2009, NEUROIMAGE, V48, P637, DOI 10.1016/j.neuroimage.2009.06.073; McHale JF, 1999, J IMMUNOL, V163, P3993; Melaragno MG, 2004, J MOL CELL CARDIOL, V37, P881, DOI 10.1016/j.yjmcc.2004.06.018; Nishioku T, 2010, J PHARMACOL SCI, V112, P251, DOI 10.1254/jphs.09292SC; O'Connor KC, 2005, J IMMUNOL, V175, P1974, DOI 10.4049/jimmunol.175.3.1974; Ozaki H, 1999, J IMMUNOL, V163, P553; Prieto AL, 2007, NEUROSCIENCE, V150, P319, DOI 10.1016/j.neuroscience.2007.09.047; Prieto AL, 2000, J COMP NEUROL, V425, P295; Radic MZ, 2006, J IMMUNOL, V176, P68, DOI 10.4049/jimmunol.176.1.68; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Sakic B, 2000, J NEUROIMMUNOL, V104, P147, DOI 10.1016/S0165-5728(99)00277-5; Sakic B, 1998, J NEUROIMMUNOL, V87, P162, DOI 10.1016/S0165-5728(98)00085-X; SAKIC B, 1993, BEHAV BRAIN RES, V54, P57, DOI 10.1016/0166-4328(93)90048-U; Saller F, 2009, BLOOD, V114, P2307, DOI 10.1182/blood-2009-03-209031; SAMUEL W, 1994, NEUROLOGY, V44, P2081, DOI 10.1212/WNL.44.11.2081; SCHNIDER A, 1995, J NEUROL NEUROSUR PS, V59, P644, DOI 10.1136/jnnp.59.6.644-a; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Sloviter RS, 2003, J COMP NEUROL, V459, P44, DOI 10.1002/cne.10630; Smith SS, 2008, NEUROSCI LETT, V442, P158, DOI 10.1016/j.neulet.2008.07.005; Suh CH, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3088; Tomietto P, 2007, ARTHRIT RHEUM-ARTHR, V57, P1461, DOI 10.1002/art.23098; Tsao N, 2001, J MED MICROBIOL, V50, P812, DOI 10.1099/0022-1317-50-9-812; Vaknin-Dembinsky A, 2007, J NEUROL SCI, V259, P90, DOI 10.1016/j.jns.2006.11.022; Vyshkina T, 2008, LAB INVEST, V88, P796, DOI 10.1038/labinvest.2008.53; Wallet MA, 2008, J EXP MED, V205, P219, DOI 10.1084/jem.20062293; Yang GY, 1999, MOL BRAIN RES, V69, P135, DOI 10.1016/S0169-328X(99)00007-8; Ye F, 2011, J IMMUNOL, V187, P4178, DOI 10.4049/jimmunol.1101201; Ye F, 2011, INVEST OPHTH VIS SCI, V52, P4239, DOI 10.1167/iovs.10-6700; Zandman-Goddard G, 2007, SEMIN ARTHRITIS RHEU, V36, P297, DOI 10.1016/j.semarthrit.2006.11.003; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386	58	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e64812	10.1371/journal.pone.0064812	http://dx.doi.org/10.1371/journal.pone.0064812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840307	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800005
J	Srivastava, S; Ratha, BK				Srivastava, Shilpee; Ratha, B. K.			Unique Hepatic Cytosolic Arginase Evolved Independently in Ureogenic Freshwater Air-Breathing Teleost, Heteropneustes fossilis	PLOS ONE			English	Article							ORNITHINE-UREA CYCLE; RAT-LIVER ARGINASE; NITRIC-OXIDE; SUBCELLULAR-LOCALIZATION; MITOCHONDRIAL ARGINASE; NITROGEN-METABOLISM; MOLECULAR-FORMS; METAL-IONS; L-ARGININE; ENZYMES	Hepatic cytosolic arginase (ARG I), an enzyme of the urea cycle operating in the liver of ureotelic animals, is reported to be present in an ammoniotelic freshwater air-breathing teleost, Heteropneustes fossilis which has ureogenic potential. Antibodies available against mammalian ARG I showed no cross reactivity with the H. fossilis ARG I. We purified unique ARG I from H. fossilis liver. Purified ARG I is a homotrimer with molecular mass 75 kDa and subunit molecular mass of 24 kDa. The pI value of the enzyme was 8.5. It showed maximum activity at pH 10.5 and 55 degrees C. The Km of purified enzyme for L-arginine was 2.65+/-0.39 mM. L-ornithine and N-omega-hydroxy-L-arginine showed inhibition of the ARG I activity, with Ki values 0.52+/-0.02 mM and 0.08+/-0.006 mM, respectively. Antibody raised against the purified fish liver ARG I showed exclusive specificity, and has no cross reactivity against fish liver ARG II and mammalian liver ARG I and ARG II. We found another isoform of arginase bound to the outer membrane of the mitochondria which was released by 150-200 mM KCl in the extraction medium. This isoform was immunologically different from the soluble cytosolic and mitochondrial arginase. The results of present study support that hepatic cytosolic arginase evolved in this ureogenic freshwater teleost, H. fossilis. Phylogenetic analysis confirms an independent evolution event that occurred much after the evolution of the cytosolic arginase of ureotelic vertebrates.	[Srivastava, Shilpee; Ratha, B. K.] Banaras Hindu Univ, Dept Zool, Biochem Adaptat Lab, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Srivastava, S (corresponding author), Assam Univ Silchar, Dept Biotechnol, Silchar, Assam, India.	shilp.vastava@gmail.com		Srivastava, Shilpee/0000-0003-0995-2916	University Grants Commission, Department of Science and Technology; Banaras Hindu University; UGC research fellowship in science for meritorious students	University Grants Commission, Department of Science and Technology; Banaras Hindu University; UGC research fellowship in science for meritorious students	The study was financially supported by the University Grants Commission, Department of Science and Technology and Banaras Hindu University. S.S. was supported by UGC research fellowship in science for meritorious students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PM, 1995, J EXP BIOL, V198, P755; Ash DE, 2004, J NUTR, V134, p2760S, DOI 10.1093/jn/134.10.2760S; BASCUR L, 1966, BIOCHIM BIOPHYS ACTA, V128, P149, DOI 10.1016/0926-6593(66)90151-2; BORKOVICH KA, 1987, J BIOL CHEM, V262, P7081; BROWN GW, 1959, J BIOL CHEM, V234, P1769; Cama E, 2003, BIOCHEMISTRY-US, V42, P8445, DOI 10.1021/bi034340j; CARVAJAL N, 1987, COMP BIOCHEM PHYS B, V88, P229, DOI 10.1016/0305-0491(87)90105-2; CARVAJAL N, 1995, COMP BIOCHEM PHYS B, V112, P153, DOI 10.1016/0305-0491(95)00027-6; CASEY CA, 1985, COMP BIOCHEM PHYS B, V82, P307, DOI 10.1016/0305-0491(85)90246-9; CASEY CA, 1982, J BIOL CHEM, V257, P8449; Cederbaum SD, 2004, MOL GENET METAB, V81, pS38, DOI 10.1016/j.ymgme.2003.10.012; CHEUNG CW, 1981, ARCH BIOCHEM BIOPHYS, V209, P643, DOI 10.1016/0003-9861(81)90324-6; Colleluori DM, 2001, BIOCHEMISTRY-US, V40, P9356, DOI 10.1021/bi010783g; Custot J, 1997, J AM CHEM SOC, V119, P4086, DOI 10.1021/ja970285o; Dabir S, 2005, INT J BIOL SCI, V1, P114; DAGHIGH F, 1994, BIOCHEM BIOPH RES CO, V202, P174, DOI 10.1006/bbrc.1994.1909; Di Costanzo L, 2010, ARCH BIOCHEM BIOPHYS, V496, P101, DOI 10.1016/j.abb.2010.02.004; DKHAR J, 1991, BIOCHEM INT, V25, P1061; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fitzpatrick JM, 2009, INT J PARASITOL, V39, P267, DOI 10.1016/j.ijpara.2008.06.015; FREEDLAND RA, 1984, BIOCHIM BIOPHYS ACTA, V802, P407, DOI 10.1016/0304-4165(84)90357-X; FUENTES JM, 1994, ARCH INT PHYSIOL BIO, V102, P255, DOI 10.3109/13813459409003940; GARGANTA CL, 1986, ANAL BIOCHEM, V154, P388, DOI 10.1016/0003-2697(86)90003-5; GASIOROWSKA I, 1970, ACTA BIOCHIM POL, V17, P19; Gotoh T, 1996, FEBS LETT, V395, P119, DOI 10.1016/0014-5793(96)01015-0; Iyer R, 1998, J INHERIT METAB DIS, V21, P86, DOI 10.1023/A:1005313809037; Jansen G, 2006, MOL PHYLOGENET EVOL, V38, P65, DOI 10.1016/j.ympev.2005.09.011; JANSSENS PA, 1966, SCIENCE, V152, P358, DOI 10.1126/science.152.3720.358; JENKINSON CP, 1994, BIOCHEM MED METAB B, V51, P156, DOI 10.1006/bmmb.1994.1020; Jenkinson CP, 1996, COMP BIOCHEM PHYS B, V114, P107, DOI 10.1016/0305-0491(95)02138-8; Joerink M, 2006, MOL IMMUNOL, V43, P1116, DOI 10.1016/j.molimm.2005.07.022; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kossel A, 1904, HOPPE SEYLERZ Z PHYS, P321; KUHN NJ, 1995, ARCH BIOCHEM BIOPHYS, V320, P24, DOI 10.1006/abbi.1995.1338; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li H, 2001, AM J PHYSIOL-ENDOC M, V280, pE75, DOI 10.1152/ajpendo.2001.280.1.E75; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maarsingh H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-23; MOMMSEN TP, 1989, SCIENCE, V243, P72, DOI 10.1126/science.2563172; MORA J, 1965, BIOCHEM J, V96, P588, DOI 10.1042/bj0960588; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Nissim I, 2005, J BIOL CHEM, V280, P17715, DOI 10.1074/jbc.M500607200; PACE CN, 1980, ANAL BIOCHEM, V109, P261, DOI 10.1016/0003-2697(80)90646-6; Patil NB, 1990, BIOTECHNOL TECH, V4, P133; PATTERTON D, 1994, J BIOL CHEM, V269, P25328; Perozich J, 1998, BBA-PROTEIN STRUCT M, V1382, P23, DOI 10.1016/S0167-4838(97)00131-3; POREMBSKA Z, 1984, ACTA BIOCHIM POL, V31, P223; Porembska Zofia, 1993, Acta Biochimica Polonica, V40, P465; RECZKOWSKI RS, 1994, ARCH BIOCHEM BIOPHYS, V312, P31, DOI 10.1006/abbi.1994.1276; Saha N, 2007, FISH PHYSIOL BIOCHEM, V33, P283, DOI 10.1007/s10695-007-9172-3; SAHA N, 1987, J EXP ZOOL, V241, P137, DOI 10.1002/jez.1402410117; SAHA N, 1994, COMP BIOCHEM PHYS B, V108, P315, DOI 10.1016/0305-0491(94)90083-3; Saha N, 1998, COMP BIOCHEM PHYS A, V120, P195, DOI 10.1016/S1095-6433(98)00026-9; SINGH RA, 1990, ARCH INT PHYSIOL BIO, V98, P411, DOI 10.3109/13813459009114003; SPECTOR EB, 1994, INT J DEV NEUROSCI, V12, P337, DOI 10.1016/0736-5748(94)90083-3; Srivastava S, 2013, COMP BIOCHEM PHYS B, V164, P133, DOI 10.1016/j.cbpb.2012.11.007; Steele SL, 2005, PHYSIOL BIOCHEM ZOOL, V78, P216, DOI 10.1086/427052; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TARRAB R, 1974, EUR J BIOCHEM, V49, P457, DOI 10.1111/j.1432-1033.1974.tb03850.x; Tormanen CD, 2006, J ENZYM INHIB MED CH, V21, P119, DOI 10.1080/14756360500483420; Tormanen CD, 1997, J INORG BIOCHEM, V66, P111, DOI 10.1016/S0162-0134(96)00191-2; TOURIAN A, 1975, BIOCHEMISTRY-US, V14, P4055, DOI 10.1021/bi00689a020; TURKOGLU S, 1991, INT J BIOCHEM, V23, P147, DOI 10.1016/0020-711X(91)90182-M; Turner GE, 2006, BBA-GEN SUBJECTS, V1760, P848, DOI 10.1016/j.bbagen.2006.02.012; Viator Ryan J., 2008, BMC Biochemistry, V9, P15, DOI 10.1186/1471-2091-9-15; Vockley JG, 1996, GENOMICS, V38, P118, DOI 10.1006/geno.1996.0606; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Withers PC, 1998, CLIN EXP PHARMACOL P, V25, P722, DOI 10.1111/j.1440-1681.1998.tb02284.x; Wright PA, 2004, J EXP BIOL, V207, P2033, DOI 10.1242/jeb.00958; ZAMECKA E, 1988, BIOCHEM MED METAB B, V39, P258, DOI 10.1016/0885-4505(88)90083-7	71	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66057	10.1371/journal.pone.0066057	http://dx.doi.org/10.1371/journal.pone.0066057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840400	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800027
J	Dalmais, M; Antelme, S; Ho-Yue-Kuang, S; Wang, Y; Darracq, O; d'Yvoire, MB; Cezard, L; Legee, F; Blondet, E; Oria, N; Troadec, C; Brunaud, V; Jouanin, L; Hofte, H; Bendahmane, A; Lapierre, C; Sibout, R				Dalmais, Marion; Antelme, Sebastien; Ho-Yue-Kuang, Severine; Wang, Yin; Darracq, Olivier; d'Yvoire, Madeleine Bouvier; Cezard, Laurent; Legee, Frederic; Blondet, Eddy; Oria, Nicolas; Troadec, Christelle; Brunaud, Veronique; Jouanin, Lise; Hoefte, Herman; Bendahmane, Abdelafid; Lapierre, Catherine; Sibout, Richard			A TILLING Platform for Functional Genomics in Brachypodium distachyon	PLOS ONE			English	Article							ACID O-METHYLTRANSFERASE; AGROBACTERIUM-MEDIATED TRANSFORMATION; INDUCED POINT MUTATIONS; DOWN-REGULATION; ARABIDOPSIS-THALIANA; MAIZE; GENE; DISCOVERY; LIGNINS; MUTANT	The new model plant for temperate grasses, Brachypodium distachyon offers great potential as a tool for functional genomics. We have established a sodium azide-induced mutant collection and a TILLING platform, called "BRACHYTIL", for the inbred line Bd21-3. The TILLING collection consists of DNA isolated from 5530 different families. Phenotypes were reported and organized in a phenotypic tree that is freely available online. The tilling platform was validated by the isolation of mutants for seven genes belonging to multigene families of the lignin biosynthesis pathway. In particular, a large allelic series for BdCOMT6, a caffeic acid O-methyl transferase was identified. Some mutants show lower lignin content when compared to wild-type plants as well as a typical decrease of syringyl units, a hallmark of COMT-deficient plants. The mutation rate was estimated at one mutation per 396 kb, or an average of 680 mutations per line. The collection was also used to assess the Genetically Effective Cell Number that was shown to be at least equal to 4 cells in Brachypodium distachyon. The mutant population and the TILLING platform should greatly facilitate functional genomics approaches in this model organism.	[Dalmais, Marion; Blondet, Eddy; Troadec, Christelle; Brunaud, Veronique; Bendahmane, Abdelafid] Univ Evry Val dEssonne, INRA, URGV, Evry, France; [Antelme, Sebastien; Ho-Yue-Kuang, Severine; Wang, Yin; Darracq, Olivier; d'Yvoire, Madeleine Bouvier; Cezard, Laurent; Legee, Frederic; Oria, Nicolas; Jouanin, Lise; Hoefte, Herman; Lapierre, Catherine; Sibout, Richard] INRA, Inst Jean Pierre Bourgin, Saclay Plant Sci, F-78026 Versailles, France; [Antelme, Sebastien; Ho-Yue-Kuang, Severine; Wang, Yin; Darracq, Olivier; d'Yvoire, Madeleine Bouvier; Cezard, Laurent; Legee, Frederic; Oria, Nicolas; Jouanin, Lise; Hoefte, Herman; Lapierre, Catherine; Sibout, Richard] AgroParisTech, Inst Jean Pierre Bourgin, Saclay Plant Sci, Versailles, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Sibout, R (corresponding author), INRA, Inst Jean Pierre Bourgin, Saclay Plant Sci, F-78026 Versailles, France.	richard.sibout@versailles.inra.fr	Lapierre, Catherine/AAD-9209-2020	TROADEC, Christelle/0000-0003-1927-7352; ORCID, Stef/0000-0002-3661-2784; Dalmais, Marion/0000-0002-1673-3095; Bendahmane, Abdelhafid/0000-0003-3246-868X	European FP7 project [211982]; Agence Nationale de la Recherche (ANR) [ANR-08-KBBE-004, ANR-10-BLAN-1528]	European FP7 project; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was funded by the European FP7 project no 211982 "RENEWALL" and the Agence Nationale de la Recherche (ANR) projects ANR-08-KBBE-004 "CELLWALL" and ANR-10-BLAN-1528 "PHENOWALL". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov E, 2012, PLANT PHYSL; Barriere Y., 2007, GENES GENOMES GENOMI, V1, P133; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bragg JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041916; BretagneSagnard B, 1996, J EXP BOT, V47, P189, DOI 10.1093/jxb/47.2.189; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; Chen L, 2004, FUNCT PLANT BIOL, V31, P235, DOI 10.1071/FP03254; Courtial A, MAYDICA IN PRESS; d'Yvoire MB, 2013, PLANT J, V73, P496, DOI 10.1111/tpj.12053; Dence CW, 1992, METHODS LIGNIN CHEM, P33, DOI DOI 10.1007/978-3-642-74065-7_3; Gady ALF, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-13; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; Goujon T, 2003, PLANT MOL BIOL, V51, P973, DOI 10.1023/A:1023022825098; GRAND C, 1985, PHYSIOL VEG, V23, P905; Hamberger B, 2007, CAN J BOT, V85, P1182, DOI 10.1139/B07-098; Harrington MJ, 2012, ADV BOT RES, V61, P77, DOI 10.1016/B978-0-12-416023-1.00003-3; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Jung JH, 2011, IN VITRO CELL DEV-AN, V47, pS36; Kim Bong Gyu, 2005, Agricultural Chemistry and Biotechnology, V48, P113; Kurowska M, 2011, J APPL GENET, V52, P371, DOI 10.1007/s13353-011-0061-1; LAPIERRE C, 1988, CR ACAD SCI III-VIE, V307, P723; LAPIERRE C, 1995, RES CHEM INTERMEDIAT, V21, P397, DOI 10.1007/BF03052266; LAPIERRE C, 1993, FORAGE CELL WALL STRUCTURE AND DIGESTIBILITY, P133; Lapierre C., 2010, LIGNIN LIGNANS ADV C, P11, DOI [10.1201/ebk1574444865-c2, DOI 10.1201/EBK1574444865-C2]; Lee SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-5; Li YC, 2012, BIOTECHNOL BIOFUELS, V5, DOI [10.1186/1754-6834-5-71, 10.1186/1754-6834-5-2]; Louie GV, 2010, PLANT CELL, V22, P4114, DOI 10.1105/tpc.110.077578; Marita JM, 2003, J AGR FOOD CHEM, V51, P1313, DOI 10.1021/jf0260592; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Murat F, 2010, GENOME RES, V20, P1545, DOI 10.1101/gr.109744.110; Oliver AL, 2005, CROP SCI, V45, P2234, DOI 10.2135/cropsci2004.0644; Pacurar DI, 2008, TRANSGENIC RES, V17, P965, DOI 10.1007/s11248-007-9159-y; Page DR, 2002, NAT REV GENET, V3, P124, DOI 10.1038/nrg730; Ralph J, 2001, 5 HYDROXYCONIFERYL A, V2001, P27; Rawat N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-205; Robert D, 2000, ABSTR PAP AM CHEM S, V219, pU270; Sattler SE, 2012, BIOENERG RES, V5, P855, DOI 10.1007/s12155-012-9197-z; Sattler SE, 2010, PLANT SCI, V178, P229, DOI 10.1016/j.plantsci.2010.01.001; Slade AJ, 2005, TRANSGENIC RES, V14, P109, DOI 10.1007/s11248-005-2770-x; Slade AJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-69; Talame V, 2008, PLANT BIOTECHNOL J, V6, P477, DOI 10.1111/j.1467-7652.2008.00341.x; Thole V, 2010, PLANT BIOTECHNOL J, V8, P734, DOI 10.1111/j.1467-7652.2010.00518.x; Thole V, 2009, NAT PROTOC, V4, P650, DOI 10.1038/nprot.2009.32; Till BJ, 2003, METH MOL B, V236, P205; Till BJ, 2003, GENOME RES, V13, P524, DOI 10.1101/gr.977903; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Vain P, 2008, PLANT BIOTECHNOL J, V6, P236, DOI 10.1111/j.1467-7652.2007.00308.x; VIGNOLS F, 1995, PLANT CELL, V7, P407, DOI 10.1105/tpc.7.4.407; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang TL, 2012, PLANT BIOTECHNOL J, V10, P761, DOI 10.1111/j.1467-7652.2012.00708.x; Weil CF, 2009, PLANT PHYSIOL, V149, P158, DOI 10.1104/pp.108.128785; Xin ZG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-103; Zubieta C, 2003, PLANT CELL, V15, P1704, DOI 10.1105/tpc.014548	56	48	48	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65503	10.1371/journal.pone.0065503	http://dx.doi.org/10.1371/journal.pone.0065503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840336	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200022
J	Grindon, AJ; Davison, A				Grindon, Adele J.; Davison, Angus			Irish Cepaea nemoralis Land Snails Have a Cryptic Franco-Iberian Origin That Is Most Easily Explained by the Movements of Mesolithic Humans	PLOS ONE			English	Article							GENETIC-VARIATION; SOFTWARE PACKAGE; SELECTION; MODEL; DNA; COLONIZATION; POPULATIONS; DISPERSAL; ACCURATE; IRELAND	The origins of flora and fauna that are only found in Ireland and Iberia, but which are absent from intervening countries, is one of the enduring questions of biogeography. As Southern French, Iberian and Irish populations of the land snail Cepaea nemoralis sometimes have a similar shell character, we used mitochondrial phylogenies to begin to understand if there is a shared "Lusitanian" history. Although much of Europe contains snails with A and D lineages, by far the majority of Irish individuals have a lineage, C, that in mainland Europe was only found in a restricted region of the Eastern Pyrenees. A past extinction of lineage C in the rest of Europe cannot be ruled out, but as there is a more than 8000 year continuous record of Cepaea fossils in Ireland, the species has long been a food source in the Pyrenees, and the Garonne river that flanks the Pyrenees is an ancient human route to the Atlantic, then we suggest that the unusual distribution of the C lineage is most easily explained by the movements of Mesolithic humans. If other Irish species have a similarly cryptic Lusitanian element, then this raises the possibility of a more widespread and significant pattern.	[Grindon, Adele J.; Davison, Angus] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England	University of Nottingham	Davison, A (corresponding author), Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England.	angus.davison@nottingham.ac.uk	Davison, Angus/C-3156-2009	Davison, Angus/0000-0003-2554-8585	University of Nottingham, Genetics Society; Malacological Society of London; Conchological Society of Great Britain and Ireland	University of Nottingham, Genetics Society; Malacological Society of London; Conchological Society of Great Britain and Ireland	The work was supported by the University of Nottingham, Genetics Society, the Carr Scholarship the Malacological Society of London, and the Conchological Society of Great Britain and Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arias P., 2005, PYRENEAN PREHISTORY, V2, P123; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beatty GE, 2013, J BIOGEOGR, V40, P335, DOI 10.1111/j.1365-2699.2012.02789.x; Carden RF, 2012, QUATERNARY SCI REV, V42, P74, DOI 10.1016/j.quascirev.2012.02.012; Cook L. M., 1960, Proceedings of the Malacological Society of London, V34, P1; Cunliffe B., 2001, FACING OCEAN ATLANTI; Davison A, 2000, BIOL J LINN SOC, V70, P697, DOI 10.1006/bijl.1999.0426; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Edwards CJ, 2012, QUATERNARY SCI REV, V57, P95, DOI 10.1016/j.quascirev.2012.10.010; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gittenberger E, 2006, NATURE, V439, P409, DOI 10.1038/439409a; Gittenberger E, 2004, MOL PHYLOGENET EVOL, V30, P64, DOI 10.1016/S1055-7903(03)00182-9; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Herman JS, 2011, P ROY SOC B-BIOL SCI, V278, P3601, DOI 10.1098/rspb.2011.0321; Hill EW, 2000, NATURE, V404, P351, DOI 10.1038/35006158; Ibrahim KM, 1996, HEREDITY, V77, P282, DOI 10.1038/hdy.1996.142; Jesse R, 2011, PLOS ONE, V6, P7; Jordan NR, 2012, CONSERV GENET, V13, P1195, DOI 10.1007/s10592-012-0365-7; Kerney M.P., 1979, FIELD GUIDE LAND SNA; Lubell D., 2004, DOCUMENTA PRAEHISTOR, V31, P1; Mascheretti S, 2003, P ROY SOC B-BIOL SCI, V270, P1593, DOI 10.1098/rspb.2003.2406; Maydt J, 2006, BIOINFORMATICS, V22, P1064, DOI 10.1093/bioinformatics/btl057; McDevitt AD, 2011, HEREDITY; MOORE PD, 1987, NATURE, V328, P381, DOI 10.1038/328381a0; O'Meara DB, 2012, BIOL J LINN SOC, V106, P893, DOI 10.1111/j.1095-8312.2012.01927.x; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; PREECE RC, 1986, J BIOGEOGR, V13, P487, DOI 10.2307/2844814; Richards PM, 2013, MOL ECOL, V22, P3077, DOI 10.1111/mec.12262; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe G, 2006, MOL PHYLOGENET EVOL, V39, P335, DOI 10.1016/j.ympev.2005.08.021; Searle JB, 2009, P ROY SOC B-BIOL SCI, V276, P4287, DOI 10.1098/rspb.2009.1422; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Speller GR, 2006, MOLLUSCAN BIOSTRAIGR; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Thomaz D, 1996, P ROY SOC B-BIOL SCI, V263, P363, DOI 10.1098/rspb.1996.0056; Wada S, 2012, J BIOGEOGR, V39, P69, DOI 10.1111/j.1365-2699.2011.02559.x; Welter-Schultes FW, 2008, J MOLLUS STUD, V74, P79, DOI 10.1093/mollus/eym047; Wernham C., 2002, MIGRATION ATLAS MOVE; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Zugasti FIG, 2011, ENVIRON ARCHAEOL, V16, P36, DOI 10.1179/146141010X12640787648306	47	27	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65792	10.1371/journal.pone.0065792	http://dx.doi.org/10.1371/journal.pone.0065792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840368	gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200035
J	Hess, BM; Xue, JF; Markillie, LM; Taylor, RC; Wiley, HS; Ahring, BK; Linggi, B				Hess, Becky M.; Xue, Junfeng; Markillie, Lye Meng; Taylor, Ronald C.; Wiley, H. Steven; Ahring, Birgitte K.; Linggi, Bryan			Coregulation of Terpenoid Pathway Genes and Prediction of Isoprene Production in Bacillus subtilis Using Transcriptomics	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOSYNTHETIC-PATHWAY; EXPRESSION; BACTERIA; LEAVES; MICROORGANISMS; IDENTIFICATION; METABOLISM; EVOLUTION; EMISSION	The isoprenoid pathway converts pyruvate to isoprene and related isoprenoid compounds in plants and some bacteria. Currently, this pathway is of great interest because of the critical role that isoprenoids play in basic cellular processes, as well as the industrial value of metabolites such as isoprene. Although the regulation of several pathway genes has been described, there is a paucity of information regarding system level regulation and control of the pathway. To address these limitations, we examined Bacillus subtilis grown under multiple conditions and determined the relationship between altered isoprene production and gene expression patterns. We found that with respect to the amount of isoprene produced, terpenoid genes fall into two distinct subsets with opposing correlations. The group whose expression levels positively correlated with isoprene production included dxs, which is responsible for the commitment step in the pathway, ispD, and two genes that participate in the mevalonate pathway, yhfS and pksG. The subset of terpenoid genes that inversely correlated with isoprene production included ispH, ispF, hepS, uppS, ispE, and dxr. A genome-wide partial least squares regression model was created to identify other genes or pathways that contribute to isoprene production. These analyses showed that a subset of 213 regulated genes was sufficient to create a predictive model of isoprene production under different conditions and showed correlations at the transcriptional level. We conclude that gene expression levels alone are sufficiently informative about the metabolic state of a cell that produces increased isoprene and can be used to build a model that accurately predicts production of this secondary metabolite across many simulated environmental conditions.	[Hess, Becky M.; Xue, Junfeng; Ahring, Birgitte K.] Washington State Univ Tricities, Bioprod Sci & Engn Lab, Richland, WA USA; [Hess, Becky M.] Pacific NW Natl Lab, Chem & Biol Signature Sci Grp, Richland, WA 99352 USA; [Markillie, Lye Meng] Pacific NW Natl Lab, Richland, WA 99352 USA; [Taylor, Ronald C.] Pacific NW Natl Lab, Computat Biol & Bioinformat Grp, Richland, WA 99352 USA; [Wiley, H. Steven; Linggi, Bryan] Pacific NW Natl Lab, Environm & Mol Sci Lab, Richland, WA 99352 USA	Washington State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Linggi, B (corresponding author), Pacific NW Natl Lab, Environm & Mol Sci Lab, Richland, WA 99352 USA.	Bryan.Linggi@pnnl.gov		Taylor, Ronald/0000-0001-9777-9767; Wiley, Steven/0000-0003-0232-6867	Washington State University; Washington State STAR researcher program; United States Department of Energy (DOE); United States Department of Energy [DE-AC05-76RL01830]	Washington State University; Washington State STAR researcher program; United States Department of Energy (DOE)(United States Department of Energy (DOE)); United States Department of Energy(United States Department of Energy (DOE))	Funding is provided by Washington State University and financial support from the Washington State STAR researcher program to B. A. K. Portions of this work were conducted as part of a multi-capability research campaign in the W. R. Wiley Environmental Molecular Sciences Laboratory (EMSL), a national scientific user facility sponsored by the United States Department of Energy (DOE) and is a contribution of the PNNL Foundational Scientific Focus Area. Pacific Northwest National Laboratory is a multi-program national laboratory operated by Battelle for the United States Department of Energy under contract DE-AC05-76RL01830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Broun P, 2001, P NATL ACAD SCI USA, V98, P8925, DOI 10.1073/pnas.171310598; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Butcher RA, 2007, P NATL ACAD SCI USA, V104, P1506, DOI 10.1073/pnas.0610503104; Calderone CT, 2006, P NATL ACAD SCI USA, V103, P8977, DOI 10.1073/pnas.0603148103; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Connolly J.D., 1991, DICT TERPENOIDS, P2156; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; FEIN JE, 1976, J BACTERIOL, V127, P1427, DOI 10.1128/JB.127.3.1427-1442.1976; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Gollnick P, 2005, ANNU REV GENET, V39, P47, DOI 10.1146/annurev.genet.39.073003.093745; Harker M, 1999, FEBS LETT, V448, P115, DOI 10.1016/S0014-5793(99)00360-9; HARTFORD OM, 1992, J GEN MICROBIOL, V138, P2061, DOI 10.1099/00221287-138-10-2061; Julsing MK, 2007, APPL MICROBIOL BIOT, V75, P1377, DOI 10.1007/s00253-007-0953-5; Kajiwara S, 1997, BIOCHEM J, V324, P421, DOI 10.1042/bj3240421; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karin JJ, 2012, PHYS BIOL, V9; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kim SW, 2001, BIOTECHNOL BIOENG, V72, P408, DOI 10.1002/1097-0290(20000220)72:4<408::AID-BIT1003>3.0.CO;2-H; Kleerebezem M, 2000, ENZYME MICROB TECH, V26, P840, DOI 10.1016/S0141-0229(00)00180-0; Krogh S, 1996, MICROBIOL-UK, V142, P2031, DOI 10.1099/13500872-142-8-2031; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; KUZMA J, 1995, CURR MICROBIOL, V30, P97, DOI 10.1007/BF00294190; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Leonard E, 2010, P NATL ACAD SCI USA, V107, P13654, DOI 10.1073/pnas.1006138107; Loreto F, 2001, PLANT PHYSIOL, V126, P993, DOI 10.1104/pp.126.3.993; Loreto F, 2001, PLANT PHYSIOL, V127, P1781, DOI 10.1104/pp.010497; Mader U, 2012, NUCLEIC ACIDS RES, V40, pD1278, DOI 10.1093/nar/gkr923; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Mathews J, 2009, INT J HYDROGEN ENERG, V34, P7404, DOI 10.1016/j.ijhydene.2009.05.078; Nakano MM, 1998, J BACTERIOL, V180, P5344, DOI 10.1128/JB.180.20.5344-5350.1998; Nguyen HD, 2007, CURR MICROBIOL, V55, P89, DOI 10.1007/s00284-006-0419-5; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Nuccio ML, 1999, CURR OPIN PLANT BIOL, V2, P128, DOI 10.1016/S1369-5266(99)80026-0; Park SJ, 2005, APPL MICROBIOL BIOT, V68, P567, DOI 10.1007/s00253-005-0081-z; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Sharkey TD, 2001, ANNU REV PLANT PHYS, V52, P407, DOI 10.1146/annurev.arplant.52.1.407; Sharkey TD, 2005, PLANT PHYSIOL, V137, P700, DOI 10.1104/pp.104.054445; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shirk MC, 2002, BIOTECHNOL PROGR, V18, P1109, DOI 10.1021/bp0255412; Sivy TL, 2011, BIOSCI BIOTECH BIOCH, V75, P2376, DOI 10.1271/bbb.110572; Sivy TL, 2002, BIOCHEM BIOPH RES CO, V294, P71, DOI 10.1016/S0006-291X(02)00435-7; Sonenshein AL, 2007, NAT REV MICROBIOL, V5, P917, DOI 10.1038/nrmicro1772; STEPHANOPOULOS G, 1991, SCIENCE, V252, P1675, DOI 10.1126/science.1904627; Valgepea K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-166; Velikova V, 2008, PLANT CELL ENVIRON, V31, P1882, DOI 10.1111/j.1365-3040.2008.01893.x; Wagner WP, 2000, J NAT PROD, V63, P37, DOI 10.1021/np990286p; Wiberley AE, 2009, PLANT CELL ENVIRON, V32, P939, DOI 10.1111/j.1365-3040.2009.01980.x; Withers ST, 2007, APPL ENVIRON MICROB, V73, P6277, DOI 10.1128/AEM.00861-07; Xiang S, 2007, J BIOL CHEM, V282, P2676, DOI 10.1074/jbc.M610235200; Xue JF, 2011, APPL ENVIRON MICROB, V77, P2399, DOI 10.1128/AEM.02341-10; Yang JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033509; Yang ZRW, 2004, PROTEIN SCI, V13, P830, DOI 10.1110/ps.03330104; Yanofsky C, 2007, RNA, V13, P1141, DOI 10.1261/rna.620507; Yuan LZ, 2006, METAB ENG, V8, P79, DOI 10.1016/j.ymben.2005.08.005; Zhou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047513	60	24	26	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66104	10.1371/journal.pone.0066104	http://dx.doi.org/10.1371/journal.pone.0066104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840410	Green Submitted, gold, Green Published			2022-12-27	WOS:000322361200056
J	Mao, HY; Lu, XL; Karush, JM; Huang, XY; Yang, X; Ba, YN; Wang, Y; Liu, NS; Zhou, JQ; Lian, JF				Mao, Haiyan; Lu, Xiaoli; Karush, Justin Michael; Huang, Xiaoyan; Yang, Xi; Ba, Yanna; Wang, Ying; Liu, Ningsheng; Zhou, Jianqing; Lian, Jiangfang			Pharmacologic Approach to Defective Protein Trafficking in the E637K-hERG Mutant with PD-118057 and Thapsigargin	PLOS ONE			English	Article							LONG-QT SYNDROME; HERG POTASSIUM CHANNEL; K+ CHANNEL; CARDIAC-ARRHYTHMIA; I-KR; MECHANISM; MUTATION; BINDING; G601S; AFTERDEPOLARIZATIONS	Background: Treatment of LQT2 is inadequate. Many drugs which can pharmacologically rescue defective protein trafficking in LQT2 also result in potent blockade of HERG current, negating their therapeutic benefit. It is reported that PD-118057 and thapsigargin can rescue LQT2 without hERG channel blockade, but the precise mechanism of action is unknown. Furthermore, the effect of PD-118057 and thapsigargin on the dominant negative E637K-hERG mutant has not been previously investigated. Objective: In this study, we investigated: (a) the effect of PD-118057 and thapsigargin on the current amplitudes of WT-hERG and WT/E637K-hERG channels; (b) the effect of PD-118057 and thapsigargin on the biophysical properties of WT-hERG and WT/E637K-hERG channels; (c) whether drug treatment can rescue channel processing and trafficking defects of the WT/E637K-hERG mutant. Methods: The whole-cell Patch-clamp technique was used to assess the effect of PD-118057 and thapsigargin on the electrophysiological characteristics of the rapidly activating delayed rectifier K+ current (I-kr) of the hERG protein channel. Western blot was done to investigate pharmacological rescue on hERG protein channel function. Results: In our study, PD-118057 was shown to significantly enhance both the maximum current amplitude and tail current amplitude, but did not alter the gating and kinetic properties of the WT-hERG channel, with the exception of accelerating steady-state inactivation. Additionally, thapsigargin shows a similar result as PD-118057 for the WT-hERG channel, but with the exception of attenuating steady-state inactivation. However, for the WT/E637K-hERG channel, PD-118057 had no effect on either the current or on the gating and kinetic properties. Furthermore, thapsigargin treatment did not alter the current or the gating and kinetic properties of the WT/E637K-hERG channel, with the exception of opening at more positive voltages. Conclusion: Our findings illustrate that neither PD-118057 nor thapsigargin play a role in correcting the dominant-negative effect of the E637K-hERG mutant.	[Mao, Haiyan; Huang, Xiaoyan; Yang, Xi; Ba, Yanna; Wang, Ying; Zhou, Jianqing; Lian, Jiangfang] Ningbo Univ, Sch Med, LiHuiLi Hosp, Ningbo 315211, Zhejiang, Peoples R China; [Lu, Xiaoli] Peoples Hosp Anji Cty, Huzhou, Peoples R China; [Karush, Justin Michael] Mem Sloan Kettering Canc Ctr, Dept Thorac Surg, New York, NY 10021 USA; [Liu, Ningsheng] Nanjing Med Univ, Minist Hlth, Key Lab Antibody Tech, Dept Pathol, Nanjing, Jiangsu, Peoples R China	Ningbo University; Memorial Sloan Kettering Cancer Center; Nanjing Medical University	Lian, JF (corresponding author), Ningbo Univ, Sch Med, LiHuiLi Hosp, Ningbo 315211, Zhejiang, Peoples R China.	hjmpin@163.com	lu, xl/HDO-8340-2022		Advanced Key Scientific and Technological Programs of NingBo [2011C51001]; Fund of NingBo Science and Technology Innovation team [2011B82015]; National Natural Science Foundation of China [30772155]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, Ningbo personnel training project (first level), the project of Ningbo medicine and science [2009A02]	Advanced Key Scientific and Technological Programs of NingBo; Fund of NingBo Science and Technology Innovation team; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, Ningbo personnel training project (first level), the project of Ningbo medicine and science	The research was supported by the grants from: Advanced Key Scientific and Technological Programs of NingBo (2011C51001), Fund of NingBo Science and Technology Innovation team (2011B82015), National Natural Science Foundation of China (30772155), Zhejiang Provincial Program for the Cultivation of High-level Innovative Health talents, Ningbo personnel training project (first level), the project of Ningbo medicine and science(2009A02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Akimoto K, 1998, HUM MUTAT, pS184; Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; Anson BD, 2004, AM J PHYSIOL-HEART C, V286, pH2434, DOI 10.1152/ajpheart.00891.2003; ANTZELEVITCH C, 1994, J AM COLL CARDIOL, V23, P259, DOI 10.1016/0735-1097(94)90529-0; Bian JS, 2001, CIRC RES, V89, P1168, DOI 10.1161/hh2401.101375; Casis O, 2006, MOL PHARMACOL, V69, P658, DOI 10.1124/mol.105.019943; Cui J, 2000, CURR BIOL, V10, P671, DOI 10.1016/S0960-9822(00)00516-9; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; De Ponti F, 2000, EUR J CLIN PHARMACOL, V56, P1, DOI 10.1007/s002280050714; De Ponti F, 2001, EUR J CLIN PHARMACOL, V57, P185, DOI 10.1007/s002280100290; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; Ficker E, 2000, J MOL CELL CARDIOL, V32, P2327, DOI 10.1006/jmcc.2000.1263; Ficker E, 2000, AM J PHYSIOL-HEART C, V279, pH1748, DOI 10.1152/ajpheart.2000.279.4.H1748; Furutani M, 1999, CIRCULATION, V99, P2290, DOI 10.1161/01.CIR.99.17.2290; Hayashi K, 2002, CARDIOVASC RES, V54, P67, DOI 10.1016/S0008-6363(02)00240-7; Hua F, 2004, AM J PHYSIOL-HEART C, V286, pH2342, DOI 10.1152/ajpheart.00793.2003; Hua F, 2004, CIRC RES, V94, P810, DOI 10.1161/01.RES.0000121102.24277.89; Huang N, 2011, CELL BIOL INT, V35, P193, DOI 10.1042/CBI20100022; JANUARY CT, 1989, CIRC RES, V64, P977, DOI 10.1161/01.RES.64.5.977; Kang JS, 2005, MOL PHARMACOL, V67, P827, DOI 10.1124/mol.104.006577; Lees-Miller JP, 2000, MOL PHARMACOL, V57, P367; Lian JF, 2010, CAN J CARDIOL, V26, P417, DOI 10.1016/S0828-282X(10)70439-6; McPate MJ, 2005, BIOCHEM BIOPH RES CO, V334, P441, DOI 10.1016/j.bbrc.2005.06.112; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Paulussen A, 2002, J BIOL CHEM, V277, P48610, DOI 10.1074/jbc.M206569200; Perry M, 2009, P NATL ACAD SCI USA, V106, P20075, DOI 10.1073/pnas.0906597106; Priori SG, 2004, JAMA-J AM MED ASSOC, V292, P1341, DOI 10.1001/jama.292.11.1341; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sanguinetti MC, 2005, TRENDS PHARMACOL SCI, V26, P119, DOI 10.1016/j.tips.2005.01.003; Schwartz PJ, 2001, CIRCULATION, V103, P89; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; SURAWICZ B, 1989, J AM COLL CARDIOL, V14, P172, DOI 10.1016/0735-1097(89)90069-7; Thomas D, 2003, CARDIOVASC RES, V59, P14, DOI 10.1016/S0008-6363(03)00386-9; Zhou J, 2005, MOL PHARMACOL, V68, P876, DOI 10.1124/mol.105.014035; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	41	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65481	10.1371/journal.pone.0065481	http://dx.doi.org/10.1371/journal.pone.0065481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840331	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200019
J	Vanlandingham, PA; Fore, TR; Chastain, LR; Royer, SM; Bao, H; Reist, NE; Zhang, B				Vanlandingham, Phillip A.; Fore, Taylor R.; Chastain, Lerin R.; Royer, Suzanne M.; Bao, Hong; Reist, Noreen E.; Zhang, Bing			Epsin 1 Promotes Synaptic Growth by Enhancing BMP Signal Levels in Motoneuron Nuclei	PLOS ONE			English	Article							DROSOPHILA NEUROMUSCULAR-JUNCTION; CLATHRIN-MEDIATED ENDOCYTOSIS; FACTOR-BETA 2; TGF-BETA; C-ELEGANS; DEUBIQUITINATING ENZYME; RETROGRADE SIGNAL; AXONAL-TRANSPORT; DENDRITIC GROWTH; NERVOUS-SYSTEM	Bone morphogenetic protein (BMP) retrograde signaling is crucial for neuronal development and synaptic plasticity. However, how the BMP effector phospho-Mother against decapentaplegic (pMad) is processed following receptor activation remains poorly understood. Here we show that Drosophila Epsin1/Liquid facets (Lqf) positively regulates synaptic growth through post-endocytotic processing of pMad signaling complex. Lqf and the BMP receptor Wishful thinking (Wit) interact genetically and biochemically. lqf loss of function (LOF) reduces bouton number whereas overexpression of lqf stimulates bouton growth. Lqf-stimulated synaptic overgrowth is suppressed by genetic reduction of wit. Further, synaptic pMad fails to accumulate inside the motoneuron nuclei in lqf mutants and lqf suppresses synaptic overgrowth in spinster (spin) mutants with enhanced BMP signaling by reducing accumulation of nuclear pMad. Interestingly, lqf mutations reduce nuclear pMad levels without causing an apparent blockage of axonal transport itself. Finally, overexpression of Lqf significantly increases the number of multivesicular bodies (MVBs) in the synapse whereas lqf LOF reduces MVB formation, indicating that Lqf may function in signaling endosome recycling or maturation. Based on these observations, we propose that Lqf plays a novel endosomal role to ensure efficient retrograde transport of BMP signaling endosomes into motoneuron nuclei.	[Vanlandingham, Phillip A.; Fore, Taylor R.; Chastain, Lerin R.; Bao, Hong; Zhang, Bing] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Royer, Suzanne M.; Reist, Noreen E.] Colorado State Univ, Dept Biomed Sci, Mol Cellular & Integrat Neurosci Program, Ft Collins, CO 80523 USA	University of Oklahoma System; University of Oklahoma - Norman; Colorado State University	Zhang, B (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	zhangbing@Missouri.edu		Fore, Taylor/0000-0002-8144-613X; Reist, Noreen/0000-0002-1647-3166	NIH/NINDS [RO1 NS060878]; NSF [IOS-0822236, IOS-1025556]; Direct For Biological Sciences [1126578] Funding Source: National Science Foundation	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NSF(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by an NIH/NINDS grant (RO1 NS060878 to B.Z.) and in part by NSF grants (IOS-0822236 and IOS-1025556 to B.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Ball RW, 2010, NEURON, V66, P536, DOI 10.1016/j.neuron.2010.04.011; Bao H, 2008, TRAFFIC, V9, P2190, DOI 10.1111/j.1600-0854.2008.00832.x; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; Budnik V, 2006, FLY NEUROMUSCULAR JU; Cadavid ALM, 2000, DEVELOPMENT, V127, P1727; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; Chin J, 2006, J NEUROPHYSIOL, V95, P3286, DOI 10.1152/jn.00770.2005; Chin J, 2002, J NEUROSCI, V22; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Coyle IP, 2004, NEURON, V41, P521, DOI 10.1016/S0896-6273(04)00016-9; Csikos G, 2009, AUTOPHAGY, V5, P636, DOI 10.4161/auto.5.5.8168; da Silva S, 2011, P NATL ACAD SCI USA, V108, P3395, DOI 10.1073/pnas.1014411108; De Camilli P, 2002, FEBS LETT, V513, P11, DOI 10.1016/S0014-5793(01)03306-3; Dent EW, 2011, ADV NEUROBIOL, V5, P97, DOI 10.1007/978-1-4419-7368-9_6; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Fuentes-Medel Y, 2012, CURR BIOL, V22, P1831, DOI 10.1016/j.cub.2012.07.063; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; Heupel K, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-25; Higashi-Kovtun ME, 2010, J NEUROSCI, V30, P5253, DOI 10.1523/JNEUROSCI.3739-09.2010; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hurd DD, 1996, GENETICS, V144, P1075; James RE, 2011, DEVELOPMENT, V138, P3273, DOI 10.1242/dev.066142; Ji SJ, 2012, NEURON, V74, P95, DOI 10.1016/j.neuron.2012.02.022; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Jiang Y, 2000, NEUROSCIENCE, V97, P735, DOI 10.1016/S0306-4522(00)00084-1; Katsuno M, 2011, Curr Mol Med, V11, P48, DOI 10.2174/156652411794474356; Kazazic M, 2009, TRAFFIC, V10, P235, DOI 10.1111/j.1600-0854.2008.00858.x; Keshishian H, 2004, TRENDS NEUROSCI, V27, P143, DOI 10.1016/j.tins.2004.01.004; Kim NC, 2010, DEV DYNAM, V239, P2413, DOI 10.1002/dvdy.22368; Kim S, 2010, J CELL BIOL, V188, P717, DOI 10.1083/jcb.200911126; Kwon Y, 2008, NAT NEUROSCI, V11, P871, DOI 10.1038/nn.2170; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Merino C, 2009, J CELL BIOL, V185, P713, DOI 10.1083/jcb.200809127; Milton VJ, 2011, P NATL ACAD SCI USA, V108, P17521, DOI 10.1073/pnas.1014511108; Milward K, 2011, P NATL ACAD SCI USA, V108, P20672, DOI 10.1073/pnas.1106134109; Nahm M, 2010, J CELL BIOL, V191, P661, DOI 10.1083/jcb.201007086; Nahm M, 2010, J NEUROSCI, V30, P8138, DOI 10.1523/JNEUROSCI.0256-10.2010; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; O'Connor-Giles KM, 2008, NEURON, V58, P507, DOI 10.1016/j.neuron.2008.03.007; O'Connor-Giles KM, 2008, FLY, V2, DOI 10.4161/fly.7133; Overstreet E, 2003, CURR BIOL, V13, P854, DOI 10.1016/S0960-9822(03)00326-9; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Phillips AM, 2000, J NEUROSCI, V20, P8254, DOI 10.1523/JNEUROSCI.20-22-08254.2000; Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189; Reist NE, 1998, J NEUROSCI, V18, P7662; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Rodal AA, 2011, J CELL BIOL, V193, P201, DOI 10.1083/jcb.201009052; Shigetani Y, 2000, DEV BIOL, V228, P73, DOI 10.1006/dbio.2000.9932; Shoji-Kasai Y, 2007, J CELL SCI, V120, P3830, DOI 10.1242/jcs.012450; Smith RB, 2012, J CELL SCI, V125, P3752, DOI 10.1242/jcs.094292; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Sweeney ST, 2002, NEURON, V36, P403, DOI 10.1016/S0896-6273(02)01014-0; Tian XL, 2004, DEVELOPMENT, V131, P5807, DOI 10.1242/dev.01459; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Von Bartheld CS, 2011, PROG NEUROBIOL, V93, P313, DOI 10.1016/j.pneurobio.2011.01.003; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wendland B, 2002, NAT REV MOL CELL BIO, V3, P971, DOI 10.1038/nrm970; White JQ, 2012, NEURON, V75, P593, DOI 10.1016/j.neuron.2012.03.044; Withers GS, 2000, EUR J NEUROSCI, V12, P106, DOI 10.1046/j.1460-9568.2000.00889.x; Woodman PG, 2008, CURR OPIN CELL BIOL, V20, P408, DOI 10.1016/j.ceb.2008.04.001; Wu CB, 2009, J PROTEOMICS, V72, P46, DOI 10.1016/j.jprot.2008.10.007; Zheng F, 2009, MOL PSYCHIATR, V14, P332, DOI 10.1038/sj.mp.4002131; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	74	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65997	10.1371/journal.pone.0065997	http://dx.doi.org/10.1371/journal.pone.0065997			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840387	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200046
J	Altintas, DM; Allioli, N; Decaussin, M; de Bernard, S; Ruffion, A; Samarut, J; Vlaeminck-Guillem, V				Altintas, Dogus Murat; Allioli, Nathalie; Decaussin, Myriam; de Bernard, Simon; Ruffion, Alain; Samarut, Jacques; Vlaeminck-Guillem, Virginie			Differentially Expressed Androgen-Regulated Genes in Androgen-Sensitive Tissues Reveal Potential Biomarkers of Early Prostate Cancer	PLOS ONE			English	Article							ADULT-RAT MOTONEURONS; EPITHELIAL-CELLS; RECEPTOR; DIAGNOSIS; TRANSFORMATION; NORMALIZATION; DD3(PCA3); BREAST; TUMORS; GRADE	Background: Several data favor androgen receptor implication in prostate cancer initiation through the induction of several gene activation programs. The aim of the study is to identify potential biomarkers for early diagnosis of prostate cancer (PCa) among androgen-regulated genes (ARG) and to evaluate comparative expression of these genes in normal prostate and normal prostate-related androgen-sensitive tissues that do not (or rarely) give rise to cancer. Methods: ARG were selected in non-neoplastic adult human prostatic epithelial RWPE-1 cells stably expressing an exogenous human androgen receptor, using RNA-microarrays and validation by qRT-PCR. Expression of 48 preselected genes was quantified in tissue samples (seminal vesicles, prostate transitional zones and prostate cancers, benign prostatic hypertrophy obtained from surgical specimens) using TaqMan (R) low-density arrays. The diagnostic performances of these potential biomarkers were compared to that of genes known to be associated with PCa (i.e. PCA3 and DLX1). Results and Discussion: By crossing expression studies in 26 matched PCa and normal prostate transitional zone samples, and 35 matched seminal vesicle and PCa samples, 14 genes were identified. Similarly, 9 genes were overexpressed in 15 benign prostatic hypertrophy samples, as compared to PCa samples. Overall, we selected 8 genes of interest to evaluate their diagnostic performances in comparison with that of PCA3 and DLX1. Among them, 3 genes: CRYAB, KCNMA1 and SDPR, were overexpressed in all 3 reference non-cancerous tissues. The areas under ROC curves of these genes reached those of PCA3 (0.91) and DLX1 (0.94). Conclusions: We identified ARG with reduced expression in PCa and with significant diagnostic values for discriminating between cancerous and non-cancerous prostatic tissues, similar that of PCA3. Given their expression pattern, they could be considered as potentially protective against prostate cancer. Moreover, they could be complementary to known genes overexpressed in PCa and included along with them in multiplex diagnostic tools.	[Altintas, Dogus Murat; Allioli, Nathalie; Decaussin, Myriam; Ruffion, Alain; Samarut, Jacques; Vlaeminck-Guillem, Virginie] Univ Lyon, Ecole Normale Super Lyon, CNRS UMR5242,IGFL, INRA1288, Lyon, France; [Allioli, Nathalie] Univ Lyon 1, Inst Sci Pharmaceut & Biol ISPB Lyon, F-69365 Lyon, France; [Decaussin, Myriam; Ruffion, Alain; Samarut, Jacques; Vlaeminck-Guillem, Virginie] Univ Lyon 1, Fac Med Est, F-69365 Lyon, France; [Decaussin, Myriam; Ruffion, Alain; Samarut, Jacques; Vlaeminck-Guillem, Virginie] Univ Lyon 1, Fac Lyon Sud, F-69365 Lyon, France; [Decaussin, Myriam] Hosp Civils Lyon, Hop Lyon Sud, Serv Anat & Cytol Pathol, Pierre Benite, France; [de Bernard, Simon] AltraBio, Lyon, France; [Ruffion, Alain] Hosp Civils Lyon, Hop Lyon Sud, Serv Urol, Pierre Benite, France; [Samarut, Jacques; Vlaeminck-Guillem, Virginie] Hosp Civils Lyon, Hop Lyon Sud, Unite Med Oncol Mol & Transfert, Pierre Benite, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; CHU Lyon; CHU Lyon	Samarut, J (corresponding author), Univ Lyon, Ecole Normale Super Lyon, CNRS UMR5242,IGFL, INRA1288, Lyon, France.	jacques.samarut@ens-lyon.fr; virginie.vlaeminck-guillem@univ-lyon1.fr	Altintas, Dogus/AAL-2866-2021; Altintas, Dogus/AAA-3066-2021; Samarut, Jacques/AAD-2587-2019	Migliaccio, Antimo/0000-0002-4197-2055; Altintas, Dogus/0000-0001-7153-4462	French League Against Cancer under the ''Equipe Labellisee'' program; National Cancer Institute (INCA); National and Regional Cancer Programs; French Ministry of National Education, Research and Technology (MENRT Grant)	French League Against Cancer under the ''Equipe Labellisee'' program; National Cancer Institute (INCA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)Institut National du Cancer (INCA) France); National and Regional Cancer Programs; French Ministry of National Education, Research and Technology (MENRT Grant)	This work was supported by grants from the French League Against Cancer under the ''Equipe Labellisee'' program, by the National Cancer Institute (INCA) and the National and Regional Cancer Programs. DA was a recipient of a PhD grant from the French Ministry of National Education, Research and Technology (MENRT Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altintas DM, 2011, MOL CELL ENDOCRINOL, V332, P149, DOI 10.1016/j.mce.2010.10.007; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Auprich M, 2011, EUR UROL, V60, P1045, DOI 10.1016/j.eururo.2011.08.003; Balcerczak E, 2003, NEOPLASMA, V50, P97; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Bialkowska-Hobrzanska Hanna, 2006, Can J Urol, V13, P2967; Bradford TJ, 2006, UROL ONCOL-SEMIN ORI, V24, P538, DOI 10.1016/j.urolonc.2006.07.004; Bussemakers MJG, 1999, CANCER RES, V59, P5975; CATALONA WJ, 1993, JAMA-J AM MED ASSOC, V270, P948, DOI 10.1001/jama.270.8.948; Culig Z, 2003, UROLOGY, V62, P21, DOI 10.1016/S0090-4295(03)00698-8; de Kok JB, 2002, CANCER RES, V62, P2695; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Doane AS, 2006, ONCOGENE, V25, P3994, DOI 10.1038/sj.onc.1209415; Ferreira LB, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-507; Floriano-Sanchez E, 2009, CLIN INVEST MED, V32, pE258; Goulter AB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-34; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Han GZ, 2005, P NATL ACAD SCI USA, V102, P1151, DOI 10.1073/pnas.0408925102; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hessels D, 2003, EUR UROL, V44, P8, DOI 10.1016/S0302-2838(03)00201-X; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Klecka J, 2010, ANTICANCER RES, V30, P665; Kristiansen G, 2003, PROSTATE, V54, P34, DOI 10.1002/pros.10161; Landers KA, 2005, INT J CANCER, V114, P950, DOI 10.1002/ijc.20760; Li X, 2008, CANCER SCI, V99, P1326, DOI 10.1111/j.1349-7006.2008.00816.x; Lin H, 2004, J BIOL CHEM, V279, P29302, DOI 10.1074/jbc.M403664200; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; MATSUMOTO A, 1994, HORM BEHAV, V28, P357, DOI 10.1006/hbeh.1994.1032; MATSUMOTO A, 1992, NEUROSCI RES, V14, P133, DOI 10.1016/0168-0102(92)90089-U; Merlo GR, 2000, INT J DEV BIOL, V44, P619; O'Malley KJ, 2009, PROSTATE, V69, P1716, DOI 10.1002/pros.21034; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Pascal LE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-452; Reissigl A, 1997, PROSTATE, V30, P130; RHIM JS, 1994, P NATL ACAD SCI USA, V91, P11874, DOI 10.1073/pnas.91.25.11874; Rittenhouse H, 2013, CLIN CHEM, V59, P32, DOI 10.1373/clinchem.2012.198739; Sorensen KD, 2010, EXPERT REV MOL DIAGN, V10, P49, DOI 10.1586/ERM.09.74; Stanbrough M, 2001, P NATL ACAD SCI USA, V98, P10823, DOI 10.1073/pnas.191235898; Thompson M, 2008, PROSTATE, V68, P1248, DOI 10.1002/pros.20792; Torring N, 2003, PROSTATE, V56, P142, DOI 10.1002/pros.10245; Vanaja DK, 2009, CANCER INVEST, V27, P549, DOI 10.1080/07357900802620794; Vare P, 2008, ONCOL REP, V19, P25; Vest D, 2010, BJU INT, V105, P1490, DOI 10.1111/j.1464-410X.2010.09313.x; Vlaeminck-Guillem V, 2010, UROLOGY, V75, P447, DOI 10.1016/j.urology.2009.03.046; Wang YZ, 1998, PROSTATE, V35, P165; Webber MM, 1997, CARCINOGENESIS, V18, P1225, DOI 10.1093/carcin/18.6.1225; Windus LCE, 2012, EXP CELL RES, V318, P2507, DOI 10.1016/j.yexcr.2012.07.013	47	23	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66278	10.1371/journal.pone.0066278	http://dx.doi.org/10.1371/journal.pone.0066278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840433	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400011
J	Munoz, AR; Marquez, AL; Real, R				Munoz, Antonio-Roman; Luz Marquez, Ana; Real, Raimundo			Updating Known Distribution Models for Forecasting Climate Change Impact on Endangered Species	PLOS ONE			English	Article							EAGLE HIERAAETUS-FASCIATUS; IMPORTANT BIRD AREAS; BONELLIS EAGLE; LAND-USE; POTENTIAL IMPACTS; SPRING ARRIVAL; HABITAT; CONSERVATION; POPULATION; RANGE	To plan endangered species conservation and to design adequate management programmes, it is necessary to predict their distributional response to climate change, especially under the current situation of rapid change. However, these predictions are customarily done by relating de novo the distribution of the species with climatic conditions with no regard of previously available knowledge about the factors affecting the species distribution. We propose to take advantage of known species distribution models, but proceeding to update them with the variables yielded by climatic models before projecting them to the future. To exemplify our proposal, the availability of suitable habitat across Spain for the endangered Bonelli's Eagle (Aquila fasciata) was modelled by updating a pre-existing model based on current climate and topography to a combination of different general circulation models and Special Report on Emissions Scenarios. Our results suggested that the main threat for this endangered species would not be climate change, since all forecasting models show that its distribution will be maintained and increased in mainland Spain for all the XXI century. We remark on the importance of linking conservation biology with distribution modelling by updating existing models, frequently available for endangered species, considering all the known factors conditioning the species' distribution, instead of building new models that are based on climate change variables only.	[Munoz, Antonio-Roman; Luz Marquez, Ana; Real, Raimundo] Univ Malaga, Fac Sci, Dept Anim Biol, Biogeog Divers & Conservat Res Team, E-29071 Malaga, Spain; [Munoz, Antonio-Roman] Fdn Migres, Pelayo, Algeciras, Spain; [Munoz, Antonio-Roman] Univ Malaga, Fac Educ Sci, Depto Didact Matemat Ciencias Sociales & Ciencias, E-29071 Malaga, Spain	Universidad de Malaga; Universidad de Malaga	Munoz, AR (corresponding author), Univ Malaga, Fac Sci, Dept Anim Biol, Biogeog Divers & Conservat Res Team, E-29071 Malaga, Spain.	roman@uma.es	Márquez, Ana Luz/K-8345-2014; MUÑOZ, Antonio Román/K-8259-2014; Real, Raimundo/E-6559-2010	Márquez, Ana Luz/0000-0001-5586-9334; MUÑOZ, Antonio Román/0000-0002-0253-7632; Real, Raimundo/0000-0002-6642-1284	Ministerio de Ciencia e Innovacion of Spain; FEDER [CGL2009-11316/BOS]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission)	This work was partially financed by the Ministerio de Ciencia e Innovacion of Spain and FEDER (project CGL2009-11316/BOS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola M, 2004, GLOBAL CHANGE BIOL, V10, P1610, DOI 10.1111/j.1365-2486.2004.00823.x; Alagador D, 2011, BIOL CONSERV, V144, P811, DOI 10.1016/j.biocon.2010.11.011; Ali S, 2001, HDB BIRDS INDIA PAKI, VI; Aragon P, 2010, GLOBAL ECOL BIOGEOGR, V19, P40, DOI 10.1111/j.1466-8238.2009.00488.x; Balbontin J, 2005, BIOL CONSERV, V126, P74, DOI 10.1016/j.biocon.2005.04.023; Balbontin J, 2003, BIOL CONSERV, V109, P417, DOI 10.1016/S0006-3207(02)00168-4; Barbet-Massin M, 2009, BIOL LETTERS, V5, P248, DOI 10.1098/rsbl.2008.0715; Barbosa AM, 2003, BIOL CONSERV, V114, P377, DOI 10.1016/S0006-3207(03)00066-1; BirdLife International, 2004, BIRDS EUR POP EST TR; BirdLife International/EBCC, 2000, BIRDLIFE CONS SER, V10; Bjorholm S, 2005, GLOBAL ECOL BIOGEOGR, V14, P423, DOI 10.1111/j.1466-822x.2005.00167.x; Bosch R, 2010, IBIS, V152, P105, DOI 10.1111/j.1474-919X.2009.00985.x; Brunet M, 2007, GENERACION ESCENARIO; Buisson L, 2008, GLOBAL CHANGE BIOL, V14, P2232, DOI 10.1111/j.1365-2486.2008.01657.x; Calef MP, 2005, J BIOGEOGR, V32, P863, DOI 10.1111/j.1365-2699.2004.01185.x; Capel TT, 1981, CLIMAS ESPANA; Carrascal LM, 2009, ECOL RES, V24, P565, DOI 10.1007/s11284-008-0527-8; Carrete M, 2006, OIKOS, V112, P680, DOI 10.1111/j.0030-1299.2006.14528.x; Castro A, 2008, ARDEOLA, V55, P71; Cramp S., 1980, HDB BIRDS EUROPE MID, VII; Del Moral J.C., 2018, AGUILA PERDICERA ESP, DOI [10.31170/0066, DOI 10.31170/0066]; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Elorriaga J, 2013, OSTRICH, V84, P41, DOI 10.2989/00306525.2013.772922; Elorriaga Javier, 2010, British Birds, V103, P396; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Estes LD, 2011, ANIM CONSERV, V14, P521, DOI 10.1111/j.1469-1795.2011.00457.x; European Raptors, BIOL CONS WEBS; Farfan MA, 2008, ITAL J ZOOL, V75, P161, DOI 10.1080/11250000701868717; FERNANDEZ C, 1990, Journal of Raptor Research, V24, P124; Font I., 2000, CLIMATOLOGIA ESPANA; Freeman SN, 2003, IBIS, V145, P400, DOI 10.1046/j.1474-919X.2003.00177.x; Gaston A, 2010, ECOL MODEL, V221, P2576, DOI 10.1016/j.ecolmodel.2010.07.016; Gil Sanchez Jose Ma., 1996, Ardeola, V43, P189; Gil-Sanchez JM, 2004, BIOL CONSERV, V118, P685, DOI 10.1016/j.biocon.2003.10.017; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gordo O, 2005, GLOBAL CHANGE BIOL, V11, P12, DOI 10.1111/j.1365-2486.2004.00875.x; Gordo O, 2006, GLOBAL CHANGE BIOL, V12, P1993, DOI 10.1111/j.1365-2486.2006.01178.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Halupka L, 2008, J AVIAN BIOL, V39, P95, DOI 10.1111/j.0908-8857.2008.04047.x; Hannah L, 2005, CLIMATE CHANGE BIODI, P363; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hirzel AH, 2001, ECOL MODEL, V145, P111, DOI 10.1016/S0304-3800(01)00396-9; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Huntley B., 2007, CLIMATIC ATLAS EUROP; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; HUSTLER K, 1988, CONDOR, V90, P583, DOI 10.2307/1368346; IPCC, 2008, CLIMATE CHANGE 2007; IPCC, 2001, ADV CLIM CHANG RES; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Julliard R, 2004, GLOBAL CHANGE BIOL, V10, P148, DOI 10.1111/j.1365-2486.2003.00723.x; Kuncheva LI, 2001, FUZZY SET SYST, V122, P401, DOI 10.1016/S0165-0114(99)00161-X; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY; Leggett J, 1992, CLIMATE CHANGE 1992, P69; Lemoine N, 2007, CONSERV BIOL, V21, P495, DOI 10.1111/j.1523-1739.2006.00633.x; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lopez-Lopez P, 2007, ANIM CONSERV, V10, P208, DOI 10.1111/j.1469-1795.2006.00089.x; Lopez-Lopez P, 2006, J ORNITHOL, V147, P97, DOI 10.1007/s10336-005-0019-3; Lopez-Lopez P, 2004, ARDEOLA, V51, P275; Lopez-Lopez P, 2007, BIODIVERS CONSERV, V16, P3755, DOI 10.1007/s10531-007-9179-1; Lopez-Lopez P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017196; Marquez AL, 2011, CLIMATIC CHANGE, V108, P135, DOI 10.1007/s10584-010-0010-8; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; Moleon M, 2006, AGUILA PERDICERA ESP, P24; Moleon M, 2011, J RAPTOR RES, V45, P353, DOI 10.3356/JRR-11-30.1; Morillo C, 2000, BIOL CONSERV, V95, P165, DOI 10.1016/S0006-3207(00)00031-8; Munoz AR, 2006, DIVERS DISTRIB, V12, P656, DOI 10.1111/j.1472-4642.2006.00272.x; Munoz AR, 2005, DIVERS DISTRIB, V11, P477, DOI 10.1111/j.1366-9516.2005.00188.x; Munoz AR, 2013, ACTA ORNITH IN PRESS, V48; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Niamir A, 2011, DIVERS DISTRIB, V17, P1173, DOI 10.1111/j.1472-4642.2011.00793.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parry ML, 2000, ASSESSMENT POTENTIAL; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Portner H.-O., 2022, CLIMATE CHANGE 2022, P3; Ptaszyk J, 2003, J ORNITHOL, V144, P323, DOI 10.1046/j.1439-0361.2003.03011.x; Randin CF, 2009, J VEG SCI, V20, P996, DOI 10.1111/j.1654-1103.2009.01098.x; Real J, 1997, BIOL CONSERV, V79, P59, DOI 10.1016/S0006-3207(96)00100-0; Real J, 2001, BIRD STUDY, V48, P221, DOI 10.1080/00063650109461221; Real J., 2004, LIBRO ROJO AVES ESPA, P154; Real J., 2003, ATLAS AVES REPROD ES, P192; Real R, 2006, ENVIRON ECOL STAT, V13, P237, DOI 10.1007/s10651-005-0003-3; Real R, 2010, ECOGRAPHY, V33, P304, DOI 10.1111/j.1600-0587.2010.06251.x; Rivalan P, 2010, IBIS, V152, P6, DOI 10.1111/j.1474-919X.2009.00977.x; Robinson RA, 2004, J ANIM ECOL, V73, P670, DOI 10.1111/j.0021-8790.2004.00841.x; Rocamora G., 1994, BIRDLIFE CONSERV SER, P184; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sanchez E, 2004, GLOBAL PLANET CHANGE, V44, P163, DOI 10.1016/j.gloplacha.2004.06.010; Sanz JJ, 2003, GLOBAL CHANGE BIOL, V9, P461, DOI 10.1046/j.1365-2486.2003.00575.x; Serreze MC, 2010, CONSERV BIOL, V24, P10, DOI 10.1111/j.1523-1739.2009.01408.x; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Thomson DL, 1997, J ANIM ECOL, V66, P414, DOI 10.2307/5986; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Tryjanowski P, 2005, J ORNITHOL, V146, P200, DOI 10.1007/s10336-005-0079-4; Virkkala R, 2008, BIOL CONSERV, V141, P1343, DOI 10.1016/j.biocon.2008.03.007; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Walther GR., 2001, FINGERPRINTS CLIMATE; White C.M., 1994, NEW WORLD VULTURES G; Zalakevicius M, 2006, J ORNITHOL, V147, P326, DOI 10.1007/s10336-005-0016-6	104	15	16	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e65462	10.1371/journal.pone.0065462	http://dx.doi.org/10.1371/journal.pone.0065462			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840330	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400005
J	Wang, P; Huang, SS; Wang, F; Ren, Y; Hehir, M; Wang, X; Cai, J				Wang, Ping; Huang, Shuaishuai; Wang, Feng; Ren, Yu; Hehir, Michael; Wang, Xue; Cai, Jie			Cyclic AMP-Response Element Regulated Cell Cycle Arrests in Cancer Cells	PLOS ONE			English	Article							A GENE-EXPRESSION; BINDING-PROTEIN; BCL-2 EXPRESSION; D1 EXPRESSION; TRANSCRIPTION FACTOR; MEDIATED ACTIVATION; DOWN-REGULATION; BETA-CATENIN; CREB; TRICHOSANTHIN	Recently, we have demonstrated that trichosanthin (TCS), a promising agent for the treatment of cervical adenocarcinoma, inhibited HeLa cell proliferation through the PKC/MAPK/CREB signal pathway. Furthermore, TCS down-regulated Bcl-2 expression was abrogated by a decoy oligonucleotide (OGN) to the cyclic AMP-responsive element (CRE). The decoy OGN blocked the binding of CRE-binding protein (CREB) to Bcl-2. These results suggested that CRE-mediated gene expression may play a pivotal role in HeLa cell proliferation. However, little is known about the effect of TCS on cell cycle arrests, particularly, whether the genes involved in cell cycle were regulated by CRE. Our present study shows that the arrests of S, G1 and G2/M phases were accompanied by the significant down-regulation of cyclin A, D1 and CDK 2, 4 in HeLa cells, cyclin D1, E and CDK 2, 4 in Caski and C33a cells, and cyclin A, B1, E and CDK 2 in SW1990 cells. However, the cell cycle arrests were reversed via the significant up-regulation of cyclin A and D1, by the combined treatment of TCS and CRE. In conclusion, these data demonstrate for the first time that specific cell cycle arrests in cancer cells can be induced by TCS by inhibiting the binding of CREB to CRE on genes related to cell proliferation.	[Wang, Ping; Huang, Shuaishuai; Hehir, Michael; Wang, Xue] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China; [Wang, Feng] Ningbo Univ, Ningbo Med Ctr, LiHuiLi Hosp, Sch Med, Ningbo 315211, Zhejiang, Peoples R China; [Ren, Yu] Ningbo Univ, Ningbo Urol & Nephrol Hosp, Dept Urol Surg, Ningbo 315211, Zhejiang, Peoples R China; [Cai, Jie] Ningbo Univ, Sch Med, Ningbo Women & Childrens Hosp, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Ningbo University; Ningbo University; Ningbo University	Wang, P (corresponding author), Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China.	pinoav@hotmail.com; doctor_caijie@hotmail.com			National Natural Science Foundation of China [81071653]; Natural Science Foundation of Zhejiang Province [Y2111136]; Advanced Key Scientific and Technological Programs of Ningbo [2011C51005]; Natural Science Foundation of Ningbo City [2011A610050]; K. C. Wong Magna Fund in Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Advanced Key Scientific and Technological Programs of Ningbo; Natural Science Foundation of Ningbo City; K. C. Wong Magna Fund in Ningbo University	This work was supported by the grants from the National Natural Science Foundation of China (81071653), Natural Science Foundation of Zhejiang Province (Y2111136), Advanced Key Scientific and Technological Programs of Ningbo (2011C51005), Natural Science Foundation of Ningbo City (2011A610050) and K. C. Wong Magna Fund in Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier F, 1999, P NATL ACAD SCI USA, V96, P1433, DOI 10.1073/pnas.96.4.1433; Catalano S, 2009, J CELL PHYSIOL, V218, P490, DOI 10.1002/jcp.21622; DESDOUETS C, 1995, MOL CELL BIOL, V15, P3301; Freeland K, 2001, MOL BRAIN RES, V92, P98, DOI 10.1016/S0169-328X(01)00158-9; Giampuzzi M, 2005, BBA-MOL CELL RES, V1745, P370, DOI 10.1016/j.bbamcr.2005.04.012; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jiang QS, 2011, MOL BIOL REP, V38, P2863, DOI 10.1007/s11033-010-0432-4; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kim MJ, 2006, J ENDOCRINOL, V188, P623, DOI 10.1677/joe.1.06480; Kothapalli D, 2003, MOL PHARMACOL, V64, P249, DOI 10.1124/mol.64.2.249; Li M, 2010, ANAT REC, V293, P986, DOI 10.1002/ar.21142; MARAGANORE JM, 1987, J BIOL CHEM, V262, P11628; Moriuchi A, 2003, BIOCHEM BIOPH RES CO, V300, P415, DOI 10.1016/S0006-291X(02)02867-X; NAKAMURA T, 1995, EXP CELL RES, V216, P422, DOI 10.1006/excr.1995.1053; Park YG, 2001, BIOCHEM BIOPH RES CO, V281, P1213, DOI 10.1006/bbrc.2001.4521; Peng B, 2008, GYNECOL ONCOL, V108, P173, DOI 10.1016/j.ygyno.2007.09.016; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Pradeep A, 2004, ONCOGENE, V23, P3689, DOI 10.1038/sj.onc.1207454; Pugazhenthi S, 1999, J BIOL CHEM, V274, P2829, DOI 10.1074/jbc.274.5.2829; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Saeki K, 1999, BIOCHEM J, V338, P49, DOI 10.1042/0264-6021:3380049; Schneider G, 2002, J BIOL CHEM, V277, P43599, DOI 10.1074/jbc.M204787200; Sherr CJ, 2000, CANCER RES, V60, P3689; Shimizu M, 1998, EXP CELL RES, V239, P93, DOI 10.1006/excr.1997.3884; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wang P, 2007, LIFE SCI, V81, P1130, DOI 10.1016/j.lfs.2007.08.016; Wang P, 2007, BIOCHEM BIOPH RES CO, V363, P101, DOI 10.1016/j.bbrc.2007.08.141; Wang P, 2010, BIOMATERIALS, V31, P6201, DOI 10.1016/j.biomaterials.2010.04.034; Wang P, 2010, MOL BIOL REP, V37, P1891, DOI 10.1007/s11033-009-9629-9; Wang P, 2009, CELL BIOL INT, V33, P1149, DOI 10.1016/j.cellbi.2009.08.002; Wang P, 2009, CELL BIOL TOXICOL, V25, P479, DOI 10.1007/s10565-008-9102-x; Watanabe G, 1996, P NATL ACAD SCI USA, V93, P12861, DOI 10.1073/pnas.93.23.12861; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Won YJ, 2009, BIOCHEM BIOPH RES CO, V380, P655, DOI 10.1016/j.bbrc.2009.01.159; Yamazoe S, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-53; Yu Z, 2007, GYNECOL ONCOL, V106, P541, DOI 10.1016/j.ygyno.2007.05.024; Zhao K, 2012, MOL BIOL REP, V39, P2607, DOI 10.1007/s11033-011-1013-x	40	17	24	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e65661	10.1371/journal.pone.0065661	http://dx.doi.org/10.1371/journal.pone.0065661			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840351	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400006
J	Yuan, Y; Yokoyama, M; Maeda, Y; Terasawa, H; Harada, S; Sato, H; Yusa, K				Yuan, Yuzhe; Yokoyama, Masaru; Maeda, Yosuke; Terasawa, Hiromi; Harada, Shinji; Sato, Hironori; Yusa, Keisuke			Structure and Dynamics of the gp120 V3 Loop That Confers Noncompetitive Resistance in R5 HIV-1(JR-FL) to Maraviroc	PLOS ONE			English	Article							MOLECULE CCR5 INHIBITOR; VIRUS TYPE-1 ENVELOPE; HIV-1 GP120; DETERMINANTS; VICRIVIROC; ESCAPE; ENTRY; SENSITIVITY; CORECEPTOR; INFECTION	Maraviroc, an (HIV-1) entry inhibitor, binds to CCR5 and efficiently prevents R5 human immunodeficiency virus type 1 (HIV-1) from using CCR5 as a coreceptor for entry into CD4(+) cells. However, HIV-1 can elude maraviroc by using the drug-bound form of CCR5 as a coreceptor. This property is known as noncompetitive resistance. HIV-1(V3-M5) derived from HIV-1(JR-FLan) is a noncompetitive-resistant virus that contains five mutations (I304V/F312W/T314A/E317D/I318V) in the gp120 V3 loop alone. To obtain genetic and structural insights into maraviroc resistance in HIV-1, we performed here mutagenesis and computer-assisted structural study. A series of site-directed mutagenesis experiments demonstrated that combinations of V3 mutations are required for HIV-1(JR-FLan) to replicate in the presence of 1 mu M maraviroc, and that a T199K mutation in the C2 region increases viral fitness in combination with V3 mutations. Molecular dynamic (MD) simulations of the gp120 outer domain V3 loop with or without the five mutations showed that the V3 mutations induced (i) changes in V3 configuration on the gp120 outer domain, (ii) reduction of an anti-parallel beta-sheet in the V3 stem region, (iii) reduction in fluctuations of the V3 tip and stem regions, and (iv) a shift of the fluctuation site at the V3 base region. These results suggest that the HIV-1 gp120 V3 mutations that confer maraviroc resistance alter structure and dynamics of the V3 loop on the gp120 outer domain, and enable interactions between gp120 and the drug-bound form of CCR5.	[Yuan, Yuzhe] Chinese Acad Med Sci, Transfus Transmitted Dis Ctr, Inst Blood Transfus, Chengdu, Sichuan Provinc, Peoples R China; [Yokoyama, Masaru; Sato, Hironori] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Maeda, Yosuke; Terasawa, Hiromi; Harada, Shinji] Kumamoto Univ, Grad Sch Med Sci, Dept Med Virol, Kumamoto, Japan; [Yusa, Keisuke] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo, Japan	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Blood Transfusion - CAMS; National Institute of Infectious Diseases (NIID); Kumamoto University; National Institute of Health Sciences - Japan	Yusa, K (corresponding author), Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo, Japan.	yusak@nihs.go.jp			Ministry of Health, Labour and Welfare; Global COE program Education and Research Center Aiming at the Control of AIDS from the Ministry of Education, Science, Sports and Culture, Japan; National Natural Science Foundation of China [81201329]; Chinese Academy of Medical Sciences; Peking Union Medical College; Grants-in-Aid for Scientific Research [23590548] Funding Source: KAKEN	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Global COE program Education and Research Center Aiming at the Control of AIDS from the Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences; Peking Union Medical College; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Health, Labour and Welfare and by the Global COE program Education and Research Center Aiming at the Control of AIDS from the Ministry of Education, Science, Sports and Culture, Japan. Y.Y. was supported by National Natural Science Foundation of China (81201329), scholarship for youth from Chinese Academy of Medical Sciences and Peking Union Medical College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba M, 2007, ANTIMICROB AGENTS CH, V51, P707, DOI 10.1128/AAC.01079-06; Berro R, 2012, VIROLOGY, V427, P158, DOI 10.1016/j.virol.2012.02.006; Case D, 2006, AMBER 9; Cormier EG, 2002, J VIROL, V76, P8953, DOI 10.1128/JVI.76.17.8953-8957.2002; Cormier EG, 2001, J VIROL, V75, P5541, DOI 10.1128/JVI.75.12.5541-5549.2001; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; Fadel H, 2007, DRUG TODAY, V43, P749, DOI 10.1358/dot.2007.43.11.1131763; Gorry Paul R, 2011, Curr HIV/AIDS Rep, V8, P45, DOI 10.1007/s11904-010-0069-x; Gulick RM, 2007, J INFECT DIS, V196, P304, DOI 10.1086/518797; Hachiya A, 2001, ANTIMICROB AGENTS CH, V45, P495, DOI 10.1128/AAC.45.2.495-501.2001; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kuhmann SE, 2004, J VIROL, V78, P2790, DOI 10.1128/JVI.78.6.2790-2807.2004; Lusso P, 2005, J VIROL, V79, P6957, DOI 10.1128/JVI.79.11.6957-6968.2005; Maeda Y, 2000, J VIROL, V74, P1787, DOI 10.1128/JVI.74.4.1787-1793.2000; Maeda Y, 2011, AIDS CLIN RES; Mariani R, 2000, J VIROL, V74, P3859, DOI 10.1128/JVI.74.8.3859-3870.2000; Marozsan AJ, 2005, VIROLOGY, V338, P182, DOI 10.1016/j.virol.2005.04.035; Moore JP, 2009, CURR OPIN HIV AIDS, V4, P118, DOI 10.1097/COH.0b013e3283223d46; Naganawa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003206; Ode H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00258; Ogert RA, 2008, VIROLOGY, V373, P387, DOI 10.1016/j.virol.2007.12.009; Pugach P, 2007, VIROLOGY, V361, P212, DOI 10.1016/j.virol.2006.11.004; Rizzuto C, 2000, AIDS RES HUM RETROV, V16, P741, DOI 10.1089/088922200308747; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Roche M, 2011, J VIROL, V85, P4330, DOI 10.1128/JVI.00106-11; Thorpe IF, 2007, P NATL ACAD SCI USA, V104, P8821, DOI 10.1073/pnas.0610064104; Tilton JC, 2010, J VIROL, V84, P10863, DOI 10.1128/JVI.01109-10; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Tilton JC, 2010, AIDS RES HUM RETROV, V26, P13, DOI 10.1089/aid.2009.0132; Trkola A, 2002, P NATL ACAD SCI USA, V99, P395, DOI 10.1073/pnas.012519099; Westby M, 2007, J VIROL, V81, P2359, DOI 10.1128/JVI.02006-06; Westby Mike, 2010, Antiviral Chemistry & Chemotherapy, V20, P179, DOI 10.3851/IMP1507; Yokoyama M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037530; Yuan YZ, 2011, VIROLOGY, V413, P293, DOI 10.1016/j.virol.2011.02.019; Yusa K, 2005, J BIOL CHEM, V280, P30083, DOI 10.1074/jbc.M414360200	38	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e65115	10.1371/journal.pone.0065115	http://dx.doi.org/10.1371/journal.pone.0065115			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840315	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400003
J	Gaitan-Espitia, JD; Nespolo, RF; Opazo, JC				Diego Gaitan-Espitia, Juan; Nespolo, Roberto F.; Opazo, Juan C.			The Complete Mitochondrial Genome of the Land Snail Cornu aspersum (Helicidae: Mollusca): Intra-Specific Divergence of Protein-Coding Genes and Phylogenetic Considerations within Euthyneura	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; COMPLETE SEQUENCE; HELIX-ASPERSA; EVOLUTIONARY RELATIONSHIPS; SUBSTITUTION; GASTROPODA; DNA; ORGANIZATION; SYSTEMATICS; SELECTION	The complete sequences of three mitochondrial genomes from the land snail Cornu aspersum were determined. The mitogenome has a length of 14050 bp, and it encodes 13 protein-coding genes, 22 transfer RNA genes and two ribosomal RNA genes. It also includes nine small intergene spacers, and a large AT-rich intergenic spacer. The intra-specific divergence analysis revealed that COX1 has the lower genetic differentiation, while the most divergent genes were NADH1, NADH3 and NADH4. With the exception of Euhadra herklotsi, the structural comparisons showed the same gene order within the family Helicidae, and nearly identical gene organization to that found in order Pulmonata. Phylogenetic reconstruction recovered Basommatophora as polyphyletic group, whereas Eupulmonata and Pulmonata as paraphyletic groups. Bayesian and Maximum Likelihood analyses showed that C. aspersum is a close relative of Cepaea nemoralis, and with the other Helicidae species form a sister group of Albinaria caerulea, supporting the monophyly of the Stylommatophora clade.	[Diego Gaitan-Espitia, Juan; Nespolo, Roberto F.; Opazo, Juan C.] Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Diego Gaitan-Espitia, Juan] Univ Austral Chile, Fac Ciencias, Programa Doctorado Ciencias Menc Ecol & Evoluc, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile	Opazo, JC (corresponding author), Univ Austral Chile, Inst Ciencias Ambientales & Evolut, Valdivia, Chile.	jopazo@gmail.com	Gaitan-Espitia, Juan Diego/A-9945-2012; Nespolo, Roberto/D-5601-2015; Nespolo, Roberto/D-5601-2015	Gaitan-Espitia, Juan Diego/0000-0001-8781-5736; Nespolo, Roberto/0000-0001-9337-0606; Opazo, Juan C./0000-0001-7938-4083; Nespolo, Roberto/0000-0003-0825-9618	Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1090423]; CONICYT Chile	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was funded by a grant to RFN from the Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1090423). JDGE was supported by a doctoral fellowship from CONICYT Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2001, BIOL TERRESTRIAL MOL; Arnaud JF, 2003, HEREDITY, V90, P451, DOI 10.1038/sj.hdy.6800256; Artacho P, 2006, INTEGR COMP BIOL, V46, pE167; Barker G.M., 2001, P1, DOI 10.1079/9780851993188.0001; Blier PU, 2006, J EXP ZOOL PART B, V306B, P425, DOI 10.1002/jez.b.21089; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Brown W.M., 1985, MOL EVOLUTIONARY GEN, P399; Carlini DB, 1999, B MAR SCI, V64, P57; Dayrat B, 2002, ZOOL J LINN SOC-LOND, V135, P403, DOI 10.1046/j.1096-3642.2002.00018.x; Dayrat B, 2011, MOL PHYLOGENET EVOL, V59, P425, DOI 10.1016/j.ympev.2011.02.014; Gaitan-Espitia JD, 2013, EVOL ECOL RES, V15, P61; Gaitan-Espitia JD, 2013, COMP BIOCHEM PHYS A, V165, P169, DOI 10.1016/j.cbpa.2013.03.002; Dreyer H, 2004, MOL PHYLOGENET EVOL, V31, P605, DOI 10.1016/j.ympev.2003.08.007; Drummond AJ, 2010, GENEIOUS; Grande C, 2004, MOL BIOL EVOL, V21, P303, DOI 10.1093/molbev/msh016; Grande C, 2002, MOL BIOL EVOL, V19, P1672, DOI 10.1093/oxfordjournals.molbev.a003990; Grande C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-61; Groenenberg DSJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-114; Guiller A, 2001, MOL ECOL, V10, P81, DOI 10.1046/j.1365-294X.2001.01145.x; Guiller A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-18; HATZOGLOU E, 1995, GENETICS, V140, P1353; Jorger KM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-323; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kilpert F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-241; Klussmann-Kolb A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-57; Knudsen B, 2006, MOL PHYLOGENET EVOL, V38, P459, DOI 10.1016/j.ympev.2005.08.017; Kurabayashi A, 2000, MOL BIOL EVOL, V17, P266, DOI 10.1093/oxfordjournals.molbev.a026306; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Madison W., 2005, MACCLADE 4 ANAL PHYL; McArthur AG, 2003, SM S COMP E, P140; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Naya DE, 2011, EVOL ECOL RES, V13, P647; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Oliveira DCSG, 2008, MOL BIOL EVOL, V25, P2167, DOI 10.1093/molbev/msn159; Peltanova A, 2012, BIOL INVASIONS, V14, P759, DOI 10.1007/s10530-011-0121-9; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Ray DA, 2002, J EXP ZOOL, V294, P334, DOI 10.1002/jez.10198; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roth B., 2006, CHECKLIST LAND SNAIL, V3; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Scheffler IE, 2008, MITOCHONDRIA, 2NDEDITION, P1; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Simison W. Brian, 2008, P447; Simison WB, 2006, MOL PHYLOGENET EVOL, V39, P562, DOI 10.1016/j.ympev.2005.11.006; Smietanka B, 2010, J MOL EVOL, V71, P385, DOI 10.1007/s00239-010-9393-4; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Villani G, 2000, FREE RADICAL BIO MED, V29, P202, DOI 10.1016/S0891-5849(00)00303-8; Wade CM, 2000, J MOLLUS STUD, V66, P565, DOI 10.1093/mollus/66.4.565; Wade CM, 2006, BIOL J LINN SOC, V87, P593, DOI 10.1111/j.1095-8312.2006.00596.x; Wade CM, 2001, P ROY SOC B-BIOL SCI, V268, P413, DOI 10.1098/rspb.2000.1372; White TR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-295; Wirth T, 1999, MOL BIOL EVOL, V16, P1645, DOI 10.1093/oxfordjournals.molbev.a026078; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yamazaki N, 1997, GENETICS, V145, P749	58	31	31	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67299	10.1371/journal.pone.0067299	http://dx.doi.org/10.1371/journal.pone.0067299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826260	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400129
J	Huys, A; Thibault, PA; Wilson, JA				Huys, Adam; Thibault, Patricia A.; Wilson, Joyce A.			Modulation of Hepatitis C Virus RNA Accumulation and Translation by DDX6 and miR-122 Are Mediated by Separate Mechanisms	PLOS ONE			English	Article							MESSENGER-RNA; P-BODY; PROCESSING BODIES; INFECTIOUS VIRUS; STRESS GRANULES; CELL-LINES; REPLICATION; MICRORNA; HELICASE; COMPONENTS	DDX6 and other P-body proteins are required for efficient replication of Hepatitis C Virus (HCV) by unknown mechanisms. DDX6 has been implicated in miRNA induced gene silencing, and since efficient HCV replication and translation relies on the cellular microRNA, miR-122, we hypothesized that DDX6 had a role in the mechanism of action of miR-122. However, by using multiple HCV translation and replication assays we have found this is not the case. DDX6 silencing decreased HCV replication and translation, but did not affect the ability of miR-122 to stimulate HCV translation or promote HCV RNA accumulation. In addition, the negative effect of DDX6 silencing on HCV replication and translation was not dependent on miR-122 association with the HCV genome. Thus, DDX6 does not have a role in the activity of miR-122, and it appears that DDX6 and miR-122 modulate HCV through distinct pathways. This effect was seen in both Huh7.5 cells and in Hep3B cells, indicating that the effects are not cell type specific. Since infections by other viruses in the Flaviviridae family, including Dengue and West Nile Virus, also disrupt P-bodies and are regulated by DDX6, we speculate that DDX6 may have a common function that support the replication of several Flaviviruses.	[Huys, Adam; Thibault, Patricia A.; Wilson, Joyce A.] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada; [Huys, Adam; Thibault, Patricia A.; Wilson, Joyce A.] Univ Saskatchewan, Vaccine & Infect Dis Org Int Vaccine Ctr VIDO Int, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Wilson, JA (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada.	joyce.wilson@usask.ca	Thibault, Patricia A./K-1570-2015	Thibault, Patricia A./0000-0002-7313-0848; Wilson, Joyce/0000-0002-5051-3088	University of Saskatchewan College of Graduate Studies; Department of Microbiology and Immunology; NSERC; National CIHR Research Training Program in Hepatitis C virus (NCRTP17 HepC); University of Saskatchewan; National Science and Engineering Research Foundation [RGPIN-342475]; Saskatchewan Health Research Foundation, (RAPID)	University of Saskatchewan College of Graduate Studies; Department of Microbiology and Immunology; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); National CIHR Research Training Program in Hepatitis C virus (NCRTP17 HepC)(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; National Science and Engineering Research Foundation; Saskatchewan Health Research Foundation, (RAPID)	A.H. acknowledges the University of Saskatchewan College of Graduate Studies, and the Department of Microbiology and Immunology for funding. P.A.T. would also like to acknowledge the NSERC and the National CIHR Research Training Program in Hepatitis C virus (NCRTP17 HepC) for masters and doctoral scholarships. J.A.W. acknowledges funding provided by the University of Saskatchewan, National Science and Engineering Research Foundation (RGPIN-342475) and Saskatchewan Health Research Foundation, (RAPID 1927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariumi Y, 2011, J VIROL, V85, P6882, DOI 10.1128/JVI.02418-10; Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004; Beckham CJ, 2007, J VIROL, V81, P9759, DOI 10.1128/JVI.00844-07; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Braun JE, 2013, ADV EXP MED BIOL, V768, P147, DOI 10.1007/978-1-4614-5107-5_9; Chahar HS, 2013, VIROLOGY, V436, P1, DOI 10.1016/j.virol.2012.09.041; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104; Ernoult-Lange M, 2012, RNA, V18, P1702, DOI 10.1261/rna.034314.112; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eystathioy T, 2003, HYBRIDOMA HYBRIDOM, V22, P79, DOI 10.1089/153685903321947996; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Jangra RK, 2010, J VIROL, V84, P6810, DOI 10.1128/JVI.00397-10; Jangra RK, 2010, J VIROL, V84, P6615, DOI 10.1128/JVI.00417-10; Jones CT, 2007, J VIROL, V81, P8374, DOI 10.1128/JVI.00690-07; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Jopling CL, 2008, BIOCHEM SOC T, V36, P1220, DOI 10.1042/BST0361220; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kato T, 2005, J CLIN MICROBIOL, V43, P5679, DOI 10.1128/JCM.43.11.5679-5684.2005; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Larsen LSZ, 2008, J VIROL, V82, P2501, DOI 10.1128/JVI.01814-07; Li Y, 2013, P NATL ACAD SCI USA, V110, P1881, DOI 10.1073/pnas.1213515110; Lohmann V, 2003, J VIROL, V77, P3007, DOI 10.1128/JVI.77.5.3007-3019.2003; Machlin ES, 2011, P NATL ACAD SCI USA, V108, P3193, DOI 10.1073/pnas.1012464108; Mas A, 2006, J VIROL, V80, P246, DOI 10.1128/JVI.80.1.246-251.2006; Minshall N, 2009, MOL BIOL CELL, V20, P2464, DOI 10.1091/mbc.E09-01-0035; Miyaji K, 2003, J VIRAL HEPATITIS, V10, P241, DOI 10.1046/j.1365-2893.2003.00447.x; Naarmann IS, 2010, RNA, V16, P2189, DOI 10.1261/rna.2211110; Pager CT, 2013, VIROLOGY, V435, P472, DOI 10.1016/j.virol.2012.10.027; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Perez-Vilaro G, 2012, J VIROL, V86, P8740, DOI 10.1128/JVI.07167-11; Roberts APE, 2011, NUCLEIC ACIDS RES, V39, P7716, DOI 10.1093/nar/gkr426; Sainz B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006561; Scheller N, 2009, P NATL ACAD SCI USA, V106, P13517, DOI 10.1073/pnas.0906413106; Serman A, 2007, NUCLEIC ACIDS RES, V35, P4715, DOI 10.1093/nar/gkm491; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Sweet T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001342; Thibault PA, 2013, VIROLOGY, V436, P179, DOI 10.1016/j.virol.2012.11.007; Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836; Wilson JA, 2011, J VIROL, V85, P2342, DOI 10.1128/JVI.02046-10; Yao B, 2011, METHODS MOL BIOL, V725, P45, DOI 10.1007/978-1-61779-046-1_4; Yu SF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002303; Zhang C, 2012, VIROLOGY, V433, P479, DOI 10.1016/j.virol.2012.08.039	47	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67437	10.1371/journal.pone.0067437	http://dx.doi.org/10.1371/journal.pone.0067437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826300	Green Submitted, gold, Green Published			2022-12-27	WOS:000321738400147
J	Mikaelsson, E; Osterborg, A; Jeddi-Tehrani, M; Kokhaei, P; Ostadkarampour, M; Hadavi, R; Gholamin, M; Akhondi, M; Shokri, F; Rabbani, H; Mellstedt, H				Mikaelsson, Eva; Osterborg, Anders; Jeddi-Tehrani, Mahmood; Kokhaei, Parviz; Ostadkarampour, Mahyar; Hadavi, Reza; Gholamin, Mehran; Akhondi, Mehdi; Shokri, Fazel; Rabbani, Hodjattallah; Mellstedt, Hakan			A Proline/Arginine-Rich End Leucine-Rich Repeat Protein (PRELP) Variant Is Uniquely Expressed in Chronic Lymphocytic Leukemia Cells	PLOS ONE			English	Article							GENE-EXPRESSION; MATRIX PROTEIN; FIBROMODULIN; BINDS	Proline/arginine-rich end leucine-rich repeat protein (PRELP) belongs to the small leucine-rich proteoglycan (SLRP) family, normally expressed in extracellular matrix of collagen-rich tissues. We have previously reported on another SLRP, fibromodulin (FMOD) in patients with chronic lymphocytic leukemia (CLL). PRELP is structurally similar to FMOD with adjacent localization on chromosome 1 (1q32.1). As cluster-upregulation of genes may occur in malignancies, the aim of our study was to analyze PRELP expression in CLL. PRELP was expressed (RT-PCR) in all CLL patients (30/30), as well as in some patients with mantle cell lymphoma (3/5), but not in healthy donor leukocytes (0/20) or tumor samples from other hematological malignancies (0/35). PRELP was also detected in CLL cell-lines (4/4) but not in cell-lines from other hematological tumors (0/9). PRELP protein was detected in all CLL samples but not in normal leukocytes. Deglycosylation experiments revealed a CLL-unique 38 kDa core protein, with an intact signal peptide. This 38 kDa protein was, in contrast to the normal 55 kDa size, not detected in serum which, in combination with the uncleaved signal peptide, suggests cellular retention. The unique expression of a 38 kDa PRELP in CLL cells may suggest involvement in the pathobiology of CLL and merits further studies.	[Mikaelsson, Eva; Osterborg, Anders; Jeddi-Tehrani, Mahmood; Kokhaei, Parviz; Mellstedt, Hakan] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Immune & Gene Therapy Lab, Stockholm, Sweden; [Osterborg, Anders; Mellstedt, Hakan] Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden; [Osterborg, Anders; Mellstedt, Hakan] Karolinska Univ Hosp Solna, Dept Oncol, Stockholm, Sweden; [Jeddi-Tehrani, Mahmood; Ostadkarampour, Mahyar; Hadavi, Reza; Shokri, Fazel; Rabbani, Hodjattallah] ACECR, Avicenna Res Inst, Monoclonal Antibody Res Ctr, Tehran, Iran; [Kokhaei, Parviz] Semnan Univ Med Sci, Dept Immunol, Semnan, Iran; [Gholamin, Mehran] Mashhad Univ Med Sci, Sch Med, Human Genet Lab, Immunol Res Ctr, Mashhad, Iran; [Akhondi, Mehdi] ACECR, Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran; [Shokri, Fazel] Univ Tehran Med Sci, Sch Publ Hlth, Dept Immunol, Tehran, Iran	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Academic Center for Education, Culture & Research (ACECR); Semnan University of Medical Sciences; Mashhad University Medical Science; Academic Center for Education, Culture & Research (ACECR); Tehran University of Medical Sciences	Mikaelsson, E (corresponding author), Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Immune & Gene Therapy Lab, Stockholm, Sweden.	eva.mikaelsson@ki.se	Jeddi-Tehrani, Mahmood/HDM-1013-2022; kokhaei, parviz/I-5326-2017; gholamin, mehran/O-2519-2018	gholamin, mehran/0000-0002-0123-5755; Asgari, Mohammad Reza/0000-0003-0263-7614; Kokhaei, Parviz/0000-0001-6544-4209; Akhondi, Mohammad mehdi/0000-0003-1707-3874; Jeddi-Tehrani, Mahmood/0000-0002-8831-4711	Swedish Cancer Society; Stockholm County Council; Torsten and Ragnar Soderberg Foundation; Cancer Society in Stockholm; King Gustaf V Jubilee Fund; Cancer and Allergy Foundation; Swedish Research Council/SIDA/SAREC; Felix Mindus Research Foundation; EU-grant [EUCAAD-200755]; Iranian Ministry of Health and Medical Education; Karolinska Institute Foundations	Swedish Cancer Society(Swedish Cancer Society); Stockholm County Council(Stockholm County Council); Torsten and Ragnar Soderberg Foundation; Cancer Society in Stockholm; King Gustaf V Jubilee Fund; Cancer and Allergy Foundation; Swedish Research Council/SIDA/SAREC; Felix Mindus Research Foundation; EU-grant; Iranian Ministry of Health and Medical Education; Karolinska Institute Foundations(Karolinska Institutet)	The study was supported by grants from the Swedish Cancer Society, the Stockholm County Council, the Torsten and Ragnar Soderberg Foundation, the Cancer Society in Stockholm, the King Gustaf V Jubilee Fund, the Cancer and Allergy Foundation, the Swedish Research Council/SIDA/SAREC, Felix Mindus Research Foundation, EU-grant (EUCAAD-200755) the Iranian Ministry of Health and Medical Education, the Cancer and Allergy Foundation, and the Karolinska Institute Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639; Bengtsson E, 2002, J BIOL CHEM, V277, P15061, DOI 10.1074/jbc.M108285200; Bengtsson E, 2000, J BIOL CHEM, V275, P40695, DOI 10.1074/jbc.M007917200; DaneshManesh AH, 2008, INT J CANCER, V123, P1190, DOI 10.1002/ijc.23587; Drexler HG., 2001, LEUKEMIA LYMPHOMA CE, P2, DOI [10.1016/B978-012221970-2/50002-4, DOI 10.1016/B978-012221970-2/50002-4]; Edge ASB, 2003, BIOCHEM J, V376, P339, DOI 10.1042/BJ20030673; FERREIRA A, 1989, DEV BRAIN RES, V49, P215, DOI 10.1016/0165-3806(89)90023-0; Grover J, 1996, GENOMICS, V38, P109, DOI 10.1006/geno.1996.0605; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Harris N. L., 2000, Histopathology (Oxford), V36, P69; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lu YP, 2002, PATHOL INT, V52, P519, DOI 10.1046/j.1440-1827.2002.01384.x; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Mikaelsson E, 2005, BLOOD, V105, P4828, DOI 10.1182/blood-2004-10-3941; Rufo A, 2008, BONE, V42, pS39, DOI 10.1016/j.bone.2007.12.062; SZTROLOVICS R, 1994, GENOMICS, V23, P715, DOI 10.1006/geno.1994.1567; WENDELHANSEN V, 1994, LEUKEMIA, V8, P476	18	9	10	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67601	10.1371/journal.pone.0067601	http://dx.doi.org/10.1371/journal.pone.0067601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826326	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400162
J	Wang, XJ; Misawa, R; Zielinski, MC; Cowen, P; Jo, JH; Periwal, V; Ricordi, C; Khan, A; Szust, J; Shen, JH; Millis, M; Witkowski, P; Hara, M				Wang, Xiaojun; Misawa, Ryosuke; Zielinski, Mark C.; Cowen, Peter; Jo, Junghyo; Periwal, Vipul; Ricordi, Camillo; Khan, Aisha; Szust, Joel; Shen, Junhui; Millis, Michael; Witkowski, Piotr; Hara, Manami			Regional Differences in Islet Distribution in the Human Pancreas - Preferential Beta-Cell Loss in the Head Region in Patients with Type 2 Diabetes	PLOS ONE			English	Article							RAT; MASS; QUANTIFICATION; ARCHITECTURE; POLYPEPTIDE; INSULIN; CANCER; SECRETION; GLUCAGON; SURVIVAL	While regional heterogeneity in islet distribution has been well studied in rodents, less is known about human pancreatic histology. To fill gaps in our understanding, regional differences in the adult human pancreas were quantitatively analyzed including the pathogenesis of type 2 diabetes (T2D). Cadaveric pancreas specimens were collected from the head, body and tail regions of each donor, including subjects with no history of diabetes or pancreatic diseases (n = 23) as well as patients with T2D (n = 12). The study further included individuals from whom islets were isolated (n = 7) to study islet yield and function in a clinical setting of islet transplantation. The whole pancreatic sections were examined using an innovative large-scale image capture and unbiased detailed quantitative analyses of the characteristics of islets from each individual (architecture, size, shape and distribution). Islet distribution/density is similar between the head and body regions, but is >2-fold higher in the tail region. In contrast to rodents, islet cellular composition and architecture were similar throughout the pancreas and there was no difference in glucose-stimulated insulin secretion in islets isolated from different regions of the pancreas. Further studies revealed preferential loss of large islets in the head region in patients with T2D. The present study has demonstrated distinct characteristics of the human pancreas, which should provide a baseline for the future studies integrating existing research in the field and helping to advance bi-directional research between humans and preclinical models.	[Wang, Xiaojun; Misawa, Ryosuke; Millis, Michael; Witkowski, Piotr] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Wang, Xiaojun] Third Mil Med Univ, Southwest Hosp, Inst Hepatobiliary Surg, Chongqing, Peoples R China; [Zielinski, Mark C.; Cowen, Peter; Shen, Junhui; Hara, Manami] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Jo, Junghyo; Periwal, Vipul] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD USA; [Ricordi, Camillo; Khan, Aisha; Szust, Joel] Univ Miami, Cell Transplant Ctr, Miami, FL USA	University of Chicago; Army Medical University; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Miami	Hara, M (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	mhara@uchicago.edu	Hara, Masayuki/AAH-4361-2019; RICORDI, CAMILLO/AAA-4740-2019; Jo, Junghyo/D-4889-2011	Ricordi, Camillo/0000-0001-8092-7153; Zielinski, Mark/0000-0002-6950-6689	US Public Health Service Grant [DK-020595, DK-072473, AG-042151]; intramural research program of the NIH, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, P60DK020595, ZIADK075038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG042151] Funding Source: NIH RePORTER	US Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); intramural research program of the NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study is supported by US Public Health Service Grant DK-020595 to the University of Chicago Diabetes Research and Training Center (Animal Models Core), DK-072473, AG-042151, and a gift from the Kovler Family Foundation (to MH); and the intramural research program of the NIH, NIDDK (to JJ and VP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000035; Artinyan A, 2008, HPB, V10, P371, DOI 10.1080/13651820802291233; BAETENS D, 1979, SCIENCE, V206, P1323, DOI 10.1126/science.390711; Bartosch-Harlid A, 2010, PANCREATOLOGY, V10, P423, DOI 10.1159/000264676; Bouvier AM, 2010, PANCREAS, V39, P1243, DOI 10.1097/MPA.0b013e3181e1d5b3; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Chandra J, 2012, CLIN RADIOL     0703, V3; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; ELAYAT AA, 1995, J ANAT, V186, P629; GERSELL DJ, 1979, DIABETES, V28, P11, DOI 10.2337/diabetes.28.1.11; Henquin JC, 2011, DIABETOLOGIA, V54, P1720, DOI 10.1007/s00125-011-2118-4; Hornblad A, 2011, ISLETS, V3, P204, DOI 10.4161/isl.3.4.16417; Ichii H, 2005, AM J TRANSPLANT, V5, P1635, DOI 10.1111/j.1600-6143.2005.00913.x; Kharouta M, 2009, DIABETES RES CLIN PR, V85, P252, DOI 10.1016/j.diabres.2009.06.021; Kilimnik G, 2012, ISLETS, V4, P167, DOI 10.4161/isl.19256; Kilimnik G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027445; Kilimnik G, 2009, AM J PHYSIOL-ENDOC M, V297, pE1331, DOI 10.1152/ajpendo.00479.2009; Kim A, 2011, JOVE-J VIS EXP, DOI 10.3791/2471; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; Lau MK, 2010, PANCREAS, V39, P458, DOI 10.1097/MPA.0b013e3181bd6489; LECLERCQMEYER V, 1985, HORM RES, V21, P19, DOI 10.1159/000180021; Li DH, 2012, MOL CARCINOGEN, V51, P64, DOI 10.1002/mc.20771; MALAISSELAGAE F, 1979, DIABETOLOGIA, V17, P361, DOI 10.1007/BF01236270; Miller K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007739; Nathan H, 2009, J SURG ONCOL, V99, P87, DOI 10.1002/jso.21189; ORCI L, 1978, LANCET, V2, P1200; R Development Core Team, 2011, R LANG ENV STAT COMP; RAHIER J, 1983, J CLIN ENDOCR METAB, V56, P441, DOI 10.1210/jcem-56-3-441; RAHIER J, 1983, DIABETOLOGIA, V24, P366; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Sata N, 2009, J HEPATO-BILIARY-PAN, V16, P485, DOI 10.1007/s00534-009-0077-7; STEFAN Y, 1982, DIABETES, V31, P694, DOI 10.2337/diabetes.31.8.694; Steiner DJ, 2010, ISLETS, V2, P135, DOI 10.4161/isl.2.3.11815; TASAKA Y, 1989, TOHOKU J EXP MED, V159, P123, DOI 10.1620/tjem.159.123; TRIMBLE ER, 1981, AM J PHYSIOL, V240, pE422, DOI 10.1152/ajpendo.1981.240.4.E422; TRIMBLE ER, 1982, J CLIN INVEST, V69, P405, DOI 10.1172/JCI110464; Wang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055501; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Yukawa M, 1999, ANAT HISTOL EMBRYOL, V28, P13, DOI 10.1046/j.1439-0264.1999.00148.x	41	101	103	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67454	10.1371/journal.pone.0067454	http://dx.doi.org/10.1371/journal.pone.0067454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826303	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400149
J	Li, H; Li, N; Xu, Q; Xiao, CL; Wang, HC; Guo, Z; Zhang, J; Sun, XS; He, QY				Li, Hui; Li, Nan; Xu, Qian; Xiao, Chuanle; Wang, Hongcui; Guo, Zhong; Zhang, Jing; Sun, Xuesong; He, Qing-Yu			Lipoprotein FtsB in Streptococcus pyogenes Binds Ferrichrome in Two Steps with Residues Tyr137 and Trp204 as Critical Ligands	PLOS ONE			English	Article							IRON TRANSPORT; PROTEIN FHUD; SIDEROPHORE; MANGANESE; MTSABC	Lipoprotein FtsB is a component of the FtsABCD transporter that is responsible for ferrichrome binding and uptake in the Gram-positive pathogen Streptococcus pyogenes. In the present study, FtsB was cloned and purified from the bacteria and its Fch binding characteristics were investigated in detail by using various biophysical and biochemical methods. Based on the crystal structures of homogeneous proteins, FtsB was simulated to have bi-lobal structure forming a deep cleft with four residues in the cleft as potential ligands for Fch binding. With the assistance of site-directed mutagenesis, residue Trp204 was confirmed as a key ligand and Tyr137 was identified to be another essential residue for Fch binding. Kinetics experiments demonstrated that Fch binding in FtsB occurred in two steps, corresponding to the bindings to Tyr137 at N-lobe and Trp204 from C-lobe, respectively, and so that closing the protein conformation. Without either residue Tyr137 or Trp204, Fch binding in the protein as mutants Fch-Y137A and Fch-W204A may have a loose conformation, resembling the apo-proteins in proteolysis resistance and migration behaviors in native gel. This study revealed the inconsistence in the key amino acids among Fch-binding proteins from Gram-positive and -negative bacteria, providing interesting findings for understanding the differences between Gram-positive and -negative bacteria in the mechanism of iron uptake via siderophore (Fch) binding and transport.	[Li, Hui; Li, Nan; Xu, Qian; Xiao, Chuanle; Wang, Hongcui; Guo, Zhong; Zhang, Jing; Sun, Xuesong; He, Qing-Yu] Jinan Univ, Coll Life Sci & Technol, Inst Life & Hlth Engn, Key Lab Funct Prot Res,Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China	Jinan University	Sun, XS (corresponding author), Jinan Univ, Coll Life Sci & Technol, Inst Life & Hlth Engn, Key Lab Funct Prot Res,Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China.	tsunxs@jnu.edu.cn; tqyhe@jnu.edu.cn	He, Qing-Yu/H-7078-2014	He, Qing-Yu/0000-0003-0503-9492	National Natural Science Foundation of China [21271086, 31000373]; Guangdong Natural Science Research Grant [32209003, 10451063201005247]; Fundamental Research Funds for the Central Universities [11610101, 21611201]; Pearl River Rising Star of Science and Technology of Guangzhou City [2011J2200003]; National Program on Key Basic Research Project (973 Program) [2011CB910701]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Research Grant; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Pearl River Rising Star of Science and Technology of Guangzhou City; National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (21271086, to QYH; 31000373, to XS) Guangdong Natural Science Research Grant (32209003, to QYH; 10451063201005247 to QYH), the Fundamental Research Funds for the Central Universities (11610101 to QYH; 21611201, to XS), the Pearl River Rising Star of Science and Technology of Guangzhou City (2011J2200003, to XS) and National Program on Key Basic Research Project (973 Program, 2011CB910701, to XS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Andrews SC, 1998, ADV MICROB PHYSIOL, V40, P281, DOI 10.1016/S0065-2911(08)60134-4; Chu BC, 2010, BIOMETALS, V23, P601, DOI 10.1007/s10534-010-9361-x; Chu BCH, 2011, BIOL CHEM, V392, P39, DOI 10.1515/BC.2011.012; Clarke TE, 2000, NAT STRUCT BIOL, V7, P287; Clarke TE, 2002, BIOMETALS, V15, P121, DOI 10.1023/A:1015249530156; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Hanks TS, 2006, INFECT IMMUN, V74, P5132, DOI 10.1128/IAI.00176-06; Hanks TS, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-62; Higgins CF, 2001, SCIENCE, V293, P1782, DOI 10.1126/science.1065588; Huang HY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002691; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; Klein JS, 2011, METALLOMICS, V3, P1098, DOI 10.1039/c1mt00073j; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Nies D., 2007, MOL MICROBIOLOGY HEA, P189, DOI DOI 10.1007/7171; Raymond KN, 2004, BIOCH PHYS PROPERTIE, P3; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sun XS, 2009, J INORG BIOCHEM, V103, P1074, DOI 10.1016/j.jinorgbio.2009.05.004; Sun XS, 2009, BIOCHEMISTRY-US, V48, P6184, DOI 10.1021/bi900552c; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811	22	7	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65682	10.1371/journal.pone.0065682	http://dx.doi.org/10.1371/journal.pone.0065682			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840354	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800016
J	Fisher, SA; Doree, C; Brunskill, SJ; Mathur, A; Martin-Rendon, E				Fisher, Sheila A.; Doree, Carolyn; Brunskill, Susan J.; Mathur, Anthony; Martin-Rendon, Enca			Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							MONONUCLEAR-CELLS; DOUBLE-BLIND; TRANSENDOCARDIAL INJECTION; TRANSPLANTATION; FAILURE; THERAPY; DELIVERY	Objective: To evaluate bone marrow stem cell treatment (BMSC) in patients with ischemic heart disease (IHD) and no option of revascularization. Background: Autologous BMSC therapy has emerged as a novel approach to treat patients with acute myocardial infarction or chronic ischemia and heart failure following percutaneous or surgical revascularization, respectively. However, the effect of the treatment has not been systematic evaluated in patients who are not eligible for revascularization. Methods: MEDLINE (1950-2012), EMBASE (1980-2012), CENTRAL (The Cochrane Library 2012, Issue 8) and ongoing trial databases were searched for relevant randomized controlled trials. Trials where participants were diagnosed with IHD, with no option for revascularization and who received any dose of stem cells by any delivery route were selected for inclusion. Study and participant characteristics, details of the intervention and comparator, and outcomes measured were recorded by two reviewers independently. Primary outcome measures were defined as mortality and measures of angina; secondary outcomes were heart failure, quality of life measures, exercise/performance and left ventricular ejection fraction (LVEF). Results: Nine trials were eligible for inclusion. BMSC treatment significantly reduced the risk of mortality (Relative Risk 0.33; 95% Confidence Interval 0.17 to 0.65; P = 0.001). Patients who received BMSC showed a significantly greater improvement in CCS angina class (Mean Difference -0.55; 95% Confidence Interval -1.00 to -0.10; P = 0.02) and significantly fewer angina episodes per week at the end of the trial (Mean Difference -5.21; 95% Confidence Interval -7.35 to -3.07; P < 0.00001) than those who received no BMSC. In addition, the treatment significantly improved quality of life, exercise/performance and LVEF in these patients. Conclusions: BMSC treatment has significant clinical benefit as stand-alone treatment in patients with IHD and no other treatment option. These results require confirmation in large well-powered trials with long-term follow-up to fully evaluate the clinical efficacy of this treatment.	[Fisher, Sheila A.; Doree, Carolyn; Brunskill, Susan J.] John Radcliffe Hosp, Systemat Review Initiat, NHS Blood & Transplant, Oxford OX3 9DU, England; [Fisher, Sheila A.; Doree, Carolyn; Brunskill, Susan J.; Martin-Rendon, Enca] Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford, England; [Mathur, Anthony] Queen Mary Univ London, CV Biomed Res Unit, Barts & London Sch Med & Dent, London, England; [Martin-Rendon, Enca] John Radcliffe Hosp, NHS Blood & Transplant, Stem Cell Res Lab, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of London; Queen Mary University London; University of Oxford	Martin-Rendon, E (corresponding author), Univ Oxford, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford, England.	enca.rendon@ndcls.ox.ac.uk	Martin-Rendon, Enca/K-6457-2016	Doree, Carolyn/0000-0001-6955-7497; MAthur, Anthony/0000-0001-7941-9653	National Health Service Blood and Transplant (NHSBT); National Institute for Health Research (NIHR) [RP-PG-0310-1001]; Oxford Biomedical Research Centre Programme	National Health Service Blood and Transplant (NHSBT); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Oxford Biomedical Research Centre Programme	This research was supported by the National Health Service Blood and Transplant (NHSBT), the National Institute for Health Research (NIHR), Oxford Biomedical Research Centre Programme (SAF, CD and SJB), and the NIHR under its Programme Grant Scheme (RP-PG-0310-1001, EMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; [Anonymous], 2011, REV MAN REVMAN COMP; Bartunek J, 2011, C CURE MULTICENTER T; Brunskill SJ, 2009, EUR J HEART FAIL, V11, P887, DOI 10.1093/eurjhf/hfp101; Clifford DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037373; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; Hendrikx M, 2006, CIRCULATION, V114, pI101, DOI 10.1161/CIRCULATIONAHA.105.000505; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hu SS, 2011, J AM COLL CARDIOL, V57, P2409, DOI 10.1016/j.jacc.2011.01.037; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Martin-Rendon E, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub2; Oldridge N, 2002, Monaldi Arch Chest Dis, V58, P10; Patel AN, 2005, J THORAC CARDIOV SUR, V130, P1631, DOI 10.1016/j.jtcvs.2005.07.056; Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B; Perin EC, 2012, JAMA-J AM MED ASSOC, V307, P1717, DOI 10.1001/jama.2012.418; Perin EC, 2012, AM HEART J, V163, P415, DOI 10.1016/j.ahj.2011.11.020; Perin EC, 2011, AM HEART J, V161, P1078, DOI 10.1016/j.ahj.2011.01.028; Pokushalov E, 2010, J CARDIOVASC TRANSL, V3, P160, DOI 10.1007/s12265-009-9123-8; Strauer BE, 2005, J AM COLL CARDIOL, V46, P1651, DOI 10.1016/j.jacc.2005.01.069; Tse HF, 2007, EUR HEART J, V28, P2998, DOI 10.1093/eurheartj/ehm485; van Ramshorst J, 2011, CIRC-CARDIOVASC IMAG, V4, P122, DOI 10.1161/CIRCIMAGING.110.957548; van Ramshorst J, 2009, JAMA-J AM MED ASSOC, V301, P1997, DOI 10.1001/jama.2009.685; Wang SH, 2010, CARDIOLOGY, V117, P140, DOI 10.1159/000320217; Willerson JT, 2010, AM HEART J, V160, P215, DOI 10.1016/j.ahj.2010.03.029; Zhao Q, 2008, ANN THORAC SURG, V86, P1833, DOI 10.1016/j.athoracsur.2008.08.068	29	65	73	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e64669	10.1371/journal.pone.0064669	http://dx.doi.org/10.1371/journal.pone.0064669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840302	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200003
J	Kernbauer, E; Maier, V; Rauch, I; Muller, M; Decker, T				Kernbauer, Elisabeth; Maier, Verena; Rauch, Isabella; Mueller, Mathias; Decker, Thomas			Route of Infection Determines the Impact of Type I Interferons on Innate Immunity to Listeria monocytogenes	PLOS ONE			English	Article							SUPPRESS MACROPHAGE ACTIVATION; IFN; MICE; INDUCTION; RESISTANT; APOPTOSIS; SUSCEPTIBILITY; LYMPHOCYTES; INTERNALIN; INVASION	Listeria monocytogenes is a food-borne pathogen which causes mild to life threatening disease in humans. Ingestion of contaminated food delivers the pathogen to the gastrointestinal tract, where it crosses the epithelial barrier and spreads to internal organs. Type I interferons (IFN-I) are produced during infection and decrease host resistance after systemic delivery of L. monocytogenes. Here we show that mice benefit from IFN-I production following infection with L. monocytogenes via the gastrointestinal route. Intragastric infection lead to increased lethality of IFN-I receptor chain 1-deficient (Ifnar1-/-) animals and to higher bacterial numbers in liver and spleen. Compared to infection from the peritoneum, bacteria infecting via the intestinal tract localized more often to periportal and pericentral regions of the liver and less frequently to the margins of liver lobes. Vigorous replication of intestine-borne L. monocytogenes in the livers of Ifnar1-/- mice 48 h post infection was accompanied by the formation of large inflammatory infiltrates in this organ and massive death of surrounding hepatocytes. This was not observed in Ifnar1-/- mice after intraperitoneal infection. The inflammatory response to infection is shaped by alterations in splenic cytokine production, particularly IFN gamma, which differs after intragastric versus intraperitoneal infection. Taken together, our data suggest that the adverse or beneficial role of a cytokine may vary with the route of infection and that IFN-I are not harmful when infection with L. monocytogenes occurs via the natural route.	[Kernbauer, Elisabeth; Maier, Verena; Rauch, Isabella; Decker, Thomas] Univ Vienna, Max F Perutz Labs, Vienna, Austria; [Mueller, Mathias] Univ Vet Med Vienna, Inst Anim Breeding & Genet, Vienna, Austria; [Mueller, Mathias] Univ Vet Med Vienna, Biomodels Austria, Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Decker, T (corresponding author), Univ Vienna, Max F Perutz Labs, Vienna, Austria.	thomas.decker@univie.ac.at	Rauch, Isabella/AAN-6495-2020	Rauch, Isabella/0000-0003-1897-5693; Muller, Mathias/0000-0002-7879-3552	Austrian Science Foundation [SFB-28]; Austrian Science Fund (FWF) [F 2803] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Foundation through SFB-28 to TD and MM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; BUKHOLM G, 1984, INFECT IMMUN, V45, P62, DOI 10.1128/IAI.45.1.62-66.1984; Cabanes D, 2008, CURR PROTOC MICROBIO, V9; Carrero JA, 2006, J EXP MED, V203, P933, DOI 10.1084/jem.20060045; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Carrero JA, 2007, IMMUNOL RES, V38, P333, DOI 10.1007/s12026-007-0017-z; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Chiba S, 2011, MICROBIOL IMMUNOL, V55, P123, DOI 10.1111/j.1348-0421.2010.00292.x; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Czuprynski CJ, 2003, INFECT IMMUN, V71, P682, DOI 10.1128/IAI.71.2.682-689.2003; Dai WJ, 1997, J IMMUNOL, V158, P2259; DALRYMPLE SA, 1995, INFECT IMMUN, V63, P2262, DOI 10.1128/IAI.63.6.2262-2268.1995; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; HARTY JT, 1995, IMMUNITY, V3, P109, DOI 10.1016/1074-7613(95)90163-9; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Kernbauer E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002763; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Monk IR, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-318; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Navarini AA, 2006, P NATL ACAD SCI USA, V103, P15535, DOI 10.1073/pnas.0607325103; NIESEL DW, 1986, INFECT IMMUN, V52, P828, DOI 10.1128/IAI.52.3.828-833.1986; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pentecost M, 2006, PLOS PATHOG, V2, P29, DOI 10.1371/journal.ppat.0020003; Pentecost M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000900; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pietras EM, 2011, CELL RES, V21, P1068, DOI 10.1038/cr.2011.59; Pron B, 2001, CELL MICROBIOL, V3, P331, DOI 10.1046/j.1462-5822.2001.00120.x; Rauch I, 2013, JAK STAT, P96; Rayamajhi M, 2010, VIRULENCE, V1, P418, DOI 10.4161/viru.1.5.12787; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Reutterer B, 2008, CELL MICROBIOL, V10, P1116, DOI 10.1111/j.1462-5822.2007.01114.x; Rogers HW, 1996, J IMMUNOL, V156, P679; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stockinger S, 2002, J IMMUNOL, V169, P6522, DOI 10.4049/jimmunol.169.11.6522; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Vadia S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002356; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; Zwaferink H, 2008, J IMMUNOL, V180, P4116, DOI 10.4049/jimmunol.180.6.4116	43	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65007	10.1371/journal.pone.0065007	http://dx.doi.org/10.1371/journal.pone.0065007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840314	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200009
J	Stolen, M; Leger, JS; Durden, WN; Mazza, T; Nilson, E				Stolen, Megan; Leger, Judy St.; Durden, Wendy Noke; Mazza, Teresa; Nilson, Erika			Fatal Asphyxiation in Bottlenose Dolphins (Tursiops truncatus) from the Indian River Lagoon	PLOS ONE			English	Article								Multiple single case reports of asphyxiation in dolphins caused by fish lodged in the esophagus exist. However, the significance of this cause of mortality in a single population has not been documented. We performed a retrospective evaluation of pathology records from stranded bottlenose dolphins (Tursiops truncatus) from the Indian River Lagoon to evaluate the impact of this cause of death on this population. From 1997 to 2011, asphyxiation due to choking was identified as the cause of death in 14 of 350 cases (4%). Sampling of an unrelated but adjacent population over this same period yielded 186 necropsy cases of bottlenose dolphins with no cases of asphyxiation. Asphyxiated animals presented with a fish lodged in the cranial esophagus associated with a dislocated and obstructed or compressed larynx. There was no clear sex predilection. Affected animals included 12 adults and two juveniles. The fish species involved included sheepshead, black chin tilapia and striped mojarra. In five cases, recreational fishing gear was also present. Cetacean choking is related to selection of prey fish species with strong dorsal spines and may be secondarily associated with fish attached to fishing gear. Prey abundance and dolphin behavior may influence these selections. Environmental alterations leading to changes in prey availability or increased interactions with fishing gear may change the significance of fatal choking in dolphin populations.	[Stolen, Megan; Durden, Wendy Noke; Mazza, Teresa] Hubbs SeaWorld Res Inst, Melbourne Beach, FL USA; [Leger, Judy St.; Nilson, Erika] SeaWorld San Diego, San Diego, CA USA		Stolen, M (corresponding author), Hubbs SeaWorld Res Inst, Melbourne Beach, FL USA.	mstolen@hswri.org	St. Leger, Judy/AAD-3565-2019	St. Leger, Judy/0000-0002-6213-3429	John H. Prescott Marine Mammal Stranding Grant	John H. Prescott Marine Mammal Stranding Grant	Funding provided by the John H. Prescott Marine Mammal Stranding Grant www.nmfs.noaa.gov/pr/health/prescott. Discover Florida's Oceans Specialty License Plate, www.discoverfloridasoceans.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, THESIS U MIAMI CORAL; Barros N.B., 1990, P309; Bossart Gregory D., 2003, Florida Scientist, V66, P226; Byard Roger W, 2003, J Clin Forensic Med, V10, P85, DOI 10.1016/S1353-1131(03)00009-9; Byard RW, 2010, FORENSIC SCI MED PAT, V6, P207, DOI 10.1007/s12024-010-9143-3; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; GILMORE R G JR, 1977, Bulletin of the Florida State Museum Biological Sciences, V22, P101; Harris MP, 2008, IBIS, V150, P413, DOI 10.1111/j.1474-919X.2007.00780.x; Hoese HD, 1992, FISHES GULF MEXICO; Jennings Dawn P., 1992, Northeast Gulf Science, V12, P111; MacLeod CD, 2007, ANAT REC, V290, P539, DOI 10.1002/ar.20539; Mignucci-Giannoni Antonio A., 2009, Aquatic Mammals, V35, P48, DOI 10.1578/AM.35.1.2009.48; Mulligan TJ, 1983, FLORIDA SCI, V46, P250; NOAA, 2009, STOCK ASS REP BOTTL; REIDENBERG JS, 1987, ANAT RECORD, V218, P98, DOI 10.1002/ar.1092180115; REIDENBERG JS, 1988, ANAT REC, V221, P884, DOI 10.1002/ar.1092210413; Reynolds J.E., 1999, BIOL MARINE MAMMALS; Stolen M, 2013, MAR MAMMAL SCI, V29, P356, DOI 10.1111/j.1748-7692.2012.00575.x; Watson Alastair, 2005, Aquatic Mammals, V31, P447, DOI 10.1578/AM.31.4.2005.447	19	9	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66828	10.1371/journal.pone.0066828	http://dx.doi.org/10.1371/journal.pone.0066828			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840535	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200107
J	Basu, S; Ray, A; Dittel, BN				Basu, Sreemanti; Ray, Avijit; Dittel, Bonnie N.			Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens	PLOS ONE			English	Article							MARGINAL ZONE; IMMUNE-RESPONSE; 2-ARACHIDONOYLGLYCEROL; LYMPHOCYTES; ACTIVATION; MICE	The cannabinoid receptor 2 (CB2) has been reported to modulate B cell functions including migration, proliferation and isotype class switching. Since these processes are required for the generation of the germinal center (GC) and antigen-specific plasma and memory cells following immunization with a T-dependent antigen, CB2 has the capacity to alter the quality and magnitude of T-dependent immune responses. To address this question, we immunized WT and CB2(-/-) mice with the T-dependent antigen 4-hydroxy-3-nitrophenylacetyl (NP)-chicken-gamma-globulin (CGG) and measured GC B cell formation and the generation of antigen-specific B cells and serum immunoglobulin (Ig). While there was a significant reduction in the number of splenic GC B cells in CB2(-/-) mice early in the response there was no detectable difference in the number of NP-specific IgM and IgG1 plasma cells. There was also no difference in NP-specific IgM and class switched IgG1 in the serum. In addition, we found no defect in the homing of plasma cells to the bone marrow (BM) and affinity maturation, although memory B cell cells in the spleen were reduced in CB2(-/-) mice. CB2-deficient mice also generated similar levels of antigen-specific IgM and IgG in the serum as WT following immunization with sheep red blood cells (sRBC). This study demonstrates that although CB2 plays a role in promoting GC and memory B cell formation/maintenance in the spleen, it is dispensable on all immune cell types required for the generation of antigen-specific IgM and IgG in T-dependent immune responses.	[Basu, Sreemanti; Ray, Avijit; Dittel, Bonnie N.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53233 USA; [Basu, Sreemanti; Dittel, Bonnie N.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Versiti Blood Center of Wisconsin; Medical College of Wisconsin	Dittel, BN (corresponding author), BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53233 USA.	bonnie.dittel@bcw.edu	Ray, Avijit/K-5611-2015	Ray, Avijit/0000-0002-1732-9836	National Institutes of Health [R01 AI069358]; National Multiple Sclerosis Research Grant [4432-A-5]; Blood Center Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Research Grant; Blood Center Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01 AI069358, the National Multiple Sclerosis Research Grant 4432-A-5 and the Blood Center Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo M, 2008, J NEUROIMMUNE PHARM, V3, P35, DOI 10.1007/s11481-007-9088-9; Attanavanich K, 2004, J IMMUNOL, V172, P803, DOI 10.4049/jimmunol.172.2.803; Basu S, 2011, J IMMUNOL, V187, P5720, DOI 10.4049/jimmunol.1102195; Basu S, 2011, IMMUNOL RES, V51, P26, DOI 10.1007/s12026-011-8210-5; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; DEROCQ JM, 1995, FEBS LETT, V369, P177, DOI 10.1016/0014-5793(95)00746-V; GALIEGUE S, 1995, EUR J BIOCHEM, V232, P54, DOI 10.1111/j.1432-1033.1995.tb20780.x; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Koganei A, 2007, J IMMUNOTOXICOL, V4, P77, DOI 10.1080/15476910601161691; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Muppidi JR, 2011, J EXP MED, V208, P1941, DOI 10.1084/jem.20111083; Newton CA, 2012, J NEUROIMMUNE PHARM, V7, P591, DOI 10.1007/s11481-012-9361-4; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Rubtsov AV, 2008, J IMMUNOL, V180, P3882, DOI 10.4049/jimmunol.180.6.3882; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Song HF, 2003, J EXP MED, V198, P1923, DOI 10.1084/jem.20031498; Springs AEB, 2008, J LEUKOCYTE BIOL, V84, P1574, DOI 10.1189/jlb.0508282; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; Tanikawa T, 2007, MICROBIOL IMMUNOL, V51, P1013, DOI 10.1111/j.1348-0421.2007.tb03985.x; Ziring D, 2006, IMMUNOGENETICS, V58, P714, DOI 10.1007/s00251-006-0138-x	27	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67587	10.1371/journal.pone.0067587	http://dx.doi.org/10.1371/journal.pone.0067587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826323	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000091
J	Koehoorn, M; Trask, CM; Teschke, K				Koehoorn, Mieke; Trask, Catherine M.; Teschke, Kay			Recruitment for Occupational Research: Using Injured Workers as the Point of Entry into Workplaces	PLOS ONE			English	Article							WOOD DUST; HEALTH; SAFETY; EXPOSURE; RISK; INDUSTRIES; CHALLENGES; STRATEGIES; HAZARDS; COST	Objective: To investigate the feasibility, costs and sample representativeness of a recruitment method that used workers with back injuries as the point of entry into diverse working environments. Methods: Workers' compensation claims were used to randomly sample workers from five heavy industries and to recruit their employers for ergonomic assessments of the injured worker and up to 2 co-workers. Results: The final study sample included 54 workers from the workers' compensation registry and 72 co-workers. This sample of 126 workers was based on an initial random sample of 822 workers with a compensation claim, or a ratio of 1 recruited worker to approximately 7 sampled workers. The average recruitment cost was CND$262/injured worker and CND$240/participating worksite including co-workers. The sample was representative of the heavy industry workforce, and was successful in recruiting the self-employed (8.2%), workers from small employers (, 20 workers, 38.7%), and workers from diverse working environments (49 worksites, 29 worksite types, and 51 occupations). Conclusions: The recruitment rate was low but the cost per participant reasonable and the sample representative of workers in small worksites. Small worksites represent a significant portion of the workforce but are typically underrepresented in occupational research despite having distinct working conditions, exposures and health risks worthy of investigation.	[Koehoorn, Mieke; Teschke, Kay] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Trask, Catherine M.] Univ Saskatchewan, Canadian Ctr Hlth & Safety Agr, Saskatoon, SK, Canada	University of British Columbia; University of Saskatchewan	Koehoorn, M (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada.	mieke.koehoorn@ubc.ca		Trask, Catherine/0000-0003-0799-1735	WorkSafeBC Research Secretariat [RS202/03-013]; University of British Columbia Centre for Health and Environment Research; Michael Smith Foundation for Health Research; WorkSafeBC Training Award; Canadian Institutes of Health Research Strategic Training Program Bridging Public Health, Engineering and Policy Research (the Bridge Program)	WorkSafeBC Research Secretariat; University of British Columbia Centre for Health and Environment Research; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); WorkSafeBC Training Award; Canadian Institutes of Health Research Strategic Training Program Bridging Public Health, Engineering and Policy Research (the Bridge Program)(Canadian Institutes of Health Research (CIHR))	The work was supported in part by the WorkSafeBC Research Secretariat (grant #RS202/03-013) and the University of British Columbia Centre for Health and Environment Research. The authors were supported in part by a Michael Smith Foundation for Health Research Senior Scholar Award (http://www.msfhr.org), a Michael Smith Foundation for Health Research PhD Trainee Award, a WorkSafeBC Training Award (http://www.worksafebc.com) and by the Canadian Institutes of Health Research Strategic Training Program Bridging Public Health, Engineering and Policy Research (the Bridge Program; http://www.bridge.ubc.ca). The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Association of Workers Compensation Boards of Canada (AWCBC), 2008, KEY STAT MEAS; BARBEAU E, 2004, PREV CHRONIC DIS, V1, P1; Barbeau EM, 2007, INT J HEALTH SERV, V37, P127, DOI 10.2190/B0N2-5850-6467-0230; Bolen S, 2006, CANCER-AM CANCER SOC, V106, P1197, DOI 10.1002/cncr.21745; Brunette MJ, 2004, INJURY PREV, V10, P244, DOI 10.1136/ip.2004.005389; Bull N, 2002, OCCUP MED-OXFORD, V52, P70, DOI 10.1093/occmed/52.2.70; Butterfield PG, 2003, APPL NURS RES, V16, P46, DOI 10.1053/apnr.2003.50004; Eakin JM, 1998, SOCIOL HEALTH ILL, V20, P896, DOI 10.1111/1467-9566.00134; Eakin JM, 2010, CAN J PUBLIC HEALTH, V101, pS29, DOI 10.1007/BF03403843; EDERER F, 1975, AM J EPIDEMIOL, V102, P111, DOI 10.1093/oxfordjournals.aje.a112138; Kidd P, 2004, AM J IND MED, V45, P297, DOI 10.1002/ajim.10335; Koehoorn M, 2010, J OCCUP ENVIRON MED, V52, P908, DOI 10.1097/JOM.0b013e3181f02806; Lavoue J, 2013, ANN OCCUP HYG, V57, P77, DOI 10.1093/annhyg/mes055; Lee T, 2011, ANN OCCUP HYG, V55, P180, DOI 10.1093/annhyg/meq075; Lentz TJ, 2006, J OCCUP ENVIRON HYG, V3, pD8, DOI 10.1080/15459620500496715; Mathiassen SE, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-76; Mayhew C., 1997, IND RELAT J, V28, P192, DOI [10.1111/1468-2338.00054, DOI 10.1111/1468-2338.00054]; Messing K, 1997, WOMEN HEALTH, V25, P39, DOI 10.1300/J013v25n04_03; Mills PK, 2007, ENVIRON RES, V104, P282, DOI 10.1016/j.envres.2006.11.008; Moser M, 2004, 200417 NR NAT I WORK, P17; Office of the Information and Privacy Commissioner, 2006, FREED INF PROT PRIV; Parker DL, 2012, AM J IND MED, V55, P474, DOI 10.1002/ajim.22027; Quinlan M, 1999, ECON IND DEMOCRACY, V20, P427, DOI 10.1177/0143831X99203005; Rezagholi M, 2010, ANN OCCUP HYG, V54, P858, DOI 10.1093/annhyg/meq072; Rongo LMB, 2004, J EXPO ANAL ENV EPID, V14, P544, DOI 10.1038/sj.jea.7500375; Rytkonen E, 2006, INT ARCH OCC ENV HEA, V79, P521, DOI 10.1007/s00420-005-0079-y; Schmiemann M., 2008, ENTERPRISES SIZE CLA; Sobeih TM, 2006, J OCCUP ENVIRON MED, V48, P68, DOI 10.1097/01.jom.0000181756.38010.d2; Stoddard AM, 2005, PREV CHRONIC DIS, V2, P1; Teschke K, 2010, CAN J PUBLIC HEALTH, V101, P159, DOI 10.1007/BF03404364; Trask C, 2010, PREMUS 2010 AUG 29 S; Trask C, 2007, AM J IND MED, V50, P687, DOI 10.1002/ajim.20497; Village J, 2009, APPL ERGON, V40, P538, DOI 10.1016/j.apergo.2008.09.001; Western Economic Diversification Canada and BC Stats, 2007, SMALL BUS PROF 2007; WorkSafeBC, 2005, STAT 2005 AW ACT; WorkSafeBC, 2007, SMALL BUS STAT 2003; Yin-Poole W., 2012, MANY WEAPONS ARE BOR	37	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68354	10.1371/journal.pone.0068354	http://dx.doi.org/10.1371/journal.pone.0068354			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IX	23826387	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000140
J	Lindauer, E; Dupuis, L; Muller, HP; Neumann, H; Ludolph, AC; Kassubek, J				Lindauer, Eva; Dupuis, Luc; Mueller, Hans-Peter; Neumann, Heiko; Ludolph, Albert C.; Kassubek, Jan			Adipose Tissue Distribution Predicts Survival in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							SPINAL-CORD-INJURY; HUNTINGTONS-DISEASE PATIENTS; RESTING ENERGY-EXPENDITURE; BODY-MASS INDEX; ALZHEIMERS-DISEASE; NUTRITIONAL-STATUS; ALS PATIENTS; DYSFUNCTION; FAT; METABOLISM	Background: amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that leads to death within a few years after diagnosis. Malnutrition and weight loss are frequent and are indexes of poor prognosis. Total body fat and fat distribution have not been studied in ALS patients. Objectives: Our aim was to describe adipose tissue content and distribution in ALS patients. Design: We performed a cross-sectional study in a group of ALS patients (n = 62, mean disease duration 22 months) along with age and gender matched healthy controls (n = 62) using a MRI-based method to study quantitatively the fat distribution. Results: Total body fat of ALS patients was not changed as compared with controls. However, ALS patients displayed increased visceral fat and an increased ratio of visceral to subcutaneous fat. Visceral fat was not correlated with clinical severity as judged using the ALS functional rating scale (ALS-FRS-R), while subcutaneous fat in ALS patients correlated positively with ALS-FRS-R and disease progression. Multiple regression analysis showed that gender and ALS-FRS-R, but not site of onset, were significant predictors of total and subcutaneous fat. Increased subcutaneous fat predicted survival in male patients but not in female patients (p<0.05). Conclusions: Fat distribution is altered in ALS patients, with increased visceral fat as compared with healthy controls. Subcutaneous fat content is a predictor of survival of ALS patients.	[Lindauer, Eva; Mueller, Hans-Peter; Ludolph, Albert C.; Kassubek, Jan] Univ Ulm, Dept Neurol, D-89069 Ulm, Germany; [Dupuis, Luc] INSERM, U1118, Strasbourg, France; [Dupuis, Luc] Univ Strasbourg, Fac Med, Strasbourg, France; [Neumann, Heiko] Univ Ulm, Inst Neural Informat Proc, D-89069 Ulm, Germany	Ulm University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ulm University	Ludolph, AC (corresponding author), Univ Ulm, Dept Neurol, D-89069 Ulm, Germany.	albert.ludolph@rku.de	Dupuis, Luc/A-6981-2012; Kassubek, Jan/F-2774-2015; Kassubek, Jan/O-1740-2019; Kassubek, Jan/GPX-0910-2022	Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270; Kassubek, Jan/0000-0002-7106-9270				Adibhatla Rao Muralikrishna, 2008, V49, P241, DOI 10.1007/978-1-4020-8831-5_9; Aziz NA, 2010, J NEUROL NEUROSUR PS, V81, P1233, DOI 10.1136/jnnp.2009.191833; Aziz NA, 2010, CLIN ENDOCRINOL, V73, P206, DOI 10.1111/j.1365-2265.2009.03661.x; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Baltadzhieva R, 2005, CURR OPIN NEUROL, V18, P487, DOI 10.1097/01.wco.0000183114.76056.0e; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Buchholz AC, 2004, CURR OPIN CLIN NUTR, V7, P635, DOI 10.1097/00075197-200411000-00008; Desport JC, 2000, AMYOTROPH LATERAL SC, V1, P91; Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059; Desport JC, 2003, AM J CLIN NUTR, V77, P1179, DOI 10.1093/ajcn/77.5.1179; Desport JC, 2001, AM J CLIN NUTR, V74, P328; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Dorst J, 2011, J NEUROL, V258, P613, DOI 10.1007/s00415-010-5805-z; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Edwards LA, 2008, AM J CLIN NUTR, V87, P600, DOI 10.1093/ajcn/87.3.600; Fain JN, 2001, HUM MOL GENET, V10, P145, DOI 10.1093/hmg/10.2.145; Fergani A, 2007, J LIPID RES, V48, P1571, DOI 10.1194/jlr.M700017-JLR200; Gallo V, 2013, NEUROLOGY, V80, P829, DOI 10.1212/WNL.0b013e3182840689; Gamba P, 2012, ANN NY ACAD SCI, V1259, P54, DOI 10.1111/j.1749-6632.2012.06513.x; Gibbons ZC, 2008, AMYOTROPH LATERAL SC, V9, P67, DOI 10.1080/17482960701642437; Gorgey AS, 2011, J SPINAL CORD MED, V34, P99, DOI 10.1179/107902610X12911165975106; Groah SL, 2009, J SPINAL CORD MED, V32, P25, DOI 10.1080/10790268.2009.11760749; Jawaid A, 2010, EUR J NEUROL; Jawaid A.MurthySB, 2010, AMYOTROPH LATERAL SC; Karlsborg M, 2003, EUR J NEUROL, V10, P229, DOI 10.1046/j.1468-1331.2003.00578.x; Kasarskis EJ, 1996, AM J CLIN NUTR, V63, P130, DOI 10.1093/ajcn/63.1.130; Liusuwan A, 2004, J SPINAL CORD MED, V27, pS24, DOI 10.1080/10790268.2004.11753781; Liusuwan RA, 2007, J SPINAL CORD MED, V30, pS105; Marin B, 2011, J NEUROL NEUROSUR PS, V82, P628, DOI 10.1136/jnnp.2010.211474; Mattson MP, 2007, NEUROMOL MED, V9, P17, DOI 10.1385/NMM:9:1:17; Misra A, 1997, OBES RES, V5, P93, DOI 10.1002/j.1550-8528.1997.tb00648.x; Muller HP, 2011, NMR BIOMED, V24, P17, DOI 10.1002/nbm.1549; Nelson MD, 2007, J SPINAL CORD MED, V30, pS127; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Phan J, 2009, HUM MOL GENET, V18, P1006, DOI 10.1093/hmg/ddn428; Piguet O, 2011, LANCET NEUROL, V10, P162, DOI 10.1016/S1474-4422(10)70299-4; Piguet O, 2011, ANN NEUROL, V69, P312, DOI 10.1002/ana.22244; Pradat PF, 2010, AMYOTROPH LATERAL SC, V11, P166, DOI 10.3109/17482960902822960; Sabour H, 2012, NUTRITION, V28, P143, DOI 10.1016/j.nut.2011.04.007; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Tanko LB, 2003, CIRCULATION, V107, P1626, DOI 10.1161/01.CIR.0000057974.74060.68; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; Wang YF, 2005, AM J CLIN NUTR, V81, P555	46	54	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67783	10.1371/journal.pone.0067783	http://dx.doi.org/10.1371/journal.pone.0067783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826340	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000098
J	Luo, D; Qian, YQ; Han, L; Liu, JX; Sun, ZY				Luo, Dong; Qian, Yong-Qiang; Han, Lei; Liu, Jun-Xiang; Sun, Zhen-Yuan			Phenotypic Responses of a Stoloniferous Clonal Plant Buchloe dactyloides to Scale-Dependent Nutrient Heterogeneity	PLOS ONE			English	Article							DIVISION-OF-LABOR; ENVIRONMENTAL HETEROGENEITY; PHYSIOLOGICAL INTEGRATION; MORPHOLOGICAL PLASTICITY; FRAGARIA-CHILOENSIS; PHOTOSYNTHETIC EFFICIENCY; GROWTH; RAMETS; BENEFITS; NITROGEN	Clonal plants could modify phenotypic responses to nutrients heterogeneously distributed both in space and time by physiological integration. It will take times to do phenotypic responses to modifications which are various in different growth periods. An optimal phenotype is reached when there is a match between nutrient conditions and foraging ability. A single plantlet of Buchloe dactyloides with two stolons was transplanted into heterogeneous nutrient conditions. One stolon grew in homogeneous nutrient patch, while the other cultured in different scales of heterogeneous nutrient patches. As compared to the other nutrient treatment, heterogeneous nutrient treatments with small scale of 25x25 cm resulted in a higher biomass, and larger number of ramets, clumps and stolons in B. dactyloides at both genet and clonal fragment levels. Significant differences of number of ramets, clumps and stolons were detected at the rapid growth stage, but not in the early stage of the experiment. Foraging ability was more efficient in heterogeneous than in homogeneous nutrient conditions as assessed by higher root mass and root to shoot ratio. Different nutrient treatments did not prompt significant differences in internode and root length. Physiological integration significantly increased biomass, but did not influence other growth or morphological characters. These results suggest that physiological integration modifies phenotypic plasticity of B. dactyloides for efficient foraging of nutrients in heterogeneous nutrient conditions. These effects are more pronounced at genet and clonal fragment levels when the patch scale is 25x25 cm. Time is a key factor when phenotypic plasticity of B. dactyloides in heterogeneous nutrient conditions is examined.	[Luo, Dong] China Agr Univ, Coll Agr & Biotechnol, Dept Ornamental Hort, Beijing 100094, Peoples R China; [Luo, Dong; Qian, Yong-Qiang; Han, Lei; Liu, Jun-Xiang; Sun, Zhen-Yuan] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF	Sun, ZY (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	sunzy@caf.ac.cn			National Natural Science Foundation of China [31070625, 31100505]; grant for National Non-profit Research Institutions [CAFYBB2012043, RIF2010-11]; Beijing Natural Science Foundation [6122031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); grant for National Non-profit Research Institutions; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This research is supported by the National Natural Science Foundation of China (31070625, 31100505), grant for National Non-profit Research Institutions (CAFYBB2012043, RIF2010-11), and Beijing Natural Science Foundation (6122031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P137; Alpert P, 1999, OECOLOGIA, V120, P69, DOI 10.1007/s004420050834; Alpert P, 1996, J ECOL, V84, P395, DOI 10.2307/2261201; BIRCH CPD, 1994, J ECOL, V82, P653, DOI 10.2307/2261272; Brezina S, 2006, FLORA, V201, P461, DOI 10.1016/j.flora.2005.10.003; BULLOCK JM, 1994, NEW PHYTOL, V128, P737, DOI 10.1111/j.1469-8137.1994.tb04037.x; Cain ML, 1999, OECOLOGIA, V118, P397, DOI 10.1007/s004420050741; CAIN ML, 1994, ECOLOGY, V75, P933, DOI 10.2307/1939417; Caldwell M.M., 1994, EXPLOITATION ENV HET; Day KJ, 2001, THESIS U SUSSEX UK; de Kroon H, 2005, NEW PHYTOL, V166, P73, DOI 10.1111/j.1469-8137.2004.01310.x; de Kroon H., 1990, CLONAL GROWTH PLANTS, P113; DEKROON H, 1995, J ECOL, V83, P143, DOI 10.2307/2261158; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Einsmann JC, 1999, J ECOL, V87, P609, DOI 10.1046/j.1365-2745.1999.00376.x; EVANS JP, 1992, AM J BOT, V79, P1344, DOI 10.2307/2445132; Farley RA, 1999, J ECOL, V87, P849, DOI 10.1046/j.1365-2745.1999.00396.x; Fransen B, 1998, OECOLOGIA, V115, P351, DOI 10.1007/s004420050527; FRIEDMAN D, 1991, OECOLOGIA, V86, P76, DOI 10.1007/BF00317392; GERSANI M, 1992, PLANT CELL ENVIRON, V15, P463, DOI 10.1111/j.1365-3040.1992.tb00997.x; Gruntman M, 2004, P NATL ACAD SCI USA, V101, P3863, DOI 10.1073/pnas.0306604101; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; He WM, 2011, J ECOL, V99, P1202, DOI 10.1111/j.1365-2745.2011.01848.x; Hodge A, 1999, J EXP BOT, V50, P1243, DOI 10.1093/jexbot/50.336.1243; Huber H, 1998, OIKOS, V81, P576, DOI 10.2307/3546778; Huber-Sannwald E, 1998, ECOLOGY, V79, P2267, DOI 10.1890/0012-9658(1998)079[2267:EONPAR]2.0.CO;2; Hutchings M.J., 2000, ECOLOGICAL CONSEQUEN, P91; HUTCHINGS MJ, 1994, ADV ECOL RES, V25, P159, DOI 10.1016/S0065-2504(08)60215-9; Jackson RB, 1996, J ECOL, V84, P891, DOI 10.2307/2960560; JACKSON RB, 1993, J ECOL, V81, P683, DOI 10.2307/2261666; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; Liu HD, 2009, FLORA, V204, P298, DOI 10.1016/j.flora.2008.03.003; Macek P, 2003, PLANT ECOL, V168, P31, DOI 10.1023/A:1024460525317; Marshall C, 1999, PLANT ECOL, V141, P1; Oborny B, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P155; OBORNY B, 1994, FOLIA GEOBOT PHYTOTX, V29, P139, DOI 10.1007/BF02803791; Oborny B., 1995, ABSTR BOT, V11, P115; Pigliucci M, 2003, AM NAT, V161, P68, DOI 10.1086/345460; Pitelka L.F., 1985, POPULATION BIOL EVOL, P399; Price EAC, 1999, PLANT ECOL, V141, P3, DOI 10.1023/A:1009838300691; Qian YQ, 2010, J AM SOC HORTIC SCI, V135, P310, DOI 10.21273/JASHS.135.4.310; Roiloa SR, 2006, ANN BOT-LONDON, V98, P1043, DOI 10.1093/aob/mcl185; Roiloa SR, 2007, J ECOL, V95, P397, DOI 10.1111/j.1365-2745.2007.01216.x; Roiloa SR, 2005, INT J PLANT SCI, V166, P795, DOI 10.1086/431804; Ryel RJ, 1998, ECOLOGY, V79, P2735, DOI 10.1890/0012-9658(1998)079[2735:NAFSWP]2.0.CO;2; Saitoh T, 2002, J ECOL, V90, P78, DOI 10.1046/j.0022-0477.2001.00631.x; SALZMAN AG, 1985, OECOLOGIA, V65, P273, DOI 10.1007/BF00379229; SCHMID B, 1990, EVOL TREND PLANT, V4, P25; SKALOVA H, 1992, FUNCT ECOL, V6, P282, DOI 10.2307/2389518; SLADE AJ, 1987, OECOLOGIA, V73, P425, DOI 10.1007/BF00385260; Song YB, 2013, OECOLOGIA, V171, P317, DOI 10.1007/s00442-012-2430-9; Stuefer JF, 1996, VEGETATIO, V127, P55, DOI 10.1007/BF00054847; STUEFER JF, 1994, J ECOL, V82, P511, DOI 10.2307/2261260; Stuefer JF, 1996, FUNCT ECOL, V10, P328, DOI 10.2307/2390280; vanVuuren MMI, 1996, PLANT SOIL, V178, P185, DOI 10.1007/BF00011582; Wang N, 2008, ANN BOT-LONDON, V101, P671, DOI 10.1093/aob/mcn005; Weinig C, 2001, EVOLUTION, V55, P930, DOI 10.1554/0014-3820(2001)055[0930:PPEILC]2.0.CO;2; Welham CVJ, 2002, OECOLOGIA, V130, P231, DOI 10.1007/s004420100791; Wijesinghe DK, 1997, J ECOL, V85, P17, DOI 10.2307/2960624; Wijesinghe DK, 1999, J ECOL, V87, P860, DOI 10.1046/j.1365-2745.1999.00395.x; WIJESINGHE DK, 1994, J ECOL, V82, P495, DOI 10.2307/2261258; Wijesinghe DK, 2001, J ECOL, V89, P972, DOI 10.1111/j.1365-2745.2001.00618.x; Xu L, 2012, ANN BOT-LONDON, V109, P1001, DOI 10.1093/aob/mcs006; Yu FH, 2008, ANN BOT-LONDON, V102, P571, DOI 10.1093/aob/mcn119; Yu FH, 2009, AM J BOT, V96, P1983, DOI 10.3732/ajb.0800426	65	9	12	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67396	10.1371/journal.pone.0067396	http://dx.doi.org/10.1371/journal.pone.0067396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826285	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000073
J	Xu, J; Audenaert, K; Hofte, M; De Vleesschauwer, D				Xu, Jing; Audenaert, Kris; Hofte, Monica; De Vleesschauwer, David			Abscisic Acid Promotes Susceptibility to the Rice Leaf Blight Pathogen Xanthomonas oryzae pv oryzae by Suppressing Salicylic Acid-Mediated Defenses	PLOS ONE			English	Article							REAL-TIME PCR; DISEASE RESISTANCE; PSEUDOMONAS-SYRINGAE; BOTRYTIS-CINEREA; ABIOTIC STRESS; ANTAGONISTIC INTERACTION; FUNCTIONAL-ANALYSIS; MAGNAPORTHE-GRISEA; HORMONE CROSSTALK; SIGNALING PATHWAY	The plant hormone abscisic acid (ABA) is involved in a wide variety of plant processes, including the initiation of stress-adaptive responses to various environmental cues. Recently, ABA also emerged as a central factor in the regulation and integration of plant immune responses, although little is known about the underlying mechanisms. Aiming to advance our understanding of ABA-modulated disease resistance, we have analyzed the impact, dynamics and interrelationship of ABA and the classic defense hormone salicylic acid (SA) during progression of rice infection by the leaf blight pathogen Xanthomonas oryzae pv. oryzae (Xoo). Consistent with ABA negatively regulating resistance to Xoo, we found that exogenously administered ABA renders rice hypersusceptible to infection, whereas chemical and genetic disruption of ABA biosynthesis and signaling, respectively, led to enhanced Xoo resistance. In addition, we found successful Xoo infection to be associated with extensive reprogramming of ABA biosynthesis and response genes, suggesting that ABA functions as a virulence factor for Xoo. Interestingly, several lines of evidence indicate that this immune-suppressive effect of ABA is due at least in part to suppression of SA-mediated defenses that normally serve to limit pathogen growth. Resistance induced by the ABA biosynthesis inhibitor fluridone, however, appears to operate in a SA-independent manner and is likely due to induction of non-specific physiological stress. Collectively, our findings favor a scenario whereby virulent Xoo hijacks the rice ABA machinery to cause disease and highlight the importance of ABA and its crosstalk with SA in shaping the outcome of rice-Xoo interactions.	[Xu, Jing; Audenaert, Kris; Hofte, Monica; De Vleesschauwer, David] Univ Ghent, Phytopathol Lab, B-9000 Ghent, Belgium; [Audenaert, Kris] Ghent Univ Coll, Fac Appl Biosci Engn, Ghent, Belgium	Ghent University; Ghent University; HOGENT University College of Applied Sciences & Arts	De Vleesschauwer, D (corresponding author), Univ Ghent, Phytopathol Lab, B-9000 Ghent, Belgium.	david.devleesschauwer@ugent.be	Hofte, Monica MR/A-6154-2008; De Vleesschauwer, David/L-9126-2014	De Vleesschauwer, David/0000-0002-1992-0734; Hofte, Monica/0000-0002-0850-3249	Ghent University BOF/GOA; China Scholarship Council; Research Foundation Flanders (FWO-Vlaanderen)	Ghent University BOF/GOA(Ghent University); China Scholarship Council(China Scholarship Council); Research Foundation Flanders (FWO-Vlaanderen)(FWO)	Financial support was provided by grants from the Special Research Fund of Ghent University BOF/GOA (http://www.ugent.be/en/research/funding) and by grants from the China Scholarship Council to J.X. and the Research Foundation Flanders (FWO-Vlaanderen, www.fwo.be) to D.D.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achuo E. A., 2003, Communications in Agricultural and Applied Biological Sciences, V68, P49; Achuo EA, 2006, PLANT PATHOL, V55, P178, DOI 10.1111/j.1365-3059.2006.01340.x; Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Asselbergh B, 2008, MOL PLANT MICROBE IN, V21, P709, DOI 10.1094/MPMI-21-6-0709; Asselbergh B, 2008, MOL PLANT PATHOL, V9, P11, DOI [10.1111/j.1364-3703.2007.00437.x, 10.1111/J.1364-3703.2007.00437.X]; Audenaert K, 2002, PLANT PHYSIOL, V128, P491, DOI 10.1104/pp.010605; Bailey TA, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P185, DOI 10.1007/978-1-4020-9500-9_19; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Cao FY, 2011, J PLANT RES, V124, P489, DOI 10.1007/s10265-011-0409-y; Chu ZH, 2006, THEOR APPL GENET, V112, P455, DOI 10.1007/s00122-005-0145-6; Cui J, 2005, P NATL ACAD SCI USA, V102, P1791, DOI 10.1073/pnas.0409450102; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; De Vleesschauwer D, 2012, PLANT PHYSIOL, V158, P1833, DOI 10.1104/pp.112.193672; De Vleesschauwer D, 2010, PLANT PHYSIOL, V152, P2036, DOI 10.1104/pp.109.152702; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Fan J, 2009, PLANT PHYSIOL, V150, P1750, DOI 10.1104/pp.109.137943; Flors V, 2008, PLANT J, V54, P81, DOI 10.1111/j.1365-313X.2007.03397.x; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Goel AK, 2008, MOL PLANT MICROBE IN, V21, P361, DOI 10.1094/MPMI-21-3-0361; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Grewal RK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-49; Ho YP, 2013, MOL PLANT MICROBE IN, DOI [10.1094/mpmi-1006-1012-0164-r, DOI 10.1094/MPMI-1006-1012-0164-R]; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jiang CJ, 2010, MOL PLANT MICROBE IN, V23, P791, DOI 10.1094/MPMI-23-6-0791; KAUFFMAN HE, 1973, PLANT DIS REP, V57, P537; Koga H, 2004, PHYSIOL MOL PLANT P, V65, P3, DOI 10.1016/j.pmpp.2004.11.002; Lackman P, 2011, P NATL ACAD SCI USA, V108, P5891, DOI 10.1073/pnas.1103010108; Liu HB, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-2; Mang HG, 2012, PLANT CELL, V24, P1271, DOI 10.1105/tpc.112.096198; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Mohr PG, 2007, FUNCT INTEGR GENOMIC, V7, P181, DOI 10.1007/s10142-006-0041-4; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Oritani T, 2003, NAT PROD REP, V20, P414, DOI 10.1039/b109859b; Peleg Z, 2011, PLANT BIOTECHNOL J, V9, P747, DOI 10.1111/j.1467-7652.2010.00584.x; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Qiu DY, 2008, MOL PLANT, V1, P538, DOI 10.1093/mp/ssn012; Qiu DY, 2007, MOL PLANT MICROBE IN, V20, P492, DOI 10.1094/MPMI-20-5-0492; Qiu YP, 2009, ENVIRON EXP BOT, V65, P35, DOI 10.1016/j.envexpbot.2008.07.002; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Ryu HS, 2006, PLANT CELL REP, V25, P836, DOI 10.1007/s00299-006-0138-1; Seo YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002020; Sharma R, 2013, MOL PLANT, V6, P250, DOI 10.1093/mp/sss147; Shen XL, 2011, PLANT CELL ENVIRON, V34, P179, DOI 10.1111/j.1365-3040.2010.02219.x; Shimono M, 2007, PLANT CELL, V19, P2064, DOI 10.1105/tpc.106.046250; Siewers V, 2006, APPL ENVIRON MICROB, V72, P4619, DOI 10.1128/AEM.02919-05; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; Tao Z, 2009, PLANT PHYSIOL, V151, P936, DOI 10.1104/pp.109.145623; Taylor IB, 2000, J EXP BOT, V51, P1563, DOI 10.1093/jexbot/51.350.1563; Thaler JS, 2004, ECOLOGY, V85, P48, DOI 10.1890/02-0710; Ton J, 2004, PLANT J, V38, P119, DOI 10.1111/j.1365-313X.2004.02028.x; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Wang YP, 2011, PLANT J, V68, P249, DOI 10.1111/j.1365-313X.2011.04683.x; Watanabe H, 2001, PLANT GROWTH REGUL, V34, P273, DOI 10.1023/A:1013333718573; Xiong LM, 2003, PLANT PHYSIOL, V133, P29, DOI 10.1104/pp.103.025395; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Yang DL, 2008, MOL PLANT, V1, P528, DOI 10.1093/mp/ssn021; Yang YN, 2004, PLANT J, V40, P909, DOI 10.1111/j.1365-313X.2004.02267.x; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Yazawa K, 2012, PHYSIOL MOL PLANT P, V78, P1, DOI 10.1016/j.pmpp.2011.12.003; Yuan YX, 2007, PLANT BIOTECHNOL J, V5, P313, DOI 10.1111/j.1467-7652.2007.00243.x; Zabala MD, 2009, PLANT J, V59, P375, DOI 10.1111/j.1365-313X.2009.03875.x; Zhang ZL, 2009, PLANT MOL BIOL, V70, P139, DOI 10.1007/s11103-009-9463-4	72	106	107	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67413	10.1371/journal.pone.0067413	http://dx.doi.org/10.1371/journal.pone.0067413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826294	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000079
J	Haller, S; Spiegler, J; Hemmelmann, C; Kuster, H; Vochem, M; Moller, J; Muller, D; Kribs, A; Hoehn, T; Hartel, C; Herting, E; Gopel, W				Haller, Sebastian; Spiegler, Juliane; Hemmelmann, Claudia; Kuester, Helmut; Vochem, Matthias; Moeller, Jens; Mueller, Dirk; Kribs, Angela; Hoehn, Thomas; Haertel, Christoph; Herting, Egbert; Goepel, Wolfgang		German Neonatal Network	Polymorphisms in FTO and MAF Genes and Birth Weight, BMI, Ponderal Index, Weight Gain in a Large Cohort of Infants with a Birth Weight below 1500 Grams	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OBESITY; CHILDHOOD; VARIANT; MASS; AGE	Background: The FTO gene, located on chromosome 16q12.2, and the MAF gene, located on chromosome 16q22-23, were identified as genes harboring common variants with an impact on obesity predisposition. We studied the association of common variants with birth weight, gain of body weight, body mass index (BMI), Ponderal index and relevant neonatal outcomes in a large German cohort of infants with a birth weight below 1500 grams. Methods: The single nucleotide polymorphisms rs9939609 (FTO gene) and rs1424233 (MAF gene) were genotyped using allelic discrimination assays in a prospective multicenter cohort study conducted in 15 neonatal intensive care units in Germany from September 2003 until January 2008. DNA samples were extracted from buccal swabs according to standard protocols. Results: 1946 infants were successfully genotyped at FTO and 2149 infants at MAF. Allele frequencies were not significantly different from other European cohorts. The polymorphisms were in Hardy-Weinberg equilibrium. The polymorphisms did not show associations with birth weight, BMI and Ponderal Index at discharge, and weight gain, neither testing for a dominant, additive nor for a recessive model. Discussion: Since an association of the polymorphisms with weight gain has been demonstrated in multiple populations, the lack of association in a population of preterm infants with regular tube feeding after birth and highly controlled feeding volumes provides evidence for the hypothesis that these polymorphisms affect food intake behavior and hunger rather than metabolism and energy consumption.	[Haller, Sebastian; Spiegler, Juliane; Haertel, Christoph; Herting, Egbert; Goepel, Wolfgang] Med Univ Lubeck, Dept Pediat, D-23538 Lubeck, Germany; [Hemmelmann, Claudia] Med Univ Lubeck, Inst Med Biometry & Stat, D-23538 Lubeck, Germany; [Kuester, Helmut] Univ Gottingen, Dept Pediat, Gottingen, Germany; [Vochem, Matthias] Olgahosp Stuttgart, Stuttgart, Germany; [Moeller, Jens] Childrens Hosp Saarbrucken, Saarbrucken, Germany; [Mueller, Dirk] Childrens Hosp Kassel, Kassel, Germany; [Kribs, Angela] Univ Cologne, Dept Pediat, D-50931 Cologne, Germany; [Hoehn, Thomas] Univ Dusseldorf, Dept Pediat, D-40225 Dusseldorf, Germany	University of Lubeck; University of Lubeck; University of Gottingen; Klinikum Stuttgart; University of Cologne; Heinrich Heine University Dusseldorf	Gopel, W (corresponding author), Med Univ Lubeck, Dept Pediat, D-23538 Lubeck, Germany.	goepel@vlbw.de	Möller, Jens/H-1204-2017; Spiegler, Juliane/AAK-1740-2020; Härtel, Christoph/ABD-8841-2020; Haller, Sebastian/P-1634-2014	Möller, Jens/0000-0003-1767-5859; Spiegler, Juliane/0000-0002-1737-0628; Haller, Sebastian/0000-0001-8242-711X	German Ministry for Education and Research (BMBF) [01ER0805]	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	German Ministry for Education and Research (BMBF grant-number: 01ER0805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Bray GA, 2006, ENDOCRINE, V29, P109, DOI 10.1385/ENDO:29:1:109; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Fenton Tanis R, 2003, BMC Pediatr, V3, P13; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hartel C, 2009, J PEDIATR GASTR NUTR, V48, P464, DOI 10.1097/MPG.0b013e31818c5fc3; Huuskonen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051635; Lopez-Bermejo A, 2008, J CLIN ENDOCR METAB, V93, P1501, DOI 10.1210/jc.2007-2343; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Rzehak P, 2010, OBESITY FACTS, V3, P173, DOI 10.1159/000314612; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Serria MS, 2003, BIOCHEM BIOPH RES CO, V310, P318, DOI 10.1016/j.bbrc.2003.08.144; Spiegler J, 2008, J PEDIATR GASTR NUTR, V46, P113, DOI 10.1097/01.mpg.0000304466.45541.f2; Tsuchiya M, 2006, PANCREAS, V32, P408, DOI 10.1097/01.mpa.0000220867.64787.99; Velders FP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049131; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; Wellek S, 2010, BIOMETRICAL J, V52, P253, DOI 10.1002/bimj.200900249	20	5	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66331	10.1371/journal.pone.0066331	http://dx.doi.org/10.1371/journal.pone.0066331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840443	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400024
J	Mouritsen, H; Atema, J; Kingsford, MJ; Gerlach, G				Mouritsen, Henrik; Atema, Jelle; Kingsford, Michael J.; Gerlach, Gabriele			Sun Compass Orientation Helps Coral Reef Fish Larvae Return to Their Natal Reef	PLOS ONE			English	Article							REGIONAL MAGNETIC-FIELDS; GREAT-BARRIER-REEF; PELAGIC LARVAE; PRESETTLEMENT FISHES; MONARCH BUTTERFLIES; SWIMMING ABILITIES; MIGRATING BIRDS; MARINE FISHES; SEA-TURTLES; POPULATIONS	Reef fish sustain populations on isolated reefs and show genetic diversity between nearby reefs even though larvae of many species are swept away from the natal site during pelagic dispersal. Retention or recruitment to natal reefs requires orientation capabilities that enable larvae to find their way. Although olfactory and acoustically based orientation has been implicated in homing when larvae are in the reef's vicinity, it is still unclear how they cope with greater distances. Here we show evidence for a sun compass mechanism that can bring the larvae to the vicinity of their natal reef. In a circular arena, pre-settlement larvae and early settlers (<24 hours) of the cardinal fish, Ostorhinchus doederleini, showed a strong SSE directional swimming response, which most likely has evolved to compensate for the locally prevailing large scale NNW current drift. When fish were clock-shifted 6 hours, they changed their orientation by ca. 180 degrees as predicted by the tropical sun curve at One Tree Island, i.e. they used a time-compensated sun compass. Furthermore, the fish oriented most consistently at times of the day when the sun azimuth is easy to determine. Microsatellite markers showed that the larvae that had just arrived at One Tree Island genetically belonged to either the local reef population or to Fitzroy Reef located 12 kilometers to the SSE. The use of a sun compass adds a missing long-distance link to the hierarchy of other sensory abilities that can direct larvae to the region of origin, including their natal reef. Predominant local recruitment, in turn, can contribute to genetic isolation and potential speciation.	[Mouritsen, Henrik; Gerlach, Gabriele] Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, D-26111 Oldenburg, Germany; [Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Forschungszentrum Neurosensor, D-26111 Oldenburg, Germany; [Atema, Jelle] Boston Univ, Marine Program, Boston, MA 02215 USA; [Kingsford, Michael J.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia; [Kingsford, Michael J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Boston University; James Cook University; James Cook University	Mouritsen, H (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Biol & Umweltwissensch, D-26111 Oldenburg, Germany.	henrik.mouritsen@uni-oldenburg.de; atema@bu.edu; Gabriele.gerlach@uni-oldenburg.de	Gerlach, Gabriele/K-5919-2012; Mouritsen, Henrik/A-5401-2010; Kingsford, Michael J/C-2015-2008	Mouritsen, Henrik/0000-0001-7082-4839; Kingsford, Michael J/0000-0003-1704-6198	Volkswagen Stiftung; DFG [Ge842/6-1]; ARC; ARC Centre of Excellence for Coral Reef Studies;  [7236-02]	Volkswagen Stiftung(Volkswagen); DFG(German Research Foundation (DFG)); ARC(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council); 	This work was funded by a Lichtenberg professorship from the Volkswagen Stiftung to HM; DFG Ge842/6-1 to GG; Grant no. 7236-02, ARC grants, and funding from the ARC Centre of Excellence for Coral Reef Studies to MJK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1996, J EXP BIOL, V199, P9; Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Armsworth PR, 2000, MAR ECOL PROG SER, V195, P231, DOI 10.3354/meps195231; Atema J, 2002, MAR ECOL PROG SER, V241, P151, DOI 10.3354/meps241151; Barber PH, 2002, P ROY SOC B-BIOL SCI, V269, P1591, DOI 10.1098/rspb.2002.2026; Batschelet E, 1981, CIRCULAR STAT BIOL; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Burgess SC, 2007, MAR ECOL PROG SER, V341, P233, DOI 10.3354/meps341233; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Chapman JW, 2011, CURR BIOL, V21, pR861, DOI 10.1016/j.cub.2011.08.014; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Dixson DL, 2008, P ROY SOC B-BIOL SCI, V275, P2831, DOI 10.1098/rspb.2008.0876; Fiksen O, 2007, MAR ECOL PROG SER, V347, P195, DOI 10.3354/meps06978; Finn MD, 1996, MAR FRESHWATER RES, V47, P423, DOI 10.1071/MF9960423; Fisher R, 2000, MAR ECOL PROG SER, V202, P163, DOI 10.3354/meps202163; Fuxjager MJ, 2011, J EXP BIOL, V214, P2504, DOI 10.1242/jeb.055921; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; GOODYEAR CP, 1969, ANIM BEHAV, V17, P636, DOI 10.1016/S0003-3472(69)80005-9; HASLER AD, 1958, LIMNOL OCEANOGR, V3, P353, DOI 10.4319/lo.1958.3.4.0353; Hein CM, 2011, NATURE, V471, pE11, DOI 10.1038/nature09875; Hein CM, 2010, J R SOC INTERFACE, V7, pS227, DOI 10.1098/rsif.2009.0376.focus; HELBIG AJ, 1989, ETHOLOGY, V82, P307; Hogan JD, 2012, OECOLOGIA, V168, P61, DOI 10.1007/s00442-011-2058-1; Jones GP, 2009, CORAL REEFS, V28, P307, DOI 10.1007/s00338-009-0469-9; Kingsford M, 1997, J FISH BIOL, V51, P176, DOI 10.1111/j.1095-8649.1997.tb06099.x; Kingsford MJ, 2002, B MAR SCI, V70, P309; Kingsford MJ, 2001, MAR BIOL, V138, P853, DOI 10.1007/s002270000455; Kramer G., 1952, Ibis, V94, P265, DOI 10.1111/j.1474-919X.1952.tb01817.x; Leis JM, 2011, INTEGR COMP BIOL, V51, P826, DOI 10.1093/icb/icr004; Leis JM, 2003, MAR ECOL PROG SER, V252, P239, DOI 10.3354/meps252239; Leis JM, 2002, MAR ECOL PROG SER, V232, P259, DOI 10.3354/meps232259; Lohmann KJ, 2001, SCIENCE, V294, P364, DOI 10.1126/science.1064557; Mann DA, 2007, MAR ECOL PROG SER, V338, P307, DOI 10.3354/meps338307; Miller-Sims V, 2004, MOL ECOL NOTES, V4, P336, DOI 10.1111/j.1471-8286.2004.00689.x; Mouritsen H, 2000, J THEOR BIOL, V207, P283, DOI 10.1006/jtbi.2000.2171; Mouritsen H, 2003, AVIAN MIGRATION, P493; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Mouritsen H, 2013, P NATL ACAD SCI USA, V110, P7348, DOI 10.1073/pnas.1221701110; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Planes S, 1998, MAR BIOL, V130, P361, DOI 10.1007/s002270050256; QUINN TP, 1980, J COMP PHYSIOL, V137, P243, DOI 10.1007/BF00657119; Radford CA, 2011, CORAL REEFS, V30, P295, DOI 10.1007/s00338-010-0710-6; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Stobutzki IC, 1997, MAR ECOL PROG SER, V149, P35, DOI 10.3354/meps149035; Thorrold SR, 2006, CAN J FISH AQUAT SCI, V63, P1193, DOI 10.1139/F06-048; Tolimieri N, 2000, MAR ECOL PROG SER, V207, P219, DOI 10.3354/meps207219; Wehner R, 1998, J AVIAN BIOL, V29, P370, DOI 10.2307/3677156; WILTSCHKO R, 1978, OIKOS, V30, P195, DOI 10.2307/3543479; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	52	56	59	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66039	10.1371/journal.pone.0066039	http://dx.doi.org/10.1371/journal.pone.0066039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840396	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000321424400018
J	de Winter, J; Happee, R				de Winter, Joost; Happee, Riender			Why Selective Publication of Statistically Significant Results Can Be Effective	PLOS ONE			English	Article							PUBLISHED RESEARCH; FALSE; BIAS; SCIENCE; PSYCHOLOGY; REPLICABILITY; EPIDEMIOLOGY; VALIDITY; NULL	Concerns exist within the medical and psychological sciences that many published research findings are not replicable. Guidelines accordingly recommend that the file drawer effect should be eliminated and that statistical significance should not be a criterion in the decision to submit and publish scientific results. By means of a simulation study, we show that selectively publishing effects that differ significantly from the cumulative meta-analytic effect evokes the Proteus phenomenon of poorly replicable and alternating findings. However, the simulation also shows that the selective publication approach yields a scientific record that is content rich as compared to publishing everything, in the sense that fewer publications are needed for obtaining an accurate meta-analytic estimation of the true effect. We conclude that, under the assumption of self-correcting science, the file drawer effect can be beneficial for the scientific collective.	[de Winter, Joost; Happee, Riender] Delft Univ Technol, Dept BioMech Engn, Delft, Netherlands	Delft University of Technology	de Winter, J (corresponding author), Delft Univ Technol, Dept BioMech Engn, Delft, Netherlands.	j.c.f.dewinter@tudelft.nl	Happee, Riender/A-2621-2011; de Winter, Joost/AAD-7043-2020	Happee, Riender/0000-0001-5878-3472; de Winter, Joost/0000-0002-1281-8200				Alsheikh-Ali AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024357; Asendorpf JB, 2013, EUR J PERSONALITY, V27, P108, DOI 10.1002/per.1919; Bertamini M, 2012, PERSPECT PSYCHOL SCI, V7, P67, DOI 10.1177/1745691611429353; Binfield P, 2009, ELPUB2009 C EL PUBL, P69; Boffetta P, 2008, JNCI-J NATL CANCER I, V100, P988, DOI 10.1093/jnci/djn191; Bronowski J., 1979, ORIGINS KNOWLEDGE IM; Callaham ML, 1998, JAMA-J AM MED ASSOC, V280, P254, DOI 10.1001/jama.280.3.254; Cook C, 2010, J MAN MANIP THER, V18, P61, DOI 10.1179/106698110X12640740712617; Davison M, 2005, J EXP ANAL BEHAV, V83, P85, DOI 10.1901/jeab.2005.27-04; Dirnagl U, 2010, J CEREBR BLOOD F MET, V30, P1263, DOI 10.1038/jcbfm.2010.51; Drummond C, 2009, INT C MACH LEARN MON; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Fanelli D, 2012, SCIENTOMETRICS, V90, P891, DOI 10.1007/s11192-011-0494-7; Ferguson CJ, 2012, PERSPECT PSYCHOL SCI, V7, P555, DOI 10.1177/1745691612459059; Fiedler K, 2012, PERSPECT PSYCHOL SCI, V7, P661, DOI 10.1177/1745691612462587; Giner-Sorolla R, 2012, PERSPECT PSYCHOL SCI, V7, P562, DOI 10.1177/1745691612457576; Ioannidis J, 2012, FREIB GERM ANN LECT; Ioannidis J, 2013, J MATH PSYC IN PRESS; Ioannidis JPA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010036; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2012, PERSPECT PSYCHOL SCI, V7, P645, DOI 10.1177/1745691612464056; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; JAGACINSKI RJ, 1977, HUM FACTORS, V19, P331, DOI 10.1177/001872087701900403; John LK, 2012, PSYCHOL SCI, V23, P524, DOI 10.1177/0956797611430953; Makel MC, 2012, PERSPECT PSYCHOL SCI, V7, P537, DOI 10.1177/1745691612460688; Nelson LD, 2012, PSYCHOL INQ, V23, P291, DOI 10.1080/1047840X.2012.705245; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P531, DOI 10.1177/1745691612463401; Pautasso M, 2010, SCIENTOMETRICS, V85, P193, DOI 10.1007/s11192-010-0233-5; Pfeiffer T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018362; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Schooler J, 2011, NATURE, V470, P437, DOI 10.1038/470437a; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; STERLING TD, 1995, AM STAT, V49, P108, DOI 10.2307/2684823; Sune P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054583; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	41	27	27	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66463	10.1371/journal.pone.0066463	http://dx.doi.org/10.1371/journal.pone.0066463			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190LY	23840479	gold, Green Published			2022-12-27	WOS:000322342800064
J	Sceneay, J; Liu, MCP; Chen, A; Wong, CSF; Bowtell, DDL; Moller, A				Sceneay, Jaclyn; Liu, Mira C. P.; Chen, Anna; Wong, Christina S. F.; Bowtell, David D. L.; Moeller, Andreas			The Antioxidant N-Acetylcysteine Prevents HIF-1 Stabilization under Hypoxia In Vitro but Does Not Affect Tumorigenesis in Multiple Breast Cancer Models In Vivo	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; INDUCIBLE FACTOR 1-ALPHA; PAS DOMAIN PROTEIN-1; LUNG-CANCER; PROLYL HYDROXYLATION; RANDOMIZED-TRIAL; ORTHOTOPIC MODEL; PROSTATE-CANCER; TUMOR-GROWTH; O-2 TENSION	Intratumoral hypoxia is a poor prognostic factor associated with reduced disease-free survival in many cancer types, including breast cancer. Hypoxia encourages tumor cell proliferation, stimulates angiogenesis and lymphangiogenesis, and promotes epithelial-mesenchymal transition and metastasis. Tumor cells respond to a hypoxic state by stabilizing the Hif-1 alpha subunit of the Hypoxia-Inducible Factor (HIF) transcription factor to promote expression of various tumor-and metastasis-promoting hypoxic response genes. The antioxidant N-acetylcysteine (NAC) was recently shown to prevent Hif-1 alpha stabilization under hypoxia, and has been identified as a potential alternative method to target the hypoxic response in tumors. We utilized three orthotopic syngeneic murine models of breast cancer, the PyMT, EO771 and 4T1.2 models, to investigate the ability of NAC to modulate the hypoxic response in vitro and in vivo. While NAC prevented Hif-1 alpha stabilization under hypoxia in vitro and increased levels of glutathione in the blood of mice in vivo, this did not translate to a difference in tumor growth or the hypoxic state of the tumor compared to untreated control mice. In addition, NAC treatment actually increased metastatic burden in an experimental metastasis model. This work raises questions regarding the validity of NAC as an anti-tumorigenic agent in breast cancer, and highlights the need to further investigate its properties in vivo in different cancer models.	[Sceneay, Jaclyn; Liu, Mira C. P.; Chen, Anna; Bowtell, David D. L.] Peter MacCallum Canc Ctr, Canc Genom & Genet Lab, East Melbourne, Vic, Australia; [Sceneay, Jaclyn; Chen, Anna; Bowtell, David D. L.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Sceneay, Jaclyn; Wong, Christina S. F.; Moeller, Andreas] Queensland Inst Med Res, Tumour Microenvironm Lab, Herston, Qld 4006, Australia; [Bowtell, David D. L.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; University of Melbourne; QIMR Berghofer Medical Research Institute; Peter Maccallum Cancer Center; University of Melbourne	Moller, A (corresponding author), Queensland Inst Med Res, Tumour Microenvironm Lab, Bramston Terrace, Herston, Qld 4006, Australia.	andreas.moller@qimr.edu.au	Bowtell, David/H-1007-2016; Möller, Andreas/O-1063-2015; Wong, Christina SF/G-9972-2017	Bowtell, David/0000-0001-9089-7525; Möller, Andreas/0000-0002-8618-6998; Chen, Anna/0000-0002-2534-7014	Association of International Cancer Research [09/0676]; State Trustees Australia Foundation; National Breast Cancer Foundation Australia [ECF-11-09]	Association of International Cancer Research; State Trustees Australia Foundation; National Breast Cancer Foundation Australia	Association of International Cancer Research (www.aicr.org.uk) project grant (09/0676) to AM, State Trustees Australia Foundation (http://www.statetrustees.com.au/community/state-trustees-australia-foundation) scholarship to JS, National Breast Cancer Foundation Australia (www.nbcf.org.au) Fellowship (ECF-11-09) to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2004, AM J PATHOL, V164, P1683, DOI 10.1016/S0002-9440(10)63727-3; Aitio ML, 2006, BRIT J CLIN PHARMACO, V61, P5, DOI 10.1111/j.1365-2125.2005.02523.x; ALBINI A, 1995, INT J CANCER, V61, P121, DOI 10.1002/ijc.2910610121; Albini A, 2001, CANCER RES, V61, P8171; Allegra L, 2002, ARZNEIMITTEL-FORSCH, V52, P669; Bidwell B. N., 2012, NAT MED; Brok J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003328.pub2; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Calvani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038388; CASEY AE, 1951, P SOC EXP BIOL MED, V77, P358; D'Agostini F, 1998, INT J ONCOL, V13, P217; Davreux CJ, 1997, SHOCK, V8, P432, DOI 10.1097/00024382-199712000-00007; DeFlora S, 1996, INT J CANCER, V67, P842, DOI 10.1002/(SICI)1097-0215(19960917)67:6<842::AID-IJC14>3.0.CO;2-3; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heller AR, 2001, CRIT CARE MED, V29, P272, DOI 10.1097/00003246-200102000-00009; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Kallio PJ, 1999, J BIOL CHEM, V274, P6519, DOI 10.1074/jbc.274.10.6519; Kelloff G J, 1994, J Cell Biochem Suppl, V20, P63; Klein EA, 2001, J UROLOGY, V166, P1311, DOI 10.1016/S0022-5347(05)65759-X; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Kummar S, 2011, CLIN CANCER RES, V17, P5123, DOI 10.1158/1078-0432.CCR-11-0682; Lee K, 2009, P NATL ACAD SCI USA, V106, P2353, DOI 10.1073/pnas.0812801106; Lelekakis M, 1999, CLIN EXP METASTAS, V17, P163, DOI 10.1023/A:1006689719505; Liu M, 2005, CANCER RES, V65, P5325, DOI 10.1158/0008-5472.CAN-04-4589; LOEHRER PJ, 1986, CANCER TREAT REP, V70, P919; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Luwor RB, 2005, ONCOGENE, V24, P4433, DOI 10.1038/sj.onc.1208625; MAASILTA P, 1992, RADIOTHER ONCOL, V25, P192, DOI 10.1016/0167-8140(92)90267-X; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mantovani G, 2003, J MOL MED-JMM, V81, P664, DOI 10.1007/s00109-003-0476-1; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Millea PJ, 2009, AM FAM PHYSICIAN, V80, P265; Moeller BJ, 2007, CANCER METAST REV, V26, P241, DOI 10.1007/s10555-007-9056-0; Moller A, 2009, ONCOGENE, V28, P289, DOI 10.1038/onc.2008.382; MORGAN LR, 1982, EUR J CANCER CLIN ON, V18, P113, DOI 10.1016/0277-5379(82)90035-9; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; PASTORINO U, 1991, ONCOLOGY-BASEL, V48, P131; Pries AR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000394; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Sceneay J, 2012, CANC RES; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Shimojo Y, 2012, CLIN EXP METASTASIS; Sjoo F, 2003, BONE MARROW TRANSPL, V32, P349, DOI 10.1038/sj.bmt.1704143; Thomas GV, 2006, NAT MED, V12, P122, DOI 10.1038/nm1337; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; van Zandwijk N, 2000, JNCI-J NATL CANCER I, V92, P977, DOI 10.1093/jnci/92.12.977; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wong CSF, 2012, CANCER RES, V72, P1694, DOI 10.1158/0008-5472.CAN-11-3310; Young RJ, 2010, METHODS MOL BIOL, V611, P151, DOI 10.1007/978-1-60327-345-9_12; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001	66	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66388	10.1371/journal.pone.0066388	http://dx.doi.org/10.1371/journal.pone.0066388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840457	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800056
J	Yasui, K; Reimer, JD; Liu, YH; Yao, XY; Kubo, D; Shu, DG; Li, Y				Yasui, Kinya; Reimer, James D.; Liu, Yunhuan; Yao, Xiaoyong; Kubo, Daisuke; Shu, Degan; Li, Yong			A Diploblastic Radiate Animal at the Dawn of Cambrian Diversification with a Simple Body Plan: Distinct from Cnidaria?	PLOS ONE			English	Article							NEMATOSTELLA-VECTENSIS; SOUTHERN SHAANXI; ESTABLISHMENT; GASTRULATION; PUNCTATUS; METAZOAN; POSITION; POLARITY; CHINA; AXIS	Background: Microfossils of the genus Punctatus include developmental stages such as blastula, gastrula, and hatchlings, and represent the most complete developmental sequence of animals available from the earliest Cambrian. Despite the extremely well-preserved specimens, the evolutionary position of Punctatus has relied only on their conical remains and they have been tentatively assigned to cnidarians. We present a new interpretation of the Punctatus body plan based on the developmental reconstruction aided by recent advances in developmental biology. Results: Punctatus developed from a rather large egg, gastrulated in a mode of invagination from a coeloblastura, and then formed a mouth directly from the blastopore. Spiny benthic hatchlings were distinguishable from swimming or crawling ciliate larvae found in cnidarians and sponges. A mouth appeared at the perihatching embryonic stage and was renewed periodically during growth, and old mouths transformed into the body wall, thus elongating the body. Growing animals retained a small blind gut in a large body cavity without partitioning by septa and did not form tentacles, pedal discs or holdfasts externally. A growth center at the oral pole was sufficient for body patterning throughout life, and the body patterning did not show any bias from radial symmetry. Conclusions: Contrary to proposed cnidarian affinity, the Punctatus body plan has basic differences from that of cnidarians, especially concerning a spacious body cavity separating ectoderm from endoderm. The lack of many basic cnidarian characters in the body patterning of Punctatus leads us to consider its own taxonomic group, potentially outside of Cnidaria.	[Yasui, Kinya] Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Higashihiroshima, Hiroshima 724, Japan; [Reimer, James D.] Univ Ryukyus, Trans Disciplinary Org Subtrop Isl Studies, Rising Star Program, Nishihara, Okinawa 90301, Japan; [Liu, Yunhuan; Yao, Xiaoyong] Changan Univ, Univ Museum Geol, Xian, Peoples R China; [Liu, Yunhuan; Shu, Degan] Northwest Univ, Early Life Inst, Dept Geol, State Key Lab Continental Dynam, Xian, Shaanxi, Peoples R China; [Kubo, Daisuke] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Li, Yong] Changan Univ, Sch Earth Sci & Land Resources, Key Lab Western Chinas Mineral Resources & Geol, Xian, Peoples R China	Hiroshima University; University of the Ryukyus; Chang'an University; Northwest University Xi'an; University of Tokyo; Chang'an University	Yasui, K (corresponding author), Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Higashihiroshima, Hiroshima 724, Japan.	furaha@sci.hiroshima-u.ac.jp	Reimer, James Davis/AAP-1331-2020	yao, xiaoyong/0000-0002-9329-8955				Amiel A, 2009, DEV BIOL, V327, P191, DOI 10.1016/j.ydbio.2008.12.007; Bengtson S, 1997, SCIENCE, V277, P1645, DOI 10.1126/science.277.5332.1645; BLADESECKELBARGER PI, 1992, BIOL BULL-US, V182, P41, DOI 10.2307/1542179; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; Byrum C.A., 2004, P33; Chen F, 2008, CHINESE SCI BULL, V53, P3860, DOI 10.1007/s11434-008-0452-9; Chiori R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004231; Degnan BM, 2005, INTEGR COMP BIOL, V45, P335, DOI 10.1093/icb/45.2.335; Dong XP, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0071; Dornbos S. Q., 2000, GSATODAY GEOL SOC AM, V10, P2; Ereskovsky AV, 2010, COMPARATIVE EMBRYOLOGY OF SPONGES, P1, DOI 10.1007/978-90-481-8575-7; Freeman G., 1980, P97; FREEMAN G, 1977, J EMBRYOL EXP MORPH, V42, P237; Greeff R, 1869, Z WISS ZOOL, V20, P37; Han JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013276; Heip C, 1975, 10 EUR S MAR BIOL OS, V2, P285; Ishii H, 2003, J PLANKTON RES, V25, P1447, DOI 10.1093/plankt/fbg094; Kraus Y, 2006, DEV GENES EVOL, V216, P119, DOI 10.1007/s00427-005-0038-3; Lee PN, 2007, DEV BIOL, V310, P169, DOI 10.1016/j.ydbio.2007.05.040; Leme JDM, 2008, PALAEONTOLOGY, V51, P649, DOI 10.1111/j.1475-4983.2008.00775.x; Leys SP, 2002, INVERTEBR BIOL, V121, P171; Li P, 2007, CHINESE SCI BULL, V52, P2820, DOI 10.1007/s11434-007-0447-y; Li Z.P., 1984, SHAANXI GEOLOGY, V2, P73; Liu Yun-huan, 2009, Acta Palaeontologica Sinica, V48, P688; Martin VJ, 1977, BIOL BULL, V192, P345; Martindale MQ, 2009, DEV CELL, V17, P162, DOI 10.1016/j.devcel.2009.07.024; Martindale MQ, 1999, DEV BIOL, V214, P243, DOI 10.1006/dbio.1999.9427; Momose T, 2008, DEVELOPMENT, V135, P2105, DOI 10.1242/dev.021543; MORRIS SC, 1992, J PALEONTOL, V66, P384, DOI 10.1017/S0022336000033953; Pang K, 2008, DEV GENES EVOL, V218, P307, DOI 10.1007/s00427-008-0222-3; Ryan JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000153; Schuchert P, 2006, REV SUISSE ZOOL, V113, P325, DOI 10.5962/bhl.part.80356; Sendino C, 2011, ACTA PALAEONTOL POL, V56, P659, DOI 10.4202/app.2010.0028; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Steiner M, 2004, GEOBIOS-LYON, V37, P259, DOI 10.1016/j.geobios.2003.08.001; Tamulonis C, 2011, DEV BIOL, V351, P217, DOI 10.1016/j.ydbio.2010.10.017; Technau U, 2011, DEVELOPMENT, V138, P1447, DOI 10.1242/dev.048959; van Iten H., 1991, P145; Van Iten H, 2006, J SYST PALAEONTOL, V4, P109, DOI 10.1017/S1477201905001793; Van Iten H, 2010, PALAEONTOLOGY, V53, P191, DOI 10.1111/j.1475-4983.2009.00925.x; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; Yuan D, 2008, DEV GENES EVOL, V218, P525, DOI 10.1007/s00427-008-0254-8; Zhao Y, 1999, LETHAIA, V32, P181, DOI 10.1111/j.1502-3931.1999.tb00538.x	43	13	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65890	10.1371/journal.pone.0065890	http://dx.doi.org/10.1371/journal.pone.0065890			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840375	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800022
J	Epstein, JH; Baker, ML; Zambrana-Torrelio, C; Middleton, D; Barr, JA; DuBovi, E; Boyd, V; Pope, B; Todd, S; Crameri, G; Walsh, A; Pelican, K; Fielder, MD; Davies, AJ; Wang, LF; Daszak, P				Epstein, Jonathan H.; Baker, Michelle L.; Zambrana-Torrelio, Carlos; Middleton, Deborah; Barr, Jennifer A.; DuBovi, Edward; Boyd, Victoria; Pope, Brian; Todd, Shawn; Crameri, Gary; Walsh, Allyson; Pelican, Katey; Fielder, Mark D.; Davies, Angela J.; Wang, Lin-Fa; Daszak, Peter			Duration of Maternal Antibodies against Canine Distemper Virus and Hendra Virus in Pteropid Bats	PLOS ONE			English	Article							NIPAH VIRUS; EMERGING VIRUSES; RESERVOIR HOSTS; INFECTION; HENIPAVIRUS; VACCINATION; GIGANTEUS; PLACENTA; MEASLES	Old World frugivorous bats have been identified as natural hosts for emerging zoonotic viruses of significant public health concern, including henipaviruses (Nipah and Hendra virus), Ebola virus, and Marburg virus. Epidemiological studies of these viruses in bats often utilize serology to describe viral dynamics, with particular attention paid to juveniles, whose birth increases the overall susceptibility of the population to a viral outbreak once maternal immunity wanes. However, little is understood about bat immunology, including the duration of maternal antibodies in neonates. Understanding duration of maternally derived immunity is critical for characterizing viral dynamics in bat populations, which may help assess the risk of spillover to humans. We conducted two separate studies of pregnant Pteropus bat species and their offspring to measure the half-life and duration of antibodies to 1) canine distemper virus antigen in vaccinated captive Pteropus hypomelanus; and 2) Hendra virus in wild-caught, naturally infected Pteropus alecto. Both of these pteropid bat species are known reservoirs for henipaviruses. We found that in both species, antibodies were transferred from dam to pup. In P. hypomelanus pups, titers against CDV waned over a mean period of 228.6 days (95% CI: 185.4-271.8) and had a mean terminal phase half-life of 96.0 days (CI 95%: 30.7-299.7). In P. alecto pups, antibodies waned over 255.13 days (95% CI: 221.0-289.3) and had a mean terminal phase half-life of 52.24 days (CI 95%: 33.76-80.83). Each species showed a duration of transferred maternal immunity of between 7.5 and 8.5 months, which was longer than has been previously estimated. These data will allow for more accurate interpretation of age-related Henipavirus serological data collected from wild pteropid bats.	[Epstein, Jonathan H.; Zambrana-Torrelio, Carlos; Daszak, Peter] EcoHlth Alliance, New York, NY 10001 USA; [Baker, Michelle L.; Middleton, Deborah; Barr, Jennifer A.; Boyd, Victoria; Todd, Shawn; Crameri, Gary; Wang, Lin-Fa] CSIRO, Australian Anim Hlth Lab, Geelong, Vic, Australia; [DuBovi, Edward] Cornell Univ, Anim Hlth Diagnost Ctr, Ithaca, NY USA; [Pope, Brian] Lubee Bat Conservancy, Gainesville, FL USA; [Walsh, Allyson] San Diego Zoo Inst Conservat Res, Escondido, CA USA; [Pelican, Katey] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Epstein, Jonathan H.; Fielder, Mark D.; Davies, Angela J.] Univ Kingston, Fac Sci Engn & Comp, Kingston Upon Thames KT1 2EE, Surrey, England; [Wang, Lin-Fa] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore	EcoHealth Alliance; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Cornell University; Zoological Society of San Diego; University of Minnesota System; University of Minnesota Twin Cities; Kingston University; National University of Singapore	Epstein, JH (corresponding author), EcoHlth Alliance, New York, NY 10001 USA.	epstein@ecohealthalliance.org	Baker, Michelle/AAX-9171-2020; Crameri, Gary/H-8441-2013; daszak, peter/U-4588-2017; Zambrana-Torrelio, Carlos/AAH-3911-2020; wang, lin/GSE-3040-2022; Baker, Michelle L/C-9694-2013; amsalu, ribka/G-8780-2019	Baker, Michelle/0000-0002-7993-9971; daszak, peter/0000-0002-2046-5695; Zambrana-Torrelio, Carlos/0000-0002-5614-7496; Baker, Michelle L/0000-0002-7993-9971; Barr, Jennifer/0000-0001-5266-9142; Wang, Lin-Fa/0000-0003-2752-0535	National Institutes of Health (NIH) National Institute for Allergy and Infectious Disease [K08AI067549]; NIH Fogarty International Center [R01TW005869]; Australian Research Council [FT110100234]; Commonwealth Science and Industrial Research Organization OCE Science Leaders award; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI067549] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute for Allergy and Infectious Disease; NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Australian Research Council(Australian Research Council); Commonwealth Science and Industrial Research Organization OCE Science Leaders award; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by National Institutes of Health (NIH) National Institute for Allergy and Infectious Disease award K08AI067549; NIH Fogarty International Center award R01TW005869; Australian Research Council Future Fellowship FT110100234; Commonwealth Science and Industrial Research Organization OCE Science Leaders award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877; [Anonymous], 2004, ECOLOGY HENDRA VIRUS; Baker ML, 2013, ZOONOSES PUBLIC HLTH, V60, P104, DOI 10.1111/j.1863-2378.2012.01528.x; Baker ML, 2010, IMMUNOGENETICS, V62, P173, DOI 10.1007/s00251-010-0425-4; Bossart KN, 2007, J VIROL METHODS, V142, P29, DOI 10.1016/j.jviromet.2007.01.003; Bratsch S, 2011, DEV COMP IMMUNOL, V35, P421, DOI 10.1016/j.dci.2010.06.004; Broder CC, 2012, CURR OPIN VIROL, V2, P176, DOI 10.1016/j.coviro.2012.02.016; Butler JE, 2011, DEV COMP IMMUNOL, V35, P273, DOI 10.1016/j.dci.2010.08.011; Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Daniels P, 2001, MICROBES INFECT, V3, P289, DOI 10.1016/S1286-4579(01)01382-X; Drexler JF, 2011, EMERG INFECT DIS, V17, P449, DOI 10.3201/eid1703.100526; Enders AC, 2012, PLACENTA, V33, P319, DOI 10.1016/j.placenta.2012.02.008; Enders AC, 2004, PLACENTA, V25, pS3, DOI 10.1016/j.placenta.2004.01.011; Epstein JH, 2008, EMERG INFECT DIS, V14, P1309, DOI 10.3201/eid1408.071492; Epstein Jonathan H, 2006, Curr Infect Dis Rep, V8, P59, DOI 10.1007/s11908-006-0036-2; Hall L.S., 2000, FLYING FOXES FRUIT B; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Hasebe F, 2012, EMERG INFECT DIS, V18, P536, DOI 10.3201/eid1803.111121; Hayman DTS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002739; Henipavirus Ecology Research Group (HERG), 2006, P186; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Iehle C, 2007, EMERG INFECT DIS, V13, P159, DOI 10.3201/eid1301.060791; Johara MY, 2001, EMERG INFECT DIS, V7, P439; Jones DP, 2000, MAMMALIAN SPECIES, V639, P1, DOI [10.1644/1545-1410(2000)639<0001:PH>2.0.CO;2, DOI 10.1644/1545-1410(2000)639<0001:PH>2.0.CO;2]; Karim KB, 1996, ANN ANAT, V178, P523, DOI 10.1016/S0940-9602(96)80110-5; Kunz T., 2000, MAMMAL SPECIES, V642, P1, DOI 10.1644/1545-1410(2000)6422.0.co;2; Larson LJ, 2006, VET THER, V7, P113; Leuridan E, 2007, VACCINE, V25, P6296, DOI 10.1016/j.vaccine.2007.06.020; Leuridan E, 2010, BMJ, V340, pc1626, DOI 10.1136/bmj.c1626; Mestecky J, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Mouzin DE, 2004, JAVMA-J AM VET MED A, V224, P55, DOI 10.2460/javma.2004.224.55; Muller T, 2005, J VET MED B, V52, P432, DOI 10.1111/j.1439-0450.2005.00896.x; Olson JG, 2002, EMERG INFECT DIS, V8, P987, DOI 10.3201/eid0809.010515; Pastoret PP, 2007, J COMP PATHOL, V137, pS2, DOI 10.1016/j.jcpa.2007.04.003; Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201; Philbey AW, 2008, AUST VET J, V86, P449, DOI 10.1111/j.1751-0813.2008.00361.x; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Rahman SA, 2010, EMERG INFECT DIS, V16, P1990, DOI 10.3201/eid1612.091790; Sohayati AR, 2011, EPIDEMIOL INFECT, V139, P1570, DOI 10.1017/S0950268811000550; Sohayati AL, 2007, PTEROPUS HYPOMELANUS; TALIAFERRO WH, 1957, J CELL COMPAR PHYSL, V50, P1, DOI 10.1002/jcp.1030500403; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364; Wynne JW, PLOS ONE; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	52	30	30	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67584	10.1371/journal.pone.0067584	http://dx.doi.org/10.1371/journal.pone.0067584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826322	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000321150000090
J	Garg, R; Caino, MC; Kazanietz, MG				Garg, Rachana; Caino, M. Cecilia; Kazanietz, Marcelo G.			Regulation of Transcriptional Networks by PKC Isozymes: Identification of c-Rel as a Key Transcription Factor for PKC-Regulated Genes	PLOS ONE			English	Article							PROTEIN-KINASE-C; PROSTATE-CANCER CELLS; NF-KAPPA-B; ESTER-INDUCED APOPTOSIS; DELTA; ACTIVATION; EPSILON; RECEPTOR; PHOSPHORYLATION; EXPRESSION	Background: Activation of protein kinase C (PKC), a family of serine-threonine kinases widely implicated in cancer progression, has major impact on gene expression. In a recent genome-wide analysis of prostate cancer cells we identified distinctive gene expression profiles controlled by individual PKC isozymes and highlighted a prominent role for PKC delta in transcriptional activation. Principal Findings: Here we carried out a thorough bioinformatics analysis to dissect transcriptional networks controlled by PKC alpha, PKC delta, and PKC epsilon, the main diacylglycerol/phorbol ester PKCs expressed in prostate cancer cells. Despite the remarkable differences in the patterns of transcriptional responsive elements (REs) regulated by each PKC, we found that c-Rel represents the most frequent RE in promoters regulated by all three PKCs. In addition, promoters of PKC delta-regulated genes were particularly enriched with REs for CREB, NF-E2, RREB, SRF, Oct-1, Evi-1, and NF-kappa B. Most notably, by using transcription factor-specific RNAi we were able to identify subsets of PKC delta-regulated genes modulated by c-Rel and CREB. Furthermore, PKC delta-regulated genes condensed under the c-Rel transcriptional regulation display significant functional interconnections with biological processes such as angiogenesis, inflammatory response, and cell motility. Conclusion/Significance: Our study identified candidate transcription factors in the promoters of PKC regulated genes, in particular c-Rel was found as a key transcription factor in the control of PKC delta-regulated genes. The deconvolution of PKC-regulated transcriptional networks and their nodes may greatly help in the identification of PKC effectors and have significant therapeutics implications.	[Garg, Rachana; Caino, M. Cecilia; Kazanietz, Marcelo G.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Kazanietz, MG (corresponding author), Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA.	marcelog@upenn.edu	Garg, Rachana/AAQ-9518-2020	Garg, Rachana/0000-0002-7808-1053; Caino, M. Cecilia/0000-0001-8294-8070	NIH [R01-CA89202]; Prostate Cancer Research Program of Department of Defense Congressionally Directed Medical Research Program; NATIONAL CANCER INSTITUTE [R01CA089202] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Research Program of Department of Defense Congressionally Directed Medical Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R01-CA89202 from NIH to M.G.K. R.G. is supported by a post-doctoral fellowship from the Prostate Cancer Research Program of Department of Defense Congressionally Directed Medical Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Kandil A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029934; Aziz MH, 2007, CANCER RES, V67, P8828, DOI 10.1158/0008-5472.CAN-07-1604; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Belguise K, 2007, J CLIN INVEST, V117, P4009, DOI 10.1172/JCI32424; Benavides F, 2011, CELL CYCLE, V10, P268, DOI 10.4161/cc.10.2.14469; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Caino MC, 2012, ONCOGENE, V31, P2593, DOI 10.1038/onc.2011.428; Caino MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031714; Caino MC, 2011, J BIOL CHEM, V286, P11254, DOI 10.1074/jbc.M110.194332; Chen XF, 2003, CANCER RES, V63, P1059; CHIU R, 1987, NATURE, V329, P648, DOI 10.1038/329648a0; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; Diaz-Meco MT, 2012, IMMUNOL REV, V246, P154, DOI 10.1111/j.1600-065X.2012.01093.x; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Garg R, 2008, CARCINOGENESIS, V29, P1249, DOI 10.1093/carcin/bgn114; Garg R, 2012, J BIOL CHEM, V287, P37570, DOI 10.1074/jbc.M112.398925; Gilmore Thomas D, 2011, Genes Cancer, V2, P695, DOI 10.1177/1947601911421925; Gonye Gregory E., 2007, V408, P49, DOI 10.1007/978-1-59745-547-3_4; Gonzalez-Guerrico AM, 2005, J BIOCHEM MOL BIOL, V38, P639; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gugasyan R, 2004, MOL CELL BIOL, V24, P5733, DOI 10.1128/MCB.24.13.5733-5745.2004; Gutierrez-Uzquiza A, 2012, J BIOL CHEM, V287, P2632, DOI 10.1074/jbc.M111.323709; Hsia CY, 2002, INT IMMUNOL, V14, P905, DOI 10.1093/intimm/dxf055; Kenneth NS, 2010, EMBO J, V29, P2966, DOI 10.1038/emboj.2010.171; Kharait S, 2006, BIOCHEM BIOPH RES CO, V343, P848, DOI 10.1016/j.bbrc.2006.03.044; King KE, 2008, CANCER RES, V68, P5122, DOI 10.1158/0008-5472.CAN-07-6123; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Loegering Daniel J, 2011, Enzyme Res, V2011, P537821, DOI 10.4061/2011/537821; Meng Y, 2008, MOL CANCER THER, V7, P2192, DOI 10.1158/1535-7163.MCT-08-0333; Meshki J, 2010, J BIOL CHEM, V285, P26033, DOI 10.1074/jbc.M110.128371; Meyer CF, 1996, J BIOL CHEM, V271, P8971, DOI 10.1074/jbc.271.15.8971; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Mukhopadhyay NK, 2006, EXP CELL RES, V312, P3782, DOI 10.1016/j.yexcr.2006.07.017; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Ng SW, 2012, NATURE, V482, P111, DOI 10.1038/nature10731; Parthasarathy S, 2011, J GASTROEN HEPATOL, V26, P382, DOI 10.1111/j.1440-1746.2010.06526.x; Persaud SD, 2005, INT J ONCOL, V27, P149; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Satomi Y, 2012, ANTICANCER RES, V32, P807; Sumitomo M, 2002, J CLIN INVEST, V109, P827, DOI 10.1172/JCI200214146; TAN TH, 1992, MOL CELL BIOL, V12, P4067, DOI 10.1128/MCB.12.9.4067; Vadigepalli Rajanikanth, 2003, OMICS A Journal of Integrative Biology, V7, P235, DOI 10.1089/153623103322452378; Villar J, 2007, CANCER RES, V67, P10859, DOI 10.1158/0008-5472.CAN-07-2041; von Burstin VA, 2010, MOL PHARMACOL, V78, P325, DOI 10.1124/mol.110.064741; Wang HB, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227991; Wermuth PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027110; WU HC, 1994, INT J CANCER, V57, P406, DOI 10.1002/ijc.2910570319; Xiao LQ, 2009, J BIOL CHEM, V284, P29365, DOI 10.1074/jbc.M109.007971; Xiao LQ, 2009, MOL CARCINOGEN, V48, P187, DOI 10.1002/mc.20476; Yoshida K, 2006, J BIOL CHEM, V281, P5734, DOI 10.1074/jbc.M512074200; Zhu Tongbo, 2010, Genes Cancer, V1, P142, DOI 10.1177/1947601909360989	55	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67319	10.1371/journal.pone.0067319	http://dx.doi.org/10.1371/journal.pone.0067319			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826267	gold, Green Submitted, Green Published			2022-12-27	WOS:000321150000062
J	Williams, RL; Goodenough, AE; Hart, AG; Stafford, R				Williams, Rachel L.; Goodenough, Anne E.; Hart, Adam G.; Stafford, Richard			Using Long-Term Volunteer Records to Examine Dormouse (Muscardinus avellanarius) Nestbox Selection	PLOS ONE			English	Article							COMMON DORMOUSE; SITE SELECTION; NESTING-BEHAVIOR; CONSERVATION; SCIENCE; PROGRAMS; SUCCESS; EDGE; L.	Within ecology, there are unanswered questions about species-habitat interactions, which could potentially be resolved by a pragmatic analysis of a long-term volunteer-collected dataset. Here, we analysed 18 years of volunteer-collected data from a UK dormouse nestbox monitoring programme to determine the influence of habitat variables on nestbox choice by common dormice (Muscardinus avellanarius). We measured a range of habitat variables in a coppiced woodland in Gloucestershire, UK, and analysed these in relation to dormouse nestbox occupancy records (by dormice, other small mammals, and birds) collected by volunteers. While some characteristics of the woodland had changed over 18 years, simple transformation of the data and interpretation of the results indicated that the dataset was informative. Using stepwise regressions, multiple environmental and ecological factors were found to determine nestbox selection. Distance from the edge of the wood was the most influential (this did not change over 18 years), with boxes in the woodland interior being selected preferentially. There was a significant negative relationship with the presence of ferns (indicative of damp shady conditions). The presence of oak (a long-lived species), and the clumped structural complexity of the canopy were also important factors in the final model. There was no evidence of competition between dormice and birds or other mammals. The results provide greater understanding of artificial dormouse nest-site requirements and indicate that, in terms of habitat selection, long-term volunteer-collected datasets contribute usefully to understanding the requirements of species with an important conservation status.	[Williams, Rachel L.; Goodenough, Anne E.; Hart, Adam G.] Univ Gloucestershire, Sch Nat & Social Sci, Cheltenham, Glos, England; [Stafford, Richard] Bournemouth Univ, Sch Appl Sci, Poole BH12 5BB, Dorset, England	University of Gloucestershire; Bournemouth University	Williams, RL (corresponding author), Univ Gloucestershire, Sch Nat & Social Sci, Cheltenham, Glos, England.	rachel.williams_31@hotmail.com	Stafford, Rick/B-1059-2013	Stafford, Rick/0000-0002-1964-5787; Goodenough, Anne/0000-0002-7662-6670				ANDREN H, 1992, ECOLOGY, V73, P794, DOI 10.2307/1940158; Batary P, 2004, CONSERV BIOL, V18, P389, DOI 10.1111/j.1523-1739.2004.00184.x; Bracewell M, 2009, NEST MAT PREFERENCES; Brewer C, 2002, CONSERV BIOL, V16, P4, DOI 10.1046/j.1523-1739.2002.01613.x; BRIGHT PW, 1994, J APPL ECOL, V31, P329, DOI 10.2307/2404547; BRIGHT PW, 1992, J ZOOL, V226, P589, DOI 10.1111/j.1469-7998.1992.tb07502.x; BRIGHT PW, 1991, J ZOOL, V224, P177, DOI 10.1111/j.1469-7998.1991.tb04797.x; BRIGHT PW, 1990, BIOL CONSERV, V54, P307, DOI 10.1016/0006-3207(90)90143-D; Carey AB, 1997, J WILDLIFE MANAGE, V61, P684, DOI 10.2307/3802176; Chanin P, 2003, 524 ENGL NAT; Cosarinsky MI, 2012, J INSECT BEHAV, V25, P222, DOI 10.1007/s10905-011-9290-8; Crick HQP, 2003, BIRD STUDY, V50, P254, DOI 10.1080/00063650309461318; Cudworth NL, 2011, J WILDLIFE MANAGE, V75, P1668, DOI 10.1002/jwmg.194; Devictor V, 2010, DIVERS DISTRIB, V16, P354, DOI 10.1111/j.1472-4642.2009.00615.x; Eden S, 2009, LIVING DORMICE; England Natural, 2008, LIC APPL FORMS; Evans C, 2005, CONSERV BIOL, V19, P589, DOI 10.1111/j.1523-1739.2005.00s01.x; Fowler J., 1998, PRACTICAL STAT FIELD, P130; Goodenough A. E., 2012, ISRN Ecology, V2012, P619842; Goodenough AE, 2009, ACTA OECOL, V35, P598, DOI 10.1016/j.actao.2009.05.003; Goodenough AE, 2008, ETHOL ECOL EVOL, V20, P375, DOI 10.1080/08927014.2008.9522518; Goswami A, 2007, RESOUR ENERG DEV, V4, P89; Harris S, 2004, MAMMAL REV, V34, P157, DOI 10.1046/j.0305-1838.2003.00030.x; Higby Louisa K., 2012, International Journal of Zoology, V2012, P1; Irwin A., 1995, CITIZEN SCI STUDY PE, DOI DOI 10.4324/9780203202395; Jukaitis R, 2000, EST J ECOL, V5, P42; Juskaitis R, 2003, FOLIA ZOOL, V52, P239; Juskaitis Rimvydas, 2007, Acta Zoologica Lituanica, V17, P151; Juskaitis R, 2007, POL J ECOL, V55, P795; Juskaitis Rimvydas, 1997, Natura Croatica, V6, P177; Kaneko Y., 2010, INT J ECOL, V2010; Kilgas P, 2012, J ORNITHOL, V153, P833, DOI 10.1007/s10336-011-0801-3; Koops K, 2012, AM J PHYS ANTHROPOL, V148, P351, DOI 10.1002/ajpa.22056; Kuroe M, 2007, ACTA THERIOL, V52, P355, DOI 10.1007/BF03194233; Lutermann H, 2010, ANIM BEHAV, V79, P1211, DOI 10.1016/j.anbehav.2010.02.017; Magana M, 2010, IBIS, V152, P77, DOI 10.1111/j.1474-919X.2009.00976.x; Marsh ACW, 2000, ACTA THERIOL, V45, P443, DOI 10.4098/AT.arch.00-45; McCaffrey Rachel E., 2005, Urban Habitats, V3, P70; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; MINOT EO, 1986, J ANIM ECOL, V55, P331, DOI 10.2307/4712; MORRIS DW, 1991, AM NAT, V138, P702, DOI 10.1086/285244; MORRIS PA, 1990, BIOL CONSERV, V51, P1, DOI 10.1016/0006-3207(90)90027-M; Newman C, 2003, BIOL CONSERV, V113, P189, DOI 10.1016/S0006-3207(02)00374-9; dos Santos AJN, 2012, SCI AGR, V69, P281, DOI 10.1590/S0103-90162012000400008; Page CN, 1997, FERNS BRITAIN IRELAN; PATON PWC, 1994, CONSERV BIOL, V8, P17, DOI 10.1046/j.1523-1739.1994.08010017.x; PTES, 2012, DORM MON; PTES and Natural England, 2012, NAT DORM MON PROGR S; RICHARDS CGJ, 1984, MAMMAL REV, V14, P19, DOI 10.1111/j.1365-2907.1984.tb00335.x; Sara M, 2003, ACTA ZOOL HUNG S1, V49; Smith GC, 2007, WILDLIFE RES, V34, P427; Solomon NG, 2005, J MAMMAL, V86, P555, DOI 10.1644/1545-1542(2005)86[555:FANLOP]2.0.CO;2; Thode H.C., 2002, TESTING NORMALITY; Wolton R, 2009, MAMMALIA, V73, P7, DOI 10.1515/MAMM.2009.001	54	12	13	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67986	10.1371/journal.pone.0067986	http://dx.doi.org/10.1371/journal.pone.0067986			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826351	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000105
J	Dmitrieva, L; Kondakov, AA; Oleynikov, E; Kydyrmanov, A; Karamendin, K; Kasimbekov, Y; Baimukanov, M; Wilson, S; Goodman, SJ				Dmitrieva, Lilia; Kondakov, Andrey A.; Oleynikov, Eugeny; Kydyrmanov, Aidyn; Karamendin, Kobey; Kasimbekov, Yesbol; Baimukanov, Mirgaliy; Wilson, Susan; Goodman, Simon J.			Assessment of Caspian Seal By-Catch in an Illegal Fishery Using an Interview-Based Approach	PLOS ONE			English	Article							MARINE MEGAFAUNA; CONSERVATION; BYCATCH; IMPACTS	The Caspian seal (Pusa caspica) has declined by more than 90% since 1900 and is listed as endangered by IUCN. We made the first quantitative assessment of Caspian seal by-catch mortality in fisheries in the north Caspian Sea by conducting semi-structured interviews in fishing communities along the coasts of Russia (Kalmykia, Dagestan), Kazakhstan and Turkmenistan. We recorded a documented minimum by-catch of 1,215 seals in the survey sample, for the 2008-2009 fishing season, 93% of which occurred in illegal sturgeon fisheries. Due to the illegal nature of the fishery, accurately quantifying total fishing effort is problematic and the survey sample could reflect less than 10% of poaching activity in the north Caspian Sea. Therefore total annual by-catch may be significantly greater than the minimum documented by the survey. The presence of high by-catch rates was supported independently by evidence of net entanglement from seal carcasses, during a mass stranding on the Kazakh coast in May 2009, where 30 of 312 carcasses were entangled in large mesh sturgeon net remnants. The documented minimum by-catch may account for 5 to 19% of annual pup production. Sturgeon poaching therefore not only represents a serious threat to Caspian sturgeon populations, but may also be having broader impacts on the Caspian Sea ecosystem by contributing to a decline in one of the ecosystem's key predators. This study demonstrates the utility of interview-based approaches in providing rapid assessments of by-catch in illegal small-scale fisheries, which are not amenable to study by other methods.	[Dmitrieva, Lilia; Goodman, Simon J.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [Kondakov, Andrey A.; Oleynikov, Eugeny] Russian Acad Sci, Southern Sci Ctr, Inst Arid Zones, Rostov Na Donu, Russia; [Kydyrmanov, Aidyn; Karamendin, Kobey] Inst Microbiol & Virol, Alma Ata, Kazakhstan; [Kasimbekov, Yesbol; Baimukanov, Mirgaliy] Inst Hydrobiol & Ecol, Karasaysky Raion, Almaty, Kazakhstan; [Wilson, Susan] Tara Seal Res Ctr, Killyleagh, County Down, North Ireland	University of Leeds; Institute of Arid Zones; Russian Academy of Sciences; Southern Scientific Center, Russian Academy of Sciences; Institute of Microbiology & Virology Kazakhstan; Institute of Hydrobiology & Ecology	Dmitrieva, L (corresponding author), Univ Leeds, Sch Biol, Leeds, W Yorkshire, England.	sealilia@gmail.com; s.j.goodman@leeds.ac.uk	Baimukanov, Mirgaliy/AAS-1254-2020; Karamendin, Kobey/ABF-8722-2021; Karamendin, Kobey/AAQ-1903-2020; Kydyrmanov, Aidyn/P-8825-2019	Karamendin, Kobey/0000-0003-0829-3330; Kydyrmanov, Aidyn/0000-0002-8374-6128; Goodman, Simon/0000-0003-4118-8575; Baimukanov, Mirgaliy/0000-0002-5039-3901	Darwin Initiative grant from United Kingdom government's Department of Environment, Food and Rural Affairs (DEFRA) [162-15-24]	Darwin Initiative grant from United Kingdom government's Department of Environment, Food and Rural Affairs (DEFRA)	This study was supported by Darwin Initiative grant 162-15-24, from the United Kingdom government's Department of Environment, Food and Rural Affairs (DEFRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIERNACKI P, 1981, SOCIOL METHOD RES, V10, P141, DOI 10.1177/004912418101000205; Faugier J, 1997, J ADV NURS, V26, P790, DOI 10.1046/j.1365-2648.1997.00371.x; Gavin MC, 2010, CONSERV BIOL, V24, P89, DOI 10.1111/j.1523-1739.2009.01387.x; Goldsworthy SD, 2007, BIOL CONSERV, V139, P269, DOI 10.1016/j.biocon.2007.07.010; Goodman SJ, 2012, COLLECTION IN PRESS; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Harkonen T, 2008, IUCN RED LIST THREAT; Harkonen T, 2008, AMBIO, V37, P356, DOI 10.1579/07-R-345.1; Harkonen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043130; IUCN, 2012, IUCN RED LIST THREAT; Karamanlidis Alexandros A., 2008, Endangered Species Research, V5, P205, DOI 10.3354/esr00092; Krylov V.I., 1990, Finnish Game Research, V47, P32; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Lopez A, 2003, BIOL CONSERV, V111, P25, DOI 10.1016/S0006-3207(02)00244-6; Moore JE, 2010, BIOL CONSERV, V143, P795, DOI 10.1016/j.biocon.2009.12.023; Pourkazemi M, 2006, J APPL ICHTHYOL, V22, P12, DOI 10.1111/j.1439-0426.2007.00923.x; Ranta E, 1996, AMBIO, V25, P363; Rojas-Bracho L, 2006, MAMMAL REV, V36, P179, DOI 10.1111/j.1365-2907.2006.00088.x; Russian Federal Fisheries Agency Order N825, 2010, APPR TOT ALL CATCH A; Sipil? T., 2003, THESIS U HELSINKI; Strukova E, 2010, STUDY EC BIORESOURCE; Verevkin M., 2008, P 5 INT C MAR MAMM H, P562; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x; Zydelis R, 2009, CONSERV BIOL, V23, P608, DOI 10.1111/j.1523-1739.2009.01172.x	24	20	20	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67074	10.1371/journal.pone.0067074	http://dx.doi.org/10.1371/journal.pone.0067074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840590	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400069
J	Raybaud, V; Beaugrand, G; Goberville, E; Delebecq, G; Destombe, C; Valero, M; Davoult, D; Morin, P; Gevaert, F				Raybaud, Virginie; Beaugrand, Gregory; Goberville, Eric; Delebecq, Gaspard; Destombe, Christophe; Valero, Myriam; Davoult, Dominique; Morin, Pascal; Gevaert, Francois			Decline in Kelp in West Europe and Climate	PLOS ONE			English	Article							LAMINARIA-DIGITATA; PATTERNS; SEAWEEDS; MACROALGAE; TEMPERATE; IMPACT; ERRORS	Kelp ecosystems form widespread underwater forests playing a major role in structuring the biodiversity at a regional scale. Some seaweeds such as Laminaria digitata are also economically important, being exploited for their alginate and iodine content. Although some studies have shown that kelp ecosystems are regressing and that multiple causes are likely to be at the origin of the disappearance of certain populations, the extent to which global climate change may play a role remains speculative. Here we show that many populations of L. digitata along European coasts are on the verge of local extinction due to a climate-caused increase in sea temperature. By modeling the spatial distribution of the seaweed, we evaluate the possible implications of global climate change for the geographical patterns of the species using temperature data from the Coupled Model Intercomparison Project phase 5 (CMIP5). Projections of the future range of L. digitata throughout the 21st century show large shifts in the suitable habitat of the kelp and a northward retreat of the southern limit of its current geographic distribution from France to Danish coasts and the southern regions of the United Kingdom. However, these projections depend on the intensity of warming. A medium to high warming is expected to lead to the extirpation of the species as early as the first half of the 21st century and there is high confidence that regional extinction will spread northwards by the end of this century. These changes are likely to cause the decline of species whose life cycle is closely dependent upon L. digitata and lead to the establishment of new ecosystems with lower ecological and economic values.	[Raybaud, Virginie; Beaugrand, Gregory; Goberville, Eric; Delebecq, Gaspard; Gevaert, Francois] Univ Lille 1, UMR LOG 8187, Lab Oceanol & Geosci, Wimereux, France; [Raybaud, Virginie; Beaugrand, Gregory; Goberville, Eric; Delebecq, Gaspard; Gevaert, Francois] CNRS, UMR LOG 8187, Lab Oceanol & Geosci, Wimereux, France; [Beaugrand, Gregory] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England; [Goberville, Eric] Univ Lille 1, UMR GEPV 8198, Lab Genet & Evolut Populat Vegetales, F-59655 Villeneuve Dascq, France; [Destombe, Christophe; Valero, Myriam; Davoult, Dominique; Morin, Pascal] Univ Paris 06, UMR AD2M 7144, Lab Adaptat & Divers Milieu Marin, Stn Biol Roscoff, Roscoff, France; [Destombe, Christophe; Valero, Myriam; Davoult, Dominique; Morin, Pascal] CNRS, UMR AD2M 7144, Lab Adaptat & Divers Milieu Marin, Stn Biol Roscoff, Roscoff, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite	Raybaud, V (corresponding author), Univ Lille 1, UMR LOG 8187, Lab Oceanol & Geosci, Wimereux, France.	virginie.raybaud@univ-lille1.fr	Morin, Pascal/A-1112-2016; Valero, Myriam/C-7550-2011; Goberville, Eric/A-2621-2017; Davoult, dominique/D-5932-2012; Valero, Myriam/M-6052-2019; Gevaert, Francois/B-9629-2018	Morin, Pascal/0000-0003-2766-1821; Valero, Myriam/0000-0002-9000-1423; Goberville, Eric/0000-0002-1843-7855; Davoult, dominique/0000-0001-8678-3998; Valero, Myriam/0000-0002-9000-1423; Gevaert, Francois/0000-0002-5078-1154; Destombe, Christophe/0000-0001-5656-9659; BEAUGRAND, GREGORY/0000-0002-0712-5223; Raybaud, Virginie/0000-0001-6426-3326	"region Nord-Pas de Calais", through the program BIODIMAR; Centre National de la Recherche Scientifique (CNRS)	"region Nord-Pas de Calais", through the program BIODIMAR(Region Hauts-de-France); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the "region Nord-Pas de Calais", through the program BIODIMAR and the "Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker J.G., 2007, EOS T AM GEOPHYS UN, V88, P14, DOI [DOI 10.1029/2007EO020003, 10.1029/2007EO020003]; [Anonymous], 1998, LAMINAIRES COTES BRE; Bartsch I, 2008, EUR J PHYCOL, V43, P1, DOI 10.1080/09670260701711376; Beaugrand G, 2011, MAR ECOL PROG SER, V424, P175, DOI 10.3354/meps08939; Beaugrand G, 2009, DEEP-SEA RES PT II, V56, P656, DOI 10.1016/j.dsr2.2008.12.022; Bekkby T, 2011, DEV SPATIAL MODELS S; Bekkby T, 2009, ICES J MAR SCI, V66, P2106, DOI 10.1093/icesjms/fsp195; Billot C, 2003, MARINE ECOLOGY PROGR, V253, P21; Birkett D, 1998, OVERVIEW DYNAMIC SEN, VVII, P174; BOLTON JJ, 1982, MAR BIOL, V66, P89, DOI 10.1007/BF00397259; BREEMAN AM, 1994, BOT MAR, V37, P171, DOI 10.1515/botm.1994.37.3.171; Casey KS, 2010, OCEANOGRAPHY FROM SPACE: REVISITED, P273, DOI 10.1007/978-90-481-8681-5_16; Clayton MN, 1997, POLAR BIOL, V17, P141, DOI 10.1007/s003000050116; Cosson J, 1999, CRYPTOGAMIE ALGOL, V20, P35, DOI 10.1016/S0181-1568(99)80005-1; Cosson J, 1973, SOC PHYCOL FRANCE B, P104; Davoult D, 2011, CAH BIOL MAR, V52, P429; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Elton C., 1927, ANIMAL ECOLOGY; Engelen AH, 2011, CAH BIOL MAR, V52, P441; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gayral P, 1973, EXPOSE SYNOPTIQUE DO; Gevaert F, 2008, J SEA RES, V60, P215, DOI 10.1016/j.seares.2008.06.006; Grinnell J., 1917, Auk Cambridge Mass, V34; Hardy F, 2006, CHECK LIST ATLAS SEA; Hawkins SJ, 2008, CLIM RES, V37, P123, DOI 10.3354/cr00768; Hawkins SJ, 2009, MAR ECOL PROG SER, V396, P245, DOI 10.3354/meps08378; HAWKINS SJ, 1985, MAR ECOL PROG SER, V20, P265, DOI 10.3354/meps020265; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; IBANEZ F, 1981, LIMNOL OCEANOGR, V26, P336, DOI 10.4319/lo.1981.26.2.0336; Karsten U, 2007, PHYCOL RES, V55, P257, DOI 10.1111/j.1440-1835.2007.00468.x; Laepple T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033576; Legendre P., 2012, NUMERICAL ECOLOGY; Lenoir S, 2011, GLOBAL CHANGE BIOL, V17, P115, DOI 10.1111/j.1365-2486.2010.02229.x; Levitus S., 1982, CLIMATOLOGICAL ATLAS; Lippert H, 2001, POLAR BIOL, V24, P512; Luning K, 1990, SEAWEEDS THEIR ENV B; MANN KH, 1973, SCIENCE, V182, P975, DOI 10.1126/science.182.4116.975; Meleder V, 2010, MAR BIOL, V157, P1525, DOI 10.1007/s00227-010-1426-4; MIELKE PW, 1981, MON WEATHER REV, V109, P120, DOI 10.1175/1520-0493(1981)109<0120:AOMRPP>2.0.CO;2; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Muller R, 2009, BOT MAR, V52, P617, DOI 10.1515/BOT.2009.080; Pedersen M, 2001, HYDROBIOLOGIA, V459, P83, DOI 10.1023/A:1012506507322; Perez R., 1971, Revue des Travaux, Institut des Peches Maritimes, V35, P287; Peterson AT, 2001, BIOSCIENCE, V51, P363, DOI 10.1641/0006-3568(2001)051[0363:PSIUEN]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Podesta GP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017178; Raybaud V, 2011, J MARINE SYST, V84, P1, DOI 10.1016/j.jmarsys.2010.08.001; Rombouts I, 2012, ESTUAR COAST SHELF S, V99, P153, DOI 10.1016/j.ecss.2011.12.026; Sainsbury K.J., 1982, THEORY MANAGEMENT TR, V360, P167; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; STOCKWELL DRB, 2007, NICHE MODELING PREDI; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Valero M, 2011, CAH BIOL MAR, V52, P467; Van den Hoek C, 1990, DEV HYDROBIOL, P57; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x; WHITTAKER RH, 1973, AM NAT, V107, P321, DOI 10.1086/282837; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]	59	111	112	12	221	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66044	10.1371/journal.pone.0066044	http://dx.doi.org/10.1371/journal.pone.0066044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840397	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400019
J	Zhang, MM; Zhang, S; Wu, J; Sun, Y; Li, LL; Du, WJ; Liu, JJ; Hou, JB; Yu, B				Zhang, Maomao; Zhang, Shuo; Wu, Jian; Sun, Yong; Li, Lili; Du, Wenjuan; Liu, Jingjin; Hou, Jingbo; Yu, Bo			The Immunosuppressant Protosappanin A Promotes Dendritic Cell-Mediated Expansion of Alloantigen-Specific Tregs and Prolongs Allograft Survival in Rats	PLOS ONE			English	Article							REGULATORY T-CELLS; DONOR LYMPHOCYTE INFUSION; IN-VIVO; TRANSPLANTATION TOLERANCE; GRAFT-REJECTION; INDUCTION; CD4(+)CD25(+); ACTIVATION; MATURATION; IMMUNITY	Protosappanin A (PrA), an immunosuppressive ingredient of the medicinal herb Caesalpinia sappan L, prolongs heart allograft survival in rats, possibly by impairing the function of antigen-presenting cells (APCs). We examined the effects of PrA on the maturation and function of dendritic cells (DCs), a potent class of APCs, and the downstream cell-cell and intracellular signaling pathways mediating the immunosuppressive activity of PrA. PrA inhibited LPS-stimulated maturation of Wistar rat DCs in vitro as reflected by reduced expression of costimulatory molecules (CD80 and CD86) and reduced expression of TLR4 and NF-kappa B, two critical signaling components for antigen recognition. PrA also enhanced the release of IL-10 and decreased the release of IL-12 from DCs, but had no effect on the production of TGF-beta. In mixed cultures, Wistar DCs pretreated with PrA impaired the proliferation of Sprague Dawley (SD) rat T cells while promoting the expansion of SD rat CD4(+)CD25(+) regulatory T cells (Tregs). Both oral PrA treatment and infusion of PrA-pretreated Wistar DCs prolonged cardiac allograft survival (Wistar donor, SD recipient) and expanded recipient CD4(+)CD25(+)Foxp3(+) Tregs. Donor spleen cells, but not spleen cells from a third rat strain (DA), supported the expansion of recipient CD4(+)CD25(+)Foxp3(+) Tregs and suppressed recipient T cell proliferation. We conclude that PrA triggers a tolerogenic state in DCs that allows for the induction of alloantigen-specific Tregs and the suppression of allograft rejection in vivo.	[Zhang, Maomao; Zhang, Shuo; Wu, Jian; Li, Lili; Du, Wenjuan; Liu, Jingjin; Hou, Jingbo; Yu, Bo] Chinese Minist Educ, Key Lab Myocardial Ischemia, Harbin, Heilongjiang Pr, Peoples R China; [Zhang, Maomao; Zhang, Shuo; Wu, Jian; Sun, Yong; Li, Lili; Du, Wenjuan; Liu, Jingjin; Hou, Jingbo; Yu, Bo] Harbin Med Univ, Affiliated Hosp 2, Dept Cardiol, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University	Hou, JB (corresponding author), Chinese Minist Educ, Key Lab Myocardial Ischemia, Harbin, Heilongjiang Pr, Peoples R China.	jingbohou@163.com		Hou, Jingbo/0000-0002-9671-5099	National Natural Science Foundation of China [81200180]; New Teachers' Fund for Doctor Stations, Ministry of Education [20122307120021]; Postdoctoral Foundation of China [2011M501065]; Foundation of Heilongjiang Educational Committee [12531286]; Key Laboratory of Myocardial Ischemia Mechanism and Treatment (Harbin Medical University, Ministry of Education) [KF201001, KF201211]; Second Affliated Hospital of Harbin Medical University [BS2011-18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Teachers' Fund for Doctor Stations, Ministry of Education; Postdoctoral Foundation of China(China Postdoctoral Science Foundation); Foundation of Heilongjiang Educational Committee; Key Laboratory of Myocardial Ischemia Mechanism and Treatment (Harbin Medical University, Ministry of Education); Second Affliated Hospital of Harbin Medical University	This work was supported by the National Natural Science Foundation of China (81200180), New Teachers' Fund for Doctor Stations, Ministry of Education (20122307120021), the Postdoctoral Foundation of China (2011M501065), Foundation of Heilongjiang Educational Committee (12531286), Key Laboratory of Myocardial Ischemia Mechanism and Treatment (Harbin Medical University, Ministry of Education, KF201001, KF201211), and the doctoral research fund of Second Affliated Hospital of Harbin Medical University (BS2011-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Battaglia M, 2006, DIABETES, V55, P40, DOI 10.2337/diabetes.55.1.40; Beriou G, 2005, TRANSPLANTATION, V79, P969, DOI 10.1097/01.TP.0000158277.50073.35; Bonham CA, 2002, J IMMUNOL, V169, P3382, DOI 10.4049/jimmunol.169.6.3382; Borges FT, 2012, J AM SOC NEPHROL; Braudeau C, 2007, TRANSPL INT, V20, P845, DOI 10.1111/j.1432-2277.2007.00537.x; Caretto D, 2010, J IMMUNOL, V184, P30, DOI 10.4049/jimmunol.0903412; Cobbold SP, 2008, J NEPHROL, V21, P485; Coquerelle C, 2008, IMMUNOL LETT, V119, P12, DOI 10.1016/j.imlet.2008.05.005; Critchley WR, 2012, IMMUNOLOGY, V136, P123, DOI 10.1111/j.1365-2567.2012.03560.x; Ezzelarab M, 2011, SEMIN IMMUNOL, V23, P252, DOI 10.1016/j.smim.2011.06.007; Hattori T, 2012, J LEUKOCYTE BIOL, V91, P621, DOI 10.1189/jlb.1011500; Huurman VAL, 2009, AM J TRANSPLANT, V9, P382, DOI 10.1111/j.1600-6143.2008.02479.x; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Lange C, 2007, IMMUNOL CELL BIOL, V85, P575, DOI 10.1038/sj.icb.7100088; Lundsgaard D, 2005, DIABETES, V54, P1040, DOI 10.2337/diabetes.54.4.1040; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; Mahnke K, 2007, J DERMATOL SCI, V46, P159, DOI 10.1016/j.jdermsci.2007.03.002; McCurry KR, 2006, TRANSPL INT, V19, P525, DOI 10.1111/j.1432-2277.2006.00306.x; Moreau A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00218; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Nishimura E, 2004, INT IMMUNOL, V16, P1189, DOI 10.1093/intimm/dxh122; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225, DOI 10.1016/S0022-5223(19)42744-X; Peche H, 2005, AM J TRANSPLANT, V5, P255, DOI 10.1111/j.1600-6143.2004.00683.x; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Schildknecht A, 2010, P NATL ACAD SCI USA, V107, P199, DOI 10.1073/pnas.0910620107; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shen EX, 2011, CELL BIOL INT, V35, P705, DOI 10.1042/CBI20100528; Shukla S, 2004, CLIN CANCER RES, V10, P3169, DOI 10.1158/1078-0432.CCR-03-0586; Thomson AW, 2009, TRANSPLANTATION, V87, pS86, DOI 10.1097/TP.0b013e3181a2dcec; Walker WE, 2006, J IMMUNOL, V177, P5307, DOI 10.4049/jimmunol.177.8.5307; Wu J, 2008, TRANSPL P, V40, P3719, DOI 10.1016/j.transproceed.2008.06.097; Wu J, 2010, N-S ARCH PHARMACOL, V381, P83, DOI 10.1007/s00210-009-0461-5; Xia GL, 2006, BIOL BLOOD MARROW TR, V12, P397, DOI 10.1016/j.bbmt.2005.11.519; Xia GL, 2004, BIOL BLOOD MARROW TR, V10, P748, DOI 10.1016/j.bbmt.2004.07.004; Yang H, 2012, TRANSPLANTATION, V93, P580, DOI 10.1097/TP.0b013e318244dd67; Zhang M, 2004, J MOL MED, V82, P240, DOI 10.1007/s00109-003-0521-0; Zhang MM, 2011, J IMMUNOL, V187, P1674, DOI 10.4049/jimmunol.1001937; Zhang XS, 2008, CLIN IMMUNOL, V127, P313, DOI 10.1016/j.clim.2008.01.013	39	4	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66336	10.1371/journal.pone.0066336	http://dx.doi.org/10.1371/journal.pone.0066336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840445	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400025
J	Han, M; Huang, XF; Chen, DC; Xiu, M; Kosten, TR; Zhang, XY				Han, Mei; Huang, Xu-Feng; Chen, Da Chun; Xiu, Meihong; Kosten, Thomas R.; Zhang, Xiang Yang			Diabetes and Cognitive Deficits in Chronic Schizophrenia: A Case-Control Study	PLOS ONE			English	Article							1ST-EPISODE SCHIZOPHRENIA; NEUROPSYCHOLOGICAL STATUS; REPEATABLE BATTERY; GENDER-DIFFERENCES; SOCIAL COGNITION; DETERMINANTS; PERFORMANCE; IMPAIRMENT; MEMORY; BRAIN	Cognitive impairment occurs in both schizophrenia and diabetes. There is currently limited understanding whether schizophrenia with diabetes has more serious cognitive deficits than schizophrenia without diabetes or diabetes only. This study assessed cognitive performance in 190 healthy controls, 106 diabetes only, 127 schizophrenia without diabetes and 55 schizophrenia with diabetes. This study was conducted from January 2008 to December 2010. Compared to healthy controls, all patient groups had significantly decreased total and five index RBANS scores (all p<0.01-p<0.001), except for the visuospatial/constructional index. Schizophrenia with diabetes performed worse than schizophrenia without diabetes in immediate memory (p<0.01) and total RBANS scores (<0.05), and showed a trend for decreased attention (p = 0.052) and visuospatial/constructional capacity (p = 0.063). Schizophrenia with diabetes performed worse than diabetes only in immediate memory (p<0.001) and attention (p<0.05), and showed a trend for decreased total RBANS scores (p = 0.069). Regression analysis showed that the RBANS had modest correlations with schizophrenia' PANSS scores, their duration of current antipsychotic treatment, and diagnosis of diabetes. Schizophrenia with co-morbid diabetes showed more cognitive impairment than schizophrenia without diabetes and diabetes only, especially in immediate memory and attention.	[Han, Mei; Huang, Xu-Feng] Univ Wollongong, Ctr Translat Neurosci, Sch Hlth Sci, IHMRI, Wollongong, NSW, Australia; [Han, Mei; Huang, Xu-Feng] Schizophrenia Res Inst, Sydney, NSW, Australia; [Chen, Da Chun; Xiu, Meihong; Kosten, Thomas R.; Zhang, Xiang Yang] Peking Univ, Beijing HuiLongGuan Hosp, Beijing 100871, Peoples R China; [Kosten, Thomas R.; Zhang, Xiang Yang] Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Kosten, Thomas R.; Zhang, Xiang Yang] Michael E DeBakey VA Med Ctr, Houston, TX USA	University of Wollongong; Peking University; Baylor College of Medicine; Baylor College of Medicine	Huang, XF (corresponding author), Univ Wollongong, Ctr Translat Neurosci, Sch Hlth Sci, IHMRI, Wollongong, NSW, Australia.	xhuang@uow.edu.au; xyzhang@bcm.edu	Huang, Xu-Feng/D-6053-2013; Huang, Xu-Feng/H-7408-2015; Kosten, Thomas/AAI-5998-2021	Huang, Xu-Feng/0000-0002-5895-2253; Huang, Xu-Feng/0000-0002-5895-2253; 	United States National Institutes of Health [U01-MH79639, K05-DA0454, P50-DA18827]; Department of Veterans Affairs VISN 16, Mental Illness Research, Education and Clinical Center (MIRECC); Stanley Medical Research Institute [03T-459, 05T-726]; National Health and Medical Research Committee of Australia (NHMRC) [635245]; Schizophrenia Research Institute (SRI) Australia; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH079639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000454] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs VISN 16, Mental Illness Research, Education and Clinical Center (MIRECC)(US Department of Veterans Affairs); Stanley Medical Research Institute; National Health and Medical Research Committee of Australia (NHMRC); Schizophrenia Research Institute (SRI) Australia; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the United States National Institutes of Health U01-MH79639, K05-DA0454, P50-DA18827 and the Department of Veterans Affairs VISN 16, Mental Illness Research, Education and Clinical Center (MIRECC), and the Stanley Medical Research Institute (03T-459 and 05T-726), the National Health and Medical Research Committee of Australia (NHMRC) (635245) and the Schizophrenia Research Institute (SRI) Australia (2010). These funders had no further role in study design; in the collection, analysis and interpretation of data; in writing of the report; and in the decision to submit the paper for publication.	Abe Y, 2009, NEUROSCIENCE, V161, P95, DOI 10.1016/j.neuroscience.2009.03.022; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Albus M, 2006, EUR ARCH PSY CLIN N, V256, P442, DOI 10.1007/s00406-006-0667-1; Allen KV, 2004, EUR J PHARMACOL, V490, P169, DOI 10.1016/j.ejphar.2004.02.054; Antonova E, 2004, SCHIZOPHR RES, V70, P117, DOI 10.1016/j.schres.2003.12.002; BASKIN DG, 1987, ANNU REV PHYSIOL, V49, P335, DOI 10.1146/annurev.ph.49.030187.002003; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bowie CR, 2005, PSYCHIAT CLIN N AM, V28, P613, DOI 10.1016/j.psc.2005.05.004; Cheng Y, 2011, ARCH MED SCI, V7, P850, DOI 10.5114/aoms.2011.25561; Condray Ruth, 2011, Front Biosci (Schol Ed), V3, P298, DOI 10.2741/s153; Convit A, 2005, NEUROBIOL AGING, V26, pS31, DOI 10.1016/j.neurobiolaging.2005.09.018; Couture SM, 2006, SCHIZOPHRENIA BULL, V32, pS44, DOI 10.1093/schbul/sbl029; Crook JM, 2000, BIOL PSYCHIAT, V48, P381, DOI 10.1016/S0006-3223(00)00918-5; Crosby-Nwaobi R, 2012, DIABETES RES CLIN PR, V96, P101, DOI 10.1016/j.diabres.2011.11.010; Daban C, 2005, J PSYCHIATR RES, V39, P391, DOI 10.1016/j.jpsychires.2004.09.001; De Silva PN, 2011, MED HYPOTHESES, V77, P529, DOI 10.1016/j.mehy.2011.06.022; Dickinson D, 2008, PSYCHOSOMATICS, V49, P123, DOI 10.1176/appi.psy.49.2.123; Dixon L, 2000, SCHIZOPHRENIA BULL, V26, P903, DOI 10.1093/oxfordjournals.schbul.a033504; du Bois TM, 2009, EUR NEUROPSYCHOPHARM, V19, P256, DOI 10.1016/j.euroneuro.2008.12.002; Duff K, 2008, ARCH CLIN NEUROPSYCH, V23, P603, DOI 10.1016/j.acn.2008.06.004; Guo Xiaofeng, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P724, DOI 10.3969/j.issn.1672-7347.2011.08.004; Hall J, 2010, PSYCHOL MED, V40, P761, DOI 10.1017/S0033291709991000; Han M, 2012, PROG NEURO-PSYCHOPH, V39, P358, DOI 10.1016/j.pnpbp.2012.07.010; Hassing LB, 2004, AGE AGEING, V33, P355, DOI 10.1093/ageing/afh100; Heckers S, 2010, CURR TOP BEHAV NEURO, V4, P529, DOI 10.1007/7854_2010_43; Heinrichs RW, 2005, AM PSYCHOL, V60, P229, DOI 10.1037/0003-066X.60.3.229; Hoff AL, 2005, SCHIZOPHR RES, V78, P27, DOI 10.1016/j.schres.2005.05.010; JAKOBSEN J, 1987, DIABETES, V36, P597, DOI 10.2337/diabetes.36.5.597; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keefe RSE, 2007, J CLIN PSYCHIAT, V68, P8; Konradi C, 2011, SCHIZOPHR RES, V131, P165, DOI 10.1016/j.schres.2011.06.007; Kumar Rajeev, 2009, Indian J Psychiatry, V51 Suppl 1, pS35; Leifker FR, 2009, SCHIZOPHR RES, V115, P82, DOI 10.1016/j.schres.2009.09.004; Manschot SM, 2007, DIABETOLOGIA, V50, P2388, DOI 10.1007/s00125-007-0792-z; Manschot SM, 2006, DIABETES, V55, P1106, DOI 10.2337/diabetes.55.04.06.db05-1323; Messier C, 2005, NEUROBIOL AGING, V26, pS26, DOI 10.1016/j.neurobiolaging.2005.09.014; Miller SL, 2008, P NATL ACAD SCI USA, V105, P2181, DOI 10.1073/pnas.0706818105; Newcomer JW, 1999, SCHIZOPHRENIA BULL, V25, P321, DOI 10.1093/oxfordjournals.schbul.a033381; Papanikolaou Y, 2006, DIABETOLOGIA, V49, P855, DOI 10.1007/s00125-006-0183-x; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rouillon F, 2005, EUR PSYCHIAT, V20, pS345, DOI 10.1016/S0924-9338(05)80189-0; Ruis C, 2009, DIABETES CARE, V32, P1261, DOI 10.2337/dc08-2143; Shean Glenn D, 2007, Expert Rev Neurother, V7, P817, DOI 10.1586/14737175.7.7.817; Smith M, 2008, BRIT J PSYCHIAT, V192, P406, DOI 10.1192/bjp.bp.107.037184; Sota TL, 2003, SCHIZOPHR RES, V62, P175, DOI 10.1016/S0920-9964(02)00373-0; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stevens A, 2002, PSYCHOPHARMACOLOGY, V160, P299, DOI 10.1007/s00213-001-0974-1; Stone WS, 2011, NEUROBIOL LEARN MEM, V96, P544, DOI 10.1016/j.nlm.2011.04.006; Stranahan AM, 2008, NAT NEUROSCI, V11, P309, DOI 10.1038/nn2055; Umegaki H, 2012, GERIATR GERONTOL INT, V12, P103, DOI 10.1111/j.1447-0594.2011.00817.x; van den Berg E, 2006, DRUG TODAY, V42, P741, DOI 10.1358/dot.2006.42.11.1003542; Vaz-Serra A, 2010, ACTA MEDICA PORT, V23, P1043; Walters JTR, 2010, ARCH GEN PSYCHIAT, V67, P692, DOI 10.1001/archgenpsychiatry.2010.81; Woodward ND, 2005, INT J NEUROPSYCHOPH, V8, P457, DOI 10.1017/S146114570500516X; [World Health Organization Organization WH], 1998, REP WHO CONS OB, P3; Zhang BH, 2009, RELIABILITY VALIDITY, V28, P865; Zhang XY, 2012, J CLIN PSYCHIAT, V73, P1025, DOI 10.4088/JCP.11m07422	57	16	18	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66299	10.1371/journal.pone.0066299	http://dx.doi.org/10.1371/journal.pone.0066299			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840437	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800046
J	Liu, GH; Gasser, RB; Nejsum, P; Wang, Y; Chen, Q; Song, HQ; Zhu, XQ				Liu, Guo-Hua; Gasser, Robin B.; Nejsum, Peter; Wang, Yan; Chen, Qiang; Song, Hui-Qun; Zhu, Xing-Quan			Mitochondrial and Nuclear Ribosomal DNA Evidence Supports the Existence of a New Trichuris Species in the Endangered Francois' Leaf-Monkey	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; NONHUMAN-PRIMATES; ITS1-5.8S-ITS2 SEGMENT; NEMATODA TRICHURIDAE; HELMINTH-PARASITES; TRICHIURA; SEQUENCE; SUIS; PIG; GENOMES	The whipworm of humans, Trichuris trichiura, is responsible for a neglected tropical disease (NTD) of major importance in tropical and subtropical countries of the world. Whipworms also infect animal hosts, including pigs, dogs and non-human primates, cause clinical disease (trichuriasis) similar to that of humans. Although Trichuris species are usually considered to be host specific, it is not clear whether non-human primates are infected with T. trichiura or other species. In the present study, we sequenced the complete mitochondrial (mt) genome as well as the first and second internal transcribed spacers (ITS-1 and ITS-2) of Trichuris from the Francois' leaf-monkey (langur), and compared them with homologous sequences from human-and pig-derived Trichuris. In addition, sequence comparison of a conserved mt ribosomal gene among multiple individual whipworms revealed substantial nucleotide differences among these three host species but limited sequence variation within each of them. The molecular data indicate that the monkey-derived whipworm is a separate species from that of humans. Future work should focus on detailed population genetic and morphological studies (by electron microscopy) of whipworms from various non-humans primates and humans.	[Liu, Guo-Hua; Wang, Yan; Song, Hui-Qun; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Gasser, Robin B.] Univ Melbourne, Fac Vet Sci, Melbourne, Vic, Australia; [Nejsum, Peter] Univ Copenhagen, Dept Vet Dis Biol, Copenhagen, Denmark; [Nejsum, Peter] Univ Copenhagen, Dept Basic Anim & Vet Sci, Copenhagen, Denmark; [Liu, Guo-Hua; Zhu, Xing-Quan] Hunan Agr Univ, Coll Vet Med, Changsha, Hunan, Peoples R China; [Chen, Qiang] Guangzhou ZhongDa Med Equipment Co Ltd, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; University of Melbourne; University of Copenhagen; University of Copenhagen; Hunan Agricultural University	Gasser, RB (corresponding author), Univ Melbourne, Fac Vet Sci, Melbourne, Vic, Australia.	robinbg@unimelb.edu.au; xingquanzhu1@hotmail.com	Gasser, Robin/ABH-6185-2020	Gasser, Robin/0000-0002-4423-1690; Nejsum, Peter/0000-0002-6673-8505	International Science & Technology Cooperation Program of China [2013DFA31840]; Science Fund for Creative Research Groups of Gansu Province [1210RJIA006]; Australian Research Council (ARC); National Health and Medical Research Council (NHMRC); Melbourne Water Corporation (MWC); Alexander von Humboldt Foundation	International Science & Technology Cooperation Program of China; Science Fund for Creative Research Groups of Gansu Province(Science Fund for Creative Research Groups); Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Melbourne Water Corporation (MWC); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by the International Science & Technology Cooperation Program of China (Grant No. 2013DFA31840) to XQZ and RBG. This work was also supported by the Science Fund for Creative Research Groups of Gansu Province (Grant No. 1210RJIA006) to XQZ. RBG's research is supported by the Australian Research Council (ARC), National Health and Medical Research Council (NHMRC) and Melbourne Water Corporation (MWC); the Alexander von Humboldt Foundation is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEER RJS, 1976, RES VET SCI, V20, P47, DOI 10.1016/S0034-5288(18)33478-7; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blouin MS, 2002, INT J PARASITOL, V32, P527, DOI 10.1016/S0020-7519(01)00357-5; Callejon R, 2009, PARASITOL RES, V104, P715, DOI 10.1007/s00436-008-1280-1; Callejon R, 2012, VET PARASITOL, V186, P350, DOI 10.1016/j.vetpar.2011.11.033; Callejon R, 2010, PARASITOL RES, V107, P631, DOI 10.1007/s00436-010-1908-9; CHANDLER ASA C., 1930, JOUR PARASITOL, V16, P198, DOI 10.2307/3271514; Cliffe LJ, 2004, ADV PARASIT, V57, P255, DOI 10.1016/S0065-308X(04)57004-5; Cutillas C, 2004, J PARASITOL, V90, P648, DOI 10.1645/GE-3295RN; Cutillas C, 2002, PARASITOL RES, V88, P574, DOI 10.1007/s00436-002-0596-5; Cutillas C, 2009, ACTA TROP, V111, P299, DOI 10.1016/j.actatropica.2009.05.011; Cutillas C, 2007, PARASITOL RES, V100, P383, DOI 10.1007/s00436-006-0275-z; Robles MD, 2011, J PARASITOL, V97, P319, DOI 10.1645/GE-2434.1; DUBIN S, 1975, AM J PUBLIC HEALTH, V65, P1242, DOI 10.2105/AJPH.65.11.1242; Duckworth JW, 2010, PRIMATE CONSERV, P1; Gasser RB, 1999, INT J PARASITOL, V29, P1965, DOI 10.1016/S0020-7519(99)00153-8; Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002; Gasser RB, 2008, BIOTECHNOL ADV, V26, P325, DOI 10.1016/j.biotechadv.2008.03.003; Gasser RB, 2006, NAT PROTOC, V1, P3121, DOI 10.1038/nprot.2006.485; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hu G, 2002, 19 C INT PRIM SOC 4, P74; Hu HG, 1993, J SICHUAN TEACH COLL, V14, P62; Hu M, 2002, INT J PARASITOL, V32, P145, DOI 10.1016/S0020-7519(01)00316-2; Hu M, 2007, NAT PROTOC, V2, P2339, DOI 10.1038/nprot.2007.358; Jex AR, 2010, BIOTECHNOL ADV, V28, P151, DOI 10.1016/j.biotechadv.2009.11.002; Jex AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-79; Khalafalla RE, 2011, PARASITOL RES, V108, P337, DOI 10.1007/s00436-010-2066-9; KNIGHT RA, 1971, J PARASITOL, V57, P302, DOI 10.2307/3278032; Lavrov DV, 2001, GENETICS, V157, P621; Legesse M, 2004, ACTA TROP, V90, P231, DOI 10.1016/j.actatropica.2003.12.003; Li HQ, 2007, J YANAN U NATURAL SC, V26, P60; Li YB, 2007, ORYX, V41, P38, DOI 10.1017/S0030605307001500; Lin K, 2011, FUJIAN ANIM HUSBANDR, V6, P1; Liu GH, 2013, J HELMINTHO IN PRESS; Liu GH, 2012, INFECT GENET EVOL, V12, P1635, DOI 10.1016/j.meegid.2012.08.005; Liu GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042172; Liu GH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001539; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Ma Q, 2004, CHINESE J ZOOL, V39, P53; Michaud C, 2003, J MED PRIMATOL, V32, P341, DOI 10.1046/j.1600-0684.2003.00037.x; Munene E, 1998, VET PARASITOL, V78, P195, DOI 10.1016/S0304-4017(98)00143-5; Muriuki SMK, 1998, ACTA TROP, V71, P73, DOI 10.1016/S0001-706X(98)00040-0; Nissen S, 2012, VET PARASITOL, V188, P68, DOI 10.1016/j.vetpar.2012.03.004; Oliveros R, 2000, PARASITOL RES, V86, P1008, DOI 10.1007/PL00008519; OOI HK, 1993, J VET MED SCI, V55, P363, DOI 10.1292/jvms.55.363; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Qi M, 2011, CHINA ANIM HUSBANDRY, V38, P188; Ravasi DF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044187; Ravasi DF, 2012, S AFR J WILDL RES, V42, P35; Roepstorff A, 2011, VET PARASITOL, V180, P72, DOI 10.1016/j.vetpar.2011.05.029; Salaba O, 2013, PARASITOL R IN PRESS; Spakulova, 1994, SYST PARASITOL, V29, P113; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Traversa D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-32; Wei L.-y., 1990, Chinese Journal of Zoology, V25, P3; Yang MingHa, 1998, Chinese Journal of Veterinary Medicine, V24, P19; Zhu XQ, 1999, INT J PARASITOL, V29, P469, DOI 10.1016/S0020-7519(98)00226-4	60	35	37	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66249	10.1371/journal.pone.0066249	http://dx.doi.org/10.1371/journal.pone.0066249			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840431	gold, Green Published			2022-12-27	WOS:000322342800043
J	Vaumourin, E; Gasqui, P; Buffet, JP; Chapuis, JL; Pisanu, B; Ferquel, E; Vayssier-Taussat, M; Vourc'h, G				Vaumourin, Elise; Gasqui, Patrick; Buffet, Jean-Philippe; Chapuis, Jean-Louis; Pisanu, Benoit; Ferquel, Elisabeth; Vayssier-Taussat, Muriel; Vourc'h, Gwenael			A Probabilistic Model in Cross-Sectional Studies for Identifying Interactions between Two Persistent Vector-Borne Pathogens in Reservoir Populations	PLOS ONE			English	Article							BURGDORFERI SENSU-LATO; IXODES-RICINUS TICKS; BORRELIA-BURGDORFERI; BANK VOLES; DIFFERENTIAL TRANSMISSION; SPECIES COOCCURRENCE; COMMUNITY STRUCTURE; BARTONELLA SPP.; INFECTION; RODENTS	Background: In natural populations, individuals are infected more often by several pathogens than by just one. In such a context, pathogens can interact. This interaction could modify the probability of infection by subsequent pathogens. Identifying when pathogen associations correspond to biological interactions is a challenge in cross-sectional studies where the sequence of infection cannot be demonstrated. Methodology/Principal Findings: Here we modelled the probability of an individual being infected by one and then another pathogen, using a probabilistic model and maximum likelihood statistics. Our model was developed to apply to cross-sectional data, vector-borne and persistent pathogens, and to take into account confounding factors. Our modelling approach was more powerful than the commonly used Chi-square test of independence. Our model was applied to detect potential interaction between Borrelia afzelii and Bartonella spp. that infected a bank vole population at 11% and 57% respectively. No interaction was identified. Conclusions/Significance: The modelling approach we proposed is powerful and can identify the direction of potential interaction. Such an approach can be adapted to other types of pathogens, such as non-persistents. The model can be used to identify when co-occurrence patterns correspond to pathogen interactions, which will contribute to understanding how organism communities are assembled and structured. In the long term, the model's capacity to better identify pathogen interactions will improve understanding of infectious risk.	[Vaumourin, Elise; Gasqui, Patrick; Vourc'h, Gwenael] INRA, Epidemiol Anim UR346, F-63122 St Genes Champanelle, France; [Vaumourin, Elise; Buffet, Jean-Philippe; Vayssier-Taussat, Muriel] INRA, USC Bartonella & Tiques, Maisons Alfort, France; [Chapuis, Jean-Louis; Pisanu, Benoit] Museum Natl Hist Nat, UMR CNRS CERSP P6 7204, F-75231 Paris, France; [Ferquel, Elisabeth] Inst Pasteur, Equipe Borrelia, Paris, France	INRAE; INRAE; Museum National d'Histoire Naturelle (MNHN); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Vaumourin, E (corresponding author), INRA, Epidemiol Anim UR346, F-63122 St Genes Champanelle, France.	elise.vaumourin@clermont.inra.fr			Animal Health department of National Institute of Agronomic Research; Auvergne region; Metaprogramme MEM (projet Patho-ID) of INRA; EU [FP7-261504 EDENext]	Animal Health department of National Institute of Agronomic Research; Auvergne region(Region Auvergne-Rhone-Alpes); Metaprogramme MEM (projet Patho-ID) of INRA; EU(European Commission)	This modelling work was supported by the Animal Health department of National Institute of Agronomic Research (http://www.inra.fr), Auvergne region (http://www.auvergnesciences.com), the Metaprogramme MEM (projet Patho-ID) of INRA and the EU grant FP7-261504 EDENext. It is catalogued by the EDENext Steering Committee as EDENext090 (http://www.edenext.eu). The contents of this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anguita J, 2003, FEMS MICROBIOL REV, V27, P493, DOI 10.1016/S0168-6445(03)00036-6; Bai Y, 2011, APPL ENVIRON MICROB, V77, P1728, DOI 10.1128/AEM.02203-10; Bajer A, 2001, PARASITOLOGY, V122, P43, DOI 10.1017/S0031182000007058; Beldomenico PM, 2008, J ANIM ECOL, V77, P984, DOI 10.1111/j.1365-2656.2008.01413.x; Bergemann Tracy L, 2012, J Biom Biostat, VSuppl 7; Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009; Bown KJ, 2004, EMERG INFECT DIS, V10, P684, DOI 10.3201/eid1004.030455; Buffet JP, 2012, COMP IMMUNOL MICROB, V35, P583, DOI 10.1016/j.cimid.2012.07.002; Chomel BB, 2009, VET RES, V40, p1 22; Cox FEG, 2001, PARASITOLOGY, V122, pS23, DOI 10.1017/S003118200001698X; Diterich I, 2003, INFECT IMMUN, V71, P3979, DOI 10.1128/IAI.71.7.3979-3987.2003; Fabre F, 2010, J THEOR BIOL, V265, P377, DOI 10.1016/j.jtbi.2010.04.027; Fenner AL, 2011, J ANIM ECOL, V80, P835, DOI 10.1111/j.1365-2656.2011.01825.x; Fikrig E, 2006, MICROBES INFECT, V8, P1390, DOI 10.1016/j.micinf.2005.12.022; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Gotelli NJ, 2010, OECOLOGIA, V162, P463, DOI 10.1007/s00442-009-1474-y; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Greene CE, 1996, J CLIN MICROBIOL, V34, P1682, DOI 10.1128/JCM.34.7.1682-1685.1996; Halos L, 2005, VET RES, V36, P79, DOI 10.1051/vetres:2004052; Hawlena H, 2005, OECOLOGIA, V146, P200, DOI 10.1007/s00442-005-0187-0; Hellard E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029618; Holt PG, 2000, ALLERGY, V55, P688, DOI 10.1034/j.1398-9995.2000.00118.x; Horner-Devine MC, 2007, ECOLOGY, V88, P1345, DOI 10.1890/06-0286; Hovius JWR, 2007, TRENDS PARASITOL, V23, P434, DOI 10.1016/j.pt.2007.07.001; Humair PF, 1999, PARASITOLOGY, V118, P33, DOI 10.1017/S0031182098003564; Kosoy M, 2004, VECTOR-BORNE ZOONOT, V4, P296, DOI 10.1089/vbz.2004.4.296; Kosoy MY, 1999, J WILDLIFE DIS, V35, P275, DOI 10.7589/0090-3558-35.2.275; KRASNOV B. R., 2008, FUNCTIONAL EVOLUTION; Kurtenbach K, 1998, APPL ENVIRON MICROB, V64, P1169; LUFT BJ, 1993, RES MICROBIOL, V144, P251, DOI 10.1016/0923-2508(93)90009-Q; Marsot M, 2011, APPL ENVIRON MICROB, V77, P5716, DOI 10.1128/AEM.01846-10; Maurer JJ, 2011, ANNU REV FOOD SCI T, V2, P259, DOI 10.1146/annurev.food.080708.100730; Merrell DS, 2004, NATURE, V430, P250, DOI 10.1038/nature02760; Mwangi TW, 2006, ANN TROP MED PARASIT, V100, P551, DOI 10.1179/136485906X118468; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Paziewska A, 2012, PARASITOLOGY, V139, P881, DOI 10.1017/S0031182012000170; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Pulliainen AT, 2012, FEMS MICROBIOL REV, V36, P563, DOI 10.1111/j.1574-6976.2012.00324.x; Rohani P, 2003, NATURE, V422, P885, DOI 10.1038/nature01542; Saisongkorh Watcharee, 2009, Journal of the Medical Association of Thailand, V92, P707; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sinski E, 2006, ANN AGR ENV MED, V13, P295; SINSKY RJ, 1989, J CLIN MICROBIOL, V27, P1723, DOI 10.1128/JCM.27.8.1723-1727.1989; Slots J, 2003, J PERIODONTAL RES, V38, P318, DOI 10.1034/j.1600-0765.2003.00659.x; Sonenshine DE., 1993, BIOL TICKS; Soubeyrand S, 2007, J R SOC INTERFACE, V4, P985, DOI 10.1098/rsif.2007.1154; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P487, DOI 10.1111/j.1469-0691.2011.03492.x; Tadin A, 2012, VECTOR-BORNE ZOONOT, V12, P388, DOI 10.1089/vbz.2011.0632; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Telfer S, 2008, PARASITOLOGY, V135, P767, DOI 10.1017/S0031182008000395; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Tello JS, 2008, OIKOS, V117, P693, DOI [10.1111/j.2008.0030-1299.16212.x, 10.1111/j.0030-1299.2008.16212.x]; Tollenaere C, 2008, J EVOLUTION BIOL, V21, P1307, DOI 10.1111/j.1420-9101.2008.01563.x; Tsai YL, 2010, AM J TROP MED HYG, V83, P917, DOI 10.4269/ajtmh.2010.10-0083; Ulrich W, 2007, OIKOS, V116, P2053, DOI 10.1111/j.2007.0030-1299.16173.x; Ulrich W, 2010, ECOLOGY, V91, P3384, DOI 10.1890/09-2157.1; Vourc'h G, 2007, VECTOR-BORNE ZOONOT, V7, P637, DOI 10.1089/vbz.2007.0111; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557	60	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66167	10.1371/journal.pone.0066167	http://dx.doi.org/10.1371/journal.pone.0066167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840418	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800039
J	Proops, L; Rayner, J; Taylor, AM; McComb, K				Proops, Leanne; Rayner, Jenny; Taylor, Anna M.; McComb, Karen			The Responses of Young Domestic Horses to Human-Given Cues	PLOS ONE			English	Article							DOGS CANIS-FAMILIARIS; HUMAN POINTING GESTURES; FOLLOW GAZE DIRECTION; OBJECT-CHOICE TASKS; VISUAL-ATTENTION; COMMUNICATIVE SIGNS; INFANT CHIMPANZEES; SPECIES FOLLOW; CORVUS-CORAX; EYE GAZE	It has been suggested that the process of domestication, at least in some species, has led to an innate predisposition to be skilled at reading human communicative and attentional cues. Adult domestic horses (Equus caballus) are highly sensitive to subtle bodily cues when determining if a person is attending to them but they are less adept at using human communicative cues in object choice tasks. Here we provide the first study into the ontogeny of such skills in order to gain insights into the mechanisms underlying these abilities. Compared with adult horses, youngsters under the age of three could use body orientation but not more subtle cues such as head movement and open/closed eyes to correctly choose an attentive person to approach for food. Across two object choice experiments, the performance of young horses was comparable to that of adult horses - subjects were able to correctly choose a rewarded bucket using marker placement, pointing and touching cues but could not use body orientation, gaze, elbow pointing or tapping cues. Taken together these results do not support the theory that horses possess an innate predisposition to be particularly skilled at using human cues. Horses' ability to determine whether humans are attending to them using subtle body cues appears to require significant experience to fully develop and their perhaps less remarkable use of limited cues in object choice tasks, although present at a much earlier age, is likely to reflect a more general learning ability related to stimulus enhancement rather than a specific 'human-reading' skill.	[Proops, Leanne; Rayner, Jenny; Taylor, Anna M.; McComb, Karen] Univ Sussex, Dept Psychol, Brighton, Sussex, England	University of Sussex	Proops, L (corresponding author), Univ Sussex, Dept Psychol, Brighton, Sussex, England.	leanne.proops@gmail.com	Proops, Leanne/N-9380-2019	Proops, Leanne/0000-0002-8661-1229	Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a studentship from the Biotechnology and Biological Sciences Research Council (to L. P., supervised by K. M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BBSRC website: http://www.bbsrc.ac.uk/.	Albiach-Serrano A, 2012, APPL ANIM BEHAV SCI, V141, P25, DOI 10.1016/j.applanim.2012.07.005; ANDERSON JR, 1995, ANIM BEHAV, V49, P201, DOI 10.1016/0003-3472(95)80168-5; BARONCOHEN S, 1994, CAH PSYCHOL COGN, V13, P513; Barth J, 2005, ANIM COGN, V8, P84, DOI 10.1007/s10071-004-0235-x; Bateman PW, 2011, J ZOOL, V285, P316, DOI 10.1111/j.1469-7998.2011.00846.x; Brauer J, 2005, J COMP PSYCHOL, V119, P145, DOI 10.1037/0735-7036.119.2.145; Brauer J, 2004, APPL ANIM BEHAV SCI, V88, P299, DOI 10.1016/j.applanim.2004.03.004; Bugnyar T, 2004, P ROY SOC B-BIOL SCI, V271, P1331, DOI 10.1098/rspb.2004.2738; Bugnyar T, 2011, P ROY SOC B-BIOL SCI, V278, P634, DOI 10.1098/rspb.2010.1514; Bulloch MJ, 2008, ANIM BEHAV, V76, P1147, DOI 10.1016/j.anbehav.2008.01.033; BURGER J, 1992, J COMP PSYCHOL, V106, P97; Burghardt G.M., 1991, P53; Byrnit JT, 2009, ANIM COGN, V12, P401, DOI 10.1007/s10071-008-0200-1; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Carter J, 2008, P ROY SOC B-BIOL SCI, V275, P1709, DOI 10.1098/rspb.2008.0095; Dally JM, 2006, SCIENCE, V312, P1662, DOI 10.1126/science.1126539; Des Roches ADB, 2008, PHYSIOL BEHAV, V94, P487, DOI 10.1016/j.physbeh.2008.03.002; Farmer K, 2010, ANIM COGN, V13, P229, DOI 10.1007/s10071-009-0260-x; Ferrari PF, 2000, P NATL ACAD SCI USA, V97, P13997, DOI 10.1073/pnas.250241197; Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076; Gacsi M, 2004, ANIM COGN, V7, P144, DOI 10.1007/s10071-003-0205-8; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Gacsi M, 2009, ANIM COGN, V12, P471, DOI 10.1007/s10071-008-0208-6; HAMPTON RR, 1994, BEHAVIOUR, V130, P41, DOI 10.1163/156853994X00136; Hare B, 2004, ANIM BEHAV, V68, P571, DOI 10.1016/j.anbehav.2003.11.011; Hare B, 2005, CURR BIOL, V15, P226, DOI 10.1016/j.cub.2005.01.040; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hare B, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2009.06.031; Hattori Y, 2007, ANIM COGN, V10, P141, DOI 10.1007/s10071-006-0049-0; Hostetter AB, 2007, ANIM COGN, V10, P55, DOI 10.1007/s10071-006-0031-x; Hothersall B, 2010, ANIM COGN, V13, P63, DOI 10.1007/s10071-009-0245-9; Itakura S, 2004, JPN PSYCHOL RES, V46, P216, DOI 10.1111/j.1468-5584.2004.00253.x; Jaime M, 2009, ANIM COGN, V12, P559, DOI 10.1007/s10071-009-0214-3; Kaminski J, 2005, ANIM BEHAV, V69, P11, DOI 10.1016/j.anbehav.2004.05.008; Kaminski J, 2004, ANIM COGN, V7, P216, DOI 10.1007/s10071-004-0214-2; Krueger K, 2011, ANIM COGN, V14, P187, DOI 10.1007/s10071-010-0352-7; Maros K, 2008, ANIM COGN, V11, P457, DOI 10.1007/s10071-008-0136-5; Miklosi A, 2005, J COMP PSYCHOL, V119, P179, DOI 10.1037/0735-7036.119.2.179; Miklosi A, 1997, DEV PSYCHOBIOL, V30, P283; Mulcahy NJ, 2012, ANIM BEHAV, V83, P313, DOI 10.1016/j.anbehav.2011.11.019; Myowa-Yamakoshi M, 2003, COGNITION, V89, pB53, DOI 10.1016/S0010-0277(03)00071-4; Myowa-Yamakoshi M, 2001, PSYCHOLOGIA, V44, P24; Okamoto-Barth S, 2008, DEVELOPMENTAL SCI, V11, P98, DOI 10.1111/j.1467-7687.2007.00658.x; Pack AA, 2004, J COMP PSYCHOL, V118, P160, DOI 10.1037/0735-7036.118.2.160; Povinelli DJ, 1996, MONOGR SOC RES CHILD, V61, P1, DOI 10.1111/j.1540-5834.1996.tb00481.x; Povinelli DJ, 1997, COGNITIVE DEV, V12, P327, DOI 10.1016/S0885-2014(97)90017-4; Proops L, 2012, P ROY SOC B-BIOL SCI, V279, P3131, DOI 10.1098/rspb.2012.0626; Proops L, 2010, ANIM BEHAV, V79, P1205, DOI 10.1016/j.anbehav.2010.02.015; Proops L, 2010, ANIM COGN, V13, P197, DOI 10.1007/s10071-009-0257-5; Reaux JE, 1999, CHILD DEV, V70, P275, DOI 10.1111/1467-8624.00021; Reid PJ, 2009, BEHAV PROCESS, V80, P325, DOI 10.1016/j.beproc.2008.11.002; Riedel J, 2008, ANIM BEHAV, V75, P1003, DOI 10.1016/j.anbehav.2007.08.010; Sandel AA, 2011, ANIM BEHAV, V81, P925, DOI 10.1016/j.anbehav.2011.01.020; Sankey C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018331; Scheumann M, 2004, ANIM COGN, V7, P224, DOI 10.1007/s10071-004-0216-0; Schloegl C, 2007, ANIM BEHAV, V74, P769, DOI 10.1016/j.anbehav.2006.08.017; Schwab C, 2006, J COMP PSYCHOL, V120, P169, DOI 10.1037/0735-7036.120.3.169; Soproni K, 2002, J COMP PSYCHOL, V116, P27, DOI 10.1037//0735-7036.116.1.27; Soproni K, 2001, J COMP PSYCHOL, V115, P122, DOI 10.1037//0735-7036.115.2.122; Tempelmann S, 2011, ANIM COGN, V14, P433, DOI 10.1007/s10071-011-0378-5; Tomasello M, 1997, CHILD DEV, V68, P1067, DOI 10.2307/1132292; Tomasello M, 1998, ANIM BEHAV, V55, P1063, DOI 10.1006/anbe.1997.0636; Udell MAR, 2008, ANIM BEHAV, V76, P1767, DOI 10.1016/j.anbehav.2008.07.028; Udell MAR, 2010, BIOL REV, V85, P327, DOI 10.1111/j.1469-185X.2009.00104.x; Udell MAR, 2010, ANIM BEHAV, V79, P717, DOI 10.1016/j.anbehav.2009.12.027; Vick SJ, 2003, J COMP PSYCHOL, V117, P209, DOI 10.1037/0735-7036.117.2.209; Viranyi Z, 2004, BEHAV PROCESS, V66, P161, DOI 10.1016/j.beproc.2004.01.012; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y; von Bayern AMP, 2009, CURR BIOL, V19, P602, DOI 10.1016/j.cub.2009.02.062; Wilkinson A, 2010, ANIM COGN, V13, P765, DOI 10.1007/s10071-010-0320-2; Wynne CDL, 2008, ANIM BEHAV, V76, pE1, DOI 10.1016/j.anbehav.2008.03.010	71	24	25	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67000	10.1371/journal.pone.0067000	http://dx.doi.org/10.1371/journal.pone.0067000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840572	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200116
J	Soares, JM; Sampaio, A; Ferreira, LM; Santos, NC; Marques, P; Marques, F; Palha, JA; Cerqueira, JJ; Sousa, N				Soares, Jose Miguel; Sampaio, Adriana; Ferreira, Luis Miguel; Santos, Nadine Correia; Marques, Paulo; Marques, Fernanda; Palha, Joana Almeida; Cerqueira, Joao Jose; Sousa, Nuno			Stress Impact on Resting State Brain Networks	PLOS ONE			English	Article							DEFAULT-MODE; FUNCTIONAL CONNECTIVITY; PREPULSE INHIBITION; ALZHEIMERS-DISEASE; PREFRONTAL CORTEX; MAJOR DEPRESSION; CINGULATE CORTEX; ATTENTION; DORSAL; MEMORY	Resting state brain networks (RSNs) are spatially distributed large-scale networks, evidenced by resting state functional magnetic resonance imaging (fMRI) studies. Importantly, RSNs are implicated in several relevant brain functions and present abnormal functional patterns in many neuropsychiatric disorders, for which stress exposure is an established risk factor. Yet, so far, little is known about the effect of stress in the architecture of RSNs, both in resting state conditions or during shift to task performance. Herein we assessed the architecture of the RSNs using functional magnetic resonance imaging (fMRI) in a cohort of participants exposed to prolonged stress (participants that had just finished their long period of preparation for the medical residence selection exam), and respective gender-and age-matched controls (medical students under normal academic activities). Analysis focused on the pattern of activity in resting state conditions and after deactivation. A volumetric estimation of the RSNs was also performed. Data shows that stressed participants displayed greater activation of the default mode (DMN), dorsal attention (DAN), ventral attention (VAN), sensorimotor (SMN), and primary visual (VN) networks than controls. Importantly, stressed participants also evidenced impairments in the deactivation of resting state-networks when compared to controls. These functional changes are paralleled by a constriction of the DMN that is in line with the pattern of brain atrophy observed after stress exposure. These results reveal that stress impacts on activation-deactivation pattern of RSNs, a finding that may underlie stress-induced changes in several dimensions of brain activity.	[Soares, Jose Miguel; Sampaio, Adriana; Ferreira, Luis Miguel; Santos, Nadine Correia; Marques, Paulo; Marques, Fernanda; Palha, Joana Almeida; Cerqueira, Joao Jose; Sousa, Nuno] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Soares, Jose Miguel; Ferreira, Luis Miguel; Santos, Nadine Correia; Marques, Paulo; Marques, Fernanda; Palha, Joana Almeida; Cerqueira, Joao Jose; Sousa, Nuno] ICVS 3Bs, PT Govt Associate Lab, Braga, Portugal; [Soares, Jose Miguel; Ferreira, Luis Miguel; Santos, Nadine Correia; Marques, Paulo; Marques, Fernanda; Palha, Joana Almeida; Cerqueira, Joao Jose; Sousa, Nuno] Clin Acad Ctr Braga, Braga, Portugal; [Sampaio, Adriana] Univ Minho, Sch Psychol, Neuropsychophysiol Lab, CIPsi, Braga, Portugal	Universidade do Minho; Universidade do Minho	Sousa, N (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Campus Gualtar, Braga, Portugal.	njcsousa@ecsaude.uminho.pt	Santos, Nadine Correia/AAC-2873-2019; Santos, Nadine/K-7431-2015; Palha, Joana Almeida/C-2745-2009; Cerqueira, Joao J/B-4579-2008; Sampaio, Adriana/AAI-9641-2021; Sousa, Nuno/C-2782-2009; Sampaio, Adriana/C-8361-2011; Sousa, Nuno JC/N-9137-2017; Marques, Fernanda/D-4238-2012; Marques, Paulo/E-4378-2014	Santos, Nadine/0000-0001-8110-7173; Palha, Joana Almeida/0000-0002-8866-368X; Cerqueira, Joao J/0000-0003-3155-2775; Sampaio, Adriana/0000-0001-7347-1282; Sousa, Nuno JC/0000-0002-8755-5126; Marques, Fernanda/0000-0002-3612-1870; Marques, Paulo/0000-0002-6304-4989; Soares, Jose Miguel/0000-0001-6558-4973	SwitchBox-FP7-HEALTH [259772-2]; Fundacao para a Ciencia e Tecnologia (FCT, Portugal) [SFRH/BPD/33379/2008]	SwitchBox-FP7-HEALTH; Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology)	JMS, NCS and PM are supported by fellowships of the project SwitchBox-FP7-HEALTH-2010-grant 259772-2; FM is supported by the fellowship SFRH/BPD/33379/2008 funded by the Fundacao para a Ciencia e Tecnologia (FCT, Portugal). The work was supported by SwitchBox-FP7-HEALTH-2010-grant 259772-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Anticevic A, 2010, NEUROIMAGE, V49, P2638, DOI 10.1016/j.neuroimage.2009.11.008; ARTHUR AZ, 1987, PERCEPT MOTOR SKILL, V64, P75, DOI 10.2466/pms.1987.64.1.75; Bartels A, 2005, NEUROIMAGE, V24, P339, DOI 10.1016/j.neuroimage.2004.08.044; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bessa JM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.001.2009; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brier MR, 2012, J NEUROSCI, V32, P8890, DOI 10.1523/JNEUROSCI.5698-11.2012; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carey PD, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-30; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Correa N, 2005, INT CONF ACOUST SPEE, P401; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Duan XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032532; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Ganis G, 2004, COGNITIVE BRAIN RES, V20, P226, DOI 10.1016/j.cogbrainres.2004.02.012; Gentili C, 2009, BRAIN RES BULL, V79, P409, DOI 10.1016/j.brainresbull.2009.02.002; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Grillon C, 1997, PSYCHOPHYSIOLOGY, V34, P511, DOI 10.1111/j.1469-8986.1997.tb01737.x; Guerrero-Pedraza A, 2012, PSYCHOL MED, V42, P73, DOI 10.1017/S0033291711001073; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hahn A, 2011, NEUROIMAGE, V56, P881, DOI 10.1016/j.neuroimage.2011.02.064; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Harrison BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022964; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Kim H, 2010, NEUROIMAGE, V50, P1648, DOI 10.1016/j.neuroimage.2010.01.051; Lemogne C, 2012, J AFFECT DISORDERS, V136, pE1, DOI 10.1016/j.jad.2010.11.034; Liao W, 2011, BRAIN RES, V1388, P167, DOI 10.1016/j.brainres.2011.03.018; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Majerus S, 2012, CEREB CORTEX, V22, P1086, DOI 10.1093/cercor/bhr174; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mantini D, 2009, NEUROIMAGE, V44, P265, DOI 10.1016/j.neuroimage.2008.08.019; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mayer JS, 2010, HUM BRAIN MAPP, V31, P126, DOI 10.1002/hbm.20850; McCabe C, 2011, MOL PSYCHIATR, V16, P592, DOI 10.1038/mp.2010.138; McCabe C, 2011, NEUROIMAGE, V57, P1317, DOI 10.1016/j.neuroimage.2011.05.051; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; Meda SA, 2012, BIOL PSYCHIAT, V71, P881, DOI 10.1016/j.biopsych.2012.01.025; Pijlman FTA, 2003, EUR NEUROPSYCHOPHARM, V13, P369, DOI 10.1016/S0924-977X(03)00040-3; Pomarol-Clotet E, 2008, PSYCHOL MED, V38, P1185, DOI 10.1017/S0033291708003565; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Scheidegger M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044799; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Soares JM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.59; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Thomason ME, 2008, NEUROIMAGE, V41, P1493, DOI 10.1016/j.neuroimage.2008.03.029; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wee CY, 2012, NEUROIMAGE, V59, P2045, DOI 10.1016/j.neuroimage.2011.10.015; Wolf RC, 2011, J PSYCHIATR NEUROSCI, V36, P402, DOI 10.1503/jpn.100150; Woodward ND, 2011, SCHIZOPHR RES, V130, P86, DOI 10.1016/j.schres.2011.03.010; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035; Zou QH, 2013, HUM BRAIN MAPP, V34, P3204, DOI 10.1002/hbm.22136	73	71	71	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66500	10.1371/journal.pone.0066500	http://dx.doi.org/10.1371/journal.pone.0066500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840493	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200088
J	Dudkiewicz, M; Lenart, A; Pawlowski, K				Dudkiewicz, Malgorzata; Lenart, Anna; Pawlowski, Krzysztof			A Novel Predicted Calcium-Regulated Kinase Family Implicated in Neurological Disorders	PLOS ONE			English	Article							LINKED MENTAL-RETARDATION; CYSTEINE-RICH DOMAIN; CRYSTAL-STRUCTURE; GOLGI PROTEIN; SEQUENCE; AUTISM; PHOSPHORYLATES; CANCER; SERVER; GENES	The catalogues of protein kinases, the essential effectors of cellular signaling, have been charted in Metazoan genomes for a decade now. Yet, surprisingly, using bioinformatics tools, we predicted protein kinase structure for proteins coded by five related human genes and their Metazoan homologues, the FAM69 family. Analysis of three-dimensional structure models and conservation of the classic catalytic motifs of protein kinases present in four out of five human FAM69 proteins suggests they might have retained catalytic phosphotransferase activity. An EF-hand Ca2+-binding domain in FAM69A and FAM69B proteins, inserted within the structure of the kinase domain, suggests they may function as Ca2+-dependent kinases. The FAM69 genes, FAM69A, FAM69B, FAM69C, C3ORF58 (DIA1) and CXORF36 (DIA1R), are by large uncharacterised molecularly, yet linked to several neurological disorders in genetics studies. The C3ORF58 gene is found deleted in autism, and resides in the Golgi. Unusually high cysteine content and presence of signal peptides in some of the family members suggest that FAM69 proteins may be involved in phosphorylation of proteins in the secretory pathway and/or of extracellular proteins.	[Dudkiewicz, Malgorzata; Pawlowski, Krzysztof] Warsaw Univ Life Sci, Warsaw, Poland; [Lenart, Anna; Pawlowski, Krzysztof] Polish Acad Sci, Nencki Inst Expt Biol, Warsaw, Poland	Warsaw University of Life Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Pawlowski, K (corresponding author), Warsaw Univ Life Sci, Warsaw, Poland.	krzysztof_pawlowski@sggw.pl	Pawłowski, Krzysztof/C-2949-2013; Dudkiewicz, Małgorzata/AAG-4553-2020	Pawłowski, Krzysztof/0000-0002-5367-0935; Dudkiewicz, Malgorzata/0000-0003-4432-2530				Alcina A, 2010, EUR J HUM GENET, V18, P827, DOI 10.1038/ejhg.2009.240; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014534; Aziz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014547; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Beltrami A, 2011, CRYSTAL STRUCTURE HU; Bonardi V, 2012, CURR OPIN IMMUNOL, V24, P41, DOI 10.1016/j.coi.2011.12.006; Boudsocq M, 2012, BIOCHEM J, V447, P291, DOI 10.1042/BJ20112072; Chandran V, 2006, J MOL BIOL, V357, P400, DOI 10.1016/j.jmb.2005.11.093; Cheek S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-6; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dong J, 2009, PLANT CELL, V21, P1846, DOI 10.1105/tpc.109.066878; Dudkiewicz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032138; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edwards AM, 2011, NATURE, V470, P163, DOI 10.1038/470163a; Eglen R, 2011, PHARMACOL THERAPEUT, V130, P144, DOI 10.1016/j.pharmthera.2011.01.007; FAHEY RC, 1977, J MOL EVOL, V10, P155, DOI 10.1007/BF01751808; Farah CA, 2012, ADV EXP MED BIOL, V740, P663, DOI 10.1007/978-94-007-2888-2_29; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Feige MJ, 2011, CURR OPIN CELL BIOL, V23, P167, DOI 10.1016/j.ceb.2010.10.012; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gershburg E, 2008, BBA-PROTEINS PROTEOM, V1784, P203, DOI 10.1016/j.bbapap.2007.08.009; Giannandrea M, 2010, AM J HUM GENET, V86, P185, DOI 10.1016/j.ajhg.2010.01.011; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Good CD, 2003, BRAIN, V126, P2431, DOI 10.1093/brain/awg242; Goonesekere NCW, 2010, COMPUT BIOL CHEM, V34, P210, DOI 10.1016/j.compbiolchem.2010.04.001; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; Hagerman R, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-12; Hall T, 2012, BIOEDIT; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; HOMMEL U, 1994, NAT STRUCT BIOL, V1, P383, DOI 10.1038/nsb0694-383; Imuta Y, 2009, DEV DYNAM, V238, P210, DOI 10.1002/dvdy.21822; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; Jaroszewski L, 2000, PROTEIN SCI, V9, P1487, DOI 10.1110/ps.9.8.1487; Jaroszewski L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000205; Jensen LR, 2007, EUR J HUM GENET, V15, P68, DOI 10.1038/sj.ejhg.5201714; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kaszuba K, 2010, J PHYS CHEM B, V114, P8374, DOI 10.1021/jp909971f; Kinoshita M, 2009, DEVELOPMENT, V136, P2069, DOI 10.1242/dev.026435; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Koike T, 2009, BIOCHEM J, V421, P157, DOI 10.1042/BJ20090474; Lederer D, 2012, AM J HUM GENET, V90, P119, DOI 10.1016/j.ajhg.2011.11.021; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Manning BD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.263pe15; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Molendijk AJ, 2008, PLANT J, V53, P909, DOI 10.1111/j.1365-313X.2007.03384.x; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nakagawa H, 2011, INT J BIOCHEM CELL B, V43, P423, DOI 10.1016/j.biocel.2010.11.015; Papoian GA, 2004, P NATL ACAD SCI USA, V101, P3352, DOI 10.1073/pnas.0307851100; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Pawlowski K, 2001, TRENDS BIOCHEM SCI, V26, P85, DOI 10.1016/S0968-0004(00)01729-1; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Prichard MN, 2009, REV MED VIROL, V19, P215, DOI 10.1002/rmv.615; Ruiz-Trillo I, 2004, CURR BIOL, V14, pR946, DOI 10.1016/j.cub.2004.10.037; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samir Amina Azizi, 2000, Molecular Cell Biology Research Communications, V4, P188, DOI 10.1006/mcbr.2000.0277; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stiegler AL, 2009, J MOL BIOL, V393, P1, DOI 10.1016/j.jmb.2009.07.091; Suga H, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002733; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Takatalo MS, 2009, J DENT RES, V88, P534, DOI 10.1177/0022034509338452; Takatalo M, 2008, DEV DYNAM, V237, P2243, DOI 10.1002/dvdy.21646; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tennant-Eyles AJ, 2011, BIOCHEM BIOPH RES CO, V406, P471, DOI 10.1016/j.bbrc.2011.02.076; Thiselton DL, 2002, GENOMICS, V79, P560, DOI 10.1006/geno.2002.6733; Torruella G, 2012, MOL BIOL EVOL, V29, P531, DOI 10.1093/molbev/msr185; Wang KS, 2010, SCHIZOPHR RES, V124, P192, DOI 10.1016/j.schres.2010.09.002; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Yurtsever Z, 2012, J BIOL CHEM, V287, P42138, DOI 10.1074/jbc.M112.410282	88	29	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66427	10.1371/journal.pone.0066427	http://dx.doi.org/10.1371/journal.pone.0066427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840464	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400013
J	Boyle, PA; Yu, L; Gamble, KJ; Bennett, DA				Boyle, Patricia A.; Yu, Lei; Gamble, Keith J.; Bennett, David A.			Temporal Discounting Is Associated with an Increased Risk of Mortality among Community-Based Older Persons without Dementia	PLOS ONE			English	Article							DELAYED REWARDS; AGE-DIFFERENCES; LIFE; RATES; PREFERENCES	Background: Temporal discounting is an important determinant of many health and financial outcomes, but we are not aware of studies that have examined the association of temporal discounting with mortality. Methods: Participants were 406 older persons without dementia from the Rush Memory and Aging Project, a longitudinal cohort study of aging. Temporal discounting was measured using standard preference elicitation questions. Individual discount rates were estimated using a well-established hyperbolic function and used to predict the risk of mortality during up to 5 years of follow-up. Results: The mean estimate of discounting was 0.45 (SD = 0.33, range: 0.08-0.90), with higher scores indicating a greater propensity to prefer smaller immediate rewards over larger but delayed ones. During up to 5 years of follow-up (mean = 3.6 years), 62 (15% of 406) persons died. In a proportional hazards model adjusted for age, sex, and education, temporal discounting was associated with an increased risk of mortality (HR = 1.103, 95% CI 1.024, 1.190, p = 0.010). Thus, a person with the highest discount rate (score = 0.90) was about twice more likely to die over the study period compared to a person with the lowest discount rate (score = 0.08). Further, the association of discounting with mortality persisted after adjustment for the level of global cognitive function, the burden of vascular risk factors and diseases, and an indicator of psychological well being (i.e., purpose in life). Conclusion: Temporal discounting is associated with an increased risk of mortality in old age after accounting for global cognitive function and indicators of physical and mental health.	[Boyle, Patricia A.; Yu, Lei; Bennett, David A.] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA; [Boyle, Patricia A.] Rush Univ, Dept Behav Sci, Med Ctr, Chicago, IL 60612 USA; [Yu, Lei; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Gamble, Keith J.] Depaul Univ, Dept Finance, Chicago, IL 60604 USA	Rush University; Rush University; Rush University; DePaul University	Boyle, PA (corresponding author), Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA.	Patricia_Boyle@rush.edu	Yu, Lei/AAT-3685-2020		National Institute on Aging [R21AG30765, R01AG17917, R01AG34374, R01AG33678]; Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING [R01AG034374, R01AG017917, R01AG033678] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Illinois Department of Public Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institute on Aging Grants R21AG30765 (Bennett), R01AG17917 (Bennett), R01AG34374 (Boyle), R01AG33678 (Boyle), and the Illinois Department of Public Health. The funding agencies had no role in the design, conduct, or interpretation of the data or preparation of the manuscript.	Bennett DA, 2005, NEUROLOGY, V64, P834, DOI 10.1212/01.WNL.0000152982.47274.9E; Bennett DA, 2012, ANN NEUROL, V72, P599, DOI 10.1002/ana.23654; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bickel WK, 2001, ADDICTION, V96, P73, DOI 10.1046/j.1360-0443.2001.961736.x; Boyle PA, 2009, PSYCHOSOM MED, V71, P574, DOI 10.1097/PSY.0b013e3181a5a7c0; Burks SV, 2009, P NATL ACAD SCI USA, V106, P7745, DOI 10.1073/pnas.0812360106; Chabris CF, 2008, J RISK UNCERTAINTY, V37, P237, DOI 10.1007/s11166-008-9053-x; Critchfield TS, 2001, J APPL BEHAV ANAL, V34, P101, DOI 10.1901/jaba.2001.34-101; de Wit H, 2007, PERS INDIV DIFFER, V42, P111, DOI 10.1016/j.paid.2006.06.026; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Green L, 1999, BEHAV PROCESS, V46, P89, DOI 10.1016/S0376-6357(99)00021-2; Green L, 1996, PSYCHOL AGING, V11, P79, DOI 10.1037/0882-7974.11.1.79; Hesketh B, 1988, J VOCAT BEHAV, V52, P89; Hsu M, 2008, ADV HEALTH ECON HEAL, V20, P203, DOI 10.1016/S0731-2199(08)20009-9; Kirby KN, 1997, J EXP PSYCHOL GEN, V126, P54, DOI 10.1037/0096-3445.126.1.54; Kirby KN, 1999, J EXP PSYCHOL GEN, V128, P78, DOI 10.1037/0096-3445.128.1.78; Kirby KN, 1996, PSYCHON B REV, V3, P100, DOI 10.3758/BF03210748; Kirby KN, 2005, LEARN INDIVID DIFFER, V15, P213, DOI 10.1016/j.lindif.2005.01.003; Laibson D, 1998, EUR ECON REV, V42, P861, DOI 10.1016/S0014-2921(97)00132-3; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; Lockenhoff CE, 2011, PSYCHOL AGING, V26, P274, DOI 10.1037/a0023280; Meier S, 2010, AM ECON J-APPL ECON, V2, P193, DOI 10.1257/app.2.1.193; Myerson J, 2001, J EXP ANAL BEHAV, V76, P235, DOI 10.1901/jeab.2001.76-235; Read D, 2004, ORGAN BEHAV HUM DEC, V94, P22, DOI 10.1016/j.obhdp.2004.01.002; SAS Institute, SAS STAT US GUID VER; Shamosh NA, 2008, INTELLIGENCE, V36, P289, DOI 10.1016/j.intell.2007.09.004; Taylor M., 2009, FINANCIAL CAPABILITY; Vuchinich RE, 1998, EXP CLIN PSYCHOPHARM, V6, P292, DOI 10.1037/1064-1297.6.3.292; Whelan R, 2009, PSYCHOL REC, V59, P247, DOI 10.1007/BF03395661	29	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67376	10.1371/journal.pone.0067376	http://dx.doi.org/10.1371/journal.pone.0067376			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IX	23826281	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000070
J	Parets, SE; Conneely, KN; Kilaru, V; Fortunato, SJ; Syed, TA; Saade, G; Smith, AK; Menon, R				Parets, Sasha E.; Conneely, Karen N.; Kilaru, Varun; Fortunato, Stephen J.; Syed, Tariq Ali; Saade, George; Smith, Alicia K.; Menon, Ramkumar			Fetal DNA Methylation Associates with Early Spontaneous Preterm Birth and Gestational Age	PLOS ONE			English	Article							FACTOR-BINDING PROTEIN-1; CORTICOTROPIN-RELEASING HORMONE; HUMAN-PREGNANCY; MEMBRANE RUPTURE; GROWTH; DISEASE; ARRAY; RISK; TRANSCRIPTION; EPIGENETICS	Spontaneous preterm birth (PTB, <37 weeks gestation) is a major public health concern, and children born preterm have a higher risk of morbidity and mortality throughout their lives. Recent studies suggest that fetal DNA methylation of several genes varies across a range of gestational ages (GA), but it is not yet clear if fetal epigenetic changes associate with PTB. The objective of this study is to interrogate methylation patterns across the genome in fetal leukocyte DNA from African Americans with early PTB (24(1/7)-34(0/7) weeks; N = 22) or term births (39(0/7)-40(6/7) weeks; N = 28) and to evaluate the association of each CpG site with PTB and GA. DNA methylation was assessed across the genome with the HumanMethylation450 BeadChip. For each individual sample and CpG site, the proportion of DNA methylation was estimated. The associations between methylation and PTB or GA were evaluated by fitting a separate linear model for each CpG site, adjusting for relevant covariates. Overall, 29 CpG sites associated with PTB (FDR<.05; 5.7x10(-10)<p<2.9x10(-6)) independent of GA. Also, 9637 sites associated with GA (FDR<.05; 9.5x10(-16)<p<1.0x10(-3)), with 61.8% decreasing in methylation with shorter GA. GA-associated CpG sites were depleted in the CpG islands of their respective genes (p<2.2x10(-16)). Gene set enrichment analysis (GSEA) supported enrichment of GA-associated CpG sites in genes that play a role in embryonic development as well as the extracellular matrix. Additionally, this study replicated the association of several CpG sites associated with gestational age in other studies (CRHBP, PIK3CD and AVP). Dramatic differences in fetal DNA methylation are evident in fetuses born preterm versus at term, and the patterns established at birth may provide insight into the long-term consequences associated with PTB.	[Parets, Sasha E.; Smith, Alicia K.] Emory Univ, Genet & Mol Biol Program, Atlanta, GA 30322 USA; [Conneely, Karen N.] Emory Univ, Dept Human Genet, Sch Med, Atlanta, GA USA; [Kilaru, Varun; Smith, Alicia K.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Fortunato, Stephen J.] Perinatal Res Ctr, Nashville, TN USA; [Syed, Tariq Ali; Saade, George; Menon, Ramkumar] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med Perinatal Res, Galveston, TX 77555 USA	Emory University; Emory University; Emory University; University of Texas System; University of Texas Medical Branch Galveston	Smith, AK (corresponding author), Emory Univ, Genet & Mol Biol Program, Atlanta, GA 30322 USA.	alicia.smith@emory.edu; Ram.menon@utmb.edu	Fortunato, Stephen J/L-7545-2013; Smith, Alicia/W-6809-2019	Smith, Alicia/0000-0002-8537-5156	March of Dimes, USA [21-FY08-557]; NIMH [MH085806]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER	March of Dimes, USA(March of Dimes); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by Grants from March of Dimes, USA (#21-FY08-557) to R Menon and NIMH (MH085806) to Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2011, BIRTH DEFECTS RES A, V91, P728, DOI 10.1002/bdra.20770; Alisch RS, 2012, GENOME RES, V22, P623, DOI 10.1101/gr.125187.111; Alva JA, 2004, CURR OPIN HEMATOL, V11, P278, DOI 10.1097/01.moh.0000130309.44976.ad; Aparicio IM, 2010, REPRODUCTION, V140, P83, DOI 10.1530/REP-10-0040; Barfield RT, 2012, BIOINFORMATICS, V28, P1280, DOI 10.1093/bioinformatics/bts124; Barker DJP, 2010, EUR J HEART FAIL, V12, P819, DOI 10.1093/eurjhf/hfq069; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Behrman RE, 2007, PRETERM BIRTH CAUSES; Beyan H, 2012, GENOME RES, V22, P2138, DOI 10.1101/gr.134304.111; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Botsis D, 2006, EUR J OBSTET GYN R B, V128, P108, DOI 10.1016/j.ejogrb.2005.10.022; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Fortunato SJ, 1999, J PERINAT MED, V27, P362, DOI 10.1515/JPM.1999.049; Ginder GD, 2008, CURR TOP DEV BIOL, V82, P85, DOI 10.1016/S0070-2153(07)00004-X; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Harris SJ, 2009, CURR OPIN INVEST DR, V10, P1151; Hillhouse EW, 2002, REPRODUCTION, V124, P323, DOI 10.1530/reprod/124.3.323; Hobel CJ, 1999, ANN NY ACAD SCI, V897, P54, DOI 10.1111/j.1749-6632.1999.tb07878.x; Hogg K, 2012, CLIN PHARMACOL THER, V92, P716, DOI 10.1038/clpt.2012.141; Hoyo C, 2012, CANCER CAUSE CONTROL, V23, P635, DOI 10.1007/s10552-012-9932-y; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jeffcoat M K, 2001, Ann Periodontol, V6, P183, DOI 10.1902/annals.2001.6.1.183; Kilaru V, 2012, EPIGENETICS-US, V7, P225, DOI 10.4161/epi.7.3.19284; Kyrklund-Blomberg NB, 2005, ACTA OBSTET GYN SCAN, V84, P572, DOI 10.1111/j.0001-6349.2005.00848.x; LOCKWOOD CJ, 1994, AM J OBSTET GYNECOL, V171, P146, DOI 10.1016/0002-9378(94)90461-8; Loftin Ryan W, 2010, Rev Obstet Gynecol, V3, P10; Martina NA, 1997, J CLIN ENDOCR METAB, V82, P1894, DOI 10.1210/jc.82.6.1894; Maymon E, 2000, AM J OBSTET GYNECOL, V183, P887, DOI 10.1067/mob.2000.108878; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Menon R, 2012, REPROD SCI, V19, P6, DOI 10.1177/1933719111424446; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nosarti C, 2012, ARCH GEN PSYCHIAT, V69, P610, DOI 10.1001/archgenpsychiatry.2011.1374; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6; Pan H, 2012, EPIGENETICS-US, V7, P1173, DOI 10.4161/epi.22102; Paulsen M, 2001, J PATHOL, V195, P97, DOI 10.1002/path.890; PERKINS AV, 1993, J ENDOCRINOL, V138, P149, DOI 10.1677/joe.0.1380149; Perkins E, 2012, J PEDIATR-US, V161, P31, DOI 10.1016/j.jpeds.2012.01.015; Ribeiro MSJ, 2009, NUCLEIC ACIDS RES, V37, P6691, DOI 10.1093/nar/gkp724; Roessler Jessica, 2012, BMC Res Notes, V5, P210, DOI 10.1186/1756-0500-5-210; Romero R, 2002, AM J OBSTET GYNECOL, V187, P1125, DOI 10.1067/mob.2002.127312; Rutanen EM, 1996, CLIN CHIM ACTA, V253, P91, DOI 10.1016/0009-8981(96)80001-E; Schroeder JW, 2011, EPIGENETICS-US, V6, P1498, DOI 10.4161/epi.6.12.18296; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Stunkel W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039744; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tency I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049042; Vogel I, 2004, IN VIVO, V18, P37; Wang DL, 2012, EPIGENETICS-US, V7, P594, DOI 10.4161/epi.20117; Watanabe T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003132; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Yuan W, 2001, EUR J EPIDEMIOL, V17, P829, DOI 10.1023/A:1015626329533	58	69	69	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67489	10.1371/journal.pone.0067489	http://dx.doi.org/10.1371/journal.pone.0067489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826308	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000084
J	Haeno, H; Maruvka, YE; Iwasa, Y; Michor, F				Haeno, Hiroshi; Maruvka, Yosef E.; Iwasa, Yoh; Michor, Franziska			Stochastic Tunneling of Two Mutations in a Population of Cancer Cells	PLOS ONE			English	Article							COLORECTAL-CANCER; DYNAMICS; INSTABILITY; INITIATION; EVOLUTION; LEUKEMIA; THERAPY; CRYPT; MODEL; TIME	Cancer initiation, progression, and the emergence of drug resistance are driven by specific genetic and/or epigenetic alterations such as point mutations, structural alterations, DNA methylation and histone modification changes. These alterations may confer advantageous, deleterious or neutral effects to mutated cells. Previous studies showed that cells harboring two particular alterations may arise in a fixed-size population even in the absence of an intermediate state in which cells harboring only the first alteration take over the population; this phenomenon is called stochastic tunneling. Here, we investigated a stochastic Moran model in which two alterations emerge in a cell population of fixed size. We developed a novel approach to comprehensively describe the evolutionary dynamics of stochastic tunneling of two mutations. We considered the scenarios of large mutation rates and various fitness values and validated the accuracy of the mathematical predictions with exact stochastic computer simulations. Our theory is applicable to situations in which two alterations are accumulated in a fixed-size population of binary dividing cells.	[Haeno, Hiroshi; Iwasa, Yoh] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Maruvka, Yosef E.; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Maruvka, Yosef E.; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Kyushu University; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Iwasa, Y (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan.	yohiwasa@kyudai.jp; michor@jimmy.harvard.edu	Iwasa, Yoh/G-5368-2010	Iwasa, Yoh/0000-0003-0691-1852; Maruvka, Yosef/0000-0002-8918-9887	NCI; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altland A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.088101; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Dingli D, 2006, STEM CELLS, V24, P2603, DOI 10.1634/stemcells.2006-0136; Durrett R, 2008, PROBAB APPL SER, P1, DOI 10.1007/978-0-387-78168-6_1; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; FISHER JC, 1958, NATURE, V181, P651, DOI 10.1038/181651b0; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GISHIZKY ML, 1992, SCIENCE, V256, P836, DOI 10.1126/science.1375394; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Iwasa Y, 2006, GENETICS, V172, P2557, DOI 10.1534/genetics.105.049791; Iwasa Y, 2004, GENETICS, V166, P1571, DOI 10.1534/genetics.166.3.1571; Iwasa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017866; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Komarova NL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000990; Komarova NL, 2003, J THEOR BIOL, V223, P433, DOI 10.1016/S0022-5193(03)00120-6; Lehmann L, 2009, THEOR POPUL BIOL, V76, P35, DOI 10.1016/j.tpb.2009.03.006; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Loeb LA, 2001, CANCER RES, V61, P3230; Lynch M, 2010, P NATL ACAD SCI USA, V107, P16577, DOI 10.1073/pnas.1010836107; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Michor F, 2004, CELL CYCLE, V3, P358; Moran P., 1962, STAT PROCESSES EVOLU; Nicolas P, 2007, PLOS COMPUT BIOL, V3, P364, DOI 10.1371/journal.pcbi.0030028; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; Nowak MA, 2004, P NATL ACAD SCI USA, V101, P10635, DOI 10.1073/pnas.0400747101; Perucho M, 1996, BIOL CHEM, V377, P675; Proulx SR, 2011, THEOR POPUL BIOL, V80, P197, DOI 10.1016/j.tpb.2011.07.003; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roeder I, 2006, NAT MED, V12, P1181, DOI 10.1038/nm1487; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Schweinsberg J, 2008, ELECTRON J PROBAB, V13, P1442, DOI 10.1214/EJP.v13-540; Shah NP, 2007, J CLIN INVEST, V117, P2562, DOI 10.1172/JCI30890; van Leeuwen IMM, 2006, CELL PROLIFERAT, V39, P157, DOI 10.1111/j.1365-2184.2006.00378.x; Weinreich DM, 2005, EVOLUTION, V59, P1175; Weissman DB, 2010, GENETICS, V186, P1389, DOI 10.1534/genetics.110.123240; Weissman DB, 2009, THEOR POPUL BIOL, V75, P286, DOI 10.1016/j.tpb.2009.02.006	44	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65724	10.1371/journal.pone.0065724	http://dx.doi.org/10.1371/journal.pone.0065724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840359	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400011
J	Liu, YY; Li, LF; Yang, CT; Lu, KH; Huang, CC; Kao, KC; Chiou, SH				Liu, Yung-Yang; Li, Li-Fu; Yang, Cheng-Ta; Lu, Kai-Hsi; Huang, Chung-Chi; Kao, Kuo-Chin; Chiou, Shih-Hwa			Suppressing NF-kappa B and NKRF Pathways by Induced Pluripotent Stem Cell Therapy in Mice with Ventilator-Induced Lung Injury	PLOS ONE			English	Article							REPRESSING FACTOR; SYSTEMIC INFLAMMATION; BASAL REPRESSION; ACTIVATION; NRF; DIFFERENTIATION; INTERLEUKIN-8; MECHANISMS; INDUCTION; PROMOTER	Background: High-tidal-volume mechanical ventilation used in patients with acute lung injury (ALI) can induce the release of inflammatory cytokines, as macrophage inflammatory protein-2 (MIP-2), recruitment of neutrophils, and disruption of alveolar epithelial and endothelial barriers. Induced pluripotent stem cells (iPSCs) have been shown to improve ALI in mice, but the mechanisms regulating the interactions between mechanical ventilation and iPSCs are not fully elucidated. Nuclear factor kappa B (NF-kappa B) and NF-kappa B repressing factor (NKRF) have been proposed to modulate the neutrophil activation involved in ALI. Thus, we hypothesized intravenous injection of iPSCs or iPSC-derived conditioned medium (iPSC-CM) would decrease high-tidal-volume ventilation-induced neutrophil infiltration, oxidative stress, and MIP-2 production through NF-kappa B/NKRF pathways. Methods: Male C57BL/6 mice, aged between 6 and 8 weeks, weighing between 20 and 25 g, were exposed to high-tidal-volume (30 ml/kg) mechanical ventilation with room air for 1 to 4 h after 5 x 10(7) cells/kg mouse iPSCs or iPSC-CM administration. Nonventilated mice were used as control groups. Results: High-tidal-volume mechanical ventilation induced the increases of integration of iPSCs into the injured lungs of mice, microvascular permeability, neutrophil infiltration, malondialdehyde, MIP-2 production, and NF-kappa B and NKRF activation. Lung injury indices including inflammation, lung edema, ultrastructure pathologic changes and functional gas exchange impairment induced by mechanical ventilation were attenuated with administration of iPSCs or iPSC-CM, which was mimicked by pharmacological inhibition of NF-kappa B activity with SN50 or NKRF expression with NKRF short interfering RNA. Conclusions: Our data suggest that iPSC-based therapy attenuates high-tidal-volume mechanical ventilation-induced lung injury, at least partly, through inhibition of NF-kappa B/NKRF pathways. Notably, the conditioned medium of iPSCs revealed beneficial effects equal to those of iPSCs.	[Liu, Yung-Yang] Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan; [Liu, Yung-Yang; Chiou, Shih-Hwa] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Li, Li-Fu; Yang, Cheng-Ta; Huang, Chung-Chi; Kao, Kuo-Chin] Chang Gung Mem Hosp, Dept Med, Div Pulm & Crit Care Med, Taoyuan, Taiwan; [Li, Li-Fu; Yang, Cheng-Ta; Huang, Chung-Chi; Kao, Kuo-Chin] Chang Gung Univ, Dept Med, Taoyuan, Taiwan; [Li, Li-Fu; Yang, Cheng-Ta; Huang, Chung-Chi; Kao, Kuo-Chin] Chang Gung Mem Hosp, Dept Resp Therapy, Taoyuan, Taiwan; [Lu, Kai-Hsi] Fu Jen Catholic Univ, Grad Inst Basic Med, New Taipei City, Taiwan; [Lu, Kai-Hsi] Cheng Hsin Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chiou, Shih-Hwa] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chiou, Shih-Hwa] Natl Yang Ming Univ, Sch Med, Inst Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Fu Jen Catholic University; Cheng Hsin General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Li, LF (corresponding author), Chang Gung Mem Hosp, Dept Med, Div Pulm & Crit Care Med, Taoyuan, Taiwan.	lfp3434@adm.cgmh.org.tw; shchiou@vghtpe.gov.tw		Yang, Cheng-Ta/0000-0003-1846-1027	National Science Council, Taiwan [101-2314-B-182A-088-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	The work was supported by National Science Council, Taiwan 101-2314-B-182A-088-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Abraham E, 2000, CRIT CARE MED, V28, pN100, DOI 10.1097/00003246-200004001-00012; Abreu SC, 2011, INTENS CARE MED, V37, P1421, DOI 10.1007/s00134-011-2268-3; Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Araujo IM, 2010, CRIT CARE MED, V38, P1733, DOI 10.1097/CCM.0b013e3181e796d2; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Chen SJ, 2010, STEM CELLS DEV, V19, P1757, DOI 10.1089/scd.2009.0452; Curley GF, 2012, THORAX, V67, P496, DOI 10.1136/thoraxjnl-2011-201059; Feng XS, 2002, P NATL ACAD SCI USA, V99, P14212, DOI 10.1073/pnas.212306199; Froese N, 2006, MOL CELL BIOL, V26, P293, DOI 10.1128/MCB.26.1.293-302.2006; Gupta N, 2007, J IMMUNOL, V179, P1855, DOI 10.4049/jimmunol.179.3.1855; Hegeman MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015653; Held HD, 2001, AM J RESP CRIT CARE, V163, P711, DOI 10.1164/ajrccm.163.3.2003001; Ho SC, 2009, J IMMUNOL, V183, P411, DOI 10.4049/jimmunol.0803729; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Huang Y, 2011, CLIN TOXICOL, V49, P298, DOI 10.3109/15563650.2011.566882; Kadzik RS, 2012, CELL STEM CELL, V10, P355, DOI 10.1016/j.stem.2012.03.013; Lee JW, 2009, P NATL ACAD SCI USA, V106, P16357, DOI 10.1073/pnas.0907996106; Lee JW, 2009, EXPERT OPIN BIOL TH, V9, P1259, DOI 10.1517/14712590903213651; Lee KY, 2012, EUR RESPIR J, V40, P863, DOI 10.1183/09031936.00146811; Li HY, 2011, BIOMATERIALS, V32, P5994, DOI 10.1016/j.biomaterials.2011.05.009; Li LF, 2004, AM J RESP CRIT CARE, V169, P518, DOI 10.1164/rccm.200305-660OC; Li LF, 2003, AM J PHYSIOL-LUNG C, V285, pL464, DOI 10.1152/ajplung.00031.2003; Li LF, 2009, CRIT CARE, V13, DOI 10.1186/cc7949; Liu YY, 2009, TRANSL RES, V154, P228, DOI 10.1016/j.trsl.2009.06.006; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; Matthay MA, 2010, CHEST, V138, P965, DOI 10.1378/chest.10-0518; Miki K, 2012, STEM CELL TRANSL MED, V1, P430, DOI 10.5966/sctm.2011-0038; Moine P, 2000, SHOCK, V13, P85, DOI 10.1097/00024382-200013020-00001; Mou HM, 2012, CELL STEM CELL, V10, P385, DOI 10.1016/j.stem.2012.01.018; Ning QM, 2007, RESPIROLOGY, V12, P792, DOI 10.1111/j.1440-1843.2007.01166.x; Nourbakhsh M, 1999, EMBO J, V18, P6415, DOI 10.1093/emboj/18.22.6415; Nourbakhsh M, 2001, J BIOL CHEM, V276, P4501, DOI 10.1074/jbc.M007532200; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Otte JM, 2009, NUTR CANCER, V61, P103, DOI 10.1080/01635580802372625; Park HS, 2009, RESPIROLOGY, V14, P27, DOI 10.1111/j.1440-1843.2008.01447.x; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC; Reboll MR, 2011, J BIOCHEM, V150, P553, DOI 10.1093/jb/mvr099; Ricard JD, 2003, EUR RESPIR J, V22, p2S, DOI 10.1183/09031936.03.00420103; Rojas M, 2005, AM J RESP CELL MOL, V33, P145, DOI 10.1165/rcmb.2004-0330OC; Schmitz ML, 2001, TRENDS BIOCHEM SCI, V26, P186, DOI 10.1016/S0968-0004(00)01753-9; Stagg J, 2007, TISSUE ANTIGENS, V69, P1, DOI 10.1111/j.1399-0039.2006.00739.x; Syrkina O, 2008, RESPIROLOGY, V13, P333, DOI 10.1111/j.1440-1843.2008.01279.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tremblay LN, 2006, INTENS CARE MED, V32, P24, DOI 10.1007/s00134-005-2817-8; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Uhlig U, 2002, EUR RESPIR J, V20, P946, DOI 10.1183/09031936.02.01612001; Wright Jeffrey G, 2003, Am J Respir Med, V2, P211; Yagi H, 2010, MOL THER, V18, P1857, DOI 10.1038/mt.2010.155; Yang KY, 2011, CHEST, V140, P1243, DOI 10.1378/chest.11-0539; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zingarelli B, 2003, CRIT CARE MED, V31, pS105, DOI 10.1097/00003246-200301001-00015	54	17	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66760	10.1371/journal.pone.0066760	http://dx.doi.org/10.1371/journal.pone.0066760			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840526	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400038
J	Schuhfried, E; Mark, TD; Biasioli, F				Schuhfried, Erna; Maerk, Tilmann D.; Biasioli, Franco			Primary Ion Depletion Kinetics (PIDK) Studies as a New Tool for Investigating Chemical Ionization Fragmentation Reactions with PTR-MS	PLOS ONE			English	Article							REACTION-MASS-SPECTROMETRY; TRACE GAS-ANALYSIS; FLOW TUBE; SULFIDES; O-2(+); SIFT; H3O+; NO+	We report on a new approach for studying fragmentation channels in Proton Transfer Reaction-Mass Spectrometry (PTR-MS), which we name primary ion depletion kinetics (PIDK). PTR-MS is a chemical ionization mass spectrometric (CIMS) technique deploying hydronium ions for the chemical ionization. Induced by extremely high concentrations of analyte M, depletion of the primary ions in the drift tube occurs. This is observed as quasi zero concentration of the primary ion H3O+, and constant MH+. Under these non-standard conditions, we find an overall changed fragmentation. We offer two explanations. Either the changed fragmentation pattern is the result of secondary proton transfer reactions. Or, alternatively, the fast depletion of H3O+ leads to reduced heating of H3O+ in the drift field, and consequently changed fragmentation following protonation of the analyte M. In any case, we use the observed changes in fragmentation as a successful new approach to fragmentation studies, and term it primary ion depletion kinetics, PIDK. PIDK easily yields an abundance of continuous data points with little deviation, because they are obtained in one experimental run, even for low abundant fragments. This is an advantage over traditional internal kinetic energy variation studies (electric field per number density (E/N) variation studies). Also, some interpretation on the underlying fragmentation reaction mechanisms can be gleamed. We measure low occurring fragmentation (<2% of MH+) of the compounds dimethyl sulfide, DMS, a compound that reportedly does not fragment, diethyl sulfide DES, and dipropyl sulfide DPS. And we confirm and complement the results with traditional E/N studies. Summing up, the new approach of primary ion depletion kinetics allows for the identification of dehydrogenation [MH+ -H-2] and adduct formation (RMH+) as low abundant fragmentation channels in monosulfides.	[Schuhfried, Erna; Maerk, Tilmann D.] Leopold Franzens Univ Innsbruck, Inst Ionenphys & Angew Phys, Innsbruck, Tyrol, Austria; [Biasioli, Franco] Fdn Edmund Mach, Res & Innovat Ctr, Food Qual & Nutr Dept, Trentino, Italy	University of Innsbruck; Fondazione Edmund Mach	Schuhfried, E (corresponding author), Leopold Franzens Univ Innsbruck, Inst Ionenphys & Angew Phys, Innsbruck, Tyrol, Austria.	erna.schuhfried@uibk.ac.at	biasioli, franco/AAM-4121-2021; Biasioli, Franco/AGZ-3915-2022; Märk, Tilmann D/J-1650-2014; Biasioli, Franco/A-3278-2012	Biasioli, Franco/0000-0001-5715-9686; Biasioli, Franco/0000-0001-5715-9686	Provincia Autonoma di Trento	Provincia Autonoma di Trento(Autonomous Province of Trento)	Work partly supported by Provincia Autonoma di Trento (FB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ammann C, 2004, INT J MASS SPECTROM, V239, P87, DOI 10.1016/j.ijms.2004.08.012; Antolasic F., 2012, MOL WEIGHT CALCULATO; Antolasic F., 2012, ELEMENTAL COMPOSITIO; Brown P, 2010, INT J MASS SPECTROM, V294, P103, DOI 10.1016/j.ijms.2010.05.028; Buhr K, 2002, INT J MASS SPECTROM, V221, P1, DOI 10.1016/S1387-3806(02)00896-5; de Gouw J, 2003, INT J MASS SPECTROM, V223, P365, DOI 10.1016/S1387-3806(02)00926-0; GLOSIK J, 1995, INT J MASS SPECTROM, V149, P499, DOI 10.1016/0168-1176(95)04281-O; HANSEL A, 1995, INT J MASS SPECTROM, V149, P609, DOI 10.1016/0168-1176(95)04294-U; Ianni J.C, 2014, KINTECUS; Karl T, 2003, INT J MASS SPECTROM, V223, P383, DOI 10.1016/S1387-3806(02)00927-2; Lindinger W, 1998, CHEM SOC REV, V27, P347, DOI 10.1039/a827347z; Schuhfried E, 2013, J MASS SPECTROM, V48, P367, DOI 10.1002/jms.3153; Schuhfried E, 2011, CHEMOSPHERE, V83, P311, DOI 10.1016/j.chemosphere.2010.12.051; Schwarz K, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/2/027002; Smith D, 2011, ANALYST, V136, P2009, DOI 10.1039/c1an15082k; Spanel P, 1999, RAPID COMMUN MASS SP, V13, P585, DOI 10.1002/(SICI)1097-0231(19990415)13:7<585::AID-RCM527>3.0.CO;2-K; Spanel P, 1998, INT J MASS SPECTROM, V176, P167, DOI 10.1016/S1387-3806(98)14004-6; Spanel P, 2003, INT J MASS SPECTROM, V228, P269, DOI 10.1016/S1387-3806(03)00214-8; Spanel P, 2009, INT J MASS SPECTROM, V280, P128, DOI 10.1016/j.ijms.2008.07.021; Steinbacher M, 2004, INT J MASS SPECTROM, V239, P117, DOI 10.1016/j.ijms.2004.07.015; Tani A, 2004, INT J MASS SPECTROM, V239, P161, DOI 10.1016/j.ijms.2004.07.020; Williams TL, 1998, INT J MASS SPECTROM, V172, P149, DOI 10.1016/S0168-1176(97)00081-5; Wright M. R., 2004, INTRO CHEM KINETICS; Yeretzian C, 2003, INT J MASS SPECTROM, V223, P115, DOI 10.1016/S1387-3806(02)00785-6	24	1	1	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66925	10.1371/journal.pone.0066925	http://dx.doi.org/10.1371/journal.pone.0066925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840555	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400054
J	Soto-Ortiz, L; Brody, JP				Soto-Ortiz, Luis; Brody, James P.			Similarities in the Age-Specific Incidence of Colon and Testicular Cancers	PLOS ONE			English	Article							MULTISTAGE CARCINOGENESIS; MISSING HERITABILITY; BREAST-CANCER; FETAL ORIGINS; MODEL; ACETYLATION; EPIGENOMICS; PATTERNS; DECLINE; DISEASE	Colon cancers are thought to be an inevitable result of aging, while testicular cancers are thought to develop in only a small fraction of men, beginning in utero. These models of carcinogenesis are, in part, based upon age-specific incidence data. The specific incidence for colon cancer appears to monotonically increase with age, while that of testicular cancer increases to a maximum value at about 35 years of age, then declines to nearly zero by the age of 80. We hypothesized that the age-specific incidence for these two cancers is similar; the apparent difference is caused by a longer development time for colon cancer and the lack of age-specific incidence data for people over 84 years of age. Here we show that a single distribution can describe the age-specific incidence of both colon carcinoma and testicular cancer. Furthermore, this distribution predicts that the specific incidence of colon cancer should reach a maximum at about age 90 and then decrease. Data on the incidence of colon carcinoma for women aged 85-99, acquired from SEER and the US Census, is consistent with this prediction. We conclude that the age specific data for testicular cancers and colon cancers is similar, suggesting that the underlying process leading to the development of these two forms of cancer may be similar.	[Soto-Ortiz, Luis; Brody, James P.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA	University of California System; University of California Irvine	Brody, JP (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA.	jpbrody@uci.edu		Brody, James/0000-0002-7995-5197; Soto, Luis/0000-0001-6329-7057				Anderson WF, 2006, CANCER EPIDEM BIOMAR, V15, P1899, DOI 10.1158/1055-9965.EPI-06-0191; Arbeev KG, 2005, DEMOGR RES, V12, P273, DOI 10.4054/DemRes.2005.12.11; Arbeev KG, 2005, DEMOGR RES, V12, P237, DOI 10.4054/DemRes.2005.12.10; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Armitage P, 2004, BRIT J CANCER, V91, P1983, DOI 10.1038/sj.bjc.6602297; Balducci L, 2005, NAT REV CANCER, V5, P655, DOI 10.1038/nrc1675; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Brody JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025978; Calkins K, 2011, CURR PROB PEDIATR AD, V41, P158, DOI 10.1016/j.cppeds.2011.01.001; Campisi J, 2003, NAT REV CANCER, V3, P339, DOI 10.1038/nrc1073; Campisi J, 2009, AGING CELL, V8, P221, DOI 10.1111/j.1474-9726.2009.00475.x; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Cullen Karen A, 2009, Natl Health Stat Report, P1; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Doll R, 1997, BRIT J RADIOL, V70, P130, DOI 10.1259/bjr.70.830.9135438; Driver JA, 2008, BMJ, V337; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; FEARON ER, 1987, SCIENCE, V238, P193, DOI 10.1126/science.2889267; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Frank S. A., 2007, DYNAMICS CANC INCIDE; Frank SA, 2003, NATURE, V422, P494, DOI 10.1038/422494a; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gordon RA, 2003, TOXICOL IND HEALTH, V19, P125, DOI 10.1191/0748233703th195oa; Harding C, 2008, CANCER RES, V68, P4465, DOI 10.1158/0008-5472.CAN-07-1670; Harding C, 2012, CANCER-AM CANCER SOC, V118, P1371, DOI 10.1002/cncr.26376; Harding R, 2012, SEMIN FETAL NEONAT M, V17, P67, DOI 10.1016/j.siny.2012.01.005; Heidenreich WF, 1997, RISK ANAL, V17, P391, DOI 10.1111/j.1539-6924.1997.tb00878.x; Herrero-Jimenez P, 1998, MUTAT RES-FUND MOL M, V400, P553, DOI 10.1016/S0027-5107(98)00067-0; Jiao S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052535; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jirtle RL, 1999, EXP CELL RES, V248, P18, DOI 10.1006/excr.1999.4453; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lasdon L. S., 1978, ACM Transactions on Mathematical Software, V4, P34, DOI 10.1145/355769.355773; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McGlynn KA, 2001, CANCER INVEST, V19, P842, DOI 10.1081/CNV-100107746; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moolgavkar SH, 2004, INT J EPIDEMIOL, V33, P1182, DOI 10.1093/ije/dyh288; MOOLGAVKAR SH, 1979, J NATL CANCER I, V62, P493, DOI 10.1093/jnci/62.3.493; Morgenthaler S, 2004, J MATH BIOL, V49, P455, DOI 10.1007/s00285-004-0271-9; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Pompei F, 2002, TOXICOL IND HEALTH, V18, P365, DOI 10.1191/0748233702th164oa; Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Soto-Ortiz L, 2012, AIP ADV, V2, DOI 10.1063/1.3699050; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; Surveillance Research Program National Cancer Institute, 2015, SEER STAT SOFTW VERS; Tiwari RC, 2006, STAT METHODS MED RES, V15, P547, DOI 10.1177/0962280206070621; TRICHOPOULOS D, 1990, LANCET, V335, P939, DOI 10.1016/0140-6736(90)91000-Z; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Yajnik CS, 2004, J NUTR, V134, P205, DOI 10.1093/jn/134.1.205; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	62	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66694	10.1371/journal.pone.0066694	http://dx.doi.org/10.1371/journal.pone.0066694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840520	Green Published, gold			2022-12-27	WOS:000321424400034
J	Tsekouras, K; Goncharenko, I; Colvin, ME; Huang, KC; Gopinathan, A				Tsekouras, Konstantinos; Goncharenko, Igor; Colvin, Michael E.; Huang, Kerwyn Casey; Gopinathan, Ajay			Design of High-Specificity Nanocarriers by Exploiting Non-Equilibrium Effects in Cancer Cell Targeting	PLOS ONE			English	Article							LOW-AFFINITY; MULTIVALENCY; SURFACE	Although targeting of cancer cells using drug-delivering nanocarriers holds promise for improving therapeutic agent specificity, the strategy of maximizing ligand affinity for receptors overexpressed on cancer cells is suboptimal. To determine design principles that maximize nanocarrier specificity for cancer cells, we studied a generalized kinetics-based theoretical model of nanocarriers with one or more ligands that specifically bind these overexpressed receptors. We show that kinetics inherent to the system play an important role in determining specificity and can in fact be exploited to attain orders of magnitude improvement in specificity. In contrast to the current trend of therapeutic design, we show that these specificity increases can generally be achieved by a combination of low rates of endocytosis and nanocarriers with multiple low-affinity ligands. These results are broadly robust across endocytosis mechanisms and drug-delivery protocols, suggesting the need for a paradigm shift in receptor-targeted drug-delivery design.	[Tsekouras, Konstantinos; Goncharenko, Igor; Gopinathan, Ajay] Univ Calif Merced, Dept Phys, Merced, CA USA; [Colvin, Michael E.] Univ Calif Merced, Dept Chem & Biochem, Merced, CA USA; [Huang, Kerwyn Casey] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	University of California System; University of California Merced; University of California System; University of California Merced; Stanford University	Huang, KC (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	kchuang@stanford.edu; agopinathan@ucmerced.edu		Tsekouras, Konstantinos/0000-0002-4936-5620; Gopinathan, Ajay/0000-0002-9369-8780	National Science Foundation [EF-1038697]; James S. McDonnell Foundation; University of California Institute for Mexico; United States (UC MEXUS); George E. Brown, Jr. Award	National Science Foundation(National Science Foundation (NSF)); James S. McDonnell Foundation; University of California Institute for Mexico; United States (UC MEXUS); George E. Brown, Jr. Award	The authors acknowledge support from National Science Foundation grant EF-1038697. AG also acknowledges support from a James S. McDonnell Foundation Award, a University of California Institute for Mexico and the United States (UC MEXUS) grant, and a George E. Brown, Jr. Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2011, CURR MED CHEM, V18, P1367; Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Badjic JD, 2005, ACCOUNTS CHEM RES, V38, P723, DOI 10.1021/ar040223k; Baker M, 2010, NATURE, V464, P1225, DOI 10.1038/4641225a; Bartlett DW, 2007, P NATL ACAD SCI USA, V104, P15549, DOI 10.1073/pnas.0707461104; Carlson CB, 2007, ACS CHEM BIOL, V2, P119, DOI 10.1021/cb6003788; Collins BE, 2004, CURR OPIN CHEM BIOL, V8, P617, DOI 10.1016/j.cbpa.2004.10.004; Hlavacek WS, 2002, MATH BIOSCI, V176, P185, DOI 10.1016/S0025-5564(02)00091-3; Hong S, 2007, CHEM BIOL, V14, P107, DOI 10.1016/j.chembiol.2006.11.015; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Joshi A, 2008, CHEM-EUR J, V14, P7738, DOI 10.1002/chem.200800278; Kitov PI, 2003, J AM CHEM SOC, V125, P16271, DOI 10.1021/ja038223n; Kolomeisky AB, 2011, J PHYS CHEM LETT, V2, P1502, DOI 10.1021/jz2004914; Langer R, 2001, SCIENCE, V293, P58, DOI 10.1126/science.1063273; Licata NA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158102; Martinez-Veracoechea FJ, 2011, P NATL ACAD SCI USA, V108, P10963, DOI 10.1073/pnas.1105351108; Mulder A, 2004, ORG BIOMOL CHEM, V2, P3409, DOI 10.1039/b413971b; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Perelson AS, 1997, REV MOD PHYS, V69, P1219, DOI 10.1103/RevModPhys.69.1219; Poirier C, 2008, BBA-BIOMEMBRANES, V1778, P2450, DOI 10.1016/j.bbamem.2008.07.005; Rolland O, 2009, NEW J CHEM, V33, P1809, DOI 10.1039/b901054h; Ross JF, 1994, CANCER, V73, P9; Wang SH, 2011, SOFT MATTER, V7, P4435, DOI 10.1039/c0sm01417f; Wu AM, 2005, NAT 245 BIOTECHNOL, V23, P9	25	0	0	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65623	10.1371/journal.pone.0065623	http://dx.doi.org/10.1371/journal.pone.0065623			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840346	gold, Green Submitted, Green Published			2022-12-27	WOS:000321424400009
J	Xu, ZS; Lin, YQ; Xu, J; Zhu, B; Zhao, W; Peng, RH; Yao, QH				Xu, Zhi-Sheng; Lin, Ya-Qiu; Xu, Jing; Zhu, Bo; Zhao, Wei; Peng, Ri-He; Yao, Quan-Hong			Selective Detoxification of Phenols by Pichia pastoris and Arabidopsis thaliana Heterologously Expressing the PtUGT72B1 from Populus trichocarpa	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; GLYCOSYLTRANSFERASES; GLUCOSYLTRANSFERASE; HYDROQUINONE; METABOLISM; CLONING	Phenols are present in the environment and commonly in contact with humans and animals because of their wide applications in many industries. In a previous study, we reported that uridine diphosphate-glucose-dependent glucosyltransferase PtUGT72B1 from Populus trichocarpa has high activity in detoxifying trichlorophenol by conjugating glucose. In this study, more experiments were performed to determine the substrate specificity of PtUGT72B1 towards phenolic compounds. Among seven phenols tested, three were glucosylated by PtUGT72B1 including phenol, hydroquinone, and catechol. Transgenic Arabidopsis plants expressing the enzyme PtUGT72B1 showed higher resistance to hydroquinone and catechol but more sensitivity to phenol than wild type plants. Transgenic Pichia pastoris expressing PtUGT72B1 showed enhanced resistance to all three phenols. Compared with wild type Arabidopsis plants, transgenic Arabidopsis plants showed higher removal efficiencies and exported more glucosides of phenol, phenyl beta-D-glucopyranoside, to the medium after cultured with the three phenols. Protein extracts from transgenic Arabidopsis plants showed enhanced conjugating activity towards phenol, hydroquinone and catechol. PtUGT72B1 showed much higher expression level in Pichia pastoris than in Arabidopsis plants. Kinetic analysis of the PtUGT72B1 was also performed.	[Xu, Zhi-Sheng; Lin, Ya-Qiu; Yao, Quan-Hong] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Xu, Zhi-Sheng; Lin, Ya-Qiu; Xu, Jing; Zhu, Bo; Zhao, Wei; Peng, Ri-He; Yao, Quan-Hong] Shanghai Acad Agr Sci, Agr Biotechnol Res Ctr, Shanghai, Peoples R China	Nanjing Agricultural University; Shanghai Academy of Agricultural Sciences	Yao, QH (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	yaoquanhong_sh@yahoo.com.cn			Shanghai Municipal Committee of Agriculture [2009-6-4, 2011-1-8]; International Scientific and Technological Cooperation [2010DFA62320, 11230705900]; National Natural Science Foundation [31071486]	Shanghai Municipal Committee of Agriculture; International Scientific and Technological Cooperation; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The research was supported by the Key Project Fund of the Shanghai Municipal Committee of Agriculture (No.2009-6-4) and the Key Project Fund of the Shanghai Municipal Committee of Agriculture (No.2011-1-8) and International Scientific and Technological Cooperation (2010DFA62320, 11230705900) and National Natural Science Foundation (31071486). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achnine L, 2005, PLANT J, V41, P875, DOI 10.1111/j.1365-313X.2005.02344.x; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazier-Hicks M, 2005, PLANT J, V42, P556, DOI 10.1111/j.1365-313X.2005.02398.x; Eapen S, 2007, BIOTECHNOL ADV, V25, P442, DOI 10.1016/j.biotechadv.2007.05.001; Gandia-Herrero F, 2008, PLANT J, V56, P963, DOI 10.1111/j.1365-313X.2008.03653.x; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Hard GC, 1997, TOXICOL PATHOL, V25, P132, DOI 10.1177/019262339702500202; Jackson RG, 2002, PLANT J, V32, P573, DOI 10.1046/j.1365-313X.2002.01445.x; Jackson RG, 2001, J BIOL CHEM, V276, P4350, DOI 10.1074/jbc.M006185200; Jagetia GC, 1997, TOXICOL LETT, V93, P205, DOI 10.1016/S0378-4274(97)00093-3; Jones P, 2003, J BIOL CHEM, V278, P43910, DOI 10.1074/jbc.M303523200; Ko JH, 2006, PLANT CELL REP, V25, P741, DOI 10.1007/s00299-006-0119-4; Liao Y, 2006, PLANT PHYSIOL, V142, P620, DOI 10.1104/pp.106.085936; Lim EK, 2002, J BIOL CHEM, V277, P586, DOI 10.1074/jbc.M109287200; Loutre C, 2003, PLANT J, V34, P485, DOI 10.1046/j.1365-313X.2003.01742.x; Luque T, 2002, EUR J BIOCHEM, V269, P819, DOI 10.1046/j.0014-2956.2001.02723.x; Messner B, 2003, PLANTA, V217, P138, DOI 10.1007/s00425-002-0969-0; Modolo LV, 2007, PLANT MOL BIOL, V64, P499, DOI 10.1007/s11103-007-9167-6; Osmani SA, 2008, PLANT PHYSIOL, V148, P1295, DOI 10.1104/pp.108.128256; Osmani SA, 2009, PHYTOCHEMISTRY, V70, P325, DOI 10.1016/j.phytochem.2008.12.009; Paquette S, 2003, PHYTOCHEMISTRY, V62, P399, DOI 10.1016/S0031-9422(02)00558-7; Pascal-Lorber S, 2003, J AGR FOOD CHEM, V51, P4712, DOI 10.1021/jf034230j; Poppenberger B, 2005, P NATL ACAD SCI USA, V102, P15253, DOI 10.1073/pnas.0504279102; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; Poppenberger B, 2006, APPL ENVIRON MICROB, V72, P4404, DOI 10.1128/AEM.02544-05; Schweigert N, 2001, ENVIRON MICROBIOL, V3, P81, DOI 10.1046/j.1462-2920.2001.00176.x; Su ZH, 2012, ENVIRON SCI TECHNOL, V46, P4016, DOI 10.1021/es203753b; TAYSSE L, 1995, TOXICOLOGY, V98, P207, DOI 10.1016/0300-483X(94)03011-P; Thorsoe KS, 2005, PLANT PHYSIOL, V139, P664, DOI 10.1104/pp.105.063842; Tobias H, 1976, BIOORGAN MED CHEM, V10, P1731; Tsutsui T, 1997, MUTAT RES, V373, P112; Warnecke D, 1999, J BIOL CHEM, V274, P13048, DOI 10.1074/jbc.274.19.13048; Witte S, 2009, PLANTA, V229, P1135, DOI 10.1007/s00425-009-0902-x	35	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66878	10.1371/journal.pone.0066878	http://dx.doi.org/10.1371/journal.pone.0066878			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840543	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400046
J	Ge, J; Tian, AX; Wang, QS; Kong, PZ; Yu, Y; Li, XQ; Cao, XC; Feng, YM				Ge, Jie; Tian, Ai-Xian; Wang, Qing-Shan; Kong, Peng-Zhou; Yu, Yue; Li, Xiao-Qing; Cao, Xu-Chen; Feng, Yu-Mei			The GSTP1 105Val Allele Increases Breast Cancer Risk and Aggressiveness but Enhances Response to Cyclophosphamide Chemotherapy in North China	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; GENETIC POLYMORPHISMS; ADJUVANT CHEMOTHERAPY; P1 POLYMORPHISMS; GSTM1; GSTT1; M1; T1; SUSCEPTIBILITY; METABOLISM	The glutathione-S-transferase (GST) family contributes to the inactivation of various toxic compounds formed as secondary metabolites during oxidative stress. GSTP1 accounts for the majority of the GST family enzymatic activity, and the activity of GSTP1 enzyme can be altered by the presence of the Ile105Val polymorphism. In this study, we examined the polymorphic frequency of GSTP1 Ile105Val genotype in 920 breast cancer patients and 783 healthy controls in women of North China. Results showed that GSTP1 105Val allele (Ile/Val and Val/Val) was associated with a higher breast cancer risk (OR = 1.38, 95% CI: 1.14-1.69; P = 0.001) and more aggressive tumors with histological grade III (OR = 1.15, 95% CI: 1.05-1.26; P = 0.001), lymph node metastases (OR = 2.35, 95% CI: 1.72-3.21; P < 0.001), as well as ER negative (OR = 1.77, 95% CI: 1.31-2.39; P < 0.001) than those carrying the Ile/Ile allele. However, the patients with the GSTP1 105Val genotype had a better disease free survival after cyclophosphamide (CTX)-based chemotherapy than those with Ile/Ile (HR = 0.77, 95% CI: 0.45-0.91; P < 0.001). Furthermore, in vitro cellular experiments demonstrated that breast cancer cells with the GSTP1 105Val allele were significantly more sensitive to CTX-induced proliferation inhibition. Thus, we conclude that the GSTP1 105Val allele increases breast cancer risk and aggressiveness and enhance response to CTX-based chemotherapy in women of North China. Detection of the GSTP1 Ile105Val genotype may help screen for high-risk populations and direct individualized therapy.	[Ge, Jie; Tian, Ai-Xian; Wang, Qing-Shan; Kong, Peng-Zhou; Yu, Yue; Li, Xiao-Qing; Feng, Yu-Mei] Tianjin Med Univ, Canc Inst & Hosp, Dept Biochem & Mol Biol, Tianjin, Peoples R China; [Ge, Jie; Cao, Xu-Chen] Tianjin Med Univ, Canc Inst & Hosp, Dept Breast Surg, Tianjin, Peoples R China; [Ge, Jie; Wang, Qing-Shan; Li, Xiao-Qing; Cao, Xu-Chen; Feng, Yu-Mei] Tianjin Med Univ, Canc Inst & Hosp, Key Lab Breast Canc Prevent & Treatment, Minist Educ, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Feng, YM (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Dept Biochem & Mol Biol, Tianjin, Peoples R China.	ymfeng@tijmu.edu.cn	Yu, Yue/AAG-8381-2020	Yu, Yue/0000-0003-2053-9866	National Natural Science Foundation of China [30872518, 81272357]; Major Program of Applied Basic Research Projects of Tianjin [06YFJMJC12900, 09JCZDJC19800]; Technology Program of Tianjin Health Bureau [2011kZ83]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Program of Applied Basic Research Projects of Tianjin; Technology Program of Tianjin Health Bureau	This study was supported by the National Natural Science Foundation of China (No. 30872518 and No. 81272357), the Major Program of Applied Basic Research Projects of Tianjin (No. 06YFJMJC12900 and No. 09JCZDJC19800) and the Technology Program of Tianjin Health Bureau (No. 2011kZ83). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Chen XH, 2011, BREAST CANCER RES TR, V125, P575, DOI 10.1007/s10549-010-1032-7; Chia S, 2008, J CLIN ONCOL, V26, P786, DOI 10.1200/JCO.2008.15.0243; Curran JE, 2000, CANCER LETT, V153, P113, DOI 10.1016/S0304-3835(00)00361-X; DIRVEN HAAM, 1994, CANCER RES, V54, P6215; Egan KM, 2004, CANCER EPIDEM BIOMAR, V13, P197, DOI 10.1158/1055-9965.EPI-03-0294; Eichelbaum M, 2006, ANNU REV MED, V57, P119, DOI 10.1146/annurev.med.56.082103.104724; Feng YM, 2007, BREAST CANCER RES TR, V103, P319, DOI 10.1007/s10549-006-9385-7; Harries LW, 1997, CARCINOGENESIS, V18, P641, DOI 10.1093/carcin/18.4.641; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; HAYES JD, 1995, FREE RADICAL RES, V22, P193, DOI 10.3109/10715769509147539; Hohaus S, 2005, CLIN CANCER RES, V11, P2175, DOI 10.1158/1078-0432.CCR-04-1250; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johansson AS, 1998, J MOL BIOL, V278, P687, DOI 10.1006/jmbi.1998.1708; Kadouri L, 2008, BRIT J CANCER, V98, P2006, DOI 10.1038/sj.bjc.6604394; Kim SU, 2004, J BIOCHEM MOL BIOL, V37, P582; Lee SA, 2008, AM J CLIN NUTR, V87, P753, DOI 10.1093/ajcn/87.3.753; Levine MN, 2006, NEW ENGL J MED, V355, P1920, DOI 10.1056/NEJMe068204; Millikan R, 2000, CANCER EPIDEM BIOMAR, V9, P567; Mitrunen K, 2001, CANCER EPIDEM BIOMAR, V10, P229; Ragaz J, 2005, JNCI-J NATL CANCER I, V97, P116, DOI 10.1093/jnci/djh297; Samson M, 2007, ASIAN PAC J CANCER P, V8, P253; Saxena A, 2012, EXP THER MED, V4, P1097, DOI 10.3892/etm.2012.710; Saxena A, 2009, BREAST CANCER RES TR, V115, P537, DOI 10.1007/s10549-008-0098-y; SCHRODER KR, 1995, ARCH TOXICOL, V69, P505, DOI 10.1007/s002040050205; Sergentanis TN, 2010, BREAST CANCER RES TR, V121, P195, DOI 10.1007/s10549-009-0520-0; Sivonova M, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-32; Smith G, 1995, CANCER SURV, V25, P27; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Vogl FD, 2004, CANCER EPIDEM BIOMAR, V13, P1473; Watson MA, 1998, CARCINOGENESIS, V19, P275, DOI 10.1093/carcin/19.2.275; White DL, 2008, AM J EPIDEMIOL, V167, P377, DOI 10.1093/aje/kwm315; Yang G, 2005, CANCER-AM CANCER SOC, V103, P52, DOI 10.1002/cncr.20729; Yao S, 2010, CLIN CANCER RES, V16, P6169, DOI 10.1158/1078-0432.CCR-10-0281; Zhang J, 2005, DRUG METAB REV, V37, P611, DOI 10.1080/03602530500364023	35	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67589	10.1371/journal.pone.0067589	http://dx.doi.org/10.1371/journal.pone.0067589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826324	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400160
J	Ragunathan, P; Sridaran, D; Weigel, A; Shabayek, S; Spellerberg, B; Ponnuraj, K				Ragunathan, Preethi; Sridaran, Divya; Weigel, Anja; Shabayek, Sarah; Spellerberg, Barbara; Ponnuraj, Karthe			Metal Binding Is Critical for the Folding and Function of Laminin Binding Protein, Lmb of Streptococcus agalactiae	PLOS ONE			English	Article							TREPONEMA-PALLIDUM TROA; ZINC TRANSPORT PROTEIN; CRYSTAL-STRUCTURE; ZNUA; REVEALS; FAMILY	Lmb is a 34 kDa laminin binding surface adhesin of Streptococcus agalactiae. The structure of Lmb reported by us recently has shown that it consists of a metal binding crevice, in which a zinc ion is coordinated to three highly conserved histidines. To elucidate the structural and functional significance of the metal ion in Lmb, these histidines have been mutated to alanine and single, double and triple mutants were generated. These mutations resulted in insolubility of the protein and revealed altered secondary and tertiary structures, as evidenced by circular dichroism and fluorescence spectroscopy studies. The mutations also significantly decreased the binding affinity of Lmb to laminin, implicating the role played by the metal binding residues in maintaining the correct conformation of the protein for its binding to laminin. A highly disordered loop, proposed to be crucial for metal acquisition in homologous structures, was deleted in Lmb by mutation (Delta Lmb) and its crystal structure was solved at 2.6 angstrom. The Delta Lmb structure was identical to the native Lmb structure with a bound zinc ion and exhibited laminin binding activity similar to wild type protein, suggesting that the loop might not have an important role in metal acquisition or adhesion in Lmb. Targeted mutations of histidine residues confirmed the importance of the zinc binding crevice for the structure and function of the Lmb adhesin.	[Ragunathan, Preethi; Sridaran, Divya; Ponnuraj, Karthe] Univ Madras, Ctr Adv Study Crystallog & Biophys, Chennai, Tamil Nadu, India; [Weigel, Anja; Shabayek, Sarah; Spellerberg, Barbara] Univ Ulm, Inst Med Microbiol & Hyg, D-89069 Ulm, Germany	University of Madras; Ulm University	Spellerberg, B (corresponding author), Univ Ulm, Inst Med Microbiol & Hyg, D-89069 Ulm, Germany.	barbara.spellerberg@uniklinik-ulm.de; pkarthe@hotmail.com	Shabayek, Sarah/AAG-1960-2019; Spellerberg, Barbara/D-3443-2011	Shabayek, Sarah/0000-0001-8218-674X; Spellerberg, Barbara/0000-0001-7552-8764	Department of Biotechnology (DBT), Government of India; Forschungszentrum Julich BMBH (FZJ), Federal Republic of Germany; Department of Science and Technology, Government of India; Ministry of Foreign Affairs/Sincrotrone Trieste, Italy	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); Forschungszentrum Julich BMBH (FZJ), Federal Republic of Germany; Department of Science and Technology, Government of India(Department of Science & Technology (India)); Ministry of Foreign Affairs/Sincrotrone Trieste, Italy	Department of Biotechnology (DBT), Government of India and Forschungszentrum Julich BMBH (FZJ), Federal Republic of Germany for financial support and Department of Science and Technology, Government of India, and Ministry of Foreign Affairs/Sincrotrone Trieste, Italy, for the financial support to visit Elettra synchrotron facility for data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee S, 2003, J MOL BIOL, V333, P1061, DOI 10.1016/j.jmb.2003.09.008; Bartels K.S., 2003, AUTOMAR MANUAL V 1 4; BROWN JC, 1990, BIOCHEM J, V270, P463, DOI 10.1042/bj2700463; Gorelik JV, 2001, CELL BIOL INT, V25, P395, DOI 10.1006/cbir.2000.0642; Ilari A, 2011, J MOL BIOL, V409, P630, DOI 10.1016/j.jmb.2011.04.036; Lawrence MC, 1998, STRUCTURE, V6, P1553, DOI 10.1016/S0969-2126(98)00153-1; Lee YH, 2002, J BACTERIOL, V184, P2300, DOI 10.1128/JB.184.8.2300-2304.2002; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Li H, 2007, J MOL BIOL, V368, P1358, DOI 10.1016/j.jmb.2007.02.107; Linke C, 2009, J BACTERIOL, V191, P5814, DOI 10.1128/JB.00485-09; Loisel E, 2008, J MOL BIOL, V381, P594, DOI 10.1016/j.jmb.2008.05.068; Maruvada R, 2009, FASEB J, V23, P3967, DOI 10.1096/fj.09-138149; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Ragunathan P, 2009, ACTA CRYSTALLOGR D, V65, P1262, DOI 10.1107/S0907444909038359; Ragunathan P, 2009, ACTA CRYSTALLOGR F, V65, P492, DOI 10.1107/S1744309109012743; Rioux S, 2011, MICROBIOL-SGM, V157, P336, DOI 10.1099/mic.0.042184-0; Schuchat A, 1999, LANCET, V353, P51, DOI 10.1016/S0140-6736(98)07128-1; Spellerberg B, 1999, INFECT IMMUN, V67, P871, DOI 10.1128/IAI.67.2.871-878.1999; Tenenbaum T, 2007, MICROBES INFECT, V9, P714, DOI 10.1016/j.micinf.2007.02.015; Wei BX, 2007, BIOCHEMISTRY-US, V46, P8734, DOI 10.1021/bi700763w	20	11	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67517	10.1371/journal.pone.0067517	http://dx.doi.org/10.1371/journal.pone.0067517			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826314	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400154
J	Jairam, PM; de Jong, PA; Mali, WPTM; Isgum, I; de Koning, HJ; van der Aalst, C; Oudkerk, M; Vliegenthart, R; van der Graaf, Y				Jairam, Pushpa M.; de Jong, Pim A.; Mali, Willem P. Th. M.; Isgum, Ivana; de Koning, Harry J.; van der Aalst, Carlijn; Oudkerk, Matthijs; Vliegenthart, Rozemarijn; van der Graaf, Yolanda			Impact of Cardiovascular Calcifications on the Detrimental Effect of Continued Smoking on Cardiovascular Risk in Male Lung Cancer Screening Participants	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; COMPUTED-TOMOGRAPHY; PRIMARY PREVENTION; NATURAL-HISTORY; CESSATION; CALCIUM; REDUCTION; LESIONS; EVENTS; STROKE	Background: Current smokers have an increased cardiovascular disease (CVD) risk compared to ex-smokers due to reversible as well as irreversible effects of smoking. We investigated if current smokers remain to have an increased CVD risk compared to ex-smokers in subjects with a long and intense smoking history. We in addition studied if the effect of smoking continuation on CVD risk is independent of or modified by the presence of cardiovascular calcifications. Methods: The cohort used comprised a sample of 3559 male lung cancer screening trial participants. We conducted a case-cohort study using all CVD cases and a random sample of 10% (n = 341) from the baseline cohort (subcohort). A weighted Cox proportional hazards model was used to estimate the hazard ratios for current smoking status in relation to CVD events. Results: During a median follow-up of 2.6 years (max. 3.7 years), 263 fatal and non-fatal cardiovascular events (cases) were identified. Age, packyears and cardiovascular calcification adjusted hazard ratio of current smokers compared to former smokers was 1.33 (95% confidence interval 1.00-1.77). In additional analyses that incorporated multiplicative interaction terms, neither coronary nor aortic calcifications modified the association between smoking status and cardiovascular risk (P = 0.08). Conclusions: Current smokers have an increased CVD risk compared to former smokers even in subjects with a long and intense smoking history. Smoking exerts its hazardous effects on CVD risk by pathways partly independent of cardiovascular calcifications.	[Jairam, Pushpa M.; van der Graaf, Yolanda] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Jairam, Pushpa M.; de Jong, Pim A.; Mali, Willem P. Th. M.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Isgum, Ivana] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [de Koning, Harry J.; van der Aalst, Carlijn] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Oudkerk, Matthijs; Vliegenthart, Rozemarijn] Univ Groningen, Univ Med Ctr Groningen, Ctr Med Imaging North East Netherlands, Groningen, Netherlands; [Vliegenthart, Rozemarijn] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; University of Groningen; University of Groningen	Jairam, PM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	pjairam@umcutrecht.nl	Isgum, Ivana/H-8659-2014; Mali, Willem PThM/I-1123-2014; de+Koning, Harry/AAF-9062-2019; de Jong, Pim A/G-7220-2014; van der Aalst, Carlijn/AAG-7522-2019	Isgum, Ivana/0000-0003-1869-5034; Mali, Willem PThM/0000-0003-4391-0904; de+Koning, Harry/0000-0003-4682-3646; de Jong, Pim A/0000-0003-4840-6854; Oudkerk, Matthijs/0000-0003-2800-4110	Netherlands Organization for Health Research and Development (ZonMw); Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Siemens Germany; G. Ph. Verhagen Stichting; Rotterdam Oncologic Thoracic Steering Committee (ROTS); Erasmus Trust Fund; Stichting tegen Kanker; Vlaamse Liga tegen Kanker	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Koningin Wilhelmina Fonds (KWF); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ); Siemens Germany(Siemens AG); G. Ph. Verhagen Stichting; Rotterdam Oncologic Thoracic Steering Committee (ROTS); Erasmus Trust Fund; Stichting tegen Kanker; Vlaamse Liga tegen Kanker	The current study is a part of the NELSON study and is supported by the Netherlands Organization for Health Research and Development (ZonMw), Koningin Wilhelmina Fonds (KWF), Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen (RvvZ), Siemens Germany, G. Ph. Verhagen Stichting, Rotterdam Oncologic Thoracic Steering Committee (ROTS), Erasmus Trust Fund, Stichting tegen Kanker and Vlaamse Liga tegen Kanker. No relationship with industry exists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; BENJAMIN EJ, 1992, NEW ENGL J MED, V327, P374, DOI 10.1056/NEJM199208063270602; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; desBruin A., 2004, STAT J UN EC COMM EU, V21, P23; DOBSON AJ, 1991, J CLIN EPIDEMIOL, V44, P1247, DOI 10.1016/0895-4356(91)90157-5; Eisen A, 2008, CIRCULATION, V118, P1328, DOI 10.1161/CIRCULATIONAHA.107.712141; Elmariah S, 2012, J AM COLL CARDIOL; Goldenberg I, 2003, ARCH INTERN MED, V163, P2301, DOI 10.1001/archinte.163.19.2301; Gondrie MJ, EUR RADIOL, V21, P963; Groenwold RHH, 2009, J CLIN EPIDEMIOL, V62, P22, DOI 10.1016/j.jclinepi.2008.02.011; Grundy SM, 1998, CIRCULATION, V97, P1876, DOI 10.1161/01.CIR.97.18.1876; HALON DA, 1983, AM J CARDIOL, V52, P921, DOI 10.1016/0002-9149(83)90506-4; Jacobs PC, J COMPUT ASSIST TOMO, V34, P279; Jockel KH, 2009, ATHEROSCLEROSIS, V203, P221, DOI 10.1016/j.atherosclerosis.2008.05.041; Johnson HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035332; Khan R, 2009, CAN J CARDIOL, V25, P533, DOI 10.1016/S0828-282X(09)70144-8; MacLean D R, 1999, Can J Cardiol, V15 Suppl G, p17G; McElduff P, 1998, AUST NZ J PUBL HEAL, V22, P787, DOI 10.1111/j.1467-842X.1998.tb01494.x; McEvoy JW, 2012, JACC-CARDIOVASC IMAG, V5, P1037, DOI 10.1016/j.jcmg.2012.02.017; Min JK, 2010, J AM COLL CARDIOL, V55, P1110, DOI 10.1016/j.jacc.2009.08.088; Onland-Moret NC, 2007, J CLIN EPIDEMIOL, V60, P350, DOI 10.1016/j.jclinepi.2006.06.022; Paas G, 2002, RES VALIDITY LMR; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; PRENTICE RL, 1986, BIOMETRICS, V42, P301, DOI 10.2307/2531051; Rivera JJ, 2009, ATHEROSCLEROSIS, V206, P451, DOI 10.1016/j.atherosclerosis.2009.05.027; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Schmermund A, 2000, AM J CARDIOL, V86, P127, DOI 10.1016/S0002-9149(00)00847-X; Shemesh J, 2006, CLIN IMAG, V30, P181, DOI 10.1016/j.clinimag.2005.11.002; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; STRONG JP, 1992, ARCH PATHOL LAB MED, V116, P1268; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; WHO, 2013, CARD DIS CVD PREV CO; WHO, 2010, INT STAT CLASS DIS R; Wong KKL, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-7; Wong ND, 2003, AM J CARDIOL, V92, P951, DOI 10.1016/S0002-9149(03)00976-7	39	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66484	10.1371/journal.pone.0066484	http://dx.doi.org/10.1371/journal.pone.0066484			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840486	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800068
J	Midtvedt, T; Zabarovsky, E; Norin, E; Bark, J; Gizatullin, R; Kashuba, V; Ljungqvist, O; Zabarovska, V; Mollby, R; Ernberg, I				Midtvedt, Tore; Zabarovsky, Eugene; Norin, Elisabeth; Bark, Johan; Gizatullin, Rinat; Kashuba, Vladimir; Ljungqvist, Olle; Zabarovska, Veronika; Mollby, Roland; Ernberg, Ingemar			Increase of Faecal Tryptic Activity Relates to Changes in the Intestinal Microbiome: Analysis of Crohn's Disease with a Multidisciplinary Platform	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; SECRETORY TRYPSIN-INHIBITOR; GERM-FREE; PHYSIOLOGICAL-ACTIVITY; SPECIES COMPOSITION; MICROFLORA; FLORA; MICROARRAYS; SYSTEMS; STRAIN	Objective: To investigate-by molecular, classical and functional methods-the microbiota in biopsies and faeces from patients with active Crohn's disease (CD) and controls. Design: The microbiota in biopsies was investigated utilizing a novel molecular method and classical cultivation technology. Faecal samples were investigated by classical technology and four functional methods, reflecting alterations in short chain fatty acids pattern, conversion of cholesterol and bilirubin and inactivation of trypsin. Results: By molecular methods we found more than 92% similarity in the microbiota on the biopsies from the two groups. However, 4.6% of microbes found in controls were lacking in CD patients. Furthermore, NotI representation libraries demonstrate two different clusters representing CD patients and controls, respectively. Utilizing conventional technology, Bacteroides (alt. Parabacteroides) was less frequently detected in the biopsies from CD patients than from controls. A similar reduction in the number of Bacteroides was found in faecal samples. Bacteroides is the only group of bacteria known to be able to inactivate pancreatic trypsin. Faecal tryptic activity was high in CD patients, and inversely correlated to the levels of Bacteroides. Conclusions: CD patients have compositional and functional alterations in their intestinal microbiota, in line with the global description hypothesis rather than the candidate microorganism theory. The most striking functional difference was high amount of faecal tryptic activity in CD patients, inversely correlated to the levels of Bacteroides in faeces.	[Midtvedt, Tore; Zabarovsky, Eugene; Norin, Elisabeth; Gizatullin, Rinat; Kashuba, Vladimir; Zabarovska, Veronika; Mollby, Roland; Ernberg, Ingemar] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Ljungqvist, Olle] Orebro Univ Hosp, Dept Surg, Orebro, Sweden; [Bark, Johan] Sophiahemmet Hosp, Stockholm Gastro Ctr, IBD Unit, Stockholm, Sweden	Karolinska Institutet; Orebro University	Ernberg, I (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	ingemar.ernberg@ki.se	Kashuba, Vladimir/AAO-7742-2020; Kashuba, Vladimir I/N-3732-2017	Kashuba, Vladimir I/0000-0001-9416-8282; Norin, Elisabeth/0000-0001-5589-6850	Stitching af Jochnick Foundation; Vetenskapsradet (VR); Cancerfonden; Soderbergska stiftelsen; Karolinska Institutet Funds; Bengt E Gustafsson Funds	Stitching af Jochnick Foundation; Vetenskapsradet (VR)(Swedish Research Council); Cancerfonden(Swedish Cancer Society); Soderbergska stiftelsen; Karolinska Institutet Funds; Bengt E Gustafsson Funds	This study was supported primarily by a generous donation from the Stitching af Jochnick Foundation (c/o Citco Nederland B.V., Naritaweg 165, 1043 BW Amsterdam, the Netherlands) and also, to some extent by grants from Vetenskapsradet (VR), Cancerfonden, Soderbergska stiftelsen, Karolinska Institutet Funds and Bengt E Gustafsson Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm JS, 2002, PEDIAT ALLERG IMM-UK, V13, P402, DOI 10.1034/j.1399-3038.2002.01062.x; Benno P., 2003, Microbial Ecology in Health and Disease, V15, P169, DOI 10.1080/08910600310020622; BENNO P, 1993, SCAND J GASTROENTERO, V28, P839, DOI 10.3109/00365529309104019; BERGSTRAND LO, 1981, ACTA CHIR SCAND, V147, P711; BERGSTRAND LO, 1981, ACTA CHIR SCAND, V147, P707; Bergstrand LO, 1981, THESIS KAROLINSKA I; Cardona ME, 2001, SCAND J LAB ANIM SCI, V28, P75; Collinder E, 2000, EQUINE VET J, V32, P222, DOI 10.2746/042516400776563653; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DUMONCEAU JM, 1994, ACTA GASTRO-ENT BELG, V57, P301; HOVERSTAD T, 1984, SCAND J GASTROENTERO, V19, P375, DOI 10.1080/00365521.1984.12005738; Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319; Li JF, 2002, P NATL ACAD SCI USA, V99, P10724, DOI 10.1073/pnas.132271699; Man SM, 2011, NAT REV GASTRO HEPAT, V8, P152, DOI 10.1038/nrgastro.2011.3; Marchbank T, 1996, AM J PATHOL, V148, P715; Marteau P, 2004, ALIMENT PHARM THER, V20, P18, DOI 10.1111/j.1365-2036.2004.02062.x; Martinez-Medina M, 2009, INFLAMM BOWEL DIS, V15, P872, DOI 10.1002/ibd.20860; MIDTVEDT AC, 1993, J PEDIATR GASTR NUTR, V17, P161, DOI 10.1097/00005176-199308000-00006; MIDTVEDT AC, 1988, J PEDIATR GASTR NUTR, V7, P559, DOI 10.1097/00005176-198807000-00014; Norin E, 1988, MICROB ECOL HEALTH D, V1, P65; Norin E., 2006, GASTROINTESTINAL MIC, P273; NORIN KE, 1986, LAB ANIM, V20, P234, DOI 10.1258/002367786780865656; NORIN KE, 1986, LAB ANIM, V20, P67, DOI 10.1258/002367786781062188; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; PLAYFORD RJ, 1995, AM J PATHOL, V146, P310; Ramare F, 1996, APPL ENVIRON MICROB, V62, P1434, DOI 10.1128/AEM.62.4.1434-1436.1996; RASMUSSEN HS, 1988, SCAND J GASTROENTERO, V23, P178, DOI 10.3109/00365528809103964; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; SAXERHOLT H, 1984, SCAND J CLIN LAB INV, V44, P573, DOI 10.3109/00365518409083613; Schippa S, 2009, INFLAMM BOWEL DIS, V15, P661, DOI 10.1002/ibd.20818; Suzuki T, 2008, J PHARMACOL SCI, V106, P469, DOI 10.1254/jphs.FP0071422; VANDEMERWE JP, 1982, DIGESTION, V24, P1, DOI 10.1159/000198767; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; World Health Organization, 1997, INT J OCCUP MED ENV, V10, P113; Zabarovska V, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng005; Zabarovsky ER, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng096; ZIJLSTRA JB, 1977, CLIN CHIM ACTA, V78, P243, DOI 10.1016/0009-8981(77)90312-6	37	36	40	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66074	10.1371/journal.pone.0066074	http://dx.doi.org/10.1371/journal.pone.0066074			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840402	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800028
J	Arnett, EB; Hein, CD; Schirmacher, MR; Huso, MMP; Szewczak, JM				Arnett, Edward B.; Hein, Cris D.; Schirmacher, Michael R.; Huso, Manuela M. P.; Szewczak, Joseph M.			Evaluating the Effectiveness of an Ultrasonic Acoustic Deterrent for Reducing Bat Fatalities at Wind Turbines	PLOS ONE			English	Article							ENERGY FACILITIES; ECHOLOCATING BATS; SOCIAL CALLS; VARIABILITY; HYPOTHESES; IMPACTS; NOISE	Large numbers of bats are killed by wind turbines worldwide and minimizing fatalities is critically important to bat conservation and acceptance of wind energy development. We implemented a 2-year study testing the effectiveness of an ultrasonic acoustic deterrent for reducing bat fatalities at a wind energy facility in Pennsylvania. We randomly selected control and treatment turbines that were searched daily in summer and fall 2009 and 2010. Estimates of fatality, corrected for field biases, were compared between treatment and control turbines. In 2009, we estimated 21-51% fewer bats were killed per treatment turbine than per control turbine. In 2010, we determined an approximate 9% inherent difference between treatment and control turbines and when factored into our analysis, variation increased and between 2% more and 64% fewer bats were killed per treatment turbine relative to control turbines. We estimated twice as many hoary bats were killed per control turbine than treatment turbine, and nearly twice as many silver-haired bats in 2009. In 2010, although we estimated nearly twice as many hoary bats and nearly 4 times as many silver-haired bats killed per control turbine than at treatment turbines during the treatment period, these only represented an approximate 20% increase in fatality relative to the pre-treatment period for these species when accounting for inherent differences between turbine sets. Our findings suggest broadband ultrasound broadcasts may reduce bat fatalities by discouraging bats from approaching sound sources. However, effectiveness of ultrasonic deterrents is limited by distance and area ultrasound can be broadcast, in part due to rapid attenuation in humid conditions. We caution that an operational deterrent device is not yet available and further modifications and experimentation are needed. Future efforts must also evaluate cost-effectiveness of deterrents in relation to curtailment strategies to allow a cost-benefit analysis for mitigating bat fatalities.	[Arnett, Edward B.; Hein, Cris D.; Schirmacher, Michael R.] Bat Conservat Int, Austin, TX USA; [Huso, Manuela M. P.] US Geol Survey, Forest & Range Expt Stn, Corvallis, OR USA; [Szewczak, Joseph M.] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA	United States Department of the Interior; United States Geological Survey; California State University System; California State Polytechnic University, Humboldt	Arnett, EB (corresponding author), Theodore Roosevelt Conservat Partnership, Loveland, CO USA.	earnett@trcp.org	Huso, Manuela M/F-9771-2013	Hein, Cris/0000-0003-3040-7998	Iberdrola Renewables; U.S. Department of Energy (DOE); National Renewable Energy Lab; Pennsylvania Game Commission; Bat Conservation International; American Wind and Wildlife Institute; American Wind Energy Association	Iberdrola Renewables; U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Renewable Energy Lab; Pennsylvania Game Commission; Bat Conservation International; American Wind and Wildlife Institute; American Wind Energy Association	This study was funded by Iberdrola Renewables, U.S. Department of Energy (DOE), National Renewable Energy Lab, Pennsylvania Game Commission, Bat Conservation International, American Wind and Wildlife Institute, and member companies of the American Wind Energy Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnett EB, 2013, BAT EVOLUTI IN PRESS; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Arnett EB, 2011, FRONT ECOL ENVIRON, V9, P209, DOI 10.1890/100103; Baerwald EF, 2009, J MAMMAL, V90, P1341, DOI 10.1644/09-MAMM-S-104R.1; Baerwald EF, 2009, J WILDLIFE MANAGE, V73, P1077, DOI 10.2193/2008-233; Barlow KE, 1997, ANIM BEHAV, V53, P991, DOI 10.1006/anbe.1996.0398; BELTON P., 1962, ENTOMOL EXPTL ET APPL, V5, P281, DOI 10.1111/j.1570-7458.1962.tb00592.x; Brown R.G., 1972, WOODY PLANTS MARYLAN; Cochran WG., 1963, SAMPLING TECHNIQUES; Cryan PM, 2008, J WILDLIFE MANAGE, V72, P845, DOI 10.2193/2007-371; Cryan PM, 2009, J MAMMAL, V90, P1330, DOI 10.1644/09-MAMM-S-076R1.1; Energy Information Administration, 2010, ANN EN OUTL 2010 PRO; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gillam EH, 2007, ANIM BEHAV, V74, P277, DOI 10.1016/j.anbehav.2006.12.006; GRIFFIN DR, 1963, J EXP ZOOL, V152, P229, DOI 10.1002/jez.1401520303; Griffin DR, 1958, LISTENING DARK; Hewitt JE, 2001, ECOL APPL, V11, P1502, DOI 10.2307/3060935; Horn JW, 2008, J WILDLIFE MANAGE, V72, P123, DOI 10.2193/2006-465; Hristov NI, 2005, NATURWISSENSCHAFTEN, V92, P164, DOI 10.1007/s00114-005-0611-7; Huang F, 2011, J STORED PRODUCTS RE, V39, P413; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; HURLEY S, 1980, B ENVIRON CONTAM TOX, V25, P503, DOI 10.1007/BF01985562; Huso MMP, 2011, ENVIRONMETRICS, V22, P318, DOI 10.1002/env.1052; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Kunz Thomas H., 2009, P1; Larsen RJ, 2007, ACTA CHIROPTEROL, V9, P423, DOI 10.3161/1733-5329(2007)9[423:MNBSAC]2.0.CO;2; MACKEY RL, 1989, CAN J ZOOL, V67, P1167, DOI 10.1139/z89-168; Manly B.F.J., 1997, RANDOMIZATION MONTE; MOHL B, 1989, J COMP PHYSIOL A, V165, P119, DOI 10.1007/BF00613805; Nicholls B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006246; Parson S, 2009, ECOLOGICAL BEHAV MET; Pennsylvania Game Commission, 2007, PENNS GAM COMM WIND; Pollak G.D., 1989, NEURAL BASIS ECHOLOC; Racey PA, 2003, BAT ECOLOGY, P680; Robbins LW, 2008, NORTHEAST NAT, V15, P275, DOI 10.1656/1092-6194(2008)15[275:ETEOTS]2.0.CO;2; Rydell J, 2010, ACTA CHIROPTEROL, V12, P261, DOI 10.3161/150811010X537846; Steele R.G.D., 1997, PRINCIPLES PROCEDURE, P666; Strausbaugh P.D., 1978, FLORA W VIRGINIA; Strickland M.D., 2011, COMPREHENSIVE GUIDE; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036; Ulanovsky N, 2004, P ROY SOC B-BIOL SCI, V271, P1467, DOI 10.1098/rspb.2004.2750; Winhold L, 2008, NORTHEAST NAT, V15, P263, DOI 10.1656/1092-6194(2008)15[263:NSFBIT]2.0.CO;2; Winhold L, 2008, ACTA CHIROPTEROL, V10, P359, DOI 10.3161/150811008X414935	45	48	52	3	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65794	10.1371/journal.pone.0065794	http://dx.doi.org/10.1371/journal.pone.0065794			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840369	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200036
J	Bae, YJ; Hwang, YW; Yoon, SY; Kim, S; Lee, T; Lee, YS; Kwon, HS; Cho, YS; Shin, MJ; Moon, HB; Kim, TB				Bae, Yun-Jeong; Hwang, Ye Won; Yoon, Sun-young; Kim, Sujeong; Lee, Taehoon; Lee, Yoon Su; Kwon, Hyouk-Soo; Cho, You Sook; Shin, Myung Jin; Moon, Hee-Bom; Kim, Tae-Bum			The Effectiveness of Automatic Recommending System for Premedication in Reducing Recurrent Radiocontrast Media Hypersensitivity Reactions	PLOS ONE			English	Article							IODINATED CONTRAST-MEDIA; SURVEILLANCE; PREVENTION; MANAGEMENT; ALLERGY; KOREA	Background: Non-ionic radiocontrast media (RCM) is rarely associated with hypersensitivity reactions. Premedication of patients who reacted previously to RCM with systemic corticosteroids and/or antihistamines can help reduce recurrent hypersensitivity reactions. However, premedication is still not prescribed in many cases for various reasons. This study aimed to determine the effectiveness of our novel RCM hypersensitivity surveillance and automatic recommending system for premedication. Methods and Results: Hospitalized patients with a history of RCM hypersensitivity were identified in an electronic medical record system that included a mandatory reporting system for past adverse drug reactions. In 2009, a novel automatic prescription system was added that classified index RCM reactions by severity and dispensed appropriate corticosteroid and/or antihistamine pretreatment prior to new RCM exposures. The data from 12 months under the previous system and 12 months under the current system were compared. The two systems had similar overall premedication rates (91% and 95%) but the current system was associated with a significantly higher corticosteroid premedication rate (65% vs. 14%), which significantly reduced the breakthrough reaction rate (6.7% vs. 15.2%). The current system was also associated with increased corticosteroid and antihistamine premedication of patients with a mild index reaction (61% vs. 7%) and a reduction in their breakthrough reaction rate (6% vs. 15%). Conclusions: Premedication with corticosteroid and/or antihistamine, which was increased by our novel automatic prescription system, significantly reduced breakthrough reactions in patients with a history of RCM hypersensitivity.	[Bae, Yun-Jeong; Yoon, Sun-young; Kim, Sujeong; Lee, Taehoon; Lee, Yoon Su; Kwon, Hyouk-Soo; Cho, You Sook; Moon, Hee-Bom; Kim, Tae-Bum] Univ Ulsan, Coll Med, Div Allergy & Clin Immunol, Dept Internal Med,Asan Med Ctr, Seoul, South Korea; [Bae, Yun-Jeong] Asan Med Ctr, Dept Hlth Med, Hlth Screening & Promot Ctr, Seoul, South Korea; [Hwang, Ye Won; Kwon, Hyouk-Soo; Cho, You Sook; Kim, Tae-Bum] Asan Med Ctr, Pharmacovigilance Ctr, Seoul, South Korea; [Shin, Myung Jin] Univ Ulsan, Coll Med, Dept Radiol, Asan Med Ctr, Seoul, South Korea	University of Ulsan; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan	Kim, TB (corresponding author), Univ Ulsan, Coll Med, Div Allergy & Clin Immunol, Dept Internal Med,Asan Med Ctr, Seoul, South Korea.	allergy@medimail.co.kr	Lee, Taehoon/AHA-1437-2022	Lee, Taehoon/0000-0002-9224-0866; Cho, You Sook/0000-0001-8767-2667	National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea [A111218-PG01]	National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea	This study was supported by a grant from the National Project for Personalized Genomic Medicine, Ministry for Health & Welfare, Republic of Korea (A111218-PG01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockow K, 2005, ALLERGY, V60, P150, DOI 10.1111/j.1398-9995.2005.00745.x; Caimmi S, 2010, CLIN EXP ALLERGY, V40, P805, DOI 10.1111/j.1365-2222.2010.03493.x; Christiansen C, 2005, TOXICOLOGY, V209, P185, DOI 10.1016/j.tox.2004.12.020; CLASSEN DC, 1991, JAMA-J AM MED ASSOC, V266, P2847, DOI 10.1001/jama.266.20.2847; Davenport MS, 2009, RADIOLOGY, V253, P372, DOI 10.1148/radiol.2532090465; Dormann H, 2000, DRUG SAFETY, V22, P161, DOI 10.2165/00002018-200022020-00007; Freed KS, 2001, AM J ROENTGENOL, V176, P1389, DOI 10.2214/ajr.176.6.1761389; GREENBERGER PA, 1991, J ALLERGY CLIN IMMUN, V87, P867, DOI 10.1016/0091-6749(91)90135-B; Idee JM, 2005, FUND CLIN PHARMACOL, V19, P263, DOI 10.1111/j.1472-8206.2005.00326.x; Kim SH, 2011, EUR J RADIOL, V80, P363, DOI 10.1016/j.ejrad.2010.06.014; Kopp AF, 2008, ACTA RADIOL, V49, P902, DOI 10.1080/02841850802282811; LASSER EC, 1987, NEW ENGL J MED, V317, P845, DOI 10.1056/NEJM198710013171401; Liccardi G, 2008, J INVEST ALLERG CLIN, V18, P1; Park CS, 2008, PHARMACOEPIDEM DR S, V17, P919, DOI 10.1002/pds.1612; Segal AJ, 2011, INVEST RADIOL, V46, P147, DOI 10.1097/RLI.0b013e3181f5409e; Thomsen HS, 2011, EUR J RADIOL, V80, P77, DOI 10.1016/j.ejrad.2010.12.104; Thong BYH, 2003, ANN ALLERG ASTHMA IM, V90, P342, DOI 10.1016/S1081-1206(10)61804-2; Tramer MR, 2006, BRIT MED J, V333, P675, DOI 10.1136/bmj.38905.634132.AE	18	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66014	10.1371/journal.pone.0066014	http://dx.doi.org/10.1371/journal.pone.0066014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840391	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200049
J	Bergman, P; Lindh, AU; Bjorkhem-Bergman, L; Lindh, JD				Bergman, Peter; Lindh, Asa U.; Bjorkhem-Bergman, Linda; Lindh, Jonatan D.			Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							D SUPPLEMENTATION; CHOLECALCIFEROL; TUBERCULOSIS; PREVENTION; PNEUMONIA; MORTALITY; RECEPTOR; INFANTS; CELLS; KABUL	Background: Low levels of 25-OH vitamin D are associated with respiratory tract infection (RTI). However, results from randomized controlled trials are inconclusive. Therefore, we performed a systematic review and meta-analysis to assess the preventive effect of vitamin D supplementation on RTI. Methods: Randomized, controlled trials of vitamin D for prevention of RTI were used for the analysis. The risks of within-trial and publication bias were assessed. Odds ratios of RTI were pooled using a random-effects model. Heterogeneity was assessed using Cochran's Q and I-2. Meta-regressions and subgroup analyses were used to assess the influence of various factors on trial outcome. The pre-defined review protocol was registered at the PROSPERO international prospective register of systematic reviews, registration number CRD42013003530. Findings: Of 1137 citations retrieved, 11 placebo-controlled studies of 5660 patients were included in the meta-analysis. Overall, vitamin D showed a protective effect against RTI (OR, 0.64; 95% CI, 0.49 to 0.84). There was significant heterogeneity among studies (Cohran's Q p, 0.0001, I-2 = 72%). The protective effect was larger in studies using once-daily dosing compared to bolus doses (OR = 0.51 vs OR = 0.86, p = 0.01). There was some evidence that results may have been influenced by publication bias. Interpretation: Results indicate that vitamin D has a protective effect against RTI, and dosing once-daily seems most effective. Due to heterogeneity of included studies and possible publication bias in the field, these results should be interpreted with caution.	[Bergman, Peter] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Bergman, Peter] Karolinska Inst, Dept Med, CIM, Stockholm, Sweden; [Lindh, Asa U.] Northern Stockholm Psychiat, St Goran Hosp, Stockholm, Sweden; [Bjorkhem-Bergman, Linda; Lindh, Jonatan D.] Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Lindh, JD (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden.	jonatan.lindh@ki.se		Bergman, Peter/0000-0003-3306-3713	Karolinska Institutet; Stockholm County Council; Magnus Bergwall foundation; Ake Wiberg foundation	Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Magnus Bergwall foundation; Ake Wiberg foundation	The work was financially supported by Karolinska Institutet (PB, LBB, JDL), Stockholm County Council (PB, LBB, JDL), Magnus Bergwall (PB) and Ake Wiberg foundations (PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia JF, 2007, EPIDEMIOL INFECT, V135, P1095, DOI 10.1017/S0950268807008308; Avenell A, 2007, AGE AGEING, V36, P574, DOI 10.1093/ageing/afm091; Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333; Bergman P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001663; Bischoff-Ferrari HA, 2010, ARCH INTERN MED, V170, P813, DOI 10.1001/archinternmed.2010.67; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Camargo CA, 2012, PEDIATRICS, V130, pE561, DOI 10.1542/peds.2011-3029; Charan J, 2012, J PHARMACOL PHARMACO, V3, P300, DOI 10.4103/0976-500X.103685; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Choudhary N, 2012, INDIAN PEDIATR, V49, P449, DOI 10.1007/s13312-012-0073-x; Coussens AK, 2012, P NATL ACAD SCI USA, V109, P15449, DOI 10.1073/pnas.1200072109; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Gombart AF, 2005, FASEB J, V19, P1067, DOI 10.1096/fj.04-3284com; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Heaney RP, 2012, NEW ENGL J MED, V367, P77, DOI 10.1056/NEJMe1206858; Henry HL, 2011, BEST PRACT RES CL EN, V25, P531, DOI 10.1016/j.beem.2011.05.003; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hollis BW, 2011, CURR OPIN CLIN NUTR, V14, P598, DOI 10.1097/MCO.0b013e32834be798; HOLLIS BW, 1977, J NUTR, V107, P606, DOI 10.1093/jn/107.4.606; Jolliffe DA, 2012, J STEROID BIOCH MOL; Jorde R, 2012, SCAND J INFECT DIS, V44, P126, DOI 10.3109/00365548.2011.621446; Khoo AL, 2011, J INFECT DIS, V203, P122, DOI 10.1093/infdis/jiq008; Kimball S, 2011, J CLIN ENDOCR METAB, V96, P2826, DOI 10.1210/jc.2011-0325; Kumar GT, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2975; Laaksi I, 2010, J INFECT DIS, V202, P809, DOI 10.1086/654881; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Li-Ng M, 2009, EPIDEMIOL INFECT, V137, P1396, DOI 10.1017/S0950268809002404; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Majak P, 2011, J ALLERGY CLIN IMMUN, V127, P1294, DOI 10.1016/j.jaci.2010.12.016; Manaseki-Holland S, 2012, LANCET, V379, P1419, DOI 10.1016/S0140-6736(11)61650-4; Manaseki-Holland S, 2010, TROP MED INT HEALTH, V15, P1148, DOI 10.1111/j.1365-3156.2010.02578.x; Martineau AR, 2012, LANCET, V379, P1373, DOI 10.1016/S0140-6736(12)60405-X; Moreira-Pfrimer LDF, 2009, ANN NUTR METAB, V54, P291, DOI 10.1159/000235874; Murdoch DR, 2012, JAMA-J AM MED ASSOC, V308, P1333, DOI 10.1001/jama.2012.12505; Nielsen NO, 2010, BRIT J NUTR, V104, P1487, DOI 10.1017/S0007114510002333; Pfeffer PE, 2012, THORAX, V67, P1018, DOI 10.1136/thoraxjnl-2012-202139; Rivas-Santiago B, 2012, INT J ANTIMICROB AGE; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Vieth R, 2009, ANTICANCER RES, V29, P3675	45	206	216	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65835	10.1371/journal.pone.0065835	http://dx.doi.org/10.1371/journal.pone.0065835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840373	gold, Green Published			2022-12-27	WOS:000322361200039
J	Diaz-Fernandez, S; Arroyo, B; Casas, F; Martinez-Haro, M; Vinuela, J				Diaz-Fernandez, Silvia; Arroyo, Beatriz; Casas, Fabian; Martinez-Haro, Monica; Vinuela, Javier			Effect of Game Management on Wild Red-Legged Partridge Abundance	PLOS ONE			English	Article							BREEDING SUCCESS; ALECTORIS-RUFA; STRATEGY EVALUATION; POPULATION-DENSITY; RESTOCKING; PRESSURE; DISEASE; RISKS; BIRDS; SIZE	The reduction of game and fish populations has increased investment in management practices. Hunting and fishing managers use several tools to maximize harvest. Managers need to know the impact their management has on wild populations. This issue is especially important to improve management efficacy and biodiversity conservation. We used questionnaires and field bird surveys in 48 hunting estates to assess whether red-legged partridge Alectoris rufa young/adult ratio and summer abundance were related to the intensity of management (provision of supplementary food and water, predator control and releases of farm-bred partridges), harvest intensity or habitat in Central Spain. We hypothesized that partridge abundance would be higher where management practices were applied more intensively. Variation in young/adult ratio among estates was best explained by habitat, year and some management practices. Density of feeders and water points had a positive relationship with this ratio, while the density of partridges released and magpies controlled were negatively related to it. The variables with greatest relative importance were feeders, releases and year. Variations in post-breeding red-legged partridge abundance among estates were best explained by habitat, year, the same management variables that influenced young/adult ratio, and harvest intensity. Harvest intensity was negatively related to partridge abundance. The other management variables had the same type of relationship with abundance as with young/adult ratio, except magpie control. Variables with greatest relative importance were habitat, feeders, water points, releases and harvest intensity. Our study suggests that management had an overall important effect on post-breeding partridge abundance. However, this effect varied among tools, as some had the desired effect (increase in partridge abundance), whereas others did not or even had a negative relationship (such as release of farm-reared birds) and can be thus considered inefficient or even detrimental. We advise reconsidering their use from both ecological and economical points of view.	[Diaz-Fernandez, Silvia; Arroyo, Beatriz; Casas, Fabian; Martinez-Haro, Monica; Vinuela, Javier] JCCM, UCLM, CSIC, Inst Invest Recursos Cineget,IREC, Ciudad Real, Spain; [Casas, Fabian] CSIC, Estn Expt Zonas Aridas, La Canada De San Urbano, Almeria, Spain; [Martinez-Haro, Monica] Univ Coimbra, Dept Life Sci, IMAR Inst Mar, Coimbra, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Universidade de Coimbra	Diaz-Fernandez, S (corresponding author), JCCM, UCLM, CSIC, Inst Invest Recursos Cineget,IREC, Ciudad Real, Spain.	silviadiazfernandez@gmail.com	Casas, Fabian/Y-3021-2018; Casas, Fabian/AAE-9846-2020; Arroyo, Beatriz/A-3504-2013; Martinez-Haro, Mónica/B-8363-2015	Casas, Fabian/0000-0003-3662-6585; Casas, Fabian/0000-0003-3662-6585; Arroyo, Beatriz/0000-0002-4657-6609; Martinez-Haro, Mónica/0000-0002-4326-5805; Vinuela, Javier/0000-0002-8916-0398	European Commission [212160]; Consejeria de Agricultura of JCCM; Ministerio de Ciencia y Tecnologia [CGL2008-04282/BOS]; European Social Fund (ESF); JCCM; JAE-Doc; ESF; Portuguese Foundation for Science and Technology (FCT); POPH programme;  [SFRH/BPD/73890/2010]	European Commission(European CommissionEuropean Commission Joint Research Centre); Consejeria de Agricultura of JCCM; Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Social Fund (ESF)(European Social Fund (ESF)); JCCM; JAE-Doc; ESF(European Commission); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); POPH programme; 	This work was supported by the European Commission under the 7th Framework Programme for RTD through project HUNT (212160, FP7-ENV-2007-1), the Consejeria de Agricultura of JCCM through project "Efecto del medio natural, las practicas agricolas, ganaderas y de gestion cinegetica sobre las poblaciones de caza menor en los cotos pertenecientes a la Asociacion de cotos de caza Sierra de Alcaraz-Campo de Montiel", and the Ministerio de Ciencia y Tecnologia (CGL2008-04282/BOS). S. Diaz-Fernandez had a predoctoral grant funded by the European Social Fund (ESF) and by JCCM (Operational Programme PRINCET 2005-2010). F. Casas was supported by a JAE-Doc contract funded by the ESF. Currently, M. Martinez-Haro is supported by a postdoctoral grant (Ref: SFRH/BPD/73890/2010) funded by the Portuguese Foundation for Science and Technology (FCT), the ESF and POPH programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, LEY ORGANICA 15 1999, P43088; Arroyo B., 2002, IMPACT HUNTING MANAG; Arroyo B, 2012, EUR J WILDLIFE RES, V58, P847, DOI 10.1007/s10344-012-0632-4; Beja P, 2009, EUR J WILDLIFE RES, V55, P227, DOI 10.1007/s10344-008-0236-1; Bennett E, 2000, WORKING PAPER; Bibby CJ, 1992, BIRD CENSUS TECHNIQU; Blanco-Aguiar JA, 2008, ANIM CONSERV, V11, P535, DOI 10.1111/j.1469-1795.2008.00212.x; Blanco-Aguiar JA, 2007, THESIS COMPLUTENSE U; Borralho R, 1998, IBIS, V140, P620, DOI 10.1111/j.1474-919X.1998.tb04707.x; Buckland S.T., 2001, pi; Buenestado FJ, 2008, AGR ECOSYST ENVIRON, V126, P158, DOI 10.1016/j.agee.2008.01.020; Bunnefeld N, 2011, TRENDS ECOL EVOL, V26, P441, DOI 10.1016/j.tree.2011.05.003; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Casas F, 2010, ENVIRON CONSERV, V37, P177, DOI 10.1017/S0376892910000299; Casas F, 2009, IBIS, V151, P743, DOI 10.1111/j.1474-919X.2009.00958.x; Cody M.L., 1985, HABITATS SELECTION B; Comite de etica del CSIC, 2011, COD GOOD SCI PRACT C; DEGEN AA, 1985, PHYSIOL ZOOL, V58, P1; DeStefano S, 2000, J RANGE MANAGE, V53, P255, DOI 10.2307/4003428; Diaz-Fernandez S, 2012, J WILDLIFE MANAGE, V76, P1354, DOI 10.1002/jwmg.391; Draycott RAH, 2005, WILDLIFE BIOL, V11, P177, DOI 10.2981/0909-6396(2005)11[177:EOSSFO]2.0.CO;2; Duarte J, 2012, THESIS U MALAGA MALA; Duckworth J. C., 2003, Landscape Research, V28, P171, DOI 10.1080/0142639032000070184; Ferreras P, 2010, CONTRATO ASISTENCIA; Fletcher K, 2010, J APPL ECOL, V47, P263, DOI 10.1111/j.1365-2664.2010.01793.x; Fortuna Miguel Angel, 2002, Ardeola, V49, P59; Lacasa VRG, 2010, EUR J WILDLIFE RES, V56, P591, DOI 10.1007/s10344-009-0352-6; Gonzalez-Redondo P., 2004, REV ESPANOLA ESTUD A, V204, P179; Gortazar C, 2006, EUR J WILDLIFE RES, V52, P81, DOI 10.1007/s10344-005-0022-2; Gortazar C, 2002, Z JAGDWISS, V48, P94, DOI 10.1007/BF02193547; Gortazar C, 2000, Z JAGDWISS, V46, P23, DOI 10.1007/BF02240661; Grado SC, 2001, WILDLIFE SOC B, V29, P846; Guthery F.S., 2002, TECHNOLOGY BOBWHITE; Hoodless AN, 1999, J APPL ECOL, V36, P147, DOI 10.1046/j.1365-2664.1999.00388.x; Hudson P.J., 1992, GROUSE SPACE TIME; Keane A, 2005, BIOL CONSERV, V126, P216, DOI 10.1016/j.biocon.2005.05.011; Lucio A. J., 1992, Gibier Faune Sauvage, V9, P417; Lucio Antonio J., 1990, Ardeola, V37, P207; MARM, 2006, AN EST FOR; Garrido EM, 2009, B ASOC GEOGR ESP, P325; Messmer TA, 1999, WILDLIFE SOC B, V27, P75; Millan J, 2004, EUR J WILDLIFE RES, V50, P97, DOI 10.1007/s10344-004-0041-4; Millan J, 2003, WILDLIFE BIOL, V9, P229, DOI 10.2981/wlb.2003.055; Milner-Gulland EJ, 2010, BIOL LETTERS, V6, P719, DOI 10.1098/rsbl.2010.0588; Mustin K, 2011, BIODIVERSITY IMPACTS; PEPIN D, 1990, Gibier Faune Sauvage, V7, P145; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rios-Saldana A, 2010, THESIS U CASTILLA LA; Sauer J.R., 2008, N AM BREEDING BIRD S; Schluter M, 2012, NAT RESOUR MODEL, V25, P219, DOI 10.1111/j.1939-7445.2011.00108.x; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x; Tabachnick B. G., 2013, USING MULTIVARIATE S; Tapper SC, 1996, J APPL ECOL, V33, P965, DOI 10.2307/2404678; Valkama J, 2005, BIOL REV, V80, P171, DOI 10.1017/S146479310400658X; van Poorten BT, 2011, P NATL ACAD SCI USA, V108, P12554, DOI 10.1073/pnas.1013919108; Vargas JM, 2006, EUR J WILDLIFE RES, V52, P188, DOI 10.1007/s10344-006-0028-4; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Villanua D, 2007, THESIS U CASTILLA LA; Villanua D, 2008, EUR J WILDLIFE RES, V54, P199, DOI 10.1007/s10344-007-0130-2; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	61	28	28	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66671	10.1371/journal.pone.0066671	http://dx.doi.org/10.1371/journal.pone.0066671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840515	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200097
J	Fortin, JM; Currie, DJ				Fortin, Jean-Michel; Currie, David J.			Big Science vs. Little Science: How Scientific Impact Scales with Funding	PLOS ONE			English	Article							BASE-LINE GRANT; EVERY QUALIFIED RESEARCHER; SYSTEM EXCEEDS; COST; CANADA	Agencies that fund scientific research must choose: is it more effective to give large grants to a few elite researchers, or small grants to many researchers? Large grants would be more effective only if scientific impact increases as an accelerating function of grant size. Here, we examine the scientific impact of individual university-based researchers in three disciplines funded by the Natural Sciences and Engineering Research Council of Canada (NSERC). We considered four indices of scientific impact: numbers of articles published, numbers of citations to those articles, the most cited article, and the number of highly cited articles, each measured over a four-year period. We related these to the amount of NSERC funding received. Impact is positively, but only weakly, related to funding. Researchers who received additional funds from a second federal granting council, the Canadian Institutes for Health Research, were not more productive than those who received only NSERC funding. Impact was generally a decelerating function of funding. Impact per dollar was therefore lower for large grant-holders. This is inconsistent with the hypothesis that larger grants lead to larger discoveries. Further, the impact of researchers who received increases in funding did not predictably increase. We conclude that scientific impact (as reflected by publications) is only weakly limited by funding. We suggest that funding strategies that target diversity, rather than "excellence", are likely to prove to be more productive.	[Fortin, Jean-Michel; Currie, David J.] Univ Ottawa, Ottawa Carleton Inst Biol, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Currie, DJ (corresponding author), Univ Ottawa, Ottawa Carleton Inst Biol, Ottawa, ON K1N 6N5, Canada.	dcurrie@uottawa.ca			Undergraduate Research Opportunity Program grant; University of Ottawa; NSERC	Undergraduate Research Opportunity Program grant; University of Ottawa; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by an Undergraduate Research Opportunity Program grant, and a work-study grant at the University of Ottawa to JMF, and a (mid-sized) grant from NSERC to DJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2012, SCIENCE, V337, P1583, DOI 10.1126/science.1230529; [Anonymous], 2010, CAUT B, P57; Azoulay P, 2012, NATURE, V484, P31, DOI 10.1038/484031a; Azoulay P, 2011, RAND J ECON, V42, P527, DOI 10.1111/j.1756-2171.2011.00140.x; Berg JM, 2012, NATURE, V489, P203, DOI 10.1038/489203a; Campbell D, 2010, AM J EVAL, V31, P66, DOI 10.1177/1098214009354774; Commission on the Reform of Ontario's Public Services, 2012, PUBL SERV ONT PATH S; Dorsey ER, 2009, PLOS ONE, P4; Feder T., 2012, PHYS TODAY, V65, P20; Gordon R, 2009, ACCOUNT RES, V16, P232, DOI 10.1080/08989620903065590; Gordon R, 2009, ACCOUNT RES, V16, P13, DOI 10.1080/08989620802689821; Joos B, 2012, CAUT B, V59, pA4; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; National Science Foundation, 2010, REP NAT SCI BOARD NA; Natural Sciences and Engineering Reseach Council of Canada, 2012, FAQ DISC GRANTS COMP; Peters RH, 1996, CAN J FISH AQUAT SCI, V53, P670, DOI 10.1139/cjfas-53-3-670; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Roorda S, 2009, ACCOUNT RES, V16, P229, DOI 10.1080/08989620903065475; Sanderson I, 2002, PUBLIC ADMIN, V80, P1, DOI 10.1111/1467-9299.00292; Tatsioni A, 2010, FASEB J, V24, P1335, DOI 10.1096/fj.09-148239	20	112	116	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65263	10.1371/journal.pone.0065263	http://dx.doi.org/10.1371/journal.pone.0065263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840323	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200013
J	Ricci, F; Staurenghi, G; Lepre, T; Missiroli, F; Zampatti, S; Cascella, R; Borgiani, P; Marsella, LT; Eandi, CM; Cusumano, A; Novelli, G; Giardina, E				Ricci, Federico; Staurenghi, Giovanni; Lepre, Tiziana; Missiroli, Filippo; Zampatti, Stefania; Cascella, Raffaella; Borgiani, Paola; Marsella, Luigi Tonino; Eandi, Chiara Maria; Cusumano, Andrea; Novelli, Giuseppe; Giardina, Emiliano			Haplotypes in IL-8 Gene Are Associated to Age-Related Macular Degeneration: A Case-Control Study	PLOS ONE			English	Article							HUMAN INTERLEUKIN-8 RECEPTOR; C-REACTIVE PROTEIN; IN-VITRO; RISK; PROGRESSION; MODELS; CANCER; POLYMORPHISMS; INFLAMMATION; POPULATION	Background: Age-related macular degeneration (AMD) is the main cause of blindness in the developed world. The etiology of AMD is multifactorial due to the interaction between genetic and environmental factors. IL-8 has a role in inflammation and angiogenesis; we report the genetic characterization of IL-8 allele architecture and evaluate the role of SNPs or haplotypes in the susceptibility to wet AMD, case-control study. Methods: Case-control study including 721 AMD patients and 660 controls becoming from Italian population. Genotyping was carried out by Real Time-PCR. Differences in the frequencies were estimated by the chi-square test. Direct sequencing was carried out by capillary electrophoresis trough ABI3130xl. Results: rs2227306 showed a p-value of 4.15*10(-5) and an Odds Ratio (OR) for T allele of 1.39 [1.19-1.62]. After these positive results, we sequenced the entire IL-8 regulatory and coding regions of 60 patients and 30 controls stratified for their genotype at rs2227306. We defined two different haplotypes involving rs4073 (A/T), rs2227306 (C/T), rs2227346 (C/T) and rs1126647 (A/T): A-T-T-T (p-value: 2.08*10(-9); OR: 1.68 [1.43-1.97]) and T-C-C-A (p-value: 7.07*10(-11); OR: 0.60 [0.51-0.70]). To further investigate a potential functional role of associated haplotypes, we performed an expression study on RNA extracted from whole blood of 75 donors to verify a possible direct correlation between haplotype and gene expression, failing to reveal significant differences. Conclusions: These results suggest a possible secondary role of IL-8 gene in the development of the disease. This paper outlines the importance of association between inflammation and AMD. Moreover IL-8 is a new susceptibility genomic biomarker of AMD.	[Ricci, Federico; Missiroli, Filippo; Cusumano, Andrea] Policlin Tor Vergata, UOSD Patol Retin Fdn, Rome, Italy; [Staurenghi, Giovanni] Univ Milan, Sacco Hosp, Eye Clin, Dept Clin Sci Luigi Sacco, Milan, Italy; [Lepre, Tiziana; Zampatti, Stefania; Cascella, Raffaella; Borgiani, Paola; Marsella, Luigi Tonino; Giardina, Emiliano] Univ Roma Tor Vergata, Sch Med, Ctr Excellence Genom Risk Assessment Multifactori, Dept Biomed & Prevent, Rome, Italy; [Eandi, Chiara Maria] Univ Turin, Eye Clin, Dept Clin Physiopathol, Turin, Italy; [Novelli, Giuseppe] Natl Agcy Evaluat Univ & Res ANVUR, Rome, Italy; [Novelli, Giuseppe] S Pietro Fatebenefratelli Hosp, Rome, Italy	University of Rome Tor Vergata; Policlin Tor Vergata; University of Milan; Luigi Sacco Hospital; University of Rome Tor Vergata; University of Turin	Giardina, E (corresponding author), Univ Roma Tor Vergata, Sch Med, Ctr Excellence Genom Risk Assessment Multifactori, Dept Biomed & Prevent, Rome, Italy.	emiliano.giardina@uniroma2.it	Cascella, Raffaella/G-9040-2019; Novelli, Giuseppe/A-5195-2013; Giardina, Emiliano/J-1965-2012; Novelli, Giuseppe/T-8822-2019; Zampatti, Stefania/AAC-4589-2022; Novelli, Giuseppe/GQB-3329-2022; ricci, federico/AAC-3836-2020; Staurenghi, Giovanni/K-4388-2017	Cascella, Raffaella/0000-0002-2148-0758; Novelli, Giuseppe/0000-0002-7781-602X; Zampatti, Stefania/0000-0003-2502-7157; Novelli, Giuseppe/0000-0002-7781-602X; ricci, federico/0000-0002-4224-9280; giardina, emiliano/0000-0002-2741-5009; Marsella, Luigi Tonino/0000-0002-7005-7526; BORGIANI, PAOLA/0000-0003-0859-4328; Staurenghi, Giovanni/0000-0002-2299-5251; Eandi, Chiara Maria/0000-0003-3656-1689	Macula & Genoma Foundation-onlus	Macula & Genoma Foundation-onlus	This work was supported by the "Macula & Genoma Foundation-onlus". We are very grateful to all the staff of the Centre of Excellence for Genomic risk Assessment in Multifactorial and Complex Diseases, School of Medicine, University of Rome "Tor Vergata" for their effort in our study.	Andia DC, 2012, ARCH ORAL BIOL; Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Gao LB, 2010, EUR J CANCER, V46, P1333, DOI 10.1016/j.ejca.2010.03.011; Goverdhan SV, 2008, BRIT J OPHTHALMOL, V92, P537, DOI 10.1136/bjo.2007.123190; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Klein R, 2011, ARCH OPHTHALMOL-CHIC, V129, P1605, DOI 10.1001/archophthalmol.2011.372; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; MacDermott RP, 1999, J CLIN IMMUNOL, V19, P266, DOI 10.1023/A:1020583306627; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; Nakagome K, 2012, INT ARCH ALLERGY IMM, V158, P96, DOI 10.1159/000337801; Neale BM, 2010, P NATL ACAD SCI USA, V107, P7395, DOI 10.1073/pnas.0912019107; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Remick DG, 2005, CRIT CARE MED, V33, pS466, DOI 10.1097/01.CCM.0000186783.34908.18; Rennie CA, 2012, EYE, V26, P109, DOI 10.1038/eye.2011.256; Ricci F, 2009, ARCH OPHTHALMOL-CHIC, V127, P1368, DOI 10.1001/archophthalmol.2009.237; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P774, DOI 10.1001/archopht.123.6.774; Seddon JM, 2004, JAMA-J AM MED ASSOC, V291, P704, DOI 10.1001/jama.291.6.704; Seddon JM, 2011, OPHTHALMOLOGY, V118, P2203, DOI 10.1016/j.ophtha.2011.04.029; Simonini A, 2000, CIRCULATION, V101, P1519, DOI 10.1161/01.CIR.101.13.1519; Spencer KL, 2012, ARCH OPHTHALMOL-CHIC, V130, P116, DOI 10.1001/archopthalmol.2011.1370; Telander DG, 2011, SEMIN OPHTHALMOL, V26, P192, DOI 10.3109/08820538.2011.570849; Tsai YY, 2008, INVEST OPHTH VIS SCI, V49, P693, DOI 10.1167/iovs.07-0125; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Warle MC, 2003, LIVER TRANSPLANT, V9, P170, DOI 10.1053/jlts.2002.50014; Wu GD, 1997, J BIOL CHEM, V272, P2396; Yu Y, 2012, INVEST OPHTH VIS SCI, V53, P1548, DOI 10.1167/iovs.11-8657; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	32	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66978	10.1371/journal.pone.0066978	http://dx.doi.org/10.1371/journal.pone.0066978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840568	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200113
J	Stanley, DA; Knight, ME; Stout, JC				Stanley, Dara A.; Knight, Mairi E.; Stout, Jane C.			Ecological Variation in Response to Mass-Flowering Oilseed Rape and Surrounding Landscape Composition by Members of a Cryptic Bumblebee Complex	PLOS ONE			English	Article							BOMBUS-TERRESTRIS HYMENOPTERA; NEST DENSITY; COLONY GROWTH; SIBSHIP RECONSTRUCTION; FORAGING DISTANCE; CONSERVATION; DECLINE; SCALE; BEES; DNA	The Bombus sensu stricto species complex is a widespread group of cryptic bumblebee species which are important pollinators of many crops and wild plants. These cryptic species have, until now, largely been grouped together in ecological studies, and so little is known about their individual colony densities, foraging ranges or habitat requirements, which can be influenced by land use at a landscape scale. We used mass-flowering oilseed rape fields as locations to sample bees of this complex, as well as the second most common visitor to oilseed rape B. lapidarius, and molecular RFLP methods to distinguish between the cryptic species. We then used microsatellite genotyping to identify sisters and estimate colony densities, and related both proportions of cryptic species and their colony densities to the composition of the landscape surrounding the fields. We found B. lucorum was the most common member of the complex present in oilseed rape followed by B. terrestris. B. cryptarum was also present in all but one site, with higher proportions found in the east of the study area. High numbers of bumblebee colonies were estimated to be using oilseed rape fields as a forage resource, with B. terrestris colony numbers higher than previous estimates from non-mass-flowering fields. We also found that the cryptic species responded differently to surrounding landscape composition: both relative proportions of B. cryptarum in samples and colony densities of B. lucorum were negatively associated with the amount of arable land in the landscape, while proportions and colony densities of other species did not respond to landscape variables at the scale measured. This suggests that the cryptic species have different ecological requirements (which may be scale-dependent) and that oilseed rape can be an important forage resource for many colonies of bumblebees. Given this, we recommend sustainable management of this crop to benefit bumblebees.	[Stanley, Dara A.; Stout, Jane C.] Univ Dublin Trinity Coll, Sch Nat Sci, Dept Bot, Dublin 2, Ireland; [Stanley, Dara A.; Stout, Jane C.] Univ Dublin Trinity Coll, Trinity Ctr Biodivers Res, Dublin 2, Ireland; [Knight, Mairi E.] Univ Plymouth, Sch Biomed & Biol Sci, Plymouth PL4 8AA, Devon, England	Trinity College Dublin; Trinity College Dublin; University of Plymouth	Stanley, DA (corresponding author), Univ Dublin Trinity Coll, Sch Nat Sci, Dept Bot, Dublin 2, Ireland.	stanleyd@tcd.ie	Stanley, Dara/K-2295-2012; Stout, Jane/AAS-8867-2020; Stanley, Dara/AAR-2947-2020; Stout, Jane C/B-1631-2010	Stanley, Dara/0000-0001-8948-8409; Stout, Jane/0000-0002-2027-0863; Stanley, Dara/0000-0001-8948-8409; Stout, Jane C/0000-0002-2027-0863	project SIMBIOSYS as part of the Science, Technology, Research and Innovation for the Environment (STRIVE) Programme [2007-B-CD-1-S1]; Irish Government under the National Development Plan	project SIMBIOSYS as part of the Science, Technology, Research and Innovation for the Environment (STRIVE) Programme; Irish Government under the National Development Plan	This research was funded by the project SIMBIOSYS (www.simbiosys.ie, 2007-B-CD-1-S1) as part of the Science, Technology, Research and Innovation for the Environment (STRIVE) Programme, financed by the Irish Government under the National Development Plan 2007-2013, administered on behalf of the Department of the Environment, Heritage and Local Government by the Irish Environmental Protection Agency (EPA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2008, MOL ECOL RESOUR, V8, P1219, DOI 10.1111/j.1755-0998.2008.02355.x; Bertsch A, 2005, INSECT SOC, V52, P45, DOI 10.1007/s00040-004-0761-1; Bommarco R, 2012, OECOLOGIA, V169, P1025, DOI 10.1007/s00442-012-2271-6; Bommarco R, 2012, P ROY SOC B-BIOL SCI, V279, P309, DOI 10.1098/rspb.2011.0647; Byrne E, 2011, THESIS TRINITY COLL; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Carvell C, 2012, OIKOS, V121, P734, DOI 10.1111/j.1600-0706.2011.19832.x; Chapman RE, 2003, MOL ECOL, V12, P2801, DOI 10.1046/j.1365-294X.2003.01957.x; Charman TG, 2010, MOL ECOL, V19, P2661, DOI 10.1111/j.1365-294X.2010.04697.x; CORBET SA, 1991, BEE WORLD, V72, P47, DOI 10.1080/0005772X.1991.11099079; Darvill B, 2004, OIKOS, V107, P471, DOI 10.1111/j.0030-1299.2004.13510.x; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; EPA, 2006, COR LAND COV IR LAND; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; ESTOUP A, 1995, MOL ECOL, V4, P89, DOI 10.1111/j.1365-294X.1995.tb00195.x; Fitzpatrick U, 2006, REGIONAL RED LIST IR; Fitzpatrick U, 2007, BIOL CONSERV, V136, P185, DOI 10.1016/j.biocon.2006.11.012; Frondel M, 2005, ENERG POLICY, V35, P1675; Funk CR, 2006, MOL ECOL NOTES, V6, P83, DOI 10.1111/j.1471-8286.2005.01147.x; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Goulson D, 2005, BIOL CONSERV, V122, P1, DOI 10.1016/j.biocon.2004.06.017; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2004, APIDOLOGIE, V35, P55, DOI 10.1051/apido:2003062; Goulson D, 2002, OECOLOGIA, V130, P267, DOI 10.1007/s004420100803; Goulson D, 2001, APIDOLOGIE, V32, P105, DOI 10.1051/apido:2001115; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hanley ME, 2011, OIKOS, V120, P1618, DOI 10.1111/j.1600-0706.2011.19233.x; Heard MS, 2007, BIOL LETTERS, V3, P638, DOI 10.1098/rsbl.2007.0425; Herrmann F, 2007, MOL ECOL, V16, P1167, DOI 10.1111/j.1365-294X.2007.03226.x; Holehouse KA, 2003, INSECT SOC, V50, P277, DOI 10.1007/s00040-003-0672-6; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Knight ME, 2009, INSECT CONSERV DIVER, V2, P116, DOI 10.1111/j.1752-4598.2009.00049.x; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Lepais O, 2010, MOL ECOL, V19, P819, DOI 10.1111/j.1365-294X.2009.04500.x; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Morandin LA, 2007, BASIC APPL ECOL, V8, P117, DOI 10.1016/j.baae.2006.06.003; Murray TE, 2008, CONSERV GENET, V9, P653, DOI 10.1007/s10592-007-9394-z; Murray TE, 2012, J APPL ECOL, V49, P998, DOI 10.1111/j.1365-2664.2012.02175.x; Osborne JL, 2008, J APPL ECOL, V45, P784, DOI 10.1111/j.1365-2664.2007.01359.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Palmer TM, 2003, AM NAT, V162, pS63, DOI 10.1086/378682; R Core Team, 2018, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Tanaka H, 2001, INSECT SOC, V48, P44, DOI 10.1007/PL00001744; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Waters J, 2011, INSECT CONSERV DIVER, V4, P46, DOI 10.1111/j.1752-4598.2010.00101.x; Westphal C, 2003, ECOL LETT, V6, P961, DOI 10.1046/j.1461-0248.2003.00523.x; Westphal C, 2009, J APPL ECOL, V46, P187, DOI 10.1111/j.1365-2664.2008.01580.x; Westphal C, 2006, OECOLOGIA, V149, P289, DOI 10.1007/s00442-006-0448-6; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williams PH, 2012, SYST BIODIVERS, V10, P21, DOI 10.1080/14772000.2012.664574; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Wolf S, 2010, APIDOLOGIE, V41, P45, DOI 10.1051/apido/2009048; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003; Zuur Alain F., 2009, P1	61	11	11	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65516	10.1371/journal.pone.0065516	http://dx.doi.org/10.1371/journal.pone.0065516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840338	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200023
J	Vendrig, JC; Coffeng, LE; Fink-Gremmels, J				Vendrig, Johannes Cornelis; Coffeng, Luc Edgar; Fink-Gremmels, Johanna			Effects of Separate and Concomitant TLR-2 and TLR-4 Activation in Peripheral Blood Mononuclear Cells of Newborn and Adult Horses	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; INNATE IMMUNE-RESPONSE; PATTERN-RECOGNITION; ADAPTIVE IMMUNITY; RHODOCOCCUS-EQUI; GENE-EXPRESSION; NEONATAL FOALS; INDUCTION; INFECTION; INFLAMMATION	Deficient innate and adaptive immune responses cause newborn mammals to be more susceptible to bacterial infections than adult individuals. Toll-like receptors (TLRs) are known to play a pivotal role in bacterial recognition and subsequent immune responses. Several studies have indicated that activation of certain TLRs, in particular TLR-2, can result in suppression of inflammatory pathology. In this study, we isolated peripheral blood mononuclear cells (PBMCs) from adult and newborn horses to investigate the influence of TLR-2 activation on the inflammatory response mediated by TLR-4. Data were analysed in a Bayesian hierarchical linear regression model, accounting for variation between horses. In general, cytokine responses were lower in PBMCs derived from foals compared with PBMCs from adult horses. Whereas in foal PBMCs expression of TLR-2, TLR-4, and TLR-9 was not influenced by separate and concomitant TLR-2 and TLR-4 activation, in adult horse PBMCs, both TLR ligands caused significant up-regulation of TLR-2 and down-regulation of TLR-9. Moreover, in adult horse PBMCs, interleukin-10 protein production and mRNA expression increased significantly following concomitant TLR-2 and TLR-4 activation (compared with sole TLR-4 activation). In foal PBMCs, this effect was not observed. In both adult and foal PBMCs, the lipopolysaccharide-induced pro-inflammatory response was not influenced by pre-incubation and co-stimulation with the specific TLR-2 ligand Pam3-Cys-Ser-Lys4. This indicates that the published data on other species cannot be translated directly to the horse, and stresses the necessity to confirm results obtained in other species in target animals. Future research should aim to identify other methods or substances that enhance TLR functionality and bacterial defence in foals, thereby lowering susceptibility to life-threatening infections during the first period of life.	[Vendrig, Johannes Cornelis; Fink-Gremmels, Johanna] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [Coffeng, Luc Edgar] Erasmus MC, Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands	Utrecht University; Erasmus University Rotterdam; Erasmus MC	Vendrig, JC (corresponding author), Univ Utrecht, Fac Vet Med, Utrecht, Netherlands.	J.C.Vendrig@uu.nl	Coffeng, Luc/AAL-6631-2021; Fink-Gremmels, Johanna/G-3707-2012	Coffeng, Luc/0000-0002-4425-2264; 	Utrecht University	Utrecht University	This research was funded institutionally by Utrecht University (fundamental research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsadik A, 2011, HUM IMMUNOL, V72, P1188, DOI 10.1016/j.humimm.2011.08.015; Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394; Bernheiden M, 2001, J ENDOTOXIN RES, V7, P447, DOI 10.1179/096805101101533061; Borchers AT, 2009, J GASTROENTEROL, V44, P26, DOI 10.1007/s00535-008-2296-0; Breathnach CC, 2006, VET IMMUNOL IMMUNOP, V112, P199, DOI 10.1016/j.vetimm.2006.02.010; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Dowling D, 2008, CYTOKINE, V41, P254, DOI 10.1016/j.cyto.2007.11.020; Figueiredo MD, 2009, VET IMMUNOL IMMUNOP, V127, P125, DOI 10.1016/j.vetimm.2008.09.028; Flaminio M Julia B F, 2007, J Immune Based Ther Vaccines, V5, P1, DOI 10.1186/1476-8518-5-1; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Jacks S, 2007, CLIN VACCINE IMMUNOL, V14, P669, DOI 10.1128/CVI.00042-07; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Liu M, 2011, CYTOKINE, V56, P356, DOI 10.1016/j.cyto.2011.07.017; Liu T, 2009, VACCINE, V27, P674, DOI 10.1016/j.vaccine.2008.11.040; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005601; Merant C, 2009, VET IMMUNOL IMMUNOP, V131, P1, DOI 10.1016/j.vetimm.2009.03.002; Nyirenda Mukanthu H., 2009, Inflammation & Allergy Drug Targets, V8, P124; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Re F, 2004, J IMMUNOL, V173, P7548, DOI 10.4049/jimmunol.173.12.7548; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Testro AG, 2009, J GASTROEN HEPATOL, V24, P943, DOI 10.1111/j.1440-1746.2009.05854.x	28	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66897	10.1371/journal.pone.0066897	http://dx.doi.org/10.1371/journal.pone.0066897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840549	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200109
J	Hovi, T; Savolainen-Kopra, C; Smura, T; Blomqvist, S; Al-Hello, H; Roivainen, M				Hovi, Tapani; Savolainen-Kopra, Carita; Smura, Teemu; Blomqvist, Soile; Al-Hello, Haider; Roivainen, Merja			Evolution of Type 2 Vaccine Derived Poliovirus Lineages. Evidence for Codon-Specific Positive Selection at Three Distinct Locations on Capsid Wall	PLOS ONE			English	Article							IMMUNODEFICIENT PATIENT; WILD POLIOVIRUS; OUTBREAK; RECOMBINATION; CIRCULATION; PROTEIN; VP1; NEUTRALIZATION; POLIOMYELITIS; MECHANISMS	Partial sequences of 110 type 2 poliovirus strains isolated from sewage in Slovakia in 2003-2005, and most probably originating from a single dose of oral poliovirus vaccine, were subjected to a detailed genetic analysis. Evolutionary patterns of these vaccine derived poliovirus strains (SVK-aVDPV2) were compared to those of type 1 and type 3 wild poliovirus (WPV) lineages considered to have a single seed strain origin, respectively. The 102 unique SVK-aVDPV VP1 sequences were monophyletic differing from that of the most likely parental poliovirus type 2/Sabin (PV2 Sabin) by 12.5-15.6%. Judging from this difference and from the rate of accumulation of synonymous transversions during the 22 month observation period, the relevant oral poliovirus vaccine dose had been administered to an unknown recipient more than 12 years earlier. The patterns of nucleotide substitution during the observation period differed from those found in the studied lineages of WPV1 or 3, including a lower transition/transversion (Ts/Tv) bias and strikingly lower Ts/Tv rate ratios at the 2nd codon position for both purines and pyrimidines. A relatively low preference of transitions at the 2nd codon position was also found in the large set of VP1 sequences of Nigerian circulating (c)VDPV2, as well as in the smaller sets from the Hispaniola cVDPV1 and Egypt cVDPV2 outbreaks, and among aVDPV1 and aVDPV2 strains recently isolated from sewage in Finland. Codon-wise analysis of synonymous versus non-synonymous substitution rates in the VP1 sequences suggested that in five codons, those coding for amino acids at sites 24, 144, 147, 221 and 222, there may have been positive selection during the observation period. We conclude that pattern of poliovirus VP1 evolution in prolonged infection may differ from that found in WPV epidemics. Further studies on sufficiently large independent datasets are needed to confirm this suggestion and to reveal its potential significance.	[Hovi, Tapani; Savolainen-Kopra, Carita; Smura, Teemu; Blomqvist, Soile; Al-Hello, Haider; Roivainen, Merja] Natl Inst Hlth & Welf THL, Virol Unit, Dept Infect Dis Surveillance & Control, Helsinki, Finland	Finland National Institute for Health & Welfare	Hovi, T (corresponding author), Natl Inst Hlth & Welf THL, Virol Unit, Dept Infect Dis Surveillance & Control, Helsinki, Finland.	tapani.hovi@thl.fi	Hovi, Tapani/AAJ-4828-2020; Smura, Teemu P/C-4063-2016; Smura, Teemu/K-6421-2012; Hovi, Tapani/AAG-9156-2020	Smura, Teemu/0000-0002-9187-3151; Al-Hello, Haider/0000-0001-8206-1226				Agol VI, 2006, CURR TOP MICROBIOL, V299, P211; Blomqvist S, 2004, J VIROL, V78, P4876, DOI 10.1128/JVI.78.9.4876-4883.2004; Blomqvist S, 2003, J GEN VIROL, V84, P573, DOI 10.1099/vir.0.18708-0; Blomqvist S, 2010, VIRUS RES, V151, P246, DOI 10.1016/j.virusres.2010.05.006; Burns CC, 2013, J VIROL, V87, P4907, DOI 10.1128/JVI.02954-12; Cernakova B, 2005, EUR J CLIN MICROBIOL, V24, P438, DOI 10.1007/s10096-005-1331-9; Cherkasova EA, 2002, J VIROL, V76, P6791, DOI 10.1128/JVI.76.13.6791-6799.2002; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; FRICKS CE, 1990, J VIROL, V64, P1934, DOI 10.1128/JVI.64.5.1934-1945.1990; Gavrilin GV, 2000, J VIROL, V74, P7381, DOI 10.1128/JVI.74.16.7381-7390.2000; Hovi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066849; HUOVILAINEN A, 1987, J GEN VIROL, V68, P1373, DOI 10.1099/0022-1317-68-5-1373; JARVIS TC, 1992, EMBO J, V11, P3135, DOI 10.1002/j.1460-2075.1992.tb05386.x; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kew OM, 1995, SEMIN VIROL, V6, P401, DOI 10.1016/S1044-5773(05)80017-4; KINNUNEN L, 1991, J GEN VIROL, V72, P2483, DOI 10.1099/0022-1317-72-10-2483; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Lentz KN, 1997, STRUCTURE, V5, P961, DOI 10.1016/S0969-2126(97)00249-9; Lin J, 2012, J VIROL, V86, P5959, DOI 10.1128/JVI.05990-11; Liu HM, 2000, J VIROL, V74, P11153, DOI 10.1128/JVI.74.23.11153-11161.2000; Martin J, 2006, BIOLOGICALS, V34, P117, DOI 10.1016/j.biologicals.2006.02.005; Martin J, 2000, J VIROL, V74, P3001, DOI 10.1128/JVI.74.7.3001-3010.2000; Martin J, 2002, J VIROL, V76, P10921, DOI 10.1128/JVI.76.21.10921-10928.2002; MATEU MG, 1995, VIRUS RES, V38, P1, DOI 10.1016/0168-1702(95)00048-U; Minor P, 2009, VACCINE, V27, P2649, DOI 10.1016/j.vaccine.2009.02.071; Mulders MN, 1999, J GEN VIROL, V80, P907, DOI 10.1099/0022-1317-80-4-907; Nei M, 2000, MOL EVOLUTION PHYLOG, P40; Odoom JK, 2008, J VIROL, V82, P9179, DOI 10.1128/JVI.00468-08; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; ROIVAINEN M, 1993, VIROLOGY, V195, P762, DOI 10.1006/viro.1993.1427; ROIVAINEN M, 1987, J VIROL, V61, P3749, DOI 10.1128/JVI.61.12.3749-3753.1987; Roivainen M, 2010, EURO SURVEILL, V15; SABIN A. B., 1973, Journal of Biology, V1, P115, DOI 10.1016/0092-1157(73)90048-6; Savolainen-Kopra C, 2010, REV MED VIROL, V20, P358, DOI 10.1002/rmv.663; Shulman LM, 2000, J CLIN MICROBIOL, V38, P3729, DOI 10.1128/JCM.38.10.3729-3734.2000; Simonen ML, 2010, VIRUS RES, V147, P91, DOI 10.1016/j.virusres.2009.10.012; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; van der Sanden S, 2009, J VIROL, V83, P8693, DOI 10.1128/JVI.02388-08; Yang CF, 2005, J VIROL, V79, P12623, DOI 10.1128/JVI.79.20.12623-12634.2005; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003	48	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66836	10.1371/journal.pone.0066836	http://dx.doi.org/10.1371/journal.pone.0066836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840537	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400020
J	He, Y; Lian, GL; Lin, SY; Ye, ZY; Li, QX				He, Ying; Lian, Guili; Lin, Shuyong; Ye, Zhiyun; Li, Qinxi			MDM2 Inhibits Axin-Induced p53 Activation Independently of Its E3 Ligase Activity	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; DNA-DAMAGE; DEGRADATION; COMPLEX; DAXX; PROTEIN; PATHWAY; KINASE	MDM2 plays a crucial role in negatively regulating the functions of tumor suppressor p53. Here we show that MDM2 can inhibit Axin-stimulated p53-dependent apoptosis by suppressing p53 phosphorylation at Ser 46 and apoptosis-related p53 transactivational activity. Interestingly, the ubiquitin E3 ligase activity of MDM2 is not required for this inhibitory effect. Mechanically, either wildtype MDM2 or its E3-dead mutant, disrupts the Axin-based HIPK2/p53 complex formation by blocking the binding of p53 and HIPK2 to Axin. MDM2Dp53, a deletion mutant that lacks p53 binding domain fails to exert the inhibitory effect, demonstrating that the interaction of MDM2 and p53, but not its E3 ligase activity toward p53 plays key role in suppressing Axin-stimulated p53 activation. Our results thus have revealed a novel aspect of the mechanism by which MDM2 regulates p53 activities.	[He, Ying; Lian, Guili; Lin, Shuyong; Ye, Zhiyun; Li, Qinxi] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China	Xiamen University	Li, QX (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	liqinxi@xmu.edu.cn	Lin, Shu-Yong/B-7726-2012	Lin, Shu-Yong/0000-0002-4419-1713	"973" program [2009CB522200]; Natural Science Foundation of China [31101014, 30871280]; Fundamental Research Funds for the Central Universities [2011]; project 111 [B06016];  [NCET-09-0675]	"973" program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); project 111(Ministry of Education, China - 111 Project); 	This work was supported by the "973" program (2009CB522200), the grants from Natural Science Foundation of China (#31101014 and #30871280), the program for NCET-09-0675, the Fundamental Research Funds for the Central Universities (#2011) and the "project 111" (#B06016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chi SW, 2005, J BIOL CHEM, V280, P38795, DOI 10.1074/jbc.M508578200; Di Stefana V, 2005, FEBS LETT, V579, P5473, DOI 10.1016/j.febslet.2005.09.008; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Latonen L, 2001, ONCOGENE, V20, P6784, DOI 10.1038/sj.onc.1204883; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Li QX, 2007, CANCER RES, V67, P66, DOI 10.1158/0008-5472.CAN-06-1671; Li QX, 2009, NAT CELL BIOL, V11, P1128, DOI 10.1038/ncb1927; Lin SC, 2007, CELL RES, V17, P301, DOI 10.1038/cr.2007.16; Marine JC, 2010, CELL DEATH DIFFER, V17, P93, DOI 10.1038/cdd.2009.68; Rinaldo C, 2007, MOL CELL, V25, P739, DOI 10.1016/j.molcel.2007.02.008; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; TOKINO T, 1994, HUM MOL GENET, V3, P1537, DOI 10.1093/hmg/3.9.1537; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wawrzynow B, 2007, J BIOL CHEM, V282, P32603, DOI 10.1074/jbc.M702767200; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247	21	5	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67529	10.1371/journal.pone.0067529	http://dx.doi.org/10.1371/journal.pone.0067529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826318	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000088
J	Ouyang, ZT; Gao, Y; Xie, X; Guo, HQ; Zhang, TT; Zhao, B				Ouyang, Zu-Tao; Gao, Yu; Xie, Xiao; Guo, Hai-Qiang; Zhang, Ting-Ting; Zhao, Bin			Spectral Discrimination of the Invasive Plant Spartina alterniflora at Multiple Phenological Stages in a Saltmarsh Wetland	PLOS ONE			English	Article							CHONGMING ISLAND; VEGETATION; DONGTAN	Spartina alterniflora has widely invaded the saltmarshes of the Yangtze River Estuary and brought negative effects to the ecosystem. Remote sensing technique has recently been used to monitor its distribution, but the similar morphology and canopy structure among S. alterniflora and its neighbor species make it difficult even with high-resolution images. Nevertheless, these species have divergence on phenological stages throughout the year, which cause distinguishing spectral characteristics among them and provide opportunities for discrimination. The field spectra of the S. alterniflora community as well as its major victims, native Phragmites australis and Scirpus mariqueter, were measured in 2009 and 2010 at multi-phenological stages in the Yangtze River Estuary, aiming to find the most appropriate periods for mapping S. alterniflora. Collected spectral data were analyzed separately for every stage firstly by re-sampling reflectance curves into continued 5-nm-wide hyper-spectral bands and then by re-sampling into broad multi-spectral bands - the same as the band ranges of the TM sensor, as well as calculating commonly used vegetation indices. The results showed that differences among saltmarsh communities' spectral characteristics were affected by their phenological stages. The germination and early vegetative growth stage and the flowering stage were probably the best timings to identify S. alterniflora. Vegetation indices like NDVI, ANVI, VNVI, and RVI are likely to enhance spectral separability and also make it possible to discriminate S. alterniflora at its withering stage.	[Ouyang, Zu-Tao; Gao, Yu; Xie, Xiao; Guo, Hai-Qiang; Zhang, Ting-Ting; Zhao, Bin] Fudan Univ, Coastal Ecosyst Res Stn Yangtze River Estuary, Key Lab Biodivers Sci & Ecol Engn, Minist Educ,Inst Biodivers Sci, Shanghai 200433, Peoples R China; [Ouyang, Zu-Tao] Univ Toledo, Dept Environm Sci, Toledo, OH 43606 USA	Fudan University; University System of Ohio; University of Toledo	Zhao, B (corresponding author), Fudan Univ, Coastal Ecosyst Res Stn Yangtze River Estuary, Key Lab Biodivers Sci & Ecol Engn, Minist Educ,Inst Biodivers Sci, Shanghai 200433, Peoples R China.	zhaobin@fudan.edu.cn	Zhao, Bin/I-3651-2013; Zhao, Bin/E-5349-2010	Zhao, Bin/0000-0002-3530-2469; 	National Natural Science Foundation of China [31170450, 30870409, 40471087]; Science and Technology Commission of Shanghai [10dz1200603]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM))	This study was supported by a grant from the National Natural Science Foundation of China (Grant Nos. 31170450, 30870409, and 40471087) and the Science and Technology Commission of Shanghai (No. 10dz1200603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam E, 2010, WETL ECOL MANAG, V18, P281, DOI 10.1007/s11273-009-9169-z; Artigas FJ, 2005, INT J REMOTE SENS, V26, P5209, DOI 10.1080/01431160500218952; BEST E P H, 1981, Hydrobiological Bulletin, V15, P165, DOI 10.1007/BF02255175; Chen ZY, 2004, HYDROBIOLOGIA, V528, P99, DOI 10.1007/s10750-004-1888-9; Cochrane MA, 2000, INT J REMOTE SENS, V21, P2075, DOI 10.1080/01431160050021303; Daughtry CST, 1998, REMOTE SENS ENVIRON, V64, P192, DOI 10.1016/S0034-4257(98)00002-9; EVERITT JH, 1987, WEED SCI, V35, P427; Gao Zhan-Guo, 2006, Zhiwu Shengtai Xuebao, V30, P252; Hansen PM, 2003, REMOTE SENS ENVIRON, V86, P542, DOI 10.1016/S0034-4257(03)00131-7; He MM, 2010, INT J REMOTE SENS, V31, P4319, DOI 10.1080/01431160903252343; Hochberg EJ, 2003, IEEE T GEOSCI REMOTE, V41, P1724, DOI 10.1109/TGRS.2003.815408; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256; Koger CH, 2003, WEED TECHNOL, V17, P696, DOI 10.1614/WT02-122; Li B, 2009, ECOL ENG, V35, P511, DOI 10.1016/j.ecoleng.2008.05.013; Ma ZJ, 2004, BIODIVERS CONSERV, V13, P333, DOI 10.1023/B:BIOC.0000006502.96131.59; Ouyang ZT, 2011, ECOL INFORM, V6, P136, DOI 10.1016/j.ecoinf.2011.01.002; Pena-Barragan JM, 2006, WEED RES, V46, P10, DOI 10.1111/j.1365-3180.2006.00488.x; Pu R. L., 2000, HYPERSPECTRAL REMOTE; Richards J, 1993, REMOTE SENSING DIGIT, V2nd; Rosso PH, 2005, INT J REMOTE SENS, V26, P5169, DOI 10.1080/01431160500218770; Rouse J.W., 1973, EARTH RES TECHN SAT, P309; Schmidt KS, 2003, REMOTE SENS ENVIRON, V85, P92, DOI 10.1016/S0034-4257(02)00196-7; Swain P.H., 1978, REMOTE SENSING QUANT; Thomson AG, 2004, INT J REMOTE SENS, V25, P4151, DOI 10.1080/01431160310001647688; Yan YE, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012838; Zhao B, 2005, CHINESE GEOGR SCI, V15, P151, DOI 10.1007/s11769-005-0008-8	27	44	45	7	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67315	10.1371/journal.pone.0067315	http://dx.doi.org/10.1371/journal.pone.0067315			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826265	gold, Green Submitted, Green Published			2022-12-27	WOS:000321150000060
J	Wong, TT; Collodi, P				Wong, Ten-Tsao; Collodi, Paul			Inducible Sterilization of Zebrafish by Disruption of Primordial Germ Cell Migration	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; CHEMOKINE; EXPRESSION; GENE; ANTISENSE; GUIDANCE; RECEPTOR; CXCR4; RNA	During zebrafish development, a gradient of stromal-derived factor 1a (Sdf1a) provides the directional cue that guides the migration of the primordial germ cells (PGCs) to the gonadal tissue. Here we describe a method to produce large numbers of infertile fish by inducing ubiquitous expression of Sdf1a in zebrafish embryos resulting in disruption of the normal PGC migration pattern. A transgenic line of zebrafish, Tg(hsp70:sdf1a-nanos3, EGFP), was generated that expresses Sdf1a under the control of the heat-shock protein 70 (hsp70) promoter and nanos3 3'UTR. To better visualize the PGCs, the Tg(hsp70: sdf1a-nanos3, EGFP) fish were crossed with another transgenic line, Tg(kop:DsRed-nanos3), that expresses DsRed driven by the PGC-specific kop promoter. Heat treatment of the transgenic embryos caused an induction of Sdf1a expression throughout the embryo resulting in the disruption of their normal migration. Optimal embryo survival and disruption of PGC migration was achieved when transgenic embryos at the 4- to 8-cell stage were incubated at 34.5 degrees C for 18 hours. Under these conditions, disruption of PGC migration was observed in 100% of the embryos. Sixty-four adult fish were developed from three separate batches of heat-treated embryos and all were found to be infertile males. When each male was paired with a wild-type female, only unfertilized eggs were produced and histological examination revealed that each of the adult male fish possessed severely under-developed gonads that lacked gametes. The results demonstrate that inducible Sdf1a expression is an efficient and reliable strategy to produce infertile fish. This approach makes it convenient to generate large numbers of infertile adult fish while also providing the capability to maintain a fertile brood stock.	[Wong, Ten-Tsao; Collodi, Paul] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Wong, TT (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	Wong20@purdue.edu	Wong, Ten-Tsao/J-7524-2017	Wong, Ten-Tsao/0000-0001-5573-9767	Purdue Office of Technology Commercialization	Purdue Office of Technology Commercialization	This work was supported by a Trask Innovation Fund grant from the Purdue Office of Technology Commercialization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI PKMM, 1989, AQUACULTURE, V76, P157, DOI 10.1016/0044-8486(89)90260-3; Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Arai K, 2001, AQUACULTURE, V197, P205, DOI 10.1016/S0044-8486(01)00588-9; BARTLEY DM, 1997, FAO AQUACULTURE NEWS, V17, P7; Blaser H, 2005, J CELL SCI, V118, P4027, DOI 10.1242/jcs.02522; Braat AK, 1999, DEV DYNAM, V216, P153, DOI 10.1002/(SICI)1097-0177(199910)216:2<153::AID-DVDY6>3.0.CO;2-1; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Donaldson EM, 1987, CURRENT STATUS INDEU, P108; Draper BW, 2007, DEV BIOL, V305, P589, DOI 10.1016/j.ydbio.2007.03.007; Halloran MC, 2000, DEVELOPMENT, V127, P1953; Herpin A, 2008, DEV BIOL, V320, P319, DOI 10.1016/j.ydbio.2008.03.030; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-3; Hsu CC, 2010, MAR BIOTECHNOL, V12, P466, DOI 10.1007/s10126-009-9248-4; Hu SY, 2010, MAR BIOTECHNOL, V12, P569, DOI 10.1007/s10126-009-9244-8; Hu W, 2007, AQUACULTURE, V271, P498, DOI 10.1016/j.aquaculture.2007.04.075; Johnstone R, 1993, RECENT ADV AQUACULTU, P69; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Koprunner M, 2001, GENE DEV, V15, P2877; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Seligny JFPD, 2010, STATE WORLD FISHERY; Stebler J, 2004, DEV BIOL, V272, P351, DOI 10.1016/j.ydbio.2004.05.009; Takeuchi T, 2010, MECH DEVELOP, V127, P146, DOI 10.1016/j.mod.2009.09.005; Uzbekova S, 2000, J MOL ENDOCRINOL, V25, P337, DOI 10.1677/jme.0.0250337; Van Eenennaam AL, 2011, NAT BIOTECHNOL, V29, P706, DOI 10.1038/nbt.1938; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Weidinger G, 1999, DEVELOPMENT, V126, P5295; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wong TT, 2013, BIOCHEM BIOPH RES CO, V430, P347, DOI 10.1016/j.bbrc.2012.11.014; Wong TT, 2004, BIOL REPROD, V71, P1026, DOI 10.1095/biolreprod.104.028019; Zohar Y, 2004, PATENT FULL TEXT IMA	32	24	27	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68455	10.1371/journal.pone.0068455	http://dx.doi.org/10.1371/journal.pone.0068455			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826390	Green Submitted, gold, Green Published			2022-12-27	WOS:000321150000143
J	Lindstrom, BR; Mattsson-Marn, IB; Golkar, A; Olsson, A				Lindstrom, Bjorn R.; Mattsson-Marn, Isak Berglund; Golkar, Armita; Olsson, Andreas			In Your Face: Risk of Punishment Enhances Cognitive Control and Error-Related Activity in the Corrugator Supercilii Muscle	PLOS ONE			English	Article							PREFRONTAL CORTEX; MOTIVATIONAL INFLUENCES; RESPONSE-INHIBITION; FACIAL EXPRESSIONS; INTEGRATIVE THEORY; NEGATIVE AFFECT; CINGULATE; DOPAMINE; INSIGHTS; MODEL	Cognitive control is needed when mistakes have consequences, especially when such consequences are potentially harmful. However, little is known about how the aversive consequences of deficient control affect behavior. To address this issue, participants performed a two-choice response time task where error commissions were expected to be punished by electric shocks during certain blocks. By manipulating (1) the perceived punishment risk (no, low, high) associated with error commissions, and (2) response conflict (low, high), we showed that motivation to avoid punishment enhanced performance during high response conflict. As a novel index of the processes enabling successful cognitive control under threat, we explored electromyographic activity in the corrugator supercilii (cEMG) muscle of the upper face. The corrugator supercilii is partially controlled by the anterior midcingulate cortex (aMCC) which is sensitive to negative affect, pain and cognitive control. As hypothesized, the cEMG exhibited several key similarities with the core temporal and functional characteristics of the Error-Related Negativity (ERN) ERP component, the hallmark index of cognitive control elicited by performance errors, and which has been linked to the aMCC. The cEMG was amplified within 100 ms of error commissions (the same time-window as the ERN), particularly during the high punishment risk condition where errors would be most aversive. Furthermore, similar to the ERN, the magnitude of error cEMG predicted post-error response time slowing. Our results suggest that cEMG activity can serve as an index of avoidance motivated control, which is instrumental to adaptive cognitive control when consequences are potentially harmful.	[Lindstrom, Bjorn R.; Mattsson-Marn, Isak Berglund; Golkar, Armita; Olsson, Andreas] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Lindstrom, Bjorn R.; Golkar, Armita; Olsson, Andreas] Stockholm Brain Inst, Stockholm, Sweden	Karolinska Institutet	Lindstrom, BR (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	bjorn.lindstrom@ki.se		Golkar, Armita/0000-0003-3077-0391	Swedish Science Council (Vetenskapsradet) [421-2010-2084]	Swedish Science Council (Vetenskapsradet)(Swedish Research Council)	This research was supported by a grant from Swedish Science Council (Vetenskapsradet; 421-2010-2084) to A.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts K, 2012, COGNITION, V124, P117, DOI 10.1016/j.cognition.2012.05.009; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bates D. M., 2007, LME4 LINEAR MIXED EF; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boureau YL, 2011, NEUROPSYCHOPHARMACOL, V36, P74, DOI 10.1038/npp.2010.151; Bradley MM, 2005, PSYCHOL SCI, V16, P468; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Brown JW, 2007, COGN AFFECT BEHAV NE, V7, P266, DOI 10.3758/CABN.7.4.266; Burrows AM, 2008, BIOESSAYS, V30, P212, DOI 10.1002/bies.20719; Burrows AM, 2009, J ANAT, V215, P320, DOI 10.1111/j.1469-7580.2009.01113.x; Calvo MG, 2008, BEHAV RES METHODS, V40, P109, DOI 10.3758/BRM.40.1.109; Carp J, 2009, PSYCHOPHYSIOLOGY, V46, P336, DOI 10.1111/j.1469-8986.2008.00773.x; Chiew KS, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00279; Danielmeier C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00233; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Dayan P, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P175, DOI 10.1016/B978-0-12-374176-9.00012-9; Dayan P, 2009, ANNU REV NEUROSCI, V32, P95, DOI 10.1146/annurev.neuro.051508.135607; DeCaro MS, 2011, J EXP PSYCHOL GEN, V140, P390, DOI 10.1037/a0023466; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dreisbach G, 2012, BRAIN COGNITION, V78, P94, DOI 10.1016/j.bandc.2011.12.003; Duerden EG, 2013, HUM BRAIN MAPP, V34, P109, DOI 10.1002/hbm.21416; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fox J., 2019, R COMPANION APPL REG, V.; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; Gomez P, 2007, J EXP PSYCHOL GEN, V136, P389, DOI 10.1037/0096-3445.136.3.389; Hajcak G, 2005, BIOL PSYCHOL, V70, P67, DOI 10.1016/j.biopsycho.2004.12.001; Hajcak G, 2005, PSYCHOPHYSIOLOGY, V42, P151, DOI 10.1111/j.1469-8986.2005.00270.x; Hajcak G, 2012, CURR DIR PSYCHOL SCI, V21, P101, DOI 10.1177/0963721412436809; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jimura K, 2010, P NATL ACAD SCI USA, V107, P8871, DOI 10.1073/pnas.1002007107; Kenner NM, 2010, J NEUROSCI, V30, P8512, DOI 10.1523/JNEUROSCI.1096-10.2010; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078; Lim SL, 2009, P NATL ACAD SCI USA, V106, P16841, DOI 10.1073/pnas.0904551106; Locke HS, 2008, COGN AFFECT BEHAV NE, V8, P99, DOI 10.3758/CABN.8.1.99; MacDonald KB, 2008, PSYCHOL REV, V115, P1012, DOI 10.1037/a0013327; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Morecraft RJ, 2001, BRAIN, V124, P176, DOI 10.1093/brain/124.1.176; Morecraft RJ, 2004, NEUROLOGIST, V10, P235, DOI 10.1097/01.nrl.0000138734.45742.8d; Mostofsky SH, 2008, J COGNITIVE NEUROSCI, V20, P751, DOI 10.1162/jocn.2008.20500; Mushtaq F, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00249; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; Pessoa L, 2009, TRENDS COGN SCI, V13, P160, DOI 10.1016/j.tics.2009.01.006; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; PRKACHIN KM, 1992, PAIN, V51, P297, DOI 10.1016/0304-3959(92)90213-U; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Riesel A, 2012, PSYCHOPHYSIOLOGY, V49, P239, DOI 10.1111/j.1469-8986.2011.01298.x; Robinson OJ, 2011, COGN AFFECT BEHAV NE, V11, P217, DOI 10.3758/s13415-011-0030-5; Schacht A, 2010, COGN AFFECT BEHAV NE, V10, P349, DOI 10.3758/CABN.10.3.349; Schacht A, 2009, PSYCHOL RES-PSYCH FO, V73, P843, DOI 10.1007/s00426-008-0192-0; Schouppe N, 2012, Q J EXP PSYCHOL, V65, P1052, DOI 10.1080/17470218.2012.685080; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shackman AJ, 2011, J NEUROSCI, V31, P1156, DOI 10.1523/JNEUROSCI.3384-10.2011; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Simoes-Franklin C, 2010, HUM BRAIN MAPP, V31, P458, DOI 10.1002/hbm.20879; TEIGEN KH, 1994, THEOR PSYCHOL, V4, P525, DOI 10.1177/0959354394044004; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931	68	47	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65692	10.1371/journal.pone.0065692	http://dx.doi.org/10.1371/journal.pone.0065692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DN	23840356	Green Submitted, Green Published, gold			2022-12-27	WOS:000321424400010
J	Loria, JRD; Rohmann, K; Droemann, D; Kujath, P; Rupp, J; Goldmann, T; Dalhoff, K				Loria, Johannes Rotta Detto; Rohmann, Kristina; Droemann, Daniel; Kujath, Peter; Rupp, Jan; Goldmann, Torsten; Dalhoff, Klaus			Nontypeable Haemophilus Influenzae Infection Upregulates the NLRP3 Inflammasome and Leads to Caspase-1-Dependent Secretion of Interleukin-1 beta - A Possible Pathway of Exacerbations in COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; DIFFERENTIAL REQUIREMENT; ACTIVATION; LUNG; MACROPHAGES; IL-1-BETA; RECEPTOR; ADAPTERS; INNATE	Rationale: Nontypeable Haemophilus influenzae (NTHi) is the most common cause for bacterial exacerbations in chronic obstructive pulmonary disease (COPD). Recent investigations suggest the participation of the inflammasome in the pathomechanism of airway inflammation. The inflammasome is a cytosolic protein complex important for early inflammatory responses, by processing Interleukin-1 beta (IL-1 beta) to its active form. Objectives: Since inflammasome activation has been described for a variety of inflammatory diseases, we investigated whether this pathway plays a role in NTHi infection of the airways. Methods: A murine macrophage cell line (RAW 264.7), human alveolar macrophages and human lung tissue (HLT) were stimulated with viable or non-viable NTHi and/or nigericin, a potassium ionophore. Secreted cytokines were measured with ELISA and participating proteins detected via Western Blot or immunohistochemistry. Measurements and Main Results: Western Blot analysis of cells and immunohistochemistry of lung tissue detected the inflammasome key components NLRP3 and caspase-1 after stimulation, leading to a significant induction of IL-1 beta expression (RAW: control at the lower detection limit vs. NTHi 505 +/- 111pg/ml, p<0.01). Inhibition of caspase-1 in human lung tissue led to a significant reduction of IL-1 beta and IL-18 levels (IL-1 beta: NTHi 24 h 17423 +/- 3198pg/ml vs. NTHi+Z-YVAD-FMK 6961 +/- 1751pg/ml, p<0.01). Conclusion: Our data demonstrate the upregulation of the NRLP3-inflammasome during NTHi-induced inflammation in respiratory cells and tissues. Our findings concerning caspase-1 dependent IL-1 beta release suggest a role for the inflammasome in respiratory tract infections with NTHi which may be relevant for the pathogenesis of bacterial exacerbations in COPD.	[Loria, Johannes Rotta Detto; Rohmann, Kristina; Droemann, Daniel; Rupp, Jan; Dalhoff, Klaus] Univ Clin Schleswig Holstein, Med Clin 3, Lubeck, Germany; [Rupp, Jan] Univ Clin Schleswig Holstein, Inst Med Microbiol & Hyg, Lubeck, Germany; [Kujath, Peter] Univ Clin Schleswig Holstein, Dept Surg Thorac Surg, Lubeck, Germany; [Goldmann, Torsten] Res Ctr Borstel, Borstel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Forschungszentrum Borstel	Loria, JRD (corresponding author), Univ Clin Schleswig Holstein, Med Clin 3, Campus Luebeck, Lubeck, Germany.	johannes.rottadettoloria@medizin.uni-luebeck.de	Rupp, Jan/C-8794-2011; Goldmann, Torsten/E-5906-2010	Rupp, Jan/0000-0001-8722-1233; Goldmann, Torsten/0000-0002-1621-560X	German Center for Lung Research	German Center for Lung Research	This work was supported by the German Center for Lung Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Sater AA, 2009, DRUG TODAY, V45, P105; Arlehamn CSL, 2010, J BIOL CHEM, V285, P10508, DOI 10.1074/jbc.M109.067298; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Beasley V, 2012, INT J CHRONIC OBSTR, V7, P555, DOI 10.2147/COPD.S28286; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Busillo JM, 2011, J BIOL CHEM, V286, P38703, DOI 10.1074/jbc.M111.275370; Cai SS, 2012, J IMMUNOL, V188, P5623, DOI 10.4049/jimmunol.1200195; Chin CL, 2005, AM J RESP CRIT CARE, V172, P85, DOI 10.1164/rccm.200412-1687OC; Cohen TS, 2013, J CLIN INVEST, V123, P1630, DOI 10.1172/JCI66142; Couillin I, 2009, J IMMUNOL, V183, P8195, DOI 10.4049/jimmunol.0803154; Davies John Q, 2005, Methods Mol Biol, V290, P105; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Droemann D, 2003, HISTOCHEM CELL BIOL, V119, P103, DOI 10.1007/s00418-003-0497-4; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Goldmann T, 2002, PATHOL RES PRACT, V198, P91, DOI 10.1078/0344-0338-00192; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kuipers MT, 2012, ANESTHESIOLOGY, V116, P1104, DOI 10.1097/ALN.0b013e3182518bc0; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Lupfer CR, 2012, VIRULENCE, V3, P262, DOI 10.4161/viru.20266; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Perret M, 2012, CELL MICROBIOL, V14, P1019, DOI 10.1111/j.1462-5822.2012.01772.x; Robinson AB, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00301; Rohmann K, 2011, CELL TISSUE RES, V343, P167, DOI 10.1007/s00441-010-1048-7; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Schmidt E P, 2010, J Cell Death, V3, P41; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; Shaw PJ, 2011, TRENDS MOL MED, V17, P57, DOI 10.1016/j.molmed.2010.11.001; Shimada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021477; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Tran Hai B, 2012, J Allergy (Cairo), V2012, P819176, DOI 10.1155/2012/819176; Wanderer AA, 2008, ISR MED ASSOC J, V10, P837	41	37	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66818	10.1371/journal.pone.0066818	http://dx.doi.org/10.1371/journal.pone.0066818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840534	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400042
J	Spinellis, D; Louridas, P				Spinellis, Diomidis; Louridas, Panos			The Carbon Footprint of Conference Papers	PLOS ONE			English	Article							ETHICS	The action required to stem the environmental and social implications of climate change depends crucially on how humankind shapes technology, economy, lifestyle and policy. With transport CO2 emissions accounting for about a quarter of the total, we examine the contribution of CO2 output by scientific travel. Thankfully for the reputation of the scientific community, CO2 emissions associated with the trips required to present a paper at a scientific conference account for just 0.003% of the yearly total. However, with CO2 emissions for a single conference trip amounting to 7% of an average individual's total CO2 emissions, scientists should lead by example by demonstrating leadership in addressing the issue.	[Spinellis, Diomidis; Louridas, Panos] Athens Univ Econ & Business, Dept Management Sci & Technol, Athens, Greece; [Louridas, Panos] Greek Res & Technol Network, Athens, Greece	Athens University of Economics & Business	Louridas, P (corresponding author), Athens Univ Econ & Business, Dept Management Sci & Technol, Athens, Greece.	louridas@aueb.gr	Spinellis, Diomidis/E-3600-2010	Spinellis, Diomidis/0000-0003-4231-1897	European Union (European Social Fund); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework; Thalis -Athens University of Economics and Business-Software Engineering Research Platform	European Union (European Social Fund)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework; Thalis -Athens University of Economics and Business-Software Engineering Research Platform	This research has been co-financed by the European Union (European Social Fund) and Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework. Research Funding Program: Thalis -Athens University of Economics and Business-Software Engineering Research Platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcott H, 2010, SCIENCE, V327, P1204, DOI 10.1126/science.1180775; Associated Press, 2009, ASS PRESS; Broome J, 2008, SCI AM, V298, P96, DOI 10.1038/scientificamerican0608-96; Burke IC, 2010, SCIENCE, V330, P1476, DOI 10.1126/science.330.6010.1476-a; Department of Energy and Climate Change, 2009, ACT CO2 CALC VERS 2; Gardiner SM, 2004, ETHICS, V114, P555, DOI 10.1086/382247; IATA, 2013, FACT SHEET IND STAT; IATA, 2010, FIN FOR; International Energy Agency, 2009, CO2 EM FUEL COMB 200; International Monetary Fund, 2010, WORLD EC OUTL DAT; Kennedy C, 2009, ENVIRON SCI TECHNOL, V43, P7297, DOI 10.1021/es900213p; Lawrence S, 1998, SCIENCE, V280, P98, DOI 10.1126/science.280.5360.98; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Reuters, 2009, COP SUMM CARB FOOTPR; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Rogelj J, 2013, NATURE, V493, P79, DOI 10.1038/nature11787; SINNOTT RW, 1984, SKY TELESCOPE, V68, P159; Vuuren D, 2008, CLIMATIC CHANGE, V91, P237, DOI 10.1007/s10584-008-9485-y	18	54	54	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66508	10.1371/journal.pone.0066508	http://dx.doi.org/10.1371/journal.pone.0066508			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840496	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400028
J	Marx, I; Hopcke, C; Berger, C; Wandschneider, R; Herpertz, SC				Marx, Ivo; Hoepcke, Cornelia; Berger, Christoph; Wandschneider, Roland; Herpertz, Sabine C.			The Impact of Financial Reward Contingencies on Cognitive Function Profiles in Adult ADHD	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY-DISORDER; DEFICIT HYPERACTIVITY DISORDER; DUAL PATHWAY MODEL; DELAY AVERSION; RESPONSE-INHIBITION; WORKING-MEMORY; EXECUTIVE FUNCTIONS; TIME PERCEPTION; BEHAVIORAL-INHIBITION; SUSTAINED ATTENTION	Objectives: Although it is well established that cognitive performance in children with attention-deficit/hyperactivity disorder (ADHD) is affected by reward and that key deficits associated with the disorder may thereby be attenuated or even compensated, this phenomenon in adults with ADHD has thus far not been addressed. Therefore, the aim of the present study was to examine the motivating effect of financial reward on task performance in adults with ADHD by focusing on the domains of executive functioning, attention, time perception, and delay aversion. Methods: We examined male and female adults aged 18-40 years with ADHD (n = 38) along with a matched control group (n = 40) using six well-established experimental paradigms. Results: Impaired performance in the ADHD group was observed for stop-signal omission errors, n-back accuracy, reaction time variability in the continuous performance task, and time reproduction accuracy, and reward normalized time reproduction accuracy. Furthermore, when rewarded, subjects with ADHD exhibited longer reaction times and fewer false positives in the continuous performance task, which suggests the use of strategies to prevent impulsivity errors. Conclusions: Taken together, our results support the existence of both cognitive and motivational mechanisms for the disorder, which is in line with current models of ADHD. Furthermore, our data suggest cognitive strategies of "stopping and thinking" as a possible underlying mechanism for task improvement that seems to be mediated by reward, which highlights the importance of the interaction between motivation and cognition in adult ADHD.	[Marx, Ivo; Hoepcke, Cornelia; Berger, Christoph; Wandschneider, Roland] Univ Rostock, Dept Psychiat & Psychotherapy, D-18055 Rostock, Germany; [Herpertz, Sabine C.] Heidelberg Univ, Dept Gen Psychiat, Heidelberg, Germany	University of Rostock; Ruprecht Karls University Heidelberg	Marx, I (corresponding author), Univ Rostock, Dept Psychiat & Psychotherapy, D-18055 Rostock, Germany.	ivo.marx@med.uni-rostock.de	Marx, Ivo/G-5584-2011; Herpertz, Sabine C/AAW-4885-2020	Herpertz, Sabine C/0000-0001-9676-1928; Berger, Christoph/0000-0002-0832-5526; Marx, Ivo/0000-0002-3054-598X	Deutsche Gesellschaft fur Nervenheilkunde M-V [896114]	Deutsche Gesellschaft fur Nervenheilkunde M-V	This work was funded by a programme grant from Deutsche Gesellschaft fur Nervenheilkunde M-V (project number 896114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase H, 2006, J CHILD PSYCHOL PSYC, V47, P457, DOI 10.1111/j.1469-7610.2005.01468.x; Adamo N, 2014, J ATTEN DISORD, V18, P434, DOI 10.1177/1087054712439419; Adams ZW, 2011, PSYCHOL ASSESSMENT, V23, P427, DOI 10.1037/a0022112; Andreou P, 2007, PSYCHOL MED, V37, P1703, DOI 10.1017/S0033291707000815; Balint S, 2009, PSYCHOL MED, V39, P1337, DOI 10.1017/S0033291708004236; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2001, NEUROPSYCHOLOGY, V15, P351, DOI 10.1037//0894-4105.15.3.351; Barkley RA, 1999, MENT RETARD DEV D R, V5, P177, DOI 10.1002/(SICI)1098-2779(1999)5:3<177::AID-MRDD3>3.0.CO;2-G; Barkley RA, 2006, ATTENTION DEFICIT HY; Barratt ES, 1985, MOTIVATION EMOTION P; Bauermeister JJ, 2005, J CLIN CHILD ADOLESC, V34, P151, DOI 10.1207/s15374424jccp3401_14; Bayerl M, 2010, NEUROREPORT, V21, P442, DOI 10.1097/WNR.0b013e328338b9be; Bekker EM, 2005, PSYCHOL MED, V35, P807, DOI 10.1017/S0033291704003459; Bidwell LC, 2007, BIOL PSYCHIAT, V62, P991, DOI 10.1016/j.biopsych.2007.04.003; Bitsakou P, 2009, NEUROPSYCHOLOGIA, V47, P446, DOI 10.1016/j.neuropsychologia.2008.09.015; Boonstra AM, 2005, PSYCHOL MED, V35, P1097, DOI 10.1017/S003329170500499X; Carlson CL, 2000, COGNITIVE THER RES, V24, P87, DOI 10.1023/A:1005455009154; Carter J D, 2003, J Atten Disord, V6, P153, DOI 10.1177/108705470300600402; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Chamberlain SR, 2007, BIOL PSYCHIAT, V62, P977, DOI 10.1016/j.biopsych.2007.03.003; Conners C.K., 1998, CONNERS ADULT ADHD R; CORKUM PV, 1996, J ATTEN DISORD, V1, P114; Dalen Lindy, 2004, Neural Plasticity, V11, P1, DOI 10.1155/NP.2004.1; Demurie E, 2011, J CHILD PSYCHOL PSYC, V52, P1164, DOI 10.1111/j.1469-7610.2010.02374.x; Epstein JN, 2001, J CLIN EXP NEUROPSYC, V23, P362, DOI 10.1076/jcen.23.3.362.1186; Fayyad J, 2007, BRIT J PSYCHIAT, V190, P402, DOI 10.1192/bjp.bp.106.034389; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; HASE, 2008, HASE HOMBURGER ADHS; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Himpel S, 2009, PSYCHOL MED, V39, P1745, DOI 10.1017/S003329170900542X; Hoerger ML, 2006, J APPL BEHAV ANAL, V39, P147, DOI 10.1901/jaba.2006.171-04; Johnson KA, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-15; Karalunas SL, 2011, J CLIN CHILD ADOLESC, V40, P837, DOI 10.1080/15374416.2011.614578; Konrad K, 2000, CHILD NEUROPSYCHOL, V6, P286, DOI 10.1076/chin.6.4.286.3145; Kuntsi J, 2001, J CHILD PSYCHOL PSYC, V42, P199, DOI 10.1111/1469-7610.00711; Kuntsi J, 2010, ARCH GEN PSYCHIAT, V67, P1159, DOI 10.1001/archgenpsychiatry.2010.139; Kuntsi J, 2009, J INT NEUROPSYCH SOC, V15, P570, DOI 10.1017/S135561770909081X; Lambek R, 2010, J CHILD PSYCHOL PSYC, V51, P895, DOI 10.1111/j.1469-7610.2010.02248.x; Liddle EB, 2011, J CHILD PSYCHOL PSYC, V52, P761, DOI 10.1111/j.1469-7610.2010.02333.x; Lijffijt M, 2005, J ABNORM PSYCHOL, V114, P216, DOI 10.1037/0021-843X.114.2.216; Logan Gordon D., 1994, P189; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Luman M, 2009, J ABNORM CHILD PSYCH, V37, P1123, DOI 10.1007/s10802-009-9334-0; MacLaren VV, 2007, APPL PSYCHOPHYS BIOF, V32, P155, DOI [10.1007/s10484-007-9042-x, 10.1007/sl0484-007-9042-x]; Marco R, 2009, NEUROPSYCHOLOGY, V23, P367, DOI 10.1037/a0014914; Marx I, 2011, J BEHAV THER EXP PSY, V42, P488, DOI 10.1016/j.jbtep.2011.05.005; Marx I, 2010, J NEURAL TRANSM, V117, P403, DOI 10.1007/s00702-009-0345-3; McInerney RJ, 2003, CHILD NEUROPSYCHOL, V9, P91, DOI 10.1076/chin.9.2.91.14506; Meaux Julie B, 2003, J Pediatr Health Care, V17, P64, DOI 10.1016/S0891-5245(02)88326-2; Michel JA, 2005, CHILD NEUROPSYCHOL, V11, P295, DOI 10.1080/092970490911270; Muller UC, 2006, J NEUROSCI METH, V151, P45, DOI 10.1016/j.jneumeth.2005.10.022; Mullins C, 2005, J AM ACAD CHILD PSY, V44, P169, DOI 10.1097/00004583-200502000-00009; Murphy KR, 2002, J NERV MENT DIS, V190, P147, DOI 10.1097/00005053-200203000-00003; Niederhofer H, 2008, PSYCHOL REP, V102, P616, DOI 10.2466/PRO.102.2.616-620; Nigg JT, 1998, J ABNORM PSYCHOL, V107, P468, DOI 10.1037/0021-843X.107.3.468; Nigg JT, 2005, J ABNORM PSYCHOL, V114, P706, DOI 10.1037/0021-843X.114.3.706; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P785, DOI 10.1017/S0954579405050376; Nigg JT, 2005, BIOL PSYCHIAT, V57, P1224, DOI 10.1016/j.biopsych.2004.08.025; Oosterlaan J, 1998, J CHILD PSYCHOL PSYC, V39, P411, DOI 10.1111/1469-7610.00336; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Quay HC, 1997, J ABNORM CHILD PSYCH, V25, P7, DOI 10.1023/A:1025799122529; Retz-Junginger P, 2003, NERVENARZT, V74, P987, DOI 10.1007/s00115-002-1447-4; Retz-Junginger P, 2002, NERVENARZT, V73, P830, DOI 10.1007/s00115-001-1215-x; Rheinberg F, 2001, DIAGNOSTICA, V47, P57, DOI 10.1026//0012-1924.47.2.57; Rosler M, 2004, NERVENARZT, V75, P888, DOI 10.1007/s00115-003-1622-2; Rubia K, 2009, NEUROPHARMACOLOGY, V57, P640, DOI 10.1016/j.neuropharm.2009.08.013; Rucklidge Julia, 2007, J Atten Disord, V10, P288, DOI 10.1177/1087054706289942; Sagvolden T, 2005, BEHAV BRAIN SCI, V28, P397, DOI 10.1017/S0140525X05000075; Scahill L, 2000, CHILD ADOL PSYCH CL, V9, P541; Schecklmann M, 2013, J ATTEN DISORD, V17, P470, DOI 10.1177/1087054711429702; Scheres A, 2001, J CHILD PSYCHOL PSYC, V42, P347, DOI 10.1111/1469-7610.00728; Schoechlin C, 2005, ARCH CLIN NEUROPSYCH, V20, P727, DOI 10.1016/j.acn.2005.04.005; Sergeant J, 2000, NEUROSCI BIOBEHAV R, V24, P7, DOI 10.1016/S0149-7634(99)00060-3; Sergeant JA, 2005, BIOL PSYCHIAT, V57, P1248, DOI 10.1016/j.biopsych.2004.09.010; Sergeant JA, 2002, BEHAV BRAIN RES, V130, P3, DOI 10.1016/S0166-4328(01)00430-2; Shanahan MA, 2008, DEV NEUROPSYCHOL, V33, P137, DOI 10.1080/87565640701884238; Smith A, 2002, J CHILD PSYCHOL PSYC, V43, P529, DOI 10.1111/1469-7610.00043; Solanto MV, 2007, J ABNORM CHILD PSYCH, V35, P729, DOI 10.1007/s10802-007-9123-6; Solanto MV, 2001, J ABNORM CHILD PSYCH, V29, P215, DOI 10.1023/A:1010329714819; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sonuga-Barke EJS, 2010, NEUROPSYCHOL REV, V20, P86, DOI 10.1007/s11065-009-9115-0; Sonuga-Barke EJS, 2003, J AM ACAD CHILD PSY, V42, P1335, DOI 10.1097/01.chi.0000087564.34977.21; Sonuga-Barke EJS, 2002, BEHAV BRAIN RES, V130, P29, DOI 10.1016/S0166-4328(01)00432-6; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; SONUGABARKE EJS, 1992, J CHILD PSYCHOL PSYC, V33, P387, DOI 10.1111/j.1469-7610.1992.tb00874.x; Stevens J, 2002, DEV NEUROPSYCHOL, V21, P117, DOI 10.1207/S15326942DN2102_1; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; Taanila AM, 2009, INT J CIRCUMPOL HEAL, V68, P133, DOI 10.3402/ijch.v68i2.18324; Tewes U, 1994, HAMBURG WECHSLER INT, V2; Thorell LB, 2007, J CHILD PSYCHOL PSYC, V48, P1061, DOI 10.1111/j.1469-7610.2007.01777.x; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Toplak M, 2005, J ABNORM CHILD PSYCH, V33, P639, DOI 10.1007/s10802-005-6743-6; Uebel H, 2010, J CHILD PSYCHOL PSYC, V51, P210, DOI 10.1111/j.1469-7610.2009.02139.x; Valera EM, 2010, AM J PSYCHIAT, V167, P86, DOI 10.1176/appi.ajp.2009.09020249; Valko L, 2010, J NEURAL TRANSM, V117, P1213, DOI 10.1007/s00702-010-0473-9; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Vloet TD, 2010, J ABNORM CHILD PSYCH, V38, P961, DOI 10.1007/s10802-010-9422-1; Vollmeyer R, 1998, Z PADAGOG PSYCHOL, V12, P11; Wilbertz G, 2012, NEUROIMAGE, V60, P353, DOI 10.1016/j.neuroimage.2011.12.011; Wilhelm C, 2011, WORLD J BIOL PSYCHIA, V12, P118, DOI 10.3109/15622975.2011.602225; Willcutt EG, 2001, J ABNORM PSYCHOL, V110, P157, DOI 10.1037//0021-843X.1001.1.157; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Wood AC, 2011, PSYCHOL MED, V41, P861, DOI 10.1017/S003329171000108X; Yang BR, 2011, PSYCHOL MED, V41, P2593, DOI 10.1017/S0033291711000869	104	32	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67002	10.1371/journal.pone.0067002	http://dx.doi.org/10.1371/journal.pone.0067002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190LY	23840573	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800113
J	Mukherjee, A; Roy, SK				Mukherjee, Anindit; Roy, Shyamal K.			Expression of ErbB3-Binding Protein-1 (EBP1) during Primordial Follicle Formation: Role of Estradiol-17 beta	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; PROSTATE-CANCER CELLS; STIMULATING-HORMONE; HAMSTER OVARY; MOLECULAR-CLONING; BREAST-CANCER; ER-ALPHA; GROWTH; ESTROGEN; BINDING	The formation of primordial follicles involves the interaction between the oocytes and surrounding somatic cells, which differentiate into granulosa cells. Estradiol-17 beta (E) promotes primordial follicle formation in vivo and in vitro; however, the underlying mechanisms are poorly understood. The expression of an ERBB3-binding protein 1 (EBP1) is downregulated in 8-day old hamster ovaries concurrent with the increase in serum estradiol levels and the formation of primordial follicles. The objectives of the present study were to determine the spatio-temporal expression and putative E regulation of EBP1 in ovarian cells during perinatal development with respect to primordial follicle formation. Hamster EBP1 nucleic acid and amino acid sequences were more than 93% and 98% similar, respectively, to those of mouse and human, and contained nucleolar localization signal, RNA-binding domain and several phosphorylation sites. EBP1 protein was present in somatic cells and oocytes from E15, and declined in oocytes by P1 and in somatic cells by P5. Thereafter, EBP1 expression increased through P7 with a transient decline on P8 primarily in interstitial cells. EBP1 mRNA levels mirrored protein expression pattern. E treatment on P1 and P4 upregulated EBP1 expression by P8 whereas E treatment on P4 downregulated it by 72 h suggesting a compensatory upregulation due to E pretreatment. Treatment with an FSH-antiserum, which suppressed primordial follicle formation, prevented the decline in EBP1 levels, and the effect was reversed by E treatment. Therefore, the results provide the first evidence that EBP1 may play an important role in mediating the effect of E in the differentiation of somatic cells into granulosa cells during primordial follicle formation.	[Mukherjee, Anindit; Roy, Shyamal K.] Univ Nebraska Med Ctr, Dept Cellular Physiol, Omaha, NE USA; [Mukherjee, Anindit; Roy, Shyamal K.] Univ Nebraska Med Ctr, Dept Integrat Physiol, Omaha, NE USA; [Roy, Shyamal K.] Univ Nebraska Med Ctr, Dept Obstet & Gynecol, Omaha, NE USA; [Roy, Shyamal K.] Univ Nebraska Med Ctr, Olson Ctr Womens Hlth, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Roy, SK (corresponding author), Univ Nebraska Med Ctr, Dept Cellular Physiol, Omaha, NE USA.	skroy@unmc.edu			National Institute of Child Health and Human Development, NIH [R01-HD38468]; Olson Center for Women's Health at UNMC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038468] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Olson Center for Women's Health at UNMC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a Grant (R01-HD38468) from the National Institute of Child Health and Human Development, NIH, and financial support from the Olson Center for Women's Health at UNMC to S. K. Roy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; Akinmade D, 2007, INT J ONCOL, V31, P851; Bocca SM, 2008, ENDOCRINE, V33, P254, DOI 10.1007/s12020-008-9081-y; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Ghosh A, 2013, BRIT J CANCER, V108, P557, DOI 10.1038/bjc.2013.11; Hashimoto O, 2005, P NATL ACAD SCI USA, V102, P5426, DOI 10.1073/pnas.0409533102; Kowalinski E, 2007, FEBS LETT, V581, P4450, DOI 10.1016/j.febslet.2007.08.024; Lamartine J, 1997, CYTOGENET CELL GENET, V78, P31, DOI 10.1159/000134621; Lessor TJ, 2000, J CELL PHYSIOL, V183, P321, DOI 10.1002/(SICI)1097-4652(200006)183:3<321::AID-JCP4>3.0.CO;2-O; Liu ZX, 2006, P NATL ACAD SCI USA, V103, P10917, DOI 10.1073/pnas.0602923103; Maheshwari A, 2008, ZYGOTE, V16, P285, DOI 10.1017/S0967199408004802; Mukherjee A, 2012, MOL CELL ENDOCRINOL, V348, P87, DOI 10.1016/j.mce.2011.07.043; Okada M, 2007, J BIOL CHEM, V282, P36744, DOI 10.1074/jbc.M706169200; Pepling ME, 2012, REPRODUCTION, V143, P139, DOI 10.1530/REP-11-0299; RADOMSKI N, 1995, EXP CELL RES, V220, P434, DOI 10.1006/excr.1995.1335; Roy SK, 2000, ENDOCRINOLOGY, V141, P4449, DOI 10.1210/en.141.12.4449; ROY SK, 1987, BIOL REPROD, V37, P39, DOI 10.1095/biolreprod37.1.39; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Squatrito M, 2004, ONCOGENE, V23, P4454, DOI 10.1038/sj.onc.1207579; Wang C, 2008, ENDOCRINOLOGY, V149, P4452, DOI 10.1210/en.2008-0441; Wang C, 2007, ENDOCRINOLOGY, V148, P1707, DOI 10.1210/en.2006-1193; Wang C, 2009, ENDOCRINOLOGY, V150, P1886, DOI 10.1210/en.2008-0900; Xia XM, 2001, BIOCHEM BIOPH RES CO, V289, P240, DOI 10.1006/bbrc.2001.5942; Yang PX, 2004, ENDOCRINOLOGY, V145, P5757, DOI 10.1210/en.2004-0779; Yang PX, 2002, ENDOCRINOLOGY, V143, P2385, DOI 10.1210/en.143.6.2385; Yoo JY, 1999, GENE, V229, P215, DOI 10.1016/S0378-1119(98)00604-0; Yoo JY, 2000, BRIT J CANCER, V82, P683; Zachos NC, 2003, BIOL REPROD, V68, P1911, DOI 10.1095/biolreprod.102.011494; Zachos NC, 2008, BIOL REPROD, V79, P1160, DOI 10.1095/biolreprod.108.067900; Zhang YM, 2004, BIOL REPROD, V70, P1580, DOI 10.1095/biolreprod.103.026898; Zhang YX, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-69; Zhang YX, 2005, P NATL ACAD SCI USA, V102, P9890, DOI 10.1073/pnas.0503829102; Zhang YX, 2004, J BIOL CHEM, V279, P26126, DOI 10.1074/jbc.M314305200; Zhou H, 2011, ANTICANCER RES, V31, P3129	35	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67068	10.1371/journal.pone.0067068	http://dx.doi.org/10.1371/journal.pone.0067068			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840586	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800118
J	Wang, Y; Xu, L; Chen, YL; Shen, H; Gong, YQ; Limera, C; Liu, LW				Wang, Yan; Xu, Liang; Chen, Yinglong; Shen, Hong; Gong, Yiqin; Limera, Cecilia; Liu, Liwang			Transcriptome Profiling of Radish (Raphanus sativus L.) Root and Identification of Genes Involved in Response to Lead (Pb) Stress with Next Generation Sequencing	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; RNA-SEQ DATA; ABIOTIC STRESSES; PLANT-RESPONSES; CANDIDATE GENES; DROUGHT STRESS; CADMIUM STRESS; TOXICITY; EXPRESSION; GROWTH	Lead (Pb), one of the most toxic heavy metals, can be absorbed and accumulated by plant roots and then enter the food chain resulting in potential health risks for human beings. The radish (Raphanus sativus L.) is an important root vegetable crop with fleshy taproots as the edible parts. Little is known about the mechanism by which radishes respond to Pb stress at the molecular level. In this study, Next Generation Sequencing (NGS)-based RNA-seq technology was employed to characterize the de novo transcriptome of radish roots and identify differentially expressed genes (DEGs) during Pb stress. A total of 68,940 assembled unique transcripts including 33,337 unigenes were obtained from radish root cDNA samples. Based on the assembled de novo transcriptome, 4,614 DEGs were detected between the two libraries of untreated (CK) and Pb-treated (Pb1000) roots. Gene Ontology (GO) and pathway enrichment analysis revealed that upregulated DEGs under Pb stress are predominately involved in defense responses in cell walls and glutathione metabolism-related processes, while downregulated DEGs were mainly involved in carbohydrate metabolism-related pathways. The expression patterns of 22 selected genes were validated by quantitative real-time PCR, and the results were highly accordant with the Solexa analysis. Furthermore, many candidate genes, which were involved in defense and detoxification mechanisms including signaling protein kinases, transcription factors, metal transporters and chelate compound biosynthesis related enzymes, were successfully identified in response to heavy metal Pb. Identification of potential DEGs involved in responses to Pb stress significantly reflected alterations in major biological processes and metabolic pathways. The molecular basis of the response to Pb stress in radishes was comprehensively characterized. Useful information and new insights were provided for investigating the molecular regulation mechanism of heavy metal Pb accumulation and tolerance in root vegetable crops.	[Wang, Yan; Xu, Liang; Shen, Hong; Gong, Yiqin; Limera, Cecilia; Liu, Liwang] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Chen, Yinglong] Univ Western Australia, Sch Earth & Environm, Perth, WA 6009, Australia; [Chen, Yinglong] Univ Western Australia, UWAs Inst Agr, Perth, WA 6009, Australia	Nanjing Agricultural University; University of Western Australia; University of Western Australia		nauliulw@njau.edu.cn	Chen, Yinglong/D-2104-2011	Chen, Yinglong/0000-0003-0798-8683	NSFC [31171956]; National Key Technologies R&D Program of China [2012BAD02B01, 2011GB23600006]; Key Technologies R&D Program of Jiangsu Province, China [BE2010328]; Program for NCET, MOE [NCET-10-0473]; PAPD of Jiangsu Higher Education Institutions; Fundamental Research Funds for the Central Universities [KYZ201209]	NSFC(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program of China(National Key Technology R&D Program); Key Technologies R&D Program of Jiangsu Province, China; Program for NCET, MOE; PAPD of Jiangsu Higher Education Institutions; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the NSFC (31171956), the National Key Technologies R&D Program of China (2012BAD02B01,2011GB23600006), the Key Technologies R&D Program of Jiangsu Province, China (BE2010328), the Program for NCET, MOE (NCET-10-0473), the PAPD of Jiangsu Higher Education Institutions, and the Fundamental Research Funds for the Central Universities (KYZ201209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aery NC, 2012, PROG BIOL CONTROL, V12, P241, DOI 10.1007/978-94-007-1933-0_10; Anjum NA, 2012, ENVIRON EXP BOT, V75, P307, DOI 10.1016/j.envexpbot.2011.07.002; [Anonymous], ENV EXP BOT; [Anonymous], P 2012 IEEE INT ELEC, DOI DOI 10.1109/IEVC.2012.6183163; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Chen M, 2008, J HAZARD MATER, V160, P324, DOI 10.1016/j.jhazmat.2008.03.036; Chen XP, 2013, PLANT BIOTECHNOL J, V11, P115, DOI 10.1111/pbi.12018; Chen YY, 2011, ENVIRON GEOCHEM HLTH, V33, P515, DOI 10.1007/s10653-010-9368-9; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Cobbett CS, 2000, CURR OPIN PLANT BIOL, V3, P211, DOI 10.1016/S1369-5266(00)00066-2; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; DalCorso G, 2010, PLANT SIGNAL BEHAV, V5, P663, DOI 10.4161/psb.5.6.11425; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; dos Reis SP, 2012, INT J MOL SCI, V13, P8628, DOI 10.3390/ijms13078628; Douchiche O, 2010, ANN BOT-LONDON, V105, P481, DOI 10.1093/aob/mcp306; El Beltagi HS, 2010, NOT BOT HORTI AGROBO, V38, P76; Estrella-Gomez NE, 2012, ENVIRON EXP BOT, V75, P188, DOI 10.1016/j.envexpbot.2011.09.001; Eun SO, 2000, PHYSIOL PLANTARUM, V110, P357, DOI 10.1034/j.1399-3054.2000.1100310.x; Fan XD, 2013, GENE, V512, P392, DOI 10.1016/j.gene.2012.09.100; GLAESER H, 1991, CURR GENET, V19, P207, DOI 10.1007/BF00336488; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gupta DK, 2010, J HAZARD MATER, V177, P437, DOI 10.1016/j.jhazmat.2009.12.052; Gupta N, 2012, ENVIRON MONIT ASSESS, V184, P6673, DOI 10.1007/s10661-011-2450-7; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Hao DC, 2012, DRUG DEVELOP RES, V73, P487, DOI 10.1002/ddr.21041; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hyun TK, 2012, PLANT MOL BIOL, V79, P413, DOI 10.1007/s11103-012-9919-9; Inoue H, 2013, J PLANT RES, V126, P51, DOI 10.1007/s10265-012-0494-6; Jakoby M, 2002, TRENDS PLANT SCI, V7, P106, DOI 10.1016/S1360-1385(01)02223-3; Jayalakshmi N., 2011, Plant Cell Biotechnology and Molecular Biology, V12, P1; Jonak C, 2004, PLANT PHYSIOL, V136, P3276, DOI 10.1104/pp.104.045724; Jung KH, 2012, J PLANT BIOL, V55, P458, DOI 10.1007/s12374-012-0271-z; Krzeslowska M, 2011, ACTA PHYSIOL PLANT, V33, P35, DOI 10.1007/s11738-010-0581-z; Kupper H, 2017, METAL IONS LIFE SCI, V17, P491, DOI [10.1590/S1677-04202005000100004, 10.1515/9783110434330-015]; Lan HX, 2012, MOL BIOL REP, P1; LANE SD, 1977, NEW PHYTOL, V79, P281, DOI 10.1111/j.1469-8137.1977.tb02206.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li XM, 2012, J HAZARD MATER, V213, P55, DOI 10.1016/j.jhazmat.2012.01.052; Lin YF, 2012, CELL MOL LIFE SCI, V69, P3187, DOI 10.1007/s00018-012-1089-z; Ling-Li He, 2008, 2008 2nd International Conference on Bioinformatics and Biomedical Engineering (ICBBE '08), P4602; Lister R, 2009, CURR OPIN PLANT BIOL, V12, P107, DOI 10.1016/j.pbi.2008.11.004; Liu JU, 2003, PLANT SCI, V165, P793, DOI 10.1016/S0168-9452(03)00273-5; Liu T, 2009, ENVIRON EXP BOT, V67, P377, DOI 10.1016/j.envexpbot.2009.03.016; Liu WT, 2010, J ENVIRON MANAGE, V91, P781, DOI 10.1016/j.jenvman.2009.10.009; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P2017, DOI 10.1093/pcp/pcr153; Nachappa P, 2012, MOL GENET GENOMICS, V287, P803, DOI 10.1007/s00438-012-0713-9; Opdenakker K, 2012, INT J MOL SCI, V13, P7828, DOI 10.3390/ijms13067828; Pourrut B, 2011, REV ENVIRON CONTAM T, V213, P113, DOI 10.1007/978-1-4419-9860-6_4; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rossato LV, 2012, ECOTOXICOLOGY, V21, P111, DOI 10.1007/s10646-011-0771-5; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Seth CS, 2012, BOT REV, P1; Shahid M, 2012, J HAZARD MATER, V219, P1, DOI 10.1016/j.jhazmat.2012.01.060; Sharma J., 2013, MOL STRESS PHYSL PLA, DOI [10.1007/978-81-322-0807-5_12, DOI 10.1007/978-81-322-0807-5_12]; Shen Y, 2013, PHYSIOL PLANTARUM, V147, P270, DOI 10.1111/j.1399-3054.2012.01670.x; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Shi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047810; Shu X, 2012, ENVIRON SCI POLLUT R, V19, P893, DOI 10.1007/s11356-011-0625-y; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Suzuki N, 2001, PLANT CELL ENVIRON, V24, P1177, DOI 10.1046/j.1365-3040.2001.00773.x; Thapa G, 2012, BIOMETALS, V25, P489, DOI 10.1007/s10534-012-9541-y; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wang G, 2012, ACTA PHYSIOL PLANT, V34, P107, DOI 10.1007/s11738-011-0809-6; Wang LZ, 2005, CHINESE RADISH; Wang WX, 2011, SCI REP-UK, V1, DOI 10.1038/srep00055; Wang XS, 2012, MOL BIOL REP, V39, P8147, DOI 10.1007/s11033-012-1662-4; Ward JA, 2012, AM J BOT, V99, P267, DOI 10.3732/ajb.1100334; Xie Fuliang, 2012, Plant Mol Biol; Xu YY, 2012, BIOCHEM BIOPH RES CO, V424, P398, DOI 10.1016/j.bbrc.2012.06.119; Yadav SK, 2010, S AFR J BOT, V76, P167, DOI 10.1016/j.sajb.2009.10.007; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yu SC, 2012, PLANT MOL BIOL REP, V30, P17, DOI 10.1007/s11105-011-0313-6; Zenoni S, 2010, PLANT PHYSIOL, V152, P1787, DOI 10.1104/pp.109.149716; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhao Y, 2012, MOL BIOL REP, P1; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266	80	73	81	3	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66539	10.1371/journal.pone.0066539	http://dx.doi.org/10.1371/journal.pone.0066539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840502	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800075
J	Costumero, V; Barros-Loscertales, A; Bustamante, JC; Ventura-Campos, N; Fuentes, P; Rosell-Negre, P; Avila, C				Costumero, Victor; Barros-Loscertales, Alfonso; Carlos Bustamante, Juan; Ventura-Campos, Noelia; Fuentes, Paola; Rosell-Negre, Patricia; Avila, Cesar			Reward Sensitivity Is Associated with Brain Activity during Erotic Stimulus Processing	PLOS ONE			English	Article							BEHAVIORAL ACTIVATION SYSTEM; ORBITOFRONTAL CORTEX; DECISION-MAKING; NUCLEUS-ACCUMBENS; SEXUAL AROUSAL; HUMAN MALES; INDIVIDUAL-DIFFERENCES; SENSATION SEEKING; NEURAL RESPONSES; PERSONALITY	The behavioral approach system (BAS) from Gray's reinforcement sensitivity theory is a neurobehavioral system involved in the processing of rewarding stimuli that has been related to dopaminergic brain areas. Gray's theory hypothesizes that the functioning of reward brain areas is modulated by BAS-related traits. To test this hypothesis, we performed an fMRI study where participants viewed erotic and neutral pictures, and cues that predicted their appearance. Forty-five heterosexual men completed the Sensitivity to Reward scale (from the Sensitivity to Punishment and Sensitivity to Reward Questionnaire) to measure BAS-related traits. Results showed that Sensitivity to Reward scores correlated positively with brain activity during reactivity to erotic pictures in the left orbitofrontal cortex, left insula, and right ventral striatum. These results demonstrated a relationship between the BAS and reward sensitivity during the processing of erotic stimuli, filling the gap of previous reports that identified the dopaminergic system as a neural substrate for the BAS during the processing of other rewarding stimuli such as money and food.	[Costumero, Victor; Barros-Loscertales, Alfonso; Carlos Bustamante, Juan; Ventura-Campos, Noelia; Fuentes, Paola; Rosell-Negre, Patricia; Avila, Cesar] Univ Jaume 1, Dept Psicol Basica Clin & Psicobiol, Castellon de La Plana, Spain	Universitat Jaume I	Costumero, V (corresponding author), Univ Jaume 1, Dept Psicol Basica Clin & Psicobiol, Castellon de La Plana, Spain.	vcostume@uji.es	Avila, Cesar/B-4370-2011; Barrós-Loscertales, Alfonso/AAA-5611-2019; Costumero, Víctor/A-5784-2019; Fuentes-Claramonte, Paola/AAC-1196-2021; Barros-Loscertales, Alfonso/D-7069-2013; 2010, BRAINGLOT Consolider Ingenio/D-1235-2009; Bustamante, Juan Carlos/J-7534-2015; Campos, Noelia Ventura/L-4877-2014	Avila, Cesar/0000-0002-5840-605X; Barrós-Loscertales, Alfonso/0000-0002-2456-6653; Costumero, Víctor/0000-0002-8743-5239; Fuentes-Claramonte, Paola/0000-0002-1428-7976; Bustamante, Juan Carlos/0000-0002-8201-0469; Campos, Noelia Ventura/0000-0002-0443-8048; Rosell Negre, Patricia/0000-0002-2440-8495	Brainglot project of the CONSOLIDER-INGENIO Programme [CSD2007-00012]; MINECO [PSI2010-20168]; Universitat Jaume I [P1.1B2011-09, P1-1A2010-01]; FEPAD; Spanish National Drug Strategy Ministerio de Sanidad y Consumo [4623/2011]; GeneralitatValenciana [GV/2012/042]	Brainglot project of the CONSOLIDER-INGENIO Programme; MINECO(Spanish Government); Universitat Jaume I; FEPAD; Spanish National Drug Strategy Ministerio de Sanidad y Consumo; GeneralitatValenciana(Center for Forestry Research & Experimentation (CIEF)European CommissionGeneral Electric)	This research was supported by the Brainglot project of the CONSOLIDER-INGENIO 2010 Programme (CSD2007-00012). Also, the project was supported by grants PSI2010-20168 from MINECO, P1.1B2011-09 from Universitat Jaume I and FEPAD to CA, and grants 4623/2011 from Spanish National Drug Strategy Ministerio de Sanidad y Consumo, GV/2012/042 from the GeneralitatValenciana and P1-1A2010-01 from Universitat Jaume I to ABL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abler B, 2006, NEUROIMAGE, V31, P790, DOI 10.1016/j.neuroimage.2006.01.001; Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Aluja A, 2005, NEUROPSYCHOBIOLOGY, V51, P28, DOI 10.1159/000082852; Aluja A, 2004, NEUROPSYCHOBIOLOGY, V50, P102, DOI 10.1159/000077947; Arnow BA, 2002, BRAIN, V125, P1014, DOI 10.1093/brain/awf108; Avila C, 2008, REINFORCEMENT SENSITIVITY THEORY OF PERSONALITY, P228; Barros-Loscertales A, 2006, EUR J NEUROSCI, V24, P2071, DOI 10.1111/j.1460-9568.2006.05084.x; Barros-Loscertales A, 2010, SOC COGN AFFECT NEUR, V5, P18, DOI 10.1093/scan/nsq012; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Buhler M, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-30; Camara E, 2010, J NEUROSCI, V30, P11398, DOI 10.1523/JNEUROSCI.0111-10.2010; Carpenter D, 2008, J SEX RES, V45, P36, DOI 10.1080/00224490701808076; Carter RM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.021.2009; Caseras X, 2003, PERS INDIV DIFFER, V34, P999, DOI 10.1016/S0191-8869(02)00084-3; Corr PJ, 2004, NEUROSCI BIOBEHAV R, V28, P317, DOI 10.1016/j.neubiorev.2004.01.005; Corr PJ, 2001, PERS INDIV DIFFER, V30, P333, DOI 10.1016/S0191-8869(00)00028-3; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Deco G, 2005, CEREB CORTEX, V15, P15, DOI 10.1093/cercor/bhh103; Depue RA, 1999, BEHAV BRAIN SCI, V22, P491; Eppinger B, 2011, ANN NY ACAD SCI, V1235, P1, DOI 10.1111/j.1749-6632.2011.06230.x; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Georgiadis JR, 2005, J COMP NEUROL, V493, P33, DOI 10.1002/cne.20735; Gottfried JA, 2002, J NEUROSCI, V22, P10829; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; GRAY JA, 1970, BEHAV RES THER, V8, P249, DOI 10.1016/0005-7967(70)90069-0; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Gray JR, 2005, COGN AFFECT BEHAV NE, V5, P182, DOI 10.3758/CABN.5.2.182; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hahn T, 2012, NEUROIMAGE, V59, P1842, DOI 10.1016/j.neuroimage.2011.08.042; Hahn T, 2009, NEUROIMAGE, V46, P1148, DOI 10.1016/j.neuroimage.2009.03.038; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Jarcho JM, 2012, DEV COGN NEUROS-NETH, V2, P437, DOI 10.1016/j.dcn.2012.04.002; KANTOROWITZ DA, 1978, BEHAV RES THER, V16, P117, DOI 10.1016/0005-7967(78)90049-9; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Klucken T, 2009, J SEX MED, V6, P3071, DOI 10.1111/j.1743-6109.2009.01405.x; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Kuhn S, 2011, J SEX MED, V8, P2269, DOI 10.1111/j.1743-6109.2011.02322.x; Lang J.P., 1999, A4 U FLOR CTR RES PS; Mackiewicz KL, 2006, P NATL ACAD SCI USA, V103, P14200, DOI 10.1073/pnas.0601648103; Matthews G, 1999, PERS INDIV DIFFER, V26, P583, DOI 10.1016/S0191-8869(98)00158-5; Mcclure SM, 2004, NEUROSCIENTIST, V10, P260, DOI 10.1177/1073858404263526; Molto J, 1999, REV PSICOLOGIA GEN A, V52, P55; Moulier V, 2006, NEUROIMAGE, V33, P689, DOI 10.1016/j.neuroimage.2006.06.037; Mouras H, 2008, NEUROIMAGE, V42, P1142, DOI 10.1016/j.neuroimage.2008.05.051; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Pauli WM, 2012, J COGNITIVE NEUROSCI, V24, P351, DOI 10.1162/jocn_a_00155; Pickering A.D., 2001, ADV INDIVIDUAL DIFFE, P113; Pickering AD., 1997, HDB PERS THEORY RES, P277; Redoute J, 2000, HUM BRAIN MAPP, V11, P162, DOI 10.1002/1097-0193(200011)11:3<162::AID-HBM30>3.0.CO;2-A; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; ROLLS ET, 1999, BRAIN EMOTION; Sescousse G, 2010, J NEUROSCI, V30, P13095, DOI 10.1523/JNEUROSCI.3501-10.2010; Simon JJ, 2010, NEUROIMAGE, V49, P1868, DOI 10.1016/j.neuroimage.2009.09.016; Spicer J, 2007, NEUROIMAGE, V34, P455, DOI 10.1016/j.neuroimage.2006.09.012; Spicer Kristen Rae, 2010, Commun Integr Biol, V3, P282; Stoleru S, 1999, ARCH SEX BEHAV, V28, P1, DOI 10.1023/A:1018733420467; Stoleru S, 2012, NEUROSCI BIOBEHAV R, V36, P1481, DOI 10.1016/j.neubiorev.2012.03.006; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Voigt DC, 2009, PERS INDIV DIFFER, V47, P89, DOI 10.1016/j.paid.2009.02.003; Volz KG, 2004, NEUROIMAGE, V21, P848, DOI 10.1016/j.neuroimage.2003.10.028; Wahlstrom D, 2010, NEUROSCI BIOBEHAV R, V34, P631, DOI 10.1016/j.neubiorev.2009.12.007; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Walter M, 2009, HUM BRAIN MAPP, V30, P312, DOI 10.1002/hbm.20506; Windmann S, 2006, J COGNITIVE NEUROSCI, V18, P1198, DOI 10.1162/jocn.2006.18.7.1198; Zelenski JM, 1999, J PERS, V67, P761, DOI 10.1111/1467-6494.00072; ZUCKERMAN M, 1986, PERS INDIV DIFFER, V7, P49, DOI 10.1016/0191-8869(86)90107-8	72	24	24	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66940	10.1371/journal.pone.0066940	http://dx.doi.org/10.1371/journal.pone.0066940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840558	Green Published, gold			2022-12-27	WOS:000321148400025
J	Gonzalez, LM; Williamson, I; Piedrahita, JA; Blikslager, AT; Magness, ST				Gonzalez, Liara M.; Williamson, Ian; Piedrahita, Jorge A.; Blikslager, Anthony T.; Magness, Scott T.			Cell Lineage Identification and Stem Cell Culture in a Porcine Model for the Study of Intestinal Epithelial Regeneration	PLOS ONE			English	Article							MOUSE SMALL INTESTINE; SMALL-BOWEL RESECTION; GLUCAGON-LIKE PEPTIDE-2; BARRIER FUNCTION; IN-VITRO; PANETH CELLS; SECRETORY-CELL; GROWTH-FACTOR; BRUSH-BORDER; GASTROINTESTINAL-TRACT	Significant advances in intestinal stem cell biology have been made in murine models; however, anatomical and physiological differences between mice and humans limit mice as a translational model for stem cell based research. The pig has been an effective translational model, and represents a candidate species to study intestinal epithelial stem cell (IESC) driven regeneration. The lack of validated reagents and epithelial culture methods is an obstacle to investigating IESC driven regeneration in a pig model. In this study, antibodies against Epithelial Adhesion Molecule 1 (EpCAM) and Villin marked cells of epithelial origin. Antibodies against Proliferative Cell Nuclear Antigen (PCNA), Minichromosome Maintenance Complex 2 (MCM2), Bromodeoxyuridine (BrdU) and phosphorylated Histone H3 (pH3) distinguished proliferating cells at various stages of the cell cycle. SOX9, localized to the stem/progenitor cells zone, while HOPX was restricted to the +4/'reserve' stem cell zone. Immunostaining also identified major differentiated lineages. Goblet cells were identified by Mucin 2 (MUC2); enteroendocrine cells by Chromogranin A (CGA), Gastrin and Somatostatin; and absorptive enterocytes by carbonic anhydrase II (CAII) and sucrase isomaltase (SIM). Transmission electron microscopy demonstrated morphologic and subcellular characteristics of stem cell and differentiated intestinal epithelial cell types. Quantitative PCR gene expression analysis enabled identification of stem/progenitor cells, post mitotic cell lineages, and important growth and differentiation pathways. Additionally, a method for long-term culture of porcine crypts was developed. Biomarker characterization and development of IESC culture in the porcine model represents a foundation for translational studies of IESC-driven regeneration of the intestinal epithelium in physiology and disease.	[Gonzalez, Liara M.; Piedrahita, Jorge A.; Blikslager, Anthony T.] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [Gonzalez, Liara M.; Blikslager, Anthony T.] N Carolina State Univ, Dept Clin Sci, Raleigh, NC 27695 USA; [Piedrahita, Jorge A.] N Carolina State Univ, Raleigh, NC 27695 USA; [Williamson, Ian; Magness, Scott T.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Magness, Scott T.] Univ N Carolina, Chapel Hill, NC USA; [Williamson, Ian; Magness, Scott T.] Univ N Carolina, UNC NCSU Biomed Engn, Chapel Hill, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Magness, ST (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA.	magness@med.unc.edu		Williamson, Ian/0000-0003-2795-6099; Blikslager, Anthony/0000-0002-0867-7310; Magness, Scott/0000-0002-2746-1224	National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000083]; NIH/NCSU Comparative Medicine and Translational Research Training Program (CMTRTP) [R01DK091427, R03DK089126, T32RR024394]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000083] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR024394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK089126, P30DK034987, R01DK091427] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011130] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH/NCSU Comparative Medicine and Translational Research Training Program (CMTRTP); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Award Number UL1TR000083 (STM/JP). Additional support provided by R01DK091427 (STM), R03DK089126 (STM), NIH/NCSU Comparative Medicine and Translational Research Training Program (CMTRTP) T32RR024394. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elmagd KM, 2012, ANN SURG, V256, P494, DOI 10.1097/SLA.0b013e318265f310; Ahlman H, 2001, ANN ONCOL, V12, pS63, DOI 10.1093/annonc/12.suppl_2.S63; Amasaki T, 2001, J VET MED SCI, V63, P967, DOI 10.1292/jvms.63.967; Argenzio RA, 1997, J PHARMACOL EXP THER, V283, P692; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Bines JE, 2002, J GASTROEN HEPATOL, V17, P1170, DOI 10.1046/j.1440-1746.2002.02872.x; Bjerknes M, 2006, DEV BIOL, V300, P722, DOI 10.1016/j.ydbio.2006.07.040; Blache P, 2004, J CELL BIOL, V166, P37, DOI 10.1083/jcb.200311021; Blikslager AT, 2007, PHYSIOL REV, V87, P545, DOI 10.1152/physrev.00012.2006; Blikslager AT, 1997, SURGERY, V121, P526, DOI 10.1016/S0039-6060(97)90107-0; Blikslager AT, 1999, SURGERY, V125, P186, DOI 10.1016/S0039-6060(99)70264-3; Blikslager AT, 1999, AM J PHYSIOL-GASTR L, V276, pG28, DOI 10.1152/ajpgi.1999.276.1.G28; Block T, 2011, EUR J VASC ENDOVASC, V41, P281, DOI 10.1016/j.ejvs.2010.09.012; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; CHENG H, 1974, AM J ANAT, V141, P481, DOI 10.1002/aja.1001410404; CHENG H, 1974, AM J ANAT, V141, P503, DOI 10.1002/aja.1001410405; CHENG H, 1974, AM J ANAT, V141, P521, DOI 10.1002/aja.1001410406; Cilieborg MS, 2011, J NUTR, V141, P223, DOI 10.3945/jn.110.128561; Davidson LA, 2012, BBA-MOL BASIS DIS, V1822, P1600, DOI 10.1016/j.bbadis.2012.06.011; DEBRAY H, 1981, EUR J BIOCHEM, V117, P41; Dekaney CM, 2009, AM J PHYSIOL-GASTR L, V297, pG461, DOI 10.1152/ajpgi.90446.2008; Dellmann H, 1987, TXB VET HISTOLOGY, P187; DOBBINS WO, 1991, ULTRASTRUCT PATHOL, V15, P15, DOI 10.3109/01913129109021301; Du Plessis J, 2013, J HEPATOL, V58, P1125, DOI 10.1016/j.jhep.2013.01.038; Dykstra MJ, 2003, BIOL ELECT MICROSCOP; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Flisikowska T, 2012, GASTROENTEROLOGY, V143, P1173, DOI 10.1053/j.gastro.2012.07.110; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Foster DM, 2012, GASTROENTEROLOGY, V143, P133, DOI 10.1053/j.gastro.2012.03.030; Fox RG, 2012, AM J PHYSIOL-GASTR L, V302, pG914, DOI 10.1152/ajpgi.00402.2011; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Garrison AP, 2009, AM J PHYSIOL-GASTR L, V296, pG643, DOI 10.1152/ajpgi.90588.2008; Gayle J, 2002, SURGERY, V132, P461, DOI 10.1067/msy.2002.125320; Ghaleb AM, 2011, DEV BIOL, V349, P310, DOI 10.1016/j.ydbio.2010.11.001; Gookin JL, 2006, AM J PHYSIOL-GASTR L, V290, pG164, DOI 10.1152/ajpgi.00460.2004; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Gunawardene AR, 2011, INT J EXP PATHOL, V92, P219, DOI 10.1111/j.1365-2613.2011.00767.x; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Johansson ME, 2013, NAT REV GASTRO HEPAT, DOI DOI 10.1038/NRGASTR0.2013.35.ACCESSED; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; LEBLOND CP, 1948, ANAT REC, V100, P357, DOI 10.1002/ar.1091000306; Li QM, 2011, INT J MOL SCI, V12, P1727, DOI 10.3390/ijms12031727; Lichtenstein GR, 2010, INFLAMM BOWEL DIS, V16, P338, DOI 10.1002/ibd.20997; Marathe CS, 2013, PEPTIDES, V44, P75, DOI 10.1016/j.peptides.2013.01.014; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V293, pG413, DOI 10.1152/ajpgi.00304.2006; Moeser AJ, 2007, AM J PHYSIOL-GASTR L, V292, pG173, DOI 10.1152/ajpgi.00197.2006; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; MYER MS, 1982, ONDERSTEPOORT J VET, V49, P131; Nagy ES, 2004, J PEDIATR GASTR NUTR, V39, P487, DOI 10.1097/00005176-200411000-00008; National Institute of Health, 2012, NIH S IMPR AN MOD RE; Nejdfors P, 2000, SCAND J GASTROENTERO, V35, P501, DOI 10.1080/003655200750023769; O'Brien LE, 2011, CELL, V147, P603, DOI 10.1016/j.cell.2011.08.048; Paris MC, 2004, DIGEST DIS SCI, V49, P1688, DOI 10.1023/B:DDAS.0000043388.52260.2f; Patterson JK, 2008, EXP BIOL MED, V233, P651, DOI 10.3181/0709-MR-262; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Pereira-Fantini PM, 2008, JPEN-PARENTER ENTER, V32, P266, DOI 10.1177/0148607108316197; Pereira-Fantini PM, 2008, J PEDIATR GASTR NUTR, V46, P20, DOI 10.1097/01.mpg.0000304449.46434.06; Pereira-Fantini PM, 2011, HISTOCHEM CELL BIOL, V135, P195, DOI 10.1007/s00418-011-0778-2; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; PortelaGomes GM, 1997, J HISTOCHEM CYTOCHEM, V45, P815, DOI 10.1177/002215549704500606; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Potten CS, 2001, CELL GROWTH DIFFER, V12, P265; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Pruitt SC, 2010, STEM CELLS, V28, P1250, DOI 10.1002/stem.450; Ramalingam S, 2012, AM J PHYSIOL-GASTR L, V302, pG10, DOI 10.1152/ajpgi.00277.2011; RHOADS JM, 1989, J PEDIATR GASTR NUTR, V9, P225, DOI 10.1097/00005176-198908000-00016; RHOADS JM, 1990, AM J PHYSIOL, V259, pG99, DOI 10.1152/ajpgi.1990.259.1.G99; RHOADS JM, 1991, GASTROENTEROLOGY, V100, P683, DOI 10.1016/0016-5085(91)80012-X; Rizk P, 2012, WIRES SYST BIOL MED, V4, P475, DOI 10.1002/wsbm.1176; RODRIGUEZ IR, 1984, EUR J BIOCHEM, V143, P575, DOI 10.1111/j.1432-1033.1984.tb08408.x; Rothenberg ME, 2012, GASTROENTEROLOGY, V142, P1195, DOI 10.1053/j.gastro.2012.02.006; Rowland KJ, 2011, AM J PHYSIOL-GASTR L, V301, pG1, DOI 10.1152/ajpgi.00039.2011; Sala FG, 2009, J SURG RES, V156, P205, DOI 10.1016/j.jss.2009.03.062; Sang YM, 2006, MAMM GENOME, V17, P332, DOI 10.1007/s00335-005-0158-0; Sangild PT, 2006, GASTROENTEROLOGY, V130, P1776, DOI 10.1053/j.gastro.2006.02.026; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SATOH Y, 1990, J ELECTRON MICR TECH, V16, P69, DOI 10.1002/jemt.1060160109; Schwartz CA, 2012, ROFO-FORTSCHR RONTG, V184, P520, DOI 10.1055/s-0031-1299414; Smith F, 2010, AM J PHYSIOL-GASTR L, V298, pG352, DOI 10.1152/ajpgi.00081.2009; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Stelzner M, 2012, AM J PHYSIOL-GASTR L, V302, pG1359, DOI 10.1152/ajpgi.00493.2011; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tang ZH, 2010, ACAD RADIOL, V17, P1146, DOI 10.1016/j.acra.2010.04.014; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Trautmann A, 1952, FUNDAMENTALS HISTOLO; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011; VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763; VanDussen KL, 2010, DEV BIOL, V346, P215, DOI 10.1016/j.ydbio.2010.07.026; Voortman T, 2012, J AGR FOOD CHEM, V60, P9035, DOI 10.1021/jf2045697; WAGNER JE, 1973, CAN J COMP MED, V37, P177; WEST AB, 1988, GASTROENTEROLOGY, V94, P343, DOI 10.1016/0016-5085(88)90421-0; Willing BP, 2007, J ANIM SCI, V85, P3256, DOI 10.2527/jas.2007-0320; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Wrackmeyer U, 2006, BIOCHEMISTRY-US, V45, P9188, DOI 10.1021/bi060570x; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zhou C, 2013, ALCOHOL, V47, P231, DOI 10.1016/j.alcohol.2013.01.003; ZWEIBAUM A, 1984, INT J CANCER, V34, P591, DOI 10.1002/ijc.2910340502	113	89	91	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66465	10.1371/journal.pone.0066465	http://dx.doi.org/10.1371/journal.pone.0066465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840480	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400014
J	Suominen, T; Uutela, P; Ketola, RA; Bergquist, J; Hillered, L; Finel, M; Zhang, HB; Laakso, A; Kostiainen, R				Suominen, Tina; Uutela, Paivi; Ketola, Raimo A.; Bergquist, Jonas; Hillered, Lars; Finel, Moshe; Zhang, Hongbo; Laakso, Aki; Kostiainen, Risto			Determination of Serotonin and Dopamine Metabolites in Human Brain Microdialysis and Cerebrospinal Fluid Samples by UPLC-MS/MS: Discovery of Intact Glucuronide and Sulfate Conjugates	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN UDP-GLUCURONOSYLTRANSFERASES; MONOAMINE METABOLITES; INTRACEREBRAL MICRODIALYSIS; BIOGENIC-AMINES; BODY-FLUIDS; MOUSE-BRAIN; RAT-BRAIN; EXPRESSION; NEUROTRANSMITTERS	An UPLC-MS/MS method was developed for the determination of serotonin (5-HT), dopamine (DA), their phase I metabolites 5-HIAA, DOPAC and HVA, and their sulfate and glucuronide conjugates in human brain microdialysis samples obtained from two patients with acute brain injuries, ventricular cerebrospinal fluid (CSF) samples obtained from four patients with obstructive hydrocephalus, and a lumbar CSF sample pooled mainly from patients undergoing spinal anesthesia in preparation for orthopedic surgery. The method was validated by determining the limits of detection and quantification, linearity, repeatability and specificity. The direct method enabled the analysis of the intact phase II metabolites of 5-HT and DA, without hydrolysis of the conjugates. The method also enabled the analysis of the regioisomers of the conjugates, and several intact glucuronide and sulfate conjugates were identified and quantified for the first time in the human brain microdialysis and CSF samples. We were able to show the presence of 5-HIAA sulfate, and that dopamine-3-O-sulfate predominates over dopamine-4-O-sulfate in the human brain. The quantitative results suggest that sulfonation is a more important phase II metabolism pathway than glucuronidation in the human brain.	[Suominen, Tina; Kostiainen, Risto] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, Helsinki, Finland; [Uutela, Paivi; Ketola, Raimo A.; Finel, Moshe; Zhang, Hongbo] Univ Helsinki, Fac Pharm, Ctr Drug Res, Helsinki, Finland; [Bergquist, Jonas] Uppsala Univ, BMC, Dept Chem, Uppsala, Sweden; [Bergquist, Jonas] Uppsala Univ, Sci Life Lab, Uppsala, Sweden; [Hillered, Lars] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Laakso, Aki] Univ Helsinki, Cent Hosp, Dept Neurosurg, Helsinki, Finland	University of Helsinki; University of Helsinki; Uppsala University; Uppsala University; Uppsala University; University of Helsinki; Helsinki University Central Hospital	Kostiainen, R (corresponding author), Univ Helsinki, Fac Pharm, Div Pharmaceut Chem, Helsinki, Finland.	Risto.Kostiainen@helsinki.fi	Zhang, Hongbo/O-8330-2019; Kostiainen, Risto K/B-5491-2008; Bergquist, Jonas/C-5894-2015	Zhang, Hongbo/0000-0002-1071-4416; Bergquist, Jonas/0000-0002-4597-041X; Laakso, Aki/0000-0002-5312-4926; Hillered, Lars/0000-0002-2808-9292; Kostiainen, Risto/0000-0003-2454-4574	Swedish Research Council [621-2008-3562, 621-2011-4423]; Uppsala Berzelii Technology Center for Neurodiagnostics; Academy of Finland [251575]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala Berzelii Technology Center for Neurodiagnostics; Academy of Finland(Academy of Finland)	The Swedish Research Council (621-2008-3562, 621-2011-4423) and Uppsala Berzelii Technology Center for Neurodiagnostics supported portions of the research. The Academy of Finland is acknowledged for financial support (project 251575). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARBEAU A, 1969, Canadian Medical Association Journal, V101, P59; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bergquist J, 2002, MASS SPECTROM REV, V21, P2, DOI 10.1002/mas.10016; BUCHT G, 1981, J NEURAL TRANSM, V51, P185, DOI 10.1007/BF01248951; CEDARBAUM JM, 1991, NEUROLOGY, V41, P1567, DOI 10.1212/WNL.41.10.1567; Court MH, 2012, XENOBIOTICA, V42, P266, DOI 10.3109/00498254.2011.618954; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; ELCHISAK MA, 1983, J NEUROCHEM, V41, P893, DOI 10.1111/j.1471-4159.1983.tb04825.x; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Falany CN, 2000, BIOCHEM J, V346, P857, DOI 10.1042/0264-6021:3460857; Fried I, 2001, NAT NEUROSCI, V4, P201, DOI 10.1038/84041; Gamage N, 2006, TOXICOL SCI, V90, P5, DOI 10.1093/toxsci/kfj061; GORDON EK, 1976, LIFE SCI, V18, P1285, DOI 10.1016/0024-3205(76)90206-X; HERREGODTS P, 1985, J CHROMATOGR, V345, P33, DOI 10.1016/0378-4347(85)80132-8; HERREGODTS P, 1991, BRAIN RES, V542, P300, DOI 10.1016/0006-8993(91)91582-L; HIDAKA H, 1972, BIOCHIM BIOPHYS ACTA, V268, P132, DOI 10.1016/0005-2744(72)90207-0; HILLERED L, 1990, ACTA NEUROCHIR, V102, P91, DOI 10.1007/BF01405420; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; Itaaho K, 2007, BIOCHEM PHARMACOL, V74, P504, DOI 10.1016/j.bcp.2007.05.003; Itaaho K, 2009, DRUG METAB DISPOS, V37, P768, DOI 10.1124/dmd.108.025692; Jantti SE, 2010, ANAL CHEM, V82, P3168, DOI 10.1021/ac902321z; KANTHAN R, 1995, J NEUROSCI METH, V60, P151, DOI 10.1016/0165-0270(95)00006-G; Kanthan R, 1996, NEUROCHEM RES, V21, P563, DOI 10.1007/BF02527754; Kilpatrick M, 2010, J NEUROSCI METH, V190, P106, DOI 10.1016/j.jneumeth.2010.04.013; King CD, 1999, ARCH BIOCHEM BIOPHYS, V365, P156, DOI 10.1006/abbi.1999.1155; KONRADI C, 1992, BRAIN RES, V579, P285, DOI 10.1016/0006-8993(92)90062-E; KOYAMA E, 1988, CLIN CHEM, V34, P680; Krishnaswamy S, 2003, DRUG METAB DISPOS, V31, P133, DOI 10.1124/dmd.31.1.133; Kurkela M, 2003, J BIOL CHEM, V278, P3536, DOI 10.1074/jbc.M206136200; Kurkela M, 2007, PHARMACOGENET GENOM, V17, P115, DOI 10.1097/FPC.0b013e328011b598; MACKAY AVP, 1978, J NEUROCHEM, V30, P841, DOI 10.1111/j.1471-4159.1978.tb10792.x; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; MEYERSON BA, 1990, LIFE SCI, V46, P301, DOI 10.1016/0024-3205(90)90037-R; Ohno S, 2009, DRUG METAB DISPOS, V37, P32, DOI 10.1124/dmd.108.023598; OWENS MJ, 1994, CLIN CHEM, V40, P288; PRZEDBORSKI S, 1995, MOVEMENT DISORD, V10, P28, DOI 10.1002/mds.870100107; RATGE D, 1985, J NEURAL TRANSM, V62, P267, DOI 10.1007/BF01252241; RENSKERS KJ, 1980, J NEUROCHEM, V34, P1362, DOI 10.1111/j.1471-4159.1980.tb11216.x; Riches Z, 2009, DRUG METAB DISPOS, V37, P2255, DOI 10.1124/dmd.109.028399; RIVETT AJ, 1982, J NEUROCHEM, V39, P1009, DOI 10.1111/j.1471-4159.1982.tb11490.x; Gonzalez RR, 2011, J NEUROSCI METH, V198, P187, DOI 10.1016/j.jneumeth.2011.03.023; SCHEININ M, 1984, ACTA PHARMACOL TOX, V55, P88; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; SHARPLESS NS, 1981, BRAIN RES, V217, P107, DOI 10.1016/0006-8993(81)90188-8; Sneitz N, 2009, PHARMACOGENET GENOM, V19, P923, DOI 10.1097/FPC.0b013e3283330767; Song P, 2012, ANAL CHEM, V84, P412, DOI 10.1021/ac202794q; Staub F, 2000, NEUROSURGERY, V47, P1106, DOI 10.1097/00006123-200011000-00016; Su FL, 2009, CHROMATOGRAPHIA, V69, P207, DOI 10.1365/s10337-008-0879-9; SWAHN CG, 1976, PSYCHOPHARMACOLOGY, V48, P147, DOI 10.1007/BF00423253; SWAHN CG, 1976, J NEURAL TRANSM, V39, P281, DOI 10.1007/BF01266304; Thorre K, 1997, J CHROMATOGR B, V694, P297, DOI 10.1016/S0378-4347(97)00126-6; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; TYCE GM, 1985, J NEUROCHEM, V44, P322, DOI 10.1111/j.1471-4159.1985.tb07149.x; TYCE GM, 1986, FASEB J, V45, P2247; Uutela P, 2009, ANAL CHEM, V81, P8417, DOI 10.1021/ac901320z; Uutela P, 2009, ANAL CHEM, V81, P427, DOI 10.1021/ac801846w; VANKAMMEN DP, 1986, ARCH GEN PSYCHIAT, V43, P978; Webster RA, 2002, NEUROTRANSMITTERS DR, P137, DOI DOI 10.1002/0470846577; WESTER P, 1987, J CHROMATOGR-BIOMED, V415, P275, DOI 10.1016/S0378-4347(00)83219-3; YAMAMOTO T, 1985, J CHROMATOGR, V342, P261, DOI 10.1016/S0378-4347(00)84516-8	61	50	51	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68007	10.1371/journal.pone.0068007	http://dx.doi.org/10.1371/journal.pone.0068007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826355	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000109
J	Bodemer, N; Ruggeri, A; Galesic, M				Bodemer, Nicolai; Ruggeri, Azzurra; Galesic, Mirta			When Dread Risks Are More Dreadful than Continuous Risks: Comparing Cumulative Population Losses over Time	PLOS ONE			English	Article							TERRORIST ATTACKS; EVOLUTION; SEPTEMBER-11	People show higher sensitivity to dread risks, rare events that kill many people at once, compared with continuous risks, relatively frequent events that kill many people over a longer period of time. The different reaction to dread risks is often considered a bias: If the continuous risk causes the same number of fatalities, it should not be perceived as less dreadful. We test the hypothesis that a dread risk may have a stronger negative impact on the cumulative population size over time in comparison with a continuous risk causing the same number of fatalities. This difference should be particularly strong when the risky event affects children and young adults who would have produced future offspring if they had survived longer. We conducted a series of simulations, with varying assumptions about population size, population growth, age group affected by risky event, and the underlying demographic model. Results show that dread risks affect the population more severely over time than continuous risks that cause the same number of fatalities, suggesting that fearing a dread risk more than a continuous risk is an ecologically rational strategy.	[Bodemer, Nicolai; Ruggeri, Azzurra; Galesic, Mirta] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany; [Bodemer, Nicolai; Galesic, Mirta] Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Berlin, Germany	Max Planck Society; Max Planck Society	Bodemer, N (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany.	bodemer@mpib-berlin.mpg.de	Galesic, Mirta/B-8327-2012	Galesic, Mirta/0000-0002-3537-8359				Barnthouse LW, 2004, ENVIRON TOXICOL CHEM, V23, P500, DOI 10.1897/02-521; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Gaissmaier W, 2012, PSYCHOL SCI, V23, P1449, DOI 10.1177/0956797612447804; Galesic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032837; Gigerenzer G, 2006, RISK ANAL, V26, P347, DOI 10.1111/j.1539-6924.2006.00753.x; Gigerenzer G, 2004, PSYCHOL SCI, V15, P286, DOI 10.1111/j.0956-7976.2004.00668.x; Gigerenzer G, 2009, JNCI-J NATL CANCER I, V101, P1216, DOI 10.1093/jnci/djp237; HASSAN FA, 1981, DEMOGRAPHIC ARCHAEOL; Hertwig R, 2005, J EXP PSYCHOL LEARN, V31, P621, DOI 10.1037/0278-7393.31.4.621; Hill KR, 2011, SCIENCE, V331, P1286, DOI 10.1126/science.1199071; Howeden LM, 2011, AGE SEX COMPOSITION; Kokko H, 2001, P ROY SOC B-BIOL SCI, V268, P187, DOI 10.1098/rspb.2000.1349; Krause J, 2002, LIVING GROUPS; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Lee R. B., MAN HUNTER, P3; LICHTENSTEIN S, 1978, J EXP PSYCHOL-HUM L, V4, P551, DOI 10.1037/0278-7393.4.6.551; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Preclec D, 1998, ECONOMETRICA, V66, P497; PRESTON MG, 1948, AM J PSYCHOL, V61, P183, DOI 10.2307/1416964; Sivak M, 2003, AM SCI, V91, P6; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Statistisches Bundesamt, 2011, GES TOD DEUTSCHL; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Wang XT, 1996, ETHOL SOCIOBIOL, V17, P1, DOI 10.1016/0162-3095(95)00103-4	25	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66544	10.1371/journal.pone.0066544	http://dx.doi.org/10.1371/journal.pone.0066544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DN	23840503	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400029
J	Song, YP; Ma, W; Yi, XR; Wang, SM; Sun, XJ; Tian, JM; Wang, SK; Zheng, CM; Zhang, BY; Xu, ZJ; Marley, G				Song, Yapei; Ma, Wei; Yi, Xiangren; Wang, Shumei; Sun, Xiaojie; Tian, Jiming; Wang, Shukang; Zheng, Chunmei; Zhang, Bingyin; Xu, Zhijian; Marley, Gifty			Chronic Diseases Knowledge and Related Factors among the Elderly in Jinan, China	PLOS ONE			English	Article							BLOOD-PRESSURE; HYPERTENSION; MEDICATION; PREVENTION; PREVALENCE; ATTITUDES; ADHERENCE; CANCER	Background: It has been reported that the prevalence of chronic diseases is high among old people and they have poor chronic diseases knowledge. This study was therefore designed to evaluate the awareness rate of chronic diseases knowledge among people aged over 60 years, to explore its related factors and to provide evidence for future health education. Methods: A cross-sectional study was conducted from April to August in 2011. People aged 60 years and above from 3 communities in Jinan were selected by cluster sampling. Nine hundred and twenty five participants were interviewed face-to-face using a structured questionnaire. Results: The awareness rates of chronic diseases knowledge varied from 29.5% to 90.2%. Four healthy lifestyles including quitting smoking and less drinking, keeping broad-minded, maintaining balanced diet and moderate physical activity were best known (from 86.3% to 90.2%). The least known knowledge were 2 complications of hypertension: nephropathy (29.5%) and retinopathy (37.2%). Participants with the following characteristics or behaviors were more likely to have higher chronic diseases knowledge: younger age, female, Han Chinese, higher level of education, having health insurance, participating in societies, having family history of chronic diseases, frequently gathering with friends/relatives, usually going to provincial hospitals/hospitals affiliated with medical universities, usually going to municipal hospitals and usually going to community health center/station. Conclusions: Old people in Jinan had incomplete chronic diseases knowledge and the overall awareness rate was not high. The older people's chronic diseases knowledge should be improved and health education programs should target males, older people with lower educational level, having no health insurance, having no family history of chronic diseases, participating in no societies, and less frequently gathering with friends/relatives. Also, lower level medical facilities should improve their skills of health education.	[Song, Yapei; Ma, Wei; Wang, Shumei; Wang, Shukang; Zhang, Bingyin; Xu, Zhijian; Marley, Gifty] Shandong Univ, Sch Publ Hlth, Jinan 250100, Peoples R China; [Yi, Xiangren; Tian, Jiming; Zheng, Chunmei] Shandong Univ, Coll Phys Educ, Jinan 250100, Peoples R China; [Sun, Xiaojie] Shandong Univ, Ctr Hlth Management & Policy, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Ma, W (corresponding author), Shandong Univ, Sch Publ Hlth, Jinan 250100, Peoples R China.	weima@sdu.edu.cn	Ma, Wei/C-4748-2019; Ma, Wei/L-2374-2019	Ma, Wei/0000-0002-8092-3280; Ma, Wei/0000-0002-8092-3280; Marley, Gifty/0000-0002-0025-3062	Independent Innovation Foundation of Shandong University (IIFSDU) [2010JC008]	Independent Innovation Foundation of Shandong University (IIFSDU)	This study was supported by the Independent Innovation Foundation of Shandong University (IIFSDU) 2010JC008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qazaz HK, 2011, INT J CLIN PHARM-NET, V33, P1028, DOI 10.1007/s11096-011-9582-2; Bruce DG, 2003, J DIABETES COMPLICAT, V17, P82, DOI 10.1016/S1056-8727(02)00191-5; Chekuri A, 2012, J OBSTET GYNAECOL, V32, P691, DOI 10.3109/01443615.2012.689889; Chen JH, 2011, CHIN PRIM HLTH CARE, V25, P47; [陈洁 Chen Jie], 2010, [中国全科医学, Chinese General Practice], V13, P2794; Chen W Q, 2013, CHINA CANC, V22, P2; China National Committee on Ageing, 2006, FOR REP CHIN POP AG; Chinese Health Ministry Information Office, 2009, NTR; Fan YL, 2007, MODERN PREVENTIVE ME, V34, P1535; Franklin SS, 2004, AM J HYPERTENS, V17, p49S, DOI 10.1016/j.amjhyper.2004.08.020; Gao L.P., 2011, CHINESE HLTH EC, V30, P91; Guan J, 2005, CHIN GEN PRACT, V8, P1741; He C, 2010, PRACTICAL PREVENTIVE, V17, P1547; Hu DS, 2008, DIABETES RES CLIN PR, V81, P250, DOI 10.1016/j.diabres.2008.04.008; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Karaeren H, 2009, ANATOL J CARDIOL, V9, P183; Koo JH, 2012, GASTROINTEST ENDOSC, V76, P126, DOI 10.1016/j.gie.2012.03.168; Leng Yan, 2011, Chinese Journal of Prevention and Control of Chronic Diseases, V19, P38; [利基林 Li Jilin], 2011, [中国公共卫生, China Public Health], V27, P472; Li L, 2006, CHINESE HLTH EC, V25, P36; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Li LM, 2007, EPIDEMIOLOGY, P231; Liu L-Y, 2009, CHIN J PUBLIC HLTH, V25, P1275; [刘向东 LIU Xiangdong], 2006, [中国糖尿病杂志, Chinese Journal of Diabetes], V14, P275; Luo HB, 2004, CHINA J MODERN MED, V14, P80; Ma JS, 2004, CHIN J PUBLIC HLTH, V20, P751; Mamudu HM, 2011, GLOB PUBLIC HEALTH, V6, P347, DOI 10.1080/17441692.2011.574230; Ministry of Health of the People's Republic of China, 2011, NAT BAS PUBL HLTH SE; Ministry of Health of the People's Republic of China, 2008, MAIN COND 3 NAT DEAT; Murata GH, 2003, DIABETOLOGIA, V46, P1170, DOI 10.1007/s00125-003-1161-1; Niu TH, 2010, CHIN PRIM HLTH CARE, V24, P37; Ong CS, 2010, PREV MED, V50, P304, DOI 10.1016/j.ypmed.2010.02.013; Organization WH, 2009, GLOB HLTH RISKS MORT; STAMLER J, 1984, AM J MED, V76, P13, DOI 10.1016/0002-9343(84)90953-7; Sun JD, 2008, ESTIMATION BURDEN MA; UN, 2010, WORLD POPULATION AGI; Vierck E, 2003, AGING DEMOGRAPHICS H, V127; Wang RL, 2011, J NINGXIA MED U, V33, P953; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2012, WORLD HLTH STAT 2012; Wright-Nunes JA, 2012, PATIENT EDUC COUNS, V88, P184, DOI 10.1016/j.pec.2012.02.015; Wu XM, 2011, CHINA MOD DOCT, V49, P27; Yang J, 2005, CHIN J PUBLIC HLTH, V21, P131; Zhang JJ, 2010, CHIN J HLTH ED, V26, P905; Zhou G, 2011, CHIN J HLTH ED, V27, P490; Zhou Qin, 2010, Chinese Journal of Prevention and Control of Chronic Diseases, V18, P587; Zhou W, 2007, CHIN J HLTH ED, V23, P868	47	17	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e68599	10.1371/journal.pone.0068599	http://dx.doi.org/10.1371/journal.pone.0068599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826394	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400179
J	Hofmeijer, J; Franssen, H; van Schelven, LJ; van Putten, MJAM				Hofmeijer, Jeannette; Franssen, Hessel; van Schelven, Leonard J.; van Putten, Michel J. A. M.			Why Are Sensory Axons More Vulnerable for Ischemia than Motor Axons?	PLOS ONE			English	Article							HUMAN PERIPHERAL-NERVE; HUMAN DIABETIC NERVES; EXCITABILITY PROPERTIES; CUTANEOUS AFFERENTS; POLYNEUROPATHY; NEUROPATHY; CURRENTS; DEPOLARIZATION; SENSITIVITY; RESISTANCE	Objective: In common peripheral neuropathies, sensory symptoms usually prevail over motor symptoms. This predominance of sensory symptoms may result from higher sensitivity of sensory axons to ischemia. Methods: We measured median nerve compound sensory action potentials (CSAPs), compound muscle action potentials (CMAPs), and excitability indices in five healthy subjects during forearm ischemia lasting up to disappearance of both CSAPs and CMAPs. Results: Ischemia induced: (1) earlier disappearance of CSAPs than CMAPs (mean +/- standard deviation 30 +/- 5 vs. 46 +/- 6 minutes), (2) initial changes compatible with axonal depolarization on excitability testing (decrease in threshold, increase in strength duration time constant (SDTC) and refractory period, and decrease in absolute superexcitability) which were all more prominent in sensory than in motor axons, and (3) a subsequent decrease of SDTC reflecting a decrease in persistent Na+ conductance during continuing depolarisation. Interpretation: Our study shows that peripheral sensory axons are more vulnerable for ischemia than motor axons, with faster inexcitability during ischemia. Excitability studies during ischemia showed that this was associated with faster depolarization and faster persistent Na+ channel inactivation in sensory than in motor axons. These findings might be attributed to differences in ion channel composition between sensory and motor axons and may contribute to the predominance of sensory over motor symptoms in common peripheral neuropathies.	[Hofmeijer, Jeannette; van Putten, Michel J. A. M.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands; [Hofmeijer, Jeannette] Rijnstate Hosp, Dept Neurol, Arnhem, Netherlands; [Franssen, Hessel; van Schelven, Leonard J.] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands; [Franssen, Hessel; van Schelven, Leonard J.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [van Putten, Michel J. A. M.] Medisch Spectrum Twente, Dept Clin Neurophysiol, Enschede, Netherlands	University of Twente; Rijnstate Hospital; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Medical Spectrum Twente	Hofmeijer, J (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands.	jhofmeijer@rijnstate.nl	van Putten, Michel J.A.M./D-6519-2018; van Schelven, Leonard J/B-4226-2008	van Putten, Michel J.A.M./0000-0001-8319-3626; van Schelven, Leonard J/0000-0001-7903-0306				BOSTOCK H, 1991, J PHYSIOL-LONDON, V441, P537, DOI 10.1113/jphysiol.1991.sp018766; BOSTOCK H, 1994, BRAIN, V117, P225, DOI 10.1093/brain/117.2.225; Bostock H, 1996, J PHYSL, V487, P47; Caruso G, 1971, J NEUROL NEUROSUR PS, V36, P455; FINK BR, 1982, PAIN, V12, P307, DOI 10.1016/0304-3959(82)90176-2; Franssen H, 2010, J PERIPHER NERV SYST, V15, P227, DOI 10.1111/j.1529-8027.2010.00275.x; FUJIMURA H, 1991, BRAIN, V114, P1929, DOI 10.1093/brain/114.4.1929; Grosskreutz J, 1999, J PHYSIOL-LONDON, V518, P301, DOI 10.1111/j.1469-7793.1999.0301r.x; Han SE, 2008, CLIN NEUROPHYSIOL, V119, P2054, DOI 10.1016/j.clinph.2008.04.295; Han SE, 2009, J PERIPHER NERV SYST, V14, P190, DOI 10.1111/j.1529-8027.2009.00231.x; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Howells J, 2012, J PHYSIOL-LONDON, V590, P1625, DOI 10.1113/jphysiol.2011.225573; Huynh W, 2011, MUSCLE NERVE, V44, P841, DOI 10.1002/mus.22209; Kiernan MC, 2000, MUSCLE NERVE, V23, P399, DOI 10.1002/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G; Kiernan MC, 1996, BRAIN, V119, P1099, DOI 10.1093/brain/119.4.1099; Kiernan MC, 2001, BRAIN, V124, P816, DOI 10.1093/brain/124.4.816; Kiernan MC, 2000, BRAIN, V123, P2542, DOI 10.1093/brain/123.12.2542; KOZU H, 1992, J NEUROL SCI, V111, P204, DOI 10.1016/0022-510X(92)90070-2; Krishnan AV, 2008, BRAIN, V131, P1209, DOI 10.1093/brain/awn052; Krishnan AV, 2005, BRAIN, V128, P1178, DOI 10.1093/brain/awh476; Kuwabara S, 2002, INTERNAL MED, V41, P360, DOI 10.2169/internalmedicine.41.360; Lin CSY, 2002, J PHYSIOL-LONDON, V538, P435, DOI 10.1113/jphysiol.2001.012478; Lin CSY, 2002, J PHYSIOL-LONDON, V541, P1025, DOI 10.1113/jphysiol.2002.017848; Maurer K, 2012, J PERIPHER NERV SYST, V17, P102, DOI 10.1111/j.1529-8027.2012.00381.x; Misawa S, 2006, CLIN NEUROPHYSIOL, V117, P815, DOI 10.1016/j.clinph.2005.11.019; Mogyoros I, 1996, BRAIN, V119, P439, DOI 10.1093/brain/119.2.439; Mogyoros I, 1997, BRAIN, V120, P317, DOI 10.1093/brain/120.2.317; NIELSEN VK, 1981, ANN NEUROL, V9, P597, DOI 10.1002/ana.410090614; NOTERMANS NC, 1994, J NEUROL NEUROSUR PS, V57, P1525, DOI 10.1136/jnnp.57.12.1525; NUKADA H, 1985, EXP NEUROL, V87, P369, DOI 10.1016/0014-4886(85)90227-4; OLNEY RK, 1987, MUSCLE NERVE, V10, P728, DOI 10.1002/mus.880100809; PARRY GJ, 1982, ANN NEUROL, V11, P147, DOI 10.1002/ana.410110207; ROSS MA, 1993, MED CLIN N AM, V77, P111, DOI 10.1016/S0025-7125(16)30275-9; SCHNEIDER U, 1992, ANN NEUROL, V31, P605, DOI 10.1002/ana.410310607; SENEVIRATNE KN, 1968, J NEUROL NEUROSUR PS, V31, P348, DOI 10.1136/jnnp.31.4.348; SENEVIRATNE KN, 1968, J NEUROL NEUROSUR PS, V31, P338, DOI 10.1136/jnnp.31.4.338; STRUPP M, 1990, J NEUROL SCI, V99, P271, DOI 10.1016/0022-510X(90)90161-F; Tan SH, 2012, J RECONSTR MICROSURG, V28, P387, DOI 10.1055/s-0032-1315761; Teunissen LL, 2002, J NEUROL NEUROSUR PS, V72, P590, DOI 10.1136/jnnp.72.5.590; WEIGL P, 1989, ELECTROEN CLIN NEURO, V73, P369, DOI 10.1016/0013-4694(89)90115-6; Z'Graggen WJ, 2008, EUR J ANAESTH, V25, P68, DOI 10.1017/S0265021508003505; Z'Graggen WJ, 2006, BRAIN, V129, P2461, DOI 10.1093/brain/awl191	42	33	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e67113	10.1371/journal.pone.0067113	http://dx.doi.org/10.1371/journal.pone.0067113			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840596	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800119
J	Jiao, CW; Xie, YZ; Yang, XL; Li, HR; Li, XM; Pan, HH; Cai, MH; Zhong, HM; Yang, BB				Jiao, Chunwei; Xie, Yi-Zhen; Yang, Xiangling; Li, Haoran; Li, Xiang-Min; Pan, Hong-Hui; Cai, Mian-Hua; Zhong, Hua-Mei; Yang, Burton B.			Anticancer Activity of Amauroderma rude	PLOS ONE			English	Article							LUCIDUM FR KARST; GANODERMA-LUCIDUM; CELL-PROLIFERATION; ANTITUMOR-ACTIVITY; CANCER CELLS; POLYSACCHARIDE; APOPTOSIS; TUMOR; ANGIOGENESIS; METASTASIS	More and more medicinal mushrooms have been widely used as a miraculous herb for health promotion, especially by cancer patients. Here we report screening thirteen mushrooms for anti-cancer cell activities in eleven different cell lines. Of the herbal products tested, we found that the extract of Amauroderma rude exerted the highest activity in killing most of these cancer cell lines. Amauroderma rude is a fungus belonging to the Ganodermataceae family. The Amauroderma genus contains approximately 30 species widespread throughout the tropical areas. Since the biological function of Amauroderma rude is unknown, we examined its anti-cancer effect on breast carcinoma cell lines. We compared the anti-cancer activity of Amauroderma rude and Ganoderma lucidum, the most well-known medicinal mushrooms with anti-cancer activity and found that Amauroderma rude had significantly higher activity in killing cancer cells than Ganoderma lucidum. We then examined the effect of Amauroderma rude on breast cancer cells and found that at low concentrations, Amauroderma rude could inhibit cancer cell survival and induce apoptosis. Treated cancer cells also formed fewer and smaller colonies than the untreated cells. When nude mice bearing tumors were injected with Amauroderma rude extract, the tumors grew at a slower rate than the control. Examination of these tumors revealed extensive cell death, decreased proliferation rate as stained by Ki67, and increased apoptosis as stained by TUNEL. Suppression of c-myc expression appeared to be associated with these effects. Taken together, Amauroderma rude represented a powerful medicinal mushroom with anti-cancer activities.	[Jiao, Chunwei; Xie, Yi-Zhen; Li, Xiang-Min; Pan, Hong-Hui; Cai, Mian-Hua; Zhong, Hua-Mei] Guangdong Inst Microbiol, Guangzhou, Guangdong, Peoples R China; [Jiao, Chunwei; Yang, Xiangling; Li, Haoran; Yang, Burton B.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Li, Haoran; Yang, Burton B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Yang, BB (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada.	byang@sri.utoronto.ca	Li, Hao/GPS-9834-2022	Yang, Xiangling/0000-0002-5881-4299	Canadian Institutes of Health Research [MOP-102635, MOP-111171]; Career Investigator Award from Heart and Stroke Foundation of Ontario [CI 7418]; Government of Guangdong Province	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Career Investigator Award from Heart and Stroke Foundation of Ontario; Government of Guangdong Province	This work was supported by grants from Canadian Institutes of Health Research (MOP-102635, MOP-111171) to BBY who is the recipient of a Career Investigator Award (CI 7418) from the Heart and Stroke Foundation of Ontario. The study was also supported by a grant from the Government of Guangdong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bao PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039343; El-Mekkawy S, 1998, PHYTOCHEMISTRY, V49, P1651, DOI 10.1016/S0031-9422(98)00254-4; Eliza WLY, 2012, RECENT PATENTS INFLA, V6, P78, DOI [10.2174/187221312798889275, 10.2174/187221312798889310]; Engebraaten O, 1999, INT J CANCER, V82, P219, DOI 10.1002/(SICI)1097-0215(19990719)82:2<219::AID-IJC12>3.0.CO;2-#; Eo SK, 1999, J ETHNOPHARMACOL, V68, P175, DOI 10.1016/S0378-8741(99)00086-0; Fang L, 2012, CELL CYCLE, V11, P4352, DOI 10.4161/cc.22670; Gao YH, 2002, LIFE SCI, V72, P731, DOI 10.1016/S0024-3205(02)02301-9; Hsu MJ, 2002, J LEUKOCYTE BIOL, V72, P207; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Ji Z, 2011, ONCOL LETT, V2, P565, DOI 10.3892/ol.2011.275; Joseph S, 2011, ACTA PHARMACEUT, V61, P335, DOI 10.2478/v10007-011-0030-6; Kim TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046208; Kirk PM., 2008, DICT FUNGI, V10th ed; KOHDA H, 1985, CHEM PHARM BULL, V33, P1367; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013599; LIEU CW, 1992, ANTICANCER RES, V12, P1211; Lin Z B, 2001, Zhongguo Zhong Xi Yi Jie He Za Zhi, V21, P883; Luk SU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019804; MARUYAMA H, 1989, J PHARMACOBIO-DYNAM, V12, P118, DOI 10.1248/bpb1978.12.118; MURASUGI A, 1991, J BIOL CHEM, V266, P2486; Park EJ, 1997, BIOL PHARM BULL, V20, P417, DOI 10.1248/bpb.20.417; Sakamoto J, 1988, Gan To Kagaku Ryoho, V15, P1935; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Shang DJ, 2011, ONCOL REP, V25, P267, DOI 10.3892/or_00001070; Sheng W, 2005, MOL BIOL CELL, V16, P1330, DOI 10.1091/mbc.e04-04-0295; Sliva D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047873; Suarez-Arroyo IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057431; Tamagawa K, 2012, LANGENBECK ARCH SURG, V397, P475, DOI 10.1007/s00423-011-0896-2; TSUKAGOSHI S, 1984, CANCER TREAT REV, V11, P131, DOI 10.1016/0305-7372(84)90005-7; Wang SY, 1997, INT J CANCER, V70, P699, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;699::AID-IJC12&gt;3.0.CO;2-5; Welti S, 2010, FUNGAL DIVERS, V43, P103, DOI 10.1007/s13225-010-0036-2; Wu QP, 2006, ENZYME MICROB TECH, V40, P32, DOI 10.1016/j.enzmictec.2005.10.034; Wu QP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044579; Wu TS, 2001, J NAT PROD, V64, P1121, DOI 10.1021/np010115w; Xie YZ, 2006, ENZYME MICROB TECH, V40, P177, DOI 10.1016/j.enzmictec.2005.10.051; Zhang JS, 2010, LIFE SCI, V87, P628, DOI 10.1016/j.lfs.2010.09.026; Zhao SF, 2011, INT J ONCOL, V38, P1319, DOI 10.3892/ijo.2011.965; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje	40	29	31	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66504	10.1371/journal.pone.0066504	http://dx.doi.org/10.1371/journal.pone.0066504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840494	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800073
J	Paubelle, E; Zylbersztejn, F; Alkhaeir, S; Suarez, F; Callens, C; Dussiot, M; Isnard, F; Rubio, MT; Damaj, G; Gorin, NC; Marolleau, JP; Monteiro, RC; Moura, IC; Hermine, O				Paubelle, Etienne; Zylbersztejn, Florence; Alkhaeir, Sawsaneh; Suarez, Felipe; Callens, Celine; Dussiot, Michael; Isnard, Francoise; Rubio, Marie-Therese; Damaj, Gandhi; Gorin, Norbert-Claude; Marolleau, Jean-Pierre; Monteiro, Renato C.; Moura, Ivan C.; Hermine, Olivier			Deferasirox and Vitamin D Improves Overall Survival in Elderly Patients with Acute Myeloid Leukemia after Demethylating Agents Failure	PLOS ONE			English	Article							DIFFERENTIATING AGENTS; OLDER PATIENTS; AML; CYTOGENETICS; TRIAL; CELLS; CARE	The prognosis of acute myeloid leukemia (AML) in elderly (>= 65 years) patients is poor and treatment remains non-consensual especially for those who are not eligible for intensive therapies. Our group has shown that in vitro the iron chelator deferasirox (DFX) synergizes with vitamin D (VD) to promote monocyte differentiation in primary AML cells. Herein, we present results from a retrospective case-control study in which the association of DFX (1-2 g/d) and 25-hydroxycholecalciferol (100,000 IU/week) (DFX/VD) was proposed to patients following demethylating agents failure. Median survival of patients treated with DFX/VD combination (n = 17) was significantly increased in comparison with matched patients receiving best supportive care (BSC) alone (n = 13) (10.4 versus 4 months respectively). In addition, the only factor associated to an increased overall survival in DFX/VD-treated patients was serum VD levels. We conclude that DFX/VD treatment correlated with increased overall survival of AML patients in this retrospective cohort of elderly patients.	[Paubelle, Etienne; Zylbersztejn, Florence; Alkhaeir, Sawsaneh; Callens, Celine; Dussiot, Michael; Hermine, Olivier] Univ Paris 05, Fac Med, Hop Necker, CNRS UMR 8147, Paris, France; [Paubelle, Etienne; Zylbersztejn, Florence; Alkhaeir, Sawsaneh; Dussiot, Michael; Monteiro, Renato C.; Moura, Ivan C.] INSERM U699, Paris, France; [Paubelle, Etienne; Zylbersztejn, Florence; Alkhaeir, Sawsaneh; Suarez, Felipe; Dussiot, Michael; Moura, Ivan C.; Hermine, Olivier] Univ Sorbonne Paris Cite, Hop Necker, IHU Imagine, AP HP, Paris, France; [Paubelle, Etienne; Suarez, Felipe; Hermine, Olivier] Hop Necker Enfants Malad, AP HP, Serv Hematol Clin, Paris, France; [Dussiot, Michael; Hermine, Olivier] Lab Excellence Globules Rouges GR Ex, Paris, France; [Isnard, Francoise; Rubio, Marie-Therese] Univ Paris 06, Dept Hematol, AP HP Hop St Antoine, Paris, France; [Damaj, Gandhi; Marolleau, Jean-Pierre] CHU Sud, Amiens, France; [Monteiro, Renato C.] Hop Bichat Claude Bernard, AP HP, Serv Immunol, F-75877 Paris, France; [Monteiro, Renato C.; Moura, Ivan C.] Fac Med, Paris, France; [Monteiro, Renato C.; Moura, Ivan C.] Univ Paris 07, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Hermine, O (corresponding author), Univ Paris 05, Fac Med, Hop Necker, CNRS UMR 8147, Paris, France.	olivier.hermine@nck.aphp.fr	Moura, Ivan C/A-9510-2013; Hermine, Olivier/Q-7072-2018; Monteiro, Renato C/U-8633-2017; Cruz Moura, Ivan/A-9510-2013	Moura, Ivan C/0000-0002-2977-0354; Monteiro, Renato C/0000-0001-5202-5646; Cruz Moura, Ivan/0000-0002-8418-2803; Hermine, Olivier/0000-0003-2574-3874	Fondation pour la Recherche Medicale (FRM); fondation de France; Ligue contre le cancer, le canceropole; Institut National du Cancer (INCA); association Laurette Fugain; Association pour la Recherche contre le Cancer (ARC)	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); fondation de France(Fondation de France); Ligue contre le cancer, le canceropole; Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); association Laurette Fugain; Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR))	The Fondation pour la Recherche Medicale (FRM), the fondation de France, Ligue contre le cancer, le canceropole, Institut National du Cancer (INCA), association Laurette Fugain and the Association pour la Recherche contre le Cancer (ARC) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Callens C, 2010, J EXP MED, V207, P731, DOI 10.1084/jem.20091488; Estey E, 2009, BEST PRACT RES CL HA, V22, P529, DOI 10.1016/j.beha.2009.08.007; Fenaux P, 2010, J CLIN ONCOL, V28, P562, DOI 10.1200/JCO.2009.23.8329; Ferrero D, 2004, HAEMATOLOGICA, V89, P619; Frohling S, 2006, BLOOD, V108, P3280, DOI 10.1182/blood-2006-04-014324; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Hughes PJ, 2010, LEUKEMIA RES, V34, P553, DOI 10.1016/j.leukres.2009.09.010; Kantarjian HM, 2012, J CLIN ONCOL, V30, P2670, DOI 10.1200/JCO.2011.38.9429; Lichtman SM, 1999, AM J HEMATOL, V61, P262, DOI 10.1002/(SICI)1096-8652(199908)61:4<262::AID-AJH7>3.0.CO;2-B; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; Messa E, 2010, HAEMATOL-HEMATOL J, V95, P1308, DOI 10.3324/haematol.2009.016824; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Quintas-Cardama A, 2012, BLOOD; Rose C, 2010, LEUKEMIA RES, V34, P864, DOI 10.1016/j.leukres.2009.12.004	16	29	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65998	10.1371/journal.pone.0065998	http://dx.doi.org/10.1371/journal.pone.0065998			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840388	Green Submitted, gold, Green Published			2022-12-27	WOS:000322342800026
J	Schmidlin, T; Hurlimann, E; Silue, KD; Yapi, RB; Houngbedji, C; Kouadio, BA; Acka-Douabele, CA; Kouassi, D; Ouattara, M; Zouzou, F; Bonfoh, B; N'Goran, EK; Utzinger, J; Raso, G				Schmidlin, Thomas; Huerlimann, Eveline; Silue, Kigbafori D.; Yapi, Richard B.; Houngbedji, Clarisse; Kouadio, Bernadette A.; Acka-Douabele, Cinthia A.; Kouassi, Dongo; Ouattara, Mamadou; Zouzou, Fabien; Bonfoh, Bassirou; N'Goran, Eliezer K.; Utzinger, Juerg; Raso, Giovanna			Effects of Hygiene and Defecation Behavior on Helminths and Intestinal Protozoa Infections in Taabo, Cote d'Ivoire	PLOS ONE			English	Article							NEGLECTED TROPICAL DISEASES; SCHISTOSOMA-HAEMATOBIUM; PARASITIC INFECTIONS; ETHER-CONCENTRATION; HOOKWORM INFECTION; DIFFERENT SETTINGS; STOOL SAMPLES; KATO-KATZ; DIAGNOSIS; HEALTH	Background: More than 1 billion people are currently infected with soil-transmitted helminths and schistosomes. The global strategy to control helminthiases is the regular administration of anthelmintic drugs to at-risk populations. However, rapid re-infection occurs in areas where hygiene, access to clean water, and sanitation are inadequate. Methodology: In July 2011, inhabitants from two villages and seven hamlets of the Taabo health demographic surveillance system in south-central Cote d'Ivoire provided stool and urine samples. Kato-Katz and ether-concentration methods were used for the diagnosis of Schistosoma mansoni, soil-transmitted helminths (Ascaris lumbricoides, Trichuris trichiura, and hookworm), and intestinal protozoa. Urine samples were subjected to a filtration method for the diagnosis of Schistosoma haematobium. A questionnaire was administered to households to obtain information on knowledge, attitude, practice, and beliefs in relation to hygiene, sanitation, and defecation behavior. Logistic regression models were employed to assess for associations between questionnaire data and parasitic infections. Principal Findings: A total of 1,894 participants had complete data records. Parasitological examinations revealed prevalences of hookworm, S. haematobium, T. trichiura, S. mansoni, and A. lumbricoides of 33.5%, 7.0%, 1.6%, 1.3% and 0.8%, respectively. Giardia intestinalis and Entamoeba histolytica/E. dispar were detected in 15.0% and 14.4% of the participants, respectively. Only one out of five households reported the presence of a latrine, and hence, open defecation was common. Logistic regression analysis revealed that age, sex, socioeconomic status, hygiene, and defecation behavior are determinants for helminths and intestinal protozoa infections. Conclusions/Significance: We found that inadequate sanitation and hygiene behavior are associated with soil-transmitted helminths and intestinal protozoa infections in the Taabo area of south-central Cote d'Ivoire. Our data will serve as a benchmark to monitor the effect of community-led total sanitation and hygiene education to reduce the transmission of helminthiases and intestinal protozoa infections.	[Schmidlin, Thomas; Huerlimann, Eveline; Utzinger, Juerg; Raso, Giovanna] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Schmidlin, Thomas; Huerlimann, Eveline; Utzinger, Juerg; Raso, Giovanna] Univ Basel, Basel, Switzerland; [Schmidlin, Thomas; Huerlimann, Eveline; Silue, Kigbafori D.; Yapi, Richard B.; Houngbedji, Clarisse; Kouadio, Bernadette A.; Acka-Douabele, Cinthia A.; Kouassi, Dongo; Zouzou, Fabien; Bonfoh, Bassirou; N'Goran, Eliezer K.; Raso, Giovanna] Ctr Suisse Rech Sci Cote dIvoire, Dept Environm & Sante, Abidjan, Cote Ivoire; [Silue, Kigbafori D.; Yapi, Richard B.; Ouattara, Mamadou; N'Goran, Eliezer K.] Univ Felix Houphouet Boigny, Unite Format & Rech Biosci, Abidjan, Cote Ivoire; [Houngbedji, Clarisse] Univ Nangui Abrogoua, Unite Format & Rech Sci Nat, Abidjan, Cote Ivoire; [Kouadio, Bernadette A.] Univ Alassane Ouattara, Unite Format & Rech Commun Milieu & Soc, Bouake, Cote Ivoire; [Kouassi, Dongo] Univ Felix Houphouet Boigny, Unite Format & Rech Sci Terre & Ressources Minier, Abidjan, Cote Ivoire	University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Raso, G (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland.	giovanna.raso@unibas.ch	Huerlimann, Eveline/J-2687-2019	Huerlimann, Eveline/0000-0001-6212-8198; Yapi, Richard Brou/0000-0002-5167-2961; Dongo, Kouassi/0000-0002-2032-290X; Kigbafori Dieudonne, Silue/0000-0003-1003-9294; Ouattara, Mamadou/0000-0002-4650-9676	UBS Optimus Foundation; Swiss National Science Foundation [IZ70Z0_123900, 32003B_132949/1]; Swiss Tropical and Public Health Institute	UBS Optimus Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Tropical and Public Health Institute	This study received financial support from the UBS Optimus Foundation. Jurg Utzinger and Giovanna Raso acknowledge financial support from the Swiss National Science Foundation (project no. IZ70Z0_123900 and project no. 32003B_132949/1). Thomas Schmidlin acknowledges financial support from the Swiss Tropical and Public Health Institute (Teaching & Training). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acka CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000910; ALLEN AVH, 1970, J CLIN PATHOL, V23, P545, DOI 10.1136/jcp.23.6.545; [Anonymous], 2008, HDB COMMUNITY LED TO; [Anonymous], 2006, PREV CHEM HUM HELM C; Bartram J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000367; Becker SL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-37; Becker SL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001292; Booth M, 2003, PARASITOLOGY, V127, P525, DOI 10.1017/S0031182003004128; Cort WW, 1929, AM J HYG, V10, P0614, DOI 10.1093/oxfordjournals.aje.a112772; Coulibaly JT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-135; Cringoli G, 2010, NAT PROTOC, V5, P503, DOI 10.1038/nprot.2009.235; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Ejemot RJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004265.pub2; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Furst T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064380; Furst T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001855; Geerts S, 2000, CLIN MICROBIOL REV, V13, P207, DOI 10.1128/CMR.13.2.207-222.2000; Glinz D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000754; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Jenkins MW, 2007, SOC SCI MED, V64, P2427, DOI 10.1016/j.socscimed.2007.03.010; Jia TW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001621; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Knopp S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000331; Knopp S, 2010, CLIN INFECT DIS, V51, P1420, DOI 10.1086/657310; Kouadio M'Bra Kd, 2013, BMC Hematol, V13, P5, DOI 10.1186/2052-1839-13-5; Mara D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000363; MARTI H, 1990, SCHWEIZ MED WSCHR, V120, P1473; Mineno T, 2003, CURR PHARM DESIGN, V9, P841, DOI 10.2174/1381612033455260; Montresor A., 1998, WORLD HLTH ORG; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; N'Goran EK, 2003, AM J TROP MED HYG, V68, P24, DOI 10.4269/ajtmh.2003.68.24; N'Goran EK, 2001, TROP MED INT HEALTH, V6, P817, DOI 10.1046/j.1365-3156.2001.00785.x; QUINNELL RJ, 1993, PARASITOLOGY, V106, P379, DOI 10.1017/S0031182000067123; Raso G, 2005, TROP MED INT HEALTH, V10, P42, DOI 10.1111/j.1365-3156.2004.01352.x; Righetti AA, 2013, J INFECT DIS, V207, P1604, DOI 10.1093/infdis/jit066; Righetti AA, 2012, AM J TROP MED HYG, V87, P425, DOI 10.4269/ajtmh.2012.11-0788; SAVIOLI L, 1990, AM J TROP MED HYG, V43, P289, DOI 10.4269/ajtmh.1990.43.289; Savioli L, 2009, PARASITOLOGY, V136, P1677, DOI 10.1017/S0031182009991181; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Scherrer AU, 2009, ACTA TROP, V109, P226, DOI 10.1016/j.actatropica.2008.11.015; Singer BH, 2007, P NATL ACAD SCI USA, V104, P16038, DOI 10.1073/pnas.0700900104; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; STILES CHARLES WARDELL, 1939, JOUR PARASITOL, V25, P283, DOI 10.2307/3272014; Toure S, 2008, B WORLD HEALTH ORGAN, V86, P780, DOI 10.2471/BLT.07.048694; Utzinger J, 2003, LANCET, V362, P1932, DOI 10.1016/S0140-6736(03)14968-9; Utzinger J, 2010, CLIN MICROBIOL INFEC, V16, P267, DOI 10.1111/j.1469-0691.2009.02782.x; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; Utzinger J, 2001, PARASITOLOGY, V122, P537, DOI 10.1017/S0031182001007752; Utzinger J, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13727; Utzinger J, 2011, ACTA TROP, V120, pS121, DOI 10.1016/j.actatropica.2010.08.020; Verweij JJ, 2007, AM J TROP MED HYG, V77, P685, DOI 10.4269/ajtmh.2007.77.685; WAGSTAFF A, 1991, SOC SCI MED, V33, P545, DOI 10.1016/0277-9536(91)90212-U; WALSH JA, 1986, REV INFECT DIS, V8, P228; WHO UNICEF, 2010, PROGR SAN DRINK WAT; World Health Organization, 2002, WHO TRADITIONAL MED, P1; Ziegelbauer K, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001162	60	61	63	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65722	10.1371/journal.pone.0065722	http://dx.doi.org/10.1371/journal.pone.0065722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840358	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000322342800017
J	Ballarini, F; Martinez, MC; Perez, MD; Moncada, D; Viola, H				Ballarini, Fabricio; Cecilia Martinez, Maria; Diaz Perez, Magdalena; Moncada, Diego; Viola, Haydee			Memory in Elementary School Children Is Improved by an Unrelated Novel Experience	PLOS ONE			English	Article							LONG-TERM-MEMORY; CAPTURE HYPOTHESIS; SPATIAL-MEMORY; LATE-LTP; CONSOLIDATION; POTENTIATION; ACTIVATION; RETRIEVAL; EXPOSURE; TAG	Education is the most traditional means with formative effect on the human mind, learning and memory being its fundamental support. For this reason, it is essential to find different strategies to improve the students performance. Based on previous work, we hypothesized that a novel experience could exert an enhancing effect on learning and memory within the school environment. Here we show that novel experience improved the memory of literary or graphical activities when it is close to these learning sessions. We found memory improvements in groups of students who had experienced a novel science lesson 1 hour before or after the reading of a story, but not when these events were 4 hours apart. Such promoting effect on long-term memory (LTM) was also reproduced with another type of novelty (a music lesson) and also after another type of learning task (a visual memory). Interestingly, when the lesson was familiar, it failed to enhance the memory of the other task. Our results show that educationally relevant novel events experienced during normal school hours can improve LTM for tasks/activities learned during regular school lessons. This effect is restricted to a critical time window around learning and is particularly dependent on the novel nature of the associated experience. These findings provide a tool that could be easily transferred to the classroom by the incorporation of educationally novel events in the school schedule as an extrinsic adjuvant of other information acquired some time before or after it. This approach could be a helpful tool for the consolidation of certain types of topics that generally demand a great effort from the children.	[Ballarini, Fabricio; Cecilia Martinez, Maria; Diaz Perez, Magdalena; Moncada, Diego; Viola, Haydee] Univ Buenos Aires, Fac Med, Consejo Nacl Invest Cientif & Tecn Argentina, Inst Biol Celular & Neurociencias, Buenos Aires, DF, Argentina; [Viola, Haydee] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Viola, H (corresponding author), Univ Buenos Aires, Fac Med, Consejo Nacl Invest Cientif & Tecn Argentina, Inst Biol Celular & Neurociencias, Buenos Aires, DF, Argentina.	hviola@fmed.uba.ar	Moncada, Diego/AAV-3903-2021	Martinez, Maria Cecilia/0000-0002-1110-111X; Moncada, Diego/0000-0002-5530-0989	Universidad de Buenos Aires; Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)	Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT)	This work was supported by grants from the Universidad de Buenos Aires and the Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; Almaguer-Melian W, 2012, P NATL ACAD SCI USA, V109, P953, DOI 10.1073/pnas.1114198109; Ballarini F, 2009, P NATL ACAD SCI USA, V106, P14599, DOI 10.1073/pnas.0907078106; Barco A, 2008, NEUROSCI BIOBEHAV R, V32, P831, DOI 10.1016/j.neubiorev.2008.01.002; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Frey U, 1998, NEUROPHARMACOLOGY, V37, P545, DOI 10.1016/S0028-3908(98)00040-9; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Karpicke JD, 2008, SCIENCE, V319, P966, DOI 10.1126/science.1152408; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Lisman J, 2011, TRENDS NEUROSCI, V34, P536, DOI 10.1016/j.tins.2011.07.006; Lu Y, 2011, J NEUROSCI, V31, P11762, DOI 10.1523/JNEUROSCI.2707-11.2011; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Moncada D, 2007, J NEUROSCI, V27, P7476, DOI 10.1523/JNEUROSCI.1083-07.2007; Moncada D, 2011, P NATL ACAD SCI USA, V108, P12931, DOI 10.1073/pnas.1104495108; MULLER GE, 1900, PSYCHOL ERGANZUNGSBA, V1, P1; Nouchi R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029676, DOI 10.1371/J0URNAL.-P0NE.0029676]; Owen AM, 2010, NATURE, V465, P775, DOI 10.1038/nature09042; Redondo RL, 2011, NAT REV NEUROSCI, V12, P17, DOI 10.1038/nrn2963; Rey A., 1959, CTR PSYCHOLOGIE APPL; Roediger HL, 2011, TRENDS COGN SCI, V15, P20, DOI 10.1016/j.tics.2010.09.003; Roozendaal B, 2011, BEHAV NEUROSCI, V125, P797, DOI 10.1037/a0026187; Schwabe L, 2008, NEUROBIOL LEARN MEM, V90, P44, DOI 10.1016/j.nlm.2008.02.002; Schweizer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024372; Shin MS, 2006, NAT PROTOC, V1, P892, DOI 10.1038/nprot.2006.115; Wang SH, 2010, P NATL ACAD SCI USA, V107, P19537, DOI 10.1073/pnas.1008638107; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010	31	41	41	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66875	10.1371/journal.pone.0066875	http://dx.doi.org/10.1371/journal.pone.0066875			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840541	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200108
J	Jordan, JJ; Rand, DG; Arbesman, S; Fowler, JH; Christakis, NA				Jordan, Jillian J.; Rand, David G.; Arbesman, Samuel; Fowler, James H.; Christakis, Nicholas A.			Contagion of Cooperation in Static and Fluid Social Networks	PLOS ONE			English	Article							INFINITELY REPEATED GAMES; ALTRUISTIC PUNISHMENT; PROMOTE COOPERATION; EMOTIONAL CONTAGION; PRISONERS-DILEMMA; MECHANICAL TURK; EVOLUTION; BEHAVIOR; HUMANS; RECIPROCITY	Cooperation is essential for successful human societies. Thus, understanding how cooperative and selfish behaviors spread from person to person is a topic of theoretical and practical importance. Previous laboratory experiments provide clear evidence of social contagion in the domain of cooperation, both in fixed networks and in randomly shuffled networks, but leave open the possibility of asymmetries in the spread of cooperative and selfish behaviors. Additionally, many real human interaction structures are dynamic: we often have control over whom we interact with. Dynamic networks may differ importantly in the goals and strategic considerations they promote, and thus the question of how cooperative and selfish behaviors spread in dynamic networks remains open. Here, we address these questions with data from a social dilemma laboratory experiment. We measure the contagion of both cooperative and selfish behavior over time across three different network structures that vary in the extent to which they afford individuals control over their network ties. We find that in relatively fixed networks, both cooperative and selfish behaviors are contagious. In contrast, in more dynamic networks, selfish behavior is contagious, but cooperative behavior is not: subjects are fairly likely to switch to cooperation regardless of the behavior of their neighbors. We hypothesize that this insensitivity to the behavior of neighbors in dynamic networks is the result of subjects' desire to attract new cooperative partners: even if many of one's current neighbors are defectors, it may still make sense to switch to cooperation. We further hypothesize that selfishness remains contagious in dynamic networks because of the well-documented willingness of cooperators to retaliate against selfishness, even when doing so is costly. These results shed light on the contagion of cooperative behavior in fixed and fluid networks, and have implications for influence-based interventions aiming at increasing cooperative behavior.	[Jordan, Jillian J.; Rand, David G.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Arbesman, Samuel] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Arbesman, Samuel] Ewing Marion Kauffman Fdn, Kansas City, MO USA; [Jordan, Jillian J.; Rand, David G.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA; [Christakis, Nicholas A.] Yale Univ, Dept Sociol, New Haven, CT USA; [Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [Fowler, James H.] Univ Calif San Diego, Dept Med Genet, La Jolla, CA 92093 USA	Harvard University; Harvard University; Yale University; Yale University; University of California System; University of California San Diego; University of California System; University of California San Diego	Rand, DG (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	david.rand@yale.edu	Fowler, James H/C-2750-2008	Fowler, James H/0000-0001-7795-1638; Rand, David/0000-0001-8975-2783	National Institute on Aging [P01-AG031093]; Pioneer Portfolio of the Robert Wood Johnson Foundation; Science of Generosity Initiative of the University of Notre Dame; John Templeton Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031093] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Pioneer Portfolio of the Robert Wood Johnson Foundation; Science of Generosity Initiative of the University of Notre Dame; John Templeton Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Grant P01-AG031093 from the National Institute on Aging (http://www.nia.nih.gov/), a grant from the Pioneer Portfolio of the Robert Wood Johnson Foundation (http://www.rwjf.org/en/about-rwjf/program-areas/pioneer.html), and by the Science of Generosity Initiative of the University of Notre Dame, supported by The John Templeton Foundation (http://www.templeton.org/). D. G. R. is also supported by a grant from The John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031461; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barsade SG, 2002, ADMIN SCI QUART, V47, P644, DOI 10.2307/3094912; Bearman PS, 2004, AM J PUBLIC HEALTH, V94, P89, DOI 10.2105/AJPH.94.1.89; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Christakis N.A., 2008, BRIT MED J, P337; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Cohen L, 2008, J POLIT ECON, V116, P951, DOI 10.1086/592415; Dal Bo P, 2005, AM ECON REV, V95, P1591; Dal Bo P, 2011, AM ECON REV, V101, P411, DOI 10.1257/aer.101.1.411; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Espin AM, 2012, P ROY SOC B-BIOL SCI, V279, P4923, DOI 10.1098/rspb.2012.2043; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; Fudenberg D, 2012, AM ECON REV, V102, P720, DOI 10.1257/aer.102.2.720; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Grechenig K, 2010, J EMPIR LEGAL STUD, V7, P847, DOI 10.1111/j.1740-1461.2010.01197.x; Grujic J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047718; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hill AL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000968; Hill AL, 2010, P ROY SOC B-BIOL SCI, V277, P3827, DOI 10.1098/rspb.2010.1217; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; HOWES MJ, 1985, J PERS SOC PSYCHOL, V49, P1110, DOI 10.1037/0022-3514.49.4.1110; Jackson MO, 2009, ANNU REV ECON, V1, P489, DOI 10.1146/annurev.economics.050708.143238; Joiner TE, 1999, CLIN PSYCHOL-SCI PR, V6, P149, DOI 10.1093/clipsy/6.2.149; Marmaros D, 2002, EUR ECON REV, V46, P870, DOI 10.1016/S0014-2921(01)00221-5; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ostrom E., 1990, GOVERNING COMMONS EV; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Pugh SD, 2001, ACAD MANAGE J, V44, P1018, DOI 10.2307/3069445; Rand DG, 2013, P NATL ACAD SCI USA, V110, P2581, DOI 10.1073/pnas.1214167110; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Rand DG, 2012, J THEOR BIOL, V299, P172, DOI 10.1016/j.jtbi.2011.03.004; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Rand DG, 2013, ITS THOUGHT COUNTS R; Sacerdote B, 2001, Q J ECON, V116, P681, DOI 10.1162/00335530151144131; Salganik MJ, 2006, SCIENCE, V311, P854, DOI 10.1126/science.1121066; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; van Veelen M, 2012, P NATL ACAD SCI USA, V109, P9929, DOI 10.1073/pnas.1206694109; VanderWeele TJ, 2011, SOCIOL METHOD RES, V40, P240, DOI 10.1177/0049124111404821	52	53	53	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66199	10.1371/journal.pone.0066199	http://dx.doi.org/10.1371/journal.pone.0066199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190ST	23840422	Green Published, gold			2022-12-27	WOS:000322361200060
J	Rutten, FH; Groenwold, RHH; Sachs, APE; Grobbee, DE; Hoes, AW				Rutten, Frans H.; Groenwold, Rolf H. H.; Sachs, Alfred P. E.; Grobbee, Diederick E.; Hoes, Arno W.			beta-Blockers and All-Cause Mortality in Adults with Episodes of Acute Bronchitis: An Observational Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; RESPIRATORY-TRACT; AIR-POLLUTION; RISK; INFECTIONS; COMMUNITY; EXACERBATIONS; ASSOCIATION; MORBIDITY; STATINS	Background: Recent observational studies suggest that beta-blockers may improve long-term prognosis in patients with chronic obstructive pulmonary disease (COPD). We assessed whether beta-blocker use improves all-cause mortality in patients with episodes of acute bronchitis. Methods: An observational cohort study using data from the electronic medical records of 23 general practices in the Netherlands. The data included standardized information about daily patient contacts, diagnoses, and drug prescriptions. Cox regression was applied with time-varying treatment and covariates. Results: The study included 4,493 patients aged 45 years and older, with at least one episode of acute bronchitis between 1996 and 2006. The mean (SD) age of the patients was 66.9 (11.7) years, and 41.9% were male. During a mean (SD) follow up period of 7.7 (2.5) years, 20.4% developed COPD. In total, 22.7% had cardiovascular comorbidities, resulting in significant higher mortality rates than those without (51.7% vs. 12.0%, p<0.001). The adjusted hazard ratio of cardioselective beta-blocker use for mortality was 0.62 (95% confidence interval [CI], 0.50-0.77), and 1.01 (95% CI 0.75-1.36) for non-selective ones. Some other cardiovascular drugs also reduced the risk of mortality, with adjusted HRs of 0.60 (95% CI 0.46-0.79) for calcium channel blockers, 0.88 (95% CI 0.73-1.06) for ACE inhibitors/angiotensin receptor blockers, and 0.42 (95% CI 0.31-0.57) for statins, respectively. Conclusion: Cardiovascular comorbidities are common and increase the risk of mortality in adults with episodes of acute bronchitis. Cardioselective beta-blockers, but also calcium channel blockers and statins may reduce mortality, possibly as a result of cardiovascular protective properties.	[Rutten, Frans H.; Groenwold, Rolf H. H.; Sachs, Alfred P. E.; Grobbee, Diederick E.; Hoes, Arno W.] Univ Med Ctr Utrecht, Dept Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Rutten, FH (corresponding author), Univ Med Ctr Utrecht, Dept Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	f.h.rutten@umcutrecht.nl	Grobbee, Diederick/C-7651-2014	Grobbee, Diederick/0000-0003-4472-4468				Alviar CL, 2011, MED HYPOTHESES, V76, P517, DOI 10.1016/j.mehy.2010.12.006; Au DH, 2004, AM J MED, V117, P925, DOI 10.1016/j.amjmed.2004.07.043; Bent S, 1999, AM J MED, V107, P62, DOI 10.1016/S0002-9343(99)00167-9; BOLDY DAR, 1990, RESP MED, V84, P377, DOI 10.1016/S0954-6111(08)80072-8; Bont J, 2007, FAM PRACT, V24, P317, DOI 10.1093/fampra/cmm023; Dransfield MT, 2008, THORAX, V63, P301, DOI 10.1136/thx.2007.081893; Etminan M, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-48; Fahey T, 1998, BRIT MED J, V316, P906, DOI 10.1136/bmj.316.7135.906; Frey P, 2011, CURR OPIN CARDIOL, V26, P424, DOI 10.1097/HCO.0b013e328349683d; Gonzales R, 2000, ANN INTERN MED, V133, P981, DOI 10.7326/0003-4819-133-12-200012190-00014; Grobbee DE, 1997, BRIT MED J, V315, P1151; Groenwold RHH, 2009, J CLIN EPIDEMIOL, V62, P22, DOI 10.1016/j.jclinepi.2008.02.011; HALLETT JS, 1985, ANN ALLERGY, V55, P568; ICPC-2. International Classification of Primary Care, 1998, ICPC 2 INT CLASSIFIC; Johnston F, 2011, ENVIRON RES, V111, P811, DOI 10.1016/j.envres.2011.05.007; Jonsson JS, 1998, BRIT MED J, V317, P1433, DOI 10.1136/bmj.317.7170.1433; Lin R, 2008, PULM PHARMACOL THER, V21, P115, DOI 10.1016/j.pupt.2007.06.003; Lipsett MJ, 2011, AM J RESP CRIT CARE, V184, P828, DOI 10.1164/rccm.201012-2082OC; MACFARLANE JT, 1993, LANCET, V341, P511, DOI 10.1016/0140-6736(93)90275-L; Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039; MELBYE H, 1994, EUR RESPIR J, V7, P1239, DOI 10.1183/09031936.94.07071239; Nicholson KG, 1997, BRIT MED J, V315, P1060, DOI 10.1136/bmj.315.7115.1060; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Rutten FH, 2006, EUR J HEART FAIL, V8, P706, DOI 10.1016/j.ejheart.2006.01.010; Rutten FH, 2010, ARCH INTERN MED, V170, P880, DOI 10.1001/archinternmed.2010.112; Sandstrom T, 2008, EPIDEMIOLOGY, V19, P808, DOI 10.1097/EDE.0b013e31818809e0; Short PM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2549; Singanayagam A, 2012, EUR RESPIR J, V39, P187, DOI 10.1183/09031936.00049111; Smith SM, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858, DOI 10.1002/14651858.CD000245.PUB2]; Soyseth V, 2007, EUR RESPIR J, V29, P279, DOI 10.1183/09031936.00106406; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; Wark P, 2011, CLIN EVID; WILLIAMSON HA, 1987, J FAM PRACTICE, V25, P251	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67122	10.1371/journal.pone.0067122	http://dx.doi.org/10.1371/journal.pone.0067122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840599	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200120
J	Zhang, FR; Zeng, XF; Yang, FJ; Huang, ZM; Liu, H; Ma, X; Qiao, SY				Zhang, Fengrui; Zeng, Xiangfang; Yang, Fengjuan; Huang, Zhimin; Liu, Hong; Ma, Xi; Qiao, Shiyan			Dietary N-Carbamylglutamate Supplementation Boosts Intestinal Mucosal Immunity in Escherichia coli Challenged Piglets	PLOS ONE			English	Article							L-ARGININE; SERUM IGA; GROWTH; PERFORMANCE; DIARRHEA; ANTIGEN	N-carbamylglutamate (NCG) has been shown to enhance performance in neonatal piglets. However, few studies have demonstrated the effect of NCG on the intestinal mucosal barrier. This study was conducted to determine the effects of dietary NCG supplementation on intestinal mucosal immunity in neonatal piglets after an Escherichia coli (E. coli) challenge. New-born piglets (4 d old) were assigned randomly to one of four treatments (n = 7), including (I) sham challenge, (II) sham challenge +50 mg/kg NCG, (III) E. coli challenge, and (IV) E. coli challenge +50 mg/kg NCG. On d 8, pigs in the E. coli challenge groups (III and IV) were orally challenged with 5 mL of E. coli K88 (10(8) CFU/mL), whereas pigs in the sham challenge groups (I and II) were orally dosed with an equal volume of water. On d 13, all piglets were sacrificed, and samples were collected and examined. The results show that average daily gain in the E. coli challenged piglets (III and IV) was decreased (P-E.coli<0.05). However, it tended to be higher in the NCG treated piglets (II and IV). Ileum secretory IgA, as well as IFN-gamma, IL-2, IL-4 and IL-10 in ileal homogenates, were increased in E. coli challenged piglets (III and IV). Similarly, ileum SIgA and IL-10 levels, and CD4+ percentage in NCG treated piglets (II and IV) were higher than no-NCG treated piglets (P-NCG<0.05). However, the IL-2 level was only decreased in the piglets of E. coli challenge + NCG group (IV) compared with E. coli challenge group (III) (P<0.05). No change in the IL-2 level of the sham challenged piglets (III) was observed. In conclusion, dietary NCG supplementation has some beneficial effects on intestinal mucosal immunity in E. coli challenged piglets, which might be associated with stimulated lymphocyte proliferation and cytokine synthesis. Our findings have an important implication that NCG may be used to reduce diarrhea in neonatal piglets.	[Zhang, Fengrui; Zeng, Xiangfang; Yang, Fengjuan; Huang, Zhimin; Liu, Hong; Ma, Xi; Qiao, Shiyan] China Agr Univ, State Key Lab Anim Nutr, Minist Agr, Feed Ind Ctr, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Qiao, SY (corresponding author), China Agr Univ, State Key Lab Anim Nutr, Minist Agr, Feed Ind Ctr, Beijing 100094, Peoples R China.	qiaoshy@mafic.ac.cn	Ma, Xi/J-4625-2019	Ma, Xi/0000-0003-4562-9331	National Key Basic Research Program of China [2012CB124702, 2013CB117303]	National Key Basic Research Program of China(National Basic Research Program of China)	This project was financially supported by National Key Basic Research Program of China (No: 2012CB124702 and 2013CB117303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC. Arilington V, 2003, OFF METH AN ASS OFF; BARBUL A, 1990, NUTRITION, V6, P53; Borghetti P, 2006, VET IMMUNOL IMMUNOP, V110, P17, DOI 10.1016/j.vetimm.2005.09.001; Camerlink I, 2010, HOMEOPATHY, V99, P57, DOI 10.1016/j.homp.2009.10.003; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Frank JW, 2007, J NUTR, V137, P315, DOI 10.1093/jn/137.2.315; GUFFON N, 1995, J INHERIT METAB DIS, V18, P61, DOI 10.1007/BF00711374; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; JONES GW, 1972, INFECT IMMUN, V6, P918, DOI 10.1128/IAI.6.6.918-927.1972; Kidd Parris, 2003, Altern Med Rev, V8, P223; Kim SW, 2007, J NUTR, V137, P2168; Kobayashi T, 1998, BIOSCI BIOTECH BIOCH, V62, P2334, DOI 10.1271/bbb.62.2334; KRAMER DR, 1995, IMMUNOL CELL BIOL, V73, P389, DOI 10.1038/icb.1995.61; Levast B, 2010, VET IMMUNOL IMMUNOP, V137, P261, DOI 10.1016/j.vetimm.2010.06.004; Liu Y, 2008, BRIT J NUTR, V100, P552, DOI 10.1017/S0007114508911612; MarkowskaDaniel I, 1996, COMP IMMUNOL MICROB, V19, P219, DOI 10.1016/0147-9571(96)00008-2; O'Connor MF, 2001, ANESTH ANALG, V93, P809, DOI 10.1097/00000539-200110000-00001; Ochoa JB, 2001, JPEN-PARENTER ENTER, V25, P23, DOI 10.1177/014860710102500123; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Pluske J, 2003, WEANING THE PIG: CONCEPTS AND CONSEQUENCES, P15; Puiman PJ, 2011, J NUTR, V141, P63, DOI 10.3945/jn.110.131888; Qiao SF, 2005, WORLD J GASTROENTERO, V11, P6216, DOI 10.3748/wjg.v11.i39.6216; Ren WK, 2013, BRIT J NUTR, V109, P867, DOI 10.1017/S0007114512002681; Rooke JA, 2002, LIVEST PROD SCI, V78, P13, DOI 10.1016/S0301-6226(02)00182-3; Vaerman JP, 1997, VET IMMUNOL IMMUNOP, V58, P301, DOI 10.1016/S0165-2427(97)00041-X; WILSON MR, 1974, J ANIM SCI, V38, P1018, DOI 10.2527/jas1974.3851018x; WU GY, 1994, J NUTR, V124, P415, DOI 10.1093/jn/124.3.415; Wu GY, 1997, AM J PHYSIOL-GASTR L, V272, pG1382, DOI 10.1152/ajpgi.1997.272.6.G1382; Wu GY, 2004, J NUTR, V134, p2783S, DOI 10.1093/jn/134.10.2783S; Wu SD, 2012, PEPTIDES, V35, P225, DOI 10.1016/j.peptides.2012.03.030; Wu X, 2010, AMINO ACIDS, V39, P831, DOI 10.1007/s00726-010-0538-y; Yi GF, 2005, J ANIM SCI, V83, P634; Zeng XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041192; Zhu H, 2012, INNATE IMMUNITY	34	27	29	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66280	10.1371/journal.pone.0066280	http://dx.doi.org/10.1371/journal.pone.0066280			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840434	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200065
J	Gan, YM; Liu, F; Chen, D; Wu, Q; Qin, Q; Wang, CY; Li, SH; Zhang, XD; Wang, YH; Wang, KB				Gan, Yimei; Liu, Fang; Chen, Dan; Wu, Qiong; Qin, Qin; Wang, Chunying; Li, Shaohui; Zhang, Xiangdi; Wang, Yuhong; Wang, Kunbo			Chromosomal Locations of 5S and 45S rDNA in Gossypium Genus and Its Phylogenetic Implications Revealed by FISH	PLOS ONE			English	Article							LOCI; EVOLUTION; GENOME; LOCALIZATION; IDENTIFICATION; HYBRIDIZATION; 18S-5.8S-26S; COLLINEARITY; PATTERNS; HISTORY	We investigated the locations of 5S and 45S rDNA in Gossypium diploid A, B, D, E, F, G genomes and tetraploid genome (AD) using multi-probe fluorescent in situ hybridization (FISH) for evolution analysis in Gossypium genus. The rDNA numbers and sizes, and synteny relationships between 5S and 45S were revealed using 5S and 45S as double-probe for all species, and the rDNA-bearing chromosomes were identified for A, D and AD genomes with one more probe that is single-chromosome-specific BAC clone from G. hirsutum (A(1)D(1)). Two to four 45S and one 5S loci were found in diploid-species except two 5S loci in G. incanum (E-4), the same as that in tetraploid species. The 45S on the 7th and 9th chromosomes and the 5S on the 9th chromosomes seemed to be conserved in A, D and AD genomes. In the species of B, E, F and G genomes, the rDNA numbers, sizes, and synteny relationships were first reported in this paper. The rDNA pattern agrees with previously reported phylogenetic history with some disagreements. Combined with the whole-genome sequencing data from G. raimondii (D-5) and the conserved cotton karyotype, it is suggested that the expansion, decrease and transposition of rDNA other than chromosome rearrangements might occur during the Gossypium evolution.	[Liu, Fang; Chen, Dan; Wang, Chunying; Li, Shaohui; Zhang, Xiangdi; Wang, Yuhong; Wang, Kunbo] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol China, Anyang, Henan, Peoples R China; [Gan, Yimei] Chinese Acad Trop Agr Sci, Inst Trop Bioscience & Biotechnol, Key Lab Biol & Genet Resources Trop Crops, Minist Agr China, Haikou, Hainan, Peoples R China; [Wu, Qiong] Chinese Acad Trop Agr Sci, Haikou Expt Stn, Haikou, Hainan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences	Wang, KB (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol China, Anyang, Henan, Peoples R China.	wkbcri@163.com			State Key Laboratory of Cotton Biology Open Fund [CB2013A06]; National High Technology Research and Development Program [2009AA101104]; Essential Science Research Funds to National Non-profit Institutes of China [SJA1201]	State Key Laboratory of Cotton Biology Open Fund; National High Technology Research and Development Program(National High Technology Research and Development Program of China); Essential Science Research Funds to National Non-profit Institutes of China	This work was supported by State Key Laboratory of Cotton Biology Open Fund (No. CB2013A06), National High Technology Research and Development Program (No.: 2009AA101104), Essential Science Research Funds to National Non-profit Institutes of China (No. SJA1201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogunic F, 2011, PLANT BIOLOGY, V13, P194, DOI 10.1111/j.1438-8677.2010.00326.x; Chacon J, 2012, AM J BOT, V99, P1501, DOI 10.3732/ajb.1200104; Chang YC, 2009, J AM SOC HORTIC SCI, V134, P567, DOI 10.21273/JASHS.134.5.567; Chung MC, 2008, THEOR APPL GENET, V116, P745, DOI 10.1007/s00122-007-0705-z; Comai L, 2000, PLANT MOL BIOL, V43, P387, DOI 10.1023/A:1006480722854; CRANE CF, 1993, GENOME, V36, P1015, DOI 10.1139/g93-135; Cronn RC, 2002, AM J BOT, V89, P707, DOI 10.3732/ajb.89.4.707; Cronn RC, 2003, EVOLUTION, V89, P707; Dobigny G, 2003, CYTOGENET GENOME RES, V103, P94, DOI 10.1159/000076296; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; Forrester NW, 1995, CHALLENGING FUTURE, P313; FRYXELL P A, 1987, Aliso, V11, P539; Fryxell PA, 1979, NATURA HIST COTTON T; Gan YM, 2012, GENES GENET SYST, V87, P233, DOI 10.1266/ggs.87.233; Gan YM, 2011, GENES GENET SYST, V86, P165, DOI 10.1266/ggs.86.165; Hamon P, 2009, CHROMOSOME RES, V17, P291, DOI 10.1007/s10577-009-9033-2; Hanson RE, 1996, CHROMOSOMA, V105, P55, DOI 10.1007/BF02510039; Ji YF, 1999, CHROMOSOMA, V108, P200, DOI 10.1007/s004120050369; JOHNSON BL, 1970, AM J BOT, V57, P1081, DOI 10.2307/2441274; Krishnan P, 2001, J HERED, V92, P295, DOI 10.1093/jhered/92.3.295; Lavania UC, 2005, J HERED, V96, P155, DOI 10.1093/jhered/esi018; LEITCH IJ, 1992, GENOME, V35, P1013, DOI 10.1139/g92-155; LINDELAURSEN I, 1992, GENOME, V35, P1032, DOI 10.1139/g92-158; Liu ZL, 2003, AM J BOT, V90, P17, DOI 10.3732/ajb.90.1.17; Martinez J, 2010, PLANT SYST EVOL, V289, P223, DOI 10.1007/s00606-010-0345-7; Martins C, 2001, GENETICA, V111, P439, DOI 10.1023/A:1013799516717; Moscone EA, 1999, GENOME, V42, P1224, DOI 10.1139/gen-42-6-1224; Peng RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033847; PHILLIPS LL, 1966, AM J BOT, V53, P328, DOI 10.2307/2439872; PRICE HJ, 1990, J HERED, V81, P365; Raina SN, 1999, GENOME, V42, P52, DOI 10.1139/gen-42-1-52; Robledo G, 2009, THEOR APPL GENET, V118, P1295, DOI 10.1007/s00122-009-0981-x; Rosato M, 2008, ANN BOT-LONDON, V102, P15, DOI 10.1093/aob/mcn055; Sambrook J., 2002, MOL CLONING LAB MANU; Schweizer D, 1987, CHROMOSOMES TODAY, V9, P61, DOI DOI 10.1007/978-94-010-9166-4_7; Vaio M, 2005, ANN BOT-LONDON, V96, P191, DOI 10.1093/aob/mci168; VALICEK P, 1978, COTON FIBRES TROP, V33, P431; WANG CY, 2001, COTTON SCI, V13, P75; Wang K, 2008, GENETICS, V178, P1117, DOI 10.1534/genetics.107.083576; Wang K, 2007, THEOR APPL GENET, V115, P675, DOI 10.1007/s00122-007-0598-x; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; WENDEL JF, 1992, SYST BOT, V17, P115, DOI 10.2307/2419069; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; WENDEL JF, 1991, EVOLUTION, V45, P694, DOI 10.1111/j.1558-5646.1991.tb04339.x; Wendel JF, 2010, PHYSIOLOGY OF COTTON, P1, DOI 10.1007/978-90-481-3195-2_1; Wendel Jonathan F., 2009, V3, P3, DOI 10.1007/978-0-387-70810-2_1; [吴琼 Wu Qiong], 2010, [科学通报, Chinese Science Bulletin], V55, P2099	47	22	24	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68207	10.1371/journal.pone.0068207	http://dx.doi.org/10.1371/journal.pone.0068207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826377	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000131
J	Cheng, LB; Li, SY; Yin, JJ; Li, LJ; Chen, XH				Cheng, Libao; Li, Shuyan; Yin, Jingjing; Li, Liangjun; Chen, Xuehao			Genome-Wide Analysis of Differentially Expressed Genes Relevant to Rhizome Formation in Lotus Root (Nelumbo nucifera Gaertn)	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; TUBER FORMATION; JASMONIC ACID; MALATE-DEHYDROGENASE; ABSCISIC-ACID; TRANSCRIPTIONAL REGULATION; ALCOHOL-DEHYDROGENASE; PHOTOPERIODIC CONTROL; ANTHER DEVELOPMENT; FLOODING STRESS	Lotus root is a popular wetland vegetable which produces edible rhizome. At the molecular level, the regulation of rhizome formation is very complex, which has not been sufficiently addressed in research. In this study, to identify differentially expressed genes (DEGs) in lotus root, four libraries (L1 library: stolon stage, L2 library: initial swelling stage, L3 library: middle swelling stage, L4: later swelling stage) were constructed from the rhizome development stages. High-throughput tag-sequencing technique was used which is based on Solexa Genome Analyzer Platform. Approximately 5.0 million tags were sequenced, and 4542104, 4474755, 4777919, and 4750348 clean tags including 151282, 137476, 215872, and 166005 distinct tags were obtained after removal of low quality tags from each library respectively. More than 43% distinct tags were unambiguous tags mapping to the reference genes, and 40% were unambiguous tag-mapped genes. From L1, L2, L3, and L4, total 20471, 18785, 23448, and 21778 genes were annotated, after mapping their functions in existing databases. Profiling of gene expression in L1/L2, L2/L3, and L3/L4 libraries were different among most of the selected 20 DEGs. Most of the DEGs in L1/L2 libraries were relevant to fiber development and stress response, while in L2/L3 and L3/L4 libraries, major of the DEGs were involved in metabolism of energy and storage. All up-regulated transcriptional factors in four libraries and 14 important rhizome formation-related genes in four libraries were also identified. In addition, the expression of 9 genes from identified DEGs was performed by qRT-PCR method. In a summary, this study provides a comprehensive understanding of gene expression during the rhizome formation in lotus root.	[Cheng, Libao; Li, Shuyan; Yin, Jingjing; Li, Liangjun; Chen, Xuehao] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Li, LJ (corresponding author), Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China.	ljli@yzu.edu.cn; xhchen@yzu.edu.cn			Special Fund for Agro-scientific Research in the Public Interest [200903017-02]; China Postdoctoral Science Foundation [2012M511805]; Jiangsu Postdoctoral Science Foundation [1102144C]	Special Fund for Agro-scientific Research in the Public Interest; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (200903017-02), China Postdoctoral Science Foundation (2012M511805) and Jiangsu Postdoctoral Science Foundation (1102144C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelenda JA, 2011, CURR OPIN BIOTECH, V22, P287, DOI 10.1016/j.copbio.2010.11.013; Abeles F, 1992, ETHYLENE PLANT BIOL; ANDREWS DL, 1988, BIOCHEM J, V252, P199, DOI 10.1042/bj2520199; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Appeldoorn NJG, 1997, PLANTA, V202, P220, DOI 10.1007/s004250050122; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; BALAMANI V, 1986, PLANT PHYSIOL, V80, P856, DOI 10.1104/pp.80.4.856; Banerjee AK, 2006, PLANT CELL, V18, P3443, DOI 10.1105/tpc.106.042473; BANFALVI Z, 1994, MOL GEN GENET, V245, P517, DOI 10.1007/BF00302265; Baudry A, 2010, PLANT CELL, V22, P606, DOI 10.1105/tpc.109.072843; Baxter-Burrell A, 2003, ANN BOT-LONDON, V91, P129, DOI 10.1093/aob/mcf119; Becker B, 2006, PLANTA, V224, P380, DOI 10.1007/s00425-006-0222-3; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bhat S. R., 1994, Indian Journal of Experimental Biology, V32, P340; Borgi W, 2007, FITOTERAPIA, V78, P16, DOI 10.1016/j.fitote.2006.09.010; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Braz R, 2007, LAT AM J PHARM, V26, P706; Burton W. G., 1992, The potato crop: the scientific basis for improvement., P608; Carrera E, 2000, PLANT J, V22, P247, DOI 10.1046/j.1365-313x.2000.00736.x; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Chen H, 2004, PLANT J, V38, P276, DOI 10.1111/j.1365-313X.2004.02048.x; Crawford RMM, 1996, J EXP BOT, V47, P145, DOI 10.1093/jxb/47.2.145; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; CUSHMAN JC, 1993, PHOTOSYNTH RES, V35, P15, DOI 10.1007/BF02185408; Debeljak N, 2002, PLANT GROWTH REGUL, V36, P253, DOI 10.1023/A:1016570319387; DELVALLEE I, 1988, J PLANT PHYSIOL, V132, P210, DOI 10.1016/S0176-1617(88)80163-9; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Dijkwel PP, 1997, PLANT CELL, V9, P583, DOI 10.1105/tpc.9.4.583; Feng JX, 2005, PLANT MOL BIOL, V59, P853, DOI 10.1007/s11103-005-1511-0; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Fernie AR, 2001, PLANT PHYSIOL, V127, P1459, DOI [10.1104/pp.127.4.1459, 10.1104/pp.010764]; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Fukao T, 2006, PLANT CELL, V18, P2021, DOI 10.1105/tpc.106.043000; GALIS I, 1995, J PLANT GROWTH REGUL, V14, P143, DOI 10.1007/BF00210916; Geigenberger P, 2004, PLANT CELL ENVIRON, V27, P655, DOI 10.1111/j.1365-3040.2004.01183.x; GEIGENBERGER P, 1994, PLANTA, V193, P486, DOI 10.1007/BF02411552; Gibbs J, 2003, FUNCT PLANT BIOL, V30, P1, DOI [10.1071/PP98095_ER, 10.1071/PP98095]; Gibson SI, 2005, CURR OPIN PLANT BIOL, V8, P93, DOI 10.1016/j.pbi.2004.11.003; GIETL C, 1992, BIOCHIM BIOPHYS ACTA, V1100, P217, DOI 10.1016/0167-4838(92)90476-T; Grichko VP, 2001, PLANT PHYSIOL BIOCH, V39, P1, DOI 10.1016/S0981-9428(00)01213-4; GRIERSON C, 1994, PLANT J, V5, P815, DOI 10.1046/j.1365-313X.1994.5060815.x; Hameister S, 2007, J MOL EVOL, V65, P437, DOI 10.1007/s00239-007-9025-9; Hanashiro I, 2008, PLANT CELL PHYSIOL, V49, P925, DOI 10.1093/pcp/pcn066; HANNAPEL DJ, 1991, PHYSIOL PLANTARUM, V83, P568, DOI [10.1034/j.1399-3054.1991.830405.x, 10.1111/j.1399-3054.1991.tb02469.x]; HANNAPEL DJ, 1985, PLANT PHYSIOL, V78, P700, DOI 10.1104/pp.78.4.700; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hoeren FU, 1998, GENETICS, V149, P479; Hu FY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-18; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Inui H, 2010, FEBS LETT, V584, P2393, DOI 10.1016/j.febslet.2010.04.031; Ishizawa K, 1999, PLANT CELL ENVIRON, V22, P505, DOI 10.1046/j.1365-3040.1999.00439.x; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Jackson SD, 1999, PLANT PHYSIOL, V119, P1, DOI 10.1104/pp.119.1.1; Jackson SD, 1996, PLANT J, V9, P159, DOI 10.1046/j.1365-313X.1996.09020159.x; Jasik J, 2006, J PLANT GROWTH REGUL, V25, P45, DOI 10.1007/s00344-005-0048-4; Jung SH, 2003, PLANT MOL BIOL, V52, P553, DOI 10.1023/A:1024866716987; Kim KJ, 2005, ACTA HORTIC, P661, DOI 10.17660/ActaHortic.2005.673.91; Kim MC, 2009, MOL PLANT, V2, P13, DOI 10.1093/mp/ssn091; Kim WY, 2007, NATURE, V449, P356, DOI 10.1038/nature06132; KODA Y, 1992, INT REV CYTOL, V135, P155, DOI 10.1016/S0074-7696(08)62040-9; Kolomiets MV, 2001, PLANT CELL, V13, P613, DOI 10.1105/tpc.13.3.613; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Krizek BA, 2009, PLANT PHYSIOL, V150, P1916, DOI 10.1104/pp.109.141119; KUIPERS AGJ, 1994, PLANT CELL, V6, P43, DOI 10.1105/tpc.6.1.43; Lee MW, 2001, MOL PLANT MICROBE IN, V14, P527, DOI 10.1094/MPMI.2001.14.4.527; Liu JB, 2010, J SCI FOOD AGR, V90, P2482, DOI 10.1002/jsfa.4110; Mach J, 2011, PLANT CELL, V23, P4166, DOI 10.1105/tpc.111.231210; MacLeod RAF, 1999, INT J CANCER, V83, P555; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Masuda J, 2007, PLANTA, V226, P909, DOI 10.1007/s00425-007-0536-9; Meng XiangBing, 2005, Plant Molecular Biology Reporter, V23, P301, DOI 10.1007/BF02772762; MINGOCASTEL AM, 1976, PLANT PHYSIOL, V57, P480, DOI 10.1104/pp.57.4.480; Mueller MJ, 1997, PHYSIOL PLANTARUM, V100, P653, DOI 10.1034/j.1399-3054.1997.1000329.x; MULLERROBER B, 1992, EMBO J, V11, P1229, DOI 10.1002/j.1460-2075.1992.tb05167.x; Nakamura T, 1998, PLANT PHYSIOL, V118, P451, DOI 10.1104/pp.118.2.451; NEUTEBOOM CE, 2002, PGRSAQ, V30, P77; PAIVA E, 1983, PLANT PHYSIOL, V71, P161, DOI 10.1104/pp.71.1.161; Park WM, 1983, PLANT MOL BIOL REP, V1, P61, DOI [10.1007/BF02680300, DOI 10.1007/BF02680300]; Pedersen O, 2009, PLANT J, V58, P147, DOI 10.1111/j.1365-313X.2008.03769.x; PERATA P, 1993, PLANT SCI, V93, P1, DOI 10.1016/0168-9452(93)90029-Y; PERL A, 1991, PLANT SCI, V73, P87, DOI 10.1016/0168-9452(91)90129-V; Poovaiah BW, 1996, J PLANT PHYSIOL, V149, P553, DOI 10.1016/S0176-1617(96)80333-6; Qi XH, 2011, GENOMICS, DOI [10.1016/j.ygeno 2011.12.008, DOI 10.1016/J.YGEN0]; Racusen D, 1985, FOOD IND, V9, P61; RAVNIKAR M, 1993, J PLANT GROWTH REGUL, V12, P73, DOI 10.1007/BF00193236; Rayirath UP, 2011, PLANT CELL TISS ORG, V105, P253, DOI 10.1007/s11240-010-9861-y; Reddy ASN, 1996, J BIOL CHEM, V271, P7052, DOI 10.1074/jbc.271.12.7052; Rocha M, 2010, PLANT PHYSIOL, V152, P1501, DOI 10.1104/pp.109.150045; ROCHASOSA M, 1989, EMBO J, V8, P23, DOI 10.1002/j.1460-2075.1989.tb03344.x; Rook F, 2001, PLANT J, V26, P421, DOI 10.1046/j.1365-313X.2001.2641043.x; Sahi Chandan, 2006, Functional & Integrative Genomics, V6, P263, DOI 10.1007/s10142-006-0032-5; Sakamoto Y, 1977, LOTUS; SAWHNEY VK, 1986, J PLANT PHYSIOL, V125, P467, DOI 10.1016/S0176-1617(86)80009-8; Scheibe R, 2004, PHYSIOL PLANTARUM, V120, P21, DOI 10.1111/j.0031-9317.2004.0222.x; SEMBDNER G, 1993, ANNU REV PLANT PHYS, V44, P569, DOI 10.1146/annurev.pp.44.060193.003033; Sheen J, 1999, CURR OPIN PLANT BIOL, V2, P410, DOI 10.1016/S1369-5266(99)00014-X; Shiao TI, 2002, BIOTECHNOL BIOENG, V77, P455, DOI 10.1002/bit.10147; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Slocum PD, 1996, WATER GARDENING WATE; Stupar RM, 2006, GENETICS, V172, P1263, DOI 10.1534/genetics.105.051219; SUBBAIAH CC, 1994, PLANT PHYSIOL, V105, P369, DOI 10.1104/pp.105.1.369; SUGE H, 1975, PLANT CELL PHYSIOL, V16, P65, DOI 10.1093/oxfordjournals.pcp.a075128; Terashima M, 2002, CIRCULATION, V106, P887, DOI 10.1161/01.CIR.0000030708.86783.92; Thimann KV, 1934, P R SOC LOND B-CONTA, V114, P317, DOI 10.1098/rspb.1934.0010; Tiessen A, 2003, PLANT J, V35, P490, DOI 10.1046/j.1365-313X.2003.01823.x; Tjaden J, 1998, PLANT J, V16, P531, DOI 10.1046/j.1365-313X.1998.00317.x; VANCANNEYT G, 1989, PLANT CELL, V1, P533, DOI 10.1105/tpc.1.5.533; Vartapetian BB, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; Vij S, 2007, PLANT BIOTECHNOL J, V5, P361, DOI 10.1111/j.1467-7652.2007.00239.x; VREUGDENHIL D, 1989, PHYSIOL PLANTARUM, V75, P525, DOI 10.1111/j.1399-3054.1989.tb05619.x; VREUGDENHIL D, 1994, PLANT GROWTH REGUL, V14, P257, DOI 10.1007/BF00024801; Wang FD, 2012, GENOMICS, DOI [10.1016/j.ygeno.02.005, DOI 10.1016/J.YGEN0.02.005]; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wu T, 2010, J PLANT PHYSIOL, V167, P905, DOI 10.1016/j.jplph.2010.02.004; Xie ZD, 2010, PLANT J, V64, P731, DOI 10.1111/j.1365-313X.2010.04364.x; Xu X, 1998, PLANT PHYSIOL, V117, P575, DOI 10.1104/pp.117.2.575; Xue JH, 2012, J SYST EVOL, V50, P477, DOI 10.1111/j.1759-6831.2012.00224.x; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009; Zhang HW, 2004, PLANTA, V220, P262, DOI 10.1007/s00425-004-1347-x; Zhou SF, 2011, AFR J BIOTECHNOL, V10, P17934, DOI 10.5897/AJB11.1383; Zhu Y, 2003, J BIOL CHEM, V278, P47803, DOI 10.1074/jbc.M302806200	121	42	47	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67116	10.1371/journal.pone.0067116	http://dx.doi.org/10.1371/journal.pone.0067116			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840598	Green Submitted, gold, Green Published			2022-12-27	WOS:000321424400072
J	Muller, MS; Scheu, S; Jousset, A				Mueller, Maren Stella; Scheu, Stefan; Jousset, Alexandre			Protozoa Drive the Dynamics of Culturable Biocontrol Bacterial Communities	PLOS ONE			English	Article							PSEUDOMONAS-FLUORESCENS CHA0; SOIL-BORNE PATHOGENS; BIOSYNTHETIC LOCUS; BIOLOGICAL-CONTROL; PLANT-PATHOGENS; RHIZOSPHERE; 2,4-DIACETYLPHLOROGLUCINOL; SPP.; POPULATIONS; SUPPRESSION	Some soil bacteria protect plants against soil-borne diseases by producing toxic secondary metabolites. Such beneficial biocontrol bacteria can be used in agricultural systems as alternative to agrochemicals. The broad spectrum toxins responsible for plant protection also inhibit predation by protozoa and nematodes, the main consumers of bacteria in soil. Therefore, predation pressure may favour biocontrol bacteria and contribute to plant health. We analyzed the effect of Acanthamoeba castellanii on semi-natural soil bacterial communities in a microcosm experiment. We determined the frequency of culturable bacteria carrying genes responsible for the production of the antifungal compounds 2,4-diacetylphloroglucinol (DAPG), pyrrolnitrin (PRN) and hydrogen cyanide (HCN) in presence and absence of A. castellanii. We then measured if amoebae affected soil suppressiveness in a bioassay with sugar beet seedlings confronted to the fungal pathogen Rhizoctonia solani. Amoebae increased the frequency of both DAPG and HCN positive bacteria in later plant growth phases (2 and 3 weeks), as well as the average number of biocontrol genes per bacterium. The abundance of DAPG positive bacteria correlated with disease suppression, suggesting that their promotion by amoebae may enhance soil health. However, the net effect of amoebae on soil suppressiveness was neutral to slightly negative, possibly because amoebae slow down the establishment of biocontrol bacteria on the recently emerged seedlings used in the assay. The results indicate that microfaunal predators foster biocontrol bacterial communities. Understanding interactions between biocontrol bacteria and their predators may thus help developing environmentally friendly management practices of agricultural systems.	[Mueller, Maren Stella; Scheu, Stefan; Jousset, Alexandre] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany	University of Gottingen	Jousset, A (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany.	ajousse@gwdg.de	Scheu, Stefan/H-7049-2015; Jousset, Alexandre/C-7607-2011		German Science Foundation (DFG); Georg August University Gottingen	German Science Foundation (DFG)(German Research Foundation (DFG)); Georg August University Gottingen	The authors acknowledge support by the Open Access Program of the German Science Foundation (DFG) and the Publication Funds of the Georg August University Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KS, 2004, BIOL FERT SOILS, V40, P230, DOI 10.1007/s00374-004-0774-y; [Anonymous], 1988, NEW KEY FRESHWATER S; Baehler E, 2006, MOL PLANT MICROBE IN, V19, P313, DOI 10.1094/MPMI-19-0313; Bennett AJ, 2008, BIOL CONTROL, V44, P349, DOI 10.1016/j.biocontrol.2007.11.005; Blumer C, 2000, ARCH MICROBIOL, V173, P170, DOI 10.1007/s002039900127; Bonkowski M, 2002, SOIL BIOL BIOCHEM, V34, P1709, DOI 10.1016/S0038-0717(02)00157-8; FENTON AM, 1992, APPL ENVIRON MICROB, V58, P3873, DOI 10.1128/AEM.58.12.3873-3878.1992; Garbeva P, 2004, SOIL BIOL BIOCHEM, V36, P1453, DOI 10.1016/j.soilbio.2004.03.009; GOULD WD, 1985, APPL ENVIRON MICROB, V49, P28, DOI 10.1128/AEM.49.1.28-32.1985; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Henkes GJ, 2011, J EXP BOT, V62, P4337, DOI 10.1093/jxb/err149; Jousset A, 2008, FUNCT ECOL, V22, P714, DOI 10.1111/j.1365-2435.2008.01411.x; Jousset A, 2006, APPL ENVIRON MICROB, V72, P7083, DOI 10.1128/AEM.00557-06; Jousset A, 2010, APPL ENVIRON MICROB, V76, P5263, DOI 10.1128/AEM.02941-09; Jousset A, 2009, ISME J, V3, P666, DOI 10.1038/ismej.2009.26; KEEL C, 1992, MOL PLANT MICROBE IN, V5, P4, DOI 10.1094/MPMI-5-004; KEEL C, 1990, SYMBIOSIS, V9, P327; Latz E, 2012, J ECOL, V100, P597, DOI 10.1111/j.1365-2745.2011.01940.x; Mazzola M, 2009, APPL ENVIRON MICROB, V75, P6804, DOI 10.1128/AEM.01272-09; Neidig N, 2011, MICROB ECOL, V61, P853, DOI 10.1007/s00248-011-9821-z; Pedersen AL, 2011, FEMS MICROBIOL LETT, V316, P16, DOI 10.1111/j.1574-6968.2010.02182.x; Pedersen AL, 2009, MICROB ECOL, V57, P501, DOI 10.1007/s00248-008-9455-y; Prieme A, 1996, FEMS MICROBIOL ECOL, V21, P59; Raaijmakers JM, 1997, APPL ENVIRON MICROB, V63, P881, DOI 10.1128/AEM.63.3.881-887.1997; Raaijmakers JM, 1998, MOL PLANT MICROBE IN, V11, P144, DOI 10.1094/MPMI.1998.11.2.144; Ronn R, 2002, APPL ENVIRON MICROB, V68, P6094, DOI 10.1128/AEM.68.12.6094-6105.2002; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rosenberg K, 2009, ISME J, V3, P675, DOI 10.1038/ismej.2009.11; Svercel M, 2007, J MICROBIOL METH, V70, P209, DOI 10.1016/j.mimet.2007.03.018; VOSS JG, 1964, J GEN MICROBIOL, V35, P313, DOI 10.1099/00221287-35-2-313; Weller DM, 2007, PHYTOPATHOLOGY, V97, P250, DOI 10.1094/PHYTO-97-2-0250; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010	32	18	20	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66200	10.1371/journal.pone.0066200	http://dx.doi.org/10.1371/journal.pone.0066200			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840423	Green Published, gold			2022-12-27	WOS:000321424400021
J	Wilson, TW; Fox, HS; Robertson, KR; Sandkovsky, U; O'Neill, J; Heinrichs-Graham, E; Knott, NL; Swindells, S				Wilson, Tony W.; Fox, Howard S.; Robertson, Kevin R.; Sandkovsky, Uriel; O'Neill, Jennifer; Heinrichs-Graham, Elizabeth; Knott, Nichole L.; Swindells, Susan			Abnormal MEG Oscillatory Activity during Visual Processing in the Prefrontal Cortices and Frontal Eye-Fields of the Aging HIV Brain	PLOS ONE			English	Article							DEFAULT MODE NETWORK; WORKING-MEMORY; RESTING-STATE; NEUROCOGNITIVE DISORDERS; ANTIRETROVIRAL TREATMENT; MAGNETOENCEPHALOGRAPHY; ACTIVATION; LOCALIZATION; IMPAIRMENT; INFECTION	Objective: Shortly after infection, HIV enters the brain and causes widespread inflammation and neuronal damage, which ultimately leads to neuropsychological impairments. Despite a large body of neuroscience and imaging studies, the pathophysiology of these HIV-associated neurocognitive disorders (HAND) remains unresolved. Previous neuroimaging studies have shown greater activation in HIV-infected patients during strenuous tasks in frontal and parietal cortices, and less activation in the primary sensory cortices during rest and sensory stimulation. Methods: High-density magnetoencephalography (MEG) was utilized to evaluate the basic neurophysiology underlying attentive, visual processing in older HIV-infected adults and a matched non-infected control group. Unlike other neuroimaging methods, MEG is a direct measure of neural activity that is not tied to brain metabolism or hemodynamic responses. During MEG, participants fixated on a centrally-presented crosshair while intermittent visual stimulation appeared in their top-right visual-field quadrant. All MEG data was imaged in the time-frequency domain using beamforming. Results: Uninfected controls had increased neuronal synchronization in the 6-12 Hz range within the right dorsolateral prefrontal cortex, right frontal eye-fields, and the posterior cingulate. Conversely, HIV-infected patients exhibited decreased synchrony in these same neural regions, and the magnitude of these decreases was correlated with neuropsychological performance in several cortical association regions. Conclusions: MEG-based imaging holds potential as a noninvasive biomarker for HIV-related neuronal dysfunction, and may help identify patients who have or may develop HAND. Reduced synchronization of neural populations in the association cortices was strongly linked to cognitive dysfunction, and likely reflects the impact of HIV on neuronal and neuropsychological health.	[Wilson, Tony W.; Fox, Howard S.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Wilson, Tony W.] Univ Nebraska Med Ctr, Dept Neurol Sci, Omaha, NE USA; [Sandkovsky, Uriel; O'Neill, Jennifer; Swindells, Susan] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA; [Wilson, Tony W.; Heinrichs-Graham, Elizabeth; Knott, Nichole L.] Univ Nebraska Med Ctr, Ctr Magnetoencephalog, Omaha, NE USA; [Robertson, Kevin R.] Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27599 USA; [Heinrichs-Graham, Elizabeth] Univ Nebraska, Dept Psychol, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Nebraska System	Wilson, TW (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.	Tony.W.Wilson@gmail.com		Heinrichs-Graham, Elizabeth/0000-0002-7914-5258; Wilson, Tony W/0000-0002-5053-8306; Fox, Howard/0000-0003-2032-374X	NIH [P30 MH062261]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH grant P30 MH062261 (HSF). The Center for Magnetoencephalography at the University of Nebraska Medical Center was founded through an endowment from an anonymous donor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ances BM, 2009, NEUROLOGY, V73, P702, DOI 10.1212/WNL.0b013e3181b59a97; Ances B, 2011, NEUROIMAGE, V54, P2156, DOI 10.1016/j.neuroimage.2010.09.081; Ances BM, 2010, J INFECT DIS, V201, P336, DOI 10.1086/649899; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Becker JT, 2012, BRAIN IMAGING BEHAV, V6, P366, DOI 10.1007/s11682-012-9149-4; Becker JT, 2012, J NEUROSCI METH, V206, P176, DOI 10.1016/j.jneumeth.2012.02.022; Bonnefond M, 2012, CURR BIOL, V22, P1969, DOI 10.1016/j.cub.2012.08.029; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V55, P1804, DOI 10.1016/j.neuroimage.2010.10.074; Carey CL, 2004, CLIN NEUROPSYCHOL, V18, P234, DOI 10.1080/13854040490501448; Chang L, 2008, J NEUROIMMUNE PHARM, V3, P95, DOI 10.1007/s11481-007-9092-0; Chang L, 2004, NEUROIMAGE, V23, P1336, DOI 10.1016/j.neuroimage.2004.07.067; Chang L, 2004, ANN NEUROL, V56, P259, DOI 10.1002/ana.20190; Chang L, 2001, NEUROLOGY, V57, P1001, DOI 10.1212/WNL.57.6.1001; Chang L, 1999, NEUROLOGY, V52, P100, DOI 10.1212/WNL.52.1.100; Cysique LA, 2009, NEUROPSYCHOL REV, V19, P169, DOI 10.1007/s11065-009-9092-3; Ernst MD, 2004, STAT SCI, V19, P676, DOI 10.1214/088342304000000396; Ernst T, 2002, NEUROLOGY, V59, P1343, DOI 10.1212/01.WNL.0000031811.45569.B0; Ernst T, 2009, ANN NEUROL, V65, P316, DOI 10.1002/ana.21594; Foster BL, 2012, NEUROIMAGE, V60, P384, DOI 10.1016/j.neuroimage.2011.12.019; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Harezlak J, 2011, AIDS, V25, P625, DOI 10.1097/QAD.0b013e3283427da7; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hoechstetter K, 2004, BRAIN TOPOGR, V16, P233; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Konrad K, 2010, HUM BRAIN MAPP, V31, P904, DOI 10.1002/hbm.21058; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Lentz MR, 2009, NEUROLOGY, V72, P1465, DOI 10.1212/WNL.0b013e3181a2e90a; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Michels L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010298; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; Palva S, 2011, J NEUROSCI, V31, P5013, DOI 10.1523/JNEUROSCI.5592-10.2011; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Talairach G, 1988, COPLANAR STEREOTAXIC; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Thompson PM, 2005, P NATL ACAD SCI USA, V102, P15647, DOI 10.1073/pnas.0502548102; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Woods SP, 2005, ARCH CLIN NEUROPSYCH, V20, P1061, DOI 10.1016/j.acn.2005.06.007; Yiannoutsos CT, 2004, NEUROIMAGE, V23, P928, DOI 10.1016/j.neuroimage.2004.07.033	48	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66241	10.1371/journal.pone.0066241	http://dx.doi.org/10.1371/journal.pone.0066241			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840428	Green Published, gold			2022-12-27	WOS:000322342800042
J	Bennett, AE; Macrae, AM; Moore, BD; Caul, S; Johnson, SN				Bennett, Alison E.; Macrae, Anna M.; Moore, Ben D.; Caul, Sandra; Johnson, Scott N.			Early Root Herbivory Impairs Arbuscular Mycorrhizal Fungal Colonization and Shifts Defence Allocation in Establishing Plantago lanceolata	PLOS ONE			English	Article							DETERRENT IRIDOID GLYCOSIDES; FOLIAR-FEEDING INSECTS; CHEMICAL DEFENSE; GROWTH-RESPONSES; VINE WEEVILS; HOST-PLANT; INDUCTION; MUTUALISM; PERFORMANCE; GENERALIST	Research into plant-mediated indirect interactions between arbuscular mycorrhizal (AM) fungi and insect herbivores has focussed on those between plant shoots and above-ground herbivores, despite the fact that only below-ground herbivores share the same part of the host plant as AM fungi. Using Plantago lanceolata L., we aimed to characterise how early root herbivory by the vine weevil (Otiorhynchus sulcatus F.) affected subsequent colonization by AM fungi (Glomus spp.) and determine how the two affected plant growth and defensive chemistry. We exposed four week old P. lanceolata to root herbivory and AM fungi using a 2x2 factorial design (and quantified subsequent effects on plant biomass and iridoid glycosides (IGs) concentrations. Otiorhynchus sulcatus reduced root growth by c. 64%, whereas plant growth was unaffected by AM fungi. Root herbivory reduced extent of AM fungal colonization (by c. 61%). O. sulcatus did not influence overall IG concentrations, but caused qualitative shifts in root and shoot IGs, specifically increasing the proportion of the more toxic catalpol. These changes may reflect defensive allocation in the plant against further attack. This study demonstrates that very early root herbivory during plant development can shape future patterns of AM fungal colonization and influence defensive allocation in the plant.	[Bennett, Alison E.; Caul, Sandra; Johnson, Scott N.] James Hutton Inst, Dundee, Scotland; [Macrae, Anna M.] Univ Dundee, Coll Life Sci, Dundee, Scotland; [Moore, Ben D.] James Hutton Inst, Aberdeen, Scotland	James Hutton Institute; University of Dundee; James Hutton Institute	Bennett, AE (corresponding author), James Hutton Inst, Dundee, Scotland.	alibenne@bio.indiana.edu	Johnson, Scott/HDN-6310-2022; Moore, Ben D/C-3447-2008; Johnson, Scott N/B-2268-2012; Moore, Ben/AAE-7885-2020	Moore, Ben D/0000-0002-6995-4721; Moore, Ben/0000-0002-6995-4721; Johnson, Scott/0000-0002-8388-8345	Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	This research was funded by the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD) Workpackage Themes one and three. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardgett R.D., 2010, ABOVEGROUND BELOWGRO; Barto EK, 2010, J ECOL, V98, P745, DOI 10.1111/j.1365-2745.2010.01658.x; Bennett AE, 2006, AM NAT, V167, P141, DOI 10.1086/499379; Bennett AE, 2007, ECOLOGY, V88, P210, DOI 10.1890/0012-9658(2007)88[210:MSDAPG]2.0.CO;2; Bennett AE, 2009, OECOLOGIA, V160, P771, DOI 10.1007/s00442-009-1338-5; Bever JD, 2002, PLANT SOIL, V244, P281, DOI 10.1023/A:1020221609080; Bever JD, 2002, P ROY SOC B-BIOL SCI, V269, P2595, DOI 10.1098/rspb.2002.2162; Biere A, 2004, OECOLOGIA, V140, P430, DOI 10.1007/s00442-004-1603-6; BIRCH ANE, 1992, J SCI FOOD AGR, V60, P1, DOI 10.1002/jsfa.2740600102; Bobbitt JM, 1969, CYCLOPENTANOID TERPE, P1; Bowers M.D., 1991, P297; BOWERS MD, 1988, J CHEM ECOL, V14, P319, DOI 10.1007/BF01022549; BOWERS MD, 1993, ECOLOGY, V74, P1778, DOI 10.2307/1939936; BOWERS MD, 1992, J CHEM ECOL, V18, P985, DOI 10.1007/BF00980057; BREEN JP, 1994, ANNU REV ENTOMOL, V39, P401, DOI 10.1146/annurev.en.39.010194.002153; Clark KE, 2012, CROP PROT, V32, P76, DOI 10.1016/j.cropro.2011.10.008; CLAY K, 1988, ECOLOGY, V69, P10, DOI 10.2307/1943155; Currie AF, 2006, SOIL BIOL BIOCHEM, V38, P1994, DOI 10.1016/j.soilbio.2005.11.015; Currie AF, 2011, APPL SOIL ECOL, V47, P77, DOI 10.1016/j.apsoil.2010.12.002; Darrow K, 1999, J CHEM ECOL, V25, P1427, DOI 10.1023/A:1020991229072; De Deyn GB, 2009, OECOLOGIA, V160, P433, DOI 10.1007/s00442-009-1312-2; Delph LF, 2004, EVOLUTION, V58, P1936, DOI 10.1111/j.0014-3820.2004.tb00481.x; DUFF RB, 1965, BIOCHEM J, V96, P1; Erb M, 2008, PLANT PHYSIOL, V146, P867, DOI 10.1104/pp.107.112169; Erb M, 2009, TRENDS PLANT SCI, V14, P653, DOI 10.1016/j.tplants.2009.08.006; Fontana A, 2009, J CHEM ECOL, V35, P833, DOI 10.1007/s10886-009-9654-0; Fuchs A, 2004, J CHEM ECOL, V30, P1723, DOI 10.1023/B:JOEC.0000042398.13765.83; GANGE AC, 1994, NEW PHYTOL, V128, P79, DOI 10.1111/j.1469-8137.1994.tb03989.x; Gange AC, 2001, NEW PHYTOL, V150, P611, DOI 10.1046/j.1469-8137.2001.00137.x; GANGE AC, 1994, ENTOMOL EXP APPL, V70, P115, DOI 10.1007/BF02380519; Gange Alan C., 2007, P124, DOI 10.1017/CBO9780511542701.007; GARDNER DR, 1988, J CHEM ECOL, V14, P2147, DOI 10.1007/BF01014022; GEHRING CA, 1994, TRENDS ECOL EVOL, V9, P251, DOI 10.1016/0169-5347(94)90290-9; Gehring C, 2009, ENVIRON ENTOMOL, V38, P93, DOI 10.1603/022.038.0111; Hartley SE, 2009, ANNU REV ENTOMOL, V54, P323, DOI 10.1146/annurev.ento.54.110807.090614; Heinemeyer A, 2004, J EXP BOT, V55, P525, DOI 10.1093/jxb/erh049; JOHNS T, 1990, EUPHYTICA, V50, P203, DOI 10.1007/BF00023646; Johnson SN, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P153, DOI 10.1079/9781845934613.0153; Johnson S, 2008, EAST EUR JEW AFF, V38, P1, DOI 10.1080/13501670801912053; Johnson SN, 2011, GLOBAL CHANGE BIOL, V17, P688, DOI 10.1111/j.1365-2486.2010.02264.x; Johnson SN, 2010, AGR FOREST ENTOMOL, V12, P277, DOI 10.1111/j.1461-9563.2010.00473.x; Johnson SN, 2003, OECOLOGIA, V134, P388, DOI 10.1007/s00442-002-1139-6; Kaplan I, 2008, ECOLOGY, V89, P392, DOI 10.1890/07-0471.1; Koricheva J, 2009, ECOLOGY, V90, P2088, DOI 10.1890/08-1555.1; Marak HB, 2003, EVOLUTION, V57, P2519, DOI 10.1111/j.0014-3820.2003.tb01496.x; Marak HB, 2002, CHEMOECOLOGY, V12, P185, DOI 10.1007/PL00012667; Marak HB, 2002, J CHEM ECOL, V28, P2429, DOI 10.1023/A:1021475800765; Marak HB, 2000, J EVOLUTION BIOL, V13, P985, DOI 10.1046/j.1420-9101.2000.00233.x; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Oghushi T, 2007, ECOLOGICAL COMMUNITI; Polis GA, 1998, NATURE, V395, P744, DOI 10.1038/27323; Smith FF, 1932, BIOL CONTROL BLACK V; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stamp NE, 1996, ECOLOGY, V77, P535, DOI 10.2307/2265628; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; van Dam NM, 2009, ANNU REV ECOL EVOL S, V40, P373, DOI 10.1146/annurev.ecolsys.110308.120314; van Dam NM, 2006, CHEMOECOLOGY, V16, P17, DOI 10.1007/s00049-005-0323-7; Wamberg C, 2003, PEDOBIOLOGIA, V47, P281, DOI 10.1078/0031-4056-00191; Wurst S, 2008, J CHEM ECOL, V34, P1360, DOI 10.1007/s10886-008-9537-9	59	20	20	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66053	10.1371/journal.pone.0066053	http://dx.doi.org/10.1371/journal.pone.0066053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840398	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200052
J	Gusmao, R; Quintao, S; McDaid, D; Arensman, E; Van Audenhove, C; Coffey, C; Varnik, A; Varnik, P; Coyne, J; Hegerl, U				Gusmao, Ricardo; Quintao, Sonia; McDaid, David; Arensman, Ella; Van Audenhove, Chantal; Coffey, Claire; Vaernik, Airi; Vaernik, Peeter; Coyne, James; Hegerl, Ulrich			Antidepressant Utilization and Suicide in Europe: An Ecological Multi-National Study	PLOS ONE			English	Article							MENTAL-DISORDERS; RATES; PREVENTION; ALCOHOL; HEALTH; DEPRESSION; COUNTRIES; PATTERNS; BEHAVIOR; HUNGARY	Background: Research concerning the association between use of antidepressants and incidence of suicide has yielded inconsistent results and is the subject of considerable controversy. The first aim is to describe trends in the use of antidepressants and rates of suicide in Europe, adjusted for gross domestic product, alcohol consumption, unemployment, and divorce. The second aim is to explore if any observed reduction in the rate of suicide in different European countries preceded the trend for increased use of antidepressants. Methods: Data were obtained for 29 European countries between 1980 and 2009. Pearson correlations were used to explore the direction and magnitude of associations. Generalized linear mixed models and Poisson regression distribution were used to clarify the effects of antidepressants on suicide rates, while an autoregressive adjusted model was used to test the interaction between antidepressant utilization and suicide over two time periods: 1980-1994 and 1995-2009. Findings: An inverse correlation was observed in all countries between recorded Standardised Death Rate (SDR) for suicide and antidepressant Defined Daily Dosage (DDD), with the exception of Portugal. Variability was marked in the association between suicide and alcohol, unemployment and divorce, with countries depicting either a positive or a negative correlation with the SDR for suicide. Every unit increase in DDD of an antidepressant per 1000 people per day, adjusted for these confounding factors, reduces the SDR by 0.088. The correlation between DDD and suicide related SDR was negative in both time periods considered, albeit more pronounced between 1980 and 1994. Conclusions: Suicide rates have tended to decrease more in European countries where there has been a greater increase in the use of antidepressants. These findings underline the importance of the appropriate use of antidepressants as part of routine care for people diagnosed with depression, therefore reducing the risk of suicide.	[Gusmao, Ricardo; Quintao, Sonia] Univ Nova Lisboa, Fac Ciencias Med, CEDOC, Dept Saude Mental, P-1200 Lisbon, Portugal; [Gusmao, Ricardo] Ctr Hosp Lisboa Ocidental, Dept Psiquiatria & Saude Mental, Lisbon, Portugal; [McDaid, David] Univ London London Sch Econ & Polit Sci, LSE Hlth & Social Care, Personal Social Serv Res Unit, London WC2A 2AE, England; [Arensman, Ella; Coffey, Claire] Natl Suicide Res Fdn, Cork, Ireland; [Van Audenhove, Chantal] Katholieke Univ Leuven, LUCAS, Louvain, Belgium; [Vaernik, Airi; Vaernik, Peeter] Estonian Swedish Mental Hlth & Suicidol Inst ERSI, Tallinn, Estonia; [Coyne, James] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Coyne, James] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Hlth Psychol Sect, Groningen, Netherlands; [Hegerl, Ulrich] Univ Leipzig, Dept Psychiat, D-04109 Leipzig, Germany	Universidade Nova de Lisboa; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; University of London; London School Economics & Political Science; KU Leuven; University of Pennsylvania; Pennsylvania Medicine; University of Groningen; Leipzig University	Gusmao, R (corresponding author), Univ Nova Lisboa, Fac Ciencias Med, CEDOC, Dept Saude Mental, P-1200 Lisbon, Portugal.	rgusmao@mac.com	McDaid, David/E-5959-2014; Gusmao, Ricardo/AAT-5016-2020	McDaid, David/0000-0003-0744-2664; Gusmao, Ricardo/0000-0002-6334-4607; Quintao, Sonia/0000-0003-0199-7618; Van Audenhove, Chantal/0000-0002-5504-5439; Hegerl, Ulrich/0000-0002-3039-7470; Arensman, Ella/0000-0003-0376-1203	European Community [223138]	European Community(European Commission)	The OSPI project has received funding from the European Community's Seventh Framework Programme, FP7/2007-2013 (http://ec.europa.eu/research/fp7/index_en.cfm) under grant agreement no223138. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus D, 2003, MMW Fortschr Med, V145, P42; Baldessarini RJ, 2007, HARVARD REV PSYCHIAT, V15, P133, DOI 10.1080/10673220701551102; Barth A, 2011, J OCCUP ENVIRON MED, V53, P313, DOI 10.1097/JOM.0b013e31820d161c; Bertolote JM, 2003, BRIT J PSYCHIAT, V183, P382, DOI 10.1192/bjp.183.5.382; Blakely TA, 2003, J EPIDEMIOL COMMUN H, V57, P594, DOI 10.1136/jech.57.8.594; Bradvik L, 2010, ARCH SUICIDE RES, V14, P266, DOI 10.1080/13811118.2010.494146; Bridge JA, 2008, INT REV PSYCHIATR, V20, P209, DOI 10.1080/09540260801889245; Bridge JA, 2007, JAMA-J AM MED ASSOC, V297, P1683, DOI 10.1001/jama.297.15.1683; Carta MG, 2004, SOC PSYCH PSYCH EPID, V39, P883, DOI 10.1007/s00127-004-0871-0; Ciuna A, 2004, EUR J CLIN PHARMACOL, V60, P629, DOI 10.1007/s00228-004-0810-8; Desai RA, 2005, AM J PSYCHIAT, V162, P311, DOI 10.1176/appi.ajp.162.2.311; Edwards LJ, 2000, PEDIATR PULM, V30, P330, DOI 10.1002/1099-0496(200010)30:4<330::AID-PPUL10>3.0.CO;2-D; Fernandez A, 2007, BRIT J PSYCHIAT, V190, P172, DOI 10.1192/bjp.bp.106.023507; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Gibbons RD, 2005, ARCH GEN PSYCHIAT, V62, P165, DOI 10.1001/archpsyc.62.2.165; Gibbons RD, 2007, AM J PSYCHIAT, V164, P1044, DOI 10.1176/appi.ajp.164.7.1044; Gibbons RD, 2012, ARCH GEN PSYCHIAT, V69, P572, DOI 10.1001/archgenpsychiatry.2011.2044; Gibbons RD, 2006, AM J PSYCHIAT, V163, P1898, DOI 10.1176/appi.ajp.163.11.1898; Hammad TA, 2006, ARCH GEN PSYCHIAT, V63, P332, DOI 10.1001/archpsyc.63.3.332; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hegerl U, 2007, WORLD J BIOL PSYCHIA; Hegerl U, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-428; Helgason T, 2004, BRIT J PSYCHIAT, V184, P157, DOI 10.1192/bjp.184.2.157; Hirschfeld RMA, 2000, ARCH GEN PSYCHIAT, V57, P325, DOI 10.1001/archpsyc.57.4.325; Isacsson G, 2000, ACTA PSYCHIAT SCAND, V102, P113, DOI 10.1034/j.1600-0447.2000.102002113.x; ISACSSON G, 1994, BRIT MED J, V308, P506, DOI 10.1136/bmj.308.6927.506; Isacsson G, 1996, J AFFECT DISORDERS, V41, P1, DOI 10.1016/0165-0327(96)00050-X; Johannessen HA, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-68; Kadusevicius Edmundas, 2006, Medicina (Kaunas), V42, P1020; Kapusta ND, 2009, ACTA PSYCHIAT SCAND, V119, P236, DOI 10.1111/j.1600-0447.2008.01314.x; King M, 2008, BRIT J PSYCHIAT, V192, P362, DOI 10.1192/bjp.bp.107.039966; Knapp M., 2007, MENTAL HLTH POLICY P; Knapp M., 2007, J MENT HEALTH, V16, p167, DOI [DOI 10.1080/09638230701279857, 10.1080/09638230701279857]; Lewis G, 1998, BMJ-BRIT MED J, V317, P1283, DOI 10.1136/bmj.317.7168.1283; LEWIS G, 1994, LANCET, V344, P822, DOI 10.1016/S0140-6736(94)92379-5; Ludwig J, 2005, J POLICY ANAL MANAG, V24, P249, DOI 10.1002/pam.20089; Ludwig J, 2009, J HEALTH ECON, V28, P659, DOI 10.1016/j.jhealeco.2009.02.002; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Milane MS, 2006, PLOS MED, V3, P816, DOI 10.1371/journal.pmed.0030190; Milea D, 2010, CURR MED RES OPIN, V26, P1343, DOI 10.1185/03007991003772096; Moller HJ, 2008, EUR ARCH PSY CLIN N, V258, P3, DOI 10.1007/s00406-008-3002-1; Moller HJ, 2006, EUR ARCH PSY CLIN N, V256, P476, DOI 10.1007/s00406-006-0689-8; Mojtabai R, 2008, J CLIN PSYCHIAT, V69, P1064, DOI 10.4088/JCP.v69n0704; Moller-Leimkuhler AM, 2000, FORTSCHR NEUROL PSYC, V68, P489, DOI 10.1055/s-2000-10030; MORGENSTERN H, 1982, AM J PUBLIC HEALTH, V72, P1336, DOI 10.2105/AJPH.72.12.1336; OECD, OECD HLTH DAT PHARM; Organization for Economic Co-Operation and Development, 2012, HLTH GLANC EUR 2012; Organization for Economic Co-operation and Development, 2009, SOC GLANC 2009 OECD; Parker G, 2009, BRIT J PSYCHIAT, V194, P1, DOI 10.1192/bjp.bp.108.054767; Pirkola S, 2009, LANCET, V373, P147, DOI 10.1016/S0140-6736(08)61848-6; Pirkola S, 2007, PSYCHIAT SERV, V58, P221, DOI 10.1176/appi.ps.58.2.221; Po W, 1993, PHARMACOEPIDEM DR S, V2, P79; Pomerantz JM, 2004, J CLIN PSYCHIAT, V65, P395; Pompili M, 2010, INT J ENV RES PUB HE, V7, P1392, DOI 10.3390/ijerph7041392; Quitkin FM, 2000, AM J PSYCHIAT, V157, P327, DOI 10.1176/appi.ajp.157.3.327; Rehkopf DH, 2006, PSYCHOL MED, V36, P145, DOI 10.1017/S003329170500588X; Rihmer Z, 2000, BRIT J PSYCHIAT, V177, P84, DOI 10.1192/bjp.177.1.84; Rihmer Z, 1995, J AFFECT DISORDERS, V35, P147, DOI 10.1016/0165-0327(95)00055-0; Rihmer Z, 2001, ACTA PSYCHIAT SCAND, V103, P238; SCHWARTZ S, 1994, AM J PUBLIC HEALTH, V84, P819, DOI 10.2105/AJPH.84.5.819; Shah A, 2010, INT J SOC PSYCHIATR, V56, P448, DOI 10.1177/0020764009342384; Sher L, 2006, QJM-INT J MED, V99, P57, DOI 10.1093/qjmed/hci146; SKOG OJ, 1995, ADDICTION, V90, P1053, DOI 10.1046/j.1360-0443.1995.90810534.x; Stack S, 2000, SUICIDE LIFE-THREAT, V30, P163; Stone KJ, 2003, AM FAM PHYSICIAN, V68, P498; Szanto K, 2007, ARCH GEN PSYCHIAT, V64, P914, DOI 10.1001/archpsyc.64.8.914; TEICHER MH, 1993, DRUG SAFETY, V8, P186, DOI 10.2165/00002018-199308030-00002; TEICHER MH, 1990, AM J PSYCHIAT, V147, P207; Varnik P, 2012, INJURY PREV, V18, P321, DOI 10.1136/injuryprev-2011-040070; Varnik P, 2010, FORENSIC SCI INT, V202, P86, DOI 10.1016/j.forsciint.2010.04.032; van der PoeL C.L., 2011, CRISIS, P2011; van Praag H M, 2002, Crisis, V23, P77; Van Praag HM, 2003, WORLD J BIOL PSYCHIA, V4, P184, DOI 10.1080/15622970310029917; Viola R, 2008, PHARMACOEPIDEM DR S, V17, P401, DOI 10.1002/pds.1574; Wasserman D, 1998, ACTA PSYCHIAT SCAND, V98, P1, DOI 10.1111/j.1600-0447.1998.tb10758.x; Wheeler BW, 2009, PHARMACOEPIDEM DR S, V18, P579, DOI 10.1002/pds.1753; WHO Collaborating Centre for Drug Statistics Methodology, 2009, GUID ATC CLASS DDD A; WHO Regional Office for Europe, 2011, EUR HLTH ALL DAT HFA; WHO Regional Office for Europe, 2011, EUR MORT DAT MDB; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012; World Health Organization, 2007, WHO GLOB INF SYST AL; Zahl PH, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-62; Zhang J, 2009, EUR PSYCHIAT	84	84	84	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66455	10.1371/journal.pone.0066455	http://dx.doi.org/10.1371/journal.pone.0066455			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190ST	23840475	Green Published, Green Accepted, gold			2022-12-27	WOS:000322361200082
J	Peters, D; Berger, J; Langnaese, K; Derst, C; Madai, VI; Krauss, M; Fischer, KD; Veh, RW; Laube, G				Peters, Daniela; Berger, Jana; Langnaese, Kristina; Derst, Christian; Madai, Vince I.; Krauss, Michael; Fischer, Klaus-Dieter; Veh, Ruediger W.; Laube, Gregor			Arginase and Arginine Decarboxylase - Where Do the Putative Gate Keepers of Polyamine Synthesis Reside in Rat Brain?	PLOS ONE			English	Article							SPERMIDINE/SPERMINE-LIKE IMMUNOREACTIVITY; METHYL-D-ASPARTATE; CEREBRAL-CORTEX; AGMATINE; LOCALIZATION; RECEPTORS; ORNITHINE; NEUROTRANSMITTER; RECTIFICATION; INTERNEURONS	Polyamines are important regulators of basal cellular functions but also subserve highly specific tasks in the mammalian brain. With this respect, polyamines and the synthesizing and degrading enzymes are clearly differentially distributed in neurons versus glial cells and also in different brain areas. The synthesis of the diamine putrescine may be driven via two different pathways. In the "classical" pathway urea and carbon dioxide are removed from arginine by arginase and ornithine decarboxylase. The alternative pathway, first removing carbon dioxide by arginine decarboxlyase and then urea by agmatinase, may serve the same purpose. Furthermore, the intermediate product of the alternative pathway, agmatine, is an endogenous ligand for imidazoline receptors and may serve as a neurotransmitter. In order to evaluate and compare the expression patterns of the two gate keeper enzymes arginase and arginine decarboxylase, we generated polyclonal, monospecific antibodies against arginase-1 and arginine decarboxylase. Using these tools, we immunocytochemically screened the rat brain and compared the expression patterns of both enzymes in several brain areas on the regional, cellular and subcellular level. In contrast to other enzymes of the polyamine pathway, arginine decarboxylase and arginase are both constitutively and widely expressed in rat brain neurons. In cerebral cortex and hippocampus, principal neurons and putative interneurons were clearly labeled for both enzymes. Labeling, however, was strikingly different in these neurons with respect to the subcellular localization of the enzymes. While with antibodies against arginine decarboxylase the immunosignal was distributed throughout the cytoplasm, arginase-like immunoreactivity was preferentially localized to Golgi stacks. Given the apparent congruence of arginase and arginine decarboxylase distribution with respect to certain cell populations, it seems likely that the synthesis of agmatine rather than putrescine may be the main purpose of the alternative pathway of polyamine synthesis, while the classical pathway supplies putrescine and spermidine/spermine in these neurons.	[Peters, Daniela; Berger, Jana; Derst, Christian; Madai, Vince I.; Krauss, Michael; Veh, Ruediger W.; Laube, Gregor] Charite, Inst Integrat Neuroanat, D-13353 Berlin, Germany; [Langnaese, Kristina; Fischer, Klaus-Dieter] Otto Von Guericke Univ, Fak Med, Inst Biochem & Zellbiol, Magdeburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Otto von Guericke University	Veh, RW (corresponding author), Charite, Inst Integrat Neuroanat, D-13353 Berlin, Germany.	ruediger.veh@charite.de	Madai, Vince/GYD-7365-2022; Madai, Vince/AAF-5525-2020	Madai, Vince/0000-0002-8552-6954; Madai, Vince/0000-0002-8552-6954; Veh, Rudiger/0000-0002-6253-9808				Ahern GP, 2006, J BIOL CHEM, V281, P8991, DOI 10.1074/jbc.M513429200; Bell MR, 2011, NAT NEUROSCI, V14, P505, DOI 10.1038/nn.2777; Benedikt J, 2012, NEUROREPORT, V23, P1021, DOI 10.1097/WNR.0b013e32835aa04b; Berkels R, 2004, CARDIOVASC DRUG REV, V22, P7; Bernstein HG, 2011, AMINO ACIDS, V40, P453, DOI 10.1007/s00726-010-0657-5; Bernstein HG, 2012, NEUROPHARMACOLOGY, V62, P237, DOI 10.1016/j.neuropharm.2011.07.012; Bernstein HG, 1999, PROG NEUROBIOL, V57, P485, DOI 10.1016/S0301-0082(98)00065-3; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Braissant O, 1999, MOL BRAIN RES, V70, P231, DOI 10.1016/S0169-328X(99)00151-5; Cederbaum SD, 2004, MOL GENET METAB, V81, pS38, DOI 10.1016/j.ymgme.2003.10.012; Chen GG, 2010, NEUROPSYCHOPHARMACOL, V35, P1477, DOI 10.1038/npp.2010.17; Coleman CS, 2004, BIOCHEM J, V379, P849, DOI 10.1042/BJ20040035; Deignan JL, 2007, AM J PHYSIOL-CELL PH, V293, pC1296, DOI 10.1152/ajpcell.00393.2006; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Ferchmin PA, 2000, BRAIN RES, V859, P273, DOI 10.1016/S0006-8993(00)01973-9; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Fiori LM, 2008, J PSYCHIATR NEUROSCI, V33, P102; Gotoh T, 1996, FEBS LETT, V395, P119, DOI 10.1016/0014-5793(96)01015-0; Halaris A, 2007, CNS DRUGS, V21, P885, DOI 10.2165/00023210-200721110-00002; HUANG XQ, 1990, COMPUT APPL BIOSCI, V6, P373; Iyer RK, 2002, MOL CELL BIOL, V22, P4491, DOI 10.1128/MCB.22.13.4491-4498.2002; Kilpelainen P, 2000, J NEUROSCI RES, V62, P675, DOI 10.1002/1097-4547(20001201)62:5<675::AID-JNR6>3.0.CO;2-S; KOENIG H, 1990, STROKE, V21, P98; Krauss A, 2007, J NEUROCHEM, V103, P679, DOI 10.1111/j.1471-4159.2007.04770.x; Krauss M, 2006, J NEUROCHEM, V97, P174, DOI 10.1111/j.1471-4159.2006.03721.x; Kucheryavykh YV, 2008, GLIA, V56, P775, DOI 10.1002/glia.20652; LAITINEN PH, 1986, BIOCHEM J, V236, P613, DOI 10.1042/bj2360613; Laschet J, 1999, EPILEPSY RES, V35, P161, DOI 10.1016/S0920-1211(99)00009-1; Laube G, 1997, GLIA, V19, P171, DOI 10.1002/(SICI)1098-1136(199702)19:2<171::AID-GLIA8>3.0.CO;2-3; Laube G, 2002, J COMP NEUROL, V444, P369, DOI 10.1002/cne.10157; LI G, 1994, SCIENCE, V263, P966, DOI 10.1126/science.7906055; Lopez-Contreras AJ, 2006, J BIOL CHEM, V281, P30896, DOI 10.1074/jbc.M602840200; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; Madai, 2012, VIRT PREEMB LAB METH; Madai VI, 2012, AMINO ACIDS, V43, P1399, DOI 10.1007/s00726-011-1195-5; MEYER KH, 1991, J HISTOCHEM CYTOCHEM, V39, P749, DOI 10.1177/39.6.1674516; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; Morris SM, 1997, GENE, V193, P157, DOI 10.1016/S0378-1119(97)00099-1; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Okamoto A, 1997, BIOSCI BIOTECH BIOCH, V61, P1582, DOI 10.1271/bbb.61.1582; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Piletz JE, 2003, ANN NY ACAD SCI, V1009, P64, DOI 10.1196/annals.1304.007; Reis DJ, 2000, TRENDS PHARMACOL SCI, V21, P187, DOI 10.1016/S0165-6147(00)01460-7; SHIN WW, 1985, J NEUROCHEM, V44, P1056, DOI 10.1111/j.1471-4159.1985.tb08724.x; STRAUS W, 1982, J HISTOCHEM CYTOCHEM, V30, P491, DOI 10.1177/30.5.6176617; TROJANOWSKI JQ, 1983, J HISTOCHEM CYTOCHEM, V31, P1217, DOI 10.1177/31.10.6350434; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; Vockley JG, 1996, GENOMICS, V38, P118, DOI 10.1006/geno.1996.0606; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; WILSON VJ, 1968, J NEUROPHYSIOL, V31, P166, DOI 10.1152/jn.1968.31.2.166; Yu H, 2001, J NEUROSCI RES, V66, P406, DOI 10.1002/jnr.1233	51	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66735	10.1371/journal.pone.0066735	http://dx.doi.org/10.1371/journal.pone.0066735			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840524	Green Submitted, gold, Green Published			2022-12-27	WOS:000322361200103
J	Shahinas, D; Thornton, CS; Tamber, GS; Arya, G; Wong, A; Jamieson, FB; Ma, JH; Alexander, DC; Low, DE; Pillai, DR				Shahinas, Dea; Thornton, Christina S.; Tamber, Gurdip Singh; Arya, Gitanjali; Wong, Andrew; Jamieson, Frances B.; Ma, Jennifer H.; Alexander, David C.; Low, Donald E.; Pillai, Dylan R.			Comparative Genomic Analyses of Streptococcus pseudopneumoniae Provide Insight into Virulence and Commensalism Dynamics	PLOS ONE			English	Article							ARGININE TRANSLOCATION SYSTEM; MULTIPLE SEQUENCE ALIGNMENT; GENETIC-TRANSFORMATION; BINDING PROTEIN; IRON UPTAKE; PNEUMONIAE; COMPETENCE; IDENTIFICATION; NEURAMINIDASE; RECOMBINATION	Streptococcus pseudopneumoniae (SPPN) is a recently described species of the viridans group streptococci (VGS). Although the pathogenic potential of S. pseudopneumoniae remains uncertain, it is most commonly isolated from patients with underlying medical conditions, such as chronic obstructive pulmonary disease. S. pseudopneumoniae can be distinguished from the closely related species, S. pneumoniae and S. mitis, by phenotypic characteristics, including optochin resistance in the presence of 5% CO2, bile insolubility, and the lack of the pneumococcal capsule. Previously, we reported the draft genome sequence of S. pseudopneumoniae IS7493, a clinical isolate obtained from an immunocompromised patient with documented pneumonia. Here, we use comparative genomics approaches to identify similarities and key differences between S. pseudopneumoniae IS7493, S. pneumoniae and S. mitis. The genome structure of S. pseudopneumoniae IS7493 is most closely related to that of S. pneumoniae R6, but several recombination events are evident. Analysis of gene content reveals numerous unique features that distinguish S. pseudopneumoniae from other streptococci. The presence of loci for competence, iron transport, pneumolysin production and antimicrobial resistance reinforce the phylogenetic position of S. pseudopneumoniae as an intermediate species between S. pneumoniae and S. mitis. Additionally, the presence of several virulence factors and antibiotic resistance mechanisms suggest the potential of this commensal species to become pathogenic or to contribute to increasing antibiotic resistance levels seen among the VGS.	[Shahinas, Dea; Jamieson, Frances B.; Alexander, David C.; Low, Donald E.] Univ Toronto, Toronto, ON, Canada; [Thornton, Christina S.; Pillai, Dylan R.] Univ Calgary, Dept Microbiol Immunol & Infect Dis, Calgary, AB, Canada; [Tamber, Gurdip Singh; Arya, Gitanjali; Wong, Andrew; Jamieson, Frances B.; Ma, Jennifer H.; Alexander, David C.] Publ Hlth Ontario, Toronto, ON, Canada; [Ma, Jennifer H.; Alexander, David C.] Publ Hlth Ontario, DNA Core Facil, Toronto, ON, Canada; [Pillai, Dylan R.] Univ Calgary, Calgary, AB, Canada	University of Toronto; University of Calgary; University of Calgary	Shahinas, D (corresponding author), Univ Toronto, Toronto, ON, Canada.	dea.shahinas@mail.utoronto.ca			Ontario Agency for Health Protection and Promotion	Ontario Agency for Health Protection and Promotion	This study was funded by the Ontario Agency for Health Protection and Promotion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-41; Arbique JC, 2004, J CLIN MICROBIOL, V42, P4686, DOI 10.1128/JCM.42.10.4686-4696.2004; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Brown JS, 2001, INFECT IMMUN, V69, P6702, DOI 10.1128/IAI.69.11.6702-6706.2001; Carrolo M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-191; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Cerda P, 2007, INT MICROBIOL, V10, P57, DOI 10.2436/20.1501.01.8; Croucher NJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-120; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Dawid S, 2007, INFECT IMMUN, V75, P443, DOI 10.1128/IAI.01775-05; Del Grosso M, 2007, ANTIMICROB AGENTS CH, V51, P4184, DOI 10.1128/AAC.00598-07; Denapaite D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009426; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; Gualdi L, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-200; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; Hakenbeck R, 2009, FEMS MICROBIOL REV, V33, P572, DOI 10.1111/j.1574-6976.2009.00172.x; Harf-Monteil C, 2006, J CLIN MICROBIOL, V44, P2240, DOI 10.1128/JCM.02643-05; Havarstein LS, 2006, MOL MICROBIOL, V59, P1297, DOI 10.1111/j.1365-2958.2005.05021.x; Havarstein LS, 1996, MOL MICROBIOL, V21, P863, DOI 10.1046/j.1365-2958.1996.521416.x; Iannelli F, 2005, FEMS MICROBIOL LETT, V252, P321, DOI 10.1016/j.femsle.2005.09.008; Johnston C, 2010, J CLIN MICROBIOL, V48, P2762, DOI 10.1128/JCM.01746-09; Jorgensen JH, 2007, CLIN INFECT DIS, V44, P280, DOI 10.1086/510431; Keith ER, 2006, J CLIN MICROBIOL, V44, P923, DOI 10.1128/JCM.44.3.923-927.2006; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; King SJ, 2005, J BACTERIOL, V187, P5376, DOI 10.1128/JB.187.15.5376-5386.2005; Laurens C, 2012, ANTIMICROB AGENTS CH, V56, P4504, DOI 10.1128/AAC.06374-11; Lavander M, 2006, INFECT IMMUN, V74, P1768, DOI 10.1128/IAI.74.3.1768-1776.2006; Leegaard TM, 2010, MICROBIOL-SGM, V156, P838, DOI 10.1099/mic.0.035345-0; Leung MH, 2012, J CLIN MICROBIOL, V50, P1684, DOI 10.1128/JCM.00131-12; Llull D, 2006, J CLIN MICROBIOL, V44, P1250, DOI 10.1128/JCM.44.4.1250-1256.2006; Lofling J, 2011, CELL MICROBIOL, V13, P186, DOI 10.1111/j.1462-5822.2010.01560.x; Long JP, 2004, INFECT IMMUN, V72, P4309, DOI 10.1128/IAI.72.7.4309-4313.2004; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Molina R, 2009, EMBO REP, V10, P246, DOI 10.1038/embor.2008.245; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pestova EV, 1996, MOL MICROBIOL, V21, P853, DOI 10.1046/j.1365-2958.1996.501417.x; Pikis A, 2001, J INFECT DIS, V184, P582, DOI 10.1086/322803; Pillai DR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-642; Poulsen K, 1998, INFECT IMMUN, V66, P181, DOI 10.1128/IAI.66.1.181-190.1998; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Raskin DM, 2006, CELL, V124, P703, DOI 10.1016/j.cell.2006.02.002; Romero P, 2004, J BACTERIOL, V186, P8229, DOI 10.1128/JB.186.24.8229-8239.2004; Shahinas D, 2011, J BACTERIOL, V193, P6102, DOI 10.1128/JB.06075-11; Standish AJ, 2005, P NATL ACAD SCI USA, V102, P7701, DOI 10.1073/pnas.0409377102; Takamatsu D, 2004, MOL MICROBIOL, V52, P189, DOI 10.1111/j.1365-2958.2004.03978.x; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Tong HH, 2002, ACTA OTO-LARYNGOL, V122, P413, DOI 10.1080/00016480260000111; Tunkel AR, 2002, CLIN INFECT DIS, V34, P1524, DOI 10.1086/340402; Vestrheim DF, 2011, INFECT GENET EVOL, V11, P1703, DOI 10.1016/j.meegid.2011.07.003; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Whatmore AM, 1999, J BACTERIOL, V181, P3144, DOI 10.1128/JB.181.10.3144-3154.1999; Xiao W, 2005, CHEST, V128, P2316, DOI 10.1378/chest.128.4.2316; Xu Z, 2009, NUCLEIC ACIDS RES, V37, pW174, DOI 10.1093/nar/gkp278; Zbinden A, 2012, INT J SYST EVOL MICR	63	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65670	10.1371/journal.pone.0065670	http://dx.doi.org/10.1371/journal.pone.0065670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840352	gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200030
J	Stevens, A; Nocita, M; Toth, G; Montanarella, L; van Wesemael, B				Stevens, Antoine; Nocita, Marco; Toth, Gergely; Montanarella, Luca; van Wesemael, Bas			Prediction of Soil Organic Carbon at the European Scale by Visible and Near InfraRed Reflectance Spectroscopy	PLOS ONE			English	Article							NIR; MANAGEMENT; MODELS; MATTER; CLAY	Soil organic carbon is a key soil property related to soil fertility, aggregate stability and the exchange of CO2 with the atmosphere. Existing soil maps and inventories can rarely be used to monitor the state and evolution in soil organic carbon content due to their poor spatial resolution, lack of consistency and high updating costs. Visible and Near Infrared diffuse reflectance spectroscopy is an alternative method to provide cheap and high-density soil data. However, there are still some uncertainties on its capacity to produce reliable predictions for areas characterized by large soil diversity. Using a large-scale EU soil survey of about 20,000 samples and covering 23 countries, we assessed the performance of reflectance spectroscopy for the prediction of soil organic carbon content. The best calibrations achieved a root mean square error ranging from 4 to 15 g C kg(-1) for mineral soils and a root mean square error of 50 g C kg(-1) for organic soil materials. Model errors are shown to be related to the levels of soil organic carbon and variations in other soil properties such as sand and clay content. Although errors are similar to 5 times larger than the reproducibility error of the laboratory method, reflectance spectroscopy provides unbiased predictions of the soil organic carbon content. Such estimates could be used for assessing the mean soil organic carbon content of large geographical entities or countries. This study is a first step towards providing uniform continental-scale spectroscopic estimations of soil organic carbon, meeting an increasing demand for information on the state of the soil that can be used in biogeochemical models and the monitoring of soil degradation.	[Stevens, Antoine; Nocita, Marco; van Wesemael, Bas] UCLouvain, Georges Lemaitre Ctr Earth & Climate Res, Earth & Life Inst, Louvain, Belgium; [Nocita, Marco; Toth, Gergely; Montanarella, Luca] Commiss European Communities, Joint Res Ctr, SOIL Act Land Resource Management Unit, I-21020 Ispra, Italy	Universite Catholique Louvain; European Commission Joint Research Centre; EC JRC ISPRA Site	Stevens, A (corresponding author), UCLouvain, Georges Lemaitre Ctr Earth & Climate Res, Earth & Life Inst, Louvain, Belgium.	antoine.stevens@uclouvain.be	Van+Wesemael, Bas/Y-2444-2019; Montanarella, Luca/AAE-7112-2019	Toth, Gergely/0000-0002-4201-1678; van Wesemael, Bas/0000-0003-4007-0241; Stevens, Antoine/0000-0002-1588-7519	European Commission (FP7-ENV-2007-1) under the DIGISOIL project [211523]	European Commission (FP7-ENV-2007-1) under the DIGISOIL project	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The research in this paper is funded by the European Commission (FP7-ENV-2007-1) under the DIGISOIL project (no211523). A. S. is postdoctoral researcher of the Fonds de la Recherche scientifique-FNRS (F.R.S.-FNRS, Belgium).	African Union Commission, 2012, AFR UN HUM RIGHTS ME, P5; [Anonymous], 2004, NEARINFRARED SPECTRO; Baritz R, 2011, SOIL CARBON IN SENSITIVE EUROPEAN ECOSYSTEMS: FROM SCIENCE TO LAND MANAGEMENT, P49; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; Bellon-Maurel V, 2011, SOIL BIOL BIOCHEM, V43, P1398, DOI 10.1016/j.soilbio.2011.02.019; Bellon-Maurel V, 2010, TRAC-TREND ANAL CHEM, V29, P1073, DOI 10.1016/j.trac.2010.05.006; Ben-Dor E, 2009, REMOTE SENS ENVIRON, V113, pS38, DOI 10.1016/j.rse.2008.09.019; Ben-Dor E., 1999, MANUAL REMOTE SENSIN, V3, P111; BenDor E, 1997, REMOTE SENS ENVIRON, V61, P1, DOI 10.1016/S0034-4257(96)00120-4; BENDOR E, 1995, SOIL SCI SOC AM J, V59, P364, DOI 10.2136/sssaj1995.03615995005900020014x; Breiman L., 1984, CLASSIFICATION REGRE; Brown DJ, 2006, GEODERMA, V132, P273, DOI 10.1016/j.geoderma.2005.04.025; Brown DJ, 2005, GEODERMA, V129, P251, DOI 10.1016/j.geoderma.2005.01.001; Clark R.N., 1999, REMOTE SENSING EARTH, P3, DOI DOI 10.1111/J.1945-5100.2004.TB00079.X; CLARK RN, 1984, J GEOPHYS RES, V89, P6329, DOI 10.1029/JB089iB07p06329; ELVIDGE CD, 1990, INT J REMOTE SENS, V11, P1775, DOI 10.1080/01431169008955129; European Commission and the Europan Soil Bureau Network, 2004, EUR SOIL DAT DISTR; Eurostat, 2009, C3 EUR; Eurostat, 2009, LUCAS 2009 SURV; FAO IUSS Working Group, 1998, WORLD REF BAS SOIL R; Fearn T., 2010, CHEMOMETRIC SPACE, V21, P13; Fearn T, 2008, NIR NEWS, V16, P7; Ge YF, 2011, GEODERMA, V161, P202, DOI 10.1016/j.geoderma.2010.12.020; Genot V, 2011, J NEAR INFRARED SPEC, V19, P117, DOI 10.1255/jnirs.923; Hastie T., 2009, UNSUPERVISED LEARNIN; ICRAF-ISRIC, 2010, GLOB DISTR SOIL SPEC; KENNARD RW, 1969, TECHNOMETRICS, V11, P137, DOI 10.2307/1266770; Kuang B, 2012, EUR J SOIL SCI, V63, P421, DOI 10.1111/j.1365-2389.2012.01456.x; Kuhn M, 2012, CARET CLASSIFICATION; Kuhn M., 2012, VARIABLE SELECTION U; Ladoni M, 2010, PRECIS AGRIC, V11, P82, DOI 10.1007/s11119-009-9123-3; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; McDowell M.L., 2012, APPL ENVIRON SOIL SC, DOI [10.1155/2012/294121, DOI 10.1155/2012/294121]; Minasny B, 2008, CHEMOMETR INTELL LAB, V94, P72, DOI 10.1016/j.chemolab.2008.06.003; N?meth T., 2011, LAND QUALITY LAND US, P209; Nduwamungu C, 2009, CAN J SOIL SCI, V89, P531, DOI 10.4141/CJSS08076; O'Rourke SM, 2011, SOIL USE MANAGE, V27, P143, DOI 10.1111/j.1475-2743.2011.00337.x; Quinlan J.R., 1993, MACHINE LEARNING P 1, P236, DOI [10.1016/B978-1-55860-307-3.50037-X, DOI 10.1016/B978-1-55860-307-3.50037-X]; R Development Core Team, 2012, R LANG ENV STAT COMP; Rinnan A, 2009, TRAC-TREND ANAL CHEM, V28, P1201, DOI 10.1016/j.trac.2009.07.007; Rossel RAV, 2012, EUR J SOIL SCI, V63, P848, DOI 10.1111/j.1365-2389.2012.01495.x; Rossel RAV, 2010, GEODERMA, V158, P46, DOI 10.1016/j.geoderma.2009.12.025; Sanchez PA, 2009, SCIENCE, V325, P680, DOI 10.1126/science.1175084; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Shepherd KD, 2002, SOIL SCI SOC AM J, V66, P988, DOI 10.2136/sssaj2002.0988; Shepherd KD, 2007, J NEAR INFRARED SPEC, V15, P1, DOI 10.1255/jnirs.716; Sorensen LK, 2005, SOIL SCI SOC AM J, V69, P159, DOI 10.2136/sssaj2005.0159; Stenberg B, 2010, ADV AGRON, V107, P163, DOI 10.1016/S0065-2113(10)07005-7; Stenberg B, 2010, GEODERMA, V158, P15, DOI 10.1016/j.geoderma.2010.04.008; Van Oost K, 2007, SCIENCE, V318, P626, DOI 10.1126/science.1145724; van Wesemael B, 2010, P NATL ACAD SCI USA, V107, P14926, DOI 10.1073/pnas.1002592107; Vasques GM, 2010, J ENVIRON QUAL, V39, P923, DOI 10.2134/jeq2009.0314; Viscarra Rossel R. A., 2009, NIR NEWS, V20, P14, DOI [10.1255/nirn.1131, DOI 10.1255/NIRN.1131]; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; West LT, 2010, SOIL CARBON STOCKS U, P14	55	238	246	16	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66409	10.1371/journal.pone.0066409	http://dx.doi.org/10.1371/journal.pone.0066409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840459	gold, Green Submitted, Green Published			2022-12-27	WOS:000322361200071
J	Wen, YW; Tsai, YW; Wu, DBC; Chen, PF				Wen, Yu-Wen; Tsai, Yi-Wen; Wu, David Bin-Chia; Chen, Pei-Fen			The Impact of Outliers on Net-Benefit Regression Model in Cost-Effectiveness Analysis	PLOS ONE			English	Article							EFFECTIVENESS ACCEPTABILITY CURVES; ECONOMIC-EVALUATION; ROBUST ESTIMATION; CLINICAL-TRIAL; ALONGSIDE; FRAMEWORK; THERAPY; RATIOS	Ordinary least square (OLS) in regression has been widely used to analyze patient-level data in cost-effectiveness analysis (CEA). However, the estimates, inference and decision making in the economic evaluation based on OLS estimation may be biased by the presence of outliers. Instead, robust estimation can remain unaffected and provide result which is resistant to outliers. The objective of this study is to explore the impact of outliers on net-benefit regression (NBR) in CEA using OLS and to propose a potential solution by using robust estimations, i.e. Huber M-estimation, Hampel M-estimation, Tukey's bisquare M-estimation, MM-estimation and least trimming square estimation. Simulations under different outlier-generating scenarios and an empirical example were used to obtain the regression estimates of NBR by OLS and five robust estimations. Empirical size and empirical power of both OLS and robust estimations were then compared in the context of hypothesis testing. Simulations showed that the five robust approaches compared with OLS estimation led to lower empirical sizes and achieved higher empirical powers in testing cost-effectiveness. Using real example of antiplatelet therapy, the estimated incremental net-benefit by OLS estimation was lower than those by robust approaches because of outliers in cost data. Robust estimations demonstrated higher probability of cost-effectiveness compared to OLS estimation. The presence of outliers can bias the results of NBR and its interpretations. It is recommended that the use of robust estimation in NBR can be an appropriate method to avoid such biased decision making.	[Wen, Yu-Wen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Coll Med, Tao Yuan, Taiwan; [Tsai, Yi-Wen] Natl Yang Ming Univ, Inst Hlth & Welf Policy, Taipei 112, Taiwan; [Wu, David Bin-Chia] Monash Univ Sunway Campus, Discipline Pharm, Kuala Lumpur, Malaysia; [Chen, Pei-Fen] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Miaoli, Taiwan	Chang Gung University; National Yang Ming Chiao Tung University; Monash University; Monash University Sunway; National Health Research Institutes - Taiwan	Wu, DBC (corresponding author), Monash Univ Sunway Campus, Discipline Pharm, Kuala Lumpur, Malaysia.	david.wu@monash.edu	wen, yu/AAJ-7482-2021; Wu, David Bin-Chia/H-3267-2019; Chen, Pei-Fen/K-8584-2013	Chen, Pei-Fen/0000-0001-5470-321X	Chang Gung Medical Research Program [CMRPD1A0272]	Chang Gung Medical Research Program	This research was supported by the grant: the Chang Gung Medical Research Program grant (Grant Number: CMRPD1A0272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alma OG, 2011, J CONT MATH SCI, V6, P409; Anderson C., 2003, UNDERSTANDING STAT, V2, P79, DOI DOI 10.1207/S15328031US0202_01; [Anonymous], 2004, PRACTICAL ASSESSMENT; Anscombe Frank J., 1960, TECHNOMETRICS J STAT, V2, P123; Bhuridej P, 2007, J PUBLIC HEALTH DENT, V67, P191, DOI 10.1111/j.1752-7325.2007.00025.x; Chatterjee S., 2006, REGRESSION ANAL EXAM, DOI DOI 10.1002/0470055464; Donoho D., 1983, FESTSCHRIFT EL LEHMA, P157; Edgeworth F.Y., 1887, HERMATHENA, V13, P279; HAMPEL FR, 1974, J AM STAT ASSOC, V69, P383, DOI 10.2307/2285666; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hoch JS, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-68; Hoch JS, 2002, HEALTH ECON, V11, P415, DOI 10.1002/hec.678; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Hund E, 2002, ANAL CHIM ACTA, V463, P53, DOI 10.1016/S0003-2670(02)00337-9; Indurkhya A, 2001, STAT MED, V20, P1469, DOI 10.1002/sim.683; Irvine L, 2010, AGE AGEING, V39, P710, DOI 10.1093/ageing/afq108; KRASKER WS, 1982, J AM STAT ASSOC, V77, P595, DOI 10.2307/2287719; Latour CHM, 2007, J PSYCHOSOM RES, V62, P363, DOI 10.1016/j.jpsychores.2006.10.016; LAWRANCE AJ, 1995, J R STAT SOC B, V57, P181; Liang YZ, 1996, CHEMOMETR INTELL LAB, V32, P1, DOI 10.1016/0169-7439(95)00006-2; Lin S-W, 2006, 11 ANN C AS PAC DEC, P569; Lothgren M, 2000, HEALTH ECON, V9, P623, DOI 10.1002/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V; Lynch FL, 2011, ARCH GEN PSYCHIAT, V68, P253, DOI 10.1001/archgenpsychiatry.2011.9; Maronna R.A., 2006, ROBUST STAT; Momeni M, 2010, WORLD ACAD SCI ENG T, V47, P521; Roberts TE, 2011, BMJ, V342; Rousseeuw P. J., 2003, ROBUST REGRESSION OU; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; Rousseeuw PJ, 1984, ROBUST NONLINEAR TIM, P256; Safiih LM, 2010, 6 IMT GT C MATH STAT, P449; Schumacker R.E., 2002, MULTIPLE LINEAR REGR, V28, P10; Seber G.A., 1977, LINEAR REGRESSION AN; SIMPSON DG, 1992, J AM STAT ASSOC, V87, P439, DOI 10.2307/2290275; Tukey JW, 1977, EXPLORATORY DATA ANA; VANHOUT BA, 1994, HEALTH ECON, V3, P309, DOI 10.1002/hec.4730030505; Vazquez-Polo FJ, 2005, HEALTH ECON, V14, P545, DOI 10.1002/hec.947; Welsch RE, 1980, REGRESSION SENSITIVI; Willan AR, 2004, HEALTH ECON, V13, P461, DOI 10.1002/hec.843; Wu David Bin-Chia, 2012, J Med Econ, V15, P434, DOI 10.3111/13696998.2011.653510; YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366; Yohai VJ, 1991, DIRECTIONS ROBUST 2	41	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65930	10.1371/journal.pone.0065930	http://dx.doi.org/10.1371/journal.pone.0065930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190ST	23840378	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200041
J	Troggio, M; Surbanovski, N; Bianco, L; Moretto, M; Giongo, L; Banchi, E; Viola, R; Fernandez, FF; Costa, F; Velasco, R; Cestaro, A; Sargent, DJ				Troggio, Michela; Surbanovski, Nada; Bianco, Luca; Moretto, Marco; Giongo, Lara; Banchi, Elisa; Viola, Roberto; Fernandez, Felicdad Fernandez; Costa, Fabrizio; Velasco, Riccardo; Cestaro, Alessandro; Sargent, Daniel James			Evaluation of SNP Data from the Malus Infinium Array Identifies Challenges for Genetic Analysis of Complex Genomes of Polyploid Origin	PLOS ONE			English	Article							GENOTYPING ASSAY; BRASSICA-NAPUS; LINKAGE MAP; MAIZE; DISCOVERY; SEQUENCES; ROSACEAE; HISTORY; QUALITY; MARKERS	High throughput arrays for the simultaneous genotyping of thousands of single-nucleotide polymorphisms (SNPs) have made the rapid genetic characterisation of plant genomes and the development of saturated linkage maps a realistic prospect for many plant species of agronomic importance. However, the correct calling of SNP genotypes in divergent polyploid genomes using array technology can be problematic due to paralogy, and to divergence in probe sequences causing changes in probe binding efficiencies. An Illumina Infinium II whole-genome genotyping array was recently developed for the cultivated apple and used to develop a molecular linkage map for an apple rootstock progeny (M432), but a large proportion of segregating SNPs were not mapped in the progeny, due to unexpected genotype clustering patterns. To investigate the causes of this unexpected clustering we performed BLAST analysis of all probe sequences against the 'Golden Delicious' genome sequence and discovered evidence for paralogous annealing sites and probe sequence divergence for a high proportion of probes contained on the array. Following visual re-evaluation of the genotyping data generated for 8,788 SNPs for the M432 progeny using the array, we manually re-scored genotypes at 818 loci and mapped a further 797 markers to the M432 linkage map. The newly mapped markers included the majority of those that could not be mapped previously, as well as loci that were previously scored as monomorphic, but which segregated due to divergence leading to heterozygosity in probe annealing sites. An evaluation of the 8,788 probes in a diverse collection of Malus germplasm showed that more than half the probes returned genotype clustering patterns that were difficult or impossible to interpret reliably, highlighting implications for the use of the array in genome-wide association studies.	[Troggio, Michela; Surbanovski, Nada; Bianco, Luca; Moretto, Marco; Giongo, Lara; Banchi, Elisa; Viola, Roberto; Costa, Fabrizio; Velasco, Riccardo; Cestaro, Alessandro; Sargent, Daniel James] Fdn Edmund Mach, Ctr Res & Innovat, San Michele All Adige, Italy; [Fernandez, Felicdad Fernandez] East Malling Res, East Malling, Kent, England	Fondazione Edmund Mach	Sargent, DJ (corresponding author), Fdn Edmund Mach, Ctr Res & Innovat, San Michele All Adige, Italy.	dan.sargent@fmach.it	Sargent, Daniel James/A-2933-2014; Viola, Roberto/D-2277-2010; Viola, Roberto/F-3657-2014	Sargent, Daniel James/0000-0002-6686-7147; Cestaro, Alessandro/0000-0003-1439-5165; Bianco, Luca/0000-0002-0196-8422; Moretto, Marco/0000-0003-4555-7243; Viola, Roberto/0000-0002-8202-8503; Costa, Fabrizio/0000-0003-1416-1078; Banchi, Elisa/0000-0002-6598-0447; Velasco, Riccardo/0000-0002-8760-5031	research office of the Provincia Autonoma di Trento	research office of the Provincia Autonoma di Trento	This work was funded by the research office of the Provincia Autonoma di Trento. The funding was awarded to the Fondazione Edmund Mach. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antanaviciute L, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-203; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Bus A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-281; Chagne D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031745; Durstewitz G, 2010, GENOME, V53, P948, DOI 10.1139/G10-079; Felcher KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036347; Force A, 1999, AM ZOOL, V39, p78A; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jung S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-129; Martinez-Garcia PJ, 2013, PLANT MOL BIOL, V81, P161, DOI 10.1007/s11103-012-9989-8; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Micheletti D, 2011, TREE GENET GENOMES, V7, P857, DOI 10.1007/s11295-011-0380-8; Myles S, 2013, TRENDS GENET, V29, P190, DOI 10.1016/j.tig.2013.01.006; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Neidle S., 2002, NUCL ACID STRUCTURE; Ollitrault P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-13; Pindo M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-12; Potter D, 2007, PLANT SYST EVOL, V266, P5, DOI 10.1007/s00606-007-0539-9; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Riedelsheimer C, 2012, P NATL ACAD SCI USA, V109, P8872, DOI 10.1073/pnas.1120813109; Sargent DJ, 2009, TREE GENET GENOMES, V5, P133, DOI 10.1007/s11295-008-0178-5; Scaglione D, 2012, PLANT BIOTECHNOL J, V10, P956, DOI 10.1111/j.1467-7652.2012.00725.x; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035668; Vezzulli S, 2008, THEOR APPL GENET, V117, P499, DOI 10.1007/s00122-008-0794-3; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Ward JA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-2; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123	34	12	12	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67407	10.1371/journal.pone.0067407	http://dx.doi.org/10.1371/journal.pone.0067407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826289	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000077
J	Hu, YW; Ma, X; Huang, JL; Mao, XR; Yang, JY; Zhao, JY; Li, SF; Qiu, YR; Yang, J; Zheng, L; Wang, Q				Hu, Yan-Wei; Ma, Xin; Huang, Jin-Lan; Mao, Xin-Ru; Yang, Jun-Yao; Zhao, Jia-Yi; Li, Shu-Fen; Qiu, Yu-Rong; Yang, Jia; Zheng, Lei; Wang, Qian			Dihydrocapsaicin Attenuates Plaque Formation through a PPAR gamma/LXR alpha Pathway in apoE(-/-) Mice Fed a High-Fat/High-Cholesterol Diet	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; LIVER X RECEPTOR; LIPID-METABOLISM; DENSITY-LIPOPROTEIN; SIGNALING PATHWAY; HEART-DISEASE; SR-BI; ATHEROSCLEROSIS; CAPSAICIN; INFLAMMATION	Aims: Atherosclerosis is a chronic inflammatory disease and represents the major cause of cardiovascular morbidity and mortality. There is evidence that dihydrocapsaicin (DHC) can exert multiple pharmacological and physiological effects. Here, we explored the effect of DHC in atherosclerotic plaque progression in apoE(-/-) mice fed a high-fat/high-cholesterol diet. Methods and Results: apoE(-/-) mice were randomly divided into two groups and fed a high-fat/high-cholesterol diet with or without DHC for 12 weeks. We demonstrated that cellular cholesterol content was significantly decreased while apoA1-mediated cholesterol efflux was significantly increased following treatment with DHC in THP-1 macrophage-derived foam cells. We also observed that plasma levels of TG, LDL-C, VLDL-C, IL-1 beta, IL-6, TNF-alpha and CRP were markedly decreased while plasma levels of apoA1 and HDL-C were significantly increased, and consistent with this, atherosclerotic lesion development was significantly inhibited by DHC treatment of apoE(-/-) mice fed a high-fat/high-cholesterol diet. Moreover, treatment with both LXR alpha siRNA and PPAR gamma siRNA made the up-regulation of DHC on ABCA1, ABCG1, ABCG5, SR-B1, NPC1, CD36, LDLR, HMGCR, apoA1 and apoE expression notably abolished while made the down-regulation of DHC on SRA1 expression markedly compensated. And treatment with PPAR gamma siRNA made the DHC-induced up-regulation of LXR alpha expression notably abolished while treatment with LXR alpha siRNA had no effect on DHC-induced PPAR gamma expression. Conclusion: These observations provide direct evidence that DHC can significantly decrease atherosclerotic plaque formation involving in a PPAR gamma/LXR alpha pathway and thus DHC may represent a promising candidate for a therapeutic agent for the treatment or prevention of atherosclerosis.	[Hu, Yan-Wei; Huang, Jin-Lan; Mao, Xin-Ru; Yang, Jun-Yao; Zhao, Jia-Yi; Li, Shu-Fen; Qiu, Yu-Rong; Yang, Jia; Zheng, Lei; Wang, Qian] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China; [Ma, Xin] Southern Med Univ, Nanfang Hosp, Dept Anesthesiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Zheng, L (corresponding author), Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China.	nfyyzl@163.com; nfyywangqian@163.com			National Natural Sciences Foundation of China [81071416, 81271905]; Guangdong Provincial Natural Sciences Foundation of China [S2012020010920]; President Foundation of Nanfang Hospital, Southern Medical University	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Sciences Foundation of China; President Foundation of Nanfang Hospital, Southern Medical University	This study was supported by the National Natural Sciences Foundation of China (81071416 and 81271905), Guangdong Provincial Natural Sciences Foundation of China (S2012020010920) and President Foundation of Nanfang Hospital, Southern Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2009, THROMB RES, V124, P721, DOI 10.1016/j.thromres.2009.05.001; Ahuja KDK, 2006, BRIT J NUTR, V96, P239, DOI 10.1079/BJN20061788; Ahuja KDK, 2006, J AGR FOOD CHEM, V54, P6436, DOI 10.1021/jf061331j; Akimoto S, 2009, J NUTR SCI VITAMINOL, V55, P282, DOI 10.3177/jnsv.55.282; Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Barbier O, 2002, ARTERIOSCL THROM VAS, V22, P717, DOI 10.1161/01.ATV.0000015598.86369.04; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; CORDELL GA, 1993, ANN PHARMACOTHER, V27, P330, DOI 10.1177/106002809302700316; Dai XY, 2008, J CARDIOVASC PHARM, V51, P467, DOI 10.1097/FJC.0b013e31816a5be3; Dai XY, 2007, INFLAMMATION, V30, P105, DOI 10.1007/s10753-007-9026-2; Davis RA, 2001, ARTERIOSCL THROM VAS, V21, P887, DOI 10.1161/01.ATV.21.6.887; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Elangbam CS, 2001, TOXICOL PATHOL, V29, P224, DOI 10.1080/019262301317052495; Fitzgerald ML, 2010, ATHEROSCLEROSIS, V211, P361, DOI 10.1016/j.atherosclerosis.2010.01.011; Fosgerau K, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-39; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hu YW, 2010, J ATHEROSCLER THROMB, V17, P493, DOI 10.5551/jat.3152; Hu Yan-Wei, 2009, Atherosclerosis, V204, pe35, DOI 10.1016/j.atherosclerosis.2008.11.003; Hu YW, 2010, CLIN CHIM ACTA, V411, P617, DOI 10.1016/j.cca.2009.12.027; Hui DY, 2008, AM J PHYSIOL-GASTR L, V294, pG839, DOI 10.1152/ajpgi.00061.2008; Imaizumi K, 2011, J TOXICOL SCI, V36, P109, DOI 10.2131/jts.36.109; Inoue S, 2002, CIRCULATION, V106, P2700, DOI 10.1161/01.CIR.0000038140.80105.AD; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Ma X, 2009, CARDIOVASC DRUG THER, V23, P199, DOI 10.1007/s10557-009-6165-8; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Navab KD, 2011, CURR PHARM DESIGN, V17, P17; Oh SH, 2008, AUTOPHAGY, V4, P1009, DOI 10.4161/auto.6886; Ohashi R, 2005, QJM-INT J MED, V98, P845, DOI 10.1093/qjmed/hci136; Ory DS, 2004, CIRC RES, V95, P660, DOI 10.1161/01.RES.0000143422.83209.be; Osterud B, 2003, PHYSIOL REV, V83, P1069, DOI 10.1152/physrev.00005.2003; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Park KK, 1998, ANTICANCER RES, V18, P4201; Pedersen Terje R, 2006, Diab Vasc Dis Res, V3, pS1; Peng J, 2010, EUR J PHARMACOL, V627, P1, DOI 10.1016/j.ejphar.2009.10.053; PITTMAN RC, 1982, J BIOL CHEM, V257, P7994; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Saggini A, 2011, INT J IMMUNOPATH PH, V24, P567, DOI 10.1177/039463201102400303; Sanz J, 2011, J AM COLL CARDIOL, V58, P779, DOI 10.1016/j.jacc.2011.03.052; Shepherd J, 2004, ATHEROSCLEROSIS SUPP, V5, P91, DOI 10.1016/j.atherosclerosissup.2004.08.029; Tabas I, 2000, BBA-MOL CELL BIOL L, V1529, P164, DOI 10.1016/S1388-1981(00)00146-3; Wang K, 2008, EXP BIOL MED, V233, P496, DOI 10.3181/0708-MR-231; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Zhang QH, 2010, J CHROMATOGR B, V878, P2292, DOI 10.1016/j.jchromb.2010.06.040	50	25	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66876	10.1371/journal.pone.0066876	http://dx.doi.org/10.1371/journal.pone.0066876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840542	gold, Green Submitted, Green Published			2022-12-27	WOS:000321424400045
J	Griebeler, EM; Klein, N; Sander, PM				Griebeler, Eva Maria; Klein, Nicole; Sander, P. Martin			Aging, Maturation and Growth of Sauropodomorph Dinosaurs as Deduced from Growth Curves Using Long Bone Histological Data: An Assessment of Methodological Constraints and Solutions	PLOS ONE			English	Article							LIFE-HISTORY; BODY-SIZE; SEXUAL-MATURITY; PATTERNS; EVOLUTION; RATES; SIMILARITY; PLASTICITY; PHYSIOLOGY; INSIGHTS	Information on aging, maturation, and growth is important for understanding life histories of organisms. In extinct dinosaurs, such information can be derived from the histological growth record preserved in the mid-shaft cortex of long bones. Here, we construct growth models to estimate ages at death, ages at sexual maturity, ages at which individuals were fully-grown, and maximum growth rates from the growth record preserved in long bones of six sauropod dinosaur individuals (one indeterminate mamenchisaurid, two Apatosaurus sp., two indeterminate diplodocids, and one Camarasaurus sp.) and one basal sauropodomorph dinosaur individual (Plateosaurus engelhardti). Using these estimates, we establish allometries between body mass and each of these traits and compare these to extant taxa. Growth models considered for each dinosaur individual were the von Bertalanffy model, the Gompertz model, and the logistic model (LGM), all of which have inherently fixed inflection points, and the Chapman-Richards model in which the point is not fixed. We use the arithmetic mean of the age at the inflection point and of the age at which 90% of asymptotic mass is reached to assess respectively the age at sexual maturity or the age at onset of reproduction, because unambiguous indicators of maturity in Sauropodomorpha are lacking. According to an AIC-based model selection process, the LGM was the best model for our sauropodomorph sample. Allometries established are consistent with literature data on other Sauropodomorpha. All Sauropodomorpha reached full size within a time span similar to scaled-up modern mammalian megaherbivores and had similar maximum growth rates to scaled-up modern megaherbivores and ratites, but growth rates of Sauropodomorpha were lower than of an average mammal. Sauropodomorph ages at death probably were lower than that of average scaled-up ratites and megaherbivores. Sauropodomorpha were older at maturation than scaled-up ratites and average mammals, but younger than scaled-up megaherbivores.	[Griebeler, Eva Maria] Johannes Gutenberg Univ Mainz, Inst Zool, Dept Ecol, D-55122 Mainz, Germany; [Klein, Nicole; Sander, P. Martin] Univ Bonn, Div Paleontol, Steinmann Inst, Bonn, Germany	Johannes Gutenberg University of Mainz; University of Bonn	Griebeler, EM (corresponding author), Johannes Gutenberg Univ Mainz, Inst Zool, Dept Ecol, D-55122 Mainz, Germany.	em.griebeler@uni-mainz.de			Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Our research was generously funded by the Deutsche Forschungsgemeinschaft (DFG) through a variety of grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, 2 INT S INF THEOR, P276; Andrews R.M., 1982, Biology of Reptilia, V13, P273; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Bonnan MF, 2004, PALEOBIOLOGY, V30, P444, DOI 10.1666/0094-8373(2004)030<0444:MAOHAF>2.0.CO;2; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; Calder WA., 1984, SIZE FUNCTION LIFE H; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; Chinsamy Anusuya, 1993, Modern Geology, V18, P319; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; Curry KA, 1999, J VERTEBR PALEONTOL, V19, P654, DOI 10.1080/02724634.1999.10011179; del Hoyo J, 2013, HDB BIRDS WORLD; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Erickson GM, 2009, ANAT REC, V292, P1514, DOI 10.1002/ar.20992; FITZHUGH HA, 1976, J ANIM SCI, V42, P1036, DOI 10.2527/jas1976.4241036x; FRAZER NB, 1985, COPEIA, P73; Gaillard JM, 1997, P ROY SOC B-BIOL SCI, V264, P859, DOI 10.1098/rspb.1997.0120; Gaudin Timothy J., 2006, P1; Glazier DS, 2010, BIOL REV, V85, P111, DOI 10.1111/j.1469-185X.2009.00095.x; GOULD SJ, 1971, AM NAT, V105, P113, DOI 10.1086/282710; Griebeler Eva Maria, 2011, P263; Hailey A, 1999, CAN J ZOOL, V77, P181, DOI 10.1139/cjz-77-2-181; HALLIDAY TR, 1988, J HERPETOL, V22, P253, DOI 10.2307/1564148; Hendriks AJ, 2008, OECOLOGIA, V155, P705, DOI 10.1007/s00442-007-0952-3; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Jackson FD, 2008, PALEOBIOLOGY, V34, P229, DOI 10.1666/0094-8373(2008)034[0229:COWVCI]2.0.CO;2; Janensch WJ., 1961, PALAEONTOGRAPHICA S, P177; Kilbourne BM, 2010, J ANAT, V217, P135, DOI 10.1111/j.1469-7580.2010.01253.x; Klein N., 2011, BIOL SAUROPOD DINOSA; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klein N, 2007, SP PALAEONT, P169; Klein N, 2009, FOSS REC, V12, P121, DOI 10.1002/mmng.200900002; Kohler M, 2012, NATURE, V487, P358, DOI 10.1038/nature11264; Laws R.M., 1975, ELEPHANTS THEIR HABI; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Lehman TM, 2008, PALEOBIOLOGY, V34, P264, DOI 10.1666/0094-8373(2008)034[0264:MGRFSD]2.0.CO;2; MAGNUSSON WE, 1995, COPEIA, P498; MAZZETTA GV, 2004, HIST BIOL, P1; McIntosh John S., 1997, P264; Owen-Smith R.N., 1988, MEGAHERBIVORES INFLU, DOI [10.1017/CBO9780511565441, DOI 10.1017/CBO9780511565441]; Padian K, 2004, DINOSAURIA, 2ND EDITION, P660; PERRY SF, 2011, BIOL SAUROPOD DINOSA, P57; Putter A, 1920, PFLUG ARCH GES PHYS, V180, P298, DOI 10.1007/BF01755094; REID REH, 1981, NATURE, V292, P49, DOI 10.1038/292049a0; Reiss M.J., 1989, ALLOMETRY GROWTH REP; Remes K, 2009, FOSS REC, V12, P23, DOI 10.1002/mmng.200800008; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; RICKLEFS RE, 1968, IBIS, V110, P419, DOI 10.1111/j.1474-919X.1968.tb00058.x; Ricqles A., 1991, BONE BONE MATRIX BON, V3, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X; Ritz J, 2010, HERPETOL J, V20, P213; Sander P.M., 2003, PALAEONTOL Z, V77, P161, DOI DOI 10.1007/BF03004566; Sander PM, 2008, SCIENCE, V322, P200, DOI 10.1126/science.1160904; Sander PM, 2008, PALAEONTOGR ABT A, V284, P69; Sander P. Martin, 2011, P276; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Sander PM, 2005, SCIENCE, V310, P1800, DOI 10.1126/science.1120125; Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SHINE R, 1992, AM NAT, V139, P1257, DOI 10.1086/285385; Shrader AM, 2006, J ZOOL, V270, P40, DOI 10.1111/j.1469-7998.2006.00108.x; Stearns S.C., 1999, EVOLUTION LIFE HIST; Stein K., 2009, METHODS FOSSIL PREPA; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; VONBERTALANFFY L, 1957, Q REV BIOL, V32, P217, DOI 10.1086/401873; Werner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028442; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; Wings O, 2007, J VERTEBR PALEONTOL, V27, p167A; Wings O, 2011, NEUES JAHRB GEOL P-A, V262, P129, DOI 10.1127/0077-7749/2011/0183; Woodward HN, 2011, J HERPETOL, V45, P339; YATES AM, ACTA PALAEO IN PRESS; ZULLINGER EM, 1984, J MAMMAL, V65, P607, DOI 10.2307/1380844; [No title captured]	81	36	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67012	10.1371/journal.pone.0067012	http://dx.doi.org/10.1371/journal.pone.0067012			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840575	gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200117
J	Hoeltzenbein, M; Stieler, K; Panse, M; Wacker, E; Schaefer, C				Hoeltzenbein, Maria; Stieler, Katja; Panse, Mary; Wacker, Evelin; Schaefer, Christof			Allopurinol Use during Pregnancy - Outcome of 31 Prospectively Ascertained Cases and a Phenotype Possibly Indicative for Teratogenicity	PLOS ONE			English	Article							PREPREGNANCY OBESITY; RISK-FACTOR; EXPOSURE; WOMEN	Allopurinol is a purine analogue that inhibits xanthine oxidase. It is mainly used for the treatment of hyperuricemia in patients with gout or tumor lysis syndrome. Experience with allopurinol in pregnancy is scarce. In 2011, Kozenko et al. reported on a child with multiple malformations after maternal treatment with allopurinol throughout pregnancy. Possible teratogenicity of allopurinol was proposed due to the similarity of the pattern of malformations in children with mycophenolate embryopathy. A possible common mechanism of both drugs, i.e. disruption of purine synthesis, was discussed. We report on the outcome of 31 prospectively ascertained pregnancies with allopurinol exposure at least during first trimester. Pregnancy outcomes were 2 spontaneous abortions, 2 elective terminations of pregnancy and 27 live born children. The overall rate of major malformations (3.7%) and of spontaneous abortions (cumulative incidence 11%, 95%-CI 3-40) were both within the normal range. However, there was one child with severe malformations including microphthalmia, cleft lip and palate, renal hypoplasia, low-set ears, hearing deficit, bilateral cryptorchidism, and micropenis. The striking similarity of the anomalies in this child and the case described by Kozenko et al. might be considered as a signal for teratogenicity. Thus, we would recommend caution with allopurinol treatment in the first trimester, until further data are available.	[Hoeltzenbein, Maria; Stieler, Katja; Panse, Mary; Wacker, Evelin; Schaefer, Christof] Charite, Berlin Inst Clin Teratol & Drug Risk Assessment P, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hoeltzenbein, M (corresponding author), Charite, Berlin Inst Clin Teratol & Drug Risk Assessment P, D-13353 Berlin, Germany.	Maria.Hoeltzenbein@charite.de	Hoeltzenbein, Maria/AAP-4145-2020; Hoeltzenbein, Maria/B-1134-2016	Hoeltzenbein, Maria/0000-0002-2451-4247; Hoeltzenbein, Maria/0000-0002-2451-4247; Beck, Evelin/0000-0003-1008-8563	German Federal Institute for Drugs and Medical Devices	German Federal Institute for Drugs and Medical Devices	The study has been performed with financial support from the German Federal Institute for Drugs and Medical Devices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali R, 2009, LEUKEMIA RES, V33, P567, DOI 10.1016/j.leukres.2008.05.019; Anderka M, 2012, BIRTH DEFECTS RES A, V94, P22, DOI 10.1002/bdra.22865; Bhole V, 2010, ARTHRITIS RHEUM-US, V62, P1069, DOI 10.1002/art.27338; BRAGONIER JR, 1964, P SOC EXP BIOL MED, V116, P685; Briggs GG., 2017, DRUGS PREGNANCY LACT; Brown Monique L., 2001, Obstetrics and Gynecology, V97, p39S, DOI 10.1016/S0029-7844(01)01236-4; Carey JC, 2009, BIRTH DEFECTS RES A, V85, P63, DOI 10.1002/bdra.20533; Carmichael SL, 2010, BIRTH DEFECTS RES A, V88, P804, DOI 10.1002/bdra.20679; CODDINGTON CC, 1979, AM J OBSTET GYNECOL, V133, P107, DOI 10.1016/0002-9378(79)90420-4; FARBER M, 1976, OBSTET GYNECOL, V47, P226; FUJII T, 1972, JPN J PHARMACOL, V22, P201, DOI 10.1254/jjp.22.201; Gulmezoglu AM, 1997, BRIT J OBSTET GYNAEC, V104, P689, DOI 10.1111/j.1471-0528.1997.tb11979.x; Hoeltzenbein M, 2012, AM J MED GENET A, V158A, P588, DOI 10.1002/ajmg.a.35223; Hoentjen F, 2013, INFLAMM BOWEL DIS, V19, P363, DOI 10.1002/ibd.23021; Jones KL, 2011, AM J MED GENET C, V157C, P188, DOI 10.1002/ajmg.c.30311; Kozenko M, 2011, AM J MED GENET A, V155A, P2247, DOI 10.1002/ajmg.a.34139; Meister R, 2008, REPROD TOXICOL, V26, P31, DOI 10.1016/j.reprotox.2008.06.006; Merks JHM, 2003, AM J MED GENET A, V123A, P211, DOI 10.1002/ajmg.a.20249; Miller SL, 2012, NEUROENDOCRINOLOGY, V96, P13, DOI 10.1159/000336378; Norby SM, 2004, AM J KIDNEY DIS, V43, P277, DOI 10.1053/j.ajkd.2003.10.034; Rasmussen SA, 2003, BIRTH DEFECTS RES A, V67, P193, DOI 10.1002/bdra.10012; Schaefer C, 2008, REPROD TOXICOL, V26, P36, DOI 10.1016/j.reprotox.2008.05.064; Seinen ML, 2013, INFLAMM BOWEL DIS, V19, pE37, DOI 10.1002/ibd.22945; Seinen ML, 2011, NUCLEOS NUCLEOT NUCL, V30, P1085, DOI 10.1080/15257770.2011.597371; Smyth A, 2010, CLIN J AM SOC NEPHRO, V5, P2060, DOI 10.2215/CJN.00240110; Struthers A, 2012, HEART, V98, P1543, DOI 10.1136/heartjnl-2012-302249; Stuebe AM, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.04.035; Tendron A, 2002, PEDIATR NEPHROL, V17, P121, DOI 10.1007/s00467-001-0776-z; Voigt M, 2010, Z GEBURTSH NEONATOL, V214, P24, DOI 10.1055/s-0029-1241833; Waller DK, 2007, ARCH PEDIAT ADOL MED, V161, P745, DOI 10.1001/archpedi.161.8.745	30	14	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66637	10.1371/journal.pone.0066637	http://dx.doi.org/10.1371/journal.pone.0066637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840514	gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200096
J	Kaplinsky, NJ; Gilbert, SF; Cebra-Thomas, J; Lillevali, K; Saare, M; Chang, EY; Edelman, HE; Frick, MA; Guan, Y; Hammond, RM; Hampilos, NH; Opoku, DSB; Sariahmed, K; Sherman, EA; Watson, R				Kaplinsky, Nicholas J.; Gilbert, Scott F.; Cebra-Thomas, Judith; Lillevaeli, Kersti; Saare, Merly; Chang, Eric Y.; Edelman, Hannah E.; Frick, Melissa A.; Guan, Yin; Hammond, Rebecca M.; Hampilos, Nicholas H.; Opoku, David S. B.; Sariahmed, Karim; Sherman, Eric A.; Watson, Ray			The Embryonic Transcriptome of the Red-Eared Slider Turtle (Trachemys scripta)	PLOS ONE			English	Article							CARAPACIAL RIDGE; EVOLUTION; ALIGNMENT; ORIGIN; SERIES; GENES; FORMS; SHELL	The bony shell of the turtle is an evolutionary novelty not found in any other group of animals, however, research into its formation has suggested that it has evolved through modification of conserved developmental mechanisms. Although these mechanisms have been extensively characterized in model organisms, the tools for characterizing them in non-model organisms such as turtles have been limited by a lack of genomic resources. We have used a next generation sequencing approach to generate and assemble a transcriptome from stage 14 and 17 Trachemys scripta embryos, stages during which important events in shell development are known to take place. The transcriptome consists of 231,876 sequences with an N-50 of 1,166 bp. GO terms and EC codes were assigned to the 61,643 unique predicted proteins identified in the transcriptome sequences. All major GO categories and metabolic pathways are represented in the transcriptome. Transcriptome sequences were used to amplify several cDNA fragments designed for use as RNA in situ probes. One of these, BMP5, was hybridized to a T. scripta embryo and exhibits both conserved and novel expression patterns. The transcriptome sequences should be of broad use for understanding the evolution and development of the turtle shell and for annotating any future T. scripta genome sequences.	[Kaplinsky, Nicholas J.; Gilbert, Scott F.; Chang, Eric Y.; Edelman, Hannah E.; Frick, Melissa A.; Guan, Yin; Hammond, Rebecca M.; Hampilos, Nicholas H.; Opoku, David S. B.; Sariahmed, Karim; Sherman, Eric A.; Watson, Ray] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA; [Cebra-Thomas, Judith] Millersville Univ Pennsylvania, Dept Biol, Millersville, PA 17551 USA; [Lillevaeli, Kersti; Saare, Merly] Univ Tartu, Dept Dev Biol, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Lillevaeli, Kersti] Univ Tartu, Dept Physiol, Fac Med, EE-50090 Tartu, Estonia	Swarthmore College; Pennsylvania State System of Higher Education (PASSHE); Millersville University of Pennsylvania; University of Tartu; University of Tartu	Kaplinsky, NJ (corresponding author), Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA.	nkaplin1@swarthmore.edu	Lilleväli, Kersti/AGD-6838-2022	Lilleväli, Kersti/0000-0001-5470-3818; Frick, Melissa/0000-0002-2402-2728; Kaplinsky, Nick/0000-0002-1759-1826; Watson, Ray/0000-0003-0697-6912; Sherman, Erin/0000-0002-1835-8604	Swarthmore College; Estonian Ministry of Education and Research [SF0180019s11]	Swarthmore College; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work was funded by Swarthmore College (Swarthmore.edu). KL and MS were supported by grant SF0180019s11 from Estonian Ministry of Education and Research (http://www.hm.ee/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BURKE AC, 1989, J MORPHOL, V199, P363, DOI 10.1002/jmor.1051990310; Cebra-Thomas J, 2005, J EXP ZOOL PART B, V304B, P558, DOI 10.1002/jez.b.21059; Cebra-Thomas JA, 2007, EVOL DEV, V9, P267, DOI 10.1111/j.1525-142X.2007.00159.x; Clark K, 2001, GENESIS, V31, P111, DOI 10.1002/gene.10012; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford NG, 2012, BIOL LETT; Darnell DK, 2007, CYTOGENET GENOME RES, V117, P30, DOI 10.1159/000103162; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; GAFFNEY E S, 1990, Bulletin of the American Museum of Natural History, P1; GAFFNEY ES, 1987, SCIENCE, V237, P289, DOI 10.1126/science.237.4812.289; Geetha-Loganathan P, 2006, ANAT EMBRYOL, V211, pS87, DOI 10.1007/s00429-006-0129-6; Gilbert Scott F., 2008, P1; Gilbert Scott F., 2009, V266, P57, DOI 10.1007/978-1-4020-9636-5_5; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GREEN EL, 1946, AM NAT, V80, P619, DOI 10.1086/281482; Greenbaum E, 2002, CAN J ZOOL, V80, P1350, DOI 10.1139/Z02-111; Greenbaum E, 2002, J MORPHOL, V254, P272, DOI 10.1002/jmor.10036; Guenther C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000308; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawashima-Ohya Y, 2011, EVOL DEV, V13, P260, DOI 10.1111/j.1525-142X.2011.00474.x; Kuraku S, 2005, EVOL DEV, V7, P3, DOI 10.1111/j.1525-142X.2005.05002.x; Lyson TR, 2012, BIOL LETTERS, V8, P104, DOI 10.1098/rsbl.2011.0477; Lyson TR, 2010, BIOL LETTERS, V6, P830, DOI 10.1098/rsbl.2010.0371; Milinkovitch MC, 2007, J EXP ZOOL PART B, V308B, P337, DOI 10.1002/jez.b.21180; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Moustakas JE, 2008, EVOL DEV, V10, P29, DOI 10.1111/j.1525-142X.2007.00210.x; Rowan BA, 2011, DEV CELL, V21, P65, DOI 10.1016/j.devcel.2011.05.021; Rozen S, 2000, Methods Mol Biol, V132, P365; Shaffer HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r28; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Storm EE, 1996, DEVELOPMENT, V122, P3969; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tzika AC, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-19; Wang Z, 2013, NAT GENET; Wilkinson DG, 1993, SITU HYBRIDIZATION P, P75; YNTEMA CL, 1970, J MORPHOL, V132, P235, DOI 10.1002/jmor.1051320209; YNTEMA CL, 1968, J MORPHOL, V125, P219, DOI 10.1002/jmor.1051250207; Zuzarte-Luis V, 2004, DEV BIOL, V272, P39, DOI 10.1016/j.ydbio.2004.04.015	41	17	18	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66357	10.1371/journal.pone.0066357	http://dx.doi.org/10.1371/journal.pone.0066357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840449	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200069
J	Kucharova, V; Strand, TA; Almaas, E; Naas, AE; Brautaset, T; Valla, S				Kucharova, Veronika; Strand, Trine Aakvik; Almaas, Eivind; Naas, Adrian E.; Brautaset, Trygve; Valla, Svein			Non-Invasive Analysis of Recombinant mRNA Stability in Escherichia coli by a Combination of Transcriptional Inducer Wash-Out and qRT-PCR	PLOS ONE			English	Article							GENE-EXPRESSION; PM PROMOTER; SIGMA(70) SUBUNIT; SIGNAL SEQUENCES; LEVEL PRODUCTION; DNA-REGION; STEM-LOOP; TRANSLATION; POLYMERASE; PROTEINS	mRNA stability is one among many parameters that can potentially affect the level of recombinant gene expression in bacteria. Blocking of the entire prokaryotic transcription machinery by addition of rifampicin is commonly used in protocols for analysis of mRNA stability. Here we show that such treatment can be effectively replaced by a simple, non-invasive method based on removal of the relevant transcriptional inducers and that the mRNA decay can then be followed by qRT-PCR. To establish the methodology we first used the m-toluate-inducible XylS/Pm expression cassette as a model system and analyzed several examples of DNA modifications causing gene expression stimulation in Escherichia coli. The new method allowed us to clearly discriminate whether an improvement in mRNA stability contributes to observed increases in transcript amounts for each individual case. To support the experimental data a simple mathematical fitting model was developed to calculate relative decay rates. We extended the relevance of the method by demonstrating its application also for an IPTG-inducible expression cassette (LacI/P-tac) and by analyzing features of the bacteriophage T7-based expression system. The results suggest that the methodology is useful in elucidating factors controlling mRNA stability as well as other specific features of inducible expression systems. Moreover, as expression systems based on diffusible inducers are almost universally available, the concept can be most likely used to measure mRNA decay for any gene in any cell type that is heavily used in molecular biology research.	[Kucharova, Veronika; Almaas, Eivind; Naas, Adrian E.; Valla, Svein] Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway; [Strand, Trine Aakvik; Brautaset, Trygve] SINTEF Mat & Chem, Dept Mol Biol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); SINTEF	Valla, S (corresponding author), Norwegian Univ Sci & Technol, Dept Biotechnol, N-7034 Trondheim, Norway.	svein.valla@biotech.ntnu.no	Pettersen, Veronika Kuchařová/X-2818-2019	Pettersen, Veronika Kuchařová/0000-0002-7108-9562; Almaas, Eivind/0000-0002-9125-326X	Research Council of Norway [182672/i40]	Research Council of Norway(Research Council of Norway)	The project was funded by the Research Council of Norway, grant no. 182672/i40. Web-site: http://www.forskningsradet.no/en/Home_page/1177315753906. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allert M, 2010, J MOL BIOL, V402, P905, DOI 10.1016/j.jmb.2010.08.010; Arnold TE, 1998, RNA, V4, P319; Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Aune TEV, 2010, MICROB BIOTECHNOL, V3, P38, DOI 10.1111/j.1751-7915.2009.00126.x; Bakke I, 2009, APPL ENVIRON MICROB, V75, P2002, DOI 10.1128/AEM.02315-08; Balzer S, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-26; Berg L, 2012, J BIOTECHNOL, V158, P224, DOI 10.1016/j.jbiotec.2011.07.012; Berg L, 2009, MICROB BIOTECHNOL, V2, P379, DOI 10.1111/j.1751-7915.2009.00107.x; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Blatny JM, 1997, PLASMID, V38, P35, DOI 10.1006/plas.1997.1294; Blatny JM, 1997, APPL ENVIRON MICROB, V63, P370, DOI 10.1128/AEM.63.2.370-379.1997; Brautaset T, 2009, MICROB BIOTECHNOL, V2, P15, DOI 10.1111/j.1751-7915.2008.00048.x; Bricker AL, 1999, J BACTERIOL, V181, P3587, DOI 10.1128/JB.181.11.3587-3590.1999; Brodolin K, 2004, NAT STRUCT MOL BIOL, V11, P551, DOI 10.1038/nsmb768; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Carrier TA, 1997, BIOTECHNOL PROGR, V13, P699, DOI 10.1021/bp970095h; Carrier TA, 1997, BIOTECHNOL BIOENG, V55, P577, DOI 10.1002/(SICI)1097-0290(19970805)55:3<577::AID-BIT16>3.3.CO;2-6; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; De Mey M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-34; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; EMORY SA, 1992, GENE DEV, V6, P135, DOI 10.1101/gad.6.1.135; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Ferrer-Miralles N, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-17; Gong F, 2003, J BACTERIOL, V185, P6472, DOI 10.1128/JB.185.21.6472-6476.2003; Graumann Klaus, 2006, Biotechnology Journal, V1, P164, DOI 10.1002/biot.200500051; Heggeset TMB, 2013, APPL ENVIRON MICROB, V79, P559, DOI 10.1128/AEM.02407-12; Huang Jr C, 2012, J IND MICROBIOL BIOT, P1; Iost I, 1995, EMBO J, P14; Jakobsen OM, 2006, J BACTERIOL, P188; Kaberdin VR, 2006, FEMS MICROBIOL REV, V30, P967, DOI 10.1111/j.1574-6976.2006.00043.x; Komarova AV, 2005, J BACTERIOL, V187, P1344, DOI 10.1128/JB.187.4.1344-1349.2005; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lale R, 2011, APPL ENVIRON MICROB, V77, P2648, DOI 10.1128/AEM.02091-10; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Makarova OV, 1995, P NATL ACAD SCI USA, V92, P12250, DOI 10.1073/pnas.92.26.12250; Marques S, 1999, MOL MICROBIOL, V31, P1105, DOI 10.1046/j.1365-2958.1999.01249.x; Miksch G, 2005, J BIOTECHNOL, V120, P25, DOI 10.1016/j.jbiotec.2005.04.027; Nickels BE, 2004, NAT STRUCT MOL BIOL, V11, P544, DOI 10.1038/nsmb757; RAMOS JL, 1990, J MOL BIOL, V211, P373, DOI 10.1016/0022-2836(90)90358-S; Ramos JL, 1997, ANNU REV MICROBIOL, V51, P341, DOI 10.1146/annurev.micro.51.1.341; Retallack DM, 2012, PROTEIN EXPRES PURIF, V81, P157, DOI 10.1016/j.pep.2011.09.010; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Schweizer HP, 2001, CURR OPIN BIOTECH, V12, P439, DOI 10.1016/S0958-1669(00)00242-1; Seber G. A. F., 2003, NONLINEAR REGRESSION; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Sletta H, 2007, APPL ENVIRON MICROB, V73, P906, DOI 10.1128/AEM.01804-06; Sletta H, 2004, APPL ENVIRON MICROB, V70, P7033, DOI 10.1128/AEM.70.12.7033-7039.2004; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; Srivastava P, 2005, PROTEIN EXPRES PURIF, V40, P221, DOI 10.1016/j.pep.2004.06.017; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Vavrova L, 2010, RES MICROBIOL, V161, P791, DOI 10.1016/j.resmic.2010.09.004; Vytvytska O, 2000, GENE DEV, V14, P1109; Wegrzyn A, 1998, FEBS LETT, V440, P172, DOI 10.1016/S0014-5793(98)01449-5; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002; Winther-Larsen HC, 2000, METAB ENG, V2, P92, DOI 10.1006/mben.1999.0143; Winther-Larsen HC, 2000, METAB ENG, V2, P79, DOI 10.1006/mben.1999.0142	59	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66429	10.1371/journal.pone.0066429	http://dx.doi.org/10.1371/journal.pone.0066429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840466	gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200076
J	Kuhnast, S; Louwe, MC; Heemskerk, MM; Pieterman, EJ; van Klinken, JB; van den Berg, SAA; Smit, JWA; Havekes, LM; Rensen, PCN; van der Hoorn, JWA; Princen, HMG; Jukema, JW				Kuhnast, Susan; Louwe, Mieke C.; Heemskerk, Mattijs M.; Pieterman, Elsbet J.; van Klinken, Jan B.; van den Berg, Sjoerd A. A.; Smit, Johannes W. A.; Havekes, Louis M.; Rensen, Patrick C. N.; van der Hoorn, Jose W. A.; Princen, Hans M. G.; Jukema, J. Wouter			Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol	PLOS ONE			English	Article							EXTENDED-RELEASE NIACIN; ESTER TRANSFER PROTEIN; HIGH-DENSITY-LIPOPROTEIN; NICOTINIC-ACID; COMBINATION THERAPY; PREVENTION; STATIN; HDL; TRIGLYCERIDES; INFLAMMATION	Objective: Niacin potently lowers triglycerides, mildly decreases LDL-cholesterol, and largely increases HDL-cholesterol. Despite evidence for an atheroprotective effect of niacin from previous small clinical studies, the large outcome trials, AIM-HIGH and HPS2-THRIVE did not reveal additional beneficial effects of niacin (alone or in combination with laropiprant) on top of statin treatment. We aimed to address this apparent discrepancy by investigating the effects of niacin without and with simvastatin on atherosclerosis development and determine the underlying mechanisms, in APOE*3Leiden.CETP mice, a model for familial dysbetalipoproteinemia (FD). Approach and Results: Mice were fed a western-type diet containing cholesterol without or with niacin (120 mg/kg/day), simvastatin (36 mg/kg/day) or their combination for 18 weeks. Similarly as in FD patients, niacin reduced total cholesterol by -39% and triglycerides by -50%, (both P<0.001). Simvastatin and the combination reduced total cholesterol (-30%; -55%, P<0.001) where the combination revealed a greater reduction compared to simvastatin (-36%, P<0.001). Niacin decreased total cholesterol and triglycerides primarily by increasing VLDL clearance. Niacin increased HDL-cholesterol (+28%, P<0.01) and mildly increased reverse cholesterol transport. All treatments reduced monocyte adhesion to the endothelium (-46%; -47%, P<0.01; -53%, P<0.001), atherosclerotic lesion area (-78%; -49%, P<0.01; -87%, P<0.001) and severity. Compared to simvastatin, the combination increased plaque stability index [(SMC+collagen)/macrophages] (3-fold, P<0.01). Niacin and the combination reduced T cells in the aortic root (-71%, P<0.01; -81%, P<0.001). Lesion area was strongly predicted by nonHDL-cholesterol (R-2 = 0.69, P<0.001) and to a much lesser extent by HDL-cholesterol (R-2 = 0.20, P<0.001). Conclusion: Niacin decreases atherosclerosis development mainly by reducing nonHDL-cholesterol with modest HDL-cholesterol-raising and additional anti-inflammatory effects. The additive effect of niacin on top of simvastatin is mostly dependent on its nonHDL-cholesterol-lowering capacities. These data suggest that clinical beneficial effects of niacin are largely dependent on its ability to lower LDL-cholesterol on top of concomitant lipid-lowering therapy.	[Kuhnast, Susan; Pieterman, Elsbet J.; Havekes, Louis M.; van der Hoorn, Jose W. A.; Princen, Hans M. G.] TNO Metab Hlth Res, Leiden, Netherlands; [Kuhnast, Susan; van der Hoorn, Jose W. A.; Jukema, J. Wouter] Leiden Univ, Dept Cardiol, Med Ctr, Leiden, Netherlands; [Louwe, Mieke C.; Smit, Johannes W. A.; Havekes, Louis M.; Rensen, Patrick C. N.] Leiden Univ, Dept Endocrinol & Metab Dis, Med Ctr, Leiden, Netherlands; [Heemskerk, Mattijs M.; van Klinken, Jan B.; van den Berg, Sjoerd A. A.] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [Kuhnast, Susan; Louwe, Mieke C.; Heemskerk, Mattijs M.; van Klinken, Jan B.; van den Berg, Sjoerd A. A.; Smit, Johannes W. A.; Havekes, Louis M.; Rensen, Patrick C. N.; van der Hoorn, Jose W. A.; Jukema, J. Wouter] Leiden Univ, Einthoven Lab Expt Vasc Med, Med Ctr, Leiden, Netherlands	Netherlands Organization Applied Science Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kuhnast, S (corresponding author), TNO Metab Hlth Res, Leiden, Netherlands.	susan.jordaan@tno.nl	Jukema, J. Wouter/ABD-6503-2021; Louwe, Mieke/ABH-3414-2020; Rensen, Patrick C.N./D-7176-2018; van den Berg, Sjoerd A/R-9541-2018; Smit, J.W.A./H-8091-2014; Louwe, Mieke C./ABC-2290-2020; Princen, Hans MG/AID-9392-2022	Jukema, J. Wouter/0000-0002-3246-8359; Rensen, Patrick C.N./0000-0002-8455-4988; Smit, J.W.A./0000-0003-1052-9314; Princen, Hans MG/0000-0002-7206-1596; /0000-0003-2790-5144; Louwe, Mieke C./0000-0002-4797-4991; van den Berg, Sjoerd/0000-0001-8967-376X; van den Berg, Sjoerd/0000-0001-5937-7505	project PREDICCt [01C-104]; Netherlands Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Dutch Heart Foundation [2009T038]	project PREDICCt; Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; Dutch Heart Foundation(Netherlands Heart Foundation)	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project PREDICCt (grant 01C-104), and was supported by the Netherlands Heart Foundation, Dutch Diabetes Research Foundation and Dutch Kidney Foundation. PCNR is an Established Investigator of the Dutch Heart Foundation (grant 2009T038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bijland S, 2010, J BIOL CHEM, V285, P25168, DOI 10.1074/jbc.M110.123992; Birjmohun RS, 2005, J AM COLL CARDIOL, V45, P185, DOI 10.1016/j.jacc.2004.10.031; Blumenthal RS, 2009, NEW ENGL J MED, V361, P2178, DOI 10.1056/NEJMe0908838; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Bruckert E, 2010, ATHEROSCLEROSIS, V210, P353, DOI 10.1016/j.atherosclerosis.2009.12.023; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Carlson LA, 2005, J INTERN MED, V258, P94, DOI 10.1111/j.1365-2796.2005.01528.x; CARLSON LA, 1973, ATHEROSCLEROSIS, V18, P1, DOI 10.1016/0021-9150(73)90113-5; de Haan W, 2008, CIRCULATION, V117, P2515, DOI 10.1161/CIRCULATIONAHA.107.761965; DEKNIJFF P, 1991, J CLIN INVEST, V88, P643, DOI 10.1172/JCI115349; Delsing DJM, 2001, CIRCULATION, V103, P1778, DOI 10.1161/01.CIR.103.13.1778; Digby JE, 2010, ATHEROSCLEROSIS, V209, P89, DOI 10.1016/j.atherosclerosis.2009.08.045; Fabbrini E, 2010, J CLIN ENDOCR METAB, V95, P2727, DOI 10.1210/jc.2009-2622; Foks AC, 2011, ATHEROSCLEROSIS, V218, P53, DOI 10.1016/j.atherosclerosis.2011.04.029; Giugliano RP, 2011, NEW ENGL J MED, V365, P2318, DOI 10.1056/NEJMe1112346; GRUNDY SM, 1981, J LIPID RES, V22, P24; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; HOOGWERF BJ, 1984, ATHEROSCLEROSIS, V51, P251, DOI 10.1016/0021-9150(84)90172-2; Kamanna VS, 2008, AM J CARDIOL, V101, p20B, DOI 10.1016/j.amjcard.2008.02.029; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Lamon-Fava S, 2008, ARTERIOSCL THROM VAS, V28, P1672, DOI 10.1161/ATVBAHA.108.164541; Lee JMS, 2009, J AM COLL CARDIOL, V54, P1787, DOI 10.1016/j.jacc.2009.06.036; Li ZS, 2012, BIOCHEM PHARMACOL, V84, P821, DOI 10.1016/j.bcp.2012.06.020; Lukasova M, 2011, J CLIN INVEST, V121, P1163, DOI 10.1172/JCI41651; McBride R, 2011, AM HEART J, V161, P538, DOI 10.1016/j.ahj.2010.12.007; McKenney J, 2010, J CLIN LIPIDOL, V4, P105, DOI 10.1016/j.jacl.2010.02.002; Meyers CD, 2004, CURR OPIN LIPIDOL, V15, P659, DOI 10.1097/00041433-200412000-00006; Michos ED, 2012, J AM COLL CARDIOL, V59, P2058, DOI 10.1016/j.jacc.2012.01.045; Naik SU, 2006, CIRCULATION, V113, P90, DOI 10.1161/CIRCULATIONAHA.105.560177; Niesor EJ, 2010, J LIPID RES, V51, P3443, DOI 10.1194/jlr.M008706; Rensen PCN, 1997, J LIPID RES, V38, P1070; Sanford M, 2008, DRUGS, V68, P2373, DOI 10.2165/0003495-200868160-00008; Sharma M, 2011, CURR OPIN CARDIOL, V26, P420, DOI 10.1097/HCO.0b013e3283499ef1; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Taylor AJ, 2004, CIRCULATION, V110, P3512, DOI 10.1161/01.CIR.0000148955.19792.8D; Taylor AJ, 2006, CURR MED RES OPIN, V22, P2243, DOI 10.1185/030079906X148508; Taylor AJ, 2009, NEW ENGL J MED, V361, P2113, DOI 10.1056/NEJMoa0907569; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; van der Hoorn JWA, 2009, BRIT J PHARMACOL, V156, P1067, DOI 10.1111/j.1476-5381.2008.00109.x; van der Hoorn JWA, 2008, ARTERIOSCL THROM VAS, V28, P2016, DOI 10.1161/ATVBAHA.108.171363; van der Hoorn JWA, 2007, J HYPERTENS, V25, P2454, DOI 10.1097/HJH.0b013e3282ef79f7; VANDENMAAGDENBERG AMJM, 1993, J BIOL CHEM, V268, P10540; Wang W, 2001, AM J PHYSIOL-ENDOC M, V280, pE540, DOI 10.1152/ajpendo.2001.280.3.E540; Westerterp M, 2006, ARTERIOSCL THROM VAS, V26, P2552, DOI 10.1161/01.ATV.0000243925.65265.3c; Wu BJ, 2010, ARTERIOSCL THROM VAS, V30, P968, DOI 10.1161/ATVBAHA.109.201129	46	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66467	10.1371/journal.pone.0066467	http://dx.doi.org/10.1371/journal.pone.0066467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840481	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200084
J	Manfrin, C; Tom, M; De Moro, G; Gerdol, M; Guarnaccia, C; Mosco, A; Pallavicini, A; Giulianini, PG				Manfrin, Chiara; Tom, Moshe; De Moro, Gianluca; Gerdol, Marco; Guarnaccia, Corrado; Mosco, Alessandro; Pallavicini, Alberto; Giulianini, Piero Giulio			Application of D-Crustacean Hyperglycemic Hormone Induces Peptidases Transcription and Suppresses Glycolysis-Related Transcripts in the Hepatopancreas of the Crayfish Pontastacus leptodactylus - Results of a Transcriptomic Study	PLOS ONE			English	Article							EYESTALK ABLATION; ASTACUS-LEPTODACTYLUS; KURUMA PRAWN; DIFFERENTIAL EXPRESSION; FUNCTIONAL-ASPECTS; CANCER-PRODUCTUS; FAMILY PEPTIDES; CHH; ISOFORMS; GLAND	The crustacean Hyperglycemic Hormone (cHH) is a neuropeptide present in many decapods. Two different chiral isomers are simultaneously present in Astacid crayfish and their specific biological functions are still poorly understood. The present study is aimed at better understanding the potentially different effect of each of the isomers on the hepatopancreatic gene expression profile in the crayfish Pontastacus leptodactylus, in the context of short term hyperglycemia. Hence, two different chemically synthesized cHH enantiomers, containing either L- or D-Phe(3), were injected to the circulation of intermolt females following removal of their X organ-Sinus gland complex. The effects triggered by the injection of the two alternate isomers were detected after one hour through measurement of circulating glucose levels. Triggered changes of the transcriptome expression profile in the hepatopancreas were analyzed by RNA-seq. A whole transcriptome shotgun sequence assembly provided the assumedly complete transcriptome of P. leptodactylus hepatopancreas, followed by RNA-seq analysis of changes in the expression level of many genes caused by the application of each of the hormone isomers. Circulating glucose levels were much higher in response to the D-isoform than to the L-isoform injection, one hour from injection. Similarly, the RNA-seq analysis confirmed a stronger effect on gene expression following the administration of D-cHH, while just limited alterations were caused by the L-isomer. These findings demonstrated a more prominent short term effect of the D-cHH on the transcription profile and shed light on the effect of the D-isomer on specific functional gene groups. Another contribution of the study is the construction of a de novo assembly of the hepatopancreas transcriptome, consisting of 39,935 contigs, that dramatically increases the molecular information available for this species and for crustaceans in general, providing an efficient tool for studying gene expression patterns in this organ.	[Manfrin, Chiara; De Moro, Gianluca; Gerdol, Marco; Mosco, Alessandro; Pallavicini, Alberto; Giulianini, Piero Giulio] Univ Trieste, Dipartimento Sci Vita, Trieste, Italy; [Tom, Moshe] Israel Oceanog & Limnol Res, Haifa, Israel; [Guarnaccia, Corrado] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy	University of Trieste; Israel Oceanographic & Limnological Research Institute; International Center for Genetic Engineering & Biotechnology (ICGEB)	Giulianini, PG (corresponding author), Univ Trieste, Dipartimento Sci Vita, Trieste, Italy.	giuliani@units.it	Gerdol, Marco/D-2115-2013; Pallavicini, Alberto/H-9281-2019; Pallavicini, Alberto/J-4158-2012	Gerdol, Marco/0000-0001-6411-0813; Pallavicini, Alberto/0000-0001-7174-4603; Pallavicini, Alberto/0000-0001-7174-4603; Giulianini, Piero Giulio/0000-0001-5356-7754; Mosco, Alessandro/0000-0002-4885-3665; De Moro, Gianluca/0000-0002-5542-0278	PRIN (Progetti di Ricerca di Interesse Nazionale), Ministero dell'Istruzione, dell'Universita e della Ricerca [20109XZEPR_002]	PRIN (Progetti di Ricerca di Interesse Nazionale), Ministero dell'Istruzione, dell'Universita e della Ricerca	This work was supported by PRIN (Progetti di Ricerca di Interesse Nazionale) 2010-11 Prot. 20109XZEPR_002, Ministero dell'Istruzione, dell'Universita e della Ricerca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahearn GA, 2004, J COMP PHYSIOL B, V174, P439, DOI 10.1007/s00360-004-0438-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2002, NOVART FDN SYMP, V247, P66; Avarre JC, 2001, GEN COMP ENDOCR, V124, P257, DOI 10.1006/gcen.2001.7710; Baggerly KA, 2003, BIOINFORMATICS, V19, P1477, DOI 10.1093/bioinformatics/btg173; Balik Ismet, 2005, Turkish Journal of Zoology, V29, P295; Barim O, 2010, ECOTOX ENVIRON SAFE, V73, P138, DOI 10.1016/j.ecoenv.2009.08.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Castro PF, 2012, J CRUSTACEAN BIOL, V32, P607, DOI 10.1163/193724012X634206; Ceccaldi H.J., 1989, AQUACULTURE, V9, P243, DOI DOI 10.1007/S00248-011-9936-2; CHANG ES, 1985, AM ZOOL, V25, P179; Chaves AR, 2000, COMP BIOCHEM PHYS A, V126, P407, DOI 10.1016/S1095-6433(00)00225-7; Chung JS, 2010, GEN COMP ENDOCR, V166, P447, DOI 10.1016/j.ygcen.2009.12.011; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Kleijn DPV, 1998, J ENDOCRINOL, V156, P291, DOI 10.1677/joe.0.1560291; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fanjul-Moles ML, 2006, COMP BIOCHEM PHYS C, V142, P390, DOI 10.1016/j.cbpc.2005.11.021; Fernandez-Pozo N, COMMUNICATION; Fu Q, 2005, BIOCHEM BIOPH RES CO, V337, P765, DOI 10.1016/j.bbrc.2005.09.111; Giulianini Piero Giulio, 2006, P225; Giulianini PG, 2007, MICRON, V38, P49, DOI 10.1016/j.micron.2006.03.019; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Harlioglu AG, 2012, FOOD SCI TECHNOL INT, V18, P93, DOI 10.1177/1082013211414261; Hopkins PM, 2012, GEN COMP ENDOCR, V175, P357, DOI 10.1016/j.ygcen.2011.12.002; Hsu YWA, 2008, GEN COMP ENDOCR, V155, P517, DOI 10.1016/j.ygcen.2007.09.001; Hubenova Tania A., 2009, AACL Bioflux, V2, P261; JAMES MO, 1989, XENOBIOTICA, V19, P1063, DOI 10.3109/00498258909043162; Jia CX, 2012, MOL CELL PROTEOMICS, V11, P1951, DOI 10.1074/mcp.M112.020537; Jung Hyang-Jin, 2011, PLOS ONE, P6; KALLEN JL, 1990, BIOL BULL-US, V179, P351, DOI 10.2307/1542327; Kawahara-Miki R, 2011, PLOS ONE, P6; Keller R, 1988, METABOLIC HORMONE CR, P315; Khayat M, 1998, GEN COMP ENDOCR, V110, P307, DOI 10.1006/gcen.1998.7078; Lebaupain F, 2012, PEPTIDES, V34, P65, DOI 10.1016/j.peptides.2012.01.019; Lee KJ, 2007, GEN COMP ENDOCR, V154, P174, DOI 10.1016/j.ygcen.2007.05.019; Malev O, 2010, COMP BIOCHEM PHYS C, V152, P433, DOI 10.1016/j.cbpc.2010.07.006; Mosco A, 2012, PLOS ONE, P7; Mosco A, 2008, REGUL PEPTIDES, V147, P88, DOI 10.1016/j.regpep.2008.01.005; Nagai C, 2011, GEN COMP ENDOCR, V172, P293, DOI 10.1016/j.ygcen.2011.03.019; Okumura T, 2006, COMP BIOCHEM PHYS A, V143, P246, DOI 10.1016/j.cbpa.2005.12.002; Ollivaux C, 2000, EUR J BIOCHEM, V267, P5106, DOI 10.1046/j.1432-1327.2000.01574.x; Ollivaux C, 2009, FEBS J, V276, P4790, DOI 10.1111/j.1742-4658.2009.07180.x; Palacios E., 1999, Journal of Applied Aquaculture, V9, P1, DOI 10.1300/J028v09n03_01; Rivera-Perez C, 2010, AQUACULTURE, V300, P163, DOI 10.1016/j.aquaculture.2009.12.030; ROSAS C, 1993, COMP BIOCHEM PHYS A, V104, P183, DOI 10.1016/0300-9629(93)90027-2; Santos EA, 1997, PHYSIOL ZOOL, V70, P415, DOI 10.1086/515846; SANTOS EA, 1993, J COMP PHYSIOL B, V163, P374; SEDLMEIER D, 1988, REGUL PEPTIDES, V20, P91, DOI 10.1016/0167-0115(88)90042-0; Serrano L, 2004, J HISTOCHEM CYTOCHEM, V52, P1129, DOI 10.1369/jhc.4A6292.2004; Shechter A, 2007, J EXP BIOL, V210, P3525, DOI 10.1242/jeb.006791; Soyez D, 2003, RECENT DATA CRUSTACE; Stemmler EA, 2007, GEN COMP ENDOCR, V154, P184, DOI 10.1016/j.ygcen.2007.06.025; Sudha K, 2007, J CRUSTACEAN BIOL, V27, P304, DOI 10.1651/S-2750.1; Susanto GN, 2001, J EXP ZOOL, V289, P433, DOI 10.1002/jez.1024; Team R. D. C, 2011, R LANG ENV STAT COMP; TESHIMA S, 1989, COMP BIOCHEM PHYS B, V92, P45, DOI 10.1016/0305-0491(89)90311-8; Tsutsui N, 2005, GEN COMP ENDOCR, V144, P232, DOI 10.1016/j.ygcen.2005.06.001; Tunca E, 2013, ARCH ENV CONTAM TOXI; Uawisetwathana U, 2011, PLOS ONE, P6; VANHERP F, 1978, AQUACULTURE, V14, P289, DOI 10.1016/0044-8486(78)90013-3; Venkitraman PR, 2008, ITAL J ZOOL, V75, P345, DOI 10.1080/11250000802255905; Vilella S, 2003, J COMP PHYSIOL B, V173, P679, DOI 10.1007/s00360-003-0379-z; VOGT G, 1989, HISTOCHEMISTRY, V91, P373, DOI 10.1007/BF00493824; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; YASUDA A, 1994, GEN COMP ENDOCR, V95, P387, DOI 10.1006/gcen.1994.1138; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zmora N, 2009, SALINE SYSTEMS, P5	69	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65176	10.1371/journal.pone.0065176	http://dx.doi.org/10.1371/journal.pone.0065176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840318	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200011
J	Singh, SP; Agnihotri, P; Pratap, JV				Singh, Saurabh Pratap; Agnihotri, Pragati; Pratap, J. Venkatesh			Characterization of a Novel Putative S-Adenosylmethionine Decarboxylase-Like Protein from Leishmania donovani	PLOS ONE			English	Article							TRYPANOSOMA-CRUZI; ORNITHINE-DECARBOXYLASE; PUTRESCINE ACTIVATION; VISCERAL LEISHMANIASIS; ALLOSTERIC REGULATION; STRUCTURAL BASIS; BINDING; BRAZILIENSIS; INHIBITION; PREDICTION	In addition to the S-adenosylmethionine decarboxylase (AD) present in all organisms, trypanosomatids including Leishmania spp. possess an additional copy, annotated as the putative S-adenosylmethionine decarboxylase-like proenzyme (ADL). Phylogenetic analysis confirms that ADL is unique to trypanosomatids and has several unique features such as lack of autocatalytic cleavage and a distinct evolutionary lineage, even from trypanosomatid ADs. In Trypanosoma ADL was found to be enzymaticaly dead but plays an essential regulatory role by forming a heterodimer complex with AD. However, no structural or functional information is available about ADL from Leishmania spp. Here, in this study, we report the cloning, expression, purification, structural and functional characterization of Leishmania donovani (L. donovani) ADL using biophysical, biochemical and computational techniques. Biophysical studies show that, L. donovani ADL binds S-adenosylmethionine (SAM) and putrescine which are natural substrates of AD. Computational modeling and docking studies showed that in comparison to the ADs of other organisms including human, residues involved in putrescine binding are partially conserved while the SAM binding residues are significantly different. In silico protein-protein interaction study reveals that L. donovani ADL can interact with AD. These results indicate that L. donovani ADL posses a novel substrate binding property and may play an essential role in polyamine biosynthesis with a different mode of function from known proteins of the S-adenosylmethionine decarboxylase super family.	[Singh, Saurabh Pratap; Agnihotri, Pragati; Pratap, J. Venkatesh] Cent Drug Res Inst, Mol & Struct Biol Div, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Pratap, JV (corresponding author), Cent Drug Res Inst, Mol & Struct Biol Div, Mahatma Gandhi Marg, Lucknow 226001, Uttar Pradesh, India.	jvpratap@cdri.res.in	Singh, Saurabh Pratap/AAI-2988-2020; Agnihotri, Pragati/AAA-3087-2019	Singh, Saurabh Pratap/0000-0001-7604-645X; Agnihotri, Pragati/0000-0003-3392-0594	CSIR network	CSIR network(Council of Scientific & Industrial Research (CSIR) - India)	Funding from CSIR network projects - "Genomics and Informatics Solutions for Integrating Biology (GENESIS)" and "Understanding the role of the Host molecule in Parasite Infection (HOPE)" is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale S, 2008, BIOCHEMISTRY-US, V47, P13404, DOI 10.1021/bi801732m; Basselin M, 2000, MOL BIOCHEM PARASIT, V109, P37, DOI 10.1016/S0166-6851(00)00234-6; Bennett EM, 2002, BIOCHEMISTRY-US, V41, P14509, DOI 10.1021/bi026710u; Beswick TC, 2006, BIOCHEMISTRY-US, V45, P7797, DOI 10.1021/bi0603975; Boitz JM, 2009, INFECT IMMUN, V77, P756, DOI 10.1128/IAI.01236-08; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clyne T, 2002, BIOCHEMISTRY-US, V41, P13207, DOI 10.1021/bi026541d; Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153; Coutinho SG, 1996, EXP PARASITOL, V84, P144, DOI 10.1006/expr.1996.0100; Ekstrom JL, 1999, STRUCTURE, V7, P583, DOI 10.1016/S0969-2126(99)80074-4; Ekstrom JL, 2001, BIOCHEMISTRY-US, V40, P9495, DOI 10.1021/bi010736o; GILLIS D, 1995, PEDIATR INFECT DIS J, V14, P247, DOI 10.1097/00006454-199503000-00019; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Jiang YQ, 1999, J BIOL CHEM, V274, P3781, DOI 10.1074/jbc.274.6.3781; Kandpal M, 1997, LIFE SCI, V60, P1793, DOI 10.1016/S0024-3205(97)00139-2; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kinch LN, 1999, MOL BIOCHEM PARASIT, V101, P1, DOI 10.1016/S0166-6851(98)00181-9; Kinch LN, 2000, BIOCHEMISTRY-US, V39, P3336, DOI 10.1021/bi991493r; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Krauth-Siegel Luise R., 2007, V44, P231; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; LLC. Schrodinger, PYMOL MOL GRAPH SYST; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; MACHADO ES, 1992, MEM I OSWALDO CRUZ, V87, P487, DOI 10.1590/S0074-02761992000400005; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; METCALF BW, 1979, MOL PHARMACOL, V16, P539; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; PAINTER GR, 1991, J BIOL CHEM, V266, P19362; PAJUNEN A, 1988, J BIOL CHEM, V263, P17040; PEGG AE, 1988, J BIOL CHEM, V263, P11008; Pegg AE, 1998, BIOCHEM SOC T, V26, P580, DOI 10.1042/bst0260580; Persson K, 1998, BIOCHEM J, V333, P527, DOI 10.1042/bj3330527; Picard-Jean F, 2007, BIOCHEM J, V407, P331, DOI 10.1042/BJ20070853; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Roberts SC, 2002, J BIOL CHEM, V277, P5902, DOI 10.1074/jbc.M110118200; Roberts SC, 2001, MOL BIOCHEM PARASIT, V115, P217, DOI 10.1016/S0166-6851(01)00293-6; ROST B, 1994, COMPUT APPL BIOSCI, V10, P53; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; STANLEY BA, 1994, J BIOL CHEM, V269, P7901; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Tolbert WD, 2003, STRUCTURE, V11, P285, DOI 10.1016/S0969-2126(03)00026-1; Tolbert WD, 2001, BIOCHEMISTRY-US, V40, P9484, DOI 10.1021/bi010735w; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Willert EK, 2007, P NATL ACAD SCI USA, V104, P8275, DOI 10.1073/pnas.0701111104; Willert EK, 2009, MOL BIOCHEM PARASIT, V168, P1, DOI 10.1016/j.molbiopara.2009.05.009; Xiong HS, 1997, J BIOL CHEM, V272, P28342, DOI 10.1074/jbc.272.45.28342	55	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65912	10.1371/journal.pone.0065912	http://dx.doi.org/10.1371/journal.pone.0065912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840377	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200040
J	Tharadra, SK; Medina, A; Ray, A				Tharadra, Sana Khalid; Medina, Adriana; Ray, Anandasankar			Advantage of the Highly Restricted Odorant Receptor Expression Pattern in Chemosensory Neurons of Drosophila	PLOS ONE			English	Article							FEEDBACK-REGULATION ENSURES; GENE CHOICE; ANTENNAL LOBE; AVOIDANCE-BEHAVIOR; OLFACTORY NEURONS; SYSTEM; MOUSE; LARVA; CIRCUIT; TASTE	A fundamental molecular feature of olfactory systems is that individual neurons express only one receptor from a large odorant receptor gene family. While numerous theories have been proposed, the functional significance and evolutionary advantage of generating a sophisticated one-receptor-per neuron expression pattern is not well understood. Using the genetically tractable Drosophila melanogaster as a model, we demonstrate that the breakdown of this highly restricted expression pattern of an odorant receptor in neurons leads to a deficit in the ability to exploit new food sources. We show that animals with ectopic co-expression of odorant receptors also have a competitive disadvantage in a complex environment with limiting food sources. At the level of the olfactory system, we find changes in both the behavioral and electrophysiological responses to odorants that are detected by endogenous receptors when an olfactory receptor is broadly misexpressed in chemosensory neurons. Taken together these results indicate that restrictive expression patterns and segregation of odorant receptors to individual neuron classes are important for sensitive odor-detection and appropriate olfactory behaviors.	[Tharadra, Sana Khalid; Medina, Adriana; Ray, Anandasankar] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Ray, A (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	anand.ray@ucr.edu		Ray, Anandasankar/0000-0003-4133-2581	Whitehall Foundation	Whitehall Foundation	This work was partly funded by a grant given to Anandasankar Ray by the Whitehall Foundation (http://www.whitehall.org/). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Asahina K, 2008, CURR BIOL, V18, P1153, DOI 10.1016/j.cub.2008.06.075; Bai L, 2009, J NEUROSCI, V29, P12940, DOI 10.1523/JNEUROSCI.3525-09.2009; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fuss SH, 2007, CELL, V130, P373, DOI 10.1016/j.cell.2007.06.023; Fuss SH, 2009, MOL CELL NEUROSCI, V41, P101, DOI 10.1016/j.mcn.2009.02.014; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Jafari S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001280; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Kwon JY, 2011, J NEUROSCI, V31, P15300, DOI 10.1523/JNEUROSCI.3363-11.2011; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Magklara A, 2011, CELL, V145, P555, DOI 10.1016/j.cell.2011.03.040; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; Ramaekers A, 2005, CURR BIOL, V15, P982, DOI 10.1016/j.cub.2005.04.032; Ray A, 2008, PLOS BIOL, V6, P1069, DOI 10.1371/journal.pbio.0060125; Ray A, 2007, NEURON, V53, P353, DOI 10.1016/j.neuron.2006.12.010; Serizawa S, 2005, CHEM SENSES, V30, pI99, DOI 10.1093/chemse/bjh133; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Sim CK, 2012, GENE DEV, V26, P2483, DOI 10.1101/gad.201665.112; Stortkuhl KF, 2005, CHEM SENSES, V30, P81, DOI 10.1093/chemse/bji003; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Tichy AL, 2008, J NEUROSCI, V28, P7121, DOI 10.1523/JNEUROSCI.2063-08.2008; Tom W, 2011, MOL CELL NEUROSCI, V46, P252, DOI 10.1016/j.mcn.2010.09.008; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306	32	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66173	10.1371/journal.pone.0066173	http://dx.doi.org/10.1371/journal.pone.0066173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840419	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200058
J	Wang, D; He, YN; Li, YP; Luan, DC; Zhai, FY; Yang, XG; Ma, GS				Wang, Dong; He, Yuna; Li, Yanping; Luan, Dechun; Zhai, Fengying; Yang, Xiaoguang; Ma, Guansheng			Joint Association of Dietary Pattern and Physical Activity Level with Cardiovascular Disease Risk Factors among Chinese Men: A Cross-Sectional Study	PLOS ONE			English	Article							LIFE-STYLE; BLOOD-PRESSURE; METABOLIC SYNDROME; DIABETES-MELLITUS; PLASMA BIOMARKERS; ATTRIBUTABLE RISK; POPULATION; PREVENTION; OBESITY; INTERVENTION	The purpose of this cross-sectional study was to investigate the joint associations of physical activity level (PAL) and dietary patterns in relation to cardiovascular disease (CVD) risk factors among Chinese men. The study population consisted of 13 511 Chinese males aged 18-59 years from the 2002 China National Nutrition and Health Survey. Based on dietary data collected by a food frequency questionnaire, four dietary patterns were identified and labeled as "Green Water'' (high consumption of rice, vegetables, seafood, pork, and poultry), "Yellow Earth'' (high consumption of wheat flour products and starchy tubers), "New Affluent'' (high consumption of animal sourced foods and soybean products), and "Western Adopter'' (high consumption of animal sourced foods, cakes, and soft drinks). From the information collected by a 1-year physical activity questionnaire, PAL was calculated and classified into 4 categories: sedentary, low active, active, and very active. As compared with their counterparts from the New Affluent pattern, participants who followed the Green Water pattern had a lower likelihood of abdominal obesity (AO; 50.2%), hypertension (HT; 37.9%), hyperglycemia (HG; 41.5%), elevated triglyceride (ETG; 14.5%), low HDL (LHDL; 39.8%), and metabolic syndrome (MS; 51.9%). When compared to sedentary participants, the odds ratio of participants with very active PAL was 0.62 for AO, 0.85 for HT, 0.71 for HG, 0.76 for ETG, 0.74 for LHDL, and 0.58 for MS. Individuals who followed both very active PAL and the Green Water pattern had a lower likelihood of CVD risk factors (AO: 65.8%, HT: 39.1%, HG: 57.4%, ETG: 35.4%, LHDL: 56.1%, and MS: 75.0%), compared to their counterparts who followed both sedentary PAL and the New Affluent pattern. In addition, adherence to both healthy dietary pattern and very active PAL presented a remarkable potential for CVD risk factor prevention.	[Wang, Dong; He, Yuna; Li, Yanping; Luan, Dechun; Zhai, Fengying; Yang, Xiaoguang; Ma, Guansheng] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Food Safety, Beijing, Peoples R China; [Wang, Dong; Li, Yanping] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [He, Yuna] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Luan, Dechun] Liaoning Prov Ctr Dis Control & Prevent, Shenyang, Liaoning Provin, Peoples R China	Chinese Center for Disease Control & Prevention; Harvard University; Harvard T.H. Chan School of Public Health; Wageningen University & Research	Wang, D (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Food Safety, Beijing, Peoples R China.	dow471@mail.harvard.edu; mags@chinacdc.cn	Ma, Guansheng/AAD-6767-2020; Wang, Dong D./AAU-2951-2021; Li, Yanping/H-6437-2011	Wang, Dong D./0000-0002-0897-3048; Li, Yanping/0000-0002-0412-2748	Ministry of Health; Ministry of Science and Technology, China [2001DEA30035, 2003DIA6N008]	Ministry of Health; Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This study was supported by the Ministry of Health and Ministry of Science and Technology, China (Grant numbers: 2001DEA30035, 2003DIA6N008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2009, PREV MED, V48, P326, DOI 10.1016/j.ypmed.2009.01.015; Aadahl M, 2007, EUR J EPIDEMIOL, V22, P369, DOI 10.1007/s10654-006-9100-3; Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Aires N, 2003, EUR J EPIDEMIOL, V18, P479, DOI 10.1023/A:1024682523710; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Barengo NC, 2006, EUR J CARDIOV PREV R, V13, P51, DOI 10.1097/00149831-200602000-00008; BENICHOU J, 1990, BIOMETRICS, V46, P991, DOI 10.2307/2532443; Bertrais S, 2005, OBES RES, V13, P936, DOI 10.1038/oby.2005.108; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Carnethon MR, 2006, DIABETES CARE, V29, P914, DOI 10.2337/diacare.29.04.06.dc05-1729; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Conlin PR, 2000, AM J HYPERTENS, V13, P949, DOI 10.1016/S0895-7061(99)00284-8; Cui XH, 2007, CANCER EPIDEM BIOMAR, V16, P1443, DOI 10.1158/1055-9965.EPI-07-0059; DOWSE GK, 1991, DIABETES CARE, V14, P271, DOI 10.2337/diacare.14.4.271; Drafting Committee for Chinese Guidelines for Prevention and Treatment of Patients with Hypertension, 2000, ZHONGHUA GAO XUE YA, V2, P7; Engel LS, 2003, J NATL CANCER I, V95, P1404, DOI 10.1093/jnci/djg047; Ford ES, 2005, OBES RES, V13, P608, DOI 10.1038/oby.2005.65; Forman JP, 2009, JAMA-J AM MED ASSOC, V302, P401, DOI 10.1001/jama.2009.1060; Fung TT, 2001, AM J CLIN NUTR, V73, P61; Fung TT, 2000, AM J EPIDEMIOL, V152, P1171, DOI 10.1093/aje/152.12.1171; GAO YT, 1994, INT J CANCER, V58, P192, DOI 10.1002/ijc.2910580208; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; He YN, 2009, DIABETES CARE, V32, P1972, DOI 10.2337/dc09-0714; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Institute of Medicine Food and Nutrition Board, 2002, DIET REF INT EN CARB; Iqbal R, 2008, CIRCULATION, V118, P1929, DOI 10.1161/CIRCULATIONAHA.107.738716; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Ji BT, 2002, EUR J CANCER PREV, V11, P237, DOI 10.1097/00008469-200206000-00007; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Kerver JM, 2003, AM J CLIN NUTR, V78, P1103, DOI 10.1093/ajcn/78.6.1103; Kim YO, 2009, NUTR RES PRACT, V3, P162, DOI 10.4162/nrp.2009.3.2.162; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kronenberg F, 2000, ATHEROSCLEROSIS, V153, P433, DOI 10.1016/S0021-9150(00)00426-3; Laaksonen DE, 2002, DIABETES CARE, V25, P1612, DOI 10.2337/diacare.25.9.1612; LaMonte MJ, 2005, J APPL PHYSIOL, V99, P1205, DOI 10.1152/japplphysiol.00193.2005; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Li Yan-ping, 2006, Zhonghua Yufang Yixue Zazhi, V40, P273; Li YP, 2011, J NUTR, V141, P1834, DOI 10.3945/jn.111.143883; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Ma G, 2008, OBES REV, V9, P113, DOI 10.1111/j.1467-789X.2007.00451.x; Ma G, 2007, YING YANG XUE BAO, V29, P217; Ma G, 2005, YING YANG XUE BAO, V27, P362; Ministry of Health, 2010, CHIN HLTH STAT YB; Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21; Nguyen THHD, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-141; O'Donovan G, 2005, INT J OBESITY, V29, P1063, DOI 10.1038/sj.ijo.0803004; Panagiotakos DB, 2003, CORONARY ARTERY DIS, V14, P533, DOI 10.1097/00019501-200312000-00003; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; RAO K, 1992, HEAT TRANSFER ENG, V13, P9; Ratner R, 2005, DIABETES CARE, V28, P888, DOI 10.2337/diacare.28.4.888; Sacks FM, 2010, NEW ENGL J MED, V362, P2102, DOI 10.1056/NEJMct0911013; Sadakane A, 2008, J EPIDEMIOL, V18, P58, DOI 10.2188/jea.18.58; Saha S, 2010, INT J ENV RES PUB HE, V7, P3150, DOI 10.3390/ijerph7083150; Shah M, 2007, AM J CLIN NUTR, V85, P1251, DOI 10.1093/ajcn/85.5.1251; Shi L, 2011, BRIT J NUTR, V105, P747, DOI 10.1017/S0007114510004307; Shi Z, 2005, EUR J CLIN NUTR, V59, P1439, DOI 10.1038/sj.ejcn.1602259; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; van Dam RM, 2003, AM J CLIN NUTR, V77, P1156, DOI 10.1093/ajcn/77.5.1156; Wang D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-925; WHO / IDF, 2006, DEF DIAGN DIAB MELL; World Health Organization (WHO), 2009, CARD DIS; Yu ZJ, 2009, PREV MED, V48, P272, DOI 10.1016/j.ypmed.2009.01.004; Zhai FY, 2009, NUTR REV, V67, pS56, DOI 10.1111/j.1753-4887.2009.00160.x; Zhao LC, 2004, HYPERTENSION, V43, P1332, DOI 10.1161/01.HYP.0000128243.06502.bc; Zhou B., 2002, ZHONGHUA LIU XING BI, V1, P5	70	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66210	10.1371/journal.pone.0066210	http://dx.doi.org/10.1371/journal.pone.0066210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840426	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200062
J	Carcagno, S; Semal, C; Demany, L				Carcagno, Samuele; Semal, Catherine; Demany, Laurent			No Need for Templates in the Auditory Enhancement Effect	PLOS ONE			English	Article							INFERIOR COLLICULUS; SPECTRAL AMPLITUDE; FREQUENCY; MASKING; ADAPTATION; HEARING; NOISE	The audibility of a target tone in a multitone background masker is enhanced by the presentation of a precursor sound consisting of the masker alone. There is evidence that precursor-induced neural adaptation plays a role in this perceptual enhancement. However, the precursor may also be strategically used by listeners as a spectral template of the following masker to better segregate it from the target. In the present study, we tested this hypothesis by measuring the audibility of a target tone in a multitone masker after the presentation of precursors which, in some conditions, were made dissimilar to the masker by gating their components asynchronously. The precursor and the following sound were presented either to the same ear or to opposite ears. In either case, we found no significant difference in the amount of enhancement produced by synchronous and asynchronous precursors. In a second experiment, listeners had to judge whether a synchronous multitone complex contained exactly the same tones as a preceding precursor complex or had one tone less. In this experiment, listeners performed significantly better with synchronous than with asynchronous precursors, showing that asynchronous precursors were poorer perceptual templates of the synchronous multitone complexes. Overall, our findings indicate that precursor-induced auditory enhancement cannot be fully explained by the strategic use of the precursor as a template of the following masker. Our results are consistent with an explanation of enhancement based on selective neural adaptation taking place at a central locus of the auditory system.	[Carcagno, Samuele] Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Bordeaux, France; Univ Bordeaux 2, Neurophysiol Lab, CNRS, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Carcagno, S (corresponding author), Univ Bordeaux, Inst Neurosci Cognit & Integrat Aquitaine, Bordeaux, France.	samuele.carcagno@u-bordeaux2.fr	Carcagno, Samuele/H-4015-2019; Semal, Catherine/D-8592-2014; Demany, Laurent/D-7984-2014	Carcagno, Samuele/0000-0002-1868-5795; Semal, Catherine/0000-0002-2075-6265; Demany, Laurent/0000-0001-5549-9628	Agence Nationale de la Recherche (LEAP, Programme Blanc)	Agence Nationale de la Recherche (LEAP, Programme Blanc)(French National Research Agency (ANR))	This work was supported by a grant from the Agence Nationale de la Recherche (www.agence-nationale-recherche.fr; LEAP, Programme Blanc 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrne AJ, 2011, J ACOUST SOC AM, V129, P2088, DOI 10.1121/1.3552880; Carcagno S., BASIC ASPEC IN PRESS; Carcagno S, 2012, JARO-J ASSOC RES OTO, V13, P693, DOI 10.1007/s10162-012-0339-y; CARLYON RP, 1989, HEARING RES, V41, P223, DOI 10.1016/0378-5955(89)90014-2; Erviti M, 2011, J ACOUST SOC AM, V129, P3837, DOI 10.1121/1.3589257; Guinan JJ, 2011, SPRINGER HANDB AUDIT, V38, P39, DOI 10.1007/978-1-4419-7070-1_3; Hicks ML, 1999, J ACOUST SOC AM, V105, P326, DOI 10.1121/1.424526; HOLM S, 1979, SCAND J STAT, V6, P65; Kidd G, 2011, J ACOUST SOC AM, V130, P3926, DOI 10.1121/1.3658442; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lilaonitkul W, 2012, J NEUROPHYSIOL, V107, P1598, DOI 10.1152/jn.00549.2011; Lilaonitkul W, 2009, JARO-J ASSOC RES OTO, V10, P459, DOI 10.1007/s10162-009-0163-1; Lilaonitkul W, 2009, J NEUROPHYSIOL, V101, P1394, DOI 10.1152/jn.90925.2008; Moore B. C. J., 1995, HDB PERCEPTION COGNI, V6, P387, DOI DOI 10.1016/B978-012505626-7/50013-3; Moore BCJ, 2012, PHILOS T R SOC B, V367, P919, DOI 10.1098/rstb.2011.0355; Nelson PC, 2010, J NEUROSCI, V30, P6577, DOI 10.1523/JNEUROSCI.0277-10.2010; PALMER AR, 1995, J ACOUST SOC AM, V97, P1786, DOI 10.1121/1.412055; POPELAR J, 1982, ACTA NEUROBIOL EXP, V42, P299; Richards VM, 2004, J ACOUST SOC AM, V116, P2278, DOI 10.1121/1.1784433; Schouten JF, 1940, P K NED AKAD WETENSC, V43, P356; SEMPLE MN, 1979, J NEUROPHYSIOL, V42, P1626, DOI 10.1152/jn.1979.42.6.1626; Strickland EA, 2004, J ACOUST SOC AM, V115, P2234, DOI 10.1121/1.1691036; SUMMERFIELD Q, 1984, PERCEPT PSYCHOPHYS, V35, P203, DOI 10.3758/BF03205933; SUMMERFIELD Q, 1987, J ACOUST SOC AM, V81, P700, DOI 10.1121/1.394838; THIBODEAU LM, 1991, J ACOUST SOC AM, V89, P2843, DOI 10.1121/1.400722; Viemeister N.F., BASIC ASPEC IN PRESS; Viemeister N.F., 1980, PSYCHOPHYSICAL PHYSL, P190, DOI DOI 10.1007/978-94-009-9144-6_28; VIEMEISTER NF, 1982, J ACOUST SOC AM, V71, P1502, DOI 10.1121/1.387849; Walsh KP, 2010, J ACOUST SOC AM, V127, P955, DOI 10.1121/1.3279832; WRIGHT BA, 1992, PHILOS T ROY SOC B, V336, P325, DOI 10.1098/rstb.1992.0065	30	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67874	10.1371/journal.pone.0067874	http://dx.doi.org/10.1371/journal.pone.0067874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826348	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000321150000103
J	Chen, GQ; Liu, XH; Zhang, LL; Cao, HJ; Lu, JP; Lin, FC				Chen, Guoqing; Liu, Xiaohong; Zhang, Lilin; Cao, Huijuan; Lu, Jianping; Lin, Fucheng			Involvement of MoVMA11, a Putative Vacuolar ATPase c ' Subunit, in Vacuolar Acidification and Infection-Related Morphogenesis of Magnaporthe oryzae	PLOS ONE			English	Article							RICE BLAST FUNGUS; GENES-ENCODING SUBUNITS; H+-ATPASE; V-ATPASE; SACCHAROMYCES-CEREVISIAE; CRYPTOCOCCUS-NEOFORMANS; APPRESSORIUM TURGOR; CATALYTIC SUBUNIT; CYTOSOLIC PH; PROTON PUMPS	Many functions of vacuole depend on the activity of vacuolar ATPase which is essential to maintain an acidic lumen and create the driving forces for massive fluxes of ions and metabolites through vacuolar membrane. In filamentous fungus Magnaporthe oryzae, subcellular colocalization and quinacrine staining suggested that the V1V0 domains of V-ATPase were fully assembled and the vacuoles were kept acidic during infection-related developments. Targeted gene disruption of MoVMA11 gene, encoding the putative c' subunit of V-ATPase, impaired vacuolar acidification and mimicked the phenotypes of yeast V-ATPase mutants in the poor colony morphology, abolished asexual and sexual reproductions, selective carbon source utilization, and increased calcium and heavy metals sensitivities, however, not in the typical pH conditional lethality. Strikingly, aerial hyphae of the MoVMA11 null mutant intertwined with each other to form extremely thick filamentous structures. The results also implicated that MoVMA11 was involved in cell wall integrity and appressorium formation. Abundant non-melanized swollen structures and rare, small appressoria without penetration ability were produced at the hyphal tips of the Delta Movma11 mutant on onion epidermal cells. Finally, the MoVMA11 null mutant lost pathogenicity on both intact and wounded host leaves. Overall, our data indicated that MoVMA11, like other fungal VMA genes, is associated with numerous cellular functions and highlighted that V-ATPase is essential for infection-related morphogenesis and pathogenesis in M. oryzae.	[Chen, Guoqing; Liu, Xiaohong; Cao, Huijuan; Lin, Fucheng] Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Lilin; Lu, Jianping] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Lin, Fucheng] Zhengzhou Tobacco Inst CNTC, China Tobacco Gene Res Ctr, Zhengzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhengzhou Tobacco Research Institute of CNTC	Lin, FC (corresponding author), Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	fuchenglin@zju.edu.cn	Lin, Fucheng/ABE-7591-2021; Lu, Jianping/AFL-6811-2022; Chen, Guoqing/W-5308-2019	Lin, Fucheng/0000-0002-4127-8143; Lu, Jianping/0000-0001-9601-0040; Chen, Guoqing/0000-0002-8448-6938	National Natural Science Foundation of China [30925029, 31000077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Grants (No. 30925029 and 31000077) funded by the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 1997, GENE DEV, V11, P3206, DOI 10.1101/gad.11.23.3206; Arino J, 2010, MICROBIOL MOL BIOL R, V74, P95, DOI 10.1128/MMBR.00042-09; Atkinson HA, 2002, FUNGAL GENET BIOL, V37, P233, DOI 10.1016/S1087-1845(02)00535-2; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; Bowman BJ, 2009, EUKARYOT CELL, V8, P1845, DOI 10.1128/EC.00174-09; Bowman EJ, 2000, J BIOL CHEM, V275, P167, DOI 10.1074/jbc.275.1.167; Brakhage AA, 2005, MED MYCOL, V43, pS75, DOI 10.1080/13693780400028967; Chavez C, 2006, J BIOL CHEM, V281, P27052, DOI 10.1074/jbc.M603883200; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; Davis-Kaplan SR, 2004, J BIOL CHEM, V279, P4322, DOI 10.1074/jbc.M310680200; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Deng YZ, 2009, AUTOPHAGY, V5, P33, DOI 10.4161/auto.5.1.7175; Dou XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016439; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; Erickson T, 2001, MOL MICROBIOL, V42, P1121, DOI 10.1046/j.1365-2958.2001.02712.x; Finnigan GC, 2012, NATURE, V481, P360, DOI 10.1038/nature10724; Flannery AR, 2004, J BIOL CHEM, V279, P39856, DOI 10.1074/jbc.M406767200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Forster C, 1999, J BIOL CHEM, V274, P9442, DOI 10.1074/jbc.274.14.9442; Gao HM, 2013, RES MICROBIOL, V164, P300, DOI 10.1016/j.resmic.2013.01.001; Gilbert MJ, 2006, NATURE, V440, P535, DOI 10.1038/nature04567; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; Graham LA, 2000, J EXP BIOL, V203, P61; Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iwaki T, 2004, MOL GENET GENOMICS, V271, P197, DOI 10.1007/s00438-003-0971-7; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2000, J EXP BIOL, V203, P81; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; Kong LA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002526; Kuroki Y, 2002, FEMS MICROBIOL LETT, V209, P277, DOI 10.1016/S0378-1097(02)00551-7; Lau GW, 1998, FUNGAL GENET BIOL, V24, P228, DOI 10.1006/fgbi.1998.1053; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lichter A, 1998, FUNGAL GENET BIOL, V25, P63, DOI 10.1006/fgbi.1998.1087; Liu TB, 2008, J ZHEJIANG UNIV-SC B, V9, P811, DOI 10.1631/jzus.B0860011; Liu XH, 2007, EUKARYOT CELL, V6, P997, DOI 10.1128/EC.00011-07; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; Melin P, 2004, MICROBIOL-SGM, V150, P743, DOI 10.1099/mic.0.26807-0; Mitchell TK, 2003, NEW PHYTOL, V159, P53, DOI 10.1046/j.1469-8137.2003.00787.x; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Ohneda M, 2002, FUNGAL GENET BIOL, V37, P29, DOI 10.1016/S1087-1845(02)00033-6; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Parker D, 2008, NAT PROTOC, V3, P435, DOI 10.1038/nprot.2007.499; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Poltermann S, 2005, MICROBIOL-SGM, V151, P1645, DOI 10.1099/mic.0.27505-0; Powell AJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-147; Powell B, 2000, J BIOL CHEM, V275, P23654, DOI 10.1074/jbc.M004440200; Rho HS, 2001, MOL CELLS, V12, P407; Ryan M, 2008, MOL BIOL CELL, V19, P5131, DOI 10.1091/mbc.E08-06-0629; Sambade M, 2005, GENETICS, V170, P1539, DOI 10.1534/genetics.105.042812; Schachtschabel D, 2012, FUNGAL GENET BIOL, V49, P284, DOI 10.1016/j.fgb.2011.12.008; Strasser B, 2011, EMBO J, V30, P4126, DOI 10.1038/emboj.2011.335; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Thines E, 2000, PLANT CELL, V12, P1703, DOI 10.1105/tpc.12.9.1703; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; VALENT B, 1991, GENETICS, V127, P87; Veneault-Fourrey C, 2006, SCIENCE, V312, P580, DOI 10.1126/science.1124550; Veses V, 2008, CURR OPIN MICROBIOL, V11, P503, DOI 10.1016/j.mib.2008.09.017; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; WEISMAN LS, 1987, J CELL BIOL, V105, P1539, DOI 10.1083/jcb.105.4.1539; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	70	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67804	10.1371/journal.pone.0067804	http://dx.doi.org/10.1371/journal.pone.0067804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826342	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000099
J	Hu, JR; Li, Y; Li, P				Hu, Jianran; Li, Yu; Li, Ping			MARVELD1 Inhibits Nonsense-Mediated RNA Decay by Repressing Serine Phosphorylation of UPF1	PLOS ONE			English	Article							EXON-JUNCTION COMPLEX; SURVEILLANCE COMPLEX; PROTEIN; TRANSLATION; EXPRESSION; BINDING; IDENTIFICATION; NMD	We have observed low expression levels of MARVELD1, a novel tumor repressor, in multiple tumors; however, its function in normal cells has not been explored. We recently reported that MARVELD1 interacts with importin beta 1, which plays an important role in nonsense-mediated RNA decay(NMD). Here, we demonstrate that MARVELD1 substantially inhibits nonsense-mediated RNA decay by decreasing the pioneer round of translation but not steady-state translation, and we identify MARVELD1 as an important component of the molecular machinery containing UPF1 and Y14. Furthermore, we determined the specific regions of MARVELD1 and UPF1 responsible for their interaction. We also showed that MARVELD1 promotes the dissociation of SMG1 from UPF1, resulting in the repression of serine phosphorylation of UPF1, and subsequently blocks the recruitment of SMG5, which is required for ensuing SMG5-mediated exonucleolytic decay. Our observations provide molecular insight into the potential function of MARVELD1 in nonsense-mediated RNA decay.	[Hu, Jianran; Li, Yu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China; [Li, Ping] Harbin Inst Technol, Sch Municipal & Environm Engn, Harbin 150006, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology	Li, Y (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150006, Peoples R China.	liyugene@126.com		, Ping/0000-0002-7741-1321				Bhattacharya A, 2000, RNA, V6, P1226, DOI 10.1017/S1355838200000546; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Chin SY, 2004, GENE DEV, V18, P745, DOI 10.1101/gad.1170204; Cho H, 2013, NUCLEIC ACIDS RES, V41, P1319, DOI 10.1093/nar/gks1222; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Fiorini F, 2013, NUCLEIC ACIDS RES, V41, P1; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Hwang J, 2010, MOL CELL, V39, P396, DOI 10.1016/j.molcel.2010.07.004; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Okada-Katsuhata Y, 2012, NUCLEIC ACIDS RES, V40, P1251, DOI 10.1093/nar/gkr791; Paillusson A, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni052; Sato H, 2009, GENE DEV, V23, P2537, DOI 10.1101/gad.1817109; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Shigeoka T, 2012, NUCLEIC ACIDS RES, V40, P6887, DOI 10.1093/nar/gks344; Singh G, 2007, MOL CELL, V27, P780, DOI 10.1016/j.molcel.2007.06.030; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Wang D, 2011, J BIOL CHEM, V286, P40038, DOI 10.1074/jbc.M111.266361; Wang D, 2011, MOL CELL BIOL, V31, P3670, DOI 10.1128/MCB.05704-11; Wang Shan, 2009, Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao, V25, P735; Wang S, 2009, CANCER LETT, V282, P77, DOI 10.1016/j.canlet.2009.03.008; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yu YT, 2012, CANCER SCI, V103, P716, DOI 10.1111/j.1349-7006.2012.02220.x; Zeng FL, 2011, MOL CELLS, V31, P267, DOI 10.1007/s10059-011-0037-3	30	7	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68291	10.1371/journal.pone.0068291	http://dx.doi.org/10.1371/journal.pone.0068291			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826386	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000139
J	Roche, LM; Kromschroeder, L; Atwill, ER; Dahlgren, RA; Tate, KW				Roche, Leslie M.; Kromschroeder, Lea; Atwill, Edward R.; Dahlgren, Randy A.; Tate, Kenneth W.			Water Quality Conditions Associated with Cattle Grazing and Recreation on National Forest Lands	PLOS ONE			English	Article							WESTERN SIERRA-NEVADA; ESCHERICHIA-COLI; ORGANIC NITROGEN; MANAGEMENT STRATEGIES; INDICATOR BACTERIA; FECAL-COLIFORM; SURFACE RUNOFF; STREAM; PERSISTENCE; TRANSPORT	There is substantial concern that microbial and nutrient pollution by cattle on public lands degrades water quality, threatening human and ecological health. Given the importance of clean water on multiple-use landscapes, additional research is required to document and examine potential water quality issues across common resource use activities. During the 2011 grazing-recreation season, we conducted a cross sectional survey of water quality conditions associated with cattle grazing and/or recreation on 12 public lands grazing allotments in California. Our specific study objectives were to 1) quantify fecal indicator bacteria (FIB; fecal coliform and E. coli), total nitrogen, nitrate, ammonium, total phosphorus, and soluble-reactive phosphorus concentrations in surface waters; 2) compare results to a) water quality regulatory benchmarks, b) recommended maximum nutrient concentrations, and c) estimates of nutrient background concentrations; and 3) examine relationships between water quality, environmental conditions, cattle grazing, and recreation. Nutrient concentrations observed throughout the grazing-recreation season were at least one order of magnitude below levels of ecological concern, and were similar to U. S. Environmental Protection Agency (USEPA) estimates for background water quality conditions in the region. The relative percentage of FIB regulatory benchmark exceedances widely varied under individual regional and national water quality standards. Relative to USEPA's national E. coli FIB benchmarks-the most contemporary and relevant standards for this study-over 90% of the 743 samples collected were below recommended criteria values. FIB concentrations were significantly greater when stream flow was low or stagnant, water was turbid, and when cattle were actively observed at sampling. Recreation sites had the lowest mean FIB, total nitrogen, and soluble-reactive phosphorus concentrations, and there were no significant differences in FIB and nutrient concentrations between key grazing areas and non-concentrated use areas. Our results suggest cattle grazing, recreation, and provisioning of clean water can be compatible goals across these national forest lands.	[Roche, Leslie M.; Kromschroeder, Lea; Tate, Kenneth W.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Atwill, Edward R.] Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; [Dahlgren, Randy A.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Roche, LM (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	lmroche@ucdavis.edu		Roche, Leslie/0000-0003-2954-8056; Dahlgren, Randy/0000-0002-8961-875X	USDA Forest Service, Pacific Southwest Region	USDA Forest Service, Pacific Southwest Region(United States Department of Agriculture (USDA)United States Forest Service)	This research was funded by USDA Forest Service, Pacific Southwest Region. The funders did provide field data collection assistance. The funders had no role in data analysis, decision to publish, or preparation of the manuscript.	Adams MJ, 2009, J HERPETOL, V43, P132, DOI 10.1670/08-016R2.1; Ahearn DS, 2004, J HYDROL, V295, P47, DOI 10.1016/j.jhydrol.2004.02.016; Ahearn DS, 2005, J HYDROL, V313, P234, DOI 10.1016/j.jhydrol.2005.02.038; Allan JD., 2021, STREAM ECOLOGY STRUC, DOI [DOI 10.1007/978-3-030-61286-3, 10.1007/978-3-030-61286-3]; Alm EW, 2006, J GREAT LAKES RES, V32, P401, DOI 10.3394/0380-1330(2006)32[401:PAPGOT]2.0.CO;2; [Anonymous], 2000, AMBIENT WATER QUALIT; [Anonymous], 2008, SOIL SURVEY GEOGRAPH; Belsky AJ, 1999, J SOIL WATER CONSERV, V54, P419; Bernal S, 2005, BIOGEOCHEMISTRY, V75, P351, DOI 10.1007/s10533-005-1246-7; BLM, 1999, UT STUD RES MEAS; Brunson MW, 1996, J RANGE MANAGE, V49, P69, DOI 10.2307/4002728; Byappanahalli Muruleedhara N., 2006, Journal of Water and Health, V4, P313, DOI 10.2166/wh.2006.018; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Campbell JL, 2000, BIOGEOCHEMISTRY, V49, P123, DOI 10.1023/A:1006383731753; Clark ML, 2000, 004198 US GEOL SURV; Clary WP, 2000, J RANGE MANAGE, V53, P562, DOI 10.2307/4003148; Cline C, 1973, EFFECTS FOREST FERTI; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; CVRWQCB, 2011, WAT QUAL CONTR PLAN; Dahlgren R. A., 2004, Environmental instrumentation and analysis handbook, P547, DOI 10.1002/0471473332.ch25; Delcurto T, 2005, RANGELAND ECOL MANAG, V58, P119, DOI 10.2111/1551-5028(2005)58&lt;119:MSFSBC&gt;2.0.CO;2; Derlet RW, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/760108; Derlet RW, 2006, WILD ENVIRON MED, V17, P15, DOI 10.1580/PR05-05.1; Doane TA, 2003, ANAL LETT, V36, P2713, DOI 10.1081/AL-120024647; DORAN JW, 1981, J SOIL WATER CONSERV, V36, P166; Eaton A. D., 2005, STANDARD METHODS EXA; Edwards DR, 1997, T ASAE, V40, P103, DOI 10.13031/2013.21254; Field KG, 2007, WATER RES, V41, P3517, DOI 10.1016/j.watres.2007.06.056; GARY HL, 1983, J SOIL WATER CONSERV, V38, P124; Gentner BJ, 2002, J RANGE MANAGE, V55, P2, DOI 10.2307/4003256; George MR, 2011, CONSERVATION BENEFIT, P213; Green MB, 2006, J AM WATER RESOUR AS, V42, P659, DOI 10.1111/j.1752-1688.2006.tb04483.x; Hill BH, 2010, FRESHWATER BIOL, V55, P1005, DOI 10.1111/j.1365-2427.2009.02337.x; Huntsinger L., 2010, PASTORALISM, V1, P9; Jamieson R, 2005, WATER RES, V39, P2665, DOI 10.1016/j.watres.2005.04.040; Jamieson RC, 2003, WATER QUAL RES J CAN, V38, P33, DOI 10.2166/wqrj.2003.004; Kaushal SS, 2005, BIOGEOCHEMISTRY, V74, P303, DOI 10.1007/s10533-004-4723-5; Knox AK, 2007, CALIF AGR, V61, P159, DOI 10.3733/ca.v061n04p159; Krupa M, 2011, AGR ECOSYST ENVIRON, V144, P290, DOI 10.1016/j.agee.2011.09.004; LAU YL, 1993, WATER RES, V27, P355, DOI 10.1016/0043-1354(93)90034-F; LEONARD RL, 1979, ECOL MONOGR, V49, P281, DOI 10.2307/1942486; Lewis DJ, 2009, WATER SCI TECHNOL, V60, P1731, DOI 10.2166/wst.2009.561; Long JS, 1997, REGRESSION MODELS CA; LRWQCB, 2005, WAT QUAL CONTR PLAN; MACDONALD LH, 1991, 910991001 US EPA; Mackenthun K. M., 1973, CLEANER AQUATIC ENV; Miller WW, 2005, WATER AIR SOIL POLL, V163, P3, DOI 10.1007/s11270-005-7473-7; Myers L., 2012, Journal of Environmental Protection, V3, P823; North Coast Regional Water Quality Control Board (NCRWQCB), 2011, WAT QUAL CONTR PLAN; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; Pinheiro J, 2001, MIXED EFFECTS MODELS; Porath ML, 2002, J ANIM SCI, V80, P346; Puckett M, 2002, QUALITY ASSURANCE MA; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Roche LM, 2012, RANGELAND ECOL MANAG, V65, P56, DOI 10.2111/REM-D-11-00092.1; Roche LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035734; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; SCHEPERS JS, 1982, J ENVIRON QUAL, V11, P351, DOI 10.2134/jeq1982.00472425001100030005x; Schnabel WE, 2010, J COLD REG ENG, V24, P54, DOI 10.1061/(ASCE)CR.1943-5495.0000013; SHERER BM, 1992, J ENVIRON QUAL, V21, P591, DOI 10.2134/jeq1992.00472425002100040011x; StataCorp, 2021, STATA STAT SOFTWARE; STEPHENSON GR, 1982, J RANGE MANAGE, V35, P119, DOI 10.2307/3898537; Sulak A., 2002, General Technical Report - Pacific Southwest Research Station, USDA Forest Service, P43; Tate KW, 2007, ENVIRON MONIT ASSESS, V124, P289, DOI 10.1007/s10661-006-9226-5; TAYLOR FR, 1989, GREAT BASIN NAT, V49, P491; TIEDEMANN AR, 1987, J RANGE MANAGE, V40, P322, DOI 10.2307/3898729; USEPA, 1986, QUAL CRIT WAT; USEPA, 1987, SURF WAT MON FRAM CH; USEPA, 2012, RECREATIONAL WATER Q; USFS, 1995, SHAST TRIN NAT FOR L; USFS, 2004, 2004 SIERR NEV FOR P; USFS, 2011, GRAZ STAT SUMM FISC; USFS, 2009, CALVEG 2000 USDA FOR; USFS, 1990, TAH NAT FOR LAND RES; USFS, 2012, NAT VIS US MON RES U, VUSDA Forest Service; USFS, 1988, PLUM NAT FOR LAND RE; USFS, 2010, KLAM NAT FOR LAND RE; USFS, 2010, STAN NAT FOR LAND RE; van Verseveld WJ, 2008, J HYDROL, V358, P268, DOI 10.1016/j.jhydrol.2008.06.009; VANDONSEL DJ, 1971, WATER RES, V5, P1079, DOI 10.1016/0043-1354(71)90040-6; VERDOUW H, 1978, WATER RES, V12, P399, DOI 10.1016/0043-1354(78)90107-0; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; YU ZS, 1994, COMMUN SOIL SCI PLAN, V25, P3161, DOI 10.1080/00103629409369255	84	29	30	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68127	10.1371/journal.pone.0068127	http://dx.doi.org/10.1371/journal.pone.0068127			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826370	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000124
J	Sharma, M; Kumar, L; Jain, A; Verma, V; Sharma, V; Kushwaha, B; Lal, N; Kumar, L; Rawat, T; Dwivedi, AK; Maikhuri, JP; Sharma, VL; Gupta, G				Sharma, Monika; Kumar, Lokesh; Jain, Ashish; Verma, Vikas; Sharma, Vikas; Kushwaha, Bhavana; Lal, Nand; Kumar, Lalit; Rawat, Tara; Dwivedi, Anil K.; Maikhuri, Jagdamba P.; Sharma, Vishnu L.; Gupta, Gopal			Designed Chemical Intervention with Thiols for Prophylactic Contraception	PLOS ONE			English	Article							NON-DETERGENT SPERMICIDES; TRICHOMONAS-VAGINALIS; SPERM MOTILITY; IN-VITRO; ANAEROBIC PROTOZOA; DISULFIDE ESTERS; POTENT; AGENTS; METRONIDAZOLE; NITAZOXANIDE	Unlike somatic cells, sperm have several-fold more available-thiols that are susceptible to redox-active agents. The present study explains the mechanism behind the instant sperm-immobilizing and trichomonacidal activities of pyrrolidinium pyrrolidine-1-carbodithioate (PPC), a novel thiol agent rationally created for prophylactic contraception by minor chemical modifications of some known thiol drugs. PPC, and its three derivatives (with potential active-site blocked by alkylation), were synthesized and evaluated against live human sperm and metronidazole-susceptible and resistant Trichomonas vaginalis, in vitro. Sperm hexokinase activity was evaluated by coupled enzyme assay. PPC irreversibly immobilized 100% human sperm in similar to 30 seconds and totally eliminated Trichomonas vaginalis more efficiently than nonoxynol-9 and metronidazole. It significantly inhibited (P<0.001) thiol-sensitive sperm hexokinase. However, the molecule completely lost all its biological activities once its thiol group was blocked by alkylation. PPC was subsequently formulated into a mucoadhesive vaginal film using GRaS excipients and evaluated for spermicidal and microbicidal activities (in vitro), and contraceptive efficacy in rabbits. PPC remained fully active in quick-dissolving, mucoadhesive vaginal-film formulation, and these PPC-films significantly reduced pregnancy and fertility rates in rabbits. The films released similar to 90% of PPC in simulated vaginal fluid (pH 4.2) at 37 degrees C in 5 minutes, in vitro. We have thus discovered a common target (reactive thiols) on chiefly-anaerobic, redox-sensitive cells like sperm and Trichomonas, which is susceptible to designed chemical interference for prophylactic contraception. The active thiol in PPC inactivates sperm and Trichomonas via interference with crucial sulfhydryl-disulfide based reactions, e. g. hexokinase activation in human sperm. In comparison to non-specific surfactant action of OTC spermicide nonoxynol-9, the action of thiol-active PPC is apparently much more specific, potent and safe. PPC presents a proof-of-concept for prophylactic contraception via manipulation of thiols in vagina for selective targeting of sperm and Trichomonas, and qualifies as a promising lead for the development of dually protective vaginal-contraceptive.	[Sharma, Monika; Kumar, Lokesh; Jain, Ashish; Verma, Vikas; Sharma, Vikas; Kushwaha, Bhavana; Maikhuri, Jagdamba P.; Gupta, Gopal] CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India; [Lal, Nand; Kumar, Lalit; Rawat, Tara; Sharma, Vishnu L.] CSIR Cent Drug Res Inst, Div Med & Proc Chem, Lucknow, Uttar Pradesh, India; [Dwivedi, Anil K.] CSIR Cent Drug Res Inst, Div Pharmaceut, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Gupta, G (corresponding author), CSIR Cent Drug Res Inst, Div Endocrinol, Lucknow, Uttar Pradesh, India.	gupta.gopal@rediffmail.com	Jain, Ashish/GOJ-9782-2022; Kumar, Lokesh/AAB-6852-2019; Kushwaha, Bhavana/T-8371-2019	Jain, Ashish/0000-0003-4053-9265; Kumar, Lokesh/0000-0001-7073-9618; dwivedi, monika/0000-0001-6158-8096	University Grants Commission, New Delhi; Indian Council of Medical Research, New Delhi; Council of Scientific and Industrial Research, New Delhi, India; CSIR Network Project (PROGRAM); Ministry of Health and Family Welfare, Government of India	University Grants Commission, New Delhi(University Grants Commission, India); Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR Network Project (PROGRAM); Ministry of Health and Family Welfare, Government of India	Authors acknowledge the grant of research fellowships by the University Grants Commission, New Delhi (LK, VS, NL), the Indian Council of Medical Research, New Delhi (VV, AJ) and the Council of Scientific and Industrial Research, New Delhi (LK), India. VV is enrolled with the Integral University, Lucknow, India, for PhD. This study was supported by grants from the CSIR Network Project (PROGRAM) and Ministry of Health and Family Welfare, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adagu IS, 2002, J ANTIMICROB CHEMOTH, V49, P103, DOI 10.1093/jac/49.1.103; Bach SP, 2000, GASTROENTEROLOGY, V118, P81, DOI 10.1016/S0016-5085(00)70416-1; Castle PE, 1998, CONTRACEPTION, V58, P51, DOI 10.1016/S0010-7824(98)00059-6; Damme VL, 2002, LANCET, V360, P971; duBouchet L, 1998, SEX TRANSM DIS, V25, P176, DOI 10.1097/00007435-199803000-00012; Dwivedi AK, 2007, BIOORGAN MED CHEM, V15, P6642, DOI 10.1016/j.bmc.2007.08.024; Gupta G, 2005, HUM REPROD, V20, P2301, DOI 10.1093/humrep/dei041; HOMM RE, 1976, CONTRACEPTION, V13, P479, DOI 10.1016/S0010-7824(76)80033-9; Jain A, 2011, ANTIMICROB AGENTS CH, V55, P4343, DOI 10.1128/AAC.00199-11; Jain RK, 2007, HUM REPROD, V22, P708, DOI 10.1093/humrep/del448; Jain RK, 2010, HUM REPROD, V25, P1165, DOI 10.1093/humrep/deq036; Jain RK, 2009, HUM REPROD, V24, P590, DOI 10.1093/humrep/den415; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kumar L, 2011, BIOORG MED CHEM LETT, V21, P176, DOI 10.1016/j.bmcl.2010.11.042; Kumar STVSK, 2006, BIOORGAN MED CHEM, V14, P6593, DOI 10.1016/j.bmc.2006.06.003; MACLEOD J, 1951, J GEN PHYSIOL, V34, P705, DOI 10.1085/jgp.34.5.705; MERCADO E, 1976, BIOL REPROD, V14, P632, DOI 10.1095/biolreprod14.5.632; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Nakamura N, 2008, BIOL REPROD, V79, P537, DOI 10.1095/biolreprod.108.067561; NESBAKKEN R, 1963, BIOCHEM J, V87, P526, DOI 10.1042/bj0870526; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Pal C, 2012, ANTIOXID REDOX SIGN, V17, P555, DOI 10.1089/ars.2011.4436; REISINGER EC, 1990, LANCET, V335, P679, DOI 10.1016/0140-6736(90)90802-C; SELIGMAN J, 1994, J REPROD FERTIL, V101, P435; Sobel J. D., 2001, Clinical Infectious Diseases, V33, P1341, DOI 10.1086/323034; Somers PK, 2000, FREE RADICAL BIO MED, V28, P1532, DOI 10.1016/S0891-5849(00)00257-4; Stephenson J., 2000, JAMA-J AM MED ASSOC, V8, P284; TARRANT ME, 1973, BIOCHEM PHARMACOL, V22, P639, DOI 10.1016/0006-2952(73)90378-X; Tayal SC, 2010, INT J STD AIDS, V21, P217, DOI 10.1258/ijsa.2009.009085; Thorn G.D., 1962, DITHIOCARBAMATES REL; Turner RM, 2003, J ANDROL, V24, P790; Upcroft JA, 2001, ANTIMICROB AGENTS CH, V45, P1810, DOI 10.1128/AAC.45.6.1810-1814.2001; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001; Westrop GD, 2009, J BIOL CHEM, V284, P33485, DOI 10.1074/jbc.M109.054320; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wright JM, 2010, PARASITOL RES, V107, P847, DOI 10.1007/s00436-010-1938-3; Zodpey S P, 2007, Indian J Public Health, V51, P70	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67365	10.1371/journal.pone.0067365	http://dx.doi.org/10.1371/journal.pone.0067365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826278	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000068
J	Shokhirev, MN; Hoffmann, A				Shokhirev, Maxim Nikolaievich; Hoffmann, Alexander			FlowMax: A Computational Tool for Maximum Likelihood Deconvolution of CFSE Time Courses	PLOS ONE			English	Article							LYMPHOCYTE DIVISION; CELL; MODEL; PROLIFERATION; FLUORESCENCE; NF-KAPPA-B1; ACTIVATION; SURVIVAL; GROWTH; TPL2	The immune response is a concerted dynamic multi-cellular process. Upon infection, the dynamics of lymphocyte populations are an aggregate of molecular processes that determine the activation, division, and longevity of individual cells. The timing of these single-cell processes is remarkably widely distributed with some cells undergoing their third division while others undergo their first. High cell-to-cell variability and technical noise pose challenges for interpreting popular dye-dilution experiments objectively. It remains an unresolved challenge to avoid under-or over-interpretation of such data when phenotyping gene-targeted mouse models or patient samples. Here we develop and characterize a computational methodology to parameterize a cell population model in the context of noisy dye-dilution data. To enable objective interpretation of model fits, our method estimates fit sensitivity and redundancy by stochastically sampling the solution landscape, calculating parameter sensitivities, and clustering to determine the maximum-likelihood solution ranges. Our methodology accounts for both technical and biological variability by using a cell fluorescence model as an adaptor during population model fitting, resulting in improved fit accuracy without the need for ad hoc objective functions. We have incorporated our methodology into an integrated phenotyping tool, FlowMax, and used it to analyze B cells from two NFkB knockout mice with distinct phenotypes; we not only confirm previously published findings at a fraction of the expended effort and cost, but reveal a novel phenotype of nfkb1/p105/50 in limiting the proliferative capacity of B cells following B-cell receptor stimulation. In addition to complementing experimental work, FlowMax is suitable for high throughput analysis of dye dilution studies within clinical and pharmacological screens with objective and quantitative conclusions.	[Shokhirev, Maxim Nikolaievich; Hoffmann, Alexander] Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA; [Shokhirev, Maxim Nikolaievich; Hoffmann, Alexander] San Diego Ctr Syst Biol, La Jolla, CA USA; [Shokhirev, Maxim Nikolaievich] Univ Calif San Diego, Grad Program Bioinformat & Syst Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hoffmann, A (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA.	ahoffmann@ucsd.edu			NSF [DGE-1144086]; NIH/NIAID [AI083453]; San Diego Center for Systems Biology (SDCSB); NIGMS [P50 GM085763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); San Diego Center for Systems Biology (SDCSB); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M.N. Shokhirev is funded by an NSF Graduate Research Fellowship (DGE-1144086). The study was supported by NIH/NIAID grant AI083453 and the San Diego Center for Systems Biology (SDCSB) funded by NIGMS grant P50 GM085763. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu GR, 2006, BBA-MOL CELL RES, V1763, P174, DOI 10.1016/j.bbamcr.2005.12.010; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Banerjee A, 2008, BLOOD, V112, P5063, DOI 10.1182/blood-2007-10-120832; Banks HT, 2011, J IMMUNOL METHODS, V373, P143, DOI 10.1016/j.jim.2011.08.014; Callard R, 2007, IMMUNOL REV, V216, P119; De Boer RJ, 2006, B MATH BIOL, V68, P1011, DOI 10.1007/s11538-006-9094-8; Duffy KR, 2012, SCIENCE, V335, P338, DOI 10.1126/science.1213230; Hasenauer J, 2012, B MATH BIOL, V74, P2692, DOI 10.1007/s11538-012-9774-5; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hawkins ED, 2009, P NATL ACAD SCI USA, V106, P13457, DOI 10.1073/pnas.0905629106; Hawkins ED, 2007, NAT PROTOC, V2, P2057, DOI 10.1038/nprot.2007.297; Hulspas R, 2009, CYTOM PART B-CLIN CY, V76B, P355, DOI 10.1002/cyto.b.20485; Hyrien O, 2008, J AM STAT ASSOC, V103, P222, DOI 10.1198/016214507000000194; Hyrien O, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-41; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Luzyanina T, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-26; Metzger P, 2012, P 9 INT WORKSH COMP, P60; Miao HY, 2012, B MATH BIOL, V74, P300, DOI 10.1007/s11538-011-9668-y; Murphy K., 2007, JANEWAYS IMMUNOBIOLO; Pohl T, 2002, P NATL ACAD SCI USA, V99, P4514, DOI 10.1073/pnas.072071599; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Roederer M, 2011, CYTOM PART A, V79A, P95, DOI 10.1002/cyto.a.21010; Savinova OV, 2009, MOL CELL, V34, P591, DOI 10.1016/j.molcel.2009.04.033; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Subramanian VG, 2008, J MATH BIOL, V56, P861, DOI 10.1007/s00285-007-0142-2; WESTON SA, 1990, J IMMUNOL METHODS, V133, P87, DOI 10.1016/0022-1759(90)90322-M; Zilman A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012775	27	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67620	10.1371/journal.pone.0067620	http://dx.doi.org/10.1371/journal.pone.0067620			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826329	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000093
J	Domingo, P; Mateo, MG; Pruvost, A; Torres, F; Salazar, J; Gutierrez, MD; Cabeza, MC; Domingo, JC; Fernandez, I; Villarroya, F; Vidal, F; Baiget, M; de la Calle-Martin, O				Domingo, Pere; Gracia Mateo, Maria; Pruvost, Alain; Torres, Ferran; Salazar, Juliana; del Mar Gutierrez, Maria; Carmen Cabeza, Ma; Carles Domingo, Joan; Fernandez, Irene; Villarroya, Francesc; Vidal, Francesc; Baiget, Montserrat; de la Calle-Martin, Oscar			Polymorphisms of Pyrimidine Pathway Enzymes Encoding Genes and HLA-B*40:01 Carriage in Stavudine-Associated Lipodystrophy in HIV- Infected Patients	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; FAT CHANGES; LAMIVUDINE; TRIPHOSPHATE; POPULATION; ABACAVIR; PROTECT; HAART	Purpose: To assess in a cohort of Caucasian patients exposed to stavudine (d4T) the association of polymorphisms in pyrimidine pathway enzymes and HLA-B*40:01 carriage with HIV/Highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome (HALS). Methods: Three-hundred and thirty-six patients, 187 with HALS and 149 without HALS, and 72 uninfected subjects were recruited. The diagnosis of HALS was performed following the criteria of the Lipodystrophy Severity Grading Scale. Polymorphisms in the thymidylate synthase (TS) and methylene-tetrahydrofolate reductase (MTHFR) genes were determined by direct sequencing, HLA-B genotyping by PCR-SSOr Luminex Technology, and intracellular levels of stavudine triphosphate (d4T-TP) by a LC-MS/MS assay method. Results: HALS was associated with the presence of a low expression TS genotype polymorphism (64.7% vs. 42.9%, OR = 2.43; 95% CI: 1.53-3.88, P<0.0001). MTHFR gene polymorphisms and HLA-B*40: 01 carriage were not associated with HALS or d4T-TP intracellular levels. Low and high expression TS polymorphisms had different d4T-TP intracellular levels (25.60 vs. 13.60 fmol/10(6) cells, P<0.0001). Independent factors associated with HALS were(OR [95% CI]: (a) Combined TS and MTHFR genotypes (p = 0.006, reference category (ref.): 'A+A'; OR for 'A+B' vs. ref.: 1.39 [0.69-2.80]; OR for 'B+A' vs. ref.: 2.16 [1.22-3.83]; OR for 'B+B' vs. ref.: 3.13, 95% CI: 1.54-6.35), (b) maximum viral load >= 5 log10 (OR: 2.55, 95% CI: 1.56-4.14, P = 0.001), (c) use of EFV (1.10 [1.00-1.21], P = 0.008, per year of use). Conclusion: HALS is associated with combined low-expression TS and MTHFR associated with high activity polymorphisms but not with HLA-B* 40: 01 carriage in Caucasian patients with long-term exposure to stavudine.	[Domingo, Pere; Gracia Mateo, Maria; del Mar Gutierrez, Maria; Carmen Cabeza, Ma; Fernandez, Irene] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Infect Dis Unit, E-08193 Barcelona, Spain; [Pruvost, Alain] CEA, IBiTecS, SPI, Lab Etud Metab Medicaments, Gif Sur Yvette, France; [Torres, Ferran] Hosp Clin Barcelona, IDIBAPS, Barcelona, Spain; [Torres, Ferran] Univ Autonoma Barcelona, Sch Med, Biostat Unit, E-08193 Barcelona, Spain; [Salazar, Juliana] CIBERER, U705, Barcelona, Spain; [Carles Domingo, Joan; Villarroya, Francesc] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Vidal, Francesc] Univ Rovira & Virgili, Hosp Univ Joan 23, IISPV, Infect Dis & HIV AIDS Unit,Dept Internal Med, E-43007 Tarragona, Spain; [Baiget, Montserrat] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Genet, E-08193 Barcelona, Spain; [de la Calle-Martin, Oscar] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Immunol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau	Domingo, P (corresponding author), Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Infect Dis Unit, E-08193 Barcelona, Spain.	pdomingo@santpau.cat	Domingo, Pere/CAF-3577-2022; Torres, Ferran/D-1296-2011; Domingo, Pere/AAP-7571-2021; Pedrol, Joan Carles C Domingo/A-4856-2019; de la Calle-Martin, Oscar/Q-3353-2016; Villarroya, Francesc/K-4357-2014	Torres, Ferran/0000-0002-7355-7913; Domingo, Pere/0000-0003-1138-5770; Pedrol, Joan Carles C Domingo/0000-0002-6356-0836; de la Calle-Martin, Oscar/0000-0001-9717-053X; Vidal, Francesc/0000-0002-6692-6186; PRUVOST, ALAIN/0000-0002-7781-7735; Villarroya, Francesc/0000-0003-1266-9142	Fondo de Investigaciones Sanitarias [FIS PI08/00256, PI10/2635, PI11/0376]; Fundacion para la Investigacion y Prevencion del SIDA en Espana [FIPSE 36610, 36572/06]; Ministerio de Sanidad, Politica Social e Igualdad [EC11-293]; Programa de Suport als Grups de Recerca AGAUR [2009 SGR 1061]; Red de Investigacion en SIDA [RIS RD12/0017/0005, RD12/0017/0014]; Programa de Intensificacion de Investigadores, Instituto de Salud Carlos III [INT12/383, INT11/240, INT12/282]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Fundacion para la Investigacion y Prevencion del SIDA en Espana; Ministerio de Sanidad, Politica Social e Igualdad(Spanish Government); Programa de Suport als Grups de Recerca AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Red de Investigacion en SIDA; Programa de Intensificacion de Investigadores, Instituto de Salud Carlos III(Instituto de Salud Carlos III)	This work has been partially funded by Fondo de Investigaciones Sanitarias (FIS PI08/00256, PI10/2635 and PI11/0376), Fundacion para la Investigacion y Prevencion del SIDA en Espana (FIPSE 36610, 36572/06), Ministerio de Sanidad, Politica Social e Igualdad (EC11-293), Programa de Suport als Grups de Recerca AGAUR (2009 SGR 1061), and Red de Investigacion en SIDA (RIS RD12/0017/0005, RD12/0017/0014). Pere Domingo and Francesc Vidal are supported by grants from the Programa de Intensificacion de Investigadores, Instituto de Salud Carlos III (INT12/383, INT11/240 and INT12/282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allele Frequency Net Database, 2005, ALLELE FREQUENCY NET; Asensi V, 2008, GENET MED, V10, P215, DOI 10.1097/GIM.0b013e3181632713; Asensi V, 2006, AIDS RES HUM RETROV, V22, P830, DOI 10.1089/aid.2006.22.830; Benech H, 2004, ANAL BIOCHEM, V330, P172, DOI 10.1016/j.ab.2004.03.015; CDC, 1993, MMWR-MORBID MORTAL W, V41, P1; Chang KH, 2002, J INFECTION, V44, P33, DOI 10.1053/jinf.2001.0924; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cordery DV, 2012, AIDS, V26, P2337, DOI 10.1097/QAD.0b013e32835ab213; Domingo P, 2012, AIDS REV, V14, P112; Domingo P, 2011, ANTIMICROB AGENTS CH, V55, P1428, DOI 10.1128/AAC.01589-10; Domingo P, 2010, CLIN INFECT DIS, V50, P1033, DOI 10.1086/651117; Dorak MT, 2006, GENES IMMUN, V7, P450, DOI 10.1038/sj.gene.6364315; FLEISS JL, 1980, BIOMETRICS, V36, P343, DOI 10.2307/2529990; Fontdevila J, 2005, ANTIVIR THER, V10, pL28; Mateo MG, 2012, EXPERT OPIN DRUG SAF, V11, P473, DOI 10.1517/14740338.2012.676639; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Guggr JP, 2007, ANTIVIR THER, V12, P853; Gutierrez MD, 2011, CURR MED CHEM, V18, P209; Janet D., 2005, ELASHOFF 2005 NQUERY; Kawakami K, 2003, CANCER RES, V63, P6004; Lemieux S, 1996, AM J CLIN NUTR, V64, P685, DOI 10.1093/ajcn/64.5.685; Lichtenstein KA, 2001, AIDS, V15, P1389, DOI 10.1097/00002030-200107270-00008; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Marcuello E, 2006, CANCER CHEMOTH PHARM, V57, P835, DOI 10.1007/s00280-005-0089-1; Marsh S, 2000, Hum Mutat, V16, P528; Marsh S, 1999, GENOMICS, V58, P310, DOI 10.1006/geno.1999.5833; McComsey GA, 2011, CLIN INFECT DIS, V53, P185, DOI 10.1093/cid/cir324; Perez-Molina JA, 2008, J ANTIMICROB CHEMOTH, V62, P234, DOI 10.1093/jac/dkn191; Pruvost A, 2001, RAPID COMMUN MASS SP, V15, P1401, DOI 10.1002/rcm.384; Pruvost A, 2008, J MASS SPECTROM, V43, P224, DOI 10.1002/jms.1294; Rockstroh JK, 2011, CLIN INFECT DIS, V53, P807, DOI 10.1093/cid/cir510; Veloso S, 2011, AIDS RES HUM RETROV, V27, P143, DOI 10.1089/aid.2009.0312; Vidal F, 2010, AIDS REV, V12, P15; Villarroya F, 2005, TRENDS PHARMACOL SCI, V26, P88, DOI 10.1016/j.tips.2004.12.005; Wangsomboonsiri W, 2010, CLIN INFECT DIS, V50, P597, DOI 10.1086/650003	35	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67035	10.1371/journal.pone.0067035	http://dx.doi.org/10.1371/journal.pone.0067035			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840581	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400065
J	Fletcher, JM; Tefft, N				Fletcher, Jason M.; Tefft, Nathan			The Long-Term Effects of Stress on Partner Weight Characteristics	PLOS ONE			English	Article							PREFERENCES; CYCLE	Background: Recent experimental evidence suggests that stressed males find heavier women more attractive than non-stressed males. The aim of this study is to examine whether these results also appear in actual mating patterns of adults from a national sample. Methods: Regression analysis linking partner weight measures to own measures of childhood stress, as measured by mistreatment. Cross-sectional data from the National Longitudinal Study of Adolescent Health, Romantic Partners Sample is used to measure partner weight, childhood stressful events, and socio-demographic characteristics. Childhood experiences of adult mistreatment are retrospectively collected. Results: Men who experienced childhood mistreatment are more likely to have obese female partners during young adulthood. The results are strongest for interactions with social services, adult neglect and physical abuse. We also present novel evidence of the opposite association in similarly stressed women whose male partners are more likely to be thin. Conclusions: These results suggest that preferences for partner characteristics are sensitive to histories of stress and that previously hypothesized patterns occur outside the experimental setting.	[Fletcher, Jason M.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06520 USA; [Tefft, Nathan] Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Seattle, WA 98195 USA	Yale University; University of Washington; University of Washington Seattle	Fletcher, JM (corresponding author), Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06520 USA.	jason.fletcher@yale.edu						Becker GS, 1974, UMI, P299; Braun MF, 2006, J SOC PERS RELAT, V23, P805, DOI 10.1177/0265407506068264; Breiding MJ, 2008, ANN EPIDEMIOL, V18, P538, DOI 10.1016/j.annepidem.2008.02.005; Buckingham ET, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0342-3; Burkhauser RV, 2008, J HEALTH ECON, V27, P519, DOI 10.1016/j.jhealeco.2007.05.005; Courtiol A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013010; Fletcher JM, 2009, SOC SCI MED, V68, P799, DOI 10.1016/j.socscimed.2008.12.005; Gobin RL, 2012, J TRAUMA DISSOCIATIO, V13, P152, DOI 10.1080/15299732.2012.642752; Gowin JL, 2013, PSYCHOPHARMACOLOGY, V227, P661, DOI 10.1007/s00213-013-2992-1; Larson CM, 2013, HORM BEHAV, V63, P128, DOI 10.1016/j.yhbeh.2012.10.005; Maisey DS, 1999, LANCET, V353, P1500, DOI 10.1016/S0140-6736(99)00438-9; Neigh GN, 2009, TRAUMA VIOLENCE ABUS, V10, P389, DOI 10.1177/1524838009339758; Nelson LD, 2005, PSYCHOL SCI, V16, P167, DOI 10.1111/j.0956-7976.2005.00798.x; Pawlowski B, 2005, BIOL PSYCHOL, V70, P38, DOI 10.1016/j.biopsycho.2005.02.002; Pettijohn T. F., 2009, J SOC EVOL CULT PSYC, V3, P216, DOI [DOI 10.1037/H0099321, 10.1037/h0099321]; Swami V, 2008, J SOCIO-ECON, V37, P1363, DOI DOI 10.1016/j.socec.2007.03.006; Swami V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042593; Swami V, 2010, PERS SOC PSYCHOL B, V36, P309, DOI 10.1177/0146167209359702	18	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66353	10.1371/journal.pone.0066353	http://dx.doi.org/10.1371/journal.pone.0066353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DN	23840447	gold, Green Submitted, Green Published			2022-12-27	WOS:000321424400026
J	Wroe, S; Chamoli, U; Parr, WCH; Clausen, P; Ridgely, R; Witmer, L				Wroe, Stephen; Chamoli, Uphar; Parr, William C. H.; Clausen, Philip; Ridgely, Ryan; Witmer, Lawrence			Comparative Biomechanical Modeling of Metatherian and Placental Saber-Tooths: A Different Kind of Bite for an Extreme Pouched Predator	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; GEOMETRIC MORPHOMETRICS; MICROMECHANICAL MODEL; FEEDING-BEHAVIOR; MANDIBLE SHAPE; EVOLUTION; FORCE; CONVERGENCE; MORPHOLOGY; SKULL	Questions surrounding the dramatic morphology of saber-tooths, and the presumably deadly purpose to which it was put, have long excited scholarly and popular attention. Among saber-toothed species, the iconic North American placental, Smilodon fatalis, and the bizarre South American sparassodont, Thylacosmilus atrox, represent extreme forms commonly forwarded as examples of convergent evolution. For S. fatalis, some consensus has been reached on the question of killing behaviour, with most researchers accepting the canine-shear bite hypothesis, wherein both head-depressing and jaw closing musculatures played a role in delivery of the fatal bite. However, whether, or to what degree, T. atrox may have applied a similar approach remains an open question. Here we apply a three-dimensional computational approach to examine convergence in mechanical performance between the two species. We find that, in many respects, the placental S. fatalis (a true felid) was more similar to the metatherian T. atrox than to a conical-toothed cat. In modeling of both saber-tooths we found that jaw-adductor-driven bite forces were low, but that simulations invoking neck musculature revealed less cranio-mandibular stress than in a conical-toothed cat. However, our study also revealed differences between the two saber-tooths likely reflected in the modus operandi of the kill. Jaw-adductor-driven bite forces were extremely weak in T. atrox, and its skull was even better-adapted to resist stress induced by head-depressors. Considered together with the fact that the center of the arc described by the canines was closer to the jaw-joint in Smilodon, our results are consistent with both jaw-closing and neck musculature playing a role in prey dispatch for the placental, as has been previously suggested. However, for T. atrox, we conclude that the jaw-adductors probably played no major part in the killing bite. We propose that the metatherian presents a more complete commitment to the already extreme saber-tooth 'lifestyle'.	[Wroe, Stephen; Clausen, Philip] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Wroe, Stephen; Chamoli, Uphar; Parr, William C. H.] Univ Newcastle, Sch Engn, Callaghan, NSW 2308, Australia; [Chamoli, Uphar] Univ New S Wales, St George Clin Sch, Sydney, NSW, Australia; [Ridgely, Ryan; Witmer, Lawrence] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University of New South Wales Sydney; University of Newcastle; University of New South Wales Sydney; University System of Ohio; Ohio University	Wroe, S (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	s.wroe@unsw.edu.au	Wroe, Stephen/A-4462-2010; Chamoli, Uphar/AAF-7290-2020; Clausen, Philip/G-7337-2013	Wroe, Stephen/0000-0002-5813-9182; Clausen, Philip/0000-0003-1186-6419; Wroe, Stephen/0000-0002-6365-5915; Chamoli, Uphar/0000-0002-8396-5814; Witmer, Lawrence/0000-0002-7610-0118	Australian Research Council [DP0666374, DP0987985]; United States National Science Foundation [IOB-0517257, IOS-1050154]; Ohio University Heritage College of Osteopathic Medicine; Ohio Supercomputer Center; Division Of Integrative Organismal Systems [1050154] Funding Source: National Science Foundation	Australian Research Council(Australian Research Council); United States National Science Foundation(National Science Foundation (NSF)); Ohio University Heritage College of Osteopathic Medicine; Ohio Supercomputer Center; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	SW acknowledges support from the Australian Research Council (DP0666374 and DP0987985). LW and RR acknowledge support from the United States National Science Foundation (IOB-0517257, IOS-1050154), Ohio University Heritage College of Osteopathic Medicine, and the Ohio Supercomputer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEN W A, 1985, Contributions in Science (Los Angeles), P1; Anton M, 2004, ZOOL J LINN SOC-LOND, V140, P207, DOI 10.1111/j.1096-3642.2003.00093.x; Argot C, 2004, ALCHERINGA, V28, P229, DOI 10.1080/03115510408619283; Argot C, 2004, ZOOL J LINN SOC-LOND, V140, P487, DOI 10.1111/j.1096-3642.2004.00110.x; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bourke J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002200; Bryant Harold N., 1996, P283; Chamoli U, 2011, J THEOR BIOL, V283, P217, DOI 10.1016/j.jtbi.2011.05.020; Christiansen P, 2005, J MORPHOL, V266, P369, DOI 10.1002/jmor.10384; Christiansen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002807; Christiansen P, 2007, ZOOL J LINN SOC-LOND, V151, P423, DOI 10.1111/j.1096-3642.2007.00321.x; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; Christiansen P, 2011, ZOOL J LINN SOC-LOND, V162, P220, DOI 10.1111/j.1096-3642.2010.00675.x; Churcher C.S., 1985, Australian Mammalogy, V8, P201; Ercoli MD, 2012, ZOOL J LINN SOC-LOND, V165, P224, DOI 10.1111/j.1096-3642.2011.00793.x; Ercoli MD, 2011, AMEGHINIANA, V48, P462, DOI 10.5710/AMGH.v48i4(347); Degrange FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011856; EMERSON SB, 1980, PALEOBIOLOGY, V6, P295, DOI 10.1017/S0094837300006813; Eng CM, 2009, J EXP BIOL, V212, P4040, DOI 10.1242/jeb.029983; Evans SP, 2012, J BIOMECH, V45, P2702, DOI 10.1016/j.jbiomech.2012.08.003; Forasiepi AM, 2010, ZOOTAXA, P55; Frisbie DD, 2008, VET COMP ORTHOPAED, V19, P142; Fry BG, 2009, P NATL ACAD SCI USA, V106, P8969, DOI 10.1073/pnas.0810883106; Goin F.J., 1989, Anales de la Academia Nacional de Ciencias Exactas Fisicas y Naturales de Buenos Aires, V39, P219; Goin F. J., 1997, HIST NEOTROPICAL FAU, P185; Goswami A, 2011, P ROY SOC B-BIOL SCI, V278, P1831, DOI 10.1098/rspb.2010.2031; Hartstone-Rose A, 2012, ANAT REC, V295, P1336, DOI 10.1002/ar.22518; Huber DR, 2005, J EXP BIOL, V208, P3553, DOI 10.1242/jeb.01816; KURTEN B, 1954, COMMENT BIOL SOC SCI, V13, P1; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Marshall L.G., 1976, PALEOBIOS, V23, P1; MARTIN L D, 1980, Transactions of the Nebraska Academy of Sciences, V8, P141; Martin LD, 2000, NATURWISSENSCHAFTEN, V87, P41, DOI 10.1007/s001140050007; Matthew WD, 1910, B AM MUS NAT HIST, V28, P289; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Meachen-Samuels JA, 2012, PALEOBIOLOGY, V38, P1, DOI 10.1666/10036.1; Moazen M, 2009, P NATL ACAD SCI USA, V106, P8273, DOI 10.1073/pnas.0813156106; O'Higgins P, 2011, J ANAT, V218, P3, DOI 10.1111/j.1469-7580.2010.01301.x; Oldfield CC, 2012, J ZOOL, V286, P163, DOI 10.1111/j.1469-7998.2011.00862.x; Parr WCH, 2013, J BIOMECH, V46, P200, DOI 10.1016/j.jbiomech.2012.11.011; Parr WCH, 2012, J THEOR BIOL, V301, P1, DOI 10.1016/j.jtbi.2012.01.030; Prevosti FJ, 2012, ZOOL J LINN SOC-LOND, V164, P836, DOI 10.1111/j.1096-3642.2011.00785.x; Rayfield EJ, 2005, ANAT REC PART A, V283A, P349, DOI 10.1002/ar.a.20168; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Slater GJ, 2009, J EVOLUTION BIOL, V22, P2278, DOI 10.1111/j.1420-9101.2009.01845.x; Slater GJ, 2008, PALEOBIOLOGY, V34, P403, DOI 10.1666/07061.1; Slater GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013870; Strait DS, 2010, ANAT REC, V293, P583, DOI 10.1002/ar.21122; Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Therrien F, 2005, ZOOL J LINN SOC-LOND, V145, P393, DOI 10.1111/j.1096-3642.2005.00194.x; THOMASON JJ, 1986, J MORPHOL, V189, P199, DOI 10.1002/jmor.1051890210; THOMASON JJ, 1991, CAN J ZOOL, V69, P2326, DOI 10.1139/z91-327; Tsafnat N, 2011, J ANAT, V218, P40, DOI 10.1111/j.1469-7580.2010.01289.x; Tseng ZJ, 2010, J MORPHOL, V271, P1386, DOI 10.1002/jmor.10881; Turnbull W. D., 1970, Fieldiana (Geol.), V18, P147; TURNBULL WD, 1976, ESSAYS PALAEONTOLOGY, P169; Van Valkenburgh Blaire, 2002, Paleontological Society Papers, V8, P267; Warren JC, 1853, P BOSTON SOC NAT HIS, VIV, P256; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2008, J ZOOL, V276, P336, DOI 10.1111/j.1469-7998.2008.00494.x; Wroe S, 1999, AUST J ZOOL, V47, P489, DOI 10.1071/ZO99006; Wroe S, 2008, ZOOLOGY, V111, P196, DOI 10.1016/j.zool.2007.07.008; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Wroe S, 2007, EVOLUTION, V61, P1251, DOI 10.1111/j.1558-5646.2007.00101.x; Wroe Stephen, 2010, P466; Wroe S, 2010, P ROY SOC B-BIOL SCI, V277, P3579, DOI 10.1098/rspb.2010.0509	69	31	31	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66888	10.1371/journal.pone.0066888	http://dx.doi.org/10.1371/journal.pone.0066888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840547	Green Published, gold			2022-12-27	WOS:000321424400049
J	Baum, E; Randall, AZ; Zeller, M; Barbour, AG				Baum, Elisabeth; Randall, Arlo Z.; Zeller, Michael; Barbour, Alan G.			Inferring Epitopes of a Polymorphic Antigen Amidst Broadly Cross-Reactive Antibodies Using Protein Microarrays: A Study of OspC Proteins of Borrelia burgdorferi	PLOS ONE			English	Article							OUTER SURFACE PROTEIN; LINKED-IMMUNOSORBENT-ASSAY; LYME-DISEASE SPIROCHETE; SENSU-STRICTO; HEMATOGENOUS DISSEMINATION; ACTIVE IMMUNIZATION; CRYSTAL-STRUCTURE; IMMUNE-RESPONSE; C OSPC; INFECTION	Epitope mapping studies aim to identify the binding sites of antibody-antigen interactions to enhance the development of vaccines, diagnostics and immunotherapeutic compounds. However, mapping is a laborious process employing time-and resource-consuming 'wet bench' techniques or epitope prediction software that are still in their infancy. For polymorphic antigens, another challenge is characterizing cross-reactivity between epitopes, teasing out distinctions between broadly cross-reactive responses, limited cross-reactions among variants and the truly type-specific responses. A refined understanding of cross-reactive antibody binding could guide the selection of the most informative subsets of variants for diagnostics and multivalent subunit vaccines. We explored the antibody binding reactivity of sera from human patients and Peromyscus leucopus rodents infected with Borrelia burgdorferi to the polymorphic outer surface protein C (OspC), an attractive candidate antigen for vaccine and improved diagnostics for Lyme disease. We constructed a protein microarray displaying 23 natural variants of OspC and quantified the degree of cross-reactive antibody binding between all pairs of variants, using Pearson correlation calculated on the reactivity values using three independent transforms of the raw data: (1) logarithmic, (2) rank, and (3) binary indicators. We observed that the global amino acid sequence identity between OspC pairs was a poor predictor of cross-reactive antibody binding. Then we asked if specific regions of the protein would better explain the observed cross-reactive binding and performed in silico screening of the linear sequence and 3-dimensional structure of OspC. This analysis pointed to residues 179 through 188 the fifth C-terminal helix of the structure as a major determinant of type-specific cross-reactive antibody binding. We developed bioinformatics methods to systematically analyze the relationship between local sequence/structure variation and cross-reactive antibody binding patterns among variants of a polymorphic antigen, and this method can be applied to other polymorphic antigens for which immune response data is available for multiple variants.	[Baum, Elisabeth; Barbour, Alan G.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA; [Baum, Elisabeth; Barbour, Alan G.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Randall, Arlo Z.; Zeller, Michael] Univ Calif Irvine, Sch Informat & Comp Sci, Inst Genom & Bioinformat, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Baum, E (corresponding author), Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA.	ebaum@uci.edu		Baum-Jones, Elisabeth/0000-0001-6348-3378	National Institutes of Health [AI078734, K99 LM010821, AI100236, AI065359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI078734, R21AI100236, U54AI065359] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K99LM010821] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funding provided by National Institutes of Health grants AI078734 (EB), K99 LM010821 (AR), and AI100236 and AI065359 (AGB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bacon RM, 2003, J INFECT DIS, V187, P1187, DOI 10.1086/374395; Barbour AG, 2008, INFECT IMMUN, V76, P3374, DOI 10.1128/IAI.00048-08; Barbour AG, 2010, MBIO, V1, DOI 10.1128/mBio.00153-10; Baum E, 2012, MBIO, V3, DOI 10.1128/mBio.00434-12; Blomqvist K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052679; Bockenstedt LK, 1997, INFECT IMMUN, V65, P4661, DOI 10.1128/IAI.65.11.4661-4667.1997; Brown EL, 2005, VACCINE, V23, P3687, DOI 10.1016/j.vaccine.2005.02.006; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Chen Ping, 2011, Virologica Sinica, V26, P1, DOI 10.1007/s12250-011-3159-4; Davies DH, 2008, J VIROL, V82, P652, DOI 10.1128/JVI.01706-07; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; DRESSLER F, 1993, J INFECT DIS, V167, P392, DOI 10.1093/infdis/167.2.392; Drew DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051023; Du WD, 2007, DIAGN MICR INFEC DIS, V59, P355, DOI 10.1016/j.diagmicrobio.2007.06.006; Dykhuizen DE, 2008, AM J TROP MED HYG, V78, P806, DOI 10.4269/ajtmh.2008.78.806; Earnhart CG, 2005, INFECT IMMUN, V73, P7869, DOI 10.1128/IAI.73.12.7869-7877.2005; Earnhart CG, 2007, VACCINE, V25, P466, DOI 10.1016/j.vaccine.2006.07.052; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eicken C, 2001, J BIOL CHEM, V276, P10010, DOI 10.1074/jbc.M010062200; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gilmore RD, 1996, INFECT IMMUN, V64, P2234, DOI 10.1128/IAI.64.6.2234-2239.1996; Girard YA, 2009, APPL ENVIRON MICROB, V75, P7243, DOI 10.1128/AEM.01704-09; Ivanova L, 2009, CLIN IMMUNOL, V132, P393, DOI 10.1016/j.clim.2009.05.017; Jobe DA, 2003, CLIN DIAGN LAB IMMUN, V10, P573, DOI 10.1128/CDLI.10.4.573-578.2003; Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071; Kraiczy P, 2000, J MED MICROBIOL, V49, P917, DOI 10.1099/0022-1317-49-10-917; Kringelum JV, 2013, MOL IMMUNOL, V53, P24, DOI 10.1016/j.molimm.2012.06.001; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; Lovrich SD, 2005, CLIN DIAGN LAB IMMUN, V12, P746, DOI 10.1128/CDLI.12.6.746-751.2005; Mathiesen MJ, 1998, J CLIN MICROBIOL, V36, P3474, DOI 10.1128/JCM.36.12.3474-3479.1998; Mathiesen MJ, 1998, INFECT IMMUN, V66, P4073; Mbow ML, 1999, INFECT IMMUN, V67, P5470, DOI 10.1128/IAI.67.10.5470-5472.1999; Montgomery RR, 1996, J EXP MED, V183, P261, DOI 10.1084/jem.183.1.261; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Porwancher RB, 2011, CLIN VACCINE IMMUNOL, V18, P851, DOI 10.1128/CVI.00409-10; PREACMURSIC V, 1992, INFECTION, V20, P342, DOI 10.1007/BF01710681; Probert WS, 1997, J INFECT DIS, V175, P400, DOI 10.1093/infdis/175.2.400; PROBERT WS, 1994, INFECT IMMUN, V62, P1920, DOI 10.1128/IAI.62.5.1920-1926.1994; Rousselle JC, 1998, J INFECT DIS, V178, P733, DOI 10.1086/515382; Seinost G, 1999, ARCH DERMATOL, V135, P1329, DOI 10.1001/archderm.135.11.1329; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Travinsky B, 2010, EMERG INFECT DIS, V16, P1147, DOI 10.3201/eid1607.091452; Wang G, 2001, INFECT IMMUN, V69, P4303, DOI 10.1128/IAI.69.7.4303-4312.2001; Wang GQ, 2002, J INFECT DIS, V186, P782, DOI 10.1086/343043; WILSKE B, 1993, INFECT IMMUN, V61, P2182, DOI 10.1128/IAI.61.5.2182-2191.1993; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922; Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602; Zhong WM, 1997, P NATL ACAD SCI USA, V94, P12533, DOI 10.1073/pnas.94.23.12533	52	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67445	10.1371/journal.pone.0067445	http://dx.doi.org/10.1371/journal.pone.0067445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826301	Green Published, gold			2022-12-27	WOS:000321738400148
J	Koba, C; Haruta, M; Matsunaga, Y; Matsumura, K; Haga, E; Sasaki, Y; Ikeda, T; Takamatsu, K; Nishimura, Y; Senju, S				Koba, Chihiro; Haruta, Miwa; Matsunaga, Yusuke; Matsumura, Keiko; Haga, Eriko; Sasaki, Yuko; Ikeda, Tokunori; Takamatsu, Koutaro; Nishimura, Yasuharu; Senju, Satoru			Therapeutic Effect of Human iPS-Cell-Derived Myeloid Cells Expressing IFN-beta against Peritoneally Disseminated Cancer in Xenograft Models	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MACROPHAGE ACTIVATION; GAMMA-INTERFERON; DENDRITIC CELLS; GASTRIC-CANCER; IN-VITRO; DIRECTED DIFFERENTIATION; INDUCTION; GENERATION; MONOCYTES	We recently developed a method to generate myeloid cells with proliferation capacity from human iPS cells. iPS-ML (iPS-cell-derived myeloid/macrophage line), generated by introducing proliferation and anti-senescence factors into iPS-cell-derived myeloid cells, grew continuously in an M-CSF-dependent manner. A large number of cells exhibiting macrophage-like properties can be readily obtained by using this technology. In the current study, we evaluated the possible application of iPS-ML in anti-cancer therapy. We established a model of peritoneally disseminated gastric cancer by intraperitoneally injecting NUGC-4 human gastric cancer cells into SCID mice. When iPS-ML were injected intraperitoneally into the mice with pre-established peritoneal NUGC-4 tumors, iPS-ML massively accumulated and infiltrated into the tumor tissues. iPS-ML expressing IFN-beta (iPS-ML/IFN-beta) significantly inhibited the intra-peritoneal growth of NUGC-4 cancer. Furthermore, iPS-ML/IFN-beta also inhibited the growth of human pancreatic cancer MIAPaCa-2 in a similar model. iPS-ML are therefore a promising treatment agent for peritoneally disseminated cancers, for which no standard treatment is currently available.	[Koba, Chihiro; Haruta, Miwa; Matsunaga, Yusuke; Matsumura, Keiko; Haga, Eriko; Sasaki, Yuko; Ikeda, Tokunori; Takamatsu, Koutaro; Nishimura, Yasuharu; Senju, Satoru] Kumamoto Univ, Grad Sch Biomed Sci, Dept Immunogenet, Kumamoto, Japan; [Koba, Chihiro; Haruta, Miwa; Matsunaga, Yusuke; Matsumura, Keiko; Haga, Eriko; Sasaki, Yuko; Ikeda, Tokunori; Takamatsu, Koutaro; Senju, Satoru] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Kumamoto University; Japan Science & Technology Agency (JST)	Senju, S (corresponding author), Kumamoto Univ, Grad Sch Biomed Sci, Dept Immunogenet, Kumamoto, Japan.	senjusat@gpo.kumamoto-u.ac.jp	Ikeda, Tokunori/S-6043-2019		MEXT, Japan [23650609, 24300334, 23659158]; Princess Takamatsu Cancer Research Fund; Ministry of Health and Welfare, Japan; Japan Science and Technology Agency (JST)	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Princess Takamatsu Cancer Research Fund; Ministry of Health and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was supported in part by Grants-in-Aid Nos. 23650609 and 24300334 to Y.N. and 23659158 to S.S. from the MEXT, Japan; a grant to Y.N. from Princess Takamatsu Cancer Research Fund; Research Grant to S.S. for Intractable Diseases from Ministry of Health and Welfare, Japan; and a grant to S.S. from the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam Z, 1994, Vnitr Lek, V40, P329; ANDREESEN R, 1990, CANCER RES, V50, P7450; Andreesen R, 1998, J LEUKOCYTE BIOL, V64, P419, DOI 10.1002/jlb.64.4.419; BACIK I, 1994, J IMMUNOL, V152, P381; Baron-Bodo W, 2005, IMMUNOBIOLOGY, V210, P267, DOI 10.1016/j.imbio.2005.05.021; Bonnotte B, 2001, J IMMUNOL, V167, P5077, DOI 10.4049/jimmunol.167.9.5077; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Choi KD, 2009, J CLIN INVEST, V119, P2818, DOI 10.1172/JCI38591; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Haruta M, 2012, GENE THER; Hermans IF, 2000, J IMMUNOL, V164, P3095, DOI 10.4049/jimmunol.164.6.3095; Karlsson KR, 2008, EXP HEMATOL, V36, P1167, DOI 10.1016/j.exphem.2008.04.009; Kaufman DS, 2009, BLOOD, V114, P3513, DOI 10.1182/blood-2009-03-191304; Kim DY, 2006, ACTA CHIR BELG, V106, P665; Klimchenko O, 2011, BLOOD, V117, P3065, DOI 10.1182/blood-2010-07-295246; Klimp AH, 2002, CRIT REV ONCOL HEMAT, V44, P143, DOI 10.1016/S1040-8428(01)00203-7; Kuniyasu H, 1997, CELL GROWTH DIFFER, V8, P47; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Li DH, 2010, CLIN CANCER RES, V16, P4313, DOI 10.1158/1078-0432.CCR-09-1942; Lindmark H, 2004, EXP CELL RES, V300, P335, DOI 10.1016/j.yexcr.2004.06.025; Loyer V, 1999, J IMMUNOL, V163, P6462; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Matsunaga Y, 2008, J IMMUNOL, V181, P6635, DOI 10.4049/jimmunol.181.9.6635; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Monnet I, 2002, CHEST, V121, P1921, DOI 10.1378/chest.121.6.1921; Moore KJ, 1998, ARTERIOSCL THROM VAS, V18, P1647, DOI 10.1161/01.ATV.18.10.1647; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Odegaard JI, 2007, J LEUKOCYTE BIOL, V81, P711, DOI 10.1189/jlb.0906590; PACE JL, 1985, J IMMUNOL, V134, P977; PACE JL, 1983, J IMMUNOL, V130, P2011; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Roukos DH, 2000, CANCER TREAT REV, V26, P243, DOI 10.1053/ctrv.2000.0164; Senju S, 2011, GENE THER, V18, P874, DOI 10.1038/gt.2011.22; Senju S, 2009, STEM CELLS, V27, P1021, DOI 10.1002/stem.33; Sharkis SJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003920; Shime H, 2012, P NATL ACAD SCI USA, V109, P2066, DOI 10.1073/pnas.1113099109; Shyu RY, 2000, J SURG ONCOL, V75, P122, DOI 10.1002/1096-9098(200010)75:2<122::AID-JSO9>3.0.CO;2-4; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yonemura Y, 2007, CANCER SCI, V98, P11, DOI 10.1111/j.1349-7006.2006.00350.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	43	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67567	10.1371/journal.pone.0067567	http://dx.doi.org/10.1371/journal.pone.0067567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826321	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400159
J	Gerber, PA; Hevezi, P; Buhren, BA; Martinez, C; Schrumpf, H; Gasis, M; Grether-Beck, S; Krutmann, J; Homey, B; Zlotnik, A				Gerber, Peter Arne; Hevezi, Peter; Buhren, Bettina Alexandra; Martinez, Cynthia; Schrumpf, Holger; Gasis, Marcia; Grether-Beck, Susanne; Krutmann, Jean; Homey, Bernhard; Zlotnik, Albert			Systematic Identification and Characterization of Novel Human Skin-Associated Genes Encoding Membrane and Secreted Proteins	PLOS ONE			English	Article							EPIDERMAL DIFFERENTIATION COMPLEX; WHEY ACIDIC PROTEIN; BREAST-CANCER; BARRIER FUNCTION; KERATINOCYTE DIFFERENTIATION; ANTIMICROBIAL ACTIVITY; EXPRESSION ANALYSIS; CELL-PROLIFERATION; COUPLED RECEPTORS; ATOPIC-DERMATITIS	Through bioinformatics analyses of a human gene expression database representing 105 different tissues and cell types, we identified 687 skin-associated genes that are selectively and highly expressed in human skin. Over 50 of these represent uncharacterized genes not previously associated with skin and include a subset that encode novel secreted and plasma membrane proteins. The high levels of skin-associated expression for eight of these novel therapeutic target genes were confirmed by semi-quantitative real time PCR, western blot and immunohistochemical analyses of normal skin and skin-derived cell lines. Four of these are expressed specifically by epidermal keratinocytes; two that encode G-protein-coupled receptors (GPR87 and GPR115), and two that encode secreted proteins (WFDC5 and SERPINB7). Further analyses using cytokine-activated and terminally differentiated human primary keratinocytes or a panel of common inflammatory, autoimmune or malignant skin diseases revealed distinct patterns of regulation as well as disease associations that point to important roles in cutaneous homeostasis and disease. Some of these novel uncharacterized skin genes may represent potential biomarkers or drug targets for the development of future diagnostics or therapeutics.	[Hevezi, Peter; Zlotnik, Albert] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Gerber, Peter Arne; Buhren, Bettina Alexandra; Martinez, Cynthia; Schrumpf, Holger; Gasis, Marcia; Homey, Bernhard] Univ Dusseldorf, Dept Dermatol, Dusseldorf, Germany; [Grether-Beck, Susanne; Krutmann, Jean] Leibniz Res Inst Environm Med, Inst Umweltmed Forsch, Dusseldorf, Germany	University of California System; University of California Irvine; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF)	Zlotnik, A (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA.	azlotnik@uci.edu	Gerber, Peter Arne/M-2746-2013	Gerber, Peter Arne/0000-0003-1657-1863	National Institutes of Health-National Institute of Allergy and Infectious Diseases [R21AI906278, R01-AI093548]; MAARS from European Union [EU-HEALTH.2010.2.4.5-2]; German Research Foundation [Ho 2092/5-2]; University of Duesseldorf; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093548] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MAARS from European Union; German Research Foundation(German Research Foundation (DFG)); University of Duesseldorf; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The University of California Irvine group was supported by R21AI906278 and R01-AI093548 (to A.Z.) grants from the National Institutes of Health-National Institute of Allergy and Infectious Diseases. The Duesseldorf group was supported by a MAARS EU-HEALTH.2010.2.4.5-2 from the European Union, and Ho 2092/5-2 from the German Research Foundation (to BH) and a Strategic Research Grant of the University of Duesseldorf (Strategischer Forschungsfond - SFF, "Novel skin genes - roles in homeostasis and disease") to PAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bikle DD, 2003, J CELL BIOCHEM, V88, P290, DOI 10.1002/jcb.10339; Bikle DD, 1996, J CLIN INVEST, V97, P1085, DOI 10.1172/JCI118501; Bingle CD, 2008, TRENDS IMMUNOL, V29, P444, DOI 10.1016/j.it.2008.07.001; Blumenberg M, 2006, OMICS, V10, P243, DOI 10.1089/omi.2006.10.243; Burkhardt AM, 2012, J IMMUNOL, V188, P6399, DOI 10.4049/jimmunol.1102903; Carter D, 2002, BIOCHEMISTRY-US, V41, P6714, DOI 10.1021/bi0159884; Chassain C, 2001, J NEUROSCI METH, V111, P9, DOI 10.1016/S0165-0270(01)00425-3; Chou RH, 2012, ONCOL REP, V27, P238, DOI 10.3892/or.2011.1497; Clauss A, 2002, BIOCHEM J, V368, P233, DOI 10.1042/BJ20020869; Colpitts TL, 2002, TUMOR BIOL, V23, P263, DOI 10.1159/000068566; Culleton J, 2007, INT J CANCER, V120, P1087, DOI 10.1002/ijc.22471; Curto EV, 2002, BIOCHEM BIOPH RES CO, V291, P1052, DOI 10.1006/bbrc.2002.6542; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Flamant L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-391; Franke WW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003061; Frederick MJ, 2000, AM J PATHOL, V156, P1937, DOI 10.1016/S0002-9440(10)65067-5; Fredriksson R, 2002, FEBS LETT, V531, P407, DOI 10.1016/S0014-5793(02)03574-3; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Gregori C, 1998, J BIOL CHEM, V273, P25237, DOI 10.1074/jbc.273.39.25237; Grether-Beck S, 2008, EXP DERMATOL, V17, P771, DOI 10.1111/j.1600-0625.2007.00693.x; Grether-Beck S, 2012, J INVEST DERMATOL, V132, P1561, DOI 10.1038/jid.2012.42; Gugger M, 2008, DIS MARKERS, V24, P41, DOI 10.1155/2008/857474; Haider AS, 2008, J INVEST DERMATOL, V128, P606, DOI 10.1038/sj.jid.5701067; Harder J, 2005, J LEUKOCYTE BIOL, V77, P476, DOI 10.1189/jlb.0704409; Henderson RH, 2010, MOL VIS, V16, P46; Hoffjan S, 2007, BRIT J DERMATOL, V157, P441, DOI 10.1111/j.1365-2133.2007.07999.x; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; Homey B, 2002, NAT MED, V8, P157, DOI 10.1038/nm0202-157; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; Justesen J, 2000, CELL MOL LIFE SCI, V57, P1593, DOI 10.1007/PL00000644; Kakinuma T, 2003, J ALLERGY CLIN IMMUN, V111, P592, DOI 10.1067/mai.2003.114; Kemmer D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001440; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Kim SJ, 2006, ANN CLIN LAB SCI, V36, P115; Lee J, 2005, FASEB J, V19, P1356, DOI 10.1096/fj.04-3552fje; Lee S, 2012, CANCER RES, V72, P4574, DOI 10.1158/0008-5472.CAN-12-0636; Li GL, 2011, BIOMARK MED, V5, P249, DOI [10.2217/BMM.11.20, 10.2217/bmm.11.20]; Liu ZZ, 2010, CLIN EXP METASTAS, V27, P251, DOI 10.1007/s10585-010-9323-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maerki C, 2009, J IMMUNOL, V182, P507, DOI 10.4049/jimmunol.182.1.507; Meuter S, 2008, CYTOKINE, V44, P248, DOI 10.1016/j.cyto.2008.08.009; Miksicek RJ, 2002, CANCER RES, V62, P2736; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Miyata T, 2002, J CLIN INVEST, V109, P585, DOI 10.1172/JCI200214336; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; Rahman P, 2006, ARTHRITIS RHEUM-US, V54, P2321, DOI 10.1002/art.21928; RAUBENHEIMER EJ, 1987, CRC CR REV CL LAB SC, V25, P161, DOI 10.3109/10408368709105881; Ray R, 2005, J BIOL CHEM, V280, P9761, DOI 10.1074/jbc.C400581200; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Remington SG, 2008, INVEST OPHTH VIS SCI, V49, P2856, DOI 10.1167/iovs.07-1496; Rinn JL, 2008, J INVEST DERMATOL, V128, P776, DOI 10.1038/sj.jid.5700986; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Samudre SS, 2010, INVEST OPHTH VIS SCI, V52, P6265; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Scott A, 2011, BIOCHEM SOC T, V39, P1437, DOI 10.1042/BST0391437; Shiiba M, 2010, ONCOL REP, V24, P241, DOI 10.3892/or_00000852; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Sjodin A, 2003, J INVEST DERMATOL, V121, P428, DOI 10.1046/j.1523-1747.2003.12374.x; Sjodin A, 2008, ANTICANCER RES, V28, P1493; Skliris GP, 2008, HISTOPATHOLOGY, V52, P355, DOI 10.1111/j.1365-2559.2007.02955.x; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Spiekstra SW, 2005, EXP DERMATOL, V14, P109, DOI 10.1111/j.0906-6705.2005.00226.x; Stewart GD, 2008, CURR OPIN CLIN NUTR, V11, P208, DOI 10.1097/MCO.0b013e3282fb7b8d; Stoeckelhuber M, 2006, HISTOCHEM CELL BIOL, V126, P103, DOI 10.1007/s00418-005-0137-2; Toulza E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r107; VOLZ A, 1993, GENOMICS, V18, P92, DOI 10.1006/geno.1993.1430; Wang JC, 2004, P NATL ACAD SCI USA, V101, P15603, DOI 10.1073/pnas.0407008101; Watson MA, 1996, CANCER RES, V56, P860; Weigelt B, 2003, J CANCER RES CLIN, V129, P735, DOI 10.1007/s00432-003-0514-y; Wittenberger T, 2001, J MOL BIOL, V307, P799, DOI 10.1006/jmbi.2001.4520; Wong DJ, 2005, J INVEST DERMATOL, V125, P175, DOI 10.1111/j.0022-202X.2005.23827.x; Wu ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005227; Yoon JM, 2010, INT J MOL MED, V26, P415, DOI 10.3892/ijmm_00000481; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40; Zhang X, 2009, MOL REPROD DEV, V76, P160, DOI 10.1002/mrd.20938; Zhang YH, 2009, CANCER RES, V69, P6049, DOI 10.1158/0008-5472.CAN-09-0621	82	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e63949	10.1371/journal.pone.0063949	http://dx.doi.org/10.1371/journal.pone.0063949			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840300	gold, Green Published			2022-12-27	WOS:000322342800003
J	Liu, SY; Liu, TC; Teng, YL; Lee, LA; Lai, TJ; Wu, CM				Liu, Shu-Yu; Liu, Tien-Chen; Teng, Ya-Ling; Lee, Li-Ang; Lai, Te-Jen; Wu, Che-Ming			Environmental Sounds Recognition in Children with Cochlear Implants	PLOS ONE			English	Article							PRELINGUALLY DEAF-CHILDREN; SPEECH-INTELLIGIBILITY; AUDITORY PERFORMANCE; PERCEPTION	The aims of this study were (1) to document the recognition performance of environmental sounds (ESs) in Mandarin-speaking children with cochlear implants (CIs) and to analyze the possible associated factors with the ESs recognition; (2) to examine the relationship between perception of ESs and receptive vocabulary level; and (3) to explore the acoustic factors relevant to perceptual outcomes of daily ESs in pediatric CI users. Forty-seven prelingually deafened children between ages 4 to 10 years participated in this study. They were divided into pre-school (group A: age 4-6) and school-age (group B: age 7 to 10) groups. Sound Effects Recognition Test (SERT) and the Chinese version of the revised Peabody Picture Vocabulary Test (PPVT-R) were used to assess the auditory perception ability. The average correct percentage of SERT was 61.2% in the preschool group and 72.3% in the older group. There was no significant difference between the two groups. The ESs recognition performance of children with CIs was poorer than that of their hearing peers (90% in average). No correlation existed between ESs recognition and receptive vocabulary comprehension. Two predictive factors: pre-implantation residual hearing and duration of CI usage were found to be associated with recognition performance of daily-encountered ESs. Acoustically, sounds with distinct temporal patterning were easier to identify for children with CIs. In conclusion, we have demonstrated that ESs recognition is not easy for children with CIs and a low correlation existed between linguistic sounds and ESs recognition in these subjects. Recognition ability of ESs in children with CIs can only be achieved by natural exposure to daily-encountered auditory stimuli if sounds other than speech stimuli were less emphasized in routine verbal/oral habilitation program. Therefore, task-specific measures other than speech materials can be helpful to capture the full profile of auditory perceptual progress after implantation.	[Liu, Shu-Yu; Lai, Te-Jen] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Liu, Shu-Yu] Chung Shan Med Univ, Sch Speech Language Pathol & Audiol, Taichung, Taiwan; [Liu, Tien-Chen] Natl Taiwan Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Teng, Ya-Ling] Chung Shan Med Univ, Sch Occupat Therapy, Taichung, Taiwan; [Lee, Li-Ang; Wu, Che-Ming] Chang Gung Univ, Chang Gung Mem Hosp, Dept Otolaryngol, Linkou, Taiwan; [Lai, Te-Jen] Chung Shan Med Univ Hosp, Dept Psychiat, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; National Taiwan University; National Taiwan University Hospital; Chung Shan Medical University; Chang Gung Memorial Hospital; Chang Gung University; Chung Shan Medical University; Chung Shan Medical University Hospital	Lai, TJ (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	tejenlai@hotmail.com; bobwu506@hotmail.com	Li-Ang, Lee/AAO-6876-2020	Li-Ang, Lee/0000-0001-8414-595X; CHE-MING, WU/0000-0001-5245-0482				Allen MC, 1998, AM J OTOL, V19, P742; Finitzo-Hieber T, 1977, SOUND EFFECTS RECOGN; FINITZOHIEBER T, 1980, EAR HEARING, V1, P271, DOI 10.1097/00003446-198009000-00007; Forli F, 2011, ACTA OTORHINOLARYNGO, V31, P281; Gygi B, 2007, FRONT BIOSCI-LANDMRK, V12, P3152, DOI 10.2741/2303; Inverso Y, 2009, PERSPECTIVES HEARING, V19, P43; Inverso Y, 2010, EAR HEARING, V31, P505, DOI 10.1097/AUD.0b013e3181d99a52; Kelsay DMR, 1996, AM J OTOL, V17, P866; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Lewis JW, 2004, CEREB CORTEX, V14, P1008, DOI 10.1093/cercor/bhh061; Limb Charles J, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P337, DOI 10.1097/01.moo.0000244192.59184.bd; Liu SY, 2011, INT J PEDIATR OTORHI, V75, P12; Liu SY, 2010, J SPEECH LANG HEAR A, V26, P1; Lu L., 1994, PEABODY PICTURE VOCA; Proops DW, 1999, J LARYNGOL OTOL, V113, P5, DOI 10.1017/S0022215100146018; Ramsdell D.A.., 1978, HEARING AND DEAFNESS, P499; Reed CM, 2005, EAR HEARING, V26, P48, DOI 10.1097/00003446-200502000-00005; Shafiro V, 2008, EAR HEARING, V29, P401, DOI 10.1097/AUD.0b013e31816a0cf1; Shafiro V, 2008, EAR HEARING, V29, P775, DOI 10.1097/AUD.0b013e31817e08ea; Shafiro V, 2012, TRENDS AMPLIF, V16, P83, DOI 10.1177/1084713812454225; Shafiro V, 2011, EAR HEARING, V32, P511, DOI 10.1097/AUD.0b013e3182064a87; Svirsky MA, 2000, PSYCHOL SCI, V11, P153, DOI 10.1111/1467-9280.00231; Wang NM, 2011, OTOL NEUROTOL, V32, P937, DOI 10.1097/MAO.0b013e31821789d1; Wu CM, 2008, CLIN OTOLARYNGOL, V33, P35, DOI 10.1111/j.1749-4486.2007.01585.x; Wu CM, 2011, AUDIOL NEURO-OTOL, V16, P359, DOI 10.1159/000322310; Zheng Y, 2011, INT J PEDIATR OTORHI, V75, P1418, DOI 10.1016/j.ijporl.2011.08.005	26	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66100	10.1371/journal.pone.0066100	http://dx.doi.org/10.1371/journal.pone.0066100			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840408	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800031
J	Szulkin, A; Nilsonne, G; Mundt, F; Wasik, AM; Souri, P; Hjerpe, A; Dobra, K				Szulkin, Adam; Nilsonne, Gustav; Mundt, Filip; Wasik, Agata M.; Souri, Pega; Hjerpe, Anders; Dobra, Katalin			Variation in Drug Sensitivity of Malignant Mesothelioma Cell Lines with Substantial Effects of Selenite and Bortezomib, Highlights Need for Individualized Therapy	PLOS ONE			English	Article							PROTEASOME INHIBITOR PS-341; ACUTE MYELOID-LEUKEMIA; PROSTATE-CANCER CELLS; PLEURAL MESOTHELIOMA; LUNG-CANCER; INDUCED APOPTOSIS; PHASE-II; THIOREDOXIN REDUCTASE; PROTEIN EXPRESSION; MULTIPLE-MYELOMA	Background: Malignant mesothelioma cells have an epithelioid or sarcomatoid morphology, both of which may be present in the same tumor. The sarcomatoid phenotype is associated with worse prognosis and heterogeneity of mesothelioma cells may contribute to therapy resistance, which is often seen in mesothelioma. This study aimed to investigate differences in sensitivity between mesothelioma cell lines to anti-cancer drugs. We studied two novel drugs, selenite and bortezomib and compared their effect to four conventional drugs. We also investigated the immunoreactivity of potential predictive markers for drug sensitivity; Pgp, MRP-1, ERCC1, RRM1, TS, xCT and proteasome 20S subunit. Materials and methods: We treated six mesothelioma cell lines with selenite, bortezomib, carboplatin, pemetrexed, doxorubicin or gemcitabine as single agents and in combinations. Viability was measured after 24 and 48 hours. Immunocytochemistry was used to detect predictive markers. Results: As a single agent, selenite was effective on four out of six cell lines, and in combination with bortezomib yielded the greatest response in the studied mesothelioma cell lines. Cells with an epithelioid phenotype were generally more sensitive to the different drugs than the sarcomatoid cells. Extensive S-phase arrest was seen in pemetrexed-sensitive cell lines. MRP-1 predicted sensitivity of cell lines to treatment with carboplatin and xCT predicted pemetrexed effect. Conclusions: The observed heterogeneity in sensitivity of mesothelioma cell lines with different morphology highlights the need for more individualized therapy, requiring development of methods to predict drug sensitivity of individual tumors. Selenite and bortezomib showed a superior effect compared to conventional drugs, motivating clinical testing of these agents as future treatment regime components for patients with malignant mesothelioma.	[Szulkin, Adam; Nilsonne, Gustav; Mundt, Filip; Wasik, Agata M.; Souri, Pega; Hjerpe, Anders; Dobra, Katalin] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Nilsonne, Gustav] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Nilsonne, Gustav] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Stockholm University	Szulkin, A (corresponding author), Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden.	adam.szulkin@ki.se		Nilsonne, Gustav/0000-0001-5273-0150	Swedish Heart and Lung Foundation; AFA Insurance; Cancer Research Foundations of Radiumhemmet; Cancer and Allergy foundation	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); AFA Insurance; Cancer Research Foundations of Radiumhemmet; Cancer and Allergy foundation	This study has been supported by the Swedish Heart and Lung Foundation (http://www.hjart-lungfonden.se/), AFA Insurance (http://www.afaforsakring.se/), The Cancer Research Foundations of Radiumhemmet (www.rahfo.se) and the Cancer and Allergy foundation (www.cancerochallergifonden.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 1999, CANCER RES, V59, P2615; Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; BALDEW GS, 1991, BIOCHEM PHARMACOL, V41, P1429, DOI 10.1016/0006-2952(91)90558-M; Barbone D, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.58; Barbone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052753; Bepler G, 2006, J CLIN ONCOL, V24, P4731, DOI 10.1200/JCO.2006.06.1101; Bjorkhem-Bergman L, 2002, BIOCHEM PHARMACOL, V63, P1875, DOI 10.1016/S0006-2952(02)00981-4; Blayney JK, 2012, EUR J CANCER, V48, P2983, DOI 10.1016/j.ejca.2012.05.018; Borczuk AC, 2007, ONCOGENE, V26, P610, DOI 10.1038/sj.onc.1209809; Buque A, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-25; CAVALIERI RR, 1966, J NUCL MED, V7, P197; Ceresoli GL, 2006, J CLIN ONCOL, V24, P1443, DOI 10.1200/JCO.2005.04.3190; Ceresoli GL, 2001, LUNG CANCER, V34, P279, DOI 10.1016/S0169-5002(01)00257-4; Dobra K, 2000, EXP CELL RES, V258, P12, DOI 10.1006/excr.2000.4915; ELFERINK F, 1987, CANCER TREAT REP, V71, P1231; Ellis P, 2006, J THORAC ONCOL, V1, P591, DOI 10.1097/01243894-200607000-00017; Endo K, 1996, CANCER, V77, P1681; Fan TWM, 2006, DRUG METAB REV, V38, P707, DOI 10.1080/03602530600959599; Fennell DA, 2008, NAT CLIN PRACT ONCOL, V5, P136, DOI 10.1038/ncponc1039; Fennell DA, 2012, J THORAC ONCOL, V7, P1466, DOI 10.1097/JTO.0b013e318260dfb9; Gandin V, 2009, FEBS J, V276, P532, DOI 10.1111/j.1742-4658.2008.06800.x; Gordon GJ, 2008, CANCER CHEMOTH PHARM, V61, P549, DOI 10.1007/s00280-007-0500-1; Gordon GJ, 2009, JNCI-J NATL CANCER I, V101, P678, DOI 10.1093/jnci/djp061; Gordon GJ, 2005, AM J PATHOL, V166, P1827, DOI 10.1016/S0002-9440(10)62492-3; Hazarika M, 2005, CLIN CANCER RES, V11, P982; Hillerdal G, 2008, J THORAC ONCOL, V3, P1325, DOI 10.1097/JTO.0b013e31818b174d; Hu HB, 2006, MOL CANCER THER, V5, P1873, DOI 10.1158/1535-7163.MCT-06-0063; Kim TS, 2003, BIOCHEM PHARMACOL, V66, P2301, DOI 10.1016/j.bcp.2003.08.021; Kindler HL, 2008, CURR TREAT OPTION ON, V9, P171, DOI 10.1007/s11864-008-0071-3; KLOMINEK J, 1989, CANCER RES, V49, P6118; KUMATORI A, 1990, P NATL ACAD SCI USA, V87, P7071, DOI 10.1073/pnas.87.18.7071; LeBlanc R, 2002, CANCER RES, V62, P4996; Lightcap ES, 2000, CLIN CHEM, V46, P673; Lopez-Rios F, 2006, CANCER RES, V66, P2970, DOI 10.1158/0008-5472.CAN-05-3907; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; Ma WL, 2009, CLIN CANCER RES, V15, P3820, DOI 10.1158/1078-0432.CCR-08-3034; Madeja Z, 2005, BIOCHEM PHARMACOL, V69, P1765, DOI 10.1016/j.bcp.2005.02.023; Matondo M, 2010, LEUKEMIA RES, V34, P498, DOI 10.1016/j.leukres.2009.09.020; Mechetner E, 1998, CLIN CANCER RES, V4, P389; Nilsonne G, 2006, FREE RADICAL BIO MED, V41, P874, DOI 10.1016/j.freeradbiomed.2006.04.031; Nilsonne G, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-92; Olm E, 2009, P NATL ACAD SCI USA, V106, P11400, DOI 10.1073/pnas.0902204106; Orlowski RZ, 2007, J CLIN ONCOL, V25, P3892, DOI 10.1200/JCO.2006.10.5460; Orlowski RZ, 2002, J CLIN ONCOL, V20, P4420, DOI 10.1200/JCO.2002.01.133; Pakdaman A, 1998, BIOL TRACE ELEM RES, V62, P1, DOI 10.1007/BF02820015; PELINENLUND K, 1990, CARCINOGENESIS, V11, P673, DOI 10.1093/carcin/11.4.673; Philippeaux MM, 2004, HISTOCHEM CELL BIOL, V122, P249, DOI 10.1007/s00418-004-0701-1; Ren SX, 2010, CANCER INVEST, V28, P1078, DOI 10.3109/07357901003735659; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Righi L, 2010, J CLIN ONCOL, V28, P1534, DOI 10.1200/JCO.2009.25.9275; Rudolf E, 2008, CELL BIOL TOXICOL, V24, P123, DOI 10.1007/s10565-007-9022-1; SCHMITTER D, 1992, INT J CANCER, V51, P296, DOI 10.1002/ijc.2910510220; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Shih C, 1997, CANCER RES, V57, P1116; Sieja K, 2004, GYNECOL ONCOL, V93, P320, DOI 10.1016/j.ygyno.2003.12.013; Soini Y, 2001, ANN ONCOL, V12, P1239, DOI 10.1023/A:1012292230480; Su CX, 2011, MED ONCOL, V28, P1411, DOI 10.1007/s12032-010-9553-9; Sun XJ, 2006, CANCER LETT, V232, P161, DOI 10.1016/j.canlet.2005.02.022; Sun XJ, 2005, J PATHOL, V207, P91, DOI 10.1002/path.1810; Sun XJ, 2000, DIFFERENTIATION, V66, P181, DOI 10.1111/j.1432-0436.2000.660404.x; Suzuki Y, 2001, IND HEALTH, V39, P183, DOI 10.2486/indhealth.39.183; Team RC, 2012, R LANG ENV STAT COMP; Tonkinson JL, 1997, CANCER CHEMOTH PHARM, V39, P521, DOI 10.1007/s002800050608; Tonkinson JL, 1999, CANCER RES, V59, P3671; US food and drug administration, 2004, AL PROD LAB ROCKV; US food and drug administration, 2003, DOX HYDR PROD LAB RO; US food and drug administration, 1996, GEMZ PROD LAB ROCKV; US food and drug administration, 2008, VELC PROD LAB ROCKV; US food and drug administration, 2004, PAR PROD LAB ROCKV; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; WAGNER J C, 1960, Br J Ind Med, V17, P260; Wang Y, 2009, CANC CHEMOTHER PHARM; Weir L, 2011, ANAL BIOCHEM, V414, P31, DOI 10.1016/j.ab.2011.02.030; Yang TY, 2011, EUR J PHARMACOL, V663, P17, DOI 10.1016/j.ejphar.2011.04.057; Zhao R, 2006, CANCER RES, V66, P2296, DOI 10.1158/0008-5472.CAN-05-2216; Zimling ZG, 2012, CANCER CHEMOTH PHARM, V70, P743, DOI 10.1007/s00280-012-1965-0; Zimmermann T, 2005, BIOL TRACE ELEM RES, V106, P193, DOI 10.1385/BTER:106:3:193; Zucali PA, 2011, CLIN CANCER RES, V17, P2581, DOI 10.1158/1078-0432.CCR-10-2873	81	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65903	10.1371/journal.pone.0065903	http://dx.doi.org/10.1371/journal.pone.0065903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840376	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800023
J	Ahooghalandari, P; Hanke, N; Thorpe, M; Witte, A; Messinger, J; Hellman, L				Ahooghalandari, Parvin; Hanke, Nina; Thorpe, Michael; Witte, Andreas; Messinger, Josef; Hellman, Lars			Mutations in Arg143 and Lys192 of the Human Mast Cell Chymase Markedly Affect the Activity of Five Potent Human Chymase Inhibitors	PLOS ONE			English	Article							EXTENDED SUBSTRATE-SPECIFICITY; ANGIOTENSIN-II; RECOGNITION PROFILE; GRANULE PROTEASES; SERINE PROTEASES; ALPHA-CHYMASE; SIMILARITIES; CLONING; CARBOXYPEPTIDASE; REGULATORS	Chymotrypsin-like serine proteases are found in high abundance in mast cell granules. By site-directed mutatgenesis, we have previously shown that basic amino acids in positions 143 and 192 (Arg and Lys respectively) of the human mast cell chymase are responsible for an acidic amino acid residue preference in the P2' position of substrates. In order to study the influence of these two residues in determining the specificity of chymase inhibitors, we have synthesized five different potent inhibitors of the human chymase. The inhibitory effects of these compounds were tested against the wild-type enzyme, against two single mutants Arg143Gln and Lys192Met and against a double mutant, Arg143Gln+Lys192Met. We observed a markedly reduced activity of all five inhibitors with the double mutant, indicating that these two basic residues are involved in conferring the specificity of these inhibitors. The single mutants showed an intermediate phenotype, with the strongest effect on the inhibitor by the mutation in Lys192. The Lys192 and the double mutations also affected the rate of cleavage of angiotensin I but did not seem to affect the specificity in the cleavage of the Tyr(4)-Ile(5) bond. A more detailed knowledge about which amino acids that confer the specificity of an enzyme can prove to be of major importance for development of highly specific inhibitors for the human chymase and other medically important enzymes.	[Ahooghalandari, Parvin; Thorpe, Michael; Hellman, Lars] Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Uppsala, Sweden; [Hanke, Nina; Witte, Andreas; Messinger, Josef] Abbott Prod, Hannover, Germany	Uppsala University	Hellman, L (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Uppsala, Sweden.	Lars.Hellman@icm.uu.se	Thorpe, Michael/P-6838-2015	Thorpe, Michael/0000-0002-4771-0080	Swedish National Research Council (VRNT); Abbott AG Germany	Swedish National Research Council (VRNT); Abbott AG Germany	This study was supported by grants from the Swedish National Research Council (VRNT) and from Abbott AG Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Andersson MK, 2010, FEBS J, V277, P2255, DOI 10.1111/j.1742-4658.2010.07642.x; Andersson MK, 2009, INT IMMUNOL, V21, P95, DOI 10.1093/intimm/dxn128; Caughey GH, 2008, J BIOL CHEM, V283, P13943, DOI 10.1074/jbc.M710502200; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Chandrasekharan UM, 1996, SCIENCE, V271, P502, DOI 10.1126/science.271.5248.502; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gallwitz M, 2006, IMMUNOGENETICS, V58, P655, DOI 10.1007/s00251-006-0126-1; Gallwitz M, 2010, INT IMMUNOL, V22, P421, DOI 10.1093/intimm/dxq021; Guo CY, 2001, J CLIN INVEST, V107, P703, DOI 10.1172/JCI9997; HUANG RY, 1994, IMMUNOGENETICS, V40, P397, DOI 10.1007/BF00177823; HUANG RY, 1991, EUR J IMMUNOL, V21, P1611, DOI 10.1002/eji.1830210706; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Itoh H, 1996, BIOCHEM J, V314, P923, DOI 10.1042/bj3140923; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Kervinen J, 2010, BIOCHEM PHARMACOL, V80, P1033, DOI 10.1016/j.bcp.2010.06.014; KINOSHITA A, 1991, J BIOL CHEM, V266, P19192; Kunder CA, 2011, BLOOD, V118, P5383, DOI 10.1182/blood-2011-07-358432; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Lutzelschwab C, 1997, J EXP MED, V185, P13, DOI 10.1084/jem.185.1.13; Muilenburg DJ, 2002, BBA-PROTEIN STRUCT M, V1596, P346, DOI 10.1016/S0167-4838(02)00224-8; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Pereira PJB, 1999, J MOL BIOL, V286, P163, DOI 10.1006/jmbi.1998.2462; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Reimer JM, 2008, MOL IMMUNOL, V45, P2116, DOI 10.1016/j.molimm.2007.10.015; Saito K, 2003, BIOCHEM BIOPH RES CO, V302, P773, DOI 10.1016/S0006-291X(03)00263-8; Sanker S, 1997, J BIOL CHEM, V272, P2963, DOI 10.1074/jbc.272.5.2963; Serafin W E, 1990, Monogr Allergy, V27, P31; Southan C, 2001, DRUG DISCOV TODAY, V6, P681, DOI 10.1016/S1359-6446(01)01793-7; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje	32	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65988	10.1371/journal.pone.0065988	http://dx.doi.org/10.1371/journal.pone.0065988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840386	gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200045
J	Li, F; Yu, X; Szynkarski, CK; Meng, C; Zhou, BY; Barhoumi, R; White, RE; Heaps, CL; Stallone, JN; Han, GC				Li, Fen; Yu, Xuan; Szynkarski, Claudia K.; Meng, Cong; Zhou, Beiyan; Barhoumi, Rola; White, Richard E.; Heaps, Cristine L.; Stallone, John N.; Han, Guichun			Activation of GPER Induces Differentiation and Inhibition of Coronary Artery Smooth Muscle Cell Proliferation	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; VASCULAR INJURY RESPONSE; GROWTH-FACTOR RECEPTOR; ESTROGEN-RECEPTOR; INTIMAL HYPERPLASIA; BLOOD-PRESSURE; CANCER CELLS; EXPRESSION; GPR30; INDUCTION	Background: Vascular pathology and dysfunction are direct life-threatening outcomes resulting from atherosclerosis or vascular injury, which are primarily attributed to contractile smooth muscle cells (SMCs) dedifferentiation and proliferation by re-entering cell cycle. Increasing evidence suggests potent protective effects of G-protein coupled estrogen receptor 1 (GPER) activation against cardiovascular diseases. However, the mechanism underlying GPER function remains poorly understood, especially if it plays a potential role in modulating coronary artery smooth muscle cells (CASMCs). Methodology/Principal Findings: The objective of our study was to understand the functional role of GPER in CASMC proliferation and differentiation in coronary arteries using from humans and swine models. We found that the GPER agonist, G-1, inhibited both human and porcine CASMC proliferation in a concentration- (10(-8) to 10(-5) M) and time-dependent manner. Flow cytometry revealed that treatment with G-1 significantly decreased the proportion of S-phase and G2/M cells in the growing cell population, suggesting that G-1 inhibits cell proliferation by slowing progression of the cell cycle. Further, G-1-induced cell cycle retardation was associated with decreased expression of cyclin B, up-regulation of cyclin D1, and concomitant induction of p21, and partially mediated by suppressed ERK1/2 and Akt pathways. In addition, G-1 induces SMC differentiation evidenced by increased alpha-smooth muscle actin (alpha-actin) and smooth muscle protein 22 alpha (SM22 alpha) protein expressions and inhibits CASMC migration induced by growth medium. Conclusion: GPER activation inhibits CASMC proliferation by suppressing cell cycle progression via inhibition of ERK1/2 and Akt phosphorylation. GPER may constitute a novel mechanism to suppress intimal migration and/or synthetic phenotype of VSMC.	[Li, Fen; Yu, Xuan; Szynkarski, Claudia K.; Heaps, Cristine L.; Stallone, John N.; Han, Guichun] Texas A&M Univ, Michael E DeBakey Inst, Womens Hlth Div, College Stn, TX 77843 USA; [Meng, Cong; Zhou, Beiyan] Texas A&M Univ, Dept Physiol & Pharmacol, College Stn, TX USA; [Barhoumi, Rola] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX USA; [Li, Fen] Henan Normal Univ, Coll Life Sci, Xinxiang, Henan Province, Peoples R China; [White, Richard E.] Philadelphia Coll Osteopath Med, Dept Basic Sci, Suwanee, GA USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Henan Normal University	Han, GC (corresponding author), Texas A&M Univ, Michael E DeBakey Inst, Womens Hlth Div, College Stn, TX 77843 USA.	ghan@cvm.tamu.edu		Yu, Xuan/0000-0003-3343-7105; Zhou, Beiyan/0000-0003-0638-2428	American Heart Association [11BGIA7370061]; NIH-NCRR [1S10RR22532-01]; NIH [P30-ES09106, P42-ES04917, T32 ES07273, R01 ES002710]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002710] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work is supported by Beginning Grant-In-Aid from American Heart Association [11BGIA7370061 to G.H.]. Confocal microscopy was performed in the Texas A&M University College of Veterinary Medicine & Biomedical Sciences Image Analysis Laboratory, supported by NIH-NCRR (1S10RR22532-01), and NIH grants P30-ES09106, P42-ES04917, T32 ES07273 and R01 ES002710. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Chan QKY, 2010, CELL DEATH DIFFER, V17, P1511, DOI 10.1038/cdd.2010.20; Chaterji S, 2010, TISSUE ENG PT A, V16, P1901, DOI [10.1089/ten.tea.2009.0271, 10.1089/ten.TEA.2009.0271]; Deschamps AM, 2009, AM J PHYSIOL-HEART C, V297, pH1806, DOI 10.1152/ajpheart.00283.2009; Dubey RK, 2000, ARTERIOSCL THROM VAS, V20, P964, DOI 10.1161/01.ATV.20.4.964; Farhat MY, 1996, FASEB J, V10, P615, DOI 10.1096/fasebj.10.5.8621060; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Filigheddu N, 2011, CELL SIGNAL, V23, P1988, DOI 10.1016/j.cellsig.2011.07.009; FOEGH ML, 1994, J VASC SURG, V19, P722, DOI 10.1016/S0741-5214(94)70047-8; Granada JF, 2005, ARTERIOSCL THROM VAS, V25, P2343, DOI 10.1161/01.ATV.0000184779.01822.9d; Gupta GK, 2011, EXP MOL PATHOL, V91, P346, DOI 10.1016/j.yexmp.2011.04.004; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Iafrati MD, 1997, NAT MED, V3, P545, DOI 10.1038/nm0597-545; Ignatov T, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.07.034; Karas RH, 1999, P NATL ACAD SCI USA, V96, P15133, DOI 10.1073/pnas.96.26.15133; Karas RH, 2001, CIRC RES, V89, P534, DOI 10.1161/hh1801.097239; Kawagoe J, 2007, ENDOCRINOLOGY, V148, P6092, DOI 10.1210/en.2007-0188; Kim JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE1110, DOI 10.1152/ajpendo.00464.2004; Lindsey SH, 2009, ENDOCRINOLOGY, V150, P3753, DOI 10.1210/en.2008-1664; Liu HM, 2007, LIFE SCI, V80, P800, DOI 10.1016/j.lfs.2006.11.014; Martensson UEA, 2009, ENDOCRINOLOGY, V150, P687, DOI 10.1210/en.2008-0623; Mathew OP, 2010, BIOMED PHARMACOTHER, V64, P733, DOI 10.1016/j.biopha.2010.09.017; Odenlund M, 2009, AMINO ACIDS, V36, P273, DOI 10.1007/s00726-008-0060-7; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Ranganna K, 2003, MOL CELL BIOCHEM, V254, P21, DOI 10.1023/A:1027383710582; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Riendeau V, 2009, FREE RADICAL RES, V43, P1019, DOI 10.1080/10715760903040610; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; Selzman CH, 1998, J SURG RES, V80, P380, DOI 10.1006/jsre.1998.5487; Sivritas D, 2011, BASIC RES CARDIOL, V106, P563, DOI 10.1007/s00395-011-0174-z; Takahashi K, 2003, J ENDOCRINOL, V178, P319, DOI 10.1677/joe.0.1780319; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tian JQ, 1999, AM J PHYSIOL-CELL PH, V276, pC1245, DOI 10.1152/ajpcell.1999.276.6.C1245; YAN GZ, 1995, J NEUROSCI, V15, P6200; Yena S, 2006, ANN CHIR, V131, P22, DOI 10.1016/j.anchir.2005.08.005; Yu JJ, 2005, J CLIN MICROBIOL, V43, P5462, DOI 10.1128/JCM.43.11.5462-5469.2005; Yu X, 2011, AM J PHYSIOL-ENDOC M, V301, pE882, DOI 10.1152/ajpendo.00037.2011; Yun ES, 2011, TOXICOL IN VITRO, V25, P1335, DOI 10.1016/j.tiv.2011.05.001; Zhao Y, 2013, BIOCH BIOPHYS RES CO	42	50	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e64771	10.1371/journal.pone.0064771	http://dx.doi.org/10.1371/journal.pone.0064771			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840305	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200004
J	Yoon, I; Hamaguchi, K; Borzenets, IV; Finkelstein, G; Mooney, R; Donald, BR				Yoon, Inho; Hamaguchi, Kosuke; Borzenets, Ivan V.; Finkelstein, Gleb; Mooney, Richard; Donald, Bruce R.			Intracellular Neural Recording with Pure Carbon Nanotube Probes	PLOS ONE			English	Article							MICROELECTRODE ARRAY; ACTION-POTENTIALS; ELECTRODE ARRAYS; CHANNELRHODOPSIN-2	The computational complexity of the brain depends in part on a neuron's capacity to integrate electrochemical information from vast numbers of synaptic inputs. The measurements of synaptic activity that are crucial for mechanistic understanding of brain function are also challenging, because they require intracellular recording methods to detect and resolve millivolt-scale synaptic potentials. Although glass electrodes are widely used for intracellular recordings, novel electrodes with superior mechanical and electrical properties are desirable, because they could extend intracellular recording methods to challenging environments, including long term recordings in freely behaving animals. Carbon nanotubes (CNTs) can theoretically deliver this advance, but the difficulty of assembling CNTs has limited their application to a coating layer or assembly on a planar substrate, resulting in electrodes that are more suitable for in vivo extracellular recording or extracellular recording from isolated cells. Here we show that a novel, yet remarkably simple, millimeter-long electrode with a sub-micron tip, fabricated from self-entangled pure CNTs can be used to obtain intracellular and extracellular recordings from vertebrate neurons in vitro and in vivo. This fabrication technology provides a new method for assembling intracellular electrodes from CNTs, affording a promising opportunity to harness nanotechnology for neuroscience applications.	[Yoon, Inho; Donald, Bruce R.] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA; [Hamaguchi, Kosuke; Mooney, Richard] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Borzenets, Ivan V.; Finkelstein, Gleb] Duke Univ, Dept Phys, Durham, NC 27706 USA; [Donald, Bruce R.] Duke Univ, Dept Comp Sci, Durham, NC 27706 USA; [Donald, Bruce R.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University; Duke University	Mooney, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	mooney@neuro.duke.edu; brd+plos13@cs.duke.edu	Borzenets, Ivan/M-9912-2015	Borzenets, Ivan/0000-0002-1577-8312; Hamaguchi, Kosuke/0000-0002-0540-320X; Mooney, Richard/0000-0002-3308-1367	Duke Institute for Brain Sciences; National Institutes of Health [NS-79929, GM-65982, GM-78031]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS079929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002524] Funding Source: NIH RePORTER	Duke Institute for Brain Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was partially supported by a grant to R.M., G.F., and B.R.D. from the Duke Institute for Brain Sciences, and by National Institutes of Health grants (NS-79929 (to R. M. and B. R. D), GM-65982 (to B. R. D), and GM-78031 (to B. R. D)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angle MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043194; Borzenets IV, 2012, J APPL PHYS, V111, DOI 10.1063/1.3702802; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cheung KC, 2007, BIOSENS BIOELECTRON, V22, P1783, DOI 10.1016/j.bios.2006.08.035; de Asis ED, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/12/125101; Duan XJ, 2012, NAT NANOTECHNOL, V7, P174, DOI [10.1038/nnano.2011.223, 10.1038/NNANO.2011.223]; Ensell G, 1996, J MICROELECTROMECH S, V5, P117, DOI 10.1109/84.506199; Jensen W, 2006, IEEE T BIO-MED ENG, V53, P934, DOI 10.1109/TBME.2006.872824; Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174; Ma J, 2009, ACS NANO, V3, P3679, DOI 10.1021/nn900787h; Moxon KA, 2004, IEEE T BIO-MED ENG, V51, P647, DOI 10.1109/TBME.2003.821037; Musallam S, 2007, J NEUROSCI METH, V160, P122, DOI 10.1016/j.jneumeth.2006.09.005; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Normann RA, 1999, VISION RES, V39, P2577, DOI 10.1016/S0042-6989(99)00040-1; Pellinen DS, 2005, P ANN INT IEEE EMBS, P5272, DOI 10.1109/IEMBS.2005.1615669; Robinson JT, 2012, NAT NANOTECHNOL, V7, P180, DOI [10.1038/nnano.2011.249, 10.1038/NNANO.2011.249]; Schrlau MG, 2009, ACS NANO, V3, P563, DOI 10.1021/nn800851d; Shoval A, 2009, FRONTIERS NEUROENGIN, P2; Tang J, 2003, ADV MATER, V15, P1352, DOI 10.1002/adma.200305086; Voge CM, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/1/011001; Wise KD, 2004, P IEEE, V92, P76, DOI 10.1109/JPROC.2003.820544; Xie C, 2012, NAT NANOTECHNOL, V7, P185, DOI [10.1038/nnano.2012.8, 10.1038/NNANO.2012.8]; Yeh SR, 2009, LANGMUIR, V25, P7718, DOI 10.1021/la900264x; Zheng JP, 2010, TALANTA, V81, P1045, DOI 10.1016/j.talanta.2010.01.059	25	42	43	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65715	10.1371/journal.pone.0065715	http://dx.doi.org/10.1371/journal.pone.0065715			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840357	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200032
J	Yu, Y; Liu, ZQ; Liu, XY; Yang, L; Geng, XR; Yang, G; Liu, ZG; Zheng, PY; Yang, PC				Yu, Yong; Liu, Zhi-Qiang; Liu, Xiao-Yu; Yang, Li; Geng, Xiao-Rui; Yang, Gui; Liu, Zhi-Gang; Zheng, Peng-Yuan; Yang, Ping-Chang			Stress-Derived Corticotropin Releasing Factor Breaches Epithelial Endotoxin Tolerance	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CLAUDIN-2 EXPRESSION; PSYCHOLOGICAL STRESS; BARRIER DYSFUNCTION; CROHNS-DISEASE; MUCOSAL INFLAMMATION; PSYCHOSOCIAL STRESS; MAST-CELLS; RAT MODEL; PERMEABILITY	Background and aims: Loss of the endotoxin tolerance of intestinal epithelium contributes to a number of intestinal diseases. The etiology is not clear. Psychological stress is proposed to compromise the intestinal barrier function. The present study aims to elucidate the role of the stress-derived corticotropin releasing factor (CRF) in breaching the established intestinal epithelial endotoxin tolerance. Methods: Epithelial cells of HT-29, T84 and MDCK were exposed to lipopolysaccharide to induce the endotoxin tolerance; the cells were then stimulated with CRF. The epithelial barrier function was determined using as indicators of the endotoxin tolerant status. A water-avoid stress mouse model was employed to test the role of CRF in breaching the established endotoxin tolerance in the intestine. Results: The established endotoxin tolerance in the epithelial cell monolayers was broken down by a sequent exposure to CRF and LPS manifesting a marked drop of the transepithelial resistance (TER) and an increase in the permeability to a macromolecular tracer, horseradish peroxidase (HRP). The exposure to CRF also increased the expression of Cldn2 in the epithelial cells, which could be mimicked by over expression of TLR4 in epithelial cells. Over expression of Cldn2 resulted in low TER in epithelial monolayers and high permeability to HRP. After treating mice with the 10-day chronic stress, the intestinal epithelial barrier function was markedly compromised, which could be prevented by blocking either CRF, or TLR4, or Cldn2. Conclusions: Psychological stress-derived CRF can breach the established endotoxin tolerance in the intestinal mucosa.	[Yu, Yong; Liu, Zhi-Qiang; Yang, Li; Zheng, Peng-Yuan] Zhengzhou Univ, Dept Gastroenterol, Hosp 2, Zhengzhou 450052, Peoples R China; [Liu, Xiao-Yu; Liu, Zhi-Gang; Yang, Ping-Chang] Shenzhen Univ, Allergy & Immunol Inst, Sch Med, Shenzhen, Peoples R China; [Geng, Xiao-Rui; Yang, Gui] ENT Hosp, Longgang Cent Hosp, Shenzhen, Peoples R China; [Geng, Xiao-Rui; Yang, Gui] Shenzhen ENT Inst, Shenzhen, Peoples R China	Zhengzhou University; Shenzhen University	Zheng, PY (corresponding author), Zhengzhou Univ, Dept Gastroenterol, Hosp 2, Zhengzhou 450052, Peoples R China.	pengyuanzheng@163.com; pcy2356@163.com	Yang, Ping-Chang/K-4669-2019		973 Program of China [2011CB512006]; Natural Science Foundation of SZU [000004]; National Natural Science Foundation of China [81271950, 31101280, 31070799]; Shenzhen Municipal Research Key Laboratory Programme [SW201110010]	973 Program of China(National Basic Research Program of China); Natural Science Foundation of SZU; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Municipal Research Key Laboratory Programme	This study was supported by grants from 973 Program (#2011CB512006) of China, the Natural Science Foundation of SZU (#000004), the National Natural Science Foundation of China (No. 81271950, 31101280, 31070799) and Shenzhen Municipal Research Key Laboratory Programme (SW201110010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Belgnaoui A, 2012, PSYCHONEUROENDOCRINO, V37, P1885, DOI 10.1016/j.psyneuen.2012.03.024; Chang J, 2011, AM J PHYSIOL-GASTR L, V300, pG884, DOI 10.1152/ajpgi.00319.2010; CIOCCA DR, 1990, BREAST CANCER RES TR, V15, P175, DOI 10.1007/BF01806354; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Demaude J, 2009, LIFE SCI, V84, P847, DOI 10.1016/j.lfs.2009.03.016; Denizot J, 2012, INFLAMM BOWEL DIS, V18, P294, DOI 10.1002/ibd.21787; Fang HW, 2010, J MED MICROBIOL, V59, P573, DOI 10.1099/jmm.0.009662-0; Hashimoto M, 2001, PHYSIOL BEHAV, V73, P125, DOI 10.1016/S0031-9384(01)00473-5; Henriksen M, 2006, SCAND J GASTROENTERO, V41, P1037, DOI 10.1080/00365520600554527; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; HONGKUAN F, 2004, J ENDOTOXIN RES, V10, P71; Kim DH, 2010, J KOREAN MED SCI, V25, P1330, DOI 10.3346/jkms.2010.25.9.1330; Kosztolanyi A, 2012, HORM BEHAV, V61, P734, DOI 10.1016/j.yhbeh.2012.03.011; Kuge T, 2006, LIFE SCI, V79, P913, DOI 10.1016/j.lfs.2006.03.002; Lenoir C, 2008, LIFE SCI, V82, P519, DOI 10.1016/j.lfs.2007.12.007; Lotz M, 2006, J EXP MED, V203, P973, DOI 10.1084/jem.20050625; Lyte M, 2011, CELL TISSUE RES, V343, P23, DOI 10.1007/s00441-010-1050-0; Mazzon E, 2008, AM J PHYSIOL-GASTR L, V294, pG1268, DOI 10.1152/ajpgi.00014.2008; Nahid MA, 2011, J IMMUNOL, V186, P1723, DOI 10.4049/jimmunol.1002311; Naliboff BD, 2012, AM J GASTROENTEROL, V107, P451, DOI 10.1038/ajg.2011.377; Pasternak BA, 2010, INFLAMM BOWEL DIS, V16, P856, DOI 10.1002/ibd.21132; Reber SO, 2011, BRAIN BEHAV IMMUN, V25, P1153, DOI 10.1016/j.bbi.2011.03.004; Roth MK, 2012, NEUROPHARMACOLOGY, V63, P1118, DOI 10.1016/j.neuropharm.2012.07.034; Santos J, 2001, GUT, V48, P630, DOI 10.1136/gut.48.5.630; Seksik P, 2010, INNATE IMMUN-LONDON, V16, P381, DOI 10.1177/1753425909357076; Smith AJ, 2010, JAIDS-J ACQ IMM DEF, V55, P306, DOI 10.1097/QAI.0b013e3181ecfeca; Soderholm JD, 2002, GASTROENTEROLOGY, V123, P1099, DOI 10.1053/gast.2002.36019; Sun LL, 2011, CURR OPIN GASTROEN, V27, P321, DOI 10.1097/MOG.0b013e32834661b4; Suzuki T, 2011, J BIOL CHEM, V286, P31263, DOI 10.1074/jbc.M111.238147; Tang LY, 2008, CAN J GASTROENTEROL, V22, P475, DOI 10.1155/2008/109218; Teitelbaum AA, 2008, AM J PHYSIOL-GASTR L, V295, pG452, DOI 10.1152/ajpgi.90210.2008; Vicario M, 2010, BRAIN BEHAV IMMUN, V24, P1166, DOI 10.1016/j.bbi.2010.06.002; Wallon C, 2008, GUT, V57, P50, DOI 10.1136/gut.2006.117549; Wallon C, 2011, GASTROENTEROLOGY, V140, P1597, DOI 10.1053/j.gastro.2011.01.042; Wang RP, 2011, STRESS, V14, P567, DOI 10.3109/10253890.2011.571729; Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78; Wu L, 2007, IMMUNOL CELL BIOL, V85, P538, DOI 10.1038/sj.icb.7100079; Yang PC, 2006, AM J PATHOL, V168, P104, DOI 10.2353/ajpath.2006.050575; Yang PC, 2000, J CLIN INVEST, V106, P879, DOI 10.1172/JCI9258; Yu LC, 2012, J ALLERGY CAIRO; Zhang YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058606; Zheng PY, 2009, GUT, V58, P1473, DOI 10.1136/gut.2009.181701	42	32	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65760	10.1371/journal.pone.0065760	http://dx.doi.org/10.1371/journal.pone.0065760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840363	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200033
J	Daniil, G; Zannis, VI; Chroni, A				Daniil, Georgios; Zannis, Vassilis I.; Chroni, Angeliki			Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEIN; BINDING CASSETTE TRANSPORTER; ATHEROSCLEROTIC LESION DEVELOPMENT; ABCG1(-/-) BONE-MARROW; B TYPE-I; ALVEOLAR MACROPHAGES; CELLULAR CHOLESTEROL; PLASMA-MEMBRANE; DEFICIENT MICE	ATP binding cassette transporter G1 (ABCG1) mediates the cholesterol transport from cells to high-density lipoprotein (HDL), but the role of apolipoprotein A-I (apoA-I), the main protein constituent of HDL, in this process is not clear. To address this, we measured cholesterol efflux from HEK293 cells or J774 mouse macrophages overexpressing ABCG1 using as acceptors reconstituted HDL (rHDL) containing wild-type or various mutant apoA-I forms. It was found that ABCG1-mediated cholesterol efflux was severely reduced (by 89%) when using rHDL containing the carboxyl-terminal deletion mutant apoA-I[Delta(185-243)]. ABCG1-mediated cholesterol efflux was not affected or moderately decreased by rHDL containing amino-terminal deletion mutants and several mid-region deletion or point apoA-I mutants, and was restored to 69-99% of control by double deletion mutants apoA-I[Delta(1-41)Delta(185-243)] and apoA-I[Delta(1-59)Delta(185-243)]. These findings suggest that the central helices alone of apoA-I associated to rHDL can promote ABCG1-mediated cholesterol efflux. Further analysis showed that rHDL containing the carboxyl-terminal deletion mutant apoA-I[Delta(185-243)] only slightly reduced (by 22%) the ABCG1-mediated efflux of 7-ketocholesterol, indicating that depending on the sterol type, structural changes in rHDL-associated apoA-I affect differently the ABCG1-mediated efflux of cholesterol and 7-ketocholesterol. Overall, our findings demonstrate that rHDL-associated apoA-I structural changes affect the capacity of rHDL to accept cellular cholesterol by an ABCG1-mediated process. The structure-function relationship seen here between rHDL-associated apoA-I mutants and ABCG1-mediated cholesterol efflux closely resembles that seen before in lipid-free apoA-I mutants and ABCA1-dependent cholesterol efflux, suggesting that both processes depend on the same structural determinants of apoA-I.	[Daniil, Georgios; Chroni, Angeliki] Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece; [Zannis, Vassilis I.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Med, Boston, MA 02118 USA; [Zannis, Vassilis I.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Dept Biochem, Boston, MA 02118 USA	National Centre of Scientific Research "Demokritos"; Boston University; Boston University	Chroni, A (corresponding author), Natl Ctr Sci Res Demokritos, Inst Biosci & Applicat, Athens, Greece.	achroni@bio.demokritos.gr		Chroni, Angeliki/0000-0003-3107-1189	General Secretariat of Research and Technology of Greece [Synergasia 09SYN-12-897]; Ministry of Education, Lifelong Learning and Religious Affairs of Greece [Thalis 3569]; Hellenic Society of Lipidology, Atherosclerosis and Vascular Disease; National Institutes of Health [HL48739]; National Center for Scientific Research "Demokritos"	General Secretariat of Research and Technology of Greece(Greek Ministry of Development-GSRT); Ministry of Education, Lifelong Learning and Religious Affairs of Greece; Hellenic Society of Lipidology, Atherosclerosis and Vascular Disease; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Scientific Research "Demokritos"	Funding for this work was provided by the General Secretariat of Research and Technology of Greece (Synergasia 09SYN-12-897), the Ministry of Education, Lifelong Learning and Religious Affairs of Greece (Thalis 3569), the Hellenic Society of Lipidology, Atherosclerosis and Vascular Disease and the National Institutes of Health (grant HL48739). GD received financial support from the graduate student fellowship program of National Center for Scientific Research "Demokritos". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bach D, 2008, BIOCHEMISTRY-US, V47, P3004, DOI 10.1021/bi702070b; Baldan A, 2006, ARTERIOSCL THROM VAS, V26, P2301, DOI 10.1161/01.ATV.0000240051.22944.dc; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borhani DW, 1997, P NATL ACAD SCI USA, V94, P12291, DOI 10.1073/pnas.94.23.12291; Cavelier C, 2006, BBA-MOL CELL BIOL L, V1761, P655, DOI 10.1016/j.bbalip.2006.04.012; Chroni A, 2004, BIOCHEMISTRY-US, V43, P10442, DOI 10.1021/bi049782p; Chroni A, 2004, BIOCHEMISTRY-US, V43, P2126, DOI 10.1021/bi035813p; Chroni A, 2003, J BIOL CHEM, V278, P6719, DOI 10.1074/jbc.M205232200; Cuchel M, 2010, ARTERIOSCL THROM VAS, V30, P526, DOI 10.1161/ATVBAHA.109.196105; Dafnis I, 2010, J NEUROCHEM, V115, P873, DOI 10.1111/j.1471-4159.2010.06756.x; Eberini I, 2002, BIOCHEM J, V362, P627, DOI 10.1042/0264-6021:3620627; Edmondson AC, 2011, CIRC-CARDIOVASC GENE, V4, P145, DOI 10.1161/CIRCGENETICS.110.957563; Favari E, 2009, BIOCHEMISTRY-US, V48, P11067, DOI 10.1021/bi901564g; GALIS ZS, 1995, ANN NY ACAD SCI, V748, P501; GALLA HJ, 1980, BIOCHIM BIOPHYS ACTA, V596, P108, DOI 10.1016/0005-2736(80)90174-1; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Gorshkova IN, 2002, BIOCHEMISTRY-US, V41, P10529, DOI 10.1021/bi025807d; GRAINGER DJ, 1994, NATURE, V370, P460, DOI 10.1038/370460a0; Hashimoto M, 1999, EXP GERONTOL, V34, P687, DOI 10.1016/S0531-5565(99)00025-X; KAN CC, 1992, BIOCHEMISTRY-US, V31, P1866, DOI 10.1021/bi00121a040; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Khalil N, 1996, AM J RESP CELL MOL, V15, P252, DOI 10.1165/ajrcmb.15.2.8703482; KUNITAKE ST, 1990, ARTERIOSCLEROSIS, V10, P25, DOI 10.1161/01.ATV.10.1.25; Laccotripe M, 1997, J BIOL CHEM, V272, P17511, DOI 10.1074/jbc.272.28.17511; Lee M, 2002, ARTERIOSCL THROM VAS, V22, P2086, DOI 10.1161/01.ATV.0000041405.07367.B5; Li D, 2010, J BIOL CHEM, V285, P33499, DOI 10.1074/jbc.M110.159772; Li D, 2010, ARTERIOSCL THROM VAS, V30, P1354, DOI 10.1161/ATVBAHA.110.204230; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; Lindstedt L, 1996, J CLIN INVEST, V97, P2174, DOI 10.1172/JCI118658; Lindstedt L, 1999, J BIOL CHEM, V274, P22627, DOI 10.1074/jbc.274.32.22627; Lindstedt L, 2000, BIOCHEM BIOPH RES CO, V277, P552, DOI 10.1006/bbrc.2000.3704; Liu T, 2002, J BIOL CHEM, V277, P21576, DOI 10.1074/jbc.M112103200; Lorenzi I, 2008, BBA-MOL CELL BIOL L, V1781, P306, DOI 10.1016/j.bbalip.2008.04.006; Massey JB, 2005, BIOCHEMISTRY-US, V44, P10423, DOI 10.1021/bi0506425; Massey JB, 2006, CURR OPIN LIPIDOL, V17, P296, DOI 10.1097/01.mol.0000226123.17629.ab; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Neufeld EB, 2001, J BIOL CHEM, V276, P27584, DOI 10.1074/jbc.M103264200; Out R, 2007, ARTERIOSCL THROM VAS, V27, P594, DOI 10.1161/01.ATV.0000257136.24308.0c; Out R, 2006, ARTERIOSCL THROM VAS, V26, P2295, DOI 10.1161/01.ATV.0000237629.29842.4c; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Russell REK, 2002, AM J RESP CELL MOL, V26, P602, DOI 10.1165/ajrcmb.26.5.4685; Saito H, 2004, J BIOL CHEM, V279, P20974, DOI 10.1074/jbc.M402043200; Sankaranarayanan S, 2009, J LIPID RES, V50, P275, DOI 10.1194/jlr.M800362-JLR200; Schou J, 2012, ARTERIOSCL THROM VAS, V32, P506, DOI 10.1161/ATVBAHA.111.234872; Sturek JM, 2010, J CLIN INVEST, V120, P2575, DOI 10.1172/JCI41280; Tarling EJ, 2011, P NATL ACAD SCI USA, V108, P19719, DOI 10.1073/pnas.1113021108; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Vedhachalam C, 2004, J BIOL CHEM, V279, P49931, DOI 10.1074/jbc.M406924200; Wang M, 2007, J LIPID RES, V48, P633, DOI 10.1194/jlr.M600470-JLR200; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2006, ARTERIOSCL THROM VAS, V26, P1310, DOI 10.1161/01.ATV.0000218998.75963.02; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JCI32057; Xie Q, 2006, ARTERIOSCL THROM VAS, V26, pE143, DOI 10.1161/01.ATV.0000245790.47112.b2; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P1430, DOI 10.1161/ATVBAHA.110.207142; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4	61	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67993	10.1371/journal.pone.0067993	http://dx.doi.org/10.1371/journal.pone.0067993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826352	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000106
J	Hausch, S; Shurin, JB; Matthews, B				Hausch, Stephen; Shurin, Jonathan B.; Matthews, Blake			Variation in Body Shape across Species and Populations in a Radiation of Diaptomid Copepods	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; CALANOID COPEPODS; SIZE; MORPHOLOGY; DIVERGENCE; HYPOTHESIS; EFFICIENCY; DIVERSITY; EVOLUTION; SELECTION	Inter and intra-population variation in morphological traits, such as body size and shape, provides important insights into the ecological importance of individual natural populations. The radiation of Diaptomid species (similar to 400 species) has apparently produced little morphological differentiation other than those in secondary sexual characteristics, suggesting sexual, rather than ecological, selection has driven speciation. This evolutionary history suggests that species, and conspecific populations, would be ecologically redundant but recent work found contrasting ecosystem effects among both species and populations. This study provides the first quantification of shape variation among species, populations, and/or sexes (beyond taxonomic illustrations and body size measurements) to gain insight into the ecological differentiation of Diaptomids. Here we quantify the shape of five Diaptomid species (family Diaptomidae) from four populations each, using morphometric landmarks on the prosome, urosome, and antennae. We partition morphological variation among species, populations, and sexes, and test for phenotype-by-environment correlations to reveal possible functional consequences of shape variation. We found that intraspecific variation was 18-35% as large as interspecific variation across all measured traits. Interspecific variation in body size and relative antennae length, the two traits showing significant sexual dimorphism, were correlated with lake size and geographic location suggesting some niche differentiation between species. Observed relationships between intraspecific morphological variation and the environment suggest that divergent selection in contrasting lakes might contribute to shape differences among local populations, but confirming this requires further analyses. Our results show that although Diaptomid species differ in their reproductive traits, they also differ in other morphological traits that might indicate ecological differences among species and populations.	[Hausch, Stephen; Shurin, Jonathan B.; Matthews, Blake] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	University of British Columbia	Hausch, S (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	sjhausch@ucalgary.ca	Matthews, Blake/B-5608-2009	Matthews, Blake/0000-0001-9089-704X	NSERC; NSERC USRA; NSERC CGS; PDF	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC USRA(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC CGS(Natural Sciences and Engineering Research Council of Canada (NSERC)); PDF	Funding provided by NSERC Discovery grant (to JS), NSERC USRA (to SH), NSERC CGS and PDF (to BM) (http://www.nserc-crsng.gc.ca/index_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akester RJ, 2000, CAN J ZOOL, V78, P240, DOI 10.1139/cjz-78-2-240; Arnqvist G, 1998, NATURE, V393, P784, DOI 10.1038/31689; Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107; BC Ministry of Environment, 2009, HABITATWIZARD LAND R; Blades PI, 1980, EVOLUTION ECOLOGY ZO, P39; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; BOXSHALL GA, 1985, PHILOS T ROY SOC B, V311, P303, DOI 10.1098/rstb.1985.0155; Chambel MR, 2007, ANN FOREST SCI, V64, P87, DOI 10.1051/forest:2006092; Chase J.M., 2009, ECOLOGICAL NICHES LI; Clark JS, 2010, SCIENCE, V327, P1129, DOI 10.1126/science.1183506; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Dryden I, 2009, SHAPES STAT SHAPE AN, P11; Dussart B. H., 2001, INTRO COPEPODA, P344; GILBERT JJ, 1983, ANNU REV ECOL SYST, V14, P1, DOI 10.1146/annurev.es.14.110183.000245; Gillooly JF, 2000, LIMNOL OCEANOGR, V45, P22, DOI 10.4319/lo.2000.45.1.0022; GRANT PR, 1995, EVOLUTION, V49, P241, DOI 10.1111/j.1558-5646.1995.tb02236.x; HALL DJ, 1976, ANNU REV ECOL SYST, V7, P177, DOI 10.1146/annurev.es.07.110176.001141; Harmon LJ, 2005, EVOLUTION, V59, P409; Harmon LJ, 2006, EVOLUTION, V60, P2622; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; Hart RC, 2011, HYDROBIOLOGIA, V668, P61, DOI 10.1007/s10750-010-0400-y; HERZIG A, 1983, HYDROBIOLOGIA, V100, P65, DOI 10.1007/BF00027423; HESSEN DO, 1989, POLAR BIOL, V10, P71; HUTCHINSON G. E., 1951, ECOLOGY, V32, P571, DOI 10.2307/1931745; JACOBY CA, 1983, MAR BIOL, V76, P77, DOI 10.1007/BF00393058; LAIR N, 1992, HYDROBIOLOGIA, V248, P137, DOI 10.1007/BF00006081; LANDRY MR, 1988, B MAR SCI, V43, P509; LANDRY MR, 1980, LIMNOL OCEANOGR, V25, P545, DOI 10.4319/lo.1980.25.3.0545; Leibold MA, 2010, ECOL LETT, V13, P1290, DOI 10.1111/j.1461-0248.2010.01523.x; LOSOS JB, 1990, ECOL MONOGR, V60, P369, DOI 10.2307/1943062; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Matthews B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026700; Matthews B, 2011, ECOL LETT, V14, P690, DOI 10.1111/j.1461-0248.2011.01627.x; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Northcate T.G., 1975, Verhandlungen Int Verein Theor Angew Limnol, V19, P2378; Ohtsuka S, 2001, HYDROBIOLOGIA, V453, P441, DOI 10.1023/A:1013162605809; Olsson M, 2002, EVOLUTION, V56, P1538; Palkovacs EP, 2009, ECOLOGY, V90, P300, DOI 10.1890/08-1673.1; Pasternak A. F., 2006, J ICHTHYOL, V46, P220, DOI DOI 10.1134/S0032945206110129; Pinheiro J, 2008, NLME LINEAR NONLINE, P31; R Core Team, 2020, R LANG ENV STAT COMP; REZNICK D, 1982, EVOLUTION, V36, P160, DOI 10.1111/j.1558-5646.1982.tb05021.x; Sandercock GA, 1998, KEY SPECIES FRESHWAT; Sandercock GA, 1994, INTRO KEY FRESHWATER; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; Siepielski AM, 2010, ECOLOGY, V91, P847, DOI 10.1890/09-0609.1; Svanback R, 2003, OIKOS, V102, P273, DOI 10.1034/j.1600-0706.2003.12657.x; Thum RA, 2007, OIKOS, V116, P759, DOI 10.1111/j.2007.0030-1299.15782.x; Thum RA, 2009, BIOL J LINN SOC, V96, P150, DOI 10.1111/j.1095-8312.2008.01105.x; VERMEIJ GJ, 1978, AM NAT, V112, P833, DOI 10.1086/283326; WAINWRIGHT PC, 1991, AM ZOOL, V31, P680; Whitehead A, 2006, MOL ECOL, V15, P1197, DOI 10.1111/j.1365-294X.2006.02868.x	52	6	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68272	10.1371/journal.pone.0068272	http://dx.doi.org/10.1371/journal.pone.0068272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826384	gold, Green Published			2022-12-27	WOS:000321150000137
J	Lattanzi, A; Gentner, B; Corno, D; Di Tomaso, T; Mestdagh, P; Speleman, F; Naldini, L; Gritti, A				Lattanzi, Annalisa; Gentner, Bernhard; Corno, Daniela; Di Tomaso, Tiziano; Mestdagh, Pieter; Speleman, Frank; Naldini, Luigi; Gritti, Angela			Dynamic Activity of miR-125b and miR-93 during Murine Neural Stem Cell Differentiation In Vitro and in the Subventricular Zone Neurogenic Niche	PLOS ONE			English	Article							ADULT NEUROGENESIS; MICRORNA EXPRESSION; SITU HYBRIDIZATION; LENTIVIRAL VECTOR; MIRNA EXPRESSION; PROLIFERATION; ROLES; BRAIN; CLUSTER; PATHWAY	Several microRNAs (miRNAs) that are either specifically enriched or highly expressed in neurons and glia have been described, but the identification of miRNAs modulating neural stem cell (NSC) biology remains elusive. In this study, we exploited high throughput miRNA expression profiling to identify candidate miRNAs enriched in NSC/early progenitors derived from the murine subventricular zone (SVZ). Then, we used lentiviral miRNA sensor vectors (LV. miRT) to monitor the activity of shortlisted miRNAs with cellular and temporal resolution during NSC differentiation, taking advantage of in vitro and in vivo models that recapitulate physiological neurogenesis and gliogenesis and using known neuronal-and glial-specific miRNAs as reference. The LV. miRT platform allowed us monitoring endogenous miRNA activity in low represented cell populations within a bulk culture or within the complexity of CNS tissue, with high sensitivity and specificity. In this way we validated and extended previous results on the neuronal-specific miR-124 and the astroglial-specific miR-23a. Importantly, we describe for the first time a cell type-and differentiation stage-specific modulation of miR-93 and miR-125b in SVZ-derived NSC cultures and in the SVZ neurogenic niche in vivo, suggesting key roles of these miRNAs in regulating NSC function.	[Lattanzi, Annalisa; Gentner, Bernhard; Corno, Daniela; Di Tomaso, Tiziano; Naldini, Luigi; Gritti, Angela] Ist Sci San Raffaele, Telethon Inst Gene Therapy TIGET, I-20132 Milan, Italy; [Lattanzi, Annalisa] Univ Perugia, Sect Biochem & Mol Biol, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Mestdagh, Pieter; Speleman, Frank] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Naldini, Luigi] Univ Vita Salute San Raffaele, Sch Med, Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Perugia; Ghent University; Ghent University Hospital; Vita-Salute San Raffaele University	Gritti, A (corresponding author), Ist Sci San Raffaele, Telethon Inst Gene Therapy TIGET, I-20132 Milan, Italy.	gritti.angela@hsr.it	Gritti, Angela/K-2729-2016; speleman, frank/AAR-5184-2020	Gritti, Angela/0000-0002-9845-0370; speleman, frank/0000-0002-6628-8559; Mestdagh, Pieter/0000-0001-7821-9684; Gentner, Bernhard/0000-0001-6024-4718; Lattanzi, Annalisa/0000-0002-3953-9172; NALDINI, Luigi/0000-0002-7835-527X	Comitato Telethon Fondazione Onlus [TGT06B02, TGT11B02, TGT11D02]; ERC	Comitato Telethon Fondazione Onlus(Fondazione Telethon); ERC(European Research Council (ERC)European Commission)	Partial funding for this work has been provided by Comitato Telethon Fondazione Onlus (Grants TGT06B02 and TGT11B02 to A. G; TGT11D02 to L.N.) and ERC grant to L.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerblom M, 2012, J NEUROSCI, V32, P8879, DOI 10.1523/JNEUROSCI.0558-12.2012; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bian S, 2013, CELL REP; Bonfanti L, 2011, EUR J NEUROSCI, V34, P930, DOI 10.1111/j.1460-9568.2011.07832.x; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Brown BD, 2007, BLOOD, V110, P4144, DOI 10.1182/blood-2007-03-078493; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Cavazzin C, 2006, GLIA; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Colin A, 2009, GLIA, V57, P667, DOI 10.1002/glia.20795; Cui Y, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-116; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Di Stefano B, 2011, STEM CELLS, V29, P1684, DOI 10.1002/stem.726; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Farrell BC, 2011, INT J DEV NEUROSCI, V29, P31, DOI 10.1016/j.ijdevneu.2010.10.001; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Gao ZL, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00067; Gentner B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001522; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; Gritti A, 2009, J COMP NEUROL, V517, P333, DOI 10.1002/cne.22153; Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z; Ihrie RA, 2011, NEURON, V70, P674, DOI 10.1016/j.neuron.2011.05.004; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jovicic A, 2013, J NEUROSCI, V33, P5127, DOI 10.1523/JNEUROSCI.0600-12.2013; Kawahara H, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00030; Kawashima H, 2010, NEUROSCIENCE, V165, P1301, DOI 10.1016/j.neuroscience.2009.11.057; Klein C, 2005, DEVELOPMENT, V132, P4497, DOI 10.1242/dev.02037; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lang MF, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00071; Lattanzi A, 2010, HUM MOL GENET, V19, P2208, DOI 10.1093/hmg/ddq099; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Le MTN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002242; Lemasson M, 2005, J NEUROSCI, V25, P6816, DOI 10.1523/JNEUROSCI.1114-05.2005; Li MA, 2012, BIOESSAYS, V34, P670, DOI 10.1002/bies.201200019; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Maiorano NA, 2010, RNA BIOL, V7, P528, DOI 10.4161/rna.7.5.12262; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Mullokandov G, 2012, NAT METHODS, V9, P840, DOI [10.1038/nmeth.2078, 10.1038/NMETH.2078]; Neri M, 2011, STEM CELLS, V29, P1559, DOI 10.1002/stem.701; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Pogue AI, 2010, NEUROSCI LETT, V476, P18, DOI 10.1016/j.neulet.2010.03.054; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Rybak A, 2009, NAT CELL BIOL, V11, P1411, DOI 10.1038/ncb1987; Sachdeva R, 2010, P NATL ACAD SCI USA, V107, P11602, DOI 10.1073/pnas.1006568107; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Silver DJ, 2009, TRENDS NEUROSCI, V32, P303, DOI 10.1016/j.tins.2009.01.008; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Stappert L, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059011, 10.1371/annotation/b03fbc42-8f70-4873-9cce-854e48249a13]; Thompson RC, 2007, METHODS, V43, P153, DOI 10.1016/j.ymeth.2007.04.008; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Yu JY, 2008, EXP CELL RES, V314, P2618, DOI 10.1016/j.yexcr.2008.06.002; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107	68	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67411	10.1371/journal.pone.0067411	http://dx.doi.org/10.1371/journal.pone.0067411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826292	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000078
J	Leong, S; Simo, G; Camara, M; Jamonneau, V; Kabore, J; Ilboudo, H; Bucheton, B; Hoheisel, JD; Clayton, C				Leong, Smiths; Simo, Gustave; Camara, Mamadou; Jamonneau, Vincent; Kabore, Jacques; Ilboudo, Hamidou; Bucheton, Bruno; Hoheisel, Joerg D.; Clayton, Christine			The miRNA and mRNA Signatures of Peripheral Blood Cells in Humans Infected with Trypanosoma brucei gambiense	PLOS ONE			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; SLEEPING SICKNESS DIAGNOSIS; MICRORNA EXPRESSION; CANCER CELLS; PROLIFERATION; BIOMARKERS; DISEASE; SERUM; SURVEILLANCE; PATHOGENESIS	Simple, reliable tools for diagnosis of human African Trypanosomiases could ease field surveillance and enhance patient care. In particular, current methods to distinguish patients with (stage II) and without (stage I) brain involvement require samples of cerebrospinal fluid. We describe here an exploratory study to find out whether miRNAs from peripheral blood leukocytes might be useful in diagnosis of human trypanosomiasis, or for determining the stage of the disease. Using microarrays, we measured miRNAs in samples from Trypanosoma brucei gambiense-infected patients (9 stage I, 10 stage II), 8 seronegative parasite-negative controls and 12 seropositive, but parasite-negative subjects. 8 miRNAs (out of 1205 tested) showed significantly lower expression in patients than in seronegative, parasite-negative controls, and 1 showed increased expression. There were no clear differences in miRNAs between patients in different disease stages. The miRNA profiles could not distinguish seropositive, but parasitologically negative samples from controls and results within this group did not correlate with those from the trypanolysis test. Some of the regulated miRNAs, or their predicted mRNA targets, were previously reported changed during other infectious diseases or cancer. We conclude that the changes in miRNA profiles of peripheral blood lymphocytes in human African trypanosomiasis are related to immune activation or inflammation, are probably disease-non-specific, and cannot be used to determine the disease stage. The approach has little promise for diagnostics but might yield information about disease pathology.	[Leong, Smiths; Hoheisel, Joerg D.] Deutsch Krebsforschungszentrum DKFZ, Div Funct Genome Anal, Heidelberg, Germany; [Simo, Gustave] Univ Dschang, Dept Biochem, Dschang, West Cameroon, Cameroon; [Camara, Mamadou] Programme Natl Lutte Trypanosomiase Humaine Afric, Conakry, Guinea; [Camara, Mamadou; Jamonneau, Vincent; Kabore, Jacques; Ilboudo, Hamidou; Bucheton, Bruno] Ctr Int Rech Dev Elevage Zone Subhumide CIRDES, Bobo Dioulasso, Burkina Faso; [Jamonneau, Vincent; Bucheton, Bruno] Inst Rech Dev, UMR 177, Montpellier, France; [Clayton, Christine] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Institut de Recherche pour le Developpement (IRD); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Clayton, C (corresponding author), Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany.	cclayton@zmbh.uni-heidelberg.de	Jamonneau, Vincent/K-1124-2016; Clayton, Christine/K-7700-2019	Jamonneau, Vincent/0000-0001-8427-0769; Clayton, Christine/0000-0002-6384-0731; Bauer, Andrea/0000-0002-7919-0497; ILBOUDO, Hamidou/0000-0003-3936-7718; Camara, Mamadou/0000-0001-7785-6649	German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD); Alexander von Humboldt Foundation	German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	SL was supported by a grant from the German Academic Exchange Service (Deutscher Akademischer Austauschdienst, DAAD). GS was supported by the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2012, ADV GENET, V80, P1, DOI 10.1016/B978-0-12-404742-6.00001-6; Barrett MP, 2010, CURR OPIN INFECT DIS, V23, P603, DOI 10.1097/QCO.0b013e32833f9fd0; Biyashev D, 2012, BLOOD, V119, P2679, DOI 10.1182/blood-2011-07-370635; Boda C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006184; Boeri M, 2012, CANCER J, V18, P268, DOI 10.1097/PPO.0b013e318258b743; Bucheton B, 2011, PARASITE IMMUNOL, V33, P438, DOI 10.1111/j.1365-3024.2011.01287.x; Burchmore R, 2012, EXPERT REV ANTI-INFE, V10, P1283, DOI [10.1586/ERI.12.124, 10.1586/eri.12.124]; Camara M, 2010, TROP MED INT HEALTH, V15, P796, DOI 10.1111/j.1365-3156.2010.02546.x; Chen JM, 2011, AM J PATHOL, V179, P2162, DOI 10.1016/j.ajpath.2011.07.010; Cheung TH, 2012, CELL CYCLE, V11, P2876, DOI 10.4161/cc.21278; Courtin D, 2006, TROP MED INT HEALTH, V11, P647, DOI 10.1111/j.1365-3156.2006.01612.x; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Deborggraeve S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000972; Delic D, 2011, PARASITOL RES, V108, P1111, DOI 10.1007/s00436-010-2152-z; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dumas Michel, 1996, Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales, V190, P395; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; El-Assaad F, 2011, INFECT IMMUN, V79, P2379, DOI 10.1128/IAI.01136-10; Fischer L, 2011, NEURO-ONCOLOGY, V13, P1090, DOI 10.1093/neuonc/nor107; Gao XN, 2011, LEUKEMIA RES, V35, P1226, DOI 10.1016/j.leukres.2011.06.010; Gong AY, 2010, J INFECT DIS, V201, P160, DOI 10.1086/648589; GREENWOOD BM, 1980, T ROY SOC TROP MED H, V74, P716, DOI 10.1016/0035-9203(80)90184-4; Guan P, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-54; Hamada S, 2012, MOL CANCER RES, V10, P3, DOI 10.1158/1541-7786.MCR-11-0272; Healy NA, 2012, INT J CANCER, V131, P2215, DOI 10.1002/ijc.27642; Hu GK, 2010, J INFECT DIS, V202, P125, DOI 10.1086/653212; Hu HJ, 2012, ACTA BIOCH BIOPH SIN, V44, P424, DOI [10.1093/abbs/gms018, 10.1093/abbs/gms018.]; Huang Y, 2012, NUCLEIC ACIDS RES, V40, P10478, DOI 10.1093/nar/gks789; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Ilboudo H, 2011, MICROBES INFECT, V13, P943, DOI 10.1016/j.micinf.2011.05.007; Jacobs RT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001151; Jamonneau V, 2004, ANN TROP MED PARASIT, V98, P329, DOI 10.1179/000349804225003406; Jamonneau V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001691; Jamonneau V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000917; Jusufovic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045577; Kallio MA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-507; KAZYUMBA G, 1986, CLIN EXP IMMUNOL, V65, P10; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; LAMBERT PH, 1981, J CLIN INVEST, V67, P77, DOI 10.1172/JCI110035; Lejon V, 2002, T ROY SOC TROP MED H, V96, P329, DOI 10.1016/S0035-9203(02)90115-X; Leonardo TR, 2012, NAT CELL BIOL, V14, P1114, DOI 10.1038/ncb2613; Liston A, 2012, CELL MOL LIFE SCI, V69, P3533, DOI 10.1007/s00018-012-1124-0; Liu YH, 2011, MOL IMMUNOL, V48, P1084, DOI 10.1016/j.molimm.2011.02.001; MacLean L, 2007, J INFECT DIS, V196, P1620, DOI 10.1086/522011; Maina N, 2004, INFECT IMMUN, V72, P3063, DOI 10.1128/IAI.72.5.3063-3065.2004; Morrison LJ, 2010, INFECT IMMUN, V78, P1096, DOI 10.1128/IAI.00943-09; Njiru ZK, 2008, INT J PARASITOL, V38, P589, DOI 10.1016/j.ijpara.2007.09.006; OKOMOASSOUMOU MC, 1995, AM J TROP MED HYG, V53, P539, DOI 10.4269/ajtmh.1995.53.539; Radwanska M, 2002, AM J TROP MED HYG, V67, P289, DOI 10.4269/ajtmh.2002.67.289; Rhind SG, 1997, CLIN IMMUNOL IMMUNOP, V83, P185, DOI 10.1006/clin.1997.4350; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001007; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; Stelzer Gil, 2011, Human Genomics, V5, P709; Sternberg J, 2010, PARASITOLOG IN PRESS; Tiberti N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040909; Vickers K.C., 2012, HEPATOLOGY; Wang JX, 2012, STEM CELLS, V30, P1405, DOI 10.1002/stem.1121; Wastling SL, 2011, PARASITOLOGY, V138, P1480, DOI 10.1017/S0031182011000230; Zeiner GM, 2010, RNA, V16, P1268, DOI 10.1261/rna.2069310; Zeiner GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008742; Zhang Z, 2012, OSTEOARTHR CARTILAGE, V20, P1638, DOI 10.1016/j.joca.2012.08.024; Zhou R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002702	62	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67312	10.1371/journal.pone.0067312	http://dx.doi.org/10.1371/journal.pone.0067312			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826264	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000059
J	Zhang, H; Yang, Y; Takeda, A; Yoshimura, T; Oshima, Y; Sonoda, KH; Ishibashi, T				Zhang, Han; Yang, Yang; Takeda, Atsunobu; Yoshimura, Takeru; Oshima, Yuji; Sonoda, Koh-Hei; Ishibashi, Tatsuro			A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VIVO ANGIOGENESIS; MACULAR DEGENERATION; CYTOKINE PRODUCTION; VEGF EXPRESSION; GENE-EXPRESSION; BINDING-SITES; FACTOR PAF; CELLS; RAT	Choroidal neovascularization (CNV) is a critical pathogenesis in age-related macular degeneration (AMD), the most common cause of blindness in developed countries. To date, the precise molecular and cellular mechanisms underlying CNV have not been elucidated. Platelet-activating factor (PAF) has been previously implicated in angiogenesis; however, the roles of PAF and its receptor (PAF-R) in CNV have not been addressed. The present study reveals several important findings concerning the relationship of the PAF-R signaling with CNV. PAF-R was detected in a mouse model of laser-induced CNV and was upregulated during CNV development. Experimental CNV was suppressed by administering WEB2086, a novel PAF-R antagonist. WEB2086-dependent suppression of CNV occurred via the inhibition of macrophage infiltration and the expression of proangiogenic (vascular endothelial growth factor) and proinflammatory molecules (monocyte chemotactic protein-1 and IL-6) in the retinal pigment epithelium-choroid complex. Additionally, WEB2086-induced PAF-R blockage suppresses experimentally induced subretinal fibrosis, which resembles the fibrotic subretinal scarring observed in neovascular AMD. As optimal treatment modalities for neovascular AMD would target the multiple mechanisms of AMD-associated vision loss, including neovascularization, inflammation and fibrosis, our results suggest PAF-R as an attractive molecular target in the treatment of AMD.	[Zhang, Han; Yang, Yang; Takeda, Atsunobu; Yoshimura, Takeru; Oshima, Yuji; Ishibashi, Tatsuro] Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka, Japan; [Zhang, Han] China Med Univ, Hosp 1, Dept Ophthalmol, Shenyang, Peoples R China; [Sonoda, Koh-Hei] Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, Ube, Yamaguchi 755, Japan	Kyushu University; China Medical University; Yamaguchi University	Zhang, H (corresponding author), Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Fukuoka, Japan.	zhanghan0614@139.com		Zhang, Han/0000-0002-9338-0051; Yoshimura, Takeru/0000-0002-5983-7193	Ministry of Education, Science, Sports and Culture of Japan; Grants-in-Aid for Scientific Research [23689071] Funding Source: KAKEN	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants C (K-H. S.) and grant-in-aid for Young Scientists (A) (A. T.) from the Ministry of Education, Science, Sports and Culture of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aponte M, 2008, CANCER RES, V68, P5839, DOI 10.1158/0008-5472.CAN-07-5771; BITO H, 1994, EUR J BIOCHEM, V221, P211, DOI 10.1111/j.1432-1033.1994.tb18731.x; BRAQUET P, 1989, J LIPID MEDIATOR, V1, P75; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; BUSSOLINO F, 1995, J CLIN INVEST, V96, P940, DOI 10.1172/JCI118142; CAMUSSI G, 1995, J IMMUNOL, V154, P6492; Camussi G, 1997, J IMMUNOL, V158, P1302; CASALSSTENZEL J, 1987, J PHARMACOL EXP THER, V241, P974; Chen J, 1997, J PHARMACOL EXP THER, V280, P1219; COHEN RA, 1994, CURR EYE RES, V13, P139, DOI 10.3109/02713689409042408; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Doi K, 2006, AM J PATHOL, V168, P1413, DOI 10.2353/ajpath.2006.050634; DOMINGO MT, 1989, BIOCHEM BIOPH RES CO, V160, P250, DOI 10.1016/0006-291X(89)91648-3; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; Fukuda AI, 1996, HUM REPROD, V11, P2746; Funatsu H, 2005, GRAEF ARCH CLIN EXP, V243, P3, DOI 10.1007/s00417-004-0950-7; GIRI SN, 1995, EXP LUNG RES, V21, P287, DOI 10.3109/01902149509068833; Grisanti S, 2008, PROG RETIN EYE RES, V27, P372, DOI 10.1016/j.preteyeres.2008.05.002; Grossniklaus HE, 2002, MOL VIS, V8, P119; He YG, 2009, CURR EYE RES, V34, P957, DOI 10.3109/02713680903231135; Holtkamp GM, 2001, PROG RETIN EYE RES, V20, P29, DOI 10.1016/S1350-9462(00)00017-3; Honda Z, 2002, J BIOCHEM, V131, P773, DOI 10.1093/oxfordjournals.jbchem.a003164; Hwang JC, 2011, OPHTHAL SURG LAS IM, V42, DOI 10.3928/15428877-20100924-01; Ishibashi T, 1997, GRAEF ARCH CLIN EXP, V235, P159, DOI 10.1007/BF00941723; Izumi T, 1995, BBA-LIPID LIPID MET, V1259, P317, DOI 10.1016/0005-2760(95)00171-9; Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018; Jo YJ, 2011, INVEST OPHTH VIS SCI, V52, P6089, DOI 10.1167/iovs.10-5189; Kasperska-Zajac A, 2008, INFLAMMATION, V31, P112, DOI 10.1007/s10753-007-9056-9; Kent D, 2003, MOL VIS, V9, P747; Kim HA, 2011, CELL PHYSIOL BIOCHEM, V27, P55, DOI 10.1159/000325205; Ko HM, 2002, CANCER RES, V62, P1809; Ma X, 2004, INVEST OPHTH VIS SCI, V45, P2915, DOI 10.1167/iovs.04-0128; Ma X, 2000, INVEST OPHTH VIS SCI, V41, P1696; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Montrucchio G, 2000, PHYSIOL REV, V80, P1669, DOI 10.1152/physrev.2000.80.4.1669; MONTRUCCHIO G, 1994, J EXP MED, V180, P377, DOI 10.1084/jem.180.1.377; Montrucchio G, 2000, ARTERIOSCL THROM VAS, V20, P80, DOI 10.1161/01.ATV.20.1.80; Montrucchio G, 1998, AM J PATHOL, V153, P1589, DOI 10.1016/S0002-9440(10)65747-1; Mori M, 1997, INVEST OPHTH VIS SCI, V38, P2672; Nagai N, 2006, ARTERIOSCL THROM VAS, V26, P2252, DOI 10.1161/01.ATV.0000240050.15321.fe; Nilsson G, 2000, IMMUNOLOGY, V99, P314, DOI 10.1046/j.1365-2567.2000.00972.x; Ogata M, 2004, ANESTH ANALG, V98, P1767, DOI 10.1213/01.ANE.0000112310.93297.AF; Proudfoot JM, 2003, J PHARMACOL EXP THER, V305, P846, DOI 10.1124/jpet.102.047795; Robert EG, 2001, CURR PHARM DESIGN, V7, P1615, DOI 10.2174/1381612013397203; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rosenfeld PJ, 2011, OPHTHALMOLOGY, V118, P523, DOI 10.1016/j.ophtha.2010.07.011; Ruiz-Ortega M, 1998, NEPHROL DIAL TRANSPL, V13, P886, DOI 10.1093/ndt/13.4.886; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; Semkova I, 2003, INVEST OPHTH VIS SCI, V44, P5349, DOI 10.1167/iovs.02-0732; Sirois MG, 1997, AM J PHYSIOL-HEART C, V272, pH2746, DOI 10.1152/ajpheart.1997.272.6.H2746; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; THIERRY A, 1989, EUR J PHARMACOL, V163, P97, DOI 10.1016/0014-2999(89)90400-7; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Tsutsumi-Miyahara C, 2004, BRIT J OPHTHALMOL, V88, P1217, DOI 10.1136/bjo.2003.036392; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yang HH, 1997, J IMMUNOL, V158, P2771; Yang Y, 2004, GUT, V53, P877, DOI 10.1136/gut.2003.024893; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zhang H, 2009, BIOCHEM BIOPH RES CO, V381, P471, DOI 10.1016/j.bbrc.2009.01.178	61	23	23	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68173	10.1371/journal.pone.0068173	http://dx.doi.org/10.1371/journal.pone.0068173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826375	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000129
J	Drolet, M; Boily, MC; Van de Velde, N; Franco, EL; Brisson, M				Drolet, Melanie; Boily, Marie-Claude; Van de Velde, Nicolas; Franco, Eduardo L.; Brisson, Marc			Vaccinating Girls and Boys with Different Human Papillomavirus Vaccines: Can It Optimise Population-Level Effectiveness?	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; HPV VACCINATION; GENITAL WARTS; INTRAEPITHELIAL NEOPLASIA; ECONOMIC-EVALUATION; COST-EFFECTIVENESS; NATURAL-HISTORY; QUADRIVALENT; WOMEN; INFECTION	Background: Decision-makers may consider vaccinating girls and boys with different HPV vaccines to benefit from their respective strengths; the quadrivalent (HPV4) prevents anogenital warts (AGW) whilst the bivalent (HPV2) may confer greater cross-protection. We compared, to a girls-only vaccination program with HPV4, the impact of vaccinating: 1) both genders with HPV4, and 2) boys with HPV4 and girls with HPV2. Methods: We used an individual-based transmission-dynamic model of heterosexual HPV infection and diseases. Our base-case scenario assumed lifelong efficacy of 100% against vaccine types, and 46,29,8,18,6% and 77,43,79,8,0% efficacy against HPV-31,-33,-45,-52,-58 for HPV4 and HPV2, respectively. Results: Assuming 70% vaccination coverage and lifelong cross-protection, vaccinating boys has little additional benefit on AGW prevention, irrespective of the vaccine used for girls. Furthermore, using HPV4 for boys and HPV2 for girls produces greater incremental reductions in SCC incidence than using HPV4 for both genders (12 vs 7 percentage points). At 50% vaccination coverage, vaccinating boys produces incremental reductions in AGW of 17 percentage points if both genders are vaccinated with HPV4, but increases female incidence by 16 percentage points if girls are switched to HPV2 (heterosexual male incidence is incrementally reduced by 24 percentage points in both scenarios). Higher incremental reductions in SCC incidence are predicted when vaccinating boys with HPV4 and girls with HPV2 versus vaccinating both genders with HPV4 (16 vs 12 percentage points). Results are sensitive to vaccination coverage and the relative duration of protection of the vaccines. Conclusion: Vaccinating girls with HPV2 and boys with HPV4 can optimize SCC prevention if HPV2 has higher/longer cross-protection, but can increase AGW incidence if vaccination coverage is low among boys.	[Drolet, Melanie; Van de Velde, Nicolas; Brisson, Marc] Hop St Sacrement, Ctr Rech CHU Quebec, Quebec City, PQ, Canada; [Drolet, Melanie; Van de Velde, Nicolas; Brisson, Marc] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada; [Boily, Marie-Claude; Brisson, Marc] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Franco, Eduardo L.] McGill Univ, Div Canc Epidemiol, Montreal, PQ, Canada	Laval University; Laval University; Imperial College London; McGill University	Brisson, M (corresponding author), Hop St Sacrement, Ctr Rech CHU Quebec, Quebec City, PQ, Canada.	marc.brisson@uresp.ulaval.ca	; Franco, Eduardo/C-6445-2014	Boily, Marie-Claude/0000-0003-3919-006X; Franco, Eduardo/0000-0002-4409-8084	Canada Research Chairs program; Canadian Institutes of Health Research [83320]; Merck Frosst; GlaxoSmithKline; Sanofi Aventis MSD; Merck	Canada Research Chairs program(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Merck Frosst; GlaxoSmithKline(GlaxoSmithKline); Sanofi Aventis MSD; Merck(Merck & Company)	This work was supported by the Canada Research Chairs program (support for MB) and a team grant from the Canadian Institutes of Health Research (grant no. 83320). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MB has consulted and received reimbursement for travel expenses from Merck Frosst and GlaxoSmithKline. NVdV has consulted for Sanofi Aventis MSD and Merck. ELF has served as occasional consultant to companies involved with HPV vaccination (Merck and GlaxoSmithKline). MD and MCB have no conflicts of interest to declare.	Ades S, 2008, INT J CANCER, V122, P2820, DOI 10.1002/ijc.23459; Australian Government, 2011, THER GOODS ADM AUSTR; Backes DM, 2009, CANCER CAUSE CONTROL, V20, P449, DOI 10.1007/s10552-008-9276-9; Bauer HM, 2012, AM J PUBLIC HEALTH, V102, P833, DOI 10.2105/AJPH.2011.300465; BC Cancer Agency, 2009, CERV CANC SCREEN PRO; Berenson AB, 2012, J PEDIATR ADOL GYNEC, V25, P218, DOI 10.1016/j.jpag.2012.01.003; Bogaards JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001147; Brisson M, 2011, J INFECT DIS, V204, P372, DOI 10.1093/infdis/jir285; Brisson M, 2009, PUBLIC HEALTH GENOM, V12, P343, DOI 10.1159/000214924; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Cancer Research UK HPV vaccines, 2013, HPV VACC PROGR; Chesson HW, 2011, VACCINE, V29, P8443, DOI 10.1016/j.vaccine.2011.07.096; Colucci R, 2011, HPV VACCINATION PROG; Comite sur l'immunisation du Quebec (CIQ), VACC VPH QUEB MIS JO; Coutlee F, 2011, J MED VIROL, V83, P1034, DOI 10.1002/jmv.22081; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116; Demers A, 2009, EPIDEMIOLOGY CERVICA; Donovan B, 2011, LANCET INFECT DIS, V11, P39, DOI 10.1016/S1473-3099(10)70225-5; Drolet M, 2012, PSYCHO-ONCOLOGY, V21, P1071, DOI 10.1002/pon.2003; Drolet M, 2011, SEX TRANSM DIS, V38, P949, DOI 10.1097/OLQ.0b013e3182215512; Einstein MH, 2011, HUM VACCINES, V7, P1343, DOI 10.4161/hv.7.12.18281; Elbasha EH, 2010, VACCINE, V28, P6858, DOI 10.1016/j.vaccine.2010.08.030; Fairley CK, 2009, SEX TRANSM INFECT, V85, P499, DOI 10.1136/sti.2009.037788; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garland SM, 2009, J INFECT DIS, V199, P805, DOI 10.1086/597071; Georgousakis M, 2012, LANCET INFECT DIS, V12, P627, DOI 10.1016/S1473-3099(12)70031-2; Gillison ML, 2008, CANCER-AM CANCER SOC, V113, P3036, DOI 10.1002/cncr.23764; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Grulich AE, 2003, AUST NZ J PUBL HEAL, V27, P155, DOI 10.1111/j.1467-842X.2003.tb00803.x; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kim JJ, 2008, VACCINE, V26, pK76, DOI 10.1016/j.vaccine.2008.06.009; Kliewer E, 2008, 20 YEAR TRENDS 1985; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Liddon N, 2010, J ADOLESCENT HEALTH, V46, P113, DOI 10.1016/j.jadohealth.2009.11.199; Liu S, 2001, INT J GYNECOL CANCER, V11, P24, DOI 10.1046/j.1525-1438.2001.011001024.x; Malagon T, 2012, LANCET INFECT DIS, V12, P781, DOI 10.1016/S1473-3099(12)70187-1; Mayrand MH, 2006, INT J CANCER, V119, P615, DOI 10.1002/ijc.21897; Naud P, 2011, 27 INT PAP C CLIN WO; Olsen J, 2010, INT J TECHNOL ASSESS, V26, P183, DOI 10.1017/S0266462310000085; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; POU AM, 1995, ANN OTO RHINOL LARYN, V104, P758, DOI 10.1177/000348949510401002; Public Health Agency of Canada, 2012, 38 PUBL HLTH AG CAN; Public Health Agency of Canada, 2011, CANC SURV ON LIN; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Read TRH, 2011, SEX TRANSM INFECT, V87, P544, DOI 10.1136/sextrans-2011-050234; Richardson H, 2003, CANCER EPIDEM BIOMAR, V12, P485; Romanowski B, 2010, 26 INT PAP C CLIN WO; Roteli-Martins CM, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.18865; Statistics Canada, 2005, CAN HLTH SURV CCHS C; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222; U.S. Food and Drug Administration, 2009, COT 16 2009 APPR LET; Van de Velde N, 2012, JNCI-J NATL CANCER I, V104, P1712, DOI 10.1093/jnci/djs395; Van de Velde N, 2010, VACCINE, V28, P5473, DOI 10.1016/j.vaccine.2010.05.056	57	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67072	10.1371/journal.pone.0067072	http://dx.doi.org/10.1371/journal.pone.0067072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840589	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400068
J	Lee, WC				Lee, Wen-Chung			Assessing Causal Mechanistic Interactions: A Peril Ratio Index of Synergy Based on Multiplicativity	PLOS ONE			English	Article							SUFFICIENT CAUSES MODEL; ADDITIVE INTERACTION; RISKS; RATES	The assessments of interactions in epidemiology have traditionally been based on risk-ratio, odds-ratio or rate-ratio multiplicativity. However, many epidemiologists fail to recognize that this is mainly for statistical conveniences and often will misinterpret a statistically significant interaction as a genuine mechanistic interaction. The author adopts an alternative metric system for risk, the 'peril'. A peril is an exponentiated cumulative rate, or simply, the inverse of a survival (risk complement) or one plus an odds. The author proposes a new index based on multiplicativity of peril ratios, the 'peril ratio index of synergy based on multiplicativity' (PRISM). Under the assumption of no redundancy, PRISM can be used to assess synergisms in sufficient cause sense, i.e., causal co-actions or causal mechanistic interactions. It has a less stringent threshold to detect a synergy as compared to a previous index of 'relative excess risk due to interaction'. Using the new PRISM criterion, many situations in which there is not evidence of interaction judged by the traditional indices are in fact corresponding to bona fide positive or negative synergisms.	[Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan; [Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Lee, WC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan.	wenchung@ntu.edu.tw		Lee, Wen-Chung/0000-0003-3171-7672	National Science Council, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This paper is partly supported by grants from the National Science Council, Taiwan. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD R, 1993, EPIDEMIOLOGY, V4, P517, DOI 10.1097/00001648-199311000-00007; ALLARD R, 1993, EPIDEMIOLOGY, V4, P37, DOI 10.1097/00001648-199301000-00008; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Gatto Nicolle M, 2010, Epidemiol Perspect Innov, V7, P5, DOI 10.1186/1742-5573-7-5; Greene W, 2010, ECON LETT, V107, P291, DOI 10.1016/j.econlet.2010.02.014; Greenland S, 2002, INT J EPIDEMIOL, V31, P1030, DOI 10.1093/ije/31.5.1030; Khoury MJ, 1996, AM J EPIDEMIOL, V144, P207; Lee WC, 2013, EPIDEMIOLOGY, V24, P174, DOI 10.1097/EDE.0b013e318277f122; Lee WC, 2012, EPIDEMIOLOGY, V23, P446, DOI 10.1097/EDE.0b013e31824ea1d8; Li RL, 2007, ANN EPIDEMIOL, V17, P227, DOI 10.1016/j.annepidem.2006.10.009; Liao SF, 2010, ANN EPIDEMIOL, V20, P568, DOI 10.1016/j.annepidem.2010.04.003; Madsen AM, 2011, HUM HERED, V72, P63, DOI 10.1159/000330780; Rothman K, 1986, MODERN EPIDEMIOLOGY; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Suzuki E, 2012, AM J EPIDEMIOL, V175, P567, DOI 10.1093/aje/kwr333; Suzuki E, 2011, EPIDEMIOLOGY, V22, P131, DOI 10.1097/EDE.0b013e3181febc5c; Vanderweele TJ, 2008, BIOMETRIKA, V95, P49, DOI 10.1093/biomet/asm090; VanderWeele TJ, 2007, EPIDEMIOLOGY, V18, P329, DOI 10.1097/01.ede.0000260218.66432.88; VanderWeele TJ, 2011, BIOMETRICS, V67, P1414, DOI 10.1111/j.1541-0420.2011.01629.x; VanderWeele TJ, 2011, EPIDEMIOLOGY, V22, P713, DOI 10.1097/EDE.0b013e31821db503; VanderWeele TJ, 2011, AM J EPIDEMIOL, V173, P1140, DOI 10.1093/aje/kwr009; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P6, DOI 10.1097/EDE.0b013e31818f69e7; Wang JF, 2010, INT J GEOGR INF SCI, V24, P107, DOI 10.1080/13658810802443457; Wang TE, 2010, EPIDEMIOLOGY, V21, P726, DOI 10.1097/EDE.0b013e3181e94274; Weinberg CR, 2009, GENOMICS, V93, P10, DOI 10.1016/j.ygeno.2008.06.002; Weinberg CR, 2007, EPIDEMIOLOGY, V18, P569, DOI 10.1097/EDE.0b013e318126c11d; WEINBERG CR, 1986, AM J EPIDEMIOL, V123, P162, DOI 10.1093/oxfordjournals.aje.a114211; Zou GY, 2008, AM J EPIDEMIOL, V168, P212, DOI 10.1093/aje/kwn104	28	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67424	10.1371/journal.pone.0067424	http://dx.doi.org/10.1371/journal.pone.0067424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826299	gold, Green Submitted, Green Published			2022-12-27	WOS:000321738400146
J	Sonnweber, RS; Stobbe, N; Romero, OZ; Slice, DE; Fieder, M; Wallner, B				Sonnweber, Ruth S.; Stobbe, Nina; Romero, Olmo Zavala; Slice, Dennis E.; Fieder, Martin; Wallner, Bernard			A New Method for the Analysis of Soft Tissues with Data Acquired under Field Conditions	PLOS ONE			English	Article							MACAQUES MACACA-SYLVANUS; GEOMETRIC MORPHOMETRICS; SHAPE; REVOLUTION; SWELLINGS; BIOLOGY; SIZE	Analyzing soft-tissue structures is particularly challenging due to the lack of homologous landmarks that can be reliably identified across time and specimens. This is particularly true when data are to be collected under field conditions. Here, we present a method that combines photogrammetric techniques and geometric morphometrics methods (GMM) to quantify soft tissues for their subsequent volumetric analysis. We combine previously developed methods for landmark data acquisition and processing with a custom program for volumetric computations. Photogrammetric methods are a particularly powerful tool for field studies as they allow for image acquisition with minimal equipment requirements and for the acquisition of the spatial coordinates of points (anatomical landmarks or others) from these images. For our method, a limited number of homologous landmarks, i.e., points that can be found on any specimen independent of space and time, and further distinctive points, which may vary over time, space and subject, are identified on two-dimensional photographs and their three-dimensional coordinates estimated using photogrammetric methods. The three-dimensional configurations are oriented by the spatial principal components (PCs) of the homologous points. Crucially, this last step orients the configuration such that x and y-information (PC1 and PC2 coordinates) constitute an anatomically-defined plane with the z-values (PC3 coordinate) in the direction of interest for volume computation. The z-coordinates are then used to estimate the volume of the tissue. We validate our method using a physical, geometric model of known dimensions and physical (wax) models designed to approximate perineal swellings in female macaques. To demonstrate the usefulness and potential of our method, we use it to estimate the volumes of Barbary macaque sexual swellings recorded in the field with video images. By analyzing both the artificial data and real monkey swellings, we validate our method's accuracy and illustrate its potential for application in important areas of biological research.	[Sonnweber, Ruth S.; Stobbe, Nina] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Romero, Olmo Zavala; Slice, Dennis E.] Florida State Univ, Dept Comp Sci, Tallahassee, FL 32306 USA; [Slice, Dennis E.; Fieder, Martin; Wallner, Bernard] Univ Vienna, Dept Anthropol, Vienna, Austria; [Sonnweber, Ruth S.] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Vienna; State University System of Florida; Florida State University; University of Vienna; University of Vienna	Sonnweber, RS (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	ruth-sophie.sonnweber@univie.ac.at	Sonnweber, Ruth/AAV-3181-2020; Wallner, Bernard/B-1089-2009	Sonnweber, Ruth/0000-0001-9850-1492; Zavala-Romero, Olmo/0000-0001-7088-3820	ERC (European Research Council) [230604]	ERC (European Research Council)(European Research Council (ERC))	While writing the manuscript, Ruth Sonnweber and Nina Stobbe were supported by ERC (European Research Council) Advanced Grant SOMACCA (The Syntax of Mind: A Computational Comparative Apporach) (230604) awarded to W. Tecumseh Fitch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; BOOKSTEIN FL, 1982, ANNU REV ECOL SYST, V13, P451, DOI 10.1146/annurev.es.13.110182.002315; Buchanan B, 2010, J ARCHAEOL SCI, V37, P350, DOI 10.1016/j.jas.2009.09.047; Chiari Y, 2008, BIOL J LINN SOC, V95, P425, DOI 10.1111/j.1095-8312.2008.01055.x; de Bruyn PJN, 2009, AQUAT BIOL, V5, P31, DOI 10.3354/ab00135; Dixon AF, 1983, PRIMATE SEXUALITY CO; Hennessy RJ, 2002, BIOL PSYCHIAT, V51, P507, DOI 10.1016/S0006-3223(01)01327-0; Hennessy RJ, 2001, EUR J ORTHODONT, V23, P275, DOI 10.1093/ejo/23.3.275; KUSTER J, 1984, FOLIA PRIMATOL, V43, P69, DOI 10.1159/000156173; Mohle U, 2005, AM J PRIMATOL, V66, P351, DOI 10.1002/ajp.20161; Postma M, 2013, POLAR BIOL, V36, P719, DOI 10.1007/s00300-013-1298-4; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 2003, J HUM EVOL, V44, P665, DOI 10.1016/S0047-2484(03)00047-2; Rohlf FJ, 2000, AM J PHYS ANTHROPOL, V111, P463, DOI 10.1002/(SICI)1096-8644(200004)111:4<463::AID-AJPA3>3.0.CO;2-B; Rohlf FJ, 2008, NTSYSPC NUMERICAL TA; Schaefer Katrin, 2009, Biology Theory, V4, P98, DOI 10.1162/biot.2009.4.1.98; Sheets HD, PRACTICAL COMPANION; SLICE DE, 1998, SOFTWARE MORPHOMETRI; Waite JN, 2009, POLAR BIOL, V32, P1221, DOI 10.1007/s00300-009-0649-7; Wallner B, 2006, NEUROENDOCRINOL LETT, V27, P253; Zinner D, 2002, NATURE, V420, P142, DOI 10.1038/420142a	21	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67521	10.1371/journal.pone.0067521	http://dx.doi.org/10.1371/journal.pone.0067521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826315	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400155
J	MacKay, KB; Tu, YP; Young, SG; Clarke, SG				MacKay, Kennen B.; Tu, Yiping; Young, Stephen G.; Clarke, Steven G.			Circumventing Embryonic Lethality with Lcmt1 Deficiency: Generation of Hypomorphic Lcmt1 Mice with Reduced Protein Phosphatase 2A Methyltransferase Expression and Defects in Insulin Signaling	PLOS ONE			English	Article							LEUCINE CARBOXYL METHYLTRANSFERASE; PP2A CATALYTIC SUBUNIT; MIDDLE TUMOR-ANTIGEN; TAU-HYPERPHOSPHORYLATION; REGULATORY SUBUNITS; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; ALPHA SUBUNIT; OKADAIC ACID; BOVINE BRAIN	Protein phosphatase 2A (PP2A), the major serine/threonine phosphatase in eukaryotic cells, is a heterotrimeric protein composed of structural, catalytic, and targeting subunits. PP2A assembly is governed by a variety of mechanisms, one of which is carboxyl-terminal methylation of the catalytic subunit by the leucine carboxyl methyltransferase LCMT1. PP2A is nearly stoichiometrically methylated in the cytosol, and although some PP2A targeting subunits bind independently of methylation, this modification is required for the binding of others. To examine the role of this methylation reaction in mammalian tissues, we generated a mouse harboring a gene-trap cassette within intron 1 of Lcmt1. Due to splicing around the insertion, Lcmt1 transcript and LCMT1 protein levels were reduced but not eliminated. LCMT1 activity and methylation of PP2A were reduced in a coordinate fashion, suggesting that LCMT1 is the only PP2A methyltransferase. These mice exhibited an insulin-resistance phenotype, indicating a role for this methyltransferase in signaling in insulin-sensitive tissues. Tissues from these animals will be vital for the in vivo identification of methylation-sensitive substrates of PP2A and how they respond to differing physiological conditions.	[MacKay, Kennen B.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [MacKay, Kennen B.; Young, Stephen G.; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Tu, Yiping; Young, Stephen G.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Young, Stephen G.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	clarke@mbi.ucla.edu		Young, Stephen/0000-0001-7270-3176	National Institutes of Health [GM026020, AG035626]; Ellison Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL090553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020, R37GM026020, T32GM007185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG035626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by National Institutes of Health grants GM026020 and AG035626 (www.nih.gov) and by the Ellison Medical Foundation (www.ellisonfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Bononi A, 2011, ENZYME RES, V2011, DOI [10.4061/2011/329098, DOI 10.4061/2011/329098]; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; Caenepeel S, 2004, P NATL ACAD SCI USA, V101, P11707, DOI 10.1073/pnas.0306880101; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chung HY, 1999, BIOCHEMISTRY-US, V38, P10371, DOI 10.1021/bi990902g; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; Deters N, 2009, BIOCHEM BIOPH RES CO, V379, P400, DOI 10.1016/j.bbrc.2008.12.140; Dissmeyer N, 2011, METHODS MOL BIOL, V779, P7, DOI 10.1007/978-1-61779-264-9_2; Dogan RI, 2007, NUCLEIC ACIDS RES, V35, pW285, DOI 10.1093/nar/gkm407; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Fellner T, 2003, GENE DEV, V17, P2138, DOI 10.1101/gad.259903; FLOER M, 1994, BIOCHEM BIOPH RES CO, V198, P372, DOI 10.1006/bbrc.1994.1052; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Godet AN, 2011, M S-MED SCI, V27, P1106, DOI 10.1051/medsci/20112712017; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Gu PY, 2012, GENESIS, V50, P429, DOI 10.1002/dvg.20815; Guenin S, 2008, INT J ONCOL, V32, P49; GUO H, 1993, J BIOL CHEM, V268, P11193; GUO H, 1993, P NATL ACAD SCI USA, V90, P2500, DOI 10.1073/pnas.90.6.2500; Himsworth HP, 2011, DIABETIC MED, V28, P1440, DOI 10.1111/j.1464-5491.2011.3508.x; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Jackson JB, 2012, NEOPLASIA, V14, P585, DOI 10.1593/neo.12768; Jangati GR, 2007, ENDOCRINE, V31, P248, DOI 10.1007/s12020-007-0046-3; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jin J, 2012, PHILOS T R SOC B, V367, P2540, DOI 10.1098/rstb.2012.0106; Jin Z, 2009, J BIOL CHEM, V284, P7190, DOI 10.1074/jbc.M807907200; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lee J, 1996, P NATL ACAD SCI USA, V93, P6043, DOI 10.1073/pnas.93.12.6043; Lee JA, 2007, J BIOL CHEM, V282, P30974, DOI 10.1074/jbc.M704861200; LI M, 1994, BIOCHEM BIOPH RES CO, V202, P1023, DOI 10.1006/bbrc.1994.2031; Liu R, 2008, J CELL MOL MED, V12, P241, DOI 10.1111/j.1582-4934.2008.00249.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longin S, 2008, EXP CELL RES, V314, P68, DOI 10.1016/j.yexcr.2007.07.030; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Lowenson JD, 2001, J BIOL CHEM, V276, P20695, DOI 10.1074/jbc.M100987200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo Y, 2007, NEUROREPORT, V18, P2005, DOI 10.1097/WNR.0b013e3282f29100; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mayer BJ, 2012, FEBS LETT, V586, P2575, DOI 10.1016/j.febslet.2012.05.002; Mayfield J, 1998, AM FAM PHYSICIAN, V58, P1355; Medina M, 2010, CURR PHARM DESIGN, V16, P2790, DOI 10.2174/138161210793176581; Mumby M, 2001, SCI STKE SIGNAL TRAN; Mumby M, 2007, ACS CHEM BIOL, V2, P99, DOI 10.1021/cb700021z; Ni YG, 2007, P NATL ACAD SCI USA, V104, P20517, DOI 10.1073/pnas.0610290104; Nolan CJ, 2010, J GASTROEN HEPATOL, V25, P1594, DOI 10.1111/j.1440-1746.2010.06473.x; Nord AS, 2006, NUCLEIC ACIDS RES, V34, pD642, DOI 10.1093/nar/gkj097; Ogris E, 1997, ONCOGENE, V15, P911, DOI 10.1038/sj.onc.1201259; Ortega-Gutierrez S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002486; Palanivel R, 2004, AM J PHYSIOL-ENDOC M, V286, pE1032, DOI 10.1152/ajpendo.00587.2003; Petritsch C, 2000, GENE DEV, V14, P3093, DOI 10.1101/gad.854200; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Ruediger R, 2011, MOL CELL BIOL, V31, P3832, DOI 10.1128/MCB.05744-11; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sents W, 2012, FEBS J; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shi YG, 2009, SCI CHINA SER C, V52, P135, DOI 10.1007/s11427-009-0018-3; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P287, DOI 10.1093/jnen/63.4.287; Sontag E, 2004, J NEUROPATH EXP NEUR, V63, P1080, DOI 10.1093/jnen/63.10.1080; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Sontag JM, 2010, J NEUROCHEM, V115, P1455, DOI 10.1111/j.1471-4159.2010.07049.x; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Tremblay ML, 2008, CELL METAB, V7, P101, DOI 10.1016/j.cmet.2008.01.004; Tsai ML, 2011, ACTA CRYSTALLOGR D, V67, P14, DOI 10.1107/S0907444910042204; Vafai SB, 2002, FEBS LETT, V518, P1, DOI 10.1016/S0014-5793(02)02702-3; Vazquez-Higuera Jose L, 2011, BMC Res Notes, V4, P327, DOI 10.1186/1756-0500-4-327; Wei HJ, 2001, J BIOL CHEM, V276, P1570, DOI 10.1074/jbc.M008694200; Wu J, 2000, EMBO J, V19, P5672, DOI 10.1093/emboj/19.21.5672; XIE HY, 1994, J BIOL CHEM, V269, P1981; Xiong Y, 2013, NEUROBIOL AGING, V34, P745, DOI 10.1016/j.neurobiolaging.2012.07.003; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yang J, 2010, LIFE SCI, V87, P659, DOI 10.1016/j.lfs.2010.10.003; Yu XX, 2001, MOL BIOL CELL, V12, P185, DOI 10.1091/mbc.12.1.185; Zdychova J, 2005, PHYSIOL RES, V54, P1, DOI 10.33549/physiolres.930582; Zhou XW, 2008, NEUROBIOL DIS, V31, P386, DOI 10.1016/j.nbd.2008.05.013; Zwaenepoel K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-393	84	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65967	10.1371/journal.pone.0065967	http://dx.doi.org/10.1371/journal.pone.0065967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840384	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800024
J	Reddy, V; Markova, G; Wallot, S				Reddy, Vasudevi; Markova, Gabriela; Wallot, Sebastian			Anticipatory Adjustments to Being Picked Up in Infancy	PLOS ONE			English	Article							POSTURAL ADJUSTMENTS; EYE; ATTENTION; ABILITY; OBJECT; AUTISM; HAND; FACE	Anticipation of the actions of others is often used as a measure of action understanding in infancy. In contrast to studies of action understanding which set infants up as observers of actions directed elsewhere, in the present study we explored anticipatory postural adjustments made by infants to one of the most common adult actions directed to them - picking them up. We observed infant behavioural changes and recorded their postural shifts on a pressure mat in three phases: (i) a prior Chat phase, (ii) from the onset of Approach of the mother's arms, and (iii) from the onset of Contact. In Study 1, eighteen 3-month-old infants showed systematic global postural changes during Approach and Contact, but not during Chat. There was an increase in specific adjustments of the arms (widening or raising) and legs (stiffening and extending or tucking up) during Approach and a decrease in thrashing/general movements during Contact. Shifts in postural stability were evident immediately after onset of Approach and more slowly after Contact, with no regular shifts during Chat. In Study 2 we followed ten infants at 2, 3 and 4 months of age. Anticipatory behavioural adjustments during Approach were present at all ages, but with greater differentiation from a prior Chat phase only at 3 and 4 months. Global postural shifts were also more phase differentiated in older infants. Moreover, there was significantly greater gaze to the mother's hands during Approach at 4 months. Early anticipatory adjustments to being picked up suggest that infants' awareness of actions directed to the self may occur earlier than of those directed elsewhere, and thus enable infants' active participation in joint actions from early in life.	[Reddy, Vasudevi] Univ Portsmouth, Portsmouth, Hants, England; [Markova, Gabriela] Acad Sci Czech Republ, Prague, Czech Republic; [Wallot, Sebastian] Aarhus Univ, Interacting Minds Ctr, Aarhus, Denmark	University of Portsmouth; Czech Academy of Sciences; Aarhus University	Reddy, V (corresponding author), Univ Portsmouth, Portsmouth, Hants, England.	vasu.reddy@port.ac.uk		Wallot, Sebastian/0000-0002-3626-3940; Markova, Gabriela/0000-0003-1092-0137	University of Portsmouth, United Kingdom; Marie-Curie Initial Training Network, "TESIS: Towards an Embodied Science of InterSubjectivity" [264828]; Czech Science Foundation [P407/10/P610]; Institute of Psychology ASCR [AV0Z70250504]	University of Portsmouth, United Kingdom; Marie-Curie Initial Training Network, "TESIS: Towards an Embodied Science of InterSubjectivity"; Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Psychology ASCR	The research was supported by the University of Portsmouth, United Kingdom. VR and SW were supported by the Marie-Curie Initial Training Network, "TESIS: Towards an Embodied Science of InterSubjectivity" (FP7-PEOPLE-2010-ITN, 264828). GM was supported by a grant of the Czech Science Foundation (P407/10/P610) and the Institute of Psychology ASCR (AV0Z70250504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S, 2004, INFANT BEHAV DEV, V27, P64, DOI 10.1016/j.infbeh.2003.06.005; [Anonymous], 2006, SUBJECTIVITY SELFHOO; ATKINSON J, 1984, HUM NEUROBIOL, V3, P61; Becchio C, 2010, CURR DIR PSYCHOL SCI, V19, P183, DOI 10.1177/0963721410370131; Bernstein N, 1967, COORDINATION REGULAT; Bertenthal B, 1998, NEUROSCI BIOBEHAV R, V22, P515, DOI 10.1016/S0149-7634(97)00038-9; BRADDICK OJ, 1983, BEHAV BRAIN RES, V10, P141, DOI 10.1016/0166-4328(83)90160-2; Brisson J, 2012, AUTISM, V16, P420, DOI 10.1177/1362361311423385; Cannon EN, 2012, DEVELOPMENTAL SCI, V15, P292, DOI 10.1111/j.1467-7687.2011.01127.x; Dusing SC, 2010, PHYS THER, V90, P1838, DOI 10.2522/ptj.2010033; Einspieler C, 2008, J PSYCHOL, V216, P148; Elsabbagh M, 2009, BIOL PSYCHIAT, V65, P31, DOI 10.1016/j.biopsych.2008.09.034; Falck-Ytter T, 2006, NAT NEUROSCI, V9, P878, DOI 10.1038/nn1729; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farroni T, 2007, COGNITION, V102, P396, DOI 10.1016/j.cognition.2006.01.007; Gallagher S, 2001, J CONSCIOUSNESS STUD, V8, P83; Gallese V, 2003, PSYCHOPATHOLOGY, V36, P171, DOI 10.1159/000072786; Gredeback G, 2010, COGNITION, V114, P197, DOI 10.1016/j.cognition.2009.09.004; Hadders-Algra M, 1998, NEUROSCI BIOBEHAV R, V22, P501, DOI 10.1016/S0149-7634(97)00036-5; Hadders-Algra Mijna, 2005, Neural Plasticity, V12, P99, DOI 10.1155/NP.2005.99; Hedberg A, 2004, EXP BRAIN RES, V157, P10, DOI 10.1007/s00221-003-1811-z; Kanakogi Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1342; Kanner L, 1943, NERV CHILD, V2, P217; LAMB ME, 1986, INT J BEHAV DEV, V9, P235, DOI 10.1177/016502548600900207; Leudar I, 2004, THEOR PSYCHOL, V14, P601, DOI 10.1177/0959354304046175; Lock A, 1984, LANGUAGE DEV, P39; Marwan N, 2011, INT J BIFURCAT CHAOS, V21, P1003, DOI 10.1142/S0218127411029008; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Penn DC, 2007, PHILOS T R SOC B, V362, P731, DOI 10.1098/rstb.2006.2023; Prechtl H., 1984, CONTINUITY NEURAL FU, P1; PRECHTL HFR, 1989, WENNER-GR C, V55, P59; Reddy V, 2003, TRENDS COGN SCI, V7, P397, DOI 10.1016/S1364-6613(03)00191-8; REDDY V., 2008, INFANTS KNOW MINDS; Reddy V, 2000, DEVELOPMENTAL SCI, V3, P186, DOI 10.1111/1467-7687.00112; Robertson SS, 2009, DEVELOPMENTAL SCI, V12, P297, DOI 10.1111/j.1467-7687.2008.00766.x; ROCHAT P, 1995, INFANT BEHAV DEV, V18, P53, DOI 10.1016/0163-6383(95)90007-1; Rosander K, 2011, NEUROPSYCHOLOGIA, V49, P2911, DOI 10.1016/j.neuropsychologia.2011.06.018; Saint-Georges C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022393; Schilbach L., BEHAV BRAIN IN PRESS; Service V., 1984, LANGUAGE DEV, P132; Sommerville JA, 2005, COGNITION, V96, pB1, DOI 10.1016/j.cognition.2004.07.004; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Trevarthen C, 1986, NATO ASI SER, P209; VONHOFSTEN C, 1993, HUM DEV, V36, P253, DOI 10.1159/000278212; VONHOFSTEN C, 1982, DEV PSYCHOL, V18, P450, DOI 10.1037/0012-1649.18.3.450; VONHOFSTEN C, 1984, DEV PSYCHOL, V20, P378, DOI 10.1037/0012-1649.20.3.378; Webber Jr C.L., 2005, TUTORIALS CONT NONLI, V94, P26; WHITE BL, 1964, CHILD DEV, V35, P349, DOI 10.1111/j.1467-8624.1964.tb05944.x; Witherington DC, 2002, INFANCY, V3, P495, DOI 10.1207/S15327078IN0304_05; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4; Woodward AL, 1999, INFANT BEHAV DEV, V22, P145, DOI 10.1016/S0163-6383(99)00007-7	51	85	85	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65289	10.1371/journal.pone.0065289	http://dx.doi.org/10.1371/journal.pone.0065289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190LY	23840324	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800010
J	Zhao, WJ; Li, D; Liu, ZJ; Zheng, XL; Wang, J; Wang, EK				Zhao, Wenjing; Li, Dan; Liu, Zuojia; Zheng, Xiliang; Wang, Jin; Wang, Erkang			Spiclomazine Induces Apoptosis Associated with the Suppression of Cell Viability, Migration and Invasion in Pancreatic Carcinoma Cells	PLOS ONE			English	Article							CANCER; INDUCTION; PROLIFERATION; MITOCHONDRIA; METASTASIS; ACTIVATION; RESISTANCE	The effective treatment for pancreatic carcinoma remains critically needed. Herein, this current study showed that spiclomazine treatment caused a reduction in viability in pancreatic carcinoma cell lines CFPAC-1 and MIA PaCa-2 in vitro. It was notable in this regard that, compared with pancreatic carcinoma cells, normal human embryonic kidney (HEK-293) and liver (HL-7702) cells were more resistant to the antigrowth effect of spiclomazine. Biochemically, spiclomazine treatment regulated the expression of protein levels in the apoptosis related pathways. Consistent with this effect, spiclomazine reduced the mitochondria membrane potential, elevated reactive oxygen species, and activated caspase-3/9. In addition, a key finding from this study was that spiclomazine suppressed migration and invasion of cancer cells through down-regulation of MMP-2/9. Collectively, the proposed studies did shed light on the antiproliferation effect of spiclomazine on pancreatic carcinoma cell lines, and further clarified the mechanisms that spiclomazine induced apoptosis associated with the suppression of migration and invasion.	[Zhao, Wenjing; Li, Dan; Liu, Zuojia; Zheng, Xiliang; Wang, Jin; Wang, Erkang] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, New York, NY USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Liu, ZJ (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.	zjliu@ciac.jl.cn; jin.wang.1@stonybrook.edu; ekwang@ciac.jl.cn	李, 丹/O-1545-2017; , 汪尔康/P-1748-2019	李, 丹/0000-0001-5904-871X; 	National Natural Science Foundation of China [11174105, 21190040]; 973 Project [2009CB930100, 2010CB933600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China)	The work was funded by the following: National Natural Science Foundation of China (11174105, 21190040); 973 Project (2009CB930100, 2010CB933600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Beauparlant P, 2003, CURR OPIN DRUG DISC, V6, P179; Bouchier-Hayes L, 2008, METHODS, V44, P222, DOI 10.1016/j.ymeth.2007.11.007; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Chen HM, 2009, CANCER LETT, V286, P161, DOI 10.1016/j.canlet.2009.05.040; Chodon D, 2007, MOL CELL BIOCHEM, V297, P73, DOI 10.1007/s11010-006-9324-2; Chu CS, 2007, CANCER LETT, V250, P268, DOI 10.1016/j.canlet.2006.10.020; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Ducreux M, 2007, BEST PRACT RES CL GA, V21, P997, DOI 10.1016/j.bpg.2007.10.025; Evans Douglas B., 1997, P1054; FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Keleg Shereen, 2003, Mol Cancer, V2, P14, DOI 10.1186/1476-4598-2-14; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim R, 2006, CANCER CHEMOTH PHARM, V57, P545, DOI 10.1007/s00280-005-0111-7; Kurosu T, 2009, CANCER RES, V69, P3927, DOI 10.1158/0008-5472.CAN-08-2978; Li D, 2013, EUR J PHARM SCI, V48, P658, DOI 10.1016/j.ejps.2012.12.023; Li Q, 2008, CANCER LETT, V261, P55, DOI 10.1016/j.canlet.2007.11.018; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037841; Lu Y, 2010, EUR J PHARMACOL, V641, P102, DOI 10.1016/j.ejphar.2010.05.043; Ma D, 2011, AM J BIOMED SCI, V3, P278, DOI DOI 10.5099/AJ110400278; McCollum AK, 2006, CANCER RES, V66, P10967, DOI 10.1158/0008-5472.CAN-06-1629; Mimeault M, 2008, CLIN PHARMACOL THER, V83, P673, DOI 10.1038/sj.clpt.6100296; Murtaza I, 2009, CANCER RES, V69, P1156, DOI 10.1158/0008-5472.CAN-08-2917; Mutou Y, 2008, TOXICOL IN VITRO, V22, P864, DOI 10.1016/j.tiv.2008.01.001; Neuzil J, 2006, FEBS LETT, V580, P5125, DOI 10.1016/j.febslet.2006.05.072; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Oberstein PE, 2011, J PANCREAS, V12, P96; Pan MH, 2007, FOOD CHEM, V102, P788, DOI 10.1016/j.foodchem.2006.06.019; Rastogi RP, 2009, EXCLI J, V8, P155; Reed JC, 2002, MOL CELL, V9, P1, DOI 10.1016/S1097-2765(02)00437-9; Ren DD, 2006, TOXICOL IN VITRO, V20, P1411, DOI 10.1016/j.tiv.2006.06.011; Ruiz Y, 2008, PHYTOCHEMISTRY, V69, P432, DOI 10.1016/j.phytochem.2007.07.025; Sanchez AM, 2007, APOPTOSIS, V12, P2013, DOI 10.1007/s10495-007-0119-z; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wang J, 2009, CANCER LETT, V283, P193, DOI 10.1016/j.canlet.2009.03.039; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; You BR, 2010, TOXICOL IN VITRO, V24, P1356, DOI 10.1016/j.tiv.2010.04.009; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zhou YJ, 2009, TOXICOL IN VITRO, V23, P288, DOI 10.1016/j.tiv.2008.12.009; Zou GM, 2008, MOL CANCER THER, V7, P2012, DOI 10.1158/1535-7163.MCT-08-0113	46	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66362	10.1371/journal.pone.0066362	http://dx.doi.org/10.1371/journal.pone.0066362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840452	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800052
J	Bokulich, NA; Ohta, M; Richardson, PM; Mills, DA				Bokulich, Nicholas A.; Ohta, Moe; Richardson, Paul M.; Mills, David A.			Monitoring Seasonal Changes in Winery-Resident Microbiota	PLOS ONE			English	Article							DIVERSITY; YEASTS; GRAPE; IDENTIFICATION; BACTERIA; STRAINS; FUNGI; ENVIRONMENT; SEQUENCES; ECOSYSTEM	During the transformation of grapes to wine, wine fermentations are exposed to a large area of specialized equipment surfaces within wineries, which may serve as important reservoirs for two-way transfer of microbes between fermentations. However, the role of winery environments in shaping the microbiota of wine fermentations and vectoring wine spoilage organisms is poorly understood at the systems level. Microbial communities inhabiting all major equipment and surfaces in a pilot-scale winery were surveyed over the course of a single harvest to track the appearance of equipment microbiota before, during, and after grape harvest. Results demonstrate that under normal cleaning conditions winery surfaces harbor seasonally fluctuating populations of bacteria and fungi. Surface microbial communities were dependent on the production context at each site, shaped by technological practices, processing stage, and season. During harvest, grape-and fermentation-associated organisms populated most winery surfaces, acting as potential reservoirs for microbial transfer between fermentations. These surfaces harbored large populations of Saccharomyces cerevisiae and other yeasts prior to harvest, potentially serving as an important vector of these yeasts in wine fermentations. However, the majority of the surface communities before and after harvest comprised organisms with no known link to wine fermentations and a near-absence of spoilage-related organisms, suggesting that winery surfaces do not overtly vector wine spoilage microbes under normal operating conditions.	[Bokulich, Nicholas A.; Ohta, Moe; Mills, David A.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA; [Bokulich, Nicholas A.; Ohta, Moe; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Bokulich, Nicholas A.; Ohta, Moe; Mills, David A.] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA; [Richardson, Paul M.] MicroTrek Inc, San Francisco, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Mills, DA (corresponding author), Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA.	damills@ucdavis.edu	Mills, David/GXF-1821-2022; Mills, David Andrew/G-2282-2011	Mills, David Andrew/0000-0003-1913-9865; Bokulich, Nicholas/0000-0002-1784-8935	Wine Spectator Scholarship; Brian Williams Scholarship Fund (American Society of Brewing Chemists Foundation); American Wine Society Educational Foundation Scholarship; Dannon Probiotics Fellow Program (The Dannon Company, Inc.)	Wine Spectator Scholarship; Brian Williams Scholarship Fund (American Society of Brewing Chemists Foundation); American Wine Society Educational Foundation Scholarship; Dannon Probiotics Fellow Program (The Dannon Company, Inc.)	NAB was supported by a Wine Spectator Scholarship, the Brian Williams Scholarship Fund (American Society of Brewing Chemists Foundation), a 2012-2013 American Wine Society Educational Foundation Scholarship, and the 2012-2013 Dannon Probiotics Fellow Program (The Dannon Company, Inc.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Blanco P, 2011, J IND MICROBIOL BIOT, V38, P235, DOI 10.1007/s10295-010-0818-2; Bokulich NA, 2013, APPL ENV MI IN PRESS; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bokulich NA, 2012, J AM SOC BREW CHEM, V70, P150, DOI 10.1094/ASBCJ-2012-0709-01; Bokulich NA, 2012, BMB REP, V45, P377, DOI 10.5483/BMBRep.2012.45.7.148; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035507; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036357; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Ciani M, 2004, ANTON LEEUW INT J G, V85, P159, DOI 10.1023/B:ANTO.0000020284.05802.d7; Ciccarone C, 2012, INT J FOOD SCI TECH, V47, P1138, DOI 10.1111/j.1365-2621.2012.02952.x; Dolci P, 2009, J APPL MICROBIOL, V106, P278, DOI 10.1111/j.1365-2672.2008.04001.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faith DP, 2006, EVOL BIOINFORM, V2, P121; Fleet GH, 2003, INT J FOOD MICROBIOL, V86, P11, DOI 10.1016/S0168-1605(03)00245-9; Fleet GH, 2008, FEMS YEAST RES, V8, P979, DOI 10.1111/j.1567-1364.2008.00427.x; Flores GE, 2013, ENVIRON MICROBIOL, V15, P588, DOI 10.1111/1462-2920.12036; Flores GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028132; Garijo P, 2009, INT J FOOD MICROBIOL, V136, P142, DOI 10.1016/j.ijfoodmicro.2009.08.018; Garijo P, 2008, INT J FOOD MICROBIOL, V125, P141, DOI 10.1016/j.ijfoodmicro.2008.03.014; Gonzalez A, 2012, BIOINFORMATICS, V28, P436, DOI 10.1093/bioinformatics/btr685; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hartman AL, 2009, P NATL ACAD SCI USA, V106, P17187, DOI 10.1073/pnas.0904847106; Hewitt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054703; Hewitt KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037849; Hierro N, 2006, APPL ENVIRON MICROB, V72, P7148, DOI 10.1128/AEM.00388-06; Kembel SW, 2012, ISME J, V6, P1469, DOI 10.1038/ismej.2011.211; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Loureiro V, 2003, INT J FOOD MICROBIOL, V86, P23, DOI 10.1016/S0168-1605(03)00246-0; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Martins G, 2012, INT J FOOD MICROBIOL, V158, P93, DOI 10.1016/j.ijfoodmicro.2012.06.013; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mercado L, 2007, FOOD MICROBIOL, V24, P403, DOI 10.1016/j.fm.2006.06.005; Mills DA, 2002, APPL ENVIRON MICROB, V68, P4884, DOI 10.1128/AEM.68.10.4884-4893.2002; Mortimer R, 1999, RES MICROBIOL, V150, P199, DOI 10.1016/S0923-2508(99)80036-9; Ocon E, 2011, J FOOD SCI, V76, pM169, DOI 10.1111/j.1750-3841.2011.02097.x; Ocon E, 2010, FOOD MICROBIOL, V27, P1023, DOI 10.1016/j.fm.2010.06.012; PEYNAUD EMILE, 1959, AMER JOUR ENOL AND VITICULTURE, V10, P69; Picco AM, 2004, AM J ENOL VITICULT, V55, P355; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Renouf V, 2005, AUST J GRAPE WINE R, V11, P316, DOI 10.1111/j.1755-0238.2005.tb00031.x; Sabate J, 2002, MICROBIOL RES, V157, P267, DOI 10.1078/0944-5013-00163; Santamaria P, 2008, EUR FOOD RES TECHNOL, V227, P1563, DOI 10.1007/s00217-008-0855-5; Sipiczki M, 2003, INT J SYST EVOL MICR, V53, P2079, DOI 10.1099/ijs.0.02649-0; Tofalo R, 2012, FOOD MICROBIOL, V29, P18, DOI 10.1016/j.fm.2011.08.014; Van Hoorde K, 2010, FOOD MICROBIOL, V27, P425, DOI 10.1016/j.fm.2009.12.001	51	132	133	3	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66437	10.1371/journal.pone.0066437	http://dx.doi.org/10.1371/journal.pone.0066437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840468	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200078
J	Georgy, GS; Nassar, NN; Mansour, HA; Abdallah, DM				Georgy, Gehan S.; Nassar, Noha N.; Mansour, Hanaa A.; Abdallah, Dalaal M.			Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; TNF-ALPHA; NEUROTROPHIC FACTOR; TRANSGENIC MODEL; GENE-EXPRESSION; NERVOUS-SYSTEM; DENTATE GYRUS; BRAIN; NEUROGENESIS; APOPTOSIS	Cerebrolysin (CBL), a mixture of several active peptide fragments and neurotrophic factors including brain-derived neurotrophic factor (BDNF), is currently used in the management of cognitive alterations in patients with dementia. Since Cognitive decline as well as increased dementia are strongly associated with diabetes and previous studies addressed the protective effect of BDNF in metabolic syndrome and type 2 diabetes; hence this work aimed to evaluate the potential neuroprotective effect of CBL in modulating the complications of hyperglycaemia experimentally induced by streptozotocin (STZ) on the rat brain hippocampus. To this end, male adult Sprague Dawley rats were divided into (i) vehicle- (ii) CBL- and (iii) STZ diabetic-control as well as (iv) STZ+CBL groups. Diabetes was confirmed by hyperglycemia and elevated glycated haemoglobin (HbA1c%), which were associated by weight loss, elevated tumor necrosis factor (TNF)-alpha and decreased insulin growth factor (IGF)-1 beta in the serum. Uncontrolled hyperglycemia caused learning and memory impairments that corroborated degenerative changes, neuronal loss and expression of caspase (Casp)-3 in the hippocampal area of STZ-diabetic rats. Behavioral deficits were associated by decreased hippocampal glutamate (GLU), glycine, serotonin (5-HT) and dopamine. Moreover, diabetic rats showed an increase in hippocampal nitric oxide and thiobarbituric acid reactive substances versus decreased non-protein sulfhydryls. Though CBL did not affect STZ-induced hyperglycemia, it partly improved body weight as well as HbA1c%. Such effects were associated by enhancement in both learning and memory as well as apparent normal cellularity in CA1 and CA3 areas and reduced Casp-3 expression. CBL improved serum TNF-alpha and IGF-1 beta, GLU and 5-HT as well as hampering oxidative biomarkers. In conclusion, CBL possesses neuroprotection against diabetes-associated cerebral neurodegeneration and cognitive decline via anti-inflammatory, antioxidant and antiapototic effects.	[Georgy, Gehan S.; Mansour, Hanaa A.] Natl Org Drug Control & Res NODCAR, Dept Pharmacol, Giza, Egypt; [Nassar, Noha N.; Abdallah, Dalaal M.] Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt	National Organization for Drug Control & Research (NODCAR); Egyptian Knowledge Bank (EKB); Cairo University	Nassar, NN (corresponding author), Cairo Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt.	nnagah@yahoo.com	mansour, ossama/F-4592-2010; Abdallah, Dalaal/GVT-0783-2022	mansour, ossama/0000-0001-8814-6431; 	Cairo University; National Organization of Drug Control and Research (NODCAR)	Cairo University(Cairo University); National Organization of Drug Control and Research (NODCAR)	Financial support was provided by Cairo University and the National Organization of Drug Control and Research (NODCAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2012, CAN J NEUROL SCI, V39, P311, DOI 10.1017/S0317167100013433; Al-Shorbagy MY, 2012, CAN J PHYSIOL PHARM, V90, P13, DOI [10.1139/Y11-096, 10.1139/y11-096]; Allegri RF, 2012, DRUG TODAY, V48, P25, DOI 10.1358/dot.2012.48(Suppl.A).1739721; Alvarez XA, 2009, INT J NEUROPSYCHOPH, V12, P867, DOI 10.1017/S1461145709990101; Arab L, 2011, CURR NEUROPHARMACOL, V9, P693, DOI 10.2174/157015911798376334; Baker BJ, 2010, GLIA, V58, P1082, DOI 10.1002/glia.20989; Baquer NZ, 2009, BIOGERONTOLOGY, V10, P377, DOI 10.1007/s10522-009-9226-2; Baydas G, 2003, FREE RADICAL BIO MED, V35, P797, DOI 10.1016/S0891-5849(03)00408-8; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; BISSE E, 1985, J CHROMATOGR, V344, P81, DOI 10.1016/S0378-4347(00)82009-5; Bouche C, 2004, ENDOCR REV, V25, P807, DOI 10.1210/er.2003-0026; Comim CM, 2012, NEUROSCI LETT, V523, P104, DOI 10.1016/j.neulet.2012.06.051; Convit A, 2003, P NATL ACAD SCI USA, V100, P2019, DOI 10.1073/pnas.0336073100; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Denis I, 2013, AGEING RES REV, V12, P579, DOI 10.1016/j.arr.2013.01.007; Deniz S, 1997, CLIN CHIM ACTA, V265, P77; Eder P, 2001, HISTOCHEM J, V33, P605, DOI 10.1023/A:1016394031947; Errico F, 2011, NEUROBIOL AGING, V32, P2229, DOI 10.1016/j.neurobiolaging.2010.01.002; Francis PT, 2010, NEUROPHARMACOLOGY, V59, P221, DOI 10.1016/j.neuropharm.2010.02.010; Garmanchuk L. V., 2009, Eksperimental'naya i Klinicheskaya Farmakologiya, V72, P28; Gillery Philippe, 2001, Journal de la Societe de Biologie, V195, P387; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; Hu NW, 2012, PHARMACOL BIOCHEM BE, V100, P855, DOI 10.1016/j.pbb.2011.04.013; Ingaramo PI, 2011, MOL IMMUNOL, V48, P1397, DOI 10.1016/j.molimm.2011.03.015; Institute for Laboratory Animal Research (ILAR), 1996, GUIDE CARE USE LAB A; Rodriguez JJ, 2012, PROG NEUROBIOL, V99, P15, DOI 10.1016/j.pneurobio.2012.06.010; Kar Manoj, 1999, Indian Journal of Experimental Biology, V37, P190; Khan ZA, 2007, EXP DIABETES RES, DOI 10.1155/2007/31867; Kim SE, 2010, EXP GERONTOL, V45, P357, DOI 10.1016/j.exger.2010.02.005; Kirana H, 2011, PHARMACOGN RES, V3, P30, DOI 10.4103/0974-8490.79112; KONTUR P, 1984, J NEUROSCI METH, V11, P5, DOI 10.1016/0165-0270(84)90003-7; Kuhad A, 2008, LIFE SCI, V83, P128, DOI 10.1016/j.lfs.2008.05.013; Lee YJ, 2001, ONCOGENE, V20, P1476, DOI 10.1038/sj.onc.1204225; Lesemann A, 2012, BRAIN RES, V1457, P51, DOI 10.1016/j.brainres.2012.03.046; Long LH, 2009, BIOCHEM BIOPH RES CO, V388, P700, DOI 10.1016/j.bbrc.2009.08.069; Lopez OL, 2003, REV NEUROLOGIA, V37, P155, DOI 10.33588/rn.3702.2002441; Marcussen AB, 2008, ACTA NEUROL SCAND, V117, P94, DOI 10.1111/j.1600-0404.2007.00910.x; Masliah E, 2012, DRUG TODAY, V48, P3, DOI 10.1358/dot.2012.48(Suppl.A).1739716; Masliah E, 1999, PHARMACOL BIOCHEM BE, V62, P239, DOI 10.1016/S0091-3057(98)00144-0; Menon PK, 2012, CNS NEUROL DISORD-DR, V11, P40; Miura Y, 2003, P NATL ACAD SCI USA, V100, P2777, DOI 10.1073/pnas.2628048100; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Murali YK, 2007, EXP CLIN ENDOCR DIAB, V115, P641, DOI 10.1055/s-2007-982500; Narayanan SN, 2010, UPSALA J MED SCI, V115, P91, DOI 10.3109/03009730903552661; Ono M, 2000, METABOLISM, V49, P129, DOI 10.1016/S0026-0495(00)90988-0; Pan WH, 2000, EXP NEUROL, V170, P357, DOI 10.1006/exnr.2001.7702; Plosker GL, 2010, CNS DRUGS, V24, P263, DOI 10.2165/11204820-000000000-00000; PRINS HK, 1969, BIOCH METHODS RED CE, P126; Ramachandran S, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/571721; Ren J, 2007, RESTOR NEUROL NEUROS, V25, P25; Rockenstein E, 2003, J NEURAL TRANSM, V110, P1313, DOI 10.1007/s00702-003-0025-7; Rockenstein E, 2007, ACTA NEUROPATHOL, V113, P265, DOI 10.1007/s00401-006-0166-5; Rong LL, 2005, RESTOR NEUROL NEUROS, V23, P355; Saravia F, 2004, J NEUROENDOCRINOL, V16, P704, DOI 10.1111/j.1365-2826.2004.01223.x; Sen S, 2005, BIOPHYS CHEM, V113, P289, DOI 10.1016/j.bpc.2004.05.005; Serkina EV, 2008, ZH NEVROL PSIKHIATR, V108, P62; Sharma B, 2011, PSYCHOPHARMACOLOGY, V215, P677, DOI 10.1007/s00213-011-2164-0; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Shonesy BC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.002; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Tatebayashi Y, 2003, ACTA NEUROPATHOL, V105, P225, DOI 10.1007/s00401-002-0636-3; Trinder P., 1969, ANN CLIN BIOCHEM, V6, p24?27, DOI DOI 10.1177/000456326900600108; Ullah N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027093; Windisch M, 1998, J NEURAL TRANSM-SUPP, P289; Winner B, 2006, EXP NEUROL, V197, P113, DOI 10.1016/j.expneurol.2005.08.028; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; Yan H, 2011, J ENDOCRINOL, V211, P27, DOI 10.1530/JOE-11-0200; Zai GCM, 2012, PROG NEURO-PSYCHOPH, V39, P96, DOI 10.1016/j.pnpbp.2012.05.014	68	24	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e64847	10.1371/journal.pone.0064847	http://dx.doi.org/10.1371/journal.pone.0064847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840309	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200007
J	Hamid, F; Wiria, AE; Wammes, LJ; Kaisar, MMM; Djuardi, Y; Versteeg, SA; Wahyuni, S; van Ree, R; Sartono, E; Supali, T; Yazdanbakhsh, M				Hamid, Firdaus; Wiria, Aprilianto E.; Wammes, Linda J.; Kaisar, Maria M. M.; Djuardi, Yenny; Versteeg, Serge A.; Wahyuni, Sitti; van Ree, Ronald; Sartono, Erliyani; Supali, Taniawati; Yazdanbakhsh, Maria			Risk Factors Associated with the Development of Atopic Sensitization in Indonesia	PLOS ONE			English	Article							INTESTINAL HELMINTH INFECTIONS; CHILDREN; PREVALENCE; ASTHMA; URBAN; IGE; IMMUNOSPIN; ASCARIS; FLORES; AREA	Background: The prevalence of allergic diseases has increased not only in high income but also in low-to-middle income countries. However, risk factors for their development are still not well established, particularly in the latter. Objective: To assess prevalence and identify risk factors for sensitization to two major inhalant allergens among children from semi-urban and rural areas in Indonesia. Method: A cross-sectional survey was performed among 1,674 school children aged 5-15 years old. Information on potential risk factors and reported allergic symptoms were obtained by questionnaire. Helminth infections were assessed. Skin prick tests (SPT) were performed, total IgE as well as allergen-specific IgE for house dust mite (HDM) and cockroach were measured. Result: The prevalence of allergic skin sensitization to both aeroallergens was significantly higher in the semi-urban than in the rural area. However, serum IgE against HDM and cockroach as well as total IgE were significantly lower in semi-urban than in rural children. In the semi-urban area, there was a significant positive association between SPT to HDM and higher paternal education but a negative one with hookworm infection. The risk factors linked to cockroach sensitization were different: being of a farmer offspring and lacking access to piped water were associated with an increased risk for a positive SPT to cockroach. No significant associations between measured risk factors and having a positive SPT were found in the rural area. Conclusion: Sensitization to HDM and cockroach is common in Indonesia, more often translating into a positive SPT in the semi-urban than in the rural setting. Whereas high paternal education and low hookworm infection were associated with increased risk of SPT to HDM, we were surprised to find parameters of lower SES were identified as risk factor for cockroach SPT.	[Hamid, Firdaus] Hasanuddin Univ, Fac Med, Dept Microbiol, Makassar, Indonesia; [Hamid, Firdaus; Wiria, Aprilianto E.; Wammes, Linda J.; Kaisar, Maria M. M.; Djuardi, Yenny; Sartono, Erliyani; Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Wiria, Aprilianto E.; Kaisar, Maria M. M.; Djuardi, Yenny; Supali, Taniawati] Univ Indonesia, Fac Med, Dept Parasitol, Jakarta, Indonesia; [Versteeg, Serge A.; van Ree, Ronald] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Wahyuni, Sitti] Hasanuddin Univ, Fac Med, Dept Parasitol, Makassar, Indonesia; [van Ree, Ronald] Univ Amsterdam, Acad Med Ctr, Dept Otorhinolaryngol, NL-1105 AZ Amsterdam, Netherlands	Universitas Hasanuddin; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Indonesia; University of Amsterdam; Academic Medical Center Amsterdam; Universitas Hasanuddin; University of Amsterdam; Academic Medical Center Amsterdam	Yazdanbakhsh, M (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands.	M.Yazdanbakhsh@lumc.nl	Yazdanbakhsh, Maria/AAI-3996-2020; Djuardi, Yenny/AGP-5890-2022; Wiria, Aprilianto Eddy/AAZ-2419-2021; Hamid, Firdaus/M-6862-2017	Yazdanbakhsh, Maria/0000-0002-7666-1441; Wiria, Aprilianto Eddy/0000-0002-6482-424X; Hamid, Firdaus/0000-0003-1788-0836; Kaisar, Maria M. M./0000-0002-7515-7673	Royal Netherlands Academy of Arts and Science (KNAW) [KNAW-05-PP-35]; European Commission [INCO-CT-2006-031714, INCO-CT-2006-032436]; Glofal [FOOD-CT-2005-032436]; Prof. Dr. P.C. Flu Foundation; EAACI (the European Academy of Allergy and Clinical Immunology); Directorate General of Higher Education (DIKTI) of the Ministry of Education Culture of the Republic of Indonesia	Royal Netherlands Academy of Arts and Science (KNAW); European Commission(European CommissionEuropean Commission Joint Research Centre); Glofal; Prof. Dr. P.C. Flu Foundation; EAACI (the European Academy of Allergy and Clinical Immunology); Directorate General of Higher Education (DIKTI) of the Ministry of Education Culture of the Republic of Indonesia	This study was funded by The Royal Netherlands Academy of Arts and Science (KNAW), Ref. KNAW-05-PP-35, European Commission contracts INCO-CT-2006-031714 and INCO-CT-2006-032436, Glofal, FOOD-CT-2005-032436, and the Prof. Dr. P.C. Flu Foundation. FH has received an EAACI (the European Academy of Allergy and Clinical Immunology) Exchange Research Fellowship 2012 and a scholarship from the Directorate General of Higher Education (DIKTI) of the Ministry of Education Culture of the Republic of Indonesia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Blackwell AD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001218; Borchers AT, 2005, J ASTHMA, V42, P225, DOI 10.1081/JAS-200051302; Cooper PJ, 2004, CLIN EXP ALLERGY, V34, P845, DOI 10.1111/j.1365-2222.2004.01958.x; Feary J, 2011, ALLERGY, V66, P569, DOI 10.1111/j.1398-9995.2010.02512.x; Flohr C, 2006, J ALLERGY CLIN IMMUN, V118, P1305, DOI 10.1016/j.jaci.2006.08.035; Flohrs K, 2012, INT ARCH ALLERGY IMM, V158, P27, DOI 10.1159/000329855; Forastiere F, 1997, EPIDEMIOLOGY, V8, P566, DOI 10.1097/00001648-199709000-00015; Hamid F, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-83; Nyan OA, 2001, CLIN EXP ALLERGY, V31, P1672, DOI 10.1046/j.1365-2222.2001.00987.x; Perzanowski MS, 2002, J PEDIATR-US, V140, P582, DOI 10.1067/mpd.2002.122937; Santos ABR, 2008, J ALLERGY CLIN IMMUN, V121, P1040, DOI 10.1016/j.jaci.2007.12.1147; Supali T, 2010, INT ARCH ALLERGY IMM, V153, P388, DOI 10.1159/000316350; van den Biggelaar AHJ, 2001, INT ARCH ALLERGY IMM, V126, P231, DOI 10.1159/000049519; von Hertzen L, 2007, ALLERGY, V62, P288, DOI 10.1111/j.1398-9995.2006.01281.x; von Mutius E, 2002, J ALLERGY CLIN IMMUN, V109, pS525, DOI 10.1067/mai.2002.124565; Weinmayr G, 2007, AM J RESP CRIT CARE, V176, P565, DOI 10.1164/rccm.200607-994OC; Wiria AE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-77; World Health Organization, 2006, WHO CHILD GROWTH STA, P312; Yobo EODA, 1997, THORAX, V52, P161, DOI 10.1136/thx.52.2.161	21	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e67064	10.1371/journal.pone.0067064	http://dx.doi.org/10.1371/journal.pone.0067064			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840583	gold, Green Submitted, Green Published			2022-12-27	WOS:000322361200118
J	Vitali, R; Palone, F; Cucchiara, S; Negroni, A; Cavone, L; Costanzo, M; Aloi, M; Dilillo, A; Stronati, L				Vitali, Roberta; Palone, Francesca; Cucchiara, Salvatore; Negroni, Anna; Cavone, Leonardo; Costanzo, Manuela; Aloi, Marina; Dilillo, Anna; Stronati, Laura			Dipotassium Glycyrrhizate Inhibits HMGB1-Dependent Inflammation and Ameliorates Colitis in Mice	PLOS ONE			English	Article							PROINFLAMMATORY CYTOKINE; ISCHEMIA-REPERFUSION; HMGB1; INJURY; CELLS; PROTEIN; RECRUITMENT; ACTIVATION; AUTOIMMUNE; RECEPTOR	Background: High mobility group box-1 (HMGB1) is a DNA-binding protein that is released from injured cells during inflammation. Advances in targeting HMGB1 represent a major challenge to improve the treatment of acute/chronic inflammation. Aim: This study is aimed at verifying whether the inhibition of HMGB1 through dipotassium glycyrrhizate (DPG) is a good strategy to reduce intestinal inflammation. Methods: Human colon adenocarcinoma cell line, HT29, human epithelial colorectal adenocarcinoma, Caco2, and murine macrophage cell line, RAW 264.7, were cultured to investigate the effect of DPG on the secretion of HMGB1. Acute colitis was induced in C57BL/6 mice through administration of 3% dextran sodium sulphate (DSS); a combined treatment with DSS and 3 or 8 mg/kg/day DPG was used to investigate the effects of DPG on intestinal inflammation. Animals were euthanized at seventh day and colonic samples underwent molecular and histological analyses. Results: DPG significantly reduces in vitro the release of HMGB1 in the extracellular matrix as well as expression levels of pro-inflammatory cytokines, TNF-alpha, IL-1beta and IL-6, by inhibiting HMGB1. Moreover, DPG significantly decreases the severity of DSS-induced colitis in mice. Murine colonic samples show decreased mRNA levels of pro-inflammatory cytokines TNF-alpha, IL-1beta and IL-6, as well as HMGB1 receptors, RAGE and TLR4. Finally, HMGB1, abundantly present in the feces of mice with DSS-induced colitis, is strongly reduced by DPG. Conclusions: HMGB1 is an early pro-inflammatory cytokine and an active protagonist of mucosal gut inflammation. DPG exerts inhibitory effects against HMGB1 activity, significantly reducing intestinal inflammation. Thus, we reason that DPG could represent an innovative tool for the management of human intestinal inflammation.	[Vitali, Roberta; Palone, Francesca; Negroni, Anna; Costanzo, Manuela; Stronati, Laura] ENEA, Dept Radiobiol & Human Hlth, Rome, Italy; [Cucchiara, Salvatore; Aloi, Marina; Dilillo, Anna] Univ Roma La Sapienza, Pediat Gastroenterol & Liver Unit, Dept Pediat & Infantile Neuropsychiat, I-00185 Rome, Italy; [Cavone, Leonardo] Univ Florence, Dept Preclin & Clin Pharmacol, Florence, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; Sapienza University Rome; University of Florence	Stronati, L (corresponding author), ENEA, Dept Radiobiol & Human Hlth, Rome, Italy.	laura.stronati@enea.it	Costanzo, Manuela/AAD-3723-2022; PALONE, FRANCESCA/AFE-8401-2022; Vitali, Roberta/K-2509-2016; Aloi, Marina/K-2496-2016; PALONE, FRANCESCA/AAE-9703-2022; Negroni, Anna/GLS-2306-2022; Cucchiara, Salvatore/K-1628-2016	PALONE, FRANCESCA/0000-0001-7700-9466; Vitali, Roberta/0000-0003-4203-0163; Aloi, Marina/0000-0001-7404-4004; PALONE, FRANCESCA/0000-0001-7700-9466; Negroni, Anna/0000-0002-2273-8837; COSTANZO, MANUELA/0000-0003-2637-7810; Stronati, Laura/0000-0001-5222-9497; Cucchiara, Salvatore/0000-0002-2939-9698	DMG Italia Srl; DMG [FILAS CR 2011-1162]	DMG Italia Srl; DMG	This study was funded by DMG Italia Srl (http://www.dmgit.com/). The grant (FILAS CR 2011-1162) of DMG has been devolved to the Pediatric Department of Sapienza University of Rome to support the research activity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Berthelot F, 2012, J INNATE IMMUN, V4, P41, DOI 10.1159/000328798; Bianchi ME, 2009, J LEUKOCYTE BIOL, V86, P573, DOI 10.1189/jlb.1008585; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen J, 2012, ATHEROSCLEROSIS, V224, P332, DOI 10.1016/j.atherosclerosis.2012.07.020; Gauley J, 2009, AUTOIMMUNITY, V42, P299, DOI 10.1080/08916930902831522; Ha YM, 2011, BIOCHEM PHARMACOL, V82, P769, DOI 10.1016/j.bcp.2011.06.041; Yuan H, 2006, WORLD J GASTROENTERO, V12, P4578, DOI 10.3748/wjg.v12.i28.4578; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hirsiger S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/315941; Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548; Huang WC, 2010, CYTOKINE, V51, P119, DOI 10.1016/j.cyto.2010.02.021; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kudo T, 2011, WORLD J GASTROENTERO, V17, P2223, DOI 10.3748/wjg.v17.i17.2223; Maxwell Joseph R, 2009, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0557s47; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Ogiku M, 2011, J PHARMACOL EXP THER, V339, P93, DOI 10.1124/jpet.111.182592; Ohnishi M, 2011, NEUROPHARMACOLOGY, V61, P975, DOI 10.1016/j.neuropharm.2011.06.026; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sundberg E, 2009, IMMUNOBIOLOGY, V214, P303, DOI 10.1016/j.imbio.2008.09.006; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Vitali R, 2011, AM J GASTROENTEROL, V106, P2029, DOI 10.1038/ajg.2011.231; Wang X, 2012, NUCL SCI TECH, V23, P1; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067; Zhai CL, 2012, ACTA PHARMACOL SIN, V33, P1477, DOI 10.1038/aps.2012.112; Zhu Shu, 2010, Inflammation & Allergy Drug Targets, V9, P60; Zhu XM, 2012, INT J BIOCHEM CELL B, V44, P1097, DOI 10.1016/j.biocel.2012.03.018	31	40	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66527	10.1371/journal.pone.0066527	http://dx.doi.org/10.1371/journal.pone.0066527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840500	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200092
J	Zhou, LQ; Zhou, W; Zhang, SL; Liu, B; Leng, YM; Zhou, RH; Kong, WJ				Zhou, Liuqing; Zhou, Wen; Zhang, Sulin; Liu, Bo; Leng, Yangming; Zhou, Renhong; Kong, Weijia			Changes in Histamine Receptors (H1, H2, and H3) Expression in Rat Medial Vestibular Nucleus and Flocculus after Unilateral Labyrinthectomy: Histamine Receptors in Vestibular Compensation	PLOS ONE			English	Article							OPTOKINETIC EYE-MOVEMENTS; CAT CEREBELLAR FLOCCULUS; TIME QUANTITATIVE PCR; ALERT GUINEA-PIG; H-3 RECEPTOR; VESTIBULOOCULAR REFLEX; NEURONAL-ACTIVITY; GENE TRANSCRIPTS; TARGET NEURONS; BRAIN-STEM	Vestibular compensation is the process of behavioral recovery following peripheral vestibular lesion. In clinics, the histaminergic medicine is the most widely prescribed for the treatment of vertigo and motion sickness, however, the molecular mechanisms by which histamine modulates vestibular function remain unclear. During recovery from the lesion, the modulation of histamine receptors in the medial vestibular nucleus (MVN) and the flocculus may play an important role. Here with the means of quantitative real-time PCR, western blotting and immunohistochemistry, we studied the expression of histamine receptors (H1, H2, and H3) in the bilateral MVN and the flocculus of rats on the 1st, 3rd, and 7th day following unilateral labyrinthectomy (UL). Our results have shown that on the ipsi-lesional flocculus the H1, H2 and H3 receptors mRNA and the protein increased significantly on the 1st and 3rd day, with compare of sham controls and as well the contralateral side of UL. However, on the 7th day after UL, this expression returned to basal levels. Furthermore, elevated mRNA and protein levels of H1, H2 and H3 receptors were observed in the ipsi-lesional MVN on the 1st day after UL compared with sham controls and as well the contralateral side of UL. However, this asymmetric expression was absent by the 3rd post-UL. Our findings suggest that the upregulation of histamine receptors in the MVN and the flocculus may contribute to rebalancing the spontaneous discharge in bilateral MVN neurons during vestibular compensation.	[Zhou, Liuqing; Zhou, Wen; Zhang, Sulin; Liu, Bo; Leng, Yangming; Zhou, Renhong; Kong, Weijia] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Otorhinolaryngol, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology	Kong, WJ (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Otorhinolaryngol, Wuhan 430074, Hubei Province, Peoples R China.	entwjkong@yahoo.com.cn	Zhang, Sulin/X-3617-2019	Zhang, Sulin/0000-0002-3609-6804; Kong, Wei-Jia/0000-0001-5410-2297	National twelfth-Five Year Research Program of China [2012BAI12B02]; National Natural Science Foundation of China [30872865, 30672309]; Key Project of the National Eleventh-Five Year Research Program of China [2007BAI18B13]	National twelfth-Five Year Research Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of the National Eleventh-Five Year Research Program of China	This work was supported by the National twelfth-Five Year Research Program of China (No. 2012BAI12B02), a grant from National Natural Science Foundation of China (No. 30872865 and No. 30672309) and the Key Project of the National Eleventh-Five Year Research Program of China (No. 2007BAI18B13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRAKSINEN MS, 1988, J COMP NEUROL, V273, P163, DOI 10.1002/cne.902730204; ARRANG JM, 1995, ANN NY ACAD SCI, V757, P314, DOI 10.1111/j.1749-6632.1995.tb17489.x; Babalian AL, 2000, J NEUROPHYSIOL, V84, P2514, DOI 10.1152/jn.2000.84.5.2514; Bergquist F, 2006, J PHYSIOL-LONDON, V577, P857, DOI 10.1113/jphysiol.2006.120493; Brown RE, 1999, J PHYSIOL-LONDON, V515, P777, DOI 10.1111/j.1469-7793.1999.777ab.x; COURJON JH, 1982, BRAIN RES, V239, P251, DOI 10.1016/0006-8993(82)90847-2; Curthoys IS, 1999, ADV OTO-RHINO-LARYNG, V55, P82; Darlington CL, 2000, PROG NEUROBIOL, V62, P313, DOI 10.1016/S0301-0082(00)00002-2; DEWAELE C, 1995, BRAIN RES REV, V20, P24, DOI 10.1016/0165-0173(94)00004-9; DEZEEUW CI, 1995, EUR J NEUROSCI, V7, P2322; DIETRICHS E, 1994, HISTOL HISTOPATHOL, V9, P603; Fan GR, 2013, BRAIN RES, V1502, P30, DOI 10.1016/j.brainres.2012.12.049; FISCHER AJEM, 1991, ACTA OTO-LARYNGOL, P24; GALIANA HL, 1984, J NEUROPHYSIOL, V51, P242, DOI 10.1152/jn.1984.51.2.242; Gliddon CM, 2005, PROG NEUROBIOL, V75, P53, DOI 10.1016/j.pneurobio.2004.11.001; Heiduschka P, 2008, GRAEF ARCH CLIN EXP, V246, P1559, DOI 10.1007/s00417-008-0895-3; Hong SM, 2009, NEUROSCI LETT, V460, P52, DOI 10.1016/j.neulet.2009.05.017; Horii A, 2001, EXP BRAIN RES, V139, P188, DOI 10.1007/s002210100763; ITO M, 1968, EXP BRAIN RES, V4, P310, DOI 10.1007/BF00235698; Johnston AR, 2002, J PHYSIOL-LONDON, V545, P903, DOI 10.1113/jphysiol.2002.024281; Kitahara T, 1997, NEUROSCIENCE, V76, P571, DOI 10.1016/S0306-4522(96)00374-0; Kitahara T, 1998, ACTA OTO-LARYNGOL, P19; Kitahara T, 1997, BRAIN RES, V765, P1, DOI 10.1016/S0006-8993(97)00436-8; Kitama T, 1999, J NEUROPHYSIOL, V82, P2235, DOI 10.1152/jn.1999.82.5.2235; Lacour M, 2001, CNS DRUGS, V15, P853, DOI 10.2165/00023210-200115110-00004; Li ZH, 2000, J NEUROPHYSIOL, V83, P2616, DOI 10.1152/jn.2000.83.5.2616; Lintunen Minnamaija, 2001, FASEB Journal, V15, P1074; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozada AF, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-32; Lozeva V, 2003, J HEPATOL, V39, P522, DOI 10.1016/S0168-8278(03)00353-2; Mizukoshi A, 2000, EXP BRAIN RES, V132, P260, DOI 10.1007/s002210000363; Nikkhah G, 1998, BEHAV BRAIN RES, V92, P85, DOI 10.1016/S0166-4328(97)00128-9; OBATA K, 1969, J NEUROCHEM, V16, P1043, DOI 10.1111/j.1471-4159.1969.tb05948.x; OVERBECK GW, 1992, HEARING RES, V59, P129, DOI 10.1016/0378-5955(92)90110-9; PANULA P, 1984, P NATL ACAD SCI-BIOL, V81, P2572, DOI 10.1073/pnas.81.8.2572; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Pillot C, 2002, NEUROSCIENCE, V114, P173, DOI 10.1016/S0306-4522(02)00135-5; POLLARD H, 1993, NEUROSCIENCE, V52, P169, DOI 10.1016/0306-4522(93)90191-H; PRECHT W, 1966, J NEUROPHYSIOL, V29, P996, DOI 10.1152/jn.1966.29.6.996; Redfern WS, 2011, J PHARMACOL TOXICOL, V63, P102, DOI 10.1016/j.vascn.2010.06.008; Ris L, 1998, J NEUROPHYSIOL, V80, P2352, DOI 10.1152/jn.1998.80.5.2352; RIS L, 1995, J NEUROPHYSIOL, V74, P2087, DOI 10.1152/jn.1995.74.5.2087; SATO Y, 1991, BRAIN RES REV, V16, P39, DOI 10.1016/0165-0173(91)90019-5; SATO Y, 1991, ACTA OTO-LARYNGOL, P237; SCHLICKER E, 1994, FUND CLIN PHARMACOL, V8, P128, DOI 10.1111/j.1472-8206.1994.tb00789.x; Shin M, 2011, J NEUROSCI, V31, P10776, DOI 10.1523/JNEUROSCI.0768-11.2011; Smith PF, 1996, TRENDS PHARMACOL SCI, V17, P421, DOI 10.1016/S0165-6147(96)10050-X; SMITH PF, 1989, BRAIN RES REV, V14, P155, DOI 10.1016/0165-0173(89)90013-1; Straka H, 2005, PROG NEUROBIOL, V76, P349, DOI 10.1016/j.pneurobio.2005.10.002; Tighilet B, 2007, EUR J PHARMACOL, V568, P149, DOI 10.1016/j.ejphar.2007.04.052; Tighilet B, 2006, J PHYSIOL-LONDON, V573, P723, DOI 10.1113/jphysiol.2006.107805; Vizuete ML, 1997, NEUROSCIENCE, V80, P321, DOI 10.1016/S0306-4522(97)00010-9; WANG JJ, 1995, EXP BRAIN RES, V105, P18; Yamanaka T, 2000, J PHYSIOL-LONDON, V523, P413, DOI 10.1111/j.1469-7793.2000.t01-1-00413.x	54	11	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66684	10.1371/journal.pone.0066684	http://dx.doi.org/10.1371/journal.pone.0066684			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840519	gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200101
J	Navarra, A; Tribbia, J; Conti, G				Navarra, Antonio; Tribbia, Joe; Conti, Giovanni			The Path Integral Formulation of Climate Dynamics	PLOS ONE			English	Article							NOISE	The chaotic nature of the atmospheric dynamics has stimulated the applications of methods and ideas derived from statistical dynamics. For instance, ensemble systems are used to make weather predictions recently extensive, which are designed to sample the phase space around the initial condition. Such an approach has been shown to improve substantially the usefulness of the forecasts since it allows forecasters to issue probabilistic forecasts. These works have modified the dominant paradigm of the interpretation of the evolution of atmospheric flows (and oceanic motions to some extent) attributing more importance to the probability distribution of the variables of interest rather than to a single representation. The ensemble experiments can be considered as crude attempts to estimate the evolution of the probability distribution of the climate variables, which turn out to be the only physical quantity relevant to practice. However, little work has been done on a direct modeling of the probability evolution itself. In this paper it is shown that it is possible to write the evolution of the probability distribution as a functional integral of the same kind introduced by Feynman in quantum mechanics, using some of the methods and results developed in statistical physics. The approach allows obtaining a formal solution to the Fokker-Planck equation corresponding to the Langevin-like equation of motion with noise. The method is very general and provides a framework generalizable to red noise, as well as to delaying differential equations, and even field equations, i.e., partial differential equations with noise, for example, general circulation models with noise. These concepts will be applied to an example taken from a simple ENSO model.	[Navarra, Antonio; Conti, Giovanni] Ctr Euromediterraneo Cambiamenti Climatici, Bologna, Italy; [Tribbia, Joe] Natl Ctr Atmospher Res, Boulder, CO 80307 USA	National Center Atmospheric Research (NCAR) - USA	Navarra, A (corresponding author), Ctr Euromediterraneo Cambiamenti Climatici, Bologna, Italy.	antonio.navarra@cmcc.it			Centro Euro-Mediterraneo sui cambiamenti Climatici (CMCC)	Centro Euro-Mediterraneo sui cambiamenti Climatici (CMCC)	Funding: Centro Euro-Mediterraneo sui cambiamenti Climatici (CMCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodai T, 2012, CHAOS, V22, DOI 10.1063/1.3697984; Dashen R, 1979, TRANSFORMATION FLUCT; DelSole T, 2001, J ATMOS SCI, V58, P3019, DOI 10.1175/1520-0469(2001)058<3019:ASMFTE>2.0.CO;2; DRUMMOND IT, 1982, J FLUID MECH, V123, P59, DOI 10.1017/S002211208200295X; Duane GS, 2004, J ATMOS SCI, V61, P2149, DOI 10.1175/1520-0469(2004)061<2149:WATASC>2.0.CO;2; Epstein E. S., 1969, J APPL METEOROL, V8, P190, DOI [10.1175/1520-0450(1969)008&LT;0190:TROIUI&GT;2.0.CO;2, DOI 10.1175/1520-0450(1969)0089]; FARRELL BF, 1995, J ATMOS SCI, V52, P1642, DOI 10.1175/1520-0469(1995)052<1642:SDOTMA>2.0.CO;2; Feynman RP., 2010, QUANTUM MECH PATH IN; Gledzer EB, 1974, RUSS MATH SURV, P117; Arenas ZG, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.051113; GOZZI E, 1994, CHAOS SOLITON FRACT, V4, P1117, DOI 10.1016/0960-0779(94)90026-4; Gritsun A, 2007, J ATMOS SCI, V64, P2558, DOI 10.1175/JAS3943.1; HAKEN H, 1976, Z PHYS B CON MAT, V24, P321, DOI 10.1007/BF01360904; HASSELMANN K, 1976, TELLUS, V28, P473, DOI 10.1111/j.2153-3490.1976.tb00696.x; Jin FF, 1997, J ATMOS SCI, V54, P811, DOI 10.1175/1520-0469(1997)054<0811:AEORPF>2.0.CO;2; Kleinert H., 2009, PATH INTEGRALS QUANT, V5th; Klyatskin VI, 2011, ELSEV INSIGHT, P1; Kravtsov S, 2005, J CLIMATE, V18, P4404, DOI 10.1175/JCLI3544.1; Lau AWC, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011123; LEITH CE, 1974, MON WEATHER REV, V102, P409, DOI 10.1175/1520-0493(1974)102<0409:TSOMCF>2.0.CO;2; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; MARTIN PC, 1973, PHYS REV A, V8, P423, DOI 10.1103/PhysRevA.8.423; MUNOZ G, 1993, J PHYS A-MATH GEN, V26, P4475, DOI 10.1088/0305-4470/26/17/051; ONSAGER L, 1953, PHYS REV, V91, P1505, DOI 10.1103/PhysRev.91.1505; Penland C, 2003, B AM METEOROL SOC, V84, P921, DOI 10.1175/BAMS-84-7-921; Pinardi N, 2008, B AM METEOROL SOC, V89, P799, DOI 10.1175/2008BAMS2511.1; Quinn JC, 2011, J COMPUT PHYS, V230, P8168, DOI 10.1016/j.jcp.2011.07.015; Risken H., 1989, FOKKER PLANCK EQUATI, DOI DOI 10.1007/978-3-642-61544-3; Rodwell MJ, 2006, J CLIMATE, V19, P6025, DOI 10.1175/JCLI3944.1; Schneider EK, 2007, J ATMOS SCI, V64, P3265, DOI 10.1175/JAS4026.1; Sura P, 2008, J CLIMATE, V21, P621, DOI 10.1175/2007JCLI1708.1; Thacker WD, 1997, J MATH PHYS, V38, P300, DOI 10.1063/1.532190; TOTH Z, 1993, B AM METEOROL SOC, V74, P2317, DOI 10.1175/1520-0477(1993)074<2317:EFANTG>2.0.CO;2; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Zinn-Justin J, 1993, QUANTUM FIELD THEORY, Vxxiv	35	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67022	10.1371/journal.pone.0067022	http://dx.doi.org/10.1371/journal.pone.0067022			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840577	Green Published, gold			2022-12-27	WOS:000321148400029
J	Vereczkei, A; Demetrovics, Z; Szekely, A; Sarkozy, P; Antal, P; Szilagyi, A; Sasvari-Szekely, M; Barta, C				Vereczkei, Andrea; Demetrovics, Zsolt; Szekely, Anna; Sarkozy, Peter; Antal, Peter; Szilagyi, Agnes; Sasvari-Szekely, Maria; Barta, Csaba			Multivariate Analysis of Dopaminergic Gene Variants as Risk Factors of Heroin Dependence	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; EXON-III POLYMORPHISM; TANDEM DUPLICATION POLYMORPHISM; RECEPTOR DRD4 GENE; FACTOR-KAPPA-B; NOVELTY SEEKING; PROMOTER REGION; ASSOCIATION ANALYSIS; TRANSPORTER GENE; FUNCTIONAL POLYMORPHISM	Background: Heroin dependence is a debilitating psychiatric disorder with complex inheritance. Since the dopaminergic system has a key role in rewarding mechanism of the brain, which is directly or indirectly targeted by most drugs of abuse, we focus on the effects and interactions among dopaminergic gene variants. Objective: To study the potential association between allelic variants of dopamine D2 receptor (DRD2), ANKK1 (ankyrin repeat and kinase domain containing 1), dopamine D4 receptor (DRD4), catechol-O-methyl transferase (COMT) and dopamine transporter (SLC6A3) genes and heroin dependence in Hungarian patients. Methods: 303 heroin dependent subjects and 555 healthy controls were genotyped for 7 single nucleotide polymorphisms (SNPs) rs4680 of the COMT gene; rs1079597 and rs1800498 of the DRD2 gene; rs1800497 of the ANKK1 gene; rs1800955, rs936462 and rs747302 of the DRD4 gene. Four variable number of tandem repeats (VNTRs) were also genotyped: 120 bp duplication and 48 bp VNTR in exon 3 of DRD4 and 40 bp VNTR and intron 8 VNTR of SLC6A3. We also perform a multivariate analysis of associations using Bayesian networks in Bayesian multilevel analysis (BN-BMLA). Findings and conclusions: In single marker analysis the TaqIA (rs1800497) and TaqIB (rs1079597) variants were associated with heroin dependence. Moreover, -521 C/T SNP (rs1800955) of the DRD4 gene showed nominal association with a possible protective effect of the C allele. After applying the Bonferroni correction TaqIB was still significant suggesting that the minor (A) allele of the TaqIB SNP is a risk component in the genetic background of heroin dependence. The findings of the additional multiple marker analysis are consistent with the results of the single marker analysis, but this method was able to reveal an indirect effect of a promoter polymorphism (rs936462) of the DRD4 gene and this effect is mediated through the -521 C/T (rs1800955) polymorphism in the promoter.	[Vereczkei, Andrea; Sasvari-Szekely, Maria; Barta, Csaba] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary; [Demetrovics, Zsolt; Szekely, Anna] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary; [Sarkozy, Peter; Antal, Peter] Tech Univ Budapest, Budapest, Hungary; [Szilagyi, Agnes] Semmelweis Univ, Res Lab, Dept Internal Med 3, H-1085 Budapest, Hungary	Semmelweis University; Eotvos Lorand University; Budapest University of Technology & Economics; Semmelweis University	Barta, C (corresponding author), Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, H-1085 Budapest, Hungary.	barta.csaba@med.semmelweis-univ.hu	Szilagyi, Agnes/F-2337-2010; Demetrovics, Zsolt/F-8613-2010; Antal, Peter/G-7894-2012; Vereczkei, Andrea/E-8326-2019	Szilagyi, Agnes/0000-0002-9769-3215; Demetrovics, Zsolt/0000-0001-5604-7551; Antal, Peter/0000-0002-4370-2198; Vereczkei, Andrea/0000-0001-6477-9306	European Union [TAMOP 4.2.1./B-09/1/KMR-2010-0003]; European Social Fund [TAMOP 4.2.1./B-09/1/KMR-2010-0003]; Janos Bolyai Research Fellowship; Hungarian Academy of Sciences; NKTH TECH [08-A1/2-2008-0120];  [OTKA F-46788];  [KAB-KT-05-0015];  [KAB-KT-10-0016]	European Union(European Commission); European Social Fund(European Social Fund (ESF)); Janos Bolyai Research Fellowship(Hungarian Academy of Sciences); Hungarian Academy of Sciences(Hungarian Academy of Sciences); NKTH TECH; ; ; 	The European Union and the European Social Fund has provided financial support under the grant agreement No.: TAMOP 4.2.1./B-09/1/KMR-2010-0003. www.nfu.hu. The study was co-funded by National Grants: OTKA F-46788, KAB-KT-05-0015 and KAB-KT-10-0016. www.otka.hu, www.szmm.gov.hu. Zsolt Demetrovics acknowledges financial support of the Janos Bolyai Research Fellowship awarded by the Hungarian Academy of Sciences. www.mta.hu. The authors would like to acknowledge the NKTH TECH 08-A1/2-2008-0120 (Genagrid) grant to P. Antal. www.nih.gov.hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antal P MA, 2008, JMLR WORKSHOP C P, V4, P74; ASGHARI V, 1995, J NEUROCHEM, V65, P1157, DOI 10.1046/j.1471-4159.1995.65031157.x; Barr CL, 2001, AM J MED GENET, V105, P84, DOI 10.1002/1096-8628(20010108)105:1<84::AID-AJMG1068>3.3.CO;2-H; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Benjamin J, 1996, NAT GENET, V12, P81, DOI 10.1038/ng0196-81; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; Bontempi S, 2007, ENDOCRINOLOGY, V148, P2563, DOI 10.1210/en.2006-1618; Boor K, 2002, CURR MED CHEM, V9, P793, DOI 10.2174/0929867024606821; Borroto-Escuela DO, 2011, BIOCHEM BIOPH RES CO, V404, P928, DOI 10.1016/j.bbrc.2010.12.083; Camara E, 2010, CEREB CORTEX, V20, P1985, DOI 10.1093/cercor/bhp263; CASTIGLIONE CM, 1995, AM J HUM GENET, V57, P1445; Chien CC, 2010, WORLD J BIOL PSYCHIA, V11, P409, DOI 10.3109/15622970903304459; Comings DE, 1996, PHARMACOGENETICS, V6, P73, DOI 10.1097/00008571-199602000-00006; Comings DE, 2000, PROG BRAIN RES, V126, P325; D'Souza UM, 2004, BIOL PSYCHIAT, V56, P691, DOI 10.1016/j.biopsych.2004.08.008; Dresel S, 2000, EUR J NUCL MED, V27, P1518, DOI 10.1007/s002590000330; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Elmer GI, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0004.2002; Etter JF, 2003, NICOTINE TOB RES, V5, P401, DOI 10.1080/1462220031000094240; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Fiorentini C, 2002, MOL ENDOCRINOL, V16, P353, DOI 10.1210/me.16.2.353; Franke P, 2000, MOL PSYCHIATR, V5, P101, DOI 10.1038/sj.mp.4000583; Gabel S, 1999, AM J ADDICTION, V8, P101; Gelernter J, 1997, AM J HUM GENET, V61, P1144, DOI 10.1086/301595; GELERNTER J, 1991, JAMA-J AM MED ASSOC, V266, P1801, DOI 10.1001/jama.266.13.1801; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Glatt SJ, 2006, AM J MED GENET B, V141B, P149, DOI 10.1002/ajmg.b.30273; GRANDY DK, 1993, HUM MOL GENET, V2, P2197, DOI 10.1093/hmg/2.12.2197-a; Guindalini C, 2006, P NATL ACAD SCI USA, V103, P4552, DOI 10.1073/pnas.0504789103; Ho AMC, 2008, ANN NY ACAD SCI, V1139, P20, DOI 10.1196/annals.1432.054; Hosak L, 2007, EUR PSYCHIAT, V22, P276, DOI 10.1016/j.eurpsy.2007.02.002; Hou QF, 2009, NEUROSCI LETT, V464, P127, DOI 10.1016/j.neulet.2009.08.004; Huang WH, 2009, NEUROPSYCHOPHARMACOL, V34, P319, DOI 10.1038/npp.2008.37; Hutchison KE, 2002, HEALTH PSYCHOL, V21, P139, DOI 10.1037//0278-6133.21.2.139; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; KENDLER KS, 1994, AM J PSYCHIAT, V151, P707; Kereszturi E, 2007, AM J MED GENET B, V144B, P231, DOI 10.1002/ajmg.b.30444; Kibitov AO, 2010, ZH NEVROL PSIKHIATR, V110, P84; Kidd KK, 1996, ALCOHOL CLIN EXP RES, V20, P697, DOI 10.1111/j.1530-0277.1996.tb01674.x; Kluger AN, 2002, MOL PSYCHIATR, V7, P712, DOI 10.1038/sj.mp.4001082; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kotler M, 1997, MOL PSYCHIATR, V2, P251, DOI 10.1038/sj.mp.4000248; Kotyuk Eszter, 2009, Neuropsychopharmacol Hung, V11, P59; Lai JH, 2010, BRAIN RES, V1359, P227, DOI 10.1016/j.brainres.2010.08.064; Lakatos K, 2002, MOL PSYCHIATR, V7, P27, DOI 10.1038/sj/mp/4000986; Laucht M, 2005, J AM ACAD CHILD PSY, V44, P477, DOI 10.1097/01.chi.0000155980.01792.7f; Laucht M, 2007, BIOL PSYCHIAT, V61, P87, DOI 10.1016/j.biopsych.2006.05.025; Lautner-Csorba O, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-42; Li T, 2000, AM J MED GENET, V96, P616, DOI 10.1002/1096-8628(20001009)96:5<616::AID-AJMG6>3.0.CO;2-7; Li T, 1997, MOL PSYCHIATR, V2, P413, DOI 10.1038/sj.mp.4000310; Lusher JM, 2001, MOL PSYCHIATR, V6, P497, DOI 10.1038/sj.mp.4000918; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; Mannisto PT, 1999, PHARMACOL REV, V51, P593; McGeary J, 2009, PHARMACOL BIOCHEM BE, V93, P222, DOI 10.1016/j.pbb.2009.03.010; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Neville MJ, 2004, HUM MUTAT, V23, P540, DOI 10.1002/humu.20039; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; NOBLE EP, 1993, DRUG ALCOHOL DEPEN, V33, P271, DOI 10.1016/0376-8716(93)90113-5; NOBLE EP, 1994, MED HYPOTHESES, V42, P257, DOI 10.1016/0306-9877(94)90127-9; Okuyama Y, 1999, BIOCHEM BIOPH RES CO, V258, P292, DOI 10.1006/bbrc.1999.0630; Okuyama Y, 2000, MOL PSYCHIATR, V5, P64, DOI 10.1038/sj.mp.4000563; de los Cobos JP, 2007, BEHAV BRAIN FUNCT, V3, DOI 10.1186/1744-9081-3-25; Persico AM, 1996, BIOL PSYCHIAT, V40, P776, DOI 10.1016/0006-3223(95)00483-1; Ponce G, 2009, NEUROTOX RES, V16, P50, DOI 10.1007/s12640-009-9046-9; Robbins TW, 1999, NATURE, V398, P567, DOI 10.1038/19208; Ronai Z, 2000, ELECTROPHORESIS, V21, P2058, DOI 10.1002/1522-2683(20000601)21:10<2058::AID-ELPS2058>3.0.CO;2-1; Ronai Z, 2004, AM J MED GENET B, V126B, P74, DOI 10.1002/ajmg.b.20112; Ronai Z, 2001, ELECTROPHORESIS, V22, P1102, DOI 10.1002/1522-2683()22:6<1102::AID-ELPS1102>3.0.CO;2-3; Ronai Z, 2001, MOL PSYCHIATR, V6, P35, DOI 10.1038/sj.mp.4000832; Rose RJ, 1998, ALCOHOL HEALTH RES W, V22, P131; Schinka JA, 2002, AM J MED GENET, V114, P643, DOI 10.1002/ajmg.10649; Seaman MI, 1999, AM J MED GENET, V88, P705, DOI 10.1002/(SICI)1096-8628(19991215)88:6<705::AID-AJMG22>3.0.CO;2-F; Shao CH, 2006, PSYCHOPHARMACOLOGY, V186, P185, DOI 10.1007/s00213-006-0375-6; Sobik L, 2005, APPETITE, V44, P253, DOI 10.1016/j.appet.2004.12.001; Spitz MR, 1998, J NATL CANCER I, V90, P358, DOI 10.1093/jnci/90.5.358; Stallings MC, 2003, DRUG ALCOHOL DEPEN, V70, P295, DOI 10.1016/S0376-8716(03)00031-0; Szantai E, 2005, PSYCHIAT GENET, V15, P259, DOI 10.1097/00041444-200512000-00008; Szilagyi Agnes, 2005, Neuropsychopharmacol Hung, V7, P28; Tarnok Z, 2007, AM J MED GENET B, V144B, P900, DOI 10.1002/ajmg.b.30517; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; Ueno S, 1999, MOL PSYCHIATR, V4, P552, DOI 10.1038/sj.mp.4000562; Ungvari I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033573; van den Bree MBM, 1998, DRUG ALCOHOL DEPEN, V52, P231, DOI 10.1016/S0376-8716(98)00101-X; VANDENBERGH DJ, 1992, MOL BRAIN RES, V15, P161, DOI 10.1016/0169-328X(92)90165-8; VANDENBERGH DJ, 1992, GENOMICS, V14, P1104, DOI 10.1016/S0888-7543(05)80138-7; VANTOL HHM, 1992, NATURE, V358, P149; Varga G, 2012, AM J MED GENET B, V159B, P281, DOI 10.1002/ajmg.b.32025; West A, 2002, MOL PSYCHIATR, V7, P962, DOI 10.1038/sj.mp.4001129; Xi ZX, 2002, ALCOHOL ALCOHOLISM, V37, P485, DOI 10.1093/alcalc/37.5.485; Young RM, 2004, ADDICT BEHAV, V29, P1275, DOI 10.1016/j.addbeh.2004.06.012	92	51	57	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66592	10.1371/journal.pone.0066592	http://dx.doi.org/10.1371/journal.pone.0066592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840506	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400016
J	Cheng, SM; Chen, W; Yang, YZ; Chu, P; Liu, XL; Zhao, MG; Tan, WG; Xu, L; Wu, QF; Guan, HY; Liu, JH; Liu, HT; Chen, RY; Jia, ZW				Cheng, Shiming; Chen, Wei; Yang, Yingzhou; Chu, Ping; Liu, Xiaoli; Zhao, Meigui; Tan, Weiguo; Xu, Li; Wu, Qingfang; Guan, Hongyun; Liu, Jinhong; Liu, Haitao; Chen, Ray Y.; Jia, Zhongwei			Effect of Diagnostic and Treatment Delay on the Risk of Tuberculosis Transmission in Shenzhen, China: An Observational Cohort Study, 1993-2010	PLOS ONE			English	Article							SMEAR-POSITIVE TUBERCULOSIS; PULMONARY TUBERCULOSIS	Introduction: To understand better the risk of tuberculosis transmission with increasing delay in tuberculosis treatment, we undertook a retrospective cohort study in Shenzhen, China. Methods: All pulmonary tuberculosis cases in the Shenzhen tuberculosis surveillance database from 1993-2010 were included. Sputum smear positivity and presence of pulmonary cavity were used as proxies for risk of tuberculosis transmission. Results: Among 48,441 pulmonary tuberculosis cases, 70% presented with symptoms of pulmonary TB, 62% were sputum smear positive, and 21% had a pulmonary cavity on chest x-ray. 95.3% of patients self-presented for evaluation of illness after a median 58 days of delay after symptoms began. The proportion presenting sputum smear positive (p<0.001) and with a pulmonary cavity (p<0.001) increased significantly with increasing duration of delay. Conclusions: Delayed diagnosis and treatment of tuberculosis is associated with a significantly increased risk of pulmonary sputum smear positivity and pulmonary cavity. To decrease risk of transmission, treatment delay needs to be reduced further.	[Cheng, Shiming; Chen, Wei] Chinese Ctr Dis Control & Prevent, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [Yang, Yingzhou; Liu, Xiaoli; Zhao, Meigui; Tan, Weiguo; Xu, Li; Wu, Qingfang; Guan, Hongyun; Liu, Jinhong] Shenzhen Chron Dis Control Ctr, Shenzhen, Peoples R China; [Chu, Ping] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Key Lab Major Dis Children,Minist Educ, Beijing, Peoples R China; [Chu, Ping] Capital Med Univ, Beijing Childrens Hosp, Beijing Pediat Res Inst, Natl Key Discipline Pediat,Minist Educ, Beijing, Peoples R China; [Liu, Haitao] Minist Hlth, Bur Dis Control & Prevent, Beijing, Peoples R China; [Chen, Ray Y.] US Embassy, US Natl Inst Hlth, Natl Inst Allergy & Infect Dis, Beijing, Peoples R China; [Jia, Zhongwei] Peking Univ, Hlth Sci Ctr, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Jia, Zhongwei] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Takemi Program Int Hlth, Boston, MA 02115 USA	Chinese Center for Disease Control & Prevention; Capital Medical University; Capital Medical University; Peking University; Harvard University; Harvard T.H. Chan School of Public Health	Yang, YZ (corresponding author), Shenzhen Chron Dis Control Ctr, Shenzhen, Peoples R China.	szyyz@china.com; urchinjj@163.com	Liu, Xiaoli/HGE-7614-2022; Chen, Ray/GRJ-6736-2022; Chen, Ray/T-5102-2019	Chen, Ray/0000-0001-6344-1442	National Nature Science Foundation [30973981]; Beijing Municipal Commission of Education [KM201010025010]; Chinese Government [2012ZX10004903]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Chinese Government	This work was supported by National Nature Science Foundation (No. 30973981) and Beijing Municipal Commission of Education (No. KM201010025010), and Chinese Government Grants (no. 2012ZX10004903). The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, INTERDISCIPLINARY PE, V10, P412; [Anonymous], 2011, GLOB TUB CONTR 2011; Bernstein Amy B, 2012, MMWR Suppl, V61, P30; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; EQUI-TB, 2005, WHO IS MOST VULN TB; Esther N, 2009, BMC HLTH SERVICES RE, V9; Gibson N, 2005, SOC SCI MED, V61, P931, DOI 10.1016/j.socscimed.2004.10.026; Gupta KB, 2006, NTI B, V42, P63; Horne DJ, 2010, INFECT CONT HOSP EP, V31, P78, DOI 10.1086/649022; Jia ZW, 2008, EMERG INFECT DIS, V14, P1413, DOI [10.3201/1409.071543, 10.3201/eid1409.071543]; Jia ZW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000371; Mesfin MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-53; Mfinanga SG, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-158; Muhammad S, 2011, BMC RES NOTES, V4, P165; Ng MK, 2004, EURASIAN GEOGR ECON, V45, P190, DOI 10.2747/1538-7216.45.3.190; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Pai M, 2009, CLIN CHEST MED, V30, P701, DOI 10.1016/j.ccm.2009.08.016; Rajendra B, 2009, BMC PUBLIC HEALTH, P9; Rodger A, 2003, BRIT MED J, V326, P909, DOI 10.1136/bmj.326.7395.909; Shenzhen Municipal Bureau of Statistics, 2009, SHENZH STAT YB 2009; Shi Jun-shi, 2009, Zhonghua Yi Shi Za Zhi, V39, P226; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Stop T, 2009, PATHWAYS BETTER DIAG; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Tatek Wondimu, 2007, Ethiopian Journal of Health Development, V21, P148; Uys PW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000757; Verhagen L, 2010, INFECTION, P1; Wang LX, 2010, B WORLD HEALTH ORGAN, V88, P937, DOI 10.2471/BLT.09.071753; Wu QF, 2006, CHINA TROPICAL MED, V6, P760; Xu L, 2010, CHINESE J ANTITUBERC, V32, P6; Zhu L-m, 2007, SHANGHAI J PREVENTIV, V2, P61	32	43	46	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67516	10.1371/journal.pone.0067516	http://dx.doi.org/10.1371/journal.pone.0067516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826313	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000087
J	Hatier, JHB; Clearwater, MJ; Gould, KS				Hatier, Jean-Hugues B.; Clearwater, Michael J.; Gould, Kevin S.			The Functional Significance of Black-Pigmented Leaves: Photosynthesis, Photoprotection and Productivity in Ophiopogon planiscapus 'Nigrescens'	PLOS ONE			English	Article							GREEN LEAVES; ANTHOCYANIN ACCUMULATION; QUERCUS-COCCIFERA; LOW-TEMPERATURE; YOUNG LEAVES; LIGHT; RED; PROTECTION; AUTUMN; PHOTOINHIBITION	Black pigmented leaves are common among horticultural cultivars, yet are extremely rare across natural plant populations. We hypothesised that black pigmentation would disadvantage a plant by reducing photosynthesis and therefore shoot productivity, but that this trait might also confer protective benefits by shielding chloroplasts against photo-oxidative stress. CO2 assimilation, chlorophyll a fluorescence, shoot biomass, and pigment concentrations were compared for near isogenic green- and black-leafed Ophiopogon planiscapus 'Nigrescens'. The black leaves had lower maximum CO2 assimilation rates, higher light saturation points and higher quantum efficiencies of photosystem II (PSII) than green leaves. Under saturating light, PSII photochemistry was inactivated less and recovered more completely in the black leaves. In full sunlight, green plants branched more abundantly and accumulated shoot biomass quicker than the black plants; in the shade, productivities of the two morphs were comparable. The data indicate a light-screening, photoprotective role of foliar anthocyanins. However, limitations to photosynthetic carbon assimilation are relatively small, insufficient to explain the natural scarcity of black-leafed plants.	[Hatier, Jean-Hugues B.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Clearwater, Michael J.] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Gould, Kevin S.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	University of Auckland; University of Waikato; Victoria University Wellington	Gould, KS (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	kevin.gould@vuw.ac.nz	Clearwater, Mike/AAU-9562-2020	Clearwater, Michael/0000-0002-8563-0671				Allen DJ, 2001, TRENDS PLANT SCI, V6, P36, DOI 10.1016/S1360-1385(00)01808-2; Arscott DB, 2000, J N AM BENTHOL SOC, V19, P263, DOI 10.2307/1468069; BOARDMAN NK, 1977, ANNU REV PLANT PHYS, V28, P355, DOI 10.1146/annurev.pp.28.060177.002035; Cai ZQ, 2005, PHOTOSYNTHETICA, V43, P91, DOI 10.1007/s11099-005-1098-3; Close DC, 2005, J PLANT PHYSIOL, V162, P37, DOI 10.1016/j.jplph.2003.10.001; Close DC, 2003, BOT REV, V69, P149, DOI 10.1663/0006-8101(2003)069[0149:TEOFA]2.0.CO;2; Davies KM, 2004, ANNU PLANT REV, V14, P214; DemmigAdams B, 1996, FASEB J, V10, P403, DOI 10.1096/fasebj.10.4.8647339; Feild TS, 2001, PLANT PHYSIOL, V127, P566, DOI 10.1104/pp.010063; GATES DM, 1965, APPL OPTICS, V4, P11, DOI 10.1364/AO.4.000011; Gould K.S., 2005, FLAVONOIDS CHEM BIOC; GOULD KS, 1995, NATURE, V378, P241, DOI 10.1038/378241b0; Gould KS, 2002, PLANT CELL ENVIRON, V25, P1261, DOI 10.1046/j.1365-3040.2002.00905.x; Gould KS, 2002, PHYSIOL PLANTARUM, V116, P127, DOI 10.1034/j.1399-3054.2002.1160116.x; Gould KS, 2004, J BIOMED BIOTECHNOL, P314, DOI 10.1155/S1110724304406147; Hada H, 2003, PLANT CELL ENVIRON, V26, P1691, DOI 10.1046/j.1365-3040.2003.01087.x; Hatier JHB, 2007, FUNCT PLANT BIOL, V34, P130, DOI 10.1071/FP06220; Hoch WA, 2003, PLANT PHYSIOL, V133, P1296, DOI 10.1104/pp.103.027631; HODGSON EA, 1965, T ROY SOC NZ BOT, V3, P67; Huber H, 1997, OECOLOGIA, V110, P478, DOI 10.1007/s004420050183; Hughes NM, 2007, NEW PHYTOL, V175, P675, DOI 10.1111/j.1469-8137.2007.02133.x; Hughes NM, 2005, NEW PHYTOL, V168, P575, DOI 10.1111/j.1469-8137.2005.01546.x; IRELAND RR, 1982, BRYOLOGIST, V85, P112, DOI 10.2307/3243151; Karageorgou P, 2006, TREE PHYSIOL, V26, P613, DOI 10.1093/treephys/26.5.613; KROL M, 1995, CAN J BOT, V73, P1119, DOI 10.1139/b95-122; LEE DW, 1987, BIOTROPICA, V19, P161, DOI 10.2307/2388739; Lee DW, 2003, ECOL RES, V18, P677, DOI 10.1111/j.1440-1703.2003.00588.x; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Manetas Y, 2003, FUNCT PLANT BIOL, V30, P265, DOI 10.1071/FP02226; Manetas Y, 2002, PHOTOSYNTHETICA, V40, P349, DOI 10.1023/A:1022614722629; Markham KR, 2004, Z NATURFORSCH C, V59, P625; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MURRAY BM, 1987, BRYOLOGIST, V90, P15, DOI 10.2307/3243268; MURRAY JR, 1991, PLANT PHYSIOL, V97, P343, DOI 10.1104/pp.97.1.343; Neill SO, 2002, PLANT CELL ENVIRON, V25, P539, DOI 10.1046/j.1365-3040.2002.00837.x; Newsham KK, 2003, OECOLOGIA, V135, P327, DOI 10.1007/s00442-003-1191-x; Nishio JN, 2000, PLANT CELL ENVIRON, V23, P539, DOI 10.1046/j.1365-3040.2000.00563.x; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; OGREN E, 1993, PLANTA, V189, P182, DOI 10.1007/BF00195075; OSMOND CB, 1987, NEW PHYTOL, V106, P161; OSMOND CB, 1995, J EXP BOT, V46, P1351, DOI 10.1093/jxb/46.special_issue.1351; PERSSON H., 1950, BRYOLOGIST, V53, P172; Pietrini F, 2002, PLANT CELL ENVIRON, V25, P1251, DOI 10.1046/j.1365-3040.2002.00917.x; Platt K, 2004, BLACK MAGIC PURPLE P; SAYRE GENEVA, 1955, BRYOLOGIST, V58, P323; Shao L, 2008, FUNCT PLANT BIOL, V35, P714, DOI 10.1071/FP08069; Smith WK, 1997, BIOSCIENCE, V47, P785, DOI 10.2307/1313100; Steyn WJ, 2002, NEW PHYTOL, V155, P349, DOI 10.1046/j.1469-8137.2002.00482.x; Sun JD, 1998, PLANT CELL PHYSIOL, V39, P1020, DOI 10.1093/oxfordjournals.pcp.a029298; Terashima I, 2009, PLANT CELL PHYSIOL, V50, P684, DOI 10.1093/pcp/pcp034; VITT DH, 1980, NEW ZEAL J BOT, V18, P367, DOI 10.1080/0028825X.1980.10427254; VONCAEMMERER S, 1981, PLANTA, V153, P376, DOI 10.1007/BF00384257; WEATHERALL IL, 1991, NEW ZEAL J BOT, V29, P197, DOI 10.1080/0028825X.1991.10416721	53	28	29	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67850	10.1371/journal.pone.0067850	http://dx.doi.org/10.1371/journal.pone.0067850			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826347	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400173
J	Silvar, C; Perovic, D; Nussbaumer, T; Spannagl, M; Usadel, B; Casas, A; Igartua, E; Ordon, F				Silvar, Cristina; Perovic, Dragan; Nussbaumer, Thomas; Spannagl, Manuel; Usadel, Bjoern; Casas, Ana; Igartua, Ernesto; Ordon, Frank			Towards Positional Isolation of Three Quantitative Trait Loci Conferring Resistance to Powdery Mildew in Two Spanish Barley Landraces	PLOS ONE			English	Article							MAP-BASED CLONING; DISEASE-RESISTANCE; GENETIC DIVERSITY; HIGH-RESOLUTION; LINKAGE MAP; GENOME; REGION; WHEAT; RICE; EVOLUTION	Three quantitative trait loci (QTL) conferring broad spectrum resistance to powdery mildew, caused by the fungus Blumeria graminis f. sp. hordei, were previously identified on chromosomes 7HS, 7HL and 6HL in the Spanish barley landrace-derived lines SBCC097 and SBCC145. In the present work, a genome-wide putative linear gene index of barley ( Genome Zipper) and the first draft of the physical, genetic and functional sequence of the barley genome were used to go one step further in the shortening and explicit demarcation on the barley genome of these regions conferring resistance to powdery mildew as well as in the identification of candidate genes. First, a comparative analysis of the target regions to the barley Genome Zippers of chromosomes 7H and 6H allowed the development of 25 new gene-based molecular markers, which slightly better delimit the QTL intervals. These new markers provided the framework for anchoring of genetic and physical maps, figuring out the outline of the barley genome at the target regions in SBCC097 and SBCC145. The outermost flanking markers of QTLs on 7HS, 7HL and 6HL defined a physical area of 4 Mb, 3.7 Mb and 3.2 Mb, respectively. In total, 21, 10 and 16 genes on 7HS, 7HL and 6HL, respectively, could be interpreted as potential candidates to explain the resistance to powdery mildew, as they encode proteins of related functions with respect to the known pathogen defense-related processes. The majority of these were annotated as belonging to the NBS-LRR class or protein kinase family.	[Silvar, Cristina] Univ A Coruna, Dept Ecol Plant & Anim Biol, La Coruna, Spain; [Silvar, Cristina; Perovic, Dragan; Ordon, Frank] Julius Kuhn Inst, Inst Resistance Res & Stress Tolerance, Quedlinburg, Germany; [Nussbaumer, Thomas; Spannagl, Manuel] Helmholtz Zentrum Munchen, MIPS IBIS, Neuherberg, Germany; [Usadel, Bjoern] Rhein Westfal TH Aachen, Inst Biol 1, Aachen, Germany; [Casas, Ana; Igartua, Ernesto] CSIC, Aula Expt Stn, Dept Genet & Plant Prod, Zaragoza, Spain	Universidade da Coruna; Julius Kuhn-Institut; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; RWTH Aachen University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Aula Dei (EEAD)	Silvar, C (corresponding author), Univ A Coruna, Dept Ecol Plant & Anim Biol, La Coruna, Spain.	c.silvar@udc.es	Igartua, Ernesto/E-7691-2012; Usadel, Björn/E-1932-2011; Casas, Ana Maria/G-3898-2011; Silvar, Cristina/G-5141-2010; Perovic, Dragan G/C-1149-2008	Igartua, Ernesto/0000-0003-2938-1719; Usadel, Björn/0000-0003-0921-8041; Casas, Ana Maria/0000-0003-3484-2655; Silvar, Cristina/0000-0002-1782-8045; Perovic, Dragan G/0000-0002-0292-1693; Spannagl, Manuel/0000-0003-0701-7035	German Federal Ministry of Education and Research within the KBBE-II call [0315702B]; Spanish Ministry of Science and Innovation [EUI2009-04075]; University of Coruna; Deutscher Akademischer Austausch Dienst; Direct For Biological Sciences [1337525] Funding Source: National Science Foundation; Division Of Undergraduate Education [0941984] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1343533] Funding Source: National Science Foundation	German Federal Ministry of Education and Research within the KBBE-II call; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University of Coruna; Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Undergraduate Education(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Project ExpResBar, funded by the German Federal Ministry of Education and Research under grant number 0315702B within the KBBE-II call, and by the Spanish Ministry of Science and Innovation, grant number EUI2009-04075. The University of Coruna and the Deutscher Akademischer Austausch Dienst funded mobility fellowships for CS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolot S, 2009, CURR OPIN PLANT BIOL, V12, P119, DOI 10.1016/j.pbi.2008.10.011; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Brueggeman R, 2002, P NATL ACAD SCI USA, V99, P9328, DOI 10.1073/pnas.142284999; Bulgarelli D, 2004, THEOR APPL GENET, V108, P1401, DOI 10.1007/s00122-003-1557-9; Bulgarelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012599; Caldwell KS, 2004, PLANT PHYSIOL, V136, P3177, DOI 10.1104/pp.104.044081; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Condon F, 2008, CROP SCI, V48, P1027, DOI 10.2135/cropsci2007.07.0415; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Drader T, 2009, THEOR APPL GENET, V118, P811, DOI 10.1007/s00122-008-0941-x; Dreiseitl A, 2003, GENET RESOUR CROP EV, V50, P345, DOI 10.1023/A:1023953819787; Feuillet C, 2012, FUNCT INTEGR GENOMIC, V12, P573, DOI 10.1007/s10142-012-0300-5; FISCHBECK G, 1991, INTEGRATED CONTROL OF CEREAL MILDEWS : VIRULENCE PATTERNS AND THEIR CHANGE, P247; Gupta SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042578; Igartua E, 1998, GENET RESOUR CROP EV, V45, P475, DOI 10.1023/A:1008662515059; Jacobs AK, 2003, PLANT CELL, V15, P2503, DOI 10.1105/tpc.016097; JANSEN RC, 1994, GENETICS, V136, P1447; Jones DA, 1996, ADV BOT RES ADV PLAN, V24, P90; Jorgensen JH, 1997, EUPHYTICA, V97, P227, DOI 10.1023/A:1003032424968; Kilian B, 2006, MOL GENET GENOMICS, V276, P230, DOI 10.1007/s00438-006-0136-6; Konig J, 2012, MOL BREEDING, V30, P1253, DOI 10.1007/s11032-012-9712-0; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Kunzel G, 2000, GENETICS, V154, P397; Lasa JM, 2008, MONOGRAFIAS INIA; Lee J, 2002, TRENDS PLANT SCI, V7, P97, DOI 10.1016/S1360-1385(02)02229-X; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Li WL, 2002, GENETICS, V160, P1153; Liu ZH, 2010, PLANT GENOME-US, V3, P41, DOI 10.3835/plantgenome2010.02.0002; Lopez P. B., 1994, Ceres (Rome), V26, P41; Malysheva-Otto L, 2007, MOL BREEDING, V20, P309, DOI 10.1007/s11032-007-9093-y; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Mayer KFX, 2009, PLANT PHYSIOL, V151, P496, DOI 10.1104/pp.109.142612; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Morrell PL, 2007, P NATL ACAD SCI USA, V104, P3289, DOI 10.1073/pnas.0611377104; Munoz-Amatriain M, 2011, PLANT GENOME-US, V4, P238, DOI 10.3835/plantgenome2011.08.0023; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pourkheirandish M, 2007, THEOR APPL GENET, V114, P1357, DOI 10.1007/s00122-007-0522-4; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Sato K, 2009, HEREDITY, V103, P110, DOI 10.1038/hdy.2009.57; Sato K, 2009, DNA RES, V16, P81, DOI 10.1093/dnares/dsn034; Schulte D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-247; Shahinnia F, 2012, THEOR APPL GENET, V124, P373, DOI 10.1007/s00122-011-1712-7; Silvar C, 2011, THEOR APPL GENET, V123, P1019, DOI 10.1007/s00122-011-1644-2; Silvar C, 2011, PLANT BREEDING, V130, P195, DOI 10.1111/j.1439-0523.2010.01843.x; Silvar C, 2010, PLANT BREEDING, V129, P45, DOI 10.1111/j.1439-0523.2009.01700.x; Silvar C, 2013, EUR J PLANT PATHOL, V136, P459, DOI 10.1007/s10658-013-0178-7; Silvar C, 2012, THEOR APPL GENET, V124, P49, DOI 10.1007/s00122-011-1686-5; Silvar C, 2010, MOL BREEDING, V25, P581, DOI 10.1007/s11032-009-9354-z; Singh R.P., 2006, CAB REV, V1, P54, DOI [10.1079/PAVSNNR20061054"10.1079/PAVSNNR20061054, DOI 10.1079/PAVSNNR20061054"10.1079/PAVSNNR20061054, 10.1079/PAVSNNR20061054]; Stein N, 2005, PLANT J, V42, P912, DOI 10.1111/j.1365-313X.2005.02424.x; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Thiel T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-209; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; van de Wouw M, 2010, THEOR APPL GENET, V120, P1241, DOI 10.1007/s00122-009-1252-6; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Varshney RK, 2007, ADV GENET, V58, P121, DOI 10.1016/S0065-2660(06)58005-8; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yahiaoui S, 2008, THEOR APPL GENET, V116, P271, DOI 10.1007/s00122-007-0665-3; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253	69	11	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67336	10.1371/journal.pone.0067336	http://dx.doi.org/10.1371/journal.pone.0067336			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826271	Green Published, gold			2022-12-27	WOS:000321738400135
J	Tseng, WEJ; Chen, CM; Chen, YC; Yi, Z; Tan, EK; Wu, YR				Tseng, Wei-En Johnny; Chen, Chiung-Mei; Chen, Yi-Chun; Yi, Zhao; Tan, Eng-King; Wu, Yih-Ru			Genetic Variations of GAK in Two Chinese Parkinson's Disease Populations: A Case-Control Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; G-ASSOCIATED KINASE; ALPHA-SYNUCLEIN; CATHEPSIN-D; METAANALYSIS; TOXICITY; LOCUS; IDENTIFICATION; AGGREGATION; REPLICATION	Cyclin G-associated kinase (GAK) modifies alpha-synuclein expression levels and affects the susceptibility of Parkinson's disease (PD). The single-nucleotide polymorphism (SNP) rs1564282 of GAK gene has a significant association to the risk of PD among Caucasian populations. To date there is only one data with regards to ethnic Chinese from Mainland China. Here, we conducted a case-control study in two independent cohorts of Han Chinese populations from Taiwan and Singapore to validate this association. A total of 1,755 subjects (871 PD patients and 884 controls) were recruited. The results showed that neither the CT, TT genotypes nor the minor allele T of SNP rs1564282 were associated with PD among the subjects from Taiwan and Singapore as well as in the pooled analysis. Differences in our study population with regards to published literature may be due to epigenetic factors and gene-gene or gene-environmental interactions. Further studies in other Chinese populations will be of interest to validate these findings.	[Tseng, Wei-En Johnny; Chen, Chiung-Mei; Chen, Yi-Chun; Wu, Yih-Ru] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan; [Yi, Zhao; Tan, Eng-King] Singapore Gen Hosp, Natl Neurosci Inst, Singapore, Singapore	Chang Gung Memorial Hospital; Chang Gung University; National Neuroscience Institute (NNI); Singapore General Hospital	Wu, YR (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan.	yihruwu@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020		Chang Gung Memorial Hospital, Taipei, Taiwan [CMRPG391182, CMRPG 3A0132]; National Science Council, Executive Yuan, Taiwan [NSC 101-2314-B-182A-065-]; National Medical Research Council, Singapore Millennium Foundation and Duke NUS Graduate Medical School	Chang Gung Memorial Hospital, Taipei, Taiwan(Chang Gung Memorial Hospital); National Science Council, Executive Yuan, Taiwan(Ministry of Science and Technology, Taiwan); National Medical Research Council, Singapore Millennium Foundation and Duke NUS Graduate Medical School(National University of SingaporeNational Medical Research Council, Singapore)	This study was sponsored by Chang Gung Memorial Hospital, Taipei, Taiwan (CMRPG391182; CMRPG 3A0132); National Science Council, Executive Yuan, Taiwan (NSC 101-2314-B-182A-065-) and "National Medical Research Council, Singapore Millennium Foundation and Duke NUS Graduate Medical School." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dean AG, OPENEPI OPEN SOURCE; Dumitriu A, 2011, HUM MOL GENET, V20, P1478, DOI 10.1093/hmg/ddr026; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Li NN, 2012, HUM GENET, V131, P1089, DOI 10.1007/s00439-011-1133-3; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Pankratz N, 2012, ANN NEUROL, V71, P370, DOI 10.1002/ana.22687; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Rhodes SL, 2011, ANN HUM GENET, V75, P195, DOI 10.1111/j.1469-1809.2010.00616.x; Saad M, 2011, HUM MOL GENET, V20, P615, DOI 10.1093/hmg/ddq497; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Sharma M, 2012, NEUROLOGY, V79, P659, DOI 10.1212/WNL.0b013e318264e353; Shimizu H, 2009, J CELL SCI, V122, P3145, DOI 10.1242/jcs.052795; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Susa M, 2010, MOL CANCER THER, V9, P3342, DOI 10.1158/1535-7163.MCT-10-0637	24	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67506	10.1371/journal.pone.0067506	http://dx.doi.org/10.1371/journal.pone.0067506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826309	gold, Green Published, Green Submitted			2022-12-27	WOS:000321738400152
J	Chung, TH; Mulligan, G; Fonseca, R; Chng, WJ				Chung, Tae-Hoon; Mulligan, George; Fonseca, Rafael; Chng, Wee Joo			A Novel Measure of Chromosome Instability Can Account for Prognostic Difference in Multiple Myeloma	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; MOLECULAR CLASSIFICATION; GENOMIC INSTABILITY; CANCER; AMPLIFICATION; PATHOGENESIS; ABERRATIONS; PROGRESSION; PREDICTION; SURVIVAL	Multiple myeloma (MM) is characterized by complex genetic abnormalities whose complexity signifies varying degree of chromosomal instability (CIN). In this study, we introduced a novel CIN measure, chromosome instability genome event count (CINGEC), which considered both copy number aberrations and interstitial breakpoints from high-resolution genome-wide assays. When assessed in two aCGH MM datasets, higher CINGEC was associated with poor survival. We then derived a CINGEC-associated gene expression profile (GEP) signature, CINGECS, using a dataset that has both aCGH and GEP. Genes in CINGECS were mainly involved in DNA damage responses besides in aneuploidy and other generic oncogenic processes contrary to other CIN associated GEP signatures. Finally, we confirmed its survival association in three GEP datasets that encompassed newly diagnosed patients treated with transplant-based protocol with or without novel agents for induction as well as relapsed patients treated with bortezomib. Furthermore, CINGECS was independent of many GEP-based prognostic signatures. In conclusion, our novel CIN measure has definite biological and clinical significance in myeloma.	[Chung, Tae-Hoon; Chng, Wee Joo] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Mulligan, George] Millenium Takeda Oncol, Cambridge, MA USA; [Fonseca, Rafael] Mayo Clin, Ctr Comprehens Canc, Scottsdale, AZ USA; [Chng, Wee Joo] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Chng, Wee Joo] Natl Univ Hlth Syst, Natl Univ Canc Inst Singapore, Dept Haematol Oncol, Singapore 117548, Singapore	National University of Singapore; Takeda Pharmaceutical Company Ltd; Takeda Oncology; Mayo Clinic; Mayo Clinic Phoenix; National University of Singapore; National University of Singapore	Chng, WJ (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore.	mdccwj@nus.edu.sg		Chung, Tae Hoon/0000-0003-1737-6322; Fonseca, Rafael/0000-0002-5938-3769	NMRC Clinician Scientist Investigator award; Singapore Cancer Syndicate Grant; Singapore National Research Foundation; Ministry of Education under the Research Center of Excellence Programme; Predolin Foundation; Mayo Clinic Cancer Center; Mayo Foundation;  [SPORE CA90297052];  [P01 CA62242];  [R01 CA83724];  [ECOG CA 21115T]; NATIONAL CANCER INSTITUTE [R01CA083724, P01CA062242, U10CA021115] Funding Source: NIH RePORTER	NMRC Clinician Scientist Investigator award(National Medical Research Council, Singapore); Singapore Cancer Syndicate Grant; Singapore National Research Foundation(National Research Foundation, Singapore); Ministry of Education under the Research Center of Excellence Programme; Predolin Foundation; Mayo Clinic Cancer Center; Mayo Foundation; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	WJC is supported by NMRC Clinician Scientist Investigator award. This work is partly supported by Singapore Cancer Syndicate Grant. This material is based on research/work supported by the Singapore National Research Foundation and the Ministry of Education under the Research Center of Excellence Programme. RF is a Clinical Investigator of the Damon Runyon Cancer Research Fund. This work is supported by grants SPORE CA90297052, P01 CA62242, R01 CA83724, ECOG CA 21115T, Predolin Foundation, Mayo Clinic Cancer Center and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bayani J, 2007, SEMIN CANCER BIOL, V17, P5, DOI 10.1016/j.semcancer.2006.10.006; Boyd KD, 2011, GENE CHROMOSOME CANC, V50, P765, DOI 10.1002/gcc.20899; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Chng WJ, 2010, LEUKEMIA, V24, P833, DOI 10.1038/leu.2010.21; Chng WJ, 2008, BLOOD, V111, P1603, DOI 10.1182/blood-2007-06-097774; Chng WJ, 2006, BLOOD, V107, P3669, DOI 10.1182/blood-2005-09-3810; Decaux O, 2008, J CLIN ONCOL, V26, P4798, DOI 10.1200/JCO.2007.13.8545; Dickens NJ, 2010, CLIN CANCER RES, V16, P1856, DOI 10.1158/1078-0432.CCR-09-2831; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Keats JJ, 2006, LEUKEMIA LYMPHOMA, V47, P2289, DOI 10.1080/10428190600822128; Khatri P, 2005, NUCLEIC ACIDS RES, V33, pW762, DOI 10.1093/nar/gki472; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Kuiper R, 2012, LEUKEMIA, V26, P2406, DOI 10.1038/leu.2012.127; Kwei KA, 2010, MOL ONCOL, V4, P255, DOI 10.1016/j.molonc.2010.04.001; Lai LA, 2007, GENE CHROMOSOME CANC, V46, P532, DOI 10.1002/gcc.20435; Moreaux J, 2011, HAEMATOL-HEMATOL J, V96, P574, DOI 10.3324/haematol.2010.033456; Mulligan G, 2007, BLOOD, V109, P3177, DOI 10.1182/blood-2006-09-044974; Munshi NC, 2011, BLOOD, V117, P4696, DOI 10.1182/blood-2010-10-300970; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ouillette P, 2010, CLIN CANCER RES, V16, P835, DOI 10.1158/1078-0432.CCR-09-2534; Ozery-Flato M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r61; Schwender H, 2009, SIGGENES MULTIPLE TE; Seshan V.E., DNACOPY DNA COPY NUM; Shammas MA, 2009, BLOOD, V113, P2290, DOI 10.1182/blood-2007-05-089193; Shaughnessy J, 2005, HEMATOLOGY, V10, P117, DOI 10.1080/10245330512331390140; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; Snijders AM, 2008, GENE CHROMOSOME CANC, V47, P71, DOI 10.1002/gcc.20509; Stewart AK, 2007, EXPERT REV MOL DIAGN, V7, P453, DOI 10.1586/14737159.7.4.453; Stewart AK, 2005, J CLIN ONCOL, V23, P6339, DOI 10.1200/JCO.2005.05.023; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Walker BA, 2006, BLOOD, V108, P1733, DOI 10.1182/blood-2006-02-005496; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	44	32	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66361	10.1371/journal.pone.0066361	http://dx.doi.org/10.1371/journal.pone.0066361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840451	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800051
J	Hsueh, YS; Lin, CL; Chiang, NJ; Yen, CC; Li, CF; Shan, YS; Ko, CH; Shih, NY; Wang, LM; Chen, TS; Chen, LT				Hsueh, Yuan-Shuo; Lin, Chih-Lung; Chiang, Nai-Jung; Yen, Chueh-Chuan; Li, Chien-Feng; Shan, Yan-Shen; Ko, Ching-Huai; Shih, Neng-Yao; Wang, Ling-Mei; Chen, Ting-Shou; Chen, Li-Tzong			Selecting Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor with Secondary KIT Activation-Loop Domain Mutations	PLOS ONE			English	Article							C-KIT; IMATINIB RESISTANCE; ANTITUMOR-ACTIVITY; FREE SURVIVAL; NILOTINIB; SORAFENIB; SAFETY; PHARMACOKINETICS; DASATINIB; PROGNOSIS	Advanced gastrointestinal stromal tumors (GIST), a KIT oncogene-driven tumor, on imatinib mesylate (IM) treatment may develop secondary KIT mutations to confer IM-resistant phenotype. Second-line sunitinib malate (SU) therapy is largely ineffective for IM-resistant GISTs with secondary exon 17 (activation-loop domain) mutations. We established an in vitro cell-based platform consisting of a series of COS-1 cells expressing KIT cDNA constructs encoding common primary +/- secondary mutations observed in GISTs, to compare the activity of several commercially available tyrosine kinase inhibitors on inhibiting the phosphorylation of mutant KIT proteins at their clinically achievable plasma steady-state concentration (Css). The inhibitory efficacies on KIT exon 11/17 mutants were further validated by growth inhibition assay on GIST48 cells, and underlying molecular-structure mechanisms were investigated by molecular modeling. Our results showed that SU more effectively inhibited mutant KIT with secondary exon 13 or 14 mutations than those with secondary exon 17 mutations, as clinically indicated. On contrary, at individual Css, nilotinib and sorafenib more profoundly inhibited the phosphorylation of KIT with secondary exon 17 mutations and the growth of GIST48 cells than IM, SU, and dasatinib. Molecular modeling analysis showed fragment deletion of exon 11 and point mutation on exon 17 would lead to a shift of KIT conformational equilibrium toward active form, for which nilotinib and sorafenib bound more stably than IM and SU. In current preclinical study, nilotinib and sorafenib are more active in IM-resistant GISTs with secondary exon 17 mutation than SU that deserve further clinical investigation.	[Hsueh, Yuan-Shuo; Chiang, Nai-Jung; Li, Chien-Feng; Shih, Neng-Yao; Chen, Li-Tzong] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Hsueh, Yuan-Shuo; Chen, Li-Tzong] Natl Cheng Kung Univ, Inst Clin Pharm & Pharmaceut Sci, Tainan 70101, Taiwan; [Lin, Chih-Lung; Wang, Ling-Mei; Chen, Ting-Shou] Ind Technol Res Inst, Biomed Technol Lab, Hsinchu, Taiwan; [Lin, Chih-Lung; Wang, Ling-Mei; Chen, Ting-Shou] Ind Technol Res Inst, Device Res Lab, Hsinchu, Taiwan; [Chiang, Nai-Jung; Chen, Li-Tzong] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Yen, Chueh-Chuan] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Yen, Chueh-Chuan] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Li, Chien-Feng] Chi Mei Fdn, Med Ctr, Dept Pathol, Tainan, Taiwan; [Shan, Yan-Shen] Natl Cheng Kung Univ Hosp, Dept Surg, Div Gen Surg, Tainan 70428, Taiwan; [Chen, Li-Tzong] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Li-Tzong] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	National Health Research Institutes - Taiwan; National Cheng Kung University; Industrial Technology Research Institute - Taiwan; Industrial Technology Research Institute - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Cheng Kung University; National Cheng Kung University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, TS (corresponding author), Ind Technol Res Inst, Biomed Technol Lab, Hsinchu, Taiwan.	CTS@itri.org.tw; leochen@nhri.org.tw	Chen, Li-Tzong/D-2071-2010; Shih, Neng-Yao/D-2086-2010	Li, Chien-Feng/0000-0002-9527-7576; Hsueh, Yuan-Shuo/0000-0002-2584-9380	Department of Health [DOH95-97-TD-I-111-TM004, DOH-101-TD111-004]; National Health Research Institute [98A1CASP02-014]	Department of Health; National Health Research Institute(National Health Research Institutes - Taiwan)	Research funds were supported to National Institute of Cancer Research from Department of Health (DOH95-97-TD-I-111-TM004 and DOH-101-TD111-004) and National Health Research Institute (98A1CASP02-014). Research compounds from Novartis and Bayer, and honorarium from Novartis, TTY, and Pharmaengine were provided to Li-Tzong Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams TJ, 2003, MOL CANCER THER, V2, P1011; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Cauchi C, 2012, CANCER CHEMOTH PHARM, V69, P977, DOI 10.1007/s00280-011-1785-7; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Demetri GD, 2009, CLIN CANCER RES, V15, P6232, DOI 10.1158/1078-0432.CCR-09-0224; Demetri GD, 2009, CLIN CANCER RES, V15, P5910, DOI 10.1158/1078-0432.CCR-09-0542; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; George S, 2009, EUR J CANCER, V45, P1959, DOI 10.1016/j.ejca.2009.02.011; George S, 2012, J CLIN ONCOL, V30, P2401, DOI 10.1200/JCO.2011.39.9394; Guo T, 2007, CLIN CANCER RES, V13, P4874, DOI 10.1158/1078-0432.CCR-07-0484; Guo TH, 2009, CLIN CANCER RES, V15, P6862, DOI 10.1158/1078-0432.CCR-09-1315; Heinrich MC, 2002, J CLIN ONCOL, V20, P1692, DOI 10.1200/JCO.2002.20.6.1692; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Heinrich MC, 2008, J CLIN ONCOL, V26, P5352, DOI 10.1200/JCO.2007.15.7461; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Huynh H, 2009, MOL CANCER THER, V8, P152, DOI 10.1158/1535-7163.MCT-08-0553; Italiano A, 2012, ANN SURG ONCOL, V19, P1551, DOI 10.1245/s10434-011-2120-6; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Kim KP, 2011, CANCER CHEMOTH PHARM, V68, P285, DOI 10.1007/s00280-010-1479-6; Kindler HL, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.15_suppl.10009; Li CF, 2008, CLIN CANCER RES, V14, P7822, DOI 10.1158/1078-0432.CCR-08-1369; Mahadevan D, 2007, ONCOGENE, V26, P3909, DOI 10.1038/sj.onc.1210173; Martin J, 2005, J CLIN ONCOL, V23, P6190, DOI 10.1200/JCO.2005.19.554; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; Montemurro M, 2009, EUR J CANCER, V45, P2293, DOI 10.1016/j.ejca.2009.04.030; Park SH, 2012, INVEST NEW DRUG, V30, P2377, DOI 10.1007/s10637-012-9795-9; Peng B, 2004, J CLIN ONCOL, V22, P935, DOI 10.1200/JCO.2004.03.050; PURCELL WP, 1967, J CHEM ENG DATA, V12, P235, DOI 10.1021/je60033a020; Sawaki A, 2011, CANCER-AM CANCER SOC, V117, P4633, DOI 10.1002/cncr.26120; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; Strumberg D, 2007, ONCOLOGIST, V12, P426, DOI 10.1634/theoncologist.12-4-426; Trent JC, 2011, J CLIN ONCOL, V29; Verweij J, 2004, LANCET, V364, P1127, DOI 10.1016/S0140-6736(04)17098-0; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9	35	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65762	10.1371/journal.pone.0065762	http://dx.doi.org/10.1371/journal.pone.0065762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840364	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800020
J	Soenmez, TT; Al-Sawaf, O; Brandacher, G; Kanzler, I; Tuchscheerer, N; Tohidnezhad, M; Kanatas, A; Knobe, M; Fragoulis, A; Tolba, R; Mitchell, D; Pufe, T; Wruck, CJ; Holzle, F; Liehn, EA				Soenmez, Tolga Taha; Al-Sawaf, Othman; Brandacher, Gerald; Kanzler, Isabella; Tuchscheerer, Nancy; Tohidnezhad, Mersedeh; Kanatas, Anastasios; Knobe, Matthias; Fragoulis, Athanassios; Tolba, Rene; Mitchell, David; Pufe, Thomas; Wruck, Christoph Jan; Hoelzle, Frank; Liehn, Elisa Anamaria			A Novel Laser-Doppler Flowmetry Assisted Murine Model of Acute Hindlimb Ischemia-Reperfusion for Free Flap Research	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; SKELETAL-MUSCLE; ISCHEMIA/REPERFUSION INJURY; SURGERY	Suitable and reproducible experimental models of translational research in reconstructive surgery that allow in-vivo investigation of diverse molecular and cellular mechanisms are still limited. To this end we created a novel murine model of acute hindlimb ischemia-reperfusion to mimic a microsurgical free flap procedure. Thirty-six C57BL6 mice (n = 6/group) were assigned to one control and five experimental groups (subject to 6, 12, 96, 120 hours and 14 days of reperfusion, respectively) following 4 hours of complete hindlimb ischemia. Ischemia and reperfusion were monitored using Laser-Doppler Flowmetry. Hindlimb tissue components (skin and muscle) were investigated using histopathology, quantitative immunohistochemistry and immunofluorescence. Despite massive initial tissue damage induced by ischemia-reperfusion injury, the structure of the skin component was restored after 96 hours. During the same time, muscle cells were replaced by young myotubes. In addition, initial neuromuscular dysfunction, edema and swelling resolved by day 4. After two weeks, no functional or neuromuscular deficits were detectable. Furthermore, upregulation of VEGF and tissue infiltration with CD34-positive stem cells led to new capillary formation, which peaked with significantly higher values after two weeks. These data indicate that our model is suitable to investigate cellular and molecular tissue alterations from ischemia-reperfusion such as occur during free flap procedures.	[Soenmez, Tolga Taha; Al-Sawaf, Othman; Hoelzle, Frank] Rhein Westfal TH Aachen, Fac Med, Dept Oral & Maxillofacial Surg, Aachen, Germany; [Soenmez, Tolga Taha; Al-Sawaf, Othman; Tohidnezhad, Mersedeh; Fragoulis, Athanassios; Pufe, Thomas; Wruck, Christoph Jan] Rhein Westfal TH Aachen, Fac Med, Inst Anat & Cell Biol, Aachen, Germany; [Soenmez, Tolga Taha; Kanzler, Isabella; Tuchscheerer, Nancy; Liehn, Elisa Anamaria] Rhein Westfal TH Aachen, Fac Med, Inst Mol Cardiovasc Res IMCAR, Aachen, Germany; [Brandacher, Gerald] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD USA; [Kanzler, Isabella] Goethe Univ Frankfurt, Dept Thorac & Cardiovasc Surg, Frankfurt, Germany; [Kanatas, Anastasios] Leeds Teaching Hosp, Dept Oral & Maxillofacial Surg, Leeds, W Yorkshire, England; [Kanatas, Anastasios] Leeds Dent Inst, St James Inst Oncol, Leeds, W Yorkshire, England; [Knobe, Matthias] Rhein Westfal TH Aachen, Fac Med, Dept Orthopaed & Trauma Surg, Aachen, Germany; [Tolba, Rene] Rhein Westfal TH Aachen, Fac Med, Inst Lab Anim Sci & Expt Surg, Aachen, Germany; [Mitchell, David] Mid Yorkshire Hosp NHS Trust, Mid Yorkshire & Leeds Teaching Hosp, Dept Oral & Maxillofacial Surg, Wakefield, England	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; Johns Hopkins University; Goethe University Frankfurt; University of Leeds; Saint James's University Hospital; University of Leeds; RWTH Aachen University; RWTH Aachen University	Soenmez, TT (corresponding author), Rhein Westfal TH Aachen, Fac Med, Dept Oral & Maxillofacial Surg, Aachen, Germany.		Fragoulis, Athanassios/K-9623-2015; Kanatas, Anastasios/ABC-3040-2021; Knobe, Matthias/Y-3537-2019; Fragoulis, Athanassios/O-1191-2019; Liehn, Elisa Anamaria/D-9623-2011; Al-Sawaf, Othman/AAU-3737-2021; Brandacher, Gerald/L-7540-2016	Knobe, Matthias/0000-0002-9166-0965; Fragoulis, Athanassios/0000-0002-6973-3080; Liehn, Elisa Anamaria/0000-0002-1253-3272; Al-Sawaf, Othman/0000-0001-9895-0570; Mitchell, David/0000-0003-4830-5332; Brandacher, Gerald/0000-0001-7790-441X; kanatas, anastasios/0000-0003-2025-748X	START program [129/10]; Interdisciplinary Centre for Clinical Research (IZKF) within the Faculty of Medicine of RWTH Aachen University [T9-3, T9-5]	START program(Austrian Science Fund (FWF)); Interdisciplinary Centre for Clinical Research (IZKF) within the Faculty of Medicine of RWTH Aachen University	This study was supported by a grant from the START program (129/10) and by a grant from the Interdisciplinary Centre for Clinical Research (IZKF) within the Faculty of Medicine of RWTH Aachen University (T9-3; T9-5). The funders had nor role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonheur JA, 2004, J SURG RES, V116, P55, DOI 10.1016/S0022-4804(03)00232-4; Brenes RA, 2012, J VASC SURG; Bui DT, 2007, PLAST RECONSTR SURG, V119, P2092, DOI 10.1097/01.prs.0000260598.24376.e1; Carroll WR, 2000, HEAD NECK-J SCI SPEC, V22, P700, DOI 10.1002/1097-0347(200010)22:7<700::AID-HED10>3.0.CO;2-H; Crawford RS, 2007, AM J PHYSIOL-HEART C, V292, pH830, DOI 10.1152/ajpheart.00581.2006; Hatoko M, 2002, ANN PLAS SURG, V48, P68, DOI 10.1097/00000637-200201000-00010; Holzle F, 2008, DTSCH ARZTEBL INT, V105, P815, DOI 10.3238/arztebl.2008.0815; Honda HM, 2005, ANN NY ACAD SCI, V1047, P248, DOI 10.1196/annals.1341.022; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Koletsis E, 2006, EXP BIOL MED, V231, P1410, DOI 10.1177/153537020623100815; Kuntscher MV, 2002, PLAST RECONSTR SURG, V109, P2398; Kyriakides C, 1999, AM J PHYSIOL-CELL PH, V277, pC1263, DOI 10.1152/ajpcell.1999.277.6.C1263; Kyriakides C, 2000, J TRAUMA, V48, P32, DOI 10.1097/00005373-200001000-00006; Mukundan C, 2001, J HISTOCHEM CYTOCHEM, V49, P1055, DOI 10.1177/002215540104900813; Pedowitz R A, 1991, Acta Orthop Scand Suppl, V245, P1; Pipinos II, 2008, VASC ENDOVASC SURG, V42, P101, DOI 10.1177/1538574408315995; Rosenthal SM, 1943, PUBLIC HEALTH REP, V58, P1429, DOI 10.2307/4584616; Vignaud A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/724914; Wakai A, 2001, J SURG RES, V99, P311, DOI 10.1006/jsre.2001.6192; Yassin MMI, 1996, WORLD J SURG, V20, P961, DOI 10.1007/s002689900144; Yassin MMI, 2002, WORLD J SURG, V26, P115, DOI 10.1007/s00268-001-0169-2	21	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66498	10.1371/journal.pone.0066498	http://dx.doi.org/10.1371/journal.pone.0066498			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840492	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800072
J	Cooper, CB; Voss, MA				Cooper, Caren B.; Voss, Margaret A.			Avian Incubation Patterns Reflect Temporal Changes in Developing Clutches	PLOS ONE			English	Article							EGG TEMPERATURE; INTERMITTENT INCUBATION; BEHAVIOR; EMBRYOS; HEAT; TIME; ATTENTIVENESS; ENERGETICS; COSTS	Incubation conditions for eggs influence offspring quality and reproductive success. One way in which parents regulate brooding conditions is by balancing the thermal requirements of embryos with time spent away from the nest for self-maintenance. Age related changes in embryo thermal tolerance would thus be expected to shape parental incubation behavior. We use data from unmanipulated Black-capped Chickadee (Poecile atricapillus) nests to examine the temporal dynamics of incubation, testing the prediction that increased heat flux from eggs as embryos age influences female incubation behavior and/or physiology to minimize temperature fluctuations. We found that the rate of heat loss from eggs increased with embryo age. Females responded to increased egg cooling rates by altering incubation rhythms (more frequent, shorter on-and off-bouts), but not brood patch temperature. Consequently, as embryos aged, females were able to increase mean egg temperature and decrease variation in temperature. Our findings highlight the need to view full incubation as more than a static rhythm; rather, it is a temporally dynamic and finely adjustable parental behavior. Furthermore, from a methodological perspective, intra- and inter-specific comparisons of incubation rhythms and average egg temperatures should control for the stage of incubation.	[Cooper, Caren B.] Cornell Lab Ornithol, Ithaca, NY USA; [Voss, Margaret A.] Penn State Univ, Sch Sci, Erie, PA 16563 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Cooper, CB (corresponding author), Cornell Lab Ornithol, Ithaca, NY USA.	caren.cooper@cornell.edu	Voss, Margaret/C-9359-2011	Voss, Margaret/0000-0002-7969-4871; Cooper, Caren/0000-0001-6263-8892				AFTON AD, 1979, CAN J ZOOL, V57, P1052, DOI 10.1139/z79-133; Ardia DR, 2009, J ANIM ECOL, V78, P4, DOI 10.1111/j.1365-2656.2008.01453.x; Arnold TW, 2011, CONDOR, V113, P107, DOI 10.1525/cond.2011.100001; BAKKEN GS, 1976, J THERM BIOL, V1, P169, DOI 10.1016/0306-4565(76)90009-7; Bryan SM, 1999, P ROY SOC B-BIOL SCI, V266, P157, DOI 10.1098/rspb.1999.0616; CHAURAND T, 1994, IBIS, V136, P285, DOI 10.1111/j.1474-919X.1994.tb01097.x; CLARK MM, 1995, TRENDS ECOL EVOL, V10, P151, DOI 10.1016/S0169-5347(00)89025-4; Conway CJ, 2000, BEHAV ECOL, V11, P178, DOI 10.1093/beheco/11.2.178; Cooper CB, 2011, FUNCT ECOL, V25, P769, DOI 10.1111/j.1365-2435.2011.01847.x; Cooper CB, 2005, J FIELD ORNITHOL, V76, P352, DOI 10.1648/0273-8570-76.4.352; DAVIS SD, 1984, AUK, V101, P556, DOI 10.1093/auk/101.3.556; Deeming DC, 2002, OX ORN SER, V13, P63; Gorman HE, 2004, P ROY SOC B-BIOL SCI, V271, P1923, DOI 10.1098/rspb.2004.2799; HAFTORN S, 1988, ORNIS SCAND, V19, P97, DOI 10.2307/3676458; Hainsworth FR, 2002, OX ORN SER, V13, P223; Hainsworth FR, 1998, J AVIAN BIOL, V29, P113, DOI 10.2307/3677188; Larsen VA, 2003, J ANIM ECOL, V72, P784, DOI 10.1046/j.1365-2656.2003.00751.x; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Martin TE, 2007, EVOLUTION, V61, P2558, DOI 10.1111/j.1558-5646.2007.00204.x; Mortola JP, 2009, COMP BIOCHEM PHYS A, V153, P359, DOI 10.1016/j.cbpa.2009.02.041; MORTON ML, 1985, AUK, V102, P25, DOI 10.2307/4086819; Olson CR, 2006, PHYSIOL BIOCHEM ZOOL, V79, P927, DOI 10.1086/506003; Poussart C, 2000, CONDOR, V102, P292, DOI 10.1650/0010-5422(2000)102[0292:TTROED]2.0.CO;2; Reid JM, 2002, OX ORN SER, V13, P314; Reid JM, 1999, ANIM BEHAV, V58, P1161, DOI 10.1006/anbe.1999.1241; RICKLEFS RE, 1968, CONDOR, V70, P121, DOI 10.2307/1365955; Ricklefs Robert E., 1998, Oxford Ornithology Series, V8, P31; Skutch A. F., 1957, Ibis, V99, P69, DOI 10.1111/j.1474-919X.1957.tb01934.x; Smith S.M., 1997, BLACK CAPPED CHICKAD; SMITH SM, 1967, CONDOR, V69, P344, DOI 10.2307/1366198; TAZAWA H, 1989, COMP BIOCHEM PHYS A, V92, P613, DOI 10.1016/0300-9629(89)90376-9; Tazawa H, 2001, J THERM BIOL, V26, P281, DOI 10.1016/S0306-4565(01)00031-6; Tinbergen JM, 2002, OX ORN SER, V13, P299; Turner J.S., 1991, P117; Turner JS, 2002, OX ORN SER, V13, P119; TURNER JS, 1987, J EXP ZOOL, P99; VLECK CM, 1981, CONDOR, V83, P229, DOI 10.2307/1367313; Voss MA, 2001, J THERM BIOL, V26, P121, DOI 10.1016/S0306-4565(00)00032-2; Wang JM, 2011, AUK, V128, P454, DOI 10.1525/auk.2011.10208; Wang JM, 2009, ANIM BEHAV, V78, P601, DOI 10.1016/j.anbehav.2009.05.022; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; WHITE FN, 1974, SCIENCE, V186, P107, DOI 10.1126/science.186.4159.107; Wiebe KL, 2000, BEHAV ECOL SOCIOBIOL, V48, P463; WILLIAMS JB, 1993, CONDOR, V95, P115, DOI 10.2307/1369392; Williams Joseph B., 1996, P375	45	16	17	4	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65521	10.1371/journal.pone.0065521	http://dx.doi.org/10.1371/journal.pone.0065521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840339	gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200024
J	Ji, J; Wang, SQ; Liu, YJ; He, QQ				Ji, Jie; Wang, Su-qing; Liu, Yu-jian; He, Qi-qiang			Physical Activity and Lung Function Growth in a Cohort of Chinese School Children: A Prospective Study	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; PULMONARY-FUNCTION; HEALTH; EXERCISE; LEVEL	Backgrounds/objectives: Evidence on the association between physical activity and lung function in children is sparse. The aim of this study was to evaluate children's lung function growth in relation to their physical activity level in Chinese children. Methods: A total of 1713 school children aged 9.89 +/- 0.86 years who were asthma-free at baseline were followed-up for 18 months from 2006 to 2008 in Guangzhou, China. Information on physical activity and other socio-economic status were obtained from self-administered questionnaires. Lung function tests were performed with a standard procedure. Results: At the baseline survey, physically active girls had significantly higher forced vital capacity (FVC) than inactive girls (1.79 l vs. 1.75 l, p<0.05). The growth rates for lung function indices were significantly higher for girls who were physically active at either or both follow-up surveys than those inactive at both surveys during the follow-up period forced expiratory flows at 25% (FEF25) difference per year (dpy) (0.20 l/s vs. 0.15 l/s), forced expiratory flows at 75% (FEF75) dpy (0.57 l/s vs. 0.45 l/s) and forced expiratory flows between 25% and 75% (FEF25-75) dpy (0.36 l/s vs. 0.28 l/s) (all p<0.05). Conclusions: Physical activity is positively associated with lung function growth among Chinese school-aged girls. Promotion of physical activity among children is of great importance.	[Ji, Jie; Wang, Su-qing; Liu, Yu-jian; He, Qi-qiang] Wuhan Univ, Sch Publ Hlth, Global Hlth Inst, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University	He, QQ (corresponding author), Wuhan Univ, Sch Publ Hlth, Global Hlth Inst, Wuhan 430072, Hubei Province, Peoples R China.	heqiqiang@gmail.com	He, Qiqiang/A-7990-2012					Berntsen S, 2008, PEDIATR EXERC SCI, V20, P402, DOI 10.1123/pes.20.4.402; Cheng YJ, 2003, BRIT J SPORT MED, V37, P521, DOI 10.1136/bjsm.37.6.521; Donaldson AV, 2012, INT J CHRONIC OBSTR, V7, P523, DOI 10.2147/COPD.S28247; Drenowatz C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-214; Eisenmann JC, 1999, PEDIATR EXERC SCI, V11, P208, DOI 10.1123/pes.11.3.208; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hallerod B, 2011, SOC SCI MED, V72, P116, DOI 10.1016/j.socscimed.2010.09.036; He QQ, 2008, PUBLIC HEALTH, V122, P1425, DOI 10.1016/j.puhe.2008.06.010; Jakes RW, 2002, AM J EPIDEMIOL, V156, P139, DOI 10.1093/aje/kwf021; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; JONES PRM, 1977, ANN HUM BIOL, V4, P155, DOI 10.1080/03014467700002041; Meszaros D, 2010, RESP MED, V104, P808, DOI 10.1016/j.rmed.2009.12.001; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nystad W, 2006, INT J TUBERC LUNG D, V10, P1399; Oja P, 2011, EPMA J, V2, P253, DOI 10.1007/s13167-011-0090-1; Pelkonen M, 2003, AM J RESP CRIT CARE, V168, P494, DOI 10.1164/rccm.200208-954OC; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Rosenkranz SK, 2012, J APPL PHYSIOL, V112, P1174, DOI 10.1152/japplphysiol.00663.2011; Seed L, 2012, RESP CARE, V57, P61, DOI 10.4187/respcare.01430; Welk GJ, 2000, RES Q EXERCISE SPORT, V71, pS59, DOI 10.1080/02701367.2000.11082788; Wetter TJ, 2001, J APPL PHYSIOL, V91, P847, DOI 10.1152/jappl.2001.91.2.847; Zhang Xin, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P781	22	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66098	10.1371/journal.pone.0066098	http://dx.doi.org/10.1371/journal.pone.0066098			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840406	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200055
J	Schmidt, S; Gericke, B; Fracasso, G; Ramarli, D; Colombatti, M; Naim, HY				Schmidt, Sonja; Gericke, Birthe; Fracasso, Giulio; Ramarli, Dunia; Colombatti, Marco; Naim, Hassan Y.			Discriminatory Role of Detergent-Resistant Membranes in the Dimerization and Endocytosis of Prostate-Specific Membrane Antigen	PLOS ONE			English	Article							MYELIN OLIGODENDROCYTE GLYCOPROTEIN; ANTIBODY CROSS-LINKING; ANCHORED PROTEINS; LIPID RAFTS; INTERNALIZATION; EXPRESSION; ASSOCIATION; CANCER; CELLS	Prostate-specific membrane antigen (PSMA) is a type-II membrane glycoprotein that was initially identified in LNCaP cells. It is expressed at elevated levels in prostate cancer. In view of the correlation between the expression levels of PSMA and disease grade and stage, PSMA is considered to be one of the most promising biomarkers in the diagnosis and treatment of prostate cancer. In LNCaP cells PSMA undergoes internalization via clathrin-coated pits followed by accumulation in the endosomes. PSMA associates with different types of detergent-resistant membranes (DRMs) along the secretory pathway. Its mature form is mainly insoluble in Lubrol WX, but does not associate with Triton X-100-DRMs. To understand the mechanism of PSMA internalization we investigated its association during internalization with DRMs. For this purpose, internalization was induced by antibody cross-linking. We demonstrate at the biochemical and cell biological levels that: [i] exclusively homodimers of PSMA are associated with Lubrol WX-DRMs, [ii] antibody-induced cross-linking of PSMA molecules results in a time-dependent partitioning into another DRMs type, namely Triton X-100-DRMs, and [iii] concomitant with its association with Triton-X-100-DRMs internalization of PSMA occurs along tubulin filaments. In a previous work (Colombatti et al. (2009) PLoS One 4: e4608) we demonstrated that the small GTPases RAS and RAC1 and the MAPKs p38 and ERK1/2 are activated during antibody cross-linking. As downstream effects of this activation we observed a strong induction of NF-kB associated with an increased expression of IL-6 and CCL5 genes and that IL-6 and CCL5 enhanced the proliferative potential of LNCaP cells synergistically. These observations together with findings reported here hypothesize a fundamental role of DRMs during activation of PSMA as platforms for trafficking, endocytosis and signalling. Understanding these mechanisms constitutes an essential prerequisite for utilization of PSMA as a therapeutically suitable target in prostate cancer.	[Schmidt, Sonja; Gericke, Birthe; Naim, Hassan Y.] Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany; [Fracasso, Giulio; Ramarli, Dunia; Colombatti, Marco] Univ Verona, Dept Pathol & Diagnost, I-37100 Verona, Italy	University of Veterinary Medicine Hannover, Foundation; University of Verona	Naim, HY (corresponding author), Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany.	Hassan.naim@tiho-hannover.de	Fracasso, Giulio/O-3955-2019; Fracasso, Giulio/E-1271-2013	Fracasso, Giulio/0000-0003-3024-0307; Fracasso, Giulio/0000-0003-3024-0307; Gericke, Birthe/0000-0002-9181-4493	University of Veterinary Medicine Hannover; AIRC 5x1000 project Application of Advanced Nanotechnology in the Development of Innovative Cancer Diagnostic Tools (; University of Verona; Fondazione Cariverona project Verona Nanomedicine Initiative; Fondazione Cariverona/AIRC Progetto Regionale	University of Veterinary Medicine Hannover; AIRC 5x1000 project Application of Advanced Nanotechnology in the Development of Innovative Cancer Diagnostic Tools ((Fondazione AIRC per la ricerca sul cancro); University of Verona; Fondazione Cariverona project Verona Nanomedicine Initiative(Fondazione Cariverona); Fondazione Cariverona/AIRC Progetto Regionale(Fondazione AIRC per la ricerca sul cancro)	This work was partially supported by institutional funds provided by the University of Veterinary Medicine Hannover (to HYN), AIRC 5x1000 project Application of Advanced Nanotechnology in the Development of Innovative Cancer Diagnostic Tools (funding attributed to MC), by the University of Verona, by Fondazione Cariverona project Verona Nanomedicine Initiative (to MC) and by Fondazione Cariverona/AIRC Progetto Regionale (to MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MO, 2007, BIOORGAN MED CHEM, V15, P6678, DOI 10.1016/j.bmc.2007.08.006; Anilkumar G, 2003, CANCER RES, V63, P2645; Anilkumar G, 2006, MICROVASC RES, V72, P54, DOI 10.1016/j.mvr.2006.03.004; Ballangrud AM, 2001, CANCER RES, V61, P2008; Bander NH, 2003, J UROLOGY, V170, P1717, DOI 10.1097/01.ju.0000091655.77601.0c; Barinka C, 2008, J MOL BIOL, V376, P1438, DOI 10.1016/j.jmb.2007.12.066; Castelletti D, 2008, BIOCHEM J, V409, P149, DOI 10.1042/BJ20070396; Chang SS, 1999, CLIN CANCER RES, V5, P2674; Chang SS, 1999, CANCER RES, V59, P3192; Christiansen JJ, 2005, MOL CANCER THER, V4, P704, DOI 10.1158/1535-7163.MCT-04-0171; Colombatti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004608; Fracasso G, 2002, PROSTATE, V53, P9, DOI 10.1002/pros.10117; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Goodman OB, 2007, INT J ONCOL, V31, P1199; HOROSZEWICZ JS, 1987, ANTICANCER RES, V7, P927; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; ISRAELI RS, 1993, CANCER RES, V53, P227; ISRAELI RS, 1994, CANCER RES, V54, P1807; Landers KA, 2005, INT J CANCER, V114, P950, DOI 10.1002/ijc.20760; Liu H, 1998, CANCER RES, V58, P4055; Marta CB, 2005, J BIOL CHEM, V280, P8985, DOI 10.1074/jbc.M413174200; Marta CB, 2003, J NEUROSCI, V23, P5461; McDevitt MR, 2000, CANCER RES, V60, P6095; Nanus DM, 2003, J UROLOGY, V170, pS84, DOI 10.1097/01.ju.0000095151.97404.7c; Pinto JT, 1996, CLIN CANCER RES, V2, P1445; Rajasekaran SA, 2003, MOL BIOL CELL, V14, P4835, DOI 10.1091/mbc.E02-11-0731; Ross JS, 2003, CLIN CANCER RES, V9, P6357; Schroeder RJ, 1998, J BIOL CHEM, V273, P1150, DOI 10.1074/jbc.273.2.1150; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Schulke N, 2003, P NATL ACAD SCI USA, V100, P12590, DOI 10.1073/pnas.1735443100; Silver DA, 1997, CLIN CANCER RES, V3, P81; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Wright GL, 1996, UROLOGY, V48, P326, DOI 10.1016/S0090-4295(96)00184-7	35	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66193	10.1371/journal.pone.0066193	http://dx.doi.org/10.1371/journal.pone.0066193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840421	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200059
J	Teng, CY; Dang, YK; Danne, JC; Waller, RF; Green, BR				Teng, Chang Ying; Dang, Yunkun; Danne, Jillian C.; Waller, Ross F.; Green, Beverley R.			Mitochondrial Genes of Dinoflagellates Are Transcribed by a Nuclear-Encoded Single-Subunit RNA Polymerase	PLOS ONE			English	Article							SPLICED LEADER; GENOME; FRAGMENTS; EVOLUTION; IDENTIFICATION; ORGANIZATION; REPLICATION; CDNAS	Dinoflagellates are a large group of algae that contribute significantly to marine productivity and are essential photosynthetic symbionts of corals. Although these algae have fully-functioning mitochondria and chloroplasts, both their organelle genomes have been highly reduced and the genes fragmented and rearranged, with many aberrant transcripts. However, nothing is known about their RNA polymerases. We cloned and sequenced the gene for the nuclear-encoded mitochondrial polymerase (RpoTm) of the dinoflagellate Heterocapsa triquetra and showed that the protein presequence targeted a GFP construct into yeast mitochondria. The gene belongs to a small gene family, which includes a variety of 3'-truncated copies that may have originated by retroposition. The catalytic C-terminal domain of the protein shares nine conserved sequence blocks with other single-subunit polymerases and is predicted to have the same fold as the human enzyme. However, the N-terminal (promoter binding/transcription initiation) domain is not well-conserved. In conjunction with the degenerate nature of the mitochondrial genome, this suggests a requirement for novel accessory factors to ensure the accurate production of functional mRNAs.	[Teng, Chang Ying; Dang, Yunkun; Green, Beverley R.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Teng, Chang Ying] Ludong Univ, Dept Life Sci, Yantai, Shandong, Peoples R China; [Danne, Jillian C.; Waller, Ross F.] Univ Melbourne, Sch Bot, Melbourne, Vic, Australia	University of British Columbia; Ludong University; University of Melbourne	Green, BR (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	brgreen@mail.ubc.ca	Waller, Ross F/D-5761-2016; Green, Beverley R./AAJ-5199-2021	Waller, Ross F/0000-0001-6961-9344; Green, Beverley R./0000-0002-4021-9387	Natural Sciences and Engineering Research Council of Canada [4688-12]; Australian Research Council [DP0663590]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Research Council(Australian Research Council)	Funding provided by Natural Sciences and Engineering Research Council of Canada grant 4688-12 to BRG (http://www.nserc-crsng.gc.ca); Australian Research Council grant DP0663590 to RFW (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold JJ, 2012, BBA-GENE REGUL MECH, V1819, P948, DOI 10.1016/j.bbagrm.2012.04.002; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Beauchemin M, 2012, P NATL ACAD SCI USA, V109, P15793, DOI 10.1073/pnas.1206683109; BONNER G, 1992, EMBO J, V11, P3767, DOI 10.1002/j.1460-2075.1992.tb05462.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cermakian N, 1997, J MOL EVOL, V45, P671, DOI 10.1007/PL00006271; Chang CC, 1999, PLANT CELL, V11, P911, DOI 10.1105/tpc.11.5.911; Chaput H, 2002, PROTIST, V153, P111, DOI 10.1078/1434-4610-00090; Dang Y, 2009, GENE, V442, P73, DOI 10.1016/j.gene.2009.04.006; Danne JC, 2011, J MOL BIOL, V408, P643, DOI 10.1016/j.jmb.2011.02.057; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Gornik SG, 2012, CURR BIOL, V22, P2303, DOI 10.1016/j.cub.2012.10.036; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Howe CJ, 2008, J EXP BOT, V59, P1035, DOI 10.1093/jxb/erm292; Huang G, 2000, LETT APPL MICROBIOL, V31, P149, DOI 10.1046/j.1365-2672.2000.00781.x; Jackson CJ, 2012, GENOME BIOL EVOL, V4, P59, DOI 10.1093/gbe/evr122; Jackson CJ, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-41; Jackson CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056777; Jaeckisch N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028012; Kabeya Y, 2005, PLANT PHYSIOL, V138, P369, DOI 10.1104/pp.105.059501; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kelley LA, 1999, NATURE PROTOCOLS, V4, P363; Krause K, 2011, PLANTA, V234, P647, DOI 10.1007/s00425-011-1494-9; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Li JN, 2001, MOL BIOCHEM PARASIT, V113, P261, DOI 10.1016/S0166-6851(01)00223-7; Liere K, 2011, J PLANT PHYSIOL, V168, P1345, DOI 10.1016/j.jplph.2011.01.005; Lin SJ, 2011, RES MICROBIOL, V162, P551, DOI 10.1016/j.resmic.2011.04.006; McEwan M, 2008, J EUKARYOT MICROBIOL, V55, P530, DOI 10.1111/j.1550-7408.2008.00357.x; Miller ML, 2006, CURR GENET, V49, P259, DOI 10.1007/s00294-005-0053-y; Nash EA, 2007, MOL BIOL EVOL, V24, P1528, DOI 10.1093/molbev/msm074; Norman JE, 2001, J MOL EVOL, V53, P351, DOI 10.1007/s002390010225; Patron NJ, 2007, BIOESSAYS, V29, P1048, DOI 10.1002/bies.20638; Richter U, 2002, GENE, V290, P95, DOI 10.1016/S0378-1119(02)00583-8; Ringel R, 2011, NATURE, V478, P269, DOI 10.1038/nature10435; Shutt TE, 2006, TRENDS GENET, V22, P90, DOI 10.1016/j.tig.2005.11.007; Slamovits CH, 2008, CURR BIOL, V18, pR550, DOI 10.1016/j.cub.2008.04.054; Slamovits CH, 2007, J MOL BIOL, V372, P356, DOI 10.1016/j.jmb.2007.06.085; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; Swayne Theresa C, 2007, Methods Mol Biol, V372, P433, DOI 10.1007/978-1-59745-365-3_31; Toyoshima Y, 2005, CRIT REV PLANT SCI, V24, P59, DOI 10.1080/07352680590910438; Wisecaver JH, 2011, ANNU REV MICROBIOL, V65, P369, DOI 10.1146/annurev-micro-090110-102841; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Yin C, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-379; Zhang H, 2007, P NATL ACAD SCI USA, V104, P4618, DOI 10.1073/pnas.0700258104; Zhang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004129; Zhang ZD, 1999, NATURE, V400, P155, DOI 10.1038/22099; Zhang ZD, 2001, MOL BIOL EVOL, V18, P1558, DOI 10.1093/oxfordjournals.molbev.a003942	51	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65387	10.1371/journal.pone.0065387	http://dx.doi.org/10.1371/journal.pone.0065387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840326	Green Published, gold			2022-12-27	WOS:000322361200015
J	Ye, YXH; Woolfit, M; Huttley, GA; Rances, E; Caragata, EP; Popovici, J; O'Neill, SL; McGraw, EA				Ye, Yixin H.; Woolfit, Megan; Huttley, Gavin A.; Rances, Edwige; Caragata, Eric P.; Popovici, Jean; O'Neill, Scott L.; McGraw, Elizabeth A.			Infection with a Virulent Strain of Wolbachia Disrupts Genome Wide-Patterns of Cytosine Methylation in the Mosquito Aedes aegypti	PLOS ONE			English	Article							LIFE-SHORTENING WOLBACHIA; DNA METHYLATION; GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; SEQUENCE; VECTOR; DENGUE; CELLS; CONSERVATION; TRNA(ASP)	Background: Cytosine methylation is one of several reversible epigenetic modifications of DNA that allow a greater flexibility in the relationship between genotype and phenotype. Methylation in the simplest models dampens gene expression by modifying regions of DNA critical for transcription factor binding. The capacity to methylate DNA is variable in the insects due to diverse histories of gene loss and duplication of DNA methylases. Mosquitoes like Drosophila melanogaster possess only a single methylase, DNMT2. Description: Here we characterise the methylome of the mosquito Aedes aegypti and examine its relationship to transcription and test the effects of infection with a virulent strain of the endosymbiont Wolbachia on the stability of methylation patterns. Conclusion: We see that methylation in the A. aegypti genome is associated with reduced transcription and is most common in the promoters of genes relating to regulation of transcription and metabolism. Similar gene classes are also methylated in aphids and honeybees, suggesting either conservation or convergence of methylation patterns. In addition to this evidence of evolutionary stability, we also show that infection with the virulent wMelPop Wolbachia strain induces additional methylation and demethylation events in the genome. While most of these changes seem random with respect to gene function and have no detected effect on transcription, there does appear to be enrichment of genes associated with membrane function. Given that Wolbachia lives within a membrane-bound vacuole of host origin and retains a large number of genes for transporting host amino acids, inorganic ions and ATP despite a severely reduced genome, these changes might represent an evolved strategy for manipulating the host environments for its own gain. Testing for a direct link between these methylation changes and expression, however, will require study across a broader range of developmental stages and tissues with methods that detect splice variants.	[Ye, Yixin H.; Woolfit, Megan; Rances, Edwige; Caragata, Eric P.; Popovici, Jean; O'Neill, Scott L.; McGraw, Elizabeth A.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Huttley, Gavin A.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia	Monash University; Australian National University; John Curtin School of Medical Research	McGraw, EA (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	beth.mcgraw@monash.edu	Popovici, Jean/K-7192-2014; O'Neill, Scott L/B-3568-2009; Huttley, Gavin A/G-5169-2015; McGraw, Elizabeth/GRF-0434-2022; O'Neill, Scott/R-9560-2019; McGraw, Elizabeth/A-6658-2012	Popovici, Jean/0000-0002-3135-1175; O'Neill, Scott L/0000-0002-4131-3615; Huttley, Gavin A/0000-0001-7224-2074; O'Neill, Scott/0000-0002-4131-3615; McGraw, Elizabeth/0000-0001-7973-088X	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by The National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Caragata EP, 2011, INSECT MOL BIOL, V20, P215, DOI 10.1111/j.1365-2583.2010.01059.x; Carlson J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)68010-X; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Evans O, 2009, J EXP BIOL, V212, P1436, DOI 10.1242/jeb.028951; Faulk C, 2011, EPIGENETICS-US, V6, P791, DOI 10.4161/epi.6.7.16209; Foret S, 2012, P NATL ACAD SCI USA, V109, P4968, DOI 10.1073/pnas.1202392109; Glastad KM, 2011, INSECT MOL BIOL, V20, P553, DOI 10.1111/j.1365-2583.2011.01092.x; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Gowher H, 2000, EMBO J, V19, P6918, DOI 10.1093/emboj/19.24.6918; Guo XB, 2011, J GASTROEN HEPATOL, V26, P1685, DOI 10.1111/j.1440-1746.2011.06808.x; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunt BG, 2010, GENOME BIOL EVOL, V2, P719, DOI 10.1093/gbe/evq057; Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108; Issa JP, 2003, CLIN IMMUNOL, V109, P103, DOI 10.1016/S1521-6616(03)00203-1; Jurkowski TP, 2008, RNA, V14, P1663, DOI 10.1261/rna.970408; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Kunert N, 2003, DEVELOPMENT, V130, P5083, DOI 10.1242/dev.00716; Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343; Lawson D, 2009, NUCLEIC ACIDS RES, V37, pD583, DOI 10.1093/nar/gkn857; Lewis ZA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001196; Lin MJ, 2005, J BIOL CHEM, V280, P861, DOI 10.1074/jbc.C400477200; Lyko F, 2000, NATURE, V408, P538, DOI 10.1038/35046205; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Marhold J, 2004, INSECT MOL BIOL, V13, P117, DOI 10.1111/j.0962-1075.2004.00466.x; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moreira LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000568; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Negri H, 2009, P ROY SOC B-BIOL SCI, V276, P2485, DOI 10.1098/rspb.2009.0324; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; ONeill SL, 1997, INFLUENTIAL PASSENGE; Paschos K, 2010, TRENDS MICROBIOL, V18, P439, DOI 10.1016/j.tim.2010.07.003; Rances E, 2008, J BACTERIOL, V190, P5020, DOI 10.1128/JB.00377-08; Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548; Riggs A. D., 1996, EPIGENETIC MECH GENE, P29; Saridaki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019708; Schaefer M, 2010, CHROMOSOMA, V119, P35, DOI 10.1007/s00412-009-0240-6; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storey JD, 2007, BIOSTATISTICS, V8, P414, DOI 10.1093/biostatistics/kxl019; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Thompson RF, 2010, AGING CELL, V9, P506, DOI 10.1111/j.1474-9726.2010.00577.x; Tolg C, 2011, LAB INVEST, V91, P825, DOI 10.1038/labinvest.2010.197; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0; Zeh JA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00375; Zheng YS, 2011, PHYS PLASMAS, V18, DOI 10.1063/1.3671970; Zhou YP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-123; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	64	48	48	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66482	10.1371/journal.pone.0066482	http://dx.doi.org/10.1371/journal.pone.0066482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840485	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200085
J	Bzhalava, D; Johansson, H; Ekstrom, J; Faust, H; Moller, B; Eklund, C; Nordin, P; Stenquist, B; Paoli, J; Persson, B; Forslund, O; Dillner, J				Bzhalava, Davit; Johansson, Hanna; Ekstrom, Johanna; Faust, Helena; Moller, Birgitta; Eklund, Carina; Nordin, Peter; Stenquist, Bo; Paoli, John; Persson, Bengt; Forslund, Ola; Dillner, Joakim			Unbiased Approach for Virus Detection in Skin Lesions	PLOS ONE			English	Article							CUTANEOUS HUMAN PAPILLOMAVIRUSES; SQUAMOUS-CELL CARCINOMA; TRANSPLANT RECIPIENTS; PYROSEQUENCING READS; DNA; CANCER; CLASSIFICATION; IDENTIFICATION; GENERATION; DIVERSITY	To assess presence of virus DNA in skin lesions, swab samples from 82 squamous cell carcinomas of the skin (SCCs), 60 actinic keratoses (AKs), paraffin-embedded biopsies from 28 SCCs and 72 kerathoacanthomas (KAs) and fresh-frozen biopsies from 92 KAs, 85 SCCs and 92 AKs were analyzed by high throughput sequencing (HTS) using 454 or Ion Torrent technology. We found total of 4,284 viral reads, out of which 4,168 were Human Papillomavirus (HPV)-related, belonging to 15 known (HPV8, HPV12, HPV20, HPV36, HPV38, HPV45, HPV57, HPV59, HPV104, HPV105, HPV107, HPV109, HPV124, HPV138, HPV147), four previously described putative (HPV 915 F 06 007 FD1, FA73, FA101, SE42) and two putatively new HPV types (SE46, SE47). SE42 was cloned, sequenced, designated as HPV155 and found to have 76% similarity to the most closely related known HPV type. In conclusion, an unbiased approach for viral DNA detection in skin tumors has found that, although some new putative HPVs were found, known HPV types constituted most of the viral DNA.	[Bzhalava, Davit; Ekstrom, Johanna; Moller, Birgitta; Eklund, Carina; Dillner, Joakim] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Bzhalava, Davit; Ekstrom, Johanna; Moller, Birgitta; Eklund, Carina; Dillner, Joakim] Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden; [Bzhalava, Davit; Ekstrom, Johanna; Moller, Birgitta; Eklund, Carina; Dillner, Joakim] Karolinska Inst, Dept Biostat, Stockholm, Sweden; [Bzhalava, Davit; Ekstrom, Johanna; Moller, Birgitta; Eklund, Carina; Dillner, Joakim] Karolinska Hosp, Dept Clin Microbiol, S-10401 Stockholm, Sweden; [Bzhalava, Davit; Ekstrom, Johanna; Moller, Birgitta; Eklund, Carina; Dillner, Joakim] Karolinska Hosp, Dept Pathol, S-10401 Stockholm, Sweden; [Johansson, Hanna; Ekstrom, Johanna; Faust, Helena; Forslund, Ola; Dillner, Joakim] Lund Univ, Dept Med Microbiol, Skane Univ Hosp, Malmo, Sweden; [Nordin, Peter] Lakarhuset, Dermatol Clin, Gothenburg, Sweden; [Stenquist, Bo; Paoli, John] Gothenburg Univ, Sahlgrenska Acad, Inst Clin Sci, Dept Dermatol & Venereol,Sahlgrenska Univ Hosp, S-41124 Gothenburg, Sweden; [Persson, Bengt] Linkoping Univ, IFM Bioinformat, Linkoping, Sweden; [Persson, Bengt] Swedish E Sci Res Ctr, Linkoping, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; Sahlgrenska University Hospital; University of Gothenburg; Linkoping University	Dillner, J (corresponding author), Karolinska Inst, Dept Lab Med, Stockholm, Sweden.	joakim.dillner@ki.se	Paoli, John/P-7629-2018	Paoli, John/0000-0003-1326-8535; Faust, Helena/0000-0002-4532-2025; Persson, Bengt/0000-0003-3165-5344; Bzhalava, Davit/0000-0002-7646-7892	Swedish Cancer Society [110569]; Swedish Research Council [3468]; Swedish government strategic program on Biomarkers in Cancer Research (BioCARE)	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish government strategic program on Biomarkers in Cancer Research (BioCARE)	The work was supported by the Swedish Cancer Society (110569), the Swedish Research Council (3468) and the Swedish government strategic program on Biomarkers in Cancer Research (BioCARE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2008, IARC PUBL, VIX, P1; Antonsson A, 2000, J VIROL, V74, P11636, DOI 10.1128/JVI.74.24.11636-11641.2000; Arron ST, 2011, J INVEST DERMATOL, V131, P1745, DOI 10.1038/jid.2011.91; Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bottalico D, 2011, J INFECT DIS, V204, P787, DOI 10.1093/infdis/jir383; Boukamp P, 2005, CARCINOGENESIS, V26, P1657, DOI 10.1093/carcin/bgi123; Buck CB, 2004, J VIROL, V78, P751, DOI 10.1128/JVI.78.2.751-757.2004; Bzhalava D, 2012, VIROLOGY, V432, P427, DOI 10.1016/j.virol.2012.06.022; Chen Z, 2007, J GEN VIROL, V88, P2952, DOI 10.1099/vir.0.83178-0; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chouhy D, 2010, VIROLOGY, V397, P205, DOI 10.1016/j.virol.2009.11.020; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Duensing S, 2004, INT J CANCER, V109, P157, DOI 10.1002/ijc.11691; Ekstrom J, 2011, INT J CANCER, V129, P2643, DOI 10.1002/ijc.26204; Ekstrom J, 2010, VIROLOGY, V397, P331, DOI 10.1016/j.virol.2009.11.027; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Forslund O, 2004, J INVEST DERMATOL, V123, P388, DOI 10.1111/j.0022-202X.2004.23205.x; Forslund O, 2003, J CUTAN PATHOL, V30, P423, DOI 10.1034/j.1600-0560.2003.00092.x; Forslund O, 2003, BRIT J DERMATOL, V149, P64, DOI 10.1046/j.1365-2133.2003.05376.x; Forslund O, 2007, J INFECT DIS, V196, P876, DOI 10.1086/521031; Foulongne V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038499; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hutchison CA, 2005, P NATL ACAD SCI USA, V102, P17332, DOI 10.1073/pnas.0508809102; Johansson H., 2013, VIROLOGY; Kohler A, 2011, J GEN VIROL, V92, P1585, DOI 10.1099/vir.0.030593-0; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kullander J, 2008, INT J CANCER, V122, P477, DOI 10.1002/ijc.23115; Li JJ, 2012, J VIROL, V86, P11936, DOI 10.1128/JVI.01988-12; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Liu L, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/251364; Meiring TL, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-164; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Nobre RJ, 2009, J VIROL, V83, P2907, DOI 10.1128/JVI.02490-08; Oberyszyn TM, 2008, CANCER LETT, V261, P127, DOI 10.1016/j.canlet.2008.01.009; Pfister H, 1997, CLIN DERMATOL, V15, P335, DOI 10.1016/S0738-081X(96)00162-9; Reichrath J, 2006, PROG BIOPHYS MOL BIO, V92, P9, DOI 10.1016/j.pbiomolbio.2006.02.010; Schatz MC, 2011, BRIEF BIOINFORM; Sturegard E, 2013, SEX TRANSM DIS, V40, P123, DOI 10.1097/OLQ.0b013e31827aa9b3; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Vasiljevic N, 2008, J GEN VIROL, V89, P2467, DOI 10.1099/vir.0.2008/001925-0; Vasiljevic N, 2007, J GEN VIROL, V88, P1479, DOI 10.1099/vir.0.82679-0; Vasiljevic N, 2009, INT J CANCER, V124, P2361, DOI 10.1002/ijc.24197; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Willner D, 2012, AM J RESP CELL MOL, V46, P127, DOI 10.1165/rcmb.2011-0253OC	52	44	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e65953	10.1371/journal.pone.0065953	http://dx.doi.org/10.1371/journal.pone.0065953			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840382	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400009
J	Alam, T; Wai, P; Held, D; Vakili, STT; Forsberg, E; Sollinger, H				Alam, Tausif; Wai, Philip; Held, Dustie; Vakili, Sahar Taba Taba; Forsberg, Erik; Sollinger, Hans			Correction of Diabetic Hyperglycemia and Amelioration of Metabolic Anomalies by Minicircle DNA Mediated Glucose-Dependent Hepatic Insulin Production	PLOS ONE			English	Article							ENGINEERED K-CELLS; IN-VIVO; GENE-TRANSFER; SKELETAL-MUSCLE; TRANSGENE EXPRESSION; PLASMID DNA; STEM-CELLS; LIVER; THERAPY; HEPATOCYTES	Type 1 diabetes mellitus (T1DM) is caused by immune destruction of insulin-producing pancreatic beta-cells. Commonly used insulin injection therapy does not provide a dynamic blood glucose control to prevent long-term systemic T1DM-associated damages. Donor shortage and the limited long-term success of islet transplants have stimulated the development of novel therapies for T1DM. Gene therapy-based glucose-regulated hepatic insulin production is a promising strategy to treat T1DM. We have developed gene constructs which cause glucose-concentration-dependent human insulin production in liver cells. A novel set of human insulin expression constructs containing a combination of elements to improve gene transcription, mRNA processing, and translation efficiency were generated as minicircle DNA preparations that lack bacterial and viral DNA. Hepatocytes transduced with the new constructs, ex vivo, produced large amounts of glucose-inducible human insulin. In vivo, insulin minicircle DNA (TA1m) treated streptozotocin (STZ)-diabetic rats demonstrated euglycemia when fasted or fed, ad libitum. Weight loss due to uncontrolled hyperglycemia was reversed in insulin gene treated diabetic rats to normal rate of weight gain, lasting similar to 1 month. Intraperitoneal glucose tolerance test (IPGT) demonstrated in vivo glucose-responsive changes in insulin levels to correct hyperglycemia within 45 minutes. A single TA1m treatment raised serum albumin levels in diabetic rats to normal and significantly reduced hypertriglyceridemia and hypercholesterolemia. Elevated serum levels of aspartate transaminase, alanine aminotransferase, and alkaline phosphatase were restored to normal or greatly reduced in treated rats, indicating normalization of liver function. Non-viral insulin minicircle DNA-based TA1m mediated glucose-dependent insulin production in liver may represent a safe and promising approach to treat T1DM.	[Alam, Tausif; Wai, Philip; Held, Dustie; Vakili, Sahar Taba Taba; Forsberg, Erik; Sollinger, Hans] Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Alam, T (corresponding author), Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI 53706 USA.	alam@surgery.wisc.edu			Juvenile Diabetes Research Foundation; Roche Organ Transplant Research Foundation	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Roche Organ Transplant Research Foundation	This study was supported in the early phase, in part, by a grant from Juvenile Diabetes Research Foundation to TA and by Roche Organ Transplant Research Foundation to TA. Both grants have since expired. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam T, 2002, TRANSPLANTATION, V74, P1781, DOI 10.1097/01.TP.0000039333.11465.D9; Auricchio A, 2002, GENE THER, V9, P963, DOI 10.1038/sj.gt.3301746; Baiu D, 2011, CURR DIABETES REP, V11, P392, DOI 10.1007/s11892-011-0218-7; Ber I, 2003, J BIOL CHEM, V278, P31950, DOI 10.1074/jbc.M303127200; Burkhardt BR, 2005, FEBS LETT, V579, P5759, DOI 10.1016/j.febslet.2005.09.060; Chen GX, 2000, DIABETES, V49, P562, DOI 10.2337/diabetes.49.4.562; Chen ZY, 2008, MOL THER, V16, P548, DOI 10.1038/sj.mt.6300399; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Cheung AT, 2000, SCIENCE, V290, P1959, DOI 10.1126/science.290.5498.1959; Dong HJ, 2002, DIABETES, V51, P130, DOI 10.2337/diabetes.51.1.130; Falqui L, 1999, HUM GENE THER, V10, P1753, DOI 10.1089/10430349950017437; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; High KA, 2011, J THROMB HAEMOST, V9, P2, DOI 10.1111/j.1538-7836.2011.04369.x; Hohmeier HE, 2004, MOL CELL ENDOCRINOL, V228, P121, DOI 10.1016/j.mce.2004.04.017; Hohmeier HE, 1997, DIABETES, V46, P968, DOI 10.2337/diabetes.46.6.968; Imai J, 2005, BIOCHEM BIOPH RES CO, V326, P402, DOI 10.1016/j.bbrc.2004.11.047; Kay MA, 2010, NAT BIOTECHNOL, V28, P1287, DOI 10.1038/nbt.1708; Kim SC, 2010, CURR STEM CELL RES T, V5, P190; Lin GT, 2009, STEM CELLS DEV, V18, P1399, DOI 10.1089/scd.2009.0010; Liu F, 2005, ADV GENET, V54, P43, DOI 10.1016/S0065-2660(05)54003-3; Lu YC, 2005, ENDOCRINOLOGY, V146, P2610, DOI 10.1210/en.2004-1109; Martinenghi S, 2002, GENE THER, V9, P1429, DOI 10.1038/sj.gt.3301804; McCaffrey AP, 2008, MOL THER, V16, P931, DOI 10.1038/mt.2008.37; Nostro MC, 2012, SEMINARS CELL DEV BI; OGAWA A, 1992, J CLIN INVEST, V90, P497, DOI 10.1172/JCI115886; Okura H, 2009, J ARTIF ORGANS, V12, P123, DOI 10.1007/s10047-009-0455-6; Ren B, 2007, DIABETOLOGIA, V50, P1910, DOI 10.1007/s00125-007-0722-0; Riu E, 2002, DIABETES, V51, P704, DOI 10.2337/diabetes.51.3.704; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Shaw JAM, 2002, J ENDOCRINOL, V172, P653, DOI 10.1677/joe.0.1720653; Shen X, 2007, MOL THER, V15, P1955, DOI 10.1038/sj.mt.6300293; Shternhall-Ron K, 2007, J AUTOIMMUN, V28, P134, DOI 10.1016/j.jaut.2007.02.010; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; Tabiin Muhammad T, 2004, J Autoimmune Dis, V1, P3, DOI 10.1186/1740-2557-1-3; Tang SC, 2004, J GENE MED, V6, P1003, DOI 10.1002/jgm.587; Tateishi K, 2008, J BIOL CHEM, V283, P31601, DOI 10.1074/jbc.M806597200; Thule PM, 2000, GENE THER, V7, P1744, DOI 10.1038/sj.gt.3301297; Thule PM, 2000, GENE THER, V7, P205, DOI 10.1038/sj.gt.3301076; Tian J, 2008, MOL THER, V16, P1146, DOI 10.1038/mt.2008.79; Tuch BE, 2003, GENE THER, V10, P490, DOI 10.1038/sj.gt.3301911; Unniappan S, 2009, J MOL MED, V87, P703, DOI 10.1007/s00109-009-0465-0; Vandermeulen G, 2011, MOL THER, V19, P1942, DOI 10.1038/mt.2011.182; Xu XF, 2011, MECH DEVELOP, V128, P412, DOI 10.1016/j.mod.2011.08.001; Yechoor V, 2009, DEV CELL, V16, P358, DOI 10.1016/j.devcel.2009.01.012; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Zhang YQ, 2008, ACTA BIOCH BIOPH SIN, V40, P149, DOI 10.1111/j.1745-7270.2008.00387.x; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	47	14	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67515	10.1371/journal.pone.0067515	http://dx.doi.org/10.1371/journal.pone.0067515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826312	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000086
J	Lopez-Sanchez, M; Munoz-Esquerre, M; Huertas, D; Gonzalez-Costello, J; Ribas, J; Manresa, F; Dorca, J; Santos, S				Lopez-Sanchez, Marta; Munoz-Esquerre, Mariana; Huertas, Daniel; Gonzalez-Costello, Jose; Ribas, Jesus; Manresa, Federico; Dorca, Jordi; Santos, Salud			High Prevalence of Left Ventricle Diastolic Dysfunction in Severe COPD Associated with A Low Exercise Capacity: A Cross-Sectional Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; VOLUME REDUCTION SURGERY; AIR-FLOW OBSTRUCTION; HEART-FAILURE; ELDERLY-PATIENTS; EMPHYSEMA; HYPERTENSION; PERFORMANCE; POPULATION; DIMENSIONS	Background: A subclinical left ventricle diastolic dysfunction (LVDD) has been described in patients with chronic obstructive pulmonary disease (COPD). Objectives: To evaluate the prevalence of LVDD in stable severe COPD patients, to analyze its relationship with exercise capacity and to look for its possible causes (lung hyperinflation, ventricular interdependence or inflammatory mechanisms). Methods: We evaluated 106 consecutive outpatients with severe COPD (FEV1 between 30-50%). Thirty-three (31%) were excluded because of previous heart disease. A pulmonary function test, a 6-minute walking test (6MWT), a Doppler echocardiography test, including diastolic dysfunction parameters, and an analysis of arterial blood gases, NT-proBNP and serum inflammatory markers (CRP, leucocytes), were performed in all patients. Results: The prevalence of LVDD in severe stable COPD patients was 90% (80% type I, n=57, and 10% type II, n=7). A significant association between a lower E/A ratio (higher LVDD type I) and a lower exercise tolerance (6-minute walked distance (6MWD)) was found (r=0.29, p<0.05). The fully adjusted multivariable linear regression model demonstrated that a lower E/A ratio, a DLCO in the quartile 4th and a higher tobacco consumption were associated with a lower 6MWD (76, 57 and 0.7 metres, respectively, p<0.05). A significant correlation between E/A ratio and PaO2 was observed (r=0.26, p<0.05), but not with static lung hyperinflation, inflammation or right ventricle overload parameters. Conclusion: In stable severe COPD patients, the prevalence of LVDD is high and this condition might contribute in their lower exercise tolerance. Hypoxemia could have a concomitant role in their pathogenesis.	[Lopez-Sanchez, Marta; Munoz-Esquerre, Mariana; Huertas, Daniel; Ribas, Jesus; Manresa, Federico; Dorca, Jordi; Santos, Salud] Hosp Univ Bellvitge, Dept Pulm Med, Barcelona, Spain; [Lopez-Sanchez, Marta] Hosp Univ Bellvitge, Dept Cardiol, Barcelona, Spain; [Munoz-Esquerre, Mariana; Gonzalez-Costello, Jose; Ribas, Jesus; Manresa, Federico; Dorca, Jordi; Santos, Salud] Univ Barcelona, Pneumol Res Grp, Inst Invest Biomed Bellvitge IDIBELL, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Santos, S (corresponding author), Hosp Univ Bellvitge, Dept Pulm Med, Barcelona, Spain.	saludsantos@bellvitgehospital.cat	Munoz-Esquerre, Mariana/F-7386-2012; Dorca, Jordi/Q-3617-2016; González-Costello, José/AAX-8465-2021	Dorca, Jordi/0000-0002-8137-878X; González-Costello, José/0000-0002-7437-3630; Santos, Salud/0000-0002-5835-1028; Ribas Sola, Jesus/0000-0001-7356-4307	Societat Catalana de Pneumologia (SOCAP); Fundacio Catalana de Pneumologia (FUCAP); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR)	Societat Catalana de Pneumologia (SOCAP); Fundacio Catalana de Pneumologia (FUCAP); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR)	Supported by grants from the Societat Catalana de Pneumologia (SOCAP) 2010, Fundacio Catalana de Pneumologia (FUCAP 2011-12) and Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR) 2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhayaratna WP, 2006, HEART, V92, P1259, DOI 10.1136/hrt.2005.080150; Abroug F, 2006, AM J RESP CRIT CARE, V174, P990, DOI 10.1164/rccm.200603-380OC; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Boussuges A, 2000, AM J RESP CRIT CARE, V162, P670, DOI 10.1164/ajrccm.162.2.9908056; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Criner GJ, 2007, AM J RESP CRIT CARE, V176, P253, DOI 10.1164/rccm.200608-1114OC; Cuttica MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029069; DINHXUAN AT, 1991, NEW ENGL J MED, V324, P1539, DOI 10.1056/NEJM199105303242203; Fischer M, 2003, EUR HEART J, V24, P320, DOI 10.1016/S0195-668X(02)00428-1; Funk GC, 2008, CHEST, V133, P1354, DOI 10.1378/chest.07-2685; Jorgensen K, 2003, CHEST, V124, P1863, DOI 10.1378/chest.124.5.1863; Jorgensen K, 2007, CHEST, V131, P1050, DOI 10.1378/chest.06-2245; Kasner M, 2012, AM J RESP CRIT CARE, V186, P181, DOI 10.1164/rccm.201110-1860OC; Larsen KO, 2006, AM J PHYSIOL-HEART C, V291, pH507, DOI 10.1152/ajpheart.00862.2005; Malerba M, 2011, J BIOL REG HOMEOS AG, V25, P443; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; Noordegraaf AV, 1997, CHEST, V112, P640, DOI 10.1378/chest.112.3.640; Peinado VI, 1999, AM J RESP CRIT CARE, V159, P1605, DOI 10.1164/ajrccm.159.5.9807059; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rabinovich RA, 2004, ARCH BRONCONEUMOL, V40, P80; Rakowski H, 1996, J Am Soc Echocardiogr, V9, P736, DOI 10.1016/S0894-7317(96)90076-0; Rutten FH, 2005, BMJ-BRIT MED J, V331, P1379, DOI 10.1136/bmj.38664.661181.55; Rutten FH, 2005, EUR HEART J, V26, P1887, DOI 10.1093/eurheartj/ehi291; Rutten FH, 2006, EUR J HEART FAIL, V8, P706, DOI 10.1016/j.ejheart.2006.01.010; Santos S, 2003, AM J RESP CRIT CARE, V167, P1250, DOI 10.1164/rccm.200210-1233OC; Scharf SM, 2002, AM J RESP CRIT CARE, V166, P314, DOI 10.1164/rccm.2107027; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; Sims MW, 2009, CHEST, V136, P412, DOI 10.1378/chest.08-2739; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Vassaux C, 2008, EUR RESPIR J, V32, P1275, DOI 10.1183/09031936.00151707; Watz H, 2008, AM J RESP CRIT CARE, V177, P743, DOI 10.1164/rccm.200707-1011OC; Watz H, 2010, CHEST, V138, P32, DOI 10.1378/chest.09-2810; Yilmaz R, 2005, J AM SOC ECHOCARDIOG, V18, P873, DOI 10.1016/j.echo.2005.01.016	40	39	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68034	10.1371/journal.pone.0068034	http://dx.doi.org/10.1371/journal.pone.0068034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826360	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000114
J	Schlacher, TA; Strydom, S; Connolly, RM; Schoeman, D				Schlacher, Thomas A.; Strydom, Simone; Connolly, Rod M.; Schoeman, David			Donor-Control of Scavenging Food Webs at the Land-Ocean Interface	PLOS ONE			English	Article							OFF-ROAD VEHICLES; GHOST CRABS; SANDY-BEACH; VERTEBRATE SCAVENGERS; BURROW ARCHITECTURE; COASTAL DUNES; IMPACTS; OCYPODE; HABITAT; SUBSIDIES	Food webs near the interface of adjacent ecosystems are potentially subsidised by the flux of organic matter across system boundaries. Such subsidies, including carrion of marine provenance, are predicted to be instrumental on open-coast sandy shores where in situ productivity is low and boundaries are long and highly permeable to imports from the sea. We tested the effect of carrion supply on the structure of consumer dynamics in a beach-dune system using broad-scale, repeated additions of carcasses at the strandline of an exposed beach in eastern Australia. Carrion inputs increased the abundance of large invertebrate scavengers (ghost crabs, Ocypode spp.), a numerical response most strongly expressed by the largest size-class in the population, and likely due to aggregative behaviour in the short term. Consumption of carrion at the beach-dune interface was rapid and efficient, driven overwhelmingly by facultative avian scavengers. This guild of vertebrate scavengers comprises several species of birds of prey (sea eagles, kites), crows and gulls, which reacted strongly to concentrations of fish carrion, creating hotspots of intense scavenging activity along the shoreline. Detection of carrion effects at several trophic levels suggests that feeding links arising from carcasses shape the architecture and dynamics of food webs at the land-ocean interface.	[Schlacher, Thomas A.; Strydom, Simone; Schoeman, David] Univ Sunshine Coast, Fac Sci, Maroochydore, Qld, Australia; [Connolly, Rod M.] Griffith Univ, Australian Rivers Inst Coast & Estuaries, Southport, Qld 4215, Australia	University of the Sunshine Coast; Griffith University	Schlacher, TA (corresponding author), Univ Sunshine Coast, Fac Sci, Maroochydore, Qld, Australia.	tschlach@usc.edu.au	Connolly, Rod M/C-4094-2008; Schlacher, Thomas/J-4614-2016	Connolly, Rod M/0000-0001-6223-1291; Schlacher, Thomas/0000-0003-2184-9217; Schoeman, David/0000-0003-1258-0885	University of the Sunshine Coast	University of the Sunshine Coast	Financial support for this study was provided by the University of the Sunshine Coast. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock AW, 1902, NATURALIST INDIAN SE; [Anonymous], 2004, FOOD WEBS LANDSCAPE; Baayen RH, 2011, LANGUAGER DATA SETS; Barreiro F, 2011, MAR ECOL PROG SER, V433, P65, DOI 10.3354/meps09130; Barros F, 2001, BIOL CONSERV, V97, P399, DOI 10.1016/S0006-3207(00)00116-6; Bascom W., 1980, WAVES BEACHES DYNAMI; Bates D, 2012, LME4 LINEAR MIXED EF; Beasley JC, 2012, OIKOS, V121, P1021, DOI 10.1111/j.1600-0706.2012.20353.x; Blazquez M, 2009, ACTA OECOL, V35, P645, DOI 10.1016/j.actao.2009.06.002; Boekel C, 1976, AUST BIRD WATCHER, V6, P245; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BROWN AC, 1981, J EXP MAR BIOL ECOL, V49, P51, DOI 10.1016/0022-0981(81)90146-5; Brown AC, 1996, REV CHIL HIST NAT, V69, P469; Carlton JT, 2003, MAR ECOL PROG SER, V256, P271, DOI 10.3354/meps256271; Catenazzi A, 2007, OIKOS, V116, P75, DOI 10.1111/j.2006.0030-1299.15230.x; Cott H, 1929, P ZOOL SOC LOND, P755; DeVault TL, 2003, OIKOS, V102, P225, DOI 10.1034/j.1600-0706.2003.12378.x; DeVault TL, 2002, ACTA THERIOL, V47, P185, DOI 10.1007/BF03192458; DeVault TL, 2011, BASIC APPL ECOL, V12, P268, DOI 10.1016/j.baae.2011.02.008; Dugan JE, 2003, ESTUAR COAST SHELF S, V58, P25, DOI 10.1016/S0272-7714(03)00045-3; Dugan JE, 2010, ESTUAR COAST, V33, P67, DOI 10.1007/s12237-009-9239-8; ECKERT J, 1971, Emu, V71, P61; Eide NE, 2012, J ANIM ECOL, V81, P640, DOI 10.1111/j.1365-2656.2011.01936.x; Everding S, 2000, EMU, V100, P192, DOI 10.1071/MU9808; Fisher NI, 1995, STAT ANAL CIRCULAR D; Gosper D.G., 1983, Corella, V7, P7; Guarino F, 2001, WILDLIFE RES, V28, P627, DOI 10.1071/WR01001; Houston D.C., 1979, SERENGETI DYNAMICS E, P263; HOUSTON DC, 1986, CONDOR, V88, P318, DOI 10.2307/1368878; IWAMOTO T, 1986, Ecological Research, V1, P249, DOI 10.1007/BF02348682; Keough MJ, 2000, ECOL APPL, V10, P871, DOI 10.1890/1051-0761(2000)010[0871:LVPPOA]2.0.CO;2; Killengreen ST, 2012, DIVERS DISTRIB, V18, P563, DOI 10.1111/j.1472-4642.2011.00861.x; King D., 1999, MONITORS BIOL VARANI; Kostecke RM, 2001, J FIELD ORNITHOL, V72, P439, DOI 10.1648/0273-8570-72.3.439; Leroux SJ, 2008, ECOL LETT, V11, P1147, DOI 10.1111/j.1461-0248.2008.01235.x; Lillywhite Harvey B., 2008, South American Journal of Herpetology, V3, P175, DOI 10.2994/1808-9798(2008)3[175:TEOICS]2.0.CO;2; Lillywhite HB, 2008, BIOSCIENCE, V58, P947, DOI 10.1641/B581008; Lucrezi S, 2010, MAR FRESHWATER RES, V61, P951, DOI 10.1071/MF09259; Lucrezi S, 2010, ENVIRON MANAGE, V45, P1352, DOI 10.1007/s00267-010-9491-5; Lucrezi S, 2009, ECOL INDIC, V9, P913, DOI 10.1016/j.ecolind.2008.10.013; Lucrezi S, 2009, ENVIRON MONIT ASSESS, V152, P413, DOI 10.1007/s10661-008-0326-2; MacGillivray WDK, 1929, EMU, V29, P115; Marchant S., 1993, HDB AUSTR NZ ANTARCT, V2; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; McLachlan A, 2006, ECOLOGY SANDY SHORES; Meager JJ, 2012, DIVERS DISTRIB, V18, P294, DOI 10.1111/j.1472-4642.2011.00873.x; Moss D, 2006, COAST MANAGE, V34, P133, DOI 10.1080/08920750500379383; PHILLIPS M, 1991, WILDLIFE RES, V18, P677, DOI 10.1071/WR9910677; Pinheiro J, 2001, MIXED EFFECTS MODELS; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, 2012, R LANG ENV STAT COMP; Rassweiler A, 2011, MAR FRESHWATER RES, V62, P510, DOI 10.1071/MF10194; ROSE A B, 1973, Emu, V73, P177; Rose MD, 1998, ECOLOGY, V79, P998, DOI 10.2307/176595; Roth JD, 2003, J ANIM ECOL, V72, P668, DOI 10.1046/j.1365-2656.2003.00739.x; Rowley I., 1973, CSIRO Wildl Res, V18, P131, DOI 10.1071/CWR9730131; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; Sanchez-Pinero F, 2000, ECOLOGY, V81, P3117, DOI 10.1890/0012-9658(2000)081[3117:BUDOAI]2.0.CO;2; Schlacher TA, 2010, VIE MILIEU, V60, P313; Schlacher TA, 2008, HYDROBIOLOGIA, V610, P345, DOI 10.1007/s10750-008-9426-9; Schlacher TA, 2008, MAR ECOL-EVOL PERSP, V29, P70, DOI 10.1111/j.1439-0485.2007.00204.x; Schlacher TA, 2008, J COASTAL RES, V24, P234, DOI 10.2112/06-0691.1; Schlacher TA, 2007, COAST MANAGE, V35, P567, DOI 10.1080/08920750701593402; Schlacher TA, 2007, MAR ECOL-EVOL PERSP, V28, P354, DOI 10.1111/j.1439-0485.2007.00156.x; Schlacher TA, 2013, ACTA OECOL, V48, P7, DOI 10.1016/j.actao.2013.01.007; Schlacher TA, 2013, ESTUAR COAST SHELF S, V118, P31, DOI 10.1016/j.ecss.2012.12.016; Schlacher TA, 2011, ECOL INDIC, V11, P284, DOI 10.1016/j.ecolind.2010.05.006; Schlacher TA, 2009, ECOSYSTEMS, V12, P311, DOI 10.1007/s10021-008-9224-2; SIMONETTI JA, 1984, MAMMALIA, V48, P608; SMITH GC, 1985, EMU, V85, P198, DOI 10.1071/MU9850198; Smith J. I. D, 1992, THESIS U QUEENSLAND; SPILLER DA, 1992, J ARACHNOL, V20, P179; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Thompson Luke M. C., 2008, Journal of Coastal Conservation, V12, P67, DOI 10.1007/s11852-008-0032-9; TROTT TJ, 1984, J EXP MAR BIOL ECOL, V78, P237; UNDERWOOD AJ, 1992, J EXP MAR BIOL ECOL, V161, P145, DOI 10.1016/0022-0981(92)90094-Q; WELLINS CA, 1989, J CHEM ECOL, V15, P1161, DOI 10.1007/BF01014819; Wilson EE, 2011, TRENDS ECOL EVOL, V26, P129, DOI 10.1016/j.tree.2010.12.011; Witman JD, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P335; Wolcott T.G., 1988, P55, DOI 10.1017/CBO9780511753428.004; WOLCOTT TG, 1978, J EXP MAR BIOL ECOL, V31, P67, DOI 10.1016/0022-0981(78)90137-5; YOUNG TP, 1994, CONSERV BIOL, V8, P410, DOI 10.1046/j.1523-1739.1994.08020410.x; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zuur Alain F., 2009, P1	85	33	33	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68221	10.1371/journal.pone.0068221	http://dx.doi.org/10.1371/journal.pone.0068221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826379	gold, Green Published			2022-12-27	WOS:000321150000133
J	Uguru, GC; Mondhe, M; Goh, S; Hesketh, A; Bibb, MJ; Good, L; Stach, JEM				Uguru, Gabriel C.; Mondhe, Madhav; Goh, Shan; Hesketh, Andrew; Bibb, Mervyn J.; Good, Liam; Stach, James E. M.			Synthetic RNA Silencing of Actinorhodin Biosynthesis in Streptomyces coelicolor A3(2)	PLOS ONE			English	Article							SMALL NONCODING RNAS; ANTIBIOTIC PRODUCTION; GENE-EXPRESSION; ANTISENSE RNAS; IDENTIFICATION; INHIBITION; ACTIVATION; PATHWAY; GROWTH; PREDICTION	We demonstrate the first application of synthetic RNA gene silencers in Streptomyces coelicolor A3(2). Peptide nucleic acid and expressed antisense RNA silencers successfully inhibited actinorhodin production. Synthetic RNA silencing was target-specific and is a new tool for gene regulation and metabolic engineering studies in Streptomyces.	[Uguru, Gabriel C.; Mondhe, Madhav; Stach, James E. M.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Goh, Shan; Good, Liam] Univ London, Royal Vet Coll, Dept Pathol & Infect Dis, London, England; [Hesketh, Andrew; Bibb, Mervyn J.] John Innes Ctr, Norwich, Norfolk, England	Newcastle University - UK; University of London; University of London Royal Veterinary College; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Stach, JEM (corresponding author), Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	jem.stach@ncl.ac.uk	Goh, Shan/A-7261-2010	Goh, Shan/0000-0002-9028-0303; Hesketh, Andrew/0000-0001-5220-8733; Stach, James/0000-0001-8787-2407; Good, Liam/0000-0002-2798-8640	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E017053/1]; BBSRC [BB/E017053/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000607, BB/E017053/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/E017053/1 (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Ausable FM, 1996, CURRENT PROTOCOLS MO; Chen YH, 2010, APPL MICROBIOL BIOT, V86, P19, DOI 10.1007/s00253-009-2428-3; D'Alia D, 2010, J BACTERIOL, V192, P1160, DOI 10.1128/JB.01374-09; Desai RP, 1999, APPL ENVIRON MICROB, V65, P936; Dryselius R, 2003, OLIGONUCLEOTIDES, V13, P427, DOI 10.1089/154545703322860753; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Goh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006061; Good L, 2001, NAT BIOTECHNOL, V19, P360, DOI 10.1038/86753; Good Liam, 2002, Methods Mol Biol, V208, P237; Hebert CG, 2008, CURR OPIN BIOTECH, V19, P500, DOI 10.1016/j.copbio.2008.08.006; Herai S, 2004, P NATL ACAD SCI USA, V101, P14031, DOI 10.1073/pnas.0406058101; Hesketh A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r161; Hindra, 2010, J BACTERIOL, V192, P4973, DOI 10.1128/JB.00681-10; HJALT TAH, 1995, NUCLEIC ACIDS RES, V23, P571, DOI 10.1093/nar/23.4.571; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Kang SG, 1998, FEMS MICROBIOL LETT, V168, P221, DOI 10.1111/j.1574-6968.1998.tb13277.x; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Livny J, 2007, CURR OPIN MICROBIOL, V10, P96, DOI 10.1016/j.mib.2007.03.005; Livny J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003197; McArthur M, 2008, P NATL ACAD SCI USA, V105, P1020, DOI 10.1073/pnas.0710724105; McArthur M, 2006, NUCLEIC ACIDS RES, V34, P5395, DOI 10.1093/nar/gkl649; Minas W, 2000, ANTON LEEUW INT J G, V78, P297, DOI 10.1023/A:1010254013352; Morita T, 2006, P NATL ACAD SCI USA, V103, P4858, DOI 10.1073/pnas.0509638103; Nakashima N, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl697; Nekhotiaeva N, 2004, MOL THER, V10, P652, DOI 10.1016/j.ymthe.2004.07.006; Panek J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-217; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROMERO NM, 1995, FEMS MICROBIOL LETT, V127, P79; ROMERO NM, 1992, NUCLEIC ACIDS RES, V20, P2767, DOI 10.1093/nar/20.11.2767; Shen N, 2009, P NATL ACAD SCI USA, V106, P8163, DOI 10.1073/pnas.0903491106; Swiercz JP, 2008, NUCLEIC ACIDS RES, V36, P7240, DOI 10.1093/nar/gkn898; Tezuka T, 2009, J BACTERIOL, V191, P4896, DOI 10.1128/JB.00087-09; Uguru GC, 2005, MOL MICROBIOL, V58, P131, DOI 10.1111/j.1365-2958.2005.04817.x; Vockenhuber MP, 2012, MICROBIOL-SGM, V158, P424, DOI 10.1099/mic.0.054205-0; Vockenhuber MP, 2011, RNA BIOL, V8, P468, DOI 10.4161/rna.8.3.14421; Wagner EGH, 2002, TRENDS GENET, V18, P223, DOI 10.1016/S0168-9525(02)02658-6; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	38	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67509	10.1371/journal.pone.0067509	http://dx.doi.org/10.1371/journal.pone.0067509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826310	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000085
J	Jiang, CY; Yang, KM; Yang, L; Miao, ZX; Wang, YH; Zhu, HB				Jiang, Chun-ying; Yang, Kang-min; Yang, Liu; Miao, Zhao-xia; Wang, Ying-hong; Zhu, Hai-bo			A H-1 NMR-Based Metabonomic Investigation of Time-Related Metabolic Trajectories of the Plasma, Urine and Liver Extracts of Hyperlipidemic Hamsters	PLOS ONE			English	Article							MASS-SPECTROMETRY; H-1-NMR SPECTROSCOPY; ATHEROSCLEROSIS; SERUM; REVEALS; DISEASE; CHOLESTEROL; PROGRESSION; ASSIGNMENT; OXIDATION	The hamster has been previously found to be a suitable model to study the changes associated with diet-induced hyperlipidemia in humans. Traditionally, studies of hyperlipidemia utilize serum-or plasma-based biochemical assays and histopathological evaluation. However, unbiased metabonomic technologies have the potential to identify novel biomarkers of disease. Thus, to obtain a better understanding of the progression of hyperlipidemia and discover potential biomarkers, we have used a proton nuclear magnetic resonance spectroscopy (H-1-NMR)-based metabonomics approach to study the metabolic changes occurring in the plasma, urine and liver extracts of hamsters fed a high-fat/high-cholesterol diet. Samples were collected at different time points during the progression of hyperlipidemia, and individual proton NMR spectra were visually and statistically assessed using two multivariate analyses (MVA): principal component analysis (PCA) and orthogonal partial least squares-discriminant analysis (OPLS-DA). Using the commercial software package Chenomx NMR suite, 40 endogenous metabolites in the plasma, 80 in the urine and 60 in the water-soluble fraction of liver extracts were quantified. NMR analysis of all samples showed a time-dependent transition from a physiological to a pathophysiological state during the progression of hyperlipidemia. Analysis of the identified biomarkers of hyperlipidemia suggests that significant perturbations of lipid and amino acid metabolism, as well as inflammation, oxidative stress and changes in gut microbiota metabolites, occurred following cholesterol overloading. The results of this study substantially broaden the metabonomic coverage of hyperlipidemia, enhance our understanding of the mechanism of hyperlipidemia and demonstrate the effectiveness of the NMR-based metabonomics approach to study a complex disease.	[Jiang, Chun-ying; Yang, Kang-min; Yang, Liu; Miao, Zhao-xia; Wang, Ying-hong; Zhu, Hai-bo] Chinese Acad Med Sci, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100730, Peoples R China; [Jiang, Chun-ying; Yang, Kang-min; Yang, Liu; Miao, Zhao-xia; Wang, Ying-hong; Zhu, Hai-bo] Chinese Acad Med Sci, Minist Hlth, Key Lab Biosynth Nat Prod, Beijing 100730, Peoples R China; [Jiang, Chun-ying; Yang, Kang-min; Yang, Liu; Miao, Zhao-xia; Wang, Ying-hong; Zhu, Hai-bo] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, YH (corresponding author), Chinese Acad Med Sci, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100730, Peoples R China.	wyh@imm.ac.cn; zhuhaibo@imm.ac			National ST Major Project [2009ZX09311-004, 2012ZX09301002-004, 2012ZX09102101-020]; Natural Sciences Foundation of Beijing [7122114, 7102115, BZ0150]; National Natural Sciences Foundation of China (NSFC) [30973527, 81273514]; Beijing Talents Funding-Project A [2011A009008000004]	National ST Major Project; Natural Sciences Foundation of Beijing(Beijing Natural Science Foundation); National Natural Sciences Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Beijing Talents Funding-Project A	This study was supported by grants from National S&T Major Project (grant numbers 2009ZX09311-004, 2012ZX09301002-004, 2012ZX09102101-020), Natural Sciences Foundation of Beijing (grant numbers 7122114, 7102115, NO. BZ0150), National Natural Sciences Foundation of China (NSFC) (grant numbers 30973527, 81273514), and Beijing Talents Funding-Project A (grant number 2011A009008000004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2002, BIOCHEM J, V364, P15, DOI 10.1042/bj3640015; ALWAIZ M, 1992, METABOLISM, V41, P135, DOI 10.1016/0026-0495(92)90140-6; Atherton HJ, 2006, PHYSIOL GENOMICS, V27, P178, DOI 10.1152/physiolgenomics.00060.2006; Barr J, 2010, J PROTEOME RES, V9, P4501, DOI 10.1021/pr1002593; Barron JT, 1998, J MOL CELL CARDIOL, V30, P709, DOI 10.1006/jmcc.1997.0637; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Beckwith-Hall BM, 2003, ANALYST, V128, P814, DOI 10.1039/b302360p; BELL JD, 1987, FEBS LETT, V215, P311, DOI 10.1016/0014-5793(87)80168-0; Bertram HC, 2012, J AGR FOOD CHEM, V60, P676, DOI 10.1021/jf203994k; Bertram HC, 2009, MOL NUTR FOOD RES, V53, P1055, DOI 10.1002/mnfr.200800344; Carr TP, 2009, J NUTR, V139, P1445, DOI 10.3945/jn.109.106328; Chen SW, 2006, DIGEST DIS SCI, V51, P2225, DOI 10.1007/s10620-006-9359-y; Cloarec O, 2005, ANAL CHEM, V77, P517, DOI 10.1021/ac048803i; Duarte IF, 2007, NMR BIOMED, V20, P401, DOI 10.1002/nbm.1073; Fan TWM, 2008, PROG NUCL MAG RES SP, V52, P69, DOI 10.1016/j.pnmrs.2007.03.002; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Hlais S, 2012, CLIN THER, V34, P1674, DOI 10.1016/j.clinthera.2012.06.019; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Jiang LM, 2012, J PROTEOME RES, V11, P3848, DOI 10.1021/pr3003529; Jung JY, 2012, BMB REP, V45, P419, DOI 10.5483/BMBRep.2012.45.7.248; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Kim IY, 2010, BIOCHEM BIOPH RES CO, V403, P428, DOI 10.1016/j.bbrc.2010.11.048; Liu ML, 2002, MAGN RESON CHEM, V40, pS83, DOI 10.1002/mrc.1121; Makinen VP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100205; Mallin K, 2004, J OCCUP ENVIRON MED, V46, P565, DOI 10.1097/01.jom.0000128156.24767.12; Martin JC, 2009, ATHEROSCLEROSIS, V206, P127, DOI 10.1016/j.atherosclerosis.2009.01.040; Melis GC, 2004, CURR OPIN CLIN NUTR, V7, P59, DOI 10.1097/00075197-200401000-00011; Murakami S, 1998, LIFE SCI, V64, P83, DOI 10.1016/S0024-3205(98)00536-0; MURRAY KN, 1966, J BIOL CHEM, V241, P3468; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Oorni K, 1997, J BIOL CHEM, V272, P21303, DOI 10.1074/jbc.272.34.21303; Peng JB, 2011, PROCESS BIOCHEM, V46, P2240, DOI 10.1016/j.procbio.2011.08.016; Pepys MB, 2005, ARTERIOSCL THROM VAS, V25, P1091, DOI 10.1161/01.ATV.0000169644.88847.28; Poeze M, 2008, CLIN NUTR, V27, P523, DOI 10.1016/j.clnu.2008.04.006; Rebouche CJ, 1998, ANNU REV NUTR, V18, P39, DOI 10.1146/annurev.nutr.18.1.39; Rull A, 2009, BIOCHIMIE, V91, P1053, DOI 10.1016/j.biochi.2009.04.019; Schicho R, 2012, J PROTEOME RES, V11, P3344, DOI 10.1021/pr300139q; Schrauwen P, 2000, DIABETES, V49, P640, DOI 10.2337/diabetes.49.4.640; Seidel A, 2006, BRIT J CANCER, V94, P1726, DOI 10.1038/sj.bjc.6603164; Simons LA, 2002, AM J CARDIOL, V90, P737, DOI 10.1016/S0002-9149(02)02600-0; Sun Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032115, 10.1371/journal.pone.0047003]; Sun YJ, 2012, J PROTEOME RES, V11, P2544, DOI 10.1021/pr2012329; TOBOREK M, 1995, ATHEROSCLEROSIS, V115, P217, DOI 10.1016/0021-9150(94)05516-L; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Valeille K, 2005, AM J PHYSIOL-HEART C, V289, pH652, DOI 10.1152/ajpheart.00130.2005; Villas-Boas SG, 2005, MASS SPECTROM REV, V24, P613, DOI 10.1002/mas.20032; Vinaixa M, 2010, J PROTEOME RES, V9, P2527, DOI 10.1021/pr901203w; WANG H, 2005, DRUG DISCOV TODAY DI, V2, P25, DOI DOI 10.1016/j.ddmec.2005.05.029; Williams HRT, 2009, AM J GASTROENTEROL, V104, P1435, DOI 10.1038/ajg.2009.175; Willker W, 1998, MAGN RESON CHEM, V36, pS79, DOI 10.1002/(SICI)1097-458X(199806)36:13<S79::AID-OMR294>3.3.CO;2-Q; WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176; Zha WB, 2009, BIOMARKERS, V14, P372, DOI 10.1080/13547500903026401; Zhang FX, 2009, TALANTA, V79, P836, DOI 10.1016/j.talanta.2009.05.010; Zhang XY, 2009, J PROTEOME RES, V8, P5188, DOI 10.1021/pr900524z	55	84	94	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66786	10.1371/journal.pone.0066786	http://dx.doi.org/10.1371/journal.pone.0066786			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840531	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400041
J	Bohm, J; Vasli, N; Malfatti, E; Le Gras, S; Feger, C; Jost, B; Monnier, N; Brocard, J; Karasoy, H; Gerard, M; Walter, MC; Reilich, P; Biancalana, V; Kretz, C; Messaddeq, N; Marty, I; Lunardi, J; Romero, NB; Laporte, J				Boehm, Johann; Vasli, Nasim; Malfatti, Edoardo; Le Gras, Stephanie; Feger, Claire; Jost, Bernard; Monnier, Nicole; Brocard, Julie; Karasoy, Hatice; Gerard, Marion; Walter, Maggie C.; Reilich, Peter; Biancalana, Valerie; Kretz, Christine; Messaddeq, Nadia; Marty, Isabelle; Lunardi, Joel; Romero, Norma B.; Laporte, Jocelyn			An Integrated Diagnosis Strategy for Congenital Myopathies	PLOS ONE			English	Article							CENTRAL CORE DISEASE; RECESSIVE RYR1 MUTATIONS; RYANODINE RECEPTOR GENE; MALIGNANT HYPERTHERMIA; NEMALINE MYOPATHY; SKELETAL-MUSCLE; NEBULIN GENE; COMMON-CAUSE; OPHTHALMOPLEGIA	Congenital myopathies are severe muscle disorders affecting adults as well as children in all populations. The diagnosis of congenital myopathies is constrained by strong clinical and genetic heterogeneity. Moreover, the majority of patients present with unspecific histological features, precluding purposive molecular diagnosis and demonstrating the need for an alternative and more efficient diagnostic approach. We used exome sequencing complemented by histological and ultrastructural analysis of muscle biopsies to identify the causative mutations in eight patients with clinically different skeletal muscle pathologies, ranging from a fatal neonatal myopathy to a mild and slowly progressive myopathy with adult onset. We identified RYR1 (ryanodine receptor) mutations in six patients and NEB (nebulin) mutations in two patients. We found novel missense and nonsense mutations, unraveled small insertions/deletions and confirmed their impact on splicing and mRNA/protein stability. Histological and ultrastructural findings of the muscle biopsies of the patients validated the exome sequencing results. We provide the evidence that an integrated strategy combining exome sequencing with clinical and histopathological investigations overcomes the limitations of the individual approaches to allow a fast and efficient diagnosis, accelerating the patient's access to a better healthcare and disease management. This is of particular interest for the diagnosis of congenital myopathies, which involve very large genes like RYR1 and NEB as well as genetic and phenotypic heterogeneity.	[Boehm, Johann; Vasli, Nasim; Le Gras, Stephanie; Feger, Claire; Jost, Bernard; Biancalana, Valerie; Kretz, Christine; Messaddeq, Nadia; Laporte, Jocelyn] Inst Genet & Biol Mol & Cellulaire, Dept Translat Med & Neurogenet, Illkirch Graffenstaden, France; [Boehm, Johann; Vasli, Nasim; Le Gras, Stephanie; Feger, Claire; Jost, Bernard; Biancalana, Valerie; Kretz, Christine; Messaddeq, Nadia; Laporte, Jocelyn] INSERM, U964, Illkirch Graffenstaden, France; [Boehm, Johann; Vasli, Nasim; Le Gras, Stephanie; Feger, Claire; Jost, Bernard; Biancalana, Valerie; Kretz, Christine; Messaddeq, Nadia; Laporte, Jocelyn] CNRS, UMR7104, Illkirch Graffenstaden, France; [Boehm, Johann; Vasli, Nasim; Le Gras, Stephanie; Feger, Claire; Jost, Bernard; Biancalana, Valerie; Kretz, Christine; Messaddeq, Nadia; Laporte, Jocelyn] Univ Strasbourg, Illkirch Graffenstaden, France; [Boehm, Johann; Vasli, Nasim; Feger, Claire; Kretz, Christine; Laporte, Jocelyn] Coll France, Chaire Genet Humaine, Illkirch Graffenstaden, France; [Malfatti, Edoardo; Romero, Norma B.] GHU La Pitie Salpetrere, Unite Morphol Neuromusculaire, Inst Myol, Paris, France; [Malfatti, Edoardo] Univ Siena, Dept Neurol Neurosurg & Behav Sci, I-53100 Siena, Italy; [Malfatti, Edoardo; Romero, Norma B.] Univ Paris 06, INSERM, CNRS, Inst Myol,GHU La Pitie Salpetriere,UR76,UMR 974,U, Paris, France; [Malfatti, Edoardo; Romero, Norma B.] GHU La Pitie Salpetriere, AP HP, Inst Myol, Ctr Reference Pathol Neuromusculaire Paris Est, Paris, France; [Le Gras, Stephanie; Jost, Bernard] Inst Genet & Biol Mol & Cellulaire, DNA Microarrays & Sequencing Platform, Illkirch Graffenstaden, France; [Monnier, Nicole; Lunardi, Joel] CHU Grenoble, Lab Biochim Genet & Mol, F-38043 Grenoble, France; [Brocard, Julie; Marty, Isabelle] INSERM, U836, Inst Neurosci, La Tronche, France; [Karasoy, Hatice] Ege Univ, Sch Med, Dept Neurol, Izmir, Turkey; [Gerard, Marion] CHU Caen, Serv Genet, Caen, France; [Walter, Maggie C.; Reilich, Peter] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80539 Munich, Germany; [Biancalana, Valerie] Nouvel Hop Civil, Fac Med, Lab Diagnost Genet, Strasbourg, France; [Messaddeq, Nadia] Inst Genet & Biol Mol & Cellulaire, Imaging Ctr, Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Siena; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Ege University; CHU de Caen NORMANDIE; Universite de Caen Normandie; University of Munich; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Laporte, J (corresponding author), Inst Genet & Biol Mol & Cellulaire, Dept Translat Med & Neurogenet, Illkirch Graffenstaden, France.	jocelyn@igbmc.fr	Böhm, Johann/O-1652-2016; Biancalana, Valerie/O-2351-2016; laporte, jocelyn/O-4888-2019; Marty, Isabelle/ABF-5362-2020; Marty, Isabelle/N-7114-2017; Laporte, Jocelyn/H-6801-2016; laporte, jocelyn/J-7008-2012	Böhm, Johann/0000-0001-8019-9504; Marty, Isabelle/0000-0003-3625-913X; Bohm, Johann/0000-0001-7370-3469; Le Gras, Stephanie/0000-0001-6293-6507; Brocard, Julie/0000-0001-9345-5191	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre national de la recherche scientifique (CNRS); University of Strasbourg; College de France; GIS Institute; Association Francaise contre les myopathies; Muscular Dystrophy Association (United States of America); Myotubular Trust; Agence Nationale de la Recherche (ANR); Muscular Dystrophy Association (MDA) [2010-52655]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Strasbourg; College de France; GIS Institute; Association Francaise contre les myopathies(Association Francaise contre les Myopathies); Muscular Dystrophy Association (United States of America)(Muscular Dystrophy Association); Myotubular Trust; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association)	This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Centre national de la recherche scientifique (CNRS), University of Strasbourg, College de France and grants from ANR, GIS Institute for rare diseases and IBiSA, Association Francaise contre les myopathies, Muscular Dystrophy Association (United States of America) and the Myotubular Trust. This work was supported by the INSERM, the CNRS, University of Strasbourg, College de France and grants from the Agence Nationale de la Recherche (ANR, grant CM-WES), Muscular Dystrophy Association (MDA, grant 2010-52655) and Myotubular Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amburgey K, 2011, ANN NEUROL, V70, P662, DOI 10.1002/ana.22510; Bevilacqua JA, 2011, NEUROPATH APPL NEURO, V37, P271, DOI 10.1111/j.1365-2990.2010.01149.x; Bohm J, 2012, ACTA NEUROPATHOL; Clarke NF, 2010, HUM MUTAT, V31, pE1544, DOI 10.1002/humu.21278; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; GILLARD EF, 1991, GENOMICS, V11, P751, DOI 10.1016/0888-7543(91)90084-R; Jungbluth H, 2005, NEUROLOGY, V65, P1930, DOI 10.1212/01.wnl.0000188870.37076.f2; Jungbluth H, 2011, SEMIN PEDIATR NEUROL, V18, P239, DOI 10.1016/j.spen.2011.10.005; Lawlor MW, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-23; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; Monnier N, 2003, HUM MOL GENET, V12, P1171, DOI 10.1093/hmg/ddg121; Nance JR, 2012, CURR NEUROL NEUROSCI, V12, P165, DOI 10.1007/s11910-012-0255-x; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, HUM MOL GENET, V19, pR119, DOI 10.1093/hmg/ddq390; North K, 2008, NEUROMUSCULAR DISORD, V18, P433, DOI 10.1016/j.nmd.2008.04.002; Pelin K, 1999, P NATL ACAD SCI USA, V96, P2305, DOI 10.1073/pnas.96.5.2305; QUANE KA, 1993, NAT GENET, V5, P51, DOI 10.1038/ng0993-51; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Romero NB, 2003, BRAIN, V126, P2341, DOI 10.1093/brain/awg244; Sewry CA, 2008, J MUSCLE RES CELL M, V29, P231, DOI 10.1007/s10974-008-9155-8; Vasli N, 2013, ACTA NEUROPATHOL, V125, P173, DOI 10.1007/s00401-012-1072-7; Wallgren-Pettersson C, 2002, NEUROMUSCULAR DISORD, V12, P674, DOI 10.1016/S0960-8966(02)00065-2; Wang CH, 2012, J CHILD NEUROL, V27, P363, DOI 10.1177/0883073812436605; Wilmshurst JM, 2010, ANN NEUROL, V68, P717, DOI 10.1002/ana.22119; ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46; Zhou HY, 2006, HUM MOL GENET, V15, P2791, DOI 10.1093/hmg/ddl221	30	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67527	10.1371/journal.pone.0067527	http://dx.doi.org/10.1371/journal.pone.0067527			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826317	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400157
J	Suzuki, T; Iyoda, M; Shibata, T; Ohtaki, H; Matsumoto, K; Shindo-Hirai, Y; Kuno, Y; Wada, Y; Yamamoto, Y; Kawaguchi, M; Shioda, S; Akizawa, T				Suzuki, Taihei; Iyoda, Masayuki; Shibata, Takanori; Ohtaki, Hirokazu; Matsumoto, Kei; Shindo-Hirai, Yuki; Kuno, Yoshihiro; Wada, Yukihiro; Yamamoto, Yasutaka; Kawaguchi, Mio; Shioda, Seiji; Akizawa, Tadao			Therapeutic Effects of Human Mesenchymal Stem Cells in Wistar-Kyoto Rats with Anti-Glomerular Basement Membrane Glomerulonephritis	PLOS ONE			English	Article							NEPHROTOXIC SERUM NEPHRITIS; MARROW STROMAL CELLS; REGULATORY T-CELLS; IMMUNE-RESPONSE; RENAL INJURY; CRESCENTIC GLOMERULONEPHRITIS; GLOMERULAR INJURY; TRANSPLANTATION; KIDNEY; MICE	Introduction: Multipotent mesenchymal stem cells (MSCs) have become a promising therapeutic approach in many clinical conditions. The hypothesis that MSCs can provide a potential therapy for human anti-glomerular basement membrane (GBM) glomerulonephritis (GN) was tested. Methods: Nephrotoxic serum nephritis was induced in Wistar-Kyoto rats on day 0. Groups of animals were given either human MSCs (hMSCs, 3 x 10(6)) or vehicle by intravenous injection on day 4; all rats were sacrificed at either day 7 or day 13. Results: Fluorescently labeled hMSCs were localized in glomeruli and tubulointerstitium 5 h after hMSC administration and persisted until 48 h, but hMSCs were barely detectable after 7 days. hMSC-treated rats had decreased kidney weight, proteinuria, and glomerular tuft area at each time point. The serum creatinine level and degree of glomerular crescent formation were decreased by hMSC treatment on day 13. ED1-positive macrophages, CD8-positive cells, and TUNEL-positive apoptotic cells in glomeruli were reduced by hMSC treatment on day 7, and this trend in apoptotic cells persisted to day 13. Renal cortical mRNA for TNF-alpha, IL-1 beta, and IL-17, and the serum IL-17A level were decreased, whereas renal cortical mRNA for IL-4 and Foxp3 and the serum IL-10 level were increased in the MSC-treated group on day 7. Collagen types I and III and TGF-beta mRNA were decreased by hMSC treatment on day 13. Conclusion: The present results demonstrated that anti-inflammatory and immunomodulatory effects were involved in the mechanism of attenuating established experimental anti-GBM GN by hMSCs. These results suggest that hMSCs are a promising therapeutic candidate for the treatment of anti-GBM GN.	[Suzuki, Taihei; Iyoda, Masayuki; Shibata, Takanori; Matsumoto, Kei; Shindo-Hirai, Yuki; Kuno, Yoshihiro; Wada, Yukihiro; Yamamoto, Yasutaka; Akizawa, Tadao] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan; [Ohtaki, Hirokazu; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Tokyo 142, Japan; [Kawaguchi, Mio] Univ Tsukuba, Inst Clin Med, Dept Resp Med, Tsukuba, Ibaraki 305, Japan	Showa University; Showa University; University of Tsukuba	Iyoda, M (corresponding author), Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan.	iyoda@med.showa-u.ac.jp			Ministry of Health, Labor and Welfare, Japan; Kyowa Hakko Kirin Co., Ltd.; Chugai Pharmaceutical Co., Ltd.	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Kyowa Hakko Kirin Co., Ltd.(Kyowa Kirin Ltd); Chugai Pharmaceutical Co., Ltd.	This work is supported in part by a Grant-in-Aid for the Research Group on Progressive Renal Diseases from the Ministry of Health, Labor and Welfare, Japan. T.A. is supported by a research grant from Kyowa Hakko Kirin Co., Ltd. and Chugai Pharmaceutical Co., Ltd. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; T.A received funding from Kyowa Hakko Kirin Co., Ltd. and Chugai Pharmaceutical Co., Ltd. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Asanuma H, 2011, J SURG RES, V168, pE51, DOI 10.1016/j.jss.2010.06.022; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Coelho SN, 1997, KIDNEY INT, V51, P646, DOI 10.1038/ki.1997.94; Duffy MM, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt75; Eliopoulos N, 2010, AM J PHYSIOL-RENAL, V299, pF1288, DOI 10.1152/ajprenal.00671.2009; Fujinaka H, 1997, J IMMUNOL, V158, P4978; Fujinaka H, 1997, J AM SOC NEPHROL, V8, P1174; GALLOP PM, 1975, PHYSIOL REV, V55, P418, DOI 10.1152/physrev.1975.55.3.418; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Herrera MB, 2004, INT J MOL MED, V14, P1035; Hirai Y, 2012, AM J PHYSIOL-RENAL, V302, pF244, DOI 10.1152/ajprenal.00113.2011; Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056; Hou M, 2007, INT J CARDIOL, V115, P220, DOI 10.1016/j.ijcard.2006.03.028; Isome M, 2004, NEPHROL DIAL TRANSPL, V19, P2997, DOI 10.1093/ndt/gfh558; Iyoda M, 2011, J AM SOC NEPHROL, V22, P1486, DOI 10.1681/ASN.2010111158; Iyoda M, 2010, AM J PHYSIOL-RENAL, V298, pF779, DOI 10.1152/ajprenal.00198.2009; Iyoda M, 2009, KIDNEY INT, V75, P1060, DOI 10.1038/ki.2009.43; KAWASAKI K, 1993, J IMMUNOL, V150, P1074; KAWASAKI K, 1992, KIDNEY INT, V41, P1517, DOI 10.1038/ki.1992.221; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Kitching AR, 1997, KIDNEY INT, V52, P52, DOI 10.1038/ki.1997.303; KIVIRIKKO KI, 1967, ANAL BIOCHEM, V19, P249, DOI 10.1016/0003-2697(67)90160-1; KOBAYASHI K, 1995, KIDNEY INT, V47, P454, DOI 10.1038/ki.1995.58; Kuno Y, 2011, BRIT J PHARMACOL, V162, P1389, DOI 10.1111/j.1476-5381.2010.01149.x; Kunter U, 2007, J AM SOC NEPHROL, V18, P1754, DOI 10.1681/ASN.2007010044; Kunter U, 2006, J AM SOC NEPHROL, V17, P2202, DOI 10.1681/ASN.2005080815; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Maggini J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009252; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Morigi M, 2008, STEM CELLS, V26, P2075, DOI 10.1634/stemcells.2007-0795; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Ooi JD, 2011, KIDNEY INT, V79, P977, DOI 10.1038/ki.2010.541; Paust HJ, 2011, KIDNEY INT, V80, P155, DOI 10.1038/ki.2011.108; Paust HJ, 2009, J AM SOC NEPHROL, V20, P969, DOI 10.1681/ASN.2008050556; Perico N, 2011, CLIN J AM SOC NEPHRO, V6, P412, DOI 10.2215/CJN.04950610; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rafei M, 2009, J IMMUNOL, V182, P5994, DOI 10.4049/jimmunol.0803962; Ramasamy R, 2007, TRANSPLANTATION, V83, P71, DOI 10.1097/01.tp.0000244572.24780.54; Reynolds J, 2002, J AM SOC NEPHROL, V13, P359, DOI 10.1681/ASN.V132359; Rossignol J, 2009, J CELL MOL MED, V13, P2547, DOI 10.1111/j.1582-4934.2009.00657.x; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Smeets B, 2009, J AM SOC NEPHROL, V20, P2604, DOI 10.1681/ASN.2009010122; Song CH, 2009, J VIROL, V83, P5918, DOI 10.1128/JVI.00165-09; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Sun LY, 2009, STEM CELLS, V27, P1421, DOI 10.1002/stem.68; Tang WW, 1996, KIDNEY INT, V50, P665, DOI 10.1038/ki.1996.363; Tipping PG, 1997, EUR J IMMUNOL, V27, P530, DOI 10.1002/eji.1830270226; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Turner JE, 2010, KIDNEY INT, V77, P1070, DOI 10.1038/ki.2010.102; Zhuo WL, 2011, UROL INT, V86, P191, DOI 10.1159/000319366	55	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67475	10.1371/journal.pone.0067475	http://dx.doi.org/10.1371/journal.pone.0067475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826305	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400150
J	Ly, BTK; Chi, HT; Yamagishi, M; Kano, Y; Hara, Y; Nakano, K; Sato, Y; Watanabe, T				Bui Thi Kim Ly; Hoang Thanh Chi; Yamagishi, Makoto; Kano, Yasuhiko; Hara, Yukihiko; Nakano, Kazumi; Sato, Yuko; Watanabe, Toshiki			Inhibition of FLT3 Expression by Green Tea Catechins in FLT3 Mutated-AML Cells	PLOS ONE			English	Article							INTERNAL TANDEM DUPLICATION; TYROSINE KINASE DOMAIN; LEUKEMIA-CELLS; MUTATIONS; RECEPTOR; GALLATE; CANCER; IDENTIFICATION; BINDING; GENE	Acute myeloid leukemia (AML) is a heterogeneous disease characterized by a block in differentiation and uncontrolled proliferation. FLT3 is a commonly mutated gene found in AML patients. In clinical trials, the presence of a FLT3-ITD mutation significantly correlates with an increased risk of relapse and dismal overall survival. Therefore, activated FLT3 is a promising molecular target for AML therapies. In this study, we have shown that green tea polyphenols including (-)-epigallocatechin-3-gallate (EGCG), (-)-epigallocatechin (EGC), and (-)-epicatechin-3-gallate (ECG) suppress the proliferation of AML cells. Interestingly, EGCG, EGC and ECG showed the inhibition of FLT3 expression in cell lines harboring FLT3 mutations. In the THP-1 cells harboring FLT3 wild-type, EGCG showed the suppression of cell proliferation but did not suppress the expression of FLT3 even at the concentration that suppress 100% cell proliferation. Moreover, EGCG-, EGC-and ECG-treated cells showed the suppression of MAPK, AKT and STAT5 phosphorylation. Altogether, we suggest that green tea polyphenols could serve as reagents for treatment or prevention of leukemia harboring FLT3 mutations.	[Bui Thi Kim Ly; Hoang Thanh Chi; Yamagishi, Makoto; Nakano, Kazumi; Watanabe, Toshiki] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan; [Kano, Yasuhiko] Tochigi Canc Ctr, Div Hematol, Utsunomiya, Tochigi, Japan; [Hara, Yukihiko] Hara Off Inc, Tea Solut, Sumida Ku, Tokyo, Japan; [Sato, Yuko] Japanese Red Cross Coll Nursing, Shibuya Ku, Tokyo, Japan	University of Tokyo; Tochigi Prefectural Cancer Center	Chi, HT (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan.	hoangchidc1985@yahoo.com	Ly, Bui/AAX-8740-2020; Hoang, Chi/AAX-8732-2020; Ly, Bui Thi Kim/AAZ-1145-2021	Hoang, Chi/0000-0002-6638-1235; Ly, Bui Thi Kim/0000-0002-8433-7035	Japan Foundation for Promotion of International Medical Research Co-operation (JF-PIMRC); Honjo International Scholarship Foundation	Japan Foundation for Promotion of International Medical Research Co-operation (JF-PIMRC); Honjo International Scholarship Foundation(Honjo International Scholarship Foundation)	This work was supported by the Japan Foundation for Promotion of International Medical Research Co-operation (JF-PIMRC). BTKL is a recipient of the scholarship from the Honjo International Scholarship Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Duhier FM, 2001, BRIT J HAEMATOL, V113, P983, DOI 10.1046/j.1365-2141.2001.02850.x; Ahn HY, 1999, MOL BIOL CELL, V10, P1093, DOI 10.1091/mbc.10.4.1093; Al Shaer L, 2008, BRIT J HAEMATOL, V141, P483, DOI 10.1111/j.1365-2141.2008.07053.x; Bagatell R, 2004, MOL CANCER THER, V3, P1021; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Breitenbuecher F, 2009, BLOOD, V113, P4074, DOI 10.1182/blood-2007-11-125476; Chen ZP, 1998, CANCER LETT, V129, P173, DOI 10.1016/S0304-3835(98)00108-6; Chi HT, 2009, CANCER BIOL THER, V8, P1934; Choudhary C, 2005, BLOOD, V106, P265, DOI 10.1182/blood-2004-07-2942; DORMER P, 1980, LEUKEMIA RES, V4, P231, DOI 10.1016/0145-2126(80)90082-X; Drexler HG, 1996, LEUKEMIA, V10, P588; Falsone SF, 2005, FEBS LETT, V579, P6350, DOI 10.1016/j.febslet.2005.10.020; Furukawa Y, 2007, LEUKEMIA, V21, P1005, DOI 10.1038/sj.leu.2404593; Grundler R, 2005, BLOOD, V105, P4792, DOI 10.1182/blood-2004-11-4430; Guo SQ, 2006, CANCER RES, V66, P5322, DOI 10.1158/0008-5472.CAN-05-4287; IIDA S, 1992, LEUKEMIA RES, V16, P1155, DOI 10.1016/0145-2126(92)90113-L; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; KANO Y, 1988, CANCER RES, V48, P351; Kano Y, 1998, CANCER CHEMOTH PHARM, V42, P91, DOI 10.1007/s002800050790; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Kiyoi H, 1999, BLOOD, V93, P3074; Kottaridis PD, 2001, BLOOD, V98, P1752, DOI 10.1182/blood.V98.6.1752; LANGE B, 1987, BLOOD, V70, P192; Lee YK, 2004, BLOOD, V104, P788, DOI 10.1182/blood-2003-08-2763; Levis M, 2011, BLOOD, V117, P3294, DOI 10.1182/blood-2010-08-301796; Li M, 2007, CANCER EPIDEM BIOMAR, V16, P598, DOI 10.1158/1055-9965.EPI-06-0892; Li YY, 2009, MOL PHARMACEUT, V6, P1152, DOI 10.1021/mp900037p; Liang YC, 1997, J CELL BIOCHEM, V67, P55, DOI 10.1002/(SICI)1097-4644(19971001)67:1<55::AID-JCB6>3.0.CO;2-V; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; MAROC N, 1993, ONCOGENE, V8, P909; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036; Minami Y, 2002, LEUKEMIA, V16, P1535, DOI 10.1038/sj.leu.2402558; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Nakao M, 1996, LEUKEMIA, V10, P1911; Ozeki K, 2004, BLOOD, V103, P1901, DOI 10.1182/blood-2003-06-1845; Pianetti S, 2002, CANCER RES, V62, P652; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Ravandi F, LEUK RES, V34, P752; Reindl C, 2006, BLOOD, V107, P3700, DOI 10.1182/blood-2005-06-2596; Shimizu M, 2008, CANCER LETT, V262, P10, DOI 10.1016/j.canlet.2007.11.026; Spiekermann K, 2002, BLOOD, V100, P3423, DOI 10.1182/blood-2002-03-0953; Stirewalt DL, 2001, BLOOD, V97, P3589, DOI 10.1182/blood.V97.11.3589; Taketani T, 2004, BLOOD, V103, P1085, DOI 10.1182/blood-2003-02-0418; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Tsao AS, 2009, CANCER PREV RES, V2, P931, DOI 10.1158/1940-6207.CAPR-09-0121; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Ustun C, 2009, EXPERT OPIN INV DRUG, V18, P1445, DOI 10.1517/13543780903179278; Welch WJ, 1991, CURR OPIN CELL BIOL, V3, P1033, DOI 10.1016/0955-0674(91)90125-I; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Yin ZY, 2009, BIOCHEMISTRY-US, V48, P336, DOI 10.1021/bi801637q	53	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66378	10.1371/journal.pone.0066378	http://dx.doi.org/10.1371/journal.pone.0066378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840454	Green Submitted, gold, Green Published			2022-12-27	WOS:000322342800054
J	Meo, SA; Al Masri, AA; Usmani, AM; Memon, AN; Zaidi, SZ				Meo, Sultan Ayoub; Al Masri, Abeer A.; Usmani, Adnan Mahmood; Memon, Almas Naeem; Zaidi, Syed Ziauddin			Impact of GDP, Spending on R&D, Number of Universities and Scientific Journals on Research Publications among Asian Countries	PLOS ONE			English	Article							NATIONAL INNOVATIVE CAPACITY; SCIENCE; TECHNOLOGY; TAIWAN; WORLD	Objectives: This study aimed to compare the impact of Gross Domestic Product (GDP) per capita, spending on Research and Development (R&D), number of universities, and Indexed Scientific Journals on total number of research documents (papers), citations per document and Hirsch index (H-index) in various science and social science subjects among Asian countries. Materials and Methods: In this study, 40 Asian countries were included. The information regarding Asian countries, their GDP per capita, spending on R&D, total number of universities and indexed scientific journals were collected. We recorded the bibliometric indicators, including total number of research documents, citations per document and H-index in various science and social sciences subjects during the period 1996-2011. The main sources for information were World Bank, SCI-mago/Scopus and Web of Science; Thomson Reuters. Results: The mean per capita GDP for all the Asian countries is 14448.31 +/- 2854.40 US$, yearly per capita spending on R&D 0.64 +/- 0.16 US$, number of universities 72.37 +/- 18.32 and mean number of ISI indexed journal per country is 17.97 +/- 7.35. The mean of research documents published in various science and social science subjects among all the Asian countries during the period 1996-2011 is 158086.92 +/- 69204.09; citations per document 8.67 +/- 0.48; and H-index 122.8 +/- 19.21. Spending on R&D, number of universities and indexed journals have a positive correlation with number of published documents, citations per document and H-index in various science and social science subjects. However, there was no association between the per capita GDP and research outcomes. Conclusion: The Asian countries who spend more on R&D have a large number of universities and scientific indexed journals produced more in research outcomes including total number of research publication, citations per documents and H-index in various science and social science subjects.	[Meo, Sultan Ayoub; Al Masri, Abeer A.] King Saud Univ, Coll Med, Univ Diabet Ctr, Dept Physiol, Riyadh 11461, Saudi Arabia; [Usmani, Adnan Mahmood] King Saud Univ, Coll Med, Univ Diabet Ctr, Riyadh 11461, Saudi Arabia; [Memon, Almas Naeem] Isra Univ, Dept Radiol, Hyderabad, Pakistan; [Zaidi, Syed Ziauddin] King Fahad Med City, Dept Hematol & Bone Marrow Transplantat, Riyadh, Saudi Arabia	King Saud University; King Saud University; King Fahad Medical City	Meo, SA (corresponding author), King Saud Univ, Coll Med, Univ Diabet Ctr, Dept Physiol, Riyadh 11461, Saudi Arabia.	sultanmeo@hotmail.com	Al-Masri, Abeer/AAL-3389-2020; Usmani, Adnan Mahmood/C-3723-2012; Meo, Sultan Ayoub/D-6719-2015; Usmani, Adnan/D-5777-2014	Usmani, Adnan Mahmood/0000-0002-2366-7583; Meo, Sultan Ayoub/0000-0001-9820-1852; Usmani, Adnan/0000-0002-2366-7583; Al-Masri, Abeer/0000-0002-3981-2132	King Saud University, Riyadh, Saudi Arabia [RGP-VPP 181]	King Saud University, Riyadh, Saudi Arabia(King Saud University)	The authors are thankful to the Deanship of Scientific Research, King Saud University, Riyadh, Saudi Arabia, for supporting the work through the research group project number RGP-VPP 181. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khader AA, 2004, SAUDI MED J, V25, P1323; Anwar MA, 1997, SCIENTOMETRICS, V40, P23, DOI 10.1007/BF02459260; Asgari B., 2007, ASIAN J TECHNOL INNO, V15, P167; Choung JY, 2000, SCIENTOMETRICS, V48, P413, DOI 10.1023/A:1005696606595; Durieux V, 2010, RADIOLOGY, V255, P342, DOI 10.1148/radiol.09090626; Halpenny D, 2010, ACAD RADIOL, V17, P768, DOI 10.1016/j.acra.2010.01.020; Hu MC, 2005, RES POLICY, V34, P1322, DOI 10.1016/j.respol.2005.04.009; Hu MC, 2007, TECHNOL FORECAST SOC, V74, P298, DOI 10.1016/j.techfore.2006.04.001; *ISI WEB KNOWL, J CIT REP; Macilwain C, 2010, NATURE, V465, P682, DOI 10.1038/465682a; Masood E, 2002, NATURE, V416, P120, DOI 10.1038/416120a; Meo SA, 2007, PAK J MED SCI, V23, P946; Preis T., 2012, SCI REP, P1, DOI DOI 10.1038/SREP00752; Van Noorden R, 2012, NATURE, V490, P326, DOI 10.1038/490326a; Wong CY, 2012, SCIENTOMETRICS, V92, P523, DOI 10.1007/s11192-012-0622-z; Zhang L, 2012, ADV MATER RES-SWITZ, V433-440, P1528, DOI 10.4028/www.scientific.net/AMR.433-440.1528	16	78	79	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66449	10.1371/journal.pone.0066449	http://dx.doi.org/10.1371/journal.pone.0066449			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190LY	23840471	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800059
J	Que, XC; Widhopf, GF; Amir, S; Hartvigsen, K; Hansen, LF; Woelkers, D; Tsimikas, S; Binder, CJ; Kipps, TJ; Witztum, JL				Que, Xuchu; Widhopf, George F., II; Amir, Shahzada; Hartvigsen, Karsten; Hansen, Lotte F.; Woelkers, Douglas; Tsimikas, Sotirios; Binder, Christoph J.; Kipps, Thomas J.; Witztum, Joseph L.			IGHV1-69-Encoded Antibodies Expressed in Chronic Lymphocytic Leukemia React with Malondialdehyde-Acetaldehyde Adduct, an Immunodominant Oxidation-Specific Epitope	PLOS ONE			English	Article							B-CELL REPERTOIRE; MONOCLONAL-ANTIBODIES; APOPTOTIC CELLS; OXIDIZED LDL; HEAVY-CHAIN; IMMUNOGLOBULIN HEAVY; POSITIVE SELECTION; GENES; RECEPTORS; NEUTRALIZATION	The immunoglobulins expressed by chronic lymphocytic leukemia (CLL) B cells are highly restricted, suggesting they are selected for binding either self or foreign antigen. Of the immunoglobulin heavy-chain variable (IGHV) genes expressed in CLL, IGHV1-69 is the most common, and often is expressed with little or no somatic mutation, and restricted IGHD and IGHJ gene usage. We found that antibodies encoded by one particular IGHV1-69 subset, designated CLL69C, with the HCDR3 encoded by the IGHD3-3 gene in reading frame 2 and IGHJ6, specifically bound to oxidation-specific epitopes (OSE), which are products of enhanced lipid peroxidation and a major target of innate natural antibodies. Specifically, CLL69C bound immunodominant OSE adducts termed MAA (malondialdehyde-acetaldehyde-adducts), which are found on apoptotic cells, inflammatory tissues, and atherosclerotic lesions. It also reacted specifically with MAA-specific peptide mimotopes. Light chain shuffling indicated that non-stochastically paired L chain of IGLV3-9 contributes to the antigen binding of CLL69C. A nearly identical CLL69C Ig heavy chain was identified from an MAA-enriched umbilical cord phage displayed Fab library, and a derived Fab with the same HCDR3 rearrangement displayed identical MAA-binding properties. These data support the concept that OSE (MAA-epitopes), which are ubiquitous products of inflammation, may play a role in clonal selection and expansion of CLL B cells.	[Que, Xuchu; Widhopf, George F., II; Hartvigsen, Karsten; Hansen, Lotte F.; Tsimikas, Sotirios; Binder, Christoph J.; Kipps, Thomas J.; Witztum, Joseph L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Widhopf, George F., II; Kipps, Thomas J.] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Amir, Shahzada; Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Hartvigsen, Karsten] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Woelkers, Douglas] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; [Binder, Christoph J.] Austrian Acad Sci, Ctr Mol Med CeMM, A-1010 Vienna, Austria	University of California System; University of California San Diego; University of California System; University of California San Diego; Medical University of Vienna; University of Copenhagen; University of California System; University of California San Diego; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Que, XC (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	xque@ucsd.edu; jwitztum@ucsd.edu	Que, Xuchu/H-2741-2019	Binder, Christoph J./0000-0001-8313-7050; Que, Xuchu/0000-0002-6751-5493	National Institutes of Health [RO1 HL086559, HL088093, P01-CA081534, R37-CA049870]; Leducq Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [R37CA049870, P01CA081534] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086559, P01HL088093] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leducq Foundation(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants RO1 HL086559 (XQ, CJB, JLW), HL088093 (XQ, CJB, JLW), P01-CA081534 for the CLL Research Consortium and R37-CA049870 (TJK) and the Leducq Foundation (CJB and JLW). XQ was supported in part by Grant-in-Aid from American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir S, 2012, J LIPID RES; BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Catera R, 2008, MOL MED, V14, P665, DOI 10.2119/2008-00102.Catera; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Chiorazzi N, 2012, CELL RES; Chiorazzi N, 2013, CELL RES, V23, P182, DOI 10.1038/cr.2012.152; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Duhren-von Minden M, 2012, NATURE, V489, P309, DOI 10.1038/nature11309; Duryee MJ, 2010, FREE RADICBIOLMED; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Forconi F, 2010, BLOOD, V115, P71, DOI 10.1182/blood-2009-06-225813; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hill GE, 1998, ATHEROSCLEROSIS, V141, P107, DOI 10.1016/S0021-9150(98)00153-1; Johnson TA, 1997, J IMMUNOL, V158, P235; KIPPS TJ, 1991, J CLIN INVEST, V87, P2087, DOI 10.1172/JCI115239; KIPPS TJ, 1989, P NATL ACAD SCI USA, V86, P5913, DOI 10.1073/pnas.86.15.5913; Kipps TJ, 2010, WILLIAMS HEMATOLOGY, P1431; Luftig MA, 2006, NAT STRUCT MOL BIOL, V13, P740, DOI 10.1038/nsmb1127; MAGEED RA, 1986, RHEUMATOL INT, V6, P179, DOI 10.1007/BF00541285; MARTIN T, 1992, J EXP MED, V175, P983, DOI 10.1084/jem.175.4.983; Mauerer K, 2005, BRIT J HAEMATOL, V129, P499, DOI 10.1111/j.1365-2141.2005.05480.x; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Myhrinder AL, 2008, BLOOD, V111, P3838, DOI 10.1182/blood-2007-11-125450; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Potter KN, 2003, BLOOD, V101, P3082, DOI 10.1182/blood-2002-08-2432; Quinn ER, 2001, BLOOD, V98, P3745, DOI 10.1182/blood.V98.13.3745; Rhee KJ, 2005, J EXP MED, V201, P55, DOI 10.1084/jem.20041849; Rolla R, 2000, HEPATOLOGY, V31, P878, DOI 10.1053/he.2000.5373; SCHROEDER HW, 1994, IMMUNOL TODAY, V15, P288, DOI 10.1016/0167-5699(94)90009-4; Shaw PX, 2001, ARTERIOSCL THROM VAS, V21, P1333, DOI 10.1161/hq0801.093587; Silverman GJ, 2006, NAT REV IMMUNOL, V6, P465, DOI 10.1038/nri1853; Stamatopoulos K, 2007, BLOOD, V109, P259, DOI 10.1182/blood-2006-03-012948; Steininger C, 2012, BLOOD, V119, P2293, DOI 10.1182/blood-2011-08-374058; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tobin G, 2006, HEMATOL ONCOL, V24, P7, DOI 10.1002/hon.760; Tobin G, 2002, BLOOD, V99, P2262, DOI 10.1182/blood.V99.6.2262; Widhopf GF, 2008, BLOOD, V111, P3137, DOI 10.1182/blood-2007-02-073130; Widhopf GF, 2001, J IMMUNOL, V166, P95, DOI 10.4049/jimmunol.166.1.95	43	13	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65203	10.1371/journal.pone.0065203	http://dx.doi.org/10.1371/journal.pone.0065203			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840319	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800008
J	Shang, XW; Li, JY; Tao, QS; Li, J; Li, X; Zhang, LH; Liu, XC; Wang, Q; Shi, XZ; Zhao, YH; Hu, S; Jiang, LX; Yang, Y				Shang, Xianwen; Li, Jiongyi; Tao, Qiushan; Li, Jing; Li, Xi; Zhang, Lihua; Liu, Xiancheng; Wang, Qing; Shi, Xiuzhong; Zhao, Yuhong; Hu, Shuang; Jiang, Lixin; Yang, Ying			Educational Level, Obesity and Incidence of Diabetes among Chinese Adult Men and Women Aged 18-59 Years Old: An 11-Year Follow-Up Study	PLOS ONE			English	Article							RISK-FACTORS; LIFE-STYLE; SOCIOECONOMIC-STATUS; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; TYPE-2; PREVALENCE; PREVENTION; AMERICAN; DISEASE	Objective: To determine whether educational level and overweight/obesity was associated with the development of diabetes among Chinese adult men and women. Methods: A cohort (2000-2011) of 10 704 participants aged 18-59 years (8 238 men, 2 466 women) in Qingdao Port Health Study (QPHS) were recruited in this study. The personal lifestyle, height, weight, waist circumference, resting heart rate, blood pressure, fasting blood glucose, total cholesterol, triglycerides and plasma uric acid were collected annually in a comprehensive health checkup program. Cox proportional hazards regression models were used to estimate the association of factors and incidence of diabetes. Results: During 110 825 person-years of follow-up, 1 056 new onset cases (9.5 per 1 000 person-years) of diabetes were identified. With normal weight as reference, the multiple-adjusted hazard ratio (HR) (95% CI) of diabetes was 1.69(1.38-2.09) for overweight and 2.24(1.66-3.02) for obesity among men, which was 1.81(1.12-2.92) and 2.58(1.37-4.86) among women, respectively. Compared with the participants with high educational level, those with low educational level had a higher risk of diabetes (multiple-adjusted HR (95% CI): 1.43(1.11-1.86)) among men. The association was not found among women and the adjusted HR (95% CI) of diabetes was 1.56(0.89-2.76). The increased risks of low educational level were independent of mediators among men, through normal weight (P for trend = 0.0313) and overweight (P for trend = 0.0212) group but not obesity group (P for trend = 0.0957). Conclusion: Baseline overweight/obesity was an independent risk factor for diabetes for both men and women. Low educational level was adversely associated with incidence of diabetes through normal weight, overweight and obesity groups, with the association being substantially attenuated by mediating factors only in the obesity group among men. The association was not found among women.	[Shang, Xianwen; Li, Jing; Li, Xi; Zhang, Lihua; Wang, Qing; Hu, Shuang; Jiang, Lixin] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, China Oxford Ctr Int Hlth Res,State Key Lab Cardi, Beijing 100730, Peoples R China; [Shang, Xianwen; Li, Jing; Li, Xi; Zhang, Lihua; Wang, Qing; Hu, Shuang; Jiang, Lixin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Li, Jiongyi; Liu, Xiancheng; Shi, Xiuzhong; Zhao, Yuhong; Yang, Ying] Qingdao Fuwai Hosp, Qingdao, Shandong, Peoples R China; [Tao, Qiushan] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking University	Jiang, LX (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Fuwai Hosp, China Oxford Ctr Int Hlth Res,State Key Lab Cardi, Beijing 100730, Peoples R China.	lixin.jiang@fwoxford.org; qdfw@163.com		Shang, Xianwen/0000-0001-6143-9349; Shang, Xianwen/0000-0002-2362-3222; Li, Xi/0000-0003-2249-688X				Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Agardh EE, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-60; Alexander CM, 2003, DIABETES, V52, P1210, DOI 10.2337/diabetes.52.5.1210; Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x; Barker DJP, 1999, ANN INTERN MED, V130, P322, DOI 10.7326/0003-4819-130-4-199902160-00019; Booth SL, 2001, NUTR REV, V59, pS21, DOI 10.1111/j.1753-4887.2001.tb06983.x; Bourdel-Marchasson I, 2000, DIABETIC MED, V17, P675, DOI 10.1046/j.1464-5491.2000.00362.x; Cabrera C, 2005, EUR J EPIDEMIOL, V20, P229, DOI 10.1007/s10654-004-5961-5; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen Chunming, 2004, Biomed Environ Sci, V17 Suppl, P1; de Munter JSL, 2007, PLOS MED, V4, P1385, DOI 10.1371/journal.pmed.0040261; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Hays LM, 1999, DIABETES CARE, V22, P706, DOI 10.2337/diacare.22.5.706; He YN, 2009, DIABETES CARE, V32, P1972, DOI 10.2337/dc09-0714; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; KINSEY JD, 1994, J NUTR, V124, pS1878, DOI 10.1093/jn/124.suppl_9.1878S; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Leyva F, 1998, ARTERIOSCL THROM VAS, V18, P208, DOI 10.1161/01.ATV.18.2.208; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lidfeldt J, 2007, AM J EPIDEMIOL, V165, P882, DOI 10.1093/aje/kwk078; Liu Jing-chao, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P311; Organization WH, 1999, DEF DIAGN CLASS DI 1; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Robbins JM, 2001, AM J PUBLIC HEALTH, V91, P76, DOI 10.2105/AJPH.91.1.76; Sacerdote C, 2012, INT J EPIDEMIOL, V41, P1162, DOI 10.1093/ije/dys091; Sheet NDF, 2005, GEN INF NAT EST DIAB; Stevens J, 2008, AM J EPIDEMIOL, V167, P1365, DOI 10.1093/aje/kwn060; Stringhini S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5452; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wan Q, 2010, DIABETIC MED, V27, P1312, DOI 10.1111/j.1464-5491.2010.03107.x; Wang CS, 2007, AM J EPIDEMIOL, V166, P196, DOI 10.1093/aje/kwm061; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	34	33	36	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66479	10.1371/journal.pone.0066479	http://dx.doi.org/10.1371/journal.pone.0066479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840484	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800067
J	Teixeira, LCRS; Yeargeau, E; Balieiro, FC; Piccolo, MC; Peixoto, RS; Greer, CW; Rosado, AS				Teixeira, Lia C. R. S.; Yeargeau, Etienne; Balieiro, Fabiano C.; Piccolo, Marisa C.; Peixoto, Raquel S.; Greer, Charles W.; Rosado, Alexandre S.			Plant and Bird Presence Strongly Influences the Microbial Communities in Soils of Admiralty Bay, Maritime Antarctica	PLOS ONE			English	Article							ROSS SEA REGION; BACTERIAL DIVERSITY; RHIZOSPHERE SOIL; VASCULAR PLANTS; GRASSLAND SOILS; PENGUIN; ISLAND; MICROARRAY; POPULATION; RESPONSES	Understanding the environmental factors that shape microbial communities is crucial, especially in extreme environments, like Antarctica. Two main forces were reported to influence Antarctic soil microbes: birds and plants. Both birds and plants are currently undergoing relatively large changes in their distribution and abundance due to global warming. However, we need to clearly understand the relationship between plants, birds and soil microorganisms. We therefore collected rhizosphere and bulk soils from six different sampling sites subjected to different levels of bird influence and colonized by Colobanthus quitensis and Deschampsia antarctica in Admiralty Bay, King George Island, Maritime Antarctic. Microarray and qPCR assays targeting 16S rRNA genes of specific taxa were used to assess microbial community structure, composition and abundance and analyzed with a range of soil physico-chemical parameters. The results indicated significant rhizosphere effects in four out of the six sites, including areas with different levels of bird influence. Acidobacteria were significantly more abundant in soils with little bird influence (low nitrogen) and in bulk soil. In contrast, Actinobacteria were significantly more abundant in the rhizosphere of both plant species. At two of the sampling sites under strong bird influence (penguin colonies), Firmicutes were significantly more abundant in D. antarctica rhizosphere but not in C. quitensis rhizosphere. The Firmicutes were also positively and significantly correlated to the nitrogen concentrations in the soil. We conclude that the microbial communities in Antarctic soils are driven both by bird and plants, and that the effect is taxa-specific.	[Teixeira, Lia C. R. S.; Peixoto, Raquel S.; Rosado, Alexandre S.] Univ Fed Rio de Janeiro, Lab Ecol Microbiana Mol, Inst Microbiol Paulo Goes, Rio De Janeiro, RJ, Brazil; [Yeargeau, Etienne; Greer, Charles W.] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada; [Balieiro, Fabiano C.] Empresa Brasileira Pesquisa Agropecuaria EMBRAPA, Rio De Janeiro, RJ, Brazil; [Piccolo, Marisa C.] Univ Sao Paulo, Lab Ciclagem Nutr, Ctr Energia Nucl Agr, BR-05508 Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; National Research Council Canada; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo	Rosado, AS (corresponding author), Univ Fed Rio de Janeiro, Lab Ecol Microbiana Mol, Inst Microbiol Paulo Goes, Rio De Janeiro, RJ, Brazil.	asrosado@micro.ufrj.br	piccolo, marisa de Cássia/D-6149-2012; Balieiro, Fabiano/AAQ-5915-2020; Yergeau, Etienne/AAZ-6145-2020; Yergeau, Etienne/B-5344-2008; Balieiro, Fabiano C/J-4390-2017; Teixeira, Lia/AFV-0851-2022; Peixoto, Raquel/V-2554-2019; Rosado, Alexandre Soares/G-1955-2012	piccolo, marisa de Cássia/0000-0003-2163-5630; Yergeau, Etienne/0000-0002-7112-3425; Balieiro, Fabiano C/0000-0002-0229-6672; Teixeira, Lia/0000-0002-2874-1973; Rosado, Alexandre Soares/0000-0001-5135-1394; Peixoto, Raquel/0000-0002-9536-3132	Brazilian Antarctic Program, PROANTAR, as part of the IPY Activity [403, 520194/2006-3]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de \Nivel Superior) [5445-09-4]; Conselho Nacional Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); CAPES	Brazilian Antarctic Program, PROANTAR, as part of the IPY Activity; CAPES (Coordenacao de Aperfeicoamento de Pessoal de \Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study received financial and logistic support from the Brazilian Antarctic Program, PROANTAR, as part of the IPY Activity # 403 "MIDIAPI Microbial Diversity of Terrestrial and Maritime ecosystems in the Antarctic Peninsula" (520194/2006-3). L.C.R.S. Teixeira was supported by a doctoral fellowship from CAPES (Coordenacao de Aperfeicoamento de Pessoal de vertical bar Nivel Superior) (5445-09-4). Professors A.S.R. and R.S.P. are also supported by Conselho Nacional Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS NJ, 1989, COLON WATERBIRD, V12, P30, DOI 10.2307/1521309; Aislabie J, 2009, CAN J MICROBIOL, V55, P21, DOI 10.1139/W08-126; Aislabie JM, 2008, GEODERMA, V144, P9, DOI 10.1016/j.geoderma.2007.10.006; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1997, MANUAL METODOS ANALI; Avery LM, 2003, POLAR BIOL, V26, P525, DOI 10.1007/s00300-003-0515-y; Beller HR, 2002, ENVIRON SCI TECHNOL, V36, P3977, DOI 10.1021/es025556w; Convey P, 2006, PLANT ECOL, V182, P1, DOI 10.1007/s11258-005-9022-2; de Ridder-Duine AS, 2005, SOIL BIOL BIOCHEM, V37, P349, DOI 10.1016/j.soilbio.2004.08.005; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Forcada J, 2006, GLOBAL CHANGE BIOL, V12, P411, DOI 10.1111/j.1365-2486.2006.01108.x; FOWBERT JA, 1994, ARCTIC ALPINE RES, V26, P290, DOI 10.2307/1551941; Ganzert L, 2011, FEMS MICROBIOLOGY EC; Ganzert L, 2011, FEMS MICROBIOL ECOL, V76, P476, DOI 10.1111/j.1574-6941.2011.01068.x; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kielak A, 2009, ISME J, V3, P378, DOI 10.1038/ismej.2008.113; Kielak A, 2008, FEMS MICROBIOL ECOL, V63, P372, DOI 10.1111/j.1574-6941.2007.00428.x; Kowalchuk GA, 2002, ANTON LEEUW INT J G, V81, P509, DOI 10.1023/A:1020565523615; Kuske CR, 2002, APPL ENVIRON MICROB, V68, P1854, DOI 10.1128/AEM.68.4.1854-1863.2002; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lin XJ, 2006, APPL ENVIRON MICROB, V72, P2679, DOI 10.1128/AEM.72.4.2679-2690.2006; Michel RFM, 2006, SOIL SCI SOC AM J, V70, P1370, DOI 10.2136/sssaj2005.0178; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Marschner P, 2004, PLANT SOIL, V261, P199, DOI 10.1023/B:PLSO.0000035569.80747.c5; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; Nunan N, 2005, APPL ENVIRON MICROB, V71, P6784, DOI 10.1128/AEM.71.11.6784-6792.2005; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Simas FNB, 2008, GEODERMA, V144, P116, DOI 10.1016/j.geoderma.2007.10.019; Simas FNB, 2007, GEODERMA, V138, P191, DOI 10.1016/j.geoderma.2006.11.011; Singh BK, 2007, APPL SOIL ECOL, V36, P147, DOI 10.1016/j.apsoil.2007.01.004; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Sokal RR., 1995, INTRO BIOSTATISTICS; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Teixeira LCRS, 2010, ISME J, V4, P989, DOI 10.1038/ismej.2010.35; TRIVELPIECE WZ, 1987, ECOLOGY, V68, P351, DOI 10.2307/1939266; WHITE MG, 1975, IBIS, V117, P371, DOI 10.1111/j.1474-919X.1975.tb04224.x; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027; Yergeau E, 2009, ISME J, V3, P340, DOI 10.1038/ismej.2008.111; Yergeau E, 2008, ENVIRON MICROBIOL, V10, P2223, DOI 10.1111/j.1462-2920.2008.01644.x; Yergeau E, 2007, ENVIRON MICROBIOL, V9, P2670, DOI 10.1111/j.1462-2920.2007.01379.x; Yergeau E, 2007, FEMS MICROBIOL ECOL, V59, P436, DOI 10.1111/j.1574-6941.2006.00200.x; Yergeau E, 2007, ISME J, V1, P163, DOI 10.1038/ismej.2007.24; Yergeau E, 2009, APPL ENVIRON MICROB, V75, P6258, DOI 10.1128/AEM.01029-09; Zdanowski MK, 2004, FEMS MICROBIOL ECOL, V50, P163, DOI 10.1016/j.femsec.2004.06.012; Zhu RB, 2009, ANTARCT SCI, V21, P427, DOI 10.1017/S0954102009990204	49	20	21	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66109	10.1371/journal.pone.0066109	http://dx.doi.org/10.1371/journal.pone.0066109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840411	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800033
J	Zennaro, C; Rastaldi, MP; Pascolo, L; Stebel, M; Trevisan, E; Artero, M; Tiribelli, C; Di Maso, V; Carraro, M				Zennaro, Cristina; Rastaldi, Maria Pia; Pascolo, Lorella; Stebel, Marco; Trevisan, Elisa; Artero, Mary; Tiribelli, Claudio; Di Maso, Vittorio; Carraro, Michele			Podocyte Expression of Membrane Transporters Involved in Puromycin Aminonucleoside-Mediated Injury	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; P-GLYCOPROTEIN; PERMEABILITY FACTORS; IN-VITRO; RAT; IDENTIFICATION; POLYPEPTIDE; NEPHROTOXICITY; FAMILY; KIDNEY	Several complex mechanisms contribute to the maintenance of the intricate ramified morphology of glomerular podocytes and to interactions with neighboring cells and the underlying basement membrane. Recently, components of small molecule transporter families have been found in the podocyte membrane, but expression and function of membrane transporters in podocytes is largely unexplored. To investigate this complex field of investigation, we used two molecules which are known substrates of membrane transporters, namely Penicillin G and Puromycin Aminonucleoside (PA). We observed that Penicillin G pre-administration prevented both in vitro and in vivo podocyte damage caused by PA, suggesting the engagement of the same membrane transporters by the two molecules. Indeed, we found that podocytes express a series of transporters which are known to be used by Penicillin G, such as members of the Organic Anion Transporter Polypeptides (OATP/Oatp) family of influx transporters, and P-glycoprotein, a member of the MultiDrug Resistance (MDR) efflux transporter family. Expression of OATP/Oatp transporters was modified by PA treatment. Similarly, in vitro PA treatment increased mRNA and protein expression of P-glycoprotein, as well as its activity, confirming the engagement of the molecule upon PA administration. In summary, we have characterized some of the small molecule transporters present at the podocyte membrane, focusing on those used by PA to enter and exit the cell. Further investigation will be needed to understand precisely the role of these transporter families in maintaining podocyte homeostasis and in the pathogenesis of podocyte injury.	[Zennaro, Cristina; Tiribelli, Claudio; Di Maso, Vittorio; Carraro, Michele] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Rastaldi, Maria Pia] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Renal Res Lab, Milan, Italy; [Rastaldi, Maria Pia] Fdn DAmico Ric Malattie Renali, Milan, Italy; [Stebel, Marco; Trevisan, Elisa] Univ Trieste, Dept Life Sci, Trieste, Italy; [Artero, Mary] Azienda Osped Univ Osped Riuniti Trieste, Trieste, Italy; [Tiribelli, Claudio] AREA Sci Pk, Liver Res Ctr, Trieste, Italy; [Pascolo, Lorella] IRCCS Burlo Garofolo Ist Cura Carattere Sci Mater, Trieste, Italy	University of Trieste; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Trieste; IRCCS Burlo Garofolo	Carraro, M (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.	m.carraro@fmc.units.it	Pascolo, Lorella/AAB-5207-2020; Tiribelli, Claudio/A-4716-2014	Pascolo, Lorella/0000-0003-1044-7263; CARRARO, MICHELE/0000-0002-8940-3361; Tiribelli, Claudio/0000-0001-6596-7595; ZENNARO, Cristina/0000-0003-4755-1064	Fondazione la Nuova Speranza onlus Lotta alla Glomeruslerosi Focale, Rho (Milano), Italy; Fondazione Benefica Kathleen Foreman Casali, Trieste, Italy; Renal Child Foundation, G. Gaslini Children Hospital, Genova, Italy	Fondazione la Nuova Speranza onlus Lotta alla Glomeruslerosi Focale, Rho (Milano), Italy; Fondazione Benefica Kathleen Foreman Casali, Trieste, Italy; Renal Child Foundation, G. Gaslini Children Hospital, Genova, Italy	This work was supported by grants from "Fondazione la Nuova Speranza onlus Lotta alla Glomeruslerosi Focale, Rho (Milano), Italy", "Fondazione Benefica Kathleen Foreman Casali, Trieste, Italy" and by "Renal Child Foundation, G. Gaslini Children Hospital, Genova, Italy". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLOREUSS E, 1994, AM J PHYSIOL-CELL PH, V267, pC1351, DOI 10.1152/ajpcell.1994.267.5.C1351; Candido R, 2005, AM J HYPERTENS, V18, P844, DOI 10.1016/j.amjhyper.2004.12.021; Carraro M, 2004, NEPHROL DIAL TRANSPL, V19, P1969, DOI 10.1093/ndt/gfh343; Carraro M, 2001, DIABETOLOGIA, V12, P143; Chen L, 2009, NEUROCHEM RES, V34, P411, DOI 10.1007/s11064-008-9797-3; del Moral RG, 1998, EXP NEPHROL, V6, P89; DIAMOND JR, 1986, AM J PATHOL, V122, P481; Doublier S, 2005, INT J MOL MED, V16, P49; Engel K, 2004, J BIOL CHEM, V279, P50042, DOI 10.1074/jbc.M407913200; Gloy J, 2000, AM J PHYSIOL-RENAL, V278, pF999, DOI 10.1152/ajprenal.2000.278.6.F999; Hsiang BN, 1999, J BIOL CHEM, V274, P37161, DOI 10.1074/jbc.274.52.37161; Ito A, 2003, INVEST OPHTH VIS SCI, V44, P4877, DOI 10.1167/iovs.02-1108; Jung SM, 2006, EXP MOL MED, V38, P485, DOI 10.1038/emm.2006.57; Kim RB, 2003, EUR J CLIN INVEST, V33, P1, DOI 10.1046/j.1365-2362.33.s2.5.x; Kullak-Ublick GA, 2001, GASTROENTEROLOGY, V120, P525, DOI 10.1053/gast.2001.21176; Lee WK, 2007, EXP MOL MED, V39, P787, DOI 10.1038/emm.2007.85; McCarthy ET, 2010, CLIN J AM SOC NEPHRO, V5, P2115, DOI 10.2215/CJN.03800609; Mikkaichi T, 2004, P NATL ACAD SCI USA, V101, P3569, DOI 10.1073/pnas.0304987101; Roch R, 2003, RENAL HANDLING DRUGS, P21; SAVIN VJ, 1992, J AM SOC NEPHROL, V3, P1260; Tamai I, 2000, BIOCHEM BIOPH RES CO, V273, P251, DOI 10.1006/bbrc.2000.2922; Tramonti G, 2006, AM J PHYSIOL-RENAL, V291, pF972, DOI 10.1152/ajprenal.00110.2006; VanWert AL, 2007, AM J PHYSIOL-RENAL, V293, pF1332, DOI 10.1152/ajprenal.00319.2007; Xia L, 2009, AM J PHYSIOL-RENAL, V296, pF1307, DOI 10.1152/ajprenal.00046.2009; Zheng CX, 2008, KIDNEY INT, V74, P596, DOI 10.1038/ki.2008.203	25	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66159	10.1371/journal.pone.0066159	http://dx.doi.org/10.1371/journal.pone.0066159			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840417	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800038
J	Edmondson, D; Richardson, S; Fausett, JK; Falzon, L; Howard, VJ; Kronish, IM				Edmondson, Donald; Richardson, Safiya; Fausett, Jennifer K.; Falzon, Louise; Howard, Virginia J.; Kronish, Ian M.			Prevalence of PTSD in Survivors of Stroke and Transient Ischemic Attack: A Meta-Analytic Review	PLOS ONE			English	Review							POSTTRAUMATIC-STRESS-DISORDER; HEART-DISEASE; SYMPTOMS; RECURRENCE; MORTALITY; SCALE; RISK	Background and Purpose: Posttraumatic stress disorder (PTSD) is common in survivors of acute life-threatening illness, but little is known about the burden of PTSD in survivors of stroke and transient ischemic attack (TIA). This study estimated the prevalence of stroke or TIA-induced posttraumatic stress disorder (PTSD) using systematic review and meta-analysis. Methods: Potentially relevant peer-reviewed journal articles were identified by searching the Ovid MEDLINE, PsycINFO, PILOTS Database, The Cochrane Library and Scopus from inception to January 2013; all searches were conducted on January 31, 2013. Observational cohort studies that assessed PTSD with specific reference to a stroke or TIA that occurred at least 1 month prior to the PTSD assessment were included. PTSD rates and characteristics of the study and sample were abstracted from all included studies. The coding of all articles included demographics, sample size, study country, and method and timing of PTSD assessment. Results: Nine studies (N = 1,138) met our inclusion criteria. PTSD rates varied significantly across studies by timing of PTSD assessment (i.e., within 1 year of stroke/TIA versus greater than 1 year post-stroke/TIA; 55% of heterogeneity explained; Q(1) = 10.30; P = .001). Using a random effects model, the estimated rate of PTSD following stroke or TIA was 23% (95% CI, 16%-33%) within 1 year of the stroke or TIA and 11% (95% CI, 8%-14%) after 1 year. Conclusions: Although PTSD is commonly thought to be triggered by external events such as combat or sexual assault, these results suggest that 1 in 4 stroke or TIA survivors develop significant PTSD symptoms due to the stroke or TIA. Screening for PTSD in a large population-based prospective cohort study with cardiovascular outcome assessments is needed to yield definitive prevalence, and determine whether stroke or TIA-induced PTSD is a risk factor for subsequent cardiovascular events or mortality.	[Edmondson, Donald; Falzon, Louise; Kronish, Ian M.] Columbia Univ, Ctr Behav Cardiovasc Hlth, Med Ctr, New York, NY 10027 USA; [Richardson, Safiya] Columbia Univ, Coll Phys & Surg, Med Ctr, New York, NY USA; [Fausett, Jennifer K.] Univ Arkansas Med Sci, Dept Psychiat, Little Rock, AR 72205 USA; [Howard, Virginia J.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA	Columbia University; Columbia University; University of Arkansas System; University of Arkansas Medical Sciences; University of Alabama System; University of Alabama Birmingham	Edmondson, D (corresponding author), Columbia Univ, Ctr Behav Cardiovasc Hlth, Med Ctr, New York, NY 10027 USA.	dee2109@columbia.edu	Falzon, Louise/AAG-2404-2019; Falzon, Louise/HCI-2175-2022; Edmondson, Donald/G-7486-2016	Falzon, Louise/0000-0002-9449-6056; Edmondson, Donald/0000-0002-4518-8196	National Heart, Lung, and Blood Institute, Bethesda, MD [HL-088117, HL-47540, HL098359]; Columbia University's CTSA grant from the National Center for Advancing Translational Sciences/National Center for Research Resources, National Institutes of Health, Bethesda, MD [UL1 RR024156]; National Cancer Institute, Bethesda, MD [CA156709]; National Institute of Neurological Disorders and Stroke, Bethesda, MD [NS038384]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL098359] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Columbia University's CTSA grant from the National Center for Advancing Translational Sciences/National Center for Research Resources, National Institutes of Health, Bethesda, MD; National Cancer Institute, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants HL-088117 and HL-47540 from the National Heart, Lung, and Blood Institute, Bethesda, MD, and supported in part by Columbia University's CTSA grant UL1 RR024156 from the National Center for Advancing Translational Sciences/National Center for Research Resources, National Institutes of Health, Bethesda, MD. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Dr. Edmondson is supported by grant CA156709 from the National Cancer Institute, Bethesda, MD. Dr. Howard is supported by grant NS038384 from the National Institute of Neurological Disorders and Stroke, Bethesda, MD. Dr. Kronish is supported by grant HL098359 from the National Heart, Lung, and Blood Institute, Bethesda, MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay H, 2010, NEUROLOGY, V74, P128, DOI 10.1212/WNL.0b013e3181ca9cff; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; Bruggimann L, 2006, NEUROLOGY, V66, P513, DOI 10.1212/01.wnl.0000194210.98757.49; Edmondson D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038915; Edmondson D, 2011, J PSYCHIATR RES, V45, P1621, DOI 10.1016/j.jpsychires.2011.07.004; Field EL, 2008, BEHAV RES THER, V46, P62, DOI 10.1016/j.brat.2007.10.006; First M. B., 2007, STRUCTURED CLIN INTE; Foa E., 1996, POSTTRAUMATIC STRESS; Fonarow GC, 2012, J AM HEART ASSOC, V1, P42, DOI 10.1161/JAHA.111.000034; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Johnston SC, 2002, NEW ENGL J MED, V347, P1687, DOI 10.1056/NEJMcp020891; Jorgensen HS, 1997, NEUROLOGY, V48, P891; Kronish IM, 2012, STROKE, V43, P2192, DOI 10.1161/STROKEAHA.112.655209; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P109, DOI 10.1001/archpsyc.64.1.109; Letamendia Clara, 2012, Gen Hosp Psychiatry, V34, pe11, DOI 10.1016/j.genhosppsych.2012.03.011; Merriman Charlotte, 2007, Psychol Health Med, V12, P592, DOI 10.1080/13548500601162747; Noble AJ, 2008, NEUROSURGERY, V63, P1095, DOI 10.1227/01.NEU.0000327580.91345.78; Sagen U, 2009, J PSYCHOSOM RES, V67, P325, DOI 10.1016/j.jpsychores.2009.03.007; Sembi S, 1998, INT J GERIATR PSYCH, V13, P315, DOI 10.1002/(SICI)1099-1166(199805)13:5<315::AID-GPS766>3.3.CO;2-G; Shamliyan T.A., 2011, DEV QUALITY CRITERIA; Wang X, 2011, PSYCHIAT RES, V188, P51, DOI 10.1016/j.psychres.2010.10.002	24	83	85	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66435	10.1371/journal.pone.0066435	http://dx.doi.org/10.1371/journal.pone.0066435			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190ST	23840467	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200077
J	Hasegawa, Y; Tachibana, Y; Sakagami, J; Zhang, M; Urade, M; Ono, T				Hasegawa, Yoko; Tachibana, Yoshihisa; Sakagami, Joe; Zhang, Min; Urade, Masahiro; Ono, Takahiro			Flavor-Enhanced Modulation of Cerebral Blood Flow during Gum Chewing	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; NEAR-INFRARED SPECTROSCOPY; ORBITOFRONTAL CORTEX; BRAIN ACTIVATION; TASTE; STIMULATION; HUMANS; MONKEY; AREAS; PET	Background: Flavor perception, the integration of taste and odor, is a critical factor in eating behavior. It remains unclear how such sensory signals influence the human brain systems that execute the eating behavior. Methods: We tested cerebral blood flow (CBF) in the frontal lobes bilaterally while subjects chewed three types of gum with different combinations of taste and odor: no taste/no odor gum (C-gum), sweet taste/no odor gum (T-gum), and sweet taste/lemon odor gum (TO-gum). Simultaneous recordings of transcranial Doppler ultrasound (TCD) and near infrared spectrometer (NIRS) were used to measure CBF during gum chewing in 25 healthy volunteers. Bilateral masseter muscle activity was also monitored. Results: We found that subjects could discriminate the type of gum without prior information. Subjects rated the TO-gum as the most flavorful gum and the C-gum as the least flavorful. Analysis of masseter muscle activity indicated that masticatory motor output during gum chewing was not affected by taste and odor. The TCD/NIRS measurements revealed significantly higher hemodynamic signals when subjects chewed the TO-gum compared to when they chewed the C-gum and T-gum. Conclusions: These data suggest that taste and odor can influence brain activation during chewing in sensory, cognitive, and motivational processes rather than in motor control.	[Hasegawa, Yoko; Urade, Masahiro] Hyogo Coll Med, Dept Dent & Oral Surg, Nishinomiya, Hyogo 6638501, Japan; [Hasegawa, Yoko; Sakagami, Joe; Ono, Takahiro] Osaka Univ, Div Oromaxillofacial Regenerat, Course Integrated Oral Sci, Grad Sch Dent, Suita, Osaka, Japan; [Tachibana, Yoshihisa] Natl Inst Physiol Sci, Div Syst Neurophysiol, Okazaki, Aichi 444, Japan; [Zhang, Min] Fourth Mil Med Univ, Dept Gen Dent & Emergency, Sch Stomatol, Xian 710032, Peoples R China	Hyogo College of Medicine; Osaka University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Air Force Military Medical University	Hasegawa, Y (corresponding author), Hyogo Coll Med, Dept Dent & Oral Surg, Nishinomiya, Hyogo 6638501, Japan.	cem17150@hyo-med.ac.jp; ono@dent.osaka-u.ac.jp	Morosolli, Aline/P-1984-2014	Hasegawa, Yoko/0000-0001-9112-5981	KAKENHI from the Ministry of Education, Science and Culture of Japan [21791887, 23792263]; Global COE Program in "In Silico Medicine'' of Osaka University	KAKENHI from the Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global COE Program in "In Silico Medicine'' of Osaka University	This study was supported by KAKENHI from the Ministry of Education, Science and Culture of Japan (grant numbers 21791887 and 23792263) and the Global COE Program in "In Silico Medicine'' of Osaka University. The authors declare no conflict of interest with any financial organization regarding the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Aaslid R., 1992, TRANSCRANIAL DOPPLER; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cerf-Ducastel B, 2003, BRAIN RES, V986, P39, DOI 10.1016/S0006-8993(03)03168-8; Cruz A, 2000, NATURE, V403, P889, DOI 10.1038/35002581; FOX PT, 1986, NATURE, V323, P806, DOI 10.1038/323806a0; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Gilbertson TA, 2000, CURR OPIN NEUROBIOL, V10, P519, DOI 10.1016/S0959-4388(00)00118-5; Hasegawa Y, 2007, J DENT RES, V86, P64, DOI 10.1177/154405910708600110; Hasegawa Y, 2009, CLIN ORAL INVEST; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; Kelly RM, 2003, J NEUROSCI, V23, P8432; Kobayashi M, 2002, EUR J NEUROSCI, V16, P975, DOI 10.1046/j.1460-9568.2002.02151.x; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Momose T, 1997, ARCH ORAL BIOL, V42, P57, DOI 10.1016/S0003-9969(96)00081-7; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Ono T, 2007, J NEUROL, V254, P1427, DOI 10.1007/s00415-007-0570-3; Onozuka M, 2002, J DENT RES, V81, P743, DOI 10.1177/154405910208101104; Onozuka M, 2003, J DENT RES, V82, P657, DOI 10.1177/154405910308200817; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Salmon G, 1973, ATLAS ARTERIES HUMAN; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Takada T, 2004, NEUROSCI LETT, V360, P137, DOI 10.1016/j.neulet.2004.02.052; Villringer K, 1997, ADV EXP MED BIOL, V413, P149; WYATT JS, 1990, J APPL PHYSIOL, V68, P1086; Yamamoto T, 2006, ARCH HISTOL CYTOL, V69, P243, DOI 10.1679/aohc.69.243	29	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66313	10.1371/journal.pone.0066313	http://dx.doi.org/10.1371/journal.pone.0066313			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840440	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200068
J	Valadez, JJ; Berendes, S; Jeffery, C; Thomson, J; Ben Othman, H; Danon, L; Turki, AA; Saffialden, R; Mirzoyan, L				Valadez, Joseph J.; Berendes, Sima; Jeffery, Caroline; Thomson, Joanna; Ben Othman, Hussain; Danon, Leon; Turki, Abdullah A.; Saffialden, Rabea; Mirzoyan, Lusine			Filling the Knowledge Gap: Measuring HIV Prevalence and Risk Factors among Men Who Have Sex with Men and Female Sex Workers in Tripoli, Libya	PLOS ONE			English	Article							INJECTION-DRUG USERS; INFECTION; POPULATIONS; PREVENTION; COUNTRIES; EPIDEMIC	Background: Publications on Libya's HIV epidemic mostly examined the victims of the tragic nosocomial HIV outbreak in the 1990s and the related dispute about the detention of foreign medical workers. The dispute resolution in 2003 included an agreement with the European Union on humanitarian cooperation and the development of Libya's first National HIV Strategy. As part of this we conducted Libya's first bio-behavioural survey among men having sex with men (MSM) and female sex workers (FSW). Methods: Using respondent-driven sampling, we conducted a cross-sectional study to estimate the prevalence of HIV, hepatitis B virus (HBV), hepatitis C virus (HCV), and related risk factors among 227 MSM and 69 FSW in Tripoli (FSW recruitment ended prematurely due to the political events in 2011). Results: For MSM we estimated an HIV prevalence of 3.1%, HBV prevalence of 2.9%, and HCV prevalence of 7.3%, and for FSW an HIV prevalence of 15.7%, HBV prevalence of 0%, and HCV prevalence of 5.2%. We detected high levels of risk behaviours, poor HIV-related knowledge, high stigma and lack of prevention programmes. These results must be interpreted in the context of the political situation which prohibited reaching an ideal sample size for FSW. Conclusion: There is urgent need to implement an effective National HIV Strategy informed by the results of this research. The risk of transmission within different risk groups and to the general population may be high given the recent military events that led to increased violence, migration, and the disruption of essential HIV-related services.	[Valadez, Joseph J.; Berendes, Sima; Jeffery, Caroline; Turki, Abdullah A.; Saffialden, Rabea; Mirzoyan, Lusine] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Thomson, Joanna; Danon, Leon] Univ Warwick, Inst Math, Coventry CV4 7AL, W Midlands, England; [Ben Othman, Hussain] Natl AIDS Programme, Natl Ctr Dis Control, Tripoli, Libya	Liverpool School of Tropical Medicine; University of Liverpool; University of Warwick	Berendes, S (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	berendes@liverpool.ac.uk	Berendes, Sima/AAH-9616-2019; Danon, Leon/AFV-8758-2022; Jeffery, Caroline/H-9975-2012	Berendes, Sima/0000-0001-7000-868X; Danon, Leon/0000-0002-7076-1871; Jeffery, Caroline/0000-0002-8023-0708; Valadez, Joseph/0000-0002-6575-6592	European Commission; Engineering and Physical Sciences Research Council [987448] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was funded by the European Commission under the terms of the project "Supporting the development and implementation of a National HIV-AIDS Strategy in Libya". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrahim MS, 2010, AIDS, V24, pS55, DOI 10.1097/01.aids.0000386734.79553.9a; Abu-Raddad LJ, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000386729.56683.33; AbuRaddad LJ, 2010, CHARACTERIZING THE HIV/AIDS EPIDEMIC IN THE MIDDLE EAST AND NORTH AFRICA: TIME FOR STRATEGIC ACTION, P1, DOI 10.1596/978-0-8213-8137-3; [Anonymous], 2007, NATURE, V448, P511, DOI 10.1038/448511a; Baral S, 2012, LANCET INFECT DIS; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Beyrer C, 2010, CLIN INFECT DIS, V50, pS108, DOI 10.1086/651481; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; El Karouaoui A, 2009, PROJECT SUPPORT DEV; FHI/Impact Behavioural Surveillance Surveys (BSS), 2000, GUID REP BEH SURV PO; Friedman SR, 2007, AIDS BEHAV, V11, P641, DOI 10.1007/s10461-006-9166-7; Frost SDW, 2006, J URBAN HEALTH, V83, pI83, DOI 10.1007/s11524-006-9104-z; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Johnston LG, 2007, CONDUCTING RESPONDEN; Kamal SM, 2010, MEDITERR J HEMATOL I, V2, DOI 10.4084/MJHID.2010.001; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Ministere de la Sante de l'Algerie, 2012, RAPP ACT RIP NAT SID; Ministere de la Sante de la Population et de la Reforme Hospitaliere Ddlp, RAPP NAT ALG SUIV JA; Mirzoyan L, 2013, JAIDS-J ACQ IMM DEF, V62, P577, DOI 10.1097/QAI.0b013e318284714a; Mumtaz G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000444; National AIDS Program E, 2012, GLOB AIDS RESP PROGR; National AIDS Program Libyan Arab Jamahiriya, 2012, UNGASS COUNTR PROGR; Pakistan National AIDS Control Program, 2011, HIV 2 GEN SURV PAK N; Rachlis B, 2007, DRUG ALCOHOL DEPEN, V90, P107, DOI 10.1016/j.drugalcdep.2007.03.014; Republique Tunisienne Ministere de la Sante Publique (, 2012, 2010 2011 RAPP ACT R; Roberts RJ, 2006, NATURE, V444, P146, DOI 10.1038/444146a; Royaume du Maroc, 2012, MIS OEUVR DECL POL V; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Simic M, 2006, J URBAN HEALTH, V83, pI6, DOI 10.1007/s11524-006-9098-6; Strathdee Steffanie A, 2010, Curr HIV/AIDS Rep, V7, P99, DOI 10.1007/s11904-010-0043-7; UNAIDS, 2009, UNAIDS GUID NOT HIV; UNAIDS, 2009, NAIDS ACT FRAM UN AC; *UNAIDS, 2011, MIDDL E N AFR REG RE; UNAIDS, 2010, 09 UN GEN ASS SPEC S; *UNAIDS WHO, GUID 2 GEN HIV SURV; UNAIDS/WHO Working Group on Global HIV/AIDS and STD Surveillance Joint United Nations Programme on HIV/AIDS United Nations Children's Fund World Health Organization, 2008, EP FACT SHEET HIV AI; Uuskula A, 2010, J URBAN HEALTH, V87, P304, DOI 10.1007/s11524-009-9427-7; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Volz E, 2008, J OFF STAT, V24, P79; WHO EMRO, 2008, INCL HIV RAP TESTS H; Yerly S, 2001, J INFECT DIS, V184, P369, DOI 10.1086/322036	43	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66701	10.1371/journal.pone.0066701	http://dx.doi.org/10.1371/journal.pone.0066701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190ST	23840521	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000322361200102
J	Wright, S; Boyd, MA; Yunihastuti, E; Law, M; Sirisanthana, T; Hoy, J; Pujari, S; Lee, MP; Petoumenos, K				Wright, Stephen; Boyd, Mark A.; Yunihastuti, Evy; Law, Matthew; Sirisanthana, Thira; Hoy, Jennifer; Pujari, Sanjay; Lee, Man Po; Petoumenos, Kathy		Int Epidemiologic Databases	Rates and Factors Associated with Major Modifications to First-Line Combination Antiretroviral Therapy: Results from the Asia-Pacific Region	PLOS ONE			English	Article							HIV OBSERVATIONAL DATABASE; RESOURCE-LIMITED SETTINGS; VIROLOGICAL FAILURE; GENERAL-POPULATION; VIRAL LOAD; BASE-LINE; MORTALITY; AIDS; PREDICTORS; INFECTION	Background: In the Asia-Pacific region many countries have adopted the WHO's public health approach to HIV care and treatment. We performed exploratory analyses of the factors associated with first major modification to first-line combination antiretroviral therapy (ART) in resource-rich and resource-limited countries in the region. Methods: We selected treatment naive HIV-positive adults from the Australian HIV Observational Database (AHOD) and the TREAT Asia HIV Observational Database (TAHOD). We dichotomised each country's per capita income into high/uppermiddle (T-H) and lower-middle/low (T-L). Survival methods stratified by income were used to explore time to first major modification of first-line ART and associated factors. We defined a treatment modification as either initiation of a new class of antiretroviral (ARV) or a substitution of two or more ARV agents from within the same ARV class. Results: A total of 4250 patients had 961 major modifications to first-line ART in the first five years of therapy. The cumulative incidence (95% CI) of treatment modification was 0.48 (0.44-0.52), 0.33 (0.30-0.36) and 0.21 (0.18-0.23) for AHOD, T-H and T-L respectively. We found no strong associations between typical patient characteristic factors and rates of treatment modification. In AHOD, relative to sites that monitor twice-yearly (both CD4 and HIV RNA-VL), quarterly monitoring corresponded with a doubling of the rate of treatment modifications. In T-H, relative to sites that monitor once-yearly (both CD4 and HIV RNA-VL), monitoring twice-yearly corresponded to a 1.8 factor increase in treatment modifications. In T-L, no sites on average monitored both CD4 & HIV RNA-VL concurrently once-yearly. We found no differences in rates of modifications for once-or twice-yearly CD4 count monitoring. Conclusions: Low-income countries tended to have lower rates of major modifications made to first-line ART compared to higher-income countries. In higher-income countries, an increased rate of RNA-VL monitoring was associated with increased modifications to first-line ART.	[Wright, Stephen; Boyd, Mark A.; Law, Matthew; Petoumenos, Kathy] Kirby Inst, Sydney, NSW, Australia; [Boyd, Mark A.] St Vincents Hosp, Sydney, NSW 2010, Australia; [Yunihastuti, Evy] Cipto Mangunkusumo Gen Hosp, Jakarta, Indonesia; [Sirisanthana, Thira] Chiang Mai Univ, Chiang Mai 50000, Thailand; [Hoy, Jennifer] Alfred Hosp, Melbourne, Vic, Australia; [Hoy, Jennifer] Monash Univ, Melbourne, Vic 3004, Australia; [Pujari, Sanjay] Inst Infect Dis, Pune, Maharashtra, India; [Lee, Man Po] Queen Elizabeth Hosp, Kowloon, Hong Kong, Peoples R China	University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; University of Indonesia; Chiang Mai University; Florey Institute of Neuroscience & Mental Health; Monash University	Wright, S (corresponding author), Kirby Inst, Sydney, NSW, Australia.	swright@kirby.unsw.edu.au	Yunihastuti, Evy/AGD-5382-2022; Hoy, Jennifer/AAK-7968-2020; LA SRI PONNAMPALAVANAR, SASHEELA SRI/B-9703-2010; Wright, Stephen/G-9643-2014	Yunihastuti, Evy/0000-0001-6650-0559; Wright, Stephen/0000-0002-8593-6056; Boyd, Mark/0000-0002-6848-3307; Templeton, David/0000-0003-2157-9587; Hoy, Jennifer/0000-0002-6948-7086; Law, Matthew/0000-0002-3540-8837	United States National Institutes of Health's National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute [U01AI069907]; Australian Government Department of Health and Ageing; Faculty of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907] Funding Source: NIH RePORTER	United States National Institutes of Health's National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Faculty of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The TREAT Asia HIV Observational Database and the Australian HIV Observational Database are initiatives of TREAT Asia, a program of amfAR, The Foundation for AIDS Research, with support from the United States National Institutes of Health's National Institute of Allergy and Infectious Diseases, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and National Cancer Institute, as part of the International Epidemiologic Databases to Evaluate AIDS (IeDEA; U01AI069907), and the Dutch Ministry of Foreign Affairs through a partnership with Stichting Aids Fonds. The Kirby Institute is funded by the Australian Government Department of Health and Ageing, and is affiliated with the Faculty of Medicine, The University of New South Wales. The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achhra Amit C, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P160, DOI 10.1177/1545109711402213; Australian HIV Observational Database, 2002, HIV MED, V3, P28; Bendavid E, 2008, ARCH INTERN MED, V168, P1910, DOI 10.1001/archinternmed.2008.1; Boyd MA, 2012, LANCET, V380, P1860, DOI 10.1016/S0140-6736(12)61154-4; Costagliola D, 2012, LANCET INFECT DIS, V12, P119, DOI 10.1016/S1473-3099(11)70248-1; Egger S, 2009, JAIDS-J ACQ IMM DEF, V50, P513, DOI 10.1097/QAI.0b013e31819906d3; Falster K, 2009, AIDS, V23, P2323, DOI 10.1097/QAD.0b013e328331910c; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; Joint United Nations Programme on HIV/AIDS, 2011, HIV AS PAC GETT ZER, P1; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; Keiser O, 2008, PLOS MED, V5, P1102, DOI 10.1371/journal.pmed.0050148; Lewden C, 2012, INT J EPIDEMIOL, V41, P433, DOI 10.1093/ije/dyr164; May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6; McManus H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048839; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Oyomopito R, 2010, HIV MED, V11, P519, DOI 10.1111/j.1468-1293.2010.00822.x; Palombi L, 2009, CLIN INFECT DIS, V48, P115, DOI 10.1086/593312; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUID US ANT AG HIV 1; Parienti JJ, 2004, CLIN INFECT DIS, V38, P1311, DOI 10.1086/383572; Reekie J, 2008, AIDS, V22, P2381, DOI 10.1097/QAD.0b013e328317a6eb; Srikantiah P, 2010, AIDS, V24, pS62, DOI 10.1097/01.aids.0000390091.45435.ea; Vella S, 2012, AIDS, V26, P1231, DOI 10.1097/QAD.0b013e32835521a3; Walker AS, 2011, CURR OPIN INFECT DIS, V24, P27, DOI 10.1097/QCO.0b013e3283423e0e; World Bank, WORLD BANK GNI PER C; World Health Organization, 2011, ANT THER HIV INF AD, P1; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	28	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e64902	10.1371/journal.pone.0064902	http://dx.doi.org/10.1371/journal.pone.0064902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840312	Green Published, gold			2022-12-27	WOS:000321148400002
J	Griffeth, VEM; Blockley, NP; Simon, AB; Buxton, RB				Griffeth, Valerie E. M.; Blockley, Nicholas P.; Simon, Aaron B.; Buxton, Richard B.			A New Functional MRI Approach for Investigating Modulations of Brain Oxygen Metabolism	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; CALIBRATED-BOLD FMRI; OXIDATIVE-METABOLISM; SOMATOSENSORY STIMULATION; VISUAL-STIMULATION; SIGNAL CHANGES; EVOKED BOLD; BASE-LINE; 1.5 TESLA; ACTIVATION	Functional MRI (fMRI) using the blood oxygenation level dependent (BOLD) signal is a common technique in the study of brain function. The BOLD signal is sensitive to the complex interaction of physiological changes including cerebral blood flow (CBF), cerebral blood volume (CBV), and cerebral oxygen metabolism (CMRO2). A primary goal of quantitative fMRI methods is to combine BOLD imaging with other measurements (such as CBF measured with arterial spin labeling) to derive information about CMRO2. This requires an accurate mathematical model to relate the BOLD signal to the physiological and hemodynamic changes; the most commonly used of these is the Davis model. Here, we propose a new nonlinear model that is straightforward and shows heuristic value in clearly relating the BOLD signal to blood flow, blood volume and the blood flow-oxygen metabolism coupling ratio. The model was tested for accuracy against a more detailed model adapted for magnetic fields of 1.5, 3 and 7T. The mathematical form of the heuristic model suggests a new ratio method for comparing combined BOLD and CBF data from two different stimulus responses to determine whether CBF and CMRO2 coupling differs. The method does not require a calibration experiment or knowledge of parameter values as long as the exponential parameter describing the CBF-CBV relationship remains constant between stimuli. The method was found to work well for 1.5 and 3T but is prone to systematic error at 7T. If more specific information regarding changes in CMRO2 is required, then with accuracy similar to that of the Davis model, the heuristic model can be applied to calibrated BOLD data at 1.5T, 3T and 7T. Both models work well over a reasonable range of blood flow and oxygen metabolism changes but are less accurate when applied to a simulated caffeine experiment in which CBF decreases and CMRO2 increases.	[Griffeth, Valerie E. M.; Simon, Aaron B.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Griffeth, Valerie E. M.; Simon, Aaron B.] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92093 USA; [Blockley, Nicholas P.; Buxton, Richard B.] Univ Calif San Diego, Dept Radiol, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA; [Buxton, Richard B.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Buxton, RB (corresponding author), Univ Calif San Diego, Dept Radiol, Ctr Funct Magnet Resonance Imaging, La Jolla, CA 92093 USA.	rbuxton@ucsd.edu		Blockley, Nicholas/0000-0003-2595-8285	National Institutes of Health (NIH) [NS-36722, MH-095298, EB-00790, EB-009830]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by funding from National Institutes of Health (NIH) grants NS-36722, MH-095298, EB-00790 and EB-009830 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ances BM, 2008, NEUROIMAGE, V39, P1510, DOI 10.1016/j.neuroimage.2007.11.015; Ances BM, 2009, HUM BRAIN MAPP, V30, P1120, DOI 10.1002/hbm.20574; Blockley NP, 2008, MAGN RESON MED, V60, P1313, DOI 10.1002/mrm.21792; Blockley NP, NMR BIOMEDI IN PRESS; Buxton RB, 1998, MAGNET RESON MED, V39, P855, DOI 10.1002/mrm.1910390602; Chen JJ, 2010, J CEREBR BLOOD F MET, V30, P1094, DOI 10.1038/jcbfm.2010.42; Chen JJ, 2009, NMR BIOMED, V22, P1054, DOI 10.1002/nbm.1411; Chen YF, 2009, NEUROIMAGE, V44, P647, DOI 10.1016/j.neuroimage.2008.09.057; Chiarelli PA, 2007, MAGN RESON MED, V57, P538, DOI 10.1002/mrm.21171; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Donahue MJ, 2009, J CEREBR BLOOD F MET, V29, P1856, DOI 10.1038/jcbfm.2009.107; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Gauthier CJ, 2011, NEUROIMAGE, V54, P1001, DOI 10.1016/j.neuroimage.2010.09.059; Griffeth VEM, 2011, NEUROIMAGE, V58, P198, DOI 10.1016/j.neuroimage.2011.05.077; Griffeth VEM, 2011, NEUROIMAGE, V57, P809, DOI 10.1016/j.neuroimage.2011.04.064; GRUBB RL, 1974, STROKE, V5, P630, DOI 10.1161/01.STR.5.5.630; Hillman EMC, 2007, NEUROIMAGE, V35, P89, DOI 10.1016/j.neuroimage.2006.11.032; Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; Jain V, 2011, J CEREBR BLOOD F MET, V31, P1504, DOI 10.1038/jcbfm.2011.34; Jones M, 2005, NEUROIMAGE, V27, P609, DOI 10.1016/j.neuroimage.2005.04.036; Kastrup A, 2002, NEUROIMAGE, V15, P74, DOI 10.1006/nimg.2001.0916; Kim SG, 1999, MAGN RESON MED, V41, P1152, DOI 10.1002/(SICI)1522-2594(199906)41:6<1152::AID-MRM11>3.0.CO;2-T; Kim T, 2007, J CEREBR BLOOD F MET, V27, P1235, DOI 10.1038/sj.jcbfm.9600429; Leontiev O, 2007, NEUROIMAGE, V35, P175, DOI 10.1016/j.neuroimage.2006.10.044; Liang CL, 2013, NEUROIMAGE, V64, P104, DOI 10.1016/j.neuroimage.2012.08.077; Lin AL, 2008, MAGN RESON MED, V60, P380, DOI 10.1002/mrm.21655; Mark CI, 2011, NEUROIMAGE, V54, P1102, DOI 10.1016/j.neuroimage.2010.08.070; Moradi F, 2012, NEUROIMAGE; Moradi F, 2012, NEUROIMAGE, V59, P601, DOI 10.1016/j.neuroimage.2011.07.078; OGAWA S, 1993, BIOPHYS J, V64, P803, DOI 10.1016/S0006-3495(93)81441-3; Perthen JE, 2008, NEUROIMAGE, V40, P237, DOI 10.1016/j.neuroimage.2007.10.049; Pike GB, 2012, NEUROIMAGE, V62, P1234, DOI 10.1016/j.neuroimage.2011.10.046; SEVERINGHAUS JW, 1979, J APPL PHYSIOL, V46, P599, DOI 10.1152/jappl.1979.46.3.599; Sicard KM, 2005, NEUROIMAGE, V25, P850, DOI 10.1016/j.neuroimage.2004.12.010; Silvennoinen MJ, 2003, MAGNET RESON MED, V49, P47, DOI 10.1002/mrm.10355; Simon AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054816; Spees WM, 2001, MAGN RESON MED, V45, P533, DOI 10.1002/mrm.1072; St Lawrence KS, 2003, MAGNET RESON MED, V50, P99, DOI 10.1002/mrm.10502; Stefanovic B, 2005, NEUROIMAGE, V28, P205, DOI 10.1016/j.neuroimage.2005.05.038; Stefanovic B, 2004, NEUROIMAGE, V22, P771, DOI 10.1016/j.neuroimage.2004.01.036; Stephan KE, 2007, NEUROIMAGE, V38, P387, DOI 10.1016/j.neuroimage.2007.07.040; Uludag K, 2004, NEUROIMAGE, V23, P148, DOI 10.1016/j.neuroimage.2004.05.013; Uludag K, 2009, NEUROIMAGE, V48, P150, DOI 10.1016/j.neuroimage.2009.05.051; van der Zwaag W, 2009, NEUROIMAGE, V47, P1425, DOI 10.1016/j.neuroimage.2009.05.015; Wong EC, 1998, MAGNET RESON MED, V39, P702, DOI 10.1002/mrm.1910390506	46	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68122	10.1371/journal.pone.0068122	http://dx.doi.org/10.1371/journal.pone.0068122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826367	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000121
J	Krishnamoorthy, S; Liu, ZH; Hong, AL; Zhu, RJ; Chen, HS; Li, TB; Zhou, XC; Gao, XL				Krishnamoorthy, Srinivasan; Liu, Zhonghua; Hong, Ailing; Zhu, Ruijuan; Chen, Haosi; Li, Tongbin; Zhou, Xiaochuan; Gao, Xiaolian			A Novel Phosphopeptide Microarray Based Interactome Map in Breast Cancer Cells Reveals Phosphoprotein-GRB2 Cell Signaling Networks	PLOS ONE			English	Article							GRB2 BINDING-SITE; T-BOC CHEMISTRY; TYROSINE KINASE; PHOSPHORYLATION SITES; PEPTIDE-SYNTHESIS; ACTIVATION MOTIF; MAST-CELLS; IN-VIVO; RECEPTOR; PROTEIN	The architecture of cellular proteins connected to form signaling pathways in response to internal and external cues is much more complex than a group of simple protein-protein interactions. Post translational modifications on proteins (e.g., phosphorylation of serine, threonine and tyrosine residues on proteins) initiate many downstream signaling events leading to protein-protein interactions and subsequent activation of signaling cascades leading to cell proliferation, cell differentiation and cell death. As evidenced by a rapidly expanding mass spectrometry database demonstrating protein phosphorylation at specific motifs, there is currently a large gap in understanding the functional significance of phosphoproteins with respect to their specific protein connections in the signaling cascades. A comprehensive map that interconnects phospho-motifs in pathways will enable identification of nodal protein interactions that are sensitive signatures indicating a disease phenotype from the physiological hemostasis and provide clues into control of disease. Using a novel phosphopeptide microarray technology, we have mapped endogenous tyrosine-phosphoproteome interaction networks in breast cancer cells mediated by signaling adaptor protein GRB2, which transduces cellular responses downstream of several RTKs through the Ras-ERK signaling cascade. We have identified several previously reported motif specific interactions and novel interactions. The peptide microarray data indicate that various phospho-motifs on a single protein are differentially regulated in various cell types and shows global downregulation of phosphoprotein interactions specifically in cells with metastatic potential. The study has revealed novel phosphoprotein mediated signaling networks, which warrants further detailed analysis of the nodes of protein-protein interaction to uncover their biomarker or therapeutic potential.	[Krishnamoorthy, Srinivasan; Liu, Zhonghua; Zhu, Ruijuan; Chen, Haosi; Gao, Xiaolian] Univ Houston, Dept Biol & Biochem, Houston, TX 77058 USA; [Hong, Ailing; Li, Tongbin; Zhou, Xiaochuan] LC Sci, Houston, TX USA	University of Houston System; University of Houston	Krishnamoorthy, S (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77058 USA.	ksrini10@gmail.com; xgao@uh.edu			NCI [4R33CA126209]	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work is supported by R33 grant from NCI (4R33CA126209) to XG and XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Araki T, 2003, J BIOL CHEM, V278, P41677, DOI 10.1074/jbc.M306461200; Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182; Boivin D, 2009, BIOCHEMISTRY-US, V48, P3998, DOI 10.1021/bi900159d; Bradley LM, 2008, J STEROID BIOCHEM, V109, P185, DOI 10.1016/j.jsbmb.2007.10.006; Cheng H, 2010, CIRC RES, V106, P21, DOI 10.1161/CIRCRESAHA.109.206920; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; DeGnore JP, 1998, J AM SOC MASS SPECTR, V9, P1175, DOI 10.1016/S1044-0305(98)00088-9; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Finlayson CA, 2003, METABOLISM, V52, P1606, DOI 10.1016/S0026-0495(03)00311-1; Fixman ED, 1997, J BIOL CHEM, V272, P20167, DOI 10.1074/jbc.272.32.20167; Gao XL, 2004, MOL DIVERS, V8, P177, DOI 10.1023/B:MODI.0000036233.58271.25; Gao XL, 2003, PROTEOMICS, V3, P2135, DOI 10.1002/pmic.200300597; Giordano S, 1997, P NATL ACAD SCI USA, V94, P13868, DOI 10.1073/pnas.94.25.13868; Gong WM, 2008, NUCLEIC ACIDS RES, V36, pD679, DOI 10.1093/nar/gkm854; Hao Q, 2006, MOL PHARMACOL, V69, P1938, DOI 10.1124/mol.105.020115; Heibeck TH, 2009, J PROTEOME RES, V8, P3852, DOI 10.1021/pr900044c; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Iwaki S, 2008, CELL SIGNAL, V20, P195, DOI 10.1016/j.cellsig.2007.10.013; Kaneda T, 2008, CANCER LETT, V270, P354, DOI 10.1016/j.canlet.2008.05.042; Kessels HWHG, 2002, P NATL ACAD SCI USA, V99, P8524, DOI 10.1073/pnas.142224499; Kontos CD, 2002, MOL CELL BIOL, V22, P1704, DOI 10.1128/MCB.22.6.1704-1713.2002; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Krishnamoorthy S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002877; Lanzino M, 2008, CURR CANCER DRUG TAR, V8, P597, DOI 10.2174/156800908786241104; Lee AV, 1999, MOL ENDOCRINOL, V13, P787, DOI 10.1210/me.13.5.787; Malbec O, 2004, J IMMUNOL, V173, P5086, DOI 10.4049/jimmunol.173.8.5086; Mancini A, 1997, ONCOGENE, V15, P1565, DOI 10.1038/sj.onc.1201518; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; Masson K, 2009, BRIT J HAEMATOL, V146, P193, DOI 10.1111/j.1365-2141.2009.07725.x; Mitra SK, 2006, ONCOGENE, V25, P5969, DOI 10.1038/sj.onc.1209588; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Paulo JA, 2013, J PROTEOMICS; Paulo JA, 2012, J PROTEOME RES, V11, P1897, DOI 10.1021/pr2011022; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Pellois JP, 2002, NAT BIOTECHNOL, V20, P922, DOI 10.1038/nbt723; Pellois JP, 2000, J COMB CHEM, V2, P355, DOI 10.1021/cc0000139; Pighi C, 2011, CELL ONCOL, V34, P141, DOI 10.1007/s13402-011-0019-7; Ross SR, 2006, J VIROL, V80, P9000, DOI 10.1128/JVI.00788-06; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Schumacher JA, 2007, J MOL DIAGN, V9, P169, DOI 10.2353/jmoldx.2007.060031; Sommers CL, 2001, J EXP MED, V194, P135, DOI 10.1084/jem.194.2.135; Taylor JT, 2008, WORLD J GASTROENTERO, V14, P4984, DOI 10.3748/wjg.14.4984; Tulasne D, 1999, MOL BIOL CELL, V10, P551, DOI 10.1091/mbc.10.3.551; Tzeng SR, 2000, PROTEIN SCI, V9, P2377, DOI 10.1110/ps.9.12.2377; Uen YH, 2013, J PROTEOMICS, V83, P197, DOI 10.1016/j.jprot.2013.03.007; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Wan J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm848; Wisniewski JR, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.44; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yang JH, 2003, J BIOL CHEM, V278, P16797, DOI 10.1074/jbc.M211060200; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Zhou X, 2011, MICRORNA PROFILING U	54	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67634	10.1371/journal.pone.0067634	http://dx.doi.org/10.1371/journal.pone.0067634			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826330	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000094
J	Lee, WS; Woo, EY; Kwon, J; Park, MJ; Lee, JS; Han, YH; Bae, IH				Lee, Woo Sang; Woo, Eun Young; Kwon, Junhye; Park, Myung-Jin; Lee, Jae-Seon; Han, Young-Hoon; Bae, In Hwa			Bcl-w Enhances Mesenchymal Changes and Invasiveness of Glioblastoma Cells by Inducing Nuclear Accumulation of beta-Catenin	PLOS ONE			English	Article							MATRIX METALLOPROTEINASE-2; GLIOMA-CELLS; INVASION; CANCER; ACTIVATION; EXPRESSION; WNT; AKT; TRANSITION; FAMILY	Bcl-w a pro-survival member of the Bcl-2 protein family, is expressed in a variety of cancer types, including gastric and colorectal adenocarcinomas, as well as glioblastoma multiforme (GBM), the most common and lethal brain tumor type. Previously, we demonstrated that Bcl-w is upregulated in gastric cancer cells, particularly those displaying infiltrative morphology. These reports propose that Bcl-w is strongly associated with aggressive characteristic, such as invasive or mesenchymal phenotype of GBM. However, there is no information from studies of the role of Bcl-w in GBM. In the current study, we showed that Bcl-w is upregulated in human glioblastoma multiforme (WHO grade IV) tissues, compared with normal and glioma (WHO grade III) tissues. Bcl-w promotes the mesenchymal traits of glioblastoma cells by inducing vimentin expression via activation of transcription factors, beta-catenin, Twist1 and Snail in glioblastoma U251 cells. Moreover, Bcl-w induces invasiveness by promoting MMP-2 and FAK activation via the PI3K-p-Akt-p-GSK3 beta-beta-catenin pathway. We further confirmed that Bcl-w has the capacity to induce invasiveness in several human cancer cell lines. In particular, Bcl-w-stimulated beta-catenin is translocated into the nucleus as a transcription factor and promotes the expression of target genes, such as mesenchymal markers or MMPs, thereby increasing mesenchymal traits and invasiveness. Our findings collectively indicate that Bcl-w functions as a positive regulator of invasiveness by inducing mesenchymal changes and that trigger their aggressiveness of glioblastoma cells.	[Lee, Woo Sang; Woo, Eun Young; Park, Myung-Jin; Lee, Jae-Seon; Han, Young-Hoon; Bae, In Hwa] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul, South Korea; [Kwon, Junhye] Sookmyung Womens Univ, Dept Biol Sci, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences; Sookmyung Women's University	Bae, IH (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul, South Korea.	ihbae@kirams.re.kr						Bae IH, 2006, CANCER RES, V66, P4991, DOI 10.1158/0008-5472.CAN-05-4254; Bae IH, 2009, CANCER LETT, V277, P22, DOI 10.1016/j.canlet.2008.11.022; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Forsyth PA, 1999, BRIT J CANCER, V79, P1828, DOI 10.1038/sj.bjc.6690291; Gibson L, 1996, ONCOGENE, V13, P665; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Han SP, 2011, CELL MOL NEUROBIOL, V31, P489, DOI 10.1007/s10571-010-9643-4; Harris TJC, 2005, TRENDS CELL BIOL, V15, P234, DOI 10.1016/j.tcb.2005.03.002; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Hoelzinger DB, 2007, J NATL CANCER I, V99, P1583, DOI 10.1093/jnci/djm187; Kamino M, 2011, CANCER SCI, V102, P540, DOI 10.1111/j.1349-7006.2010.01815.x; Kikuchi A, 2006, EXP MOL MED, V38, P1, DOI 10.1038/emm.2006.1; Kim DK, 2001, J CELL SCI, V114, P4329; Larue L, 2005, ONCOGENE, V24, P7443, DOI 10.1038/sj.onc.1209091; Le DM, 2003, J NEUROSCI, V23, P4034; Le NH, 2008, BRIT J CANCER, V98, P1886, DOI 10.1038/sj.bjc.6604401; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Liu C, 2011, CLIN EXP MED, V11, P105, DOI 10.1007/s10238-010-0110-9; Markovic DS, 2005, J NEUROPATH EXP NEUR, V64, P754, DOI 10.1097/01.jnen.0000178445.33972.a9; Mikheeva SA, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-194; Molina JR, 2010, NEOPLASIA, V12, P453, DOI 10.1593/neo.10126; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Park MJ, 2002, CANCER RES, V62, P6318; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Polakis P, 2000, GENE DEV, V14, P1837; Sareddy GR, 2009, NEUROCHEM INT, V55, P307, DOI 10.1016/j.neuint.2009.03.016; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Varga I, 2010, CENT EUR NEUROSURG, V71, P173, DOI 10.1055/s-0030-1249698; Wang HM, 2004, LAB INVEST, V84, P941, DOI 10.1038/labinvest.3700123; Wu BB, 2007, IMMUNITY, V26, P227, DOI 10.1016/j.immuni.2006.12.007; Yang HW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-301; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yue XA, 2010, BRAIN RES, V1366, P27, DOI 10.1016/j.brainres.2010.10.032; Zuo JH, 2010, MOL CANCER RES, V8, P170, DOI 10.1158/1541-7786.MCR-09-0354	40	25	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68030	10.1371/journal.pone.0068030	http://dx.doi.org/10.1371/journal.pone.0068030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826359	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000113
J	Li, G; Yang, QT; Zhu, YB; Wang, HR; Chen, XC; Zhang, XG; Lu, BF				Li, Gang; Yang, Qianting; Zhu, Yibei; Wang, Hong-Rui; Chen, Xinchun; Zhang, Xueguang; Lu, Binfeng			T-Bet and Eomes Regulate the Balance between the Effector/Central Memory T Cells versus Memory Stem Like T Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTOR EOMESODERMIN; ADOPTIVE IMMUNOTHERAPY; COLORECTAL-CANCER; VIRAL-INFECTION; CUTTING EDGE; DIFFERENTIATION; METASTASIS; COMMITMENT; EXPRESSION; RESPONSES	Memory T cells are composed of effector, central, and memory stem cells. Previous studies have implicated that both T-bet and Eomes are involved in the generation of effector and central memory CD8 T cells. The exact role of these transcription factors in shaping the memory T cell pool is not well understood, particularly with memory stem T cells. Here, we demonstrate that both T-bet or Eomes are required for elimination of established tumors by adoptively transferred CD8 T cells. We also examined the role of T-bet and Eomes in the generation of tumor-specific memory T cell subsets upon adoptive transfer. We showed that combined T-bet and Eomes deficiency resulted in a severe reduction in the number of effector/central memory T cells but an increase in the percentage of CD62L(high)CD44(low) Sca-1(+) T cells which were similar to the phenotype of memory stem T cells. Despite preserving large numbers of phenotypic memory stem T cells, the lack of both of T-bet and Eomes resulted in a profound defect in antitumor memory responses, suggesting T-bet and Eomes are crucial for the antitumor function of these memory T cells. Our study establishes that T-bet and Eomes cooperate to promote the phenotype of effector/central memory CD8 T cell versus that of memory stem like T cells.	[Li, Gang; Zhang, Xueguang] Soochow Univ, Inst Med Biotechnol, Jiangsu Inst Clin Immunol, Stem Cell Res Lab Jiangsu Prov, Suzhou, Jiangsu, Peoples R China; [Yang, Qianting; Zhu, Yibei; Lu, Binfeng] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA; [Yang, Qianting; Chen, Xinchun] Guangdong Med Coll, Peoples Hosp 3, Shenzhen Key Lab Infect & Immun, Guangdong Key Lab Emerging Infect Dis, Shenzhen, Guangdong, Peoples R China; [Zhu, Yibei] Soochow Univ, Coll Med, Dept Immunol, Suzhou, Jiangsu, Peoples R China; [Wang, Hong-Rui] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China	Soochow University - China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Guangdong Medical University; Soochow University - China; Xiamen University	Lu, BF (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA.	Binfeng@pitt.edu		Wang, Hong-Rui/0000-0002-2916-8849	NSFC [2010692006, 30930085, 31170866, 81273208]; 973 project [2013CB530501]; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); Jiangsu natural science fund [BK2011289]; National Nature Science Foundation of China [81171535];  [1R21CA167229-01A1]; NATIONAL CANCER INSTITUTE [R21CA167229] Funding Source: NIH RePORTER	NSFC(National Natural Science Foundation of China (NSFC)); 973 project(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); Jiangsu natural science fund; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work is supported by 1R21CA167229-01A1 to BL. GL is partly supported by a scholarship from NSFC (#2010692006). This work is partly supported by NSFC key grant 30930085, the 973 project (No. 2013CB530501) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD) (to XG. Zhang). Y Zhu is supported by NSFC grant 31170866, 81273208 and Jiangsu natural science fund BK2011289. QY and XC are supported by National Nature Science Foundation of China Grant No. 81171535.	Atreya I, 2007, GUT, V56, P1572, DOI 10.1136/gut.2006.117812; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Chang JT, 2011, IMMUNITY, V34, P492, DOI 10.1016/j.immuni.2011.03.017; Chen LJ, 2012, CANC IMMUNOL IMMUNOT; Chen LJ, 2011, CANCER IMMUNOL IMMUN, V60, P1047, DOI 10.1007/s00262-011-1017-3; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kato K, 2010, BIOL BLOOD MARROW TR, V16, P751, DOI 10.1016/j.bbmt.2010.01.012; Lizee G, 2012, ANN REV MED; Lord GM, 2005, BLOOD, V106, P3432, DOI 10.1182/blood-2005-04-1393; Lu BF, 2011, IMMUNOL RES, V50, P269, DOI 10.1007/s12026-011-8227-9; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Qui HZ, 2011, J IMMUNOL, V187, P3555, DOI 10.4049/jimmunol.1101244; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Wiesel M, 2012, EUR J IMMUNOL, V42, P1080, DOI 10.1002/eji.201142205; Zhang Y, 2005, NAT MED, V11, P1299, DOI 10.1038/nm1326; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749	31	38	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67401	10.1371/journal.pone.0067401	http://dx.doi.org/10.1371/journal.pone.0067401			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826287	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000321150000075
J	Sun, YH; Liu, Y; Watts, LT; Sun, QF; Zhong, ZH; Yang, GY; Bian, LG				Sun, Yuhao; Liu, Ye; Watts, Lora Talley; Sun, Qingfang; Zhong, Zhihong; Yang, Guo-Yuan; Bian, Liuguan			Genetic Associations of Angiotensin-Converting Enzyme with Primary Intracerebral Hemorrhage: A Meta-analysis	PLOS ONE			English	Article							INSERTION DELETION POLYMORPHISM; CEREBROVASCULAR-DISEASE; RISK-FACTORS; ACE GENE; HETEROGENEITY; STROKE; EPIDEMIOLOGY; POPULATION; VARIANCE; HEART	Background: A number of studies have reported an association of angiotensin-converting enzyme (ACE) gene polymorphism with primary intracerebral hemorrhage (PICH), however the reports have demonstrated inconclusive results. To clarify this conflict, we updated the previously performed meta-analysis by Peck et al., which revealed negative results, by investigating the ACE polymorphism and its correlation to PICH. Methods: PubMed and Embase databases (through Dec 2012) were searched for English articles on the relationship of the I/D polymorphism in ACE with PICH in humans. Summary odds ratios (ORs) were estimated and potential sources of heterogeneity and bias were explored. Results: A total of 805 PICH cases and 1641 control cases obtained from 8 case-control studies were included. The results suggest that in dominant genetic models, the ACE I/D polymorphic variant was associated with a 58% increase in susceptibility risk of PICH (OR = 1.58; 95% CI = 1.07-2.35 for DD vs. DI+II). However, in the subgroup analysis based on race, a significant increased risk was found in Asian DD homozygote carriers (OR = 1.76 and 95% CI = 1.16-2.66 for DD vs. DI+II), but not in Caucasian DD homozygote carriers (OR = 1.18, 95% CI = 0.36-3.88, P = 0.784 for DD vs. DI+II). The heterogeneity between studies was remarkable, and its major sources of heterogeneity were due to the year in which the study was published. No potential publication bias was observed in dominant genetic models. Conclusions: These data demonstrated evidence of a positive association between ACE I/D polymorphism with PICH, and suggested that the ACE gene is a PICH susceptible gene in Asian populations.	[Sun, Yuhao; Sun, Qingfang; Zhong, Zhihong; Yang, Guo-Yuan; Bian, Liuguan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China; [Liu, Ye; Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurol, Shanghai 200030, Peoples R China; [Watts, Lora Talley] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Med X Res Inst, Neurosci & Neuroengn Res Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Texas System; University of Texas Health San Antonio; Shanghai Jiao Tong University	Bian, LG (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China.	bian6612@yahoo.com.cn			Engineering Cross Research fund [YG2012MS06]	Engineering Cross Research fund	Engineering Cross Research fund: YG2012MS06 (YHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelros P, 2009, STROKE, V40, P1082, DOI 10.1161/STROKEAHA.108.540781; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; Catto A, 1996, STROKE, V27, P435, DOI 10.1161/01.STR.27.3.435; Chen CM, 2008, EUR J NEUROL, V15, P1206, DOI 10.1111/j.1468-1331.2008.02294.x; Chowdhury AH, 2000, CVD PREVENTION, V3, P195; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; DANSER AHJ, 1995, CIRCULATION, V92, P1387, DOI 10.1161/01.CIR.92.6.1387; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DessiFulgheri P, 1995, J HYPERTENS, V13, P1593; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Egger M, 2003, Health Technol Assess, V7, P1; EGGER M, 2001, METAANALYSIS CONTEXT; Eichel R, 2010, NEUROL RES, V32, P905, DOI 10.1179/016164110X12656393664928; Fischer M, 2002, CARDIOVASC RES, V53, P672, DOI 10.1016/S0008-6363(01)00479-5; Flaherty ML, 2005, STROKE, V36, P934, DOI 10.1161/01.STR.0000160756.72109.95; Fleming I, 2006, CIRC RES, V98, P887, DOI 10.1161/01.RES.0000217340.40936.53; Fukuda D, 2009, BIOMED PHARMACOTHER, V63, P754, DOI 10.1016/j.biopha.2009.02.006; GRIENDLING KK, 1993, CIRCULATION, V87, P1816, DOI 10.1161/01.CIR.87.6.1816; Hedges LV, 2001, PSYCHOL METHODS, V6, P203, DOI 10.1037/1082-989X.6.3.203; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Inagawa T, 2007, NEUROSURG REV, V30, P225, DOI 10.1007/s10143-007-0082-8; Ioannidis JPA, 2006, J CLIN EPIDEMIOL, V59, P1023, DOI 10.1016/j.jclinepi.2006.02.013; Juo SHH, 2009, FRONT BIOSCI-LANDMRK, V14, P4525, DOI 10.2741/3545; Kalita J, 2011, CLIN CHIM ACTA, V412, P642, DOI 10.1016/j.cca.2010.12.022; Li Y, 2010, PHARMACOGENET GENOM, V20, P298, DOI 10.1097/FPC.0b013e328338f54f; Lin JJ, 2000, J FORMOS MED ASSOC, V99, P895; MANTEL N, 1959, J NATL CANCER I, V22, P719; Nakata Y, 1997, AM J HYPERTENS, V10, P1391, DOI 10.1016/S0895-7061(97)00315-4; Peck G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003691; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; ROBINS J, 1986, AM J EPIDEMIOL, V124, P719, DOI 10.1093/oxfordjournals.aje.a114447; ROSSI GP, 1995, STROKE, V26, P1700, DOI 10.1161/01.STR.26.9.1700; Sawcer S, 2010, EUR J HUM GENET, V18, P746, DOI 10.1038/ejhg.2010.17; Slowik A, 2004, NEUROLOGY, V63, P359, DOI 10.1212/01.WNL.0000130200.12993.0C; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; TIRET L, 1992, AM J HUM GENET, V51, P197; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Woo D, 2002, NEUROSURG CLIN N AM, V13, P265, DOI 10.1016/S1042-3680(02)00011-6; Zintzaras E, 2005, GENET EPIDEMIOL, V28, P123, DOI 10.1002/gepi.20048; Zintzaras E, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1542	44	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67402	10.1371/journal.pone.0067402	http://dx.doi.org/10.1371/journal.pone.0067402			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826288	Green Published, gold, Green Submitted			2022-12-27	WOS:000321150000076
J	Hertz, CL; Mathiasen, R; Hansen, BM; Mortensen, EL; Greisen, G				Hertz, Christin L.; Mathiasen, Rene; Hansen, Bo M.; Mortensen, Erik L.; Greisen, Gorm			Personality in Adults Who Were Born Very Preterm	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; QUALITY-OF-LIFE; YOUNG-ADULTS; BEHAVIORAL OUTCOMES; SCHOOL DIFFICULTIES; INDIVIDUALS BORN; REGIONAL COHORT; CHILDREN; AGE; INFANTS	Aim: To investigate the personality in very preterm individuals (VPT; gestational age, GA, <32 weeks) at adult age in two cohorts born in 1974-76 and 1980-82, respectively, and to illuminate the effect of increased survival rates and the clinical implications of deviations in personality. Method: Demographic data were extracted for all individuals born in Denmark in 1974-76 and 1980-82. From each period one index-group each comprising 150 individuals with the lowest gestational age was selected. Thereafter two control groups born at term were matched by gender, age and residential area. Personality was assessed with the short version of NEO PI-R, and psychiatric diagnoses were obtained from the Danish Psychiatric Central Research Register. Results: Of all the individuals born <32 weeks of gestation in 1980-82 67% were alive in 2006 vs. 43% of those born in 1974-76 (p<0.0001). A total of 433 individuals participated in the study, 76% of the VPT groups (n = 227, mean GA = 27.9) and 69% of the control groups (n = 206). There were no significant differences on personality scores between the two VPT groups. Compared to the control groups, the combined VPT groups scored higher on neuroticism (p = 0.005) and agreeableness (p = 0.012), but lower on extraversion (p = 0.002). Psychiatric disorder was strongly associated with higher scores on neuroticism and lower scores on extraversion. Interpretation: Improved survival of VPT infants was not associated with increased deviances in the personality as adults. The personality traits in VPT individuals differ moderately from those of term born controls. High scores in neuroticism and low scores in extraversion were associated with increased risk psychiatric disorders. VPT adults also showed signs of positive adaptation in the form of an agreeable and confident attitude towards others. What this paper adds: The much improved survival rate in very preterm infants during the early years of active neonatology was not associated with increased risk of personality deviation. There are signs of positive adaptation in the form of increased agreeableness in young adults born very preterm.	[Hertz, Christin L.; Mathiasen, Rene; Hansen, Bo M.; Greisen, Gorm] Rigshosp, Copenhagen Univ Hosp, Dept Neonatol, DK-2100 Copenhagen, Denmark; [Mortensen, Erik L.] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Mortensen, Erik L.] Univ Copenhagen, Ctr Hlth Aging, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Hertz, CL (corresponding author), Rigshosp, Copenhagen Univ Hosp, Dept Neonatol, DK-2100 Copenhagen, Denmark.	christinlh@dadlnet.dk	Greisen, Gorm/AAA-6463-2022	Greisen, Gorm/0000-0001-8042-3262; Mortensen, Erik Lykke/0000-0002-6985-451X; Hansen, Bo Molholm/0000-0002-3087-3983	Danish Agency for Science Technology and Innovation	Danish Agency for Science Technology and Innovation	This study was funded by the Danish Agency for Science Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allin M, 2006, PEDIATRICS, V117, P309, DOI 10.1542/peds.2005-0539; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Botting N, 1997, J CHILD PSYCHOL PSYC, V38, P931, DOI 10.1111/j.1469-7610.1997.tb01612.x; Costa MacCrea, 1978, NEO PI R MAN; Hack M, 2004, PEDIATRICS, V114, P932, DOI 10.1542/peds.2003-1017-L; Hansen BM, 2004, DEV MED CHILD NEUROL, V46, P812, DOI 10.1017/S0012162204001422; Hoff B, 2004, SCAND J PSYCHOL, V45, P85, DOI 10.1111/j.1467-9450.2004.00382.x; KLEIN NK, 1989, J DEV BEHAV PEDIATR, V10, P32; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Lindstrom K, 2007, PEDIATRICS, V120, P70, DOI 10.1542/peds.2006-3260; Litt J, 2005, J LEARN DISABIL-US, V38, P130, DOI 10.1177/00222194050380020301; Marlow N, 2007, PEDIATRICS, V120, P793, DOI 10.1542/peds.2007-0440; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Mathiasen R, 2007, ACTA PAEDIATR, V96, P85; Mathiasen R, 2011, ACTA PAEDIATR, V100, P691, DOI 10.1111/j.1651-2227.2011.02136.x; Nickel JC, 2008, BJU INT, V101, P59, DOI 10.1111/j.1464-410X.2007.07196.x; Pesonen AK, 2008, J CHILD PSYCHOL PSYC, V49, P609, DOI 10.1111/j.1469-7610.2007.01874.x; Saigal S, 2000, PEDIATRICS, V105, P325, DOI 10.1542/peds.105.2.325; Saigal S, 2008, SEMIN PERINATOL, V32, P59, DOI 10.1053/j.semperi.2007.12.007; Schmidt LA, 2008, PEDIATRICS, V122, pE181, DOI 10.1542/peds.2007-3747; Terracciano A, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-22; Topp M, 2001, PAEDIATR PERINAT EP, V15, P271, DOI 10.1046/j.1365-3016.2001.00354.x; Van Gestel S, 2003, MOL PSYCHIATR, V8, P840, DOI 10.1038/sj.mp.4001367; Vestberg S, 2007, J INT NEUROPSYCH SOC, V13, P911, DOI 10.1017/S1355617707071159	24	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66881	10.1371/journal.pone.0066881	http://dx.doi.org/10.1371/journal.pone.0066881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	178DN	23840545	gold, Green Submitted, Green Published			2022-12-27	WOS:000321424400047
J	Malawista, SE; de Boisfleury, AC				Malawista, Stephen E.; de Boisfleury, Anne Chevance			Plunder of Human Blood Leukocytes Containing Ingested Material, by Other Leukocytes: Where Is the Fusagen That Allows Preservation of Membrane Integrity and Motile Function?	PLOS ONE			English	Article							POLYMORPHONUCLEAR LEUKOCYTES	In studying phagocytosis of zymosan particles by human blood monocytes in phase-contrast videomicroscopy, we found that monocytes loaded with zymosan particles became chemotactic for polymorphonuclear leukocytes (PMN) which closed on them and purloined their particle content. This despoliation usually occurred in monocytes that had begun to swell-prefiguring their death. The violent seizure of their contents by the aggressing PMN often tore the monocytes apart. However, some apparently healthy monocyte survived the removal of zymosan content by PMN or, more commonly, its removal by another monocyte. PMN-a much hardier cell in slide preparations-that were similarly loaded with zymosan particles, also attracted PMN. The latter could remove zymosan from the target cell without killing it. Thus, leukocytes were sacrificing significant portions of themselves without losing residual membrane integrity and motile function. Their behavior with respect to other particles (e. g., bacteria) will be of interest. We suggest that the membrane fusagen resides in the inner membrane leaflets when they are brought together in an extreme hourglass configuration. This event may be similar to the fragmentation of erythrocytes into intact pieces, the formation of cytokineplasts, the rear extrusion of content by migrating cells on surfaces, and the phagocytic process itself.	[Malawista, Stephen E.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Malawista, Stephen E.; de Boisfleury, Anne Chevance] Hop La Pitie Salpetriere, Ctr Ecol Cellulaire, Paris, France	Yale University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Malawista, SE (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	stephen.malawista@yale.edu						Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Brain N, 1969, NEW ENGL J MED, V281, P833; Hyun YM, 2012, J EXP MED, V209, P1349, DOI 10.1084/jem.20111426; MALAWISTA SE, 1989, J CLIN INVEST, V83, P728, DOI 10.1172/JCI113939; MALAWISTA SE, 1982, J CELL BIOL, V95, P960, DOI 10.1083/jcb.95.3.960	6	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65796	10.1371/journal.pone.0065796	http://dx.doi.org/10.1371/journal.pone.0065796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840370	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400014
J	Hoeke, L; Sharbati, J; Pawar, K; Keller, A; Einspanier, R; Sharbati, S				Hoeke, Lena; Sharbati, Jutta; Pawar, Kamlesh; Keller, Andreas; Einspanier, Ralf; Sharbati, Soroush			Intestinal Salmonella typhimurium Infection Leads to miR-29a Induced Caveolin 2 Regulation	PLOS ONE			English	Article							CELL-PROLIFERATION; EPITHELIAL-CELLS; FOCAL ADHESIONS; SHOW EVIDENCE; HOST-CELLS; MICE; EXPRESSION; INVASION; PATHOGENESIS; MECHANISMS	Background: Salmonella are able to modulate host cell functions facilitating both uptake and resistance to cellular host defence mechanisms. While interactions between bacterial modulators and cellular proteins have been the main focus of Salmonella research, relatively little is known about mammalian gene regulation in response to Salmonella infection. A major class of mammalian gene modulators consists of microRNAs. For our study we examined interactions of microRNAs and regulated mRNAs in mammalian intestinal Salmonella infections using a piglet model. Methodology/Principal Findings: After performing microRNA as well as mRNA specific microarray analysis of ileal samples from Salmonella infected as well as control piglets, we integrated expression analysis with target prediction identifying microRNAs that mainly regulate focal adhesion as well as actin cytoskeleton pathways. Particular attention was given to miR-29a, which was involved in most interactions including Caveolin 2. RT-qPCR experiments verified up-regulation of miR-29a after infection while its predicted target Caveolin 2 was significantly down-regulated as examined by transcript and protein detection. Reporter gene assays as well as RNAi experiments confirmed Caveolin 2 to be a miR-29a target. Knock-down of Caveolin 2 in intestinal epithelial cells resulted in retarded proliferation as well as increased bacterial uptake. In addition, our experiments showed that Caveolin 2 regulates the activation of the small Rho GTPase CDC42 but apparently not RAC1 in human intestinal cells. Conclusions/Significance: Our study outlines for the first time important regulation pathways in intestinal Salmonella infection pointing out that focal adhesion and organisation of actin cytoskeleton are regulated by microRNAs. Functional relevance is shown by miR-29a mediated Caveolin 2 regulation, modulating the activation state of CDC42. Further analysis of examined interactions may support the discovery of novel strategies impairing the uptake of intracellular pathogens.	[Hoeke, Lena; Sharbati, Jutta; Pawar, Kamlesh; Einspanier, Ralf; Sharbati, Soroush] Free Univ Berlin, Inst Vet Biochem, Berlin, Germany; [Keller, Andreas] Univ Saarland, Dept Human Genet, Homburg, Saar, Germany; [Keller, Andreas] Siemens AG, Healthcare Sect, Erlangen, Germany	Free University of Berlin; Saarland University; Siemens AG; Siemens Germany	Sharbati, S (corresponding author), Free Univ Berlin, Inst Vet Biochem, Berlin, Germany.	sharbati@zedat.fu-berlin.de	Pawar, Kamlesh Ganesh/M-8596-2019; Sharbati, Soroush/D-2548-2014; Keller, Andreas/ABB-6412-2021	Pawar, Kamlesh Ganesh/0000-0002-9767-0152; Keller, Andreas/0000-0002-5361-0895; Sharbati, Soroush/0000-0003-3338-7654	Deutsche Forschungsgemeinschaft [SH 465/1-1, SFB 852, B4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (SH 465/1-1 and SFB 852 project B4.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Berends BR, 1996, INT J FOOD MICROBIOL, V30, P37, DOI 10.1016/0168-1605(96)00990-7; Betts M.J., 2003, BIOINFORMA GENET, DOI DOI 10.1002/9780470059180.CH13; Boettcher JP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000457; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Chiu CH, 2004, CLIN MICROBIOL REV, V17, P311, DOI 10.1128/CMR.17.2.311-322.2004; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Corr SC, 2009, ADV FOOD NUTR RES, V56, P1, DOI 10.1016/S1043-4526(08)00601-3; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; de Almeida CJ, 2011, CELL CYCLE, V10, P2151, DOI 10.4161/cc.10.13.16234; Goetz JG, 2008, J CELL BIOL, V180, P1261, DOI 10.1083/jcb.200709019; Goetz JG, 2009, CELL ADHES MIGR, V3, P185, DOI 10.4161/cam.3.2.7295; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hayward RD, 2005, MOL MICROBIOL, V56, P590, DOI 10.1111/j.1365-2958.2005.04568.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Kum WWS, 2011, INFECT IMMUN, V79, P2554, DOI 10.1128/IAI.01235-10; Lee H, 2002, J BIOL CHEM, V277, P34556, DOI 10.1074/jbc.M204367200; Lee S, 2011, INT J ONCOL, V38, P1395, DOI 10.3892/ijo.2011.958; Lim JS, 2009, BIOCHEM BIOPH RES CO, V390, P1322, DOI 10.1016/j.bbrc.2009.10.145; Lindow M, 2012, J CELL BIOL, V199, P407, DOI 10.1083/jcb.201208082; Lippi G, 2011, J CELL BIOL, V194, P889, DOI 10.1083/jcb.201103006; Liu XY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-326; Ly KT, 2007, CELL MICROBIOL, V9, P2103, DOI 10.1111/j.1462-5822.2007.00992.x; Ma F, 2011, NAT IMMUNOL; Medina FA, 2006, INFECT IMMUN, V74, P6665, DOI 10.1128/IAI.00949-06; Misselwitz B, 2011, INFECT IMMUN, V79, P330, DOI 10.1128/IAI.00581-10; Nethe M, 2011, CELL ADHES MIGR, V5, P59, DOI 10.4161/cam.5.1.13702; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Orom U, 2012, CELL CYCLE, V11; Owen KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023123; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Razani B, 2001, J BIOL CHEM, V276, P38121; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sales G, 2010, NUCLEIC ACIDS RES, V38, pW352, DOI 10.1093/nar/gkq423; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006; Schmitt MJ, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-41; Scholven J, 2009, CELL PHYSIOL BIOCHEM, V23, P143, DOI 10.1159/000204103; Schulte LN, 2011, EMBO J, V30, P1977, DOI 10.1038/emboj.2011.94; Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Shatseva T, 2011, J CELL SCI, V124, P2826, DOI 10.1242/jcs.077529; Shi J, 2005, J BIOL CHEM, V280, P29849, DOI 10.1074/jbc.M500617200; Shi J, 2006, MOL BIOL CELL, V17, P4698, DOI 10.1091/mbc.E06-06-0492; Steibel JP, 2009, ANIM GENET, V40, P883, DOI 10.1111/j.1365-2052.2009.01928.x; Szabo I, 2009, APPL ENVIRON MICROB, V75, P2621, DOI 10.1128/AEM.01515-08; Uthe JJ, 2011, ANIM GENET, V42, P521, DOI 10.1111/j.1365-2052.2010.02171.x; van Iersel MP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-399; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang SO, 2009, CELL CYCLE, V8, P2070, DOI 10.4161/cc.8.13.8891; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Xie LK, 2011, AM J PHYSIOL-CELL PH, V301, pC1161, DOI 10.1152/ajpcell.00486.2010; Zaas David W, 2009, Commun Integr Biol, V2, P535; Zaas DW, 2009, J BIOL CHEM, V284, P9955, DOI 10.1074/jbc.M808629200	63	41	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67300	10.1371/journal.pone.0067300	http://dx.doi.org/10.1371/journal.pone.0067300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826261	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400130
J	Feulefack, JF; Luckert, MK; Mohapatra, S; Cash, SB; Alibhai, A; Kipp, W				Feulefack, Joseph F.; Luckert, Martin K.; Mohapatra, Sandeep; Cash, Sean B.; Alibhai, Arif; Kipp, Walter			Impact of Community-Based HIV/AIDS Treatment on Household Incomes in Uganda	PLOS ONE			English	Article							ANTIRETROVIRAL TREATMENT; POVERTY; TIME	Though health benefits to households in developing countries from antiretroviral treatment (ART) programs are widely reported in the literature, specific estimates regarding impacts of treatments on household incomes are rare. This type of information is important to governments and donors, as it is an indication of returns to their ART investments, and to better understand the role of HIV/AIDS in development. The objective of this study is to estimate the impact of a community-based ART program on household incomes in a previously underserved rural region of Uganda. A community-based ART program, based largely on labor contributions from community volunteers, was implemented and evaluated. All households with HIV/AIDS patients enrolled in the treatment programme (n = 134 households) were surveyed five times; once at the beginning of the treatment and every three months thereafter for a period of one year. Data were collected on household income from cash earnings and value of own production. The analysis, using ordinary least squares and quantile regressions, identifies the impact of the ART program on household incomes over the first year of the treatment, while controlling for heterogeneity in household characteristics and temporal changes. As a result of the treatment, health conditions of virtually all patients improved, and household incomes increased by approximately 30% to 40%, regardless of household income quantile. These increases in income, however, varied significantly depending on socio-demographic and socio-economic control variables. Overall, results show large and significant impacts of the ART program on household incomes, suggesting large returns to public investments in ART, and that treating HIV/AIDS is an important precondition for development. Moreover, development programs that invest in human capital and build wealth are important complements that can increase the returns to ART programs.	[Feulefack, Joseph F.; Luckert, Martin K.; Mohapatra, Sandeep] Univ Alberta, Dept Resource Econ & Environm Sociol, Edmonton, AB, Canada; [Cash, Sean B.] Tufts Univ, Friedman Sch Nutr Sci & Policy, Dept Food & Nutr Policy, Boston, MA 02111 USA; [Alibhai, Arif; Kipp, Walter] Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB, Canada	University of Alberta; Tufts University; University of Alberta	Luckert, MK (corresponding author), Univ Alberta, Dept Resource Econ & Environm Sociol, Edmonton, AB, Canada.	marty.luckert@ualberta.ca		Cash, Sean/0000-0002-7561-3392	Canadian Institutes of Health research (CIHR) [MOP-74586]	Canadian Institutes of Health research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding for this project was provided by the Canadian Institutes of Health research (CIHR), grant number MOP-74586 www.cihr.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibhai A, 2010, CURR HIV RES, V8, P370, DOI 10.2174/157016210791330400; [Anonymous], 2004, WORLD HLTH REP; Barrett CB, 2006, WORLD DEV, V34, P1, DOI 10.1016/j.worlddev.2005.06.008; Barrett CB, 2006, J DEV STUD, V42, P248, DOI 10.1080/00220380500405394; Chhagan V, 2008, HEALTH SOCIOL REV, V17, P95, DOI 10.5172/hesr.451.17.1.95; d'Adda G, 2009, AFR DEV REV, V21, P180, DOI 10.1111/j.1467-8268.2009.00207.x; Dixon S., 2001, Journal of International Development, V13, P411, DOI 10.1002/jid.795; Greener R, 2000, S AFRICAN J EC, V68, P393; Kipp W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040902; Kipp WE, 2009, AIDS CARE, V21, P118, DOI 10.1080/09540120802068761; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Krishna A, 2006, J DEV STUD, V42, P346, DOI 10.1080/00220380500405634; Kwaramba P, 1997, SOCIOECONOMIC IMPACT; Lam D, 2005, 118 CSSR U CAP TOWN; Larson BA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-240; Maher D, 2011, INT J CLIN PRACT, V65, P824, DOI 10.1111/j.1742-1241.2011.02697.x; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; Muirhead D, 2006, 16 INT AIDS C; Omar MT, 2010, P GERM DEV EC C HANN; Parker DC, 2009, INT J ENV RES PUB HE, V6, P2113, DOI 10.3390/ijerph6082113; Psacharopoulos G., 2004, EDUC ECON, V12, P111, DOI [DOI 10.1080/0964529042000239140, 10.1080/0964529042000239140]; Rubaihayo J, 2010, INFECT DIS REPORTS, V2; The World Bank Group, 2009, POV EQ; Theodore K, 2001, HIV AIDS CARIBBEAN E; Thirumurthy H, 2008, J HUM RESOUR, V43, P511, DOI 10.3368/jhr.43.3.511; *UNAIDS, 2009, AIDS EP UPD; UNAIDS, 2006, REP GLOB AIDS EP; United Nations Development Programme, 2007, ZAMB HUM DEV REP 200; United Nations Joint Program on HIV/AIDS (UNAIDS), 2010, IS THIS FUT TREATM, P46; Yamano T, 2002, 5 TEG	30	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65625	10.1371/journal.pone.0065625	http://dx.doi.org/10.1371/journal.pone.0065625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190LY	23840347	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800014
J	Cao, YX; Zhang, X; Shang, W; Xu, JJ; Wang, XH; Hu, XQ; Ao, YF; Cheng, HP				Cao, Yongxing; Zhang, Xin; Shang, Wei; Xu, Jiejia; Wang, Xianhua; Hu, Xiaoqing; Ao, Yingfang; Cheng, Heping			Proinflammatory Cytokines Stimulate Mitochondrial Superoxide Flashes in Articular Chondrocytes In Vitro and In Situ	PLOS ONE			English	Article							OSTEOARTHRITIS; METABOLISM; CARTILAGE; SURFACE	Objective: Mitochondria play important roles in many types of cells. However, little is known about mitochondrial function in chondrocytes. This study was undertaken to explore possible role of mitochondrial oxidative stress in inflammatory response in articular chondrocytes. Methods: Chondrocytes and cartilage explants were isolated from wild type or transgenic mice expressing the mitochondrial superoxide biosensor - circularly permuted yellow fluorescent protein (cpYFP). Cultured chondrocytes or cartilage explants were incubated in media containing interleukin-1 beta (10 ng/ml) or tumor necrosis factor-alpha (10 ng/ml) to stimulate an inflammatory response. Mitochondrial imaging was carried out by confocal and two-photon microscopy. Mitochondrial oxidative status was evaluated by "superoxide flash'' activity recorded with time lapse scanning. Results: Cultured chondrocytes contain abundant mitochondria that show active motility and dynamic morphological changes. In intact cartilage, mitochondrial abundance as well as chondrocyte density declines with distance from the surface. Importantly, sudden, bursting superoxide-producing events or "superoxide flashes'' occur at single-mitochondrion level, accompanied by transient mitochondrial swelling and membrane depolarization. The superoxide flash incidence in quiescent chondrocytes was similar to 4.5 and similar to 0.5 events/1000 mu m(2)* 100 s in vitro and in situ, respectively. Interleukin-1 beta or tumor necrosis factor-alpha stimulated mitochondrial superoxide flash activity by 2-fold in vitro and 5-fold in situ, without altering individual flash properties except for reduction in spatial size due to mitochondrial fragmentation. Conclusions: The superoxide flash response to proinflammatory cytokine stimulation in vitro and in situ suggests that chondrocyte mitochondria are a significant source of cellular oxidants and are an important previously under-appreciated mediator in inflammatory cartilage diseases.	[Cao, Yongxing; Zhang, Xin; Hu, Xiaoqing; Ao, Yingfang] Peking Univ, Inst Sports Med, Hosp 3, Beijing 100871, Peoples R China; [Shang, Wei; Xu, Jiejia; Wang, Xianhua; Cheng, Heping] Peking Univ, State Key Lab Biomembrane & Membrane Biotechnol, Inst Mol Med, Beijing 100871, Peoples R China	Peking University; Peking University	Ao, YF (corresponding author), Peking Univ, Inst Sports Med, Hosp 3, Beijing 100871, Peoples R China.	yingfang.ao@vip.sina.com	Heping, Cheng/AAE-2680-2019; cheng, heping/A-7299-2011	Heping, Cheng/0000-0002-9604-6702; Xu, Jiejia/0000-0003-3885-3546	National Basic Research Program of China [2013CB531200, 2011CB809102]; National Natural Science Foundation of China [81071474, 81171726]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2013CB531200 and 2011CB809102, URL: http://www.most.gov.cn) and the National Natural Science Foundation of China (81071474 and 81171726, URL: http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer CW, 2003, INT J BIOCHEM CELL B, V35, P401, DOI 10.1016/S1357-2725(02)00301-1; Brennan FM, 1998, SPRINGER SEMIN IMMUN, V20, P133, DOI 10.1007/BF00832003; Cadenas E, 1998, FREE RADICAL RES, V28, P601, DOI 10.3109/10715769809065816; Cillero-Pastor B, 2008, ARTHRITIS RHEUM-US, V58, P2409, DOI 10.1002/art.23644; Fang HQ, 2011, CELL RES, V21, P1295, DOI 10.1038/cr.2011.81; FERRELL WR, 1992, J PHYSIOL-LONDON, V449, P607, DOI 10.1113/jphysiol.1992.sp019104; Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X; Heywood HK, 2008, BIOCHEM BIOPH RES CO, V373, P224, DOI 10.1016/j.bbrc.2008.06.011; Hollander AP, 1995, J CLIN INVEST, V96, P2859, DOI 10.1172/JCI118357; Huber M, 2000, INVEST RADIOL, V35, P573, DOI 10.1097/00004424-200010000-00003; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kellner K, 2002, BIOTECHNOL BIOENG, V80, P73, DOI 10.1002/bit.10352; Knott AB, 2008, NAT REV NEUROSCI, V9, P505, DOI 10.1038/nrn2417; Lee RB, 1997, BIOCHEM J, V321, P95, DOI 10.1042/bj3210095; Li KT, 2009, BIOPHYS J, V96, p531A, DOI 10.1016/j.bpj.2008.12.2743; Li TS, 2010, STEM CELLS, V28, P1178, DOI 10.1002/stem.438; Lopez-Armada MJ, 2006, OSTEOARTHR CARTILAGE, V14, P660, DOI 10.1016/j.joca.2006.01.005; Ma Q, 2011, J BIOL CHEM, V286, P27573, DOI 10.1074/jbc.M111.241794; Maneiro E, 2003, ARTHRITIS RHEUM, V48, P700, DOI 10.1002/art.10837; Martin JA, 2012, OSTEOARTHR CARTILAGE, V20, P323, DOI 10.1016/j.joca.2012.01.003; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; OTTE P, 1991, Z RHEUMATOL, V50, P304; Ovchinnikov D, 2009, COLD SPRING HARB PRO; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Pouvreau S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013035; SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050; STOCKWELL RA, 1991, J ANAT, V175, P251; Takahashi T, 1998, ORAL SURG ORAL MED O, V85, P135, DOI 10.1016/S1079-2104(98)90415-2; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vaamonde-Garcia C, 2012, ARTHRITIS RHEUM-US, V64, P2927, DOI 10.1002/art.34508; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Wang W, 2008, CELL, V134, P279, DOI 10.1016/j.cell.2008.06.017; Ward JPT, 2008, BBA-BIOENERGETICS, V1777, P1, DOI 10.1016/j.bbabio.2007.10.010; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhou SD, 2004, ARTHRITIS RHEUM-US, V50, P3915, DOI 10.1002/art.20675	37	29	34	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66444	10.1371/journal.pone.0066444	http://dx.doi.org/10.1371/journal.pone.0066444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840469	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200079
J	Dong, MH; Zhao, L; Yuan, K; Zeng, F; Sun, JB; Liu, JX; Yu, DH; von Deneen, KM; Liang, FR; Qin, W; Tian, J				Dong, Minghao; Zhao, Ling; Yuan, Kai; Zeng, Fang; Sun, Jinbo; Liu, Jixin; Yu, Dahua; von Deneen, Karen M.; Liang, Fanrong; Qin, Wei; Tian, Jie			Length of Acupuncture Training and Structural Plastic Brain Changes in Professional Acupuncturists	PLOS ONE			English	Article							TACTILE SPATIAL-RESOLUTION; HUMAN CEREBELLUM; PREFRONTAL CORTEX; MR-IMAGES; MECHANISMS; PAIN; DISCRIMINATION; REGISTRATION; RELIABILITY; CINGULATE	Background: The research on brain plasticity has fascinated researchers for decades. Use/training serves as an instrumental factor to influence brain neuroplasticity. Parallel to acquisition of behavioral expertise, extensive use/training is concomitant with substantial changes of cortical structure. Acupuncturists, serving as a model par excellence to study tactile-motor and emotional regulation plasticity, receive intensive training in national medical schools following standardized training protocol. Moreover, their behavioral expertise is corroborated during long-term clinical practice. Although our previous study reported functional plastic brain changes in the acupuncturists, whether or not structural plastic changes occurred in acupuncturists is yet elusive. Methodology/Principal Findings: Cohorts of acupuncturists (N = 22) and non-acupuncturists (N = 22) were recruited. Behavioral tests were delivered to assess the acupuncturists' behavioral expertise. The results confirmed acupuncturists' tactile-motor skills and emotion regulation proficiency compared to non-acupuncturists. Using the voxel-based morphometry technique, we revealed larger grey matter volumes in acupuncturists in the hand representation of the contralateral primary somatosensory cortex (SI), the right lobule V/VI and the bilateral ventral anterior cingulate cortex/ventral medial prefrontal cortex. Grey matter volumes of the SI and Lobule V/VI positively correlated with the duration of acupuncture practice. Conclusions: To our best knowledge, this study provides first evidence for the anatomical alterations in acupuncturists, which would possibly be the neural correlates underlying acupuncturists' exceptional skills. On one hand, we suggest our findings may have ramifications for tactile-motor rehabilitation. On the other hand, our results in emotion regulation domain may serve as a target for our future studies, from which we can understand how modulations of aversive emotions elicited by empathic pain develop in the context of expertise. Future longitudinal study is necessary to establish the presence and direction of a causal link between practice/use and brain anatomy.	[Dong, Minghao; Yuan, Kai; Sun, Jinbo; Liu, Jixin; Yu, Dahua; von Deneen, Karen M.; Qin, Wei; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Zhao, Ling; Zeng, Fang; Liang, Fanrong] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Sichuan, Peoples R China; [Yu, Dahua] Inner Mongolia Univ Sci & Technol, Sch Informat Engn, Informat Proc Lab, Baotou, Inner Mongolia, Peoples R China; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Chengdu University of Traditional Chinese Medicine; Inner Mongolia University of Science & Technology; Chinese Academy of Sciences; Institute of Automation, CAS	Qin, W (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	wqin@xidian.edu.cn; tian@ieee.org	Dong, Minghao/A-6425-2014; Yu, Dahua/N-7242-2013; 秦, 伟/J-9770-2016; Yuan, Kai/M-9403-2013; JinBo, Sun/GLT-2082-2022; tian, jie/M-6336-2013; Tian, Jie/H-1190-2011; Life, PAM/M-9552-2013; Yuan, Kai/I-4150-2016	Dong, Minghao/0000-0002-0190-6985; Yu, Dahua/0000-0001-7850-7512; 秦, 伟/0000-0003-4583-0406; Tian, Jie/0000-0003-0498-0432; Yuan, Kai/0000-0002-3098-1124; Liang, Fanrong/0000-0003-2210-2027	Project for the National Key Basic Research and Development Program (973) [2011CB707702, 2012CB518501]; National Natural Science Foundation of China [30930112, 30970774, 81000640, 81000641, 81101036, 81030027, 81101108, 31150110171, 30901900, 81271644, 31200837]; Fundamental Research Funds for the Central Universities	Project for the National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This paper is supported by the Project for the National Key Basic Research and Development Program (973) under Grant Nos. 2011CB707702, 2012CB518501, the National Natural Science Foundation of China under Grant Nos. 30930112, 30970774, 81000640, 81000641, 81101036, 81030027, 81101108, 31150110171, 30901900, 81271644, 31200837, the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert J, 2011, HUM BRAIN MAPP; Andersson J.L.R, 2007, TR07JA2 FMRIB; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; Cheng XN, 2010, CHINESE ACUPUNCTURE; Cheng YW, 2007, CURR BIOL, V17, P1708, DOI 10.1016/j.cub.2007.09.020; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; Davis M. H., 1994, EMPATHY SOCIAL PSYCH; Diedrichsen J, 2010, CURR OPIN NEUROL, V23, P382, DOI 10.1097/WCO.0b013e32833be837; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Fields RD, 2011, NEUROSCIENTIST, V17, P185, DOI 10.1177/1073858410383696; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Goldreich D, 2003, J NEUROSCI, V23, P3439; Good C, 2002, VOXEL BASED MORPHOME; Grodd W, 2001, HUM BRAIN MAPP, V13, P55, DOI 10.1002/hbm.1025; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Herdener M, 2010, J NEUROSCI, V30, P1377, DOI 10.1523/JNEUROSCI.4513-09.2010; Jancke L, 2009, RESTOR NEUROL NEUROS, V27, P521, DOI 10.3233/RNN-2009-0519; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JOHNSON KO, 1992, ANNU REV NEUROSCI, V15, P227, DOI 10.1146/annurev.ne.15.030192.001303; JOHNSON KO, 1981, J NEUROPHYSIOL, V46, P1177, DOI 10.1152/jn.1981.46.6.1177; Koeneke S, 2004, NEUROREPORT, V15, P1279, DOI 10.1097/01.wnr.0000127463.10147.e7; Lamm C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001292; Larsell O, 1972, COMP ANATOMY HISTOLO; Lissek S, 2009, CURR BIOL, V19, P837, DOI 10.1016/j.cub.2009.03.065; Luders E, 2009, NEUROIMAGE, V45, P672, DOI 10.1016/j.neuroimage.2008.12.061; Manto MU, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00001; May A, 2011, TRENDS COGN SCI; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park IS, 2009, CEREBELLUM, V8, P334, DOI 10.1007/s12311-009-0100-1; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sathian K, 1996, NEUROLOGY, V46, P1464, DOI 10.1212/WNL.46.5.1464; Schmahmann J.D., 2000, MRI ATLAS HUMAN CERE; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Tegenthoff M, 2005, PLOS BIOL, V3, P2031, DOI 10.1371/journal.pbio.0030362; Van Boven RW, 2000, NEUROLOGY, V54, P2230; Van Boven RW, 2005, P NATL ACAD SCI USA, V102, P12601, DOI 10.1073/pnas.0505907102; VANBOVEN RW, 1994, BRAIN, V117, P149, DOI 10.1093/brain/117.1.149; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wolpert DM, 2011, NAT REV NEUROSCI; Wong M, 2011, J NEUROSCI, V31, P7028, DOI 10.1523/JNEUROSCI.6461-10.2011; Yang J. C., 1983, PAIN MEASUREMENT ASS; Zhang MM, 2005, HUM BRAIN MAPP, V25, P370, DOI 10.1002/hbm.20107; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	61	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66591	10.1371/journal.pone.0066591	http://dx.doi.org/10.1371/journal.pone.0066591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840505	gold, Green Submitted, Green Published			2022-12-27	WOS:000322361200094
J	Dorresteijn, I; Hartel, T; Hanspach, J; von Wehrden, H; Fischer, J				Dorresteijn, Ine; Hartel, Tibor; Hanspach, Jan; von Wehrden, Henrik; Fischer, Joern			The Conservation Value of Traditional Rural Landscapes: The Case of Woodpeckers in Transylvania, Romania	PLOS ONE			English	Article							MIDDLE SPOTTED WOODPECKER; HOME-RANGE SIZE; DENDROCOPOS-MINOR; SPECIES RICHNESS; SCATTERED TREES; HABITAT AREA; FOREST; WESTERN; BIRDS; FRAGMENTATION	Land use change is a major threat to global biodiversity. Forest species face the dual threats of deforestation and intensification of forest management. In regions where forests are under threat, rural landscapes that retain structural components of mature forests potentially provide valuable additional habitat for some forest species. Here, we illustrate the habitat value of traditional wood pastures for a woodpecker assemblage of six species in southern Transylvania, Romania. Wood pastures are created by long-term stable silvo-pastoral management practices, and are composed of open grassland with scattered large, old trees. Because of their demanding habitat requirements, woodpeckers share habitat with many other bird species, and have been considered as possible indicator species for bird species diversity. We first compared woodpecker assemblages between forests and wood pastures. Second, we grouped features of wood pastures into three spatial contexts and addressed how these features related to the occurrence of three woodpecker species that are formally protected. Woodpecker species composition, but not the number of species, differed between forests and wood pastures, with the green woodpecker occurring more commonly in wood pastures, and the lesser spotted woodpecker more commonly in forests. Within wood pastures, the intermediate context (especially surrounding forest cover) best explained the presence of the grey-headed and middle spotted woodpecker. By contrast, variables describing local vegetation structure and characteristics of the surrounding landscape did not affect woodpecker occurrence in wood pastures. In contrast to many other parts of Europe, in which several species of woodpeckers have declined, the traditional rural landscape of Transylvania continues to provide habitat for several woodpecker species, both in forests and wood pastures. Given the apparent habitat value of wood pastures for woodpeckers we recommend wood pastures be explicitly considered in relevant policies of the European Union, namely the Habitats Directive and the EU Common Agricultural Policy.	[Dorresteijn, Ine; Hartel, Tibor; Hanspach, Jan; von Wehrden, Henrik; Fischer, Joern] Univ Luneburg, Fac Sustainabil, D-21335 Luneburg, Germany; [von Wehrden, Henrik] Univ Luneburg, Ctr Methods, D-21335 Luneburg, Germany; [Hartel, Tibor] Sapientia Univ, Dept Environm Sci, Cluj Napoca, Romania	Leuphana University Luneburg; Leuphana University Luneburg; Sapientia Hungarian University of Transylvania	Dorresteijn, I (corresponding author), Univ Luneburg, Fac Sustainabil, D-21335 Luneburg, Germany.	ine.dorresteijn@gmail.com	Tibor, Hartel/B-3440-2012; Fischer, Joern/W-5380-2019; Fischer, Joern/C-6625-2012	Fischer, Joern/0000-0003-3187-8978; Hanspach, Jan/0000-0002-6638-8699; Dorresteijn, Ine/0000-0001-9785-4982	Alexander von Humboldt Foundation	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	The project was funded by the Alexander von Humboldt Foundation through a Sofja Kovalevskaja Award to JF. The research stay of TH in Germany is funded by the Alexander von Humboldt foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder D, 2010, BIRD STUDY, V57, P100, DOI 10.1080/00063650903437511; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; ANGELSTAM P, 1994, ANN ZOOL FENN, V31, P157; Barrientos R, 2010, FOREST ECOL MANAG, V260, P595, DOI 10.1016/j.foreco.2010.05.015; Bauhus J, 2009, FOREST ECOL MANAG, V258, P525, DOI 10.1016/j.foreco.2009.01.053; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bergmeier E, 2010, BIODIVERS CONSERV, V19, P2995, DOI 10.1007/s10531-010-9872-3; Blom S, 2012, 20 JORDBR, P20; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CONNER RN, 1991, WILSON BULL, V103, P446; Dauber J, 2006, CONSERV BIOL, V20, P1150, DOI 10.1111/j.1523-1739.2006.00373.x; Donald PF, 2006, J APPL ECOL, V43, P209, DOI 10.1111/j.1365-2664.2006.01146.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Goldberg E, 2007, J NAT CONSERV, V15, P109, DOI 10.1016/j.jnc.2007.04.001; HARTEL T., 2010, GOOD PRACTICE MANAGE; Horak J, 2013, J INSECT CONSERV, V17, P307, DOI 10.1007/s10841-012-9511-2; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Knorn J, 2012, BIOL CONSERV, V146, P204, DOI 10.1016/j.biocon.2011.12.020; Knorn J, 2009, REMOTE SENS ENVIRON, V113, P957, DOI 10.1016/j.rse.2009.01.010; Kosinski Z, 2007, POL J ECOL, V55, P519; Kumar R, 2010, J FIELD ORNITHOL, V81, P215, DOI 10.1111/j.1557-9263.2009.00267.x; Lammertink M, 2009, BIOL CONSERV, V142, P166, DOI 10.1016/j.biocon.2008.10.010; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Manning AD, 2009, J APPL ECOL, V46, P915, DOI 10.1111/j.1365-2664.2009.01657.x; Mikusinski G, 1998, CONSERV BIOL, V12, P200, DOI 10.1046/j.1523-1739.1998.96310.x; Mountford EP, 2003, FORESTRY, V76, P19, DOI 10.1093/forestry/76.1.19; Paltto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024675; Pasinelli G, 2000, BIOL CONSERV, V93, P227, DOI 10.1016/S0006-3207(99)00137-8; PETTERSSON B, 1985, HOLARCTIC ECOL, V8, P53; R Development Core Team, 2011, R LANG ENV STAT COMP; Roberge JM, 2008, BIOL CONSERV, V141, P997, DOI 10.1016/j.biocon.2008.01.010; Roberge JM, 2006, BIOL CONSERV, V130, P134, DOI 10.1016/j.biocon.2005.12.008; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Robles H, 2007, FOREST ECOL MANAG, V242, P343, DOI 10.1016/j.foreco.2007.01.052; Robles H, 2011, FOREST ECOL MANAG, V261, P1428, DOI 10.1016/j.foreco.2011.01.029; ROLSTAD J, 1995, ORNIS FENNICA, V72, P1; Rolstad J, 2000, OECOLOGIA, V124, P116, DOI 10.1007/s004420050031; Shurulinkov P, 2012, ACTA ZOOL BULGAR, V64, P43; Taboada A, 2006, FOREST ECOL MANAG, V237, P436, DOI 10.1016/j.foreco.2006.09.077; TJERNBERG M, 1993, ORNIS FENNICA, V70, P155; Tryjanowski P, 2011, ACTA ORNITHOL, V46, P1, DOI 10.3161/000164511X589857; Wiktander U, 2001, BIOL CONSERV, V100, P387, DOI 10.1016/S0006-3207(01)00045-3; WIKTANDER U, 1992, ORNIS FENNICA, V69, P113	45	35	39	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65236	10.1371/journal.pone.0065236	http://dx.doi.org/10.1371/journal.pone.0065236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840322	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200012
J	Fagundo, AB; de la Torre, R; Jimenez-Murcia, S; Aguera, Z; Pastor, A; Casanueva, FF; Granero, R; Banos, R; Botella, C; del Pino-Gutierrez, A; Fernandez-Real, JM; Fernandez-Garcia, JC; Fruhbeck, G; Gomez-Ambrosi, J; Menchon, JM; Moragrega, I; Rodriguez, R; Tarrega, S; Tinahones, FJ; Fernandez-Aranda, F				Fagundo, Ana B.; de la Torre, Rafael; Jimenez-Murcia, Susana; Agueera, Zaida; Pastor, Antoni; Casanueva, Felipe F.; Granero, Roser; Banos, Rosa; Botella, Cristina; del Pino-Gutierrez, Amparo; Fernandez-Real, Jose M.; Fernandez-Garcia, Jose C.; Fruehbeck, Gema; Gomez-Ambrosi, Javier; Menchon, Jose M.; Moragrega, Ines; Rodriguez, Roser; Tarrega, Salome; Tinahones, Francisco J.; Fernandez-Aranda, Fernando			Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans	PLOS ONE			English	Article							ABSTINENT MARIJUANA USERS; MEDIAL PREFRONTAL CORTEX; CEREBRAL-BLOOD-FLOW; CANNABINOID RECEPTOR; NUCLEUS-ACCUMBENS; ANOREXIA-NERVOSA; DECISION-MAKING; SPATIAL MEMORY; CB1 RECEPTORS; BRAIN	Animal studies point to an implication of the endocannabinoid system on executive functions. In humans, several studies have suggested an association between acute or chronic use of exogenous cannabinoids (Delta 9-tetrahydrocannabinol) and executive impairments. However, to date, no published reports establish the relationship between endocannabinoids, as biomarkers of the cannabinoid neurotransmission system, and executive functioning in humans. The aim of the present study was to explore the association between circulating levels of plasma endocannabinoids N-arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) and executive functions (decision making, response inhibition and cognitive flexibility) in healthy subjects. One hundred and fifty seven subjects were included and assessed with the Wisconsin Card Sorting Test; Stroop Color and Word Test; and Iowa Gambling Task. All participants were female, aged between 18 and 60 years and spoke Spanish as their first language. Results showed a negative correlation between 2-AG and cognitive flexibility performance (r = -.37; p<.05). A positive correlation was found between AEA concentrations and both cognitive flexibility (r = .59; p,. 05) and decision making performance (r = .23; P<.05). There was no significant correlation between either 2-AG (r = -.17) or AEA (r = -.08) concentrations and inhibition response. These results show, in humans, a relevant modulation of the endocannabinoid system on prefrontal-dependent cognitive functioning. The present study might have significant implications for the underlying executive alterations described in some psychiatric disorders currently associated with endocannabinoids deregulation (namely drug abuse/dependence, depression, obesity and eating disorders). Understanding the neurobiology of their dysexecutive profile might certainly contribute to the development of new treatments and pharmacological approaches.	[Fagundo, Ana B.; Jimenez-Murcia, Susana; del Pino-Gutierrez, Amparo; Menchon, Jose M.; Fernandez-Aranda, Fernando] Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain; [Fagundo, Ana B.; de la Torre, Rafael; Jimenez-Murcia, Susana; Agueera, Zaida; Casanueva, Felipe F.; Granero, Roser; Banos, Rosa; Botella, Cristina; Fernandez-Real, Jose M.; Fernandez-Garcia, Jose C.; Fruehbeck, Gema; Gomez-Ambrosi, Javier; Moragrega, Ines; Rodriguez, Roser; Tinahones, Francisco J.; Fernandez-Aranda, Fernando] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Barcelona, Spain; [de la Torre, Rafael; Pastor, Antoni] Hosp del Mar, Human Pharmacol & Clin Neurosci Res Grp, Neurosci Res Program, IMIM,Med Res Inst, Barcelona, Spain; [Jimenez-Murcia, Susana; Menchon, Jose M.; Fernandez-Aranda, Fernando] Univ Barcelona, Dept Clin Sci, Sch Med, Barcelona, Spain; [Pastor, Antoni] Univ Autonoma Barcelona, Dept Pharmacol, Sch Med, E-08193 Barcelona, Spain; [Casanueva, Felipe F.] Univ Santiago de Compostela, Div Endocrine, Complejo Hosp U Santiago, Santiago De Compostela, Spain; [Granero, Roser; Tarrega, Salome] Univ Autonoma Barcelona, Dept Psicobiol & Metodol, E-08193 Barcelona, Spain; [Banos, Rosa] Univ Valencia, Dept Personal Evaluat & Psychol Treatment, Valencia, Spain; [Botella, Cristina; Moragrega, Ines] Univ Jaume 1, Dept Basic Psychol Clin & Psychobiol, Castellon de La Plana, Spain; [del Pino-Gutierrez, Amparo] Univ Barcelona, Nursing Dept Publ Hlth Maternal & Child Hlth, Sch Nursing, Barcelona, Spain; [Fernandez-Real, Jose M.; Rodriguez, Roser] Hosp Dr Josep Trueta, Inst Invest Biomed Girona IdlBGi, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Fernandez-Garcia, Jose C.; Tinahones, Francisco J.] Hosp Clin Univ Virgen de Victoria, Dept Endocrinol & Nutr, Malaga, Spain; [Fruehbeck, Gema; Gomez-Ambrosi, Javier] Univ Navarra, Dept Endocrinol & Nutr, Univ Navarra Clin, E-31080 Pamplona, Spain; [Menchon, Jose M.] Inst Salud Carlos III, CIBER Salud Mental CIBERsam, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Autonomous University of Barcelona; Universidade de Santiago de Compostela; Autonomous University of Barcelona; University of Valencia; Universitat Jaume I; University of Barcelona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III	Fernandez-Aranda, F (corresponding author), Univ Hosp Bellvitge IDIBELL, Dept Psychiat, Barcelona, Spain.	ffernandez@bellvitgehospital.cat	de la Torre, Rafael/D-3561-2018; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Gómez-Ambrosi, Javier/D-2984-2017; Fernandez-Garcia, Jose Carlos/B-5312-2013; Larrea, Salomé Tárrega/AAE-2684-2020; Tárrega, Salomé/D-8876-2011; Botella, Cristina/F-9230-2010; JIMENEZ-MURCIA, SUSANA/L-9786-2014; AGÜERA, ZAIDA/K-9771-2014; Moragrega, Inés/EWO-1656-2022; Tinahones, Francisco José/AAB-2882-2020; Granero, Roser/F-9492-2016; Granero, Roser/S-3529-2019; BAÑOS, ROSA MARIA/C-6077-2011; Fernández-Real, Jose Manuel/AGH-3599-2022; del Pino-Gutiérrez, Amparo/L-5347-2014; Pastor, Antoni/AAD-4638-2020; Fernandez-Aranda, Fernando/L-9762-2014; Menchon, Jose/A-5242-2009	de la Torre, Rafael/0000-0002-6765-1866; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Gómez-Ambrosi, Javier/0000-0001-5601-1604; Fernandez-Garcia, Jose Carlos/0000-0003-2229-8488; Larrea, Salomé Tárrega/0000-0002-5820-6795; Tárrega, Salomé/0000-0002-5820-6795; Botella, Cristina/0000-0001-8783-6959; JIMENEZ-MURCIA, SUSANA/0000-0002-3596-8033; AGÜERA, ZAIDA/0000-0003-4453-4939; Granero, Roser/0000-0001-6308-3198; BAÑOS, ROSA MARIA/0000-0003-0626-7665; Fernández-Real, Jose Manuel/0000-0002-7442-9323; del Pino-Gutiérrez, Amparo/0000-0002-2854-9850; Pastor, Antoni/0000-0003-3692-0696; Fernandez-Aranda, Fernando/0000-0002-2968-9898; Ines, Moragrega/0000-0002-2012-9763; Fagundo, Ana Beatriz/0000-0003-1703-9457; Menchon, Jose/0000-0002-6231-6524; Tinahones, Francisco J/0000-0001-6871-4403	Fondo de Investigacion Sanitaria - FIS [PI081714, PI11/210]; AGAUR [2009SGR1554, 2009SGR718]	Fondo de Investigacion Sanitaria - FIS; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR))	Financial support was received from Fondo de Investigacion Sanitaria - FIS (PI081714; PI11/210) and AGAUR (2009SGR1554, 2009SGR718). Ministerio de Ciencia e Innovacion Subprograma Juan de la Cierva (JCI-2011-09248). CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn) and CIBER Salud Mental (CIBERsam), are an initiative of ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton CH, 2011, ACTA PSYCHIAT SCAND, V124, P250, DOI 10.1111/j.1600-0447.2011.01687.x; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Beltramo M, 2000, NEUROREPORT, V11, P1231, DOI 10.1097/00001756-200004270-00018; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bolla KI, 2002, NEUROLOGY, V59, P1337, DOI 10.1212/01.WNL.0000031422.66442.49; Bolla KI, 2005, NEUROIMAGE, V26, P480, DOI 10.1016/j.neuroimage.2005.02.012; Borgwardt SJ, 2008, BIOL PSYCHIAT, V64, P966, DOI 10.1016/j.biopsych.2008.05.011; Burston JJ, 2010, BRIT J PHARMACOL, V161, P103, DOI 10.1111/j.1476-5381.2010.00870.x; Busquets-Garcia A, 2011, BIOL PSYCHIAT, V70, P479, DOI 10.1016/j.biopsych.2011.04.022; Crean RD, 2011, J ADDICT MED, V5, P1, DOI 10.1097/ADM.0b013e31820c23fa; Danner UN, 2012, EUR EAT DISORD REV, V20, pe56, DOI 10.1002/erv.1098; De Vries TJ, 2005, TRENDS PHARMACOL SCI, V26, P420, DOI 10.1016/j.tips.2005.06.002; Depoortere R, 2005, NEUROPSYCHOPHARMACOL, V30, P1963, DOI 10.1038/sj.npp.1300772; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1999, LIPIDS, V34, pS319, DOI 10.1007/BF02562332; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Di Marzo V, 2000, CURR PHARM DESIGN, V6, P1361; Di Marzo V, 2008, TRENDS PHARMACOL SCI, V29, P229, DOI 10.1016/j.tips.2008.03.001; Di Marzo V, 2011, NAT NEUROSCI, V14, P9, DOI 10.1038/nn.2720; Diana M, 1998, EUR J NEUROSCI, V10, P2825, DOI 10.1111/j.1460-9568.1998.00292.x; Egerton A, 2005, NEUROPSYCHOPHARMACOL, V30, P1895, DOI 10.1038/sj.npp.1300715; Egerton A, 2006, NEUROSCI BIOBEHAV R, V30, P680, DOI 10.1016/j.neubiorev.2005.12.002; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; Egertova M, 2003, NEUROSCIENCE, V119, P481, DOI 10.1016/S0306-4522(03)00145-3; Eldreth DA, 2004, NEUROIMAGE, V23, P914, DOI 10.1016/j.neuroimage.2004.07.032; Fagundo AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043382; Gaetani S, 2008, Eat Weight Disord, V13, pe42; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Gligorovic M, 2013, J INTELLECT DEV DISA; Golden C.J., 1978, STROOP COLOR WORD TE; Gruber SA, 2005, COGNITIVE BRAIN RES, V23, P107, DOI 10.1016/j.cogbrainres.2005.02.016; Hajos N, 2002, CHEM PHYS LIPIDS, V121, P73, DOI 10.1016/S0009-3084(02)00149-4; Heaton, 1981, WISCONSIN CARD SORTI; HERKENHAM M, 1992, ANN NY ACAD SCI, V654, P19, DOI 10.1111/j.1749-6632.1992.tb25953.x; Hill MN, 2006, PSYCHOPHARMACOLOGY, V187, P245, DOI 10.1007/s00213-006-0421-4; Hill MN, 2005, NEUROPSYCHOPHARMACOL, V30, P508, DOI 10.1038/sj.npp.1300601; Klugmann Matthias, 2011, Front Behav Neurosci, V5, P37, DOI 10.3389/fnbeh.2011.00037; Kofalvi A, 2005, J NEUROSCI, V25, P2874, DOI 10.1523/JNEUROSCI.4232-04.2005; Koppel J, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-2; Lacroix L, 2002, BEHAV BRAIN RES, V133, P69, DOI 10.1016/S0166-4328(01)00442-9; Lafenetre P, 2009, NEUROPHARMACOLOGY, V57, P715, DOI 10.1016/j.neuropharm.2009.07.014; Lane SD, 2005, NEUROPSYCHOPHARMACOL, V30, P800, DOI 10.1038/sj.npp.1300620; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; Luchicchi A, 2012, MOL NEUROBIOL, V46, P374, DOI 10.1007/s12035-012-8299-0; Lundqvist T, 2005, PHARMACOL BIOCHEM BE, V81, P319, DOI 10.1016/j.pbb.2005.02.017; Maccarrone M, 2008, NAT NEUROSCI, V11, P152, DOI 10.1038/nn2042; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Mathew RJ, 1999, ACTA PSYCHIAT SCAND, V100, P67, DOI 10.1111/j.1600-0447.1999.tb10916.x; Mathew RJ, 2002, PSYCHIAT RES-NEUROIM, V116, P173, DOI 10.1016/S0925-4927(02)00069-0; Mato S, 2004, NEUROPHARMACOLOGY, V46, P716, DOI 10.1016/j.neuropharm.2003.11.004; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McDonald J, 2003, NEUROPSYCHOPHARMACOL, V28, P1356, DOI 10.1038/sj.npp.1300176; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Monteleone P, 2009, GENES BRAIN BEHAV, V8, P728, DOI 10.1111/j.1601-183X.2009.00518.x; Nomura DK, 2008, BIOORG MED CHEM LETT, V18, P5875, DOI 10.1016/j.bmcl.2008.08.007; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Pattij T, 2007, PSYCHOPHARMACOLOGY, V193, P85, DOI 10.1007/s00213-007-0773-4; Pazos MR, 2008, CURR PHARM DESIGN, V14, P2317, DOI 10.2174/138161208785740108; Petrosino S, 2009, CURR OPIN CHEM BIOL, V13, P309, DOI 10.1016/j.cbpa.2009.04.616; Pistis M, 2002, EUR J NEUROSCI, V15, P1795, DOI 10.1046/j.1460-9568.2002.02019.x; Pope HG, 2001, ARCH GEN PSYCHIAT, V58, P909, DOI 10.1001/archpsyc.58.10.909; Ramaekers JG, 2006, NEUROPSYCHOPHARMACOL, V31, P2296, DOI 10.1038/sj.npp.1301068; Robbe D, 2002, P NATL ACAD SCI USA, V99, P8384, DOI 10.1073/pnas.122149199; Rubino T, 2008, NEUROPSYCHOPHARMACOL, V33, P2760, DOI 10.1038/sj.npp.1301664; Rubino T, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00064; Schlicker E, 2001, TRENDS PHARMACOL SCI, V22, P565, DOI 10.1016/S0165-6147(00)01805-8; Sokolic L, 2011, BEHAV PHARMACOL, V22, P191, DOI 10.1097/FBP.0b013e328345c82b; Solowij N, 2002, JAMA-J AM MED ASSOC, V287, P1123, DOI 10.1001/jama.287.9.1123; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; Stefani MR, 2003, ANN NY ACAD SCI, V1003, P464, DOI 10.1196/annals.1300.064; Stefani MR, 2003, BEHAV NEUROSCI, V117, P728, DOI 10.1037/0735-7044.117.4.728; Stoving RK, 2009, J PSYCHIATR RES, V43, P671, DOI 10.1016/j.jpsychires.2008.09.007; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Takahashi RN, 2005, NEUROSCI LETT, V380, P270, DOI 10.1016/j.neulet.2005.01.049; Tchanturia K, 2012, EUR EAT DISORD REV, V20, P169, DOI 10.1002/erv.1154; Varvel SA, 2005, PSYCHOPHARMACOLOGY, V179, P863, DOI 10.1007/s00213-004-2121-2; Varvel SA, 2002, J PHARMACOL EXP THER, V301, P915, DOI 10.1124/jpet.301.3.915; Verrico CD, 2003, SYNAPSE, V49, P61, DOI 10.1002/syn.10215; Volkow ND, 1996, PSYCHIAT RES-NEUROIM, V67, P29, DOI 10.1016/0925-4927(96)02817-X; Whitlow CT, 2004, DRUG ALCOHOL DEPEN, V76, P107, DOI 10.1016/j.drugalcdep.2004.04.009; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	81	20	21	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66387	10.1371/journal.pone.0066387	http://dx.doi.org/10.1371/journal.pone.0066387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840456	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200070
J	Perry, GML; Scheinman, SJ; Asplin, JR				Perry, Guy M. L.; Scheinman, Steven J.; Asplin, John R.			Effects of Sex on Intra-Individual Variance in Urinary Solutes in Stone-Formers Collected from a Single Clinical Laboratory	PLOS ONE			English	Article							CALCIUM EXCRETION; HEALTHY-SUBJECTS; PROTEIN; OXALATE; CITRATE; VARIABILITY; PHOSPHORUS; BIOMARKER; CHILDREN; HISTORY	Background/Aims: Our work in a rodent model of urinary calcium suggests genetic and gender effects on increased residual variability in urine chemistries. Based on these findings, we hypothesized that sex would similarly be associated with residual variation in human urine solutes. Sex-related effects on residuals might affect the establishment of physiological baselines and error in medical assays. Methods: We tested the effects of sex on residual variation in urine chemistry by estimating coefficients of variation (CV) for urinary solutes in paired sequential 24-h urines (<= 72 hour interval) in 6,758 females and 9,024 males aged 16-80 submitted to a clinical laboratory. Results: Females had higher CVs than males for urinary phosphorus overall at the False Discovery Rate (P<0.01). There was no effect of sex on CV for calcium (P>0.3). Males had higher CVs for citrate (P<0.01) from ages 16-45 and females higher CVs for citrate (P<0.01) from ages 56-80, suggesting effects of an extant oestral cycle on residual variance. Conclusions: Our findings indicate the effects of sex on residual variance of the excretion of urinary solutes including phosphorus and citrate; differences in CV by sex might reflect dietary lability, differences in the fidelity of reporting or genetic differentiation in renal solute consistency. Such an effect could complicate medical analysis by the addition of random error to phenotypic assays. Renal analysis might require explicit incorporation of heterogeneity among factorial effects, and for sex in particular.	[Perry, Guy M. L.; Scheinman, Steven J.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; [Asplin, John R.] Litholink Corp, Chicago, IL USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Perry, GML (corresponding author), SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.	perryg@upstate.edu						AHLSTRAND C, 1984, J UROLOGY, V131, P77, DOI 10.1016/S0022-5347(17)50211-6; Anandaram Pallavoor S, 2006, Urol Res, V34, P249; Coe F., 1988, PREVENTION TREATMENT; Curhan GC, 1997, J AM SOC NEPHROL, V8, P1568; Fenton TR, 2009, NUTR RES, V29, P320, DOI 10.1016/j.nutres.2009.04.005; Fraser HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008635; Hamm LL, 2002, ENDOCRIN METAB CLIN, V31, P885, DOI 10.1016/S0889-8529(02)00031-2; HEGSTED M, 1981, J NUTR, V111, P553, DOI 10.1093/jn/111.3.553; Hill WG, 2010, GENET RES, V92, P381, DOI 10.1017/S0016672310000546; Holmes RP, 1998, UROL RES, V26, P195, DOI 10.1007/s002400050046; HORL WH, 1985, RES EXP MED, V185, P69, DOI 10.1007/BF01851530; Houterman S, 1997, CANCER LETT, V114, P295, DOI 10.1016/S0304-3835(97)04684-3; Ibanez-Escriche N, 2008, GENET SEL EVOL, V40, P279, DOI 10.1051/gse:2008003; Jerums G, 1995, J DIABETES COMPLICAT, V9, P308, DOI 10.1016/1056-8727(95)80029-E; Kamperis K, 2006, J UROLOGY, V176, P770, DOI 10.1016/S0022-5347(06)00300-4; Kato I, 1998, J CLIN EPIDEMIOL, V51, P1271, DOI 10.1016/S0895-4356(98)00119-X; Lancina Martin JA, 2002, ACTAS UROL ESP, V26, P111, DOI DOI 10.1016/S0210-4806(02)72742-3; Liu ES, 2011, NEW ENGL J MED, V364, P1678, DOI 10.1056/NEJMc1010928; Mackay TFC, 2005, PHILOS T R SOC B, V360, P1513, DOI 10.1098/rstb.2005.1672; Magee EA, 2004, AM J CLIN NUTR, V80, P137; Marengo SR, 2008, NAT CLIN PRACT NEPHR, V4, P368, DOI 10.1038/ncpneph0845; PARKS JH, 1986, KIDNEY INT, V30, P85, DOI 10.1038/ki.1986.155; Parks JH, 2002, J UROLOGY, V167, P1607, DOI 10.1016/S0022-5347(05)65163-4; Perry G., 2011, RAT GENOMICS MODELS, P97; Perry GML, 2003, GENETICA, V119, P35, DOI 10.1023/A:1024493013926; Perry GML, 2012, GENETICS, V191, P1003, DOI 10.1534/genetics.112.138909; Perry GML, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-56; Psihogios NG, 2008, NMR BIOMED, V21, P195, DOI 10.1002/nbm.1176; REILLY SL, 1991, AM J HUM GENET, V49, P1155; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Romero Victoriano, 2010, Rev Urol, V12, pe86; RUDMAN D, 1982, J CLIN ENDOCR METAB, V55, P1052, DOI 10.1210/jcem-55-6-1052; Ryall R, 1990, RENAL TRACT STONE ME, P307; Shutto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029105; Sims ST, 2008, J APPL PHYSIOL, V105, P121, DOI 10.1152/japplphysiol.01331.2007; Steel RGD, 1980, PRINCIPLES PROCEDURE; TRINCHIERI A, 1992, SCAND J UROL NEPHROL, V26, P379, DOI 10.3109/00365599209181230; TRINCHIERI A, 1991, BRIT J UROL, V67, P230, DOI 10.1111/j.1464-410X.1991.tb15124.x; Valenti G, 2002, AM J PHYSIOL-RENAL, V283, pF895, DOI 10.1152/ajprenal.00354.2001; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; YUEN DE, 1983, J NUTR, V113, P1374, DOI 10.1093/jn/113.7.1374	41	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e53637	10.1371/journal.pone.0053637	http://dx.doi.org/10.1371/journal.pone.0053637			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840293	gold, Green Submitted, Green Published			2022-12-27	WOS:000322361200001
J	Pieper, R; Zhang, QS; Clark, DJ; Parmar, PP; Alami, H; Suh, MJ; Kuntumalla, S; Braisted, JC; Huang, ST; Tzipori, S				Pieper, Rembert; Zhang, Quanshun; Clark, David J.; Parmar, Prashanth P.; Alami, Hamid; Suh, Moo-Jin; Kuntumalla, Srilatha; Braisted, John C.; Huang, Shih-Ting; Tzipori, Saul			Proteomic View of Interactions of Shiga Toxin-Producing Escherichia coli with the Intestinal Environment in Gnotobiotic Piglets	PLOS ONE			English	Article							ANAEROBIC SN-GLYCEROL-3-PHOSPHATE DEHYDROGENASE; RAW 264.7 MACROPHAGES; IN-VITRO; EXTRACELLULAR PROTEINS; SEROVAR TYPHIMURIUM; STATISTICAL-MODEL; SHIGELLA-FLEXNERI; EPITHELIAL-CELLS; YERSINIA-PESTIS; EXPRESSION	Background: Shiga toxin (Stx)-producing Escherichia coli cause severe intestinal infections involving colonization of epithelial Peyer's patches and formation of attachment/effacement (A/E) lesions. These lesions trigger leukocyte infiltration followed by inflammation and intestinal hemorrhage. Systems biology, which explores the crosstalk of Stx-producing Escherichia coli with the in vivo host environment, may elucidate novel molecular pathogenesis aspects. Methodology/Principal Findings: Enterohemorrhagic E. coli strain 86-24 produces Shiga toxin-2 and belongs to the serotype O157:H7. Bacterial cells were scrapped from stationary phase cultures (the in vitro condition) and used to infect gnotobiotic piglets via intestinal lavage. Bacterial cells isolated from the piglets' guts constituted the in vivo condition. Cell lysates were subjected to quantitative 2D gel and shotgun proteomic analyses, revealing metabolic shifts towards anaerobic energy generation, changes in carbon utilization, phosphate and ammonia starvation, and high activity of a glutamate decarboxylase acid resistance system in vivo. Increased abundance of pyridine nucleotide transhydrogenase (PntA and PntB) suggested in vivo shortage of intracellular NADPH. Abundance changes of proteins implicated in lipopolysaccharide biosynthesis (LpxC, ArnA, the predicted acyltransferase L7029) and outer membrane (OM) assembly (LptD, MlaA, MlaC) suggested bacterial cell surface modulation in response to activated host defenses. Indeed, there was evidence for interactions of innate immunity-associated proteins secreted into the intestines (GP340, REG3-gamma, resistin, lithostathine, and trefoil factor 3) with the bacterial cell envelope. Significance: Proteomic analysis afforded insights into system-wide adaptations of strain 86-24 to a hostile intestinal milieu, including responses to limited nutrients and cofactor supplies, intracellular acidification, and reactive nitrogen and oxygen species-mediated stress. Protein and lipopolysaccharide compositions of the OM were altered. Enhanced expression of type III secretion system effectors correlated with a metabolic shift back to a more aerobic milieu in vivo. Apparent pathogen pattern recognition molecules from piglet intestinal secretions adhered strongly to the bacterial cell surface.	[Pieper, Rembert; Clark, David J.; Parmar, Prashanth P.; Alami, Hamid; Suh, Moo-Jin; Kuntumalla, Srilatha; Braisted, John C.; Huang, Shih-Ting] J Craig Venter Inst, Rockville, MD USA; [Zhang, Quanshun; Tzipori, Saul] Tufts Univ, Div Infect Dis, Cummings Sch Vet Med, North Grafton, MA USA	J. Craig Venter Institute; Tufts University	Pieper, R (corresponding author), J Craig Venter Inst, Rockville, MD USA.	rpieper@jcvi.org	Suh, Moo-Jin/A-5436-2010	Suh, Moo-Jin/0000-0003-0003-393X; Clark, David/0000-0003-0527-8469	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [N01-AI-30050]; NIAID, NIH [N01-AI15447]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030050] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	At Tufts University, the work was supported by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) under contract number N01-AI-30050. At JCVI, the work was supported by the NIAID, NIH, under contract number N01-AI15447. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MA, 2005, J BIOL CHEM, V280, P8358, DOI 10.1074/jbc.M412637200; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Al Safadi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041628; Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Bishop RE, 1998, J MOL BIOL, V280, P583, DOI 10.1006/jmbi.1998.1894; Borelli V, 2003, INFECT IMMUN, V71, P605, DOI 10.1128/IAI.71.2.605-613.2003; Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529; BUSCHMEIER B, 1985, FEMS MICROBIOL LETT, V29, P231, DOI 10.1111/j.1574-6968.1985.tb00868.x; Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; CHUNG CH, 1983, J BIOL CHEM, V258, P1032; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Dahan S, 2004, INFECT IMMUN, V72, P5452, DOI 10.1128/IAI.72.9.5452-5459.2004; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; Donohue-Rolfe A, 2000, J INFECT DIS, V181, P1825, DOI 10.1086/315421; Dorel C, 2006, RES MICROBIOL, V157, P306, DOI 10.1016/j.resmic.2005.12.003; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Etienne-Mesmin L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023594; FINKEL SE, 1992, MOL MICROBIOL, V6, P3257, DOI 10.1111/j.1365-2958.1992.tb02193.x; Fitzhenry RJ, 2002, GUT, V50, P180, DOI 10.1136/gut.50.2.180; Forman HJ, 2002, AM J RESP CRIT CARE, V166, pS4, DOI 10.1164/rccm.2206007; FORST S, 1989, P NATL ACAD SCI USA, V86, P6052, DOI 10.1073/pnas.86.16.6052; Francez-Charlot A, 2005, J BACTERIOL, V187, P3873, DOI 10.1128/JB.187.11.3873-3877.2005; FRANZON VL, 1990, INFECT IMMUN, V58, P529, DOI 10.1128/IAI.58.2.529-535.1990; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Golby P, 1998, J BACTERIOL, V180, P6586, DOI 10.1128/JB.180.24.6586-6596.1998; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; Grys TE, 2005, INFECT IMMUN, V73, P1295, DOI 10.1128/IAI.73.3.1295-1303.2005; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; GUNSALUS RP, 1994, RES MICROBIOL, V145, P437, DOI 10.1016/0923-2508(94)90092-2; GUNSALUS RP, 1992, J BACTERIOL, V174, P7069, DOI 10.1128/jb.174.22.7069-7074.1992; Hardwidge PR, 2004, J BIOL CHEM, V279, P20127, DOI 10.1074/jbc.M401228200; Hemrajani C, 2010, P NATL ACAD SCI USA, V107, P3129, DOI 10.1073/pnas.0911609106; Herzberg M, 2006, J BACTERIOL, V188, P587, DOI 10.1128/JB.188.2.587-598.2006; HUSSAIN H, 1994, MOL MICROBIOL, V12, P153, DOI 10.1111/j.1365-2958.1994.tb01004.x; IOVANNA J, 1993, PANCREAS, V8, P597, DOI 10.1097/00006676-199309000-00011; Jarvis KG, 1996, INFECT IMMUN, V64, P4826, DOI 10.1128/IAI.64.11.4826-4829.1996; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; KELLEY JJ, 1984, J BIOL CHEM, V259, P2124; Klein AH, 2007, J BACTERIOL, V189, P5574, DOI 10.1128/JB.00564-07; Kuntumalla S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-147; KURITZKES DR, 1984, J BACTERIOL, V157, P591, DOI 10.1128/JB.157.2.591-598.1984; Lee JH, 2011, CURR MICROBIOL, V62, P1321, DOI 10.1007/s00284-010-9862-4; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Li M, 2004, APPL ENVIRON MICROB, V70, P5274, DOI 10.1128/AEM.70.9.5274-5282.2004; Lucchini S, 2005, INFECT IMMUN, V73, P88, DOI 10.1128/IAI.73.1.88-102.2005; [Neidhardt FCU Neidhardt FCea], 1996, ESCHERICHIA COLI SAL, P13; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ohl ME, 2001, ANNU REV MED, V52, P259, DOI 10.1146/annurev.med.52.1.259; Otto K, 2002, P NATL ACAD SCI USA, V99, P2287, DOI 10.1073/pnas.042521699; PAHEL G, 1979, P NATL ACAD SCI USA, V76, P4544, DOI 10.1073/pnas.76.9.4544; Parsot C, 1996, CURR TOP MICROBIOL, V209, P25; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Pieper R, 2008, PROTEOMICS, V8, P1442, DOI 10.1002/pmic.200700923; Pieper R, 2006, PROTEOMICS, V6, P4246, DOI 10.1002/pmic.200500764; Pieper R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026554; Pieper R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-30; Pieper R, 2009, PROTEOMICS, V9, P5029, DOI 10.1002/pmic.200900196; Plager DA, 1999, J BIOL CHEM, V274, P14464, DOI 10.1074/jbc.274.20.14464; PODOLSKY DK, 1993, J BIOL CHEM, V268, P12230; Poirier K, 2008, INFECT IMMUN, V76, P4814, DOI 10.1128/IAI.00446-08; Poole LB, 2000, EUR J BIOCHEM, V267, P6126, DOI 10.1046/j.1432-1327.2000.01704.x; Pruss BM, 2006, J BACTERIOL, V188, P3731, DOI 10.1128/JB.01780-05; Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38; Raivio TL, 1999, J BACTERIOL, V181, P5263, DOI 10.1128/JB.181.17.5263-5272.1999; RAMSEIER TM, 1995, MOL MICROBIOL, V16, P1157, DOI 10.1111/j.1365-2958.1995.tb02339.x; REANEY SK, 1993, J GEN MICROBIOL, V139, P1523, DOI 10.1099/00221287-139-7-1523; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sargent F, 1998, EUR J BIOCHEM, V255, P746, DOI 10.1046/j.1432-1327.1998.2550746.x; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Schmidt MA, 2010, CELL MICROBIOL, V12, P1544, DOI 10.1111/j.1462-5822.2010.01518.x; SCHRYVERS A, 1981, J BIOL CHEM, V256, P9959; Schurmann M, 2001, J BIOL CHEM, V276, P11055, DOI 10.1074/jbc.M008061200; Shi L, 2006, J BIOL CHEM, V281, P29131, DOI 10.1074/jbc.M604640200; Shi Liang, 2009, J Proteomics Bioinform, V2, P388; Shi L, 2009, INFECT IMMUN, V77, P3227, DOI 10.1128/IAI.00063-09; SIX S, 1994, J BACTERIOL, V176, P6470, DOI 10.1128/JB.176.21.6470-6478.1994; Tarkowski A, 2010, J CELL MOL MED, V14, P1419, DOI 10.1111/j.1582-4934.2009.00899.x; Tobe T, 2006, P NATL ACAD SCI USA, V103, P14941, DOI 10.1073/pnas.0604891103; TORRIANI AM, 1990, BIOESSAYS, V12, P371, DOI 10.1002/bies.950120804; Tree JJ, 2009, TRENDS MICROBIOL, V17, P361, DOI 10.1016/j.tim.2009.06.001; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; TZIPORI S, 1987, INFECT IMMUN, V55, P3117, DOI 10.1128/IAI.55.12.3117-3125.1987; Valgepea K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-166; Vingadassalom D, 2009, P NATL ACAD SCI USA, V106, P6754, DOI 10.1073/pnas.0809131106; Wang HN, 2000, J BACTERIOL, V182, P5813, DOI 10.1128/JB.182.20.5813-5822.2000; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; WEINER JH, 1988, J BACTERIOL, V170, P1505, DOI 10.1128/jb.170.4.1505-1510.1988; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wolfe AJ, 2008, J BACTERIOL, V190, P2314, DOI 10.1128/JB.01906-07; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Yew WS, 2002, J BACTERIOL, V184, P302, DOI 10.1128/JB.184.1.302-306.2002; Yin XH, 2011, CAN J VET RES, V75, P81; Yu ACY, 2012, STRUCTURE, V20, P707, DOI 10.1016/j.str.2012.02.015; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	104	11	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66462	10.1371/journal.pone.0066462	http://dx.doi.org/10.1371/journal.pone.0066462			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840478	Green Submitted, gold, Green Published			2022-12-27	WOS:000322361200083
J	Ray, DK; Mueller, ND; West, PC; Foley, JA				Ray, Deepak K.; Mueller, Nathaniel D.; West, Paul C.; Foley, Jonathan A.			Yield Trends Are Insufficient to Double Global Crop Production by 2050	PLOS ONE			English	Article							FEEDING 9 BILLION; AGRICULTURAL INTENSIFICATION; SUSTAINABLE INTENSIFICATION; FOOD-PRODUCTION; WHEAT YIELDS; LAND; RICE; BIODIVERSITY; CHALLENGE; DECLINES	Several studies have shown that global crop production needs to double by 2050 to meet the projected demands from rising population, diet shifts, and increasing biofuels consumption. Boosting crop yields to meet these rising demands, rather than clearing more land for agriculture has been highlighted as a preferred solution to meet this goal. However, we first need to understand how crop yields are changing globally, and whether we are on track to double production by 2050. Using similar to 2.5 million agricultural statistics, collected for similar to 13,500 political units across the world, we track four key global crops-maize, rice, wheat, and soybean-that currently produce nearly two-thirds of global agricultural calories. We find that yields in these top four crops are increasing at 1.6%, 1.0%, 0.9%, and 1.3% per year, non-compounding rates, respectively, which is less than the 2.4% per year rate required to double global production by 2050. At these rates global production in these crops would increase by similar to 67%, similar to 42%, similar to 38%, and similar to 55%, respectively, which is far below what is needed to meet projected demands in 2050. We present detailed maps to identify where rates must be increased to boost crop production and meet rising demands.	[Ray, Deepak K.; Mueller, Nathaniel D.; West, Paul C.; Foley, Jonathan A.] Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Ray, DK (corresponding author), Univ Minnesota, Inst Environm IonE, St Paul, MN 55108 USA.	dray@umn.edu	West, Paul C./J-1665-2015; Foley, Jonathan A/GRS-5522-2022; Ray, Deepak K/F-7720-2012; Mueller, Nathan D/E-5864-2010	West, Paul C./0000-0001-9024-1657; Mueller, Nathan D/0000-0003-1857-5104; Ray, Deepak/0000-0002-2856-9608	Gordon and Betty Moore Foundation; Institute on the Environment; National Aeronautics and Space Administration's - NASA's - Interdisciplinary Earth Science program; NSF graduate fellowship	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Institute on the Environment; National Aeronautics and Space Administration's - NASA's - Interdisciplinary Earth Science program; NSF graduate fellowship(National Science Foundation (NSF))	Research support was provided by a grant from the Gordon and Betty Moore Foundation, and by the Institute on the Environment, along with previous funding from National Aeronautics and Space Administration's - NASA's - Interdisciplinary Earth Science program. This work also benefitted from contributions by General Mills, Mosaic, Cargill, Google, PepsiCo, and Kellogg to support stakeholder outreach and public engagement. N.D.M. was supported by a NSF graduate fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew D, 2011, INT J AGR SUSTAIN, V9, P232; Brisson N, 2010, FIELD CROP RES, V119, P201, DOI 10.1016/j.fcr.2010.07.012; Cassman KG, 1999, P NATL ACAD SCI USA, V96, P5952, DOI 10.1073/pnas.96.11.5952; Dawe D, 2000, FIELD CROP RES, V66, P175, DOI 10.1016/S0378-4290(00)00075-7; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Dyson T, 1999, P NATL ACAD SCI USA, V96, P5929, DOI 10.1073/pnas.96.11.5929; Eickhout B, 2006, AGR ECOSYST ENVIRON, V116, P4, DOI 10.1016/j.agee.2006.03.009; Fan S, 2007, DRAGON ELEPHANT AGR, P465; FAO, 2013, FOOD BAL SHEETS PART; Fao WFP. IFAD, 2014, STAT FOOD INS WORLD; Finger R, 2010, FOOD POLICY, V35, P175, DOI 10.1016/j.foodpol.2009.11.004; Fischer RAT, 2010, CROP SCI, V50, pS85, DOI 10.2135/cropsci2009.10.0564; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Food and Agriculture Organization [FAO], 2009, GLOBAL AGR 2050; Gibbs H, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/011007; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Gregory PJ, 2011, J EXP BOT, V62, P5233, DOI 10.1093/jxb/err232; Hafner S, 2003, AGR ECOSYST ENVIRON, V97, P275, DOI 10.1016/S0167-8809(03)00019-7; Heathcote AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053554; Hertel TW, 2011, AM J AGR ECON, V93, P259, DOI 10.1093/ajae/aaq189; Hulme MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054597; Institution of Mechanical Engineers, 2013, GLOB FOOD WAST NOT W; Jaggard KW, 2010, PHILOS T R SOC B, V365, P2835, DOI 10.1098/rstb.2010.0153; Kummu M, 2012, SCI TOTAL ENVIRON, V438, P477, DOI 10.1016/j.scitotenv.2012.08.092; Ladha JK, 2003, FIELD CROP RES, V81, P159, DOI 10.1016/S0378-4290(02)00219-8; Lin M, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024016; Lobell DB, 2009, ANNU REV ENV RESOUR, V34, P179, DOI 10.1146/annurev.environ.041008.093740; Matson PA, 2006, CONSERV BIOL, V20, P709, DOI 10.1111/j.1523-1739.2006.00442.x; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Neumann K, 2010, AGR SYST, V103, P316, DOI 10.1016/j.agsy.2010.02.004; Organisation for Economic Cooperation and Development (OECD), 2017, OECD EC SURV UK; Peltonen-Sainio P, 2009, FIELD CROP RES, V110, P85, DOI 10.1016/j.fcr.2008.07.007; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Phalan B, 2011, FOOD POLICY, V36, pS62, DOI 10.1016/j.foodpol.2010.11.008; Pingali P, 2007, FOOD POLICY, V32, P281, DOI 10.1016/j.foodpol.2006.08.001; Pingali PL, 2012, P NATL ACAD SCI USA, V109, P12302, DOI 10.1073/pnas.0912953109; Pretty J, 2011, INT J AGR SUSTAIN, V9, P5, DOI 10.3763/ijas.2010.0583; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Supit I, 1997, AGR FOREST METEOROL, V88, P199, DOI 10.1016/S0168-1923(97)00037-3; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; van Otterdijk R., 2011, GLOBAL FOOD LOSSES F; West PC, 2010, P NATL ACAD SCI USA, V107, P19645, DOI 10.1073/pnas.1011078107	47	1619	1672	52	732	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66428	10.1371/journal.pone.0066428	http://dx.doi.org/10.1371/journal.pone.0066428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840465	Green Published, gold			2022-12-27	WOS:000322361200075
J	Ali, F; Khan, I; Samiulhaq; Shafie, S				Ali, Farhad; Khan, Ilyas; Samiulhaq; Shafie, Sharidan			Conjugate Effects of Heat and Mass Transfer on MHD Free Convection Flow over an Inclined Plate Embedded in a Porous Medium	PLOS ONE			English	Article							INFINITE VERTICAL PLATE; SLIP-FLOW; THERMAL-RADIATION; WALL TEMPERATURE; FLUID; SURFACE; SORET	The aim of this study is to present an exact analysis of combined effects of radiation and chemical reaction on the magnetohydrodynamic (MHD) free convection flow of an electrically conducting incompressible viscous fluid over an inclined plate embedded in a porous medium. The impulsively started plate with variable temperature and mass diffusion is considered. The dimensionless momentum equation coupled with the energy and mass diffusion equations are analytically solved using the Laplace transform method. Expressions for velocity, temperature and concentration fields are obtained. They satisfy all imposed initial and boundary conditions and can be reduced, as special cases, to some known solutions from the literature. Expressions for skin friction, Nusselt number and Sherwood number are also obtained. Finally, the effects of pertinent parameters on velocity, temperature and concentration profiles are graphically displayed whereas the variations in skin friction, Nusselt number and Sherwood number are shown through tables.	[Ali, Farhad; Khan, Ilyas; Samiulhaq; Shafie, Sharidan] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Johor, Malaysia	Universiti Teknologi Malaysia	Shafie, S (corresponding author), Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Skudai, Johor, Malaysia.	ridafie@yahoo.com	Ali, Farhad/Y-5301-2018; Khan, Ilyas/C-8770-2019; SHAFIE, SHARIDAN/A-2210-2013	Khan, Ilyas/0000-0002-2056-9371; SHAFIE, SHARIDAN/0000-0001-7795-2278				Ahmad N, 2012, J HEAT TRANSF, V134; Ahmed N., 2009, INT J APPL MATH MECH, V5, P87; Ali F, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.064402; [Anonymous], 2010, WORLD APPL SCI J; [Anonymous], 2011, INDIAN J SCI TECHNOL; Chandrakala P., 2010, INT J DYNAMICS FLUID, V6, P209; Cheng CY, 2008, INT COMMUN HEAT MASS, V35, P750, DOI 10.1016/j.icheatmasstransfer.2008.02.004; Cramer K.R., 1973, MAGNETO FLUID DYNAMI, P204; Guo ZX, 1999, INT J HEAT MASS TRAN, V42, P379, DOI 10.1016/S0017-9310(98)00145-8; Jingchun M, 2010, J MEMBRANE SCI, V430, P150; Kandasamy R, 2010, COMMUN NONLINEAR SCI, V15, P2109, DOI 10.1016/j.cnsns.2009.09.016; Khan I, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.104401; Magyari E, 2011, INT COMMUN HEAT MASS, V38, P554, DOI 10.1016/j.icheatmasstransfer.2011.03.006; Makinde OD, 2011, CHEM ENG COMMUN, V198, P920, DOI 10.1080/00986445.2011.545296; Makinde OD, 2010, CAN J CHEM ENG, V88, P983, DOI 10.1002/cjce.20369; Makinde OD, 2012, Z NATURFORSCH A, V67, P239, DOI 10.5560/ZNA.2012-0014; Manivannan, 2011, INT J PURE APPL SCI, V3, P19; Mishra SR, 2013, INT J HEAT MASS TRAN, V57, P433, DOI 10.1016/j.ijheatmasstransfer.2012.10.053; Muthucumaraswamy R, 2006, THEOR APPL MECH, V33, P17, DOI 10.2298/TAM0601017M; Narahari Marneni, 2011, Turkish Journal of Engineering and Environmental Sciences, V35, P187, DOI 10.3906/muh-1101-15; Narahari M., 2011, Journal of Applied Sciences, V11, P1096, DOI 10.3923/jas.2011.1096.1104; Narahari M., 2011, WORLD J MECH, V1, P176; Noor NFM, 2012, INT J HEAT MASS TRAN, V55, P2122, DOI 10.1016/j.ijheatmasstransfer.2011.12.015; Osman ANA, 2011, MATH PROBL ENGG, P1; Pal D, 2011, INT COMMUN HEAT MASS, V38, P463, DOI 10.1016/j.icheatmasstransfer.2010.12.039; Prasad VR, 2012, COMMUN NONLINEAR SCI, V17, P654, DOI 10.1016/j.cnsns.2011.04.033; Rajesh V, 2011, CHEM IND CHEM ENG Q, V17, P189, DOI 10.2298/CICEQ100829003R; Rajput U.S., 2011, APPL MATH SCI, V5, P149; Rajput U. S., 2012, INT J APPL MATH MECH, V8, P66; Samiulhaq, 2012, Z NATURFORSCH A, V67, P572, DOI 10.5560/ZNA.2012-0070; Samiulhaq, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.044401; Seth GS, 2011, HEAT MASS TRANSFER, V47, P551, DOI 10.1007/s00231-010-0740-1; Singh K.D., 2011, INT J APPL MECH ENG, V16, P277; Turkyilmazoglu M, 2013, COMPUT FLUIDS, V71, P426, DOI 10.1016/j.compfluid.2012.11.011; Turkyilmazoglu M, 2012, COMPUT FLUIDS, V70, P53, DOI 10.1016/j.compfluid.2012.01.009; Turkyilmazoglu M, 2012, INT J HEAT MASS TRAN, V55, P7635, DOI 10.1016/j.ijheatmasstransfer.2012.07.079; Turkyilmazoglu M, 2012, CHEM ENG SCI, V84, P182, DOI 10.1016/j.ces.2012.08.029; Turkyilmazoglu M, 2011, INT J MECH SCI, V53, P886, DOI 10.1016/j.ijmecsci.2011.07.012; Ziyauddin, 2010, INT J MATH MODELL SI, V3, P155	39	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e65223	10.1371/journal.pone.0065223	http://dx.doi.org/10.1371/journal.pone.0065223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840321	Green Published, gold			2022-12-27	WOS:000321148400004
J	Benz, J; Reinstein, J; Meinhart, A				Benz, Juliane; Reinstein, Jochen; Meinhart, Anton			Structural Insights into the Effector - Immunity System Tae4/Tai4 from Salmonella typhimurium	PLOS ONE			English	Article							VI SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; SEQUENCE ALIGNMENTS; CYSTEINE PEPTIDASES; PROTEIN; MECHANISM; TSE1; CONSERVATION; SUPERFAMILY; REFINEMENT	Type-6-secretion systems of Gram-negative bacteria are widely distributed needle-like multi-protein complexes that are involved in microbial defense mechanisms. During bacterial competition these injection needles dispense effector proteins into the periplasm of competing bacteria where they induce degradation of the peptidoglycan scaffold and lead to cell lysis. Donor cells co-produce immunity proteins and shuttle them into their own periplasm to prevent accidental toxication by siblings. Recently, a plethora of previously unidentified hydrolases have been suggested to be peptidoglycan degrading amidases. These hydrolases are part of effector/immunity pairs that have been associated with bacterial warfare by type-6-secretion systems. The Tae4 and Tai4 operon encoded by Salmonella typhimurium is one of these newly discovered effector/immunity pairs. The Tae4 effector proteins induce cell lysis by cleaving the gamma-D-glutamyl-L-meso-diaminopimelic acid amide bond of acceptor stem muropeptides of the Gram-negative peptidoglycan. Although homologues of the Tae4/Tai4 system have been identified in various different pathogens, little is known about the functional mechanism of effector protein activity and their inhibition by the cognate immunity proteins. Here, we present the high-resolution crystal structure of the effector Tae4 of S. typhimurium in complex with its immunity protein Tai4. We show that Tae4 contains a classical NlpC/P60-peptidase core which is common to other effector proteins of the type-6-secretion system. However, Tae4 has unique structural features that are exclusively conserved within the family of Tae4 effectors and which are important for the substrate specificity. Most importantly, we show that although the overall structure of Tai4 is different to previously described immunity proteins, the essential mode of enzyme inhibition is conserved. Additionally, we provide evidence that inhibition in the Tae4/Tai4 heterotetramer relies on a central Tai4 dimer in order to acquire functionality.	[Benz, Juliane; Reinstein, Jochen; Meinhart, Anton] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg 1, Germany	Max Planck Society	Meinhart, A (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, Jahnstr 29, D-69120 Heidelberg 1, Germany.	anton.meinhart@mpimf-heidelberg.mpg.de	Meinhart, Anton/M-9647-2014		Chica and Heinz Schaller Foundation	Chica and Heinz Schaller Foundation	This work has been supported by the Chica and Heinz Schaller Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Benz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040453; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Chou S, 2012, CELL REP, V1, P656, DOI 10.1016/j.celrep.2012.05.016; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding JJ, 2012, J BIOL CHEM, V287, P26911, DOI 10.1074/jbc.M112.368043; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; English G, 2012, MOL MICROBIOL; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PALZKILL T, 1994, J BACTERIOL, V176, P563, DOI 10.1128/jb.176.3.563-568.1994; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; ROBERTUS JD, 1972, BIOCHEMISTRY-US, V11, P4293, DOI 10.1021/bi00773a016; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Shang GJ, 2012, BIOCHEM J, V448, P201, DOI 10.1042/BJ20120668; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; STORER AC, 1994, METHOD ENZYMOL, V244, P486; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Zhang H, 2013, J BIOL CHEM, V288, P5928, DOI 10.1074/jbc.M112.434357; Zhang H, 2012, FEBS LETT, V586, P3193, DOI 10.1016/j.febslet.2012.06.036	40	14	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67362	10.1371/journal.pone.0067362	http://dx.doi.org/10.1371/journal.pone.0067362			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826277	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000067
J	Gutierrez, T; Berry, D; Yang, TT; Mishamandani, S; McKay, L; Teske, A; Aitken, MD				Gutierrez, Tony; Berry, David; Yang, Tingting; Mishamandani, Sara; McKay, Luke; Teske, Andreas; Aitken, Michael D.			Role of Bacterial Exopolysaccharides (EPS) in the Fate of the Oil Released during the Deepwater Horizon Oil Spill	PLOS ONE			English	Article							SEA HYDROTHERMAL-VENT; HYDROCARBON-DEGRADING BACTERIUM; SP-NOV.; HALOPHILIC BACTERIA; HALOMONAS-EURIHALINA; CRUDE-OIL; HYPERSALINE CONDITIONS; AROMATIC-HYDROCARBONS; FUNCTIONAL-PROPERTIES; EMULSIFYING ACTIVITY	Halomonas species are recognized for producing exopolysaccharides (EPS) exhibiting amphiphilic properties that allow these macromolecules to interface with hydrophobic substrates, such as hydrocarbons. There remains a paucity of knowledge, however, on the potential of Halomonas EPS to influence the biodegradation of hydrocarbons. In this study, the well-characterized amphiphilic EPS produced by Halomonas species strain TG39 was shown to effectively increase the solubilization of aromatic hydrocarbons and enhance their biodegradation by an indigenous microbial community from oil-contaminated surface waters collected during the active phase of the Deepwater Horizon oil spill. Three Halomonas strains were isolated from the Deepwater Horizon site, all of which produced EPS with excellent emulsifying qualities and shared high (97-100%) 16S rRNA sequence identity with strain TG39 and other EPS-producing Halomonas strains. Analysis of pyrosequence data from surface water samples collected during the spill revealed several distinct Halomonas phylotypes, of which some shared a high sequence identity (>= 97%) to strain TG39 and the Gulf spill isolates. Other bacterial groups comprising members with well-characterized EPS-producing qualities, such as Alteromonas, Colwellia and Pseudoalteromonas, were also found enriched in surface waters, suggesting that the total pool of EPS in the Gulf during the spill may have been supplemented by these organisms. Roller bottle incubations with one of the Halomonas isolates from the Deepwater Horizon spill site demonstrated its ability to effectively produce oil aggregates and emulsify the oil. The enrichment of EPS-producing bacteria during the spill coupled with their capacity to produce amphiphilic EPS is likely to have contributed to the ultimate removal of the oil and to the formation of oil aggregates, which were a dominant feature observed in contaminated surface waters.	[Gutierrez, Tony; Mishamandani, Sara; Aitken, Michael D.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA; [Gutierrez, Tony] Heriot Watt Univ, Sch Life Sci, Edinburgh, Midlothian, Scotland; [Berry, David] Univ Vienna, Fac Sci, Vienna Ecol Ctr, Dept Microbial Ecol, Vienna, Austria; [Yang, Tingting; McKay, Luke; Teske, Andreas] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Heriot Watt University; University of Vienna; University of North Carolina; University of North Carolina Chapel Hill	Gutierrez, T (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA.	Tony.Gutierrez@hw.ac.uk	Teske, Andreas/AAQ-9577-2021; Gutierrez, Tony/AAN-2479-2020; Gutierrez, Tony/D-6303-2013; Berry, David/C-8455-2011	Gutierrez, Tony/0000-0002-6127-8511; Gutierrez, Tony/0000-0002-6127-8511; Berry, David/0000-0002-8997-608X	European Community [PIOF-GA-2008-220129]; U.S. National Institute of Environmental Health Sciences [5 P42ES005948]; BP/Gulf of Mexico Research Initiative; NSF [NSF-OCE 1045115]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES005948] Funding Source: NIH RePORTER	European Community(European Commission); U.S. National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); BP/Gulf of Mexico Research Initiative; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a Marie Curie International Outgoing Fellowship (PIOF-GA-2008-220129) within the 7th European Community Framework Programme. Partial support was also provided through the U.S. National Institute of Environmental Health Sciences grant 5 P42ES005948, and through the BP/Gulf of Mexico Research Initiative to support consortium research entitled "Ecosystem Impacts of Oil and Gas Inputs to the Gulf (ECOGIG)" administered by the University of Mississippi. Andreas Teske, Tony Gutierrez and Luke McKay were also supported by NSF (RAPID Response: The microbial response to the Deepwater Horizon Oil Spill; NSF-OCE 1045115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkafi S, 2006, FEMS MICROBIOL LETT, V255, P108, DOI 10.1111/j.1574-6968.2005.00061.x; ALLDREDGE AL, 1993, DEEP-SEA RES PT I, V40, P1131, DOI 10.1016/0967-0637(93)90129-Q; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Mata JA, 2006, RES MICROBIOL, V157, P827, DOI 10.1016/j.resmic.2006.06.004; Arahal DR, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P811, DOI 10.1007/0-387-30746-x_28; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; Baelum J, 2012, ENVIRON MICROBIOL, V14, P2405, DOI 10.1111/j.1462-2920.2012.02780.x; Barkay T, 1999, APPL ENVIRON MICROB, V65, P2697; BERTRAND JC, 1983, BIOTECHNOL LETT, V5, P567, DOI 10.1007/BF01184950; Bhaskar PV, 2005, CURR SCI INDIA, V88, P45; BLACKBURN SI, 1989, J PHYCOL, V25, P577, DOI 10.1111/j.1529-8817.1989.tb00264.x; Bouchotroch S, 2000, J IND MICROBIOL BIOT, V24, P374, DOI 10.1038/sj.jim.7000002; Bozzi L, 1996, INT J BIOL MACROMOL, V18, P9, DOI 10.1016/0141-8130(95)01038-6; Calvo C, 2002, APPL MICROBIOL BIOT, V60, P347, DOI 10.1007/s00253-002-1115-4; Calvo C, 1998, J IND MICROBIOL BIOT, V20, P205, DOI 10.1038/sj.jim.2900513; Cambon-Bonavita MA, 2002, J APPL MICROBIOL, V93, P310, DOI 10.1046/j.1365-2672.2002.01689.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dea ICM, 1986, FOOD HYDROCOLLOID, V1, P71, DOI 10.1016/S0268-005X(86)80009-1; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; Diercks AR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045046; DYKSTERHOUSE SE, 1995, INT J SYST BACTERIOL, V45, P116, DOI 10.1099/00207713-45-1-116; Eastcott L., 1988, OIL CHEM POLLUT, V4, P191, DOI DOI 10.1016/S0269-8579(88)80020-0; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fingas M, 2003, MAR POLLUT BULL, V47, P369, DOI 10.1016/S0025-326X(03)00212-1; FORD T, 1991, APPL ENVIRON MICROB, V57, P1595, DOI 10.1128/AEM.57.6.1595-1601.1991; FRANCISCO DE, 1973, T AM MICROSC SOC, V92, P416, DOI 10.2307/3225245; Garcia MT, 2005, FEMS MICROBIOL ECOL, V54, P97, DOI 10.1016/j.femsec.2005.03.009; Garcia MT, 2004, INT J SYST EVOL MICR, V54, P1723, DOI 10.1099/ijs.0.63114-0; GRABER M, 1988, ENZYME MICROB TECH, V10, P198, DOI 10.1016/0141-0229(88)90067-1; Gutierrez T, 2007, J APPL MICROBIOL, V103, P1716, DOI 10.1111/j.1365-2672.2007.03407.x; Gutierrez T., 2013, ISME J IN PRESS; Gutierrez T, 2008, APPL ENVIRON MICROB, V74, P4867, DOI 10.1128/AEM.00316-08; Gutierrez T, 2007, APPL MICROBIOL BIOT, V76, P1017, DOI 10.1007/s00253-007-1091-9; Gutierrez T, 2009, BIOTECHNOL BIOENG, V103, P207, DOI 10.1002/bit.22218; Gyurcsik B, 2000, COORDIN CHEM REV, V203, P81, DOI 10.1016/S0010-8545(99)00183-6; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hansell D.A., 2001, OCEANOGRAPHY, V14, P41, DOI DOI 10.5670/OCEANOG.2001.05; Hassler CS, 2011, MAR CHEM, V123, P88, DOI 10.1016/j.marchem.2010.10.003; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hinteregger C, 1997, BIOTECHNOL LETT, V19, P1099, DOI 10.1023/A:1018488410102; JACKSON GA, 1994, DEEP-SEA RES PT I, V41, P429, DOI 10.1016/0967-0637(94)90089-2; Janecka J, 2002, APPL ENVIRON MICROB, V68, P423, DOI 10.1128/AEM.68.1.423-426.2002; Jouault SC, 2001, BBA-GEN SUBJECTS, V1528, P141, DOI 10.1016/S0304-4165(01)00185-4; KAPLAN N, 1987, APPL ENVIRON MICROB, V53, P440, DOI 10.1128/AEM.53.2.440-446.1987; Kasai Y, 2002, APPL ENVIRON MICROB, V68, P5625, DOI 10.1128/AEM.68.11.5625-5633.2002; Kasai Y, 2002, ENVIRON MICROBIOL, V4, P141, DOI 10.1046/j.1462-2920.2002.00275.x; Katsivela E., 2003, WATER AIR SOIL POLL, V3, P103; Kaye JZ, 2004, INT J SYST EVOL MICR, V54, P499, DOI 10.1099/ijs.0.02799-0; KENNEDY AFD, 1987, BIOTECHNOL APPL BIOC, V9, P12; KIYOHARA H, 1982, APPL ENVIRON MICROB, V43, P454, DOI 10.1128/AEM.43.2.454-457.1982; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LANG S, 1993, BIOSURFACTANTS PRODU, P391; Long RA, 1996, AQUAT MICROB ECOL, V10, P213, DOI 10.3354/ame010213; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Maidak BL, 1999, NUCLEIC ACIDS RES, V27, P171, DOI 10.1093/nar/27.1.171; Martinez-Checa F, 2002, APPL MICROBIOL BIOT, V58, P358, DOI 10.1007/s00253-001-0903-6; Marx JG, 2009, CAN J MICROBIOL, V55, P63, DOI 10.1139/W08-130; Melcher RJ, 2002, APPL ENVIRON MICROB, V68, P2858, DOI 10.1128/AEM.68.6.2858-2868.2002; Mihelcic James R., 1993, Biodegradation, V4, P141, DOI 10.1007/BF00695116; Mnif S, 2009, J APPL MICROBIOL, V107, P785, DOI 10.1111/j.1365-2672.2009.04251.x; Munoz JA, 2001, FOLIA MICROBIOL, V46, P297, DOI 10.1007/BF02815617; Nichols CAM, 2004, J APPL MICROBIOL, V96, P1057, DOI 10.1111/j.1365-2672.2004.02216.x; Niu HB, 2011, ENVIRON MODEL ASSESS, V16, P61, DOI 10.1007/s10666-010-9228-0; Paje MLF, 1997, MICROBIOL-UK, V143, P2975, DOI 10.1099/00221287-143-9-2975; Passow U, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035301; PEARLMAN RS, 1984, J PHYS CHEM REF DATA, V13, P555, DOI 10.1063/1.555712; Pepi M, 2005, FEMS MICROBIOL ECOL, V53, P157, DOI 10.1016/j.femsec.2004.09.013; Poli A, 2007, SYST APPL MICROBIOL, V30, P31, DOI 10.1016/j.syapm.2006.03.003; Qin GK, 2007, MICROBIOL-SGM, V153, P1566, DOI 10.1099/mic.0.2006/003327-0; QUESADA E, 1993, EXPERIENTIA, V49, P1037, DOI 10.1007/BF01929910; Quillaguaman J, 2004, INT J SYST EVOL MICR, V54, P721, DOI 10.1099/ijs.0.02800-0; Raguenes G, 1996, APPL ENVIRON MICROB, V62, P67, DOI 10.1128/AEM.62.1.67-73.1996; Roling WFM, 2002, APPL ENVIRON MICROB, V68, P5537, DOI 10.1128/AEM.68.11.5537-5548.2002; Roling WFM, 2004, APPL ENVIRON MICROB, V70, P2603, DOI 10.1128/AEM.70.5.2603-2613.2004; RONTANI JF, 1986, MAR CHEM, V20, P197, DOI 10.1016/0304-4203(86)90039-3; ROSENBERG E, 1979, APPL ENVIRON MICROB, V37, P409, DOI 10.1128/AEM.37.3.409-413.1979; Sanchez-Porro C, 2010, INT J SYST EVOL MICR, V60, P2768, DOI 10.1099/ijs.0.020628-0; Santschi P.H., 1998, BIOGEOCHEMISTRY GULF, P347; SCHULZ D, 1991, Z NATURFORSCH C, V46, P197; STUCKI G, 1987, APPL ENVIRON MICROB, V53, P292, DOI 10.1128/AEM.53.2.292-297.1987; Syutsubo K, 2001, ENVIRON MICROBIOL, V3, P371, DOI 10.1046/j.1462-2920.2001.00204.x; Teira E, 2007, ENVIRON MICROBIOL, V9, P2551, DOI 10.1111/j.1462-2920.2007.01373.x; THOMAS JM, 1986, APPL ENVIRON MICROB, V52, P290, DOI 10.1128/AEM.52.2.290-296.1986; Thomas O, 2007, TECH INSTRUMENT, V27, P1; Tolstoguzov VB, 1991, FOOD HYDROCOLLOID, V4, P429; Tomlinson E, 1986, PARTITION COEFFICIEN, P101; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; VERDUGO P, 1993, ADV POLYM SCI, V110, P145; Verdugo P, 2004, MAR CHEM, V92, P67, DOI 10.1016/j.marchem.2004.06.017; WHITEHOUSE BG, 1984, MAR CHEM, V14, P319, DOI 10.1016/0304-4203(84)90028-8; WILMOTTE A, 1993, FEBS LETT, V317, P96, DOI 10.1016/0014-5793(93)81499-P; WODZINSKI RS, 1974, APPL MICROBIOL, V27, P1081, DOI 10.1128/AEM.27.6.1081-1084.1974; WODZINSKI RS, 1977, APPL ENVIRON MICROB, V33, P660, DOI 10.1128/AEM.33.3.660-665.1977; Wolfaardt G.M., 1999, MICROBIAL EXTRACELLU; Yang CY, 2010, BIORESOURCE TECHNOL, V101, P6778, DOI 10.1016/j.biortech.2010.03.108; Zhao BS, 2009, CURR MICROBIOL, V58, P205, DOI 10.1007/s00284-008-9309-3; Ziervogel K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034816	99	110	113	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67717	10.1371/journal.pone.0067717	http://dx.doi.org/10.1371/journal.pone.0067717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826336	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000096
J	Crescenti, A; Sola, R; Valls, RM; Caimari, A; del Bas, JM; Anguera, A; Angles, N; Arola, L				Crescenti, Anna; Sola, Rosa; Valls, Rosa M.; Caimari, Antoni; del Bas, Josep M.; Anguera, Anna; Angles, Neus; Arola, Lluis			Cocoa Consumption Alters the Global DNA Methylation of Peripheral Leukocytes in Humans with Cardiovascular Disease Risk Factors: A Randomized Controlled Trial	PLOS ONE			English	Article							DIETARY POLYPHENOLS; HYPERMETHYLATION; GENISTEIN; POLYMORPHISM; GENES; HYPOMETHYLATION; INHIBITION; EXPRESSION; VARIANTS; IMPACT	DNA methylation regulates gene expression and can be modified by different bioactive compounds in foods, such as polyphenols. Cocoa is a rich source of polyphenols, but its role in DNA methylation is still unknown. The objective was to assess the effect of cocoa consumption on DNA methylation and to determine whether the enzymes involved in the DNA methylation process participate in the mechanisms by which cocoa exerts these effects in humans. The global DNA methylation levels in the peripheral blood were evaluated in 214 volunteers who were pre-hypertensive, stage-1 hypertensive or hypercholesterolemic. The volunteers were divided into two groups: 110 subjects who consumed cocoa (6 g/d) for two weeks and 104 control subjects. In addition, the peripheral blood mononuclear cells (PBMCs) from six subjects were treated with a cocoa extract to analyze the mRNA levels of the DNA methyltransferases (DNMTs), methylenetetrahydrofolate reductase (MTHFR), and methionine synthase reductase (MTRR) genes. Cocoa consumption significantly reduced the DNA methylation levels (2.991 +/- 0.366 vs. 3.909 +/- 0.380, p<0.001). Additionally, we found an association between the cocoa effects on DNA methylation and three polymorphisms located in the MTHFR, MTRR, and DNMT3B genes. Furthermore, in PBMCs, the cocoa extract significantly lowered the mRNA levels of the DNMTs, MTHFR, and MTRR. Our study demonstrates for the first time that the consumption of cocoa decreases the global DNA methylation of peripheral leukocytes in humans with cardiovascular risk factors. In vitro experiments with PBMCs suggest that cocoa may exert this effect partially via the down-regulation of DNMTs, MTHFR and MTRR, which are key genes involved in this epigenetic process.	[Crescenti, Anna; Caimari, Antoni; del Bas, Josep M.; Arola, Lluis] TECNIO, CTNS, Reus, Spain; [Sola, Rosa; Valls, Rosa M.] Univ Rovira & Virgili, IISPV, Hosp Univ St Joan Reus, Unitat Recerca Lipids & Arteriosclerosi,CIBERDEM, E-43201 Reus, Spain; [Anguera, Anna] Rottapharm Madaus SL, Barcelona, Spain; [Angles, Neus] La Morella Nuts SAU, Tarragona, Spain; [Arola, Lluis] Univ Rovira & Virgili, Nutrigen Res Grp, Dept Bioquim & Biotecnol, E-43007 Tarragona, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); Universitat Rovira i Virgili	Crescenti, A (corresponding author), TECNIO, CTNS, Reus, Spain.	anna.crescenti@ctns.cat	Valls, Rosa M/AAB-1163-2019; Arola, Lluís/C-6074-2011; SOLÀ, Rosa/N-5919-2014; Crescenti, Anna/AAA-7557-2019; del Bas, Josep M/K-2327-2014; del Bas, Josep Maria/K-9310-2019	Valls, Rosa M/0000-0002-3351-0942; Arola, Lluís/0000-0003-2767-1974; del Bas, Josep M/0000-0002-0700-2004; del Bas, Josep Maria/0000-0002-0700-2004; SOLA, Rosa/0000-0002-8359-235X; Crescenti, Anna/0000-0001-8581-0616; Caimari, Antoni/0000-0001-6144-0294	ACC1O [TECCT11-1-0012]; Ministerio de Economia y Competitividad [AGL2008-00387]	ACC1O; Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by ACC1O (TECCT11-1-0012) and the Ministerio de Economia y Competitividad (AGL2008-00387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buitrago-Lopez A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4488; Chen UL, 2009, BIOCHEM BIOPH RES CO, V378, P57, DOI 10.1016/j.bbrc.2008.10.173; Cho NY, 2007, J PATHOL, V211, P269, DOI 10.1002/path.2106; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Day JK, 2002, J NUTR, V132, p2419S, DOI 10.1093/jn/132.8.2419S; de Vogel S, 2009, CANCER EPIDEM BIOMAR, V18, P3086, DOI 10.1158/1055-9965.EPI-09-0289; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Dong M, 2006, CHEM RES TOXICOL, V19, P50, DOI 10.1021/tx050252j; Duthie SJ, 2011, P NUTR SOC, V70, P47, DOI 10.1017/S0029665110003952; Fang JY, 2003, J GASTROENTEROL, V38, P821, DOI 10.1007/s00535-003-1207-7; Fang MZ, 2007, J NUTR, V137, p223S, DOI 10.1093/jn/137.1.223S; Fang MZ, 2005, CLIN CANCER RES, V11, P7033, DOI 10.1158/1078-0432.CCR-05-0406; Fini L, 2007, J NUTR, V137, P2622, DOI 10.1093/jn/137.12.2622; Friso S, 2005, CANCER EPIDEM BIOMAR, V14, P938, DOI 10.1158/1055-9965.EPI-04-0601; Guerrero-Bosagna Carlos M., 2008, BMC Physiology, V8, P17, DOI 10.1186/1472-6793-8-17; Hammoud Saher Sue, 2013, Methods Mol Biol, V927, P451; Kato K, 2008, BRIT J CANCER, V99, P647, DOI 10.1038/sj.bjc.6604521; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Kinney SRM, 2009, CANCER PREV RES, V2, P1065, DOI 10.1158/1940-6207.CAPR-09-0010; Lee WJ, 2006, CARCINOGENESIS, V27, P269, DOI 10.1093/carcin/bgi206; Lee WJ, 2005, MOL PHARMACOL, V68, P1018, DOI 10.1124/mol.104.008367; Li Y, 2010, CURR MED CHEM, V17, P2141, DOI 10.2174/092986710791299966; Link A, 2010, BIOCHEM PHARMACOL, V80, P1771, DOI 10.1016/j.bcp.2010.06.036; Liu ZF, 2009, BIOORG MED CHEM LETT, V19, P706, DOI 10.1016/j.bmcl.2008.12.041; Majid S, 2010, CANCER-AM CANCER SOC, V116, P66, DOI 10.1002/cncr.24662; Olteanu H, 2002, BIOCHEMISTRY-US, V41, P13378, DOI 10.1021/bi020536s; Pandey M, 2010, INT J CANCER, V126, P2520, DOI 10.1002/ijc.24988; Pearce MS, 2012, INT J EPIDEMIOL, V41, P210, DOI 10.1093/ije/dys020; Perez-Jimenez J, 2010, EUR J CLIN NUTR, V64, pS112, DOI 10.1038/ejcn.2010.221; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Ramsahoye BH, 2002, METHODS, V27, P156, DOI 10.1016/S1046-2023(02)00069-5; Ried K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-39; Rimbach G, 2009, INT J MOL SCI, V10, P4290, DOI 10.3390/ijms10104290; Sola R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031103; Sola R, 2010, ATHEROSCLEROSIS, V211, P630, DOI 10.1016/j.atherosclerosis.2010.03.010; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Wang LS, 2011, CLIN CANCER RES, V17, P598, DOI 10.1158/1078-0432.CCR-10-1260; Weisberg IS, 2001, ATHEROSCLEROSIS, V156, P409, DOI 10.1016/S0021-9150(00)00671-7; Zhao JY, 2012, DIABETES, V61, P542, DOI 10.2337/db11-1048	39	41	42	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65744	10.1371/journal.pone.0065744	http://dx.doi.org/10.1371/journal.pone.0065744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840361	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400012
J	Kinnaird, JH; Weir, W; Durrani, Z; Pillai, SS; Baird, M; Shiels, BR				Kinnaird, Jane H.; Weir, William; Durrani, Zeeshan; Pillai, Sreerekha S.; Baird, Margaret; Shiels, Brian R.			A Bovine Lymphosarcoma Cell Line Infected with Theileria annulata Exhibits an Irreversible Reconfiguration of Host Cell Gene Expression	PLOS ONE			English	Article							NF-KAPPA-B; TRANSFORMED T-CELLS; TRANSCRIPTION FACTOR; PARASITE THEILERIA; MICROARRAY EXPERIMENTS; IKK SIGNALOSOMES; BINDING-PROTEIN; CDK INHIBITORS; UP-REGULATION; C-MYC	Theileria annulata, an intracellular parasite of bovine lymphoid cells, induces substantial phenotypic alterations to its host cell including continuous proliferation, cytoskeletal changes and resistance to apoptosis. While parasite induced modulation of host cell signal transduction pathways and NFkB activation are established, there remains considerable speculation on the complexities of the parasite directed control mechanisms that govern these radical changes to the host cell. Our objectives in this study were to provide a comprehensive analysis of the global changes to host cell gene expression with emphasis on those that result from direct intervention by the parasite. By using comparative microarray analysis of an uninfected bovine cell line and its Theileria infected counterpart, in conjunction with use of the specific parasitacidal agent, buparvaquone, we have identified a large number of host cell gene expression changes that result from parasite infection. Our results indicate that the viable parasite can irreversibly modify the transformed phenotype of a bovine cell line. Fifty percent of genes with altered expression failed to show a reversible response to parasite death, a possible contributing factor to initiation of host cell apoptosis. The genes that did show an early predicted response to loss of parasite viability highlighted a sub-group of genes that are likely to be under direct control by parasite infection. Network and pathway analysis demonstrated that this sub-group is significantly enriched for genes involved in regulation of chromatin modification and gene expression. The results provide evidence that the Theileria parasite has the regulatory capacity to generate widespread change to host cell gene expression in a complex and largely irreversible manner.	[Kinnaird, Jane H.; Weir, William; Durrani, Zeeshan; Pillai, Sreerekha S.; Baird, Margaret; Shiels, Brian R.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland; [Pillai, Sreerekha S.] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Edinburgh	Shiels, BR (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.	brian.shiels@glasgow.ac.uk		Shiels, Brian/0000-0001-7595-2514; Weir, William/0000-0001-8648-666X	WellcomeTrust [083488/Z/07/Z]; Higher Education Commission of Pakistan	WellcomeTrust(Wellcome Trust); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	This work was supported by the WellcomeTrust (http://www.wellcome.ac.uk/), grant number 083488/Z/07/Z. Zeeshan Durrani was funded by the Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson R, 2000, MOL BIOCHEM PARASIT, V106, P51, DOI 10.1016/S0166-6851(99)00213-3; Barber BA, 2010, ANN ANAT, V192, P261, DOI 10.1016/j.aanat.2010.07.009; Baumgartner M, 2000, CELL MICROBIOL, V2, P329, DOI 10.1046/j.1462-5822.2000.00062.x; BAYLIS HA, 1995, MOL BIOCHEM PARASIT, V69, P211, DOI 10.1016/0166-6851(94)00216-A; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Chaussepied M, 1998, MOL BIOCHEM PARASIT, V94, P215, DOI 10.1016/S0166-6851(98)00070-X; Chaussepied M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001197; Cock-Rada AM, 2012, CANCER RES, V72, P810, DOI 10.1158/0008-5472.CAN-11-1052; Dessauge G, 2005, ONCOGENE, V24, P1075, DOI 10.1038/sj.onc.1208314; Dobbelaere D, 1999, ANNU REV MICROBIOL, V53, P1, DOI 10.1146/annurev.micro.53.1.1; DOBBELAERE DAE, 1991, EUR J IMMUNOL, V21, P89, DOI 10.1002/eji.1830210114; Durrani Z, 2012, CELL MICROBIOL, V14, P1434, DOI 10.1111/j.1462-5822.2012.01809.x; Fahraeus R, 1996, CURR BIOL, V6, P84, DOI 10.1016/S0960-9822(02)00425-6; Fan JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009691; Fenner BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008799; Forget A, 2008, CELL CYCLE, V7, P3737, DOI 10.4161/cc.7.23.7187; GLASCODINE J, 1990, MOL BIOCHEM PARASIT, V40, P105, DOI 10.1016/0166-6851(90)90084-Y; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Guergnon J, 2003, BIOCHIMIE, V85, P771, DOI 10.1016/j.biochi.2003.09.013; Hall R, 1999, TROP MED INT HEALTH, V4, pA78, DOI 10.1046/j.1365-3156.1999.00454.x; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; He Y, 2010, GENE EXPRESSION, V15, P13, DOI 10.3727/105221610X12819686555051; Hermey G, 2009, CELL MOL LIFE SCI, V66, P2677, DOI 10.1007/s00018-009-0043-1; Heussler VT, 2002, SCIENCE, V298, P1033, DOI 10.1126/science.1075462; Hong FX, 2008, BIOINFORMATICS, V24, P374, DOI 10.1093/bioinformatics/btm620; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irvin A. D., 1987, Immune responses in parasitic infections: immunology, immunopathology, and immunoprophylaxis. Volume III: Protozoa, P223; Jensen K, 2008, INT J PARASITOL, V38, P313, DOI 10.1016/j.ijpara.2007.08.007; Jensen K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-224; Jensen K, 2009, INT J PARASITOL, V39, P1099, DOI 10.1016/j.ijpara.2009.02.020; Kannan S, 2011, BLOOD, V117, P2891, DOI 10.1182/blood-2009-12-253419; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Kim SK, 2007, J IMMUNOL, V178, P5154, DOI 10.4049/jimmunol.178.8.5154; Kuenzi P, 2003, J IMMUNOL, V171, P1224, DOI 10.4049/jimmunol.171.3.1224; Kuo TC, 2009, CURR OPIN IMMUNOL, V21, P173, DOI 10.1016/j.coi.2009.03.008; Leng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007589; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Liu JY, 2010, P NATL ACAD SCI USA, V107, P20494, DOI 10.1073/pnas.1007001107; Lizundia R, 2006, CANCER RES, V66, P6105, DOI 10.1158/0008-5472.CAN-05-3861; Loose M, 2007, CURR OPIN HEMATOL, V14, P307, DOI 10.1097/MOH.0b013e3281900eee; Luder CGK, 2009, INT J PARASITOL, V39, P163, DOI 10.1016/j.ijpara.2008.09.013; Machado J, 2000, MICROBES INFECT, V2, P1311, DOI 10.1016/S1286-4579(00)01284-3; Magli MC, 1997, J CELL PHYSIOL, V173, P168, DOI 10.1002/(SICI)1097-4652(199711)173:2<168::AID-JCP16>3.0.CO;2-C; Malik S, 2010, MOL CELL BIOL, V30, P399, DOI 10.1128/MCB.00907-09; Mann RS, 2009, CURR TOP DEV BIOL, V88, P63, DOI 10.1016/S0070-2153(09)88003-4; Marchetti L, 2010, NUCLEIC ACIDS RES, V38, P8105, DOI 10.1093/nar/gkq688; MCHARDY N, 1985, RES VET SCI, V39, P29, DOI 10.1016/S0034-5288(18)31765-X; Mhadhbi M, 2010, VET PARASITOL, V169, P241, DOI 10.1016/j.vetpar.2010.01.013; Morzaria S. P., 1982, CHARACTERISTICS CONT, P519; Niture SK, 2011, J BIOL CHEM, V286, P28821, DOI 10.1074/jbc.M111.255042; Oura CAL, 2006, CELL MICROBIOL, V8, P276, DOI 10.1111/j.1462-5822.2005.00620.x; Polager S, 2009, NAT REV CANCER, V9, P738, DOI 10.1038/nrc2718; Pouyet L, 2010, INFLAMM BOWEL DIS, V16, P96, DOI 10.1002/ibd.21031; Qing GL, 2005, J BIOL CHEM, V280, P9765, DOI 10.1074/jbc.C400502200; Quintana AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017362; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Sager H, 1997, J LEUKOCYTE BIOL, V61, P459, DOI 10.1002/jlb.61.4.459; Sang LY, 2010, TRENDS MOL MED, V16, P17, DOI 10.1016/j.molmed.2009.11.001; Savinova OV, 2009, MOL CELL, V34, P591, DOI 10.1016/j.molcel.2009.04.033; Schmuckli-Maurer J, 2010, CELL MICROBIOL, V12, P158, DOI 10.1111/j.1462-5822.2009.01386.x; Schmuckli-Maurer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004839; Schnittger L, 2002, MOL BIOCHEM PARASIT, V120, P247, DOI 10.1016/S0166-6851(02)00013-0; Sharifiyazdi H, 2012, VET PARASITOL, V187, P431, DOI 10.1016/j.vetpar.2012.01.016; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shiels B, 2006, INT J PARASITOL, V36, P9, DOI 10.1016/j.ijpara.2005.09.002; SHIELS B, 1992, J CELL SCI, V101, P99; Shiels BR, 2004, EUKARYOT CELL, V3, P495, DOI 10.1128/EC.3.2.495-505.2004; SHIELS BR, 1986, PARASITE IMMUNOL, V8, P69, DOI 10.1111/j.1365-3024.1986.tb00834.x; Soligo M, 2011, EUR J IMMUNOL, V41, P503, DOI 10.1002/eji.201040712; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Swan DG, 2001, J CELL SCI, V114, P2747; Taira T, 1998, GENES CELLS, V3, P549, DOI 10.1046/j.1365-2443.1998.00206.x; Vogler M, 2012, CELL DEATH DIFFER, V19, P67, DOI 10.1038/cdd.2011.158; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wu XQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029622; Zhang H, 2000, J BIOL CHEM, V275, P11092, DOI 10.1074/jbc.275.15.11092; Zheng D, 2008, CANCER RES, V68, P7650, DOI 10.1158/0008-5472.CAN-08-1137	82	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66833	10.1371/journal.pone.0066833	http://dx.doi.org/10.1371/journal.pone.0066833			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840536	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000321424400043
J	Oenema, TA; Maarsingh, H; Smit, M; Groothuis, GMM; Meurs, H; Gosens, R				Oenema, Tjitske A.; Maarsingh, Harm; Smit, Marieke; Groothuis, Geny M. M.; Meurs, Herman; Gosens, Reinoud			Bronchoconstriction Induces TGF-beta Release and Airway Remodelling in Guinea Pig Lung Slices	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; MUSCARINIC RECEPTOR STIMULATION; OBSTRUCTIVE PULMONARY-DISEASE; TIOTROPIUM BROMIDE; MECHANICAL-STRESS; EPITHELIAL-CELLS; ASTHMA; EXPRESSION; MODEL	Airway remodelling, including smooth muscle remodelling, is a primary cause of airflow limitation in asthma. Recent evidence links bronchoconstriction to airway remodelling in asthma. The mechanisms involved are poorly understood. A possible player is the multifunctional cytokine TGF-beta, which plays an important role in airway remodelling. Guinea pig lung slices were used as an in vitro model to investigate mechanisms involved in bronchoconstriction-induced airway remodelling. To address this aim, mechanical effects of bronchoconstricting stimuli on contractile protein expression and TGF-beta release were investigated. Lung slices were viable for at least 48 h. Both methacholine and TGF-beta(1) augmented the expression of contractile proteins (sm-alpha-actin, sm-myosin, calponin) after 48 h. Confocal fluorescence microscopy showed that increased sm-myosin expression was enhanced in the peripheral airways and the central airways. Mechanistic studies demonstrated that methacholine-induced bronchoconstriction mediated the release of biologically active TGF-beta, which caused the increased contractile protein expression, as inhibition of actin polymerization (latrunculin A) or TGF-beta receptor kinase (SB431542) prevented the methacholine effects, whereas other bronchoconstricting agents (histamine and KCl) mimicked the effects of methacholine. Collectively, bronchoconstriction promotes the release of TGF-beta, which induces airway smooth muscle remodelling. This study shows that lung slices are a useful in vitro model to study mechanisms involved in airway remodelling.	[Oenema, Tjitske A.; Maarsingh, Harm; Smit, Marieke; Meurs, Herman; Gosens, Reinoud] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD, Dept Mol Pharmacol, Groningen, Netherlands; [Oenema, Tjitske A.; Maarsingh, Harm; Smit, Marieke; Meurs, Herman; Gosens, Reinoud] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands; [Groothuis, Geny M. M.] Univ Groningen, Groningen Res Inst Pharm, Dept Pharmacokinet Toxicol & Targeting, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Oenema, TA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD, Dept Mol Pharmacol, Groningen, Netherlands.	t.a.oenema@rug.nl	Maarsingh, Harm/AAD-5642-2019	Gosens, Reinoud/0000-0002-5595-152X	Groningen Center for Drug Research; University of Groningen; NWO [40-00506-98-9021, 175-010-2009-023]	Groningen Center for Drug Research; University of Groningen; NWO(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Groningen Center for Drug Research and the University of Groningen. Part of the work has been performed at the University Medical Center Groningen Imaging and Microscopy Center (UMIC), which is sponsored by NWO-grants 40-00506-98-9021 and 175-010-2009-023. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muhsen S, 2011, J ALLERGY CLIN IMMUN, V128, P451, DOI 10.1016/j.jaci.2011.04.047; An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; Baarsma HA, 2011, AM J PHYSIOL-LUNG C, V301, pL956, DOI 10.1152/ajplung.00123.2011; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Bos IST, 2007, EUR RESPIR J, V30, P653, DOI 10.1183/09031936.00004907; Camoretti-Mercado B, 2000, J BIOL CHEM, V275; Camoretti-Mercado B, 2006, J BIOL CHEM, V281, P20383, DOI 10.1074/jbc.M602748200; Ceresa CC, 2009, AM J PHYSIOL-LUNG C, V296, pL1059, DOI 10.1152/ajplung.90445.2008; Chen G, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-2; Goldsmith AM, 2007, AM J PHYSIOL-LUNG C, V292, pL99, DOI 10.1152/ajplung.00269.2006; Goldsmith AM, 2006, AM J RESP CELL MOL, V34, P247, DOI 10.1165/rcmb.2005-0166OC; Gosens R, 2003, AM J RESP CELL MOL, V28, P257, DOI 10.1165/rcmb.2002-0128OC; Gosens R, 2005, AM J RESP CRIT CARE, V171, P1096, DOI 10.1164/rccm.200409-1249OC; Gosens R, 2009, EUR RESPIR J, V34, P1436, DOI 10.1183/09031936.00045209; Gosens R, 2007, AM J PHYSIOL-LUNG C, V293, pL1348, DOI 10.1152/ajplung.00346.2007; Gosens R, 2010, FASEB J, V24, P757, DOI 10.1096/fj.09-136325; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Guyot C, 2010, LIVER INT, V30, P1529, DOI 10.1111/j.1478-3231.2010.02342.x; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Halayko AJ, 1999, AM J PHYSIOL-LUNG C, V276, pL197, DOI 10.1152/ajplung.1999.276.1.L197; Halayko Andrew J, 2008, Proc Am Thorac Soc, V5, P80, DOI 10.1513/pats.200705-057VS; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Henjakovic M, 2008, TOXICOL SCI, V106, P444, DOI 10.1093/toxsci/kfn178; Kistemaker LEM, 2012, LIFE SCI, V91, P1126, DOI 10.1016/j.lfs.2012.02.021; Leguillette R, 2009, AM J RESP CRIT CARE, V179, P194, DOI 10.1164/rccm.200609-1367OC; MAGNAN A, 1994, THORAX, V49, P789, DOI 10.1136/thx.49.8.789; Oenema TA, 2012, AM J PHYSIOL-LUNG C, V303, pL589, DOI 10.1152/ajplung.00400.2011; Oenema TA, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-130; Ohta S, 2010, CLIN EXP ALLERGY, V40, P1266, DOI 10.1111/j.1365-2222.2010.03478.x; Postma Dirkje S, 2006, Proc Am Thorac Soc, V3, P434, DOI 10.1513/pats.200601-006AW; Ressler B, 2000, AM J PHYSIOL-LUNG C, V278, pL1264, DOI 10.1152/ajplung.2000.278.6.L1264; Ressmeyer AR, 2006, EUR RESPIR J, V28, P603, DOI 10.1183/09031936.06.00004206; Rosenfeldt HM, 2003, FASEB J, V17, P1789, DOI 10.1096/fj.02-0836com; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Swartz MA, 2001, P NATL ACAD SCI USA, V98, P6180, DOI 10.1073/pnas.111133298; Tatter AL, 2011, J IMMUNOL, V187, P6094, DOI 10.4049/jimmunol.1003507; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; Tschumperlin DJ, 2003, AM J RESP CELL MOL, V28, P142, DOI 10.1165/rcmb.2002-0121OC; Tschumperlin DJ, 2001, AM J RESP CRIT CARE, V164, pS90, DOI 10.1164/ajrccm.164.supplement_2.2106060; Tschumperlin DJ, 2002, AM J PHYSIOL-LUNG C, V282, pL904, DOI 10.1152/ajplung.00270.2001; van de Bovenkamp M, 2005, TOXICOL SCI, V85, P632, DOI 10.1093/toxsci/kfi127; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587; Westra IM, 2013, XENOBIOTICA, V43, P98, DOI 10.3109/00498254.2012.723151; WIGGS BR, 1992, AM REV RESPIR DIS, V145, P1251, DOI 10.1164/ajrccm/145.6.1251; Wright D, 2013, PULM PHARMACOL THER, V26, P24, DOI 10.1016/j.pupt.2012.08.006	47	68	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e65580	10.1371/journal.pone.0065580	http://dx.doi.org/10.1371/journal.pone.0065580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840342	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400007
J	Peck, LS; Souster, T; Clark, MS				Peck, Lloyd S.; Souster, Terri; Clark, Melody S.			Juveniles Are More Resistant to Warming than Adults in 4 Species of Antarctic Marine Invertebrates	PLOS ONE			English	Article							TEMPERATURE-SIZE RULE; THERMAL LIMITS; METABOLIC-RATE; CLIMATE-CHANGE; TRADE-OFFS; HISTORY; OXYGEN; OCEAN; ECTOTHERMS; POLAR	Juvenile stages are often thought to be less resistant to thermal challenges than adults, yet few studies make direct comparisons using the same methods between different life history stages. We tested the resilience of juvenile stages compared to adults in 4 species of Antarctic marine invertebrate over 3 different rates of experimental warming. The species used represent 3 phyla and 4 classes, and were the soft-shelled clam Laternula elliptica, the sea cucumber Cucumaria georgiana, the sea urchin Sterechinus neumayeri, and the seastar Odontaster validus. All four species are widely distributed, locally abundant to very abundant and are amongst the most important in the ecosystem for their roles. At the slowest rate of warming used (1 degrees C 3 days(-1)) juveniles survived to higher temperatures than adults in all species studied. At the intermediate rate (1 degrees C day(-1)) juveniles performed better in 3 of the 4 species, with no difference in the 4th, and at the fastest rate of warming (1 degrees C h(-1)) L. elliptica adults survived to higher temperatures than juveniles, but in C. georgiana juveniles survived to higher temperatures than adults and there were no differences in the other species. Oxygen limitation may explain the better performance of juveniles at the slower rates of warming, whereas the loss of difference between juveniles and adults at the fastest rate of warming suggests another mechanism sets the temperature limit here.	[Peck, Lloyd S.; Souster, Terri; Clark, Melody S.] British Antarctic Survey, Cambridge CB3 0ET, Cambs, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Peck, LS (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, Cambs, England.	l.peck@bas.ac.uk	Clark, Melody S/D-7371-2014	Clark, Melody S/0000-0002-3442-3824	Natural Environment Research Council of the UK, through the British Antarctic Survey; NERC [bas0100025, dml011000] Funding Source: UKRI; Natural Environment Research Council [bas0100025, dml011000] Funding Source: researchfish	Natural Environment Research Council of the UK, through the British Antarctic Survey; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research was supported by the Natural Environment Research Council of the UK, through the British Antarctic Survey. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2009, EXP GERONTOL, V44, P307, DOI 10.1016/j.exger.2009.02.012; Angilletta MJ, 2003, AM NAT, V162, P332; Atkinson D, 2006, EVOL DEV, V8, P202, DOI 10.1111/j.1525-142X.2006.00090.x; Atkinson D., 1996, Society for Experimental Biology Seminar Series, V59, P183; Barnes RSF, 1988, INTRO MARINE ECOLOGY; Bayne BL, 2004, INTEGR COMP BIOL, V44, P425, DOI 10.1093/icb/44.6.425; Bilyk KT, 2011, COMP BIOCHEM PHYS A, V158, P382, DOI 10.1016/j.cbpa.2010.12.010; BREY T, 1991, POLAR BIOL, V11, P227; Brockington S, 2007, MAR ECOL PROG SER, V330, P139, DOI 10.3354/meps330139; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Chapelle G, 1999, NATURE, V399, P114, DOI 10.1038/20099; Chapelle G, 2004, OIKOS, V106, P167, DOI 10.1111/j.0030-1299.2004.12934.x; Clark MS, 2013, GLOBAL CHANGE BIOL, V19, P2251, DOI 10.1111/gcb.12197; Clark MS, 2009, MAR GENOM, V2, P11, DOI 10.1016/j.margen.2009.03.003; Clarke A, 1999, J ANIM ECOL, V68, P893, DOI 10.1046/j.1365-2656.1999.00337.x; Clarke A, 2008, DEEP-SEA RES PT II, V55, P1988, DOI 10.1016/j.dsr2.2008.04.035; Dearborn JH, 1977, ADAPTATIONS ANTARCTI, P293; FOSTER BA, 1971, MAR BIOL, V8, P12, DOI 10.1007/BF00349341; GOSSELIN LA, 1995, MAR BIOL, V122, P625, DOI 10.1007/BF00350684; Gosselin LA, 1997, MAR ECOL PROG SER, V146, P265, DOI 10.3354/meps146265; Grange LJ, 2007, MAR BIOL, V153, P15, DOI 10.1007/s00227-007-0776-z; Huntsman AG, 1925, CONTR CAN BIOL, V2, P91; Husmann G, 2011, J EXP MAR BIOL ECOL, V398, P83, DOI 10.1016/j.jembe.2010.12.013; Janosik AM, 2011, POLAR BIOL, V34, P575, DOI 10.1007/s00300-010-0916-7; Killen SS, 2007, P ROY SOC B-BIOL SCI, V274, P431, DOI 10.1098/rspb.2006.3741; Lo-Yat A, 2011, GLOBAL CHANGE BIOL, V17, P1695, DOI 10.1111/j.1365-2486.2010.02355.x; MCCLINTOCK JB, 1994, MAR ECOL PROG SER, V111, P191, DOI 10.3354/meps111191; Meredith MP, 2005, GEOPHYS RES; Morley SA, 2012, MAR ECOL PROG SER, V450, P81, DOI 10.3354/meps09577; Nguyen KDT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029340; Nielsen K, 1997, ANIMAL PHYSL; Pankhurst NW, 2011, MAR FRESHWATER RES, V62, P1015, DOI 10.1071/MF10269; PEARSE JS, 1966, SCIENCE, V152, P1763, DOI 10.1126/science.152.3730.1763; PEARSE JS, 1991, AM ZOOL, V31, P65; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Peck LS, 2007, MAR BIOL, V150, P1191, DOI 10.1007/s00227-006-0428-8; Peck LS, 2011, MAR GENOM, V4, P237, DOI 10.1016/j.margen.2011.07.001; Peck LS, 2010, MAR BIOL, V157, P2051, DOI 10.1007/s00227-010-1473-x; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Peck LS, 2009, POLAR BIOL, V32, P399, DOI 10.1007/s00300-008-0532-y; Peck LS, 2007, OECOLOGIA, V154, P479, DOI 10.1007/s00442-007-0858-0; Peck LS, 2004, FUNCT ECOL, V18, P625, DOI 10.1111/j.0269-8463.2004.00903.x; Peck LS, 2003, P ROY SOC B-BIOL SCI, V270, pS166, DOI 10.1098/rsbl.2003.0054; Peck LS, 2002, POLAR BIOL, V25, P31, DOI 10.1007/s003000100308; Peck LS, 2000, GEOL SOC SPEC PUBL, V177, P441, DOI 10.1144/GSL.SP.2000.177.01.29; Philipp E, 2005, MECH AGEING DEV, V126, P610, DOI 10.1016/j.mad.2005.02.002; Portner HO, 2007, PHILOS T R SOC B, V362, P2233, DOI 10.1098/rstb.2006.1947; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2002, J EXP BIOL, V205, P2217; Portner HO, 2004, PHYSIOL BIOCHEM ZOOL, V77, P59; Richard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034655; SOMERO GN, 1967, SCIENCE, V156, P257, DOI 10.1126/science.156.3772.257; Spicer J. I., 1999, PHYSL DIVERSITY ITS; Stanwell-Smith D, 1998, BIOL BULL-US, V194, P44, DOI 10.2307/1542512; Stokes MD, 1996, ISRAEL J ZOOL, V42, pS67; Sulkin SD, 1996, CAN J FISH AQUAT SCI, V53, P2076, DOI 10.1139/cjfas-53-9-2076; Vernon H.M., 1900, J PHYSL, V25, P131; Weibel ER, 2004, RESP PHYSIOL NEUROBI, V140, P115, DOI 10.1016/j.resp.2004.01.006; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	59	31	32	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66033	10.1371/journal.pone.0066033	http://dx.doi.org/10.1371/journal.pone.0066033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840393	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000321424400016
J	Rhodes, J; Dejsirilert, S; Maloney, SA; Jorakate, P; Kaewpan, A; Salika, P; Akarachotpong, T; Prapasiri, P; Naorat, S; Areerat, P; Ruayajin, A; Sawanpanyalert, P; Akarasewi, P; Peruski, LF; Baggett, HC				Rhodes, Julia; Dejsirilert, Surang; Maloney, Susan A.; Jorakate, Possawat; Kaewpan, Anek; Salika, Prasert; Akarachotpong, Thantapat; Prapasiri, Prabda; Naorat, Sathapana; Areerat, Peera; Ruayajin, Asadang; Sawanpanyalert, Pathom; Akarasewi, Pasakorn; Peruski, Leonard F., Jr.; Baggett, Henry C.			Pneumococcal Bacteremia Requiring Hospitalization in Rural Thailand: An Update on Incidence, Clinical Characteristics, Serotype Distribution, and Antimicrobial Susceptibility, 2005-2010	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; DISEASE; RESISTANCE; INFLUENZA; CHILDREN; BURDEN; IMPACT; ASIA	Background: Streptococcus pneumoniae is an important cause of morbidity and mortality in Southeast Asia, but regional data is limited. Updated burden estimates are critical as pneumococcal conjugate vaccine (PCV) is highly effective, but not yet included in the Expanded Program on Immunization of Thailand or neighboring countries. Methods: We implemented automated blood culture systems in two rural Thailand provinces as part of population-based surveillance for bacteremia. Blood cultures were collected from hospitalized patients as clinically indicated. Results: From May 2005- March 2010, 196 cases of pneumococcal bacteremia were confirmed in hospitalized patients. Of these, 57% had clinical pneumonia, 20% required mechanical ventilation, and 23% (n = 46) died. Antibiotic use before blood culture was confirmed in 25% of those with blood culture. Annual incidence of hospitalized pneumococcal bacteremia was 3.6 per 100,000 person-years; rates were higher among children aged <5 years at 11.7 and adults >= 65 years at 14.2, and highest among infants <1 year at 33.8. The median monthly case count was higher during December-March compared to the rest of the year 6.0 vs. 1.0 (p<0.001). The most common serotypes were 23F (16%) and 14 (14%); 61% (74% in patients <5 years) were serotypes in the 10-valent PCV (PCV 10) and 82% (92% in <5 years) in PCV 13. All isolates were sensitive to penicillin, but non-susceptibility was high for co-trimoxazole (57%), erythromycin (30%), and clindamycin (20%). Conclusions: We demonstrated a high pneumococcal bacteremia burden, yet underestimated incidence because we captured only hospitalized cases, and because pre-culture antibiotics were frequently used. Our findings together with prior research indicate that PCV would likely have high serotype coverage in Thailand. These findings will complement ongoing cost effectiveness analyses and support vaccine policy evaluation in Thailand and the region.	[Rhodes, Julia; Maloney, Susan A.; Jorakate, Possawat; Kaewpan, Anek; Salika, Prasert; Akarachotpong, Thantapat; Prapasiri, Prabda; Naorat, Sathapana; Peruski, Leonard F., Jr.; Baggett, Henry C.] Thailand Minist Publ Hlth, US Ctr Dis Control & Prevent Collaborat, Global Dis Detect Reg Ctr, Int Emerging Infect Program, Nonthaburi, Thailand; [Dejsirilert, Surang; Sawanpanyalert, Pathom] Minist Publ Hlth, Natl Inst Hlth, Nonthaburi, Thailand; [Ruayajin, Asadang] Sa Kaeo Prov Hlth Off, Sa Kaeo, Thailand; [Areerat, Peera] Nakhon Phanom Prov Hlth Off, Nakhon Phanom, Thailand; [Akarasewi, Pasakorn] Minist Publ Hlth, Bur Epidemiol, Nonthaburi, Thailand	Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Ministry of Public Health - Thailand	Rhodes, J (corresponding author), Thailand Minist Publ Hlth, US Ctr Dis Control & Prevent Collaborat, Global Dis Detect Reg Ctr, Int Emerging Infect Program, Nonthaburi, Thailand.	juliar@th.cdc.gov			Pneumococcal vaccines Accelerated Development and Introduction Plan (PneumoADIP); GAVI Alliance	Pneumococcal vaccines Accelerated Development and Introduction Plan (PneumoADIP); GAVI Alliance	Partial support was provided by the Pneumococcal vaccines Accelerated Development and Introduction Plan (PneumoADIP), which was funded by the GAVI Alliance and based at the Johns Hopkins Bloomberg School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; [Anonymous], POP PROJ THAIL 2000; Baggett HC, 2012, EUR J CLIN MICROBIOL, V31, P753, DOI 10.1007/s10096-011-1370-3; Baggett HC, 2010, INT S PNEUM PNEUM DI; Baggett HC, 2009, CLIN INFECT DIS, V48, pS65, DOI 10.1086/596484; Bravo LC, 2009, VACCINE, V27, P7282, DOI 10.1016/j.vaccine.2009.04.046; *CLSI, 2008, PERF STAND ANT SUS S; Dejsirilert S, 2010, 7 INT S PNEUM PNEUM; Dejsirilert Surang, 2009, J Med Assoc Thai, V92 Suppl 4, pS19; Department of Provincial Administration, POP IND AG; Dowell SF, 2003, EMERG INFECT DIS, V9, P573, DOI 10.3201/eid0905.020556; GAVI World Bank, 2012, CREAT MARK SAV LIV F; Hennessy TW, 2005, VACCINE, V23, P5464, DOI 10.1016/j.vaccine.2005.08.100; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Mindy J., 2003, MANUAL LAB IDENTIFIC; Netsawang Supichaya, 2010, Journal of the Medical Association of Thailand, V93, pS6; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Olsen SJ, 2010, EPIDEMIOL INFECT, V138, P1811, DOI 10.1017/S0950268810000646; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Rhodes J, 2010, AM J TROP MED HYG, V83, P301, DOI 10.4269/ajtmh.2010.09-0584; Robinson KA, 2001, JAMA-J AM MED ASSOC, V285, P1729, DOI 10.1001/jama.285.13.1729; Simmerman JM, 2008, INFLUENZA OTHER RESP, V2, P81, DOI 10.1111/j.1750-2659.2008.00045.x; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Sirinavin Sayomporn, 2003, International Journal of Infectious Diseases, V7, P183, DOI 10.1016/S1201-9712(03)90050-6; Siripongpreeda Natawan, 2010, Journal of the Medical Association of Thailand, V93, pS1; Song JH, 2004, ANTIMICROB AGENTS CH, V48, P2101, DOI 10.1128/AAC.48.6.2101-2107.2004; Srifeungfung S, 2010, VACCINE, V28, P3440, DOI 10.1016/j.vaccine.2010.02.071; Srifuengfung Somporn, 2010, Journal of the Medical Association of Thailand, V93, pS27; Suwanpakdee Detchvijitr, 2010, Journal of the Medical Association of Thailand, V93, pS40; Walter ND, 2010, CLIN INFECT DIS, V50, P175, DOI 10.1086/649208; Walter ND, 2009, NEW ENGL J MED, V361, P2584, DOI 10.1056/NEJMc0904844; Wongsawat Jurai, 2010, Journal of the Medical Association of Thailand, V93, pS53	32	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66038	10.1371/journal.pone.0066038	http://dx.doi.org/10.1371/journal.pone.0066038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840395	Green Published, gold			2022-12-27	WOS:000321424400017
J	Wang, WJ; Hsieh, IF; Chen, CC				Wang, Wei-Jen; Hsieh, I-Fan; Chen, Chun-Chuan			Accelerating Computation of DCM for ERP in MATLAB by External Function Calls to the GPU	PLOS ONE			English	Article							EEG; RESPONSES; MEG; RECONSTRUCTION; NETWORK; BRAIN; FMRI; MRI	This study aims to improve the performance of Dynamic Causal Modelling for Event Related Potentials (DCM for ERP) in MATLAB by using external function calls to a graphics processing unit (GPU). DCM for ERP is an advanced method for studying neuronal effective connectivity. DCM utilizes an iterative procedure, the expectation maximization (EM) algorithm, to find the optimal parameters given a set of observations and the underlying probability model. As the EM algorithm is computationally demanding and the analysis faces possible combinatorial explosion of models to be tested, we propose a parallel computing scheme using the GPU to achieve a fast estimation of DCM for ERP. The computation of DCM for ERP is dynamically partitioned and distributed to threads for parallel processing, according to the DCM model complexity and the hardware constraints. The performance efficiency of this hardware-dependent thread arrangement strategy was evaluated using the synthetic data. The experimental data were used to validate the accuracy of the proposed computing scheme and quantify the time saving in practice. The simulation results show that the proposed scheme can accelerate the computation by a factor of 155 for the parallel part. For experimental data, the speedup factor is about 7 per model on average, depending on the model complexity and the data. This GPU-based implementation of DCM for ERP gives qualitatively the same results as the original MATLAB implementation does at the group level analysis. In conclusion, we believe that the proposed GPU-based implementation is very useful for users as a fast screen tool to select the most likely model and may provide implementation guidance for possible future clinical applications such as online diagnosis.	[Wang, Wei-Jen] Natl Cent Univ, Dept Comp Sci & Informat Engn, Tao Yuan, Taiwan; [Hsieh, I-Fan; Chen, Chun-Chuan] Natl Cent Univ, Grad Inst Biomed Engn, Tao Yuan, Taiwan	National Central University; National Central University	Chen, CC (corresponding author), Natl Cent Univ, Grad Inst Biomed Engn, Tao Yuan, Taiwan.	cchen@ncu.edu.tw			National Science Council of Taiwan [NSC 99-2321-B-008-003, NSC 100-2321-B-008-001, NSC 101-2221-E-008-003, NSC 01-2218-E-008-003]; Veterans General Hospitals and University System of Taiwan Joint Research Program [VGHUST100-G4-1-3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Veterans General Hospitals and University System of Taiwan Joint Research Program	This work was funded by National Science Council of Taiwan (NSC 99-2321-B-008-003; NSC 100-2321-B-008-001; NSC 101-2221-E-008-003; NSC 01-2218-E-008-003) and Veterans General Hospitals and University System of Taiwan Joint Research Program (VGHUST100-G4-1-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastos A, 2011, SOC NEUROSCIENCE; Brown HR, 2012, NEUROIMAGE, V63, P223, DOI 10.1016/j.neuroimage.2012.06.044; Crottaz-Herbette S, 2006, J COGNITIVE NEUROSCI, V18, P766, DOI 10.1162/jocn.2006.18.5.766; Dasgupta A, 2010, SPM FMRI MED IMAGE P; David O, 2006, NEUROIMAGE, V30, P1255, DOI 10.1016/j.neuroimage.2005.10.045; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Dudley JT, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000589; Friston KJ, 2002, NEUROIMAGE, V16, P513, DOI 10.1006/nimg.2001.1044; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garrido MI, 2007, P NATL ACAD SCI USA, V104, P20961, DOI 10.1073/pnas.0706274105; Garrido MI, 2009, NEUROIMAGE, V48, P269, DOI 10.1016/j.neuroimage.2009.06.034; Huang MX, 2005, NEUROIMAGE, V28, P99, DOI 10.1016/j.neuroimage.2005.05.036; Huang TY, 2011, MAGN RESON IMAGING, V29, P712, DOI 10.1016/j.mri.2011.02.027; JANSEN BH, 1995, BIOL CYBERN, V73, P357, DOI 10.1007/BF00199471; Kiebel SJ, 2009, HUM BRAIN MAPP, V30, P1866, DOI 10.1002/hbm.20775; Kim D, 2010, IEEE ENG MED BIO, P3321, DOI 10.1109/IEMBS.2010.5627493; Lohmann G, 2012, NEUROIMAGE, V59, P2322, DOI 10.1016/j.neuroimage.2011.09.025; Men CH, 2009, PHYS MED BIOL, V54, P6565, DOI 10.1088/0031-9155/54/21/008; Moon T. K., 1999, MATH METHODS ALGORIT; Mousazadeh H, 2011, IEEE ENG MED BIO, P4897, DOI 10.1109/IEMBS.2011.6091213; Nunna S, 2010, EL SYST DES ISED 201, P147; Pinto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000579; Raimondo F, 2012, COMPUT INTEL NEUROSC, V2012, DOI 10.1155/2012/206972; Schlogl A, 2007, CLIN NEUROPHYSIOL, V118, P98, DOI 10.1016/j.clinph.2006.09.003; Wang WJ, 2012, J SUPERCOMPUT, V61, P67, DOI 10.1007/s11227-011-0648-7; Wilson J Adam, 2009, Front Neuroeng, V2, P11, DOI 10.3389/neuro.16.011.2009; Yang JZ, 2013, MAGN RESON IMAGING, V31, P313, DOI 10.1016/j.mri.2012.06.038; Ying ZG, 2011, MED PHYS, V38, P4365, DOI 10.1118/1.3599725	29	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66599	10.1371/journal.pone.0066599	http://dx.doi.org/10.1371/journal.pone.0066599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840507	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400030
J	Carpinelli, MR; Manning, MG; Kile, BT; Rachel, AB				Carpinelli, Marina R.; Manning, Michael G.; Kile, Benjamin T.; Rachel, A. Burt			Two ENU-Induced Alleles of Atp2b2 Cause Deafness in Mice	PLOS ONE			English	Article							MEMBRANE CALCIUM-PUMP; SENSORY HAIR-CELLS; HEARING-LOSS; DEAFWADDLER MICE; POINT MUTATION; GENE; PMCA2; CADHERIN-23; MUTAGENESIS	Over 120 loci are known to cause inherited hearing loss in humans. The deafness gene has been identified for only half of these loci. With the aim of identifying some of the remaining deafness genes, we performed an ethylnitrosourea mutagenesis screen for deaf mice. We isolated two mutants with semi-dominant hearing loss, Deaf11 and Deaf13. Both contained causative mutations in Atp2b2, which encodes the plasma membrane calcium ATPase 2. The Atp2b2(Deaf11) mutation leads to a p. I1023S substitution in the tenth transmembrane domain. The Atp2b2(Deaf13) mutation leads to a p. R561S substitution in the catalytic core. Mice homozygous for these mutations display profound hearing loss. Heterozygotes display mild to moderate, progressive hearing loss.	[Carpinelli, Marina R.; Manning, Michael G.; Rachel, A. Burt] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Carpinelli, Marina R.; Manning, Michael G.] Univ Melbourne, HEARing Cooperat Res Ctr, Melbourne, Vic, Australia; Univ Melbourne, Dept Genet, Melbourne, Vic, Australia; [Carpinelli, Marina R.; Kile, Benjamin T.; Rachel, A. Burt] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Carpinelli, Marina R.; Kile, Benjamin T.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Carpinelli, MR (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	marina.carpinelli@mcri.edu.au	Kile, Benjamin/GNP-3246-2022; Kile, Benjamin T/F-6593-2011; Burt, Rachel/I-7874-2012	Kile, Benjamin/0000-0002-8836-8947; Kile, Benjamin T/0000-0002-8836-8947; Burt, Rachel/0000-0001-8827-8266; Carpinelli, Marina/0000-0001-5115-7831	HEARing CRC; Australian Government's Cooperative Research Centres Program; Victorian State Government's Operational Infrastructure Support Program; Australian Government's NHMRC IRIISS; National Collaborative Research Infrastructure Strategy grant; Garnet Passe and Rodney Williams Memorial Foundation	HEARing CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Victorian State Government's Operational Infrastructure Support Program; Australian Government's NHMRC IRIISS; National Collaborative Research Infrastructure Strategy grant(Australian GovernmentDepartment of Industry, Innovation and Science); Garnet Passe and Rodney Williams Memorial Foundation	The authors acknowledge the financial support of the HEARing CRC (www.hearingcrc.org), established and supported under the Australian Government's Cooperative Research Centres Program; the Victorian State Government's Operational Infrastructure Support Program; the Australian Government's NHMRC IRIISS (www.nhmrc.gov.au); a National Collaborative Research Infrastructure Strategy grant to the Australian Phenomics Network (www.australianphenomics.org.au); and the Garnet Passe and Rodney Williams Memorial Foundation (www.gprwmf.org.au, fellowship to MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews TD, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120061; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; Berne RM, 2004, PHYSIOLOGY, P133; BODE VC, 1984, GENETICS, V108, P457; Bortolozzi M, 2010, J BIOL CHEM, V285, P37693, DOI 10.1074/jbc.M110.170092; Carafoli E, 2011, SCI CHINA LIFE SCI, V54, P686, DOI 10.1007/s11427-011-4200-z; Carpinelli Marina R, 2012, Curr Protoc Mouse Biol, V2, P75, DOI 10.1002/9780470942390.mo110161; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Grimm C, 2009, J BIOL CHEM, V284, P13823, DOI 10.1074/jbc.M809045200; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Les EP, 1990, JAX NOTES; McCullough BJ, 2004, HEARING RES, V195, P90, DOI 10.1016/j.heares.2004.05.003; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; NobenTrauth K, 1997, GENOMICS, V44, P266, DOI 10.1006/geno.1997.4869; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Shearer AE, 2011, HEARING RES, V282, P1, DOI 10.1016/j.heares.2011.10.001; Spiden SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000238; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Sun XY, 2008, GENE, V411, P94, DOI 10.1016/j.gene.2008.01.013; Takahashi K, 1999, BIOCHEM BIOPH RES CO, V261, P773, DOI 10.1006/bbrc.1999.1102; Tsai YS, 2006, MAMM GENOME, V17, P716, DOI 10.1007/s00335-005-0191-z; Wood JD, 2004, JARO-J ASSOC RES OTO, V5, P99, DOI 10.1007/s10162-003-4022-1; Xu L, 2011, EXP ANIM TOKYO, V60, P71, DOI 10.1538/expanim.60.71; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	28	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67479	10.1371/journal.pone.0067479	http://dx.doi.org/10.1371/journal.pone.0067479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826306	Green Published, gold			2022-12-27	WOS:000321738400151
J	Sukhtankar, DD; Ko, MC				Sukhtankar, Devki D.; Ko, Mei-Chuan			Physiological Function of Gastrin-Releasing Peptide and Neuromedin B Receptors in Regulating Itch Scratching Behavior in the Spinal Cord of Mice	PLOS ONE			English	Article							MU-OPIOID RECEPTORS; DORSAL-HORN NEURONS; INTRATHECAL MORPHINE; POSTCESAREAN ANALGESIA; RANDOMIZED-TRIALS; BOMBESIN; PRURITUS; RATS; RESPONSES; HISTAMINE	Pruritus (itch) is a severe side effect associated with the use of drugs as well as hepatic and hematological disorders. Previous studies in rodents suggest that bombesin receptor subtypes i.e. receptors for gastrin-releasing peptide (GRPr) and neuromedin B (NMBr) differentially regulate itch scratching. However, to what degree spinal GRPr and NMBr regulate scratching evoked by intrathecally administered bombesin-related peptides is not known. The first aim of this study was to pharmacologically compare the dose-response curves for scratching induced by intrathecally administered bombesin-related peptides versus morphine, which is known to elicit itch in humans. The second aim was to determine if spinal GRPr and NMBr selectively or generally mediate scratching behavior. Mice received intrathecal injection of bombesin (0.01-0.3 nmol), GRP (0.01-0.3nmol), NMB (0.1-1nmol) or morphine (0.3-3 nmol) and were observed for one hour for scratching activity. Bombesin elicited most profound scratching over one hour followed by GRP and NMB, whereas morphine failed to evoke scratching response indicating the insensitivity of mouse models to intrathecal opioid-induced itch. Intrathecal pretreatment with GRPr antagonist RC-3095 (0.03-0.1 nmol) produced a parallel rightward shift in the dose response curve of GRP-induced scratching but not NMB-induced scratching. Similarly, PD168368 (1-3 nmol) only attenuated NMB but not GRP-induced scratching. Individual or co-administration of RC-3095 and PD168368 failed to alter bombesin-evoked scratching. A higher dose of RC-3095 (0.3 nmol) generally suppressed scratching induced by all three peptides but also compromised motor function in the rotarod test. Together, these data indicate that spinal GRPr and NMBr independently drive itch neurotransmission in mice and may not mediate bombesin-induced scratching. GRPr antagonists at functionally receptor-selective doses only block spinal GRP-elicited scratching but the suppression of scratching at higher doses is confounded by motor impairment.	[Sukhtankar, Devki D.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Ko, Mei-Chuan] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27103 USA	University of Michigan System; University of Michigan; Wake Forest University; Wake Forest Baptist Medical Center	Ko, MC (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27103 USA.	kowake13@gmail.com	Ko, Mei-Chuan/C-9468-2009	Ko, Mei-Chuan/0000-0003-2436-4506	National Institute of Health, NIAMS [R01-AR-059193, R21-AR-064456]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059193, R21AR064456] Funding Source: NIH RePORTER	National Institute of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The current study is supported by National Institute of Health, NIAMS, Grants R01-AR-059193 and R21-AR-064456. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2009, J NEUROPHYSIOL, V102, P2176, DOI 10.1152/jn.00463.2009; ANASTASI A, 1971, EXPERIENTIA, V27, P166, DOI 10.1007/BF02145873; Andoh T, 2011, PEPTIDES, V32, P2098, DOI 10.1016/j.peptides.2011.09.003; Bergasa NV, 2008, CLIN LIVER DIS, V12, P219, DOI 10.1016/j.cld.2007.11.009; BISHOP JF, 1986, PEPTIDES, V7, P835, DOI 10.1016/0196-9781(86)90103-8; Carstens E, 1997, J NEUROPHYSIOL, V77, P2499, DOI 10.1152/jn.1997.77.5.2499; COWAN A, 1985, LIFE SCI, V37, P135, DOI 10.1016/0024-3205(85)90416-3; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Fairbanks CA, 2003, ADV DRUG DELIVER REV, V55, P1007, DOI 10.1016/S0169-409X(03)00101-7; GMEREK DE, 1988, ANN NY ACAD SCI, V525, P291, DOI 10.1111/j.1749-6632.1988.tb38614.x; GMEREK DE, 1983, BRIT J DERMATOL, V109, P239, DOI 10.1111/j.1365-2133.1983.tb07091.x; GMEREK DE, 1983, PEPTIDES, V4, P907, DOI 10.1016/0196-9781(83)90089-X; Inan S, 2011, PEPTIDES, V32, P286, DOI 10.1016/j.peptides.2010.11.022; Jeffry J, 2011, PHYSIOLOGY, V26, P286, DOI 10.1152/physiol.00007.2011; Jensen RT, 2008, PHARMACOL REV, V60, P1, DOI 10.1124/pr.107.07108; Johnson MD, 1999, BRAIN RES, V839, P194, DOI 10.1016/S0006-8993(99)01708-4; Jones EA, 2002, QJM-INT J MED, V95, P547, DOI 10.1093/qjmed/95.8.547; KATZ R, 1980, NEUROPHARMACOLOGY, V19, P143, DOI 10.1016/0028-3908(80)90181-1; Ko MCH, 2000, ANESTHESIOLOGY, V92, P795, DOI 10.1097/00000542-200003000-00023; Ko MCH, 2004, J PHARMACOL EXP THER, V310, P169, DOI 10.1124/jpet.103.061101; Kozyrev N, 2012, J SEX MED, V9, P1303, DOI 10.1111/j.1743-6109.2012.02688.x; Kuraishi Y, 2000, J BIOMED SCI, V7, P248, DOI 10.1159/000025455; Lee H, 2003, BEHAV PHARMACOL, V14, P501, DOI 10.1097/00008877-200311000-00002; Liu XY, 2011, CELL, V147, P447, DOI 10.1016/j.cell.2011.08.043; MASUI A, 1993, EUR J PHARMACOL, V238, P297, DOI 10.1016/0014-2999(93)90860-K; Meylan N, 2009, BRIT J ANAESTH, V102, P156, DOI 10.1093/bja/aen368; Palmer CM, 1999, ANESTHESIOLOGY, V90, P437, DOI 10.1097/00000542-199902000-00018; Patel Tejesh, 2010, Skin Therapy Lett, V15, P5; Patel T, 2010, EXPERT OPIN PHARMACO, V11, P1673, DOI 10.1517/14656566.2010.484420; Popping DM, 2012, PAIN, V153, P784, DOI 10.1016/j.pain.2011.11.028; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Stander S, 2007, ACTA DERM-VENEREOL, V87, P291, DOI 10.2340/00015555-0305; Su PY, 2011, J PHARMACOL EXP THER, V337, P822, DOI 10.1124/jpet.111.178970; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Tan-No K, 2008, NEUROPEPTIDES, V42, P239, DOI 10.1016/j.npep.2008.03.003; Tsai FF, 2010, ACTA ANAESTH SCAND, V54, P1265, DOI 10.1111/j.1399-6576.2010.02310.x; Twycross R, 2003, QJM-INT J MED, V96, P7, DOI 10.1093/qjmed/hcg002; Weisshaar E, 2009, ACTA DERM-VENEREOL, V89, P339, DOI 10.2340/00015555-0662; Wu HE, 2004, J PHARMACOL EXP THER, V310, P240, DOI 10.1124/jpet.104.065334; Yamada K, 2000, BRAIN RES, V870, P20, DOI 10.1016/S0006-8993(00)02395-7	42	41	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67422	10.1371/journal.pone.0067422	http://dx.doi.org/10.1371/journal.pone.0067422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826298	gold, Green Submitted, Green Published			2022-12-27	WOS:000321738400145
J	Treloar, KK; Simpson, MJ				Treloar, Katrina K.; Simpson, Matthew J.			Sensitivity of Edge Detection Methods for Quantifying Cell Migration Assays	PLOS ONE			English	Article							IN-VITRO; GROWTH; VITRONECTIN; INVASION; IMAGES; SKIN	Quantitative imaging methods to analyze cell migration assays are not standardized. Here we present a suite of two-dimensional barrier assays describing the collective spreading of an initially-confined population of 3T3 fibroblast cells. To quantify the motility rate we apply two different automatic image detection methods to locate the position of the leading edge of the spreading population after 24, 48 and 72 hours. These results are compared with a manual edge detection method where we systematically vary the detection threshold. Our results indicate that the observed spreading rates are very sensitive to the choice of image analysis tools and we show that a standard measure of cell migration can vary by as much as 25% for the same experimental images depending on the details of the image analysis tools. Our results imply that it is very difficult, if not impossible, to meaningfully compare previously published measures of cell migration since previous results have been obtained using different image analysis techniques and the details of these techniques are not always reported. Using a mathematical model, we provide a physical interpretation of our edge detection results. The physical interpretation is important since edge detection algorithms alone do not specify any physical measure, or physical definition, of the leading edge of the spreading population. Our modeling indicates that variations in the image threshold parameter correspond to a consistent variation in the local cell density. This means that varying the threshold parameter is equivalent to varying the location of the leading edge in the range of approximately 1-5% of the maximum cell density.	[Treloar, Katrina K.; Simpson, Matthew J.] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Treloar, Katrina K.; Simpson, Matthew J.] Queensland Univ Technol, IHBI, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Simpson, MJ (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia.	matthew.simpson@qut.edu.au		Simpson, Matthew/0000-0001-6254-313X	Australian Research Council [DP120100551]	Australian Research Council(Australian Research Council)	The authors appreciate the support of the Australian Research Council Discovery Grant Number DP120100551. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOU IE, 1979, P IEEE, V67, P753, DOI 10.1109/PROC.1979.11325; [Anonymous], 2011, PRINCIPLES DEV; Ashby WJ, 2012, INTEGR BIOL-UK, V4, P1338, DOI 10.1039/c2ib20154b; Bradie B, 2006, FRIENDLY INTRO NUMER; Decaestecker C, 2007, MED RES REV, V27, P149, DOI 10.1002/med.20078; Dixit VD, 2006, J BIOL CHEM, V281, P16681, DOI 10.1074/jbc.M600223200; Geback T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-75; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Goetsch KP, 2011, ANAL BIOCHEM, V411, P158, DOI 10.1016/j.ab.2010.12.012; Gough W, 2011, J BIOMOL SCREEN, V16, P155, DOI 10.1177/1087057110393340; Guitera P, 2011, EXPERT REV ANTICANC, V11, P715, DOI [10.1586/era.11.43, 10.1586/ERA.11.43]; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Kam Yoonseok, 2009, BMC Res Notes, V2, P130, DOI 10.1186/1756-0500-2-130; Kam Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-198; Lee J, 2010, LANGMUIR, V26, P16672, DOI 10.1021/la103542y; Maini PK, 2004, APPL MATH LETT, V17, P575, DOI 10.1016/S0893-9659(04)90128-0; Maini PK, 2004, TISSUE ENG, V10, P475, DOI 10.1089/107632704323061834; Mathworks, 2012, IM ACQ TOOLB US GUID; McKenzie AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026552; Mete M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S23; Nishiyama C, 2012, NAT NEUROSCI, V15, P1211, DOI 10.1038/nn.3184; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Okumura CYM, 2012, J MOL MED, V90, P1079, DOI 10.1007/s00109-012-0882-3; Research Services Branch National Institute of Health, 2012, IMAGEJ US GUID; Sadeghi HM, 1998, J REFRACT SURG, V14, P534; Sengers BG, 2007, J R SOC INTERFACE, V4, P1107, DOI 10.1098/rsif.2007.0233; Simpson MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0007; Simpson MJ, 2012, APPL MATH MODEL, V36, P3323, DOI 10.1016/j.apm.2011.09.071; Simpson MJ, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051922; Simpson MJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041901; Simpson MJ, 2010, PHYSICA A, V389, P3779, DOI 10.1016/j.physa.2010.05.020; Simpson MJ, 2005, MATH COMPUT SIMULAT, V70, P44, DOI 10.1016/j.matcom.2005.03.019; Swanson KR, 2008, CLIN ONCOL-UK, V20, P301, DOI 10.1016/j.clon.2008.01.006; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Topman G, 2012, MED ENG PHYS, V34, P225, DOI 10.1016/j.medengphy.2011.07.014; Upton Z, 2008, J INVEST DERMATOL, V128, P1535, DOI 10.1038/sj.jid.5701148; Upton Z, 2011, INT WOUND J, V8, P522, DOI 10.1111/j.1742-481X.2011.00859.x; van Horssen R, 2011, J CELL PHYSIOL, V226, P288, DOI 10.1002/jcp.22330; Wang XJ, 2010, BIOCHEM BIOPH RES CO, V403, P264, DOI 10.1016/j.bbrc.2010.11.012; Weinberg RA, 2006, BIOL CANC; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Zaritsky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027593; Zordan MD, 2011, CYTOM PART A, V79A, P227, DOI 10.1002/cyto.a.21029	43	50	50	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67389	10.1371/journal.pone.0067389	http://dx.doi.org/10.1371/journal.pone.0067389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826283	gold, Green Submitted, Green Published			2022-12-27	WOS:000321738400139
J	Glaser, S; Obst, A; Koch, B; Henkel, B; Grieger, A; Felix, SB; Halank, M; Bruch, L; Bollmann, T; Warnke, C; Schaper, C; Ewert, R				Glaeser, Sven; Obst, Anne; Koch, Beate; Henkel, Beate; Grieger, Anita; Felix, Stephan B.; Halank, Michael; Bruch, Leonhard; Bollmann, Tom; Warnke, Christian; Schaeper, Christoph; Ewert, Ralf			Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis - The Predictive Value of Exercise Capacity and Gas Exchange Efficiency	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; LUNG; STANDARDIZATION; GUIDELINES; DIAGNOSIS; MORTALITY; IMPACT	Exercise capacity and survival of patients with IPF is potentially impaired by pulmonary hypertension. This study aims to investigate diagnostic and prognostic properties of gas exchange during exercise and lung function in IPF patients with or without pulmonary hypertension. In a multicentre setting, patients with IPF underwent right heart catheterization, cardiopulmonary exercise and lung function testing during their initial evaluation. Mortality follow up was evaluated. Seventy-three of 135 patients [82 males; median age of 64 (56; 72 years)] with IPF had pulmonary hypertension as assessed by right heart catheterization [median mean pulmonary arterial pressure 34 (27; 43) mmHg]. The presence of pulmonary hypertension was best predicted by gas exchange efficiency for carbon dioxide (cut off >= 152% predicted; area under the curve 0.94) and peak oxygen uptake (<= 56% predicted; 0.83), followed by diffusing capacity. Resting lung volumes did not predict pulmonary hypertension. Survival was best predicted by the presence of pulmonary hypertension, followed by peak oxygen uptake [HR 0.96 (0.93; 0.98)]. Pulmonary hypertension in IPF patients is best predicted by gas exchange efficiency during exercise and peak oxygen uptake. In addition to invasively measured pulmonary arterial pressure, oxygen uptake at peak exercise predicts survival in this patient population.	[Glaeser, Sven; Obst, Anne; Koch, Beate; Henkel, Beate; Grieger, Anita; Felix, Stephan B.; Bollmann, Tom; Warnke, Christian; Schaeper, Christoph; Ewert, Ralf] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med Cardiol Intens Care Pulm Med &, Greifswald, Germany; [Halank, Michael] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Internal Med 1, Dresden, Germany; [Bruch, Leonhard] BG Hosp, Trauma Hosp Berlin Assoc, Clin Internal Med, Berlin, Germany	Ernst Moritz Arndt Universitat Greifswald; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Glaser, S (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Internal Med Cardiol Intens Care Pulm Med &, Greifswald, Germany.	sven.glaeser@uni-greifswald.de						ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Boutou AK, 2011, RESPIROLOGY, V16, P451, DOI 10.1111/j.1440-1843.2010.01909.x; Criee CP, 2011, RESP MED, V105, P959, DOI 10.1016/j.rmed.2011.02.006; du Bois RM, 2011, AM J RESP CRIT CARE, V184, P459, DOI 10.1164/rccm.201011-1790OC; Fell CD, 2009, AM J RESP CRIT CARE, V179, P402, DOI 10.1164/rccm.200802-241OC; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Galie N, 2004, EUR HEART J, V25, P2243, DOI 10.1016/j.ehj.2004.09.014; Glaser S, 2012, EUR RESPIR J, V39, P29, DOI 10.1183/09031936.00009811; Glaser S, 2009, MED SCI SPORT EXER, V41, P967, DOI 10.1249/MSS.0b013e3181af696; Glaser S, 2009, RESP MED, V103, P317, DOI 10.1016/j.rmed.2008.08.005; Hansen J.E., 2011, PULMONARY FUNCTION T; JONES NL, 1985, AM REV RESPIR DIS, V131, P700; Kimura M, 2012, PULMONARY HYPERTENSI; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; Koch B, 2009, EUR RESPIR J, V33, P389, DOI 10.1183/09031936.00074208; Koch B, 2011, RESP MED, V105, P352, DOI 10.1016/j.rmed.2010.10.014; Lettieri CJ, 2006, CHEST, V129, P746, DOI 10.1378/chest.129.3.746; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Minai OA, 2012, RESP MED, V106, P1613, DOI 10.1016/j.rmed.2012.07.013; Nadrous HF, 2005, CHEST, V128, P2393, DOI 10.1378/chest.128.4.2393; Nathan SD, 2008, RESP MED, V102, P1305, DOI 10.1016/j.rmed.2008.03.022; NELSON SB, 1990, CHEST, V97, P288, DOI 10.1378/chest.97.2.288; Palange P, 2007, EUR RESPIR J, V29, P185, DOI 10.1183/09031936.00046906; Papakosta D, 2011, LUNG, V189, P391, DOI 10.1007/s00408-011-9304-5; Raghu G, 2004, NEW ENGL J MED, V350, P125, DOI 10.1056/NEJMoa030511; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Shorr AF, 2007, EUR RESPIR J, V30, P715, DOI 10.1183/09031936.00107206; Shorr AF, 2003, CHEST, V124, P922, DOI 10.1378/chest.124.3.922; Tzilas V, 2009, AM J MED SCI, V338, P481, DOI 10.1097/MAJ.0b013e3181ad5984; Wasserman K, 2004, PRINCIPLES EXERCISE, V4th; Wasserman K, 2012, PRINCIPLES EXERCISE, V5th	33	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65643	10.1371/journal.pone.0065643	http://dx.doi.org/10.1371/journal.pone.0065643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840349	Green Submitted, Green Published, gold			2022-12-27	WOS:000322342800015
J	Ma, AZ; Zhuang, XL; Wu, JM; Cui, MM; Lv, D; Liu, CZ; Zhuang, GQ				Ma, Anzhou; Zhuang, Xuliang; Wu, Junmei; Cui, Mengmeng; Lv, Di; Liu, Chunzhao; Zhuang, Guoqiang			Ascomycota Members Dominate Fungal Communities during Straw Residue Decomposition in Arable Soil	PLOS ONE			English	Article							LITTER DECOMPOSITION; PLANT RESIDUES; FOREST; NITROGEN; DIVERSITY; LIGNIN; IMPACT; CARBON; FERMENTATION; SUCCESSION	This study investigated the development of fungal community composition in arable soil during the degradation of straw residue. We explored the short-term responses of the fungal community over 28 days of decomposition in soil using culture-independent polymerase chain reaction in combination with a clone library and denaturing gradient gel electrophoresis (DGGE). Fungal cellobiohydrolase I (cbhI) genes in the soil were also characterized, and their diversity suggested the existence of a different cellulose decomposer. The DGGE profiles based on fungal internal transcribed spacer analysis showed different successions of fungal populations during residue decomposition. Members of Lecythophora and Sordariales were dominant in the early succession, while Hypocrea and Engyodontium were better adapted in the late succession. The succession of fungal communities might be related to changes of residue quality during decomposition. Collectively, sequences assigned to Ascomycota members were dominant at different stages of the fungal succession during decomposition, revealing that they were key drivers responsible for residue degradation in the arable soil tested.	[Ma, Anzhou; Zhuang, Xuliang; Wu, Junmei; Cui, Mengmeng; Zhuang, Guoqiang] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Lv, Di] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China; [Liu, Chunzhao] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China	Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES); Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Process Engineering, CAS	Zhuang, XL (corresponding author), Chinese Acad Sci, Res Ctr Ecoenvironm Sci, Beijing, Peoples R China.	xlzhuang@rcees.ac.cn; gqzhuang@rcees.ac.cn	Zhuang, Guoqiang/M-4129-2018	Zhuang, Guoqiang/0000-0001-8755-7300	National Natural Science Foundation of China [41001151, 41173089]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (41001151, 41173089). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Artham T, 2010, BIOMACROMOLECULES, V11, P20, DOI 10.1021/bm9008099; Bastian F, 2009, SOIL BIOL BIOCHEM, V41, P262, DOI 10.1016/j.soilbio.2008.10.024; Bernard L, 2007, ENVIRON MICROBIOL, V9, P752, DOI 10.1111/j.1462-2920.2006.01197.x; Bertrand I, 2009, BIORESOURCE TECHNOL, V100, P155, DOI 10.1016/j.biortech.2008.06.019; Blackwood CB, 2007, ENVIRON MICROBIOL, V9, P1306, DOI 10.1111/j.1462-2920.2007.01250.x; Dilly O, 2004, SOIL SCI PLANT NUTR, V50, P843, DOI 10.1080/00380768.2004.10408545; Dilly O, 2001, SOIL BIOL BIOCHEM, V33, P921, DOI 10.1016/S0038-0717(00)00239-X; Duong LM, 2008, FUNGAL DIVERS, V30, P23; Edwards IP, 2008, APPL ENVIRON MICROB, V74, P3481, DOI 10.1128/AEM.02893-07; Friedl MA, 2008, MICROBIOL-SGM, V154, P1229, DOI 10.1099/mic.0.2007/014175-0; GOMES J, 1989, APPL MICROBIOL BIOT, V31, P601, DOI 10.1007/BF00270803; Hadas A, 2004, SOIL BIOL BIOCHEM, V36, P255, DOI 10.1016/j.soilbio.2003.09.012; Han X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041335; Jacobsen J, 2005, J MICROBIOL METH, V60, P63, DOI 10.1016/j.mimet.2004.08.013; Johnson JMF, 2007, SOIL SCI SOC AM J, V71, P155, DOI 10.2136/sssaj2005.0419; Kellner H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010971; Kwon YJ, 2011, BIORESOURCE TECHNOL, V102, P8099, DOI 10.1016/j.biortech.2011.06.035; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Lopez MJ, 2007, ENZYME MICROB TECH, V40, P794, DOI 10.1016/j.enzmictec.2006.06.012; Lundell TK, 2010, J BASIC MICROB, V50, P5, DOI 10.1002/jobm.200900338; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Ma AZ, 2008, ENZYME MICROB TECH, V42, P543, DOI 10.1016/j.enzmictec.2008.02.009; Mondani L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025771; Nicolardot B, 2007, SOIL BIOL BIOCHEM, V39, P1631, DOI 10.1016/j.soilbio.2007.01.012; Nilsson RH, 2010, MOL ECOL RESOUR, V10, P1076, DOI 10.1111/j.1755-0998.2010.02850.x; Osono T, 2006, CAN J MICROBIOL, V52, P701, DOI 10.1139/W06-023; Osono T, 2009, FUNGAL DIVERS, V36, P101; Osono T, 2006, MYCOLOGIA, V98, P172, DOI 10.3852/mycologia.98.2.172; Phosri C, 2012, BIODIVERS CONSERV, V21, P2287, DOI 10.1007/s10531-012-0250-1; Ruan ZH, 2012, BIORESOURCE TECHNOL, V110, P198, DOI 10.1016/j.biortech.2012.01.053; Ryckeboer J, 2003, ANN MICROBIOL, V53, P349; Snajdr J, 2011, FEMS MICROBIOL ECOL, V75, P291, DOI 10.1111/j.1574-6941.2010.00999.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tian CG, 2009, P NATL ACAD SCI USA, V106, P22157, DOI 10.1073/pnas.0906810106; Vandenkoornhuyse P, 2002, SCIENCE, V295, P2051, DOI 10.1126/science.295.5562.2051; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Wakelin SA, 2007, FEMS MICROBIOL ECOL, V59, P661, DOI 10.1111/j.1574-6941.2006.00235.x; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Wu JP, 2011, FUNCT ECOL, V25, P921, DOI 10.1111/j.1365-2435.2011.01845.x; Yelle DJ, 2008, ENVIRON MICROBIOL, V10, P1844, DOI 10.1111/j.1462-2920.2008.01605.x; Zhao J, 2011, SOIL BIOL BIOCHEM, V43, P954, DOI 10.1016/j.soilbio.2011.01.010	42	103	126	14	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66146	10.1371/journal.pone.0066146	http://dx.doi.org/10.1371/journal.pone.0066146			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840414	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800036
J	Revelles, O; Millard, P; Nougayrede, JP; Dobrindt, U; Oswald, E; Letisse, F; Portais, JC				Revelles, Olga; Millard, Pierre; Nougayrede, Jean-Philippe; Dobrindt, Ulrich; Oswald, Eric; Letisse, Fabien; Portais, Jean-Charles			The Carbon Storage Regulator (Csr) System Exerts a Nutrient-Specific Control over Central Metabolism in Escherichia coli Strain Nissle 1917	PLOS ONE			English	Article							BINDING PROTEIN CSRA; ISOTOPE LABELING EXPERIMENTS; RNA MOLECULE CSRB; MOUSE INTESTINE; GLUCOSE-METABOLISM; CARBOHYDRATE-METABOLISM; GLYCOGEN BIOSYNTHESIS; MASS-SPECTROMETRY; K-12 MG1655; GENE CSRA	The role of the post-transcriptional carbon storage regulator (Csr) system in nutrient utilization and in the control of the central metabolism in E. coli reference commensal strain Nissle 1917 was investigated. Analysis of the growth capabilities of mutants altered for various components of the Csr system (csrA51, csrB, csrC and csrD mutations) showed that only the protein CsrA - the key component of the system - exerts a marked role in carbon nutrition. Attenuation of CsrA activity in the csrA51 mutant affects the growth efficiency on a broad range of physiologically relevant carbon sources, including compounds utilized by the Entner-Doudoroff (ED) pathway. Detailed investigations of the metabolomes and fluxomes of mutants and wild-type cells grown on carbon sources representative of glycolysis and of the ED pathway (glucose and gluconate, respectively), revealed significant re-adjusting of central carbon metabolism for both compounds in the csrA51 mutant. However, the metabolic re-adjusting observed on gluconate was strikingly different from that observed on glucose, indicating a nutrient-specific control of metabolism by the Csr system.	[Revelles, Olga; Millard, Pierre; Letisse, Fabien; Portais, Jean-Charles] Univ Toulouse, INSA, UPS, LISBP,INP, Toulouse, France; [Revelles, Olga; Millard, Pierre; Letisse, Fabien; Portais, Jean-Charles] INRA, UMR792, Lab Ingn Syst Biol & Proc, F-31931 Toulouse, France; [Revelles, Olga; Millard, Pierre; Letisse, Fabien; Portais, Jean-Charles] CNRS, UMR5504, Toulouse, France; [Nougayrede, Jean-Philippe; Oswald, Eric] INRA, USC1360, F-31931 Toulouse, France; [Nougayrede, Jean-Philippe; Oswald, Eric] Fac Med Toulouse, INSERM, U1043, F-31073 Toulouse, France; [Nougayrede, Jean-Philippe; Oswald, Eric] CNRS, UMR5282, Toulouse, France; [Nougayrede, Jean-Philippe; Oswald, Eric] Univ Toulouse, UPS, Ctr Physiopathol Toulouse Purpan, Toulouse, France; [Dobrindt, Ulrich] Univ Munster, Inst Hyg, D-48149 Munster, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Munster	Portais, JC (corresponding author), Univ Toulouse, INSA, UPS, LISBP,INP, Toulouse, France.	portais@insa-toulouse.fr	Dobrindt, Ulrich/AEU-2378-2022; Nougayrede, Jean-Philippe/I-6362-2019	Dobrindt, Ulrich/0000-0001-9949-1898; Nougayrede, Jean-Philippe/0000-0002-6802-1890; Portais, Jean-Charles/0000-0002-3480-0933; Fabien, Letisse/0000-0002-1490-0152; Oswald, Eric/0000-0002-3017-0081; Millard, Pierre/0000-0002-8136-9963	Institut National de la Recherche Agronomique; German Research Foundation [SFB1009, TP B05]	Institut National de la Recherche Agronomique; German Research Foundation(German Research Foundation (DFG))	The postdoctoral and PhD fellowships of OR and PM, respectively, were funded by the Institut National de la Recherche Agronomique [PM: Progran Young Researcher]. This work has benefited from the continuous support of the Region Midi-Pyrenees, the European Regional Development Fund, the French Ministry for Higher Education & Research, and SICOVAL, and the Institut National de la Recherche Agronomique. UD was supported by the German Research Foundation [SFB1009, TP B05]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON DE, 1968, BIOCHEMISTRY-US, V7, P4030, DOI 10.1021/bi00851a033; Bailey JK, 2010, J CLIN MICROBIOL, V48, P3455, DOI 10.1128/JCM.00760-10; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; CHESTER VE, 1968, J GEN MICROBIOL, V51, P47, DOI 10.1099/00221287-51-1-49; COCAIGNBOUSQUET M, 1995, J APPL BACTERIOL, V79, P108, DOI 10.1111/j.1365-2672.1995.tb03131.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Edwards AN, 2011, MOL MICROBIOL, V80, P1561, DOI 10.1111/j.1365-2958.2011.07663.x; Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; FLIEGE R, 1992, APPL ENVIRON MICROB, V58, P3826, DOI 10.1128/AEM.58.12.3826-3829.1992; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Grozdanov L, 2004, J BACTERIOL, V186, P5432, DOI 10.1128/JB.186.16.5432-5441.2004; Gudapaty S, 2001, J BACTERIOL, V183, P6017, DOI 10.1128/JB.183.20.6017-6027.2001; Hancock V, 2010, J MED MICROBIOL, V59, P392, DOI 10.1099/jmm.0.008672-0; Heux S, 2011, APPL ENVIRON MICROB, V77, P7040, DOI 10.1128/AEM.05838-11; Hobman JL, 2007, MOL MICROBIOL, V64, P881, DOI 10.1111/j.1365-2958.2007.05710.x; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Kiefer P, 2007, ANAL BIOCHEM, V360, P182, DOI 10.1016/j.ab.2006.06.032; Leatham MP, 2005, INFECT IMMUN, V73, P8039, DOI 10.1128/IAI.73.12.8039-8049.2005; LIU MY, 1995, J BACTERIOL, V177, P2663, DOI 10.1128/jb.177.10.2663-2672.1995; Liu MY, 1997, J BIOL CHEM, V272, P17502, DOI 10.1074/jbc.272.28.17502; Massou S, 2007, PHYTOCHEMISTRY, V68, P2330, DOI 10.1016/j.phytochem.2007.03.011; Massou S, 2007, METAB ENG, V9, P252, DOI 10.1016/j.ymben.2007.03.001; McKee AE, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-79; Mercante J, 2009, J MOL BIOL, V392, P511, DOI 10.1016/j.jmb.2009.07.034; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Miranda RL, 2004, INFECT IMMUN, V72, P1666, DOI 10.1128/IAI.72.3.1666-1676.2004; Murray EL, 2005, J BACTERIOL, V187, P991, DOI 10.1128/JB.187.3.991-1000.2005; Nicolas C, 2007, FEBS LETT, V581, P3771, DOI 10.1016/j.febslet.2007.06.066; Parrou JL, 1997, ANAL BIOCHEM, V248, P186, DOI 10.1006/abio.1997.2138; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Pernestig AK, 2003, J BACTERIOL, V185, P843, DOI 10.1128/JB.185.3.843-853.2003; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Phue JN, 2005, BIOTECHNOL BIOENG, V90, P805, DOI 10.1002/bit.20478; Portais JC, 1999, EUR J BIOCHEM, V265, P473, DOI 10.1046/j.1432-1327.1999.00778.x; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; SABNIS NA, 1995, J BIOL CHEM, V270, P29096, DOI 10.1074/jbc.270.49.29096; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Snider TA, 2009, VET MICROBIOL, V136, P150, DOI 10.1016/j.vetmic.2008.10.033; Sokol S, 2012, BIOINFORMATICS, V28, P687, DOI 10.1093/bioinformatics/btr716; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Taymaz-Nikerel H, 2009, ANAL BIOCHEM, V386, P9, DOI 10.1016/j.ab.2008.11.018; Timmermans J, 2010, CELL MOL LIFE SCI, V67, P2897, DOI 10.1007/s00018-010-0381-z; Timmermans J, 2009, J BACTERIOL, V191, P1722, DOI 10.1128/JB.01573-08; Todar K, 2007, PATHOGENIC E COLI ON, P11; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Wei BD, 2000, J BACTERIOL, V182, P1632, DOI 10.1128/JB.182.6.1632-1640.2000; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; Wu L, 2005, ANAL BIOCHEM, V336, P164, DOI 10.1016/j.ab.2004.09.001	56	37	40	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66386	10.1371/journal.pone.0066386	http://dx.doi.org/10.1371/journal.pone.0066386			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840455	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800055
J	Scarpetta, S; de Candia, A				Scarpetta, Silvia; de Candia, Antonio			Neural Avalanches at the Critical Point between Replay and Non-Replay of Spatiotemporal Patterns	PLOS ONE			English	Article							NEURONAL AVALANCHES; LEARNING RULE; HIPPOCAMPAL REPLAY; PREFRONTAL CORTEX; CORTICAL NETWORKS; VISUAL-CORTEX; MODEL; SEQUENCES; MEMORY; RETRIEVAL	We model spontaneous cortical activity with a network of coupled spiking units, in which multiple spatio-temporal patterns are stored as dynamical attractors. We introduce an order parameter, which measures the overlap (similarity) between the activity of the network and the stored patterns. We find that, depending on the excitability of the network, different working regimes are possible. For high excitability, the dynamical attractors are stable, and a collective activity that replays one of the stored patterns emerges spontaneously, while for low excitability, no replay is induced. Between these two regimes, there is a critical region in which the dynamical attractors are unstable, and intermittent short replays are induced by noise. At the critical spiking threshold, the order parameter goes from zero to one, and its fluctuations are maximized, as expected for a phase transition (and as observed in recent experimental results in the brain). Notably, in this critical region, the avalanche size and duration distributions follow power laws. Critical exponents are consistent with a scaling relationship observed recently in neural avalanches measurements. In conclusion, our simple model suggests that avalanche power laws in cortical spontaneous activity may be the effect of a network at the critical point between the replay and non-replay of spatio-temporal patterns.	[Scarpetta, Silvia] Univ Salerno, Dipartimento Fis ER Caianiello, Fisciano, SA, Italy; [Scarpetta, Silvia] INFN Gr Coll Salerno, Fisciano, SA, Italy; [de Candia, Antonio] Univ Naples Federico II, Dipartimento Fis, Naples, Italy; [de Candia, Antonio] CNR SPIN, Sez Napoli, Naples, Italy; [de Candia, Antonio] Complesso Univ Monte S Angelo, Sez Napoli, Ist Nazl Fis Nucl, Naples, Italy	University of Salerno; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto Superconduttori, Materiali e Dispositivi Innovativi (SPIN-CNR); Istituto Nazionale di Fisica Nucleare (INFN)	Scarpetta, S (corresponding author), Univ Salerno, Dipartimento Fis ER Caianiello, Fisciano, SA, Italy.	silvia@sa.infn.it	scarpetta, silvia/D-5217-2014; de Candia, Antonio/F-4024-2016; Scarpetta, Silvia/M-8591-2015	de Candia, Antonio/0000-0002-9869-1297; Scarpetta, Silvia/0000-0003-4189-0065	University of Naples "Federico II"; University of Salerno	University of Naples "Federico II"; University of Salerno	This work was supported by university public funds from the University of Naples "Federico II" and University of Salerno. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanel HDI, 2002, P NATL ACAD SCI USA, V99, P10132, DOI 10.1073/pnas.132651299; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beggs JM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00163; Berkes P, 2011, SCIENCE, V331, P83, DOI 10.1126/science.1195870; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Borisyuk R, 2013, BIOSYSTEMS, V112, P214, DOI 10.1016/j.biosystems.2013.03.018; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Chialvo DR, 2010, NAT PHYS, V6, P744, DOI 10.1038/NPHYS1803; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; de Arcangelis L, 2010, P NATL ACAD SCI USA, V107, P3977, DOI 10.1073/pnas.0912289107; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Euston DR, 2007, SCIENCE, V318, P1147, DOI 10.1126/science.1148979; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; GERSTNER W, 1993, BIOL CYBERN, V69, P503, DOI 10.1007/BF00199450; Gerstner W, 2002, SPIKING NEURON MODEL; Giacco F, 2011, FRONT ARTIF INTEL AP, V234, P265, DOI 10.3233/978-1-60750-972-1-265; Gilson M, 2012, PLOS COMPUT BIOL, V6, DOI [10.1371/journal.pcbi. 100258., DOI 10.1371/J0URNAL.PCBI.100258]; Girardeau G, 2011, CURR OPIN NEUROBIOL, V21, P452, DOI 10.1016/j.conb.2011.02.005; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; Lengyel M, 2005, NAT NEUROSCI, V8, P1677, DOI 10.1038/nn1561; Levina A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118110; Lombardi F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228703; Luczak A, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00030; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Marinaro M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041909; Marinaro M, 2003, NEUROCOMPUTING, V52-4, P89, DOI 10.1016/S0925-2312(02)00836-6; Marinaro M, 2007, MATH BIOSCI, V207, P322, DOI 10.1016/j.mbs.2006.10.001; Markram Henry, 2011, Front Synaptic Neurosci, V3, P4, DOI 10.3389/fnsyn.2011.00004; Millman D, 2010, NAT PHYS, V6, P801, DOI 10.1038/NPHYS1757; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Plenz D, 2007, TRENDS NEUROSCI, V30, P101, DOI 10.1016/j.tins.2007.01.005; Ringach DL, 2009, CURR OPIN NEUROBIOL, V19, P439, DOI 10.1016/j.conb.2009.07.005; Scarpetta S, 2005, HIPPOCAMPUS, V15, P979, DOI 10.1002/hipo.20124; Scarpetta S, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/28006; Scarpetta S, 2002, NEURAL COMPUT, V14, P2371, DOI 10.1162/08997660260293265; Scarpetta S, 2001, ADV NEUR IN, V13, P152; Scarpetta S, 2012, J COMPUT NEUROSCI, P1; Scarpetta S., 2010, FRONTIERS SYNAPTIC N, V2, P1; Scarpetta S, 2013, BIOSYSTEMS, V112, P258, DOI 10.1016/j.biosystems.2013.03.017; Scarpetta S, 2011, FRONT ARTIF INTEL AP, V226, P218, DOI 10.3233/978-1-60750-692-8-218; Scarpetta S, 2008, LECT NOTES COMPUT SC, V5286, P38; Segev R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.118102; Segev R, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011920; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Siegel M, 2009, P NATL ACAD SCI USA, V106, P21341, DOI 10.1073/pnas.0908193106; Stewart CV, 2006, J NEUROSCI, V26, P8148, DOI 10.1523/JNEUROSCI.0723-06.2006; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Yang HD, 2012, J NEUROSCI, V32, P1061, DOI 10.1523/JNEUROSCI.2771-11.2012	54	32	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e64162	10.1371/journal.pone.0064162	http://dx.doi.org/10.1371/journal.pone.0064162			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840301	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800004
J	Cervelli, M; Bellavia, G; D'Amelio, M; Cavallucci, V; Moreno, S; Berger, J; Nardacci, R; Marcoli, M; Maura, G; Piacentini, M; Amendola, R; Cecconi, F; Mariottini, P				Cervelli, Manuela; Bellavia, Gabriella; D'Amelio, Marcello; Cavallucci, Virve; Moreno, Sandra; Berger, Joachim; Nardacci, Roberta; Marcoli, Manuela; Maura, Guido; Piacentini, Mauro; Amendola, Roberto; Cecconi, Francesco; Mariottini, Paolo			A New Transgenic Mouse Model for Studying the Neurotoxicity of Spermine Oxidase Dosage in the Response to Excitotoxic Injury	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; ORNITHINE-DECARBOXYLASE ACTIVITY; POLYAMINE RECOGNITION SITE; CEREBRAL-ARTERY OCCLUSION; TRAUMATIC BRAIN-INJURY; KAINIC ACID; RAT-BRAIN; SPERMIDINE/SPERMINE N-1-ACETYLTRANSFERASE; HUNTINGTONS-DISEASE; CELLULAR FUNCTIONS	Spermine oxidase is a FAD-containing enzyme involved in polyamines catabolism, selectively oxidizing spermine to produce H2O2, spermidine, and 3-aminopropanal. Spermine oxidase is highly expressed in the mouse brain and plays a key role in regulating the levels of spermine, which is involved in protein synthesis, cell division and cell growth. Spermine is normally released by neurons at synaptic sites where it exerts a neuromodulatory function, by specifically interacting with different types of ion channels, and with ionotropic glutamate receptors. In order to get an insight into the neurobiological roles of spermine oxidase and spermine, we have deregulated spermine oxidase gene expression producing and characterizing the transgenic mouse model JoSMOrec, conditionally overexpressing the enzyme in the neocortex. We have investigated the effects of spermine oxidase overexpression in the mouse neocortex by transcript accumulation, immunohistochemical analysis, enzymatic assays and polyamine content in young and aged animals. Transgenic JoSMOrec mice showed in the neocortex a higher H2O2 production in respect to Wild-Type controls, indicating an increase of oxidative stress due to SMO overexpression. Moreover, the response of transgenic mice to excitotoxic brain injury, induced by kainic acid injection, was evaluated by analysing the behavioural phenotype, the immunodistribution of neural cell populations, and the ultrastructural features of neocortical neurons. Spermine oxidase overexpression and the consequently altered polyamine levels in the neocortex affects the cytoarchitecture in the adult and aging brain, as well as after neurotoxic insult. It resulted that the transgenic JoSMOrec mouse line is more sensitive to KA than Wild-Type mice, indicating an important role of spermine oxidase during excitotoxicity. These results provide novel evidences of the complex and critical functions carried out by spermine oxidase and spermine in the mammalian brain.	[Cervelli, Manuela; Bellavia, Gabriella; Moreno, Sandra; Mariottini, Paolo] Univ Roma Tre, Dipartimento Biol, Rome, Italy; [D'Amelio, Marcello; Cavallucci, Virve; Cecconi, Francesco] Fdn Santa Lucia, IRCCS, Lab Mol Neuroembryol, Rome, Italy; [Berger, Joachim] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Nardacci, Roberta; Piacentini, Mauro] IRCCS L Spallanzani, Ist Nazl Malattie Infett, Rome, Italy; [Marcoli, Manuela; Maura, Guido] Univ Genoa, Ctr Eccellenza Ric Biomed CEBR, Sez Farmacol & Tossicol, Dipartimento Farm, Genoa, Italy; [Amendola, Roberto] Agenzia Nazl Nuove Tecnol Energia & Sviluppo Econ, Ctr Ric Casaccia 2, Sez Tossicol & Sci Biomed BAS BIOTECMED, Rome, Italy	Roma Tre University; IRCCS Santa Lucia; Monash University; IRCCS Lazzaro Spallanzani; University of Genoa; Italian National Agency New Technical Energy & Sustainable Economics Development	Cervelli, M (corresponding author), Univ Roma Tre, Dipartimento Biol, Rome, Italy.	cervelli@uniroma3.it	Piacentini, Mauro/I-2411-2016; Moreno, Sandra/D-4254-2014; Nardacci, Roberta/K-6555-2016; Cecconi, Francesco/K-3969-2016; Cervelli, Manuela/ABC-6913-2020; Berger, Joachim/N-2979-2019; Amendola, Roberto/AAM-2034-2020; OLIVERIO, MARCO/F-2229-2010	Piacentini, Mauro/0000-0003-2919-1296; Nardacci, Roberta/0000-0002-9209-1207; Cecconi, Francesco/0000-0002-5614-4359; Cervelli, Manuela/0000-0001-8535-8279; Berger, Joachim/0000-0002-7859-545X; OLIVERIO, MARCO/0000-0002-0316-4364; Bellavia, Gabriella/0000-0003-0431-0180; marcoli, manuela/0000-0003-3261-5264; D'Amelio, Marcello/0000-0001-6526-1832; moreno, sandra/0000-0002-1079-3222; Cavallucci, Virve/0000-0003-3082-6359	Universita Roma Tre	Universita Roma Tre	The financial support utilized for this work was mainly from the Universita Roma Tre, the year budget was below 10,000 Euro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALHONEN L, 1995, INT J CANCER, V63, P402, DOI 10.1002/ijc.2910630317; Amendola R, 2009, CURR CANCER DRUG TAR, V9, P118, DOI 10.2174/156800909787580935; Benkovic SA, 2004, BRAIN RES, V1024, P59, DOI 10.1016/j.brainres.2004.07.021; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Cervelli M, 2004, EUR J BIOCHEM, V271, P760, DOI 10.1111/j.1432-1033.2004.03979.x; Cervelli M, 2012, AMINO ACIDS, V42, P441, DOI 10.1007/s00726-011-1014-z; Cervelli M, 2009, INT J BIOCHEM CELL B, V41, P934, DOI 10.1016/j.biocel.2008.09.009; COYLE JT, 1987, CIBA F SYMP, V126, P186; DEVERA N, 1991, J NEUROCHEM, V57, P1; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doctrow S R, 1997, Adv Pharmacol, V38, P247; FAGE D, 1992, J NEUROCHEM, V58, P2170, DOI 10.1111/j.1471-4159.1992.tb10960.x; Fiori LM, 2011, INT J NEUROPSYCHOPH, V14, P595, DOI 10.1017/S1461145710001574; Fiori LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015146; Fleidervish IA, 2008, P NATL ACAD SCI USA, V105, P18994, DOI 10.1073/pnas.0803464105; HALONEN T, 1993, EUR J NEUROSCI, V5, P1233, DOI 10.1111/j.1460-9568.1993.tb00978.x; Henley CM, 1996, J NEUROTRAUM, V13, P487, DOI 10.1089/neu.1996.13.487; HOGAN B, 1983, NATURE, V306, P313, DOI 10.1038/306313a0; Iannicola C, 2000, J NEUROCHEM, V75, P830, DOI 10.1046/j.1471-4159.2000.0750830.x; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Janne J, 2005, J CELL MOL MED, V9, P865, DOI 10.1111/j.1582-4934.2005.tb00385.x; Janne J, 2004, EUR J BIOCHEM, V271, P877, DOI 10.1111/j.1432-1033.2004.04009.x; Kaasinen K, 2000, EUR J NEUROSCI, V12, P540, DOI 10.1046/j.1460-9568.2000.00940.x; Kaasinen SK, 2003, EXP NEUROL, V183, P645, DOI 10.1016/S0014-4886(03)00186-9; Kaasinen SK, 2004, PHARM BIOCH BEHAV, V78, P3545; Kauppinen RA, 1995, PROG NEUROBIOL, V47, P545, DOI 10.1016/0301-0082(95)00037-2; Liu W, 2001, J NEUROCHEM, V79, P976, DOI 10.1046/j.1471-4159.2001.00650.x; LUKKARAINEN J, 1995, EUR J NEUROSCI, V7, P1840, DOI 10.1111/j.1460-9568.1995.tb00704.x; Lukkarinen J, 1997, STROKE, V28, P639, DOI 10.1161/01.STR.28.3.639; Lukkarinen JA, 1999, BRAIN RES, V826, P325, DOI 10.1016/S0006-8993(99)01327-X; Lukkarinen JA, 1998, EUR J NEUROSCI, V10, P2046, DOI 10.1046/j.1460-9568.1998.00216.x; MARTINEZ E, 1991, LIFE SCI, V48, P77, DOI 10.1016/0024-3205(91)90427-D; Mastroberardino P, 2002, CELL DEATH DIFFER, V9, P873, DOI 10.1038/sj.cdd.4401093; Masuko T, 2003, J NEUROCHEM, V84, P610, DOI 10.1046/j.1471-4159.2003.01558.x; MATES JM, 1992, AGENTS ACTIONS, V36, P17, DOI 10.1007/BF01991222; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; NAJM I, 1992, DEV BRAIN RES, V69, P11, DOI 10.1016/0165-3806(92)90117-F; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; PASCHEN W, 1991, BRAIN RES, V566, P354, DOI 10.1016/0006-8993(91)91726-H; PASCHEN W, 1992, MOL CHEM NEUROPATHOL, V16, P241, DOI 10.1007/BF03159973; PASCHEN W, 1990, J CEREBR BLOOD F MET, V10, P236, DOI 10.1038/jcbfm.1990.40; Pledgie A, 2005, J BIOL CHEM, V280, P39843, DOI 10.1074/jbc.M508177200; Rea G, 2004, IUBMB LIFE, V56, P167, DOI 10.1080/15216540410001673996; Schauwecker PE, 2003, MOL BRAIN RES, V112, P70, DOI 10.1016/S0169-328X(03)00048-2; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; van den Bout CJ, 2002, MECH DEVELOP, V110, P179, DOI 10.1016/S0925-4773(01)00597-4; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Wang YL, 2005, BIOCHEM J, V386, P543, DOI 10.1042/BJ20041084; Williams K, 1997, BIOCHEM J, V325, P289, DOI 10.1042/bj3250289; WILLIAMS K, 1989, MOL PHARMACOL, V36, P575; WILLIAMS K, 1990, NEURON, V5, P199, DOI 10.1016/0896-6273(90)90309-4; Yang DS, 2008, AM J PATHOL, V173, P665, DOI 10.2353/ajpath.2008.071176; Yoshida M, 2010, BIOCHEM BIOPH RES CO, V391, P1234, DOI 10.1016/j.bbrc.2009.12.049; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zhang XM, 2011, CURR NEUROPHARMACOL, V9, P388, DOI 10.2174/157015911795596540; Zhu XY, 2001, BRAIN RES, V922, P293, DOI 10.1016/S0006-8993(01)03159-6	60	35	36	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e64810	10.1371/journal.pone.0064810	http://dx.doi.org/10.1371/journal.pone.0064810			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840306	Green Published, gold			2022-12-27	WOS:000322361200005
J	Li, HY; Sun, LL; Xu, Y; Li, ZX; Luo, WT; Tang, ZP; Qiu, XS; Wang, EH				Li, Haiying; Sun, Liangliang; Xu, Ying; Li, Zixuan; Luo, Wenting; Tang, Zhongping; Qiu, Xueshan; Wang, Enhua			Overexpression of MTA3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							METASTASIS-ASSOCIATED GENE; CYCLIN D1; COMPLEX; PROTEINS; NURD	The objective of the current study was to investigate the expression pattern and clinicopathological significance of MTA3 in patients with non-small cell lung cancer (NSCLC). The expression profile of MTA3 in NSCLC tissues and adjacent noncancerous lung tissues was detected by immunohistochemistry. MTA3 was overexpressed in 62 of 108 (57.4%) human lung cancer samples and correlated with p-TNM stage (p < 0.0001), nodal metastasis (p = 0.0009) and poor prognosis (p < 0.05). In addition, the depletion of MTA3 expression with small interfering RNAs inhibited cell growth and colony formation in the A549 and H157 lung cancer cell lines. Moreover, MTA3 depletion induced cell cycle arrest at the G1/S boundary. Western blotting analysis revealed that the knockdown of MTA3 decreased the protein levels of cyclin A, cyclin D1 and p-Rb. These results indicate that MTA3 plays an important role in NSCLC progression.	[Qiu, Xueshan] China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China; China Med Univ, Coll Basic Med Sci, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University	Qiu, XS (corresponding author), China Med Univ, Dept Pathol, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China.	qiuxueshancmu@hotmail.com			National Natural Science Foundation of China [30972967]; Specialized Research Fund for the Doctoral Program of Higher Education [20092104110018]; Program for Liaoning Excellent Talents in University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for Liaoning Excellent Talents in University	This work was supported by grants from the National Natural Science Foundation of China (No. 30972967) and Specialized Research Fund for the Doctoral Program of Higher Education (No. 20092104110018) and Program for Liaoning Excellent Talents in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruning A, 2010, HISTOL HISTOPATHOL, V25, P1447, DOI 10.14670/HH-25.1447; Bruning A, 2009, HISTOCHEM CELL BIOL, V132, P33, DOI 10.1007/s00418-009-0595-z; D'Angiolella V, 2004, CELL CYCLE, V3, P132; Dannenmann C, 2008, CANCER BIOL THER, V7, P1462, DOI 10.4161/cbt.7.9.6427; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fujita N, 2004, CELL, V119, P75, DOI 10.1016/j.cell.2004.09.014; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Hunter K, 2003, NAT GENET, V34, P23, DOI 10.1038/ng0503-23b; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Keum JS, 1999, BRIT J CANCER, V81, P127, DOI 10.1038/sj.bjc.6690661; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Kwintkiewicz J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096032; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Mylonas I, 2012, HISTOPATHOLOGY, V60, P665, DOI 10.1111/j.1365-2559.2011.04103.x; PENCIL SD, 1993, BREAST CANCER RES TR, V25, P165, DOI 10.1007/BF00662141; Ratschiller D, 2003, J CLIN ONCOL, V21, P2085, DOI 10.1200/JCO.2003.03.103; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; TOH Y, 1994, J BIOL CHEM, V269, P22958; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Zhang H, 2006, CLIN CANCER RES, V12, P1479, DOI 10.1158/1078-0432.CCR-05-1519; Zhang H, 2006, GENE DEV, V20, P2943, DOI 10.1101/gad.1461706; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	26	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66679	10.1371/journal.pone.0066679	http://dx.doi.org/10.1371/journal.pone.0066679			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840517	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200099
J	Naik, H; Tsai, MC; Fiedler-Kelly, J; Qiu, P; Vakilynejad, M				Naik, Himanshu; Tsai, Max C.; Fiedler-Kelly, Jill; Qiu, Ping; Vakilynejad, Majid			A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis	PLOS ONE			English	Article							HEALTHY-SUBJECTS; ANEMIA; ERYTHROPOIETIN; HEMODIALYSIS; MODEL	Peginesatide (OMONTYS (R)) is an erythropoiesis-stimulating agent that was indicated in the United States for the treatment of anemia due to chronic kidney disease in adult patients on dialysis prior to its recent marketing withdrawal by the manufacturer. The objective of this analysis was to develop a population pharmacokinetic and pharmacodynamic model to characterize the time-course of peginesatide plasma and hemoglobin concentrations following intravenous and subcutaneous administration. Plasma samples (n = 2,665) from 672 patients with chronic kidney disease (on or not on dialysis) and hemoglobin samples (n = 18,857) from 517 hemodialysis patients (subset of the 672 patients), were used for pharmacokinetic-pharmacodynamic model development in NONMEM VI. The pharmacokinetic profile of peginesatide was best described by a two-compartment model with first-order absorption and saturable elimination. The relationship between peginesatide and hemoglobin plasma concentrations was best characterized by a modified precursor-dependent lifespan indirect response model. The estimate of maximal stimulatory effect of peginesatide on the endogenous production rate of progenitor cells (Emax) was 0.54. The estimate of peginesatide drug concentration required for 50% of maximal response (EC50) estimates was 0.4 mu g/mL. Several significant (P<0.005) covariates affected simulated peginesatide exposure by <= 36%. Based upon <= 0.2 g/dL effects on simulated hemoglobin levels, none were considered clinically relevant.	[Naik, Himanshu; Tsai, Max C.; Vakilynejad, Majid] Takeda Global Res & Dev Inc, Pharmacometr, Deerfield, IL USA; [Fiedler-Kelly, Jill] Cognigen Corp, Pharmacometr Serv, Buffalo, NY USA; [Qiu, Ping] Takeda Global Res & Dev Inc, Clin Sci, Deerfield, IL USA		Vakilynejad, M (corresponding author), Takeda Global Res & Dev Inc, Pharmacometr, Deerfield, IL USA.	majid.vakilynejad@takeda.com			Takeda Global Research & Development Center, Inc.	Takeda Global Research & Development Center, Inc.	This study was supported by Takeda Global Research & Development Center, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrand M, 2011, AAPS J, V13, P143, DOI 10.1208/s12248-011-9255-z; Besarab A, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-95; Boxenbaum H, 1998, J Pharm Pharm Sci, V1, P90; CDC, 2010, NAT CHRON KIDN DIS F; Chanu P, 2010, J CLIN PHARMACOL, V50, P507, DOI 10.1177/0091270009343931; Doshi S, 2010, J CLIN PHARMACOL, V50, p75S, DOI 10.1177/0091270010377201; Fishbane S, 2013, NEW ENGL J MED, V368, P307, DOI 10.1056/NEJMoa1203165; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1, DOI 10.1093/ndt/gfh1024; Macdougall IC, 2011, CLIN J AM SOC NEPHRO, V6, P2579, DOI 10.2215/CJN.10831210; Mircera, 2007, MIRC METH POL GLYC E; National Kidney and Urologic Diseases Information Clearinghouse, 2011, KIDN UR DIS STAT US; Olsson-Gisleskog P, 2007, CLIN PHARMACOKINET, V46, P159, DOI 10.2165/00003088-200746020-00004; PDx-Pop, 2009, PDX POP TOOLS EXP PO; Peginesatide (OMONTYS&REG;) Prescribing Information, 2012, PEG OMONTYS PRESCR I, P60015; Roskos LK, 2006, J CLIN PHARMACOL, V46, P747, DOI 10.1177/0091270006288731; UEHLINGER DE, 1992, CLIN PHARMACOL THER, V51, P76, DOI 10.1038/clpt.1992.10; US Renal Data System, 2011, US REN DAT SYST 2011, V2; Woo S, 2008, J CLIN PHARMACOL, V48, P43, DOI 10.1177/0091270007309702; Woodburn KW, 2012, XENOBIOTICA, V42, P660, DOI 10.3109/00498254.2011.649310	19	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66422	10.1371/journal.pone.0066422	http://dx.doi.org/10.1371/journal.pone.0066422			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840463	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200074
J	Saxena, R; Chandra, V; Manohar, M; Hajela, K; Debnath, U; Prabhakar, YS; Saini, KS; Konwar, R; Kumar, S; Megu, K; Roy, BG; Dwivedi, A				Saxena, Ruchi; Chandra, Vishal; Manohar, Murli; Hajela, Kanchan; Debnath, Utsab; Prabhakar, Yenamandra S.; Saini, Karan Singh; Konwar, Rituraj; Kumar, Sandeep; Megu, Kaling; Roy, Bal Gangadhar; Dwivedi, Anila			Chemotherapeutic Potential of 2-[Piperidinoethoxyphenyl]-3-Phenyl-2H-Benzo(b)pyran in Estrogen Receptor- Negative Breast Cancer Cells: Action via Prevention of EGFR Activation and Combined Inhibition of PI-3-K/Akt/FOXO and MEK/Erk/AP-1 Pathways	PLOS ONE			English	Article							ANTIIMPLANTATION AGENT; TRANSCRIPTION FACTOR; BIOLOGICAL PROFILE; GROWTH; ANTIESTROGENS; INVASION; PROGRESSION; MODULATION; EXPRESSION; APOPTOSIS	Inhibition of epidermal growth factor receptor (EGFR) signaling is considered to be a promising treatment strategy for estrogen receptor (ER)-negative breast tumors. We have investigated here the anti-breast cancer properties of a novel anti-proliferative benzopyran compound namely, 2-[piperidinoethoxyphenyl]-3-phenyl-2H-benzo(b)pyran (CDRI-85/287) in ER-negative and EGFR- overexpressing breast cancer cells. The benzopyran compound selectively inhibited the EGF-induced growth of MDA-MB 231 cells and ER-negative primary breast cancer cell culture. The compound significantly reduced tumor growth in xenograft of MDA-MB 231 cells in nude mice. The compound displayed better binding affinity for EGFR than inhibitor AG1478 as demonstrated by molecular docking studies. CDRI-85/287 significantly inhibited the activation of EGFR and downstream effectors MEK/Erk and PI-3-K/Akt. Subsequent inhibition of AP-1 promoter activity resulted in decreased transcription activation and expression of c-fos and c-jun. Dephosphorylation of downstream effectors FOXO-3a and NF-kappa B led to increased expression of p27 and decreased expression of cyclin D1 which was responsible for decreased phosphorylation of Rb and prevented the transcription of E2F- dependent genes involved in cell cycle progression from G1/S phase. The compound induced apoptosis via mitochondrial pathway and it also inhibited EGF-induced invasion of MDA-MB 231 cells as evidenced by decreased activity of MMP-9 and expression of CTGF. These results indicate that benzopyran compound CDRI-85/287 could constitute a powerful new chemotherapeutic agent against ER-negative and EGFR overexpressing breast tumors.	[Saxena, Ruchi; Chandra, Vishal; Manohar, Murli; Saini, Karan Singh; Konwar, Rituraj; Dwivedi, Anila] Cent Drug Res Inst, Div Endocrinol, CSIR, Lucknow 226001, Uttar Pradesh, India; [Hajela, Kanchan; Debnath, Utsab; Prabhakar, Yenamandra S.] Cent Drug Res Inst, CSIR, Lucknow 226001, Uttar Pradesh, India; [Kumar, Sandeep; Megu, Kaling] King Georges Med Univ, Dept Surg, Lucknow, Uttar Pradesh, India; [Roy, Bal Gangadhar] DRDO, Inst Nucl Med & Allied Sci, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); King George's Medical University; Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS)	Dwivedi, A (corresponding author), Cent Drug Res Inst, Div Endocrinol, CSIR, Lucknow 226001, Uttar Pradesh, India.	anila.dwivedi@rediffmail.com	KUMAR, SANDEEP/GZA-7182-2022; Kumar, Sandeep/AAG-6866-2021; Konwar, Rituraj/B-2272-2010; Manohar, Murli/R-8619-2018; kumar, sandeep/GMX-3097-2022; PRABHAKAR, YENAMANDRA P/A-2442-2019	Konwar, Rituraj/0000-0002-3740-8363; PRABHAKAR, YENAMANDRA P/0000-0002-9156-2441	Council of Scientific and Industrial Research, New Delhi; Ministry of Health and Family Welfare, Government of India	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); Ministry of Health and Family Welfare, Government of India	This work was supported by Council of Scientific and Industrial Research, New Delhi and Ministry of Health and Family Welfare, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders C, 2008, ONCOLOGY-NY, V22, P1233; Badve S, 2011, MODERN PATHOL, V24, P157, DOI 10.1038/modpathol.2010.200; BESCH GJ, 1983, BREAST CANCER RES TR, V3, P15, DOI 10.1007/BF01806230; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; Blesson CS, 2006, STEROIDS, V71, P993, DOI 10.1016/j.steroids.2006.08.001; Chen PS, 2007, J CELL SCI, V120, P2053, DOI 10.1242/jcs.03460; DHAR JD, 1991, CONTRACEPTION, V44, P461, DOI 10.1016/0010-7824(91)90036-F; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Dwivedi A, 1999, HUM REPROD, V14, P1090, DOI 10.1093/humrep/14.4.1090; Ellerbroek SM, 2001, CANCER RES, V61, P1855; Fatima I, 2012, MOL CELL ENDOCRINOL, V348, P198, DOI 10.1016/j.mce.2011.08.018; Griffiths Carrie L, 2012, J Pharm Pract, V25, P319, DOI 10.1177/0897190012442062; Gupta A, 2008, BIOORG MED CHEM LETT, V18, P3982, DOI 10.1016/j.bmcl.2008.06.013; Han HH, 2010, MOL CANCER RES, V8, P1477, DOI 10.1158/1541-7786.MCR-10-0114; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; JORDAN VC, 1992, CANCER, V70, P977; Kapil RS, United States Patent, Patent No. [5254,568, 5254568]; Kim S, 2008, MOLECULES, V13, P2975, DOI 10.3390/molecules13122975; Krol J, 2007, MOL CANCER THER, V6, P3169, DOI 10.1158/1535-7163.MCT-07-0507; Ling H, 2011, BREAST CANCER RES TR, V126, P609, DOI 10.1007/s10549-010-0929-5; Liu DG, 2012, MED ONCOL, V29, P401, DOI 10.1007/s12032-011-9827-x; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; MOE: The Molecular Operating Environment from Chemical Computing Group Inc, 2012, J COMPUTER AIDED MOL, V26, P775; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Rochefort H, 2003, ENDOCR-RELAT CANCER, V10, P261, DOI 10.1677/erc.0.0100261; SAEED A, 1990, J MED CHEM, V33, P3210, DOI 10.1021/jm00174a018; Saxena R, 2012, MED RES REV, V32, P166, DOI 10.1002/med.20209; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; SHARMA AP, 1990, J MED CHEM, V33, P3216, DOI 10.1021/jm00174a019; Shen Q, 2008, CANCER PREV RES, V1, P45, DOI 10.1158/1940-6207.CAPR-08-0034; Shimo T, 2006, J BONE MINER RES, V21, P1045, DOI 10.1359/JBMR.060416; SREENIVASULU S, 1992, CONTRACEPTION, V45, P81, DOI 10.1016/0010-7824(92)90144-I; SYBYL, 2006, SYBYL VERS 7 3; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Xu YZ, 2011, CANCER LETT, V313, P44, DOI 10.1016/j.canlet.2011.08.025; Zhang YG, 2008, INT J ONCOL, V33, P595, DOI 10.3892/ijo_00000045	38	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66246	10.1371/journal.pone.0066246	http://dx.doi.org/10.1371/journal.pone.0066246			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840429	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200063
J	Berriman, ADC; Clancy, D; Clough, HE; Armstrong, D; Christley, RM				Berriman, Alexander D. C.; Clancy, Damian; Clough, Helen E.; Armstrong, Derek; Christley, Robert M.			Effectiveness of Simulated Interventions in Reducing the Estimated Prevalence of Salmonella in UK Pig Herds	PLOS ONE			English	Article							TYPHIMURIUM; CHOLERAESUIS; SWINE; EXCRETION; TRANSMISSION; VACCINATION; PERSISTENCE; SLAUGHTER; EFFICACY; LIVE	Salmonella spp are a major foodborne zoonotic cause of human illness. Consumption of pork products is believed to be a major source of human salmonellosis and Salmonella control throughout the food-chain is recommended. A number of on-farm interventions have been proposed, and some have been implemented in order to try to achieve Salmonella control. In this study we utilize previously developed models describing Salmonella dynamics to investigate the potential effects of a range of these on-farm interventions. As the models indicated that the number of bacteria shed in the faeces of an infectious animal was a key factor, interventions applied within a high-shedding scenario were also analysed. From simulation of the model, the probability of infection after Salmonella exposure was found to be a key driver of Salmonella transmission. The model also highlighted that minimising physiological stress can have a large effect but only when shedding levels are not excessive. When shedding was high, weekly cleaning and disinfection was not effective in Salmonella control. However it is possible that cleaning may have an effect if conducted more often. Furthermore, separating infectious animals, shedding bacteria at a high rate, from the rest of the population was found to be able to minimise the spread of Salmonella.	[Berriman, Alexander D. C.; Clough, Helen E.; Christley, Robert M.] Univ Liverpool, Dept Epidemiol & Populat Hlth, Inst Infect & Global Hlth, Neston, Cheshire, England; [Clancy, Damian] Univ Liverpool, Dept Math Sci, Liverpool L69 3BX, Merseyside, England; [Armstrong, Derek] BPEX, Stoneleigh Pk, Warwick, England	University of Liverpool; University of Liverpool; Agriculture & Horticulture Development Board (AHDB)	Christley, RM (corresponding author), Univ Liverpool, Dept Epidemiol & Populat Hlth, Inst Infect & Global Hlth, Neston, Cheshire, England.	robc@liverpool.ac.uk	Berriman, Alexander/D-1587-2014	Christley, Robert/0000-0001-9250-3032	Biotechnology and Biological Sciences Research Council (BBSRC); BPEX, Collaborative Award in Science and Engineering (CASE) studentship	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BPEX, Collaborative Award in Science and Engineering (CASE) studentship	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and BPEX, as part of a Collaborative Award in Science and Engineering (CASE) studentship (http://www.bbsrc.ac.uk/funding/studentships/case.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHVLA, 2011, INT REP EP STUD MULT; [Anonymous], 2012, ANN REPORT ZOONOSES; Berriman ADC, 2013, SEMISTOCHAS IN PRESS; Blanchard P., 2003, Pig Journal, V52, P182; Bolton DJ, 2003, J APPL MICROBIOL, V94, P1036, DOI 10.1046/j.1365-2672.2003.01938.x; British Pig Executive, 2007, PIG YB; Davies RH, 2004, J APPL MICROBIOL, V96, P750, DOI 10.1111/j.1365-2672.2004.02192.x; DEFRA, 2011, ZOON REP UK 2009; DEFRA, 2006, ZOON AB SURV FOODB P; DEFRA, 2008, BIOS GUID PREV SPREA; Denagamage TN, 2007, FOODBORNE PATHOG DIS, V4, P539, DOI 10.1089/fpd.2007.0013; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; EFSA, 2010, QUANT MICR RISK ASS; Erdman MM, 2005, JAVMA-J AM VET MED A, V227, P460, DOI 10.2460/javma.2005.227.460; Gray JT, 1996, APPL ENVIRON MICROB, V62, P141, DOI 10.1128/AEM.62.1.141-146.1996; GRAY JT, 1995, VET MICROBIOL, V47, P43, DOI 10.1016/0378-1135(95)00060-N; Gray JT, 1996, AM J VET RES, V57, P313; Gray JT, 2001, J FOOD PROTECT, V64, P945, DOI 10.4315/0362-028X-64.7.945; GUTZMANN F, 1976, AM J VET RES, V37, P649; Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hill AA, 2008, EPIDEMIOL INFECT, V136, P320, DOI 10.1017/S0950268807008485; Ivanek R, 2004, J FOOD PROTECT, V67, P2403, DOI 10.4315/0362-028X-67.11.2403; Jensen A, 2005, SALMONELLA INFECT RI, P8793; Kranker S, 2003, J CLIN MICROBIOL, V41, P2282, DOI 10.1128/JCM.41.6.2282-2288.2003; Leek ABG, 2005, IRISH J AGR FOOD RES, V44, P247; Letellier A, 2000, CAN J VET RES, V64, P27; Lurette A, 2008, VET RES, V39, DOI 10.1051/vetres:2008026; MLC, 2006, BRIT PIG PROJ HOUS B; MORGAN IR, 1987, EPIDEMIOL INFECT, V98, P323, DOI 10.1017/S0950268800062075; Osterberg J, 2008, VET REC, V162, P580, DOI 10.1136/vr.162.18.580; Pires SM, 2011, EFSA ESTIMATIO UNPUB; Popoff MY, 2004, RES MICROBIOL, V155, P568, DOI 10.1016/j.resmic.2004.04.005; Potter Andrew, 2008, Animal Health Research Reviews, V9, P187, DOI 10.1017/S1466252308001606; ROBERTS MG, 2003, ENCY LIFE SUPPORT SY; Rostagno MH, 2011, VET REC, V169, P551, DOI 10.1136/vr.d7419; Schwarz P, 2011, VET RECORD, V169; Selke M, 2007, INFECT IMMUN, V75, P2476, DOI 10.1128/IAI.01908-06; Soumpasis I, 2009, RISK ANAL, V29, P1521, DOI 10.1111/j.1539-6924.2009.01274.x; Swanenburg M, 2001, INT J FOOD MICROBIOL, V70, P243, DOI 10.1016/S0168-1605(01)00545-1; Verbrugghe E, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-118; VLA, 2007, SALM LIV PROD GB 200; WILLIAMS LP, 1970, AM J PUBLIC HEALTH N, V60, P926, DOI 10.2105/AJPH.60.5.926; WILLIAMS RD, 1978, ANTIMICROB AGENTS CH, V14, P710, DOI 10.1128/AAC.14.5.710; Wong DMALF, 2002, LIVEST PROD SCI, V76, P215	45	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66054	10.1371/journal.pone.0066054	http://dx.doi.org/10.1371/journal.pone.0066054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840399	gold, Green Submitted, Green Published			2022-12-27	WOS:000321148400010
J	Chen, HB; Liu, YL; Zhao, CJ; Xiao, D; Zhang, JZ; Zhang, FF; Chen, MJ; Wang, H				Chen, Hongbin; Liu, Yali; Zhao, Chunjiang; Xiao, Di; Zhang, Jianzhong; Zhang, Feifei; Chen, Minjun; Wang, Hui			Comparative Proteomics-Based Identification of Genes Associated with Glycopeptide Resistance in Clinically Derived Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Strains	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; METHICILLIN-RESISTANT; PROTEIN; AGR; PREVALENCE; EXPRESSION; REGULATOR; VIRULENCE; PATTERNS; MUTATION	Heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) is associated with clinical treatment failure. However, the resistance mechanism of hVISA has not been fully clarified. In the present study, comparative proteomics analysis of two pairs of isogenic vancomycin-susceptible S. aureus (VSSA) and hVISA strains isolated from two patients identified five differentially expressed proteins, IsaA, MsrA2, Asp23, GpmA, and AhpC, present in both isolate pairs. All the proteins were up-regulated in the hVISA strains. These proteins were analyzed in six pairs of isogenic VSSA and hVISA strains, and unrelated VSSA (n = 30) and hVISA (n = 24) by real-time quantitative reverse transcriptase-PCR (qRT-PCR). Of the six pairs of isogenic strains, isaA, msrA2 and ahpC were up-regulated in all six hVISA strains; whereas asp23 and gpmA were up-regulated in five hVISA strains compared with the VSSA parental strains. In the unrelated strains, statistical analyses showed that only isaA was significantly up-regulated in the hVISA strains. Analysis of the five differentially expressed proteins in 15 pairs of persistent VSSA strains by qRT-PCR showed no differences in the expression of the five genes among the persistent strains, suggesting that these genes are not associated with persistence infection. Our results indicate that increased expression of isaA may be related to hVISA resistance.	[Chen, Hongbin; Zhao, Chunjiang; Zhang, Feifei; Wang, Hui] Peking Univ, Peoples Hosp, Dept Clin Lab, Beijing 100871, Peoples R China; [Liu, Yali; Chen, Minjun] Peking Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China; [Xiao, Di; Zhang, Jianzhong] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Wang, H (corresponding author), Peking Univ, Peoples Hosp, Dept Clin Lab, Beijing 100871, Peoples R China.	whuibj@163.com	Zhang, Jianzhong/AAM-6179-2021	Zhang, Jianzhong/0000-0001-7056-8206; Wang, Hui/0000-0001-9220-0357	Beijing Natural Science Foundation [7102130]; Programme for New Century Excellent Talents in University [NCET-10-0205]; National Natural Science Foundation of China [30971571]; Key Projects in the National Science & Technology Pillar Program [2012EP001002]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Programme for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program	This study was supported by the Beijing Natural Science Foundation (No. 7102130). It was partially supported by Programme for New Century Excellent Talents in University (NCET-10-0205), the National Natural Science Foundation of China (No. 30971571), and Key Projects in the National Science & Technology Pillar Program (2012EP001002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONGBUISSERET L, 1995, MICROBIOL-SGM, V141, P1655, DOI 10.1099/13500872-141-7-1655; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; Cui LZ, 2010, ANTIMICROB AGENTS CH, V54, P5222, DOI 10.1128/AAC.00437-10; Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P428, DOI 10.1128/AAC.50.2.428-438.2006; Cui LZ, 2005, ANTIMICROB AGENTS CH, V49, P3404, DOI 10.1128/AAC.49.8.3404-3413.2005; Davies DR, 2011, ACTA CRYSTALLOGR F, V67, P1044, DOI 10.1107/S1744309111030405; Drummelsmith J, 2007, J PROTEOME RES, V6, P4690, DOI 10.1021/pr070521m; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Hanaki H, 1998, J ANTIMICROB CHEMOTH, V42, P199, DOI 10.1093/jac/42.2.199; Howden BP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-39; Howden BP, 2006, ANTIMICROB AGENTS CH, V50, P3039, DOI 10.1128/AAC.00422-06; Ip M, 2003, J CLIN MICROBIOL, V41, P4980, DOI 10.1128/JCM.41.11.4980-4985.2003; Jones RC, 2008, J BACTERIOL, V190, P5265, DOI 10.1128/JB.00383-08; Kondo Y, 2007, ANTIMICROB AGENTS CH, V51, P264, DOI 10.1128/AAC.00165-06; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Kullik I, 1998, J BACTERIOL, V180, P4814, DOI 10.1128/JB.180.18.4814-4820.1998; Kuroda M, 2003, MOL MICROBIOL, V49, P807, DOI 10.1046/j.1365-2958.2003.03599.x; KURODA M, 1995, BIOCHEM BIOPH RES CO, V207, P978, DOI 10.1006/bbrc.1995.1281; Maor Y, 2007, J CLIN MICROBIOL, V45, P1511, DOI 10.1128/JCM.01262-06; McAleese F, 2006, J BACTERIOL, V188, P1120, DOI 10.1128/JB.188.3.1120-1133.2006; McCallum N, 2006, ANTIMICROB AGENTS CH, V50, P2352, DOI 10.1128/AAC.00073-06; Mongodin E, 2003, J BACTERIOL, V185, P4638, DOI 10.1128/JB.185.15.4638-4643.2003; Moreira B, 1997, ANTIMICROB AGENTS CH, V41, P1788, DOI 10.1128/AAC.41.8.1788; Nelson JL, 2007, ANTIMICROB AGENTS CH, V51, P616, DOI 10.1128/AAC.01057-06; Pfeltz RF, 2000, ANTIMICROB AGENTS CH, V44, P294, DOI 10.1128/AAC.44.2.294-303.2000; Pieper R, 2006, PROTEOMICS, V6, P4246, DOI 10.1002/pmic.200500764; Reipert A, 2003, ANTIMICROB AGENTS CH, V47, P568, DOI 10.1128/AAC.47.2.568-576.2003; Sakoulas G, 2005, ANTIMICROB AGENTS CH, V49, P2687, DOI 10.1128/AAC.49.7.2687-2692.2005; Sasindran SJ, 2007, FUTURE MICROBIOL, V2, P619, DOI 10.2217/17460913.2.6.619; Singh VK, 2003, MICROBIOL-SGM, V149, P2739, DOI 10.1099/mic.0.26442-0; Smith TL, 1999, NEW ENGL J MED, V340, P493, DOI 10.1056/NEJM199902183400701; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; Sun WJ, 2009, ANTIMICROB AGENTS CH, V53, P3642, DOI 10.1128/AAC.00206-09; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Ventura CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011634	36	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66880	10.1371/journal.pone.0066880	http://dx.doi.org/10.1371/journal.pone.0066880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840544	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400022
J	Hauerslev, S; Sveen, ML; Vissing, J; Krag, TO				Hauerslev, Simon; Sveen, Marie L.; Vissing, John; Krag, Thomas O.			Protein Turnover and Cellular Stress in Mildly and Severely Affected Muscles from Patients with Limb Girdle Muscular Dystrophy Type 2I	PLOS ONE			English	Article							C-JUN; KINASE; INVOLVEMENT; TARGET	Patients with Limb girdle muscular dystrophy type 2I (LGMD2I) are characterized by progressive muscle weakness and wasting primarily in the proximal muscles, while distal muscles often are spared. Our aim was to investigate if wasting could be caused by impaired regeneration in the proximal compared to distal muscles. Biopsies were simultaneously obtained from proximal and distal muscles of the same patients with LGMD2I (n = 4) and healthy subjects (n = 4). The level of past muscle regeneration was evaluated by counting internally nucleated fibers and determining actively regenerating fibers by using the developmental markers embryonic myosin heavy chain (eMHC) and neural cell adhesion molecule (NCAM) and also assessing satellite cell activation status by myogenin positivity. Severe muscle histopathology was occasionally observed in the proximal muscles of patients with LGMD2I whereas distal muscles were always relatively spared. No difference was found in the regeneration markers internally nucleated fibers, actively regenerating fibers or activation status of satellite cells between proximal and distal muscles. Protein turnover, both synthesis and breakdown, as well as cellular stress were highly increased in severely affected muscles compared to mildly affected muscles. Our results indicate that alterations in the protein turnover and myostatin levels could progressively impair the muscle mass maintenance and/or regeneration resulting in gradual muscular atrophy.	[Hauerslev, Simon; Sveen, Marie L.; Vissing, John; Krag, Thomas O.] Univ Copenhagen, Rigshosp, Dept Neurol, Neuromuscular Res Unit, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Krag, TO (corresponding author), Univ Copenhagen, Rigshosp, Dept Neurol, Neuromuscular Res Unit, DK-2100 Copenhagen, Denmark.	Thomas.Krag@rh.dk	Krag, Thomas/AAD-3307-2021	Krag, Thomas/0000-0001-9330-668X	Danish Medical Research Council; University of Copenhagen; Novo Nordisk Foundation; Lundbeck Foundation; Lundbeck Foundation [R100-2011-9460] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Copenhagen; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from the Danish Medical Research Council, the University of Copenhagen, the Novo Nordisk Foundation and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; BROOKE MH, 1969, NEUROLOGY, V19, P221, DOI 10.1212/WNL.19.3.221; Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Fanin M, 2003, AM J PATHOL, V163, P1929, DOI 10.1016/S0002-9440(10)63551-1; Kanagawa M, 2006, J HUM GENET, V51, P915, DOI 10.1007/s10038-006-0056-7; Khurana A, 2004, J MUSCLE RES CELL M, V25, P645, DOI 10.1007/s10974-004-7099-1; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Langley B, 2002, J BIOL CHEM, V277, P49831, DOI 10.1074/jbc.M204291200; Spiller MP, 2002, MOL CELL BIOL, V22, P7066, DOI 10.1128/MCB.22.20.7066-7082.2002; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Wang HX, 2008, MOL BIOL CELL, V19, P1519, DOI 10.1091/mbc.E07-08-0817; Whiteley R, 2012, J SCI MED SPORT, V15, P444, DOI 10.1016/j.jsams.2012.01.003; Xu Q, 2002, MOL BIOL CELL, V13, P1940, DOI 10.1091/mbc.02-02-0016	16	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66929	10.1371/journal.pone.0066929	http://dx.doi.org/10.1371/journal.pone.0066929			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840556	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400024
J	Veenith, TV; Carter, E; Grossac, J; Newcombe, VFJ; Outtrim, JG; Lupson, V; Williams, GB; Menon, DK; Coles, JP				Veenith, Tonny V.; Carter, Eleanor; Grossac, Julia; Newcombe, Virginia F. J.; Outtrim, Joanne G.; Lupson, Victoria; Williams, Guy B.; Menon, David K.; Coles, Jonathan P.			Inter Subject Variability and Reproducibility of Diffusion Tensor Imaging within and between Different Imaging Sessions	PLOS ONE			English	Article							PRINCIPAL EIGENVECTOR MEASUREMENTS; TRAUMATIC BRAIN-INJURY; FRACTIONAL ANISOTROPY; MEAN DIFFUSIVITY; TRACTOGRAPHY; MR; DEGENERATION; MULTICENTER; SCANNER	The aim of these studies was to provide reference data on intersubject variability and reproducibility of diffusion tensor imaging. Healthy volunteers underwent imaging on two occasions using the same 3T Siemens Verio magnetic resonance scanner. At each session two identical diffusion tensor sequences were obtained along with standard structural imaging. Fractional anisotropy, apparent diffusion coefficient, axial and radial diffusivity maps were created and regions of interest applied in normalised space. The baseline data from all 26 volunteers were used to calculate the intersubject variability, while within session and between session reproducibility were calculated from all the available data. The reproducibility of measurements were used to calculate the overall and within session 95% prediction interval for zero change. The within and between session reproducibility data were lower than the values for intersubject variability, and were different across the brain. The regional mean (range) coefficient of variation figures for within session reproducibility were 2.1 (0.9-5.5%), 1.2 (0.4-3.9%), 1.2 (0.4-3.8%) and 1.8 (0.4-4.3%) for fractional anisotropy, apparent diffusion coefficient, axial and radial diffusivity, and were lower than between session reproducibility measurements (2.4 (1.1-5.9%), 1.9 (0.7-5.7%), 1.7 (0.7-4.7%) and 2.4 (0.9-5.8%); p < 0.001). The calculated overall and within session 95% prediction intervals for zero change were similar. This study provides additional reference data concerning intersubject variability and reproducibility of diffusion tensor imaging conducted within the same imaging session and different imaging sessions. These data can be utilised in interventional studies to quantify change within a single imaging session, or to assess the significance of change in longitudinal studies of brain injury and disease.	[Veenith, Tonny V.; Carter, Eleanor; Grossac, Julia; Newcombe, Virginia F. J.; Outtrim, Joanne G.; Menon, David K.; Coles, Jonathan P.] Univ Cambridge, Div Anaesthesia, Cambridge, Cambs, England; [Lupson, Victoria; Williams, Guy B.] Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Cambridge, Cambs, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Coles, JP (corresponding author), Univ Cambridge, Div Anaesthesia, Cambridge, Cambs, England.	jpc44@wbic.cam.ac.uk	Veenith, Tonny/A-9948-2010; Veenith, Tonny/AAI-3067-2020	Veenith, Tonny/0000-0002-4125-8804; Veenith, Tonny/0000-0002-4125-8804; Newcombe, Virginia/0000-0001-6044-9035; Williams, Guy/0000-0001-5223-6654; Coles, Jonathan/0000-0003-4013-679X; Outtrim, Joanne/0000-0001-8118-6430	National Institute of Academic Anaesthesia and Raymond Beverly Sackler studentship; NIHR; Wellcome trust; Medical Research Council (UK) [G9439390 ID 65883]; UK National Institute of Health Research Biomedical Research Centre at Cambridge; UK Department of Health; MRC [G0701532, G9439390, G0600986] Funding Source: UKRI; Medical Research Council [G9439390, G0001354, G0600986, G0701532, G0001354B, G1000183B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10090, ACF-2009-14-007] Funding Source: researchfish	National Institute of Academic Anaesthesia and Raymond Beverly Sackler studentship; NIHR(National Institute for Health Research (NIHR)); Wellcome trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK National Institute of Health Research Biomedical Research Centre at Cambridge(National Institute for Health Research (NIHR)); UK Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Dr. TV Veenith was supported by clinical research training fellowship from the National Institute of Academic Anaesthesia and Raymond Beverly Sackler studentship. VFJN is supported by an NIHR academic clinical fellowship. JPC was supported by Wellcome trust project grant. DKM is supported by an NIHR Senior Investigator Award. This work was supported by a Medical Research Council (UK) Program Grant (Acute brain injury: heterogeneity of mechanisms, therapeutic targets and outcome effects (G9439390 ID 65883)), the UK National Institute of Health Research Biomedical Research Centre at Cambridge, and the Technology Platform funding provided by the UK Department of Health. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Alves GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052859; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Bisdas S, 2008, AM J NEURORADIOL, V29, P1128, DOI 10.3174/ajnr.A1044; Bozzali M, 2002, J NEUROL NEUROSUR PS, V72, P742, DOI 10.1136/jnnp.72.6.742; Brander A, 2010, ACTA RADIOL, V51, P800, DOI 10.3109/02841851.2010.495351; Cassol E, 2004, MULT SCLER J, V10, P188, DOI 10.1191/1352458504ms997oa; Cercignani M, 2003, AM J NEURORADIOL, V24, P638; Ciccarelli O, 2003, NEUROIMAGE, V19, P1545, DOI 10.1016/S1053-8119(03)00190-3; Ciccarelli O, 2003, NEUROIMAGE, V18, P348, DOI 10.1016/S1053-8119(02)00042-3; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Danielian LE, 2010, NEUROIMAGE, V49, P1572, DOI 10.1016/j.neuroimage.2009.08.062; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Hannoun S, 2012, AM J NEURORADIOL, V33, P1363, DOI 10.3174/ajnr.A2983; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Hermoye L, 2006, NEUROIMAGE, V29, P493, DOI 10.1016/j.neuroimage.2005.08.017; Thierry AGM, 2006, EUR RADIOL, V16, P1651, DOI 10.1007/s00330-006-0175-8; Huppertz HJ, 2010, NEUROIMAGE, V49, P2216, DOI 10.1016/j.neuroimage.2009.10.066; Jansen JFA, 2007, INVEST RADIOL, V42, P327, DOI 10.1097/01.rli.0000262757.10271.e5; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Landman BA, 2007, NEUROIMAGE, V36, P1123, DOI 10.1016/j.neuroimage.2007.02.056; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lemkaddem A, 2012, NEUROIMAGE, V62, P87, DOI 10.1016/j.neuroimage.2012.04.045; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Newcombe V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019214; Newcombe VFJ, 2011, BRAIN, V134, P759, DOI 10.1093/brain/awq388; Pfefferbaum A, 2003, J MAGN RESON IMAGING, V18, P427, DOI 10.1002/jmri.10377; Senda J, 2012, J NEUROL SCI, V319, P105, DOI 10.1016/j.jns.2012.04.019; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stamatakis EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014496; Studholme C, 1996, Med Image Anal, V1, P163, DOI 10.1016/S1361-8415(96)80011-9; Takao H, 2012, HUM BRAIN MAPP, V33, P466, DOI 10.1002/hbm.21225; Takao H, 2011, HUM BRAIN MAPP, V32, P1762, DOI 10.1002/hbm.21145; Takao H, 2011, NEUROIMAGE, V54, P1053, DOI 10.1016/j.neuroimage.2010.09.023; Teipel SJ, 2011, PSYCHIAT RES-NEUROIM, V194, P363, DOI [10.1016/j.pscychresns2011.05.012, 10.1016/j.pscychresns.2011.05.012]; Vollmar C, 2010, NEUROIMAGE, V51, P1384, DOI 10.1016/j.neuroimage.2010.03.046; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Zhu T, 2011, NEUROIMAGE, V56, P1398, DOI 10.1016/j.neuroimage.2011.02.010	43	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e65941	10.1371/journal.pone.0065941	http://dx.doi.org/10.1371/journal.pone.0065941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840380	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400008
J	Cubi, R; Candalija, A; Ortega, A; Gil, C; Aguilera, J				Cubi, Roger; Candalija, Ana; Ortega, Arturo; Gil, Carles; Aguilera, Jose			Tetanus Toxin Hc Fragment Induces the Formation of Ceramide Platforms and Protects Neuronal Cells against Oxidative Stress	PLOS ONE			English	Article							HEAVY-CHAIN; LIPID RAFTS; ACID SPHINGOMYELINASE; C-FRAGMENT; SYNAPTOTAGMIN-I; TERMINAL DOMAIN; RECEPTOR; KINASE; ACTIVATION; REQUIRES	Tetanus toxin (TeTx) is the protein, synthesized by the anaerobic bacteria Clostridium tetani, which causes tetanus disease. TeTx gains entry into target cells by means of its interaction with lipid rafts, which are membrane domains enriched in sphingomyelin and cholesterol. However, the exact mechanism of host membrane binding remains to be fully established. In the present study we used the recombinant carboxyl terminal fragment from TeTx (Hc-TeTx), the domain responsible for target neuron binding, showing that Hc-TeTx induces a moderate but rapid and sustained increase in the ceramide/sphingomyelin ratio in primary cultures of cerebellar granule neurons and in NGF-differentiated PC12 cells, as well as induces the formation of ceramide platforms in the plasma membrane. The mentioned increase is due to the promotion of neutral sphingomyelinase activity and not to the de novo synthesis, since GW4869, a specific neutral sphingomyelinase inhibitor, prevents neutral sphingomyelinase activity increase and formation of ceramide platforms. Moreover, neutral sphingomyelinase inhibition with GW4869 prevents Hc-TeTx-triggered signaling (Akt phosphorylation), as well as the protective effect of Hc-TeTx on PC12 cells subjected to oxidative stress, while siRNA directed against nSM2 prevents protection by Hc-TeTx of NSC-34 cells against oxidative insult. Finally, neutral sphingomyelinase activity seems not to be related with the internalization of Hc-TeTx into PC12 cells. Thus, the presented data shed light on the mechanisms triggered by TeTx after membrane binding, which could be related with the events leading to the neuroprotective action exerted by the Hc-TeTx fragment.	[Cubi, Roger; Candalija, Ana; Gil, Carles; Aguilera, Jose] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Catalunya, Spain; [Cubi, Roger; Candalija, Ana; Gil, Carles; Aguilera, Jose] Univ Autonoma Barcelona, Inst Neurociencies, Bellaterra, Catalunya, Spain; [Ortega, Arturo] Cinvestav IPN, Dept Genet & Biol Mol, Mexico City, DF, Mexico; [Aguilera, Jose] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CIBERNED	Gil, C (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Bellaterra, Catalunya, Spain.	carles.gil@uab.cat	Gil, Carles/AAI-9532-2020; Gil, Carles/C-7016-2008; Ortega, Arturo/A-2282-2008; Aguilera, Jose/N-6519-2015	Gil, Carles/0000-0003-2976-4146; Ortega, Arturo/0000-0002-9594-8114; Aguilera, Jose/0000-0002-9906-8034; Cubi, Roger/0000-0003-2762-9928; Candalija, Ana/0000-0002-5003-3789	Ministerio de Ciencia e Innovacion from the Spanish Government [BFU2009-10189, SAF2009-13626, SAF2008-00732]	Ministerio de Ciencia e Innovacion from the Spanish Government(Spanish Government)	This work was supported by grants BFU2009-10189, SAF2009-13626 and SAF2008-00732 from the Ministerio de Ciencia e Innovacion from the Spanish Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Albi E, 2004, BIOL CELL, V96, P657, DOI 10.1016/j.biolcel.2004.05.004; Baron GS, 2002, EMBO J, V21, P1031, DOI 10.1093/emboj/21.5.1031; Bentley JK, 2007, J VIROL, V81, P1186, DOI 10.1128/JVI.02309-06; Bhuiyan MIH, 2010, BIOL PHARM BULL, V33, P11, DOI 10.1248/bpb.33.11; Chai Y, 2006, BIOCHEM BIOPH RES CO, V350, P307, DOI 10.1016/j.bbrc.2006.09.045; Chaib-Oukadour I, 2004, J NEUROCHEM, V90, P1227, DOI 10.1111/j.1471-4159.2004.02586.x; Chaib-Oukadour I, 2009, MOL CELL NEUROSCI, V41, P297, DOI 10.1016/j.mcn.2009.03.006; de Chaves EIP, 2006, BBA-BIOMEMBRANES, V1758, P1995, DOI 10.1016/j.bbamem.2006.09.018; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; DOLLY JO, 1984, NATURE, V307, P457, DOI 10.1038/307457a0; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Dong M, 2003, J CELL BIOL, V162, P1293, DOI 10.1083/jcb.200305098; Dreschers S, 2007, CELL PHYSIOL BIOCHEM, V20, P241, DOI 10.1159/000104170; Falcone S, 2004, J IMMUNOL, V173, P4452, DOI 10.4049/jimmunol.173.7.4452; Gassert E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000623; Gil C, 2003, BIOCHEM J, V373, P613, DOI 10.1042/BJ20030333; Gil C, 2001, BIOCHEM J, V356, P97, DOI 10.1042/0264-6021:3560097; Gil C, 1998, J NEUROCHEM, V70, P1636; Gil C, 2000, FEBS LETT, V481, P177, DOI 10.1016/S0014-5793(00)02002-0; Gomez-Munoz A, 2005, FEBS LETT, V579, P3744, DOI 10.1016/j.febslet.2005.05.067; Grassme H, 2005, J BIOL CHEM, V280, P26256, DOI 10.1074/jbc.M500835200; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; HALPERN JL, 1993, J BIOL CHEM, V268, P11188; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Hauck CR, 2000, FEBS LETT, V478, P260, DOI 10.1016/S0014-5793(00)01851-2; Hauck CR, 1998, EMBO J, V17, P443, DOI 10.1093/emboj/17.2.443; Herreros J, 2001, MOL BIOL CELL, V12, P2947, DOI 10.1091/mbc.12.10.2947; Holopainen JM, 2000, BIOPHYS J, V78, P830, DOI 10.1016/S0006-3495(00)76640-9; Jiang K, 2008, BIOCHEMISTRY-US, V47, P787, DOI 10.1021/bi7019782; Johnston I, 2008, BBA-BIOMEMBRANES, V1778, P185, DOI 10.1016/j.bbamem.2007.09.021; Karahatay S, 2007, CANCER LETT, V256, P101, DOI 10.1016/j.canlet.2007.06.003; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Lalli G, 2003, TRENDS MICROBIOL, V11, P431, DOI 10.1016/S0966-842X(03)00210-5; Mendieta L, 2009, NEUROSCI RES, V65, P98, DOI 10.1016/j.neures.2009.06.001; Montecucco C, 2004, TRENDS MICROBIOL, V12, P442, DOI 10.1016/j.tim.2004.08.002; Moreno-Igoa M, 2010, J MOL MED, V88, P297, DOI 10.1007/s00109-009-0556-y; Munro P, 2001, BIOCHEM BIOPH RES CO, V289, P623, DOI 10.1006/bbrc.2001.6031; Murphy SC, 2006, MOL MEMBR BIOL, V23, P81, DOI 10.1080/09687860500473440; Numakawa T, 2003, J BIOL CHEM, V278, P41259, DOI 10.1074/jbc.M304409200; Peng LS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002008; Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200; Riethmuller J, 2006, BBA-BIOMEMBRANES, V1758, P2139, DOI 10.1016/j.bbamem.2006.07.017; Rogasevskaia T, 2006, J CELL SCI, V119, P2688, DOI 10.1242/jcs.03007; Rummel A, 2004, J BIOL CHEM, V279, P30865, DOI 10.1074/jbc.M403945200; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; Samet D, 1999, CHEM PHYS LIPIDS, V102, P65, DOI 10.1016/S0009-3084(99)00076-6; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; SIMPSON LL, 1980, J PHARMACOL EXP THER, V212, P16; Takahashi T, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/245090; Toivonen JM, 2010, TOXINS, V2, P2622, DOI 10.3390/toxins2112622; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Tse SML, 2005, J BIOL CHEM, V280, P25210, DOI 10.1074/jbc.M501980200; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; van der Meer-Janssen YPM, 2010, PROG LIPID RES, V49, P1, DOI 10.1016/j.plipres.2009.07.003; Veiga MP, 1999, BIOPHYS J, V76, P342, DOI 10.1016/S0006-3495(99)77201-2; Wu BX, 2010, NEUROMOL MED, V12, P320, DOI 10.1007/s12017-010-8120-z; Yeh FL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001207; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	61	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68055	10.1371/journal.pone.0068055	http://dx.doi.org/10.1371/journal.pone.0068055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826362	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000116
J	Gu, W; Song, JY; Cao, Y; Sun, QW; Yao, H; Wu, QN; Chao, JG; Zhou, JJ; Xue, WD; Duan, JA				Gu, Wei; Song, Jingyuan; Cao, Yuan; Sun, Qingwen; Yao, Hui; Wu, Qinan; Chao, Jianguo; Zhou, Juanjuan; Xue, Wenda; Duan, Jinao			Application of the ITS2 Region for Barcoding Medicinal Plants of Selaginellaceae in Pteridophyta	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; DNA BARCODE; SPECIES IDENTIFICATION; DERIVATIVES; TAMARISCINA; BIFLAVONES; EVOLUTION; SEQUENCES	Background: Selaginellaceae is a family of nonseed plants with special evolutionary significance. Plants of the family Selaginellaceae are similarly shaped and easily confused, complicating identification via traditional methods. This study explored, for the first time, the use of the DNA barcode ITS2 to identify medicinal plants of the Selaginellaceae family. Methodology/Principal Findings: In our study, 103 samples were collected from the main distribution areas in China; these samples represented 34 species and contained almost all of the medicinal plants of Selaginellaceae. The ITS2 region of the genome was amplified from these samples and sequenced using universal primers and reaction conditions. The success rates of the PCR amplification and sequencing were 100%. There was significant divergence between the interspecific and intraspecific genetic distances of the ITS2 regions, while the presence of a barcoding gap was obvious. Using the BLAST1 and nearest distance methods, our results proved that the ITS2 regions could successfully identify the species of all Selaginellaceae samples examined. In addition, the secondary structures of ITS2 in the helical regions displayed clear differences in stem loop number, size, position, and screw angle among the medicinal plants of Selaginellaceae. Furthermore, cluster analysis using the ITS2 barcode supported the relationship between the species of Selaginellaceae established by traditional morphological methods. Conclusion: The ITS2 barcode can effectively identify medicinal plants of Selaginellaceae. The results provide a scientific basis for the precise identification of plants of the family Selaginellaceae and the reasonable development of these resources. This study may broaden the application of DNA barcoding in the medicinal plant field and benefit phylogenetic investigations.	[Gu, Wei; Cao, Yuan; Wu, Qinan; Chao, Jianguo; Zhou, Juanjuan; Xue, Wenda; Duan, Jinao] Nanjing Univ Chinese Med, Coll Pharm, Nanjing, Jiangsu, Peoples R China; [Song, Jingyuan; Yao, Hui] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Sun, Qingwen] Guiyang Coll Tradit Chinese Med, Dept Pharm, Guiyang, Peoples R China	Nanjing University of Chinese Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College; Guizhou University of Traditional Chinese Medicine	Duan, JA (corresponding author), Nanjing Univ Chinese Med, Coll Pharm, Nanjing, Jiangsu, Peoples R China.	guwei9266@126.com	Xue, Wenda/AAR-9273-2020; Yao, hui/AAM-2391-2021	Xue, Wenda/0000-0001-9606-062X; Wu, Qinan/0000-0002-7836-0941	Priority Academic Program Development of Jiangsu Higher Education Institutions, PAPD [ysxk-2010]; National Natural Science Foundation of China [81102772]; Qing Lan Project; Fundamental Research Funds for the Central Universities [2012C02]	Priority Academic Program Development of Jiangsu Higher Education Institutions, PAPD; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Qing Lan Project(Jiangsu Polytech Institute); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions, PAPD(ysxk-2010), the National Natural Science Foundation of China (No. 81102772), the Qing Lan Project, and the Fundamental Research Funds for the Central Universities (No. 2012C02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Banks JA, 2009, ANNU REV PLANT BIOL, V60, P223, DOI 10.1146/annurev.arplant.59.032607.092851; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Cao Y, 2010, FITOTERAPIA, V81, P253, DOI 10.1016/j.fitote.2009.09.007; Cao Y, 2010, BIOORG MED CHEM LETT, V20, P2456, DOI 10.1016/j.bmcl.2010.03.016; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Commission CP, 2010, PHARMACOPOEIA PEOPLE, P210; de Sa PGS, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-187; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Federici S, 2013, BOT J LINN SOC, V171, P687, DOI 10.1111/boj.12034; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Gayathri V, 2011, IMMUNOPHARM IMMUNOT, V33, P351, DOI 10.3109/08923973.2010.518617; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; Korall P, 2004, MOL PHYLOGENET EVOL, V31, P852, DOI 10.1016/j.ympev.2003.10.014; Korall P, 2002, AM J BOT, V89, P506, DOI 10.3732/ajb.89.3.506; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li DZ, 2011, J SYST EVOL, V49, P165, DOI 10.1111/j.1759-6831.2011.00137.x; Li FW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026597; Li GL, 2012, P NATL ACAD SCI USA, V109, P14711, DOI 10.1073/pnas.1204300109; Liu C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S13-S4; Ma XY, 2010, BIOL PHARM BULL, V33, P1919, DOI 10.1248/bpb.33.1919; Marcon AB, 2005, ANN BOT-LONDON, V95, P271, DOI 10.1093/aob/mci022; Mishra PK, 2011, BRIT J NUTR, V106, P1154, DOI 10.1017/S0007114511001498; Pang XH, 2010, PLANTA MED, V76, P1784, DOI 10.1055/s-0030-1249806; Rai Padmalatha S, 2012, J Ayurveda Integr Med, V3, P136, DOI 10.4103/0975-9476.100177; Salvi D, 2012, MOL PHYLOGENET EVOL, V65, P792, DOI 10.1016/j.ympev.2012.07.017; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Shakirov EV, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00161; Shi LC, 2011, J SYST EVOL, V49, P261, DOI 10.1111/j.1759-6831.2011.00133.x; Smith DR, 2009, PLANT MOL BIOL, V71, P627, DOI 10.1007/s11103-009-9545-3; Song JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043971; Song JY, 2009, J ETHNOPHARMACOL, V124, P434, DOI 10.1016/j.jep.2009.05.042; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang YH, 2009, J NAT PROD, V72, P1151, DOI 10.1021/np9001515; Yang C, 2012, BEILSTEIN J ORG CHEM, V8, P1884, DOI 10.3762/bjoc.8.217; Yobi A, 2012, PLANT J, V72, P983, DOI 10.1111/tpj.12008; Zhang GG, 2012, PLANTA MED, V78, P390, DOI 10.1055/s-0031-1298175; Zhang YX, 2011, RAPID COMMUN MASS SP, V25, P2173, DOI 10.1002/rcm.5090; Zhang YP, 2011, J CHROMATOGR B, V879, P191, DOI 10.1016/j.jchromb.2010.12.004; Zheng XK, 2011, J ETHNOPHARMACOL, V133, P531, DOI 10.1016/j.jep.2010.10.028	46	46	69	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67818	10.1371/journal.pone.0067818	http://dx.doi.org/10.1371/journal.pone.0067818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826345	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000102
J	Huang, QB; Ma, X; Zhang, X; Liu, SW; Ai, Q; Shi, TP; Zhang, Y; Gao, Y; Fan, Y; Ni, D; Wang, BJ; Li, HZ; Zheng, T				Huang, Qing Bo; Ma, Xin; Zhang, Xu; Liu, Shang Wen; Ai, Qing; Shi, Tao Ping; Zhang, Yu; Gao, Yu; Fan, Yang; Ni, Dong; Wang, Bao Jun; Li, Hong Zhao; Zheng, Tao			Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; UP-REGULATION; STEM-CELLS; MICRORNAS; INVASION; VEGF; MICROVESICLES; EXPRESSION; BLOCKADE; ROLES	Background: Endothelial DLL4 plays an important role in controlling of tumor angiogenesis, which is required for tumor invasive growth and metastasis. However, the regulation of DLL4 in clear cell renal cell carcinoma (ccRCC) has not yet been systematically elucidated. Methodology: We performed bioinformatical analysis to explore miRNAs targeting DLL4. miR-30a was selected as a representative to validate its functional association in endothelial cell. Then, the expressions of DLL4 and mature miR-30a from 90 cases of ccRCC and 28 cases of nonmatched adjacent non-tumor tissues were measured by quantitative real-time PCR. Finally, the expression of miR-30a was correlated with DLL4 expression, tumor features (metastatic condition and microvessel density), and patient metastasis-free survival. The univariate and multivariate analyses were performed to select the risk factors associated with hematogenous metastasis, respectively. Principal Findings: miR-30a negatively regulated DLL4 and inhibited the proliferation and migration of endothelial cells. DLL4 was up-regulated in ccRCC and further increased in hematogenous metastatic cases, while miR-30a was down-regulated in tumor tissues and further decreased in hematogenous metastatic ccRCC (student down-regulated test, all p<0.05). Additionally, expression of miR-30a was inversely correlated with expression of DLL4 and microvessel density (linear correlation analysis, both p<0.05). Low-level miR-30a also indicated a higher probability of developing metastasis (log-rank test, p = 0.010). Most importantly, miR-30a expression was an independent predictor of ccRCC hematogenous metastasis by the univariate analysis and binary logistic regression model (both p<0.05). Conclusions: Down-regulated miR-30a in ccRCC was associated with tumor hematogenous metastasis through increasing microvessel density by targeting angiogenesis-specific DLL4.	[Huang, Qing Bo; Ma, Xin; Zhang, Xu; Ai, Qing; Shi, Tao Ping; Zhang, Yu; Gao, Yu; Fan, Yang; Ni, Dong; Wang, Bao Jun; Li, Hong Zhao; Zheng, Tao] Chinese Peoples Liberat Army Gen Hosp, PLA Med Sch, State Key Lab Kidney Dis, Dept Urol, Beijing, Peoples R China; [Liu, Shang Wen] Chinese PLA 303 Hosp, Dept Urol, Nanning, Peoples R China	Chinese People's Liberation Army General Hospital	Zhang, X (corresponding author), Chinese Peoples Liberat Army Gen Hosp, PLA Med Sch, State Key Lab Kidney Dis, Dept Urol, Beijing, Peoples R China.	xzhang@foxmail.com	zhang, xu/GYE-3558-2022		National Nature Science Foundation [81100483]; Scientific Research Project for Health Industry [201002010]; National High Technology Research and Development Program ("863" Program), People's Republic of China [2012AA02101]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Scientific Research Project for Health Industry; National High Technology Research and Development Program ("863" Program), People's Republic of China(National High Technology Research and Development Program of China)	This work was supported by National Nature Science Foundation (No. 81100483), Scientific Research Project for Health Industry (No. 201002010) and the National High Technology Research and Development Program ("863" Program, No. 2012AA02101), People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2009, DEVELOPMENT, V136, P3927, DOI 10.1242/dev.037432; Ai Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035022; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Bukowski RM, 1997, CANCER-AM CANCER SOC, V80, P1198, DOI 10.1002/(SICI)1097-0142(19971001)80:7<1198::AID-CNCR3>3.0.CO;2-H; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Daubman S, 2010, CIRC RES, V106, P423, DOI 10.1161/RES.0b013e3181d61a0d; Fang JH, 2011, HEPATOLOGY, V54, P1729, DOI 10.1002/hep.24577; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Heinzelmann J, 2011, WORLD J UROL, V29, P367, DOI 10.1007/s00345-010-0633-4; Huang ZM, 2009, J DIGEST DIS, V10, P188, DOI 10.1111/j.1751-2980.2009.00384.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jung M, 2009, J CELL MOL MED, V13, P3918, DOI 10.1111/j.1582-4934.2009.00705.x; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Le XF, 2010, CANCER MICROENVIRON, V3, P137, DOI 10.1007/s12307-010-0037-4; Li JL, 2009, FRONT BIOSCI-LANDMRK, V14, P3094, DOI 10.2741/3438; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu S, 2011, UROL ONCOL; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Motzer RJ, 2004, J CLIN ONCOL, V22, P454, DOI 10.1200/JCO.2004.06.132; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Quesenberry PJ, 2008, STEM CELL REV, V4, P137, DOI 10.1007/s12015-008-9036-y; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Santarpia L, 2010, ENDOCR-RELAT CANCER, V17, pF51, DOI 10.1677/ERC-09-0222; White NMA, 2011, BRIT J CANCER, V105, P1741, DOI 10.1038/bjc.2011.401; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Wu CL, 2013, CELL SIGNAL, V25, P1212, DOI 10.1016/j.cellsig.2013.01.028; Wu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035661; Yan MH, 2007, CLIN CANCER RES, V13, P7243, DOI 10.1158/1078-0432.CCR-07-1393; Yan MH, 2010, NATURE, V463, pE6, DOI 10.1038/nature08751; Yi ZJ, 2010, J CANCER RES CLIN, V136, P855, DOI 10.1007/s00432-009-0726-x; Zhang C, 2012, J HUAZHONG U SCI-MED, V32, P375, DOI 10.1007/s11596-012-0065-z; Zhou LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015224	45	56	59	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67294	10.1371/journal.pone.0067294	http://dx.doi.org/10.1371/journal.pone.0067294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826258	Green Submitted, gold, Green Published			2022-12-27	WOS:000321150000057
J	Kang, Y; Wang, F; Zu, HL; Yang, ZY; Xue, YW				Kang, Yue; Wang, Feng; Zu, Hongliang; Yang, Zhenyu; Xue, Yingwei			A New Subclassification of pT4 Gastric Cancers According to the Width of Serosal Invasion	PLOS ONE			English	Article							AMERICAN JOINT COMMITTEE; HEPATOCELLULAR-CARCINOMA; STAGING SYSTEM; STATISTICS; ADENOCARCINOMA; CLASSIFICATION	Objective: The purpose of this study was to propose a novel subclassification of pT4 gastric cancers according to the width of serosal changes and to investigate the validity and clinical utility of this subclassification as a predictor of prognosis. Methods: A total of 780 pT4 stage gastric cancer patients classified according to the 7th American Joint Committee on Cancer (AJCC) staging system were reviewed. Clinicopathologic features were compared between patients with narrow serosal changes (nSE), wide serosal changes (wSE) and invasions of adjacent structures (SI). Prognostic factors were evaluated by univariate and multivariate analyses. The 7th AJCC and novel pT4 subclassification were compared for prognostic performance using the linear trend chi-square test, likelihood ratio chi-square test, and Akaike information criterion (AIC) in the Cox regression analysis. Results: The appropriate serosa infiltrate cutoff value was 8 cm. Most of the evaluated clinicopathologic features significantly differed between nSE and SI cancers. Only 3 factors were significantly different between wSE and SI cancers. The 5-year survival rates for patients with the novel pT4a and pT4b cancers were 47.2% and 14.52%, respectively, while they were 41.66% and 16.34% for the 7th AJCC pT4a and pT4b cancers, respectively. The novel pT4 subclassification had better discriminatory ability, monotonicity of gradients, and homogeneity and had smaller AIC values compared with the 7th AJCC pT4. Conclusions: It is reasonable to subclassify pT4 to pT4a (nSE) and pT4b (wSE/SI) because the novel pT4 subclassification had more potential to identify the different prognoses for patients with gastric cancer.	[Kang, Yue; Wang, Feng; Zu, Hongliang; Xue, Yingwei] Harbin Med Univ, Tumor Hosp, Dept Surg Gastroenterol, Harbin, Peoples R China; [Kang, Yue; Yang, Zhenyu] Harbin Med Univ, Affiliated Hosp 2, Dept Gen Surg, Harbin, Peoples R China; [Wang, Feng] Inner Mongolia Med Univ, Affiliated Hosp, Dept Gen Surg, Hohhot, Peoples R China	Harbin Medical University; Harbin Medical University; Inner Mongolia Medical University	Xue, YW (corresponding author), Harbin Med Univ, Tumor Hosp, Dept Surg Gastroenterol, Harbin, Peoples R China.	xueyingwei2002@yahoo.com.cn	kang, yue/GYA-2003-2022		Natural Science Foundation of Heilongjiang Province [D 201169]	Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was supported by the Natural Science Foundation of Heilongjiang Province (No. D 201169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE S, 1991, SURGERY, V109, P582; Ahn HS, 2010, CANCER-AM CANCER SOC, V116, P5592, DOI 10.1002/cncr.25550; BABA H, 1989, CANCER, V64, P2482, DOI 10.1002/1097-0142(19891215)64:12<2482::AID-CNCR2820641213>3.0.CO;2-1; Bando E, 2003, J AM COLL SURGEONS, V197, P212, DOI 10.1016/S1072-7515(03)00539-8; Cho YK, 2008, CANCER-AM CANCER SOC, V112, P352, DOI 10.1002/cncr.23185; Deng JY, 2010, ANN SURG ONCOL, V17, P1259, DOI 10.1245/s10434-010-0939-x; Deng JY, 2010, ANN SURG ONCOL, V17, P1043, DOI 10.1245/s10434-009-0863-0; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jung H, 2011, CANCER-AM CANCER SOC, V117, P2371, DOI 10.1002/cncr.25778; KAJITANI T, 1981, JPN J SURG, V11, P127; Kunisaki C, 2005, ANTICANCER RES, V25, P1369; Lee CC, 2007, J GASTROEN HEPATOL, V22, P1014, DOI 10.1111/j.1440-1746.2006.04488.x; Park DJ, 2007, SURGERY, V141, P757, DOI 10.1016/j.surg.2007.01.023; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qiu MZ, 2011, ANN SURG ONCOL, V18, P1869, DOI 10.1245/s10434-010-1542-x; Rausei S, 2011, ANN SURG ONCOL, V18, P1219, DOI 10.1245/s10434-010-1346-z; Soga K, 2010, SURGERY, V147, P197, DOI 10.1016/j.surg.2009.06.032; Sun Z, 2011, ANN SURG ONCOL, V18, P1068, DOI 10.1245/s10434-010-1449-6; Ueno S, 2001, HEPATOLOGY, V34, P529, DOI 10.1053/jhep.2001.27219; Wang W, 2011, ANN SURG ONCOL, V18, P1060, DOI 10.1245/s10434-010-1424-2; Wittekind C, 2010, PATHOLOGE, V31, P333, DOI 10.1007/s00292-010-1301-6; Wittekind C, 2010, PATHOLOGE, V31, P344, DOI 10.1007/s00292-010-1304-3; Yoon HM, 2012, J AM COLL SURGEONS, V214, P88, DOI 10.1016/j.jamcollsurg.2011.09.018	25	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68042	10.1371/journal.pone.0068042	http://dx.doi.org/10.1371/journal.pone.0068042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826361	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000115
J	Maier, M; Liebert, UG; Wittekind, C; Kaiser, T; Berg, T; Wiegand, J				Maier, Melanie; Liebert, Uwe G.; Wittekind, Christian; Kaiser, Thorsten; Berg, Thomas; Wiegand, Johannes			Clinical Relevance of Minimal Residual Viremia during Long-Term Therapy with Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B	PLOS ONE			English	Article							VIRUS DNA QUANTIFICATION; TENOFOVIR DISOPROXIL FUMARATE; TIME PCR ASSAY; ENTECAVIR TREATMENT; VIRAL SUPPRESSION; LAMIVUDINE; INFECTION; PERFORMANCE; CIRRHOSIS; RESISTANCE	Background: Successful therapy of chronic hepatitis B with nucleos(t)ide analogues (NUCs) has been defined by undetectable HBV-DNA determined with conventional PCR (lower limit of detection (LLD) 60-80 IU/mL) in clinical registration trials. However, current EASL guidelines recommend highly sensitive real-time PCR (LLD<10-20 IU/mL) and define treatment response by HBV-DNA, 10 IU/mL. Aim: We evaluated frequency and relevance of minimal residual viremia (MRV) during long-term NUC-treatment in a real-life setting. Methods: Frozen serum samples (HBV-DNA negative by in-house PCR, LLD<73 IU/mL) were re-analyzed by real-time PCR (LLD<10 IU/mL, Abbott, Germany). MRV was defined by real time PCR positivity and conventional PCR negativity. Results: 237 samples of six HBsAg carriers and 27 NUC-treated CHB patients were analyzed (treatment period 28 (11-111) months, different treatment regimens with mono- or combination therapy). MRV was detected in 31/33 individuals (n = 160/237 serum samples) and more frequent in HBsAg carriers (95%) and HBeAg positive (87%) compared to HBeAg negative patients (53%) (p<0.0001, respectively). Five HBsAg carriers, five HBeAg positive, and four HBeAg negative individuals were continuously HBV-DNA positive. MRV was not significantly more often observed during NUC-monotherapies compared to combination therapies. Concomitant immunosuppressive therapy was present in nine cases and did not influence the results. Viral resistance occurred in three immunocompetent patients with adefovir or lamivudine monotherapy. Conclusions: MRV is frequently observed during long-term NUC-therapy. Adjustment of treatment with highly potent NUCs does not seem to be necessary in case of minimal residual viremia in a real-life setting.	[Maier, Melanie; Liebert, Uwe G.] Univ Klinikum Leipzig, Inst Virol, Leipzig, Germany; [Wittekind, Christian] Univ Klinikum Leipzig, Inst Pathol, Leipzig, Germany; [Kaiser, Thorsten] Univ Klinikum Leipzig, Inst Lab Med, Klin Chem & Mol Diagnost, Leipzig, Germany; [Berg, Thomas; Wiegand, Johannes] Univ Klinikum Leipzig, Dept Innere Med Dermatol & Neurol, Klin & Poliklin Gastroenterol & Rheumatol, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University; Leipzig University	Wiegand, J (corresponding author), Univ Klinikum Leipzig, Dept Innere Med Dermatol & Neurol, Klin & Poliklin Gastroenterol & Rheumatol, Leipzig, Germany.	johannes.wiegand@medizin.uni-leipzig.de		Berg, Thomas/0000-0003-0003-6241	Abbott, Wiesbaden, Germany	Abbott, Wiesbaden, Germany(Abbott Laboratories)	The project was funded by a research grant of Abbott, Wiesbaden, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg T, 2010, GASTROENTEROLOGY, V139, P1207, DOI 10.1053/j.gastro.2010.06.053; Chang TT, 2010, HEPATOLOGY, V51, P422, DOI 10.1002/hep.23327; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chevaliez S, 2008, J CLIN MICROBIOL, V46, P1716, DOI 10.1128/JCM.01248-07; Chevaliez S, 2010, J CLIN MICROBIOL, V48, P3641, DOI 10.1128/JCM.01306-10; Cornberg M, 2011, Z GASTROENTEROL, V49, P871, DOI 10.1055/s-0031-1273462; Gish R, 2012, LANCET INFECT DIS, V12, P341, DOI 10.1016/S1473-3099(11)70314-0; Gordon SC, 2013, HEPATOLOGY, V58, P505, DOI 10.1002/hep.26277; Heathcote EJ, 2011, GASTROENTEROLOGY, V140, P132, DOI 10.1053/j.gastro.2010.10.011; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Ismail AM, 2011, J CLIN MICROBIOL, V49, P3215, DOI 10.1128/JCM.00915-11; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Locarnini S, 2005, SEMIN LIVER DIS, V25, P9, DOI 10.1055/s-2005-915645; Lok AS, 2012, GASTROENTEROLOGY, V143, P619, DOI 10.1053/j.gastro.2012.05.037; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Marcellin P, 2011, HEPATOLOGY, V54, p1011A; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Papatheodoridis GV, 2011, GUT, V60, P1109, DOI 10.1136/gut.2010.221846; Schiff ER, 2011, CLIN GASTROENTEROL H, V9, P274, DOI 10.1016/j.cgh.2010.11.040; Thibault V, 2007, J CLIN MICROBIOL, V45, P3948, DOI 10.1128/JCM.01180-07; Yuen MF, 2011, AM J GASTROENTEROL, V106, P1264, DOI 10.1038/ajg.2011.45; Zoutendijk R, 2011, HEPATOLOGY, V54, P443, DOI 10.1002/hep.24406	23	7	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67481	10.1371/journal.pone.0067481	http://dx.doi.org/10.1371/journal.pone.0067481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826307	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000083
J	Randive, B; Diwan, V; De Costa, A				Randive, Bharat; Diwan, Vishal; De Costa, Ayesha			India's Conditional Cash Transfer Programme (the JSY) to Promote Institutional Birth: Is There an Association between Institutional Birth Proportion and Maternal Mortality?	PLOS ONE			English	Article							HEALTH; INTERVENTIONS; IMPACT; CARE	Background: India accounts for 19% of global maternal deaths, three-quarters of which come from nine states. In 2005, India launched a conditional cash transfer (CCT) programme, Janani Suraksha Yojana (JSY), to reduce maternal mortality ratio (MMR) through promotion of institutional births. JSY is the largest CCT in the world. In the nine states with relatively lower socioeconomic levels, JSY provides a cash incentive to all women on birthing in health institution. The cash incentive is intended to reduce financial barriers to accessing institutional care for delivery. Increased institutional births are expected to reduce MMR. Thus, JSY is expected to (a) increase institutional births and (b) reduce MMR in states with high proportions of institutional births. We examine the association between (a) service uptake, i.e., institutional birth proportions and (b) health outcome, i.e., MMR. Method: Data from Sample Registration Survey of India were analysed to describe trends in proportion of institutional births before (2005) and during (2006-2010) the implementation of the JSY. Data from Annual Health Survey (2010-2011) for all 284 districts in above-mentioned nine states were analysed to assess relationship between MMR and institutional births. Results: Proportion of institutional births increased from a pre-programme average of 20% to 49% in 5 years (p<0.05). In bivariate analysis, proportion of institutional births had a small negative correlation with district MMR (r = 20.11). The multivariate regression model did not establish significant association between institutional birth proportions and MMR [CI: -0.10, 0.68]. Conclusions: Our analysis confirmed that JSY succeeded in raising institutional births significantly. However, we were unable to detect a significant association between institutional birth proportion and MMR. This indicates that high institutional birth proportions that JSY has achieved are of themselves inadequate to reduce MMR. Other factors including improved quality of care at institutions are required for intended effect.	[Randive, Bharat; Diwan, Vishal] RD Gardi Med Coll, Dept Publ Hlth, Ujjain, Madhya Pradesh, India; [Randive, Bharat] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Diwan, Vishal; De Costa, Ayesha] Karolinska Inst, Dept Publ Hlth Sci, Div Global Hlth, Stockholm, Sweden	Umea University; Karolinska Institutet	Randive, B (corresponding author), RD Gardi Med Coll, Dept Publ Hlth, Ujjain, Madhya Pradesh, India.	bharatsarika2005@gmail.com		Diwan, Vishal/0000-0001-7948-8579; De Costa, Ayesha/0000-0003-1869-5990	EU	EU(European Commission)	Funding came from EU FP 7 grant to project MATIND. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, HLTH FAM WELF GOV IN; [Anonymous], 2012, WHO UNICEF UNFPA WOR; Attanasio O, 2005, 54 IFS BRIEF; Barham T, 2009, J HEALTH ECON, V28, P611, DOI 10.1016/j.jhealeco.2008.12.010; Behrman JR, 2005, OXFORD B ECON STAT, V67, P547, DOI 10.1111/j.1468-0084.2005.00131.x; Central Statistical Organization Ministry of Statistics and Programme Implementation Government of India, 2011, MILL DEV GOALS IND C; DEVADASAN N, 2008, STUDIES HLTH SERVICE, V24, P257; Ensor T, 2004, INT J HEALTH PLAN M, V19, P267, DOI 10.1002/hpm.762; Gertler P, 2004, AM ECON REV, V94, P336, DOI 10.1257/0002828041302109; Graham W., 2000, EUR COMM EXP M SAF M; Health system 20/20, 2012, USAID IND ANN E EX R; [India Registrar General of India], 2011, SPEC B MAT MORT IND; International Institute for Population Sciences, 2010, DISTR LEV HOUS FAC S; International Institute for Population Sciences, 1995, NAT FAM HLTH SURV NF; International Institute for Population Sciences, 2007, NATL FAMILY HLTH SUR; Jacobs Bart, 2011, HLTH POLICY PLANNING, P1; Jehan K, 2012, REPROD HEALTH MATTER, V20, P142, DOI 10.1016/S0968-8080(12)39609-2; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Ministry of Health and Family welfare, 2005, 2 MIN HLTH FAM WELF; Ministry of Health and Family welfare, MIN HLTH FAM WELF SA; Ministry of Health and Family Welfare, 2006, JAN SUR YOJ REV GUID; Ministry of Health and Family Welfare Government of India, 2012, EX SUMM NRHM PROGR; Ministry of Health and Family Welfare Government of India, 2005, NAT RUR HLTH MISS FR; Morris SS, 2004, LANCET, V364, P2030, DOI 10.1016/S0140-6736(04)17515-6; Morris SS, 2004, J NUTR, V134, P2336, DOI 10.1093/jn/134.9.2336; National Health Systems Resource Centre, 2011, PROGR EV JAN SUR YOJ; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Pearson M, 2001, DEMAND SIDE FINANCIN; Planning Commission of India, 2011, EV NRHM 7 STAT EV OR; Registrar General & Census Commissioner, 2011, ANN HLTH SURV 2010 1; Registrar General of India, 2006, SAMPL REG SYST MAT M; Registrar General of India, 2011, SRS B; Safe Motherhood Inter-Agency Group, 2000, TECHN CONS ENS SKILL; Sri BS, 2012, REPROD HEALTH MATTER, V20, P11, DOI 10.1016/S0968-8080(12)39599-2; Timothy P, 2010, FINANCIAL INCENTIVE; United Nations Population Fund India, 2009, CONC ASS JAN SUR YOJ; Witter S, 2012, 6213 WORLD BANK; World Bank, 1997, IND CHILD SURV SAF M; World Health Organization (WHO), 2004, MAK PREGN SAF CRIT R	40	150	151	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67452	10.1371/journal.pone.0067452	http://dx.doi.org/10.1371/journal.pone.0067452			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826302	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000081
J	Zhang, ZJ; Fu, SN				Zhang, Zhi Jie; Fu, Siu Ngor			Shear Elastic Modulus on Patellar Tendon Captured from Supersonic Shear Imaging: Correlation with Tangent Traction Modulus Computed from Material Testing System and Test-Retest Reliability	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; ELASTOGRAPHY; STRENGTH	Characterization of the elastic properties of a tendon could enhance the diagnosis and treatment of tendon injuries. The purpose of this study was to examine the correlation between the shear elastic modulus on the patellar tendon captured from a Supersonic Shear Imaging (SSI) and the tangent traction modulus computed from a Material testing system (MTS) on 8 fresh patellar pig tendons (Experiment I). Test-retest reliability of the shear elastic modulus captured from the SSI was established in Experiment II on 22 patellar tendons of 11 healthy human subjects using the SSI. Spearman Correlation coefficients for the shear elastic modulus and tangent traction modulus ranged from 0.82 to 1.00 (all p<0.05) on the 8 tendons. The intra and inter-operator reliabilities were 0.98 (95% CI: 0.93-0.99) and 0.97 (95% CI: 0.93-0.98) respectively. The results from this study demonstrate that the shear elastic modulus of the patellar tendon measured by the SSI is related to the tangent traction modulus quantified by the MTS. The SSI shows good intra and inter-operator repeatability. Therefore, the present study shows that SSI can be used to assess elastic properties of a tendon.	[Zhang, Zhi Jie; Fu, Siu Ngor] Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Peoples R China; [Zhang, Zhi Jie] Guangdong Prov Work Injury Rehabil Hosp, Dept Physiotherapy, Guangzhou, Guangdong, Peoples R China	Hong Kong Polytechnic University	Fu, SN (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Kowloon, Peoples R China.	rsamyfu@inet.polyu.edu.hk	Zhang, Zhi Jie/AAR-1686-2020	FU, Amy/0000-0003-4405-015X				Arya S, 2010, J APPL PHYSIOL, V108, P670, DOI 10.1152/japplphysiol.00259.2009; Bensamoun SF, 2006, J MAGN RESON IMAGING, V23, P242, DOI 10.1002/jmri.20487; Bercoff J, 2004, IEEE T ULTRASON FERR, V51, P396, DOI 10.1109/TUFFC.2004.1295425; Bouillard K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029261; Calve S, 2004, TISSUE ENG, V10, P755, DOI 10.1089/1076327041348464; Carroll CC, 2008, J APPL PHYSIOL, V105, P1907, DOI 10.1152/japplphysiol.00059.2008; Domholdt E, 1993, PHYS THERAPY RES PRI, P153; Drakonaki EE, 2009, CLIN RADIOL, V64, P1196, DOI 10.1016/j.crad.2009.08.006; Hall TJ, 2003, ULTRASOUND MED BIOL, V29, P427, DOI 10.1016/S0301-5629(02)00733-0; Hansen P, 2006, CLIN BIOMECH, V21, P54, DOI 10.1016/j.clinbiomech.2005.07.008; HAUT RC, 1992, J BIOMECH, V25, P163, DOI 10.1016/0021-9290(92)90273-4; Itoh A, 2006, RADIOLOGY, V239, P341, DOI 10.1148/radiol.2391041676; James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007; Kot BCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044348; Kubo K, 2003, EUR J APPL PHYSIOL, V88, P520, DOI 10.1007/s00421-002-0744-8; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Maganaris CN, 2002, J BIOMECH, V35, P1019, DOI 10.1016/S0021-9290(02)00047-7; Maisetti O, 2012, J BIOMECH, V45, P978, DOI 10.1016/j.jbiomech.2012.01.009; Nordez A, 2010, J APPL PHYSIOL, V108, P1389, DOI 10.1152/japplphysiol.01323.2009; NOYES FR, 1976, J BONE JOINT SURG AM, V58, P1074, DOI 10.2106/00004623-197658080-00006; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Reeves ND, 2003, J PHYSIOL-LONDON, V548, P971, DOI 10.1113/jphysiol.2002.035576; Royer D, 2011, J ACOUST SOC AM, V129, P2757, DOI 10.1121/1.3559681; Thambyah A, 2000, CLIN BIOMECH, V15, P756, DOI 10.1016/S0268-0033(00)00047-4; TKACZUK H, 1968, ACTA ORTHOP SCAND, VS, P8; Wren TAL, 2003, ANN BIOMED ENG, V31, P710, DOI 10.1114/1.1569267; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359	28	28	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68216	10.1371/journal.pone.0068216	http://dx.doi.org/10.1371/journal.pone.0068216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826378	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000132
J	Cui, L; Wong, EHM; Cheng, G; de Almeida, MF; So, MT; Sham, PC; Cherny, SS; Tam, PKH; Garcia-Barcelo, MM				Cui, Long; Wong, Emily Hoi-Man; Cheng, Guo; de Almeida, Manoel Firmato; So, Man-Ting; Sham, Pak-Chung; Cherny, Stacey S.; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce			Genetic Analyses of a Three Generation Family Segregating Hirschsprung Disease and Iris Heterochromia	PLOS ONE			English	Article							ENDOTHELIN-B RECEPTOR; WAARDENBURG-SHAH SYNDROME; ENTERIC NERVOUS-SYSTEM; HIDDEN-MARKOV MODEL; SNP GENOTYPING DATA; TYROSINE KINASE; MISSENSE MUTATION; CHINESE PATIENTS; RET MUTATIONS; EDNRB	We present the genetic analyses conducted on a three-generation family (14 individuals) with three members affected with isolated-Hirschsprung disease (HSCR) and one with HSCR and heterochromia iridum (syndromic-HSCR), a phenotype reminiscent of Waardenburg-Shah syndrome (WS4). WS4 is characterized by pigmentary abnormalities of the skin, eyes and/or hair, sensorineural deafness and HSCR. None of the members had sensorineural deafness. The family was screened for copy number variations (CNVs) using Illumina-HumanOmni2.5-Beadchip and for coding sequence mutations in WS4 genes (EDN3, EDNRB, or SOX10) and in the main HSCR gene (RET). Confocal microscopy and immunoblotting were used to assess the functional impact of the mutations. A heterozygous A/G transition in EDNRB was identified in 4 affected and 3 unaffected individuals. While in EDNRB isoforms 1 and 2 (cellular receptor) the transition results in the abolishment of translation initiation (M1V), in isoform 3 (only in the cytosol) the replacement occurs at Met91 (M91V) and is predicted benign. Another heterozygous transition (c.-248G/A; -predicted to affect translation efficiency-) in the 5'-untranslated region of EDN3 (EDNRB ligand) was detected in all affected individuals but not in healthy carriers of the EDNRB mutation. Also, a de novo CNVs encompassing DACH1 was identified in the patient with heterochromia iridum and HSCR Since the EDNRB and EDN3 variants only coexist in affected individuals, HSCR could be due to the joint effect of mutations in genes of the same pathway. Iris heterochromia could be due to an independent genetic event and would account for the additional phenotype within the family.	[Cui, Long; Cheng, Guo; So, Man-Ting; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Dept Surg, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Emily Hoi-Man; Sham, Pak-Chung; Cherny, Stacey S.] Univ Hong Kong, Dept Psychiat, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak-Chung; Cherny, Stacey S.; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Ctr Genom Sci, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak-Chung; Tam, Paul Kwong-Hang; Garcia-Barcelo, Maria-Merce] Univ Hong Kong, Ctr Reprod Dev & Growth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak-Chung; Cherny, Stacey S.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [de Almeida, Manoel Firmato] Fac Med Ciencias Med Minas Gerais, Belo Horizonte, MG, Brazil	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Garcia-Barcelo, MM (corresponding author), Univ Hong Kong, Dept Surg, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	mmgarcia@hku.hk	Cherny, Stacey S/B-3315-2008; /C-4405-2009	Cherny, Stacey S/0000-0002-0269-3352; /0000-0001-6231-3035	HKU seed funding programme for basic research [201109159019]; University of Hong Kong Strategic Research Theme on Genomics	HKU seed funding programme for basic research; University of Hong Kong Strategic Research Theme on Genomics	This work was supported by the HKU seed funding programme for basic research 201109159019 to MMGB. Support was also received from the University of Hong Kong Strategic Research Theme on Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Amiel J, 1996, HUM MOL GENET, V5, P355, DOI 10.1093/hmg/5.3.355; Auricchio A, 1999, AM J HUM GENET, V64, P1216, DOI 10.1086/302329; Auricchio A, 1996, HUM MOL GENET, V5, P351, DOI 10.1093/hmg/5.3.351; Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Bondurand N, 2012, EUR J HUM GENET, V20, P990, DOI 10.1038/ejhg.2012.29; Carrasquillo MM, 2002, NAT GENET, V32, P237, DOI 10.1038/ng998; Chatterjee TK, 1997, J BIOL CHEM, V272, P15481, DOI 10.1074/jbc.272.24.15481; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Dellinger AE, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq040; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Garcia-Barcelo M, 2005, HUM MOL GENET, V14, P191, DOI 10.1093/hmg/ddi015; Garcia-Barcelo M, 2004, CLIN CHEM, V50, P93, DOI 10.1373/clinchem.2003.022061; Garcia-Barcelo MM, 2003, J MED GENET, V40; Jabeen R, 2012, MOL BIOL REP, V39, P785, DOI 10.1007/s11033-011-0799-x; Jan IA, 2008, J PEDIATR SURG, V43, P744, DOI 10.1016/j.jpedsurg.2007.11.023; Jiang L, 2011, BIOCHEM BIOPH RES CO, V408, P620, DOI 10.1016/j.bbrc.2011.04.072; Karaca I, 2009, J PEDIATR SURG, V44, pE9, DOI 10.1016/j.jpedsurg.2009.02.057; Kenny SE, 2000, BRIT J SURG, V87, P580, DOI 10.1046/j.1365-2168.2000.01401.x; Lai JSM, 1998, EYE, V12, P1024, DOI 10.1038/eye.1998.266; LIANG JC, 1983, ARCH OPHTHALMOL-CHIC, V101, P69, DOI 10.1001/archopht.1983.01040010071011; McCallion AS, 2003, P NATL ACAD SCI USA, V100, P1826, DOI 10.1073/pnas.0337540100; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Pasini B, 1996, TRENDS GENET, V12, P138, DOI 10.1016/0168-9525(96)10012-3; Pingault V, 2001, J MED GENET, V38, P205, DOI 10.1136/jmg.38.3.205; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Read AP, 1997, J MED GENET, V34, P656, DOI 10.1136/jmg.34.8.656; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; Sarin YK, 2006, INDIAN PEDIATR, V43, P452; Scharfe C, 1999, NUCLEIC ACIDS RES, V27, P153, DOI 10.1093/nar/27.1.153; SHAH KN, 1981, J PEDIATR-US, V99, P432, DOI 10.1016/S0022-3476(81)80339-3; Sham MH, 2001, J MED GENET, V38, DOI 10.1136/jmg.38.9.e30; So MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028986; Stanchina L, 2006, DEV BIOL, V295, P232, DOI 10.1016/j.ydbio.2006.03.031; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Tsutsumi M, 1999, GENE, V228, P43, DOI 10.1016/S0378-1119(99)00014-1; Tuysuz B, 2009, AM J MED GENET A, V149A, P2290, DOI 10.1002/ajmg.a.33031; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	43	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66631	10.1371/journal.pone.0066631	http://dx.doi.org/10.1371/journal.pone.0066631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840513	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400033
J	Soltani, M; Chen, P				Soltani, M.; Chen, P.			Numerical Modeling of Interstitial Fluid Flow Coupled with Blood Flow through a Remodeled Solid Tumor Microvascular Network	PLOS ONE			English	Article							DRUG-DELIVERY; STRUCTURAL ADAPTATION; VASCULAR NETWORKS; SIMULATION; PRESSURE; MACROMOLECULES; NORMALIZATION; RELEASE; GROWTH; SIZE	Modeling of interstitial fluid flow involves processes such as fluid diffusion, convective transport in extracellular matrix, and extravasation from blood vessels. To date, majority of microvascular flow modeling has been done at different levels and scales mostly on simple tumor shapes with their capillaries. However, with our proposed numerical model, more complex and realistic tumor shapes and capillary networks can be studied. Both blood flow through a capillary network, which is induced by a solid tumor, and fluid flow in tumor's surrounding tissue are formulated. First, governing equations of angiogenesis are implemented to specify the different domains for the network and interstitium. Then, governing equations for flow modeling are introduced for different domains. The conservation laws for mass and momentum (including continuity equation, Darcy's law for tissue, and simplified Navier-Stokes equation for blood flow through capillaries) are used for simulating interstitial and intravascular flows and Starling's law is used for closing this system of equations and coupling the intravascular and extravascular flows. This is the first study of flow modeling in solid tumors to naturalistically couple intravascular and extravascular flow through a network. This network is generated by sprouting angiogenesis and consisting of one parent vessel connected to the network while taking into account the non-continuous behavior of blood, adaptability of capillary diameter to hemodynamics and metabolic stimuli, non-Newtonian blood flow, and phase separation of blood flow in capillary bifurcation. The incorporation of the outlined components beyond the previous models provides a more realistic prediction of interstitial fluid flow pattern in solid tumors and surrounding tissues. Results predict higher interstitial pressure, almost two times, for realistic model compared to the simplified model.	[Soltani, M.; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo Inst Nanotechnol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Soltani, M (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo Inst Nanotechnol, Waterloo, ON N2L 3G1, Canada.	msoltani@uwaterloo.ca			Waterloo Institute for Nanotechnology; Natural Sciences and Engineering Research Council of Canada	Waterloo Institute for Nanotechnology; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The funders for this study are Waterloo Institute for Nanotechnology and Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon T, 2003, J THEOR BIOL, V225, P257, DOI 10.1016/S0022-5193(03)00244-3; Anderson ARA, 2012, MODELING TUMOR VASCULATURE: MOLECULAR, CELLULAR, AND TISSUE LEVEL ASPECTS AND IMPLICATIONS, P105, DOI 10.1007/978-1-4614-0052-3_5; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; [Anonymous], [No title captured]; Arifin DY, 2006, ADV DRUG DELIVER REV, V58, P1274, DOI 10.1016/j.addr.2006.09.007; Arifin DY., 2007, MIMICS INNOV AWARD, P1; BAXTER LT, 1990, MICROVASC RES, V40, P246, DOI 10.1016/0026-2862(90)90023-K; Chaplain MAJ, 2012, MODELING TUMOR VASCULATURE: MOLECULAR, CELLULAR, AND TISSUE LEVEL ASPECTS AND IMPLICATIONS, P167, DOI 10.1007/978-1-4614-0052-3_8; Chauhan VP, 2012, NAT NANOTECHNOL, V7, P383, DOI [10.1038/NNANO.2012.45, 10.1038/nnano.2012.45]; Cheung SCP, 2010, AUSTRALAS PHYS ENG S, V33, P319, DOI 10.1007/s13246-010-0050-4; Ciofalo M, 1999, NANOSCALE FLUID DYNA, P219; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fung YC, 1986, BIOMECHANICS MECH PR; GIMBRONE MA, 1974, J NATL CANCER I, V52, P413, DOI 10.1093/jnci/52.2.413; Heine M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036258; Huber PE, 2005, CANCER RES, V65, P3643, DOI 10.1158/0008-5472.CAN-04-1668; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; JAIN RK, 1988, CANCER RES, V48, P7022; Jain RK, 2001, ADV DRUG DELIVER REV, V46, P149, DOI 10.1016/S0169-409X(00)00131-9; Krogh A., 1922, ANATOMY PHYSL CAPILL; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; MUTHUKKARUPPAN VR, 1982, J NATL CANCER I, V69, P699; Netti PA, 1996, MICROVASC RES, V52, P27, DOI 10.1006/mvre.1996.0041; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; Perfahl H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014790; Pozrikidis C, 2010, J MATH BIOL, V60, P75, DOI 10.1007/s00285-009-0259-6; Press W., 1992, NUMERICAL RECIPES FO; Pries AR, 2001, HYPERTENSION, V38, P1476, DOI 10.1161/hy1201.100592; Pries AR, 2001, AM J PHYSIOL-HEART C, V281, pH1015, DOI 10.1152/ajpheart.2001.281.3.H1015; Pries AR, 1996, CARDIOVASC RES, V32, P654, DOI 10.1016/S0008-6363(96)00065-X; PRIES AR, 1989, MICROVASC RES, V38, P81, DOI 10.1016/0026-2862(89)90018-6; PRIES AR, 1992, AM J PHYSIOL, V263, pH1770, DOI 10.1152/ajpheart.1992.263.6.H1770; Pries AR, 1998, AM J PHYSIOL-HEART C, V275, pH349; Pries A, 2008, MICROCIRCULATION, V15, P753, DOI 10.1080/10739680802229076; SALATHE EP, 1976, MICROVASC RES, V11, P1, DOI 10.1016/0026-2862(76)90072-8; Soltani M, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-4; Soltani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020344; Stephanou A, 2006, MATH COMPUT MODEL, V44, P96, DOI 10.1016/j.mcm.2004.07.021; Stephanou A, 2005, MATH COMPUT MODEL, V41, P1137, DOI 10.1016/j.mcm.2005.05.008; Tan WHK, 2003, BIOTECHNOL BIOENG, V82, P278, DOI 10.1002/bit.10571; VAUGHAN ATM, 1987, BRIT J RADIOL, V60, P567, DOI 10.1259/0007-1285-60-714-567; Wong K, 2006, MED BIOL ENG COMPUT, V44, P971, DOI 10.1007/s11517-006-0113-6; Wong KKL, 2013, METHODS IN RESEARCH AND DEVELOPMENT OF BIOMEDICAL DEVICES, P1, DOI 10.1142/8621; Wu Jie, 2008, Molecular & Cellular Biomechanics, V5, P217; Wu J, 2009, J BIOMECH, V42, P712, DOI 10.1016/j.jbiomech.2009.01.009; Zhao GP, 2007, ACTA MECH SINICA-PRC, V23, P477, DOI 10.1007/s10409-007-0098-x	46	77	78	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67025	10.1371/journal.pone.0067025	http://dx.doi.org/10.1371/journal.pone.0067025			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840579	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400063
J	Veras, LMC; Cunha, VRR; Lima, FCDA; Guimaraes, MA; Vieira, MM; Campelo, YDM; Sakai, VY; Lima, DF; Carvalho, PS; Ellena, JA; Silva, PRP; Vasconcelos, LC; Godejohann, M; Petrilli, HM; Constantino, VRL; Mascarenhas, YP; Leite, JRDD				Veras, Leiz M. C.; Cunha, Vanessa R. R.; Lima, Filipe C. D. A.; Guimaraes, Maria A.; Vieira, Marianne M.; Campelo, Yuri D. M.; Sakai, Vanessa Y.; Lima, David F.; Carvalho, Paulo S., Jr.; Ellena, Javier A.; Silva, Paulo R. P.; Vasconcelos, Luciene C.; Godejohann, Markus; Petrilli, Helena M.; Constantino, Vera R. L.; Mascarenhas, Yvonne P.; de Souza de Almeida Leite, Jose Roberto			Industrial Scale Isolation, Structural and Spectroscopic Characterization of Epiisopiloturine from Pilocarpus microphyllus Stapf Leaves: A Promising Alkaloid against Schistosomiasis	PLOS ONE			English	Article								This paper presents an industrial scale process for extraction, purification, and isolation of epiisopiloturine (EPI) (2(3H)-Furanone,dihydro-3-(hydroxyphenylmethyl)-4-[(1-methyl-1H-imidazol-4-yl)methyl]-, [3S-[3a(R*),4b]]), which is an alkaloid from jaborandi leaves (Pilocarpus microphyllus Stapf). Additionally for the first time a set of structural and spectroscopic techniques were used to characterize this alkaloid. EPI has shown schistomicidal activity against adults and young forms, as well as the reduction of the egg laying adult worms and low toxicity to mammalian cells (in vitro). At first, the extraction of EPI was done with toluene and methylene chloride to obtain a solution that was alkalinized with ammonium carbonate. The remaining solution was treated in sequence by acidification, filtration and alkalinization. These industrial procedures are necessary in order to remove impurities and subsequent application of the high performance liquid chromatography (HPLC). The HPLC was employed also to remove other alkaloids, to obtain EPI purity higher than 98%. The viability of the method was confirmed through HPLC and electrospray mass spectrometry, that yielded a pseudo molecular ion of m/z equal to 287.1 Da. EPI structure was characterized by single crystal X-ray diffraction (XRD), H-1 and C-13 nuclear magnetic resonance (NMR) in deuterated methanol/chloroform solution, vibrational spectroscopy and mass coupled thermal analyses. EPI molecule presents a parallel alignment of the benzene and the methyl imidazol ring separated by an interplanar spacing of 3.758 angstrom indicating a pi-pi bond interaction. The imidazole alkaloid melts at 225 degrees C and decomposes above 230 degrees C under air. EPI structure was used in theoretical Density Functional Theory calculations, considering the single crystal XRD data in order to simulate the NMR, infrared and Raman spectra of the molecule, and performs the signals attribution.	[Veras, Leiz M. C.; Guimaraes, Maria A.; Vieira, Marianne M.; Campelo, Yuri D. M.; Lima, David F.; de Souza de Almeida Leite, Jose Roberto] Univ Fed Piaui, Nucleo Pesquisa Biodiversidade & Biotecnol, Parnaiba, Piaui, Brazil; [Veras, Leiz M. C.; Lima, David F.] Univ Fed Piaui, Programa Posgrad Biotecnol RENORBIO, Teresina, Piaui, Brazil; [Cunha, Vanessa R. R.; Sakai, Vanessa Y.; Constantino, Vera R. L.] Univ Sao Paulo, Inst Quim, Dept Quim Fundamental, Sao Paulo, Brazil; [Lima, Filipe C. D. A.; Petrilli, Helena M.] Univ Sao Paulo, Inst Fis, Dept Fis Mat & Mecan, Sao Paulo, Brazil; [Campelo, Yuri D. M.] Univ Fed Piaui, Programa Mestrado Biotecnol, Parnaiba, Piaui, Brazil; [Carvalho, Paulo S., Jr.; Ellena, Javier A.; Mascarenhas, Yvonne P.] Univ Sao Paulo, Inst Fis Sao Carlos, Dept Fis & Informat, Sao Carlos, SP, Brazil; [Silva, Paulo R. P.; Vasconcelos, Luciene C.] Anidro Brasil Extracoes SA, Parnaiba, Piaui, Brazil; [Godejohann, Markus] Bruker BioSpin GmbH, Rheinstetten, Germany	Universidade Federal do Piaui; Universidade Federal do Piaui; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Piaui; Universidade de Sao Paulo; Bruker Corporation; Bruker BioSpin GmbH	Leite, JRDD (corresponding author), Univ Fed Piaui, Nucleo Pesquisa Biodiversidade & Biotecnol, Parnaiba, Piaui, Brazil.	jrsaleite@gmail.com	de Moraes, Josué/F-4762-2014; Petrilli, Helena M/I-6159-2012; Mascarenhas, Yvonne P/L-6914-2015; Ellena, Javier/B-9104-2012; Veras, Leiz M C/H-8873-2013; Véras, Leiz/ABB-4559-2020; Constantino, Vera Regina Leopoldo/B-9202-2012; Carvalho Jr, Paulo S./G-8049-2016; Lima, Filipe Camargo Dalmatti Alves/R-2375-2016	de Moraes, Josué/0000-0003-1766-7031; Petrilli, Helena M/0000-0002-7275-3357; Mascarenhas, Yvonne P/0000-0003-1918-114X; Ellena, Javier/0000-0002-0676-3098; Véras, Leiz/0000-0003-3422-2878; Constantino, Vera Regina Leopoldo/0000-0001-9276-7329; Carvalho Jr, Paulo S./0000-0002-5551-9155; Lima, Filipe Camargo Dalmatti Alves/0000-0001-7062-5450	Anidro do Brasil Extracoes S.A.; Phytobios LTDA	Anidro do Brasil Extracoes S.A.; Phytobios LTDA	The authors would like to thank Anidro do Brasil Extracoes S.A. and Phytobios LTDA for grants and supporting in access the process, waste and all industrial way. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa-Filho José M., 2006, Rev. bras. farmacogn., V16, P109, DOI 10.1590/S0102-695X2006000100020; Bento RRF, 2010, BRAZ J PHYS, V40, P217, DOI 10.1590/S0103-97332010000200016; Casabianca LB, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2816784; Cheeseman JR, 1996, J CHEM PHYS, V104, P5497, DOI 10.1063/1.471789; Dewick PM, 2008, MED NATURAL PRODUCTS, V140, P763; Dollish F. R., 1974, CHARACTERISTIC RAMAN; Frisch MJ., 2009, GAUSSIAN, V09; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hendrickson RG, 2004, J EMERG MED, V26, P429, DOI 10.1016/j.jemermed.2003.09.013; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Johnson C.K., 1996, ORNL6895; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Leite JRSA, 2011, PI09041109 BR; MARKHAM LM, 1993, J PHYS CHEM-US, V97, P10319, DOI 10.1021/j100142a010; Nusair S, 1999, SEMIN ARTHRITIS RHEU, V28, P360, DOI 10.1016/S0049-0172(99)80002-X; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Santos Ana Paula, 2004, Revista Brasileira de Ciencias Farmaceuticas, V40, P115, DOI 10.1590/S1516-93322004000200002; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Silverstein R, 2005, SPECTROMETRIC IDENTI, P204; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; Varsanyi G., 1969, VIBRATIONAL SPECTRA; Veras LM, 2012, CURR MED CHEM, V19, P2051; VOIGTLANDER HW, 1978, ARCH PHARM, V311, P927, DOI 10.1002/ardp.19783111106; WOLINSKI K, 1990, J AM CHEM SOC, V112, P8251, DOI 10.1021/ja00179a005	25	20	20	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66702	10.1371/journal.pone.0066702	http://dx.doi.org/10.1371/journal.pone.0066702			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840522	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400035
J	Kurre, R; Kouzel, N; Ramakrishnan, K; Oldewurtel, ER; Maier, B				Kurre, Rainer; Kouzel, Nadzeya; Ramakrishnan, Kanimozhi; Oldewurtel, Enno R.; Maier, Berenike			Speed Switching of Gonococcal Surface Motility Correlates with Proton Motive Force	PLOS ONE			English	Article							IV PILI; ESCHERICHIA-COLI; NEISSERIA-GONORRHOEAE; BACILLUS-SUBTILIS; INTRACELLULAR PH; SUCCINIMIDYL ESTER; TWITCHING MOTILITY; MYXOCOCCUS-XANTHUS; NITRIC-OXIDE; MOTOR	Bacterial type IV pili are essential for adhesion to surfaces, motility, microcolony formation, and horizontal gene transfer in many bacterial species. These polymers are strong molecular motors that can retract at two different speeds. In the human pathogen Neisseria gonorrhoeae speed switching of single pili from 2 mu m/s to 1 mu m/s can be triggered by oxygen depletion. Here, we address the question how proton motive force (PMF) influences motor speed. Using pHluorin expression in combination with dyes that are sensitive to transmembrane Delta pH gradient or transmembrane potential Delta psi, we measured both components of the PMF at varying external pH. Depletion of PMF using uncouplers reversibly triggered switching into the low speed mode. Reduction of the PMF by approximate to 35 mV was enough to trigger speed switching. Reducing ATP levels by inhibition of the ATP synthase did not induce speed switching. Furthermore, we showed that the strictly aerobic Myxococcus xanthus failed to move upon depletion of PMF or oxygen, indicating that although the mechanical properties of the motor are conserved, its regulatory inputs have evolved differently. We conclude that depletion of PMF triggers speed switching of gonococcal pili. Although ATP is required for gonococcal pilus retraction, our data indicate that PMF is an independent additional energy source driving the high speed mode.	[Maier, Berenike] Univ Cologne, Dept Phys, D-50931 Cologne, Germany; Univ Cologne, Bioctr, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Maier, B (corresponding author), Univ Cologne, Dept Phys, D-50931 Cologne, Germany.	berenike.maier@uni-koeln.de	Maier, Berenike/B-2350-2016	Maier, Berenike/0000-0001-6971-9927; Oldewurtel, Enno/0000-0002-2813-0259	Deutsche Forschungsgemeinschaft [MA3898, SFB 680]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was funded by the Deutsche Forschungsgemeinschaft through MA3898 and SFB 680. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand JF, 2009, FEMS MICROBIOL REV, V33, P593, DOI 10.1111/j.1574-6976.2009.00166.x; Biais N, 2010, P NATL ACAD SCI USA, V107, P11358, DOI 10.1073/pnas.0911328107; Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Breeuwer P, 1996, APPL ENVIRON MICROB, V62, P178, DOI 10.1128/AEM.62.1.178-183.1996; Clark V. L., 2010, REGULATION FUNCTION; Clausen M, 2009, J BACTERIOL, V191, P4633, DOI 10.1128/JB.00396-09; Clausen M, 2009, BIOPHYS J, V96, P1169, DOI 10.1016/j.bpj.2008.10.017; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Crocker JC, 1996, PHYS REV LETT, V77, P1897, DOI 10.1103/PhysRevLett.77.1897; Douarche C, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.198101; Falsetta ML, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00075; Falsetta ML, 2010, INFECT IMMUN, V78, P2320, DOI 10.1128/IAI.01312-09; Falsetta ML, 2009, INFECT IMMUN, V77, P3522, DOI 10.1128/IAI.00036-09; FREITAG NE, 1995, MOL MICROBIOL, V16, P575, DOI 10.1111/j.1365-2958.1995.tb02420.x; Guttenplan SB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001243; Holz C, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.178104; Hong YS, 2009, APPL ENVIRON MICROB, V75, P2346, DOI 10.1128/AEM.02671-08; Howie HL, 2005, PLOS BIOL, V3, P627, DOI 10.1371/journal.pbio.0030100; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; Kurre R, 2012, MOL MICROBIOL, V86, P857, DOI 10.1111/mmi.12022; Kurre R, 2012, BIOPHYS J, V102, P2556, DOI 10.1016/j.bpj.2012.04.020; Lissenden S, 2000, MOL MICROBIOL, V37, P839, DOI 10.1046/j.1365-2958.2000.02050.x; Lo CJ, 2007, BIOPHYS J, V93, P294, DOI 10.1529/biophysj.106.095265; Maier B, 2004, P NATL ACAD SCI USA, V101, P10961, DOI 10.1073/pnas.0402305101; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Maier B, 2013, SOFT MATTER, V9, P5667, DOI 10.1039/c3sm50546d; Martinez KA, 2012, APPL ENVIRON MICROB, V78, P3706, DOI 10.1128/AEM.00354-12; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; MeyerRosberg K, 1996, GASTROENTEROLOGY, V111, P886, DOI 10.1016/S0016-5085(96)70056-2; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Opitz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017088; Opitz D, 2009, CHEMPHYSCHEM, V10, P1614, DOI 10.1002/cphc.200800654; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Philip AF, 2010, P NATL ACAD SCI USA, V107, P17986, DOI 10.1073/pnas.1004823107; REPASKE DR, 1981, J BACTERIOL, V145, P1196, DOI 10.1128/JB.145.3.1196-1208.1981; Riondet C, 1997, BIOTECHNOL TECH, V11, P735, DOI 10.1023/A:1018492217623; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; SETTY OH, 1983, BIOPHYS J, V43, P371, DOI 10.1016/S0006-3495(83)84360-4; SHIOI J, 1980, J BACTERIOL, V144, P891, DOI 10.1128/JB.144.3.891-897.1980; SHIOI J, 1984, J BIOL CHEM, V259, P983; Skerker JM, 2001, P NATL ACAD SCI USA, V98, P6901, DOI 10.1073/pnas.121171698; SogaardAndersen L, 1996, P NATL ACAD SCI USA, V93, P2675, DOI 10.1073/pnas.93.7.2675; Steichen CT, 2008, J INFECT DIS, V198, P1856, DOI 10.1086/593336; Sun MZ, 2011, P NATL ACAD SCI USA, V108, P7559, DOI 10.1073/pnas.1101101108; Taylor BL, 1999, ANNU REV MICROBIOL, V53, P103, DOI 10.1146/annurev.micro.53.1.103; TONJUM T, 1995, MOL MICROBIOL, V16, P451, DOI 10.1111/j.1365-2958.1995.tb02410.x; Wasser IM, 2002, CHEM REV, V102, P1201, DOI 10.1021/cr0006627; Whitehead RN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-35; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x	52	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67718	10.1371/journal.pone.0067718	http://dx.doi.org/10.1371/journal.pone.0067718			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826337	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400169
J	Wang, YQ; Wang, ZH; Fu, LN; Chen, YX; Fang, JY				Wang, Yunqian; Wang, Zhenhua; Fu, Linna; Chen, Yingxuan; Fang, Jingyuan			Legume Consumption and Colorectal Adenoma Risk: A Meta-Analysis of Observational Studies	PLOS ONE			English	Article							VEGETABLE INTAKE; DIETARY FIBER; CANCER; FRUIT; COLON; PREVALENCE; SOYBEANS; POLYPS	Background: The anticancer effects of legumes have been explored extensively, but evidence from epidemiologic studies on colorectal adenoma is controversial. We performed a meta-analysis to assess these issues. Methods: A systemic search of several databases was conducted for relevant studies evaluating the relationship between legume intake and adenoma risk, with no language restriction, from January 1, 1966, to April 1, 2013. Results: Three cohort and eleven case control studies with 8,380 cases and a total of 101,856 participants were included in the analysis; the pooled odds ratio (95% confidence interval) for the highest vs. lowest consumption categories was 0.83 (0.75-0.93), with moderate level of heterogeneity (I-2 = 25.9% and P = 0.146) based on a random effects model. A decreased risk of adenoma was also observed in most of our subgroup meta-analyses. Conclusions: Higher intake of legumes significantly reduced the risk of colorectal adenoma in our meta-analysis. Nevertheless, due to possible confounders and bias, further investigations are warranted to confirm this relationship.	[Wang, Yunqian; Wang, Zhenhua; Fu, Linna; Chen, Yingxuan; Fang, Jingyuan] Shanghai Jiao Tong Univ, Div Gastroenterol & Hepatol, Renji Hosp, Shanghai 200030, Peoples R China; [Wang, Yunqian; Wang, Zhenhua; Fu, Linna; Chen, Yingxuan; Fang, Jingyuan] Shanghai Inst Digest Dis, Shanghai, Peoples R China; [Wang, Yunqian; Wang, Zhenhua; Fu, Linna; Chen, Yingxuan; Fang, Jingyuan] Shanghai Jiao Tong Univ, Minist Hlth, Key Lab Gastroenterol & Hepatol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, YX (corresponding author), Shanghai Jiao Tong Univ, Div Gastroenterol & Hepatol, Renji Hosp, Shanghai 200030, Peoples R China.	yingxuanchen2013@yahoo.cn			National Natural Science Foundation of China [81172321]; National High-tech R&D Program of China [2012AA02A506]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-tech R&D Program of China(National High Technology Research and Development Program of China)	Funding provided by the National Natural Science Foundation of China (No. 81172321, to C.Y.X), and the National High-tech R&D Program of China (No. 2012AA02A506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agurs-Collins Tanya, 2006, J Natl Black Nurses Assoc, V17, P6; Aune D, 2009, CANCER CAUSE CONTROL, V20, P1605, DOI 10.1007/s10552-009-9406-z; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BENITO E, 1993, INT J CANCER, V55, P213, DOI 10.1002/ijc.2910550208; Bingham SA, 2000, BIOCHEM SOC T, V28, P12, DOI 10.1042/bst0280012; Blumenstein I, 2013, EUR J GASTROEN HEPAT, V25, P556, DOI 10.1097/MEG.0b013e32835d1ef4; Bobe G, 2008, CANCER EPIDEM BIOMAR, V17, P1344, DOI 10.1158/1055-9965.EPI-07-0747; Clarke JM, 2012, CARCINOGENESIS, V33, P197, DOI 10.1093/carcin/bgr254; Clemente A, 2013, BOWMAN BIRK INHIBITO; Costa GED, 2006, FOOD CHEM, V94, P327, DOI 10.1016/j.foodchem.2004.11.020; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dilis V, 2009, MEDITERR J NUTR META, V1, P149, DOI 10.1007/s12349-008-0023-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; HAENSZEL W, 1973, J NATL CANCER I, V51, P1765, DOI 10.1093/jnci/51.6.1765; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HU JF, 1991, INT J EPIDEMIOL, V20, P362, DOI 10.1093/ije/20.2.362; Iscovich J, 2006, INT J CANCER, V51, P851; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KATO I, 1990, JPN J CANCER RES, V81, P1101, DOI 10.1111/j.1349-7006.1990.tb02520.x; Kennedy AR, 1998, AM J CLIN NUTR, V68, p1406S, DOI 10.1093/ajcn/68.6.1406S; KONO S, 1993, JPN J CANCER RES, V84, P13, DOI 10.1111/j.1349-7006.1993.tb02777.x; Lee Se Young, 2005, Korean J Gastroenterol, V45, P23; Lin J, 2005, CANCER CAUSE CONTROL, V16, P225, DOI 10.1007/s10552-004-4025-1; Manousos O, 2006, INT J CANCER, V32, P1; Martinez ME, 2009, GASTROENTEROLOGY, V136, P832, DOI 10.1053/j.gastro.2008.12.007; Mathers JC, 2002, BRIT J NUTR, V88, pS273, DOI [10.1079/BJN2002655, 10.1079/BJN2002717, 10.1079/BJN.2002717]; Messina MJ, 1999, AM J CLIN NUTR, V70, p439S, DOI 10.1093/ajcn/70.3.439s; Michels KB, 2006, CANCER RES, V66, P3942, DOI 10.1158/0008-5472.CAN-05-3637; Millen AE, 2007, AM J CLIN NUTR, V86, P1754; Nagata C, 2001, DIS COLON RECTUM, V44, P105, DOI 10.1007/BF02234831; Pan MH, 2011, MOL NUTR FOOD RES, V55, P32, DOI 10.1002/mnfr.201000412; Platz EA, 1997, CANCER EPIDEM BIOMAR, V6, P661; Ramadas A, 2009, ASIAN PAC J CANCER P, V10, P925; Scharlau D, 2009, MUTAT RES-REV MUTAT, V682, P39, DOI 10.1016/j.mrrev.2009.04.001; Schoenfeld JD, 2013, AM J CLIN NUTR, V97, P127, DOI 10.3945/ajcn.112.047142; Singh PN, 1998, AM J EPIDEMIOL, V148, P761, DOI 10.1093/oxfordjournals.aje.a009697; Smith-Warner SA, 2002, AM J EPIDEMIOL, V155, P1104, DOI 10.1093/aje/155.12.1104; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tantamango YM, 2011, NUTR CANCER, V63, P565, DOI 10.1080/01635581.2011.551988; Toyomura Kengo, 2002, Asian Pac J Cancer Prev, V3, P125; van Breda SGJ, 2004, CARCINOGENESIS, V25, P2207, DOI 10.1093/carcin/bgh241; van Houwelingen HC, 2002, STAT MED, V21, P589, DOI 10.1002/sim.1040; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Wilson S, 2002, CANC ENV GENE ENV IN; Witte JS, 1996, AM J EPIDEMIOL, V144, P1015, DOI 10.1093/oxfordjournals.aje.a008872; Wu HY, 2009, J NUTR, V139, P340, DOI 10.3945/jn.108.098889; Yan L, 2010, CANCER EPIDEM BIOMAR, V19, P148, DOI 10.1158/1055-9965.EPI-09-0856; Zheng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049581; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395	51	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67335	10.1371/journal.pone.0067335	http://dx.doi.org/10.1371/journal.pone.0067335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826270	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400134
J	Rousset, F; Nguyen, MVC; Grange, L; Morel, F; Lardy, B				Rousset, Francis; Minh Vu Chuong Nguyen; Grange, Laurent; Morel, Francoise; Lardy, Bernard			Heme Oxygenase-1 Regulates Matrix Metalloproteinase MMP-1 Secretion and Chondrocyte Cell Death via Nox4 NADPH Oxidase Activity in Chondrocytes	PLOS ONE			English	Article							NF-KAPPA-B; NAD(P)H OXIDASE; GENE-EXPRESSION; CYTOCHROME B(558); CARBON-MONOXIDE; COLLAGENASE; INDUCTION; IDENTIFICATION; HYPERTROPHY; ACTIVATION	Interleukin-1 beta (IL-1 beta) activates the production of reactive oxygen species (ROS) and secretion of MMPs as well as chondrocyte apoptosis. Those events lead to matrix breakdown and are key features of osteoarthritis (OA). We confirmed that in human C-20/A4 chondrocytes the NADPH oxidase Nox4 is the main source of ROS upon IL-1 beta stimulation. Since heme molecules are essential for the NADPH oxidase maturation and activity, we therefore investigated the consequences of the modulation of Heme oxygenase-1 (HO-1), the limiting enzyme in heme catabolism, on the IL-1 beta signaling pathway and more specifically on Nox4 activity. Induction of HO-1 expression decreased dramatically Nox4 activity in C-20/A4 and HEK293 T-REx (TM) Nox4 cell lines. Unexpectedly, this decrease was not accompanied by any change in the expression, the subcellular localization or the maturation of Nox4. In fact, the inhibition of the heme synthesis by succinylacetone rather than heme catabolism by HO-1, led to a confinement of the Nox4/p22(phox) heterodimer in the endoplasmic reticulum with an absence of redox differential spectrum highlighting an incomplete maturation. Therefore, the downregulation of Nox4 activity by HO-1 induction appeared to be mediated by carbon monoxide (CO) generated from the heme degradation process. Interestingly, either HO-1 or CO caused a significant decrease in the expression of MMP-1 and DNA fragmentation of chondrocytes stimulated by IL-1 beta. These results all together suggest that a modulation of Nox4 activity via heme oxygenase-1 may represent a promising therapeutic tool in osteoarthritis.	[Rousset, Francis; Minh Vu Chuong Nguyen; Grange, Laurent; Morel, Francoise; Lardy, Bernard] Univ Grenoble 1, AGIM GREPI FRE CNRS 3405, Grenoble, France; [Grange, Laurent] CHU Hop Sud, Grenoble Teaching Hosp, Dept Rheumatol, Grenoble, France; [Lardy, Bernard] Ctr Hosp Univ, Inst Biol & Pathol, Lab Biochim Enzyme & Prot DBTP, Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Rousset, F (corresponding author), Univ Grenoble 1, AGIM GREPI FRE CNRS 3405, Grenoble, France.	francisrousset@yahoo.fr	Rousset, Francis/AAA-6024-2021	Rousset, Francis/0000-0001-7747-179X	Ministere de l'Enseignement Superieur de la Recherche et Technologie, Paris; UFR de Medecine, Universite Joseph Fourier, Grenoble; Societe Francaise de Rhumatologie; Delegation a la Recherche Clinique et a l'Innovation, Centre Hospitalier Universitaire, Grenoble; Fondation Arthritis Courtin	Ministere de l'Enseignement Superieur de la Recherche et Technologie, Paris; UFR de Medecine, Universite Joseph Fourier, Grenoble; Societe Francaise de Rhumatologie; Delegation a la Recherche Clinique et a l'Innovation, Centre Hospitalier Universitaire, Grenoble; Fondation Arthritis Courtin	This work was supported by grants from the "Ministere de l'Enseignement Superieur de la Recherche et Technologie, Paris, the "UFR de Medecine, Universite Joseph Fourier, Grenoble the "Groupement des Entreprises Francaises dans la lutte contre le Cancer, delegation de Grenoble, the "Societe Francaise de Rhumatologie and the "Delegation a la Recherche Clinique et a l'Innovation, Centre Hospitalier Universitaire, Grenoble. FR is supported by grants from the Fondation Arthritis Courtin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Borden P, 1996, J BIOL CHEM, V271, P23577, DOI 10.1074/jbc.271.38.23577; Campion Y, 2007, BIOCHIMIE, V89, P1145, DOI 10.1016/j.biochi.2007.01.010; Coustry F, 2012, AM J PATHOL, V180, P738, DOI 10.1016/j.ajpath.2011.10.033; CROSS AR, 1995, J BIOL CHEM, V270, P17075, DOI 10.1074/jbc.270.29.17075; Datla SR, 2007, HYPERTENSION, V50, P636, DOI 10.1161/HYPERTENSIONAHA.107.092296; DeLeo FR, 2000, J BIOL CHEM, V275, P13986, DOI 10.1074/jbc.275.18.13986; Drissi Hicham, 2005, Molecular Aspects of Medicine, V26, P169, DOI 10.1016/j.mam.2005.01.003; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Goldring MB, 2000, ARTHRITIS RHEUM-US, V43, P1916, DOI 10.1002/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Goyal P, 2005, BIOCHEM BIOPH RES CO, V329, P32, DOI 10.1016/j.bbrc.2005.01.089; Grange L, 2006, ANTIOXID REDOX SIGN, V8, P1485, DOI 10.1089/ars.2006.8.1485; Guillen MI, 2008, RHEUMATOLOGY, V47, P1323, DOI 10.1093/rheumatology/ken264; Heraud F, 2000, ANN RHEUM DIS, V59, P959, DOI 10.1136/ard.59.12.959; Jansen T, 2010, J MOL CELL CARDIOL, V49, P186, DOI 10.1016/j.yjmcc.2010.04.011; Kim KS, 2010, J BIOL CHEM, V285, P40294, DOI 10.1074/jbc.M110.126821; Koopman WJ, 2001, ARTHRITIS ALLIED CON, P226; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Martin G, 2003, INFLAMMATION, V27, P233, DOI 10.1023/A:1025040631514; Megias J, 2008, J PHARMACOL EXP THER, V325, P56, DOI 10.1124/jpet.107.134650; Mendes AF, 2001, MEDIAT INFLAMM, V10, P209, DOI 10.1080/09629350120080401; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; MOREL F, 1985, EUR J BIOCHEM, V152, P669, DOI 10.1111/j.1432-1033.1985.tb09247.x; Morel F, 2007, B ACAD NAT MED PARIS, V191, P377, DOI 10.1016/S0001-4079(19)33082-1; Morita K, 2007, J EXP MED, V204, P1613, DOI 10.1084/jem.20062525; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Paclet MH, 2000, BIOCHEMISTRY-US, V39, P9302, DOI 10.1021/bi000483j; Poole AR, 1997, MECH MODELS RHEUMATO, P163; POOLE AR, 2001, OSTEOARTHRITIS DIAGN, P29; Rodriguez AI, 2010, ARTERIOSCL THROM VAS, V30, P98, DOI 10.1161/ATVBAHA.109.197822; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; Taille C, 2004, J BIOL CHEM, V279, P28681, DOI 10.1074/jbc.M310661200; Tchetina EV, 2006, AM J PATHOL, V168, P131, DOI 10.2353/ajpath.2006.050369; Vincenti MP, 2001, ARTHRITIS RES, V3, P381, DOI 10.1186/ar331; Yang S, 2004, J CELL BIOCHEM, V92, P238, DOI 10.1002/jcb.20048; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; Zhang LL, 2011, BIOCHIMIE, V93, P457, DOI 10.1016/j.biochi.2010.11.001	43	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66478	10.1371/journal.pone.0066478	http://dx.doi.org/10.1371/journal.pone.0066478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840483	gold, Green Submitted, Green Published			2022-12-27	WOS:000322342800066
J	Sun, HY; Lou, XM; Shan, Q; Zhang, J; Zhu, X; Zhang, J; Wang, Y; Xie, YY; Xu, NZ; Liu, SQ				Sun, Huiying; Lou, Xiaomin; Shan, Qiang; Zhang, Ju; Zhu, Xu; Zhang, Jia; Wang, Yang; Xie, Yingying; Xu, Ningzhi; Liu, Siqi			Proteolytic Characteristics of Cathepsin D Related to the Recognition and Cleavage of Its Target Proteins	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; D EXPRESSION; B ACTIVITY; ATHEROSCLEROSIS; DEGRADATION; SPECIFICITY; MACROPHAGES; HEMOGLOBIN; HYDROLYSIS; TRANSITION	Cathepsin D (CD) plays an important role in both biological and pathological processes, although the cleavage characteristics and substrate selection of CD have yet to be fully explored. We employed liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify the CD cleavage sites in bovine serum albumin (BSA). We found that the hydrophobic residues at P1 were not only a preferential factor for CD cleavage but that the hydrophobicity at P1' also contributed to CD recognition. The concept of hydrophobic scores of neighbors (HSN) was proposed to describe the hydrophobic microenvironment of CD recognition sites. The survey of CD cleavage characteristics in several proteins suggested that the HSN was a sensitive indicator for judging the favorable sites in peptides for CD cleavage, with HSN values of 0.5-1.0 representing a likely threshold. Ovalbumin (OVA), a protein resistant to CD cleavage in its native state, was easily cleaved by CD after denaturation, and the features of the cleaved peptides were quite similar to those found in BSA, where a higher HSN value indicated greater cleavability. We further conducted two-dimensional gel electrophoresis (2DE) to find more proteins that were insensitive to CD cleavage in CD-knockdown cells. Based on an analysis of secondary and three-dimensional structures, we postulated that intact proteins with a structure consisting of all a-helices would be relatively accessible to CD cleavage.	[Sun, Huiying; Lou, Xiaomin; Shan, Qiang; Zhang, Ju; Zhu, Xu; Wang, Yang; Xie, Yingying; Liu, Siqi] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Sun, Huiying; Shan, Qiang; Zhu, Xu; Wang, Yang; Xie, Yingying] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Jia] Beijing Prot Innovat, Beijing, Peoples R China; [Xu, Ningzhi] Chinese Acad Med Sci, Inst Canc, Lab Cell & Mol Biol, Beijing 100730, Peoples R China; [Xu, Ningzhi] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China; [Xu, Ningzhi] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Xu, NZ (corresponding author), Chinese Acad Med Sci, Inst Canc, Lab Cell & Mol Biol, Beijing 100730, Peoples R China.	xunzh@genomics.cn; siqiliu@genomics.cn			National Basic Research Program of China (973) [2010CB912703, 2011CB910704]; National Natural Science Foundation of China [30800568, 30901717]	National Basic Research Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973) (2010CB912703 and 2011CB910704) and the National Natural Science Foundation of China (30800568 and 30901717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelqvist H, 2012, ANN CLIN LAB SCI, V42, P231; Athauda SBP, 2002, PROTEIN PEPTIDE LETT, V9, P289, DOI 10.2174/0929866023408698; Bednarski E, 1996, J NEUROCHEM, V67, P1846, DOI 10.1046/j.1471-4159.1996.67051846.x; BEVER CT, 1995, J NEUROL SCI, V131, P71, DOI 10.1016/0022-510X(95)00039-5; Brindley PJ, 2001, MOL BIOCHEM PARASIT, V112, P103, DOI 10.1016/S0166-6851(00)00351-0; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; Byun HO, 2009, CANCER RES, V69, P4638, DOI 10.1158/0008-5472.CAN-08-4042; Carew JS, 2011, J BIOL CHEM, V286, P6602, DOI 10.1074/jbc.M110.151324; Christensen B, 2010, J BIOL CHEM, V285, P7929, DOI 10.1074/jbc.M109.075010; Conus S, 2012, J BIOL CHEM, V287, P21142, DOI 10.1074/jbc.M111.306399; COWAN R, 1990, Peptide Research, V3, P75; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; Fonovic UP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053918; Fruitier I, 1998, BIOCHEM BIOPH RES CO, V246, P719, DOI 10.1006/bbrc.1998.8614; Glondu M, 2002, ONCOGENE, V21, P5127, DOI 10.1038/sj.onc.1205657; Hakala JK, 2003, ARTERIOSCL THROM VAS, V23, P1430, DOI 10.1161/01.ATV.0000077207.49221.06; Handley CJ, 2001, MATRIX BIOL, V20, P543, DOI 10.1016/S0945-053X(01)00168-8; Hu L, 2008, CANCER RES, V68, P4666, DOI 10.1158/0008-5472.CAN-07-6276; Hughes MC, 2000, MEAT SCI, V56, P165, DOI 10.1016/S0309-1740(00)00036-X; Impens F, 2012, BIOL CHEM, V393, P915, DOI 10.1515/hsz-2012-0168; Impens F, 2010, MOL CELL PROTEOMICS, V9, P2327, DOI 10.1074/mcp.M110.001271; Kaschina E, 2009, ATHEROSCLEROSIS, V205, P396, DOI 10.1016/j.atherosclerosis.2009.01.003; Kirana Chandra, 2012, Int J Proteomics, V2012, P245819, DOI 10.1155/2012/245819; Lombardi G, 2005, J IMMUNOL, V174, P7022, DOI 10.4049/jimmunol.174.11.7022; Melzer IM, 2012, CELL DEATH DIFFER, V19, P1435, DOI 10.1038/cdd.2012.17; Moller KK, 2012, J AGR FOOD CHEM, V60, P11421, DOI 10.1021/jf302890h; OFFERMANN MK, 1983, BIOCHEM J, V211, P529, DOI 10.1042/bj2110529; Ohri SS, 2007, CANCER BIOL THER, V6, P1081, DOI 10.4161/cbt.6.7.4325; Palashoff MH, 2008, THESIS; Pimenta DC, 2000, J PROTEIN CHEM, V19, P411, DOI 10.1023/A:1026432402259; Pimenta DC, 2001, BBA-PROTEIN STRUCT M, V1544, P113, DOI 10.1016/S0167-4838(00)00209-0; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schilling O, 2007, CURR OPIN CHEM BIOL, V11, P36, DOI 10.1016/j.cbpa.2006.11.037; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Sjoberg S, 2011, CLIN REV BONE MINER, V9, P138, DOI 10.1007/s12018-011-9098-2; TURKEWITZ AP, 1988, J BIOL CHEM, V263, P16309; Urbanelli L, 2008, NEUROBIOL AGING, V29, P12, DOI 10.1016/j.neurobiolaging.2006.09.005; VANNOORT JM, 1989, J BIOL CHEM, V264, P14159; Victor BC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3058; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842	43	30	30	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65733	10.1371/journal.pone.0065733	http://dx.doi.org/10.1371/journal.pone.0065733			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840360	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800018
J	Clarke, A; Morris, GJ; Fonseca, F; Murray, BJ; Acton, E; Price, HC				Clarke, Andrew; Morris, G. John; Fonseca, Fernanda; Murray, Benjamin J.; Acton, Elizabeth; Price, Hannah C.			A Low Temperature Limit for Life on Earth	PLOS ONE			English	Article							CELLULAR DESICCATION TOLERANCE; BIOLOGICAL ICE NUCLEATORS; ANTARCTIC NEMATODE; GLASS-FORMATION; COOLING RATE; DEGREES-C; SURVIVAL; FROZEN; VITRIFICATION; DROPLETS	There is no generally accepted value for the lower temperature limit for life on Earth. We present empirical evidence that free-living microbial cells cooling in the presence of external ice will undergo freeze-induced desiccation and a glass transition (vitrification) at a temperature between -10 degrees C and -26 degrees C. In contrast to intracellular freezing, vitrification does not result in death and cells may survive very low temperatures once vitrified. The high internal viscosity following vitrification means that diffusion of oxygen and metabolites is slowed to such an extent that cellular metabolism ceases. The temperature range for intracellular vitrification makes this a process of fundamental ecological significance for free-living microbes. It is only where extracellular ice is not present that cells can continue to metabolise below these temperatures, and water droplets in clouds provide an important example of such a habitat. In multicellular organisms the cells are isolated from ice in the environment, and the major factor dictating how they respond to low temperature is the physical state of the extracellular fluid. Where this fluid freezes, then the cells will dehydrate and vitrify in a manner analogous to free-living microbes. Where the extracellular fluid undercools then cells can continue to metabolise, albeit slowly, to temperatures below the vitrification temperature of free-living microbes. Evidence suggests that these cells do also eventually vitrify, but at lower temperatures that may be below -50 degrees C. Since cells must return to a fluid state to resume metabolism and complete their life cycle, and ice is almost universally present in environments at sub-zero temperatures, we propose that the vitrification temperature represents a general lower thermal limit to life on Earth, though its precise value differs between unicellular (typically above -20 degrees C) and multicellular organisms (typically below -20 degrees C). Few multicellular organisms can, however, complete their life cycle at temperatures below similar to-2 degrees C.	[Clarke, Andrew] British Antarctic Survey, Cambridge CB3 0ET, England; [Clarke, Andrew] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Morris, G. John; Acton, Elizabeth] Asymptote Ltd, St Johns Innovat Ctr, Cambridge, England; [Fonseca, Fernanda] INRA, F-78850 Thiverval Grignon, France; [Murray, Benjamin J.; Price, Hannah C.] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of East Anglia; St Johns Innovation Centre - UK; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Leeds	Clarke, A (corresponding author), British Antarctic Survey, Madingley Rd, Cambridge CB3 0ET, England.	accl@bas.ac.uk	FONSECA, FERNANDA/HDN-9451-2022; Fonseca, Fernanda/AAR-9094-2020; Murray, Benjamin/C-1219-2010; Price, Hannah/G-1059-2015	FONSECA, FERNANDA/0000-0002-0315-6479; Fonseca, Fernanda/0000-0003-3394-182X; Murray, Benjamin/0000-0002-8198-8131; Price, Hannah/0000-0002-1608-1592	Institut National de la Recherche Agronomique; Natural Environment Research Council [NE/D009308/1, NE/H001050/1]; European Research Council [240449- ICE]; Natural Environment Research Council [bas010011] Funding Source: researchfish; NERC [bas010011, NE/D009308/1, NE/H001050/1] Funding Source: UKRI	Institut National de la Recherche Agronomique; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	A.C. is retired but received emeritus support from the British Antarctic Survey, F. F. was supported by the Institut National de la Recherche Agronomique, and B.J.M. was supported by the Natural Environment Research Council (NE/D009308/1 and NE/H001050/1) and the European Research Council (240449- ICE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels-Rausch T, 2012, REV MOD PHYS, V84, P885, DOI 10.1103/RevModPhys.84.885; Benner SA, 2010, ASTROBIOLOGY, V10, P1021, DOI 10.1089/ast.2010.0524; Bowers RM, 2009, APPL ENVIRON MICROB, V75, P5121, DOI 10.1128/AEM.00447-09; Castell JD, 2005, LIFE ANCIENT ICE; CHANG BS, 1992, CRYOBIOLOGY, V29, P632, DOI 10.1016/0011-2240(92)90067-C; Christner BC, 2008, SCIENCE, V319, P1214, DOI 10.1126/science.1149757; Christner BC, 2010, APPL MICROBIOL BIOT, V85, P481, DOI 10.1007/s00253-009-2291-2; Christner BC, 2008, P NATL ACAD SCI USA, V105, P18854, DOI 10.1073/pnas.0809816105; Chyba C.F., 2007, PLANETS LIFE EMERGIN, P388; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; CLARKE A, 1986, J EXP BOT, V37, P1285, DOI 10.1093/jxb/37.9.1285; CLARKE KJ, 1985, PROTOPLASMA, V129, P120, DOI 10.1007/BF01279909; COLLINS M A, 1989, Food Microbiology (London), V6, P135, DOI 10.1016/S0740-0020(89)80021-8; Convey P, 2000, CRYO-LETT, V21, P327; Debenedetti P.G., 1996, METASTABLE LIQUIDS C; DIMMICK RL, 1979, APPL ENVIRON MICROB, V37, P924, DOI 10.1128/AEM.37.5.924-927.1979; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Farrell AH, 2004, J MOL EVOL, V59, P666, DOI 10.1007/s00239-004-2658-z; Fonseca F, 2006, APPL ENVIRON MICROB, V72, P6474, DOI 10.1128/AEM.00998-06; Franks F, 2003, PHILOS T ROY SOC A, V361, P557, DOI 10.1098/rsta.2002.1141; Geiges O, 1996, ADV SPACE RES, V18, P109, DOI 10.1016/0273-1177(96)00006-3; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hansen LD, 2009, PURE APPL CHEM, V81, P1843, DOI 10.1351/PAC-CON-08-09-09; Hengherr S, 2009, PHYSIOL BIOCHEM ZOOL, V82, P749, DOI 10.1086/605954; Hengherr S, 2011, COMP BIOCHEM PHYS A, V160, P137, DOI 10.1016/j.cbpa.2011.05.032; Hengherr S, 2011, PHYSIOL BIOCHEM ZOOL, V84, P249, DOI 10.1086/659314; Hill KA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008002; HIRSH AG, 1985, PLANT PHYSIOL, V79, P41, DOI 10.1104/pp.79.1.41; HIRSH AG, 1987, CRYOBIOLOGY, V24, P214, DOI 10.1016/0011-2240(87)90024-1; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Jakosky BM, 2003, ASTROBIOLOGY, V3, P343, DOI 10.1089/153110703769016433; Kagoshima H, 2012, CRYOLETTERS, V33, P280; Kashefi K, 2003, SCIENCE, V301, P934, DOI 10.1126/science.1086823; KOHSHIMA S, 1984, NATURE, V310, P225, DOI 10.1038/310225a0; Koop T, 2009, PHYS CHEM CHEM PHYS, V11, P10839, DOI 10.1039/b914289d; Kosova K, 2007, BIOL PLANTARUM, V51, P601, DOI 10.1007/s10535-007-0133-6; Kostinski A, 2008, J ATMOS SCI, V65, P2961, DOI 10.1175/2008JAS2503.1; Leather S. R., 1993, ECOLOGY INSECT OVERW; Leopold A. C., 1986, MEMBRANES METABOLISM; LINDOW SE, 1982, PLANT PHYSIOL, V70, P1084, DOI 10.1104/pp.70.4.1084; Liu JJ, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001921; Mader HM, 2006, GEOLOGY, V34, P169, DOI 10.1130/G22096.1; Mazur P, 2004, LIFE IN THE FROZEN STATE, P3, DOI 10.1201/9780203647073.ch1; McCafferty DJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1192; MILLER LK, 1978, CRYOBIOLOGY, V15, P345, DOI 10.1016/0011-2240(78)90046-9; MOROWITZ HJ, 1978, FDN BIOENERGETICS; Morris GJ, 2012, CRYOBIOLOGY, V64, P71, DOI 10.1016/j.cryobiol.2011.12.002; Murray AE, 2012, P NATL ACAD SCI USA, V109, P20626, DOI 10.1073/pnas.1208607109; Murray BJ, 2012, ATMOS CHEM PHYS, V12, P8575, DOI 10.5194/acp-12-8575-2012; Murray BJ, 2012, CHEM SOC REV, V41, P6519, DOI 10.1039/c2cs35200a; Pace NR, 2001, P NATL ACAD SCI USA, V98, P805, DOI 10.1073/pnas.98.3.805; Panikova NS, 2006, SOIL BIOL BIOCHEM, V38, P785, DOI 10.1016/j.soilbio.2005.07.004; Pearce RS, 2004, LIFE IN THE FROZEN STATE, P171, DOI 10.1201/9780203647073.ch5; Pearce RS, 2001, ANN BOT-LONDON, V87, P417, DOI 10.1006/anbo.2000.1352; Pratt KA, 2009, NAT GEOSCI, V2, P397, DOI 10.1038/NGEO521; Price PB, 2004, P NATL ACAD SCI USA, V101, P4631, DOI 10.1073/pnas.0400522101; Price PB, 2000, P NATL ACAD SCI USA, V97, P1247, DOI 10.1073/pnas.97.3.1247; Rapatz G. L., 1966, CRYOBIOLOGY, P147; Reid JP, 2007, INT REV PHYS CHEM, V26, P139, DOI 10.1080/01442350601081899; Rivkina EM, 2000, APPL ENVIRON MICROB, V66, P3230, DOI 10.1128/AEM.66.8.3230-3233.2000; Rohde RA, 2008, P NATL ACAD SCI USA, V105, P8667, DOI 10.1073/pnas.0803763105; Santl-Temkiv T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053550; Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684; SCHMID WD, 1982, SCIENCE, V215, P697, DOI 10.1126/science.7058335; Schroeter B., 1994, Cryptogamic Botany, V4, P233; Seki S, 2009, CRYOBIOLOGY, V58, P157, DOI 10.1016/j.cryobiol.2008.11.011; Sformo T, 2010, J EXP BIOL, V213, P502, DOI 10.1242/jeb.035758; Slade L., 1989, PROTEIN QUALITY EFFE, P9; Takenaka N, 2007, J PHYS CHEM A, V111, P8780, DOI 10.1021/jp0738356; Tanghe A, 2003, ADV APPL MICROBIOL, V53, P129, DOI 10.1016/S0065-2164(03)53004-0; TANSEY MR, 1972, P NATL ACAD SCI USA, V69, P2426, DOI 10.1073/pnas.69.9.2426; Tominaga H, 1981, HYDROBIOLOGIA, V82, P375; von Neumann J., 1951, GEN LOGICAL THEORY A; Weinzirl J, 1929, J DAIRY SCI, V12, P182; WHARTON DA, 1995, J EXP BIOL, V198, P1381; Wisniewski M., 2004, Journal of Crop Improvement, V10, P5, DOI 10.1300/J411v10n01_02; Womack AM, 2010, PHILOS T R SOC B, V365, P3645, DOI 10.1098/rstb.2010.0283; Wowk B, 2010, CRYOBIOLOGY, V60, P11, DOI 10.1016/j.cryobiol.2009.05.007; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106	81	65	68	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66207	10.1371/journal.pone.0066207	http://dx.doi.org/10.1371/journal.pone.0066207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840425	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000322361200061
J	Manchia, M; Adli, M; Akula, N; Ardau, R; Aubry, JM; Backlund, L; Banzato, CEM; Baune, BT; Bellivier, F; Bengesser, S; Biernacka, JM; Brichant-Petitjean, C; Bui, E; Calkin, CV; Cheng, ATA; Chillotti, C; Cichon, S; Clark, S; Czerski, PM; Dantas, C; Del Zompo, M; DePaulo, JR; Detera-Wadleigh, SD; Etain, B; Falkai, P; Frisen, L; Frye, MA; Fullerton, J; Gard, S; Garnham, J; Goes, FS; Grof, P; Gruber, O; Hashimoto, R; Hauser, J; Heilbronner, U; Hoban, R; Hou, LP; Jamain, S; Kahn, JP; Kassem, L; Kato, T; Kelsoe, JR; Kittel-Schneider, S; Kliwicki, S; Kuo, PH; Kusumi, I; Laje, G; Lavebratt, C; Leboyer, M; Leckband, SG; Jaramillo, CAL; Maj, M; Malafosse, A; Martinsson, L; Masui, T; Mitchell, PB; Mondimore, F; Monteleone, P; Nallet, A; Neuner, M; Novak, T; O'Donovan, C; Osby, U; Ozaki, N; Perlis, RH; Pfennig, A; Potash, JB; Reich-Erkelenz, D; Reif, A; Reininghaus, E; Richardson, S; Rouleau, GA; Rybakowski, JK; Schalling, M; Schofield, PR; Schubert, OK; Schweizer, B; Seemuller, F; Grigoroiu-Serbanescu, M; Severino, G; Seymour, LR; Slaney, C; Smoller, JW; Squassina, A; Stamm, T; Steele, J; Stopkova, P; Tighe, SK; Tortorella, A; Turecki, G; Wray, NR; Wright, A; Zandi, PP; Zilles, D; Bauer, M; Rietschel, M; McMahon, FJ; Schulze, TG; Alda, M				Manchia, Mirko; Adli, Mazda; Akula, Nirmala; Ardau, Raffaella; Aubry, Jean-Michel; Backlund, Lena; Banzato, Claudio E. M.; Baune, Bernhard T.; Bellivier, Frank; Bengesser, Susanne; Biernacka, Joanna M.; Brichant-Petitjean, Clara; Bui, Elise; Calkin, Cynthia V.; Cheng, Andrew Tai Ann; Chillotti, Caterina; Cichon, Sven; Clark, Scott; Czerski, Piotr M.; Dantas, Clarissa; Del Zompo, Maria; DePaulo, J. Raymond; Detera-Wadleigh, Sevilla D.; Etain, Bruno; Falkai, Peter; Frisen, Louise; Frye, Mark A.; Fullerton, Jan; Gard, Sebastien; Garnham, Julie; Goes, Fernando S.; Grof, Paul; Gruber, Oliver; Hashimoto, Ryota; Hauser, Joanna; Heilbronner, Urs; Hoban, Rebecca; Hou, Liping; Jamain, Stephane; Kahn, Jean-Pierre; Kassem, Layla; Kato, Tadafumi; Kelsoe, John R.; Kittel-Schneider, Sarah; Kliwicki, Sebastian; Kuo, Po-Hsiu; Kusumi, Ichiro; Laje, Gonzalo; Lavebratt, Catharina; Leboyer, Marion; Leckband, Susan G.; Lopez Jaramillo, Carlos A.; Maj, Mario; Malafosse, Alain; Martinsson, Lina; Masui, Takuya; Mitchell, Philip B.; Mondimore, Frank; Monteleone, Palmiero; Nallet, Audrey; Neuner, Maria; Novak, Tomas; O'Donovan, Claire; Osby, Urban; Ozaki, Norio; Perlis, Roy H.; Pfennig, Andrea; Potash, James B.; Reich-Erkelenz, Daniela; Reif, Andreas; Reininghaus, Eva; Richardson, Sara; Rouleau, Guy A.; Rybakowski, Janusz K.; Schalling, Martin; Schofield, Peter R.; Schubert, Oliver K.; Schweizer, Barbara; Seemueller, Florian; Grigoroiu-Serbanescu, Maria; Severino, Giovanni; Seymour, Lisa R.; Slaney, Claire; Smoller, Jordan W.; Squassina, Alessio; Stamm, Thomas; Steele, Jo; Stopkova, Pavla; Tighe, Sarah K.; Tortorella, Alfonso; Turecki, Gustavo; Wray, Naomi R.; Wright, Adam; Zandi, Peter P.; Zilles, David; Bauer, Michael; Rietschel, Marcella; McMahon, Francis J.; Schulze, Thomas G.; Alda, Martin			Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report	PLOS ONE			English	Article							MAPPING SUSCEPTIBILITY GENES; PROPHYLACTIC LITHIUM; OBSERVER AGREEMENT; MOOD DISORDERS; ONSET; ASSOCIATION; RELIABILITY; MORTALITY; ILLNESS; AGE	Objective: The assessment of response to lithium maintenance treatment in bipolar disorder (BD) is complicated by variable length of treatment, unpredictable clinical course, and often inconsistent compliance. Prospective and retrospective methods of assessment of lithium response have been proposed in the literature. In this study we report the key phenotypic measures of the "Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder" scale currently used in the Consortium on Lithium Genetics (ConLiGen) study. Materials and Methods: Twenty-nine ConLiGen sites took part in a two-stage case-vignette rating procedure to examine inter-rater agreement [Kappa (kappa)] and reliability [intra-class correlation coefficient (ICC)] of lithium response. Annotated first-round vignettes and rating guidelines were circulated to expert research clinicians for training purposes between the two stages. Further, we analyzed the distributional properties of the treatment response scores available for 1,308 patients using mixture modeling. Results: Substantial and moderate agreement was shown across sites in the first and second sets of vignettes (kappa = 0.66 and kappa = 0.54, respectively), without significant improvement from training. However, definition of response using the A score as a quantitative trait and selecting cases with B criteria of 4 or less showed an improvement between the two stages (ICC1 = 0.71 and ICC2 = 0.75, respectively). Mixture modeling of score distribution indicated three subpopulations (full responders, partial responders, non responders). Conclusions: We identified two definitions of lithium response, one dichotomous and the other continuous, with moderate to substantial inter-rater agreement and reliability. Accurate phenotypic measurement of lithium response is crucial for the ongoing ConLiGen pharmacogenomic study.	[Manchia, Mirko; Calkin, Cynthia V.; Garnham, Julie; O'Donovan, Claire; Slaney, Claire; Alda, Martin] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Adli, Mazda; Stamm, Thomas] Charite, Dept Psychiat & Psychotherapy, D-13353 Berlin, Germany; [Akula, Nirmala; Bui, Elise; Detera-Wadleigh, Sevilla D.; Hou, Liping; Kassem, Layla; Laje, Gonzalo; Richardson, Sara; Steele, Jo; McMahon, Francis J.; Schulze, Thomas G.] NIMH, Human Genet Branch, Div Intramural Res Programs, NIH, Bethesda, MD 20892 USA; [Ardau, Raffaella; Chillotti, Caterina; Del Zompo, Maria] Univ Hosp Cagliari, Clin Pharmacol Unit, Cagliari, Italy; [Aubry, Jean-Michel; Malafosse, Alain; Nallet, Audrey] Hop Univ Geneve, Dept Mental Hlth & Psychiat, Geneva, Switzerland; [Backlund, Lena; Frisen, Louise; Martinsson, Lina] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Banzato, Claudio E. M.; Dantas, Clarissa] Univ Estadual Campinas, Dept Psychiat, Campinas, Brazil; [Baune, Bernhard T.; Clark, Scott; Schubert, Oliver K.] Univ Adelaide, Dept Psychiat, Adelaide, SA, Australia; [Bellivier, Frank; Brichant-Petitjean, Clara] Grp Hosp Lariboisiere F Widal, AP HP, Paris, France; [Bengesser, Susanne; Reininghaus, Eva] Med Univ Graz, Dept Psychiat, Graz, Austria; [Biernacka, Joanna M.; Frye, Mark A.; Seymour, Lisa R.] Mayo Clin, Dept Psychiat, Rochester, MN USA; [Cheng, Andrew Tai Ann] Acad Sinica, Inst Biomed Sci, Div Epidemiol & Genet, Taipei, Taiwan; [Cichon, Sven] Univ Bonn, Life & Brain Ctr, Dept Genom, Bonn, Germany; [Cichon, Sven] Univ Bonn, Inst Human Genet, Bonn, Germany; [Czerski, Piotr M.] Poznan Univ Med Sci, Psychiat Genet Unit, Poznan, Poland; [Del Zompo, Maria; Severino, Giovanni; Squassina, Alessio] Univ Cagliari, Dept Biomed Sci, Sect Neurosci & Clin Pharmacol, Cagliari, Italy; [DePaulo, J. Raymond; Goes, Fernando S.; Mondimore, Frank; Potash, James B.; Schweizer, Barbara; Tighe, Sarah K.; Schulze, Thomas G.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Etain, Bruno; Jamain, Stephane; Leboyer, Marion] Fac Med, Equipe 15, Inst Mondor Rech Biomed, INSERM,Unite 955, Creteil, France; [Falkai, Peter; Seemueller, Florian] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Fullerton, Jan; Schofield, Peter R.] Neurosci Res Australia Genet Mental Illness & Bra, Sydney, NSW, Australia; [Gard, Sebastien] Hop Charles Perrens, Psychiat Serv, Bordeaux, France; [Grof, Paul] Mood Disorders Ctr Ottawa, Ottawa, ON, Canada; [Grof, Paul] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Gruber, Oliver; Heilbronner, Urs; Reich-Erkelenz, Daniela; Zilles, David; Schulze, Thomas G.] Univ Gottingen, Dept Psychiat & Psychotherapy, D-37073 Gottingen, Germany; [Hashimoto, Ryota] Osaka Univ, Grad Sch Med, Osaka, Japan; [Hauser, Joanna] Poznan Univ Med Sci, Psychiat Genet Unit, Poznan, Poland; [Hoban, Rebecca; Kelsoe, John R.; Leckband, Susan G.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Hoban, Rebecca; Kelsoe, John R.] Vet Affairs San Diego Healthcare Syst, Dept Psychiat, San Diego, CA USA; [Kahn, Jean-Pierre] Ctr Hosp Univ Nancy, Serv Psychiat & Psychol Clin, Nancy, France; [Kato, Tadafumi; Kusumi, Ichiro] RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Saitama, Japan; [Kittel-Schneider, Sarah; Neuner, Maria; Reif, Andreas] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, D-97070 Wurzburg, Germany; [Kliwicki, Sebastian; Rybakowski, Janusz K.] Poznan Univ Med Sci, Dept Adult Psychiat, Poznan, Poland; [Kuo, Po-Hsiu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Kusumi, Ichiro; Masui, Takuya] Hokkaido Univ, Grad Sch Med, Dept Psychiat, Sapporo, Hokkaido, Japan; [Lavebratt, Catharina; Osby, Urban; Schalling, Martin] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Lavebratt, Catharina; Osby, Urban; Schalling, Martin] Karolinska Univ Hosp, Ctr Mol Med, Stockholm, Sweden; [Leckband, Susan G.] Vet Affairs San Diego Healthcare Syst, Dept Pharm, San Diego, CA USA; [Leckband, Susan G.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA; [Lopez Jaramillo, Carlos A.] Univ Antioquia, Dept Psychiat, Medellin, Colombia; [Maj, Mario; Monteleone, Palmiero; Tortorella, Alfonso] Univ Naples Federico II, Dept Psychiat, Naples, Italy; [Mitchell, Philip B.; Wright, Adam] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Mitchell, Philip B.; Wright, Adam] Black Dog Inst, Sydney, NSW, Australia; [Novak, Tomas; Stopkova, Pavla] Univ Prague, Prague Psychiat Ctr, Prague, Czech Republic; [Ozaki, Norio] Fujita Hlth Univ, Sch Med, Dept Psychiat, Toyoake, Aichi 47011, Japan; [Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan; [Perlis, Roy H.; Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Perlis, Roy H.; Smoller, Jordan W.] Harvard Univ, Sch Med, Boston, MA USA; [Pfennig, Andrea; Bauer, Michael] Tech Univ Dresden, Dept Psychiat & Psychotherapy, Dresden, Germany; [Potash, James B.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Rouleau, Guy A.] Univ Montreal, Ctr Hosp Univ Montreal, Ctr Excellence Neurosci, Montreal, PQ, Canada; [Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Grigoroiu-Serbanescu, Maria] Alexandru Obregia Psychiat Hosp, Biometr Psychiat Genet Res Unit, Bucharest, Romania; [Turecki, Gustavo] Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Montreal, PQ, Canada; [Wray, Naomi R.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Zandi, Peter P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Rietschel, Marcella; Schulze, Thomas G.] Heidelberg Univ, Univ Med Ctr Mannheim, Cent Inst Mental Hlth Mannheim, Dept Genet Epidemiol Psychiat, Mannheim, Germany	Dalhousie University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Cagliari; Azienda Ospedaliero-Universitaria di Cagliari; University of Geneva; Karolinska Institutet; Universidade Estadual de Campinas; University of Adelaide; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Medical University of Graz; Mayo Clinic; Academia Sinica - Taiwan; University of Bonn; University of Bonn; Poznan University of Medical Sciences; University of Cagliari; Johns Hopkins University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Munich; Neuroscience Research Australia; University of Ottawa; University of Toronto; University of Gottingen; Osaka University; Poznan University of Medical Sciences; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; CHU de Nancy; RIKEN; University of Wurzburg; Poznan University of Medical Sciences; National Taiwan University; Hokkaido University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Universidad de Antioquia; University of Naples Federico II; University of New South Wales Sydney; Black Dog Institute; Fujita Health University; Nagoya University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Technische Universitat Dresden; University of Iowa; Universite de Montreal; Universite de Montreal; McGill University; University of Queensland; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Schulze, TG (corresponding author), NIMH, Human Genet Branch, Div Intramural Res Programs, NIH, Bethesda, MD 20892 USA.	thomas.schulze@med.uni-goettingen.de; malda@dal.ca	Jamain, Stéphane/P-3710-2017; Kuo, Po-Hsiu/H-9882-2013; Heilbronner, Urs/GXF-9880-2022; Cichon, Sven/B-9618-2014; Hou, Liping/G-1648-2011; Manchia, Mirko/A-2907-2010; Reich-Erkelenz, Daniela/D-9736-2018; Stopkova, Pavla/C-6000-2019; Etain, Bruno/L-6647-2017; Cheng, Andrew/O-1159-2018; Banzato, Claudio/B-2517-2008; Schalling, Martin/F-1518-2015; Gruber, Oliver/AAY-5563-2020; Serbanescu, Maria/D-4306-2011; Adli, Mazda/GYV-2083-2022; Hashimoto, Ryota/AAE-3200-2019; Alda, Martin/F-5812-2010; Jaramillo, Carlos López/X-5806-2019; Laje, Gonzalo/L-2654-2014; Wray, Naomi/C-8639-2015; Leboyer, Marion/AAW-3648-2021; Tortorella, Alfonso Antonio Vincenzo/AAC-4694-2022; Jamain, Stéphane/L-1822-2019; Fullerton, Janice/F-8485-2013; Ozaki, Norio/M-8908-2014; Novak, Tomas/B-8008-2017; BELLIVIER, FRANK/H-5197-2012; Turecki, Gustavo/K-5100-2015; Kato, Tadafumi/J-3583-2014; McMahon, Francis J/A-7290-2009; Cichon, Sven/H-8803-2013; Falkai, Peter/E-3273-2017; Hashimoto, Ryota/P-8572-2014; Schofield, Peter/C-9669-2011	Jamain, Stéphane/0000-0002-4321-4100; Cichon, Sven/0000-0002-9475-086X; Hou, Liping/0000-0003-3972-245X; Manchia, Mirko/0000-0003-4175-6413; Reich-Erkelenz, Daniela/0000-0001-7818-539X; Stopkova, Pavla/0000-0003-2712-3652; Etain, Bruno/0000-0002-5377-1488; Cheng, Andrew/0000-0002-2698-0516; Schalling, Martin/0000-0001-5011-2922; Serbanescu, Maria/0000-0002-1304-6687; Hashimoto, Ryota/0000-0002-5941-4238; Alda, Martin/0000-0001-9544-3944; Laje, Gonzalo/0000-0003-2763-3329; Wray, Naomi/0000-0001-7421-3357; Leboyer, Marion/0000-0001-5473-3697; Fullerton, Janice/0000-0003-4014-4490; Ozaki, Norio/0000-0002-7360-4898; Novak, Tomas/0000-0001-9156-9654; Kato, Tadafumi/0000-0001-7856-3952; McMahon, Francis J/0000-0002-9469-305X; Cichon, Sven/0000-0002-9475-086X; Falkai, Peter/0000-0003-2873-8667; Hashimoto, Ryota/0000-0002-5941-4238; Kuo, Po-Hsiu/0000-0003-0365-3587; BELLIVIER, FRANK/0000-0002-3660-6640; Kittel-Schneider, Sarah/0000-0003-3057-6150; Mitchell, Philip/0000-0002-7954-5235; Garnham, Julie/0000-0002-7987-4995; Squassina, Alessio/0000-0001-7415-7607; Lopez-Jaramillo, Carlos/0000-0002-1875-1369; TORTORELLA, Alfonso Antonio Vincenzo/0000-0002-8095-2305; Czerski, Piotr M./0000-0003-0745-5916; Banzato, Claudio/0000-0002-8556-3982; Reininghaus, Eva/0000-0001-5964-4087; DePaulo, J Raymond/0000-0001-9221-9226; Martinsson, Lina/0000-0002-2938-2773; Heilbronner, Urs/0000-0001-7135-762X; Lavebratt, Catharina/0000-0003-4987-2718; Schofield, Peter/0000-0003-2967-9662; Turecki, Gustavo/0000-0003-4075-2736; Bui, Elise/0000-0002-0709-7293; Backlund, Lena/0000-0001-9399-5024; Seemuller, Florian/0000-0002-3557-1343; Adli, Mazda/0000-0002-0993-5617	Canadian Institutes of Health Research [64410]; Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI), Bucharest, Romania [89/2012]; Swiss National Foundation [32003B_125469/1]; National Institute of Mental Health (NIMH) at the National Institutes of Health (NIH), Department of Health and Human Services, United States Government; Deutsche Forschungsgemeinschaft [RI 908/7-1]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002843, U01MH092758] Funding Source: NIH RePORTER; Veterans Affairs [I01CX000363] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI), Bucharest, Romania; Swiss National Foundation(Swiss National Science Foundation (SNSF)); National Institute of Mental Health (NIMH) at the National Institutes of Health (NIH), Department of Health and Human Services, United States Government; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	The work on assessment of lithium response has been supported by a grant from Canadian Institutes of Health Research #64410 to MA. MG-S was supported by Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI), Bucharest, Romania (grant no. 89/2012). JMA and AN were supported by a grant from the Swiss National Foundation (#32003B_125469/1 to JM Aubry). ConLiGen is in part supported by funds from the Intramural Research Program of the National Institute of Mental Health (NIMH) at the National Institutes of Health (NIH), Department of Health and Human Services, United States Government. It is further supported by a grant from the Deutsche Forschungsgemeinschaft to MR, MB, and TGS (RI 908/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alda M, 2005, PROG NEURO-PSYCHOPH, V29, P1038, DOI 10.1016/j.pnpbp.2005.03.021; Alda M, 2001, BIPOLAR DISORD, V3, P318, DOI 10.1034/j.1399-5618.2001.30606.x; Angst J, 2000, BIOL PSYCHIAT, V48, P445, DOI 10.1016/S0006-3223(00)00909-4; Baldessarini RJ, 2000, ARCH GEN PSYCHIAT, V57, P187, DOI 10.1001/archpsyc.57.2.187; Bellivier F, 2003, AM J PSYCHIAT, V160, P999, DOI 10.1176/appi.ajp.160.5.999; BURDOCK EI, 1963, PERS PSYCHOL, V16, P373, DOI 10.1111/j.1744-6570.1963.tb01283.x; Cheniaux E, 2009, PSYCHOPATHOLOGY, V42, P293, DOI 10.1159/000228838; Chillotti C, 2009, RIV PSICHIATR, V44, P28; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; COPPEN A, 1973, PSYCHIAT NEUROL NEUR, V76, P501; Cruceanu C, 2009, GENOME MED, V1, DOI 10.1186/gm79; Daly AK, 2010, NAT REV GENET, V11, P241, DOI 10.1038/nrg2751; de Lara CL, 2010, INT J NEUROPSYCHOPH, V13, P1397, DOI 10.1017/S1461145710000714; Duffy A, 2007, CAN J PSYCHIAT, V52, P369, DOI 10.1177/070674370705200606; Etain B, 2006, MOL PSYCHIATR, V11, P685, DOI 10.1038/sj.mp.4001815; Fountoulakis KN, 2012, EUR ARCH PSY CLIN N, V262, pS1, DOI 10.1007/s00406-012-0323-x; Garnham J, 2007, J AFFECT DISORDERS, V104, P185, DOI 10.1016/j.jad.2007.03.003; Goodwin FK, 2007, MANIC DEPRESSIVE ILL; GROF P, 1993, BRIT J PSYCHIAT, V163, P16, DOI 10.1192/S000712500029243X; Grof P, 2002, J CLIN PSYCHIAT, V63, P942, DOI 10.4088/JCP.v63n1013; Hamshere ML, 2009, J AFFECT DISORDERS, V116, P23, DOI 10.1016/j.jad.2008.10.021; Kleindienst N, 2005, BIPOLAR DISORD, V7, P404, DOI 10.1111/j.1399-5618.2005.00244.x; Komarek A, 2011, MIXTURE METHODS INCL; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lubke G, 2008, MULTIVAR BEHAV RES, V43, P592, DOI 10.1080/00273170802490673; MAJ M, 1984, ACTA PSYCHIAT SCAND, V69, P37, DOI 10.1111/j.1600-0447.1984.tb04514.x; Maj M, 1998, AM J PSYCHIAT, V155, P30, DOI 10.1176/ajp.155.1.30; McCarthy MJ, 2010, PHARMACOGENOMICS, V11, P1439, DOI [10.2217/pgs.10.127, 10.2217/PGS.10.127]; Motsinger-Reif AA, 2010, PHARMACOGENET GENOMI; Muller-Oerlinghausen Bruno, 2005, Arch Suicide Res, V9, P307, DOI 10.1080/13811110590929550; MULLEROERLINGHAUSEN B, 1992, ACTA PSYCHIAT SCAND, V86, P218, DOI 10.1111/j.1600-0447.1992.tb03255.x; PRIEN RF, 1974, ARCH GEN PSYCHIAT, V31, P189; Rybakowski JK, 2001, BIPOLAR DISORD, V3, P63, DOI 10.1034/j.1399-5618.2001.030203.x; Sachs GS, 2003, J CLIN PSYCHIAT, V64, P18; Schulze TG, 2010, NEUROPSYCHOBIOLOGY, V62, P72, DOI 10.1159/000314708; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SOLOMON DA, 1995, J CLIN PSYCHIAT, V56, P5; Squassina A, 2009, MOL PSYCHIATR, V14, P350, DOI 10.1038/mp.2008.93; Squassina A, 2011, PHARMACOGENOMICS, V12, P1559, DOI [10.2217/PGS.11.102, 10.2217/pgs.11.102]; Turecki G, 2001, MOL PSYCHIATR, V6, P570, DOI 10.1038/sj.mp.4000888; WALLACE CS, 1968, COMPUT J, V11, P185, DOI 10.1093/comjnl/11.2.185; Yatham LN, 2005, BIPOLAR DISORD, V7, P5, DOI 10.1111/j.1399-5618.2005.00219.x	44	105	107	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65636	10.1371/journal.pone.0065636	http://dx.doi.org/10.1371/journal.pone.0065636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840348	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200028
J	Yuan, XL; Wei, QY; Komaki, R; Liu, ZS; Yang, J; Tucker, SL; Xu, T; Heymach, JV; Lu, C; Cox, JD; Liao, ZX				Yuan, Xianglin; Wei, Qingyi; Komaki, Ritsuko; Liu, Zhensheng; Yang, Ju; Tucker, Susan L.; Xu, Ting; Heymach, John V.; Lu, Charles; Cox, James D.; Liao, Zhongxing			TGF beta 1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy	PLOS ONE			English	Article							PROPHYLACTIC CRANIAL IRRADIATION; THERAPY ONCOLOGY GROUP; GROWTH-FACTOR-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1 LEVEL; TGF-BETA; RADIATION-THERAPY; BRAIN METASTASES; BREAST-CANCER; RANDOMIZED-TRIAL; CARCINOMA	Purpose: Transforming growth factor (TGF)-beta 1 signaling is involved in cancer-cell metastasis. We investigated whether single nucleotide polymorphisms (SNPs) at TGF beta 1 were associated with overall survival (OS) and distant metastasis-free survival (DMFS) in patients with non-small cell lung cancer (NSCLC) treated with definitive radiotherapy, with or without chemotherapy. Methods: We genotyped TGF beta 1 SNPs at rs1800469 (C-509T), rs1800471 (G915C), and rs1982073 (T+29C) by polymerase chain reaction-restriction fragment length polymorphism in blood samples from 205 NSCLC patients who had had definitive radiotherapy at one institution in November 1998-January 2005. We also tested whether the TGF-beta 1 rs1982073 (T+29C) SNP affected the migration and invasion of A549 and PC9 lung cancer cells. Results: Median follow-up time for all patients was 17 months (range, 1-97 months; 39 months for patients alive at the time of analysis). Multivariate analysis showed that the TGF beta 1 rs1800469 CT/CC genotype was associated with poor OS (hazard ratio [HR] = 1.463 [95% confidence interval {CI} = 1.012-2.114], P = 0.043) and shorter DMFS (HR = 1.601 [95% CI = 1.042-2.459], P=0.032) and that the TGF beta 1 rs1982073 CT/CC genotype predicted poor DMFS (HR = 1.589 [95% CI = 1.009-2.502], P = 0.046) and poor brain MFS (HR = 2.567 [95% CI = 1.155-5.702], P = 0.021) after adjustment for age, sex, race, performance status, smoking status, tumor histology and volume, stage, receipt of concurrent radiochemotherapy, number of chemotherapy cycles, and radiation dose. Transfection with TGF beta 1+29C (vs. +29T) stimulated the migration and invasion of A549 and PC9 cells, suggesting that TGF beta 1+29C may be linked with increased metastatic potential. Conclusions: TGF beta 1 genotypes at rs1800469 and rs1982073 could be useful for predicting DMFS among patients with NSCLC treated with definitive radiation therapy. These findings require validation in larger prospective trials and thorough mechanistic studies.	[Yuan, Xianglin; Yang, Ju] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan 430074, Peoples R China; [Wei, Qingyi; Liu, Zhensheng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Komaki, Ritsuko; Xu, Ting; Cox, James D.; Liao, Zhongxing] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Tucker, Susan L.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Heymach, John V.; Lu, Charles] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA	Huazhong University of Science & Technology; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Liao, ZX (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA.	zliao@mdanderson.org	Heymach, John/AAG-2361-2019	Heymach, John/0000-0001-9068-8942	Cancer Center Support (Core) Grant [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Cancer Center Support (Core) Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by Cancer Center Support (Core) Grant CA016672 to MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ampil F, 2007, LUNG CANCER, V57, P60, DOI 10.1016/j.lungcan.2007.02.006; Andre F, 2001, CANCER, V91, P2394, DOI 10.1002/1097-0142(20010615)91:12<2394::AID-CNCR1273>3.0.CO;2-6; Andreassen CN, 2005, RADIOTHER ONCOL, V75, P18, DOI 10.1016/j.radonc.2004.12.012; Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Awad MR, 1998, TRANSPLANTATION, V66, P1014, DOI 10.1097/00007890-199810270-00009; Byhardt RW, 1998, INT J RADIAT ONCOL, V42, P469, DOI 10.1016/S0360-3016(98)00251-X; Chen AM, 2007, CANCER-AM CANCER SOC, V109, P1668, DOI 10.1002/cncr.22565; Chorna I, 2005, EXP ONCOL, V27, P156; De Ruyck K, 2006, INT J RADIAT ONCOL, V65, P1240, DOI 10.1016/j.ijrobp.2006.03.047; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dornagafa-Kulawik J, 2006, ARCH IMMUNOL THER EX, V54, P143, DOI 10.1007/s00005-006-0016-0; Dunning AM, 2003, CANCER RES, V63, P2610; Ewart-Toland A, 2004, CANCER EPIDEM BIOMAR, V13, P759; Fang Shu-Mei, 2005, Ai Zheng, V24, P305; Finger EC, 2008, CARCINOGENESIS, V29, P528, DOI 10.1093/carcin/bgm289; Fong YC, 2009, LUNG CANCER, V64, P13, DOI 10.1016/j.lungcan.2008.07.010; Gaspar L, 1997, INT J RADIAT ONCOL, V37, P745, DOI 10.1016/S0360-3016(96)00619-0; Gore EM, 2011, J CLIN ONCOL, V29, P272, DOI 10.1200/JCO.2010.29.1609; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Hasegawa Y, 2001, CANCER-AM CANCER SOC, V91, P964, DOI 10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O; Hu ZB, 2005, CLIN CANCER RES, V11, P5433, DOI 10.1158/1078-0432.CCR-05-0311; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jeon HS, 2008, CANCER RES, V68, P9686, DOI 10.1158/0008-5472.CAN-08-1083; Kang Y, 2000, EXP LUNG RES, V26, P685, DOI 10.1080/01902140150216765; Kato Y, 2002, NATURE, V418, P641, DOI 10.1038/nature00969; Kong FM, 1999, CANCER-AM CANCER SOC, V86, P1712, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1712::AID-CNCR12>3.0.CO;2-V; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Mu L, 2008, BRIT J CANCER, V99, P1357, DOI 10.1038/sj.bjc.6604689; Nguyen TD, 2007, NEUROL CLIN, V25, P1173, DOI 10.1016/j.ncl.2007.07.011; Novakova-Jiresova A, 2004, RADIOTHER ONCOL, V71, P183, DOI 10.1016/j.radonc.2004.01.019; Penel N, 2001, LUNG CANCER, V33, P143, DOI 10.1016/S0169-5002(01)00202-1; PEREZ CA, 1987, CANCER, V59, P1874, DOI 10.1002/1097-0142(19870601)59:11<1874::AID-CNCR2820591106>3.0.CO;2-Z; Pottgen C, 2007, J CLIN ONCOL, V25, P4987, DOI 10.1200/JCO.2007.12.5468; Roberts AB, 1999, MICROBES INFECT, V1, P1265, DOI 10.1016/S1286-4579(99)00258-0; Saji Hisashi, 2003, Ann Thorac Cardiovasc Surg, V9, P295; Saunier EF, 2006, CURR CANCER DRUG TAR, V6, P565, DOI 10.2174/156800906778742460; Shu XO, 2004, CANCER RES, V64, P836, DOI 10.1158/0008-5472.CAN-03-3492; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Slattery ML, 2011, CANCER EPIDEM BIOMAR, V20, P57, DOI 10.1158/1055-9965.EPI-10-0843; Suardet L, 1996, INT J CANCER, V68, P126, DOI 10.1002/(SICI)1097-0215(19960927)68:1<126::AID-IJC22>3.0.CO;2-8; Tiwari N, 2012, SEMIN CANCER BIOL, V22, P194, DOI 10.1016/j.semcancer.2012.02.013; Tsuchida K, 2006, MINI-REV MED CHEM, V6, P1255, DOI 10.2174/138955706778742759; Vicent S, 2008, CANCER RES, V68, P2275, DOI 10.1158/0008-5472.CAN-07-6493; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Yavuz AA, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-80; Yoon SM, 2005, INT J RADIAT ONCOL, V63, P885, DOI 10.1016/j.ijrobp.2005.07.951; Yuan XL, 2009, J CLIN ONCOL, V27, P3370, DOI 10.1200/JCO.2008.20.6763; Zhao L, 2008, LUNG CANCER, V59, P232, DOI 10.1016/j.lungcan.2007.08.010	49	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65659	10.1371/journal.pone.0065659	http://dx.doi.org/10.1371/journal.pone.0065659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840350	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200029
J	Britch, SC; Binepal, YS; Ruder, MG; Kariithi, HM; Linthicum, KJ; Anyamba, A; Small, JL; Tucker, CJ; Ateya, LO; Oriko, AA; Gacheru, S; Wilson, WC				Britch, Seth C.; Binepal, Yatinder S.; Ruder, Mark G.; Kariithi, Henry M.; Linthicum, Kenneth J.; Anyamba, Assaf; Small, Jennifer L.; Tucker, Compton J.; Ateya, Leonard O.; Oriko, Abuu A.; Gacheru, Stephen; Wilson, William C.			Rift Valley Fever Risk Map Model and Seroprevalence in Selected Wild Ungulates and Camels from Kenya	PLOS ONE			English	Article							SAUDI-ARABIA; VERTICAL TRANSMISSION; VIRUS; OUTBREAK; ANTIBODY; PREVALENCE; PREDICTION; LIVESTOCK; EPIDEMIC; PATHWAYS	Since the first isolation of Rift Valley fever virus (RVFV) in the 1930s, there have been multiple epizootics and epidemics in animals and humans in sub-Saharan Africa. Prospective climate-based models have recently been developed that flag areas at risk of RVFV transmission in endemic regions based on key environmental indicators that precede Rift Valley fever (RVF) epizootics and epidemics. Although the timing and locations of human case data from the 2006-2007 RVF outbreak in Kenya have been compared to risk zones flagged by the model, seroprevalence of RVF antibodies in wildlife has not yet been analyzed in light of temporal and spatial predictions of RVF activity. Primarily wild ungulate serum samples from periods before, during, and after the 2006-2007 RVF epizootic were analyzed for the presence of RVFV IgM and/or IgG antibody. Results show an increase in RVF seropositivity from samples collected in 2007 (31.8%), compared to antibody prevalence observed from 2000-2006 (3.3%). After the epizootic, average RVF seropositivity diminished to 5% in samples collected from 2008-2009. Overlaying maps of modeled RVF risk assessments with sampling locations indicated positive RVF serology in several species of wild ungulate in or near areas flagged as being at risk for RVF. Our results establish the need to continue and expand sero-surveillance of wildlife species Kenya and elsewhere in the Horn of Africa to further calibrate and improve the RVF risk model, and better understand the dynamics of RVFV transmission.	[Britch, Seth C.; Linthicum, Kenneth J.] ARS, Ctr Med Agr & Vet Entomol, USDA, Gainesville, FL USA; [Binepal, Yatinder S.; Kariithi, Henry M.; Ateya, Leonard O.; Oriko, Abuu A.] Kenya Agr Res Inst, Ctr Biotechnol, Nairobi, Kenya; [Ruder, Mark G.; Wilson, William C.] ARS, Arthropod Borne Anim Dis Res Unit, Ctr Grain & Anim Hlth Res, USDA, Manhattan, KS USA; [Anyamba, Assaf; Small, Jennifer L.; Tucker, Compton J.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Gacheru, Stephen] Vet Serv, Kabete, Kenya	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Wilson, WC (corresponding author), ARS, Arthropod Borne Anim Dis Res Unit, Ctr Grain & Anim Hlth Res, USDA, Manhattan, KS USA.	william.wilson@ars.usda.gov	Wilson, William/Y-8857-2019	Wilson, William/0000-0002-7877-9224; Kariithi, Henry/0000-0002-9250-9108; Anyamba, Assaf/0000-0003-0932-9585	International Atomic Energy Agency (IAEA); US Department of Agriculture, Agricultural Research Service Project [58-5430-005-00D]; Science and Technology Directorate of the U.S. Department of Homeland Security [HSHQDC-07-00982]; Department of Defense-Armed Forces Health Surveillance Center; United States Department of Agriculture -Agricultural Research Service, Division of GEIS Operations	International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); US Department of Agriculture, Agricultural Research Service Project; Science and Technology Directorate of the U.S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Department of Defense-Armed Forces Health Surveillance Center; United States Department of Agriculture -Agricultural Research Service, Division of GEIS Operations	We are indebted to the International Atomic Energy Agency (IAEA) for the initial funding of this study. This project was also support in part by the US Department of Agriculture, Agricultural Research Service Project #58-5430-005-00D through an interagency agreement with the Science and Technology Directorate of the U.S. Department of Homeland Security under Award Number HSHQDC-07-00982. The Department of Defense-Armed Forces Health Surveillance Center, Division of GEIS Operations and the United States Department of Agriculture -Agricultural Research Service supported the RVF Monitoring and Risk Mapping project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AA, 2010, INT J INFECT DIS, V14, pE179, DOI 10.1016/j.ijid.2009.03.029; Adam I, 2008, J MED VIROL, V80, P929, DOI 10.1002/jmv.21132; Al-Afaleq AI, 2012, TROP ANIM HEALTH PRO, V44, P1535, DOI 10.1007/s11250-012-0100-x; Al-Afaleq AI, 2011, VECTOR-BORNE ZOONOT, V11, P1513, DOI 10.1089/vbz.2010.0245; Al-Hazmi M, 2003, CLIN INFECT DIS, V36, P245, DOI 10.1086/345671; Anderson EC, 1998, EPIDEMIOL INFECT, V121, P441, DOI 10.1017/S0950268898001289; [Anonymous], 1998, MMWR MORBIDITY MORTA, V47, P261; Anyamba A, 2002, PHOTOGRAMM ENG REM S, V68, P137; Anyamba Assaf, 2006, Int J Health Geogr, V5, P60, DOI 10.1186/1476-072X-5-60; Anyamba A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001465; Anyamba A, 2010, AM J TROP MED HYG, V83, P43, DOI 10.4269/ajtmh.2010.09-0289; Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106; Arishi HM, 2006, ANN TROP PAEDIATR, V26, P251, DOI 10.1179/146532806X120363; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Breiman RF, 2010, AM J TROP MED HYG, V83, P1, DOI 10.4269/ajtmh.2010.83s2a01; Clements ACA, 2007, PREV VET MED, V82, P72, DOI 10.1016/j.prevetmed.2007.05.006; COLLETT MS, 1986, VIROLOGY, V151, P151, DOI 10.1016/0042-6822(86)90114-5; Davies FG, 2010, AM J TROP MED HYG, V83, P73, DOI 10.4269/ajtmh.2010.83s2a02; DAVIES FG, 1985, B WORLD HEALTH ORGAN, V63, P941; DAVIES FG, 1980, T ROY SOC TROP MED H, V74, P815, DOI 10.1016/0035-9203(80)90213-8; El Mamy ABO, 2011, EMERG INFECT DIS, V17, P1894, DOI 10.3201/eid1710.110397; El-Gebaly M R, 1978, J Egypt Public Health Assoc, V53, P137; ELLIS DS, 1979, J GEN VIROL, V42, P329, DOI 10.1099/0022-1317-42-2-329; ELLIS DS, 1988, J MED VIROL, V24, P161, DOI 10.1002/jmv.1890240205; Evans A, 2008, EPIDEMIOL INFECT, V136, P1261, DOI 10.1017/S0950268807009806; GIORGI C, 1991, VIROLOGY, V180, P738, DOI 10.1016/0042-6822(91)90087-R; Kariithi HM, 2010, KENYA VET, V34, P13; Kasari TR, 2008, JAVMA-J AM VET MED A, V232, P514, DOI 10.2460/javma.232.4.514; LaBeaud AD, 2011, AM J TROP MED HYG, V84, P641, DOI 10.4269/ajtmh.2011.10-0187; LaBeaud AD, 2010, CURR OPIN INFECT DIS, V23, P403, DOI 10.1097/QCO.0b013e32833c3da6; Linthicum Kenneth J, 2007, Vet Ital, V43, P663; LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434; LINTHICUM KJ, 1987, SCIENCE, V235, P1656, DOI 10.1126/science.3823909; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Madani TA, 2003, CLIN INFECT DIS, V37, P1084, DOI 10.1086/378747; MALO AR, 1990, J ARID ENVIRON, V19, P1; Mohamed M, 2010, AM J TROP MED HYG, V83, P22, DOI 10.4269/ajtmh.2010.09-0318; MULLER R, 1994, J GEN VIROL, V75, P1345, DOI 10.1099/0022-1317-75-6-1345; Munyua P, 2010, AM J TROP MED HYG, V83, P58, DOI 10.4269/ajtmh.2010.09-0292; Murithi RM, 2011, EPIDEMIOL INFECT, V139, P372, DOI 10.1017/S0950268810001020; Nguku PM, 2010, AM J TROP MED HYG, V83, P5, DOI 10.4269/ajtmh.2010.09-0288; Olive MM, 2012, J WILDLIFE DIS, V48, P241, DOI 10.7589/0090-3558-48.2.241; OMER AHS, 1981, J TROP MED HYG, V84, P63; Paweska JT, 2008, VET MICROBIOL, V127, P21, DOI 10.1016/j.vetmic.2007.07.031; Paweska JT, 2005, J VIROL METHODS, V127, P10, DOI 10.1016/j.jviromet.2005.02.008; Peters C. J., 1994, HDB ZOONOSES B, P125; PRINCE SD, 1991, INT J REMOTE SENS, V12, P1301, DOI 10.1080/01431169108929727; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; Shoemaker T, 2002, EMERG INFECT DIS, V8, P1415, DOI 10.3201/eid0812.020195; TUCKER CJ, 1979, REMOTE SENS ENVIRON, V8, P127, DOI 10.1016/0034-4257(79)90013-0; TUCKER CJ, 1991, SCIENCE, V253, P299, DOI 10.1126/science.253.5017.299; Turell MJ, 2010, J MED ENTOMOL, V47, P884, DOI 10.1603/ME10007	52	51	55	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e66626	10.1371/journal.pone.0066626	http://dx.doi.org/10.1371/journal.pone.0066626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840512	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400018
J	Norman, WV; Soon, JA; Maughn, N; Dressler, J				Norman, Wendy V.; Soon, Judith A.; Maughn, Nanamma; Dressler, Jennifer			Barriers to Rural Induced Abortion Services in Canada: Findings of the British Columbia Abortion Providers Survey (BCAPS)	PLOS ONE			English	Article							FEDERATION MEMBERS; TRENDS; MANAGEMENT; CLINICS; ONTARIO; ACCESS	Background: Rural induced abortion service has declined in Canada. Factors influencing abortion provision by rural physicians are unknown. This study assessed distribution, practice, and experiences among rural compared to urban abortion providers in the Canadian province of British Columbia (BC). Methods: We used mixed methods to assess physicians on the BC registry of abortion providers. In 2011 we distributed a previously-published questionnaire and conducted semi-structured interviews. Results: Surveys were returned by 39/46 (85%) of BC abortion providers. Half were family physicians, within both rural and urban cohorts. One-quarter (17/67) of rural hospitals offer abortion service. Medical abortions comprised 14.7% of total reported abortions. The three largest urban areas reported 90% of all abortions, although only 57% of reproductive age women reside in the associated health authority regions. Each rural physician provided on average 76 (SD 52) abortions annually, including 35 (SD 30) medical abortions. Rural physicians provided surgical abortions in operating rooms, often using general anaesthesia, while urban physicians provided the same services primarily in ambulatory settings using local anaesthesia. Rural providers reported health system barriers, particularly relating to operating room logistics. Urban providers reported occasional anonymous harassment and violence. Conclusions: Medical abortions represented 15% of all BC abortions, a larger proportion than previously reported (under 4%) for Canada. Rural physicians describe addressable barriers to service provision that may explain the declining accessibility of rural abortion services. Moving rural surgical abortions out of operating rooms and into local ambulatory care settings has the potential to improve care and costs, while reducing logistical challenges facing rural physicians.	[Norman, Wendy V.; Soon, Judith A.] Univ British Columbia, Fac Med, Dept Family Practice, Vancouver, BC, Canada; [Norman, Wendy V.; Soon, Judith A.; Maughn, Nanamma; Dressler, Jennifer] British Columbia Womens Hosp, Womens Hlth Res Inst, Prov Hlth Serv Author, Vancouver, BC, Canada; [Soon, Judith A.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Norman, WV (corresponding author), Univ British Columbia, Fac Med, Dept Family Practice, Vancouver, BC, Canada.	wendy.norman@ubc.ca	Norman, Wendy V./D-6796-2015	Norman, Wendy V./0000-0003-4340-7882; Soon, Judith/0000-0002-5274-3223	Women's Health Research Institute of British Columbia Women's Hospital; Canadian Institutes of Health Research	Women's Health Research Institute of British Columbia Women's Hospital; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by the Women's Health Research Institute of British Columbia Women's Hospital. During this study Dr. Norman was supported by the Canadian Institutes of Health Research as a Fellow in interdisciplinary primary healthcare research (TUTOR-PHC), and during manuscript preparation as a Scholar of the Micheal Smith Foundation for Health Research. None of these funders had a role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, SUPPLY DISTRIBUTION; BC Stats, 2010, POP EST STAND AG GRO; British Columbia, 2010, POP EST 1986 2010 PR; British Columbia, 2012, POP PROJ 2011 2036 S; Canadian Institutes for Health Information, 2013, IND AB PERF CAN 2011; Canadian Institutes for Health Information, 2012, IND AB PERF CAN 2010; Canadian Institutes for Health Information, 2011, IND AB PERF CAN 2009; Canadian Institutes for Health Information, 2009, IND AB PERF CAN 2007; Davis VJ, 2006, J OBSTET GYNAECOL CA, V28, P1014, DOI 10.1016/S1701-2163(16)32296-4; Dunn S, 2011, PROJECT ONTARIO WOME, V2; FERRIS LE, 1995, CAN MED ASSOC J, V152, P1801; Fraser Health, 2011, NEED INV POP INFR SE; Government of BC, 2012, MAPS PROV HLTH AUTH; Government of BC, 2010, HOSP BC; Grundlingh W, 2011, 2010 SUBPROVINCIAL P; Kaposy C, 2010, HEALTH CARE ANAL, V18, P17, DOI 10.1007/s10728-008-0101-0; Lichtenberg ES, 2001, CONTRACEPTION, V64, P345, DOI 10.1016/S0010-7824(01)00279-7; Limacher JJ, 2006, J OBSTET GYNAECOL CA, V28, P142, DOI 10.1016/S1701-2163(16)32065-5; Norman WV, 2011, CONTRACEPTION, V84, P316, DOI 10.1016/j.contraception.2011.05.054; Norman WV, 2012, CONTRACEPTION, V85, P185, DOI 10.1016/j.contraception.2011.06.009; O'Connell K, 2009, CONTRACEPTION, V79, P385, DOI 10.1016/j.contraception.2008.11.005; O'Connell K, 2008, CONTRACEPTION, V78, P492, DOI 10.1016/j.contraception.2008.07.011; Ostbye T, 2001, AM J MED QUAL, V16, P99, DOI 10.1177/106286060101600305; Petrou S, 2006, BJOG-INT J OBSTET GY, V113, P879, DOI 10.1111/j.1471-0528.2006.00998.x; Pregnancy Options Service, 2010, PREGN OPT TEL SERV; Provincial Health Services Authority, 2012, DESCR MAND; R Core Team, 2012, R LANG ENV STAT COMP; Rausch M, 2012, FERTIL STERIL, V97, P355, DOI 10.1016/j.fertnstert.2011.11.044; Royal College of Obstetricians and Gynaecologists, 2011, CAR WOM REQ IND AB; Sabourin JN, 2012, J OBSTET GYNAECOL CA, V34, P532, DOI 10.1016/S1701-2163(16)35269-0; Sedgh G, 2012, LANCET, V379, P625, DOI 10.1016/S0140-6736(11)61786-8; Sethna C, 2013, WOMEN STUD INT FORUM, V38, P52, DOI 10.1016/j.wsif.2013.02.001; Shaw Jessica, 2006, REALITY CHECK CLOSE; Statistics Canada, 2008, CENS METR AR RES PRO; Statistics Canada, 2015, CENS METR AR CMA CEN; Statistics Canada, 2008, IND AB HOSP CLIN AG; Vekemans M, 2008, 1 TRIMESTER ABORTION; World Health Organization Department of Reproductive Health and Research, 2012, SAF AB TECHN POL GUI, P37	38	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67023	10.1371/journal.pone.0067023	http://dx.doi.org/10.1371/journal.pone.0067023			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840578	Green Submitted, Green Published, gold			2022-12-27	WOS:000321148400030
J	Gaser, C; Franke, K; Kloppel, S; Koutsouleris, N; Sauer, H				Gaser, Christian; Franke, Katja; Kloeppel, Stefan; Koutsouleris, Nikolaos; Sauer, Heinrich		Alzheimer's Dis Neuroimaging Initi	BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease	PLOS ONE			English	Article							AGE-RELATED-CHANGES; CEREBROSPINAL-FLUID; CSF BIOMARKERS; BASE-LINE; INDIVIDUAL BRAINAGE; MCI PATIENTS; MRI; ATROPHY; DECLINE; PATTERN	Alzheimer's disease (AD), the most common form of dementia, shares many aspects of abnormal brain aging. We present a novel magnetic resonance imaging (MRI)-based biomarker that predicts the individual progression of mild cognitive impairment (MCI) to AD on the basis of pathological brain aging patterns. By employing kernel regression methods, the expression of normal brain-aging patterns forms the basis to estimate the brain age of a given new subject. If the estimated age is higher than the chronological age, a positive brain age gap estimation (BrainAGE) score indicates accelerated atrophy and is considered a risk factor for conversion to AD. Here, the BrainAGE framework was applied to predict the individual brain ages of 195 subjects with MCI at baseline, of which a total of 133 developed AD during 36 months of follow-up (corresponding to a pre-test probability of 68%). The ability of the BrainAGE framework to correctly identify MCI-converters was compared with the performance of commonly used cognitive scales, hippocampus volume, and state-of-the-art biomarkers derived from cerebrospinal fluid (CSF). With accuracy rates of up to 81%, BrainAGE outperformed all cognitive scales and CSF biomarkers in predicting conversion of MCI to AD within 3 years of follow-up. Each additional year in the BrainAGE score was associated with a 10% greater risk of developing AD (hazard rate: 1.10 [CI: 1.07-1.13]). Furthermore, the post-test probability was increased to 90% when using baseline BrainAGE scores to predict conversion to AD. The presented framework allows an accurate prediction even with multicenter data. Its fast and fully automated nature facilitates the integration into the clinical workflow. It can be exploited as a tool for screening as well as for monitoring treatment options.	[Gaser, Christian; Franke, Katja; Sauer, Heinrich] Jena Univ Hosp, Dept Psychiat, Struct Brain Mapping Grp, Jena, Germany; [Gaser, Christian] Jena Univ Hosp, Dept Neurol, Jena, Germany; [Kloeppel, Stefan] Univ Med Ctr Freiburg, Dept Psychiat & Psychotherapy, Dept Neurol, Freiburg, Germany; [Koutsouleris, Nikolaos] Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Freiburg; University of Munich	Franke, K (corresponding author), Jena Univ Hosp, Dept Psychiat, Struct Brain Mapping Grp, Jena, Germany.	katja.franke@uni-jena.de	Gaser, Christian/F-5103-2010; Koutsouleris, Nikolaos/AAJ-7428-2020; Franke, Katja/S-7577-2017	Gaser, Christian/0000-0002-9940-099X; Franke, Katja/0000-0003-1859-5738; Kloppel, Stefan/0000-0001-6452-9964	BMBF grant [01EV0709]; ADNI (National Institutes of Health (NIH) grant [U01AG024904]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; NIH [P30 AG010129, K01 AG030514]; Dana Foundation; NATIONAL INSTITUTE ON AGING [K01AG030514, U01AG024904, P30AG010129] Funding Source: NIH RePORTER	BMBF grant(Federal Ministry of Education & Research (BMBF)); ADNI (National Institutes of Health (NIH) grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by BMBF grant 01EV0709. Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.ucla.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.ucla.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf. Data collection and sharing was funded by ADNI (National Institutes of Health (NIH) grant U01AG024904). ADNI itself is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the United States Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BENNETT KP, 2003, SIGKDD EXPLORATIONS, V2, P1; Bishop C. M, 2006, PATTERN RECOGNITION; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Cao KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013098; Chen JH, 2009, J FORMOS MED ASSOC, V108, P754, DOI 10.1016/S0929-6646(09)60402-2; Clark CM, 2003, ARCH NEUROL-CHICAGO, V60, P1696, DOI 10.1001/archneur.60.12.1696; Clark VH, 2012, NEUROBIOL AGING, V33, P2733, DOI 10.1016/j.neurobiolaging.2012.01.010; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Costafreda SG, 2011, NEUROIMAGE, V56, P212, DOI 10.1016/j.neuroimage.2011.01.050; Cuadra MB, 2005, IEEE T MED IMAGING, V24, P1548, DOI 10.1109/TMI.2005.857652; Davatzikos C, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.05.023; Deary IJ, 2002, NATURE, V418, P932, DOI 10.1038/418932a; Desikan RS, 2008, NEUROLOGY, V71, P819, DOI 10.1212/01.wnl.0000320055.57329.34; Driscoll I, 2009, NEUROLOGY, V72, P1906, DOI 10.1212/WNL.0b013e3181a82634; Duchesne S, 2009, NEUROIMAGE, V47, P1363, DOI 10.1016/j.neuroimage.2009.04.023; Dukart J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022193; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Faul AC, 2002, ADV NEUR IN, V14, P383; Filippini N, 2009, NEUROIMAGE, V44, P724, DOI 10.1016/j.neuroimage.2008.10.003; Fotenos AF, 2008, ARCH NEUROL-CHICAGO, V65, P113, DOI 10.1001/archneurol.2007.27; Franke K, 2012, GEROPSYCH, V25, P235, DOI 10.1024/1662-9647/a000074; Franke K, 2012, NEUROIMAGE, V63, P1305, DOI 10.1016/j.neuroimage.2012.08.001; Franke K, 2010, NEUROIMAGE, V50, P883, DOI 10.1016/j.neuroimage.2010.01.005; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Gaser C., 2009, NEUROIMAGE, V1, pS121, DOI [10.1016/S1053-8119(09)71151-6, DOI 10.1016/S1053-8119(09)71151-6]; Ghosh S, 2008, ADV WATER RESOUR, V31, P132, DOI 10.1016/j.advwatres.2007.07.005; Hesse C, 2001, NEUROSCI LETT, V297, P187, DOI 10.1016/S0304-3940(00)01697-9; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Josephs KA, 2008, ANN NEUROL, V63, P204, DOI 10.1002/ana.21223; Kloppel S, 2011, NEUROIMAGE, V57, P416, DOI 10.1016/j.neuroimage.2011.04.053; Mangialasche F, 2013, J INTERNAL MED; Misra C, 2009, NEUROIMAGE, V44, P1415, DOI 10.1016/j.neuroimage.2008.10.031; Nelson PT, 2011, ACTA NEUROPATHOL, V121, P571, DOI 10.1007/s00401-011-0826-y; Ohnishi T, 2001, AM J NEURORADIOL, V22, P1680; Peskind ER, 2006, ARCH NEUROL-CHICAGO, V63, P936, DOI 10.1001/archneur.63.7.936; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Querbes O, 2009, BRAIN, V132, P2036, DOI 10.1093/brain/awp105; Rajapakse JC, 1997, IEEE T MED IMAGING, V16, P176, DOI 10.1109/42.563663; Risacher SL, 2010, NEUROBIOL AGING, V31, P1401, DOI 10.1016/j.neurobiolaging.2010.04.029; Risacher SL, 2009, CURR ALZHEIMER RES, V6, P347, DOI 10.2174/156720509788929273; Saetre P, 2011, SYNAPSE, V65, P971, DOI 10.1002/syn.20933; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Schoonenboom NSM, 2012, NEUROLOGY, V78, P47, DOI 10.1212/WNL.0b013e31823ed0f0; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Snowdon DA, 2003, ANN INTERN MED, V139, P450, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00014; Spulber G, 2010, NEUROBIOL AGING, V31, P1601, DOI 10.1016/j.neurobiolaging.2008.08.018; Stonnington CM, 2010, NEUROIMAGE, V51, P1405, DOI 10.1016/j.neuroimage.2010.03.051; Strozyk D, 2003, NEUROLOGY, V60, P652, DOI 10.1212/01.WNL.0000046581.81650.D0; Teipel SJ, 2007, NEUROIMAGE, V38, P13, DOI 10.1016/j.neuroimage.2007.07.008; Tipping ME, 2000, ADV NEUR IN, V12, P652; Tipping ME, 2001, J MACH LEARN RES, V1, P211, DOI 10.1162/15324430152748236; Tipping Michael E., 2003, FAST MARGINAL LIKELI; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Vemuri P, 2009, NEUROLOGY, V73, P287, DOI 10.1212/WNL.0b013e3181af79e5; Vemuri P, 2009, NEUROLOGY, V73, P294, DOI 10.1212/WNL.0b013e3181af79fb; Walhovd KB, 2010, AM J NEURORADIOL, V31, P347, DOI 10.3174/ajnr.A1809; Wang Y, 2010, NEUROIMAGE, V50, P1519, DOI 10.1016/j.neuroimage.2009.12.092; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; Westman E, 2011, NEUROIMAGE, V54, P1178, DOI 10.1016/j.neuroimage.2010.08.044; Wilson RS, 2011, ARCH NEUROL-CHICAGO, V68, P351, DOI 10.1001/archneurol.2011.31; Wishart HA, 2006, AM J PSYCHIAT, V163, P1603, DOI 10.1176/appi.ajp.163.9.1603; Wolz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025446; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008; Zheng Y. T., 2008, P 2008 INT C CONT BA, P161	73	245	248	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67346	10.1371/journal.pone.0067346	http://dx.doi.org/10.1371/journal.pone.0067346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826273	gold, Green Published, Green Submitted			2022-12-27	WOS:000321150000064
J	Mahboubi, H; Seganathy, E; Kong, D; Stochaj, U				Mahboubi, Hicham; Seganathy, Evangeline; Kong, Dekun; Stochaj, Ursula			Identification of Novel Stress Granule Components That Are Involved in Nuclear Transport	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; IMPORTIN ALPHA FAMILY; RNA-BINDING PROTEIN; 3 DISTINCT CLASSES; LOCALIZATION SIGNAL; PROCESSING BODIES; MESSENGER-RNA; IN-VITRO; EXPRESSION; PHOSPHORYLATION	Background: Importin-alpha 1 belongs to a subfamily of nuclear transport adaptors and participates in diverse cellular functions. Best understood for its role in protein transport, importin-alpha 1 also contributes to other biological processes. For instance, arsenite treatment causes importin-alpha 1 to associate with cytoplasmic stress granules (SGs) in mammalian cells. These stress-induced compartments contain translationally arrested mRNAs, small ribosomal subunits and numerous proteins involved in mRNA transport and metabolism. At present, it is not known whether members of all three importin-alpha subfamilies locate to SGs in response to stress. Results: Here, we demonstrate that the oxidant diethyl maleate (DEM), arsenite and heat shock, promote the formation of cytoplasmic SGs that contain nuclear transport factors. Specifically, importin-alpha 1, alpha 4 and alpha 5, which belong to distinct subfamilies, and importin-beta 1 were targeted by all of these stressors to cytoplasmic SGs, but not to P-bodies. Importin-alpha family members have been implicated in transcriptional regulation, which prompted us to analyze their ability to interact with poly(A)-RNA in growing cells. Our studies show that importin-alpha 1, but not alpha 4, alpha 5, importin-beta 1 or CAS, associated with poly(A)-RNA under nonstress conditions. Notably, this interaction was significantly reduced when cells were treated with DEM. Additional studies suggest that importin-alpha 1 is likely connected to poly(A)-RNA through an indirect interaction, as the adaptor did not bind homopolymer RNA specifically in vitro. Significance: Our studies establish that members of three importin-alpha subfamilies are bona fide SG components under different stress conditions. Furthermore, importin-alpha 1 is unique in its ability to interact with poly(A)-RNA in a stress-dependent fashion, and in vitro experiments indicate that this association is indirect. Collectively, our data emphasize that nuclear transport factors participate in a growing number of cellular activities that are modulated by stress.	[Mahboubi, Hicham; Seganathy, Evangeline; Kong, Dekun; Stochaj, Ursula] McGill Univ, Dept Physiol, Montreal, PQ, Canada	McGill University	Stochaj, U (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	ursula.stochaj@mcgill.ca	Mahboubi, Hicham/E-4294-2015; stochaj, ursula/AAC-1865-2021	Mahboubi, Hicham/0000-0001-7643-0769; 	NSERC (Natural Sciences and Engineering Research Council of Canada); FQRNT (Fonds de recherche Nature et technologies Quebec); HSFC (Heart and Stroke Foundation of Canada)	NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); FQRNT (Fonds de recherche Nature et technologies Quebec); HSFC (Heart and Stroke Foundation of Canada)	This research was supported by grants and fellowships from NSERC (Natural Sciences and Engineering Research Council of Canada; www.nserc-crsng.gc.ca), FQRNT (Fonds de recherche Nature et technologies Quebec; www.fqrnt.gouv.qc.ca) and HSFC (Heart and Stroke Foundation of Canada; www.hsf.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam SA, 2009, SEMIN CELL DEV BIOL, V20, P576, DOI 10.1016/j.semcdb.2009.03.013; Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346; BOYLAND E, 1967, BIOCHEM J, V104, P95, DOI 10.1042/bj1040095; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Brown V, 1998, J BIOL CHEM, V273, P15521, DOI 10.1074/jbc.273.25.15521; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chang WL, 2009, NUCLEIC ACIDS RES, V37, P6600, DOI 10.1093/nar/gkp717; Davidovic L, 2006, HUM MOL GENET, V15, P1525, DOI 10.1093/hmg/ddl074; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fujimura K, 2010, BBA-MOL CELL RES, V1803, P865, DOI 10.1016/j.bbamcr.2010.03.020; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Hachet V, 2004, EMBO J, V23, P1526, DOI 10.1038/sj.emboj.7600154; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/S1097-2765(04)00647-1; Holt JE, 2007, CURR GENOMICS, V8, P323, DOI 10.2174/138920207782446151; Itman C, 2009, SEMIN CELL DEV BIOL, V20, P607, DOI 10.1016/j.semcdb.2009.05.002; Kamei Y, 1999, J HISTOCHEM CYTOCHEM, V47, P363, DOI 10.1177/002215549904700310; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kitamura R, 2006, J VIROL, V80, P1979, DOI 10.1128/JVI.80.4.1979-1991.2006; Kodicha M, 2012, J SIGNAL TRANSDUCT, V2012, P1; Kodiha M, 2008, CELL MOL LIFE SCI, V65, P1756, DOI 10.1007/s00018-008-7588-2; Kodiha M, 2008, BBA-MOL CELL RES, V1783, P405, DOI 10.1016/j.bbamcr.2007.10.022; Kodiha M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.137pl2; Kodiha M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008420; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kohler M, 1997, FEBS LETT, V417, P104, DOI 10.1016/S0014-5793(97)01265-9; Levin A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-112; Major AT, 2011, BBA-MOL CELL RES, V1813, P1668, DOI 10.1016/j.bbamcr.2011.03.008; Mason DA, 2009, SEMIN CELL DEV BIOL, V20, P582, DOI 10.1016/j.semcdb.2009.02.006; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Miyamoto Y, 1997, J BIOL CHEM, V272, P26375, DOI 10.1074/jbc.272.42.26375; Nachury MV, 1998, P NATL ACAD SCI USA, V95, P582, DOI 10.1073/pnas.95.2.582; Noetzel E, 2012, ONCOGENE, V31, P2101, DOI 10.1038/onc.2011.403; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Strom AC, 2001, GENOME BIOL, V2; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Tabb MM, 2000, MOL CELL BIOL, V20, P6062, DOI 10.1128/MCB.20.16.6062-6073.2000; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Wang WG, 2004, J BIOL CHEM, V279, P48376, DOI 10.1074/jbc.M409014200; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Wente SR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000562; Yasuda Y, 2012, EMBO J, V31, P83, DOI 10.1038/emboj.2011.360; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; Yasuharaa N, 2009, SEMIN CELL DEV BIOL, V20, P590, DOI 10.1016/j.semcdb.2009.05.003	59	36	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68356	10.1371/journal.pone.0068356	http://dx.doi.org/10.1371/journal.pone.0068356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826389	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000142
J	Niu, JP; Jiang, L; Guo, WH; Shao, L; Liu, Y; Wang, LQ				Niu, Jingping; Jiang, Le; Guo, Weiheng; Shao, Liang; Liu, Yi; Wang, Liqin			The Association between Leptin Level and Breast Cancer: A Meta-Analysis	PLOS ONE			English	Article							RECEPTOR GENE; SERUM LEPTIN; ADIPONECTIN; RISK; POLYMORPHISMS; OBESITY; EXPRESSION; BIAS	Background: Contradictory results have been reported regarding the association between leptin level and breast cancer. Therefore, a meta-analysis was performed to investigate this issue. Methods: Published literature from PubMed and the Chinese National Knowledge Infrastructure (CNKI) Database was retrieved. This study was performed based on different cases and control groups. The combined effect ((d) over bar) with 95% confidence interval (Cl) was calculated using fixed-effects or random-effects model analysis. Results: Overall, the mean serum leptin level of case groups was significantly higher than that of control groups. A) For 9 studies comparing breast cancer cases and healthy controls the combined effect (d) over bar was 0.58 with 95% Cl (0.48, 0.68). B) For 4 studies comparing premenopausal breast cancer cases and healthy controls the (d) over bar was 0.32 (0.12, 0.52). C) For 5 studies comparing postmenopausal cases and healthy controls the (d) over bar was 0.65 (0.46, 0.84). D) For 4 studies comparing breast cancer cases and breast benign controls the (d) over bar was 0.38 (0.17, 0.59). E) For 2 studies comparing premenopausal breast cancer cases and breast benign controls the (d) over bar was 0.33 (-0.25, 0.91). F) For 6 studies comparing postmenopausal breast cancer cases and breast benign controls the (d) over bar was 0.39 (0.19, 0.60). G) For 4 studies comparing lymph node metastasis positive cases and negative controls the (d) over bar was 0.72 (0.45, 1.00). H) For 3 studies comparing breast benign cases and healthy controls the (d) over bar was 0.71 (0.41, 1.01). Conclusion: This meta-analysis suggests that leptin level plays a role in breast cancer and has potential for development as a diagnostic tool.	[Niu, Jingping; Jiang, Le; Guo, Weiheng; Wang, Liqin] Hebei Med Univ, Dept Epidemiol & Stat, Sch Publ Hlth, Shijiazhuang, Hebei, Peoples R China; [Liu, Yi] Hebei Med Univ, Dept Toxicol, Sch Publ Hlth, Shijiazhuang, Hebei, Peoples R China; [Shao, Liang] Zhuhai Entry Exit Inspect & Quarantine Bur, Dept Vehical Inspect, Zhuhai, Guangdong, Peoples R China	Hebei Medical University; Hebei Medical University	Liu, Y (corresponding author), Hebei Med Univ, Dept Toxicol, Sch Publ Hlth, Shijiazhuang, Hebei, Peoples R China.	liuyi_judy@hotmail.com; wliqin5673696@163.com						Aliustaoglu M, 2010, MED ONCOL, V27, P388, DOI 10.1007/s12032-009-9222-z; Amir E, 2010, JNCI-J NATL CANCER I, V102, P680, DOI 10.1093/jnci/djq088; Chen DC, 2006, CANCER LETT, V237, P109, DOI 10.1016/j.canlet.2005.05.047; Cui HX, 2009, ASS ADIPONECTIN ADIP; Cust AE, 2009, BREAST CANCER RES TR, V113, P567, DOI 10.1007/s10549-008-9958-8; Du LL, 2006, CANC RES CLIN, V05, P307; Fan XL, 2009, STUDY MAMMOGRAPHIC D; Gao JX, 2005, LAB MED, V01, P28; Garofalo C, 2004, CLIN CANCER RES, V10, P6466, DOI 10.1158/1078-0432.CCR-04-0203; Givens GH, 1997, STAT SCI, V12, P221; Grossmann ME, 2012, BIOCHIMIE, V94, P2164, DOI 10.1016/j.biochi.2012.06.013; Han CZ, 2008, BIOL TRACE ELEM RES, V126, P38, DOI 10.1007/s12011-008-8182-z; Hancke K, 2010, BREAST CANCER RES TR, V119, P367, DOI 10.1007/s10549-009-0577-9; Harbord R., 2009, STAT SOFTWARE COMPON; Harris HR, 2011, CANCER PREV RES, V4, P1449, DOI 10.1158/1940-6207.CAPR-11-0125; He BS, 2012, MOL BIOL REP, V39, P3117, DOI 10.1007/s11033-011-1076-8; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang XD, 2006, J RADIOIMMUNOLOGY, V19, P267; Ishikawa M, 2004, CLIN CANCER RES, V10, P4325, DOI 10.1158/1078-0432.CCR-03-0749; Jarde T, 2011, EUR J CANCER, V47, P33, DOI 10.1016/j.ejca.2010.09.005; Jen KLC, 2005, J LAB CLIN MED, V146, P18, DOI 10.1016/j.lab.2005.02.014; Jiang DL, 2006, J RADIOIMMUNOLOGY, V05, P382; Liu CB, 2011, TUMOR BIOL, V32, P1233, DOI 10.1007/s13277-011-0227-9; Liu CL, 2007, ONCOLOGY-BASEL, V72, P75, DOI 10.1159/000111097; Liu Y, 2010, VJ RADIOIMMUNOLOGY, V03, P243; Maccio A, 2010, J MOL MED, V88, P677, DOI 10.1007/s00109-010-0611-8; Mai Jz, 2006, J EVIDENCE BASED MED, V05; Mantzoros C, 2004, J CLIN ENDOCR METAB, V89, P1102, DOI 10.1210/jc.2003-031804; Markowska A, 2004, EUR J GYNAECOL ONCOL, V25, P192; McKenna MC, 1999, HEALTH PSYCHOL, V18, P520, DOI 10.1037/0278-6133.18.5.520; Otvos L, 2011, EUR J CANCER, V47, P1578, DOI 10.1016/j.ejca.2011.01.018; Pazaitou-Panayiotou K, 2007, EUR J ENDOCRINOL, V156, P187, DOI 10.1530/EJE-06-0611; Ray A, 2012, J BIOSCIENCES, V37, P289, DOI 10.1007/s12038-012-9191-9; Rose DP, 2002, INT J ONCOL, V21, P1285; Sestak I, 2012, BREAST CANC RES TREA; Sharp S., 1998, STATA TECHNICAL B, V7; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Sun JM, 2006, CHIN J NCCL MED, V06, P360; Tessitore L, 2004, INT J ONCOL, V24, P1529; Wang LQ, 2012, BREAST CANCER RES TR, V136, P231, DOI 10.1007/s10549-012-2228-9; Wang XM, 2005, ACTA ACAD MED WEIFAN, V03, P188; Wang Y, 2011, ASS STUDY EXPRESSION; Woo HY, 2006, CANCER LETT, V237, P137, DOI 10.1016/j.canlet.2005.05.041; Yu H, 2005, J RADIOIMMUNOLOGY, V05, P327	45	75	79	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67349	10.1371/journal.pone.0067349	http://dx.doi.org/10.1371/journal.pone.0067349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826274	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000065
J	Axelsson, J; Rylander, L; Rignell-Hydbom, A; Silfver, KA; Stenqvist, A; Giwercman, A				Axelsson, Jonatan; Rylander, Lars; Rignell-Hydbom, Anna; Silfver, Karl Agren; Stenqvist, Amelie; Giwercman, Aleksander			The Impact of Paternal and Maternal Smoking on Semen Quality of Adolescent Men	PLOS ONE			English	Article							EPOXIDE-DNA ADDUCTS; ACUTE LYMPHOBLASTIC-LEUKEMIA; CONGENITAL HEART-DISEASE; RISK-FACTORS; SPERM COUNTS; CIGARETTE-SMOKING; AIR-POLLUTION; YOUNG MEN; TOBACCO CONSUMPTION; GENERAL-POPULATION	Background: Maternal smoking during pregnancy has been reported to negatively impact sperm counts of the sons. Sufficient data on the effect of paternal smoking is lacking. Objectives: We wished to elucidate the impact of maternal and paternal smoking during pregnancy and current own smoking on reproductive function of the male offspring. Methods: Semen parameters including sperm DNA integrity were analyzed in 295 adolescents from the general population close to Malmo, Sweden, recruited for the study during 2008-2010. Information on maternal smoking was obtained from the Swedish Medical Birth Register, and regarding own and paternal smoking from questionnaires. The impacts of maternal, paternal and own smoking were evaluated in a multivariate regression model and by use of models including interaction terms. Totally, three exposures and five outcomes were evaluated. Results: In maternally unexposed men, paternal smoking was associated with 46% lower total sperm count (95%CI: 21%, 64%) in maternally unexposed men. Both paternal and maternal smoking were associated with a lower sperm concentration (mean differences: 35%; 95%CI: 8.1%, 55% and 36%; 95%CI: 3.9%, 57%, respectively) if the other parent was a non-smoker. No statistically significant impact of own smoking on semen parameters was seen. Conclusions: Prenatal both maternal and paternal smoking were separately associated with some decrease in sperm count in men of whom the other parent was not reported to smoke.	[Axelsson, Jonatan; Silfver, Karl Agren; Stenqvist, Amelie; Giwercman, Aleksander] Skane Univ Hosp, Reprod Med Ctr, Malmo, Sweden; [Axelsson, Jonatan; Rylander, Lars; Rignell-Hydbom, Anna] Lund Univ, Div Occupat & Environm Med, Lund, Sweden	Lund University; Skane University Hospital; Lund University	Axelsson, J (corresponding author), Skane Univ Hosp, Reprod Med Ctr, Malmo, Sweden.	jonatan.axelsson@med.lu.se		Rylander, Lars/0000-0001-8288-8207	Swedish Cancer Society [CAN 2012/661]; Swedish Governmental funding for medical training and research; Skane University Hospital Funds; Swedish Childhood Cancer Society [PROJ10/030]	Swedish Cancer Society(Swedish Cancer Society); Swedish Governmental funding for medical training and research; Skane University Hospital Funds; Swedish Childhood Cancer Society	The study was supported by grants from the Swedish Cancer Society (CAN 2012/661), Swedish Governmental funding for medical training and research, Skane University Hospital Funds and Swedish Childhood Cancer Society (PROJ10/030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 1999, J REPROD FERTIL, V115, P1; Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a; Aitken RJ, 2001, REPRODUCTION, V122, P497, DOI 10.1530/rep.0.1220497; Andersen AG, 2000, HUM REPROD, V15, P366, DOI 10.1093/humrep/15.2.366; Castro-Jimenez MA, 2011, PREV CHRONIC DIS, V8; Axelsson J, 2011, HUM REPROD, V26, P1012, DOI 10.1093/humrep/der045; Blanco-Munoz J, 2009, PUBLIC HEALTH REP, V124, P317, DOI 10.1177/003335490912400220; Brouwers MM, 2007, EUR J PEDIATR, V166, P671, DOI 10.1007/s00431-006-0304-z; Brouwers MM, 2010, BJU INT, V105, P254, DOI 10.1111/j.1464-410X.2009.08772.x; Bungum M, 2011, ASIAN J ANDROL, V13, P69, DOI 10.1038/aja.2010.73; Carbone P, 2007, INT J ANDROL, V30, P3, DOI 10.1111/j.1365-2605.2006.00703.x; Chang Jeffrey S., 2009, V472, P103, DOI 10.1007/978-1-60327-492-0_5; Chen D, 2009, PHARMACOGENET GENOM, V19, P25, DOI 10.1097/FPC.0b013e328316d8d8; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cresci M, 2011, AM J CARDIOL, V108, P1625, DOI 10.1016/j.amjcard.2011.07.022; Danielsson M, 2012, SCAND J PUBLIC HEALT, V40, P176, DOI 10.1177/1403494812459600; DAVIS DL, 1991, LANCET, V337, P123; Edraki M., 2011, Eastern Mediterranean Health Journal, V17, P303; ESHRE, 2002, ESHRE MONOGR, P1; Fraga CG, 1996, MUTAT RES-FUND MOL M, V351, P199, DOI 10.1016/0027-5107(95)00251-0; Fukuda M, 2011, FERTIL STERIL, V95, P2542, DOI 10.1016/j.fertnstert.2011.04.069; Gianicolo EAL, 2010, CURR PHARM DESIGN, V16, P2572, DOI 10.2174/138161210792062849; Hughes IA, 2001, ENDOCRINOLOGY, V142, P3281, DOI 10.1210/en.142.8.3281; Jensen MS, 2007, EPIDEMIOLOGY, V18, P220, DOI 10.1097/01.ede.0000254061.90686.9f; Jensen MS, 2005, HUM REPROD, V20, P2559, DOI 10.1093/humrep/dei110; Jensen TK, 2004, AM J EPIDEMIOL, V159, P49, DOI 10.1093/aje/kwh002; Jensen TK, 1997, J CLIN ENDOCR METAB, V82, P4059, DOI 10.1210/jc.82.12.4059; Jorgensen N, 2011, INT J ANDROL, V34, pE37, DOI 10.1111/j.1365-2605.2010.01133.x; Kuciene R, 2010, MED LITH, V46, P635, DOI 10.3390/medicina46090090; Kurahashi N, 2005, MED SCI MONITOR, V11, pCR274; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laubenthal J, 2012, FASEB J; Liu RL, 2011, J ONCOL, V2011, DOI 10.1155/2011/854584; Milne E, 2012, AM J EPIDEMIOL, V175, P43, DOI 10.1093/aje/kwr275; Olsen Ann-Karin, 2005, Toxicol Appl Pharmacol, V207, P521, DOI 10.1016/j.taap.2005.01.060; Paasch U, 2008, INT J ANDROL, V31, P93, DOI 10.1111/j.1365-2605.2007.00860.x; Peat JK, 2002, HLTH SCI RES HDB QUA, Vxiv; Perrin J, 2011, FERTIL STERIL, V95, P2013, DOI 10.1016/j.fertnstert.2011.02.021; Pierik FH, 2004, ENVIRON HEALTH PERSP, V112, P1570, DOI 10.1289/ehp.7243; RATCLIFFE JM, 1992, REPROD TOXICOL, V6, P297, DOI 10.1016/0890-6238(92)90192-V; Ravnborg TL, 2011, HUM REPROD, V26, P1000, DOI 10.1093/humrep/der011; Richthoff J, 2002, HUM REPROD, V17, P2468, DOI 10.1093/humrep/17.9.2468; Richthoff J, 2008, INT J ANDROL, V31, P31, DOI 10.1111/j.1365-2605.2007.00752.x; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Sanchez-Pozo MC, 2013, HUM REPROD, V28, P10, DOI 10.1093/humrep/des355; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Socialstyrelsen, 2009, PREGN DEL NEWB INF S; Somers CM, 2011, SYST BIOL REPROD MED, V57, P63, DOI 10.3109/19396368.2010.500440; Somers CM, 2002, P NATL ACAD SCI USA, V99, P15904, DOI 10.1073/pnas.252499499; Storgaard L, 2003, EPIDEMIOLOGY, V14, P278, DOI 10.1097/00001648-200305000-00006; Venners SA, 2004, AM J EPIDEMIOL, V159, P993, DOI 10.1093/aje/kwh128; Virtanen HE, 2012, CURR OPIN ENDOCRINOL, V19, P228, DOI 10.1097/MED.0b013e3283537cb8; Wagner-Mahler K, 2011, INT J ANDROL, V34, pE499, DOI 10.1111/j.1365-2605.2011.01211.x; World Health Organization, 1999, WHO LAB MAN EX HUM S, Vx; WYROBEK AJ, 1993, REPROD TOXICOL, V7, P3, DOI 10.1016/0890-6238(93)90064-E; Yauk C, 2008, P NATL ACAD SCI USA, V105, P605, DOI 10.1073/pnas.0705896105; Yauk CL, 2007, CANCER RES, V67, P5103, DOI 10.1158/0008-5472.CAN-07-0279; Zenzes MT, 1999, FERTIL STERIL, V72, P330, DOI 10.1016/S0015-0282(99)00230-7; Zenzes MT, 1999, MOL HUM REPROD, V5, P125, DOI 10.1093/molehr/5.2.125; Zhang B, 2011, J CRANIO MAXILL SURG, V39, P313, DOI 10.1016/j.jcms.2010.07.005; ZHANG J, 1992, INT J EPIDEMIOL, V21, P273, DOI 10.1093/ije/21.2.273; Zitzmann M, 2003, FERTIL STERIL, V79, P1550, DOI 10.1016/S0015-0282(03)00339-X; Zwink N, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-25	65	29	31	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e66766	10.1371/journal.pone.0066766	http://dx.doi.org/10.1371/journal.pone.0066766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840528	Green Published, gold, Green Submitted			2022-12-27	WOS:000321424400040
J	Garcia-Martin, E; Agundez, JAG; Martinez, C; Benito-Leon, J; Millan-Pascual, J; Calleja, P; Diaz-Sanchez, M; Pisa, D; Turpin-Fenoll, L; Alonso-Navarro, H; Ayuso-Peralta, L; Torrecillas, D; Plaza-Nieto, JF; Jimenez-Jimenez, FJ				Garcia-Martin, Elena; Agundez, Jose A. G.; Martinez, Carmen; Benito-Leon, Julian; Millan-Pascual, Jorge; Calleja, Patricia; Diaz-Sanchez, Maria; Pisa, Diana; Turpin-Fenoll, Laura; Alonso-Navarro, Hortensia; Ayuso-Peralta, Lucia; Torrecillas, Dolores; Francisco Plaza-Nieto, Jose; Javier Jimenez-Jimenez, Felix			Vitamin D3 Receptor (VDR) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis	PLOS ONE			English	Article							D METABOLISM; POLYMORPHISMS; SUSCEPTIBILITY	Background: Some epidemiological, genetic, and experimental data suggest a possible role of vitamin D in the pathogenesis of multiple sclerosis (MS) and in experimental autoimmune encephalomyelitis. Data on the possible contribution of several single nucleotide polymorphisms (SNP) in the vitamin D receptor (VDR) gene to the risk for MS are controversial. Several studies suggested an interaction between some SNPs in the VDR gene and HLADRB1*1501 in the risk for MS. Objectives: The aim of this study was to investigate a possible influence of the SNPs rs2228570 and rs731236 in the VDR gene in the risk for MS. A secondary objective was to address the possible interactions between VDR genes and HLADRB1*1501. Methods: We analyzed the allelic and genotype frequency of VDR rs2228570, rs731236, and HLADRB1*1501 (rs3135388) in 303 patients with MS and 310 healthy controls, using TaqMan Assays. We also conducted a meta-analysis, that was carried out by using the software Meta-Disc 1.1.1 (http://www.hrc.es/investigacion/metadisc.html; Unit of Clinical Statistics, Hospital Ramon y Cajal, Madrid, Spain). Heterogeneity between studies in terms of degree of association was tested using the Q-statistic. Results: VDR rs2228570 and rs731236 allelic and genotype frequencies did not differ significantly between MS patients and controls, and were unrelated with the age of onset of MS, gender, and course of MS. HLADRB1*1501 showed a high association with the risk of developing MS 4.76(95% C. I. = 3.14-7.27; p<0.0001). The meta-analysis, after excluding data of one study that was responsible of heterogeneity for rs731236 polymorphism, showed lack of relation of both SNPs with the risk for MS. HLADRB1*1501 showed lack of interaction with VDR rs2228570 and rs731236 in increasing MS risk. Conclusions: These results suggest that VDR rs2228570 and rs731236 polymorphisms are not related with the risk for MS, and did not confirm interaction between these VDR SNPs and HLADRB1 in the risk for MS.	[Garcia-Martin, Elena; Martinez, Carmen] Univ Extremadura, Dept Biochem & Mol Biol, Caceres, Spain; [Agundez, Jose A. G.] Univ Extremadura, Dept Pharmacol, Caceres, Spain; [Benito-Leon, Julian] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Benito-Leon, Julian; Calleja, Patricia; Diaz-Sanchez, Maria] Hosp Univ Doce Octubre, Serv Neurol, Madrid, Spain; [Benito-Leon, Julian; Calleja, Patricia; Diaz-Sanchez, Maria] Univ Complutense, Dept Med, E-28040 Madrid, Spain; [Millan-Pascual, Jorge; Turpin-Fenoll, Laura; Alonso-Navarro, Hortensia] Hosp La Mancha Ctr, Neurol Sect, Ciudad Real, Spain; [Pisa, Diana] Univ Autonoma Madrid, Fac Ciencias, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; [Alonso-Navarro, Hortensia; Ayuso-Peralta, Lucia; Torrecillas, Dolores; Javier Jimenez-Jimenez, Felix] Univ Alcala, Hosp Principe Asturias, Dept Med Neurol, Madrid, Spain; [Alonso-Navarro, Hortensia; Francisco Plaza-Nieto, Jose; Javier Jimenez-Jimenez, Felix] Hosp Univ Sureste, Neurol Sect, Madrid, Spain	Universidad de Extremadura; Universidad de Extremadura; CIBERNED; Instituto de Salud Carlos III; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Prince of Asturias University Hospital; Universidad de Alcala	Jimenez-Jimenez, FJ (corresponding author), Univ Alcala, Hosp Principe Asturias, Dept Med Neurol, Madrid, Spain.	fjavier.jimenez@salud.madrid.org	Agúndez, José A. G./A-5503-2008; Benito-León, Julián/AAA-1331-2019; García-Martin, Elena/H-9828-2016	Agúndez, José A. G./0000-0001-6895-9160; Benito-León, Julián/0000-0002-1769-4809; García-Martin, Elena/0000-0002-8094-046X	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain [FIS PS09/00943, PS09/00469, RETICS RD07/0064/0016]; Junta de Extremadura, Spain [GR10068]; European Union	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Junta de Extremadura, Spain; European Union(European Commission)	This work was supported in part by Grants FIS PS09/00943, PS09/00469, and RETICS RD07/0064/0016 from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain, and GR10068 from Junta de Extremadura, Spain. Financed in part with FEDER funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agliardi C, 2011, BRAIN BEHAV IMMUN, V25, P1460, DOI 10.1016/j.bbi.2011.05.015; Agundez JAG, 2008, CLIN CHEM, V54, P1390, DOI 10.1373/clinchem.2008.105569; Baranzini SE, 2011, CURR OPIN GENET DEV, V21, P317, DOI 10.1016/j.gde.2010.12.006; Cox MB, 2012, MULT SCLER J, V18, P16, DOI 10.1177/1352458511415562; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dickinson JL, 2009, MULT SCLER, V15, P563, DOI 10.1177/1352458509102459; Duque B, 2008, MULT SCLER J, V14, P947, DOI 10.1177/1352458508089686; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Giordano Mara, 2002, Am J Pharmacogenomics, V2, P37, DOI 10.2165/00129785-200202010-00004; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Handunnetthi L, 2010, NEUROLOGY, V74, P1905, DOI 10.1212/WNL.0b013e3181e24124; Huang J, 2012, J NEUROL SCI, V313, P79, DOI 10.1016/j.jns.2011.09.024; Irizar H, 2012, MULT SCLER J, V18, P569, DOI 10.1177/1352458511426813; Kemppinen A, 2011, BRIEF FUNCT GENOMICS, V10, P61, DOI 10.1093/bfgp/elr004; MANTEL N, 1959, J NATL CANCER I, V22, P719; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Orton SM, 2011, J NEUROL SCI, V305, P116, DOI 10.1016/j.jns.2011.02.032; Partridge JM, 2004, NEUROLOGY, V62, P2323, DOI 10.1212/WNL.62.12.2323; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Pertegas Diaz S, 2003, ATEN PRIM, V10, P59; Pugliatti M, 2008, ACTA NEUROL SCAND, V117, P34, DOI 10.1111/j.1600-0404.2008.01029.x; Ramagopalan SV, 2008, J NEUROIMMUNOL, V201, P183, DOI 10.1016/j.jneuroim.2008.02.016; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Simon KC, 2010, MULT SCLER J, V16, P133, DOI 10.1177/1352458509355069; Simon KC, 2012, CURR OPIN NEUROL, V25, P246, DOI 10.1097/WCO.0b013e3283533a7e; Sioka C, 2011, J NEGAT RESULTS BIOM, V10, DOI 10.1186/1477-5751-10-3; Smolders J, 2009, ANN NY ACAD SCI, V1173, P515, DOI 10.1111/j.1749-6632.2009.04656.x; Smolders J, 2009, J NEUROIMMUNOL, V207, P117, DOI 10.1016/j.jneuroim.2008.12.011; Tajouri L, 2005, J NEUROGENET, V19, P25, DOI 10.1080/01677060590949692; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31	30	44	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65487	10.1371/journal.pone.0065487	http://dx.doi.org/10.1371/journal.pone.0065487			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840333	gold, Green Published, Green Submitted			2022-12-27	WOS:000322342800012
J	Haase, D; Kabisch, N; Haase, A				Haase, Dagmar; Kabisch, Nadja; Haase, Annegret			Endless Urban Growth? On the Mismatch of Population, Household and Urban Land Area Growth and Its Effects on the Urban Debate	PLOS ONE			English	Article							CITIES; REURBANISATION; CITY	In European cities, the rate of population growth has declined significantly, while the number of households has increased. This increase in the number of households is associated with an increase in space for housing. To date, the effects of both a declining population and decreasing household numbers remain unclear. In this paper, we analyse the relationship between population and household number development in 188 European cities from 1990-2000 and 2000-2006 to the growth of urban land area and per capita living space. Our results support a trend toward decreasing population with simultaneously increasing household number. However, we also found cites facing both a declining population and a decreasing household number. Nevertheless, the urban land area of these "double-declining" cities has continued to spread because the increasing per capita living space counteracts a reduction in land consumption. We conclude that neither a decline in population nor in household number "automatically" solve the global problem of land consumption.	[Haase, Dagmar; Kabisch, Nadja] Humboldt Univ, Helmholtz Ctr Environm Res UFZ, Dept Geog, Leipzig, Germany; [Haase, Annegret] UFZ Helmholtz Ctr Environm Res, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Humboldt University of Berlin; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Haase, D (corresponding author), Humboldt Univ, Helmholtz Ctr Environm Res UFZ, Dept Geog, Leipzig, Germany.	dagmar.haase@geo.hu-berlin.de	Kabisch, Nadja/ABE-6198-2020	Kabisch, Nadja/0000-0002-8925-4423; Haase, Dagmar/0000-0003-4065-5194	Humboldt University Berlin; Helmholtz Centre for Environmental Research - UFZ	Humboldt University Berlin; Helmholtz Centre for Environmental Research - UFZ(Helmholtz Association)	The work was not funded by any third-party institution; only by the home institutions of the authors (Humboldt University Berlin and Helmholtz Centre for Environmental Research - UFZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel S, 2011, HOUSING POLICY MATTE; Angel S., 2010, ATLAS URBAN EXPANSIO; Angel S., 2000, HOUSING POLICY MATTE; Blignaut J, 2013, CURRENT OPI IN PRESS; Bossard M, 2000, CORINE LAND COVER TE; Burdett R., 2007, ENDLESS CITY; Burton E, 2000, URBAN STUD, V37, P1969, DOI 10.1080/00420980050162184; Buzar S, 2005, PROG HUM GEOG, V29, P413, DOI 10.1191/0309132505ph558oa; Buzar S, 2007, URBAN STUD, V44, P651, DOI 10.1080/00420980601185544; Couch C, 2011, GOVERNANCE URB UNPUB; Dave S., 2010, BUILT ENV, V36, P9, DOI [DOI 10.2148/benv.36.1.9, DOI 10.2148/BENV.36.1.9]; Dempsey N., 2010, BUILD ENVIRON, V36, P116, DOI DOI 10.2148/BENV.36.1.116; Dempsey N., 2010, ENVIRONMENT, V36, P5, DOI [10.2148/benv.36.1.5, DOI 10.2148/BENV.36.1.5]; *EEA, 2008, 1 EEA; Eea E. E. A., 2001, IND FACT SHEET SIGN; EUROPEAN ENVIRONMENT AGENCY (EEA), 2006, 11 EEA; European Environmental Agency, 2012, CORINE LAND COV DAT; European Environmental Agency-EEA, 2009, HOUS CONS; Haase A, 2011, RESIDENTIAL CHANGE AND DEMOGRAPHIC CHALLENGE: THE INNER CITY OF EAST CENTRAL EUROPE IN THE 21ST CENTURY, P1; Haase A, 2010, POPUL SPACE PLACE, V16, P443, DOI 10.1002/psp.603; Hornsten L, 2000, LANDSCAPE URBAN PLAN, V51, P1, DOI 10.1016/S0169-2046(00)00097-9; Jabareen YR, 2006, J PLAN EDUC RES, V26, P38, DOI 10.1177/0739456X05285119; Jenks M., 1996, ENVIRON, V1, P5; Jenks M., 2008, WORLD CITIES URBAN F; Kabisch N, 2011, POPUL SPACE PLACE, V17, P236, DOI 10.1002/psp.600; Keilman N, 2003, NATURE, V421, P489, DOI 10.1038/421489a; Kroll F, 2010, LAND USE POLICY, V27, P726, DOI 10.1016/j.landusepol.2009.10.001; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; LESTHAEGHE R, 2002, POPULATION B UN, V44, P385; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Lutz W, 2003, SCIENCE, V299, P1991, DOI 10.1126/science.1080316; Nefs M, 2013, ENV PLAN A IN PRESS; Nuissl H, 2009, LAND USE POLICY, V26, P414, DOI 10.1016/j.landusepol.2008.05.006; Ogden PE, 2005, POPULATION B, V268, P251; Raman S., 2010, BUILD ENVIRON, V36, P63, DOI [10.2148/benv.36.1.63, DOI 10.2148/BENV.36.1.63]; Schwarz N, 2010, LANDSCAPE URBAN PLAN, V96, P29, DOI 10.1016/j.landurbplan.2010.01.007; Smith DP, 2007, ENVIRON PLANN A, V39, P142, DOI 10.1068/a38476; Steinfuhrer A, 2011, RESIDENTIAL CHANGE AND DEMOGRAPHIC CHALLENGE: THE INNER CITY OF EAST CENTRAL EUROPE IN THE 21ST CENTURY, P39; Steinfuhrer A, 2009, GEOJOURNAL, V74, P567, DOI 10.1007/s10708-008-9248-3; Steinfuhrer A, 2010, URBAN STUD, V47, P2325, DOI 10.1177/0042098009360224; Turok I, 2007, CITIES, V24, P165, DOI 10.1016/j.cities.2007.01.007; United Nations, 2011, WORLD POP PROJ 2011; van Vuuren DP, 2007, GLOBAL ENVIRON CHANG, V17, P114, DOI 10.1016/j.gloenvcha.2006.04.004; VANDEKAA DJ, 1987, POPUL BULL, V42, P1; vandenBergh JCJM, 1997, URBAN STUD, V34, P927, DOI 10.1080/0042098975899; Westerink J., 2012, EUR PLANN STUD, V25, P1; Williams K., 2000, ACHIEVING SUSTAINABL	47	100	104	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66531	10.1371/journal.pone.0066531	http://dx.doi.org/10.1371/journal.pone.0066531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	190LY	23840501	gold, Green Submitted, Green Published			2022-12-27	WOS:000322342800074
J	Huang, Y; Li, M; Li, JY; Li, M; Xia, YP; Mao, L; Hu, B				Huang, Yan; Li, Man; Li, Jian-Yong; Li, Min; Xia, Yuan-Peng; Mao, Ling; Hu, Bo			The Efficacy and Adverse Reaction of Bleeding of Clopidogrel plus Aspirin as Compared to Aspirin Alone after Stroke or TIA: A Systematic Review	PLOS ONE			English	Review							TRANSIENT ISCHEMIC ATTACK; ANTIPLATELET THERAPY; HIGH-RISK; METAANALYSIS; PREVENTION	Background and Purpose: Given the high risk of stroke after TIA (transient ischemia attack) or stroke and the adverse reaction of bleeding of antiplatelets, we undertook a meta-analysis, reviewed randomized controlled trials (RCTs) comparing aspirin plus clopidogrel with aspirin alone to determine the efficacy and adverse reaction of bleeding of the two protocols in the prevention of stroke. Methods: We analyzed the incidences of stroke, bleeding and severe bleeding by using fixed-effect model or random-effect model on the basis of the result of heterogeneity test. Results: Five qualified RCTs satisfied the inclusion criteria. We found that treatment with aspirin plus clopidogrel was associated with lower incidence of stroke (Risk Ratio (RR), 0.66, 95% confidence interval (CI), 0.47 to 0.93), higher incidence of bleeding (RR, 1.75, 95% CI, 1.48 to 2.05) as compared with aspirin-alone treatment. In terms of severe bleeding, no statistical difference existed between them (RR, 2.21, 95% CI, 0.25 to 19.52). Conclusion: The combined use of aspirin and clopidogrel is more effective than aspirin alone for patients with previous TIA or stroke for the prevention of stroke, with risk of bleeding being higher. No statistical difference was found in severe bleeding between the two treatment protocols.	[Huang, Yan; Li, Man; Li, Jian-Yong; Li, Min; Xia, Yuan-Peng; Mao, Ling; Hu, Bo] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430074, Peoples R China; [Hu, Bo] Huazhong Univ Sci & Technol, Minist Educ, Tongji Med Coll, Key Lab Neurol Dis, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Hu, B (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430074, Peoples R China.	hubo@mail.hust.edu.cn	xia, yuanpeng/S-7988-2019		National Natural Science Foundation of China [81070938]; Program for New Century Excellent Talents in University [NCET-10-0406]; Fundamental Research Funds for the Central Universities, HUST [2010JC028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities, HUST(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the Program of National Natural Science Foundation of China (number 81070938), Program for New Century Excellent Talents in University (NCET-10-0406) and the Fundamental Research Funds for the Central Universities, HUST (number 2010JC028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers GW, 2004, CHEST, V126, p483S, DOI 10.1378/chest.126.3_suppl.483S; Algra A, 1999, J NEUROL NEUROSUR PS, V66, P255, DOI 10.1136/jnnp.66.2.255; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Diener HC, 2004, LANCET, V364, P331, DOI 10.1016/S0140-6736(04)16721-4; Geeganage CM, 2012, STROKE, V43, P1058, DOI 10.1161/STROKEAHA.111.637686; Geraghty OC, 2010, CEREBROVASC DIS, V29, P460, DOI 10.1159/000297961; Guyatt G, 2001, CHEST, V119, p3S, DOI 10.1378/chest.119.1_suppl.3S; Hankey GJ, 2006, LANCET, V367, P606, DOI 10.1016/S0140-6736(06)68040-9; Hankey GJ, 2011, INT J STROKE, V6, P3, DOI 10.1111/j.1747-4949.2010.00535.x; Husted S, 2008, EUR HEART J SUPPL, V10, P19, DOI 10.1093/eurheartj/sun036; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Markus HS, 2005, CIRCULATION, V111, P2233, DOI 10.1161/01.CIR.0000163561.90680.1C; Sacco RL, 2006, STROKE, V37, P577, DOI 10.1161/01.STR.0000199147.30016.74; Sollier CBD, 2009, CEREBROVASC DIS, V28, P505, DOI 10.1159/000236915; Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600; Wong KSL, 2010, LANCET NEUROL, V9, P489, DOI 10.1016/S1474-4422(10)70060-0	16	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e65754	10.1371/journal.pone.0065754	http://dx.doi.org/10.1371/journal.pone.0065754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840362	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800019
J	Yang, J; Wang, L; Yang, F; Luo, HM; Xu, LL; Lu, JL; Zeng, SQ; Zhang, ZH				Yang, Jie; Wang, Liang; Yang, Fei; Luo, Haiming; Xu, Lingling; Lu, Jinling; Zeng, Shaoqun; Zhang, Zhihong			mBeRFP, an Improved Large Stokes Shift Red Fluorescent Protein	PLOS ONE			English	Article							IN-VIVO; FRET; VARIANT; CYAN	Herein, we describe the generation of a monomeric large Stokes shift (LSS) red fluorescent protein, mBeRFP, with excitation and emission peaks at 446 and 615 nm, respectively. Compared with two previously reported LSS-RFPs (mKeima and LSS-mKate2), mBeRFP is approximately three times brighter. In addition, mBeRFP is characterized by improved photostability, rapid maturation, an extended lifetime, and a monomeric nature. Additionally, mBeRFP can be paired with the Alexa 647 dye as a FRET donor to detect caspase 3 activity. This FRET pair has an extremely dynamic range and a large Forster radius (approximately 6.5 nm). To demonstrate the applicability of mBeRFP for imaging in living cells, we performed dual-color imaging of mBeRFP and CFP simultaneously excited by a single excitation source, and we demonstrated that these fluorescent proteins allow the clear visualization of the dynamics of Bax during cancer cell apoptosis. Thus, mBeRFP appears to be particularly useful for cellular imaging applications.	[Yang, Jie; Wang, Liang; Yang, Fei; Luo, Haiming; Xu, Lingling; Lu, Jinling; Zeng, Shaoqun; Zhang, Zhihong] Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China; [Yang, Jie; Wang, Liang; Yang, Fei; Luo, Haiming; Xu, Lingling; Lu, Jinling; Zeng, Shaoqun; Zhang, Zhihong] Huazhong Univ Sci & Technol, MoE Key Lab Biomed Photon, Dept Biomed Engn, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, ZH (corresponding author), Huazhong Univ Sci & Technol, Britton Chance Ctr Biomed Photon, Wuhan Natl Lab Optoelect, Wuhan 430074, Hubei, Peoples R China.	czyzzh@mail.hust.edu.cn		Luo, Haiming/0000-0002-6226-5800; Yang, Jie/0000-0003-4346-9100	National Basic Research Program of China [2011CB910401]; Science Fund for Creative Research Group of China [61121004]; National Natural Science Foundation of China [30800208, 81172153]	National Basic Research Program of China(National Basic Research Program of China); Science Fund for Creative Research Group of China(Science Fund for Creative Research Groups); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (Grant No. 2011CB910401), Science Fund for Creative Research Group of China (Grant No.61121004), and National Natural Science Foundation of China (Grant No. 30800208, 81172153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Chu J, 2009, BIOSENS BIOELECTRON, V25, P234, DOI 10.1016/j.bios.2009.06.008; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kawano H, 2008, NAT METHODS, V5, P373, DOI 10.1038/nmeth0508-373; Kogure T, 2006, NAT BIOTECHNOL, V24, P577, DOI 10.1038/nbt1207; Kredel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004391; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mayevsky A, 2011, J INNOV OPT HEAL SCI, V4, P337, DOI 10.1142/S1793545811001654; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Patterson GH, 2004, NAT BIOTECHNOL, V22, P1524, DOI 10.1038/nbt1204-1524; Piatkevich KD, 2010, P NATL ACAD SCI USA, V107, P5369, DOI 10.1073/pnas.0914365107; Pletnev S, 2008, J BIOL CHEM, V283, P28980, DOI 10.1074/jbc.M800599200; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shcherbakova DM, 2012, J AM CHEM SOC, V134, P7913, DOI 10.1021/ja3018972; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Smith TA, 2012, J INNOV OPT HEAL SCI, V5, DOI 10.1142/S1793545812500253; Verkhusha VV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1342, DOI 10.1023/A:1013325627378; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5	23	28	29	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e64849	10.1371/journal.pone.0064849	http://dx.doi.org/10.1371/journal.pone.0064849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840310	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800006
J	Fiorillo, AR; Tykoski, RS				Fiorillo, Anthony R.; Tykoski, Ronald S.			An Immature Pachyrhinosaurus perotorum (Dinosauria: Ceratopsidae) Nasal Reveals Unexpected Complexity of Craniofacial Ontogeny and Integument in Pachyrhinosaurus	PLOS ONE			English	Article							HORNED DINOSAURS; CENTROSAURINE; ALBERTA; ORNITHISCHIA; CANADA	A new specimen attributable to an immature individual of Pachyrhinosaurus perotorum (Dinosauria, Ceratopsidae) from the Kikak-Tegoseak Quarry in northern Alaska preserves a mix of features that provides refinement to the sequence of ontogenetic stages and transformations inferred for the development of the nasal boss in Pachyrhinosaurus. The new specimen consists of an incomplete nasal that includes the posterior part of the nasal horn, the dorsal surface between the horn and the left-side contacts for the prefrontal and frontal, and some of the left side of the rostrum posteroventral to the nasal horn. The combination of morphologies in the new specimen suggests either an additional stage of development should be recognized in the ontogeny of the nasal boss of Pachyrhinosaurus, or that the ontogenetic pathway of nasal boss development in P. perotorum was notably different from that of P. lakustai. Additionally, the presence of a distinct basal sulcus and the lateral palisade texture on the nasal horn of the specimen described here indicate that a thick, cornified horn sheath was present well before the formation of a dorsal cornified pad. A separate rugose patch on the nasal well posterior to the nasal horn is evidence for a cornified integumentary structure, most likely a thick cornified pad, on the posterior part of the nasal separate from the nasal horn prior to the onset of nasal boss formation in P. perotorum.	[Fiorillo, Anthony R.; Tykoski, Ronald S.] Perot Museum Nat & Sci, Dallas, TX USA		Fiorillo, AR (corresponding author), Perot Museum Nat & Sci, Dallas, TX USA.	anthony.fiorillo@perotmuseum.org		Fiorillo, Anthony/0000-0002-8998-0820	United States National Science Foundation [OPP 04245594]	United States National Science Foundation(National Science Foundation (NSF))	Field work was supported by the United States National Science Foundation award OPP 04245594 to Fiorillo (http://www.nsf.gov/awardsearch/showAward?AWD_ID=0424594&HistoricalAwards=false). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Conrad J. E., 1990, US GEOLOGICAL SURV C, V1990-C, P1; Currie Philip J., 2008, P1; CURRIE PJ, 1989, NAT HIST, V6, P60; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Farke AA, 2011, ACTA PALAEONTOL POL, V56, P691, DOI 10.4202/app.2010.0121; Fiorillo AR, 2012, ACTA PALAEONTOL POL, V57, P561, DOI 10.4202/app.2011.0033; Fiorillo Anthony R., 2010, P456; Hieronymus TL, 2009, ANAT REC, V292, P1370, DOI 10.1002/ar.20985; LANGSTON W, 1975, CAN J EARTH SCI, V12, P1576, DOI 10.1139/e75-142; Langston W. Jr., 1967, Canadian Journal of Earth Sciences, V4, P171; McDonald AT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022710; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Sampson S.D., 2011, NEW PERSPECTIVES HOR, P405; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Sampson SD, 1995, J VERTEBR PALEONTOL, V15, P743, DOI 10.1080/02724634.1995.10011259; STERNBERG C. M., 1950, NATION MUS CANADA MUS BULL, V118, P109	16	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65802	10.1371/journal.pone.0065802	http://dx.doi.org/10.1371/journal.pone.0065802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840371	Green Submitted, gold, Green Published			2022-12-27	WOS:000322361200037
J	Gao, LC; He, YJ; Tang, J; Yin, JY; Huang, ZY; Liu, FQ; Ouyang, DS; Chen, XP; Zhang, W; Liu, ZQ; Zhou, HH				Gao, Lichen; He, Yijing; Tang, Jie; Yin, Jiye; Huang, Zhengyu; Liu, Fangqun; Ouyang, Dongsheng; Chen, Xiaoping; Zhang, Wei; Liu, Zhaoqian; Zhou, Honghao			Genetic Variants of Pregnane X Receptor (PXR) and CYP2B6 Affect the Induction of Bupropion Hydroxylation by Sodium Ferulate	PLOS ONE			English	Article							ST-JOHNS-WORT; GLUCOCORTICOID-RECEPTOR; XENOBIOTIC RECEPTOR; ANDROSTANE-RECEPTOR; DRUG-INTERACTIONS; EXPRESSION; CYP3A4; NR1I2; IDENTIFICATION; POLYMORPHISMS	This study investigated the effects of pregnane X receptor (PXR/NR1I2) and CYP2B6 genetic variants on sodium ferulate (SF)mediated induction of bupropion hydroxylation. The pharmacokinetics of bupropion and hydroxybupropion were evaluated after an oral dose of bupropion (150 mg) administered with and without SF pretreatment for 14 days in 33 healthy subjects. The area under the time-concentration curve (AUC) ratio of AUC_hyd (AUC((0-infinity)) of hydroxybupropion)/AUC_bup (AUC((0-infinity)) of bupropion) represents the CYP2B6 hydroxylation activity, which was significantly lower in CYP2B6*6 carriers (NR1I2 TGT noncarriers or carriers) than in noncarriers in both the basal and SF-induced states (p-value, 0.05). AUC ratio and AUC_hyd of NR1I2 -24113AA variant were markedly lower than GA and GG genotypes (7.5 +/- 2.1 versus 14.5 +/- 3.3 and 20.6 +/- 1.1, and 8873 +/- 1431 versus 14,504 +/- 2218 and 17,586 +/- 1046) in the induced states. However, -24020(-)/(-) variant didn't show significant difference in the induction of CYP2B6 hydroxylation activity by SF compared with other -24020[GAGAAG]/(-) genotypes. NR1I2 TGT haplotype (-25385T+ g. 7635G+g.8055T) carriers exhibited a significantly decreased AUC ratio, compared with TGT noncarriers, in the basal states (7.6 +/- 1.0 versus 9.7 +/- 1.0), while this result wasn't observed in CYP2B6* 6 noncarriers. Moreover, individuals with complete mutation-type [CYP2B6* 6/*6+NR1I2 TGT + -24113AA + -24020 (-)/(-)] showed even lower percent difference of AUC ratio (8.7 +/- 1.2 versus 39.5 +/- 8.2) than those with complete wild-type. In conclusion, it is suggested that NR1I2 variants decrease the bupropion hydroxylation induced by SF treatment, particularly in CYP2B6*6 carriers.	[Gao, Lichen; He, Yijing; Tang, Jie; Yin, Jiye; Ouyang, Dongsheng; Chen, Xiaoping; Zhang, Wei; Liu, Zhaoqian; Zhou, Honghao] Cent S Univ, Hunan Key Lab Pharmacogenet, Inst Clin Pharmacol, Pharmacogenet Res Inst, Changsha, Hunan, Peoples R China; [Gao, Lichen; Huang, Zhengyu; Liu, Fangqun] Changsha Cent Hosp, Dept Pharm, Changsha, Hunan, Peoples R China; [He, Yijing] Univ N Carolina, Inst Pharmacogen & Individualized Therapy, Chapel Hill, NC USA	Central South University; University of North Carolina; University of North Carolina Chapel Hill	Zhou, HH (corresponding author), Cent S Univ, Hunan Key Lab Pharmacogenet, Inst Clin Pharmacol, Pharmacogenet Res Inst, Changsha, Hunan, Peoples R China.	hhzhou2003@163.com	Chen, Yao/AAJ-5658-2020; Yin, Ji-Ye/AAE-6794-2020	Liu, Zhaoqian/0000-0003-0428-3928	National Scientific Foundation of China [81001476]; 863 Project [2012AA02A518]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0946]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Scientific Foundation of China (No. 81001476), 863 Project (No. 2012AA02A518), and Program for Changjiang Scholars and Innovative Research Team in University (IRT0946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, DRUG METAB PHARMACOK, V23, P14, DOI 10.2133/dmpk.23.14; Bailey I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016703; Barone E, 2009, BIOGERONTOLOGY, V10, P97, DOI 10.1007/s10522-008-9160-8; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Chen J, 2004, EUR J DRUG METAB PH, V29, P103, DOI 10.1007/BF03190583; Chen LL, 2009, J PHARMACEUT BIOMED, V50, P127, DOI 10.1016/j.jpba.2009.03.039; Chung JY, 2011, DRUG METAB DISPOS, V39, P92, DOI 10.1124/dmd.110.035246; Dresser GK, 2003, CLIN PHARMACOL THER, V73, P41, DOI 10.1067/mcp.2003.10; Drocourt L, 2002, J BIOL CHEM, V277, P25125, DOI 10.1074/jbc.M201323200; Duniec-Dmuchowski Z, 2007, BIOCHEM PHARMACOL, V74, P1535, DOI 10.1016/j.bcp.2007.07.040; Fan L, 2009, EUR J CLIN PHARMACOL, V65, P403, DOI 10.1007/s00228-008-0594-3; Faucette SR, 2000, DRUG METAB DISPOS, V28, P1222; Folwaczny M, 2012, J PERIODONTAL RES, V47, P174, DOI 10.1111/j.1600-0765.2011.01417.x; Frank C, 2005, J MOL BIOL, V346, P505, DOI 10.1016/j.jmb.2004.12.003; Gao LC, 2012, EUR REV MED IN PRESS; Hesse LM, 2000, DRUG METAB DISPOS, V28, P1176; Hogeland GW, 2007, CLIN PHARMACOL THER, V81, P69, DOI 10.1038/sj.clpt.6100027; Hustert E, 2001, DRUG METAB DISPOS, V29, P1454; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; King CR, 2007, EUR J CLIN PHARMACOL, V63, P547, DOI 10.1007/s00228-007-0295-3; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Lamba J, 2005, CURR DRUG METAB, V6, P369, DOI 10.2174/1389200054633880; Lamba J, 2008, DRUG METAB DISPOS, V36, P169, DOI 10.1124/dmd.107.016600; Lamba V, 2003, J PHARMACOL EXP THER, V307, P906, DOI 10.1124/jpet.103.054866; Lau AJ, 2010, J PHARMACOL EXP THER, V335, P771, DOI 10.1124/jpet.110.172338; Lee AM, 2007, BIOL PSYCHIAT, V62, P635, DOI 10.1016/j.biopsych.2006.10.005; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Li TG, 2006, DRUG METAB DISPOS, V34, P756, DOI 10.1124/dmd.105.007575; Lin YS, 2009, DRUG METAB DISPOS, V37, P1295, DOI 10.1124/dmd.108.025213; Liu HQ, 2010, NEUROCHEM RES, V35, P1368, DOI 10.1007/s11064-010-0193-4; Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097; Moreira RPP, 2011, CLINICS, V66, P1041, DOI 10.1590/S1807-59322011000600020; Mukonzo JK, 2009, BRIT J CLIN PHARMACO, V68, P690, DOI 10.1111/j.1365-2125.2009.03516.x; Ni WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013792; Nyakutira C, 2008, EUR J CLIN PHARMACOL, V64, P357, DOI 10.1007/s00228-007-0412-3; Olinga P, 2008, EUR J PHARM SCI, V33, P380, DOI 10.1016/j.ejps.2008.01.008; Ourlin JC, 2003, MOL ENDOCRINOL, V17, P1693, DOI 10.1210/me.2002-0383; Pascussi JM, 2001, EUR J BIOCHEM, V268, P6346, DOI 10.1046/j.0014-2956.2001.02540.x; Saitoh A, 2007, AIDS, V21, P2191, DOI 10.1097/QAD.0b013e3282ef9695; Sandanaraj E, 2008, CLIN CANCER RES, V14, P7116, DOI 10.1158/1078-0432.CCR-08-0411; Saradhi M, 2005, CELL RES, V15, P785, DOI 10.1038/sj.cr.7290348; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; Svard J, 2010, JAIDS-J ACQ IMM DEF, V55, P536, DOI 10.1097/QAI.0b013e3181f52f0c; Traore M, 2003, BIORHEOLOGY, V40, P389; Uno Y, 2003, J HUM GENET, V48, P594, DOI 10.1007/s10038-003-0076-5; Wang BH, 2005, CARDIOVASC DRUG REV, V23, P161; Wang BH, 2004, J CARDIOVASC PHARM, V43, P549, DOI 10.1097/00005344-200404000-00010; Wang HB, 2003, DRUG METAB DISPOS, V31, P620, DOI 10.1124/dmd.31.5.620; Wang HB, 2003, J BIOL CHEM, V278, P14146, DOI 10.1074/jbc.M212482200; Wang HB, 2008, CURR DRUG METAB, V9, P598, DOI 10.2174/138920008785821710; Wang XD, 2007, CURR DRUG METAB, V8, P778, DOI 10.2174/138920007782798199; Wang XD, 2009, BRIT J CLIN PHARMACO, V67, P255, DOI 10.1111/j.1365-2125.2008.03344.x; Wyen C, 2011, J ANTIMICROB CHEMOTH, V6, P1; Yueh MF, 2005, DRUG METAB DISPOS, V33, P38, DOI 10.1124/dmd.104.001594; Zhang HM, 2011, J PHARMACOL EXP THER, V338, P803, DOI 10.1124/jpet.111.183111; Zhang J, 2001, PHARMACOGENETICS, V11, P555, DOI 10.1097/00008571-200110000-00003; Zhang YJ, 2011, BRAIN RES BULL, V86, P222, DOI 10.1016/j.brainresbull.2011.07.002	58	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e62489	10.1371/journal.pone.0062489	http://dx.doi.org/10.1371/journal.pone.0062489			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840296	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200002
J	Wang, JC; Wang, PY; Chen, HI; Wu, KL; Pai, LM; Nee, TE				Wang, Jen-Cheng; Wang, Pei-Yu; Chen, Hung-Ing; Wu, Kai-Ling; Pai, Li-Mei; Nee, Tzer-En			Lie Group Analysis of the Photo-Induced Fluorescence of Drosophila Oogenesis with the Asymmetrically Localized Gurken Protein	PLOS ONE			English	Article							RAMAN MICROSPECTROSCOPY; SPECTROSCOPY; GRADIENT; CELLS; MORPHOGEN; DYNAMICS; CBL	Lie group analysis of the photo-induced fluorescence of Drosophila oogenesis with the asymmetrically localized Gurken protein has been performed systematically to assess the roles of ligand-receptor complexes in follicle cells. The (2x2) matrix representations resulting from the polarized tissue spectra were employed to characterize the asymmetrical Gurken distributions. It was found that the fluorescence of the wild-type egg shows the Lie point symmetry X-23 at early stages of oogenesis. However, due to the morphogen regulation by intracellular proteins and extracellular proteins, the fluorescence of the embryogenesis with asymmetrically localized Gurken expansions exhibits specific symmetry features: Lie point symmetry Z(1) and Lie point symmetry X-1. The novel approach developed herein was successfully used to validate that the invariant-theoretical characterizations are consonant with the observed asymmetric fluctuations during early embryological development.	[Wang, Jen-Cheng; Chen, Hung-Ing; Wu, Kai-Ling; Nee, Tzer-En] Chang Gung Univ, Grad Inst Electroopt Engn, Tao Yuan 333, Taiwan; [Wang, Jen-Cheng; Chen, Hung-Ing; Wu, Kai-Ling; Nee, Tzer-En] Chang Gung Univ, Dept Elect Engn, Tao Yuan 333, Taiwan; [Wang, Pei-Yu; Pai, Li-Mei] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan 333, Taiwan; [Pai, Li-Mei] Chang Gung Univ, Dept Biochem, Tao Yuan 333, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University	Nee, TE (corresponding author), Chang Gung Univ, Grad Inst Electroopt Engn, Tao Yuan 333, Taiwan.	neete@mail.cgu.edu.tw		Nee, Tzer-En/0000-0002-8293-7678; Pai, Li-Mei/0000-0002-1417-6432	National Science Council of the Republic of China [NSC 100-2112-M-182-003-MY2]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of the Republic of China under Contract No. NSC 100-2112-M-182-003-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMOWITZ M, 1984, HDB MATH FUNCTIONS F; Chang WL, 2008, DEVELOPMENT, V135, P1923, DOI 10.1242/dev.017103; Cheng JX, 2002, BIOPHYS J, V83, P502, DOI 10.1016/S0006-3495(02)75186-2; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; Downes A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/101864; Goentoro LA, 2006, DEV CELL, V11, P263, DOI 10.1016/j.devcel.2006.07.004; Huang RR, 2010, LUMINESCENCE, V25, P269, DOI DOI 10.1016/J.YPMED.2005.01.012; Ibragimov N. H, 1995, CRC HDB LIE GROUP AN, VII; Ibragimov NH, 1993, CRC HDB LIE GROUP AN, VI; Ibragimov NH, 1995, CRC HDB LIE GROUP AN; Kunapareddy N, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2978061; Lopes DF, 2009, J LASER APPL, V21, P163, DOI 10.2351/1.3263117; Marie PJ, 2006, REGEN MED, V1, P539, DOI 10.2217/17460751.1.4.539; Notingher I, 2005, BIOCERAMICS; Pai LM, 2006, MECH DEVELOP, V123, P450, DOI 10.1016/j.mod.2006.04.001; Pai LM, 2000, CELL, V103, P51, DOI 10.1016/S0092-8674(00)00104-5; Pyrgiotakis G, 2009, ANN BIOMED ENG, V37, P1464, DOI 10.1007/s10439-009-9688-z; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Swain RJ, 2007, BIOCHEM SOC T, V35, P544, DOI 10.1042/BST0350544; Swain RJ, 2008, J CELL BIOCHEM, V104, P1427, DOI 10.1002/jcb.21720; Tuchin VV, 2010, SER MED PHYS BIOMED, P1, DOI 10.1201/9781439806296-f; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Verrier S, 2004, BIOPOLYMERS, V74, P157, DOI 10.1002/bip.20063; Wang PY, 2008, FLY, V2, P118, DOI 10.4161/fly.6526; Weyl H., 1983, SYMMETRY; WOLPERT L, 1994, SCIENCE, V266, P571, DOI 10.1126/science.7939707; Yakoby N, 2008, DEV CELL, V15, P725, DOI 10.1016/j.devcel.2008.09.008	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65143	10.1371/journal.pone.0065143	http://dx.doi.org/10.1371/journal.pone.0065143			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840317	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200010
J	Dressler, J; Maughn, N; Soon, JA; Norman, WV				Dressler, Jennifer; Maughn, Nanamma; Soon, Judith A.; Norman, Wendy V.			The Perspective of Rural Physicians Providing Abortion in Canada: Qualitative Findings of the BC Abortion Providers Survey (BCAPS)	PLOS ONE			English	Article							RESIDENCY PROGRAMS; ACCESS; PROVISION; SERVICES; TRENDS; US	Background: An increasing proportion of Canadian induced abortions are performed in large urban areas. For unknown reasons the number of rural abortion providers in Canadian provinces, such as British Columbia (BC), has declined substantially. This study explored the experiences of BC rural and urban physicians providing abortion services. Methods: The mixed methods BC Abortion Providers Survey employed self-administered questionnaires, distributed to all known current and some past BC abortion providers in 2011. The optional semi-structured interviews are the focus of this analysis. Interview questions probed the experiences, facilitators and challenges faced by abortion providers, and their future intentions. Interviews were transcribed and analyzed using cross-case and thematic analysis. Results: Twenty interviews were completed and transcribed, representing 13/27 (48.1%) rural abortion providers, and 7/19 (36.8%) of urban providers in BC. Emerging themes differed between urban and rural providers. Most urban providers worked within clinics and reported a supportive environment. Rural physicians, all providing surgical abortions within hospitals, reported challenging barriers to provision including operating room scheduling, anesthetist and nursing logistical issues, high demand for services, professional isolation, and scarcity of replacement abortion providers. Many rural providers identified a need to "fly under the radar'' in their small community. Discussion: This first study of experiences among rural and urban abortion providers in Canada identifies addressable challenges faced by rural physicians. Rural providers expressed a need for increased support from hospital administration and policy. Further challenges identified include a desire for continuing professional education opportunities, and for available replacement providers.	[Dressler, Jennifer; Maughn, Nanamma; Soon, Judith A.; Norman, Wendy V.] British Columbia Womens Hosp, Prov Hlth Serv Author, Womens Hlth Res Inst, Vancouver, BC, Canada; [Soon, Judith A.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Soon, Judith A.; Norman, Wendy V.] Univ British Columbia, Dept Family Practice, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Norman, WV (corresponding author), British Columbia Womens Hosp, Prov Hlth Serv Author, Womens Hlth Res Inst, Vancouver, BC, Canada.	wendy.norman@ubc.ca	Norman, Wendy V./D-6796-2015	Norman, Wendy V./0000-0003-4340-7882; Soon, Judith/0000-0002-5274-3223	Michael Smith Foundation for Health Research as a Career Investigator; Canadian Institutes of Health Research (CIHR)	Michael Smith Foundation for Health Research as a Career Investigator; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Infrastructure support was provided for the study team within the Women's Health Research Institute of the BC Women's Hospital and Health Centre, Vancouver, BC, Canada. During conduct of the study and data analysis Dr. Norman was supported as a Strategic Training Fellow in Interdisciplinary Primary Health Care Research by the Canadian Institutes of Health Research (CIHR) Strategic Training Program, TUTOR-PHC. During preparation of this manuscript she was supported by the Michael Smith Foundation for Health Research as a Career Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RH, 2010, CONTRACEPTION, V81, P531, DOI 10.1016/j.contraception.2010.01.001; Cessford TA, 2011, J OBSTET GYNAECOL CA, V33, P38, DOI 10.1016/S1701-2163(16)34771-5; Darney P D, 1993, Womens Health Issues, V3, P158, DOI 10.1016/S1049-3867(05)80250-6; Dehlendorf C, 2007, FAM MED, V39, P337; Espey E, 2008, CONTRACEPTION, V77, P205, DOI 10.1016/j.contraception.2007.11.011; Freedman L, 2010, CONTRACEPTION, V81, P525, DOI 10.1016/j.contraception.2010.01.003; Garcia M, 2008, J OBSTET GYNAECOL CA, V30, P59, DOI 10.1016/S1701-2163(16)32715-3; GRIMES DA, 1992, OBSTET GYNECOL, V80, P719; Henshaw K, 2003, PERSPECT SEX REPRO H, V35, P16; HENSHAW SK, 1995, FAM PLANN PERSPECT, V27, P54, DOI 10.2307/2135905; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P263, DOI 10.2307/2991501; Kaposy C, 2010, HEALTH CARE ANAL, V18, P17, DOI 10.1007/s10728-008-0101-0; Kumar V, 2010, FAM MED, V42, P41; MacIsaac L, 2012, CONTRACEPTION, V85, P294, DOI 10.1016/j.contraception.2011.06.014; Norman WV, 2011, CONTRACEPTION, V84, P316, DOI 10.1016/j.contraception.2011.05.054; Norman WV, 2012, CONTRACEPTION, V85, P185, DOI 10.1016/j.contraception.2011.06.009; Sethna C, 2013, WOMEN STUD INT FORUM, V38, P52, DOI 10.1016/j.wsif.2013.02.001; Statistics Canada, 2008, IND AB HOSP CLIN AG; Stats Canada, 2012, GEOGR UN CENS METR A; Steinauer JE, 2003, AM J OBSTET GYNECOL, V188, P1161, DOI 10.1067/mob.2003.309; Steinauer J, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.002; Steinauer J, 2009, CONTRACEPTION, V80, P74, DOI 10.1016/j.contraception.2008.12.015	22	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67070	10.1371/journal.pone.0067070	http://dx.doi.org/10.1371/journal.pone.0067070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	174IH	23840588	Green Published, Green Submitted, gold			2022-12-27	WOS:000321148400031
J	Khan, GA; Berglund, B; Khan, KM; Lindgren, PE; Fick, J				Khan, Ghazanfar Ali; Berglund, Bjorn; Khan, Kashif Maqbool; Lindgren, Per-Eric; Fick, Jerker			Occurrence and Abundance of Antibiotics and Resistance Genes in Rivers, Canal and near Drug Formulation Facilities - A Study in Pakistan	PLOS ONE			English	Article							WATER TREATMENT-PLANT; PRODUCTION WASTE-WATER; SOLID-PHASE EXTRACTION; VETERINARY ANTIBIOTICS; AQUATIC ENVIRONMENT; DRINKING-WATER; INTEGRONS; BACTERIA; PHARMACEUTICALS; METAL	Antibiotic resistance (AR) is a global phenomenon that has severe epidemiological ramifications world-wide. It has been suggested that antibiotics that have been discharged into the natural aquatic environments after usage or manufacture can promote the occurrence of antibiotic resistance genes (ARG). These environmental ARGs could serve as a reservoir and be horizontally transferred to human-associated bacteria and thus contribute to AR proliferation. The aim of this study was to investigate the anthropogenic load of antibiotics in Northern Pakistan and study the occurrence of ARGs in selected samples from this region. 19 sampling sites were selected; including six rivers, one dam, one canal, one sewage drain and four drug formulation facilities. Our results show that five of the rivers have antibiotic levels comparable to surface water measurements in unpolluted sites in Europe and the US. However, high levels of antibiotics could be detected in the downstream river in close vicinity of the 10 million city Lahore, 1100, 1700 and 2700 ng L-1 for oxytetracycline, trimethoprim, and sulfamethoxazole respectively. Highest detected levels were at one of the drug formulation facilities, with the measured levels of 1100, 4100, 6200, 7300, 8000, 27000, 28000 and 49000 ng L 21 of erythromycin, lincomycin, ciprofloxacin, ofloxacin, levofloxacin, oxytetracycline, trimethoprim and sulfamethoxazole respectively. ARGs were also detected at the sites and the highest levels of ARGs detected, sulI and dfrA1, were directly associated with the antibiotics detected at the highest concentrations, sulfamethoxazole and trimethoprim. Highest levels of both antibiotics and ARGs were seen at a drug formulation facility, within an industrial estate with a low number of local residents and no hospitals in the vicinity, which indicates that the levels of ARGs at this site were associated with the environmental levels of antibiotics.	[Khan, Ghazanfar Ali; Fick, Jerker] Umea Univ, Dept Chem, Umea, Sweden; [Berglund, Bjorn; Lindgren, Per-Eric] Linkoping Univ, Div Med Microbiol, Dept Clin & Expt Med, Linkoping, Sweden; [Khan, Kashif Maqbool] Univ Punjab, Coll Pharm, Lahore, Pakistan; [Lindgren, Per-Eric] Cty Hosp Ryhov, Jonkoping, Sweden	Umea University; Linkoping University; University of Punjab	Khan, GA (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	ghazanfar.ali.khan@chem.umu.se	Berglund Fick, Jerker/HDO-5788-2022	Fick, Jerker/0000-0002-3949-7371	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning FORMAS [210-2006-2132]; Foundation for Strategic Environmental Research (MISTRA)	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning FORMAS(Swedish Research Council Formas); Foundation for Strategic Environmental Research (MISTRA)	Research is funded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning FORMAS (contract no. 210-2006-2132) and in part by the Foundation for Strategic Environmental Research (MISTRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; Aminov RI, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00158; Baker-Austin C, 2006, TRENDS MICROBIOL, V14, P176, DOI 10.1016/j.tim.2006.02.006; Berg J, 2010, ENVIRON SCI TECHNOL, V44, P8724, DOI 10.1021/es101798r; Brown MG, 2009, MICROB ECOL, V57, P484, DOI 10.1007/s00248-008-9431-6; Cui CW, 2006, ENVIRON MONIT ASSESS, V121, P409, DOI 10.1007/s10661-005-9139-8; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; De Souza MJ, 2006, ECOTOXICOLOGY, V15, P379, DOI 10.1007/s10646-006-0068-2; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Fick J, 2009, ENVIRON TOXICOL CHEM, V28, P2522, DOI 10.1897/09-073.1; Graham DW, 2011, ENVIRON SCI TECHNOL, V45, P418, DOI 10.1021/es102473z; Guardabassi L, 1998, APPL ENVIRON MICROB, V64, P3499; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; Harris SJ, 2012, HUM ECOL RISK ASSESS, V18, P767, DOI 10.1080/10807039.2012.688702; Hoerger Corinne C., 2009, Integrated Environmental Assessment and Management, V5, P331, DOI 10.1897/IEAM_2008-049.1; HOLM JV, 1995, ENVIRON SCI TECHNOL, V29, P1415, DOI 10.1021/es00005a039; Kemper N, 2008, ECOL INDIC, V8, P1, DOI 10.1016/j.ecolind.2007.06.002; Khan GA, 2012, J PHARMACEUT BIOMED, V66, P24, DOI 10.1016/j.jpba.2012.02.011; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Kummerer K, 2009, J ENVIRON MANAGE, V90, P2354, DOI 10.1016/j.jenvman.2009.01.023; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Kummerer K, 2009, CHEMOSPHERE, V75, P435, DOI 10.1016/j.chemosphere.2008.12.006; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Larsson DGJ, 2007, J HAZARD MATER, V148, P751, DOI 10.1016/j.jhazmat.2007.07.008; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Li D, 2008, WATER RES, V42, P307, DOI 10.1016/j.watres.2007.07.016; Li D, 2008, ENVIRON TOXICOL CHEM, V27, P80, DOI 10.1897/07-080.1; Li D, 2010, APPL ENVIRON MICROB, V76, P3444, DOI 10.1128/AEM.02964-09; Li D, 2009, ENVIRON MICROBIOL, V11, P1506, DOI 10.1111/j.1462-2920.2009.01878.x; Lin AYC, 2008, CHEMOSPHERE, V74, P131, DOI 10.1016/j.chemosphere.2008.08.027; Martinez JL, 2009, ENVIRON POLLUT, V157, P2893, DOI 10.1016/j.envpol.2009.05.051; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Miteva VI, 2004, APPL ENVIRON MICROB, V70, P202, DOI 10.1128/AEM.70.1.202-213.2004; Nikolaou A, 2007, ANAL BIOANAL CHEM, V387, P1225, DOI 10.1007/s00216-006-1035-8; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Phillips PJ, 2010, ENVIRON SCI TECHNOL, V44, P4910, DOI 10.1021/es100356f; Prasse C, 2010, ENVIRON SCI TECHNOL, V44, P1728, DOI 10.1021/es903216p; Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es060413l; Rosewarne CP, 2010, FEMS MICROBIOL ECOL, V72, P35, DOI 10.1111/j.1574-6941.2009.00823.x; Saenz Y, 2004, ANTIMICROB AGENTS CH, V48, P3996, DOI 10.1128/AAC.48.10.3996-4001.2004; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; Segura PA, 2009, ENVIRON HEALTH PERSP, V117, P675, DOI 10.1289/ehp.11776; Sim WJ, 2011, CHEMOSPHERE, V82, P179, DOI 10.1016/j.chemosphere.2010.10.026; Stalder T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00119; Su HC, 2012, ENVIRON POLLUT, V169, P42, DOI 10.1016/j.envpol.2012.05.007; Zhang XX, 2009, APPL MICROBIOL BIOT, V82, P1169, DOI 10.1007/s00253-009-1886-y; Zuhlke S, 2004, J CHROMATOGR A, V1050, P201, DOI [10.1016/j.chroma.2004.08.051, 10.1016/S0021-9673(04)01401-3]	48	145	152	2	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e62712	10.1371/journal.pone.0062712	http://dx.doi.org/10.1371/journal.pone.0062712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840297	Green Published, gold, Green Submitted			2022-12-27	WOS:000321148400001
J	Bianco, G; Botte, V; Dubroca, L; d'Alcala, MR; Mazzocchi, MG				Bianco, Giuseppe; Botte, Vincenzo; Dubroca, Laurent; d'Alcala, Maurizio Ribera; Mazzocchi, Maria Grazia			Unexpected Regularity in Swimming Behavior of Clausocalanus furcatus Revealed by a Telecentric 3D Computer Vision System	PLOS ONE			English	Article							PSEUDODIAPTOMUS-ANNANDALEI COPEPODA; PLANKTONIC COPEPODS; MOTILITY PATTERNS; FORAGING BEHAVIOR; CALANOID COPEPODS; FEEDING-BEHAVIOR; ZOOPLANKTON; MOTION	Planktonic copepods display a large repertoire of motion behaviors in a three-dimensional environment. Two-dimensional video observations demonstrated that the small copepod Clausocalanus furcatus, one the most widely distributed calanoids at low to medium latitudes, presented a unique swimming behavior that was continuous and fast and followed notably convoluted trajectories. Furthermore, previous observations indicated that the motion of C. furcatus resembled a random process. We characterized the swimming behavior of this species in three-dimensional space using a video system equipped with telecentric lenses, which allow tracking of zooplankton without the distortion errors inherent in common lenses. Our observations revealed unexpected regularities in the behavior of C. furcatus that appear primarily in the horizontal plane and could not have been identified in previous observations based on lateral views. Our results indicate that the swimming behavior of C. furcatus is based on a limited repertoire of basic kinematic modules but exhibits greater plasticity than previously thought.	[Bianco, Giuseppe; Botte, Vincenzo; Dubroca, Laurent; d'Alcala, Maurizio Ribera; Mazzocchi, Maria Grazia] Stn Zool Anton Dohrn, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Bianco, G (corresponding author), Stn Zool Anton Dohrn, Naples, Italy.	Giuseppe.Bianco@biol.lu.se	Dubroca, Laurent/AAS-5187-2021; d'Alcala', Maurizio Ribera/B-7114-2012	Dubroca, Laurent/0000-0002-1861-0507; d'Alcala', Maurizio Ribera/0000-0002-5492-9961	Stazione Zoologica Anton Dohrn	Stazione Zoologica Anton Dohrn	This study is part of the Ph.D. thesis of G.B., University of Naples "Federico II", funded by the Stazione Zoologica Anton Dohrn. Funds for the video equipment were provided by the Center of Competence of Campania Region AMRA (Analisi e Monitoraggio del Rischio Ambientale). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bagoien E, 2005, MAR ECOL PROG SER, V300, P129, DOI 10.3354/meps300129; Bradski G., 2008, LEARNING OPENCV COMP; BROWMAN HI, 1989, J PLANKTON RES, V11, P1075, DOI 10.1093/plankt/11.5.1075; BUNDY MH, 1993, B MAR SCI, V53, P15; BUSKEY EJ, 1984, MAR BIOL, V79, P165, DOI 10.1007/BF00951825; Dur G, 2011, J EXP MAR BIOL ECOL, V402, P1, DOI 10.1016/j.jembe.2011.02.039; Dur G, 2011, HYDROBIOLOGIA, V666, P197, DOI 10.1007/s10750-010-0586-z; Dur G, 2010, J PLANKTON RES, V32, P423, DOI 10.1093/plankt/fbp141; Fragopoulu N, 2001, CRUSTACEANA, V74, P49, DOI 10.1163/156854001505433; GERRITSEN J, 1977, J FISH RES BOARD CAN, V34, P73, DOI 10.1139/f77-008; Hanning T., 2011, HIGH PRECISION CAMER; Hartley R., 2003, MULTIPLE VIEW GEOMET, Vsecond; Jahne B., 2004, PRACTICAL HDB IMAGE; Kehayias G, 1996, ICES J MAR SCI, V53, P837, DOI 10.1006/jmsc.1996.0105; Ki&DEG;rboe T., 2008, MECHANISTIC APPROACH; Kiorboe T, 2005, LIMNOL OCEANOGR, V50, P1999, DOI 10.4319/lo.2005.50.6.1999; Kiorboe T, 2011, BIOL REV, V86, P311, DOI 10.1111/j.1469-185X.2010.00148.x; Kiorboe T, 2011, J PLANKTON RES, V33, P677, DOI 10.1093/plankt/fbq159; Klopfenstein DR, 2004, MOL BIOL CELL, V15, P3729, DOI 10.1091/mbc.E04-04-0326; Kundu P. K, 1990, FLUID MECH; Mazzocchi MG, 2011, J PLANKTON RES, V33, P1163, DOI 10.1093/plankt/fbr017; Mazzocchi MG, 1999, J PLANKTON RES, V21, P1501, DOI 10.1093/plankt/21.8.1501; Mazzocchi MG, 1998, J PLANKTON RES, V20, P331, DOI 10.1093/plankt/20.2.331; Murdoch D, 2001, P 2 INT WORKSH DISTR; Paffenhofer GA, 1998, J MARINE SYST, V15, P457, DOI 10.1016/S0924-7963(97)00037-7; Paffenhofer GA, 2006, MAR ECOL PROG SER, V317, P187, DOI 10.3354/meps317187; Pattenhofer GA, 2006, MAR ECOL-EVOL PERSP, V27, P99, DOI 10.1111/j.1439-0485.2006.00086.x; Peralba A, 2004, ICES J MAR SCI, V61, P645, DOI 10.1016/j.icesjms.2004.03.019; Press W., 1992, NUMERICAL RECIPES FO; R Core Team, 2012, R LANG ENV STAT COMP; Schmitt FG, 2001, PHYSICA A, V301, P375, DOI 10.1016/S0378-4371(01)00429-0; Schnack-Schiel SB, 2010, DEEP-SEA RES PT II, V57, P2064, DOI 10.1016/j.dsr2.2010.09.010; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Strickler JR, 1998, PHILOS T R SOC B, V353, P671, DOI 10.1098/rstb.1998.0233; STRICKLER JR, 1982, SCIENCE, V218, P158, DOI 10.1126/science.218.4568.158; TISELIUS P, 1990, MAR ECOL PROG SER, V66, P23, DOI 10.3354/meps066023; Uttieri M, 2008, MAR BIOL, V153, P925, DOI 10.1007/s00227-007-0864-0; VANDUREN LA, 1995, MAR ECOL PROG SER, V126, P153, DOI 10.3354/meps126153; Viitasalo M, 1998, MAR ECOL PROG SER, V175, P129, DOI 10.3354/meps175129; Visser AW, 2006, OECOLOGIA, V148, P538, DOI 10.1007/s00442-006-0385-4; Watanabe M., 1996, Computer Vision - ECCV '96. 4th Eurpean Conference on Computer Proceedings, P439; Wiggert JD, 2005, J PLANKTON RES, V27, P1013, DOI 10.1093/plankt/fbi090	43	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67640	10.1371/journal.pone.0067640	http://dx.doi.org/10.1371/journal.pone.0067640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826331	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000095
J	Perez, SI; Tejedor, MF; Novo, NM; Aristide, L				Ivan Perez, S.; Tejedor, Marcelo F.; Novo, Nelson M.; Aristide, Leandro			Divergence Times and the Evolutionary Radiation of New World Monkeys (Platyrrhini, Primates): An Analysis of Fossil and Molecular Data	PLOS ONE			English	Article							MIDDLE MIOCENE; LA-VENTA; CLOCK; PHYLOGENIES; RODENTS; RATES; DIVERSIFICATION; SUBSTITUTION; DOLICHOCEBUS; SYSTEMATICS	The estimation of phylogenetic relationships and divergence times among a group of organisms is a fundamental first step toward understanding its biological diversification. The time of the most recent or last common ancestor (LCA) of extant platyrrhines is one of the most controversial among scholars of primate evolution. Here we use two molecular based approaches to date the initial divergence of the platyrrhine clade, Bayesian estimations under a relaxed-clock model and substitution rate plus generation time and body size, employing the fossil record and genome datasets. We also explore the robustness of our estimations with respect to changes in topology, fossil constraints and substitution rate, and discuss the implications of our findings for understanding the platyrrhine radiation. Our results suggest that fossil constraints, topology and substitution rate have an important influence on our divergence time estimates. Bayesian estimates using conservative but realistic fossil constraints suggest that the LCA of extant platyrrhines existed at ca. 29 Ma, with the 95% confidence limit for the node ranging from 27-31 Ma. The LCA of extant platyrrhine monkeys based on substitution rate corrected by generation time and body size was established between 21-29 Ma. The estimates based on the two approaches used in this study recalibrate the ages of the major platyrrhine clades and corroborate the hypothesis that they constitute very old lineages. These results can help reconcile several controversial points concerning the affinities of key early Miocene fossils that have arisen among paleontologists and molecular systematists. However, they cannot resolve the controversy of whether these fossil species truly belong to the extant lineages or to a stem platyrrhine clade. That question can only be resolved by morphology. Finally, we show that the use of different approaches and well supported fossil information gives a more robust divergence time estimate of a clade.	[Ivan Perez, S.; Aristide, Leandro] Consejo Nacl Invest Cient & Tecn, Museo La Plata, Div Antropoli, La Plata, Buenos Aires, Argentina; [Tejedor, Marcelo F.; Novo, Nelson M.] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon, Puerto Madryn, Chubut Province, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Museo La Plata; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Perez, SI (corresponding author), Consejo Nacl Invest Cient & Tecn, Museo La Plata, Div Antropoli, La Plata, Buenos Aires, Argentina.	iperez@fcnym.unlp.edu.ar	Aristide, Leandro/AES-1563-2022; Tejedor, Marcelo/AAU-4189-2021	Aristide, Leandro/0000-0001-9556-2783; Tejedor, Marcelo/0000-0003-3465-673X	FONCyT [PICT-2011-0307, PICT-2011-2520]	FONCyT(FONCyT)	Supported by grants from the FONCyT (PICT-2011-0307 to SIP and PICT-2011-2520 to MFT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine PO, 2012, P ROY SOC B-BIOL SCI, V279, P1319, DOI 10.1098/rspb.2011.1732; Aristide L, 2013, MOL PHYLOGENET EVOL; Babb PL, 2011, AM J PHYS ANTHROPOL, V146, P209, DOI 10.1002/ajpa.21567; Barroso CML, 1997, INT J PRIMATOL, V18, P651, DOI 10.1023/A:1026371408379; Benton Michael J., 2009, P35; Bertrand OC, 2012, AM MUS NOVIT, V3750; Bordas A. F., 1942, Physis Buenos Aires, V19, P265; Chiou KL, 2011, MOL PHYLOGENET EVOL, V59, P736, DOI 10.1016/j.ympev.2011.03.025; Delson E., 1984, P50; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fernandez-Duque E, 2003, BEHAV ECOL SOCIOBIOL, V54, P431, DOI 10.1007/s00265-003-0637-9; Fleagle JG, 2002, CAM S BIO EVOL ANTHR, V33, P161; Fleagle JG, 1983, MORPHOLOGIE EVOLUTIV, P141; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Fleagle JG, 2012, EARLY MIOCENE PALEOBIOLOGY IN PATAGONIA: HIGH-LATITUDE PALEOCOMMUNITIES OF THE SANTA CRUZ FORMATION, P41; Flynn JJ, 1998, TRENDS ECOL EVOL, V13, P449, DOI 10.1016/S0169-5347(98)01457-8; Frailey Carl David, 2004, Natural History Museum of Los Angeles County Science Series, V40, P71; Gibb GC, 2013, P NATL ACAD SCI USA, V110, pE611, DOI 10.1073/pnas.1217134110; Goin FJ, 2010, BONES CLONES BIOMES; Groves C.P., 2001, PRIMATE TAXONOMY; Hall T., 2004, BIOEDIT 7 0 0; Hartwig WC, 2002, CAM S BIO EVOL ANTHR, V33, P175; HARVEY PH, 1985, EVOLUTION, V39, P559, DOI 10.1111/j.1558-5646.1985.tb00395.x; HERSHKOVITZ P, 1970, Folia Primatologica, V12, P1, DOI 10.1159/000155278; Hodgson JA, 2009, P NATL ACAD SCI USA, V106, P5534, DOI 10.1073/pnas.0810346106; IUCN, 2012, IUCN RED LIST THREAT; Perez SI, 2012, MOL PHYLOGENET EVOL, V65, P621, DOI 10.1016/j.ympev.2012.07.014; Kay RF, 2004, ANAT REC PART A, V281A, P1157, DOI 10.1002/ar.a.20121; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; Kay RF, 1998, AM J PRIMATOL, V45, P317, DOI 10.1002/(SICI)1098-2345(1998)45:4<317::AID-AJP1>3.0.CO;2-Z; KAY RF, 1987, J HUM EVOL, V16, P173, DOI 10.1016/0047-2484(87)90075-3; Kay RF, 2008, J HUM EVOL, V54, P323, DOI 10.1016/j.jhevol.2007.09.002; Kay Richard F., 2010, P220; Kay RF, 2010, J HUM EVOL, V59, P218, DOI 10.1016/j.jhevol.2010.03.002; KINZEY WG, 1992, AM J PHYS ANTHROPOL, V88, P499, DOI 10.1002/ajpa.1330880406; KRAGLIEVICH JL, 1951, REV MUSEO ARGENTINO, V2, P57; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Lemey M., 2009, PHYLOGENETIC HDB PRA; Losos JB, 2011, AM NAT, V177, P709, DOI 10.1086/660020; LUCHTERHAND K, 1986, CR ACAD SCI II, V303, P1753; Madden Richard H., 1997, P499; Meldrum DJ, 1997, AM J PHYS ANTHROPOL, V102, P407, DOI 10.1002/(SICI)1096-8644(199703)102:3<407::AID-AJPA8>3.0.CO;2-R; O'Meara BC, 2012, ANNU REV ECOL EVOL S, V43, P267, DOI 10.1146/annurev-ecolsys-110411-160331; Opazo JC, 2006, MOL PHYLOGENET EVOL, V40, P274, DOI 10.1016/j.ympev.2005.11.015; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Perkins ME, 2012, EARLY MIOCENE PALEOBIOLOGY IN PATAGONIA: HIGH-LATITUDE PALEOCOMMUNITIES OF THE SANTA CRUZ FORMATION, P23; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Prufer K, 2013, P NATL ACAD SCI USA, V110, pE612, DOI 10.1073/pnas.1222027110; Rambaut A., 2007, TRACER V1 4; ROSENBERGER AL, 1991, INT J PRIMATOL, V12, P291, DOI 10.1007/BF02547590; Rosenberger AL, 2002, CAM S BIO EVOL ANTHR, V33, P151; ROSENBERGER AL, 1990, J HUM EVOL, V19, P209, DOI 10.1016/0047-2484(90)90017-6; ROSENBERGER AL, 1992, AM J PHYS ANTHROPOL, V88, P525, DOI 10.1002/ajpa.1330880408; ROSENBERGER AL, 1979, NATURE, V279, P416, DOI 10.1038/279416a0; Rosenberger AL, 2013, EVOLUTIONARY BIOL CO; Rosenberger AL, 2012, AM J PRIMATOL, V74, P692, DOI 10.1002/ajp.22037; Rosenberger AL, 2011, P ROY SOC B-BIOL SCI, V278, P67, DOI 10.1098/rspb.2010.1249; Rosenberger AL, 2010, J HUM EVOL, V59, P214, DOI 10.1016/j.jhevol.2010.03.003; Rosenberger Alfred L., 2009, P69, DOI 10.1007/978-0-387-78705-3_4; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; Schrago CG, 2007, AM J PHYS ANTHROPOL, V132, P344, DOI 10.1002/ajpa.20459; SETOGUCHI T, 1987, NATURE, V326, P692, DOI 10.1038/326692a0; Smith RJ, 1997, J HUM EVOL, V32, P523, DOI 10.1006/jhev.1996.0122; Steiper ME, 2012, P NATL ACAD SCI USA, V109, P6006, DOI 10.1073/pnas.1119506109; STIRTON R. A., 1951, UNIV CALIFORNIA PUBL BULL DEPT GEOL SCI, V28, P315; TAJIMA F, 1993, GENETICS, V135, P599; Takai M, 2001, ANTHROPOL SCI, V109, P289, DOI 10.1537/ase.109.289; Takai M, 2000, AM J PHYS ANTHROPOL, V111, P263, DOI 10.1002/(SICI)1096-8644(200002)111:2<263::AID-AJPA10>3.3.CO;2-Y; TAKAI M, 1994, J HUM EVOL, V27, P329, DOI 10.1006/jhev.1994.1049; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TATTERSALL I, 1987, FOLIA PRIMATOL, V49, P200, DOI 10.1159/000156323; Tejedor Marcelo F., 2008, Arquivos do Museu Nacional Rio de Janeiro, V66, P251; Tejedor MF, 2006, P NATL ACAD SCI USA, V103, P5437, DOI 10.1073/pnas.0506126103; Tejedor MF, 2013, REV MUSEO L IN PRESS; Vucetich Maria Guiomar, 1991, Revista Tecnica de Yacimientos Petroliferos Fiscales Bolivianos, V12, P625; Vucetich MG., 2010, PALEONTOLOGY GRAN BA, P189; Vucetich MG., 2010, PALEONTOLOGY GRAN BA, P202; Wiens John J., 2009, Journal of Biology (London), V8, P19, DOI 10.1186/jbiol112; Wildman DE, 2009, MOL PHYLOGENET EVOL, V53, P694, DOI 10.1016/j.ympev.2009.07.019; Wilke T, 2009, AM MALACOL BULL, V27, P25, DOI 10.4003/006.027.0203; Wilkinson RD, 2011, SYST BIOL, V60, P16, DOI 10.1093/sysbio/syq054; WU CI, 1985, P NATL ACAD SCI USA, V82, P1741, DOI 10.1073/pnas.82.6.1741; WYSS AR, 1993, NATURE, V365, P434, DOI 10.1038/365434a0; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024	89	55	57	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68029	10.1371/journal.pone.0068029	http://dx.doi.org/10.1371/journal.pone.0068029			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826358	Green Published, Green Submitted, gold			2022-12-27	WOS:000321150000112
J	Trattner, B; Gravot, CM; Grothe, B; Kunz, L				Trattner, Barbara; Gravot, Celine Marie; Grothe, Benedikt; Kunz, Lars			Metabolic Maturation of Auditory Neurones in the Superior Olivary Complex	PLOS ONE			English	Article							CYTOCHROME-OXIDASE ACTIVITY; EXPERIENCE-DEPENDENT REFINEMENT; HYPERPOLARIZING GLYCINE ACTION; COINCIDENCE-DETECTOR NEURONS; GERBIL MERIONES-UNGUICULATUS; INTERAURAL TIME DIFFERENCES; BRAIN-STEM; ENERGY-METABOLISM; POSTNATAL-DEVELOPMENT; TRAPEZOID BODY	Neuronal activity is energetically costly, but despite its importance, energy production and consumption have been studied in only a few neurone types. Neuroenergetics is of special importance in auditory brainstem nuclei, where neurones exhibit various biophysical adaptations for extraordinary temporal precision and show particularly high firing rates. We have studied the development of energy metabolism in three principal nuclei of the superior olivary complex (SOC) involved in precise binaural processing in the Mongolian gerbil (Meriones unguiculatus). We used immunohistochemistry to quantify metabolic markers for energy consumption (Na+/K+-ATPase) and production (mitochondria, cytochrome c oxidase activity and glucose transporter 3 (GLUT3)). In addition, we calculated neuronal ATP consumption for different postnatal ages (P0-90) based upon published electrophysiological and morphological data. Our calculations relate neuronal processes to the regeneration of Na+ gradients perturbed by neuronal firing, and thus to ATP consumption by Na+/K+-ATPase. The developmental changes of calculated energy consumption closely resemble those of metabolic markers. Both increase before and after hearing onset occurring at P12-13 and reach a plateau thereafter. The increase in Na+/K+-ATPase and mitochondria precedes the rise in GLUT3 levels and is already substantial before hearing onset, whilst GLUT3 levels are scarcely detectable at this age. Based on these findings we assume that auditory inputs crucially contribute to metabolic maturation. In one nucleus, the medial nucleus of the trapezoid body (MNTB), the initial rise in marker levels and calculated ATP consumption occurs distinctly earlier than in the other nuclei investigated, and is almost completed by hearing onset. Our study shows that the mathematical model used is applicable to brainstem neurones. Energy consumption varies markedly between SOC nuclei with their different neuronal properties. Especially for the medial superior olive (MSO), we propose that temporally precise input integration is energetically more costly than the high firing frequencies typical for all SOC nuclei.	[Trattner, Barbara; Gravot, Celine Marie; Grothe, Benedikt; Kunz, Lars] Univ Munich, Div Neurobiol, Dept Biol 2, Martinsried, Germany; [Trattner, Barbara; Gravot, Celine Marie] Univ Munich, Grad Sch System Neurosci, Martinsried, Germany	University of Munich; University of Munich	Trattner, B (corresponding author), Univ Munich, Div Neurobiol, Dept Biol 2, Martinsried, Germany.	trattner@bio.lmu.de; lars.kunz@bio.lmu.de	Grothe, Benedikt/A-7877-2010	Grothe, Benedikt/0000-0001-7317-0615	Graduate School of Systemic Neurosciences (GSN-LMU); Graduate School [1373]; DFG [CRC870/TPB13]	Graduate School of Systemic Neurosciences (GSN-LMU); Graduate School; DFG(German Research Foundation (DFG))	The authors thank the Graduate School of Systemic Neurosciences (GSN-LMU; http://www.gsn.uni-muenchen.de/index.html) and the Graduate School 1373 (DFG; http://www.dfg.de/en/index.jsp) for providing a grant to BT. This work was largely funded by the DFG (CRC870/TPB13; http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Attwell D, 2005, NAT REV NEUROSCI, V6, P841, DOI 10.1038/nrn1784; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Castro MA, 2009, J NEUROCHEM, V110, P423, DOI 10.1111/j.1471-4159.2009.06151.x; Chirila FV, 2007, J PHYSIOL-LONDON, V584, P167, DOI 10.1113/jphysiol.2007.137976; Crins TTH, 2011, J NEUROSCI, V31, P11706, DOI 10.1523/JNEUROSCI.1995-11.2011; CURTIS LM, 1993, EUR ARCH OTO-RHINO-L, V250, P265, DOI 10.1007/BF00186223; Dienel GA, 2001, J NEUROSCI RES, V66, P824, DOI 10.1002/jnr.10079; Ehrlich I, 1999, J PHYSIOL-LONDON, V520, P121, DOI 10.1111/j.1469-7793.1999.00121.x; Erecinska M, 2004, PROG NEUROBIOL, V73, P397, DOI 10.1016/j.pneurobio.2004.06.003; Ferreira JM, 2011, J NEUROSCI, V31, P1991, DOI 10.1523/JNEUROSCI.1850-09.2011; FINCK A, 1972, J COMP PHYSIOL PSYCH, V78, P375, DOI 10.1037/h0032373; Ford MC, 2009, J COMP NEUROL, V514, P92, DOI 10.1002/cne.21998; FORSYTHE ID, 1993, P ROY SOC B-BIOL SCI, V251, P151, DOI 10.1098/rspb.1993.0022; FRIAUF E, 1990, NEUROSCI LETT, V120, P58, DOI 10.1016/0304-3940(90)90167-8; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Gomez O, 2010, J ANAT, V217, P616, DOI 10.1111/j.1469-7580.2010.01291.x; GONZALEZLIMA F, 1994, BRAIN RES, V660, P34, DOI 10.1016/0006-8993(94)90836-2; GROTHE B, 1994, J NEUROSCI, V14, P1701, DOI 10.1523/JNEUROSCI.14-03-01701.1994; Grothe B, 1998, J NEUROSCI, V18, P6608; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; Hasenstaub A, 2010, P NATL ACAD SCI USA, V107, P12329, DOI 10.1073/pnas.0914886107; HEFFNER RS, 1988, BEHAV NEUROSCI, V102, P422, DOI 10.1037/0735-7044.102.3.422; Hermann J, 2007, J NEUROPHYSIOL, V98, P807, DOI 10.1152/jn.00355.2007; Hermann J, 2009, J NEUROPHYSIOL, V101, P20, DOI 10.1152/jn.90243.2008; Hertz L, 2002, INT REV NEUROBIOL, V51, P1, DOI 10.1016/S0074-7742(02)51003-5; HODGKIN A, 1975, PHILOS T ROY SOC B, V270, P297, DOI 10.1098/rstb.1975.0010; Hoffpauir BK, 2006, J NEUROSCI, V26, P5511, DOI 10.1523/JNEUROSCI.5525-05.2006; Horvath TL, 2009, TRENDS ENDOCRIN MET, V20, P78, DOI 10.1016/j.tem.2008.10.003; Howarth C, 2012, J CEREB BLOOD FLOW M; Howarth C, 2010, J CEREBR BLOOD F MET, V30, P403, DOI 10.1038/jcbfm.2009.231; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Joshi I, 2004, J NEUROSCI, V24, P183, DOI 10.1523/JNEUROSCI.1074-03.2004; Kaiser A, 2011, J COMP NEUROL, V519, P2758, DOI 10.1002/cne.22650; Kakazu Y, 1999, J NEUROSCI, V19, P2843; KANDLER K, 1995, EUR J NEUROSCI, V7, P1773, DOI 10.1111/j.1460-9568.1995.tb00697.x; Kandler K, 2004, CURR OPIN NEUROBIOL, V14, P96, DOI 10.1016/j.conb.2004.01.017; KANDLER K, 1995, J NEUROSCI, V15, P6890; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Kann O, 2003, NEUROSCIENCE, V119, P87, DOI 10.1016/S0306-4522(03)00026-5; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Khayat ZA, 1998, BIOCHEM J, V333, P713, DOI 10.1042/bj3330713; KIL J, 1995, J COMP NEUROL, V353, P317, DOI 10.1002/cne.903530302; Kim G, 2010, NEUROSCIENCE, V171, P924, DOI 10.1016/j.neuroscience.2010.09.054; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Kopp-Scheinpflug C, 2008, NEUROSCIENCE, V154, P160, DOI 10.1016/j.neuroscience.2008.01.088; Korf J, 2007, J NEUROCHEM, V103, P1697, DOI 10.1111/j.1471-4159.2007.04909.x; Lazarevic V, 2011, J NEUROSCI, V31, P10189, DOI 10.1523/JNEUROSCI.2088-11.2011; LEBOVITZ RM, 1989, EMBO J, V8, P193, DOI 10.1002/j.1460-2075.1989.tb03364.x; Leino RL, 1997, J NEUROSCI RES, V49, P617; Lesica NA, 2010, J NEUROSCI, V30, P11696, DOI 10.1523/JNEUROSCI.0846-10.2010; Lohrke S, 2005, EUR J NEUROSCI, V22, P2708, DOI 10.1111/j.1460-9568.2005.04465.x; Magnusson AK, 2005, J PHYSIOL-LONDON, V568, P497, DOI 10.1113/jphysiol.2005.094763; MANTYCH GJ, 1992, ENDOCRINOLOGY, V131, P1270, DOI 10.1210/en.131.3.1270; MULLER M, 1990, EXP BRAIN RES, V81, P140; Nakamura PA, 2011, HEARING RES, V276, P70, DOI 10.1016/j.heares.2010.11.004; Nawroth JC, 2007, J NEUROSCI, V27, P9790, DOI 10.1523/JNEUROSCI.1415-07.2007; Nehlig A, 1997, DIABETES METAB, V23, P18; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Pecka M, 2008, J NEUROSCI, V28, P6914, DOI 10.1523/JNEUROSCI.1660-08.2008; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PYSH JJ, 1970, BRAIN RES, V18, P325, DOI 10.1016/0006-8993(70)90332-X; Rautenberg PL, 2009, J COMP NEUROL, V517, P385, DOI 10.1002/cne.22166; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Ryugo DK, 2006, HEARING RES, V216, P100, DOI 10.1016/j.heares.2006.01.007; SANES DH, 1988, J NEUROSCI, V8, P682; SANES DH, 1992, DEV BRAIN RES, V67, P47, DOI 10.1016/0165-3806(92)90024-Q; Sanes DH, 2000, HEARING RES, V147, P46, DOI 10.1016/S0378-5955(00)00119-2; Schuchmann S, 2005, EUR J NEUROSCI, V21, P2721, DOI 10.1111/j.1460-9568.2005.04109.x; Scott LL, 2005, J NEUROSCI, V25, P7887, DOI 10.1523/JNEUROSCI.1016-05.2005; Seidl AH, 2005, J NEUROPHYSIOL, V94, P1028, DOI 10.1152/jn.01143.2004; SELIGMAN AM, 1968, J CELL BIOL, V38, P1, DOI 10.1083/jcb.38.1.1; Shetty PK, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00043; Smith PH, 1998, J NEUROPHYSIOL, V79, P3127, DOI 10.1152/jn.1998.79.6.3127; SOKOLOFF L, 1981, J CEREBR BLOOD F MET, V1, P7, DOI 10.1038/jcbfm.1981.4; Sonntag M, 2009, J NEUROSCI, V29, P9510, DOI 10.1523/JNEUROSCI.1377-09.2009; Taschenberger H, 2002, NEURON, V36, P1127, DOI 10.1016/S0896-6273(02)01137-6; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Tollin DJ, 2008, J NEUROSCI, V28, P4848, DOI 10.1523/JNEUROSCI.5421-07.2008; Tollin DJ, 2002, J NEUROSCI, V22, P1468, DOI 10.1523/JNEUROSCI.22-04-01468.2002; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Tritsch NX, 2010, NAT NEUROSCI, V13, P1050, DOI 10.1038/nn.2604; Tritsch NX, 2010, J NEUROSCI, V30, P1539, DOI 10.1523/JNEUROSCI.3875-09.2010; Tucci DL, 2002, JARO, V3, P89, DOI 10.1007/s101620010091; VANNUCCI RC, 1981, AM J PHYSIOL, V240, pR192, DOI 10.1152/ajpregu.1981.240.3.R192; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vannucci SJ, 1998, DEV NEUROSCI-BASEL, V20, P369, DOI 10.1159/000017333; Walcher J, 2011, J NEUROPHYSIOL; Waldvogel D, 2000, NATURE, V406, P995, DOI 10.1038/35023171; Werthat F, 2008, DEV NEUROBIOL, V68, P1454, DOI 10.1002/dneu.20660; WONGRILEY M, 1984, NATURE, V307, P262, DOI 10.1038/307262a0; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; WONGRILEY MTT, 1978, BRAIN RES, V141, P185, DOI 10.1016/0006-8993(78)90629-7; WONGRILEY MTT, 1989, VISUAL NEUROSCI, V2, P483, DOI 10.1017/S0952523800012384; WOOLF NK, 1985, DEV BRAIN RES, V17, P131, DOI 10.1016/0165-3806(85)90138-5; WOOLF NK, 1984, HEARING RES, V13, P277, DOI 10.1016/0378-5955(84)90081-9; WU SH, 1993, HEARING RES, V68, P189, DOI 10.1016/0378-5955(93)90123-I; Youssoufian M, 2008, J COMP NEUROL, V506, P442, DOI 10.1002/cne.21566; ZhuO J, 2005, J BIOL CHEM, V280, P16038, DOI 10.1074/jbc.M500054200	105	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67351	10.1371/journal.pone.0067351	http://dx.doi.org/10.1371/journal.pone.0067351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826275	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000066
J	Huang, Y; Guo, XG; Ho, SYW; Shi, HT; Li, JT; Li, J; Cai, B; Wang, YZ				Huang, Yong; Guo, Xianguang; Ho, Simon Y. W.; Shi, Haitao; Li, Jiatang; Li, Jun; Cai, Bo; Wang, Yuezhao			Diversification and Demography of the Oriental Garden Lizard (Calotes versicolor) on Hainan Island and the Adjacent Mainland	PLOS ONE			English	Article							ENVIRONMENTAL NICHE MODELS; POPULATION-GROWTH; GEOGRAPHIC DISTRIBUTIONS; GENETIC DIFFERENTIATION; DNA POLYMORPHISM; PHYLOGEOGRAPHY; EVOLUTION; DISTANCE; HISTORY; SUBSTITUTION	The Oriental garden lizard (Calotes versicolor) is one of the few non-gekkonid lizards that are geographically widespread in the tropics. We investigated its population dynamics on Hainan Island and the adjacent mainland of China and Vietnam, focusing on the impact of cyclic upheaval and submergence of land bridges during the Pleistocene. Our Bayesian phylogenetic analysis reveals two mitochondrial lineages, A and B, which are estimated to have coalesced about 0.26 million years ago (95% credibility interval: 0.05-0.61 million years ago). Lineage A contains individuals mainly from central and southern Wuzhi Mountain on Hainan Island, whereas lineage B mainly comprises individuals from other sites on the island plus the adjacent mainland. The estimated coalescence times within lineages A (0.05 million years ago) and B (0.13 million years ago) fall within a period of cyclical land-bridge formation and disappearance in the Pleistocene. A spatial analysis of molecular variance identified two distinct population groupings: I, primarily containing lineage A, and II, mainly consisting of lineage B. However, haplotypes from lineages A and B occur sympatrically, suggesting that gene flow is ongoing. Neither Wuzhi Mountain nor Qiongzhou Strait and Gulf of Tonkin act as barriers to gene flow among C. versicolor populations. Analyses of the data using mismatch distributions and extended Bayesian skyline plots provide evidence of a relatively stable population size through time for Group I, and moderate population expansions and contractions during the end of the Pleistocene for Group II. We conclude that the phylogeographical patterns of C. versicolor are the combined product of Pleistocene sea-level oscillations and nonphysical barriers to gene flow.	[Huang, Yong; Guo, Xianguang; Li, Jiatang; Li, Jun; Cai, Bo; Wang, Yuezhao] Chinese Acad Sci, Chengdu Inst Biol, Dept Herpetol, Chengdu, Sichuan, Peoples R China; [Huang, Yong] Guangxi Bot Garden Med Plants, Nanning, Guangxi, Peoples R China; [Ho, Simon Y. W.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Shi, Haitao] Hainan Normal Univ, Coll Life Sci, Haikou, Hainan, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; University of Sydney; Hainan Normal University	Wang, YZ (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Dept Herpetol, Chengdu, Sichuan, Peoples R China.	arcib@cib.ac.cn	Guo, Xianguang/C-3282-2013; Ho, Simon YW/A-8417-2008; Li, Jia-Tang/AAC-7626-2020	Guo, Xianguang/0000-0001-7721-7388; Ho, Simon YW/0000-0002-0361-2307; 	National Natural Science Foundation of China [31272281, 31071892]; Knowledge Innovative Program of the Chinese Academy of Sciences [KSCX2-EW-Q-6, KSCX2-EW-J-22]; Basic Research Program of the National Science and Technology [2006FY110500-3]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovative Program of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Basic Research Program of the National Science and Technology	This work was supported by the National Natural Science Foundation of China (31272281, 31071892), Knowledge Innovative Program of the Chinese Academy of Sciences (KSCX2-EW-Q-6, KSCX2-EW-J-22), and Basic Research Program of the National Science and Technology (2006FY110500-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BERTORELLE G, 1995, MOL BIOL EVOL, V12, P887; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Boulenger G. A., 1912, REPTILIA BATRACHIA; Crespi EJ, 2003, MOL ECOL, V12, P969, DOI 10.1046/j.1365-294X.2003.01797.x; Darwin C, 1859, ORIGIN SPECIES MEANS; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Endicott P, 2009, TRENDS ECOL EVOL, V24, P515, DOI 10.1016/j.tree.2009.04.006; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fontanella FM, 2008, MOL PHYLOGENET EVOL, V46, P1049, DOI 10.1016/j.ympev.2007.10.017; Fu YX, 1997, GENETICS, V147, P915; Godbout J, 2005, MOL ECOL, V14, P3497, DOI 10.1111/j.1365-294X.2005.02674.x; Graham CH, 2004, EVOLUTION, V58, P1781, DOI 10.1554/03-274; Gunther A.C.L.G., 1864, REPTILES BRIT INDIA; HARPENDING HC, 1994, HUM BIOL, V66, P591; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Huang ZH, 2010, MOL PHYLOGENET EVOL, V56, P273, DOI 10.1016/j.ympev.2010.01.028; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; IBM Corp, 2010, IBM SPSS STAT WIND V; Irwin DE, 2002, EVOLUTION, V56, P2383; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; KOHN AJ, 1982, MAR ECOL PROG SER, V9, P147, DOI 10.3354/meps009147; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin LH, 2010, MOL PHYLOGENET EVOL, V56, P601, DOI 10.1016/j.ympev.2010.04.032; Macdonald David W., 2001, P358; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Mao XG, 2010, MOL ECOL, V19, P2754, DOI 10.1111/j.1365-294X.2010.04704.x; Matyot Pat, 2004, Phelsuma, V12, P35; Nei M., 1987, MOL EVOLUTIONARY GEN; NEIGEL JE, 1993, GENETICS, V135, P1209; Pepper M, 2011, MOL PHYLOGENET EVOL, V61, P750, DOI 10.1016/j.ympev.2011.08.009; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pyron RA, 2010, J BIOGEOGR, V37, P2005, DOI 10.1111/j.1365-2699.2010.02336.x; Radder RS, 2006, CURR SCI INDIA, V91, P1354; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 1997, GENETICS, V145, P1219; Rutherford PL, 2003, J HERPETOL, V37, P98, DOI 10.1670/0022-1511(2003)037[0098:HUAMPO]2.0.CO;2; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; [施雅风 Shi Yafeng], 2002, [冰川冻土, Journal of Glaciology and Geocryology], V24, P687; Smith M.A., 1935, FAUNA BRIT INDIA INC, VII; Spiller DA, 1998, SCIENCE, V281, P695, DOI 10.1126/science.281.5377.695; Su Z., 2006, QUATERNARY GLACIATIO; Subramanian S, 2009, TRENDS GENET, V25, P482, DOI 10.1016/j.tig.2009.09.005; TAJIMA F, 1989, GENETICS, V123, P585; Tan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052089; Thuesen PA, 2008, J FISH BIOL, V72, P1174, DOI 10.1111/j.1095-8649.2007.01768.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wei L, 2010, BIOL J LINN SOC, V99, P582, DOI 10.1111/j.1095-8312.2009.01387.x; Wellenreuther M, 2012, ECOLOGY, V93, P1353; Wright S, 1943, GENETICS, V28, P114; Zamudio KR, 2003, EVOLUTION, V57, P1631; Zeng ZX, 1989, PHYS GEOGRAPHY HAINA; Zhang R. Z., 1999, ZOOGEOGRAPHY CHINA; Zhao E.M., 1999, FAUNA SINICA REPTILI; Zhao Huan-ting, 2007, Marine Geology & Quaternary Geology, V27, P33; Zug George R., 2006, Proceedings of the California Academy of Sciences, V57, P35	73	1	1	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e64754	10.1371/journal.pone.0064754	http://dx.doi.org/10.1371/journal.pone.0064754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840304	Green Published, Green Submitted, gold			2022-12-27	WOS:000321424400004
J	Schultz, NA; Christensen, IJ; Werner, J; Giese, N; Jensen, BV; Larsen, O; Bjerregaard, JK; Pfeiffer, P; Calatayud, D; Nielsen, SE; Yilmaz, MK; Hollander, NH; Wojdemann, M; Bojesen, SE; Nielsen, KR; Johansen, JS				Schultz, Nicolai A.; Christensen, Ib J.; Werner, Jens; Giese, Nathalia; Jensen, Benny V.; Larsen, Ole; Bjerregaard, Jon K.; Pfeiffer, Per; Calatayud, Dan; Nielsen, Svend E.; Yilmaz, Mette K.; Hollander, Niels H.; Wojdemann, Morten; Bojesen, Stig E.; Nielsen, Kaspar R.; Johansen, Julia S.			Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer	PLOS ONE			English	Article							PLASMA YKL-40; INTERLEUKIN-6 RECEPTOR; CHITINASE 3-LIKE-1; PROTEIN EXPRESSION; SIGNALING PATHWAY; MUSCLE ATROPHY; CELLS; ADENOCARCINOMA; INFLAMMATION; MARKER	Purpose: We tested the hypothesis that high plasma YKL-40 and IL-6 associate with pancreatic cancer and short overall survival. Patients and Methods: In all, 559 patients with pancreatic cancer from prospective biomarker studies from Denmark (n = 448) and Germany (n = 111) were studied. Plasma YKL-40 and IL-6 were determined by ELISAs and serum CA 19.9 by chemiluminescent immunometric assay. Results: Odds ratios (ORs) for prediction of pancreatic cancer were significant for all biomarkers, with CA 19.9 having the highest AUC (CA 19.9: OR = 2.28, 95% CI 1.97 to 2.68, p<0.0001, AUC = 0.94; YKL-40: OR = 4.50, 3.99 to 5.08, p<0.0001, AUC = 0.87; IL-6: OR = 3.68, 3.08 to 4.44, p < 0.0001, AUC = 0.87). Multivariate Cox analysis (YKL-40, IL-6, CA 19.9, age, stage, gender) in patients operated on showed that high preoperative IL-6 and CA 19.9 (dichotomized according to normal values) were independently associated with short overall survival (CA 19.9: HR = 2.51, 1.22-5.15, p = 0.013; IL-6: HR = 2.03, 1.11 to 3.70, p = 0.021). Multivariate Cox analysis of non-operable patients (Stage IIB-IV) showed that high pre-treatment levels of each biomarker were independently associated with short overall survival (YKL-40: HR = 1.30, 1.03 to 1.64, p = 0.029; IL-6: HR = 1.71, 1.33 to 2.20, p<0.0001; CA 19.9: HR = 1.54, 1.06 to 2.24, p = 0.022). Patients with preoperative elevation of both IL-6 and CA 19.9 had shorter overall survival (p<0.005) compared to patients with normal levels of both biomarkers (45% vs. 92% alive after 12 months). Conclusions: Plasma YKL-40 and IL-6 had less diagnostic impact than CA 19.9. Combination of pretreatment YKL-40, IL-6, and CA 19.9 may have clinical value to identify pancreatic cancer patients with the poorest prognosis.	[Schultz, Nicolai A.; Calatayud, Dan] Univ Copenhagen, Rigshosp, Dept Surg Gastroenterol & Transplantat, DK-2100 Copenhagen, Denmark; [Christensen, Ib J.] Univ Copenhagen, Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Christensen, Ib J.] Univ Copenhagen, Biotech Res & Innovat Ctr, Copenhagen, Denmark; [Werner, Jens; Giese, Nathalia] Heidelberg Univ, Dept Gen Visceral & Transplant Surg, Heidelberg, Germany; [Schultz, Nicolai A.; Jensen, Benny V.; Larsen, Ole] Copenhagen Univ Hosp, Dept Oncol, Herlev, Denmark; [Bjerregaard, Jon K.; Pfeiffer, Per] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark; [Nielsen, Svend E.] Hillerod Hosp, Hillerod, Denmark; [Yilmaz, Mette K.] Aalborg Univ Hosp, Dept Oncol, Aalborg, Denmark; [Hollander, Niels H.] Naestved Hosp, Dept Oncol, Naestved, Denmark; [Schultz, Nicolai A.; Wojdemann, Morten] Copenhagen Univ Hosp Herlev, Dept Surg Gastroenterol, Herlev, Denmark; [Bojesen, Stig E.] Copenhagen Univ Hosp Herlev, Dept Clin Biochem, Herlev, Denmark; [Schultz, Nicolai A.; Johansen, Julia S.] Copenhagen Univ Hosp Herlev, Dept Med, Herlev, Denmark; [Nielsen, Kaspar R.] Aalborg Univ Hosp, Dept Clin Immunol, Aalborg, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Ruprecht Karls University Heidelberg; University of Copenhagen; University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital; Naestved Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aalborg University; Aalborg University Hospital	Schultz, NA (corresponding author), Univ Copenhagen, Rigshosp, Dept Surg Gastroenterol & Transplantat, DK-2100 Copenhagen, Denmark.	nicolai-schultz@dadlnet.dk		Bojesen, Stig/0000-0002-4061-4133; Pfeiffer, Per/0000-0002-2925-0586; Bjerregaard, Jon Kroll/0000-0003-1088-7242; Wojdemann, Morten/0000-0002-1319-0187	Research Council at Herlev Hospital; Joint Proof-of-Concept Fund, the Ministry of Science, Technology and Innovation, Denmark; YKL-40 Foundation	Research Council at Herlev Hospital; Joint Proof-of-Concept Fund, the Ministry of Science, Technology and Innovation, Denmark; YKL-40 Foundation	The study was supported by grants from "The Research Council at Herlev Hospital'' and the ''Joint Proof-of-Concept Fund, the Ministry of Science, Technology and Innovation, Denmark''. Quidel provided the study with some of the YKL-40 ELISA kits. The study sponsors had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript. The authors had full access to all the data in the study and had the final responsibility for the decision to submit the manuscript for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare that the study was supported by grants from "The Research Council at Herlev Hospital" and the "Joint Proof-of-Concept Fund, the Ministry of Science, Technology and Innovation, Denmark''. Quidel provided the study with some of the YKL-40 ELISA kits. The study sponsors had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript. The authors had full access to all the data in the study and had the final responsibility for the decision to submit the manuscript for publication. There is no patent for plasma YKL-40 or IL-6 analysis for pancreatic cancer. Julia S. Johansen and Paul Price developed the monoclonal and the polyclonal antibodies used in the ELISA from Quidel. University of California, San Diego, USA has a patent regarding YKL-40 as a biomarker and receive royalties from Quidel. Julia S. Johansen does not receive royalties from UCSD, since she has donated all royalties to the "YKL-40 Foundation'' which donate travel grants to patients with cancer. For many years Julia S. Johansen received each year some YKL-40 kits from Quidel without cost, but she also bought some of the kits from Quidel. There is no contract between Julia S. Johansen and Quiedel.	Algul H, 2007, NAT CLIN PRACT GASTR, V8, P454; Ballehaninna UK, 2012, J GASTROINTEST ONCOL, V3, P105, DOI 10.3978/j.issn.2078-6891.2011.021; Barber MD, 1999, CLIN SCI, V96, P83, DOI 10.1042/CS19980185; Bojesen SE, 2011, CLIN CHIM ACTA, V412, P709, DOI 10.1016/j.cca.2011.01.022; Brochner CB, 2012, J HISTOCHEM CYTOCHEM, V60, P188, DOI 10.1369/0022155411433331; Chang ST, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-105; Chen CC, 2011, CLIN IMMUNOL, V140, P268, DOI 10.1016/j.clim.2011.04.007; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Dela Cruz CS, 2012, CELL HOST MICROBE, V12, P34, DOI 10.1016/j.chom.2012.05.017; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Ernst M, 2012, CLIN EXP PHARMACOL P, V39, P711, DOI 10.1111/j.1440-1681.2011.05659.x; Eurich K, 2009, WORLD J GASTROENTERO, V15, P5249, DOI 10.3748/wjg.15.5249; Faibish M, 2011, MOL CANCER THER, V10, P742, DOI 10.1158/1535-7163.MCT-10-0868; Francescone RA, 2011, J BIOL CHEM, V286, P15332, DOI 10.1074/jbc.M110.212514; Fujita J, 1996, INT J CANCER, V68, P637, DOI 10.1002/(SICI)1097-0215(19961127)68:5<637::AID-IJC14>3.0.CO;2-Z; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hamilton SR, 2000, WHO CLASSIFICATION T, P219; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He M, 2013, GUT, DOI 10.1136; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hogdall EVS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-8; Johansen JS, 2007, J HISTOCHEM CYTOCHEM, V55, P1213, DOI 10.1369/jhc.7A7245.2007; Johansen JS, 2009, FUTURE ONCOL, V5, P1065, DOI 10.2217/FON.09.66; Johansen JS, 2009, J CLIN ONCOL, V27, P572, DOI 10.1200/JCO.2008.18.8367; Junker N, 2005, CANCER SCI, V96, P183, DOI 10.1111/j.1349-7006.2005.00026.x; Kawada M, 2012, ONCOGENE, V31, P3111, DOI 10.1038/onc.2011.498; Knudsen LS, 2008, BIOMARKERS, V13, P59, DOI 10.1080/13547500701615017; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Martignoni ME, 2005, CLIN CANCER RES, V11, P5802, DOI 10.1158/1078-0432.CCR-05-0185; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Miyamoto Y, 2001, ANTICANCER RES, V21, P2449; Nielsen AR, 2011, CYTOKINE, V55, P152, DOI 10.1016/j.cyto.2011.03.014; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Recklies AD, 2002, BIOCHEM J, V365, P119, DOI 10.1042/BJ20020075; Rehli M, 1997, GENOMICS, V43, P221, DOI 10.1006/geno.1997.4778; Ringsholt M, 2007, J MOL HISTOL, V38, P33, DOI 10.1007/s10735-006-9075-0; Saidi A, 2008, INT J CANCER, V122, P2187, DOI 10.1002/ijc.23313; Schultz NA, 2013, INCREASES PLAS UNPUB; Schultz Nicolai A, 2010, Cancers (Basel), V2, P1453, DOI 10.3390/cancers2031453; Seufferlein T, 2012, ANN ONCOL, V23, P33, DOI 10.1093/annonc/mds224; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398; Wigmore SJ, 2002, INT J ONCOL, V21, P881; Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020; Yang JD, 2010, GUT LIVER, V4, P537, DOI 10.5009/gnl.2010.4.4.537	49	27	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67059	10.1371/journal.pone.0067059	http://dx.doi.org/10.1371/journal.pone.0067059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840582	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400066
J	Berle, D; Moulds, ML				Berle, David; Moulds, Michelle L.			Emotional Reasoning Processes and Dysphoric Mood: Cross-Sectional and Prospective Relationships`	PLOS ONE			English	Article							NONCLINICAL CHILDREN; ANXIETY; DEPRESSION; DISORDERS; PREDICTION; SYMPTOMS; DANGER	Emotional reasoning refers to the use of subjective emotions, rather than objective evidence, to form conclusions about oneself and the world [1]. Emotional reasoning appears to characterise anxiety disorders. We aimed to determine whether elevated levels of emotional reasoning also characterise dysphoria. In Study 1, low dysphoric (BDI-II <= 4; n = 28) and high dysphoric (BDI-II >= 14; n = 42) university students were administered an emotional reasoning task relevant for dysphoria. In Study 2, a larger university sample were administered the same task, with additional self-referent ratings, and were followed up 8 weeks later. In Study 1, both the low and high dysphoric participants demonstrated emotional reasoning and there were no significant differences in scores on the emotional reasoning task between the low and high dysphoric groups. In Study 2, self-referent emotional reasoning interpretations showed small-sized positive correlations with depression symptoms. Emotional reasoning tendencies were stable across an 8-week interval although not predictive of subsequent depressive symptoms. Further, anxiety symptoms were independently associated with emotional reasoning and emotional reasoning was not associated with anxiety sensitivity, alexithymia, or deductive reasoning tendencies. The implications of these findings are discussed, including the possibility that while all individuals may engage in emotional reasoning, self-referent emotional reasoning may be associated with increased levels of depressive symptoms.	[Berle, David; Moulds, Michelle L.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	University of New South Wales Sydney	Moulds, ML (corresponding author), Univ New S Wales, Sch Psychol, Sydney, NSW, Australia.	m.moulds@unsw.edu.au	Berle, David/O-3184-2014	Berle, David/0000-0002-4861-2220; Moulds, Michelle/0000-0001-7064-4248	Australian Research Fellowship from the Australian Research Council	Australian Research Fellowship from the Australian Research Council(Australian Research Council)	The studies reported in this paper were not supported by any external funding body or grant. MM is supported by an Australian Research Fellowship from the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; ANDREWS G, 2003, TREATMENT ANXIETY DI; ARNTZ A, 1995, BEHAV RES THER, V33, P917, DOI 10.1016/0005-7967(95)00032-S; Arntz A, 2004, BEHAV RES THER; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Beck A., 1993, BECK ANXIETY INVENTO; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, PSYCHOL ASSESS; Beck AT, 1985, ANXIETY DISORDERS PH; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown TA, 2001, J ABNORM PSYCHOL, V110, P585, DOI 10.1037//0021-843X.110.4.585; Engelhard IM, 2005, J BEHAV THER EXP PSY, V36, P35, DOI 10.1016/j.jbtep.2004.11.004; Engelhard IM, 2001, BEHAV RES THER, V39, P1339, DOI 10.1016/S0005-7967(00)00101-7; Forgas JP, 2008, PERSPECT PSYCHOL SCI, V3, P94, DOI 10.1111/j.1745-6916.2008.00067.x; Gangemi A, 2012, J BEHAV THER EXP PSY, V43, P1032, DOI 10.1016/j.jbtep.2012.04.005; HAAGA DAF, 1991, PSYCHOL BULL, V110, P215, DOI 10.1037/0033-2909.110.2.215; KOVACS M, 1978, AM J PSYCHIAT, V135, P525; Morren M, 2008, CHILD PSYCHIAT HUM D, V39, P351, DOI 10.1007/s10578-007-0091-4; Muris P, 2000, J PSYCHOPATHOL BEHAV, V22, P183, DOI 10.1023/A:1007588524525; Muris P, 2003, BEHAV RES THER, V41, P261, DOI 10.1016/S0005-7967(02)00005-0; Muris P, 2008, J BEHAV THER EXP PSY, V39, P73, DOI 10.1016/j.jbtep.2006.10.014; Muris P, 2010, J ANXIETY DISORD, V24, P612, DOI 10.1016/j.janxdis.2010.04.002; Nolen-Hoeksema S, 2008, PERSPECT PSYCHOL SCI, V3, P400, DOI 10.1111/j.1745-6924.2008.00088.x; NOLENHOEKSEMA S, 1991, J ABNORM PSYCHOL, V100, P569, DOI 10.1037/0021-843X.100.4.569; REISS S, 1986, BEHAV RES THER, V24, P1, DOI 10.1016/0005-7967(86)90143-9; Segal ZV, 2006, ARCH GEN PSYCHIAT, V63, P749, DOI 10.1001/archpsyc.63.7.749; WASON PC, 1968, Q J EXP PSYCHOL, V20, P273, DOI 10.1080/14640746808400161; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Weissman A.N., 1978, 62 ANN M AM ED RES A; Williams AD, 2007, BEHAV RES THER, V45, P2780, DOI 10.1016/j.brat.2007.07.001; Wisco BE, 2009, CLIN PSYCHOL REV, V29, P382, DOI 10.1016/j.cpr.2009.03.003	31	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67359	10.1371/journal.pone.0067359	http://dx.doi.org/10.1371/journal.pone.0067359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182JP	23826276	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400137
J	Clelland, CL; Read, LL; Panek, LJ; Nadrich, RH; Bancroft, C; Clelland, JD				Clelland, Catherine L.; Read, Laura L.; Panek, Laura J.; Nadrich, Robert H.; Bancroft, Carter; Clelland, James D.			Utilization of Never-Medicated Bipolar Disorder Patients towards Development and Validation of a Peripheral Biomarker Profile	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; DSM-IV DISORDERS; EARLY INTERVENTION; MAIN PITFALL; BLOOD; SCHIZOPHRENIA; MICROARRAY; ANTIDEPRESSANTS; CLASSIFICATION; UNDERDIAGNOSIS	There are currently no biological tests that differentiate patients with bipolar disorder (BPD) from healthy controls. While there is evidence that peripheral gene expression differences between patients and controls can be utilized as biomarkers for psychiatric illness, it is unclear whether current use or residual effects of antipsychotic and mood stabilizer medication drives much of the differential transcription. We therefore tested whether expression changes in first-episode, never-medicated BPD patients, can contribute to a biological classifier that is less influenced by medication and could potentially form a practicable biomarker assay for BPD. We employed microarray technology to measure global leukocyte gene expression in first-episode (n=3) and currently medicated BPD patients (n=26), and matched healthy controls (n=25). Following an initial feature selection of the microarray data, we developed a cross-validated 10-gene model that was able to correctly predict the diagnostic group of the training sample (26 medicated patients and 12 controls), with 89% sensitivity and 75% specificity (p<0.001). The 10-gene predictor was further explored via testing on an independent cohort consisting of three pairs of monozygotic twins discordant for BPD, plus the original enrichment sample cohort (the three never-medicated BPD patients and 13 matched control subjects), and a sample of experimental replicates (n=34). 83% of the independent test sample was correctly predicted, with a sensitivity of 67% and specificity of 100% (although this result did not reach statistical significance). Additionally, 88% of sample diagnostic classes were classified correctly for both the enrichment (p=0.015) and the replicate samples (p<0.001). We have developed a peripheral gene expression biomarker profile, that can classify healthy controls from patients with BPD receiving antipsychotic or mood stabilizing medication, which has both high sensitivity and specificity. Moreover, assay of three first-episode patients who had never received such medications, to first enrich the expression dataset for disease-related genes independent of medication effects, and then to test the 10-gene predictor, validates the peripheral biomarker approach for BPD.	[Clelland, Catherine L.] Columbia Univ, Dept Pathol, Med Ctr, New York, NY 10027 USA; [Clelland, Catherine L.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Med Ctr, New York, NY USA; [Read, Laura L.; Nadrich, Robert H.; Clelland, James D.] NYU, Dept Psychiat, Langone Med Ctr, New York, NY 10016 USA; [Read, Laura L.; Clelland, James D.] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA; [Nadrich, Robert H.] Bellevue Hosp Ctr, Dept Psychiat, New York, NY 10016 USA; [Bancroft, Carter] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY USA	Columbia University; Columbia University; New York University; NYU Langone Medical Center; Nathan Kline Institute for Psychiatric Research; Bellevue Hospital Center; Icahn School of Medicine at Mount Sinai	Clelland, CL (corresponding author), Columbia Univ, Dept Pathol, Med Ctr, New York, NY 10027 USA.	cc2786@columbia.edu	Clelland, Catherine/AAZ-8551-2021		National Institutes of Health (NIH) from the National Institute of Mental Health (NIMH) [R21MH066883, R21MH067941]; National Center for Research Resources (NCRR) [1UL1 RR029893]; NCRR [KL2 RR024157]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024157, UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH066883, R21MH067941] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the National Institute of Mental Health (NIMH); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants from the National Institutes of Health (NIH): Grant Numbers R21MH066883, and R21MH067941 from the National Institute of Mental Health (NIMH, to J. Clelland), Grant Number 1UL1 RR029893 from the National Center for Research Resources (NCRR), and Grant Number KL2 RR024157 (KL2 awardee C. Clelland), also from the NCRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official view of NIMH, NCRR or NIH.	Altamura AC, 2010, EUR ARCH PSY CLIN N, V260, P385, DOI 10.1007/s00406-009-0085-2; ALTSHULER LL, 1995, AM J PSYCHIAT, V152, P1130; Beech RD, 2010, BIPOLAR DISORD, V12, P813, DOI 10.1111/j.1399-5618.2010.00882.x; Berk M, 2007, MED J AUSTRALIA, V187, pS11; Berk M, 2011, BIPOLAR DISORD, V13, P87, DOI 10.1111/j.1399-5618.2011.00889.x; Berk M, 2010, J MENT HEALTH, V19, P113, DOI 10.3109/09638230903469111; Bolstad BM, 2005, STAT BIOL HEALTH, P33; Boulesteix AL, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-85; Bowden CL, 2001, PSYCHIAT SERV, V52, P51, DOI 10.1176/appi.ps.52.1.51; Bowden NA, 2006, SCHIZOPHR RES, V82, P175, DOI 10.1016/j.schres.2005.11.012; BRB Array Tools, BRB ARR TOOLS; Brickman AL, 2002, PSYCHIATR SERV, V53, P349, DOI 10.1176/appi.ps.53.3.349; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; COMBADIERE C, 1995, J BIOL CHEM, V270, P16491, DOI 10.1074/jbc.270.28.16491; Conus P, 2008, BIPOLAR DISORD, V10, P555, DOI 10.1111/j.1399-5618.2008.00610.x; Drzyzga L, 2006, BRAIN BEHAV IMMUN, V20, P532, DOI 10.1016/j.bbi.2006.02.002; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Duffy A, 2010, J AFFECT DISORDERS, V121, P127, DOI 10.1016/j.jad.2009.05.022; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; Ghaemi SN, 1999, J AFFECT DISORDERS, V52, P135, DOI 10.1016/S0165-0327(98)00076-7; Ghaemi SN, 2000, J CLIN PSYCHIAT, V61, P804, DOI 10.4088/JCP.v61n1013; Glangeaud-Freudenthal NMC, 2011, EUR PSYCHIAT, V26, P215, DOI 10.1016/j.eurpsy.2010.03.006; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; Gutierrez-Fernandez A, 2010, BIPOLAR DISORD, V12, P107, DOI 10.1111/j.1399-5618.2009.00776.x; Haack M, 1999, J PSYCHIATR RES, V33, P407, DOI 10.1016/S0022-3956(99)00021-7; Higgs BW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-70; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P161, DOI 10.4088/JCP.v64n0209; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kurian SM, 2011, MOL PSYCHIATR, V16, P37, DOI 10.1038/mp.2009.117; Le-Niculescu H, 2009, MOL PSYCHIATR, V14, P156, DOI 10.1038/mp.2008.11; LISH JD, 1994, J AFFECT DISORDERS, V31, P281, DOI 10.1016/0165-0327(94)90104-X; Lit L, 2012, PHARMACOGENOMICS J, V12, P368, DOI 10.1038/tpj.2011.23; Matigian N, 2007, MOL PSYCHIATR, V12, P815, DOI 10.1038/sj.mp.4001998; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Padmos RC, 2008, ARCH GEN PSYCHIAT, V65, P395, DOI 10.1001/archpsyc.65.4.395; Pollmacher T, 2000, J PSYCHIATR RES, V34, P369, DOI 10.1016/S0022-3956(00)00032-7; R Development Core Team, R LANG ENV STAT COMP; Ryan MM, 2006, MOL PSYCHIATR, V11, P965, DOI 10.1038/sj.mp.4001875; Rybakowski JK, 2000, PHARMACOPSYCHIATRY, V33, P159; Serretti A, 2008, MOL PSYCHIATR, V13, P742, DOI 10.1038/mp.2008.29; Simon R, 2007, CANCER INFORM, V3, P11; Smith DJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c854; Spijker S, 2010, BIOL PSYCHIAT, V68, P179, DOI 10.1016/j.biopsych.2010.03.017; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Tsuang MT, 2005, AM J MED GENET B, V133B, P1, DOI 10.1002/ajmg.b.30161; VALENZUELA DM, 1995, J NEUROSCI, V15, P6077; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Zimmerman M, 2008, J CLIN PSYCHIAT, V69, P935, DOI 10.4088/JCP.v69n0608; Zimmerman M, 2010, EXPERT REV NEUROTHER, V10, P1019, DOI 10.1586/ERN.10.64; Zimmerman M, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c855	57	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e69082	10.1371/journal.pone.0069082	http://dx.doi.org/10.1371/journal.pone.0069082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826396	Green Published, Green Submitted, gold			2022-12-27	WOS:000321738400181
J	Lambertucci, SA; Ruggiero, A				Lambertucci, Sergio A.; Ruggiero, Adriana			Cliffs Used as Communal Roosts by Andean Condors Protect the Birds from Weather and Predators	PLOS ONE			English	Article							VULTURE AEGYPIUS-MONACHUS; INFORMATION-CENTERS; POPULATION; CLIMATE; BEHAVIOR; SIZE; AGE; VARIABILITY; DISTURBANCE; SELECTION	The quality and availability of resources influence the geographical distribution of species. Social species need safe places to rest, meet, exchange information and obtain thermoregulatory benefits, but those places may also serve other important functions that have been overlooked in research. We use a large soaring bird that roosts communally in cliffs, the Andean condor (Vultur gryphus), as a model species to elucidate whether roost locations serve as a refuge from adverse weather conditions (climatic refuge hypothesis, CRH), and/or from predators or anthropogenic disturbances (threats refuge hypothesis, TRH). The CRH predicts that communal roosts will face in the opposite direction from where storms originate, and will be located in climatically stable, low precipitation areas. The TRH predicts that communal roosts will be large, poorly accessible cliffs, located far from human-made constructions. We surveyed cliffs used as communal roosts by condors in northwestern Patagonia, and compared them with alternative non-roosting cliffs to test these predictions at local and regional scales. We conclude that communal roosting places provide refuge against climate and disturbances such as, for instance, the threats of predators (including humans). Thus, it is not only the benefits gained from being aggregated per se, but the characteristics of the place selected for roosting that may both be essential for the survival of the species. This should be considered in management and conservation plans given the current scenario of global climate change and the increase in environmental disturbances.	[Lambertucci, Sergio A.; Ruggiero, Adriana] CONICET Univ Nacl Comahue, Lab Ecotono, INIBIOMA, San Carlos De Bariloche, Rio Negro, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue	Lambertucci, SA (corresponding author), CONICET Univ Nacl Comahue, Lab Ecotono, INIBIOMA, San Carlos De Bariloche, Rio Negro, Argentina.	slambertucci@comahue-conicet.gob.ar		LAMBERTUCCI, SERGIO/0000-0002-2624-2185	Agencia Nacional de Promocion Cientifca y Tecnica de Argentina (ANPCyT) [PICT 38148]	Agencia Nacional de Promocion Cientifca y Tecnica de Argentina (ANPCyT)	Funding provided by Agencia Nacional de Promocion Cientifca y Tecnica de Argentina (ANPCyT) PICT 38148. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2010, CONDOR, V112, P470, DOI 10.1525/cond.2010.090203; Allison P. D., 1999, LOGISTIC REGRESSION; BARTLETT RM, 1990, CAN J BOT, V68, P1931, DOI 10.1139/b90-254; Batschelet E, 1981, CIRCULAR STAT BIOL; Battin J, 2006, CONDOR, V108, P59, DOI 10.1650/0010-5422(2006)108[0059:CCATDA]2.0.CO;2; Bauer S, 2008, J ANIM ECOL, V77, P654, DOI 10.1111/j.1365-2656.2008.01381.x; Beauchamp G, 1999, BEHAV ECOL, V10, P675, DOI 10.1093/beheco/10.6.675; Blanco G, 1999, ANIM BEHAV, V57, P1219, DOI 10.1006/anbe.1999.1103; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carrete M, 2010, ANIM CONSERV, V13, P390, DOI 10.1111/j.1469-1795.2010.00352.x; CONOVER W. J, 1980, PRACTICAL NONPARAMET; De Martino E, 2009, ESTUDIO HOME RANGE E; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Donazar J.A., 1993, BUITRES IBERICOS BIO; Donazar JA, 1999, BEHAV ECOL SOCIOBIOL, V45, P55, DOI 10.1007/s002650050539; Donazar JA, 2002, CONDOR, V104, P832, DOI 10.1650/0010-5422(2002)104[0832:SSOACR]2.0.CO;2; EISERER LA, 1984, BIRD BEHAV, V5, P61; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Ellis DH, 2009, J RAPTOR RES, V43, P175, DOI 10.3356/JRR-08-110.1; Gelman A., 2007, DATA ANAL USING REGR; Hatchwell BJ, 2009, FUNCT ECOL, V23, P367, DOI 10.1111/j.1365-2435.2008.01511.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HIRALDO F, 1990, BIRD STUDY, V37, P128, DOI 10.1080/00063659009477048; Hooge PN, 1997, ANIMAL MOVEMENT EXTE; INDEC, 2002, CENS NAC AGR; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; KOFORD CB, 1966, CALIFORNIA CONDOR; Lambertucci SA, 2008, J FIELD ORNITHOL, V79, P147, DOI 10.1111/j.1557-9263.2008.00156.x; Lambertucci SA, 2008, J FIELD ORNITHOL, V79, P138, DOI 10.1111/j.1557-9263.2008.00155.x; Lambertucci SA, 2013, EMU, V113, P122, DOI 10.1071/MU12048; Lambertucci SA, 2010, ORYX, V44, P441, DOI 10.1017/S0030605310000451; Lambertucci SA, 2009, J RAPTOR RES, V43, P245, DOI 10.3356/JRR-08-108.1; Lambertucci SA, 2009, BIODIVERS CONSERV, V18, P2063, DOI 10.1007/s10531-008-9573-3; Larson D.W., 2000, CAMBRIDGE STUDIES EC; Margalida A, 2003, J RAPTOR RES, V37, P252; Martin TE, 2001, ECOLOGY, V82, P175, DOI 10.2307/2680095; Moran-lopez R, 2006, BIOL CONSERV, V130, P169, DOI 10.1016/j.biocon.2005.12.011; Newton I., 1979, POPULATION ECOLOGY R; Onichimowska Anna., 2012, KONIEC GRY; Paruelo Jose M., 1998, Ecologia Austral, V8, P85; PENNYCUICK CJ, 1984, IBIS, V126, P253, DOI 10.1111/j.1474-919X.1984.tb08005.x; Peters KA, 2007, J APPL ECOL, V44, P196, DOI 10.1111/j.1365-2664.2006.01248.x; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Saether BE, 2006, J ANIM ECOL, V75, P80, DOI 10.1111/j.1365-2656.2005.01023.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanchez-Zapata JA, 1999, J APPL ECOL, V36, P254, DOI 10.1046/j.1365-2664.1999.00396.x; Sarasola JH, 2005, J WILDLIFE DIS, V41, P643, DOI 10.7589/0090-3558-41.3.643; Sergio F, 2003, ANIM BEHAV, V66, P1109, DOI 10.1006/anbe.2003.2303; Shepard ELC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027375; Snyder NFR, 1986, NEST SITE BIOL CALIF, P228; Speziale KL, 2008, BIOL CONSERV, V141, P1765, DOI 10.1016/j.biocon.2008.04.017; Sutherland W. J., 2004, BIRD ECOLOGY CONSERV; Tilman D., 1982, Monographs in Population Biology, pi; Walker RS, 2003, LANDSCAPE ECOL, V18, P187; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; WEATHERHEAD PJ, 1983, AM NAT, V121, P237, DOI 10.1086/284053; Williams R.N., 1984, Raptor Research, V18, P153; Wright J, 2003, J ANIM ECOL, V72, P1003, DOI 10.1046/j.1365-2656.2003.00771.x; Zar, 2011, BIOSTAT ANAL	59	24	26	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67304	10.1371/journal.pone.0067304	http://dx.doi.org/10.1371/journal.pone.0067304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826262	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400131
J	Cobb, JE; Plant, D; Flynn, E; Tadjeddine, M; Dieude, P; Cornelis, F; Arlestig, L; Dahlqvist, SR; Goulielmos, G; Boumpas, DT; Sidiropoulos, P; Krintel, SB; Ornbjerg, LM; Hetland, ML; Klareskog, L; Haeupl, T; Filer, A; Buckley, CD; Raza, K; Witte, T; Schmidt, RE; FitzGerald, O; Veale, D; Eyre, S; Worthington, J				Cobb, Joanna E.; Plant, Darren; Flynn, Edward; Tadjeddine, Meriem; Dieude, Philippe; Cornelis, Francois; Arlestig, Lisbeth; Dahlqvist, Solbritt Rantapaa; Goulielmos, George; Boumpas, Dimitrios T.; Sidiropoulos, Prodromos; Krintel, Sophine B.; Ornbjerg, Lykke M.; Hetland, Merete L.; Klareskog, Lars; Haeupl, Thomas; Filer, Andrew; Buckley, Christopher D.; Raza, Karim; Witte, Torsten; Schmidt, Reinhold E.; FitzGerald, Oliver; Veale, Douglas; Eyre, Stephen; Worthington, Jane			Identification of the Tyrosine-Protein Phosphatase Non-Receptor Type 2 as a Rheumatoid Arthritis Susceptibility Locus in Europeans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PSORIATIC-ARTHRITIS; RISK LOCUS; POPULATION; DISEASE; COHORT	Objectives: Genome-wide association studies have facilitated the identification of over 30 susceptibility loci for rheumatoid arthritis (RA). However, evidence for a number of potential susceptibility genes have not so far reached genome-wide significance in studies of Caucasian RA. Methods: A cohort of 4286 RA patients from across Europe and 5642 population matched controls were genotyped for 25 SNPs, then combined in a meta-analysis with previously published data. Results: Significant evidence of association was detected for nine SNPs within the European samples. When meta-analysed with previously published data, 21 SNPs were associated with RA susceptibility. Although SNPs in the PTPN2 gene were previously reported to be associated with RA in both Japanese and European populations, we show genome-wide evidence for a different SNP within this gene associated with RA susceptibility in an independent European population (rs7234029, P = 4.4x10(-9)). Conclusions: This study provides further genome-wide evidence for the association of the PTPN2 locus (encoding the T cell protein tyrosine phosphastase) with Caucasian RA susceptibility. This finding adds to the growing evidence for PTPN2 being a pan-autoimmune susceptibility gene.	[Cobb, Joanna E.; Plant, Darren; Flynn, Edward; Eyre, Stephen; Worthington, Jane] Univ Manchester, Manchester Acad Hlth Sci Ctr, Cent Manchester Fdn Trust, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England; [Cobb, Joanna E.; Plant, Darren; Flynn, Edward; Eyre, Stephen; Worthington, Jane] Univ Manchester, Manchester Acad Hlth Sci Ctr, Cent Manchester Fdn Trust, NIHR Manchester Musculoskeletal BRU, Manchester, Lancs, England; [Tadjeddine, Meriem; Cornelis, Francois] GenHotel EA3886 4679, Auvergne, France; [Tadjeddine, Meriem; Cornelis, Francois] Evry Univ, Clermont Ferrand, France; [Dieude, Philippe] Hop Xavier Bichat, AP HP, Dept Rheumatol, Paris, France; [Dieude, Philippe] Hop Xavier Bichat, AP HP, INSERM, U699, Paris, France; [Dieude, Philippe] Univ Paris 07, Paris, France; [Arlestig, Lisbeth; Dahlqvist, Solbritt Rantapaa] Umea Univ, Inst Publ Hlth & Clin Med Rheumatol, Umea, Sweden; [Goulielmos, George; Boumpas, Dimitrios T.; Sidiropoulos, Prodromos] Univ Crete, Dept Med, Clin Rheumatol, Iraklion, Greece; [Krintel, Sophine B.; Ornbjerg, Lykke M.; Hetland, Merete L.] Univ Copenhagen, Glostrup Hosp, Fac Hlth Sci, DANBIO Registry,Dept Rheumatol, Glostrup, Denmark; [Klareskog, Lars] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Stockholm, Sweden; [Haeupl, Thomas] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany; [Filer, Andrew; Buckley, Christopher D.; Raza, Karim] Univ Birmingham, Rheumatol Res Grp, Birmingham, W Midlands, England; [Filer, Andrew; Buckley, Christopher D.; Raza, Karim] Sandwell & West Birmingham Hosp NHS Trust, Birmingham, W Midlands, England; [Witte, Torsten; Schmidt, Reinhold E.] Hannover Med Sch, Dept Immunol & Rheumatol, Hannover, Germany; [FitzGerald, Oliver; Veale, Douglas] Univ Coll Dublin, St Vincents Univ Hosp, UCD Sch Med & Med Sci, Dept Rheumatol, Dublin 2, Ireland; [FitzGerald, Oliver; Veale, Douglas] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	University of Manchester; University of Manchester; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Umea University; University of Crete; University of Copenhagen; Karolinska Institutet; Karolinska University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Birmingham; Hannover Medical School; University College Dublin; Saint Vincent's University Hospital; University College Dublin	Cobb, JE (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Cent Manchester Fdn Trust, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England.	joanna.cobb@manchester.ac.uk	Worthington, Jane/M-9770-2014; Witte, Torsten/B-5783-2016; Hetland, Merete L/AAE-5297-2019; Buckley, Christopher/AAN-6378-2021; Raza, Karim/AAN-3089-2021; eyre, stephen/K-3776-2017; Filer, Andrew/AAP-9179-2021	Worthington, Jane/0000-0003-0544-042X; Hetland, Merete L/0000-0003-4229-6818; Buckley, Christopher/0000-0001-6924-6402; Raza, Karim/0000-0003-1570-1232; eyre, stephen/0000-0002-1251-6974; Filer, Andrew/0000-0001-8164-6249; Klareskog, Lars/0000-0001-9601-6186; FitzGerald, Oliver/0000-0002-6607-6070; Cobb, Joanna/0000-0002-2760-3114; Veale, Douglas/0000-0003-2802-4971; Dieude, Philippe/0000-0002-4814-0307; Rantapaa Dahlqvist, Solbritt/0000-0001-8259-3863	European Community; Association Rhumatisme Travail; Versus Arthritis [20088, 19791] Funding Source: researchfish	European Community(European Commission); Association Rhumatisme Travail; Versus Arthritis(Versus Arthritis)	This research was funded by the European Community's Sixth Framework Programme AutoCure funding and the Association Rhumatisme & Travail. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bowes J, 2012, ANN RHEUM DIS, V71, P1350, DOI 10.1136/annrheumdis-2011-200802; Bowes J, 2011, ANN RHEUM DIS, V70, P1641, DOI 10.1136/ard.2011.150102; Chen R, 2011, GENES IMMUN, V12, P314, DOI 10.1038/gene.2011.8; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Hinks A, 2012, ANN RHEUM DIS, V71, P1117, DOI 10.1136/annrheumdis-2011-200814; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Okada Y, 2012, NAT GENET, V44, P511, DOI 10.1038/ng.2231; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Plant D, 2010, ANN RHEUM DIS, V69, P1548, DOI 10.1136/ard.2009.121020; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Thompson SD, 2010, ARTHRITIS RHEUM-US, V62, P3265, DOI 10.1002/art.27688; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Zikherman J, 2011, J CLIN INVEST, V121, P4618, DOI 10.1172/JCI60001	19	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66456	10.1371/journal.pone.0066456	http://dx.doi.org/10.1371/journal.pone.0066456			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840476	Green Published, gold, Green Submitted			2022-12-27	WOS:000322342800062
J	Neuser, F; Polack, M; Annaheim, C; Tucker, KL; Korte, M				Neuser, Franziska; Polack, Martin; Annaheim, Christine; Tucker, Kerry L.; Korte, Martin			Region-Specific Integration of Embryonic Stem Cell-Derived Neuronal Precursors into a Pre-Existing Neuronal Circuit	PLOS ONE			English	Article							NEUROTROPHIN RECEPTOR P75(NTR); HIPPOCAMPAL SLICE CULTURES; LONG-TERM DEPRESSION; FUNCTIONAL-INTEGRATION; ADULT NEUROGENESIS; PYRAMIDAL NEURONS; PROGENITORS; EXPRESSION; SURVIVAL; BEHAVIOR	Enduring reorganization is accepted as a fundamental process of adult neural plasticity. The most dramatic example of this reorganization is the birth and continuously occurring incorporation of new neurons into the pre-existing network of the adult mammalian hippocampus. Based on this phenomenon we transplanted murine embryonic stem (ES)-cell derived neuronal precursors (ESNPs) into murine organotypic hippocampal slice cultures (OHC) and examined their integration. Using a precise quantitative morphological analysis combined with a detailed electrophysiology, we show a region-specific morphological integration of transplanted ESNPs into different subfields of the hippocampal tissue, resulting in pyramidal neuron-like embryonic stem cell-derived neurons (ESNs) in the Cornu Ammonis (CA1 and CA3) and granule neuron-like ESNs in the dentate gyrus (DG), respectively. Subregion specific structural maturation was accompanied by the development of dendritic spines and the generation of excitatory postsynaptic currents (EPSCs). This cell type specific development does not depend upon NMDA-receptor-dependent synaptic transmission. The presented integration approach was further used to determine the cell-autonomous function of the pan-neurotrophin receptor p75 (P75(NTR)), as a possible negative regulator of ESN integration. By this means we used p75(NTR)-deficient ESNPs to study their integration into a WT organotypic environment. We show here that p75(NTR) is not necessary for integration per se but plays a suppressing role in dendritic development.	[Neuser, Franziska; Polack, Martin; Korte, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Cellular Neurobiol, Braunschweig, Germany; [Annaheim, Christine] Univ Basel, Bioctr Basel, Basel, Switzerland; [Tucker, Kerry L.] Heidelberg Univ, Inst Anat & Cell Biol, Interdisciplinary Ctr Neurosci, Heidelberg, Germany	Braunschweig University of Technology; University of Basel; Ruprecht Karls University Heidelberg	Korte, M (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Cellular Neurobiol, Pockelsstr 10A, Braunschweig, Germany.	m.korte@tu-bs.de			Georg-Christian-Lichtenberg program of the Land Niedersachsen	Georg-Christian-Lichtenberg program of the Land Niedersachsen	This work was supported by the Georg-Christian-Lichtenberg program of the Land Niedersachsen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman JB, 2006, J NEUROSCI, V26, P11413, DOI 10.1523/JNEUROSCI.3340-06.2006; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Benninger F, 2003, J NEUROSCI, V23, P7075, DOI 10.1523/JNEUROSCI.23-18-07075.2003; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bui NT, 2002, J NEUROCHEM, V81, P594, DOI 10.1046/j.1471-4159.2002.00841.x; Catts VS, 2008, EUR J NEUROSCI, V28, P883, DOI 10.1111/j.1460-9568.2008.06390.x; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Dijkhuizen PA, 2005, PROG BRAIN RES, V147, P17, DOI 10.1016/S0079-6123(04)47002-2; Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000; Gao L, 2005, BBA-GENE STRUCT EXPR, V1681, P175, DOI 10.1016/j.bbaexp.2004.10.008; Gogolla N, 2006, NAT PROTOC, V1, P1223, DOI 10.1038/nprot.2006.169; Gogolla N, 2006, NAT PROTOC, V1, P1165, DOI 10.1038/nprot.2006.168; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Ideguchi M, 2010, J NEUROSCI, V30, P894, DOI 10.1523/JNEUROSCI.4318-09.2010; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Marin-Burgin A, 2012, SCIENCE, V335, P1238, DOI 10.1126/science.1214956; McAllister A Kimberley, 2002, Results Probl Cell Differ, V39, P89; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Nikoletopoulou V, 2007, CELL STEM CELL, V1, P529, DOI 10.1016/j.stem.2007.08.011; Peljto M, 2010, CELL STEM CELL, V7, P355, DOI 10.1016/j.stem.2010.07.013; Plachta N, 2004, DEVELOPMENT, V131, P5449, DOI 10.1242/dev.01420; Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102; SHOLL DA, 1953, J ANAT, V87, P387; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Torre-Ubieta L, 2011, NEURON, V72, P22, DOI [10.1016/j.neuron.2011.09.018, DOI 10.1016/J.NEUR0N.2011.09.018]; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510; Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	38	2	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e66497	10.1371/journal.pone.0066497	http://dx.doi.org/10.1371/journal.pone.0066497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840491	gold, Green Submitted, Green Published			2022-12-27	WOS:000322342800071
J	Suspene, R; Aynaud, MM; Vartanian, JP; Wain-Hobson, S				Suspene, Rodolphe; Aynaud, Marie-Ming; Vartanian, Jean-Pierre; Wain-Hobson, Simon			Efficient Deamination of 5-Methylcytidine and 5-Substituted Cytidine Residues in DNA by Human APOBEC3A Cytidine Deaminase	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CYTOSINE DEAMINATION; MISMATCH REPAIR; FOREIGN DNA; NUCLEAR-DNA; VIF PROTEIN; IN-VIVO; HYPERMUTATION; HIV-1; RESTRICTION	Deamination of 5-methylcytidine (5MeC) in DNA results in a G: T mismatch unlike cytidine (C) deamination which gives rise to a G: U pair. Deamination of C was generally considered to arise spontaneously. It is now clear that human APOBEC3A (A3A), a polynucleotide cytidine deaminase (PCD) with specificity for single stranded DNA, can extensively deaminate human nuclear DNA. It is shown here that A3A among all human PCDs can deaminate 5-methylcytidine in a variety of single stranded DNA substrates both in vitro and in transfected cells almost as efficiently as cytidine itself. This ability of A3A to accommodate 5-methyl moiety extends to other small and physiologically relevant substituted cytidine bases such as 5-hydroxy and 5-bromocytidine. As 5MeCpG deamination hotspots characterize many genes associated with cancer it is plausible that A3A is a major player in the onset of cancer.	[Suspene, Rodolphe; Aynaud, Marie-Ming; Vartanian, Jean-Pierre; Wain-Hobson, Simon] Inst Pasteur, Mol Retrovirol Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wain-Hobson, S (corresponding author), Inst Pasteur, Mol Retrovirol Unit, Paris, France.	simon.wain-hobson@pasteur.fr		Vartanian, Jean-Pierre/0000-0001-8079-8814	Institut Pasteur; CNRS	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS))	The work was supported by grants from Institut Pasteur and the CNRS. The Molecular Retrovirology Unit is equipe labellisee par la Ligue pour la Recherche contre le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Brooks PJ, 1996, J NEUROSCI, V16, P939; BROWN TC, 1987, CELL, V50, P945, DOI 10.1016/0092-8674(87)90521-6; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Chen ZQ, 2011, PHYS CHEM CHEM PHYS, V13, P6471, DOI 10.1039/c0cp02783a; Coker HA, 2007, DNA REPAIR, V6, P235, DOI 10.1016/j.dnarep.2006.10.001; Davies MJ, 2011, J CLIN BIOCHEM NUTR, V48, P8, DOI 10.3164/jcbn.11-006FR; Delebecque F, 2006, J VIROL, V80, P605, DOI 10.1128/JVI.80.2.605-614.2006; Denissenko MF, 1997, P NATL ACAD SCI USA, V94, P3893, DOI 10.1073/pnas.94.8.3893; Derse D, 2007, P NATL ACAD SCI USA, V104, P2915, DOI 10.1073/pnas.0609444104; Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Henry M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004277; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Labet V, 2010, J PHYS CHEM A, V114, P1826, DOI 10.1021/jp9049044; Lane AE, 2010, BIOCHEM J, V430, P161, DOI 10.1042/BJ20100082; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Nabel CS, 2012, ACS CHEM BIOL, V7, P20, DOI 10.1021/cb2002895; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Noguchi C, 2005, HEPATOLOGY, V41, P626, DOI 10.1002/hep.20580; Rangam G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043279; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tsuge M, 2010, VIRUS RES, V149, P211, DOI 10.1016/j.virusres.2010.01.019; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Wijesinghe P, 2012, NUCLEIC ACIDS RES, V40, P9206, DOI 10.1093/nar/gks685; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950	41	39	41	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 20	2013	8	6							e63461	10.1371/journal.pone.0063461	http://dx.doi.org/10.1371/journal.pone.0063461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190LY	23840298	Green Published, Green Submitted, gold			2022-12-27	WOS:000322342800001
J	Carreras, C; Godley, BJ; Leon, YM; Hawkes, LA; Revuelta, O; Raga, JA; Tomas, J				Carreras, Carlos; Godley, Brendan J.; Leon, Yolanda M.; Hawkes, Lucy A.; Revuelta, Ohiana; Raga, Juan A.; Tomas, Jesus			Contextualising the Last Survivors: Population Structure of Marine Turtles in the Dominican Republic	PLOS ONE			English	Article							LOGGERHEAD SEA-TURTLES; MITOCHONDRIAL-DNA; HAWKSBILL TURTLES; CARETTA-CARETTA; CHELONIA-MYDAS; ERETMOCHELYS-IMBRICATA; CONSERVATION IMPLICATIONS; DERMOCHELYS-CORIACEA; MIGRATORY BEHAVIOR; GENETIC DIVERSITY	Nesting by three species of marine turtles persists in the Dominican Republic, despite historic threats and long-term population decline. We conducted a genetic survey of marine turtles in the Dominican Republic in order to link them with other rookeries around the Caribbean. We sequenced a 740(bp) fragment of the control region of the mitochondrial DNA of 92 samples from three marine turtle species [hawksbill (n = 48), green (n = 2) and leatherback (n = 42)], and incorporated published data from other nesting populations and foraging grounds. The leatherback turtle (Dermochelys coriacea) in the Dominican Republic appeared to be isolated from Awala-Yalimapo, Cayenne, Trinidad and St. Croix but connected with other Caribbean populations. Two distinct nesting populations of hawksbill turtles (Eremochelys imbricata) were detected in the Dominican Republic and exhibited interesting patterns of connectivity with other nesting sites and juvenile and adult male foraging aggregations. The green sea turtle (Chelonia mydas) has almost been extirpated from the Dominican Republic and limited inference could be made from our samples. Finally, results were compared with Lagrangian drifting buoys and published Lagrangian virtual particles that travelled through the Dominican Republic and Caribbean waters. Conservation implications of sink-source effects or genetic isolation derived from these complex inter-connections are discussed for each species and population.	[Carreras, Carlos; Godley, Brendan J.; Hawkes, Lucy A.; Tomas, Jesus] Univ Exeter, Ctr Ecol & Conservat, Penryn, England; [Leon, Yolanda M.] Grp Jaragua, Santo Domingo, Dominican Rep; [Leon, Yolanda M.] Inst Tecnol Santo Domingo, Santo Domingo, Dominican Rep; [Revuelta, Ohiana; Raga, Juan A.; Tomas, Jesus] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain	University of Exeter; Instituto Tecnologico de Santo Domingo (INTEC); University of Valencia	Carreras, C (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn, England.	carlos_c_h@hotmail.com	godley, brendan/O-1959-2019; Tomás, Jesús/AAA-4561-2019; godley, brendan j/A-6139-2009; Raga, Juan Antonio/L-7669-2014; Carreras, Carlos/B-6772-2012; Hawkes, Lucy/L-7407-2014	godley, brendan/0000-0003-3845-0034; godley, brendan j/0000-0003-3845-0034; Raga, Juan Antonio/0000-0003-2687-2539; Carreras, Carlos/0000-0002-2478-6445; Hawkes, Lucy/0000-0002-6696-1862; Tomas, Jesus/0000-0003-0120-7006	Spanish International Cooperation Agency (AECI) [A/2991/05, A/5641/06]; Spanish Ministry of Education and Sciences [CGL2006-02936-BOS]; General Foundation of the University of Valencia; European Union; NERC; Darwin Initiative; Biotechnology and Biological Sciences Research Council of the UK; 'Conselleria de Educacio' (Generalitat Valenciana) [Prometeo/2011/40]; Spanish Ministry of Sciences and Innovation [CGL2011-30413]	Spanish International Cooperation Agency (AECI); Spanish Ministry of Education and Sciences(Spanish Government); General Foundation of the University of Valencia; European Union(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Darwin Initiative; Biotechnology and Biological Sciences Research Council of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); 'Conselleria de Educacio' (Generalitat Valenciana)(Center for Forestry Research & Experimentation (CIEF)); Spanish Ministry of Sciences and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The present study is included as part of a conservation project funded by: the Spanish International Cooperation Agency (AECI, projects: A/2991/05 and A/5641/06), the Spanish Ministry of Education and Sciences (CGL2006-02936-BOS), the General Foundation of the University of Valencia, and the European Union (Marie Curie grants, FP6 & 7). BJG is supported by NERC and the Darwin Initiative. LAH is supported by the Biotechnology and Biological Sciences Research Council of the UK. JAR and JT are also supported by project Prometeo/2011/40 of 'Conselleria de Educacio' (Generalitat Valenciana) and project CGL2011-30413 of the Spanish Ministry of Sciences and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Grobois A, 2006, 26 ANN S SEA TURTL B, P179; Aucoin S, 2007, P GULF CARIBBEAN FIS, V60, P169; Bass AL, 2004, CONSERV GENET, V5, P783, DOI 10.1007/s10592-004-1979-1; Bass AL, 1996, MOL ECOL, V5, P321; Bass Anna L., 1999, Chelonian Conservation and Biology, V3, P195; Bass AL, 2006, J HERED, V97, P346, DOI 10.1093/jhered/esl004; Beggs Jennifer A., 2007, Endangered Species Research, V3, P159, DOI 10.3354/esr003159; Bjorndal KA, 2005, MAR BIOL, V147, P1449, DOI 10.1007/s00227-005-0045-y; Blumenthal JM, 2009, MOL ECOL, V18, P4841, DOI 10.1111/j.1365-294X.2009.04403.x; Bolker BM, 2007, MOL ECOL, V16, P685, DOI 10.1111/j.1365-294X.2006.03161.x; Bolten AB, 1998, ECOL APPL, V8, P1; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; Bowen BW, 2007, MOL ECOL, V16, P49, DOI 10.1111/j.1365-294X.2006.03096.x; Bowen BW, 2005, MOL ECOL, V14, P2389, DOI 10.1111/j.1365-294X.2005.02598.x; BOWEN BW, 1995, P NATL ACAD SCI USA, V92, P3731, DOI 10.1073/pnas.92.9.3731; Bowen BW, 2004, MOL ECOL, V13, P3797, DOI 10.1111/j.1365-294X.2004.02356.x; Browne DC, 2010, CONSERV GENET, V11, P1541, DOI 10.1007/s10592-009-9883-3; Cabin RJ., 2000, B ECOL SOC AM, V81, P246, DOI [DOI 10.2307/20168454, 10.2307/20168454]; Campagna C, 2006, DEEP-SEA RES PT I, V53, P1907, DOI 10.1016/j.dsr.2006.08.015; Carreras C, 2007, CONSERV GENET, V8, P761, DOI 10.1007/s10592-006-9224-8; Carreras C, 2006, MAR BIOL, V149, P1269, DOI 10.1007/s00227-006-0282-8; Carreras C, 2011, J HERED, V102, P666, DOI 10.1093/jhered/esr089; Chacon-Chaverri D, 2007, CHELONIAN CONSERV BI, V6, P101, DOI 10.2744/1071-8443(2007)6[101:LSTNAG]2.0.CO;2; Cotte C, 2007, P R SOC B, V274, P2385, DOI 10.1098/rspb.2007.0775; Cotte C, 2011, LIMNOL OCEANOGR, V56, P219, DOI 10.4319/lo.2011.56.1.0219; Diaz-Fernandez Rogelio, 1999, Chelonian Conservation and Biology, V3, P296; DiMatteo AD, 2009, SWOT DATABASE ONLINE; Dominguez TJ, 1994, P 14 ANN S SEA TURTL, P34; Dutton PH, 1999, J ZOOL, V248, P397, DOI 10.1111/j.1469-7998.1999.tb01038.x; Encalada SE, 1996, MOL ECOL, V5, P473; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feliz P, 2008, P 28 ANN SEA TURTL S, P247; FitzSimmons NN, 1997, GENETICS, V147, P1843; Fleming EH, 2001, SWIMMING TIDE RECENT; Formia A, 2006, CONSERV GENET, V7, P353, DOI 10.1007/s10592-005-9047-z; Fossette S, 2012, MAR ECOL PROG SER, V457, P285, DOI 10.3354/meps09581; Freake MJ, 2006, Q REV BIOL, V81, P327, DOI 10.1086/511528; Fu YX, 1997, GENETICS, V147, P915; Garofalo L, 2009, MAR BIOL, V156, P2085, DOI 10.1007/s00227-009-1239-5; Gaspar P, 2012, MAR ECOL PROG SER, V457, P265, DOI 10.3354/meps09689; Godley BJ, 2010, J APPL ECOL, V47, P769, DOI 10.1111/j.1365-2664.2010.01817.x; Goudet J, 1996, GENETICS, V144, P1933; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Hawkes LA, 2012, MAR ECOL PROG SER, V461, P223, DOI 10.3354/meps09778; Hays GC, 1997, CAN J ZOOL, V75, P40, DOI 10.1139/z97-005; Hays GC, 2013, FUNCT ECOL, V27, P748, DOI 10.1111/1365-2435.12073; Hays GC, 2010, J R SOC INTERFACE, V7, P1319, DOI 10.1098/rsif.2010.0009; Horton TW, 2011, BIOL LETTERS, V7, P674, DOI 10.1098/rsbl.2011.0279; Lahanas PN, 1998, MAR BIOL, V130, P345, DOI 10.1007/s002270050254; Laurent L, 1998, MOL ECOL, V7, P1529, DOI 10.1046/j.1365-294x.1998.00471.x; Lee PLM, 2008, J EXP MAR BIOL ECOL, V356, P25, DOI 10.1016/j.jembe.2007.12.021; Leon YM, 2004, THESIS U RHODE ISLAN; Leon Yolanda M., 1999, Chelonian Conservation and Biology, V3, P230; Leroux RA, 2012, J HERED, V103, P806, DOI 10.1093/jhered/ess055; Lohmann Kenneth J., 1997, P107; Lohmann KJ, 2008, P NATL ACAD SCI USA, V105, P19096, DOI 10.1073/pnas.0801859105; Lohmann KJ, 1999, ETHOL ECOL EVOL, V11, P1, DOI 10.1080/08927014.1999.9522838; Luke K, 2004, MAR BIOL, V144, P799, DOI 10.1007/s00227-003-1241-2; Meylan Anne B., 1999, Chelonian Conservation and Biology, V3, P200; Molfetti E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058061; Monzon-Arguello C, 2011, J EXP MAR BIOL ECOL, V407, P345, DOI 10.1016/j.jembe.2011.07.017; Monzon-Arguello C, 2010, J BIOGEOGR, V37, P1752, DOI 10.1111/j.1365-2699.2010.02326.x; Monzon-Arguello C, 2010, CONSERV GENET, V11, P1871, DOI 10.1007/s10592-010-0079-7; Monzon-Arguello C, 2010, J EXP MAR BIOL ECOL, V387, P9, DOI 10.1016/j.jembe.2010.03.004; Monzon-Arguello C, 2009, J EXP MAR BIOL ECOL, V373, P79, DOI 10.1016/j.jembe.2009.03.007; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Mortimer JA, 2007, MARINE TURTLE SPECIA; Mota JM, 2003, P 23 ANN S SEA TURTL, P197; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; Nei M, 1982, Prog Clin Biol Res, V103 Pt A, P167; Okuyama T, 2005, ECOL APPL, V15, P315, DOI 10.1890/03-5063; Ordonez C, 2007, CHELONIAN CONSERV BI, V6, P122, DOI 10.2744/1071-8443(2007)6[122:CBPTMI]2.0.CO;2; Ottenwalder J. A., 1981, THESIS U AUTONOMA SA; Ottenwalder JA, 1996, CONSERVATION MANAGEM; Patino-Martinez J, 2008, BIOL CONSERV, V141, P1982, DOI 10.1016/j.biocon.2008.05.012; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Powell R, 2009, APPL HERPETOL, V6, P103, DOI 10.1163/157075409X427153; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Putman NF, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0979; Putman NF, 2012, MAR BIOL, V159, P2117, DOI 10.1007/s00227-012-1995-5; Putman NF, 2012, J EXP BIOL, V215, P1863, DOI 10.1242/jeb.067587; Reuter A, 2006, TOURISTS TURTLES TRI; Revuelta O, 2012, ORYX, V46, P348, DOI 10.1017/S0030605311001529; Richardson PB, 2009, CHELONIAN CONSERV BI, V8, P192, DOI 10.2744/CCB-0871.1; Rolf DA, 1989, MOL BIOL EVOL, V6, P539; Ross J.P., 1983, P706; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schmidt J, 1923, NATURE, V111, P51, DOI 10.1038/111051a0; Scott R, 2012, MAR BIOL, V159, P481, DOI 10.1007/s00227-011-1825-1; Shamblin BM, 2011, MAR BIOL, V158, P571, DOI 10.1007/s00227-010-1582-6; Shillinger George L., 2012, Marine Ecology Progress Series, V457, P163; Shillinger GL, 2012, P ROY SOC B-BIOL SCI, V279, P2391, DOI 10.1098/rspb.2011.2348; Sleeman JC, 2010, J EXP MAR BIOL ECOL, V390, P84, DOI 10.1016/j.jembe.2010.05.009; Stam S, 1992, MARINE TURTLE NEWSLE, V57, P1921; Troeng S, 2005, ECOGRAPHY, V28, P394, DOI 10.1111/j.0906-7590.2005.04110.x; Troeng S, 2007, CHELONIAN CONSERV BI, V6, P117, DOI 10.2744/1071-8443(2007)6[117:LTNTAT]2.0.CO;2; Van Dam Robert P., 2008, Endangered Species Research, V4, P85, DOI 10.3354/esr00044; Vargas SM, 2008, J HERED, V99, P215, DOI 10.1093/jhered/esm120; Velez-Zuazo X, 2008, MOL ECOL, V17, P839, DOI 10.1111/j.1365-294X.2007.03635.x; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Wielgus J., 2010, COASTAL CAPITAL DOMI; ZAYKIN DV, 1993, J HERED, V84, P152, DOI 10.1093/oxfordjournals.jhered.a111304	106	13	13	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66037	10.1371/journal.pone.0066037	http://dx.doi.org/10.1371/journal.pone.0066037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840394	gold, Green Published			2022-12-27	WOS:000322361200051
J	Li, PF; Chen, L; Zhou, YH; Xia, XJ; Shi, K; Chen, ZX; Yu, JQ				Li, Pingfang; Chen, Li; Zhou, Yanhong; Xia, Xiaojian; Shi, Kai; Chen, Zhixiang; Yu, Jingquan			Brassinosteroids-Induced Systemic Stress Tolerance was Associated with Increased Transcripts of Several Defence-Related Genes in the Phloem in Cucumis sativus	PLOS ONE			English	Article							NODULE FORMATION; MESSENGER-RNA; ARABIDOPSIS; EXPRESSION; PLANTS; RESPONSES; TRAFFICKING; TRANSPORT; RANGE	Brassinosteroids (BRs), a group of naturally occurring plant steroidal compounds, are essential for plant growth, development and stress tolerance. Recent studies showed that BRs could induce systemic tolerance to biotic and abiotic stresses; however, the molecular mechanisms by which BRs signals lead to responses in the whole plant are largely unknown. In this study, 24-epibrassinosteroid (EBR)-induced systemic tolerance in Cucumis sativus L. cv. Jinyan No. 4 was analyzed through the assessment of symptoms of photooxidative stress by chlorophyll fluorescence imaging pulse amplitude modulation. Expression of defense/stress related genes were induced in both treated local leaves and untreated systemic leaves by local EBR application. With the suppressive subtractive hybridization (SSH) library using cDNA from the phloem sap of EBR-treated plants as the tester and distilled water (DW)-treated plants as the driver, 14 transcripts out of 260 clones were identified. Quantitative Real Time-Polymerase Chain Reaction (RT-qPCR) validated the specific up-regulation of these transcripts. Of the differentially expressed transcripts with known functions, transcripts for the selected four cDNAs, which encode an auxin-responsive protein (IAA14), a putative ankyrin-repeat protein, an F-box protein (PP2), and a major latex, pathogenesis-related (MLP)-like protein, were induced in local leaves, systemic leaves and roots after foliar application of EBR onto mature leaves. Our results demonstrated that EBR-induced systemic tolerance is accompanied with increased transcript of genes in the defense response in other organs. The potential role of phloem mRNAs as signaling components in mediating BR-regulated systemic resistance is discussed.	[Li, Pingfang; Chen, Li; Zhou, Yanhong; Xia, Xiaojian; Shi, Kai; Chen, Zhixiang; Yu, Jingquan] Zhejiang Univ, Dept Hort, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Jingquan] Minist Agr, Key Lab Hort Plants Growth Dev & Qual Improvement, Hangzhou, Zhejiang, Peoples R China; [Chen, Zhixiang] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA	Zhejiang University; Ministry of Agriculture & Rural Affairs; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zhou, YH (corresponding author), Zhejiang Univ, Dept Hort, Hangzhou 310003, Zhejiang, Peoples R China.	yanhongzhou@zju.edu.cn	Yu, J.Q./C-9509-2015	Yu, J.Q./0000-0002-7626-1165	National Basic Research Program of China [2009CB119000]; National Natural Science Foundation of China [31171999]; Program for New Century Excellent Talents in University	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Basic Research Program of China (2009CB119000), National Natural Science Foundation of China (31171999), and the Program for New Century Excellent Talents in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajguz A, 2009, PLANT PHYSIOL BIOCH, V47, P1, DOI 10.1016/j.plaphy.2008.10.002; Banerjee AK, 2006, PLANT CELL, V18, P3443, DOI 10.1105/tpc.106.042473; Blomster T, 2011, PLANT PHYSIOL, V157, P1866, DOI 10.1104/pp.111.181883; Dinant S, 2010, CR BIOL, V333, P307, DOI 10.1016/j.crvi.2010.01.006; Ding J, 2009, EUR J PLANT PATHOL, V124, P141, DOI 10.1007/s10658-008-9401-3; Fukaki H, 2005, PLANT J, V44, P382, DOI 10.1111/j.1365-313X.2005.02537.x; Goda H, 2002, PLANT PHYSIOL, V130, P1319, DOI 10.1104/pp.011254; Hardtke CS, 2007, TRENDS CELL BIOL, V17, P485, DOI 10.1016/j.tcb.2007.08.003; Haywood V, 2005, PLANT J, V42, P49, DOI 10.1111/j.1365-313X.2005.02351.x; Kagale S, 2007, PLANTA, V225, P353, DOI 10.1007/s00425-006-0361-6; Kanehira A, 2010, TREE GENET GENOMES, V6, P635, DOI 10.1007/s11295-010-0279-9; Kehr Julia, 2009, F1000 Biol Rep, V1, P31, DOI 10.3410/B1-31; Kim M, 2001, SCIENCE, V293, P287, DOI 10.1126/science.1059805; Krishna P, 2003, J PLANT GROWTH REGUL, V22, P289, DOI 10.1007/s00344-003-0058-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lough TJ, 2006, ANNU REV PLANT BIOL, V57, P203, DOI 10.1146/annurev.arplant.56.032604.144145; Lucas WJ, 2001, NAT REV MOL CELL BIO, V2, P849, DOI 10.1038/35099096; Mussig C, 2006, PLANT BIOLOGY, V8, P291, DOI 10.1055/s-2005-873043; Mussig C, 2002, PLANT PHYSIOL, V129, P1241, DOI 10.1104/pp.011003; Nakamura A, 2006, PLANT J, V45, P193, DOI 10.1111/j.1365-313X.2005.02582.x; Nakamura A, 2004, BIOSCI BIOTECH BIOCH, V68, P952, DOI 10.1271/bbb.68.952; Nakashita H, 2003, PLANT J, V33, P887, DOI 10.1046/j.1365-313X.2003.01675.x; Narise T, 2010, PLANT MOL BIOL, V72, P533, DOI 10.1007/s11103-009-9589-4; Omid A, 2007, J EXP BOT, V58, P3645, DOI 10.1093/jxb/erm214; Ruiz-Medrano R, 1999, DEVELOPMENT, V126, P4405; Ruiz-Medrano R, 2007, FUNCT PLANT BIOL, V34, P292, DOI 10.1071/FP06300; Sasse JM, 2003, J PLANT GROWTH REGUL, V22, P276, DOI 10.1007/s00344-003-0062-3; Shen GX, 2010, PLANT CELL, V22, P811, DOI 10.1105/tpc.109.065979; Symons GM, 2008, J EXP BOT, V59, P17, DOI 10.1093/jxb/erm098; Terakado J, 2006, J PLANT PHYSIOL, V163, P497, DOI 10.1016/j.jplph.2005.05.007; Terakado J, 2005, SOIL SCI PLANT NUTR, V51, P389, DOI 10.1111/j.1747-0765.2005.tb00044.x; van Bel AJE, 2002, TRENDS PLANT SCI, V7, P126, DOI 10.1016/S1360-1385(01)02225-7; Walz C, 2004, PHYTOCHEMISTRY, V65, P1795, DOI 10.1016/j.phytochem.2004.04.006; Xia XJ, 2011, NEW PHYTOL, V191, P706, DOI 10.1111/j.1469-8137.2011.03745.x; Xia XJ, 2009, PLANT PHYSIOL, V150, P801, DOI 10.1104/pp.109.138230; Yin YH, 2005, CELL, V120, P249, DOI 10.1016/j.cell.2004.11.044; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Zhao YD, 2003, SCIENCE, V301, P1107, DOI 10.1126/science.1084161	38	25	25	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66582	10.1371/journal.pone.0066582	http://dx.doi.org/10.1371/journal.pone.0066582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840504	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200093
J	Li, XM; Shen, QR; Zhang, DQ; Mei, XL; Ran, W; Xu, YC; Yu, GH				Li, Xiaoming; Shen, Qirong; Zhang, Dongqing; Mei, Xinlan; Ran, Wei; Xu, Yangchun; Yu, Guanghui			Functional Groups Determine Biochar Properties (pH and EC) as Studied by Two-Dimensional C-13 NMR Correlation Spectroscopy	PLOS ONE			English	Article							DIFFERENT PYROLYTIC TEMPERATURES; STRUCTURAL-PROPERTIES; CARBON; ADSORPTION; SORPTION	While the properties of biochar are closely related to its functional groups, it is unclear under what conditions biochar develops its properties. In this study, two-dimensional (2D) C-13 nuclear magnetic resonance (NMR) correlation spectroscopy was for the first time applied to investigate the development of functional groups and establish their relationship with biochar properties. The results showed that the agricultural biomass carbonized to biochars was a dehydroxylation/dehydrogenation and aromatization process, mainly involving the cleavage of O-alkylated carbons and anomeric O-C-O carbons in addition to the production of fused-ring aromatic structures and aromatic C-O groups. With increasing charring temperature, the mass cleavage of O-alkylated groups and anomeric O-C-O carbons occurred prior to the production of fused-ring aromatic structures. The regression analysis between functional groups and biochar properties (pH and electrical conductivity) further demonstrated that the pH and electrical conductivity of rice straw derived biochars were mainly determined by fused-ring aromatic structures and anomeric O-C-O carbons, but the pH of rice bran derived biochars was determined by both fused-ring aromatic structures and aliphatic O-alkylated (HCOH) carbons. In summary, this work suggests a novel tool for characterising the development of functional groups in biochars.	[Li, Xiaoming; Shen, Qirong; Mei, Xinlan; Ran, Wei; Xu, Yangchun; Yu, Guanghui] Minist Agr, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Nanjing, Jiangsu, Peoples R China; [Li, Xiaoming; Shen, Qirong; Mei, Xinlan; Ran, Wei; Xu, Yangchun; Yu, Guanghui] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Zhang, Dongqing] Baoshan Environm Protect Bur, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Yu, GH (corresponding author), Minist Agr, Key Lab Plant Nutr & Fertilizat Low Middle Reache, Nanjing, Jiangsu, Peoples R China.	yuguanghui@njau.edu.cn	Yu, Guanghui/H-4968-2013; Shen, Qirong/AAB-6531-2020	Yu, Guanghui/0000-0002-5699-779X; 	National Basic Research Program of China [2011CB100503]; National Natural Science Foundation of China [21007027]; 111 Project [B12009]; Qing Lan Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 Project(Ministry of Education, China - 111 Project); Qing Lan Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The work was funded by the National Basic Research Program of China (2011CB100503), the National Natural Science Foundation of China (21007027), the 111 Project (B12009), the Qing Lan Project of Jiangsu Province, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cantrell KB, 2012, BIORESOURCE TECHNOL, V107, P419, DOI 10.1016/j.biortech.2011.11.084; Cao XY, 2012, ENERG FUEL, V26, P5983, DOI 10.1021/ef300947s; Cao XY, 2011, ENERG FUEL, V25, P388, DOI 10.1021/ef101342v; Cao XD, 2011, ENVIRON SCI TECHNOL, V45, P4884, DOI 10.1021/es103752u; Chen BL, 2008, ENVIRON SCI TECHNOL, V42, P5137, DOI 10.1021/es8002684; Cheng HN, 2010, CARBON, V48, P2455, DOI 10.1016/j.carbon.2010.03.016; Freitas JCC, 1999, ENERG FUEL, V13, P53, DOI 10.1021/ef980075c; Hammes K, 2008, APPL GEOCHEM, V23, P2113, DOI 10.1016/j.apgeochem.2008.04.023; Harvey OR, 2011, ENVIRON SCI TECHNOL, V45, P5550, DOI 10.1021/es104401h; Keiluweit M, 2012, ENVIRON SCI TECHNOL, V46, P9333, DOI 10.1021/es302125k; Kinney TJ, 2012, BIOMASS BIOENERG, V41, P34, DOI 10.1016/j.biombioe.2012.01.033; Knicker H, 2008, ORG GEOCHEM, V39, P935, DOI 10.1016/j.orggeochem.2008.03.021; Lehmann J., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P403, DOI 10.1007/s11027-005-9006-5; Lehmann J, 2009, EARTHSCAN, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Manya JJ, 2012, ENVIRON SCI TECHNOL, V46, P7939, DOI 10.1021/es301029g; Mao JD, 2012, ENVIRON SCI TECHNOL, V46, P9571, DOI 10.1021/es301107c; Mao JD, 2002, INT J ENVIRON AN CH, V82, P183, DOI 10.1080/0306731029000953; Meyer S, 2011, ENVIRON SCI TECHNOL, V45, P9473, DOI 10.1021/es201792c; Mukherjee A, 2011, GEODERMA, V163, P247, DOI 10.1016/j.geoderma.2011.04.021; Noda I., 2004, 2 DIMENSIONAL CORREL; Rutherford DW, 2012, BIOMASS BIOENERG, V46, P693, DOI 10.1016/j.biombioe.2012.06.026; Wang LP, 2012, BIORESOURCE TECHNOL, V105, P88, DOI 10.1016/j.biortech.2011.11.064; Yu GH, 2012, ENVIRON SCI TECHNOL, V46, P6102, DOI 10.1021/es3002212; Yu GH, 2011, ENVIRON SCI TECHNOL, V45, P9224, DOI 10.1021/es201483f; Zhang GX, 2011, ENVIRON POLLUT, V159, P2594, DOI 10.1016/j.envpol.2011.06.012	26	113	121	12	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e65949	10.1371/journal.pone.0065949	http://dx.doi.org/10.1371/journal.pone.0065949			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840381	Green Published, gold, Green Submitted			2022-12-27	WOS:000322361200043
J	Reichwaldt, ES; Song, HH; Ghadouani, A				Reichwaldt, Elke S.; Song, Haihong; Ghadouani, Anas			Effects of the Distribution of a Toxic Microcystis Bloom on the Small Scale Patchiness of Zooplankton	PLOS ONE			English	Article							BLUE-GREEN-ALGAE; CYANOBACTERIAL BLOOMS; CRUSTACEAN ZOOPLANKTON; DAPHNIA-PULICARIA; CYLINDROSPERMOPSIS-RACIBORSKII; HORIZONTAL DISTRIBUTION; SPATIAL HETEROGENEITY; PHENOTYPIC PLASTICITY; WESTERN-AUSTRALIA; HABITAT SELECTION	Toxic cyanobacterial blooms can strongly affect freshwater food web structures. However, little is known about how the patchy occurrence of blooms within systems affects the spatial distribution of zooplankton communities. We studied this by analysing zooplankton community structures in comparison with the spatially distinct distribution of a toxic Microcystis bloom in a small, shallow, eutrophic lake. While toxic Microcystis was present at all sites, there were large spatial differences in the level of cyanobacterial biomass and in the zooplankton communities; sites with persistently low cyanobacterial biomass displayed a higher biomass of adult Daphnia and higher zooplankton diversity than sites with persistently high cyanobacterial biomass. While wind was the most likely reason for the spatially distinct occurrence of the bloom, our data indicate that it was the differences in cyanobacterial biomass that caused spatial differences in the zooplankton community structures. Overall, our study suggests that even in small systems with extensive blooms 'refuge sites' exist that allow large grazers to persist, which can be an important mechanism for a successful re-establishment of the biodiversity in an ecosystem after periods of cyanobacterial blooms.	[Reichwaldt, Elke S.; Song, Haihong; Ghadouani, Anas] Univ Western Australia, Sch Environm Syst Engn, Crawley, WA, Australia	University of Western Australia	Reichwaldt, ES (corresponding author), Univ Western Australia, Sch Environm Syst Engn, Crawley, WA, Australia.	elke.reichwaldt@uwa.edu.au	Ghadouani, Anas/A-2568-2008; Reichwaldt, Elke/A-4046-2012	Ghadouani, Anas/0000-0002-1252-4851; 	Australian Research Council Linkage Scheme [LP0776571]; Water Corporation of Western Australia	Australian Research Council Linkage Scheme(Australian Research Council); Water Corporation of Western Australia	This work was supported by the Australian Research Council Linkage Scheme (LP0776571) and the Water Corporation of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes N, 2006, ACTA OECOL, V29, P54, DOI 10.1016/j.actao.2005.07.006; Arnold TN, 1997, MAR FRESHWATER RES, V48, P531, DOI 10.1071/MF96088; BERTHON JL, 1995, HYDROBIOLOGIA, V300, P185, DOI 10.1007/BF00024460; Beutler M, 2002, PHOTOSYNTH RES, V72, P39, DOI 10.1023/A:1016026607048; BOON PI, 1994, AUST J MAR FRESH RES, V45, P875; Bouvy M, 2001, AQUAT MICROB ECOL, V25, P215, DOI 10.3354/ame025215; Brandl Z, 1998, J MARINE SYST, V15, P87, DOI 10.1016/S0924-7963(97)00042-0; Burks RL, 2002, FRESHWATER BIOL, V47, P343, DOI 10.1046/j.1365-2427.2002.00824.x; Cao HS, 2006, J FRESHWATER ECOL, V21, P231, DOI 10.1080/02705060.2006.9664991; Castro BB, 2007, FRESHWATER BIOL, V52, P421, DOI 10.1111/j.1365-2427.2006.01717.x; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Christoffersen Kirsten, 1996, Phycologia, V35, P42, DOI 10.2216/i0031-8884-35-6S-42.1; CUDDINGTON KM, 1994, CAN J ZOOL, V72, P1217, DOI 10.1139/z94-163; de Nie H.W., 1980, Journal of Plankton Research, V2, P317, DOI 10.1093/plankt/2.4.317; DEMOTT WR, 1991, ECOLOGY, V72, P1820, DOI 10.2307/1940981; DeMott WR, 2001, LIMNOL OCEANOGR, V46, P2054, DOI 10.4319/lo.2001.46.8.2054; Deng DG, 2008, LIMNOLOGY, V9, P1, DOI 10.1007/s10201-007-0229-x; Engstrom-Ost J, 2006, ENVIRON BIOL FISH, V76, P109, DOI 10.1007/s10641-006-9013-8; Engstrom-Ost J, 2009, J EXP MAR BIOL ECOL, V377, P54, DOI 10.1016/j.jembe.2009.06.020; Fabbro LD, 1996, MAR FRESHWATER RES, V47, P685, DOI 10.1071/MF9960685; FULTON RS, 1987, J PLANKTON RES, V9, P837, DOI 10.1093/plankt/9.5.837; FULTON RS, 1988, J PLANKTON RES, V10, P771, DOI 10.1093/plankt/10.4.771; GEORGE DG, 1981, FRESHWATER BIOL, V11, P37, DOI 10.1111/j.1365-2427.1981.tb01241.x; Ghadouani A, 2004, LIMNOL OCEANOGR, V49, P666, DOI 10.4319/lo.2004.49.3.0666; Ghadouani A, 2003, FRESHWATER BIOL, V48, P363, DOI 10.1046/j.1365-2427.2003.01010.x; Ghadouani A, 2002, J PLANKTON RES, V24, P1047, DOI 10.1093/plankt/24.10.1047; Ghadouani A, 2006, CAN J FISH AQUAT SCI, V63, P2308, DOI 10.1139/F06-117; GILBERT JJ, 1990, ECOLOGY, V71, P1727, DOI 10.2307/1937581; GRANT IF, 1983, HYDROBIOLOGIA, V106, P199, DOI 10.1007/BF00008117; Hairston NG, 2001, EVOLUTION, V55, P2203, DOI 10.1111/j.0014-3820.2001.tb00736.x; HANEY JF, 1973, LIMNOL OCEANOGR, V18, P331, DOI 10.4319/lo.1973.18.2.0331; Hansson LA, 2007, FRESHWATER BIOL, V52, P1290, DOI 10.1111/j.1365-2427.2007.01765.x; Hietala J, 1997, J PLANKTON RES, V19, P917, DOI 10.1093/plankt/19.7.917; Hietala J, 1997, FRESHWATER BIOL, V37, P299, DOI 10.1046/j.1365-2427.1997.d01-555.x; Hudnell KH, 2007, CYANOBACTERIAL HARMF; INFANTE A, 1984, HYDROBIOLOGIA, V113, P293, DOI 10.1007/BF00026615; IPCC, 2007, CONTRIBUTION WORKING; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; JACOBSEN BA, 1993, HYDROBIOLOGIA, V249, P9, DOI 10.1007/BF00008838; Kemp A, 2006, ENVIRON TOXICOL, V21, P125, DOI 10.1002/tox.20164; Kosten S, 2012, GLOBAL CHANGE BIOL, V18, P118, DOI 10.1111/j.1365-2486.2011.02488.x; KOTAK BG, 1995, J PHYCOL, V31, P248, DOI 10.1111/j.0022-3646.1995.00248.x; KREBS JR, 1993, ECOLOGICAL METHODOLO; LAMPERT W, 1981, INT REV GES HYDROBIO, V66, P285, DOI 10.1002/iroh.19810660302; LaurenMaatta C, 1997, J PLANKTON RES, V19, P141, DOI 10.1093/plankt/19.1.141; Legendre P, 2010, ECOLOGY, V91, P262, DOI 10.1890/09-0199.1; Lemaire V, 2012, EVOL APPL, V5, P168, DOI 10.1111/j.1752-4571.2011.00225.x; LIVINGSTONE DA, 1954, AM J SCI, V252, P547, DOI 10.2475/ajs.252.9.547; MALONE BJ, 1983, HYDROBIOLOGIA, V99, P101, DOI 10.1007/BF00015039; Martinick McNulty Pty Ltd, 2000, YANG LAK CATCHM WAT; MCCAULEY E, 1981, CAN J FISH AQUAT SCI, V38, P458, DOI 10.1139/f81-063; Moreno-Ostos E, 2009, INT REV HYDROBIOL, V94, P245, DOI 10.1002/iroh.200811123; Moustaka-Gouni M, 2006, LIMNOL OCEANOGR, V51, P715, DOI 10.4319/lo.2006.51.1_part_2.0715; Nang  Si SC, 2011, THESIS U W AUSTR CRA; Persson J, 2007, OIKOS, V116, P1152, DOI 10.1111/j.2007.0030-1299.15639.x; Pine-Alloul Bemadette, 2007, P203, DOI 10.1007/978-1-4020-6216-2_8; PINELALLOUL B, 1995, HYDROBIOLOGIA, V300, P17; Reichwaldt ES, 2008, FRESHWATER BIOL, V53, P872, DOI 10.1111/j.1365-2427.2007.01945.x; Reichwaldt ES, 2007, J PLANKTON RES, V29, P839, DOI 10.1093/plankt/fbm063; Reichwaldt ES, 2012, WATER RES, V46, P1372, DOI 10.1016/j.watres.2011.11.052; REINIKAINEN M, 1994, LIMNOL OCEANOGR, V39, P424, DOI 10.4319/lo.1994.39.2.0424; SANTER B, 1994, J PLANKTON RES, V16, P171, DOI 10.1093/plankt/16.2.171; Sinang SC, 2013, ENVIRON MONIT ASSESS, V185, P6379, DOI 10.1007/s10661-012-3031-0; STICH HB, 1981, NATURE, V293, P396, DOI 10.1038/293396a0; White MD, 1998, ECOGRAPHY, V21, P44, DOI 10.1111/j.1600-0587.1998.tb00393.x; Williams W. D., 1980, AUSTR FRESHWATER LIF	66	30	30	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66674	10.1371/journal.pone.0066674	http://dx.doi.org/10.1371/journal.pone.0066674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840516	Green Published, Green Submitted, gold			2022-12-27	WOS:000322361200098
J	Candelario, J; Chachisvilis, M				Candelario, Jose; Chachisvilis, Mirianas			Activity of Bradykinin B-2 Receptor Is Regulated by Long-Chain Polyunsaturated Fatty Acids	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTORS; FLUID SHEAR-STRESS; ENDOTHELIUM-DEPENDENT VASORELAXATION; PARATHYROID-HORMONE RECEPTOR; NITRIC-OXIDE SYNTHASE; EICOSAPENTAENOIC ACID; MYOCARDIAL-INFARCTION; MOLECULAR-MECHANISMS; ALLOSTERIC MACHINES; LIVING CELLS	The molecular and cellular mechanisms by which long-chain polyunsaturated fatty acids (LCPUFA) exert their beneficial effects on cardiovascular health remain obscure. While both LCPUFA and bradykinin (BK) signaling pathway play a role in the cardiovascular system, any direct link between the two is yet to be established. Using picosecond time-resolved fluorescence microscopy and a genetically engineered bradykinin B-2 receptor (B2R) sensor (B2K-CC), we detected LCPUFA-induced conformational responses in the B2R similar to those caused by its cognate ligand, BK. The selective B2R antagonist (HOE-140) blocked the eicosapentaenoic acid (EPA, C20:5, n-3) induced conformational response of the B2K-CC. Further analysis suggests that LCPUFA are capable of direct, B2R-dependent activation of extracellular ligand-regulated kinases (ERK). From a wide range of fatty acids studied, varying in chain length, saturation, and position of double bonds, EPA, docosahexaenoic (DHA, C22:6, n-3), docosadienoic (DDA, C22: 2, n-6), and dihomo-gamma linoleic (DGLA, C20: 3, n-6) fatty acids caused the highest ERK phosphorylation. EPA or DHA dependent ERK phosphorylation was inhibited by the selective B2R antagonist. We show that LCPUFA stimulates downstream signaling by B2R such as B2R-dependent phosphorylation and expression regulation of endothelial nitric-oxide synthase (eNOS). Further analysis indicated that LCPUFA also alters levels of the eNOS transcription factor, kruppel-like factor 2 (KLF2). Moreover we show that EPA increases membrane fluidity on the same time scale as B2R conformational response, suggesting that partitioning of LCPUFA into bilayer is a primary step required for receptor activation. In summary our data show that LCPUFA activate B2R receptor at nanomolar concentrations suggesting a novel molecular mechanism by which fatty acids may affect the cardiovascular system.	[Candelario, Jose; Chachisvilis, Mirianas] La Jolla Bioengn Inst, San Diego, CA 92121 USA	La Jolla Bioengineering Institute	Chachisvilis, M (corresponding author), La Jolla Bioengn Inst, San Diego, CA 92121 USA.	mirianas@alumni.caltech.edu			National Institutes of Health [HL86943, HL86943-S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants to MC from the National Institutes of Health (HL86943 and HL86943-S1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Baylin A, 2003, CIRCULATION, V107, P1586, DOI 10.1161/01.CIR.0000058165.81208.C6; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Bruno MJ, 2007, P NATL ACAD SCI USA, V104, P9638, DOI 10.1073/pnas.0701015104; Canals M, 2011, TRENDS BIOCHEM SCI, V36, P663, DOI 10.1016/j.tibs.2011.08.005; Candelario J, 2012, CELLUALR MO IN PRESS; Candelario J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052583; Candelario J, 2012, CELL MOL BIOENG, V5, P277, DOI 10.1007/s12195-012-0232-0; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Engler M B, 1994, J Cardiovasc Risk, V1, P75, DOI 10.1097/00043798-199406000-00012; Engler MB, 2000, BRIT J PHARMACOL, V131, P1793, DOI 10.1038/sj.bjp.0703754; Fan YY, 2003, J NUTR, V133, P1913, DOI 10.1093/jn/133.6.1913; Figueroa CD, 2001, HYPERTENSION, V37, P110, DOI 10.1161/01.HYP.37.1.110; FRIEDMAN MH, 1975, CIRC RES, V36, P277, DOI 10.1161/01.RES.36.2.277; Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico, 1999, LANCET, V354, P447; Gudi S, 1998, P NATL ACAD SCI USA, V95, P2515, DOI 10.1073/pnas.95.5.2515; Haidekker MA, 2001, CHEM BIOL, V8, P123, DOI 10.1016/S1074-5521(00)90061-9; Hamilton JA, 1999, DIABETES, V48, P2255, DOI 10.2337/diabetes.48.12.2255; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Kenakin T, 2004, RECEPTOR CHANNEL, V10, P51, DOI 10.1080/10606820490464316; Kenakin TP, 2012, BRIT J PHARMACOL, V165, P1659, DOI 10.1111/j.1476-5381.2011.01749.x; KLAUSNER RD, 1980, J BIOL CHEM, V255, P1286; Kramarenko II, 2009, BIOCHEM PHARMACOL, V77, P269, DOI 10.1016/j.bcp.2008.09.027; KULMACZ RJ, 1994, J BIOL CHEM, V269, P5527; LAWSON DL, 1991, EICOSANOIDS, V4, P217; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Lohse MJ, 2007, CURR OPIN PHARMACOL, V7, P547, DOI 10.1016/j.coph.2007.08.007; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Naseem Khalid M., 2005, Molecular Aspects of Medicine, V26, P33, DOI 10.1016/j.mam.2004.09.003; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Omura M, 2001, FEBS LETT, V487, P361, DOI 10.1016/S0014-5793(00)02351-6; OTTO JC, 1994, J BIOL CHEM, V269, P19868; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Poole KES, 2005, CURR OPIN PHARMACOL, V5, P612, DOI 10.1016/j.coph.2005.07.004; ROBINSON DR, 1993, J LIPID RES, V34, P1423; Saito J, 1997, ATHEROSCLEROSIS, V131, P219, DOI 10.1016/S0021-9150(97)00048-8; SALEM N, 1986, DOCOSAHEXAENOIC ACID; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Starke-Peterkovic T, 2005, AM J PHYSIOL-REG I, V288, pR663, DOI 10.1152/ajpregu.00434.2004; Storch U, 2012, AM J PHYSIOL-HEART C, V302, pH1241, DOI 10.1152/ajpheart.00818.2011; Tagawa H, 1999, J CARDIOVASC PHARM, V33, P633, DOI 10.1097/00005344-199904000-00017; Tarlton JF, 2013, BONE, V52, P578, DOI 10.1016/j.bone.2012.11.003; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Thompson AA, 2011, METHODS, V55, P310, DOI 10.1016/j.ymeth.2011.10.011; TRIFILIEFF A, 1992, J PHARMACOL EXP THER, V263, P1377; Turchiello RF, 2000, BIOPOLYMERS, V54, P211, DOI 10.1002/1097-0282(200009)54:3<211::AID-BIP70>3.0.CO;2-P; VANMETER AR, 1994, MECH AGEING DEV, V75, P95, DOI 10.1016/0047-6374(94)90079-5; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035508; Wyllie DJA, 2007, BRIT J PHARMACOL, V150, P541, DOI 10.1038/sj.bjp.0706997; YIN K, 1991, BRIT J PHARMACOL, V102, P991, DOI 10.1111/j.1476-5381.1991.tb12289.x; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang YL, 2009, AM J PHYSIOL-CELL PH, V296, pC1391, DOI 10.1152/ajpcell.00549.2008; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	67	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68151	10.1371/journal.pone.0068151	http://dx.doi.org/10.1371/journal.pone.0068151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826374	Green Submitted, gold, Green Published			2022-12-27	WOS:000321150000128
J	Khan, MA; Knox, N; Prashar, A; Alexander, D; Abdel-Nour, M; Duncan, C; Tang, P; Amatullah, H; Dos Santos, CC; Tijet, N; Low, DE; Pourcel, C; Van Domselaar, G; Terebiznik, M; Ensminger, AW; Guyard, C				Khan, Mohammad Adil; Knox, Natalie; Prashar, Akriti; Alexander, David; Abdel-Nour, Mena; Duncan, Carla; Tang, Patrick; Amatullah, Hajera; Dos Santos, Claudia C.; Tijet, Nathalie; Low, Donald E.; Pourcel, Christine; Van Domselaar, Gary; Terebiznik, Mauricio; Ensminger, Alexander W.; Guyard, Cyril			Comparative Genomics Reveal That Host-Innate Immune Responses Influence the Clinical Prevalence of Legionella pneumophila Serogroups	PLOS ONE			English	Article							SEQUENCE-BASED SCHEME; IV SECRETION SYSTEM; LEGIONNAIRES-DISEASE; O-ANTIGEN; ENVIRONMENTAL SURVEILLANCE; ESCHERICHIA-COLI; VIRULENCE SYSTEM; SERUM RESISTANCE; URINARY ANTIGEN; MURINE MODEL	Legionella pneumophila is the primary etiologic agent of legionellosis, a potentially fatal respiratory illness. Amongst the sixteen described L. pneumophila serogroups, a majority of the clinical infections diagnosed using standard methods are serogroup 1 (Sg1). This high clinical prevalence of Sg1 is hypothesized to be linked to environmental specific advantages and/or to increased virulence of strains belonging to Sg1. The genetic determinants for this prevalence remain unknown primarily due to the limited genomic information available for non-Sg1 clinical strains. Through a systematic attempt to culture Legionella from patient respiratory samples, we have previously reported that 34% of all culture confirmed legionellosis cases in Ontario (n = 351) are caused by non-Sg1 Legionella. Phylogenetic analysis combining multiple-locus variable number tandem repeat analysis and sequence based typing profiles of all non-Sg1 identified that L. pneumophila clinical strains (n = 73) belonging to the two most prevalent molecular types were Sg6. We conducted whole genome sequencing of two strains representative of these sequence types and one distant neighbour. Comparative genomics of the three L. pneumophila Sg6 genomes reported here with published L. pneumophila serogroup 1 genomes identified genetic differences in the O-antigen biosynthetic cluster. Comparative optical mapping analysis between Sg6 and Sg1 further corroborated this finding. We confirmed an altered O-antigen profile of Sg6, and tested its possible effects on growth and replication in in vitro biological models and experimental murine infections. Our data indicates that while clinical Sg1 might not be better suited than Sg6 in colonizing environmental niches, increased bloodstream dissemination through resistance to the alternative pathway of complement mediated killing in the human host may explain its higher prevalence.	[Khan, Mohammad Adil; Alexander, David; Abdel-Nour, Mena; Duncan, Carla; Tang, Patrick; Tijet, Nathalie; Low, Donald E.; Ensminger, Alexander W.; Guyard, Cyril] Publ Hlth Ontario, Toronto, ON, Canada; [Khan, Mohammad Adil; Alexander, David; Abdel-Nour, Mena; Low, Donald E.; Guyard, Cyril] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Knox, Natalie; Terebiznik, Mauricio] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Prashar, Akriti; Van Domselaar, Gary] Univ Toronto, Scarborough, ON M1C 1A4, Canada; [Amatullah, Hajera; Dos Santos, Claudia C.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Low, Donald E.; Guyard, Cyril] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Pourcel, Christine] Univ Paris 11, Inst Genet & Microbiol, Paris, France; [Ensminger, Alexander W.] Univ Toronto, Fac Med, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; Public Health Agency of Canada; University of Toronto; University Toronto Scarborough; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; UDICE-French Research Universities; Universite Paris Saclay; University of Toronto	Guyard, C (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.	cyril.guyard@oahpp.ca	Pourcel, Christine/E-4949-2017	Pourcel, Christine/0000-0002-8951-466X; Ensminger, Alexander/0000-0003-0824-3704; Abdel-Nour, Mena/0000-0003-2492-0736; Prashar, Akriti/0000-0002-1320-362X; dos Santos, Claudia/0000-0002-6446-8791; Knox, Natalie/0000-0001-6133-7799	Ontario Agency for Health Protection and Promotion; Canadian Institutes of Health Research [MOP-102514]; Natural Sciences and Engineering Research Council of Canada; Ontario Association of Medical Laboratories grants	Ontario Agency for Health Protection and Promotion; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Association of Medical Laboratories grants	This work was supported by the Ontario Agency for Health Protection and Promotion (http://www.oahpp.ca/) and the Canadian Institutes of Health Research (MOP-102514) (http://www.cihr-irsc.gc.ca/). AP and MT are supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) and the Ontario Association of Medical Laboratories grants (http://www.oaml.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Kwaik Y, 1998, APPL ENVIRON MICROB, V64, P3127; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaro F, 2012, J BACTERIOL, V194, P1613, DOI 10.1128/JB.06626-11; Arakawa K, 2007, EVOL BIOINFORM, V3, P159; Badger JH, 1999, MOL BIOL EVOL, V16, P512, DOI 10.1093/oxfordjournals.molbev.a026133; BARKER J, 1994, MICROBIOL-UK, V140, P1253, DOI 10.1099/00221287-140-6-1253; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BELLINGERKAWAHARA C, 1990, J EXP MED, V172, P1201, DOI 10.1084/jem.172.4.1201; Berk SG, 1998, APPL ENVIRON MICROB, V64, P279; Berk SG, 2008, APPL ENVIRON MICROB, V74, P2187, DOI 10.1128/AEM.01214-07; Boccia S, 2006, INFECT CONT HOSP EP, V27, P459, DOI 10.1086/503642; BRIELAND J, 1994, AM J PATHOL, V145, P1537; Brieland JK, 1997, INFECT IMMUN, V65, P5330, DOI 10.1128/IAI.65.12.5330-5333.1997; Canals R, 2007, J BACTERIOL, V189, P540, DOI 10.1128/JB.01260-06; Carratala J, 2010, CURR OPIN INFECT DIS, V23, P152, DOI 10.1097/QCO.0b013e328336835b; Cazalet C, 2008, GENOME RES, V18, P431, DOI 10.1101/gr.7229808; CHERRY WB, 1978, J CLIN MICROBIOL, V8, P329; Chiaraviglio L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002012; Christie PJ, 2000, TRENDS MICROBIOL, V8, P354, DOI 10.1016/S0966-842X(00)01792-3; CIESIELSKI CA, 1986, INFECT IMMUN, V51, P397, DOI 10.1128/IAI.51.2.397-404.1986; CONRAD DH, 1978, J EXP MED, V147, P1792, DOI 10.1084/jem.147.6.1792; Costa J, 2005, APPL ENVIRON MICROB, V71, P663, DOI 10.1128/AEM.71.2.663-671.2005; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Daha MR, 2010, CRIT REV IMMUNOL, V30, P47, DOI 10.1615/CritRevImmunol.v30.i1.30; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Demello Dominic, 2007, Am J Crit Care, V16, P317; Doleans A, 2004, J CLIN MICROBIOL, V42, P458, DOI 10.1128/JCM.42.1.458-460.2004; Duncan C, 2011, INFECT IMMUN, V79, P2168, DOI 10.1128/IAI.01304-10; DUTKA BJ, 1984, SCI TOTAL ENVIRON, V39, P237, DOI 10.1016/0048-9697(84)90081-0; DUTKA BJ, 1983, J GREAT LAKES RES, V9, P430, DOI 10.1016/S0380-1330(83)71915-5; Ensminger AW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002731; Ferguson JS, 2004, INFECT IMMUN, V72, P2564, DOI 10.1128/IAI.72.5.2564-2573.2004; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Gaia V, 2005, J CLIN MICROBIOL, V43, P2047, DOI 10.1128/JCM.43.5.2047-2052.2005; Gillespie JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004833; Giongo A, 2010, STAND GENOMIC SCI, V2, P309, DOI 10.4056/sigs.972221; Goebel EM, 2008, INFECT IMMUN, V76, P1774, DOI 10.1128/IAI.01629-07; Greenfield LK, 2012, CARBOHYD RES, V356, P12, DOI 10.1016/j.carres.2012.02.027; GROSSMAN N, 1987, J BACTERIOL, V169, P856, DOI 10.1128/jb.169.2.856-863.1987; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Harrison TG, 2009, EUR J CLIN MICROBIOL, V28, P781, DOI 10.1007/s10096-009-0705-9; Haupt TE, 2012, INFECT CONT HOSP EP, V33, P185, DOI 10.1086/663711; Helbig JH, 2002, EUR J CLIN MICROBIOL, V21, P710, DOI 10.1007/s10096-002-0820-3; Helbig JH, 2001, J MED MICROBIOL, V50, P509, DOI 10.1099/0022-1317-50-6-509; HELBIG JH, 1994, ZBL BAKT-INT J MED M, V281, P16; Hicks LA, 2012, AM J TRANSPLANT, V12, P250, DOI 10.1111/j.1600-6143.2011.03938.x; HOLDEN EP, 1984, INFECT IMMUN, V45, P18, DOI 10.1128/IAI.45.1.18-24.1984; HORWITZ MA, 1981, J EXP MED, V153, P398, DOI 10.1084/jem.153.2.398; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; JOLY JR, 1986, J CLIN MICROBIOL, V23, P768, DOI 10.1128/JCM.23.4.768-771.1986; Jules M, 2007, FEBS LETT, V581, P2829, DOI 10.1016/j.febslet.2007.05.026; Kagan JC, 2002, NAT CELL BIOL, V4, P945, DOI 10.1038/ncb883; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Knirel YA, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1035, DOI 10.1023/A:1012334012605; Kojouharova M, 2010, MOL IMMUNOL, V47, P2154, DOI 10.1016/j.molimm.2010.05.011; Kooistra O, 2001, BIOCHEMISTRY-US, V40, P7630, DOI 10.1021/bi002946r; LACHMANN PJ, 1970, J EXP MED, V131, P643, DOI 10.1084/jem.131.4.643; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Land AD, 2011, J BACTERIOL, V193, P4166, DOI 10.1128/JB.05245-11; Latreille P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-321; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Lebeau I, 2004, ARCH MICROBIOL, V181, P362, DOI 10.1007/s00203-004-0664-6; Legionellosis-United States, 2000, MMWR-MORBID MORTAL W, V60, P1083; Leoni E, 2001, WATER RES, V35, P3749, DOI 10.1016/S0043-1354(01)00075-6; Linke Burkhard, 2006, Appl Bioinformatics, V5, P193, DOI 10.2165/00822942-200605030-00008; Luck CP, 2001, INT J MED MICROBIOL, V291, P345, DOI 10.1078/1438-4221-00140; LUCK PC, 1995, ZBL BAKT-INT J MED M, V282, P35; Luneberg E, 2000, INT J MED MICROBIOL, V290, P37; Mampel J, 2006, APPL ENVIRON MICROB, V72, P2885, DOI 10.1128/AEM.72.4.2885-2895.2006; MARCUS RL, 1971, P NATL ACAD SCI USA, V68, P1351, DOI 10.1073/pnas.68.6.1351; MCCALLUM KL, 1989, INFECT IMMUN, V57, P3816, DOI 10.1128/IAI.57.12.3816-3822.1989; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; MCKINNEY RM, 1979, J CLIN MICROBIOL, V9, P103; Mekkour M, 2012, WORLD ENV, V2, P11; Merault N, 2011, APPL ENVIRON MICROB, V77, P1708, DOI 10.1128/AEM.02261-10; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; MINTZ CS, 1992, INFECT IMMUN, V60, P2769, DOI 10.1128/IAI.60.7.2769-2776.1992; Molmeret M, 2005, APPL ENVIRON MICROB, V71, P20, DOI 10.1128/AEM.71.1.20-28.2005; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; Napoli C, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-660; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Ng V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-68; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; O'Connor TJ, 2011, P NATL ACAD SCI USA, V108, P14733, DOI 10.1073/pnas.1111678108; OGAWA M, 1994, INFECT IMMUN, V62, P266, DOI 10.1128/IAI.62.1.266-270.1994; OHNO A, 1995, MICROBIOL-UK, V141, P2749, DOI 10.1099/13500872-141-10-2749; Olsen CW, 2009, EUR J CLIN MICROBIOL, V28, P817, DOI 10.1007/s10096-008-0697-x; OTTEN S, 1986, J BACTERIOL, V167, P893, DOI 10.1128/jb.167.3.893-904.1986; Pan YJ, 2011, INFECT IMMUN, V79, P997, DOI 10.1128/IAI.00906-10; PEITSCH M C, 1991, Current Opinion in Cell Biology, V3, P710, DOI 10.1016/0955-0674(91)90045-Z; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Philippe C, 2006, MED MALADIES INFECT, V36, P196, DOI 10.1016/j.medmal.2005.10.010; PLOUFFE JF, 1985, J CLIN MICROBIOL, V22, P863, DOI 10.1128/JCM.22.5.863-864.1985; PLUSCHKE G, 1983, INFECT IMMUN, V42, P907, DOI 10.1128/IAI.42.3.907-913.1983; Ramirez MS, 2011, ANTIMICROB AGENTS CH, V55, P1520, DOI 10.1128/AAC.01595-10; Rangarajan ES, 2009, J BIOL CHEM, V284, P20989, DOI 10.1074/jbc.M109.012351; Ratzow S, 2007, J CLIN MICROBIOL, V45, P1965, DOI 10.1128/JCM.00261-07; Raymond CK, 2002, J BACTERIOL, V184, P3614, DOI 10.1128/JB.184.13.3614-3622.2002; Reimer AR, 2011, EMERG INFECT DIS, V17, P2113, DOI 10.3201/eid1711.110794; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; ROGERS J, 1992, APPL ENVIRON MICROB, V58, P2326, DOI 10.1128/AEM.58.7.2326-2330.1992; Rossi V, 2010, MOL IMMUNOL, V47, P1553, DOI 10.1016/j.molimm.2010.01.013; ROWBOTHAM TJ, 1980, J CLIN PATHOL, V33, P1179, DOI 10.1136/jcp.33.12.1179; SANFORD JP, 1979, ANN INTERN MED, V90, P699, DOI 10.7326/0003-4819-90-4-699; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Schroeder GN, 2010, J BACTERIOL, V192, P6001, DOI 10.1128/JB.00778-10; Segal G, 1999, MOL MICROBIOL, V34, P799, DOI 10.1046/j.1365-2958.1999.01642.x; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Sexton JA, 2002, TRAFFIC, V3, P178, DOI 10.1034/j.1600-0854.2002.030303.x; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shukla SK, 2009, J BACTERIOL, V191, P5717, DOI 10.1128/JB.00325-09; Silk BJ, 2012, EPIDEMIOL INFECT, P1; Skaza AT, 2012, SCAND J INFECT DIS, V44, P263, DOI 10.3109/00365548.2011.635313; Sobral D, 2011, APPL ENVIRON MICROB, V77, P6899, DOI 10.1128/AEM.05556-11; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; STOUT JE, 1992, NEW ENGL J MED, V326, P151, DOI 10.1056/NEJM199201163260302; STOUT JE, 1992, EPIDEMIOL INFECT, V109, P49; Straus WL, 1996, ARCH INTERN MED, V156, P1685, DOI 10.1001/archinte.156.15.1685; Suzek BE, 2001, BIOINFORMATICS, V17, P1123, DOI 10.1093/bioinformatics/17.12.1123; Svarrer CW, 2012, J MED MICROBIOL, V61, P213, DOI 10.1099/jmm.0.035014-0; Takayanagi Noboru, 2009, Nihon Kokyuki Gakkai Zasshi, V47, P558; THACKER WL, 1983, J CLIN MICROBIOL, V18, P1113, DOI 10.1128/JCM.18.5.1113-1118.1983; THOMASON BM, 1984, J CLIN MICROBIOL, V19, P794, DOI 10.1128/JCM.19.6.794-797.1984; Tijet N, 2010, EMERG INFECT DIS, V16, P447, DOI 10.3201/eid1603.081689; TOBIN JOH, 1981, BRIT MED J, V282, P573, DOI 10.1136/bmj.282.6263.573; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Trent MS, 2004, BIOCHEM CELL BIOL, V82, P71, DOI 10.1139/o03-070; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Visca P, 2011, MICROBIOL-SGM, V157, P2582, DOI 10.1099/mic.0.047258-0; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Vogel U, 1997, INFECT IMMUN, V65, P4022, DOI 10.1128/IAI.65.10.4022-4029.1997; WACHI M, 1989, J BACTERIOL, V171, P6511, DOI 10.1128/jb.171.12.6511-6516.1989; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101; WILLIAMS P, 1983, J GEN MICROBIOL, V129, P2181; Wingender J, 2011, INT J HYG ENVIR HEAL, V214, P417, DOI 10.1016/j.ijheh.2011.05.009; WINN W C JR, 1988, Clinical Microbiology Reviews, V1, P60; Yu VL, 2002, J INFECT DIS, V186, P127, DOI 10.1086/341087; Zahringer U, 1995, Prog Clin Biol Res, V392, P113	143	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e67298	10.1371/journal.pone.0067298	http://dx.doi.org/10.1371/journal.pone.0067298			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826259	Green Submitted, Green Published, gold			2022-12-27	WOS:000321150000058
J	Rizzi, TS; van der Sluis, S; Derom, C; Thiery, E; van Kesteren, RE; Jacobs, N; Van Gestel, S; Vlietinck, R; Verhage, M; Heutink, P; Posthuma, D				Rizzi, Thais S.; van der Sluis, Sophie; Derom, Catherine; Thiery, Evert; van Kesteren, Ronald E.; Jacobs, Nele; Van Gestel, Sofie; Vlietinck, Robert; Verhage, Matthijs; Heutink, Peter; Posthuma, Danielle			FADS2 Genetic Variance in Combination with Fatty Acid Intake Might Alter Composition of the Fatty Acids in Brain	PLOS ONE			English	Article							ASSOCIATION; PLASMA; PHOSPHOLIPIDS; TRANSCRIPTION; INTELLIGENCE; ACHIEVEMENT; EXPRESSION; PREGNANCY; DISEASE; CLUSTER	Multiple lines of evidence suggest that fatty acids (FA) play an important role in cognitive function. However, little is known about the functional genetic pathways involved in cognition. The main goals of this study were to replicate previously reported interaction effects between breast feeding (BF) and FA desaturase (FADS) genetic variation on IQ and to investigate the possible mechanisms by which these variants might moderate BF effect, focusing on brain expression. Using a sample of 534 twins, we observed a trend in the moderation of BF effects on IQ by FADS2 variation. In addition, we made use of publicly available gene expression databases from both humans (193) and mice (93) and showed that FADS2 variants also correlate with FADS1 brain expression (P-value<1.1E-03). Our results provide novel clues for the understanding of the genetic mechanisms regulating FA brain expression and improve the current knowledge of the FADS moderation effect on cognition.	[Rizzi, Thais S.; van der Sluis, Sophie; van Kesteren, Ronald E.; Verhage, Matthijs; Heutink, Peter; Posthuma, Danielle] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Rizzi, Thais S.; Verhage, Matthijs; Posthuma, Danielle] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Funct Genom, Amsterdam, Netherlands; [Derom, Catherine; Van Gestel, Sofie; Vlietinck, Robert] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Human Genet, Louvain, Belgium; [Thiery, Evert] Univ Ghent, Ghent Univ Hosp, Dept Neurol, B-9000 Ghent, Belgium; [Jacobs, Nele] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Maastricht, Netherlands; [Posthuma, Danielle] Erasmus Univ, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; KU Leuven; University Hospital Leuven; Ghent University; Ghent University Hospital; Maastricht University; Erasmus University Rotterdam	Rizzi, TS (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, Amsterdam, Netherlands.	t.s.rizzi@amc.uva.nl	van Kesteren, Ronald E/E-2505-2014	van Kesteren, Ronald/0000-0002-9592-3777; van der Sluis, Sophie/0000-0001-9958-7216; Posthuma, Danielle/0000-0001-7582-2365; Van Gestel, Sofie/0000-0002-9965-6557; Derom, Catherine/0000-0001-5574-796X; Heutink, Peter/0000-0001-5218-1737; verhage, matthijs/0000-0002-6085-7503	Marguerite-Marie Delacroix Foundation; Netherlands Scientific Organization [NWO 480-05-003]; Netherlands Scientific Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, gebied Maatschappij-en Gedragswetenschappen: NWO/MaGW) [VENI-451-08-025]; Center for Neurogenomics and Cognitive research (CNCR); Twins, a nonprofit Association for Scientific Research in Multiple Births (Belgium);  [NWO-VI-016-065-318]	Marguerite-Marie Delacroix Foundation; Netherlands Scientific Organization; Netherlands Scientific Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, gebied Maatschappij-en Gedragswetenschappen: NWO/MaGW)(Netherlands Organization for Scientific Research (NWO)); Center for Neurogenomics and Cognitive research (CNCR); Twins, a nonprofit Association for Scientific Research in Multiple Births (Belgium); 	This research was supported by grants from the Marguerite-Marie Delacroix Foundation and Twins, a nonprofit Association for Scientific Research in Multiple Births (Belgium). Statistical analyses were carried out on the Genetic Cluster Computer (http://www.geneticcluster.org), which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003). Sophie van der Sluis (VENI-451-08-025) is financially supported by the Netherlands Scientific Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, gebied Maatschappij-en Gedragswetenschappen: NWO/MaGW). The authors further wish to acknowledge the financial support of NWO-VI-016-065-318, and the Center for Neurogenomics and Cognitive research (CNCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Bartels M, 2002, BEHAV GENET, V32, P237, DOI 10.1023/A:1019772628912; BRAUNGART JM, 1992, DEV PSYCHOL, V28, P1048; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Caspi A, 2007, P NATL ACAD SCI USA, V104, P18860, DOI 10.1073/pnas.0704292104; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Church MW, 2008, NEUROTOXICOL TERATOL, V30, P107, DOI 10.1016/j.ntt.2007.12.008; CLARKE SD, 1994, ANNU REV NUTR, V14, P83, DOI 10.1146/annurev.nu.14.070194.000503; Davis-Kean PE, 2005, J FAM PSYCHOL, V19, P294, DOI 10.1037/0893-3200.19.2.294; de Groot RHM, 2007, PROSTAG LEUKOTR ESS, V76, P165, DOI 10.1016/j.plefa.2007.01.001; Der G, 2006, BMJ-BRIT MED J, V333, P945, DOI 10.1136/bmj.38978.699583.55; Derom C, 2002, TWIN RES, V5, P337, DOI 10.1375/twin.5.5.337; Di Stasi D, 2004, EUR J CLIN PHARMACOL, V60, P183, DOI 10.1007/s00228-004-0758-8; DUNCAN GJ, 1994, CHILD DEV, V65, P296, DOI 10.1111/j.1467-8624.1994.tb00752.x; EMKEN EA, 1994, BBA-LIPID LIPID MET, V1213, P277, DOI 10.1016/0005-2760(94)00054-9; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Hoddinott P, 2008, BMJ-BRIT MED J, V336, P881, DOI 10.1136/bmj.39521.566296.BE; Innis SM, 2013, PROSTAG LEUKOTR ESS, V88, P91, DOI 10.1016/j.plefa.2012.05.007; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; Innis SM, 2003, J PEDIATR-US, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2; Jacobs N, 2001, BEHAV GENET, V31, P209, DOI 10.1023/A:1010257512183; JUMP DB, 1993, P NATL ACAD SCI USA, V90, P8454, DOI 10.1073/pnas.90.18.8454; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Kremmyda LS, 2011, BIOMED PAP, V155, P195, DOI 10.5507/bp.2011.052; Lawlor DA, 2006, PEDIATRICS, V117, pE894, DOI 10.1542/peds.2005-2412; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Matte TD, 2001, BRIT MED J, V323, P310, DOI 10.1136/bmj.323.7308.310; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Molto-Puigmarti C, 2010, AM J CLIN NUTR, V91, P1368, DOI 10.3945/ajcn.2009.28789; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nagin DS, 2001, ARCH GEN PSYCHIAT, V58, P389, DOI 10.1001/archpsyc.58.4.389; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Novak EM, PROSTAGLANDINS LEUKO, V86, P93; Novak EM, AM J PHYSL GASTROINT, V302, pG250; Oddy WH, 2011, PEDIATRICS, V127, pE137, DOI 10.1542/peds.2009-3489; Oddy WH, 2010, J PEDIATR-US, V156, P568, DOI 10.1016/j.jpeds.2009.10.020; Park WJ, 2009, GENE, V446, P28, DOI 10.1016/j.gene.2009.06.016; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saba L, 2006, MAMM GENOME, V17, P669, DOI 10.1007/s00335-005-0190-0; Sala-Vila A, 2008, CLIN EXP ALLERGY, V38, P1432, DOI 10.1111/j.1365-2222.2008.03072.x; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Spector AA, 1999, LIPIDS, V34, pS1, DOI 10.1007/BF02562220; Steer CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011570; Tvrzicka E, 2011, BIOMED PAP, V155, P117, DOI 10.5507/bp.2011.038; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Wechsler D., 1991, EXAMINERS MANUAL WEC; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156; Yang H, 2009, NAT METHODS, V6, P663, DOI [10.1038/NMETH.1359, 10.1038/nmeth.1359]	52	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 27	2013	8	6							e68000	10.1371/journal.pone.0068000	http://dx.doi.org/10.1371/journal.pone.0068000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IX	23826354	Green Published, gold			2022-12-27	WOS:000321150000108
J	Sarma, NJ; Yaseen, NR				Sarma, Nayan J.; Yaseen, Nabeel R.			Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; CYTOPLASMIC DYNEIN; FUNCTIONAL INTERACTION; HEMATOPOIETIC-CELLS; INTERMEDIATE CHAIN; NEURITE OUTGROWTH; MYELOID-LEUKEMIA; MOLECULAR-BASIS; MULTIPLE-MODES; FG REPEATS	The chimeric oncoprotein NUP98-HOXA9 results from the t(7;11)(p15;p15) chromosomal translocation and is associated with acute myeloid leukemia. It causes aberrant gene regulation and leukemic transformation through mechanisms that are not fully understood. NUP98-HOXA9 consists of an N-terminal portion of the nucleoporin NUP98 that contains many FG repeats fused to the DNA-binding homeodomain of HOXA9. We used a Cytotrap yeast two-hybrid assay to identify proteins that interact with NUP98-HOXA9. We identified Dynein Light Chain 1 (DYNLT1), an integral 14 KDa protein subunit of the large microtubule-based cytoplasmic dynein complex, as an interaction partner of NUP98-HOXA9. Binding was confirmed by in vitro pull down and co-immunoprecipitation assays and the FG repeat region of NUP98-HOXA9 was shown to be essential for the interaction. RNAi-mediated knockdown of DYNLT1 resulted in reduction of the ability of NUP98-HOXA9 to activate transcription and also inhibited the ability of NUP98-HOXA9 to induce proliferation of primary human hematopoietic CD34+ cells. DYNLT1 also showed a strong interaction with wild-type NUP98 and other nucleoporins containing FG repeats. Immunofluorescence analysis showed that DYNLT1 localizes primarily to the nuclear periphery, where it co-localizes with the nuclear pore complex, and to the cytoplasm. Deletion studies showed that the interactions of the nucleoporins with DYNLT1 are dependent predominantly on the C-terminal half of the DYNLT1. These data show for the first time that DYNLT1 interacts with nucleoporins and plays a role in the dysregulation of gene expression and induction of hematopoietic cell proliferation by the leukemogenic nucleoporin fusion, NUP98-HOXA9.	[Sarma, Nayan J.; Yaseen, Nabeel R.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Yaseen, NR (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	nyaseen@path.wustl.edu		Yaseen, Nabeel/0000-0001-6902-5116	National Institutes of Health [R01 HL082549, K02 HL084179]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082549, K02HL084179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01 HL082549 and K02 HL084179 (to NRY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Nabi AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012464; Bai XT, 2006, CANCER RES, V66, P4584, DOI 10.1158/0008-5472.CAN-05-3101; Bei L, 2005, J BIOL CHEM, V280, P12359, DOI 10.1074/jbc.M408138200; Bolhy S, 2011, J CELL BIOL, V192, P855, DOI 10.1083/jcb.201007118; Borrow J, 1996, NAT GENET, V12, P159, DOI 10.1038/ng0296-159; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Calvo KR, 2002, ONCOGENE, V21, P4247, DOI 10.1038/sj.onc.1205516; Campbell EA, 2003, ADV DRUG DELIVER REV, V55, P761, DOI 10.1016/S0169-409X(03)00049-8; Chou WC, 2009, LEUKEMIA; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; den Hollander P, 2006, CANCER RES, V66, P5941, DOI 10.1158/0008-5472.CAN-05-3480; DiBella LM, 2001, J BIOL CHEM, V276, P14366, DOI 10.1074/jbc.M011456200; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; FEATHERSTONE C, 1988, J CELL BIOL, V107, P1289, DOI 10.1083/jcb.107.4.1289; Galigniana MD, 2010, MOL CELL BIOL, V30, P1285, DOI 10.1128/MCB.01190-09; Gauthier-Fisher A, 2009, NAT NEUROSCI, V12, P735, DOI 10.1038/nn.2339; Ghannam G, 2004, J BIOL CHEM, V279, P866, DOI 10.1074/jbc.M307280200; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Gough SM, 2011, BLOOD, V118, P6247, DOI 10.1182/blood-2011-07-328880; Hayakawa A, 2012, J CELL BIOL, V196, P19, DOI 10.1083/jcb.201108124; Iwasaki M, 2005, BLOOD, V105, P784, DOI 10.1182/blood-2004-04-1508; Jiang JM, 2001, GENE, V281, P103, DOI 10.1016/S0378-1119(01)00787-9; Kasper LH, 1999, MOL CELL BIOL, V19, P764; King SM, 1996, J BIOL CHEM, V271, P32281, DOI 10.1074/jbc.271.50.32281; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Ma XY, 2007, BIOCHEMISTRY-US, V46, P7153, DOI 10.1021/bi700101n; Machado RD, 2003, HUM MOL GENET, V12, P3277, DOI 10.1093/hmg/ddg365; Mayotte N, 2002, BLOOD, V100, P4177, DOI 10.1182/blood-2002-04-1244; Meiri D, 2009, MOL CELL BIOL, V29, P5963, DOI 10.1128/MCB.01268-08; Mikenberg I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000589; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Naghavi MH, 2007, CURR OPIN IMMUNOL, V19, P402, DOI 10.1016/j.coi.2007.07.003; Nakamura T, 1996, NAT GENET, V12, P154, DOI 10.1038/ng0296-154; Nakano H, 2010, J BIOL CHEM, V285, P10841, DOI 10.1074/jbc.M110.105890; Oka M, 2010, MOL BIOL CELL, V21, P1885, DOI 10.1091/mbc.E09-12-1041; Payne C, 2003, J CELL SCI, V116, P4727, DOI 10.1242/jcs.00784; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Phung-Koskas T, 2005, J BIOL CHEM, V280, P1123, DOI 10.1074/jbc.M409918200; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Robinson JT, 1999, J CELL BIOL, V146, P597, DOI 10.1083/jcb.146.3.597; Romes EM, 2012, J BIOL CHEM, V287, P15862, DOI 10.1074/jbc.M111.336172; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; Roth DM, 2011, J BIOL CHEM, V286, P14335, DOI 10.1074/jbc.M110.210302; Sachdev P, 2007, EMBO J, V26, P2621, DOI 10.1038/sj.emboj.7601716; Salina D, 2002, CELL, V108, P97, DOI 10.1016/S0092-8674(01)00628-6; Salman H, 2005, BIOPHYS J, V89, P2134, DOI 10.1529/biophysj.105.060160; Sarma NJ, 2011, J BIOL CHEM, V286, P38989, DOI 10.1074/jbc.M111.297952; Scherer J, 2011, VIRUSES-BASEL, V3, P1417, DOI 10.3390/v3081417; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Splinter D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000350; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Sugai M, 2003, BIOCHEM BIOPH RES CO, V311, P24, DOI 10.1016/j.bbrc.2003.09.157; Tai AW, 1998, J BIOL CHEM, V273, P19639, DOI 10.1074/jbc.273.31.19639; Takeda A, 2006, CANCER RES, V66, P6628, DOI 10.1158/0008-5472.CAN-06-0458; Takeda A, 2010, J BIOL CHEM, V285, P16248, DOI 10.1074/jbc.M109.048785; Terry LJ, 2009, EUKARYOT CELL, V8, P1814, DOI 10.1128/EC.00225-09; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Vidalain PO, 2004, METHODS, V32, P363, DOI 10.1016/j.ymeth.2003.10.001; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Watanabe TK, 1996, CYTOGENET CELL GENET, V73, P153, DOI 10.1159/000134329; WatermanStorer CM, 1997, P NATL ACAD SCI USA, V94, P12180, DOI 10.1073/pnas.94.22.12180; Williams JC, 2005, J BIOL CHEM, V280, P21981, DOI 10.1074/jbc.M414643200; Yano H, 2005, NEUROCHEM RES, V30, P767, DOI 10.1007/s11064-005-6870-z; Yassin ER, 2010, LEUKEMIA, V24, P1001, DOI 10.1038/leu.2010.42; Yassin ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006719; Yeh TY, 2005, J CELL SCI, V118, P3431, DOI 10.1242/jcs.02472; Zaichick SV, 2011, VIRUSES-BASEL, V3, P941, DOI 10.3390/v3070941; Zhong HL, 2005, J BIOL CHEM, V280, P10675, DOI 10.1074/jbc.M412878200	75	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 26	2013	8	6							e67032	10.1371/journal.pone.0067032	http://dx.doi.org/10.1371/journal.pone.0067032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	178DN	23840580	gold, Green Published, Green Submitted			2022-12-27	WOS:000321424400064
J	Auffinger, BM; Lall, RR; Dahdaleh, NS; Wong, AP; Lam, SK; Koski, T; Fessler, RG; Smith, ZA				Auffinger, Brenda M.; Lall, Rishi R.; Dahdaleh, Nader S.; Wong, Albert P.; Lam, Sandi K.; Koski, Tyler; Fessler, Richard G.; Smith, Zachary A.			Measuring Surgical Outcomes in Cervical Spondylotic Myelopathy Patients Undergoing Anterior Cervical Discectomy and Fusion: Assessment of Minimum Clinically Important Difference	PLOS ONE			English	Article							NECK-DISABILITY-INDEX; QUALITY-OF-LIFE; BACK PAIN QUESTIONNAIRE; INTRAINDIVIDUAL CHANGES; HEALTH-STATUS; ARTICLE; RELIABILITY; SENSITIVITY; VALIDITY; STATE	Object: The concept of minimum clinically important difference (MCID) has been used to measure the threshold by which the effect of a specific treatment can be considered clinically meaningful. MCID has previously been studied in surgical patients, however few studies have assessed its role in spinal surgery. The goal of this study was to assess the role of MCID in patients undergoing anterior cervical discectomy and fusion (ACDF) for cervical spondylotic myelopathy (CSM). Methods: Data was collected on 30 patients who underwent ACDF for CSM between 2007 and 2012. Preoperative and 1-year postoperative Neck Disability Index (NDI), Visual-Analog Scale (VAS), and Short Form-36 (SF-36) Physical (PCS) and Mental (MCS) Component Summary PRO scores were collected. Five distribution- and anchor-based approaches were used to calculate MCID threshold values average change, change difference, receiver operating characteristic curve (ROC), minimum detectable change (MDC) and standard error of measurement (SEM). The Health Transition Item of the SF-36 (HTI) was used as an external anchor. Results: Patients had a significant improvement in all mean physical PRO scores postoperatively (p<0.01) NDI (29.24 to 14.82), VAS (5.06 to 1.72), and PCS (36.98 to 44.22). The five MCID approaches yielded a range of values for each PRO: 2.00-8.78 for PCS, 2.06-5.73 for MCS, 4.83-13.39 for NDI, and 0.36-3.11 for VAS. PCS was the most representative PRO measure, presenting the greatest area under the ROC curve (0.94). MDC values were not affected by the choice of anchor and their threshold of improvement was statistically greater than the chance of error from unimproved patients. Conclusion: SF-36 PCS was the most representative PRO measure. MDC appears to be the most appropriate MCID method. When MDC was applied together with HTI anchor, the MCID thresholds were: 13.39 for NDI, 3.11 for VAS, 5.56 for PCS and 5.73 for MCS.	[Auffinger, Brenda M.; Lam, Sandi K.] Univ Chicago, Sect Neurol Surg, Chicago, IL 60637 USA; [Lall, Rishi R.; Dahdaleh, Nader S.; Wong, Albert P.; Koski, Tyler; Fessler, Richard G.; Smith, Zachary A.] Northwestern Univ, Dept Neurol Surg, Chicago, IL 60611 USA	University of Chicago; Northwestern University	Smith, ZA (corresponding author), Northwestern Univ, Dept Neurol Surg, Chicago, IL 60611 USA.	zsmith@nmff.org		Lam, Sandi/0000-0003-3294-6637	Medtronic Inc.; Medtronic; Stryker; Depuy; Lanx Inc	Medtronic Inc.(Medtronic); Medtronic(Medtronic); Stryker; Depuy; Lanx Inc	RF receives educational grant support for research on spinal techniques from Medtronic Inc. However, he has no direct compensatory financial disclosures. The remaining authors have no direct compensatory financial disclosures. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; RF receives educational grant support from Medtronic, Stryker and Depuy for research on spinal techniques. Additionally he serves as a paid consultant for Lanx Inc for development of spinal surgery products. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Beaton DE, 2001, J RHEUMATOL, V28, P400; Carreon LY, 2010, SPINE J, V10, P469, DOI 10.1016/j.spinee.2010.02.007; Copay AG, 2008, SPINE J, V8, P968, DOI 10.1016/j.spinee.2007.11.006; Copay AG, 2007, SPINE J, V7, P541, DOI 10.1016/j.spinee.2007.01.008; Gallagher EJ, 2001, ANN EMERG MED, V38, P633, DOI 10.1067/mem.2001.118863; Gatchel RJ, 2010, SPINE J, V10, P321, DOI 10.1016/j.spinee.2009.10.015; Hagg O, 2003, EUR SPINE J, V12, P12, DOI 10.1007/s00586-002-0464-0; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; JENSEN MP, 1994, J CONSULT CLIN PSYCH, V62, P172, DOI 10.1037/0022-006X.62.1.172; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Kulkarni AV, 2006, J CLIN EPIDEMIOL, V59, P176, DOI 10.1016/j.jclinepi.2005.07.011; McCarthy MJH, 2007, EUR SPINE J, V16, P2111, DOI 10.1007/s00586-007-0503-y; McDowell IN C, 1996, MEARURING HEATH GUID; MONTGOMERY DM, 1992, ORTHOP CLIN N AM, V23, P487; Parker SL, 2013, J NEUROSURG-SPINE, V18, P154, DOI 10.3171/2012.10.SPINE12312; Parker SL, 2012, J NEUROSURG-SPINE, V16, P471, DOI 10.3171/2012.1.SPINE11842; Parker SL, 2012, J NEUROSURG-SPINE, V16, P61, DOI 10.3171/2011.8.SPINE1194; Parker SL, 2011, J NEUROSURG-SPINE, V14, P598, DOI 10.3171/2010.12.SPINE10472; Pool JJM, 2007, SPINE, V32, P3047, DOI 10.1097/BRS.0b013e31815cf75b; Riddle DL, 1998, PHYS THER, V78, P1197, DOI 10.1093/ptj/78.11.1197; Stratford PW, 1998, PHYS THER, V78, P1186, DOI 10.1093/ptj/78.11.1186; van der Roer N, 2006, SPINE, V31, P578, DOI 10.1097/01.brs.0000201293.57439.47; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vernon H, 2008, J MANIP PHYSIOL THER, V31, P491, DOI 10.1016/j.jmpt.2008.08.006; Vernon H, 2008, ARCH PHYS MED REHAB, V89, P1414, DOI 10.1016/j.apmr.2008.05.003; Ware J.E., 1994, SF 36 PHYS MENTAL HL; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Wells G, 2001, J RHEUMATOL, V28, P406; Wilson HD, 2011, SPINE, V36, P474, DOI 10.1097/BRS.0b013e3181d41632; Wyrwich KW, 1999, MED CARE, V37, P469, DOI 10.1097/00005650-199905000-00006; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2	32	56	56	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67408	10.1371/journal.pone.0067408	http://dx.doi.org/10.1371/journal.pone.0067408			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826290	Green Published, gold, Green Submitted			2022-12-27	WOS:000321738400140
J	Praveen, P; Frohlich, H				Praveen, Paurush; Froehlich, Holger			Boosting Probabilistic Graphical Model Inference by Incorporating Prior Knowledge from Multiple Sources	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; BIOLOGICAL KNOWLEDGE; DATABASE; DISCOVERY; KEGG	Inferring regulatory networks from experimental data via probabilistic graphical models is a popular framework to gain insights into biological systems. However, the inherent noise in experimental data coupled with a limited sample size reduces the performance of network reverse engineering. Prior knowledge from existing sources of biological information can address this low signal to noise problem by biasing the network inference towards biologically plausible network structures. Although integrating various sources of information is desirable, their heterogeneous nature makes this task challenging. We propose two computational methods to incorporate various information sources into a probabilistic consensus structure prior to be used in graphical model inference. Our first model, called Latent Factor Model (LFM), assumes a high degree of correlation among external information sources and reconstructs a hidden variable as a common source in a Bayesian manner. The second model, a Noisy-OR, picks up the strongest support for an interaction among information sources in a probabilistic fashion. Our extensive computational studies on KEGG signaling pathways as well as on gene expression data from breast cancer and yeast heat shock response reveal that both approaches can significantly enhance the reconstruction accuracy of Bayesian Networks compared to other competing methods as well as to the situation without any prior. Our framework allows for using diverse information sources, like pathway databases, GO terms and protein domain data, etc. and is flexible enough to integrate new sources, if available.	[Praveen, Paurush; Froehlich, Holger] Univ Bonn, Bonn Aachen Int Ctr IT, Bonn, Germany	University of Bonn	Praveen, P (corresponding author), Univ Bonn, Bonn Aachen Int Ctr IT, Bonn, Germany.	praveen@bit.uni-bonn.de	Fröhlich, Holger/H-1976-2017	Fröhlich, Holger/0000-0002-5328-1243; Praveen, Paurush/0000-0003-1155-4140	B-IT Research School Grant	B-IT Research School Grant	PP is supported by a B-IT Research School Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrehman D, 2011, NUCLEIC ACIDS RES, V39, pD136, DOI 10.1093/nar/gkq964; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Eyad Almasri P, 2008, P 4 INT S BIOINF RES; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Gao SG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-359; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huttenhower C, 2009, BIOINFORMATICS, V25, P3267, DOI 10.1093/bioinformatics/btp588; Ideker T, 2011, CELL, V144, P860, DOI 10.1016/j.cell.2011.03.007; Imoto Seiya, 2006, Pac Symp Biocomput, P559; Imoto Seiya, 2002, Pac Symp Biocomput, P175; James K, 2009, LECT NOTES COMPUT SC, V5647, P31, DOI 10.1007/978-3-642-02879-3_4; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Larsen P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-317; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lin D., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P296; Marbach D, 2012, NATURE METHODS, V9; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mukherjee S, 2008, P NATL ACAD SCI USA, V105, P14313, DOI 10.1073/pnas.0802272105; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Myers CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r114; Nariai N, 2004, PACIFIC S BIOCOMPUTI; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Raghavachari B, 2008, NUCLEIC ACIDS RES, V36, pD656, DOI 10.1093/nar/gkm761; Robert C.P., 2000, TECHNOMETRICS, V42, P430, DOI [10.2307/1270959, DOI 10.2307/1270959]; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sachs Karen, 2002, Sci STKE, V2002, ppe38, DOI 10.1126/stke.2002.148.pe38; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Tamada Yoshinori, 2005, Journal of Bioinformatics and Computational Biology, V3, P1295, DOI 10.1142/S0219720005001569; Tamada Y, 2003, BIOINFORMATICS, V19, pII227, DOI 10.1093/bioinformatics/btg1082; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Weile J, 2012, BIOINFORMATICS; Werhli AV, 2007, STAT APPL GENET MOL, V6; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	38	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67410	10.1371/journal.pone.0067410	http://dx.doi.org/10.1371/journal.pone.0067410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826291	gold, Green Submitted, Green Published			2022-12-27	WOS:000321738400141
J	da Silva, TP; Giacoia-Gripp, CBW; Schmaltz, CA; Sant Anna, FM; Rolla, V; Morgado, MG				da Silva, Tatiana P.; Giacoia-Gripp, Carmem B. W.; Schmaltz, Carolina A.; Sant Anna, Flavia M.; Rolla, Valeria; Morgado, Mariza G.			T Cell Activation and Cytokine Profile of Tuberculosis and HIV-Positive Individuals during Antituberculous Treatment and Efavirenz-Based Regimens	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; COMBINATION ANTIRETROVIRAL THERAPY; IMMUNE RECONSTITUTION; INFECTED PATIENTS; EXPRESSION; PATHOGENESIS; RESPONSES; ADULTS; ALPHA	Introduction: The profile of immune activation markers in tuberculosis and HIV-infected patients is already known. The impact of simultaneous infections on the immune parameters is still not fully explored. Methods: We conducted a prospective study to estimate trajectories of activated T cell subsets and the profile of anti- and pro-inflammatory cytokines in a group of HIV-TB individuals, previously naive for HAART, recruited from a randomized clinical trial during TB treatment and first antiretroviral therapy with efavirenz. Patients were evaluated according to the immunosuppression levels at baseline as group 1 (CD4<200 cells/mm(3)) and group 2 (CD4>200 cells/mm(3)). These parameters were measured at the time of HAART initiation (started about 30 days after the onset of TB treatment) and at the follow-up visits after 30, 60, 90 and 180 days. Trajectories were estimated using least squares estimates of the coefficients of a restricted cubic spline function in time after adjusting for subject effects, bootstrapping it 500 times. Results: Increase of CD4 T cell counts and suppression of HIV viral load were observed for all patients under HAART and TB treatment. Descendent trajectories were observed for the activated CD8(+)/CD38(+) and CD3(+)/HLA-DR+ T cell subsets, and for plasma concentration of gamma-interferon (IFN-gamma). Except for TNF-alpha and IL-2 discrete variations were observed for the other cytokines. Differences in the trajectories of these parameters were observed for groups 1 and 2. Higher values of IFN-gamma, IL-2, IL-6 and IL-10 were observed for group 1 from the baseline to two months after treatment initiation, whereas reduced levels of TNF-alpha were observed for this group between 60 and 120 days of HAART. Conclusion: Independent of the immunosuppression profile at baseline, HIV-TB patients under HAART were able to recover the CD4(+) T cell counts, and control viral replication and immune activation parameters over time.	[da Silva, Tatiana P.; Giacoia-Gripp, Carmem B. W.; Morgado, Mariza G.] Fundacao Oswaldo Cruz FIOCRUZ, Lab AIDS & Immunol Mol, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [Schmaltz, Carolina A.; Sant Anna, Flavia M.; Rolla, Valeria] Fundacao Oswaldo Cruz Fiocruz, Clin Res Lab Mycobacteriosis, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Morgado, MG (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Lab AIDS & Immunol Mol, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.	mmorgado@ioc.fiocruz.br	Rolla, Valeria Cavalcanti/AAI-6078-2021	Rolla, Valeria Cavalcanti/0000-0002-0841-1408; SILVA, TATIANA/0000-0002-4016-3002	MCT/CNPq/MS-SCITIE-DECIT [25/2006]	MCT/CNPq/MS-SCITIE-DECIT	MCT/CNPq/MS-SCITIE-DECIT 25/2006 is acknowledged for providing financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmi A, 2007, CLIN EXP IMMUNOL, V150, P442, DOI 10.1111/j.1365-2249.2007.03526.x; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Bacelar A, 2012, B EPIDEMIOLOGICO, V43; Bal AM, 2005, CYTOKINE, V30, P275, DOI 10.1016/j.cyto.2005.01.015; BENTWICH Z, 1995, IMMUNOL TODAY, V16, P187, DOI 10.1016/0167-5699(95)80119-7; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Cunha RMD, 2005, CLIN EXP IMMUNOL, V140, P491, DOI 10.1111/j.1365-2249.2005.02796.x; del Rey A, 2007, BRAIN BEHAV IMMUN, V21, P171, DOI 10.1016/j.bbi.2006.06.005; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Goicoechea M, 2006, J INFECT DIS, V194, P29, DOI 10.1086/504718; Graziosi C, 1996, P NATL ACAD SCI USA, V93, P4386, DOI 10.1073/pnas.93.9.4386; Hernandez-Pando R, 2009, ARCH IMMUNOL THER EX, V57, P355, DOI 10.1007/s00005-009-0042-9; Holub M, 2000, CLIN MICROBIOL INFEC, V6, P657, DOI 10.1046/j.1469-0691.2000.00175.x; Karen Bruck, 2011, B EPIDEMIOLOGICO AID; Kiran B, 2010, ARCH MED SCI, V6, P77, DOI 10.5114/aoms.2010.13511; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Lancioni CL, 2011, J INFECT DIS, V203, P992, DOI 10.1093/infdis/jiq141; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Lederman MM, 1998, J INFECT DIS, V178, P70, DOI 10.1086/515591; Mahan C, 2010, PLOS ONE, V5, P1; May MT, 2006, LANCET, V368, P451, DOI 10.1016/S0140-6736(06)69152-6; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Olobo JO, 2001, SCAND J IMMUNOL, V53, P85, DOI 10.1046/j.1365-3083.2001.00844.x; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Pean P, 2012, BLOOD, V119, P3315, DOI 10.1182/blood-2011-09-377523; Santos-Oliveira JR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-358; Serra FC, 2007, BRAZ J INFECT DIS, V11, P462, DOI 10.1590/S1413-86702007000500004; Schmaltz CAS, 2009, JAIDS-J ACQ IMM DEF, V52, P623, DOI 10.1097/QAI.0b013e3181b31e56; Stone S F, 2002, HIV Med, V3, P21, DOI 10.1046/j.1464-2662.2001.00096.x; Subramanyam S, 2004, J INTERF CYTOK RES, V24, P101, DOI 10.1089/107999004322813345; Tadokera R, 2011, EUR RESPIR J, V37, P1248, DOI 10.1183/09031936.00091010; Giacoia-Gripp CBW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028735; Worsley CM, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-36; Zhang ZN, 2006, CHINESE MED J-PEKING, V119, P1966, DOI 10.1097/00029330-200612010-00005	37	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66095	10.1371/journal.pone.0066095	http://dx.doi.org/10.1371/journal.pone.0066095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840403	gold, Green Published			2022-12-27	WOS:000322361200053
J	Suarez-Rubio, M; Wilson, S; Leimgruber, P; Lookingbill, T				Suarez-Rubio, Marcela; Wilson, Scott; Leimgruber, Peter; Lookingbill, Todd			Threshold Responses of Forest Birds to Landscape Changes around Exurban Development	PLOS ONE			English	Article							POPULATION-CHANGE; UNITED-STATES; RESIDENTIAL DEVELOPMENT; HABITAT FRAGMENTATION; RELATIVE IMPORTANCE; SPECIES RICHNESS; COMMUNITIES; PATTERNS; CONSERVATION; TRENDS	Low-density residential development (i.e., exurban development) is often embedded within a matrix of protected areas and natural amenities, raising concern about its ecological consequences. Forest-dependent species are particularly susceptible to human settlement even at low housing densities typical of exurban areas. However, few studies have examined the response of forest birds to this increasingly common form of land conversion. The aim of this study was to assess whether, how, and at what scale forest birds respond to changes in habitat due to exurban growth. We evaluated changes in habitat composition (amount) and configuration (arrangement) for forest and forest-edge species around North America Breeding Bird Survey (BBS) stops between 1986 and 2009. We used Threshold Indicator Taxa Analysis to detect change points in species occurrence at two spatial extents (400-m and 1-km radius buffer). Our results show that exurban development reduced forest cover and increased habitat fragmentation around BBS stops. Forest birds responded nonlinearly to most measures of habitat loss and fragmentation at both the local and landscape extents. However, the strength and even direction of the response changed with the extent for several of the metrics. The majority of forest birds' responses could be predicted by their habitat preferences indicating that management practices in exurban areas might target the maintenance of forested habitats, for example through easements or more focused management for birds within existing or new protected areas.	[Suarez-Rubio, Marcela] Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD USA; [Wilson, Scott] Environm Canada, Canadian Wildlife Serv, Saskatoon, SK, Canada; [Leimgruber, Peter] Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Lookingbill, Todd] Univ Richmond, Dept Geog & Environm, Richmond, VA 23173 USA	University System of Maryland; University of Maryland Center for Environmental Science; Environment & Climate Change Canada; Canadian Wildlife Service; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Richmond	Suarez-Rubio, M (corresponding author), Univ Maryland, Ctr Environm Sci, Appalachian Lab, Frostburg, MD USA.	marcela.suarezrubio@boku.ac.at	Wilson, Scott/AAC-7144-2021; Leimgruber, Peter/O-1304-2015; NUNEZ-PENA, MARIA ISABEL/B-3883-2011; Suarez Pellicioni, Macarena/H-5527-2015; colome, angels/H-2522-2015	Leimgruber, Peter/0000-0002-3682-0153; Lookingbill, Todd/0000-0003-4946-6429; NUNEZ-PENA, MARIA ISABEL/0000-0002-3677-859X; Suarez Pellicioni, Macarena/0000-0002-9056-9561; Suarez-Rubio, Marcela/0000-0002-0596-2626; colome, angels/0000-0002-2976-1853	Appalachian Laboratory, University of Maryland Center for Environmental Science	Appalachian Laboratory, University of Maryland Center for Environmental Science	This work was supported by Appalachian Laboratory, University of Maryland Center for Environmental Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JB, 1986, J GEOPHYS RES-SOLID, V91, P8098, DOI 10.1029/JB091iB08p08098; AMBUEL B, 1983, ECOLOGY, V64, P1057, DOI 10.2307/1937814; Andren H, 1997, OIKOS, V80, P193, DOI 10.2307/3546534; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], BIRDS N AM ONLINE; ASKINS RA, 1995, SCIENCE, V267, P1956, DOI 10.1126/science.267.5206.1956; Baker ME, 2010, METHODS ECOL EVOL, V1, P25, DOI 10.1111/j.2041-210X.2009.00007.x; Berger J.O., 1995, STAT DECISION THEORY, V2nd ed; Betts MG, 2010, ECOL APPL, V20, P2116, DOI 10.1890/09-1305.1; Betts MG, 2007, CONSERV BIOL, V21, P1046, DOI 10.1111/j.1523-1739.2007.00723.x; Blair RB, 2001, BIOTIC HOMOGENIZATION, P33; BLAKE JG, 1987, ECOLOGY, V68, P1724, DOI 10.2307/1939864; Bowen ME, 2007, BIOL CONSERV, V140, P273, DOI 10.1016/j.biocon.2007.08.012; Bowman J, 2003, CAN J ZOOL, V81, P195, DOI 10.1139/Z02-237; Brown DG, 2005, ECOL APPL, V15, P1851, DOI 10.1890/03-5220; BURNLEY IH, 1995, J PLAN EDUC RES, V14, P245, DOI 10.1177/0739456X9501400402; Chace JF, 2006, LANDSCAPE URBAN PLAN, V74, P46, DOI 10.1016/j.landurbplan.2004.08.007; Chace JF, 2003, LANDSCAPE URBAN PLAN, V64, P179, DOI 10.1016/S0169-2046(02)00220-7; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cooper CB, 2012, ENVIRON MANAGE, V50, P11, DOI 10.1007/s00267-012-9866-x; Dauphine N, 2009, IMPACTS FREE RANGING, P205; Donnelly Roarke, 2006, Urban Ecosystems, V9, P99, DOI 10.1007/s11252-006-7904-2; Donovan TM, 2002, ECOL APPL, V12, P364, DOI 10.1890/1051-0761(2002)012[0364:RANAST]2.0.CO;2; ENGELS TM, 1994, CONSERV BIOL, V8, P286, DOI 10.1046/j.1523-1739.1994.08010286.x; Engle David M., 1999, Great Plains Research, V9, P55; Erskine AJ, 1978, CANADIAN WILDLIFE SE, V42, P1; Evans KL, 2009, IBIS, V151, P19, DOI 10.1111/j.1474-919X.2008.00898.x; Evans M, 2011, BIRDS N AM ONLINE; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; Fraterrigo JM, 2005, LANDSCAPE URBAN PLAN, V71, P263, DOI 10.1016/S0169-2046(04)00080-5; Friesen LE, 1995, CONSERV BIOL, V9, P1408, DOI 10.1046/j.1523-1739.1995.09061408.x; Gardner RH, 1987, LANDSCAPE ECOL, V1, P19, DOI 10.1007/BF02275262; Gelman A., 2004, BAYESIAN DATA ANAL, V2nd; Graber JW, 1985, BIOL NOTES; Greenlaw JS, 1996, E TOWHEE PIPILO ERYT; GUSTAFSON EJ, 1992, LANDSCAPE ECOL, V7, P101, DOI 10.1007/BF02418941; HAGAN JM, 1993, AUK, V110, P863; Halkin SL, 1999, BIRDS N AM ONLINE; Hansen AJ, 2005, ECOL APPL, V15, P1893, DOI 10.1890/05-5221; HILL SR, 1988, AM MIDL NAT, V120, P313, DOI 10.2307/2426003; Holmes RT, 2001, AUK, V118, P589, DOI 10.1642/0004-8038(2001)118[0589:TYBPTI]2.0.CO;2; Hunt PD, 1998, CONSERV BIOL, V12, P1377, DOI 10.1046/j.1523-1739.1998.97005.x; Jones KB, 2000, ENVIRON MONIT ASSESS, V63, P159, DOI 10.1023/A:1006415029890; Kendall WL, 1996, AUK, V113, P823, DOI 10.2307/4088860; Kim KK, 2005, GROWTH CHANGE, V36, P273, DOI 10.1111/j.1468-2257.2005.00277.x; Krementz DG, 2000, WILSON BULL, V112, P243, DOI 10.1676/0043-5643(2000)112[0243:BSDAMO]2.0.CO;2; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lang JD, 2002, AUK, V119, P109, DOI 10.1642/0004-8038(2002)119[0109:WTMAHU]2.0.CO;2; Lepczyk CA, 2004, ENVIRON MANAGE, V33, P110, DOI 10.1007/s00267-003-0036-z; Lindenmayer DB, 2005, BIOL CONSERV, V124, P311, DOI 10.1016/j.biocon.2005.01.038; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Link WA, 2002, ECOLOGY, V83, P2832, DOI 10.1890/0012-9658(2002)083[2832:AHAOPC]2.0.CO;2; Link WA, 2007, ECOLOGY, V88, P49, DOI 10.1890/0012-9658(2007)88[49:SCOAPC]2.0.CO;2; Liu JG, 2003, NATURE, V421, P530, DOI 10.1038/nature01359; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mancke RG, 2000, ECOL APPL, V10, P598, DOI 10.1890/1051-0761(2000)010[0598:BBDIWE]2.0.CO;2; Marzluff John M., 2001, P19; Matlack GR, 1997, J BIOGEOGR, V24, P281, DOI 10.1046/j.1365-2699.1997.00108.x; Mazerolle DF, 2004, CAN J ZOOL, V82, P1774, DOI 10.1139/Z04-175; McDonnell MJ, 2008, LANDSCAPE ECOL, V23, P1143, DOI 10.1007/s10980-008-9253-4; McGarigal K., 2002, FRAGSTATS SPATIAL PA, DOI DOI 10.1016/S0022-3913(12)00047-9; McGranahan D.A., 1999, NATURAL AMENITIES DR; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Merenlender AM, 2009, LANDSCAPE URBAN PLAN, V92, P255, DOI 10.1016/j.landurbplan.2009.05.004; Mikusinski G, 2001, CONSERV BIOL, V15, P208, DOI 10.1046/j.1523-1739.2001.99236.x; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Newhouse MJ, 2008, WILSON J ORNITHOL, V120, P99, DOI 10.1676/06-156.1; Odell EA, 2001, CONSERV BIOL, V15, P1143, DOI 10.1046/j.1523-1739.2001.0150041143.x; PETERJOHN PG, 1994, WILDLIFE SOC B, V22, P155; Pidgeon AM, 2007, ECOL APPL, V17, P1989, DOI 10.1890/06-1489.1; Poulin JF, 2008, BIOL CONSERV, V141, P1129, DOI 10.1016/j.biocon.2008.02.012; R Core Team, 2021, R LANGUAGE ENV STAT; Radford JQ, 2005, BIOL CONSERV, V124, P317, DOI 10.1016/j.biocon.2005.01.039; Robbins C.S., 1986, BREEDING BIRD SURVEY; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; SAUER JR, 1994, AUK, V111, P50, DOI 10.2307/4088504; Sauer JR, 2003, J WILDLIFE MANAGE, V67, P372, DOI 10.2307/3802778; Sauer JR, 1995, MONITORING BIRD POPU, P151; Sherry TW, 1997, BIRDS N AM; Smith AC, 2011, ECOGRAPHY, V34, P103, DOI 10.1111/j.1600-0587.2010.06201.x; Smith RJ, 2011, BIRDS N AM ONLINE; Smith WB, 2004, FOREST RESOURCES US; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; Struyk RJ, 1996, HOUSING STUD, V11, P233, DOI 10.1080/02673039608720854; Suarez-Rubio M, 2012, REMOTE SENS ENVIRON, V124, P360, DOI 10.1016/j.rse.2012.03.029; Suarez-Rubio M, 2011, J ORNITHOL, V152, P461, DOI 10.1007/s10336-010-0605-x; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Swift TL, 2010, BIOL REV, V85, P35, DOI 10.1111/j.1469-185X.2009.00093.x; Theobald DM, 2005, ECOL SOC, V10; U.S. NABCI Committee, 2009, STAT BIRDS; US Census Bureau, 2010, STAT COUNT QUICK FAC; Valiela I, 2007, BIOSCIENCE, V57, P360, DOI 10.1641/B570410; van den Berg L, 2000, LANDSCAPE URBAN PLAN, V48, P169, DOI 10.1016/S0169-2046(00)00040-2; van Dorp D, 1987, LANDSCAPE ECOL, V1, P59, DOI 10.1007/BF02275266; Veech JA, 2007, GLOBAL ECOL BIOGEOGR, V16, P650, DOI 10.1111/j.1466-8238.2007.00315.x; Vogt P, 2007, LANDSCAPE ECOL, V22, P171, DOI 10.1007/s10980-006-9013-2; Wade AA, 2010, CONSERV BIOL, V24, P151, DOI 10.1111/j.1523-1739.2009.01296.x; Wakamiya SW, 2012, NATURAL RESOURCE DAT; Weeks Jr HP, 2011, E PHOEBE SAYORNIS PH; Weldon Cooper Center, 2010, FIN 2008 PROV 2009 P; WITH KA, 1995, ECOLOGY, V76, P2446, DOI 10.2307/2265819; Zuckerberg B, 2010, BIOL CONSERV, V143, P952, DOI 10.1016/j.biocon.2010.01.004	104	39	40	0	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 24	2013	8	6							e67593	10.1371/journal.pone.0067593	http://dx.doi.org/10.1371/journal.pone.0067593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182JP	23826325	Green Submitted, Green Published, gold			2022-12-27	WOS:000321738400161
J	Wang, Q; Cheng, XL; Zhang, DY; Gao, XJ; Zhou, L; Qin, XY; Xie, GY; Liu, K; Qin, Y; Liu, BL; Qin, MJ				Wang, Qi; Cheng, Xiao-Lan; Zhang, Dong-Yan; Gao, Xue-Jiao; Zhou, Ling; Qin, Xiao-Ying; Xie, Guo-Yong; Liu, Kang; Qin, Yong; Liu, Bao-Lin; Qin, Min-Jian			Tectorigenin Attenuates Palmitate-Induced Endothelial Insulin Resistance via Targeting ROS-Associated Inflammation and IRS-1 Pathway	PLOS ONE			English	Article							INDUCED DIABETIC-RAT; IN-VITRO; KAIKASAPONIN-III; PUERARIAE FLOS; DYSFUNCTION; TECTORIDIN; PURIFICATION; ISOFLAVONES; METABOLISM; FLOWERS	Tectorigenin is a plant isoflavonoid originally isolated from the dried flower of Pueraria thomsonii Benth. Although its anti-inflammatory and anti-hyperglycosemia effects have been well documented, the effect of tectorigenin on endothelial dysfunction insulin resistance involved has not yet been reported. Herein, this study aims to investigate the action of tectorigenin on amelioration of insulin resistance in the endothelium. Palmitic acid (PA) was chosen as a stimulant to induce ROS production in endothelial cells and successfully established insulin resistance evidenced by the specific impairment of insulin PI3K signaling. Tectorigenin effectively inhibited the ability of PA to induce the production of reactive oxygen species and collapse of mitochondrial membrane potential. Moreover, tectorigenin presented strong inhibition effect on ROS-associated inflammation, as TNF-alpha and IL-6 production in endothelial cells was greatly reduced with suppression of IKK beta/NF-kappa B phosphorylation and JNK activation. Tectorigenin also can inhibit inflammation-stimulated IRS-1 serine phosphorylation and restore the impaired insulin PI3K signaling, leading to a decreased NO production. These results demonstrated its positive regulation of insulin action in the endothelium. Meanwhile, tectorigenin down-regulated endothelin-1 and vascular cell adhesion molecule-1 overexpression, and restored the loss of insulin-mediated vasodilation in rat aorta. These findings suggested that tectorigenin could inhibit ROS-associated inflammation and ameliorated endothelial dysfunction implicated in insulin resistance through regulating IRS-1 function. Tectorigenin might have potential to be applied for the management of cardiovascular diseases involved in diabetes and insulin resistance.	[Wang, Qi; Cheng, Xiao-Lan; Zhou, Ling; Qin, Xiao-Ying; Xie, Guo-Yong; Qin, Yong; Qin, Min-Jian] China Pharmaceut Univ, Dept Resource Sci Tradit Chinese Med, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Dong-Yan] Henan Prov Peoples Hosp, Dept Pharm, Zhengzhou, Peoples R China; [Gao, Xue-Jiao] Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Taipa, Peoples R China; [Liu, Kang; Liu, Bao-Lin] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; Zhengzhou University; University of Macau; China Pharmaceutical University	Qin, MJ (corresponding author), China Pharmaceut Univ, Dept Resource Sci Tradit Chinese Med, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	minjianqin@163.com	Qin, Minjian/D-3306-2017; TAO, Jun/I-2701-2014; Chen, Lung-Wen/J-5792-2015	Qin, Minjian/0000-0001-8539-7649; TAO, Jun/0000-0002-0936-4869; Chen, Lung-Wen/0000-0002-2311-7506	National Natural Science Foundation of China [81072976]; Research and Innovation Project for College Graduates of Jiangsu Province [CXZZ11-0810]; Program for the Top Doctor Innovative Talents of China Pharmacuetical University [2011IIBPY03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research and Innovation Project for College Graduates of Jiangsu Province; Program for the Top Doctor Innovative Talents of China Pharmacuetical University	Support as provided by: National Natural Science Foundation of China (Grant No. 81072976), Research and Innovation Project for College Graduates of Jiangsu Province (CXZZ11-0810) and Program for the Top Doctor Innovative Talents of China Pharmacuetical University (2011IIBPY03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae EA, 1999, BIOL PHARM BULL, V22, P1314, DOI 10.1248/bpb.22.1314; Cao XL, 1999, J CHROMATOGR A, V855, P709, DOI 10.1016/S0021-9673(99)00715-3; Carmody RJ, 2000, CELL DEATH DIFFER, V7, P282, DOI 10.1038/sj.cdd.4400646; Choi J, 2004, J MED FOOD, V7, P31, DOI 10.1089/109662004322984671; Eringa EC, 2002, CARDIOVASC RES, V56, P464, DOI 10.1016/S0008-6363(02)00593-X; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Han T, 2012, FOOD CHEM TOXICOL, V50, P409, DOI 10.1016/j.fct.2011.10.066; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Iwata NG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029600; Jung SH, 2002, ARCH PHARM RES, V25, P306, DOI 10.1007/BF02976631; Kamiya T, 2011, J HEALTH SCI, V57, P521, DOI 10.1248/jhs.57.521; Kearney MT, 2008, EXP PHYSIOL, V93, P158, DOI 10.1113/expphysiol.2007.039172; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Lee HU, 2005, J PHARMACOL SCI, V97, P541, DOI 10.1254/jphs.SCZ040467; Lee KT, 2000, ARCH PHARM RES, V23, P461, DOI 10.1007/BF02976573; Mishra M, 2011, DIABETES RES CLIN PR, V94, P255, DOI 10.1016/j.diabres.2011.07.037; NIIHO Y, 1989, YAKUGAKU ZASSHI, V109, P424, DOI 10.1248/yakushi1947.109.6_424; Pan CH, 2008, ARCH PHARM RES, V31, P1447, DOI 10.1007/s12272-001-2129-7; Potenza MA, 2005, AM J PHYSIOL-HEART C, V289, pH813, DOI 10.1152/ajpheart.00092.2005; Verma S, 2001, HYPERTENSION, V37, P328, DOI 10.1161/01.HYP.37.2.328; Wang Q, 2013, J PHARMACEUT BIOMED, V75, P25, DOI 10.1016/j.jpba.2012.11.009; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Yuan D, 2009, J ASIAN NAT PROD RES, V11, P471, DOI 10.1080/10286020902819822; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zhang DY, 2013, J DIABETES, V5, P13, DOI 10.1111/1753-0407.12017; Zou MH, 2004, ENDOTHELIUM-J ENDOTH, V11, P89, DOI 10.1080/10623320490482619	29	69	72	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66417	10.1371/journal.pone.0066417	http://dx.doi.org/10.1371/journal.pone.0066417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23874802	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200072
J	Gong, YY; Li, JZ; Schnitzer, MJ				Gong, Yiyang; Li, Jin Zhong; Schnitzer, Mark J.			Enhanced Archaerhodopsin Fluorescent Protein Voltage Indicators	PLOS ONE			English	Article							BACTERIORHODOPSIN MUTANTS; ACTION-POTENTIALS; IN-VIVO; FRET; OPTIMIZATION; DYNAMICS; NEURONS; PROBE	A longstanding goal in neuroscience has been to develop techniques for imaging the voltage dynamics of genetically defined subsets of neurons. Optical sensors of transmembrane voltage would enhance studies of neural activity in contexts ranging from individual neurons cultured in vitro to neuronal populations in awake-behaving animals. Recent progress has identified Archaerhodopsin (Arch) based sensors as a promising, genetically encoded class of fluorescent voltage indicators that can report single action potentials. Wild-type Arch exhibits sub-millisecond fluorescence responses to trans-membrane voltage, but its light-activated proton pump also responds to the imaging illumination. An Arch mutant (Arch-D95N) exhibits no photocurrent, but has a slower, similar to 40 ms response to voltage transients. Here we present Arch-derived voltage sensors with trafficking signals that enhance their localization to the neural membrane. We also describe Arch mutant sensors (Arch-EEN and -EEQ) that exhibit faster kinetics and greater fluorescence dynamic range than Arch-D95N, and no photocurrent at the illumination intensities normally used for imaging. We benchmarked these voltage sensors regarding their spike detection fidelity by using a signal detection theoretic framework that takes into account the experimentally measured photon shot noise and optical waveforms for single action potentials. This analysis revealed that by combining the sequence mutations and enhanced trafficking sequences, the new sensors improved the fidelity of spike detection by nearly three-fold in comparison to Arch-D95N.	[Gong, Yiyang; Li, Jin Zhong; Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA; [Gong, Yiyang; Li, Jin Zhong; Schnitzer, Mark J.] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Gong, YY (corresponding author), Stanford Univ, James H Clark Ctr, Stanford, CA 94305 USA.	yiyangg@stanford.edu		Gong, Yiyang/0000-0002-1855-930X	Stanford CNC program; Stanford BioX Interdisciplinary Initiatives Program (IIP) grant; National Academies Keck Futures Initiative (NAKFI) research grant	Stanford CNC program; Stanford BioX Interdisciplinary Initiatives Program (IIP) grant; National Academies Keck Futures Initiative (NAKFI) research grant	This work was supported by the Stanford CNC program, the Stanford BioX Interdisciplinary Initiatives Program (IIP) grant, and a National Academies Keck Futures Initiative (NAKFI) research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akemann W, 2012, J NEUROPHYSIOL, V108, P2323, DOI 10.1152/jn.00452.2012; Akemann W, 2010, NAT METHODS, V7, P643, DOI [10.1038/nmeth.1479, 10.1038/NMETH.1479]; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Barnett L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043454; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chanda B, 2005, NAT NEUROSCI, V8, P1619, DOI 10.1038/nn1558; Chemla S, 2010, J PHYSIOL-PARIS, V104, P40, DOI 10.1016/j.jphysparis.2009.11.009; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Jin L, 2012, NEURON, V75, P779, DOI 10.1016/j.neuron.2012.06.040; Kalaidzidis IV, 1997, FEBS LETT, V418, P239, DOI 10.1016/S0014-5793(97)01390-2; Kolodner P, 1996, P NATL ACAD SCI USA, V93, P11618, DOI 10.1073/pnas.93.21.11618; Kralj JM, 2012, NAT METHODS, V9, P90, DOI [10.1038/NMETH.1782, 10.1038/nmeth.1782]; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; Lam AJ, 2012, NAT METHODS, V9, P1005, DOI [10.1038/NMETH.2171, 10.1038/nmeth.2171]; LANYI JK, 1992, J BIOENERG BIOMEMBR, V24, P169, DOI 10.1007/BF00762675; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Lundby A, 2010, EUR BIOPHYS J BIOPHY, V39, P1625, DOI 10.1007/s00249-010-0620-0; Lundby A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002514; MARINETTI T, 1989, P NATL ACAD SCI USA, V86, P529, DOI 10.1073/pnas.86.2.529; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; Mishina Y, 2012, BIOPHYS J, V103, P669, DOI 10.1016/j.bpj.2012.07.031; Moltke S, 1995, BIOPHYS J, V69, P2074, DOI 10.1016/S0006-3495(95)80078-0; Mutoh H, 2012, ACS CHEM NEUROSCI, V3, P585, DOI 10.1021/cn300041b; Mutoh H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004555; Perron A, 2009, CHEM BIOL, V16, P1268, DOI 10.1016/j.chembiol.2009.11.014; Peterka DS, 2011, NEURON, V69, P9, DOI 10.1016/j.neuron.2010.12.010; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Saeedi P, 2012, BIOTECHNOL LETT, V34, P455, DOI 10.1007/s10529-011-0731-4; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; SALZBERG BM, 1993, JPN J PHYSIOL, V43, pS37; SALZBERG BM, 1977, J NEUROPHYSIOL, V40, P1281, DOI 10.1152/jn.1977.40.6.1281; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; Sjulson L, 2008, J NEUROSCI, V28, P5582, DOI 10.1523/JNEUROSCI.0055-08.2008; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tsutsui H, 2008, NAT METHODS, V5, P683, DOI 10.1038/nmeth.1235; Wilt BA, 2013, BIOPHYS J, V104, P51, DOI 10.1016/j.bpj.2012.07.058	41	71	89	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2013	8	6							e66959	10.1371/journal.pone.0066959	http://dx.doi.org/10.1371/journal.pone.0066959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	190ST	23840563	Green Submitted, Green Published, gold			2022-12-27	WOS:000322361200112
J	Zhu, LH; Zhao, XC; Lai, LM; Wang, JJ; Jiang, LH; Ding, JZ; Liu, NX; Yu, YJ; Li, JS; Xiao, NW; Zheng, YR; Rimmington, GM				Zhu, Linhai; Zhao, Xuechun; Lai, Liming; Wang, Jianjian; Jiang, Lianhe; Ding, Jinzhi; Liu, Nanxi; Yu, Yunjiang; Li, Junsheng; Xiao, Nengwen; Zheng, Yuanrun; Rimmington, Glyn M.			Soil TPH Concentration Estimation Using Vegetation Indices in an Oil Polluted Area of Eastern China	PLOS ONE			English	Article							RED-EDGE; REFLECTANCE; LEAF; RESPONSES; FOREST; PREDICTION; PETROLEUM; RATIOS; RADAR; METAL	Assessing oil pollution using traditional field-based methods over large areas is difficult and expensive. Remote sensing technologies with good spatial and temporal coverage might provide an alternative for monitoring oil pollution by recording the spectral signals of plants growing in polluted soils. Total petroleum hydrocarbon concentrations of soils and the hyperspectral canopy reflectance were measured in wetlands dominated by reeds (Phragmites australis) around oil wells that have been producing oil for approximately 10 years in the Yellow River Delta, eastern China to evaluate the potential of vegetation indices and red edge parameters to estimate soil oil pollution. The detrimental effect of oil pollution on reed communities was confirmed by the evidence that the aboveground biomass decreased from 1076.5 g m(-2) to 5.3 g m(-2) with increasing total petroleum hydrocarbon concentrations ranging from 9.45 mg kg(-1) to 652 mg kg(-1). The modified chlorophyll absorption ratio index (MCARI) best estimated soil TPH concentration among 20 vegetation indices. The linear model involving MCARI had the highest coefficient of determination (R-2 = 0.73) and accuracy of prediction (RMSE = 104.2 mg kg(-1)). For other vegetation indices and red edge parameters, the R-2 and RMSE values ranged from 0.64 to 0.71 and from 120.2 mg kg(-1) to 106.8 mg kg(-1) respectively. The traditional broadband normalized difference vegetation index (NDVI), one of the broadband multispectral vegetation indices (BMVIs), produced a prediction (R-2 = 0.70 and RMSE = 110.1 mg kg(-1)) similar to that of MCARI. These results corroborated the potential of remote sensing for assessing soil oil pollution in large areas. Traditional BMVIs are still of great value in monitoring soil oil pollution when hyperspectral data are unavailable.	[Zhu, Linhai; Zhao, Xuechun; Lai, Liming; Wang, Jianjian; Jiang, Lianhe; Ding, Jinzhi; Liu, Nanxi; Zheng, Yuanrun] Chinese Acad Sci, Inst Bot, W China Subalpine Bot Garden, Key Lab Resource Plants,Beijing Bot Garden, Beijing, Peoples R China; [Zhu, Linhai; Zhao, Xuechun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yu, Yunjiang; Li, Junsheng; Xiao, Nengwen] Chinese Res Inst Environm Sci, Beijing, Peoples R China; [Rimmington, Glyn M.] Wichita State Univ, Global Learning Coll Engn, Wichita, KS USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Research Academy of Environmental Sciences; Wichita State University	Zheng, YR (corresponding author), Chinese Acad Sci, Inst Bot, W China Subalpine Bot Garden, Key Lab Resource Plants,Beijing Bot Garden, Beijing, Peoples R China.	zhengyr@ibcas.ac.cn	Ding, Jinzhi/AAE-3421-2019; liming, lai/HGB-0743-2022; Xiao, Nengwen/ACW-1426-2022; Zhu, Linhai/B-8551-2011	Ding, Jinzhi/0000-0003-3664-2702; Zhu, Linhai/0000-0001-7064-9022; Xiao, NengWen/0000-0002-7482-135X	National Key Technology R&D Program of China [2008BAC43B01]	National Key Technology R&D Program of China(National Key Technology R&D Program)	This work was supported by the National Key Technology R&D Program of China (2008BAC43B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin JM, 2003, FOREST ECOL MANAG, V176, P575, DOI 10.1016/S0378-1127(02)00314-6; Bannari A., 1995, REMOTE SENS REV, V13, P95, DOI [10.1080/02757259509532298, DOI 10.1080/02757259509532298]; Baret F., 1989, P 12 CAN S REM SENS, V3, P1355; Blackburn GA, 1998, INT J REMOTE SENS, V19, P657, DOI 10.1080/014311698215919; Broge NH, 2001, REMOTE SENS ENVIRON, V76, P156, DOI 10.1016/S0034-4257(00)00197-8; CARTER GA, 1994, INT J REMOTE SENS, V15, P697, DOI 10.1080/01431169408954109; CARTER GA, 1993, AM J BOT, V80, P239, DOI 10.2307/2445346; Chaineau CH, 2003, WATER AIR SOIL POLL, V144, P419, DOI 10.1023/A:1022935600698; [陈建 CHEN Jian], 2011, [地理科学进展, Progress in Geography], V30, P585; Cho MA, 2006, REMOTE SENS ENVIRON, V101, P181, DOI 10.1016/j.rse.2005.12.011; Clevers JGPW, 2004, INT J REMOTE SENS, V25, P3883, DOI 10.1080/01431160310001654473; COLWELL J E, 1974, Remote Sensing of Environment, V3, P175, DOI 10.1016/0034-4257(74)90003-0; Culbertson JB, 2008, J APPL ECOL, V45, P1284, DOI 10.1111/j.1365-2664.2008.01477.x; Daughtry CST, 2000, REMOTE SENS ENVIRON, V74, P229, DOI 10.1016/S0034-4257(00)00113-9; DEMETRIADESSHAH TH, 1990, REMOTE SENS ENVIRON, V33, P55, DOI 10.1016/0034-4257(90)90055-Q; Fodrie FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021609; GATES DM, 1965, APPL OPTICS, V4, P11, DOI 10.1364/AO.4.000011; GOETZ AFH, 1985, SCIENCE, V228, P1147, DOI 10.1126/science.228.4704.1147; Guyot G., 1988, J CHEM INF MODEL, P279; Haboudane D, 2004, REMOTE SENS ENVIRON, V90, P337, DOI 10.1016/j.rse.2003.12.013; Haboudane D, 2002, REMOTE SENS ENVIRON, V81, P416, DOI 10.1016/S0034-4257(02)00018-4; HORLER DNH, 1983, INT J REMOTE SENS, V4, P273, DOI 10.1080/01431168308948546; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Ji GD, 2004, ENVIRON INT, V30, P509, DOI 10.1016/j.envint.2003.10.003; Ji GD, 2007, ECOL ENG, V29, P272, DOI 10.1016/j.ecoleng.2006.04.002; KAUFMAN YJ, 1992, IEEE T GEOSCI REMOTE, V30, P261, DOI 10.1109/36.134076; KNIPLING E B, 1970, Remote Sensing of Environment, V1, P155; Kooistra L, 2004, ENVIRON POLLUT, V127, P281, DOI 10.1016/S0269-7491(03)00266-5; Kooistra L, 2003, INT J REMOTE SENS, V24, P4995, DOI 10.1080/0143116031000080769; [刘五星 LIU Wuxing], 2007, [土壤, Soils], V39, P247; MAJOR DJ, 1990, INT J REMOTE SENS, V11, P727, DOI 10.1080/01431169008955053; Mason DC, 2012, IEEE T GEOSCI REMOTE, V50, P3041, DOI 10.1109/TGRS.2011.2178030; MILLER JR, 1990, INT J REMOTE SENS, V11, P1755, DOI 10.1080/01431169008955128; Nie M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017961; Osuji LC, 2004, CHEM BIODIVERS, V1, P1569, DOI 10.1002/cbdv.200490117; Penuelas J, 1998, TRENDS PLANT SCI, V3, P151, DOI 10.1016/S1360-1385(98)01213-8; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pezeshki SR, 2000, ENVIRON POLLUT, V108, P129, DOI 10.1016/S0269-7491(99)00244-4; Pu RL, 2003, IEEE T GEOSCI REMOTE, V41, P916, DOI 10.1109/TGRS.2003.813555; Qiu GY, 1998, J HYDROL, V210, P93, DOI 10.1016/S0022-1694(98)00174-7; Ren L., 2000, AGROENVIRONMENTAL PR, V19, P360; ROCK BN, 1988, REMOTE SENS ENVIRON, V24, P109, DOI 10.1016/0034-4257(88)90008-9; Rondeaux G, 1996, REMOTE SENS ENVIRON, V55, P95, DOI 10.1016/0034-4257(95)00186-7; Rosso PH, 2005, ENVIRON POLLUT, V137, P241, DOI 10.1016/j.envpol.2005.02.025; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; SHIELDS PG, 1993, CANCER RES, V53, P3486; Smith KL, 2004, REMOTE SENS ENVIRON, V92, P207, DOI 10.1016/j.rse.2004.06.002; Thenkabail PS, 2000, REMOTE SENS ENVIRON, V71, P158, DOI 10.1016/S0034-4257(99)00067-X; WOOLLEY JT, 1971, PLANT PHYSIOL, V47, P656, DOI 10.1104/pp.47.5.656; 许学工, 2001, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V37, P111	51	91	96	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 16	2013	8	1							e54028	10.1371/journal.pone.0054028	http://dx.doi.org/10.1371/journal.pone.0054028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	072OV	23342066	Green Submitted, gold, Green Published			2022-12-27	WOS:000313682700078
J	Chauhan, JS; Rao, A; Raghava, GPS				Chauhan, Jagat Singh; Rao, Alka; Raghava, Gajendra P. S.			In silico Platform for Prediction of N-, O- and C-Glycosites in Eukaryotic Protein Sequences	PLOS ONE			English	Article							GLYCOSYLATION SITES; DATABASE	Glycosylation is one of the most abundant and an important post-translational modification of proteins. Glycosylated proteins (glycoproteins) are involved in various cellular biological functions like protein folding, cell-cell interactions, cell recognition and host-pathogen interactions. A large number of eukaryotic glycoproteins also have therapeutic and potential technology applications. Therefore, characterization and analysis of glycosites (glycosylated residues) in these proteins is of great interest to biologists. In order to cater these needs a number of in silico tools have been developed over the years, however, a need to get even better prediction tools remains. Therefore, in this study we have developed a new webserver GlycoEP for more accurate prediction of N-linked, O-linked and C-linked glycosites in eukaryotic glycoproteins using two larger datasets, namely, standard and advanced datasets. In case of standard datasets no two glycosylated proteins are more similar than 40%; advanced datasets are highly non-redundant where no two glycosites' patterns (as defined in methods) have more than 60% similarity. Further, based on our results with several algorihtms developed using different machine-learning techniques, we found Support Vector Machine (SVM) as optimum tool to develop glycosite prediction models. Accordingly, using our more stringent and non-redundant advanced datasets, the SVM based models developed in this study achieved a prediction accuracy of 84.26%, 86.87% and 91.43% with corresponding MCC of 0.54, 0.20 and 0.78, for N-, O- and C-linked glycosites, respectively. The best performing models trained on advanced datasets were then implemented as a user-friendly web server GlycoEP (http://www.imtech.res.in/raghava/glycoep/). Additionally, this server provides prediction models developed on standard datasets and allows users to scan sequons in input protein sequences.	[Chauhan, Jagat Singh; Raghava, Gajendra P. S.] Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India; [Rao, Alka] Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Raghava, GPS (corresponding author), Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India.	raghava@imtech.res.in	Raghava, Gajendra/B-1717-2009; Raghava, Gajendra P.S./AAA-2413-2022; Rao, Alka/F-9826-2010; Brown, Wendy J/G-2201-2010; matthews, charles/E-8073-2015	Raghava, Gajendra P.S./0000-0002-8902-2876; Grunseit, Anne/0000-0003-1250-3265; Chau, Josephine/0000-0001-6261-2545; van der Ploeg, Hidde/0000-0002-3719-5249; Brown, Wendy J/0000-0001-9093-4509; matthews, charles/0000-0001-8037-3103	CSIR; DBT, government of India	CSIR(Council of Scientific & Industrial Research (CSIR) - India); DBT, government of India(Department of Biotechnology (DBT) India)	This piece of work was financially supported by CSIR and DBT, government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhat AH, 2012, NUCLEIC ACIDS RES, V40, pD388, DOI 10.1093/nar/gkr911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Caragea C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-438; Chauhan JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040155; Chauhan JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-301; Christlet THT, 2001, BIOPHYS J, V80, P952, DOI 10.1016/S0006-3495(01)76074-2; Dell A, 2010, INT J MICROBIOL, V2010, P148; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Garg A, 2005, PROTEINS, V61, P318, DOI 10.1002/prot.20630; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Gupta R, 1999, NUCLEIC ACIDS RES, V27, P370, DOI 10.1093/nar/27.1.370; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hamby SE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-500; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Hart Gerald W., 1992, Current Opinion in Cell Biology, V4, P1017, DOI 10.1016/0955-0674(92)90134-X; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Krieg J, 1998, MOL BIOL CELL, V9, P301, DOI 10.1091/mbc.9.2.301; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; LEHLE L, 1978, EUR J BIOCHEM, V83, P563, DOI 10.1111/j.1432-1033.1978.tb12124.x; Li SJ, 2006, COMPUT BIOL CHEM, V30, P203, DOI 10.1016/j.compbiolchem.2006.02.002; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miyamoto S, 2006, CURR OPIN MOL THER, V8, P507; Pandhal J, 2010, BIOTECHNOL LETT, V32, P1189, DOI 10.1007/s10529-010-0289-6; Schwartz D, 2012, ESSAYS BIOCHEM, V52, P165, DOI [10.1042/bse0520165, 10.1042/BSE0520165]; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Vapnik V., 2013, NATURE STAT LAERNING; von der Lieth CW, 2004, BRIEF BIOINFORM, V5, P164, DOI 10.1093/bib/5.2.164; WILSON IBH, 1991, BIOCHEM J, V275, P529, DOI 10.1042/bj2750529	33	360	368	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2013	8	6							e67008	10.1371/journal.pone.0067008	http://dx.doi.org/10.1371/journal.pone.0067008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	174IH	23840574	gold, Green Published, Green Submitted			2022-12-27	WOS:000321148400028
J	Kim, SO; Sakchaisri, K; Thimmegowda, NR; Soung, NK; Jang, JH; Kim, YS; Lee, KS; Kwon, YT; Asami, Y; Ahn, JS; Erikson, RL; Kim, BY				Kim, Sun-Ok; Sakchaisri, Krisada; Thimmegowda, N. R.; Soung, Nak Kyun; Jang, Jae-Hyuk; Kim, Young Sang; Lee, Kyung Sang; Kwon, Yong Tae; Asami, Yukihiro; Ahn, Jong Seog; Erikson, Raymond Leo; Kim, Bo Yeon			STK295900, a Dual Inhibitor of Topoisomerase 1 and 2, Induces G(2) Arrest in the Absence of DNA Damage	PLOS ONE			English	Article							CDC25 PHOSPHATASES; CELL-CYCLE; I INHIBITORS; G2/M TRANSITION; CANCER-THERAPY; HISTONE H3; PHOSPHORYLATION; CHECKPOINT; CAMPTOTHECIN; MECHANISM	STK295900, a small synthetic molecule belonging to a class of symmetric bibenzimidazoles, exhibits antiproliferative activity against various human cancer cell lines from different origins. Examining the effect of STK295900 in HeLa cells indicates that it induces G(2) phase arrest without invoking DNA damage. Further analysis shows that STK295900 inhibits DNA relaxation that is mediated by topoisomerase 1 (Top 1) and topoisomerase 2 (Top 2) in vitro. In addition, STK295900 also exhibits protective effect against DNA damage induced by camptothecin. However, STK295900 does not affect etoposide-induced DNA damage. Moreover, STK295900 preferentially exerts cytotoxic effect on cancer cell lines while camptothecin, etoposide, and Hoechst 33342 affected both cancer and normal cells. Therefore, STK295900 has a potential to be developed as an anticancer chemotherapeutic agent.	[Kim, Sun-Ok; Sakchaisri, Krisada; Thimmegowda, N. R.; Soung, Nak Kyun; Jang, Jae-Hyuk; Ahn, Jong Seog; Kim, Bo Yeon] Korea Res Inst Biosci & Biotechnol KRIBB, Ochang, Cheongwon, South Korea; [Kim, Sun-Ok; Kim, Young Sang] Chungnam Natl Univ, Coll Nat Sci, Dept Biochem, Taejon, South Korea; [Lee, Kyung Sang] NCI, Lab Metab, NIH, Bethesda, MD 20892 USA; [Kwon, Yong Tae] Seoul Natl Univ, World Class Univ, Grad Sch Convergence Sci & Technol, Seoul, South Korea; [Kwon, Yong Tae] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Kwon, Yong Tae] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA USA; [Kwon, Yong Tae] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Asami, Yukihiro] RIKEN Adv Sci Inst, Dept Biol Chem, Wako, Saitama, Japan; [Erikson, Raymond Leo] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU); Seoul National University (SNU); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; RIKEN; Harvard University	Ahn, JS (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Ochang, Cheongwon, South Korea.	jsahn@kribb.re.kr; bykim@kribb.re.kr	Damschroder, Laura/A-1142-2007; Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; timmusk, s/0000-0001-8465-1043; Damschroder, Laura/0000-0002-3657-8459; Ryan, Kerry/0000-0002-0582-3693; Asami, Yukihiro/0000-0003-1821-9169; De Vries, Raymond/0000-0003-3087-3040	World Class Institute [2009-002]; Global RD Center (GRDC); World Class University [R31-2008-000-10103-0]; KRIBB Research Initiative program; Ministry of Education, Science and Technology (MEST) of Korea	World Class Institute; Global RD Center (GRDC); World Class University; KRIBB Research Initiative program; Ministry of Education, Science and Technology (MEST) of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the World Class Institute (2009-002), Global R&D Center (GRDC), World Class University (R31-2008-000-10103-0) programs and a grant from KRIBB Research Initiative program funded by the Ministry of Education, Science and Technology (MEST) of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Antoni L, 2007, NAT REV CANCER, V7, P925, DOI 10.1038/nrc2251; Balmain A, 2002, CELL, V108, P145, DOI 10.1016/S0092-8674(02)00622-0; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Bonnet J, 2008, BIOCHEM BIOPH RES CO, V370, P483, DOI 10.1016/j.bbrc.2008.03.117; Bower JJ, 2010, ONCOGENE, V29, P4787, DOI 10.1038/onc.2010.232; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Cai XM, 2009, CANCER TREAT REV, V35, P437, DOI 10.1016/j.ctrv.2009.02.004; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; CHEN AY, 1993, P NATL ACAD SCI USA, V90, P8131, DOI 10.1073/pnas.90.17.8131; Chiu CC, 2005, CANCER LETT, V223, P249, DOI 10.1016/j.canlet.2004.10.049; Clifford B, 2003, CANCER RES, V63, P4074; Dale AG, 2012, BIOCHEMISTRY; DOWNES CS, 1994, NATURE, V372, P467, DOI 10.1038/372467a0; Foijer F, 2006, CELL CYCLE, V5, P831, DOI 10.4161/cc.5.8.2687; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; He L, 2007, CELL SIGNAL, V19, P1713, DOI 10.1016/j.cellsig.2007.03.006; HSIANG YH, 1985, J BIOL CHEM, V260, P4873; Jin S, 2000, BIOORG MED CHEM LETT, V10, P719, DOI 10.1016/S0960-894X(00)00087-1; JORDAN MA, 1992, J CELL SCI, V102, P401; Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908; Kim BY, 2005, CARCINOGENESIS, V26, P1395, DOI 10.1093/carcin/bgi081; Kristjansdottir K, 2004, CHEM BIOL, V11, P1043, DOI 10.1016/j.chembiol.2004.07.007; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Mann J, 2001, J MED CHEM, V44, P138, DOI 10.1021/jm000297b; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Narasimhan B, 2012, MED CHEM RES, V21, P269, DOI 10.1007/s00044-010-9533-9; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Patel S, 2000, MOL PHARMACOL, V58, P560, DOI 10.1124/mol.58.3.560; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rudolph J, 2007, BIOCHEMISTRY-US, V46, P3595, DOI 10.1021/bi700026j; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Taylor WR, 2001, ONCOGENE, V20, P1803, DOI 10.1038/sj.onc.1204252; Trembley JH, 1996, CELL GROWTH DIFFER, V7, P903; TSAO YP, 1992, CANCER RES, V52, P1823; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7	46	111	116	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53908	10.1371/journal.pone.0053908	http://dx.doi.org/10.1371/journal.pone.0053908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23349762	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000314019100036
J	Kim, SYH; Kim, HM; Ryan, KA; Appelbaum, PS; Knopman, DS; Damschroder, L; De Vries, R				Kim, Scott Y. H.; Kim, H. Myra; Ryan, Kerry A.; Appelbaum, Paul S.; Knopman, David S.; Damschroder, Laura; De Vries, Raymond			How Important Is 'Accuracy' of Surrogate Decision-Making for Research Participation?	PLOS ONE			English	Article							DEMENTIA-RESEARCH; ADVANCE DIRECTIVES; CARE RESEARCH; CONSENT; DELIBERATION; BIOETHICS; CAPACITY; DISEASE; MAKERS; FAMILY	Background: There is a longstanding concern about the accuracy of surrogate consent in representing the health care and research preferences of those who lose their ability to decide for themselves. We sought informed, deliberative views of the older general public (>= 50 years old) regarding their willingness to participate in dementia research and to grant leeway to future surrogates to choose an option contrary to their stated wishes. Methodology/Principal Findings: 503 persons aged 50+ recruited by random digit dialing were randomly assigned to one of three groups: deliberation, education, or control. The deliberation group attended an all-day education/peer deliberation session; the education group received written information only. Participants were surveyed at baseline, after the deliberation session (or equivalent time), and one month after the session, regarding their willingness to participate in dementia research and to give leeway to surrogates, regarding studies of varying risk-benefit profiles (a lumbar puncture study, a drug randomized controlled trial, a vaccine randomized controlled trial, and an early phase gene transfer trial). At baseline, 48% (gene transfer scenario) to 92% (drug RCT) were willing to participate in future dementia research. A majority of respondents (57-71% depending on scenario) were willing to give leeway to future surrogate decision-makers. Democratic deliberation increased willingness to participate in all scenarios, to grant leeway in 3 of 4 scenarios (lumbar puncture, vaccine, and gene transfer), and to enroll loved ones in research in all scenarios. On average, respondents were more willing to volunteer themselves for research than to enroll their loved ones. Conclusions/Significance: Most people were willing to grant leeway to their surrogates, and this willingness was either sustained or increased after democratic deliberation, suggesting that the attitude toward leeway is a reliable opinion. Eliciting a person's current preferences about future research participation should also involve eliciting his or her leeway preferences.	[Kim, Scott Y. H.; Ryan, Kerry A.; De Vries, Raymond] Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA; [Kim, Scott Y. H.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Kim, H. Myra] Univ Michigan, Ctr Stat Consultat & Res, Ann Arbor, MI 48109 USA; [Appelbaum, Paul S.] Columbia Univ, Dept Psychiat, Div Law Eth & Psychiat, New York, NY USA; [Appelbaum, Paul S.] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Knopman, David S.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Damschroder, Laura] Ann Arbor VA Med Ctr, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Columbia University; New York State Psychiatry Institute; Mayo Clinic	Kim, SYH (corresponding author), Univ Michigan, Ctr Bioeth & Social Sci Med, Ann Arbor, MI 48109 USA.	scottkim@med.umich.edu	Damschroder, Laura/A-1142-2007; Appelbaum, Paul/AFU-3908-2022	Appelbaum, Paul/0000-0002-1940-0042; timmusk, s/0000-0001-8465-1043; Damschroder, Laura/0000-0002-3657-8459; Ryan, Kerry/0000-0002-0582-3693; Asami, Yukihiro/0000-0003-1821-9169; De Vries, Raymond/0000-0003-3087-3040	National Institute of Health [R01AG029550]; Greenwall Foundation Faculty Scholars Award in Bioethics; Janssen Pharmaceuticals	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenwall Foundation Faculty Scholars Award in Bioethics; Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Supported by National Institute of Health R01AG029550 and the Greenwall Foundation Faculty Scholars Award in Bioethics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Scott Kim, H. Myra Kim, Kerry Ryan, Paul Appelbaum, Laura Damschroder, and Raymond De Vries have declared that they have no competing interests. David Knopman has read the journal's policy and has the following conflicts: he serves as Deputy Editor for Neurology (R); serves on a Data Safety Monitoring Board for Lilly Pharmaceuticals; is an investigator in clinical trials sponsored by Janssen Pharmaceuticals, and receives research support from the National Institute of Health. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Ciroldi M, 2007, INTENS CARE MED, V33, P807, DOI 10.1007/s00134-007-0582-6; Coppolino M, 2001, CHEST, V119, P603, DOI 10.1378/chest.119.2.603; De Vries R, 2011, J EMPIR RES HUM RES, V6, P3, DOI 10.1525/jer.2011.6.3.3; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Hawkins NA, 2005, GERONTOLOGIST, V45, P107, DOI 10.1093/geront/45.1.107; Karlawish J, 2009, AM J PSYCHIAT, V166, P182, DOI 10.1176/appi.ajp.2008.08050645; Kim SYH, 2011, NEUROLOGY, V77, P2097, DOI 10.1212/WNL.0b013e31823648cb; Kim SYH, 2009, NEUROLOGY, V72, P149, DOI 10.1212/01.wnl.0000339039.18931.a2; Kim SYH, 2011, ARCH GEN PSYCHIAT, V68, P214, DOI 10.1001/archgenpsychiatry.2010.191; Kim SYH, 2010, ALZHEIMERS DEMENT, V6, P342, DOI 10.1016/j.jalz.2009.06.001; Kim SYH, 2009, J EMPIR RES HUM RES, V4, P3, DOI 10.1525/jer.2009.4.4.3; Kim SYH, 2001, AM J PSYCHIAT, V158, P712, DOI 10.1176/appi.ajp.158.5.712; Kirchhoff KT, 2010, J AM GERIATR SOC, V58, P1233, DOI 10.1111/j.1532-5415.2010.02760.x; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Puchalski CM, 2000, J AM GERIATR SOC, V48, pS84, DOI 10.1111/j.1532-5415.2000.tb03146.x; SEHGAL A, 1992, JAMA-J AM MED ASSOC, V267, P59, DOI 10.1001/jama.267.1.59; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Stocking CB, 2006, NEUROLOGY, V66, P1361, DOI 10.1212/01.wnl.0000216424.66098.55; Wendler D, 2002, AM J PSYCHIAT, V159, P585, DOI 10.1176/appi.ajp.159.4.585	19	111	116	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 31	2013	8	1							e54790	10.1371/journal.pone.0054790	http://dx.doi.org/10.1371/journal.pone.0054790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	085JH	23349762	Green Submitted, Green Published, gold			2022-12-27	WOS:000314610600042
J	Li, K; Chi, Y; Gao, K; Yan, QJ; Matsue, H; Takeda, M; Kitamura, M; Yao, J				Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Matsue, Hiroyuki; Takeda, Masayuki; Kitamura, Masanori; Yao, Jian			Connexin43 Hemichannel-Mediated Regulation of Connexin43	PLOS ONE			English	Article							JUNCTIONAL INTERCELLULAR COMMUNICATION; GAP-JUNCTIONS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; GENE-EXPRESSION; LLC-PK1 CELLS; CADMIUM CD2+; C-JUN; PLASMA-MEMBRANE; UP-REGULATION	Background: Many signaling molecules and pathways that regulate gap junctions (GJs) protein expression and function are, in fact, also controlled by GJs. We, therefore, speculated an existence of the GJ channel-mediated self-regulation of GJs. Using a cell culture model in which nonjunctional connexin43 (Cx43) hemichannels were activated by cadmium (Cd2+), we tested this hypothesis. Principal Findings: Incubation of Cx43-transfected LLC-PK1 cells with Cd2+ led to an increased expression of Cx43. This effect of Cd2+ was tightly associated with JNK activation. Inhibition of JNK abolished the elevation of Cx43. Further analysis revealed that the changes of JNK and Cx43 were controlled by GSH. Supplement of a membrane-permeable GSH analogue GSH ethyl ester or GSH precursor N-acetyl-cystein abrogated the effects of Cd2+ on JNK activation and Cx43 expression. Indeed, Cd2+ induced extracellular release of GSH. Blockade of Cx43 hemichannels with heptanol or Cx43 mimetic peptide Gap26 to prevent the efflux of GSH significantly attenuated the Cx43-elevating effects of Cd2+. Conclusions: Collectively, our results thus indicate that Cd2+-induced upregulation of Cx43 is through activation of nonjunctional Cx43 hemichannels. Our findings thus support the existence of a hemichannel-mediated self-regulation of Cx43 and provide novel insights into the molecular mechanisms of Cx43 expression and function.	[Li, Kai; Chi, Yuan; Gao, Kun; Yan, Qiaojing; Kitamura, Masanori; Yao, Jian] Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan; [Li, Kai; Takeda, Masayuki] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Urol, Chuo Ku, Yamanashi, Japan; [Li, Kai] China Med Univ, Hosp 1, Dept Surg Oncol & Gen Surg, Shenyang, Peoples R China; [Matsue, Hiroyuki] Chiba Univ, Sch Med, Dept Dermatol, Chiba 280, Japan	University of Yamanashi; University of Yamanashi; China Medical University; Chiba University	Li, K (corresponding author), Univ Yamanashi, Dept Mol Signaling, Interdisciplinary Grad Sch Med & Engn, Chuo Ku, Yamanashi, Japan.	cmu_likai@hotmail.com; yao@yamanashi.ac.jp	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	Ministry of Education, Culture, Sports, Science and Technology, Japan [17659255, 20590953, B21390324]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (17659255 and 20590953 to JY; B21390324 to HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Carmeli C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029341; Chaytor AT, 1998, J PHYSIOL-LONDON, V508, P561, DOI 10.1111/j.1469-7793.1998.561bq.x; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; D'hondt C, 2007, INVEST OPHTH VIS SCI, V48, P120, DOI 10.1167/iovs.06-0770; Evans WH, 2006, BIOCHEM J, V397, P1, DOI 10.1042/BJ20060175; Evans WH, 2012, J MEMBRANE BIOL, V245, P437, DOI 10.1007/s00232-012-9488-5; Fang X, 2011, ANTIOXID REDOX SIGN, V14, P2427, DOI 10.1089/ars.2010.3150; Gao FH, 2007, BIOCHEM BIOPH RES CO, V356, P505, DOI 10.1016/j.bbrc.2007.03.009; Gennari A, 2003, TOXICOLOGY, V183, P211, DOI 10.1016/S0300-483X(02)00546-2; Giepmans BNG, 2004, CARDIOVASC RES, V62, P233, DOI 10.1016/j.cardiores.2003.12.009; HEW KW, 1993, BIOL REPROD, V49, P840, DOI 10.1095/biolreprod49.4.840; Huang T, 2010, CANCER SCI, V101, P713, DOI 10.1111/j.1349-7006.2009.01421.x; Lawal AO, 2010, J TOXICOL SCI, V35, P465, DOI 10.2131/jts.35.465; Li K, 2011, J BIOL CHEM, V286, P41552, DOI 10.1074/jbc.M111.274449; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Loch-Caruso R, 2005, TOXICOL SCI, V85, P694, DOI 10.1093/toxsci/kfi123; Majoul IV, 2009, HISTOCHEM CELL BIOL, V132, P263, DOI 10.1007/s00418-009-0617-x; Martin PEM, 2001, J CELL SCI, V114, P3845; Mendoza-Naranjo A, 2007, J IMMUNOL, V178, P6949, DOI 10.4049/jimmunol.178.11.6949; Mitchell JA, 2001, CELL COMMUN ADHES, V8, P299, DOI 10.3109/15419060109080741; Oviedo-Orta E, 2001, FASEB J, V15, P768, DOI 10.1096/fj.00-0288com; Ponsaerts R, 2010, FASEB J, V24, P4378, DOI 10.1096/fj.09-153007; PROZIALECK WC, 1991, TOXICOL APPL PHARM, V107, P81, DOI 10.1016/0041-008X(91)90333-A; PROZIALECK WC, 1995, TOXICOL APPL PHARM, V134, P285, DOI 10.1006/taap.1995.1194; Prozialeck WC, 1997, IN VITRO CELL DEV-AN, V33, P516; Prozialeck WC, 1998, TOXICOL IN VITRO, V12, P633, DOI 10.1016/S0887-2333(98)00054-X; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Retamal MA, 2007, P NATL ACAD SCI USA, V104, P8322, DOI 10.1073/pnas.0702456104; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Salameh A, 2008, J PHARMACOL EXP THER, V326, P315, DOI 10.1124/jpet.108.136663; Shyu KG, 2004, CARDIOVASC RES, V63, P98, DOI 10.1016/j.cardiores.2004.02.018; Son MH, 2001, BIOCHEM PHARMACOL, V62, P1379, DOI 10.1016/S0006-2952(01)00780-8; Stridh MH, 2008, J BIOL CHEM, V283, P10347, DOI 10.1074/jbc.M704153200; Stridh MH, 2010, NEUROCHEM RES, V35, P1231, DOI 10.1007/s11064-010-0179-2; Tacheau C, 2008, J CELL PHYSIOL, V217, P759, DOI 10.1002/jcp.21551; Thevenod F, 2000, J BIOL CHEM, V275, P1887, DOI 10.1074/jbc.275.3.1887; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Upham BL, 1997, CARCINOGENESIS, V18, P37, DOI 10.1093/carcin/18.1.37; Upham BL, 2009, ANTIOXID REDOX SIGN, V11, P297, DOI 10.1089/ars.2008.2146; Wilhelm D, 1997, MOL CELL BIOL, V17, P4792, DOI 10.1128/MCB.17.8.4792; Yao J, 2003, CIRC RES, V93, P338, DOI 10.1161/01.RES.0000086802.21850.5D; Yao J, 2010, BRIT J PHARM, P9999; Yao J, 2007, J MEMBRANE BIOL, V217, P123, DOI 10.1007/s00232-007-9023-2; Yao J, 2009, AM J PHYSIOL-RENAL, V296, pF939, DOI 10.1152/ajprenal.90612.2008; Yokouchi M, 2008, J BIOL CHEM, V283, P4252, DOI 10.1074/jbc.M705951200	47	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2013	8	2							e58057	10.1371/journal.pone.0058057	http://dx.doi.org/10.1371/journal.pone.0058057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	098BN	23874530	Green Submitted, Green Published, gold			2022-12-27	WOS:000315519000181
J	Li, KR; Zhang, ZQ; Yao, J; Zhao, YX; Duan, J; Cao, C; Jiang, Q				Li, Ke-ran; Zhang, Zhi-qing; Yao, Jin; Zhao, Yu-xia; Duan, Jing; Cao, Cong; Jiang, Qin			Ginsenoside Rg-1 Protects Retinal Pigment Epithelium (RPE) Cells from Cobalt Chloride (CoCl2) and Hypoxia Assaults	PLOS ONE			English	Article							N-TERMINAL KINASE; SIGNALING PATHWAY; INDUCED APOPTOSIS; OXIDATIVE STRESS; IN-VITRO; RG1 PROTECTS; CANCER CELLS; PC12 CELLS; P38 MAPK; ACTIVATION	Severe retinal ischemia causes persistent visual impairments in eye diseases. Retinal pigment epithelium (RPE) cells are located near the choroidal capillaries, and are easily affected by ischemic or hypoxia. Ginsenoside Rg-1 has shown significant neuroprotective effects. This study was performed to test the cytoprotective effect of ginsenoside Rg-1 in RPE cells against hypoxia and cobalt chloride (CoCl2) assaults, and to understand the underlying mechanisms. We found that Rg-1 pre-administration significantly inhibited CoCl2- and hypoxia-induced RPE cell death and apoptosis. Reactive oxygen specisis (ROS)-dependent p38 and c-Jun NH(2)-terminal kinases (JNK) MAPK activation was required for CoCl2-induced RPE cell death, and Rg-1 pre-treatment significantly inhibited ROS production and following p38/JNK activation. Further, CoCl2 suppressed pro-survival mTOR complex 1 (mTORC1) activation in RPE cells through activating of AMP-activated protein kinase (AMPK), while Rg-1 restored mTORC1 activity through inhibiting AMPK activation. CoCl2-induced AMPK activation was also dependent on ROS production, and anti-oxidant N-acetylcysteine (NAC) prevented AMPK activation and RPE cell death by CoCl2. Our results indicated that Rg-1 could be further investigated as a novel cell-protective agent for retinal ischemia.	[Li, Ke-ran; Yao, Jin; Zhao, Yu-xia; Jiang, Qin] Nanjing Med Univ, Affiliated Eye Hosp, Dept Eye, Nanjing, Jiangsu, Peoples R China; [Zhang, Zhi-qing; Cao, Cong] Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China; [Duan, Jing] China Pharmaceut Univ, Acad Inst Pharmaceut Sci, Ctr Safety Evaluat Drugs, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Soochow University - China; China Pharmaceutical University	Cao, C (corresponding author), Soochow Univ, Inst Neurosci, Suzhou, Jiangsu, Peoples R China.	caocong@suda.edu.cn; dryaojin@yahoo.com	; Li, Ke/I-3804-2013	Yao, Jian/0000-0003-2622-0215; Li, Ke/0000-0003-4869-5393	National Natural Science Foundation of China [81070744, 81271028]; Jiangsu Province [1002009B]; Medical Science and Technology Development Project Fund of Nanjing [ZKX12047, YKK12208, YKK12207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province; Medical Science and Technology Development Project Fund of Nanjing	This work was generously supported by grants from the National Natural Science Foundation of China (Nos. 81070744, 81271028), post-doc fund of Jiangsu Province (No. 1002009B) and Medical Science and Technology Development Project Fund of Nanjing (ZKX12047, YKK12208, YKK12207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borutaite Vilmante, 2008, Biochem J, V412, pe15, DOI 10.1042/BJ20080712; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Buettner C, 2006, ANN PHARMACOTHER, V40, P83, DOI 10.1345/aph.1G216; Cao C, 2008, J BIOL CHEM, V283, P28897, DOI 10.1074/jbc.M804144200; Chen L, 2010, LAB INVEST, V90, P762, DOI 10.1038/labinvest.2010.36; Chen MB, 2012, INT J CANC; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Chen WF, 2013, NEUROCHEM INT, V62, P1065, DOI 10.1016/j.neuint.2013.03.018; Chen XC, 2002, ACTA PHARMACOL SIN, V23, P829; Chen ZY, 2013, MOL CELL BIOCHEM, V377, P35, DOI 10.1007/s11010-013-1568-z; Du JH, 2005, BIOCHEM BIOPH RES CO, V337, P1139, DOI 10.1016/j.bbrc.2005.09.174; Du ZJ, 2011, INVEST OPHTH VIS SCI, V52, P987, DOI 10.1167/iovs.10-5557; Fang F, 2012, BBA-MOL BASIS DIS, V1822, P286, DOI 10.1016/j.bbadis.2011.10.004; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardy P, 2005, PROSTAG LEUKOTR ESS, V72, P301, DOI 10.1016/j.plefa.2005.02.004; Hayashi T, 2000, DIABETES, V49, P527, DOI 10.2337/diabetes.49.4.527; Huong NTT, 1998, BIOL PHARM BULL, V21, P978, DOI 10.1248/bpb.21.978; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Joo SS, 2005, PLANTA MED, V71, P476, DOI 10.1055/s-2005-864145; Kang MR, 2012, ONCOL REP, V27, P1407, DOI 10.3892/or.2012.1644; Kefas BA, 2003, J MOL ENDOCRINOL, V30, P151, DOI 10.1677/jme.0.0300151; Kim HJ, 2013, J GINSENG RES, V37, P8, DOI 10.5142/jgr.2013.37.8; Kim MH, 2008, APOPTOSIS, V13, P295, DOI 10.1007/s10495-007-0160-y; Kunz M, 2001, CELL GROWTH DIFFER, V12, P137; Lee MS, 2010, PHYTOTHER RES, V24, P1857, DOI 10.1002/ptr.3210; Leung KW, 2007, NEUROPHARMACOLOGY, V52, P827, DOI 10.1016/j.neuropharm.2006.10.001; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li J. Q., 1997, Yaoxue Xuebao, V32, P406; Li W, 2012, BRAIN RES BULL, V88, P501, DOI 10.1016/j.brainresbull.2012.05.002; Liao BS, 2002, EXP NEUROL, V173, P224, DOI 10.1006/exnr.2001.7841; Liu QA, 2011, NEUROCHEM INT, V58, P119, DOI 10.1016/j.neuint.2010.11.004; Liu ZJ, 2010, BRAIN RES, V1333, P1, DOI 10.1016/j.brainres.2010.03.096; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushina Y, 2000, BIOCHEM J, V350, P757, DOI 10.1042/0264-6021:3500757; Mu Yan-Yue, 2012, Zhongguo Zhong Xi Yi Jie He Za Zhi, V32, P1539; Nag SA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00025; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Shen L, 2007, ACTA PHARMACOL SIN, V28, P392, DOI 10.1111/j.1745-7254.2007.00511.x; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Terai K, 2005, MOL CELL BIOL, V25, P9554, DOI 10.1128/MCB.25.21.9554-9575.2005; Vogler BK, 1999, EUR J CLIN PHARMACOL, V55, P567, DOI 10.1007/s002280050674; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang Qiao-Yun, 2013, Zhongguo Zhong Xi Yi Jie He Za Zhi, V33, P229; Wang Wei-xia, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P89; Wu CF, 2007, INT IMMUNOPHARMACOL, V7, P313, DOI 10.1016/j.intimp.2006.04.021; Wu JY, 2012, NEUROPHARMACOLOGY, V63, P349, DOI 10.1016/j.neuropharm.2012.04.005; Xu HM, 2010, NEUROPHARMACOLOGY, V58, P488, DOI 10.1016/j.neuropharm.2009.09.002; Yang XH, 2010, WORLD J GASTROENTERO, V16, P3385, DOI 10.3748/wjg.v16.i27.3385; Yao J, 2013, INT J MOL SCI, V14, P10355, DOI 10.3390/ijms140510355; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Zhang XY, 2008, INVEST OPHTH VIS SCI, V49, P3622, DOI 10.1167/iovs.07-1559; Zheng QY, 2012, BIOCH BIOPHYS RES CO; Zhu D, 2009, J CELL BIOCHEM, V108, P117, DOI 10.1002/jcb.22233; Zong Y, 2012, CURR MED CHEM, V19, P770, DOI 10.2174/092986712798992066	62	256	266	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84171	10.1371/journal.pone.0084171	http://dx.doi.org/10.1371/journal.pone.0084171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	281RE	23874530	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900080
